PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Francis, VA; Abera, AB; Matjila, M; Millar, RP; Katz, AA				Francis, Victor A.; Abera, Aron B.; Matjila, Mushi; Millar, Robert P.; Katz, Arieh A.			Kisspeptin Regulation of Genes Involved in Cell Invasion and Angiogenesis in First Trimester Human Trophoblast Cells	PLOS ONE			English	Article							EXPRESSION; METASTASIS; MIGRATION; PREECLAMPSIA; PLACENTA; RECEPTOR; KISS-1; METALLOPROTEINASES; INHIBITOR; PREGNANCY	The precise regulation of extravillous trophoblast invasion of the uterine wall is a key process in successful pregnancies. Kisspeptin (KP) has been shown to inhibit cancer cell metastasis and placental trophoblast cell migration. In this study primary cultures of first trimester human trophoblast cells have been utilized in order to study the regulation of invasion and angiogenesis-related genes by KP. Trophoblast cells were isolated from first trimester placenta and their identity was confirmed by immunostaining for cytokeratin-7. Real-time quantitative RT-PCR demonstrated that primary trophoblast cells express higher levels of GPR54 (KP receptor) and KP mRNA than the trophoblast cell line HTR8Svneo. Furthermore, trophoblast cells also expressed higher GPR54 and KP protein levels. Treating primary trophoblast cells with KP induced ERK1/2 phosphorylation, while co-treating the cells with a KP antagonist almost completely blocked the activation of ERK1/2 and demonstrated that KP through its cognate GPR54 receptor can activate ERK1/2 in trophoblast cells. KP reduced the migratory capability of trophoblast cells in a scratch-migration assay. Real-time quantitative RT-PCR demonstrated that KP treatment reduced the expression of matrix metalloproteinase 1, 2, 3, 7, 9, 10, 14 and VEGF-A, and increased the expression of tissue inhibitors of metalloproteinases 1 and 3. These results suggest that KP can inhibit first trimester trophoblast cells invasion via inhibition of cell migration and down regulation of the metalloproteinase system and VEGF-A.	[Francis, Victor A.; Abera, Aron B.; Matjila, Mushi; Millar, Robert P.; Katz, Arieh A.] Univ Cape Town, Fac Hlth Sci, MRC UCT Receptor Biol Unit, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Francis, Victor A.; Abera, Aron B.; Matjila, Mushi; Millar, Robert P.; Katz, Arieh A.] Univ Cape Town, Fac Hlth Sci, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Matjila, Mushi] Univ Cape Town, Fac Hlth Sci, Groote Schuur Hosp, Dept Obstet & Gynaecol, ZA-7925 Cape Town, South Africa; [Millar, Robert P.] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Millar, Robert P.] Univ Edinburgh, Ctr Integrated Physiol, Edinburgh, Midlothian, Scotland	University of Cape Town; University of Cape Town; University of Cape Town; University of Pretoria; University of Edinburgh	Katz, AA (corresponding author), Univ Cape Town, Fac Hlth Sci, MRC UCT Receptor Biol Unit, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	arieh.katz@uct.ac.za		Millar, Robert P/0000-0003-3606-2708	South African MRC; University of Cape Town	South African MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town	This work was supported by research grants from the South African MRC and the University of Cape Town to AAK and RPM. VAF is a Claude Leon Foundation postdoctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Burton GJ, 2009, REPRODUCTION, V138, P895, DOI 10.1530/REP-09-0092; Cartwright JE, 2012, J ENDOCRINOL, V214, P79, DOI 10.1530/JOE-12-0091; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; IRVING JA, 1995, EXP CELL RES, V217, P419, DOI 10.1006/excr.1995.1105; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Karmakar S, 2002, AM J REPROD IMMUNOL, V48, P210, DOI 10.1034/j.1600-0897.2002.01151.x; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Lian IA, 2010, PLACENTA, V31, P615, DOI 10.1016/j.placenta.2010.04.003; Luo JY, 2011, J HUAZHONG U SCI-MED, V31, P241, DOI 10.1007/s11596-011-0260-3; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Park DW, 2012, AM J REPROD IMMUNOL, V67, P132, DOI 10.1111/j.1600-0897.2011.01073.x; PIJNENBORG R, 1983, PLACENTA, V4, P397, DOI 10.1016/S0143-4004(83)80043-5; Reister F, 2006, J PERINAT MED, V34, P272, DOI 10.1515/JPM.2006.052; Roseweir AK, 2012, PLACENTA, V33, P408, DOI 10.1016/j.placenta.2012.02.001; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Sonderegger S, 2010, ENDOCRINOLOGY, V151, P211, DOI 10.1210/en.2009-0557; Stafford LJ, 2002, CANCER RES, V62, P5399; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; Tseng JJ, 2006, PLACENTA, V27, P70, DOI 10.1016/j.placenta.2004.12.011; Wu SH, 2014, PATHOL RES PRACT, V210, P47, DOI 10.1016/j.prp.2013.09.017; Wu X, 2005, J IMMUNOL, V175, P61, DOI 10.4049/jimmunol.175.1.61; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316	36	41	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99680	10.1371/journal.pone.0099680	http://dx.doi.org/10.1371/journal.pone.0099680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923321	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300085
J	Helyar, SJ; Lloyd, HA; de Bruyn, M; Leake, J; Bennett, N; Carvalho, GR				Helyar, Sarah J.; Lloyd, Hywel ap D.; de Bruyn, Mark; Leake, Jonathan; Bennett, Niall; Carvalho, Gary R.			Fish Product Mislabelling: Failings of Traceability in the Production Chain and Implications for Illegal, Unreported and Unregulated (IUU) Fishing	PLOS ONE			English	Article							BIOGEOGRAPHIC ORIGINS; BARCODING REVEALS; DNA; IDENTIFICATION; SUBSTITUTION; FISHERIES; TAXONOMY; TOOLS	Increasing consumer demand for seafood, combined with concern over the health of our oceans, has led to many initiatives aimed at tackling destructive fishing practices and promoting the sustainability of fisheries. An important global threat to sustainable fisheries is Illegal, Unreported and Unregulated (IUU) fishing, and there is now an increased emphasis on the use of trade measures to prevent IUU-sourced fish and fish products from entering the international market. Initiatives encompass new legislation in the European Union requiring the inclusion of species names on catch labels throughout the distribution chain. Such certification measures do not, however, guarantee accuracy of species designation. Using two DNA-based methods to compare species descriptions with molecular ID, we examined 386 samples of white fish, or products labelled as primarily containing white fish, from major UK supermarket chains. Species specific real-time PCR probes were used for cod (Gadus morhua) and haddock (Melanogrammus aeglefinus) to provide a highly sensitive and species-specific test for the major species of white fish sold in the UK. Additionally, fish-specific primers were used to sequence the forensically validated barcoding gene, mitochondrial cytochrome oxidase I (COI). Overall levels of congruence between product label and genetic species identification were high, with 94.34% of samples correctly labelled, though a significant proportion in terms of potential volume, were mislabelled. Substitution was usually for a cheaper alternative and, in one case, extended to a tropical species. To our knowledge, this is the first published study encompassing a large-scale assessment of UK retailers, and if representative, indicates a potentially significant incidence of incorrect product designation.	[Helyar, Sarah J.; Lloyd, Hywel ap D.; de Bruyn, Mark; Carvalho, Gary R.] Bangor Univ, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales; [Leake, Jonathan] Sunday Times, London, England; [Bennett, Niall] Greenpeace UK, London, England	Bangor University	Helyar, SJ (corresponding author), Matis, Food Safety Environm & Genet, Reykjavik, Iceland.	sarah.helyar@matis.is	de Bruyn, Mark/C-5568-2008; Helyar, Sarah/C-4988-2013	de Bruyn, Mark/0000-0003-1528-9604; Helyar, Sarah/0000-0002-1600-997X	Greenpeace; Sunday Times	Greenpeace; Sunday Times	This study was jointly funded by Greenpeace and The Sunday Times. The funder Greenpeace provided support in the form of salary for author NB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder The Sunday Times provided support in the form of salary for author JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; [Anonymous], 2000, OFFICIAL J EUROPEA L, VL17, P22; Ardura A, 2010, FOOD RES INT, V43, P1549, DOI 10.1016/j.foodres.2010.03.016; Armani A, 2011, FOOD CONTROL, V22, P888, DOI 10.1016/j.foodcont.2010.11.020; Barbuto M, 2010, FOOD RES INT, V43, P376, DOI 10.1016/j.foodres.2009.10.009; Butterworth DS, 2005, B MAR SCI, V76, P287; Byrkjedal I, 2008, J FISH BIOL, V73, P1183, DOI 10.1111/j.1095-8649.2008.01958.x; Carr SM, 1999, CAN J ZOOL, V77, P19, DOI 10.1139/cjz-77-1-19; Carr SM, 2008, MITOCHONDR DNA, V19, P490, DOI 10.1080/19401730802570942; Cawthorn DM, 2012, FOOD RES INT, V46, P30, DOI 10.1016/j.foodres.2011.11.011; Coulson MW, 2006, GENOME, V49, P1115, DOI 10.1139/G06-083; Crego-Prieto Victor, 2010, P315; Dawnay N, 2007, FORENSIC SCI INT, V173, P1, DOI 10.1016/j.forsciint.2006.09.013; EC (European Commission), 2001, OFFICIAL J EUROPEA L, V278, P6; FAO, 1990, FAO FISH SYN S125, V10; FAO, 2009, GUID EC FISH FISH PR; *FAO, 2012, SPEC FACT SHEET; FAO, 2012, STAT WORLDS FISH AQ; FAO, 2011, STAT WORLDS FISH AQ; FAO (Food and Agriculture Organization), 2001, INT PLAN ACT PREV DE; Ferrantelli V, 2012, FOOD ADDIT CONTAM A, V29, P1046, DOI 10.1080/19440049.2012.675595; Filonzi L, 2010, FOOD RES INT, V43, P1383, DOI 10.1016/j.foodres.2010.04.016; FishPop Trace Consortium, 2012, Nature Communications, V3, P1, DOI 10.1038/ncomms1845; Food and Agriculture Organization (FAO), 2004, FISH AQ COUNTR PROF; Glover KA, 2012, FISH FISH, V13, P313, DOI 10.1111/j.1467-2979.2011.00447.x; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Gold JR, 2011, BIOL J LINN SOC, V102, P915, DOI 10.1111/j.1095-8312.2011.01621.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Huxley-Jones E, 2012, CONSERV BIOL, V26, P367, DOI 10.1111/j.1523-1739.2011.01813.x; Iglesias SP, 2010, AQUAT CONSERV, V20, P319, DOI 10.1002/aqc.1083; Johnsen E, 2012, AFR J MAR SCI, V34, P43, DOI 10.2989/1814232X.2012.673274; Logan CA, 2008, BIOL CONSERV, V141, P1591, DOI 10.1016/j.biocon.2008.04.007; Marko PB, 2004, NATURE, V430, P309, DOI 10.1038/430309b; Miller DD, 2010, FRONT ECOL ENVIRON, V8, P517, DOI 10.1890/090212; MRAG, 2008, GLOB EXT ILL FISH; Ogden R, 2008, FISH FISH, V9, P462, DOI 10.1111/j.1467-2979.2008.00305.x; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pepe T, 2007, J AGR FOOD CHEM, V55, P3681, DOI 10.1021/jf063321o; Potts T, 2011, 270211 SAMS; Rademeyer RA, 2008, AFR J MAR SCI, V30, P263, DOI 10.2989/AJMS.2008.30.2.7.557; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Stokstad E, 2010, SCIENCE, V330, P1468, DOI 10.1126/science.330.6010.1468; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor MI, 2002, MOL ECOL NOTES, V2, P599, DOI 10.1046/j.1471-8286.2002.00269.x; Ursvik A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-86; von der Heyden S, 2010, ICES J MAR SCI, V67, P176, DOI 10.1093/icesjms/fsp222; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2007, MOL ECOL NOTES, V7, P899, DOI 10.1111/j.1471-8286.2007.01886.x; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; WSSD, 2002, ACONF19920 WSSD	51	103	108	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98691	10.1371/journal.pone.0098691	http://dx.doi.org/10.1371/journal.pone.0098691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921655	gold, Green Published, Green Submitted			2022-12-25	WOS:000338701300012
J	Schluter, EW; Mitz, AR; Cheer, JF; Averbeck, BB				Schluter, Erik W.; Mitz, Andrew R.; Cheer, Joseph F.; Averbeck, Bruno B.			Real-Time Dopamine Measurement in Awake Monkeys	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; PREMOTOR CORTEX; REWARD; RELEASE; VOLTAMMETRY; NEURONS; STIMULATION; PREDICTION; STRIATUM; DELIVERY	Fast-scan cyclic voltammetry (FSCV) is often used to measure real-time dopamine (DA) concentrations in awake, behaving rodents. Extending this technique to work in monkeys would provide a platform for advanced behavioral studies and a primate model for preclinical research. The present study demonstrates the feasibility of DA recordings in two awake monkeys (Macaca mulatta) using a mixture of techniques adapted from rodent, primate and brain slice work. We developed a long carbon fiber electrode to operate in the larger primate brain. This electrode was lowered into the striatum each day using a recording chamber and a detachable micromanipulator system. A manipulator also moved one or more tungsten stimulating electrodes into either the nearby striatum or the ventral tegmental area/substantia nigra pars compacta (VTA/SNc). We developed an electrical stimulation controller to reduce artifacts during electrical stimulation. We also introduce a stimulation-based methodology for estimating distances between electrodes in the brain. Dopamine responses within the striatum were evoked by either stimulation of the striatum near the FSCV electrode, or stimulation within the VTA/SNc. Unexpected juice rewards also evoked dopamine responses in the ventral striatum. Thus, we demonstrate that robust dopamine responses can be recorded from awake, behaving primates with FSCV. In addition, we describe how a stimulation technique borrowed from the neuroprosthetics field can activate the distributed monkey midbrain dopamine system in a way that mimics rodent VTA stimulation.	[Schluter, Erik W.; Mitz, Andrew R.; Averbeck, Bruno B.] NIMH, Neuropsychol Lab, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Cheer, Joseph F.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University System of Maryland; University of Maryland Baltimore	Averbeck, BB (corresponding author), NIMH, Neuropsychol Lab, Div Intramural Res, NIH, Bldg 9, Bethesda, MD 20892 USA.	bruno.averbeck@nih.gov	Cheer, Joseph F/J-6102-2014	Cheer, Joseph F/0000-0001-5086-7559; , Andrew/0000-0002-8045-0970	US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002928] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Intramural Research Program of the US National Institute of Mental Health (http://www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apawu AK, 2013, ACS CHEM NEUROSCI, V4, P895, DOI 10.1021/cn4000742; Ariansen JL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00036; Brown HD, 2011, EUR J NEUROSCI, V34, P1997, DOI 10.1111/j.1460-9568.2011.07914.x; Cheer JF, 2007, NEURON, V54, P237, DOI 10.1016/j.neuron.2007.03.021; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Dahlstroem A., 1964, ACTA PHYSL SCAND S, V232, P231; DOMESICK VB, 1988, ANN NY ACAD SCI, V537, P10, DOI 10.1111/j.1749-6632.1988.tb42094.x; Fuxe K, 2010, PROG NEUROBIOL, V90, P82, DOI 10.1016/j.pneurobio.2009.10.012; Garris PA, 1997, J NEUROCHEM, V68, P152; GHOSH S, 1988, J PHYSIOL-LONDON, V400, P617, DOI 10.1113/jphysiol.1988.sp017139; GIBSON AR, 1985, J PHYSIOL-LONDON, V358, P527, DOI 10.1113/jphysiol.1985.sp015565; Giompres P, 2005, CEREBELLUM, V4, P105, DOI 10.1080/14734220510007851; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; GODSCHALK M, 1995, NEUROSCI RES, V23, P269, DOI 10.1016/0168-0102(95)00950-7; Haber SN, 2000, J NEUROSCI, V20, P2369; Hashemi P, 2009, ANAL CHEM, V81, P9462, DOI 10.1021/ac9018846; Heien MLAV, 2003, ANALYST, V128, P1413, DOI 10.1039/b307024g; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; IKAI Y, 1992, NEUROSCIENCE, V51, P719, DOI 10.1016/0306-4522(92)90310-X; Iravani MM, 1996, NEUROSCIENCE, V70, P1025, DOI 10.1016/0306-4522(95)00396-7; JONES SR, 1994, J NEUROSCI METH, V52, P1, DOI 10.1016/0165-0270(94)90048-5; KAWAGOE KT, 1994, TALANTA, V41, P865, DOI 10.1016/0039-9140(94)E0064-X; Kishida KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023291; Kume-Kick J, 1998, J NEUROSCI METH, V84, P55, DOI 10.1016/S0165-0270(98)00087-9; Lee KH, 2011, IEEE ENG MED BIO, P677, DOI 10.1109/IEMBS.2011.6090152; McIntyre CC, 2001, ANN BIOMED ENG, V29, P227, DOI 10.1114/1.1352640; MITZ AR, 1987, J NEUROSCI, V7, P1010; Mitz AR, 2005, J NEUROSCI METH, V148, P19, DOI 10.1016/j.jneumeth.2005.07.012; MITZ AR, 1991, J NEUROSCI, V11, P1855; OLDS ME, 1981, ANNU REV PSYCHOL, V32, P523, DOI 10.1146/annurev.ps.32.020181.002515; Panin F, 2012, J PHARMACOL TOX MET, V65, P83, DOI 10.1016/j.vascn.2012.01.003; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Roberts JG, 2010, LANGMUIR, V26, P9116, DOI 10.1021/la9048924; Robinson DL, 2003, CLIN CHEM, V49, P1763, DOI 10.1373/49.10.1763; Robinson DL, 2007, FRONT NEUROENG, V1, P17; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Saleem KS, 2012, COMBINED MRI HISTOLO; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shon YM, 2010, NEUROSCI LETT, V475, P136, DOI 10.1016/j.neulet.2010.03.060; Silva L, 2012, ANAL METHODS-UK, V4, P2300, DOI 10.1039/c2ay25076d; STAMFORD JA, 1986, J NEUROSCI METH, V17, P1, DOI 10.1016/0165-0270(86)90031-2; Swiergiel AH, 1997, J NEUROSCI METH, V73, P29, DOI 10.1016/S0165-0270(96)02207-8; Thompson JL, 2012, MOL PSYCHIAT; Van Gompel JJ, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS10110; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; Wise RA, 2005, J COMP NEUROL, V493, P115, DOI 10.1002/cne.20689; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Zen JM, 2004, ANAL CHEM, V76, P4251, DOI 10.1021/ac0495135; Zhang TC, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066009	50	25	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98692	10.1371/journal.pone.0098692	http://dx.doi.org/10.1371/journal.pone.0098692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921937	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300013
J	Forsyth, DM; Woodford, L; Moloney, PD; Hampton, JO; Woolnough, AP; Tucker, M				Forsyth, David M.; Woodford, Luke; Moloney, Paul D.; Hampton, Jordan O.; Woolnough, Andrew P.; Tucker, Mark			How Does a Carnivore Guild Utilise a Substantial but Unpredictable Anthropogenic Food Source? Scavenging on Hunter-Shot Ungulate Carcasses by Wild Dogs/Dingoes, Red Foxes and Feral Cats in South-Eastern Australia Revealed by Camera Traps	PLOS ONE			English	Article							MESOPREDATOR RELEASE; FEEDING ECOLOGY; VULPES-VULPES; DINGO; MANAGEMENT; PREY; COMPETITION; ABUNDANCE; DEER; DOGS	There is much interest in understanding how anthropogenic food resources subsidise carnivore populations. Carcasses of hunter-shot ungulates are a potentially substantial food source for mammalian carnivores. The sambar deer (Rusa unicolor) is a large (>= 150 kg) exotic ungulate that can be hunted throughout the year in south-eastern Australia, and hunters are not required to remove or bury carcasses. We investigated how wild dogs/dingoes and their hybrids (Canis lupus familiaris/dingo), red foxes (Vulpes vulpes) and feral cats (Felis catus) utilised sambar deer carcasses during the peak hunting seasons (i.e. winter and spring). We placed carcasses at 1-km intervals along each of six transects that extended 4-km into forest from farm boundaries. Visits to carcasses were monitored using camera traps, and the rate of change in edible biomass estimated at,14-day intervals. Wild dogs and foxes fed on 70% and 60% of 30 carcasses, respectively, but feral cats seldom (10%) fed on carcasses. Spatial and temporal patterns of visits to carcasses were consistent with the hypothesis that foxes avoid wild dogs. Wild dog activity peaked at carcasses 2 and 3 km from farms, a likely legacy of wild dog control, whereas fox activity peaked at carcasses 0 and 4 km from farms. Wild dog activity peaked at dawn and dusk, whereas nearly all fox activity occurred after dusk and before dawn. Neither wild dogs nor foxes remained at carcasses for long periods and the amount of feeding activity by either species was a less important predictor of the loss of edible biomass than season. Reasons for the low impacts of wild dogs and foxes on sambar deer carcass biomass include the spatially and temporally unpredictable distribution of carcasses in the landscape, the rapid rate of edible biomass decomposition in warm periods, low wild dog densities and the availability of alternative food resources.	[Forsyth, David M.; Woodford, Luke; Moloney, Paul D.] Dept Environm & Primary Ind, Arthur Rylah Inst Environm Res, Heidelberg, Vic, Australia; [Hampton, Jordan O.] Ecotone Wildlife Vet Serv, Canberra, ACT, Australia; [Woolnough, Andrew P.] Dept Environm & Primary Ind, Biosecur Div, Invas Plants & Anim Branch, Melbourne, Vic, Australia; [Tucker, Mark] Melbourne Water, Reefton, Vic, Australia	Arthur Rylah Institute for Environmental Research (ARI)	Forsyth, DM (corresponding author), Dept Environm & Primary Ind, Arthur Rylah Inst Environm Res, Heidelberg, Vic, Australia.	dave.forsyth@depi.vic.gov.au	Hampton, Jordan/AAV-7736-2020	Hampton, Jordan/0000-0003-0472-3241; Forsyth, David/0000-0001-5356-9573; Woolnough, Andrew/0000-0002-6369-0294; Moloney, Paul/0000-0002-5010-214X	Victorian Department of Environment and Primary Industries	Victorian Department of Environment and Primary Industries	The work presented was funded by the Victorian Department of Environment and Primary Industries (www.depi.vic.gov.au). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than in the form of four of the authors being employees within the organisation.	Allison PD., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; Apollonio M., 2010, EUROPEAN UNGULATES T; Armstrong K.N., 2008, MAMMALS AUSTR, P470; Bentley A., 1998, INTRO DEER AUSTR SPE; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Brawata RL, 2011, WILDLIFE RES, V38, P426, DOI 10.1071/WR10169; Bridges AS, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P57, DOI 10.1007/978-4-431-99495-4_5; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Claridge AW, 2009, FOREST ECOL MANAG, V258, P814, DOI 10.1016/j.foreco.2009.05.030; Coe M., 1978, Journal of Arid Environments, V1, P71; Colman NJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3094; Congdon P. D, 2010, APPL BAYESIAN HIERAR, V1st; Corbett L. K., 1995, DINGO AUSTR ASIA; Cortes-Avizanda A, 2009, BASIC APPL ECOL, V10, P265, DOI 10.1016/j.baae.2008.03.009; Creel S, 2001, CONSERV BIOL SER, V5, P35; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Department of Primary Industries, 2013, VICT HUNT GUID 2013; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Dickman C., 1996, OVERVIEW IMPACTS FER; DICKMAN CR, 1992, TRENDS ECOL EVOL, V7, P194, DOI 10.1016/0169-5347(92)90072-J; Doncaster CP, 1997, J ZOOL, V241, P73, DOI 10.1111/j.1469-7998.1997.tb05500.x; Downes M, 1983, FOREST DEER PROJECT, VII; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; Forsyth DM, 2011, J WILDLIFE MANAGE, V75, P1488, DOI 10.1002/jwmg.179; Forsyth DM, 2009, WILDLIFE RES, V36, P231, DOI 10.1071/WR08075; FRUMP R. R., 2006, MAN EATERS EDEN LIFE; GALLOWAY A, 1989, J FORENSIC SCI, V34, P607; Gelman A., 2004, BAYESIAN DATA ANAL; Glen AS, 2007, AUSTRAL ECOL, V32, P492, DOI 10.1111/j.1442-9993.2007.01721.x; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Gormley AM, 2010, A RYLAH I ENV RES TE, V210; Gormley AM, 2009, A RYLAH I ENV RES TE, V196; Gormley AM, 2011, A RYLAH I ENV RES TE, V224; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Green GI, 1997, J WILDLIFE MANAGE, V61, P1040, DOI 10.2307/3802101; HARDEN RH, 1985, AUST WILDLIFE RES, V12, P25; HENRY JD, 1977, BEHAVIOUR, V61, P82, DOI 10.1163/156853977X00496; Hunter JS, 2007, BEHAV ECOL SOCIOBIOL, V61, P1033, DOI 10.1007/s00265-006-0336-4; Johnson CN, 2009, J APPL ECOL, V46, P641, DOI 10.1111/j.1365-2664.2009.01650.x; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Kennedy M, 2012, AUSTRAL ECOL, V37, P134, DOI 10.1111/j.1442-9993.2011.02256.x; Lazenby BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059846; Leslie David M. Jr., 2011, Mammalian Species, P1, DOI 10.1644/871.1; Letnic M, 2013, OIKOS, V122, P761, DOI 10.1111/j.1600-0706.2012.20425.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Lunn D., 2012, BUGS BOOK PRACTICAL; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Menkhorst P., 1995, MAMMALS VICTORIA DIS; Mitchell BD, 2005, AUSTRAL ECOL, V30, P581, DOI 10.1111/j.1442-9993.2005.01473.x; Mittermeier R. A, 2011, HDB MAMMALS WORLD, P350; Moloney PD, 2013, A RYLAH I ENV RES TE, V251; Moloney PD, 2012, A RYLAH I ENV RES TE, V239; Morehouse AT, 2011, FRONT ECOL ENVIRON, V9, P440, DOI 10.1890/100172; Moriarty A, 2004, WILDLIFE RES, V31, P291, DOI 10.1071/WR02100; Moseby Katherine E., 2012, International Journal of Ecology, P1; Muhly TB, 2009, ECOL ECON, V68, P2439, DOI 10.1016/j.ecolecon.2009.04.008; NEWSOME AE, 1983, AUST WILDLIFE RES, V10, P477; NEWSOME AE, 1983, AUST J ECOL, V8, P345, DOI 10.1111/j.1442-9993.1983.tb01332.x; Newsome TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063931; Newsome TM, 2013, ECOGRAPHY, V36, P914, DOI 10.1111/j.1600-0587.2013.00056.x; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; PAQUET PC, 1992, J MAMMAL, V73, P337, DOI 10.2307/1382067; Peterson Rolf O., 2003, P104; Pierce BM, 2000, ECOLOGY, V81, P1533; Plummer M., 2003, P 3 INT WORKSH DISTR; Pople AR, 2000, WILDLIFE RES, V27, P269, DOI 10.1071/WR99030; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Read JL, 2004, WILDLIFE RES, V31, P51, DOI 10.1071/WR02051; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; ROBERTSHAW JD, 1986, AUST WILDLIFE RES, V13, P141, DOI 10.1071/WR9860141; Robley Alan, 2010, Australian Mammalogy, V32, P23, DOI 10.1071/AM09030; Saunders G, 1995, MANAGING VERTEBRATE, P141; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Selva N, 2007, P ROY SOC B-BIOL SCI, V274, P1101, DOI 10.1098/rspb.2006.0232; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; Thomson P., 2001, MANAGING IMPACT DING; Towerton AL, 2011, WILDLIFE RES, V38, P208, DOI 10.1071/WR10213; Victoria Government, 2013, VICTORIA GOVT G 0926; Wallach AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006861; Wang YW, 2012, WILDLIFE RES, V39, P611, DOI 10.1071/WR11210; Welton NJ, 2005, MED DECIS MAKING, V25, P633, DOI 10.1177/0272989X05282637; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yirga G, 2012, J ANIM ECOL, V81, P1052, DOI 10.1111/j.1365-2656.2012.01977.x	88	36	39	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e97937	10.1371/journal.pone.0097937	http://dx.doi.org/10.1371/journal.pone.0097937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918425	Green Published, gold			2022-12-25	WOS:000338631000011
J	Lv, T; Gong, HQ; Liang, PJ				Lv, Ting; Gong, Hai-Qing; Liang, Pei-Ji			Caffeine-Induced Ca2+ Oscillations in Type I Horizontal Cells of the Carp Retina and the Contribution of the Store-Operated Ca2+ Entry Pathway	PLOS ONE			English	Article							CAPACITATIVE CALCIUM-ENTRY; GAP-JUNCTION CHANNELS; ENDOPLASMIC-RETICULUM; INTRACELLULAR CALCIUM; GLUTAMATE RECEPTORS; CRAC CHANNEL; RELEASE; MODULATION; INHIBITION; RYANODINE	The mechanisms of release, depletion, and refilling of endoplasmic reticulum (ER) Ca2+ were investigated in type I horizontal cells of the carp retina using a fluo-3-based Ca2+ imaging technique. Exogenous application of caffeine, a ryanodine receptor agonist, induced oscillatory intracellular free Ca2+ concentration ([Ca2+](i)) responses in a duration-and concentration-dependent manner. In Ca2+-free Ringer's solution [Ca2+](i) transients could also be induced by a brief caffeine application, whereas subsequent caffeine application induced no [Ca2+](i) increase, which implied that extracellular Ca2+ was required for ER refilling, confirming the necessity of a Ca2+ influx pathway for ER refilling. Depletion of ER Ca2+ by thapsigargin triggered a Ca2+ influx which could be blocked by the store-operated channel inhibitor 2-APB, which proved he existence of the store-operated Ca2+ entry pathway. Taken together, these results suggested that after being depleted caffeine he ER was replenished by Ca2+ influx via store-operated channels. These results reveal the fine modulation of ling, and the activation of the store-operated Ca2+ entry pathway guarantees the replenishment of the ER so can be ready for response to the subsequent stimulus.	[Lv, Ting; Gong, Hai-Qing; Liang, Pei-Ji] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liang, PJ (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	pjliang@sjtu.edu.cn			National Natural Science Foundation of China [30870836]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30870836, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian A, 1997, BRAIN RES, V762, P121, DOI 10.1016/S0006-8993(97)00374-0; Bai DL, 2006, J PHARMACOL EXP THER, V319, P1452, DOI 10.1124/jpet.106.112045; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; BYRNE NG, 1988, J PHYSIOL-LONDON, V404, P557, DOI 10.1113/jphysiol.1988.sp017306; Carrasco S, 2010, NAT CELL BIOL, V12, P416, DOI 10.1038/ncb0510-416; CURRIE KPM, 1992, BRIT J PHARMACOL, V106, P593, DOI 10.1111/j.1476-5381.1992.tb14381.x; Daher JPL, 2009, MOL CELL BIOCHEM, V327, P15, DOI 10.1007/s11010-009-0036-2; DEVRIES SH, 1992, J PHYSIOL-LONDON, V445, P201, DOI 10.1113/jphysiol.1992.sp018920; Elliott AC, 2001, CELL CALCIUM, V30, P73, DOI 10.1054/ceca.2001.0215; FABIATO A, 1977, CIRC RES, V40, P119, DOI 10.1161/01.RES.40.2.119; FLOCKERZI V, 2007, TRANSIENT RECEPTOR P; FRIEL DD, 1995, BIOPHYS J, V68, P1752, DOI 10.1016/S0006-3495(95)80352-8; Hayashida Y, 1998, NEUROSCI RES, V31, P189, DOI 10.1016/S0168-0102(98)00037-6; Hayashida Y, 2002, J NEUROPHYSIOL, V87, P172, DOI 10.1152/jn.00778.2000; Hong J, 2012, STORE OPERATED CA2 E, P57; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Huang Shi-Yong, 2006, Shengli Xuebao, V58, P407; Huang SY, 2005, NEUROREPORT, V16, P263, DOI 10.1097/00001756-200502280-00012; Huang SY, 2004, NEUROREPORT, V15, P2311, DOI 10.1097/00001756-200410250-00002; JENDEN DJ, 1969, PHARMACOL REV, V21, P1; Jiang XD, 2008, BRAIN RES, V1240, P105, DOI 10.1016/j.brainres.2008.08.094; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; Kass GEN, 1999, ENVIRON HEALTH PERSP, V107, P25, DOI 10.2307/3434469; Klaassen LJ, 2012, BRAIN RES, V1487, P25, DOI 10.1016/j.brainres.2012.04.059; Kreitzer MA, 2003, J PHYSIOL-LONDON, V546, P717, DOI 10.1113/jphysiol.2002.034421; Linn CL, 2001, J PHYSIOL-LONDON, V535, P47, DOI 10.1111/j.1469-7793.2001.00047.x; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lu T, 1994, CHINESE J NEUROANATO, V11, P299; MALCHOW RP, 1993, J NEUROSCI RES, V35, P237, DOI 10.1002/jnr.490350303; Manjarres IM, 2011, CELL CALCIUM, V49, P153, DOI 10.1016/j.ceca.2011.01.007; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; MARRION NV, 1992, J PHYSIOL-LONDON, V445, P515, DOI 10.1113/jphysiol.1992.sp018937; McMahon DG, 1996, BRAIN RES, V718, P89, DOI 10.1016/0006-8993(96)00043-1; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Mignen O, 2005, J CELL SCI, V118, P5615, DOI 10.1242/jcs.02663; Morton-Jones RT, 2008, CELL CALCIUM, V43, P356, DOI 10.1016/j.ceca.2007.07.003; NEERING IR, 1984, NATURE, V309, P158, DOI 10.1038/309158a0; NOHMI M, 1992, J PHYSIOL-LONDON, V450, P513, DOI 10.1113/jphysiol.1992.sp019140; NORMANN RA, 1976, J PHYSIOL-LONDON, V261, P15, DOI 10.1113/jphysiol.1976.sp011546; Okada T, 1999, EUR J NEUROSCI, V11, P1085, DOI 10.1046/j.1460-9568.1999.00516.x; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Porta M, 2011, BIOPHYS J, V100, P931, DOI 10.1016/j.bpj.2011.01.017; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 2003, CELL CALCIUM, V34, P339, DOI 10.1016/S0143-4160(03)00143-X; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schoppe J, 1997, CELL CALCIUM, V22, P385, DOI 10.1016/S0143-4160(97)90023-3; Shen Y, 2006, NEUROSIGNALS, V15, P174, DOI 10.1159/000096350; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Sun Z, 2012, J NEUROPHYSIOL, V107, P2624, DOI 10.1152/jn.01126.2011; Sun Z, 2009, J NEUROPHYSIOL, V101, P1774, DOI 10.1152/jn.90581.2008; Sutko JL, 1997, PHARMACOL REV, V49, P53; TACHIBANA M, 1981, J PHYSIOL-LONDON, V321, P141, DOI 10.1113/jphysiol.1981.sp013976; TACHIBANA M, 1983, J PHYSIOL-LONDON, V345, P329, DOI 10.1113/jphysiol.1983.sp014981; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; Alonso MT, 2012, MOL CELL ENDOCRINOL, V353, P37, DOI 10.1016/j.mce.2011.08.021; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Thomas NL, 2012, WILEY INTERDISCIP RE, V1, P383, DOI DOI 10.1002/WMTS.34; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Verkhratsky A, 2002, CELL CALCIUM, V32, P393, DOI 10.1016/S0143416002001896; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; WALZ B, 1995, J GEN PHYSIOL, V105, P537, DOI 10.1085/jgp.105.4.537; Wang XL, 2008, NEUROREPORT, V19, P675, DOI 10.1097/WNR.0b013e3282fb7902; Weiler R, 1996, VISION RES, V36, P3891, DOI 10.1016/S0042-6989(96)00148-4; Wu D, 1999, NEUROREPORT, V10, P3897, DOI 10.1097/00001756-199912160-00032; YAGI T, 1988, J NEUROPHYSIOL, V59, P482, DOI 10.1152/jn.1988.59.2.482; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang DQ, 2001, MOL VIS, V7, P247; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	78	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e100095	10.1371/journal.pone.0100095	http://dx.doi.org/10.1371/journal.pone.0100095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918937	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000128
J	Neuman, M; Kawachi, I; Gortmaker, S; Subramanian, SV				Neuman, Melissa; Kawachi, Ichiro; Gortmaker, Steven; Subramanian, S. V.			National Economic Development and Disparities in Body Mass Index: A Cross-Sectional Study of Data from 38 Countries	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; NUTRITION TRANSITION; SOCIOECONOMIC-STATUS; NORMAL-WEIGHT; OBESITY; OVERWEIGHT; HEALTH; TRENDS; WOMEN; WORLD	Background: Increases in body mass index (BMI) and the prevalence of overweight in low- and middle income countries (LMICs) are often ascribed to changes in global trade patterns or increases in national income. These changes are likely to affect populations within LMICs differently based on their place of residence or socioeconomic status (SES). Objective: Using nationally representative survey data from 38 countries and national economic indicators from the World Bank and other international organizations, we estimated ecological and multilevel models to assess the association between national levels of gross domestic product (GDP), foreign direct investment (FDI), and mean tariffs and BMI. Design: We used linear regression to estimate the ecological association between average annual change in economic indicators and BMI, and multilevel linear or ordered multinomial models to estimate associations between national economic indicators and individual BMI or over- and underweight. We also included cross-level interaction terms to highlight differences in the association of BMI with national economic indicators by type of residence or socioeconomic status (SES). Results: There was a positive but non-significant association of GDP and mean BMI. This positive association of GDP and BMI was greater among rural residents and the poor. There were no significant ecological associations between measures of trade openness and mean BMI, but FDI was positively associated with BMI among the poorest respondents and in rural areas and tariff levels were negatively associated with BMI among poor and rural respondents. Conclusion: Measures of national income and trade openness have different associations with the BMI across populations within developing countries. These divergent findings underscore the complexity of the effects of development on health and the importance of considering how the health effects of "globalizing" economic and cultural trends are modified by individual-level wealth and residence.	[Neuman, Melissa; Kawachi, Ichiro; Gortmaker, Steven; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Neuman, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	m.neuman@ucl.ac.uk		Neuman, Melissa/0000-0002-8870-6504	National Institutes of Health Career Development Award [NHLBI K25 HL081275]; Robert Wood Johnson Investigator Award in Health Policy Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Investigator Award in Health Policy Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S V Subramanian is supported by the National Institutes of Health Career Development Award (NHLBI K25 HL081275) and the Robert Wood Johnson Investigator Award in Health Policy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsi-Selmi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039507; [Anonymous], SAMPL MAN; [Anonymous], 2008, DEMOGRAPHIC HLTH RES; [Anonymous], MEASURING INTERPRETI; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Dearth-Wesley T, 2008, EUR J CLIN NUTR, V62, P1302, DOI 10.1038/sj.ejcn.1602853; Dickson G., 2005, International Journal of Sport Management and Marketing, V1, P169, DOI 10.1504/IJSMM.2005.007128; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Egger G, 2012, ECON HUM BIOL, V10, P147, DOI 10.1016/j.ehb.2012.01.002; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; FAO, 2004, C DAT QUAL INT ORG W; Fernald LC, 2004, JAMA-J AM MED ASSOC, V291, P2544, DOI 10.1001/jama.291.21.2544; Fezeu L, 2006, INT J EPIDEMIOL, V35, P105, DOI 10.1093/ije/dyi214; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fleischer NL, 2012, AM J EPIDEMIOL, V175, P167, DOI 10.1093/aje/kwr314; Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193; Goldstein H, 2011, MULTILEVEL STAT MODE, Vxxi; Gupta MA, 2001, J PSYCHOSOM RES, V50, P193, DOI 10.1016/S0022-3999(00)00221-X; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hawkes C, 2008, OBES REV, V9, P151, DOI 10.1111/j.1467-789X.2007.00458.x; Hawkes C, 2005, PUBLIC HEALTH NUTR, V8, P357, DOI 10.1079/PHN2004706; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; Heston Alan, 2011, PENN WORLD TABLE VER; Holdsworth M, 2004, INT J OBESITY, V28, P1561, DOI 10.1038/sj.ijo.0802739; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Jacoby E, 2003, PREV MED, V37, P396, DOI 10.1016/S0091-7435(03)00159-2; Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kennedy G., 2004, FAO Food and Nutrition Paper, P1; Loureiro ML, 2005, AM J AGR ECON, V87, P1147, DOI 10.1111/j.1467-8276.2005.00800.x; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Marcuse P, 2000, GLOBALIZING CITIES N, Vxviii; MEASURE DHS, 2010, DEM HLTH SURV; MEASURE DHS, 2011, LIST DHS FIN REP; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Monteiro CA, 2000, EUR J CLIN NUTR, V54, P342, DOI 10.1038/sj.ejcn.1600960; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Nandi A, 2011, J EPIDEMIOL COMMUN H, V65, pA347, DOI 10.1136/jech.2011.142976l.85; Nandi A, AM J CLIN NUTR; Nandi A, 2014, AM J PUBLIC HEALTH, V104, pE162, DOI 10.2105/AJPH.2013.301392; Neuman M, 2013, AM J CLIN NUTR, V97, P428, DOI 10.3945/ajcn.112.045997; Neuman M, 2011, AM J CLIN NUTR, V94, P1348, DOI 10.3945/ajcn.111.018127; ORC Macro, 2006, DEM HLTH SURV INT MA; Peytremann-Bridevaux I, 2007, PREV MED, V44, P442, DOI 10.1016/j.ypmed.2006.11.011; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; Popkin BM, 2006, FOOD POLICY, V31, P554, DOI 10.1016/j.foodpol.2006.02.008; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Pullum TW, 2008, ASSESSMENT QUALITY D; Rasbash J., 2012, MLWIN VERSION 2 25; Rutstein S.O., 2004, DHS COMP REPORTS; Rutstein SO, 2003, GUIDE DHS STAT; Sahr R, 2006, CONSUMER PRICE INDEX; Sassen Saskia., 1992, POLIT SCI QUART, V107, P370; Sassen Saskia., 2019, CITIES WORLD EC, V5th ed; Siervo M, 2006, Eat Weight Disord, V11, P100; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sobal J, 2001, INT TXB OBESITY; StataCorp, STAT STAT SOFTW REL; Stiglitz JE, 2003, GLOBALIZATION ITS DI, Vxxii; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Subramanian SV, 2006, AM J CLIN NUTR, V84, P633, DOI 10.1093/ajcn/84.3.633; Subramanian SV, 2011, LANCET, V377, P1915, DOI 10.1016/S0140-6736(11)60803-9; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tiberti L, 2007, GLOBALISATION HLTH I; UNCTAD, 2012, INW OUTW FOR DIR INV; UNCTAD, 2004, WORLD INV DIR; United Nations Population Division, 2002, WORLD URB PROSP 2001; United Nations Statistics Division, 2011, POP DENS URB; Vaessen M, 1996, POTENTIAL DEMOGRAPHI; Vaessen M, 2005, DEMOGRAPHIC HLTH SUR; Vlahov D, 2002, J URBAN HEALTH, V79, pS1, DOI 10.1093/jurban/79.suppl_1.S1; Wang H, 2007, INT J OBESITY, V31, P272, DOI 10.1038/sj.ijo.0803416; Wells JCK, 2012, SOC SCI MED, V75, P482, DOI 10.1016/j.socscimed.2012.03.029; Willett W., 1998, NUTR EPIDEMIOLOGY, pxiv; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Wirth M., 2006, MONITORING HLTH EQUI; World Bank, 2012, WORLD INT TRAD SOL	84	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99327	10.1371/journal.pone.0099327	http://dx.doi.org/10.1371/journal.pone.0099327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24919199	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000338631000076
J	Podgorski, T; Lusseau, D; Scandura, M; Sonnichsen, L; Jedrzejewska, B				Podgorski, Tomasz; Lusseau, David; Scandura, Massimo; Sonnichsen, Leif; Jedrzejewska, Bogumila			Long-Lasting, Kin-Directed Female Interactions in a Spatially Structured Wild Boar Social Network	PLOS ONE			English	Article							SUS-SCROFA; GENETIC RELATEDNESS; POPULATION-STRUCTURE; LITTER SIZE; SPACE USE; BEHAVIOR; PATTERNS; KINSHIP; ASSOCIATIONS; PERFORMANCE	Individuals can increase inclusive fitness benefits through a complex network of social interactions directed towards kin. Preferential relationships with relatives lead to the emergence of kin structures in the social system. Cohesive social groups of related individuals and female philopatry of wild boar create conditions for cooperation through kin selection and make the species a good biological model for studying kin structures. Yet, the role of kinship in shaping the social structure of wild boar populations is still poorly understood. In the present study, we investigated spatio-temporal patterns of associations and the social network structure of the wild boar Sus scrofa population in Bialowiezia National Park, Poland, which offered a unique opportunity to understand wild boar social interactions away from anthropogenic factors. We used a combination of telemetry data and genetic information to examine the impact of kinship on network cohesion and the strength of social bonds. Relatedness and spatial proximity between individuals were positively related to the strength of social bond. Consequently, the social network was spatially and genetically structured with well-defined and cohesive social units. However, spatial proximity between individuals could not entirely explain the association patterns and network structure. Genuine, kin-targeted, and temporarily stable relationships of females extended beyond spatial proximity between individuals while males interactions were short-lived and not shaped by relatedness. The findings of this study confirm the matrilineal nature of wild boar social structure and show how social preferences of individuals translate into an emergent socio-genetic population structure.	[Podgorski, Tomasz; Sonnichsen, Leif; Jedrzejewska, Bogumila] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Lusseau, David] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Scandura, Massimo] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; University of Aberdeen; University of Sassari	Podgorski, T (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	t_podgorski@ibs.bialowieza.pl	Lusseau, David/AAV-9295-2021; Podgórski, Tomasz/B-4869-2015; Lusseau, David/A-8501-2012	Lusseau, David/0000-0003-1245-3747; Podgórski, Tomasz/0000-0001-6858-7838; Scandura, Massimo/0000-0003-2754-6866	Ministry of Science and Higher Education [NN304 253935]; Mammal Research Institute PAS; BIOCONSUS project (Research Potential in Conservation and Sustainable Management of Biodiversity) [245737]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Mammal Research Institute PAS; BIOCONSUS project (Research Potential in Conservation and Sustainable Management of Biodiversity)	The study was funded by the Ministry of Science and Higher Education (grant number NN304 253935), the budget of the Mammal Research Institute PAS, and BIOCONSUS project (Research Potential in Conservation and Sustainable Management of Biodiversity, 7th Framework Programme contract no. 245737, FP7/2009-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Armitage KB, 2000, P NATL ACAD SCI USA, V97, P12149, DOI 10.1073/pnas.200196097; BOITANI L, 1994, J MAMMAL, V75, P600, DOI 10.2307/1382507; Borgatti S.P., 2002, NETDRAW GRAPH VISUAL; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Campbell RA, 2008, BIOL LETTERS, V4, P139, DOI 10.1098/rsbl.2007.0487; Carter KD, 2013, ANIM BEHAV, V85, P385, DOI 10.1016/j.anbehav.2012.11.011; Clayton L, 1999, J MAMMAL, V80, P1147, DOI 10.2307/1383165; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; CROOK JH, 1976, ANIM BEHAV, V24, P261, DOI 10.1016/S0003-3472(76)80035-8; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; DARDAILLON M, 1988, Z SAUGETIERKD, V53, P22; DELCROIX I, 1990, J REPROD FERTIL, V89, P613, DOI 10.1530/jrf.0.0890613; Edwards GR, 1996, APPL ANIM BEHAV SCI, V50, P147, DOI 10.1016/0168-1591(96)01077-5; Ferriere R, 1996, AM NAT, V147, P692, DOI 10.1086/285875; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Fowler AC, 2005, ANIM BEHAV, V69, P973, DOI 10.1016/j.anbehav.2004.07.014; Frere CH, 2010, ANIM BEHAV, V80, P481, DOI 10.1016/j.anbehav.2010.06.007; Gabor TM, 1999, J ZOOL, V247, P311, DOI 10.1111/j.1469-7998.1999.tb00994.x; Garroway CJ, 2013, BEHAV ECOL SOCIOBIOL, V67, P113, DOI 10.1007/s00265-012-1431-3; Geisser H, 2005, J ZOOL, V267, P89, DOI 10.1017/S095283690500734X; Gero S, 2008, BEHAV ECOL SOCIOBIOL, V63, P143, DOI 10.1007/s00265-008-0645-x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Greenberg CH, 2000, FOREST ECOL MANAG, V132, P199, DOI 10.1016/S0378-1127(99)00226-1; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hirsch BT, 2013, ANIM BEHAV, V85, P463, DOI 10.1016/j.anbehav.2012.12.011; Iacolina L, 2009, J MAMMAL, V90, P666, DOI 10.1644/08-MAMM-A-074R1.1; Jedrzejewska B, 1997, ACTA THERIOL, V42, P399; Jedrzejewski W, 2004, WILDLIFE SOC B, V32, P1305, DOI 10.2193/0091-7648(2004)032[1305:FTFMDF]2.0.CO;2; Kaminski G, 2005, CAN J ZOOL, V83, P474, DOI 10.1139/Z05-019; Krause J, 2007, BEHAV ECOL SOCIOBIOL, V62, P15, DOI 10.1007/s00265-007-0445-8; Kreeger T. J., 1997, HDB WILDLIFE CHEM IM; LALAND KN, 1990, ANIM LEARN BEHAV, V18, P246, DOI 10.3758/BF03205282; Lambin X, 1998, J ANIM ECOL, V67, P1, DOI 10.1046/j.1365-2656.1998.00181.x; LENTH RV, 1981, TECHNOMETRICS, V23, P149, DOI 10.2307/1268030; Lusseau D, 2006, J ANIM ECOL, V75, P14, DOI 10.1111/j.1365-2656.2005.01013.x; Lusseau D, 2008, ANIM BEHAV, V75, P1809, DOI 10.1016/j.anbehav.2007.10.029; Maher CR, 2009, BEHAV ECOL SOCIOBIOL, V63, P857, DOI 10.1007/s00265-009-0726-5; Manly BFJ, 1997, RANDOMIZATION BOOTST; MATSCHKE GH, 1967, J WILDLIFE MANAGE, V31, P109, DOI 10.2307/3798365; Midford PE, 2000, ANIM BEHAV, V59, P1199, DOI 10.1006/anbe.1999.1419; Moyer MA, 2006, J MAMMAL, V87, P255, DOI 10.1644/05-MAMM-A-192R1.1; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; PACKER C, 1995, AM NAT, V145, P833, DOI 10.1086/285771; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pomeroy PP, 2001, P ROY SOC B-BIOL SCI, V268, P711, DOI 10.1098/rspb.2000.1422; Poteaux C, 2009, J ZOOL, V278, P116, DOI 10.1111/j.1469-7998.2009.00553.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Scandura M, 2008, MOL ECOL, V17, P1745, DOI 10.1111/j.1365-294X.2008.03703.x; Scandura M, 2011, HEREDITY, V106, P1012, DOI 10.1038/hdy.2010.155; Servanty S, 2007, BEHAV ECOL, V18, P427, DOI 10.1093/beheco/arl099; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SOMERS MJ, 1995, ACTA THERIOL, V40, P257, DOI 10.4098/AT.arch.95-25; SPITZ F, 1992, ONGULES / UNGULATES 91, P385; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Truve J, 2003, WILDLIFE BIOL, V9, P51, DOI 10.2981/wlb.2003.056; Van Horn RC, 2008, ANIM BEHAV, V75, P1173, DOI 10.1016/j.anbehav.2007.08.027; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vernesi C, 2003, MOL ECOL, V12, P585, DOI 10.1046/j.1365-294X.2003.01763.x; Wang CL, 2012, GENETICS, V192, P651, DOI 10.1534/genetics.112.139519; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; White AM, 2010, BEHAVIOUR, V147, P1, DOI 10.1163/000579509X12459309054841; White AM, 2009, ANIM BEHAV, V77, P87, DOI 10.1016/j.anbehav.2008.08.030; Whitehead H, 1997, ANIM BEHAV, V53, P1053, DOI 10.1006/anbe.1996.0358; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Williams CT, 2013, BEHAV ECOL SOCIOBIOL, V67, P757, DOI 10.1007/s00265-013-1499-4; Wimmer B, 2002, BEHAV ECOL SOCIOBIOL, V52, P166, DOI 10.1007/s00265-002-0497-8; Wiszniewski J, 2010, ANIM BEHAV, V80, P895, DOI 10.1016/j.anbehav.2010.08.013; Wolf JBW, 2008, P ROY SOC B-BIOL SCI, V275, P2063, DOI 10.1098/rspb.2008.0356; Wolf JBW, 2007, ANIM BEHAV, V74, P1293, DOI 10.1016/j.anbehav.2007.02.024; Zeyl E, 2009, MOL ECOL, V18, P735, DOI 10.1111/j.1365-294X.2008.04049.x	81	52	52	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99875	10.1371/journal.pone.0099875	http://dx.doi.org/10.1371/journal.pone.0099875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919178	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000124
J	Scott, DM; Berg, MJ; Tolhurst, BA; Chauvenet, ALM; Smith, GC; Neaves, K; Lochhead, J; Baker, PJ				Scott, Dawn M.; Berg, Maureen J.; Tolhurst, Bryony A.; Chauvenet, Alienor L. M.; Smith, Graham C.; Neaves, Kelly; Lochhead, Jamie; Baker, Philip J.			Changes in the Distribution of Red Foxes (Vulpes vulpes) in Urban Areas in Great Britain: Findings and Limitations of a Media-Driven Nationwide Survey	PLOS ONE			English	Article							MANGE SARCOPTES-SCABIEI; BADGERS MELES-MELES; ECHINOCOCCUS-MULTILOCULARIS; RABIES; CITY; URBANIZATION; POPULATIONS; DISPERSAL; SELECTION; PATTERNS	Urbanization is one of the major forms of habitat alteration occurring at the present time. Although this is typically deleterious to biodiversity, some species flourish within these human-modified landscapes, potentially leading to negative and/or positive interactions between people and wildlife. Hence, up-to-date assessment of urban wildlife populations is important for developing appropriate management strategies. Surveying urban wildlife is limited by land partition and private ownership, rendering many common survey techniques difficult. Garnering public involvement is one solution, but this method is constrained by the inherent biases of non-standardised survey effort associated with voluntary participation. We used a television-led media approach to solicit national participation in an online sightings survey to investigate changes in the distribution of urban foxes in Great Britain and to explore relationships between urban features and fox occurrence and sightings density. Our results show that media-based approaches can generate a large national database on the current distribution of a recognisable species. Fox distribution in England and Wales has changed markedly within the last 25 years, with sightings submitted from 91% of urban areas previously predicted to support few or no foxes. Data were highly skewed with 90% of urban areas having >30 fox sightings per 1000 people km(-2). The extent of total urban area was the only variable with a significant impact on both fox occurrence and sightings density in urban areas; longitude and percentage of public green urban space were respectively, significantly positively and negatively associated with sightings density only. Latitude, and distance to nearest neighbouring conurbation had no impact on either occurrence or sightings density. Given the limitations associated with this method, further investigations are needed to determine the association between sightings density and actual fox density, and variability of fox density within and between urban areas in Britain.	[Scott, Dawn M.; Berg, Maureen J.; Tolhurst, Bryony A.] Univ Brighton, Div Biol & Biomed Sci, Brighton, E Sussex, England; [Chauvenet, Alienor L. M.; Smith, Graham C.] Anim Hlth & Vet Labs Agcy, Natl Wildlife Management Ctr, York, Yorks, England; [Neaves, Kelly; Lochhead, Jamie] Windfall Films, London, England; [Baker, Philip J.] Univ Reading, Sch Biol Sci, Reading, Berks, England	University of Brighton; University of Reading	Scott, DM (corresponding author), Univ Brighton, Div Biol & Biomed Sci, Brighton, E Sussex, England.	dawn.scott@brighton.ac.uk	Chauvenet, Alienor/L-9135-2015; Tolhurst, Bryony/AAT-9022-2020; Smith, Graham C/J-2593-2013	Chauvenet, Alienor/0000-0002-3743-7375; Tolhurst, Bryony/0000-0002-0198-5046; Smith, Graham C/0000-0002-9897-6794; Scott, Dawn/0000-0002-9570-2739	Channel 4	Channel 4	The research was funded by Channel 4. The funders had input into the final web site design which aided data collection, however the funders had no role in data analysis or preparation of the manuscript.	Adams J, 2008, EUR J PUBLIC HEALTH, V18, P335, DOI 10.1093/eurpub/ckm100; Baker P, 2004, 2004 MAY 1 5 TUCS AR, P153; Baker Philip, 2001, British Wildlife, V12, P411; Baker PJ, 2007, MAMMAL REV, V37, P297, DOI 10.1111/j.1365-2907.2007.00102.x; Baker PJ, 2000, ANIM BEHAV, V59, P127, DOI 10.1006/anbe.1999.1285; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Battersby J, 2005, TRACKING MAMMALS PAR, V1; BIVAND R., 2014, SPDEP SPATIAL DEPEND; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bowler DE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/147-2458-10-456; Brochier B, 2007, PREV VET MED, V80, P65, DOI 10.1016/j.prevetmed.2007.01.004; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Campbell SaH G, 2007, URBAN FOX POPULATION; Cassidy A, 2012, ENVIRON COMMUN, V6, P494, DOI 10.1080/17524032.2012.716370; CEH, 2011, LAND COV MAP 2007; Chappuis F, 2012, Rev Med Suisse, V8, P989; Chappuis F, 2012, REV MED SUISSE, V8, P992; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Crooks KR, 2010, COMMUNITY ECOLOGY UR; Davies ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039692; Davis JM, 2004, TRENDS ECOL EVOL, V19, P411, DOI 10.1016/j.tree.2004.04.006; Delahay RJ, 2009, MAMMAL REV, V39, P53, DOI 10.1111/j.1365-2907.2008.00135.x; Devenish-Nelson ES, 2013, OIKOS, V122, P705, DOI 10.1111/j.1600-0706.2012.20706.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Eigenbrod F, 2011, P ROY SOC B-BIOL SCI, V278, P3201, DOI 10.1098/rspb.2010.2754; ESRI, 2011, ARCGIS DESKT REL 10; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Fuller TK, 2010, CARNIVORE BEHAV ECOL; Gehrt SD., 2010, URBAN CARNIVORES ECO; Gloor S, 2001, MAMM BIOL, V66, P155; Gosselink TE, 2010, J WILDLIFE MANAGE, V74, P1204, DOI 10.2193/2009-108; HARRIS S, 1977, MAMMAL REV, V7, P25, DOI 10.1111/j.1365-2907.1977.tb00360.x; HARRIS S, 1986, J ANIM ECOL, V55, P575, DOI 10.2307/4740; HARRIS S, 1986, J ANIM ECOL, V55, P605, DOI 10.2307/4742; HARRIS S, 1986, J ANIM ECOL, V55, P593, DOI 10.2307/4741; HARRIS S, 1981, J APPL ECOL, V18, P455, DOI 10.2307/2402406; HARRIS S, 1984, BIOL CONSERV, V28, P349, DOI 10.1016/0006-3207(84)90041-7; Harris S., 1987, Symposia of the Zoological Society of London, P313; Harris S., 2008, MAMMALS BRIT ISLES H, V4th; Harris S., 1995, REV BRIT MAMMALS POP; Harris S, 2001, URBAN FOXES; Hof Anouschka R., 2009, Lutra, V52, P69; Hunter J, 2013, CONCURR COMP-PRACT E, V25, P454, DOI 10.1002/cpe.2923; Iossa G, 2010, TAXONOMIC ANAL URBAN; Iossa G, 2009, BEHAV ECOL, V20, P385, DOI 10.1093/beheco/arn149; JENKINS DJ, 1992, MED J AUSTRALIA, V157, P754; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Knapp S, 2008, BIODIVERS CONSERV, V17, P1595, DOI 10.1007/s10531-008-9369-5; Learmount J, 2012, VET PARASITOL, V190, P447, DOI 10.1016/j.vetpar.2012.07.003; Lloyd HG, 1980, HABITAT REQUIREMENTS, pP7; Lye GC, 2012, J INSECT CONSERV, V16, P697, DOI 10.1007/s10841-011-9450-3; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Newman TJ, 2003, ACTA THERIOL, V48, P79, DOI 10.1007/BF03194268; Office for National Statistics [ONS], 2004, CENS 2001; ONS, 2010, CENS 2010; ONS, 2011, 2010 BAS STAT B; Patton V, 2010, MAMMAL REV, V40, P313, DOI 10.1111/j.1365-2907.2010.00162.x; Pauleit S, 2005, LANDSCAPE URBAN PLAN, V71, P295, DOI [10.1016/S0169-2046(04)00083-0, 10.1016/j.landurbplan.2004.03.009]; R Core Development Team, 2013, R LANG ENV STAT COMP; Reading CJ, 1996, J BIOGEOGR, V23, P657, DOI 10.1111/j.1365-2699.1996.tb00026.x; Richardson EA, 2010, SOC SCI MED, V71, P568, DOI 10.1016/j.socscimed.2010.04.015; Ritter P, 2004, J MED INTERNET RES, V6, P19, DOI 10.2196/jmir.6.3.e29; SAMUEL WM, 1981, J WILDLIFE DIS, V17, P343, DOI 10.7589/0090-3558-17.3.343; Selonen V, 2007, P ROY SOC B-BIOL SCI, V274, P2063, DOI 10.1098/rspb.2007.0570; Smith GC, 2006, DEV BIOLOGICALS, V125, P113; SMITH GC, 1991, PHILOS T ROY SOC B, V334, P459, DOI 10.1098/rstb.1991.0127; Smith GC, 2003, VET PARASITOL, V118, P133, DOI 10.1016/j.vetpar.2003.09.017; Smith GC, 2003, J WILDLIFE DIS, V39, P278, DOI 10.7589/0090-3558-39.2.278; Soulsbury CD, 2007, MAMMAL REV, V37, P278, DOI 10.1111/j.1365-2907.2007.00101.x; Soulsbury CD, 2010, RED FOXES VULPES VUL; Stamps JA, 2009, AM NAT, V174, P623, DOI 10.1086/644526; Thorn M, 2011, ORYX, V45, P579, DOI 10.1017/S0030605311000123; Toms MP, 2006, MAMMAL REV, V36, P309, DOI 10.1111/j.1365-2907.2006.00094.x; Tratalos J, 2007, LANDSCAPE URBAN PLAN, V83, P308, DOI 10.1016/j.landurbplan.2007.05.003; Tregidgo DJ, 2013, ENVIRON POLLUT, V182, P448, DOI 10.1016/j.envpol.2013.03.034; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; UNFPA, 2007, STAT WORLD POP; Wandeler P, 2003, MOL ECOL, V12, P647, DOI 10.1046/j.1365-294X.2003.01768.x; White Lynsey A., 2009, Human Dimensions of Wildlife, V14, P419; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; Wilkinson D, 2001, MAMMAL REV, V31, P107, DOI 10.1046/j.1365-2907.2001.00076.x	83	65	71	2	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99059	10.1371/journal.pone.0099059	http://dx.doi.org/10.1371/journal.pone.0099059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919063	Green Published, Green Accepted, gold			2022-12-25	WOS:000338631000045
J	Canivell, S; Ruano, EG; Siso-Almirall, A; Kostov, B; Gonzalez-de Paz, L; Fernandez-Rebollo, E; Hanzu, FA; Parrizas, M; Novials, A; Gomis, R				Canivell, Silvia; Ruano, Elena G.; Siso-Almirall, Antoni; Kostov, Belchin; Gonzalez-de Paz, Luis; Fernandez-Rebollo, Eduardo; Hanzu, Felicia A.; Parrizas, Marcelina; Novials, Anna; Gomis, Ramon			Differential Methylation of TCF7L2 Promoter in Peripheral Blood DNA in Newly Diagnosed, Drug-Naive Patients with Type 2 Diabetes	PLOS ONE			English	Article							BETA-CELL FUNCTION; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; HOMEOSTASIS MODEL; GENOME; PATHOGENESIS; EPIGENETICS; MECHANISMS; MELLITUS; OBESITY	TCF7L2 is the susceptibility gene for Type 2 diabetes (T2D) with the largest effect on disease risk that has been discovered to date. However, the mechanisms by which TCF7L2 contributes to the disease remain largely elusive. In addition, epigenetic mechanisms, such as changes in DNA methylation patterns, might have a role in the pathophysiology of T2D. This study aimed to investigate the differences in terms of DNA methylation profile of TCF7L2 promoter gene between type 2 diabetic patients and age- and Body Mass Index (BMI)-matched controls. We included 93 type 2 diabetic patients that were recently diagnosed for T2D and exclusively on diet (without any pharmacological treatment). DNA was extracted from whole blood and DNA methylation was assessed using the Sequenom EpiTYPER system. Type 2 diabetic patients were more insulin resistant than their matched controls (mean HOMA IR 2.6 vs 1.8 in controls, P<0.001) and had a poorer beta-cell function (mean HOMA B 75.7 vs. 113.6 in controls, P<0.001). Results showed that 59% of the CpGs analyzed in TCF7L2 promoter had significant differences between type 2 diabetic patients and matched controls. In addition, fasting glucose, HOMA-B, HOMA-IR, total cholesterol and LDL-cholesterol correlated with methylation in specific CpG sites of TCF7L2 promoter. After adjustment by age, BMI, gender, physical inactivity, waist circumference, smoking status and diabetes status uniquely fasting glucose, total cholesterol and LDL-cholesterol remained significant. Taken together, newly diagnosed, drug-naive type 2 diabetic patients display specific epigenetic changes at the TCF7L2 promoter as compared to age- and BMI-matched controls. Methylation in TCF7L2 promoter is further correlated with fasting glucose in peripheral blood DNA, which sheds new light on the role of epigenetic regulation of TCF7L2 in T2D.	[Canivell, Silvia; Hanzu, Felicia A.; Novials, Anna; Gomis, Ramon] Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain; [Canivell, Silvia; Siso-Almirall, Antoni; Kostov, Belchin; Gonzalez-de Paz, Luis] IDIBAPS, PHC Res Grp, Les Corts Primary Hlth Care Ctr, Barcelona, Spain; [Canivell, Silvia; Ruano, Elena G.; Fernandez-Rebollo, Eduardo; Hanzu, Felicia A.; Parrizas, Marcelina; Novials, Anna; Gomis, Ramon] IDIBAPS, Diabet & Obes Lab, Barcelona, Spain; [Ruano, Elena G.; Fernandez-Rebollo, Eduardo; Novials, Anna; Gomis, Ramon] CIBERDEM, Barcelona, Spain; [Siso-Almirall, Antoni; Gomis, Ramon] Univ Barcelona, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona	Gomis, R (corresponding author), Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain.	ramon.gomis@idibaps.org	, EFR1981/AAV-6334-2020; Parrizas, Marcelina/AAS-3629-2021	, EFR1981/0000-0002-4378-7590; Kostov, Belchin/0000-0002-2126-3892; Siso Almirall, Antoni/0000-0001-9832-2689; Gonzalez de Paz, Luis/0000-0002-4767-8121; Novials, Anna/0000-0003-0465-2949; Parrizas, Marcelina/0000-0003-1296-8302; Canivell, Silvia/0000-0002-0280-5035; Hanzu, Felicia Alexandra/0000-0002-2399-4023	FIS [PI 1000219]; MEDIGENE project - EC Seventh Framework Programme theme FP7-HEALTH [279171]; Spanish Ministry of Science and Innovation [SAF 2010-19527]; Spanish Ministry of Science and Innovation	FIS(Instituto de Salud Carlos III); MEDIGENE project - EC Seventh Framework Programme theme FP7-HEALTH; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the FIS Grant PI 1000219, the MEDIGENE project, grant agreement number 279171, funded by the EC Seventh Framework Programme theme FP7-HEALTH-2011 and by the Spanish Ministry of Science and Innovation (under the grant agreement number SAF 2010-19527). CIBER de Diabetes y Enfermedades Metabolicas is an initiative of ISCIII (Spanish Ministry of Science and Innovation). Dr. Canivell was awarded with the Rio Hortega Grant from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2013, WORLD J DIABETES, V4, P114, DOI 10.4239/wjd.v4.i4.114; [Anonymous], 2011, DIABETES CARE, V35, pS11; Blaha MJ, 2008, OBESITY, V16, P869, DOI 10.1038/oby.2008.12; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Canivell S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075474; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ferrannini E, 2003, DIABETOLOGIA, V46, P1211, DOI 10.1007/s00125-003-1169-6; Fradin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036278; Gilbert ER, 2012, EPIGENETICS-US, V7, P841, DOI 10.4161/epi.21238; Gloyn AL, 2009, DIABETES, V58, P800, DOI 10.2337/db09-0099; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hu Y, 2014, EXP CLIN ENDOCR DIAB, V122, P71, DOI 10.1055/s-0033-1363231; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Majithia AR, 2009, CURR OPIN ENDOCRINOL, V16, P100, DOI 10.1097/MED.0b013e3283292354; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Pinney SE, 2010, TRENDS ENDOCRIN MET, V21, P223, DOI 10.1016/j.tem.2009.10.002; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Polonsky KS, 2000, INT J OBESITY, V24, pS29, DOI 10.1038/sj.ijo.0801273; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98; Prokunina-Olsson L, 2009, HUM MOL GENET, V18, P3795, DOI 10.1093/hmg/ddp321; Relton CL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000356; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Slomko H, 2012, ENDOCRINOLOGY, V153, P1025, DOI 10.1210/en.2011-1759; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; van den Boom D EM, 2008, DNA METHYLATION METH, P207; Volkmar M, 2012, EMBO J; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Wren JD, 2005, J BIOMED BIOTECHNOL, P104, DOI 10.1155/JBB.2005.104	39	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99310	10.1371/journal.pone.0099310	http://dx.doi.org/10.1371/journal.pone.0099310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914535	Green Submitted, gold, Green Published			2022-12-25	WOS:000340947700083
J	Gao, J; Zhang, Y; Zhang, CL; Qi, FY; Li, XP; Mu, SH; Peng, ZH				Gao, Jian; Zhang, Ying; Zhang, Chunling; Qi, Feiyan; Li, Xueping; Mu, Shaohua; Peng, Zhenhua			Characterization of the Floral Transcriptome of Moso Bamboo (Phyllostachys edulis) at Different Flowering Developmental Stages by Transcriptome Sequencing and RNA-Seq Analysis	PLOS ONE			English	Article							DNA-BINDING; FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; LEAF SENESCENCE; FACTOR FAMILY; GENE; EXPRESSION; CONSTANS; GENOME; MEMBER	Background: As an arborescent and perennial plant, Moso bamboo (Phyllostachys edulis (Carriere) J. Houzeau, synonym Phyllostachys heterocycla Carriere) is characterized by its infrequent sexual reproduction with flowering intervals ranging from several to more than a hundred years. However, little bamboo genomic research has been conducted on this due to a variety of reasons. Here, for the first time, we investigated the transcriptome of developing flowers in Moso bamboo by using high-throughput Illumina GAII sequencing and mapping short reads to the Moso bamboo genome and reference genes. We performed RNA-seq analysis on four important stages of flower development, and obtained extensive gene and transcript abundance data for the floral transcriptome of this key bamboo species. Results: We constructed a cDNA library using equal amounts of RNA from Moso bamboo leaf samples from non-flowering plants (CK) and mixed flower samples (F) of four flower development stages. We generated more than 67 million reads from each of the CK and F samples. About 70% of the reads could be uniquely mapped to the Moso bamboo genome and the reference genes. Genes detected at each stage were categorized to putative functional categories based on their expression patterns. The analysis of RNA-seq data of bamboo flowering tissues at different developmental stages reveals key gene expression properties during the flower development of bamboo. Conclusion: We showed that a combination of transcriptome sequencing and RNA-seq analysis was a powerful approach to identifying candidate genes related to floral transition and flower development in bamboo species. The results give a better insight into the mechanisms of Moso bamboo flowering and ageing. This transcriptomic data also provides an important gene resource for improving breeding for Moso bamboo.	[Gao, Jian; Zhang, Ying; Zhang, Chunling; Qi, Feiyan; Li, Xueping; Mu, Shaohua; Peng, Zhenhua] State Forestry Adm, Key Lab Bamboo & Rattan Sci & Technol, Int Ctr Bamboo & Rattan, Beijing, Peoples R China	International Centre for Bamboo & Rattan	Gao, J (corresponding author), State Forestry Adm, Key Lab Bamboo & Rattan Sci & Technol, Int Ctr Bamboo & Rattan, Beijing, Peoples R China.	gaojian@icbr.ac.cn; pengzhenhua@icbr.ac.cn			National High Technology Research and Development Program of China "Moso Bamboo Functional Genomics Research'' [2013AA102607-4]	National High Technology Research and Development Program of China "Moso Bamboo Functional Genomics Research''(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China "Moso Bamboo Functional Genomics Research'' (grant No. 2013AA102607-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2013, RUSS J PLANT PHYSL+, V60, P116, DOI 10.1134/S1021443712060027; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bender J, 1998, P NATL ACAD SCI USA, V95, P5655, DOI 10.1073/pnas.95.10.5655; Benjamini Y, 2001, ANN STAT, V29, P1165; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; Cui XW, 2013, BOTANY, V91, P486, DOI 10.1139/cjb-2012-0219; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Dreni L, 2007, PLANT J, V52, P690, DOI 10.1111/j.1365-313X.2007.03272.x; Dreni L, 2011, PLANT CELL, V23, P2850, DOI 10.1105/tpc.111.087007; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fornara F, 2004, PLANT PHYSIOL, V135, P2207, DOI 10.1104/pp.104.045039; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Franklin DC, 2004, J BIOGEOGR, V31, P773, DOI 10.1111/j.1365-2699.2003.01057.x; Gardiner J, 2010, INT J DEV BIOL, V54, P1389, DOI 10.1387/ijdb.093006jg; Gielis J., 1999, Systematics and Geography of Plants, V68, P147, DOI 10.2307/3668597; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; INBAR, 1999, SOC ISS CONSTR BAMB; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Jeon JS, 2000, PLANT CELL, V12, P871, DOI 10.1105/tpc.12.6.871; Judziewicz EJ, 1999, AM BAMBOOS; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Li DJ, 2009, PLANTA, V229, P1159, DOI 10.1007/s00425-009-0893-7; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin EP, 2009, PLANTA, V231, P109, DOI 10.1007/s00425-009-1033-0; Lin XC, 2010, GENET MOL RES, V9, P1085, DOI 10.4238/vol9-2gmr804; Lobovikov M., 2007, WORLD BAMBOO RESOURC, P1; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Maria DL, 2011, BMC GENOMICS, V30, P1471; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; NADGAUDA RS, 1990, NATURE, V344, P335, DOI 10.1038/344335a0; Papi M, 2002, PLANT PHYSIOL, V128, P411, DOI 10.1104/pp.010488; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Park DH, 2003, PLANT J, V34, P161, DOI 10.1046/j.1365-313X.2003.01710.x; Pelucchi N, 2002, SEX PLANT REPROD, V15, P113, DOI 10.1007/s00497-002-0151-7; Peng JR, 2009, J INTEGR PLANT BIOL, V51, P1064, DOI 10.1111/j.1744-7909.2009.00881.x; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Richards DE, 2001, ANNU REV PLANT PHYS, V52, P67, DOI 10.1146/annurev.arplant.52.1.67; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Science Press, 2006, FLORA CHINA, V22, P163; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Skirycz A, 2007, NEW PHYTOL, V175, P425, DOI 10.1111/j.1469-8137.2007.02129.x; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Tian B, 2005, CHINESE SCI BULL, V50, P145; Tian B, 2006, DNA SEQUENCE, V17, P143, DOI 10.1080/10425170600699877; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xu H, 2010, BIOTECHNOL LETT, V32, P1961, DOI 10.1007/s10529-010-0362-1; YANAGISAWA S, 1995, NUCLEIC ACIDS RES, V23, P3403, DOI 10.1093/nar/23.17.3403; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yang J, 2011, PLANT SCI, V181, P667, DOI 10.1016/j.plantsci.2011.05.003; Yang PZ, 1999, PLANT J, V18, P141, DOI 10.1046/j.1365-313X.1999.00437.x; Zhang DF, 2008, PLANT SCI, V175, P809, DOI 10.1016/j.plantsci.2008.08.002; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082	78	68	76	7	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98910	10.1371/journal.pone.0098910	http://dx.doi.org/10.1371/journal.pone.0098910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915141	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700043
J	Nigam, A; Almabruk, KH; Saxena, A; Yang, JT; Mukherjee, U; Kaur, H; Kohli, P; Kumari, R; Singh, P; Zakharov, LN; Singh, Y; Mahmud, T; Lal, R				Nigam, Aeshna; Almabruk, Khaled H.; Saxena, Anjali; Yang, Jongtae; Mukherjee, Udita; Kaur, Hardeep; Kohli, Puneet; Kumari, Rashmi; Singh, Priya; Zakharov, Lev N.; Singh, Yogendra; Mahmud, Taifo; Lal, Rup			Modification of Rifamycin Polyketide Backbone Leads to Improved Drug Activity against Rifampicin-resistant Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYCOLATOPSIS-MEDITERRANEI S699; BIOSYNTHETIC GENE-CLUSTER; RNA-POLYMERASE; ERYTHROMYCIN DERIVATIVES; SYNTHASE; CLONING; DOMAIN; SYNTHETASE; MECHANISM; SUBSTRATE	Rifamycin B, a product of Amycolatopsis mediterranei S699, is the precursor of clinically used antibiotics that are effective against tuberculosis, leprosy, and AIDS-related mycobacterial infections. However, prolonged usage of these antibiotics has resulted in the emergence of rifamycin-resistant strains of Mycobacterium tuberculosis. As part of our effort to generate better analogs of rifamycin, we substituted the acyltransferase domain of module 6 of rifamycin polyketide synthase with that of module 2 of rapamycin polyketide synthase. The resulting mutants (rifAT6::rapAT2) of A. mediterranei S699 produced new rifamycin analogs, 24-desmethylrifamycin B and 24-desmethylrifamycin SV, which contained modification in the polyketide backbone. 24-Desmethylrifamycin B was then converted to 24-desmethylrifamycin S, whose structure was confirmed by MS, NMR, and X-ray crystallography. Subsequently, 24-desmethylrifamycin S was converted to 24-desmethylrifampicin, which showed excellent antibacterial activity against several rifampicin-resistant M. tuberculosis strains.	[Nigam, Aeshna; Saxena, Anjali; Mukherjee, Udita; Kaur, Hardeep; Kohli, Puneet; Kumari, Rashmi; Singh, Priya; Lal, Rup] Univ Delhi, Dept Zool, Delhi 110007, India; [Almabruk, Khaled H.; Yang, Jongtae; Mahmud, Taifo] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Zakharov, Lev N.; Mahmud, Taifo] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA; [Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India	University of Delhi; Oregon State University; Oregon State University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Mahmud, T (corresponding author), Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	taifo.mahmud@oregonstate.edu; ruplal@gmail.com	Lal, Rup/AFP-1009-2022; Mahmud, Taifo/A-1492-2015	Mahmud, Taifo/0000-0001-9639-526X	Department of Biotechnology of the Government of India; University of Delhi; M.J. Murdock Charitable Trust; Medical Research Foundation of Oregon; Council of Scientific and Industrial Research; University Grants Commission; Government of Libya	Department of Biotechnology of the Government of India(Department of Biotechnology (DBT) India); University of Delhi(University of Delhi); M.J. Murdock Charitable Trust; Medical Research Foundation of Oregon; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); Government of Libya	The work at Delhi University was supported by grants from the Department of Biotechnology of the Government of India and Grants from the University of Delhi. Work at Oregon State University was supported by an Exceptional Opportunity Grant from the M.J. Murdock Charitable Trust and the Medical Research Foundation of Oregon. This work was also supported by research fellowships from the Council of Scientific and Industrial Research and University Grants Commission (to A. N., A. S., U. M., P. K., R. K., and P. S.) and a scholarship from the Government of Libya (to K. H. A.).	Admiraal SJ, 2003, J AM CHEM SOC, V125, P13664, DOI 10.1021/ja0379060; Admiraal SJ, 2001, BIOCHEMISTRY-US, V40, P6116, DOI 10.1021/bi010080z; [Anonymous], SHELXTL 6 10 PROGR S; Aristoff PA, 2010, TUBERCULOSIS, V90, P94, DOI 10.1016/j.tube.2010.02.001; Artsimovitch I, 2005, CELL, V122, P351, DOI 10.1016/j.cell.2005.07.014; August PR, 1998, CHEM BIOL, V5, P69, DOI 10.1016/S1074-5521(98)90141-7; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Crump JA, 2011, J CLIN MICROBIOL, V49, P3054, DOI 10.1128/JCM.01035-11; Floss HG, 2006, J BIOTECHNOL, V124, P242, DOI 10.1016/j.jbiotec.2005.12.001; Gaisser S, 1997, MOL GEN GENET, V256, P239, DOI 10.1007/s004380050566; HARTMANN GR, 1985, ANGEW CHEM INT EDIT, V24, P1009, DOI 10.1002/anie.198510093; Jacobsen JR, 1998, BIOORGAN MED CHEM, V6, P1171, DOI 10.1016/S0968-0896(98)00081-9; Kaur H, 2001, MICROBIOL RES, V156, P239, DOI 10.1078/0944-5013-00108; Khanna M, 1998, MICROBIOL RES, V153, P205; Khosla C, 2009, CURR OPIN CHEM BIOL, V13, P135, DOI 10.1016/j.cbpa.2008.12.018; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim CG, 1998, J BIOL CHEM, V273, P6030, DOI 10.1074/jbc.273.11.6030; LAL R, 1995, CRIT REV MICROBIOL, V21, P19, DOI 10.3109/10408419509113532; Lal R, 1998, J ANTIBIOT, V51, P161, DOI 10.7164/antibiotics.51.161; LAL R, 1994, BIOESSAYS, V16, P211, DOI 10.1002/bies.950160313; Lal R, 2000, TRENDS BIOTECHNOL, V18, P264, DOI 10.1016/S0167-7799(00)01443-8; LAL R, 1991, APPL ENVIRON MICROB, V57, P665, DOI 10.1128/AEM.57.3.665-671.1991; Lal R, 1996, CRIT REV MICROBIOL, V22, P201, DOI 10.3109/10408419609105481; Lal R., 1999, U. S. Patent, Patent No. [US 00598560A, 00598560]; Lau J, 1999, BIOCHEMISTRY-US, V38, P1643, DOI 10.1021/bi9820311; Marsili L., 1984, U. S. Patent, Patent No. [3,963,705, 3963705]; Molodtsov V, 2013, J MED CHEM, V56, P4758, DOI 10.1021/jm4004889; Oliynyk M, 1996, CHEM BIOL, V3, P833, DOI 10.1016/S1074-5521(96)90069-1; Prasad B, 2009, J PHARMACEUT BIOMED, V50, P475, DOI 10.1016/j.jpba.2009.05.009; Ranganathan A, 1999, CHEM BIOL, V6, P731, DOI 10.1016/S1074-5521(00)80020-4; Ruan X, 1997, J BACTERIOL, V179, P6416, DOI 10.1128/jb.179.20.6416-6425.1997; Schupp T, 1998, FEMS MICROBIOL LETT, V159, P201, DOI 10.1111/j.1574-6968.1998.tb12861.x; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; Sheldrick G. M., 1998, BRUKER SIEMENS AREA; Stassi DL, 1998, P NATL ACAD SCI USA, V95, P7305, DOI 10.1073/pnas.95.13.7305; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Stratmann A, 1999, MICROBIOL-SGM, V145, P3365, DOI 10.1099/00221287-145-12-3365; Tuteja D, 2000, PLASMID, V43, P1, DOI 10.1006/plas.1999.1426; Verma M, 2011, J BACTERIOL, V193, P5562, DOI 10.1128/JB.05819-11; Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853, DOI 10.1128/AAC.42.7.1853; Wilson MC, 2010, J AM CHEM SOC, V132, P12757, DOI 10.1021/ja105891a; Xu J, 2005, MICROBIOL-SGM, V151, P2515, DOI 10.1099/mic.0.28138-0; Xu J, 2003, ARCH BIOCHEM BIOPHYS, V411, P277, DOI 10.1016/S0003-9861(03)00004-3; Xue Q, 1999, P NATL ACAD SCI USA, V96, P11740, DOI 10.1073/pnas.96.21.11740; Yu TW, 1999, P NATL ACAD SCI USA, V96, P9051, DOI 10.1073/pnas.96.16.9051	45	30	31	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21142	21152		10.1074/jbc.M114.572636	http://dx.doi.org/10.1074/jbc.M114.572636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24923585	Green Published, hybrid			2022-12-25	WOS:000339396600064
J	Gu, JN; Bakke, AM; Valen, EC; Lein, I; Krogdahl, A				Gu, Jinni; Bakke, Anne Marie; Valen, Elin C.; Lein, Ingrid; Krogdahl, Ashild			Bt-maize (MON810) and Non-GM Soybean Meal in Diets for Atlantic Salmon (Salmo salar L.) Juveniles - Impact on Survival, Growth Performance, Development, Digestive Function, and Transcriptional Expression of Intestinal Immune and Stress Responses	PLOS ONE			English	Article							GENETICALLY-MODIFIED MAIZE; THURINGIENSIS INSECTICIDAL TOXIN; MEDIUM-CHAIN TRIGLYCERIDES; 90-DAY SAFETY ASSURANCE; ZEBRAFISH DANIO-RERIO; RATS FED GRAIN; BACILLUS-THURINGIENSIS; GENE-EXPRESSION; TRANSGENIC EXPRESSION; INDUCED ENTERITIS	Responses in Atlantic salmon (Salmo salar L.) juveniles (fry) fed diets containing genetically modified maize (Bt-maize, MON810) expressing Cry1Ab protein from first-feeding were investigated during a 99-day feeding trial. Four experimental diets were made; each diet contained, similar to 20% maize, either Bt-maize or its near-isogenic maternal line (non-GM maize). One pair was fishmeal-based while the other pair included standard (extracted) soybean meal (SBM; 16.7% inclusion level), with the intention of investigating responses to the maize varieties in healthy fish as well as in immunologically challenged fish with SBM-induced distal intestinal inflammation, respectively. Three replicate tanks of fry (0.17 +/- 0.01 g; initial mean weight +/- SEM) were fed one of the four diets and samples were taken on days 15, 36, 48 and 99. Survival, growth performance, whole body composition, digestive function, morphology of intestine, liver and skeleton, and mRNA expression of some immune and stress response parameters in the distal intestine were evaluated. After 99 days of feeding, survival was enhanced and the intended SBM-induced inflammatory response in the distal intestine of the two groups of SBM-fed fish was absent, indicating that the juvenile salmon were tolerant to SBM. Mortality, growth performance and body composition were similar in fish fed the two maize varieties. The Bt-maize fed fish, however, displayed minor but significantly decreased digestive enzyme activities of leucine aminopeptidase and maltase, as well as decreased concentration of gut bile salts, but significantly increased amylase activity at some sampling points. Histomorphological, radiographic and mRNA expression evaluations did not reveal any biologically relevant effects of Bt-maize in the gastrointestinal tract, liver or skeleton. The results suggest that the Cry1Ab protein or other compositional differences in GM Bt-maize may cause minor alterations in intestinal responses in juvenile salmon, but without affecting overall survival, growth performance, development or health.	[Gu, Jinni; Bakke, Anne Marie; Valen, Elin C.; Krogdahl, Ashild] Norwegian Univ Life Sci NMBU, NMBU Sch Vet Med, Dept Basic Sci & Aquat Med, Oslo, Norway; [Lein, Ingrid] Nofima AS, Sunndalsora, Norway	Norwegian University of Life Sciences; Nofima	Bakke, AM (corresponding author), Norwegian Univ Life Sci NMBU, NMBU Sch Vet Med, Dept Basic Sci & Aquat Med, Oslo, Norway.	annemarie.bakke@nmbu.no			European Union Seventh Framework Programme grant "Biomarkers for post market monitoring of short and long-term effects of genetically modified organisms on animal and human health'' (GMSAFOOD) [211820]; Research Council of Norway's Centre of Excellence (CoE) "Aquaculture Protein Centre'' (APC) [145949/120]	European Union Seventh Framework Programme grant "Biomarkers for post market monitoring of short and long-term effects of genetically modified organisms on animal and human health'' (GMSAFOOD); Research Council of Norway's Centre of Excellence (CoE) "Aquaculture Protein Centre'' (APC)	The study was financed by a European Union Seventh Framework Programme grant "Biomarkers for post market monitoring of short and long-term effects of genetically modified organisms on animal and human health'' (GMSAFOOD, grant no. 211820) and the Research Council of Norway's Centre of Excellence (CoE) "Aquaculture Protein Centre'' (APC, grant no. 145949/120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeverfjord G, 1996, J FISH DIS, V19, P375, DOI 10.1111/j.1365-2761.1996.tb00376.x; Bakke-McKellep AM, 2008, RES VET SCI, V84, P395, DOI 10.1016/j.rvsc.2007.06.008; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; Bakke-McKellep AM, 2007, J FISH DIS, V30, P65, DOI 10.1111/j.1365-2761.2007.00782.x; Bakke-McKellep AM, 2000, J FISH DIS, V23, P115, DOI 10.1046/j.1365-2761.2000.00218.x; Brake DG, 2004, J AGR FOOD CHEM, V52, P2097, DOI 10.1021/jf0347362; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Burton SL, 1999, J MOL BIOL, V287, P1011, DOI 10.1006/jmbi.1999.2649; Buzoianu SG, 2013, J ANIM SCI, V91, P318, DOI 10.2527/jas.2012-5360; Campbell PM, 2011, J AGR FOOD CHEM, V59, P6047, DOI 10.1021/jf200456j; Chen W, 2011, AQUACULTURE, V318, P95, DOI 10.1016/j.aquaculture.2011.04.050; Chikwati EM, 2012, BRIT J NUTR, V107, P1570, DOI 10.1017/S0007114511004892; Chowdhury EH, 2003, VET HUM TOXICOL, V45, P95; Chowdhury EH, 2003, J ANIM SCI, V81, P2546; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Francis G, 2002, AQUACULTURE, V203, P311, DOI 10.1016/S0044-8486(01)00628-7; Francis G, 2001, COMP BIOCHEM PHYS C, V129, P105, DOI 10.1016/S1532-0456(01)00189-2; Froystad-Saugen MK, 2009, AQUACULT NUTR, V15, P104, DOI 10.1111/j.1365-2095.2008.00572.x; Gu JN, 2013, BRIT J NUTR, V109, P1408, DOI 10.1017/S000711451200325X; Guerrero GG, 2007, MOL IMMUNOL, V44, P1209, DOI 10.1016/j.molimm.2006.06.007; Guimaraes V, 2010, J AGR FOOD CHEM, V58, P3222, DOI 10.1021/jf903189j; Hammond B, 2006, FOOD CHEM TOXICOL, V44, P147, DOI 10.1016/j.fct.2005.06.008; Hammond BG, 2006, FOOD CHEM TOXICOL, V44, P1092, DOI 10.1016/j.fct.2006.01.003; Hemre GI, 2007, AQUACULT NUTR, V13, P186, DOI 10.1111/j.1365-2095.2007.00465.x; KAKADE ML, 1973, J NUTR, V103, P1772, DOI 10.1093/jn/103.12.1772; KNOWLES BH, 1994, ADV INSECT PHYSIOL, V24, P275, DOI 10.1016/S0065-2806(08)60085-5; KNOWLES BH, 1984, FEBS LETT, V168, P197, DOI 10.1016/0014-5793(84)80245-8; Kortner TM, 2011, AQUACULTURE, V318, P355, DOI 10.1016/j.aquaculture.2011.05.038; Krogdahl A, 2000, AQUACULT NUTR, V6, P77; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Krogdahl A, 2005, COMP BIOCHEM PHYS A, V141, P450, DOI 10.1016/j.cbpb.2005.06.002; Krogdahl A, 2005, AQUACULT NUTR, V11, P103, DOI 10.1111/j.1365-2095.2004.00327.x; Lilleeng E, 2007, COMP BIOCHEM PHYS A, V147, P25, DOI 10.1016/j.cbpa.2006.10.043; Linderoth A, 2006, BRIT J NUTR, V95, P105, DOI 10.1079/BJN20051612; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Marzo F, 2011, J ANIM PHYSIOL AN N, V95, P591, DOI 10.1111/j.1439-0396.2010.01088.x; Meissle M, 2011, PEST MANAG SCI, V67, P1049, DOI 10.1002/ps.2221; Moreno-Fierros L, 2000, MICROBES INFECT, V2, P885, DOI 10.1016/S1286-4579(00)00398-1; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nordrum S, 2000, AQUACULTURE, V186, P341, DOI 10.1016/S0044-8486(99)00385-3; Nordrum S, 2003, AQUACULT NUTR, V9, P263, DOI 10.1046/j.1365-2095.2003.00252.x; NRC, 1993, NUTR REQ FISH, DOI [10.17226/2115, DOI 10.17226/2115]; OLLI JJ, 1994, ACTA AGR SCAND A-AN, V44, P50, DOI 10.1080/09064709409410181; Penn MH, 2011, AQUACULTURE, V310, P267, DOI 10.1016/j.aquaculture.2010.10.040; Peres A, 1996, FISH PHYSIOL BIOCHEM, V15, P237, DOI 10.1007/BF01875574; Prescott VE, 2006, PHARMACOL THERAPEUT, V111, P374, DOI 10.1016/j.pharmthera.2005.10.005; Prescott VE, 2005, J AGR FOOD CHEM, V53, P9023, DOI 10.1021/jf050594v; Sagstad A, 2008, AQUACULT NUTR, V14, DOI 10.1111/j.1365-2095.2008.00630.x; Sagstad A, 2007, J FISH DIS, V30, P201, DOI 10.1111/j.1365-2761.2007.00808.x; Sanden M, 2006, AQUACULT NUTR, V12, P1, DOI 10.1111/j.1365-2095.2006.00367.x; Sanden M, 2005, J FISH DIS, V28, P317, DOI 10.1111/j.1365-2761.2005.00618.x; Sanden M, 2013, BRIT J NUTR, V110, P2222, DOI 10.1017/S0007114513001748; Saraswathy N, 2004, ELECTRON J BIOTECHN, V7, P178; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Shimada N, 2006, APPL ENTOMOL ZOOL, V41, P295, DOI 10.1303/aez.2006.295; Sissener NH, 2011, BRIT J NUTR, V106, P42, DOI 10.1017/S0007114510005726; Sissener NH, 2010, BRIT J NUTR, V103, P3, DOI 10.1017/S0007114509991401; Sullivan M, 2007, J FISH DIS, V30, P759, DOI 10.1111/j.1365-2761.2007.00890.x; van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008; Vazquez-Padron RI, 2000, BRAZ J MED BIOL RES, V33, P147, DOI 10.1590/S0100-879X2000000200002; Vazquez-Padron RI, 1999, LIFE SCI, V64, P1897, DOI 10.1016/S0024-3205(99)00136-8; Vazquez-Padron RI, 2000, BIOCHEM BIOPH RES CO, V271, P54, DOI 10.1006/bbrc.2000.2584; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011; Walsh MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027177; Zhang X, 2005, CELL DEATH DIFFER, V12, P1407, DOI 10.1038/sj.cdd.4401675	65	15	20	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99932	10.1371/journal.pone.0099932	http://dx.doi.org/10.1371/journal.pone.0099932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923786	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300108
J	Hiroshima, Y; Maawy, A; Zhang, Y; Sato, S; Murakami, T; Yamamoto, M; Uehara, F; Miwa, S; Yano, S; Momiyama, M; Chishima, T; Tanaka, K; Bouvet, M; Endo, I; Hoffman, RM				Hiroshima, Yukihiko; Maawy, Ali; Zhang, Yong; Sato, Sho; Murakami, Takashi; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Momiyama, Masashi; Chishima, Takashi; Tanaka, Kuniya; Bouvet, Michael; Endo, Itaru; Hoffman, Robert M.			Fluorescence-Guided Surgery in Combination with UVC Irradiation Cures Metastatic Human Pancreatic Cancer in Orthotopic Mouse Models	PLOS ONE			English	Article							INCREASES SURVIVAL; COMPLETE RESECTION; STOMACH-CANCER; NUDE-MICE; LIVE MICE; TUMOR; CARCINOMA; ANTIBODY; PROTEIN; GFP	The aim of this study is to determine if ultraviolet light (UVC) irradiation in combination with fluorescence-guided surgery (FGS) can eradicate metastatic human pancreatic cancer in orthotopic nude-mouse models. Two weeks after orthotopic implantation of human MiaPaCa-2 pancreatic cancer cells, expressing green fluorescent protein (GFP), in nude mice, bright-light surgery (BLS) was performed on all tumor-bearing mice (n = 24). After BLS, mice were randomized into 3 treatment groups; BLS-only (n = 8) or FGS (n = 8) or FGS-UVC (n = 8). The residual tumors were resected using a hand-held portable imaging system under fluorescence navigation in mice treated with FGS and FGS-UVC. The surgical resection bed was irradiated with 2700 J/m(2) UVC (254 nm) in the mice treated with FGS-UVC. The average residual tumor area after FGS (n = 16) was significantly smaller than after BLS only (n = 24) (0.135 +/- 0.137 mm(2) and 3.338 +/- 2.929 mm(2), respectively; p = 0.007). The BLS treated mice had significantly reduced survival compared to FGS-and FGS-UVC-treated mice for both relapse-free survival (RFS) (p<0.001 and p<0.001, respectively) and overall survival (OS) (p<0.001 and p<0.001, respectively). FGS-UVC-treated mice had increased RFS and OS compared to FGS-only treated mice (p = 0.008 and p = 0.025, respectively); with RFS lasting at least 150 days indicating the animals were cured. The results of the present study suggest that UVC irradiation in combination with FGS has clinical potential to increase survival.	[Hiroshima, Yukihiko; Zhang, Yong; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Hiroshima, Yukihiko; Maawy, Ali; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Sato, Sho; Murakami, Takashi; Momiyama, Masashi; Chishima, Takashi; Tanaka, Kuniya; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Yokohama City University	Hoffman, RM (corresponding author), AntiCancer Inc, San Diego, CA 92111 USA.	all@anticancer.com	Miwa, Shinji/AAI-9309-2020; Yano, Shuya/AAL-8028-2020	Miwa, Shinji/0000-0002-5962-8287; Murakami, Takashi/0000-0002-9429-5705; UEHARA, FUMINARI/0000-0001-6567-2113	National Cancer Institute [CA CA132971, CA142669]; Japanese Ministry of Education, Culture, Sports, Science and Technology [23592018, 24592009]; NATIONAL CANCER INSTITUTE [R01CA132971, R01CA142669] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24592009] Funding Source: KAKEN	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by National Cancer Institute grant CA CA132971 and CA142669, and Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology for Fundamental Research(C) (#23592018 to I.E and #24592009 to K.T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZL, 1999, CLIN EXP METASTAS, V17, P265, DOI 10.1023/A:1006654600095; Bouvet M, 2002, CANCER RES, V62, P1534; Bouvet M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003375; Cao HST, 2012, HEPATO-GASTROENTEROL, V59, P1994, DOI 10.5754/hge11836; Cao HST, 2010, MOL CANCER THER, V9, P2068, DOI 10.1158/1535-7163.MCT-10-0201; FU XY, 1991, INT J CANCER, V49, P938, DOI 10.1002/ijc.2910490623; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FURUKAWA T, 1993, INT J CANCER, V53, P608, DOI 10.1002/ijc.2910530414; FURUKAWA T, 1993, CANCER RES, V53, P1204; FURUKAWA T, 1993, CANCER RES, V53, P3070; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Kato K, 2009, PANCREAS, V38, P605, DOI 10.1097/MPA.0b013e3181a4891d; Katz MH, 2003, J SURG RES, V113, P151, DOI 10.1016/S0022-4804(03)00234-8; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Kimura H, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3526356; Kimura H, 2010, J CELL BIOCHEM, V110, P1439, DOI 10.1002/jcb.22693; Kishimoto H, 2011, CELL CYCLE, V10, P2737, DOI 10.4161/cc.10.16.16756; Kishimoto H, 2009, MOL CANCER THER, V8, P3001, DOI 10.1158/1535-7163.MCT-09-0556; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; KUO TH, 1993, ANTICANCER RES, V13, P627; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Metildi CA, 2014, ANN SURG ONCOL, V21, P1405, DOI 10.1245/s10434-014-3495-y; Metildi CA, 2013, J SURG RES, V179, P87, DOI 10.1016/j.jss.2012.08.052; Metildi CA, 2012, J AM COLL SURGEONS, V215, P126, DOI 10.1016/j.jamcollsurg.2012.02.021; Metildi CA, 2012, J AM COLL SURGEONS, V214, P997, DOI 10.1016/j.jamcollsurg.2012.02.009; Miwa S, 2013, J CELL BIOCHEM, V114, P2493, DOI 10.1002/jcb.24599; Momiyama M, 2013, J CELL BIOCHEM, V114, P428, DOI 10.1002/jcb.24381; Momiyama M, 2012, ANTICANCER RES, V32, P4327; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; THEODORESCU D, 1990, P NATL ACAD SCI USA, V87, P9047, DOI 10.1073/pnas.87.22.9047; Tsai MH, 2010, ANTICANCER RES, V30, P3291; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	36	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99977	10.1371/journal.pone.0099977	http://dx.doi.org/10.1371/journal.pone.0099977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924955	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300116
J	Kizuka, T; Akasaka, M; Kadoya, T; Takamura, N				Kizuka, Toshikazu; Akasaka, Munemitsu; Kadoya, Taku; Takamura, Noriko			Visibility from Roads Predict the Distribution of Invasive Fishes in Agricultural Ponds	PLOS ONE			English	Article							LARGEMOUTH BASS; BIOLOGICAL INVASIONS; BLUEGILL SUNFISH; SPATIAL-ANALYSIS; WATER-QUALITY; LAND-USE; HABITAT; BIODIVERSITY; LANDSCAPE; DISPERSAL	Propagule pressure and habitat characteristics are important factors used to predict the distribution of invasive alien species. For species exhibiting strong propagule pressure because of human-mediated introduction of species, indicators of introduction potential must represent the behavioral characteristics of humans. This study examined 64 agricultural ponds to assess the visibility of ponds from surrounding roads and its value as a surrogate of propagule pressure to explain the presence and absence of two invasive fish species. A three-dimensional viewshed analysis using a geographic information system quantified the visual exposure of respective ponds to humans. Binary classification trees were developed as a function of their visibility from roads, as well as five environmental factors: river density, connectivity with upstream dam reservoirs, pond area, chlorophyll a concentration, and pond drainage. Traditional indicators of human-mediated introduction (road density and proportion of urban land-use area) were alternatively included for comparison instead of visual exposure. The presence of Bluegill (Lepomis macrochirus) was predicted by the ponds' higher visibility from roads and pond connection with upstream dam reservoirs. Results suggest that fish stocking into ponds and their dispersal from upstream sources facilitated species establishment. Largemouth bass (Micropterus salmoides) distribution was constrained by chlorophyll a concentration, suggesting their lower adaptability to various environments than that of Bluegill. Based on misclassifications from classification trees for Bluegill, pond visual exposure to roads showed greater predictive capability than traditional indicators of human-mediated introduction. Pond visibility is an effective predictor of invasive species distribution. Its wider use might improve management and mitigate further invasion. The visual exposure of recipient ecosystems to humans is important for many invasive species that spread with frequent instances of human-mediated introduction.	[Kizuka, Toshikazu; Akasaka, Munemitsu; Kadoya, Taku; Takamura, Noriko] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Akasaka, Munemitsu] Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 183, Japan	National Institute for Environmental Studies - Japan; Tokyo University of Agriculture & Technology	Kizuka, T (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan.	t.kizuka1981@gmail.com	Akasaka, Munemitsu/G-1172-2013	Akasaka, Munemitsu/0000-0002-0143-0841	Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan	Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan	The present study was supported by the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaboshi T, 1996, BLACK BASS; Akasaka M, 2011, OIKOS, V120, P38, DOI 10.1111/j.1600-0706.2010.18497.x; Akasaka M, 2010, FRESHWATER BIOL, V55, P909, DOI 10.1111/j.1365-2427.2009.02334.x; Alonso JC, 2012, BEHAV ECOL, V23, P491, DOI 10.1093/beheco/arr215; [Anonymous], 2009, JPN J LIMNOL; Bonvechio KI, 2006, N AM J FISH MANAGE, V26, P124, DOI 10.1577/M04-191.1; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Bourg NA, 2005, ECOLOGY, V86, P2793, DOI 10.1890/04-1666; Breiman L., 2017, CLASSIFICATION REGRE; Buchan LAJ, 1999, ECOL APPL, V9, P254, DOI 10.2307/2641184; Chipps SR, 2004, OECOLOGIA, V138, P32, DOI 10.1007/s00442-003-1396-z; Chytry M, 2008, ECOLOGY, V89, P1541, DOI 10.1890/07-0682.1; Compton TJ, 2012, FRESHWATER BIOL, V57, P938, DOI 10.1111/j.1365-2427.2012.02754.x; De Montis A, 2012, LANDSCAPE URBAN PLAN, V105, P315, DOI 10.1016/j.landurbplan.2012.01.005; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Drake DAR, 2010, ECOL APPL, V20, P2286, DOI 10.1890/09-2005.1; Ervin S, 2003, ENVIRON PLANN B, V30, P757, DOI 10.1068/b2968; Essl F, 2012, BIOL INVASIONS, V14, P1331, DOI 10.1007/s10530-011-0156-y; Fisher P, 1997, J ARCHAEOL SCI, V24, P581, DOI 10.1006/jasc.1996.0142; Freund JG, 2005, J FRESHWATER ECOL, V20, P735, DOI 10.1080/02705060.2005.9664797; Fukushima M, 1999, FRESHWATER BIOL, V42, P719, DOI 10.1046/j.1365-2427.1999.00507.x; Gido KB, 2004, BIOL CONSERV, V118, P121, DOI 10.1016/j.biocon.2003.07.015; Giorgis MA, 2011, BIOL INVASIONS, V13, P1423, DOI 10.1007/s10530-010-9900-y; GROSS MR, 1980, P NATL ACAD SCI-BIOL, V77, P6937, DOI 10.1073/pnas.77.11.6937; Hasler CT, 2009, PHYSIOL BIOCHEM ZOOL, V82, P143, DOI 10.1086/591806; Irwin ER, 2002, AM FISH S S, V31, P61; Ishii Y., 2003, JAPANESE J CONSERVAT, V8, P25; Jackson ZJ, 2010, LAKE RESERV MANAGE, V26, P14, DOI 10.1080/07438140903500586; Japan Dam Foundation, 2007, DAM YB 2007; Johnson PTJ, 2008, FRONT ECOL ENVIRON, V6, P359, DOI 10.1890/070156; Kadoya T, 2011, ECOL INDIC, V11, P1396, DOI 10.1016/j.ecolind.2011.03.001; Kaufman SD, 2009, CAN J FISH AQUAT SCI, V66, P212, DOI 10.1139/F08-205; Kawamura K, 2006, MOL ECOL, V15, P613, DOI 10.1111/j.1365-294X.2006.02823.x; Knutson MG, 2004, ECOL APPL, V14, P669, DOI 10.1890/02-5305; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kondo T, 2003, DIVERS DISTRIB, V5, P223; Land Improvement and Consolidation Division Hyogo Prefecture Government, 1990, LAND IMPR HIST HYOG; Lockwood JL, 2007, INVASION ECOLOGY; Lorini ML, 2011, NAT CONSERVACAO, V9, P129, DOI 10.4322/natcon.2011.019; MacIsaac Hugh J., 2007, V2, P347; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maezono Y, 2005, ECOL APPL, V15, P638, DOI 10.1890/02-5386; Marini L, 2012, GLOBAL ECOL BIOGEOGR, V21, P534, DOI 10.1111/j.1466-8238.2011.00702.x; Maruyama T, 1987, INTRO PROCESS FOREIG; Maruyama T, 2002, BLACK BASS ITS BIOL, P99; McKinney CL, 2001, BIOL CONSERV, V100, P243, DOI 10.1016/S0006-3207(01)00027-1; Miyata Hiroshi, 2007, Ecology and Civil Engineering, V10, P117, DOI 10.3825/ece.10.117; Moyle PB, 2006, BIOSCIENCE, V56, P515, DOI 10.1641/0006-3568(2006)56[515:PISFFI]2.0.CO;2; National Federation of Inlandwater Fisheries Cooperatices, 1992, REV EX LARG BASS MIC; Niggemann M, 2009, ECOL MODEL, V220, P1339, DOI 10.1016/j.ecolmodel.2009.02.018; OECD, 1982, EUTR WAT MON ASS CON; Oertli B, 2005, AQUAT CONSERV, V15, P535, DOI 10.1002/aqc.752; Pollnac F, 2012, BIOL INVASIONS, V14, P1753, DOI 10.1007/s10530-012-0188-y; R Core Team, 2021, R LANG ENV STAT COMP; Senou H., 2008, ALIEN FISHES JAPAN; Senou H, 2002, BLACK BASS BIOL ECOS, P47; Sevenant M, 2007, LANDSCAPE URBAN PLAN, V80, P362, DOI 10.1016/j.landurbplan.2006.09.004; Sharma GP, 2009, ENVIRON MONIT ASSESS, V157, P191, DOI 10.1007/s10661-008-0527-8; Shoup DE, 2009, T AM FISH SOC, V138, P1018, DOI 10.1577/T09-015.1; Takamura K, 2007, ECOL RES, V22, P940, DOI 10.1007/s11284-007-0415-7; Takamura N., 2012, BIODIVERSITY OBSERVA, P133, DOI DOI 10.1007/978-4-431-54032-8_10; Therneau T. M., 1997, INTRO RECURSIVE PART; Tricarico E, 2012, FISHERIES MANAG ECOL, V19, P133, DOI 10.1111/j.1365-2400.2011.00834.x; Uchida K., 2003, IRRIGATION PONDS JAP; UN CBD, 2010, COP 10 DEC X 2 STRAT; Vander Zanden MJ, 2008, CAN J FISH AQUAT SCI, V65, P1512, DOI 10.1139/F08-099; Welch EB, 2011, LAKE RESERV MANAGE, V27, P271, DOI 10.1080/07438141.2011.607553; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8; Yonekura R, 2004, ICHTHYOL RES, V51, P176, DOI 10.1007/s10228-003-0200-8; Yonekura R, 2002, ECOL RES, V17, P49, DOI 10.1046/j.1440-1703.2002.00462.x	70	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99709	10.1371/journal.pone.0099709	http://dx.doi.org/10.1371/journal.pone.0099709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923423	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300086
J	Li, M; Wang, K; Wang, X; Yang, PF				Li, Ming; Wang, Kun; Wang, Xin; Yang, Pingfang			Morphological and Proteomic Analysis Reveal the Role of Pistil under Pollination in Liriodendron chinense (Hemsl.) Sarg.	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; EMBRYO DEVELOPMENT; SEED-SET; IDENTIFICATION; GENES; HYDROLYSIS; ANNOTATION; DATABASES; BLAST2GO; POPLAR	Pollination is an important physiological process during which interaction between pollen and pistil occurs. This interaction could determine whether or not fertilization will occur and hence the ratio of plant seed setting. Liriodendron chinense (Hemsl.) Sarg. (L. chinense) exhibits a distinct phenomenon where seed setting ratio is not more than 10% in natural environment. To explore the origin of this phenomenon, we conducted a comparative morphological and proteomic analysis on L. chinense pistils upon pollination. The morphological analysis showed that pollen grows well in vitro, but much slower on pistil or nutrient medium containing pistil extract. Proteomic analysis showed that 493 proteins had changed the expression after pollination. Among them, 468 and 51 proteins were identified by isobaric tags for relative and absolute quantitation and two-dimensional gel electrophoresis respectively, and 26 proteins were common in the two methods. After proteins functional categorization, 66 differentially expressed proteins that are involved in reproduction process were found. Further analysis showed that among the reproductive process related proteins, protein disulfide-isomerase A6 and four embryo-defective proteins showed closer relations with the low seed setting phenomenon. The results indicated that the element from pistil might be the main reason leading to low seed setting in L. chinense, which will provide new insights in the mechanisms underlying L. chinense reproduction process.	[Li, Ming; Wang, Kun; Wang, Xin; Yang, Pingfang] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China; [Li, Ming; Wang, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, PF (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China.	yangpf@wbgcas.cn		Li, Ming/0000-0002-2679-6137	100 talents program of Chinese Academy of Sciences; National Natural Science Foundation of China [31300516]	100 talents program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the 100 talents program of Chinese Academy of Sciences and the National Natural Science Foundation of China (No. 31300516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlin A, 2006, BIOTECHNOL BIOENG, V93, P880, DOI 10.1002/bit.20783; Bryant N, 2011, PLANT PHYSIOL, V155, P1678, DOI 10.1104/pp.110.168120; CELEN I, 2008, HOLZFORSCHUNG, V62, P189, DOI DOI 10.1515/HF.2008.048; Chi F, 2010, PROTEOMICS, V10, P1861, DOI 10.1002/pmic.200900694; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Devic M, 2008, CR BIOL, V331, P726, DOI 10.1016/j.crvi.2008.07.014; Ducret A, 1998, PROTEIN SCI, V7, P706, DOI 10.1002/pro.5560070320; Fan Ru-Wen, 1992, Acta Botanica Sinica, V34, P437; Fan RuWen, 1996, Journal of Nanjing Forestry University, V20, P1; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gruber CW, 2007, J BIOL CHEM, V282, P20435, DOI 10.1074/jbc.M700018200; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hao Ri-Ming, 1995, Journal of Plant Resources and Environment, V4, P1; Hernandez R., 1997, STRENGTH STIFFNESS R, VVolume 554; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P29; Huang JQ, 1998, J ZHEJIANG FORESTRY, V15, P267; Huang SQ, 1999, ACTA BOT SIN, V41, P241; Huang SQ, 1998, ACTA BOT SIN, V40, P22; Huang SQ, 2002, BOT J LINN SOC, V140, P31, DOI 10.1046/j.1095-8339.2002.00080.x; Hunt D., 1998, MAGNOLIAS THEIR ALLI; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Kim KD, 2005, ENVIRON MANAGE, V36, P1, DOI 10.1007/s00267-004-1089-3; Kim YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044493; Kudi AC, 1999, J ETHNOPHARMACOL, V67, P225, DOI 10.1016/S0378-8741(98)00214-1; Li M, 2012, SEX PLANT REPROD, V25, P281, DOI 10.1007/s00497-012-0197-0; Makarov A, 2006, ANAL CHEM, V78, P2113, DOI 10.1021/ac0518811; Meinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007386; Moody RC, 1993, YELLOW POPLAR GLULAM; Moon MK, 2007, ARCH PHARM RES, V30, P299, DOI 10.1007/BF02977609; Mooney BP, 2004, PHYTOCHEMISTRY, V65, P1733, DOI 10.1016/j.phytochem.2004.04.011; Muralla R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028398; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; PARKS CR, 1990, J HERED, V81, P317, DOI 10.1093/oxfordjournals.jhered.a110996; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Qin Y, 2011, PLANT J, V68, P800, DOI 10.1111/j.1365-313X.2011.04729.x; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Wang HZ, 2008, PLANT CELL, V20, P3300, DOI 10.1105/tpc.108.062919; Wang S, 1992, RED LIST ENDANGERED; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Williams RS, 2004, FOREST PROD J, V54, P96; Xiang Q, 2004, APPL BIOCHEM BIOTECH, V113, P1127, DOI 10.1385/ABAB:115:1-3:1127; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Zhou J., 1999, CHINESE B BOT, V16, P75; Zhou J, 1994, SCI SILVAE SIN, V30, P405	47	9	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99970	10.1371/journal.pone.0099970	http://dx.doi.org/10.1371/journal.pone.0099970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924488	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300113
J	Menezes-Souza, D; Mendes, TAD; Nagem, RAP; Santos, TTD; Silva, ALT; Santoro, MM; de Carvalho, SFG; Coelho, EAF; Bartholomeu, DC; Fujiwara, RT				Menezes-Souza, Daniel; de Oliveira Mendes, Tiago Antonio; Pinto Nagem, Ronaldo Alves; de Oliveira Santos, Thais Teodoro; Teixeira Silva, Ana Luiza; Santoro, Marcelo Matos; Guimaraes de Carvalho, Silvio Fernando; Ferraz Coelho, Eduardo Antonio; Bartholomeu, Daniella Castanheira; Fujiwara, Ricardo Toshio			Mapping B-Cell Epitopes for the Peroxidoxin of Leishmania (Viannia) braziliensis and Its Potential for the Clinical Diagnosis of Tegumentary and Visceral Leishmaniasis	PLOS ONE			English	Article							IMMUNOSORBENT-ASSAY ELISA; CUTANEOUS LEISHMANIASIS; ANTIBODIES; VACCINE; IDENTIFICATION; SERODIAGNOSIS; ANTIGEN; PEROXIREDOXINS; PROMASTIGOTE; METASTASIS	The search toward the establishment of novel serological tests for the diagnosis of leishmaniasis and proper differential diagnosis may represent one alternative to the invasive parasitological methods currently used to identify infected individuals. In the present work, we investigated the potential use of recombinant peroxidoxin (rPeroxidoxin) of Leishmania (Viannia) braziliensis as a potential antigen for the immunodiagnosis of human tegumentary (TL) and visceral leishmaniasis (VL) and canine visceral leishmaniasis (CVL). Linear B-cell epitope mapping was performed to identify polymorphic epitopes when comparing orthologous sequences present in Trypanosoma cruzi, the agent for Chagas disease (CD), and the Homo sapiens and Canis familiaris hosts. The serological assay (ELISA) demonstrated that TL, VL and CVL individuals showed high levels of antibodies against rPeroxidoxin, allowing identification of infected ones with considerable sensitivity and great ability to discriminate (specificity) between non-infected and CD individuals (98.46% and 100%; 98.18% and 95.71%; 95.79% and 100%, respectively). An rPeroxidoxin ELISA also showed a greater ability to discriminate between vaccinated and infected animals, which is an important requirement for the public campaign control of CVL. A depletion ELISA assay using soluble peptides of this B-cell epitope confirmed the recognition of these sites only by Leishmania-infected individuals. Moreover, this work identifies two antigenic polymorphic linear B-cell epitopes of L. braziliensis. Specific recognition of TL and VL patients was confirmed by significantly decreased IgG reactivity against rPeroxidoxin after depletion of peptide-1-and peptide-2-specific antibodies (peptide 1: reduced by 32%, 42% and 5% for CL, ML and VL, respectively; peptide-2: reduced by 24%, 22% and 13% for CL, ML and VL, respectively) and only peptide-2 for CVL (reduced 9%). Overall, rPeroxidoxin may be a potential antigen for the immunodiagnosis of TL, VL or CVL, as it has a higher agreement with parasitological assays and is better than other reference tests that use soluble Leishmania antigens for diagnosing CVL in Brazil (EIE-LVC, Bio-manguinhos, FIOCRUZ).	[Menezes-Souza, Daniel; de Oliveira Mendes, Tiago Antonio; de Oliveira Santos, Thais Teodoro; Teixeira Silva, Ana Luiza; Bartholomeu, Daniella Castanheira; Fujiwara, Ricardo Toshio] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Pinto Nagem, Ronaldo Alves; Santoro, Marcelo Matos] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Guimaraes de Carvalho, Silvio Fernando] Univ Estadual Montes Claros, Ctr Ciencias Biol & Saude, Montes Claros, Brazil; [Ferraz Coelho, Eduardo Antonio] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil; [Ferraz Coelho, Eduardo Antonio] Univ Fed Minas Gerais, COLTEC, Dept Patol Clin, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Estadual de Montes Claros; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Fujiwara, RT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	fujiwara@icb.ufmg.br	Mendes, Tiago/AAG-1709-2021; Bartholomeu, Daniella C./J-4714-2015; Nagem, Ronaldo A P/K-3995-2012; Fujiwara, Ricardo Toshio/J-7579-2012; COELHO, EA/V-7926-2017; Menezes-Souza, Daniel DMS/N-7389-2014	Mendes, Tiago/0000-0002-5569-4893; Bartholomeu, Daniella C./0000-0003-0974-7357; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; COELHO, EA/0000-0002-6681-9014; Teixeira Silva, Ana Luiza/0000-0002-1152-9255	FAPEMIG; CNPq; CAPES; Pro-Reitoria de Pesquisa of UFMG	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pesquisa of UFMG	Funding provided by FAPEMIG, CNPq, CAPES and Pro-Reitoria de Pesquisa of UFMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2006, J INFECT DIS, V194, P1160, DOI 10.1086/507646; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Pereira VRA, 2012, DIAGN MICR INFEC DIS, V74, P292, DOI 10.1016/j.diagmicrobio.2012.06.025; Alves Waneska Alexandre, 2004, Cad. Saúde Pública, V20, P259, DOI 10.1590/S0102-311X2004000100043; ANTHONY RL, 1980, AM J TROP MED HYG, V29, P190, DOI 10.4269/ajtmh.1980.29.190; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; BADARO R, 1986, AM J TROP MED HYG, V35, P72, DOI 10.4269/ajtmh.1986.35.72; Barbosa-de-Deus R, 2002, CLIN DIAGN LAB IMMUN, V9, P1361, DOI 10.1128/CDLI.9.6.1361-1366.2002; BARRAL A, 1987, Memorias do Instituto Oswaldo Cruz, V82, P579, DOI 10.1590/S0074-02761987000400018; Basu A, 2012, PROTEIN J, V31, P93, DOI [10.1007/s10930-011-9377-2, 10.1107/S174430911105038X]; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Braga M D, 1998, Rev Soc Bras Med Trop, V31, P419, DOI 10.1590/S0037-86821998000500001; Brito MEF, 2000, CLIN DIAGN LAB IMMUN, V7, P318, DOI 10.1128/CDLI.7.2.318-321.2000; Bueno LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021289; Carneiro FRG, 2006, BIOCHEM BIOPH RES CO, V343, P260, DOI 10.1016/j.bbrc.2006.02.140; Coelho EAF, 2009, CLIN VACCINE IMMUNOL, V16, P1774, DOI 10.1128/CVI.00295-09; Coelho VTS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001430; Costa MM, 2011, J PROTEOME RES, V10, P2172, DOI 10.1021/pr101286y; Mendes TAD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002524; DEBRUIJN MHL, 1992, ACTA TROP, V52, P45, DOI 10.1016/0001-706X(92)90006-J; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; EVANS TG, 1990, AM J TROP MED HYG, V42, P118, DOI 10.4269/ajtmh.1990.42.118; Ferreira Maíra Peres, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P215, DOI 10.1590/S0036-46652006000400008; FLEISS JL, 1972, ARCH GEN PSYCHIAT, V26, P168; Giunchetti RC, 2008, RES VET SCI, V85, P106, DOI 10.1016/j.rvsc.2007.09.008; Giunchetti RC, 2007, VACCINE, V25, P7674, DOI 10.1016/j.vaccine.2007.08.009; Gretes MC, 2012, ANTIOXID REDOX SIGN, V17, P608, DOI 10.1089/ars.2011.4404; Ikonomopoulos J, 2003, VET PARASITOL, V113, P99, DOI 10.1016/S0304-4017(03)00061-X; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Linnet K, 2012, CLIN CHEM, V58, P1292, DOI 10.1373/clinchem.2012.182543; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; MAYRINK W, 1979, T ROY SOC TROP MED H, V73, P385, DOI 10.1016/0035-9203(79)90159-7; Mayrink W, 1996, MEM I OSWALDO CRUZ, V91, P695, DOI 10.1590/S0074-02761996000600006; Ndao Momar, 2009, Interdiscip Perspect Infect Dis, V2009, P278246, DOI 10.1155/2009/278246; ParanhosSilva M, 1996, AM J TROP MED HYG, V55, P39, DOI 10.4269/ajtmh.1996.55.39; Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; ROFFI J, 1980, AM J TROP MED HYG, V29, P183, DOI 10.4269/ajtmh.1980.29.183; Santarem N, 2005, IMMUNOL LETT, V101, P18, DOI 10.1016/j.imlet.2005.04.006; Santarem N, 2010, J CLIN MICROBIOL, V48, P1866, DOI 10.1128/JCM.02402-09; Souza AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066110; Todoli F, 2009, VET PARASITOL, V164, P154, DOI 10.1016/j.vetpar.2009.05.032; Vega-Lopez F, 2003, CURR OPIN INFECT DIS, V16, P97, DOI 10.1097/00001432-200304000-00006; Vexenat Ana De Cassia, 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P177, DOI 10.1590/S0036-46651996000300003; Walker J, 2006, MOL BIOCHEM PARASIT, V145, P254, DOI 10.1016/j.molbiopara.2005.10.008; Wellings DA, 1997, METHOD ENZYMOL, V289, P44	48	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99216	10.1371/journal.pone.0099216	http://dx.doi.org/10.1371/journal.pone.0099216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921246	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300046
J	Park, K; Song, B; Kim, J; Hong, I; Song, S; Lee, J; Park, S; Kim, J; An, B; Lee, HW; Lee, S; Kim, H; Lee, JC; Lee, S; Choi, S				Park, Kyungjoon; Song, Beomjong; Kim, Jeongyeon; Hong, Ingie; Song, Sangho; Lee, Junuk; Park, Sungmo; Kim, Jihye; An, Bobae; Lee, Hyun Woo; Lee, Seungbok; Kim, Hyun; Lee, Justin C.; Lee, Sukwon; Choi, Sukwoo			ABA Renewal Involves Enhancements in Both GluA2-Lacking AMPA Receptor Activity and GluA1 Phosphorylation in the Lateral Amygdala	PLOS ONE			English	Article							CALCIUM-PERMEABLE AMPA; LONG-TERM POTENTIATION; HIPPOCAMPAL INACTIVATION; GLUTAMATE RECEPTORS; CONTEXTUAL CONTROL; FEAR MEMORY; EXTINCTION; RAT; MEDIATE; RECTIFICATION	Fear renewal, the context-specific relapse of fear following fear extinction, is a leading animal model of post-traumatic stress disorders (PTSD) and fear-related disorders. Although fear extinction can diminish fear responses, this effect is restricted to the context where the extinction is carried out, and the extinguished fear strongly relapses when assessed in the original acquisition context (ABA renewal) or in a context distinct from the conditioning and extinction contexts (ABC renewal). We have previously identified Ser831 phosphorylation of GluA1 subunit in the lateral amygdala (LA) as a key molecular mechanism for ABC renewal. However, molecular mechanisms underlying ABA renewal remain to be elucidated. Here, we found that both the excitatory synaptic efficacy and GluA2-lacking AMPAR activity at thalamic input synapses onto the LA (T-LA synapses) were enhanced upon ABA renewal. GluA2-lacking AMPAR activity was also increased during low-threshold potentiation, a potential cellular substrate of renewal, at T-LA synapses. The microinjection of 1-naphtylacetyl-spermine (NASPM), a selective blocker of GluA2-lacking AMPARs, into the LA attenuated ABA renewal, suggesting a critical role of GluA2-lacking AMPARs in ABA renewal. We also found that Ser831 phosphorylation of GluA1 in the LA was increased upon ABA renewal. We developed a short peptide mimicking the Ser831-containing C-tail region of GluA1, which can be phosphorylated upon renewal (GluA1(S)); thus, the phosphorylated GluA1(S) may compete with Ser831-phosphorylated GluA1. This GluA1(S) peptide blocked the low-threshold potentiation when dialyzed into a recorded neuron. The microinjection of a cell-permeable form of GluA1(S) peptide into the LA attenuated ABA renewal. In support of the GluA1(S) experiments, a GluA1(D) peptide (in which the serine at 831 is replaced with a phosphomimetic amino acid, aspartate) attenuated ABA renewal when microinjected into the LA. These findings suggest that enhancements in both the GluA2-lacking AMPAR activity and GluA1 phosphorylation at Ser831 are required for ABA renewal.	[Park, Kyungjoon; Song, Beomjong; Hong, Ingie; Lee, Junuk; Park, Sungmo; Kim, Jihye; An, Bobae; Lee, Sukwon; Choi, Sukwoo] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Jeongyeon; Song, Sangho; Lee, Justin C.] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Kim, Jeongyeon; Song, Sangho; Lee, Justin C.] Korea Inst Sci & Technol, Ctr Connect, Seoul, South Korea; [Lee, Hyun Woo; Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Lee, Hyun Woo; Kim, Hyun] Korea Univ, Coll Med, Brain Korea Biomed Sci Program 21, Seoul 136705, South Korea; [Lee, Seungbok] Seoul Natl Univ, Dent Res Inst, Dept Cell & Dev Biol, Seoul, South Korea	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Lee, S (corresponding author), Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea.	sukwon2@snu.ac.kr; sukwoo12@snu.ac.k	Lee, Seungbok/AAS-1529-2021; Park, Kyungjoon/AAL-8086-2020	Lee, Seungbok/0000-0002-6620-6269; Park, Kyungjoon/0000-0002-7518-636X; Song, Beomjong/0000-0001-8820-7310; Kim, Hyun/0000-0002-7210-5798; Lee, Sukwon/0000-0001-7654-5769; Lee, C Justin/0000-0002-3555-0980; Lee, Junuk/0000-0002-3596-2651; Hong, Ingie/0000-0002-7246-9233	National Research Foundation (NRF) of Korea [NRF-2011-0012876]; Korean Ministry of Science and Technology; NRF of Korea grant - Korea government the Ministry of Education, Science and Technology (MEST) [2011-0018209]; Original Technology ResearchProgram for Brain Science through the NRF of Korea - MEST [2011-0019226]; Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health AMP; Welfare, Republic of Korea [HI12C1492]; Brain Korea 21 Research Fellowships from the Korean Ministry of Education	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); NRF of Korea grant - Korea government the Ministry of Education, Science and Technology (MEST)(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); Original Technology ResearchProgram for Brain Science through the NRF of Korea - MEST(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health AMP; Welfare, Republic of Korea; Brain Korea 21 Research Fellowships from the Korean Ministry of Education(Ministry of Education (MOE), Republic of Korea)	This work was supported by the National Research Foundation (NRF) of Korea Grant NRF-2011-0012876, funded by the Korean Ministry of Science and Technology (SL), by the NRF of Korea grant funded by the Korea government the Ministry of Education, Science and Technology (MEST) (No. 2011-0018209) (SC), by the Original Technology ResearchProgram for Brain Science through the NRF of Korea funded by MEST (No. 2011-0019226) (SC), and by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C1492). KP, BS, JK, IH and JL were supported by Brain Korea 21 Research Fellowships from the Korean Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Chung HJ, 2000, J NEUROSCI, V20, P7258; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Cole S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058701; Cole S, 2011, LEARN MEMORY, V18, P88, DOI 10.1101/lm.2049511; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Corcoran KA, 2004, LEARN MEMORY, V11, P598, DOI 10.1101/lm.78704; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Ehlers A, 2002, BEHAV RES THER, V40, P995, DOI 10.1016/S0005-7967(01)00077-8; Fonteyne R, 2011, EXP PSYCHOL, V58, P278, DOI 10.1027/1618-3169/a000094; Frohardt RJ, 2000, BEHAV NEUROSCI, V114, P227, DOI 10.1037/0735-7044.114.2.227; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Harris JA, 2000, J EXP PSYCHOL-ANIM B, V26, P174, DOI 10.1037//0097-7403.26.2.174; Havermans RC, 2005, LEARN MOTIV, V36, P1, DOI 10.1016/j.lmot.2004.09.002; Hermans D, 2006, BIOL PSYCHIAT, V60, P361, DOI 10.1016/j.biopsych.2005.10.006; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hong I, 2013, P NATL ACAD SCI USA, V110, P8218, DOI 10.1073/pnas.1305235110; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Kim J, 2007, BIOCHEM BIOPH RES CO, V355, P188, DOI 10.1016/j.bbrc.2007.01.125; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee S, 2013, NAT NEUROSCI, V16, P1436, DOI 10.1038/nn.3491; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Mao SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059580; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nader K, 2001, LEARN MEMORY, V8, P156, DOI 10.1101/lm.38101; Neumann DL, 2006, LEARN MOTIV, V37, P149, DOI 10.1016/j.lmot.2005.06.004; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Sapolsky RM, 2001, HIPPOCAMPUS, V11, P90, DOI 10.1002/hipo.1026; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Thomas BL, 2003, LEARN MOTIV, V34, P410, DOI 10.1016/S0023-9690(03)00037-7; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Ungor M, 2008, LEARNING MOTIVATION; Vervliet B, 2013, ANNU REV CLIN PSYCHO, V9, P215, DOI 10.1146/annurev-clinpsy-050212-185542; Wilensky AE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0006.1999; WILSON A, 1995, BEHAV NEUROSCI, V109, P828, DOI 10.1037/0735-7044.109.5.828	50	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e100108	10.1371/journal.pone.0100108	http://dx.doi.org/10.1371/journal.pone.0100108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925360	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300121
J	Yang, H; Shao, ML; Chen, LM; Chen, QS; Yu, LC; Cai, LQ; Lin, ZZ; Zhang, C; Lu, XM				Yang, Hong; Shao, Minglong; Chen, Liangmiao; Chen, Qingshou; Yu, Lechu; Cai, Lingqiao; Lin, Zhenzhen; Zhang, Chi; Lu, Xuemian			Screening Strategies for Thyroid Disorders in the First and Second Trimester of Pregnancy in China	PLOS ONE			English	Article							SUBCLINICAL HYPOTHYROIDISM; WOMEN; DYSFUNCTION; UNIVERSAL; DISEASE; RISK; COMPLICATIONS; MANAGEMENT; DEFICIENCY; OUTCOMES	Background: Thyroid dysfunction during pregnancy is associated with multiple adverse outcomes, but whether all women should be screened for thyroid disorders during pregnancy remains controversial. Objective: To evaluate the effectiveness of the targeted high risk case-finding approach for identifying women with thyroid dysfunction during the first and second trimesters of pregnancy. Methods: Levels of thyroid stimulating hormone (TSH), free thyroxine (FT4), and thyroid peroxidase antibodies (TPOAb) were measured in 3882 Chinese women during the first and second trimester of pregnancy. All tested women were divided into the high risk or non-high risk groups, based on their history, findings from physical examination, or other clinical features suggestive of a thyroid disorder. Diagnosis of thyroid disorders was made according to the standard trimester-specific reference intervals. The prevalence of thyroid disorders in each group was determined, and the feasibility of a screening approach focusing exclusively on high risk women was evaluated to estimate the ability of finding women with thyroid dysfunction. Results: The prevalence of overt hypothyroidism or hyperthyroidism in the high risk group was higher than in the non-high risk group during the first trimester (0.8% vs 0, chi(2) = 7.10, p = 0.008; 1.6% vs 0.2%, chi(2) = 7.02, p = 0.008, respectively). The prevalence of hypothyroxinemia or TPOAb positivity was significantly higher in the high risk group than in the non-high risk group during the second trimester (1.3% vs 0.5%, chi(2) = 4.49, p = 0.034; 11.6% vs 8.4%, chi(2) = 6.396, p = 0.011, respectively). The total prevalence of hypothyroidism or hyperthyroidism and the prevalence of subclinical hypothyroidism or hyperthyroidism were not statistically different between the high risk and non-high risk groups, for either the first or second trimester. Conclusion: The high risk screening strategy failed to detect the majority of pregnant women with thyroid disorders. Therefore, we recommend universal screening of sTSH, FT4, and TPOAb during the first trimester and second trimester of pregnancy.	[Yang, Hong; Chen, Liangmiao; Chen, Qingshou; Yu, Lechu; Cai, Lingqiao; Lin, Zhenzhen; Lu, Xuemian] Wenzhou Med Univ, Dept Endocrinol, Hosp 3, Ruian, Zhejiang, Peoples R China; [Yang, Hong; Chen, Liangmiao; Chen, Qingshou; Yu, Lechu; Cai, Lingqiao; Lin, Zhenzhen; Lu, Xuemian] Wenzhou Med Univ, Ruian Ctr, Hosp 3, Chinese Amer Res Inst Diabet Complicat, Ruian, Zhejiang, Peoples R China; [Shao, Minglong; Zhang, Chi] Wenzhou Med Univ, Key Lab Biotechnol Pharmaceut Engn, Sch Pharmaceut Sci, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zhang, C (corresponding author), Wenzhou Med Univ, Key Lab Biotechnol Pharmaceut Engn, Sch Pharmaceut Sci, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Zhejiang, Peoples R China.	zhangchi515@126.com; lu89118@medmail.com.cn	Cai, Lu/AAG-9920-2019	Liangmiao, Chen/0000-0002-6687-5825	Medical Science Research Foundation of Zhejiang Province [2009A198]; Science and technology project of Ruian city [20093092]; Ruian Science and Technology Plan [201002051]; Young Scientist Award from National Science Foundation of China [81000294]; National Science Foundation of China [81370917]; Research Development Fund of Wenzhou Medical University [QTJ13005]	Medical Science Research Foundation of Zhejiang Province; Science and technology project of Ruian city; Ruian Science and Technology Plan; Young Scientist Award from National Science Foundation of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Development Fund of Wenzhou Medical University	This study was supported in part by a project from Medical Science Research Foundation of Zhejiang Province (2009A198, to XL), and the third batch of Science and technology project of Ruian city (20093092, to XL), a project funding was further supported by Ruian Science and Technology Plan (201002051, to HY), a Young Scientist Award from National Science Foundation of China (81000294, to CZ), a National Science Foundation of China (81370917, to CZ) and the Research Development Fund of Wenzhou Medical University (QTJ13005, to CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan WC, 2000, J MED SCREEN, V7, P127, DOI 10.1136/jms.7.3.127; [Anonymous], 2003, THYROID, V13, P3; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Casey BM, 2006, OBSTET GYNECOL, V108, P1283, DOI 10.1097/01.AOG.0000244103.91597.c5; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; De Vivo A, 2010, THYROID, V20, P633, DOI 10.1089/thy.2009.0323; Dosiou C, 2012, J CLIN ENDOCR METAB, V97, P1536, DOI 10.1210/jc.2011-2884; Endocrine Society, 2007, Thyroid, V17, P1159; GLINOER D, 1994, J CLIN ENDOCR METAB, V79, P197, DOI 10.1210/jcem.79.1.8027226; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Hirsch D, 2013, EUR J ENDOCRINOL, V169, P313, DOI 10.1530/EJE-13-0228; Julvez J, 2013, EPIDEMIOLOGY, V24, P150, DOI 10.1097/EDE.0b013e318276ccd3; Lazarus JH, 2012, NEW ENGL J MED, V366, P493, DOI 10.1056/NEJMoa1106104; Mannisto T, 2013, J CLIN ENDOCR METAB, V98, P2725, DOI 10.1210/jc.2012-4233; Mannisto T, 2010, J CLIN ENDOCR METAB, V95, P1084, DOI 10.1210/jc.2009-1904; Negro R, 2006, J CLIN ENDOCR METAB, V91, P2587, DOI 10.1210/jc.2005-1603; Negro R, 2010, J CLIN ENDOCR METAB, V95, P1699, DOI 10.1210/jc.2009-2009; Papendieck P, 2009, J PEDIATR ENDOCR MET, V22, P547; Pop VJ, 2003, CLIN ENDOCRINOL, V59, P282, DOI 10.1046/j.1365-2265.2003.01822.x; Potlukova E, 2012, J CLIN ENDOCR METAB, V97, P1945, DOI 10.1210/jc.2011-3275; Prummel MF, 2004, EUR J ENDOCRINOL, V150, P751, DOI 10.1530/eje.0.1500751; Sheffield JS, 2004, AM J OBSTET GYNECOL, V190, P211, DOI 10.1016/S0002-9378(03)00944-X; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Su PY, 2011, J CLIN ENDOCR METAB, V96, P3234, DOI 10.1210/jc.2011-0274; Thung SF, 2009, AM J OBSTET GYNECOL, V200, pe261; Vaidya B, 2007, J CLIN ENDOCR METAB, V92, P203, DOI 10.1210/jc.2006-1748; Wang WW, 2011, EUR J ENDOCRINOL, V164, P263, DOI 10.1530/EJE-10-0660	27	16	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99611	10.1371/journal.pone.0099611	http://dx.doi.org/10.1371/journal.pone.0099611			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925135	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300081
J	Abrahao, KP; Goeldner, FO; Souza-Formigoni, MLO				Abrahao, Karina Possa; Goeldner, Francine Oliveira; Oliveira Souza-Formigoni, Maria Lucia			Individual Differences in Ethanol Locomotor Sensitization Are Associated with Dopamine D1 Receptor Intra-Cellular Signaling of DARPP-32 in the Nucleus Accumbens	PLOS ONE			English	Article							BEHAVIORAL SENSITIZATION; ALCOHOL; TOLERANCE; EXPRESSION; PHOSPHOPROTEIN; SENSITIVITY; INCREASES; C57BL/6J; DRINKING; DBA/2J	In mice there are clear individual differences in the development of behavioral sensitization to ethanol, a progressive potentiation of its psychomotor stimulant effect. Variability in the behavioral responses to ethanol has been associated with alcohol preference. Here we investigated if the functional hyperresponsiveness of D1 receptors observed in ethanol sensitized mice leads to an increased activation of DARPP-32, a central regulatory protein in medium spiny neurons, in the nucleus accumbens - a brain region known to play a role in drug reinforcement. Swiss Webster mice received ethanol (2.2 g/kg/day) or saline i.p. administrations for 21 days and were weekly evaluated regarding their locomotor activity. From those treated with ethanol, the 33% with the highest levels of locomotor activity were classified as "sensitized'' and the 33% with the lowest levels as "non-sensitized''. The latter presented similar locomotor levels to those of saline-treated mice. Different subgroups of mice received intra-accumbens administrations of saline and, 48 h later, SKF-38393, D1 receptor agonist 0.1 or 1 mg/side. Indeed, sensitized mice presented functional hyperresponsiveness of D1 receptors in the accumbens. Two weeks following the ethanol treatment, other subgroups received systemic saline or SKF 10 mg/kg, 20 min before the euthanasia. The nucleus accumbens were dissected for the Western Blot analyses of total DARPP-32 and phospho-Thr34-DARPP-32 expression. D1 receptor activation induced higher phospho-Thr34-DARPP-32 expression in sensitized mice than in non-sensitized or saline. The functionally hyperresponsiveness of D1 receptors in the nucleus accumbens is associated with an increased phospho-Thr34-DARPP-32 expression after D1 receptor activation. These data suggest that an enduring increase in the sensitivity of the dopamine D1 receptor intracellular pathway sensitivity represents a neurobiological correlate associated with the development of locomotor sensitization to ethanol.	[Abrahao, Karina Possa; Goeldner, Francine Oliveira; Oliveira Souza-Formigoni, Maria Lucia] Univ Fed Sao Paulo, Escola Paulista Med, Dept Psicobiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Souza-Formigoni, MLO (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Psicobiol, Sao Paulo, Brazil.	mlosformigoni@unifesp.br	Souza-Formigoni, Maria Lucia O/B-5736-2011; Abrahao, Karina/R-3267-2017	Souza-Formigoni, Maria Lucia O/0000-0002-6361-5630; Abrahao, Karina/0000-0002-4528-2430	Fundacao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/01819-5]; Associacao Fundo Incentivo a Pesquisa (AFIP); Conselho Nacional de de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Associacao Fundo Incentivo a Pesquisa (AFIP); Conselho Nacional de de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by Fundacao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 2008/01819-5), Associacao Fundo Incentivo a Pesquisa (AFIP), Conselho Nacional de de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao KP, 2011, INT J NEUROPSYCHOPH, V14, P175, DOI 10.1017/S1461145710000441; Abrahao KP, 2009, BEHAV BRAIN RES, V197, P404, DOI 10.1016/j.bbr.2008.10.009; Abrahao KP, 2013, J NEUROSCIE IN PRESS; Abrahao KP, 2011, NEUROPHARMACOLOGY; Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; DIANA M, 1992, ALCOHOL ALCOHOLISM, V27, P329; Fidler TL, 2011, GENES BRAIN BEHAV, V10, P264, DOI 10.1111/j.1601-183X.2010.00664.x; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Grahame NJ, 2000, PSYCHOPHARMACOLOGY, V151, P252, DOI 10.1007/s002130000388; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Lessov CN, 2001, PSYCHOPHARMACOLOGY, V155, P91, DOI 10.1007/s002130100699; Maldve RE, 2002, NAT NEUROSCI, V5, P641, DOI 10.1038/nn877; MASUR J, 1988, PSYCHOPHARMACOLOGY, V96, P547, DOI 10.1007/BF02180038; MASUR J, 1986, PHARMACOL BIOCHEM BE, V24, P1225, DOI 10.1016/0091-3057(86)90175-9; Melon LC, 2011, ALCOHOL CLIN EXP RES, V35, P1351, DOI 10.1111/j.1530-0277.2011.01471.x; Newlin DB, 1999, EXP CLIN PSYCHOPHARM, V7, P234, DOI 10.1037/1064-1297.7.3.234; Nuutinen S, 2011, NEUROSCI LETT, V503, P31, DOI 10.1016/j.neulet.2011.08.002; PAXINOS G, 2004, MOUSE BRAIN; Quadros IMH, 2002, ADDICT BIOL, V7, P291, DOI 10.1080/13556210220139505; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Reis HJ, 2007, EXPERT OPIN THER TAR, V11, P1649, DOI 10.1517/14728222.11.12.1649; Risinger FO, 2001, J NEUROSCI, V21, P340, DOI 10.1523/JNEUROSCI.21-01-00340.2001; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Scott L, 2005, PEDIATR RES, V58, P779, DOI 10.1203/01.PDR.0000180553.23507.31; SEGAL DS, 1974, PHARMACOL BIOCHEM BE, V2, P249, DOI 10.1016/0091-3057(74)90060-4; Snyder GL, 1998, J NEUROSCI, V18, P10297; Souza-Formigoni MLO, 1999, PSYCHOPHARMACOLOGY, V146, P262, DOI 10.1007/s002130051115; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; Svenningsson P, 2005, AAPS J, V7, DOI 10.1208/aapsj070235; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vanderschuren LJMJ, 1999, PSYCHOPHARMACOLOGY, V143, P244, DOI 10.1007/s002130050943; Yim HJ, 2000, ALCOHOL, V22, P107, DOI 10.1016/S0741-8329(00)00121-X	34	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98296	10.1371/journal.pone.0098296	http://dx.doi.org/10.1371/journal.pone.0098296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919054	gold, Green Published			2022-12-25	WOS:000338631000015
J	Castillo, MG; Gillespie, DOS; Allen, K; Bandosz, P; Schmid, V; Capewell, S; O'Flaherty, M				Castillo, Maria Guzman; Gillespie, Duncan O. S.; Allen, Kirk; Bandosz, Piotr; Schmid, Volker; Capewell, Simon; O'Flaherty, Martin			Future Declines of Coronary Heart Disease Mortality in England and Wales Could Counter the Burden of Population Ageing	PLOS ONE			English	Article							CARDIOVASCULAR MORTALITY; SECULAR TRENDS; UNITED-STATES; IMPACT; COHORT; PERIOD; RATES	Background: Coronary Heart Disease (CHD) remains a major cause of mortality in the United Kingdom. Yet predictions of future CHD mortality are potentially problematic due to population ageing and increase in obesity and diabetes. Here we explore future projections of CHD mortality in England & Wales under two contrasting future trend assumptions. Methods: In scenario A, we used the conventional counterfactual scenario that the last-observed CHD mortality rates from 2011 would persist unchanged to 2030. The future number of deaths was calculated by applying those rates to the 20122030 population estimates. In scenario B, we assumed that the recent falling trend in CHD mortality rates would continue. Using Lee-Carter and Bayesian Age Period Cohort (BAPC) models, we projected the linear trends up to 2030. We validate our methods using past data to predict mortality from 2002-2011. Then, we computed the error between observed and projected values. Results: In scenario A, assuming that 2011 mortality rates stayed constant by 2030, the number of CHD deaths would increase 62% or approximately 39,600 additional deaths. In scenario B, assuming recent declines continued, the BAPC model (the model with lowest error) suggests the number of deaths will decrease by 56%, representing approximately 36,200 fewer deaths by 2030. Conclusions: The decline in CHD mortality has been reasonably continuous since 1979, and there is little reason to believe it will soon halt. The commonly used assumption that mortality will remain constant from 2011 therefore appears slightly dubious. By contrast, using the BAPC model and assuming continuing mortality falls offers a more plausible prediction of future trends. Thus, despite population ageing, the number of CHD deaths might halve again between 2011 and 2030. This has implications for how the potential benefits of future cardiovascular strategies might best be calculated and presented.	[Castillo, Maria Guzman; Gillespie, Duncan O. S.; Allen, Kirk; Bandosz, Piotr; Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Schmid, Volker] Univ Munich, Dept Stat, Munich, Germany	University of Liverpool; University of Munich	Castillo, MG (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England.	M.Guzman-Castillo@liverpoola.c.uk	Gillespie, Duncan/G-1401-2013; Bandosz, Piotr/E-4964-2017; Schmid, Volker/F-3251-2010	Gillespie, Duncan/0000-0003-3450-5747; Schmid, Volker/0000-0003-2195-8130; O'Flaherty, Martin/0000-0001-8944-4131	MRC NPRI 3 Scheme; School of Public Health Research project: Modelling preventive interventions to address inequalities in CVD; MRC [G0900847] Funding Source: UKRI	MRC NPRI 3 Scheme; School of Public Health Research project: Modelling preventive interventions to address inequalities in CVD; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was in part funded by the MRC NPRI 3 Scheme (http://www.mrc.ac.uk/Ourresearch/ResearchInitiatives/NPRI/index.htm) and the School of Public Health Research project: Modelling preventive interventions to address inequalities in CVD (http://sphr.nihr.ac.uk/wp-content/uploads/2013/06/SummarySPHR-LIL-PH1-MCD1.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; BAKER D, 1993, J PUBLIC HEALTH MED, V15, P243; Bell A, 2013, SOCIAL SCI MED; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Bobak M, 2005, EPIDEMIOLOGY CORONAR, V2, P83; Booth H, 2008, ANN ACTUAR SCI, V3, P3, DOI 10.1017/S1748499500000440; Booth H, 2002, POP STUD-J DEMOG, V56, P325, DOI 10.1080/00324720215935; (C-Projections) CPN, 2010, LONG TERM PROJ METH; Capewell S, 2012, MODELLING UK BURDEN; Capewell S, 2012, NUTR METAB CARDIOVAS, V22, P307, DOI 10.1016/j.numecd.2012.01.005; Carter LawrenceR., 2001, METHODEN ZIELE, V39; Darkiewicz G, 2004, COINTEGRATION ANAL C, V0406, P1; Di Cesare M, 2009, BRIT ACTUARIAL J, V15, P185; Do Health, 2013, FREE NHS HLTH CHECK; Dye C, 2013, LANCET, V381, P413, DOI 10.1016/S0140-6736(12)61812-1; Franco M, 2007, AM J EPIDEMIOL, V166, P1374, DOI 10.1093/aje/kwm226; Franco M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1515; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Health Do, 2008, EC MOD VASC CHECKS; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Huffman MD, 2013, CIRCULATION; HUGHES K, 1986, INT J EPIDEMIOL, V15, P44, DOI 10.1093/ije/15.1.44; Huovinen E, 2006, INT J EPIDEMIOL, V35, P1246, DOI 10.1093/ije/dyl128; Hyndman R, 2013, DEMOGRAPHY FORECASTI; Jones DS, 2013, AM J PUBLIC HEALTH, pe1; Knorr-Held L, 2001, Biostatistics, V2, P109, DOI 10.1093/biostatistics/2.1.109; Kuulasmaa K, 2000, LANCET; Lahti-Koski M, 2001, INT J OBESITY, V25, P727, DOI 10.1038/sj.ijo.0801588; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Lee R, 2011, SCIENCE, V333, P569, DOI 10.1126/science.1208859; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Murray C. J. L., 2013, LANCET; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; O'Flaherty M, 2012, INT J CARDIOL, V158, P193, DOI 10.1016/j.ijcard.2011.01.016; O'Flaherty M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2613; Odden MC, 2011, AM J MED, V124, P827, DOI 10.1016/j.amjmed.2011.04.010; Ovbiagele B, 2013, STROKE; Schmid VJ, 2007, J STAT SOFTW, V21, P1; Shkolnikov V, 1996, Popul, V8, P155; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SVERRE JM, 1993, AM J EPIDEMIOL, V137, P301, DOI 10.1093/oxfordjournals.aje.a116677; Tabeau E, 2001, FORECASTING MORTALIT; Taleb N. N., 2010, BLACK SWAN, DOI DOI 10.1176/PS.2009.60.11.1564; Taylor R, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.109538; Tobias M, 2006, LOW CAN IT GO PROJEC; Vaartjes I, 2011, HEART, V97, P569, DOI 10.1136/hrt.2010.206565; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Wood J, 1999, Popul Trends, P21; WOOD SN, 1994, SIAM J SCI COMPUT, V15, P1126, DOI 10.1137/0915069; YU TS, 1995, J EPIDEMIOL COMMUN H, V49, P16, DOI 10.1136/jech.49.1.16; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187; Zatonski W, 2008, EUR J EPIDEMIOL, V23, P3, DOI 10.1007/s10654-007-9195-1	55	19	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99482	10.1371/journal.pone.0099482	http://dx.doi.org/10.1371/journal.pone.0099482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24918442	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000089
J	Dorado-Garcia, I; Medina-Sanchez, JM; Herrera, G; Cabrerizo, MJ; Carrillo, P				Dorado-Garcia, Irene; Manuel Medina-Sanchez, Juan; Herrera, Guillermo; Cabrerizo, Marco J.; Carrillo, Presentacion			Quantification of Carbon and Phosphorus Co-Limitation in Bacterioplankton: New Insights on an Old Topic	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; PHYTOPLANKTON NUTRIENT LIMITATION; BACTERIAL-GROWTH; FRESH-WATER; CLIMATE-CHANGE; DUST INPUTS; TEMPERATURE REGULATION; PLANKTONIC BACTERIA; COMMUNITY STRUCTURE; SURFACE WATERS	Because the nature of the main resource that limits bacterioplankton (e.g. organic carbon [C] or phosphorus [P]) has biogeochemical implications concerning organic C accumulation in freshwater ecosystems, empirical knowledge is needed concerning how bacteria respond to these two resources, available alone or together. We performed field experiments of resource manipulation (262 factorial design, with the addition of C, P, or both combined) in two Mediterranean freshwater ecosystems with contrasting trophic states (oligotrophy vs. eutrophy) and trophic natures (autotrophy vs. heterotrophy, measured as gross primary production: respiration ratio). Overall, the two resources synergistically co-limited bacterioplankton, i.e. the magnitude of the response of bacterial production and abundance to the two resources combined was higher than the additive response in both ecosystems. However, bacteria also responded positively to single P and C additions in the eutrophic ecosystem, but not to single C in the oligotrophic one, consistent with the value of the ratio between bacterial C demand and algal C supply. Accordingly, the trophic nature rather than the trophic state of the ecosystems proves to be a key feature determining the expected types of resource co-limitation of bacteria, as summarized in a proposed theoretical framework. The actual types of co-limitation shifted over time and partially deviated (a lesser degree of synergism) from the theoretical expectations, particularly in the eutrophic ecosystem. These deviations may be explained by extrinsic ecological forces to physiological limitations of bacteria, such as predation, whose role in our experiments is supported by the relationship between the dynamics of bacteria and bacterivores tested by SEMs (structural equation models). Our study, in line with the increasingly recognized role of freshwater ecosystems in the global C cycle, suggests that further attention should be focussed on the biotic interactions that modulate resource co-limitation of bacteria.	[Dorado-Garcia, Irene; Herrera, Guillermo; Cabrerizo, Marco J.; Carrillo, Presentacion] Univ Granada, Inst Agua, Granada, Spain; [Manuel Medina-Sanchez, Juan] Univ Granada, Fac Ciencias, Dept Ecol, Granada, Spain	University of Granada; University of Granada	Dorado-Garcia, I (corresponding author), Univ Granada, Inst Agua, Granada, Spain.	idorado@ugr.es	Carrillo, Presentación/I-1601-2015; Cabrerizo, Marco J./A-5962-2018; Cabrerizo, Marco J./O-4677-2019; Medina-Sánchez, Juan Manuel/A-4703-2013	Carrillo, Presentación/0000-0003-3794-4294; Cabrerizo, Marco J./0000-0001-5576-6095; Cabrerizo, Marco J./0000-0001-5576-6095; Medina-Sánchez, Juan Manuel/0000-0003-0991-9331	Junta de Andalucia [P09-RNM-5376]; Spanish Ministry Ciencia e Innovacion [CGL2011-23681]	Junta de Andalucia(Junta de Andalucia); Spanish Ministry Ciencia e Innovacion	This research was supported by Junta de Andalucia (Excelencia P09-RNM-5376 to JMMS) and the Spanish Ministry Ciencia e Innovacion (CGL2011-23681 to PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgeier JE, 2011, J APPL ECOL, V48, P96, DOI 10.1111/j.1365-2664.2010.01894.x; Anesio AM, 2005, APPL ENVIRON MICROB, V71, P6267, DOI 10.1128/AEM.71.10.6267-6275.2005; APHA, 2005, STANDARD METHODS EXA, V21st ed.; Apple JK, 2006, AQUAT MICROB ECOL, V43, P243, DOI 10.3354/ame043243; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BELL RT, 1993, HDB METHODS AQUATIC, P495; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; BENNER R, 1993, MAR CHEM, V41, P153, DOI 10.1016/0304-4203(93)90113-3; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Berggren M, 2010, MICROB ECOL, V60, P894, DOI 10.1007/s00248-010-9751-1; Bertoni R, 2008, J LIMNOL, V67, P120, DOI 10.4081/jlimnol.2008.120; BILLEN G, 1990, HYDROBIOLOGIA, V207, P37, DOI 10.1007/BF00041438; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; Carlsson P, 2012, J EXP MAR BIOL ECOL, V418, P37, DOI 10.1016/j.jembe.2012.03.012; Carrillo P, 2002, LIMNOL OCEANOGR, V47, P1294, DOI 10.4319/lo.2002.47.5.1294; Cherrier J, 1999, LIMNOL OCEANOGR, V44, P730, DOI 10.4319/lo.1999.44.3.0730; Coelho FJRC, 2013, ECOL EVOL, V3, P1808, DOI 10.1002/ece3.565; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cotner JB, 2002, ECOSYSTEMS, V5, P105, DOI 10.1007/s10021-001-0059-3; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; de Vicente I, 2012, BIOGEOSCIENCES, V9, P5049, DOI 10.5194/bg-9-5049-2012; Degerman R, 2013, AQUAT MICROB ECOL, V68, P131, DOI 10.3354/ame01609; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Dodds WK, 2007, AQUAT SCI, V69, P427, DOI 10.1007/s00027-007-0922-1; Ducklow H, 2008, AQUAT MICROB ECOL, V53, P13, DOI 10.3354/ame01220; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, ECOLOGY, V90, P3062, DOI 10.1890/08-1742.1; Faithfull CL, 2011, LIMNOL OCEANOGR, V56, P1703, DOI 10.4319/lo.2011.56.5.1703; Farjalla VF, 2002, HYDROBIOLOGIA, V489, P197, DOI 10.1023/A:1023288922394; Farjalla VF, 2006, MICROB ECOL, V52, P334, DOI 10.1007/s00248-006-9021-4; Farjalla VF, 2009, ENVIRON SCI POLLUT R, V16, P531, DOI 10.1007/s11356-009-0165-x; Felip M, 1996, MICROBIAL ECOL, V31, P15, DOI 10.1007/BF00175072; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Gasol JM, 2009, AQUAT MICROB ECOL, V56, P1, DOI 10.3354/ame01310; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Graneli W, 2004, AQUAT SCI, V66, P430, DOI 10.1007/s00027-004-0732-7; Hall EK, 2007, AQUAT MICROB ECOL, V49, P35, DOI 10.3354/ame01124; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Herndl GJ, 2008, AQUAT MICROB ECOL, V53, P59, DOI 10.3354/ame01225; Hoikkala L, 2009, ESTUAR COAST, V32, P720, DOI 10.1007/s12237-009-9154-z; Jansson M, 2006, MICROB ECOL, V52, P358, DOI 10.1007/s00248-006-9013-4; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kamiya E, 2007, J OCEANOGR, V63, P101, DOI 10.1007/s10872-007-0008-7; Kritzberg ES, 2006, ECOSYSTEMS, V9, P489, DOI 10.1007/s10021-005-0115-5; Kritzberg ES, 2005, AQUAT MICROB ECOL, V38, P103, DOI 10.3354/ame038103; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Lohelin JC, 1992, LATENT VARIABLE MODE; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; Medina-Sanchez JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060223; Medina-Sanchez JM, 2010, FEMS MICROBIOL ECOL, V74, P554, DOI 10.1111/j.1574-6941.2010.00969.x; MARTINEZ R, 1975, Cuadernos de Ciencias Biologicas Universidad de Granada, V4, P223; Medina-Sanchez JM, 2004, LIMNOL OCEANOGR, V49, P1722, DOI 10.4319/lo.2004.49.5.1722; Medina-Sanchez JM, 2002, FRESHWATER BIOL, V47, P2191, DOI 10.1046/j.1365-2427.2002.00969.x; Mladenov N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1411; Morales-Baquero R, 2006, LIMNOL OCEANOGR, V51, P830, DOI 10.4319/lo.2006.51.2.0830; Nurnberg Gertrud K., 1996, Lake and Reservoir Management, V12, P432; Olenina I., 2006, HELCON BALTIC SEA EN, P144; Ortega-Retuerta E, 2007, MICROB ECOL, V54, P161, DOI 10.1007/s00248-006-9186-x; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Pomeroy LR, 2007, OCEANOGRAPHY, V20, P28, DOI 10.5670/oceanog.2007.45; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Pomeroy LR, 2001, AQUAT MICROB ECOL, V23, P187, DOI 10.3354/ame023187; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; Reche I, 2001, ARCT ANTARCT ALP RES, V33, P426, DOI 10.2307/1552552; Reche I, 2009, LIMNOL OCEANOGR, V54, P869, DOI 10.4319/lo.2009.54.3.0869; ROCHA O, 1985, J PLANKTON RES, V7, P279, DOI 10.1093/plankt/7.2.279; ROTT E, 1981, SCHWEIZ Z HYDROL, V43, P34, DOI 10.1007/BF02502471; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Shukla P.R., 2022, CLIMATE CHANGE 2013; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Solic M, 2009, AQUAT MICROB ECOL, V58, P15, DOI 10.3354/ame01342; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Stets EG, 2008, LIMNOL OCEANOGR, V53, P137, DOI 10.4319/lo.2008.53.1.0137; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; TANAKA JS, 1987, CHILD DEV, V58, P134, DOI 10.1111/j.1467-8624.1987.tb03495.x; Thingstad TF, 1997, LIMNOL OCEANOGR, V42, P398, DOI 10.4319/lo.1997.42.2.0398; Vadstein O, 2003, FEMS MICROBIOL ECOL, V46, P307, DOI 10.1016/S0168-6496(03)00195-8; Vadstein O, 2000, ADV MICROB ECOL, V16, P115; Vidal LO, 2011, J PLANKTON RES, V33, P1747, DOI 10.1093/plankt/fbr059; Villar-Argaiz M, 2002, AQUAT MICROB ECOL, V29, P253, DOI 10.3354/ame029253; Vrede K, 2005, MICROB ECOL, V49, P245, DOI 10.1007/s00248-004-0259-4; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Xenopoulos MA, 2003, LIMNOL OCEANOGR, V48, P2321, DOI 10.4319/lo.2003.48.6.2321; Zubkov MV, 2006, CYTOM PART A, V69A, P1010, DOI 10.1002/cyto.a.20332; Zubkov M, 2007, J PLANKTON RES, V29, P79	91	14	14	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99288	10.1371/journal.pone.0099288	http://dx.doi.org/10.1371/journal.pone.0099288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918445	Green Published, gold			2022-12-25	WOS:000338631000071
J	Galvin, JJ; Oba, S; Fu, QJ; Baskent, D				Galvin, John J., III; Oba, Sandy; Fu, Qian-Jie; Baskent, Deniz			Single- and Multi-Channel Modulation Detection in Cochlear Implant Users	PLOS ONE			English	Article							CARRIER PULSE-RATE; AMPLITUDE-MODULATION; INTENSITY DISCRIMINATION; SPEECH RECOGNITION; STIMULATION RATE; LOUDNESS; PERCEPTION; LISTENERS; NOISE; SITE	Single-channel modulation detection thresholds (MDTs) have been shown to predict cochlear implant (CI) users' speech performance. However, little is known about multi-channel modulation sensitivity. Two factors likely contribute to multichannel modulation sensitivity: multichannel loudness summation and the across-site variance in single-channel MDTs. In this study, single- and multi-channel MDTs were measured in 9 CI users at relatively low and high presentation levels and modulation frequencies. Single-channel MDTs were measured at widely spaced electrode locations, and these same channels were used for the multichannel stimuli. Multichannel MDTs were measured twice, with and without adjustment for multichannel loudness summation (i.e., at the same loudness as for the single-channel MDTs or louder). Results showed that the effect of presentation level and modulation frequency were similar for single- and multi-channel MDTs. Multichannel MDTs were significantly poorer than single-channel MDTs when the current levels of the multichannel stimuli were reduced to match the loudness of the single-channel stimuli. This suggests that, at equal loudness, single-channel measures may over-estimate CI users' multichannel modulation sensitivity. At equal loudness, there was no significant correlation between the amount of multichannel loudness summation and the deficit in multichannel MDTs, relative to the average single-channel MDT. With no loudness compensation, multichannel MDTs were significantly better than the best single-channel MDT. The across-site variance in single-channel MDTs varied substantially across subjects. However, the across-site variance was not correlated with the multichannel advantage over the best single channel. This suggests that CI listeners combined envelope information across channels instead of attending to the best channel.	[Galvin, John J., III; Oba, Sandy; Fu, Qian-Jie] House Res Inst, Div Commun & Auditory Neurosci, Los Angeles, CA 90057 USA; [Galvin, John J., III; Oba, Sandy; Fu, Qian-Jie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA; [Galvin, John J., III; Baskent, Deniz] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands; [Galvin, John J., III; Baskent, Deniz] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Groningen; University of Groningen	Galvin, JJ (corresponding author), House Res Inst, Div Commun & Auditory Neurosci, Los Angeles, CA 90057 USA.	Jgalvin@ucla.edu		Baskent, Deniz/0000-0002-6560-1451	National Institutes of Health [R01-DC004993]; VIDI from the Netherlands Organization for Scientific Research (NWO) [016.096.397]; Netherlands Organization for Health Research and Development (ZonMw); Rosalind Franklin Fellowship from University of Groningen, University Medical Center Groningen; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VIDI from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Rosalind Franklin Fellowship from University of Groningen, University Medical Center Groningen; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Mr. Galvin, Ms. Oba, and Dr. Fu were supported by National Institutes of Health grant R01-DC004993. Dr. Baskent was supported by VIDI grant 016.096.397 from the Netherlands Organization for Scientific Research (NWO) and the Netherlands Organization for Health Research and Development (ZonMw), and a Rosalind Franklin Fellowship from University of Groningen, University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora K, 2011, INT J AUDIOL, V50, P123, DOI 10.3109/14992027.2010.527860; BUSBY PA, 1993, J ACOUST SOC AM, V94, P124, DOI 10.1121/1.408212; CAZALS Y, 1994, J ACOUST SOC AM, V96, P2048, DOI 10.1121/1.410146; Chatterjee M, 2005, J ACOUST SOC AM, V118, P993, DOI 10.1121/1.1929258; Chatterjee M, 2003, J ACOUST SOC AM, V113, P2042, DOI 10.1121/1.1555613; Chatterjee M, 2001, JARO-J ASSOC RES OTO, V2, P159, DOI 10.1007/s101620010079; Chatterjee M, 2011, J ACOUST SOC AM, V130, P1567, DOI 10.1121/1.3621445; Colletti V, 2005, LARYNGOSCOPE, V115, P1974, DOI 10.1097/01.mlg.0000178327.42926.ec; Dau T, 1997, J ACOUST SOC AM, V102, P2906, DOI 10.1121/1.420345; Dau T, 1997, J ACOUST SOC AM, V102, P2892, DOI 10.1121/1.420344; Donaldson GS, 2000, J ACOUST SOC AM, V108, P760, DOI 10.1121/1.429609; Fraser M, 2012, HEARING RES, V283, P59, DOI 10.1016/j.heares.2011.11.009; Fu QJ, 2002, NEUROREPORT, V13, P1635, DOI 10.1097/00001756-200209160-00013; Galvin JJ, 2005, JARO-J ASSOC RES OTO, V6, P269, DOI 10.1007/s10162-005-0007-6; Galvin JJ, 2013, J NEUROSCI METHODS D, DOI [10.1016/j.jneu-meth.2013.10.016, DOI 10.1016/J.JNEU-METH.2013.10.016]; Galvin JJ, 2009, HEARING RES, V250, P46, DOI 10.1016/j.heares.2009.01.009; Garadat SN, 2012, J ACOUST SOC AM, V131, P4030, DOI 10.1121/1.3701879; Geurts L, 2001, J ACOUST SOC AM, V109, P713, DOI 10.1121/1.1340650; Green T, 2012, EAR HEARING, V33, P233, DOI 10.1097/AUD.0b013e318230fff8; JESTEADT W, 1980, PERCEPT PSYCHOPHYS, V28, P85, DOI 10.3758/BF03204321; Kreft HA, 2013, JARO-J ASSOC RES OTO, V14, P591, DOI 10.1007/s10162-013-0391-2; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; McKay CM, 2003, J ACOUST SOC AM, V113, P2054, DOI 10.1121/1.1558378; McKay CM, 2001, J ACOUST SOC AM, V110, P1514, DOI 10.1121/1.1394222; McKay CM, 2010, JARO-J ASSOC RES OTO, V11, P101, DOI 10.1007/s10162-009-0188-5; Pfingst BE, 2007, J ACOUST SOC AM, V121, P2236, DOI 10.1121/1.2537501; SHANNON RV, 1992, J ACOUST SOC AM, V91, P2156, DOI 10.1121/1.403807; Wygonski J, 2002, HEL NUCLEUS RES INTE; ZENG FG, 1991, Q J EXP PSYCHOL-A, V43, P565, DOI 10.1080/14640749108400987; Zhou N, 2012, J ACOUST SOC AM, V132, P994, DOI 10.1121/1.4730907	30	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99338	10.1371/journal.pone.0099338	http://dx.doi.org/10.1371/journal.pone.0099338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918605	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000078
J	Ohshima, C; Takahashi, H; Phraephaisarn, C; Vesaratchavest, M; Keeratipibul, S; Kuda, T; Kimura, B				Ohshima, Chihiro; Takahashi, Hajime; Phraephaisarn, Chirapiphat; Vesaratchavest, Mongkol; Keeratipibul, Suwimon; Kuda, Takashi; Kimura, Bon			Establishment of a Simple and Rapid Identification Method for Listeria spp. by Using High-Resolution Melting Analysis, and Its Application in Food Industry	PLOS ONE			English	Article							SP NOV.; MONOCYTOGENES; CURVE; TOOL; PCR	Listeria monocytogenes is the causative bacteria of listeriosis, which has a higher mortality rate than that of other causes of food poisoning. Listeria spp., of which L. monocytogenes is a member, have been isolated from food and manufacturing environments. Several methods have been published for identifying Listeria spp.; however, many of the methods cannot identify newly categorized Listeria spp. Additionally, they are often not suitable for the food industry, owing to their complexity, cost, or time consumption. Recently, high-resolution melting analysis (HRMA), which exploits DNA-sequence differences, has received attention as a simple and quick genomic typing method. In the present study, a new method for the simple, rapid, and low-cost identification of Listeria spp. has been presented using the genes rarA and ldh as targets for HRMA. DNA sequences of 9 Listeria species were first compared, and polymorphisms were identified for each species for primer design. Species specificity of each HRM curve pattern was estimated using type strains of all the species. Among the 9 species, 7 were identified by HRMA using rarA gene, including 3 new species. The remaining 2 species were identified by HRMA of ldh gene. The newly developed HRMA method was then used to assess Listeria isolates from the food industry, and the method efficiency was compared to that of identification by 16S rDNA sequence analysis. The 2 methods were in coherence for 92.6% of the samples, demonstrating the high accuracy of HRMA. The time required for identifying Listeria spp. was substantially low, and the process was considerably simplified, providing a useful and precise method for processing multiple samples per day. Our newly developed method for identifying Listeria spp. is highly valuable; its use is not limited to the food industry, and it can be used for the isolates from the natural environment.	[Ohshima, Chihiro; Takahashi, Hajime; Kuda, Takashi; Kimura, Bon] Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Dept Food Sci & Technol, Minato Ku, Tokyo, Japan; [Phraephaisarn, Chirapiphat; Vesaratchavest, Mongkol] BETAGRO Grp, Ctr Res & Dev, Klongluang, Pathumthani, Thailand; [Phraephaisarn, Chirapiphat] Chulalongkorn Univ, Fac Sci, Program Biotechnol, Bangkok, Thailand; [Keeratipibul, Suwimon] Chulalongkorn Univ, Fac Sci, Dept Food Technol, Bangkok, Thailand	Tokyo University of Marine Science & Technology; Chulalongkorn University; Chulalongkorn University	Takahashi, H (corresponding author), Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Dept Food Sci & Technol, Minato Ku, Tokyo, Japan.	hajime@kaiyodai.ac.jp	KUDA, Takashi/O-1974-2014; Kimbo, Bon/O-1879-2014	Kimbo, Bon/0000-0002-3071-1343; keeratipibul, suwimon/0000-0001-7708-3084	Ministry of Education, Science, Sports and Culture of Japan [B 24380115]; Research and Development Center of BETAGRO Group	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research and Development Center of BETAGRO Group	This work was supported by Grant-in-Aid for Scientific Research (B 24380115) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Chirapiphat Phraephaisarn and Mongkol Vesaratchavest are employed by Research and Development Center of BETAGRO Group. Research and Development Center of BETAGRO Group provided support in the form of salaries for authors CP and MV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bertsch D, 2013, INT J SYST EVOL MICR, V63, P526, DOI 10.1099/ijs.0.036947-0; Cai XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067082; Cartwright EJ, 2013, LSITERIOSIS OUTBREAK; den Bakker HC, 2010, APPL ENVIRON MICROB, V76, P6085, DOI 10.1128/AEM.00447-10; Fox E, 2011, INT J FOOD MICROBIOL, V145, pS39, DOI 10.1016/j.ijfoodmicro.2010.10.012; Ganopoulos I, 2013, J SCI FOOD AGR, V93, P2281, DOI 10.1002/jsfa.6040; Gasanov U, 2005, FEMS MICROBIOL REV, V29, P851, DOI 10.1016/j.femsre.2004.12.002; Graves LM, 2010, INT J SYST EVOL MICR, V60, P1280, DOI 10.1099/ijs.0.014118-0; Halter EL, 2013, INT J SYST EVOL MICR, V63, P641, DOI 10.1099/ijs.0.036830-0; Hellberg RS, 2013, FOOD MICROBIOL, V36, P231, DOI 10.1016/j.fm.2013.06.001; Huang BX, 2007, J FOOD PROTECT, V70, P1874, DOI 10.4315/0362-028X-70.8.1874; Jadhav S, 2012, J MICROBIOL METH, V88, P327, DOI 10.1016/j.mimet.2012.01.002; Jin DZ, 2012, FEMS MICROBIOL LETT, V330, P72, DOI 10.1111/j.1574-6968.2012.02535.x; Leclercq A, 2010, INT J SYST EVOL MICR, V60, P2210, DOI 10.1099/ijs.0.017376-0; McLauchlin J, 1997, INT J FOOD MICROBIOL, V38, P77, DOI 10.1016/S0168-1605(97)00086-X; Miettinen H., 2005, INT J FOOD MICROBIOL, V112, P138; Miya S, 2010, APPL ENVIRON MICROB, V76, P3383, DOI 10.1128/AEM.01456-09; Ngui R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041996; Oliveira M, 2011, FOOD MICROBIOL, V28, P590, DOI 10.1016/j.fm.2010.11.004; Pietzka AT, 2011, J MOL DIAGN, V13, P57, DOI 10.1016/j.jmoldx.2010.11.002; Rodriguez-Lazaro D, 2004, APPL ENVIRON MICROB, V70, P6299, DOI 10.1128/AEM.70.10.6299-6301.2004; Strawn LK, 2013, APPL ENVIRON MICROB, V79, P588, DOI 10.1128/AEM.02491-12; Swaminathan B., 2001, FOOD MICROBIOLOGY FU, P383; Vogel BF, 2001, APPL ENVIRON MICROB, V67, P2586, DOI 10.1128/AEM.67.6.2586-2595.2001; Vongkamjan K, 2012, APPL ENVIRON MICROB, V78, P8666, DOI 10.1128/AEM.01859-12; Wang J, 2010, CAN J MICROBIOL, V56, P676, DOI [10.1139/w10-054, 10.1139/W10-054]; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zeinzinger J, 2012, APPL ENVIRON MICROB, V78, P3352, DOI 10.1128/AEM.07668-11	28	12	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99223	10.1371/journal.pone.0099223	http://dx.doi.org/10.1371/journal.pone.0099223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918440	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000059
J	Wang, XH; Li, QL; Hu, QS; Suntharalingam, P; From, AHL; Zhang, JY				Wang, Xiaohong; Li, Qinglu; Hu, Qingsong; Suntharalingam, Piradeep; From, Arthur H. L.; Zhang, Jianyi			Intra-Myocardial Injection of Both Growth Factors and Heart Derived Sca-1(+)/CD31(-) Cells Attenuates Post-MI LV Remodeling More Than Does Cell Transplantation Alone: Neither Intervention Enhances Functionally Significant Cardiomyocyte Regeneration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INFARCTED MYOCARDIUM; VENTRICULAR-FUNCTION; ISCHEMIC-HEART; AKT; PROTECTION; APOPTOSIS; THERAPY; MULTIPOTENT; ACTIVATION	Insulin-like growth factor 1 (IGF-1) and hepatocyte growth factor (HGF) are two potent cell survival and regenerative factors in response to myocardial injury (MI). We hypothesized that simultaneous delivery of IGF+HGF combined with Sca-1(+)/CD31(-) cells would improve the outcome of transplantation therapy in response to the altered hostile microenvironment post MI. One million adenovirus nuclear LacZ-labeled Sca-1(+)/CD31(-) cells were injected into the peri-infarction area after left anterior descending coronary artery (LAD) ligation in mice. Recombinant mouse IGF-1+HGF was added to the cell suspension prior to the injection. The left ventricular (LV) function was assessed by echocardiography 4 weeks after the transplantation. The cell engraftment, differentiation and cardiomyocyte regeneration were evaluated by histological analysis. Sca-1(+)/CD31(-) cells formed viable grafts and improved LV ejection fraction (EF) (Control, 54.5+/-2.4; MI, 17.6+/-2 3.1; Cell, 28.2+/-4.2, n = 9, P<0.01). IGF+HGF significantly enhanced the benefits of cell transplantation as evidenced by increased EF (38.8+/-2.2; n = 9, P<0.01) and attenuated adverse structural remodeling. Furthermore, IGF+HGF supplementation increased the cell engraftment rate, promoted the transplanted cell survival, enhanced angiogenesis, and minimally stimulated endogenous cardiomyocyte regeneration in vivo. The in vitro experiments showed that IGF+HGF treatment stimulated Sca-1(+)/CD31(-) cell proliferation and inhibited serum free medium induced apoptosis. Supperarray profiling of Sca-1(+)/CD31(-) cells revealed that Sca-1(+)/CD31(-) cells highly expressed various trophic factor mRNAs and IGF+HGF treatment altered the mRNAs expression patterns of these cells. These data indicate that IGF-1+HGF could serve as an adjuvant to cell transplantation for myocardial repair by stimulating donor cell and endogenous cardiac stem cell survival, regeneration and promoting angiogenesis.	[Wang, Xiaohong; Li, Qinglu; Hu, Qingsong; Suntharalingam, Piradeep; From, Arthur H. L.; Zhang, Jianyi] Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Wang, XH (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA.	wangx270@umn.edu; zhang047@umn.edu	Zhang, Jianyi/N-1949-2018; wang, xiao/HGB-7081-2022	Zhang, Jianyi/0000-0002-3955-6554; wang, xiao/0000-0002-4088-3341	American Heart Association; Lillehei Institute; National Institutes of Health [NCRR P41 RR008079]; Department of Medicine (Cardiology Division) of the University of Minnesota;  [HL 67828];  [0750160Z]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Lillehei Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine (Cardiology Division) of the University of Minnesota; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by an American Heart Association Grant-in Aid (X.W #0750160Z) and the Lillehei Institute and the Department of Medicine (Cardiology Division) of the University of Minnesota (X.W. and J.Z.), and HL 67828 (J.Z.) and support to the Center for Magnetic Resonance Research of the University of Minnesota by National Institutes of Health grant NCRR P41 RR008079 (to Kamil Ugurbil, PhD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka Y, 2006, MODERN PATHOL, V19, P588, DOI 10.1038/modpathol.3800568; Anversa P, 2005, BASIC RES CARDIOL, V100, P482, DOI 10.1007/s00395-005-0554-3; Bialik S, 1997, J CLIN INVEST, V100, P1363, DOI 10.1172/JCI119656; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Devin JK, 2008, CURR OPIN INVEST DR, V9, P983; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Gnecchi M, 2009, STEM CELLS, V27, P971, DOI 10.1002/stem.12; Guarita-Souza LC, 2006, CIRCULATION, V114, pI120, DOI 10.1161/CIRCULATIONAHA.105.000646; Jayasankar V, 2003, CIRCULATION, V108, P230, DOI 10.1161/01.cir.0000087444.53354.66; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miyagawa S, 2002, CIRCULATION, V105, P2556, DOI 10.1161/01.CIR.0000016722.37138.F2; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Penn MS, 2008, CIRC RES, V102, P1471, DOI 10.1161/CIRCRESAHA.108.175174; Rappolee DA, 1996, CIRC RES, V78, P1028, DOI 10.1161/01.RES.78.6.1028; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Tang YL, 2007, BIOCHEM BIOPH RES CO, V359, P877, DOI 10.1016/j.bbrc.2007.05.216; Ueda H, 2001, CARDIOVASC RES, V51, P41, DOI 10.1016/S0008-6363(01)00272-3; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; Wang XH, 2009, CIRCULATION, V120, pS790; Weber KT, 1997, CIRCULATION, V96, P2488; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730	36	12	14	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e95247	10.1371/journal.pone.0095247	http://dx.doi.org/10.1371/journal.pone.0095247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919180	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000004
J	Du, ZM; Xie, Y; Hu, LQ; Hu, LX; Xu, SD; Li, DX; Wang, GF; Fu, JM				Du, Zhimin; Xie, Yan; Hu, Liqun; Hu, Longxing; Xu, Shendong; Li, Daoxin; Wang, Gongfang; Fu, Jinmin			Effects of Fertilization and Clipping on Carbon, Nitrogen Storage, and Soil Microbial Activity in a Natural Grassland in Southern China	PLOS ONE			English	Article							COMMUNITY STRUCTURE; TALLGRASS PRAIRIE; CROPPING SYSTEMS; ORGANIC-CARBON; CLIMATE-CHANGE; SEQUESTRATION; DIVERSITY; DYNAMICS; DECOMPOSITION; MITIGATION	Grassland managements can affect carbon (C) and nitrogen (N) storage in grassland ecosystems with consequent feedbacks to climate change. We investigated the impacts of compound fertilization and clipping on grass biomass, plant and soil (0-20 cm depth) C, N storage, plant and soil C:N ratios, soil microbial activity and diversity, and C, N sequestration rates in grassland in situ in the National Dalaoling Forest Park of China beginning July, 2011. In July, 2012, the fertilization increased total biomass by 30.1%, plant C by 34.5%, plant N by 79.8%, soil C by 18.8% and soil N by 23.8% compared with the control, respectively. Whereas the clipping decreased total biomass, plant C and N, soil C and N by 24.9%, 30.3%, 39.3%, 18.5%, and 19.4%, respectively, when compared to the control. The plant C:N ratio was lower for the fertilization than for the control and the clipping treatments. The soil microbial activity and diversity indices were higher for the fertilization than for the control. The clipping generally exhibited a lower level of soil microbial activity and diversity compared to the control. The principal component analysis indicated that the soil microbial communities of the control, fertilization and clipping treatments formed three distinct groups. The plant C and N sequestration rates of the fertilization were significantly higher than the clipping treatment. Our results suggest that fertilization is an efficient management practice in improving the C and N storage of the grassland ecosystem via increasing the grass biomass and soil microbial activity and diversity.	[Du, Zhimin; Xie, Yan; Hu, Liqun; Hu, Longxing; Fu, Jinmin] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Hubei, Peoples R China; [Du, Zhimin; Xie, Yan; Hu, Longxing; Fu, Jinmin] Chinese Acad Sci, Grad Univ, Beijing, Hebei, Peoples R China; [Xu, Shendong; Li, Daoxin; Wang, Gongfang] Natl Dalaoling Forest Pk, Yichang, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fu, JM (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Hubei, Peoples R China.	jfu@wbgcas.cn	Hu, Longxing/AAS-8287-2020	Du, Zhimin/0000-0002-3287-738X	Chinese Academy of Sciences [XDA0505040704]; National Natural Science Foundation of China [31272194]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding came from the "Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues'' of the Chinese Academy of Sciences (No. XDA0505040704), and the National Natural Science Foundation of China (No. 31272194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anindo D. O., 1994, East African Agricultural and Forestry Journal, V59, P177; Buresh RJ, 1997, SSSA SPECIAL PUBLICA, V51, P193, DOI DOI 10.2136/SSSASPECPUB51.C8; Chang EH, 2007, SOIL SCI PLANT NUTR, V53, P132, DOI 10.1111/j.1747-0765.2007.00122.x; Chen HM., 2005, ENV SOIL SCI; Chen Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016909; Cheng XL, 2011, J PLANT ECOL, V4, P228, DOI 10.1093/jpe/rtr024; COLLINS HP, 1992, SOIL SCI SOC AM J, V56, P783, DOI 10.2136/sssaj1992.03615995005600030018x; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Deng YL, 2010, ASIAN J WATER ENVIRO, V7, P1; Dersch G, 2001, NUTR CYCL AGROECOSYS, V60, P49, DOI 10.1023/A:1012607112247; Dhillon RS, 2013, BIOMASS BIOENERG, V48, P75, DOI 10.1016/j.biombioe.2012.11.005; Dong M., 1996, SURVEY OBSERVATION A; Dumanski J, 1998, CLIMATIC CHANGE, V40, P81, DOI 10.1023/A:1005390815340; FILSER J, 1995, PLANT SOIL, V170, P123, DOI 10.1007/BF02183060; Fox CA, 2003, CAN J SOIL SCI, V83, P231, DOI 10.4141/S01-059; Fynn RWS, 2004, APPL VEG SCI, V7, P1, DOI 10.1111/j.1654-109X.2004.tb00589.x; Garland JL, 1996, SOIL BIOL BIOCHEM, V28, P213, DOI 10.1016/0038-0717(95)00112-3; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; GOETZ H, 1969, J RANGE MANAGE, V22, P384, DOI 10.2307/3895847; HAACK SK, 1995, APPL ENVIRON MICROB, V61, P1458, DOI 10.1128/AEM.61.4.1458-1468.1995; Izaurralde RC, 2001, ADV AGRON, V70, P1; Joffre R, 2001, TERRESTRIAL GLOBAL P, P83; KENNEDY AC, 1995, PLANT SOIL, V170, P75, DOI 10.1007/BF02183056; Klimes L, 2001, EVOL ECOL, V15, P363, DOI 10.1023/A:1016041100087; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Lal R, 2003, CRIT REV PLANT SCI, V22, P151, DOI 10.1080/713610854; Larkin RP, 2003, SOIL BIOL BIOCHEM, V35, P1451, DOI 10.1016/S0038-0717(03)00240-2; Liski J, 2003, GLOBAL CHANGE BIOL, V9, P575, DOI 10.1046/j.1365-2486.2003.00605.x; Lu R.K., 2000, SOIL AGRO CHEM ANAL; Magill AH, 2000, SOIL BIOL BIOCHEM, V32, P597, DOI 10.1016/S0038-0717(99)00186-8; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Masto RE, 2006, SOIL BIOL BIOCHEM, V38, P1577, DOI 10.1016/j.soilbio.2005.11.012; Melillo JM, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P445; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Nicolardot B, 2001, PLANT SOIL, V228, P83, DOI 10.1023/A:1004813801728; Paul E. A., 1989, Soil microbiology and biochemistry.; Porporato A, 2003, ADV WATER RESOUR, V26, P45, DOI 10.1016/S0309-1708(02)00094-5; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Powlson DS, 2011, EUR J SOIL SCI, V62, P42, DOI 10.1111/j.1365-2389.2010.01342.x; PYSEK P, 1991, J VEG SCI, V2, P237, DOI 10.2307/3235956; Qiu LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055433; Rochette P, 1998, CAN J SOIL SCI, V78, P283, DOI 10.4141/S97-066; RUESS RW, 1983, OECOLOGIA, V59, P253, DOI 10.1007/BF00378845; Sainju UM, 2002, SOIL TILL RES, V63, P167, DOI 10.1016/S0167-1987(01)00244-6; Sainju UM, 2008, AGR ECOSYST ENVIRON, V127, P234, DOI 10.1016/j.agee.2008.04.006; Schlesinger W.H., 1995, BIOTIC FEEDBACKS GLO, V1st, P159; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Sekiguchi H, 2007, MICROBES ENVIRON, V22, P327, DOI 10.1264/jsme2.22.327; SH Lv, 2005, J SICHUAN GRASSLAND, V6, P37; Silveira ML, 2013, SOIL BIOL BIOCHEM, V58, P42, DOI 10.1016/j.soilbio.2012.11.003; Smith J. L., 1992, Soil microbial ecology: applications in agricultural and environmental management., P65; Smith P, 1998, GLOB CHANGE BIOL, V4, P679, DOI 10.1046/j.1365-2486.1998.00185.x; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Staddon WJ, 1997, MICROB ECOL, V34, P125, DOI 10.1007/s002489900042; TANS PP, 1995, AMBIO, V24, P376; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Thibodeau L, 2000, CAN J FOREST RES, V30, P229, DOI 10.1139/cjfr-30-2-229; THORNLEY JHM, 1991, PLANT CELL ENVIRON, V14, P1007, DOI 10.1111/j.1365-3040.1991.tb00972.x; Tian G, 2009, J ENVIRON QUAL, V38, P61, DOI 10.2134/jeq2007.0471; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; ZAK DR, 1994, ECOLOGY, V75, P2333, DOI 10.2307/1940888; Zhang QF, 1990, ACTA PHYTOECOLOGICA, V14, P110; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhong WH, 2007, APPL SOIL ECOL, V36, P84, DOI 10.1016/j.apsoil.2006.12.001; Zhou J, 2008, J ENVIRON SCI-CHINA, V20, P981, DOI 10.1016/S1001-0742(08)62197-X	66	8	10	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99385	10.1371/journal.pone.0099385	http://dx.doi.org/10.1371/journal.pone.0099385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914540	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700092
J	Ingicco, T; de Vos, J; Huffman, OF				Ingicco, Thomas; de Vos, John; Huffman, O. Frank			The Oldest Gibbon Fossil (Hylobatidae) from Insular Southeast Asia: Evidence from Trinil, (East Java, Indonesia), Lower/Middle Pleistocene	PLOS ONE			English	Article							EARLY-MIDDLE PLEISTOCENE; RAIN-FOREST FAUNA; HOMO-ERECTUS; AGE; NGANDONG; SANGIRAN; QUATERNARY; SAPIENS; DUBOIS	A fossil femur excavated by Eugene Dubois between 1891-1900 in the Lower/Middle Pleistocene bonebed of the Trinil site (Java, Indonesia) was recognised by us as that of a Hylobatidae. The specimen, Trinil 5703 of the Dubois Collection (Leiden, The Netherlands), has the same distinctive form of fossilization that is seen in many of the bonebed fossils from Trinil in the collection. Anatomical comparison of Trinil 5703 to a sample of carnivore and primate femora, supported by morphometric analyses, lead to the attribution of the fossil to gibbon. Trinil 5703 therefore provides the oldest insular record of this clade, one of the oldest known Hylobatidae fossils from Southeast Asia. Because living Hylobatidae only inhabit evergreen rain forests, the paleoenvironment within the river drainage in the greater Trinil area evidently included forests of this kind during the Lower/Middle Pleistocene as revealed here.	[Ingicco, Thomas] Univ Philippines, Archaeol Studies Program, Quezon City 1101, Diliman, Philippines; [Ingicco, Thomas] MNHN CNRS, Dept Prehist, Paris, France; [Ingicco, Thomas] MNHN CNRS, UMR 7194, Paris, France; [de Vos, John] Naturalis Biodivers Ctr, Leiden, Netherlands; [Huffman, O. Frank] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA	University of the Philippines System; University of the Philippines Diliman; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Naturalis Biodiversity Center; University of Texas System; University of Texas Austin	Ingicco, T (corresponding author), Univ Philippines, Archaeol Studies Program, Quezon City 1101, Diliman, Philippines.	thomas.ingicco@upd.edu.ph	Ingicco, Thomas/AAT-2641-2020	Ingicco, Thomas/0000-0001-5576-5084				Aiello L, 1990, INTRO HUMAN EVOLUTIO; Andrews P, 1998, B SOC GEOL FR, V169, P433; [Anonymous], 1985, GEOLOGICAL RES DEV C, P49; Ansyori M, 2010, THESIS MUSEUM NATL H; Bacon AM, 2001, CAHIERS PALEOANTHROP; Badoux DM, 1959, FOSSIL MAMMALS 2 FIS; BARTSTRA GJ, 1988, J HUM EVOL, V17, P325, DOI 10.1016/0047-2484(88)90074-7; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Bettis EA, 2009, J HUM EVOL, V56, P11, DOI 10.1016/j.jhevol.2008.09.003; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Bouteaux, 2005, THESIS MUSEUM NATL H; Bouteaux A, 2010, QUATERN INT, V223, P220, DOI 10.1016/j.quaint.2009.10.007; Brasseur B., 2009, THESIS MUSEUM NATL H; Carthaus E, 1911, PITHECANTHROPUSSCHIC, P1; Chatterjee HJ, 2006, INT J PRIMATOL, V27, P699, DOI 10.1007/s10764-006-9044-1; Claude J, 2008, MORPHOMETRICS R; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.2307/2336077; Day M.H., 1973, HUMAN EVOLUTION S SO, V11, P127, DOI DOI 10.1016/J.JHEVOL.2016.04.008; de Vos J., 1989, P225; de Vos J., 1982, Modern Quaternary Research in Southeast Asia, V7, P35; DEVOS J, 1982, GEOL MIJNBOUW, V61, P207; DEVOS J, 1989, J ANTHROPOL SOC NIP, V97, P407; Dubois E, 1896, PITHECANTHROPUS EREC, VXII, P1; Dubois E., 1894, PITHECANTHROPUS EREC; Dubois E, 1891, PALEONTOLOGISCHE OND; Dubois E, 1895, B SOC BELG GEOL, V9, P151; Dubois E, 1892, PALEONTOLOGISCHE OND; Dubois E, 1924, PITHECANTHROPUS EREC, V35, P443; Duyfies J., 1936, MIJNINGENIEUR, V3, P136; Flenley J.R., 1979, EQUATORIAL RAIN FORE; Grun R, 1997, SCIENCE, V276, P1575, DOI 10.1126/science.276.5318.1575; Gupta AK, 2004, PRIMATE COMMUNITIES, P38; Hooijer D. A., 1962, Zoologische Verhandelingen, VNo. 55, P1; Hooijer D. A., 1960, Zoologische Verhandelingen, VNo. 46, P1; Huffman OF, 2001, SANGIRAN MAN CULTURE, P231; Huffman OF, 2010, PALEOANTHROPOLOGY SO, V2010, pA14; Huffman OF, 2003, J MINEARL TECHNOLOGY, V10; Indriati E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021562; Jablonski NG, 1999, INT J PRIMATOL, V20, P319, DOI 10.1023/A:1020544519463; Jablonski Nina G., 2009, P111, DOI 10.1007/978-0-387-88604-6_7; Joordens JCA, 2009, J HUM EVOL, V57, P656, DOI 10.1016/j.jhevol.2009.06.003; Jutting T. van B., 1937, Zoologische Mededeelingen Leiden, V20, P83; Kappeler M., 1984, P19; Koenigswald G. H. R.von, 1934, De Ingenieur Ned-Indie IV Mijnbouw en Geologie "De Mijnengenieur", VNo.1, P185; Kohler M, 2002, AM J PHYS ANTHROPOL, V119, P297, DOI 10.1002/ajpa.10140; Larick R, 2000, INT J PRIMATOL, V21, P731; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; LEINDERS JJM, 1985, GEOL MIJNBOUW, V64, P167; Lomolino MV, 2013, J BIOGEOGR, V40, P1427, DOI 10.1111/jbi.12096; Lyras GA, 2010, J BIOGEOGR, V37, P1007, DOI 10.1111/j.1365-2699.2010.02312.x; Manouvrier L, 1889, COMP REND C INT ANTH, P363; Mayr E., 1944, NATL RES COUNCIL B, V262, P11; Moigne A.-M., 2004, MODERN QUATERNARY RE, V19, P31; Nijman V, 2004, RAFFLES B ZOOL, V52, P271; Piganiol G, 1959, COMPTES RENDUS ASS A, V104, P660; R Development Core Team, 2009, R FDN STAT COMP; Reuter HI, 2007, INT J GEOGR INF SCI, V21, P983, DOI 10.1080/13658810601169899; Richmond BG, 2001, PHYLOGENY NEOGENE HO, P338; Rozzi R, 2013, PALAEOGEOGR PALAEOCL, V377, P73, DOI 10.1016/j.palaeo.2013.03.012; Ruff CB, 2002, AM J PHYS ANTHROPOL, V119, P305, DOI 10.1002/ajpa.10117; Rumbaugh DM, 1976, SUSPENSORY BEHAV LOC, V4; Saleki H, 1997, THESIS MUSEUM NATL H; Scherf H, 2007, THESIS U DARMSTADT; Schultz AH, 1944, AM J PHYS ANTHROP-NE, V2, P1, DOI 10.1002/ajpa.1330020102; Schuster J, 1911, MONOGRAPHIE FOSSILEN; Selenka L, 1911, PITHECANTHROPUS SCHI; Semah A-M, 1986, THESIS U PROVENCE; Semah AM, 2012, QUATERN INT, V249, P120, DOI 10.1016/j.quaint.2011.06.013; Semah AM, 2010, QUATERN INT, V223, P451, DOI 10.1016/j.quaint.2009.07.017; Semah F, 2000, J ARCHAEOL SCI, V27, P763, DOI 10.1006/jasc.1999.0482; Semah F, 2011, 1 C EUR SOC STUD HUM; Storm P, 2005, J HUM EVOL, V49, P536, DOI 10.1016/j.jhevol.2005.06.003; Storm P, 2013, J HUM EVOL, V64, P356, DOI 10.1016/j.jhevol.2012.11.002; Storm P, 2012, CR PALEVOL, V11, P191, DOI 10.1016/j.crpv.2011.04.002; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; Todd TW, 1930, CHILD DEV, V1, P79; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3; van den Bergh Gert D., 1999, Scripta Geologica, V117, P1; Van der Geer A., 2010, EVOLUTION ISLAND MAM; Van Der Geer AAE, 2008, J VERTEBR PALEONTOL, V28, P1238, DOI 10.1671/0272-4634-28.4.1238; VANDERPLICHT J, 1989, APPL GEOCHEM, V4, P339; Von Koenigswald GHR, 1940, WET MEDED K NED NATU, V28, P1; Watanabe N, 1985, GEOLOGICAL RESEARCG; Westaway KE, 2007, J HUM EVOL, V53, P709, DOI 10.1016/j.jhevol.2007.06.002; Yokoyama Y, 2008, J HUM EVOL, V55, P274, DOI 10.1016/j.jhevol.2008.01.006	85	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99531	10.1371/journal.pone.0099531	http://dx.doi.org/10.1371/journal.pone.0099531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914951	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700113
J	Kalogeris, TJ; Baines, C; Korthuis, RJ				Kalogeris, Theodore J.; Baines, Christopher; Korthuis, Ronald J.			Adenosine Prevents TNF alpha-Induced Decrease in Endothelial Mitochondrial Mass via Activation of eNOS-PGC-1 alpha Regulatory Axis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ANTECEDENT ETHANOL INGESTION; ISCHEMIA-REPERFUSION INJURY; NF-KAPPA-B; NITRIC-OXIDE; MITOTIC COMPETENT; INDUCED APOPTOSIS; PROTEIN-KINASE; BIOGENESIS; PGC-1-ALPHA	We tested whether adenosine, a cytoprotective mediator and trigger of preconditioning, could protect endothelial cells from inflammation-induced deficits in mitochondrial biogenesis and function. We examined this question using human microvascular endothelial cells exposed to TNF alpha. TNF alpha produced time and dose-dependent decreases in mitochondrial membrane potential, cellular ATP levels, and mitochondrial mass, preceding an increase in apoptosis. These effects were prevented by co-incubation with adenosine, a nitric oxide (NO) donor, a guanylate cyclase (GC) activator, or a cell-permeant cyclic GMP (cGMP) analog. The effects of adenosine were blocked by a nitric oxide synthase inhibitor, a soluble guanylate cyclase inhibitor, a morpholino antisense oligonucleotide to endothelial nitric oxide synthase (eNOS), or siRNA knockdown of the transcriptional coactivator, PGC-1 alpha. Incubation with exogenous NO, a GC activator, or a cGMP analog reversed the effect of eNOS knockdown, while the effect of NO was blocked by inhibition of GC. The protective effects of NO and cGMP analog were prevented by siRNA to PGC-1 alpha. TNF alpha also decreased expression of eNOS, cellular NO levels, and PGC-1 alpha expression, which were reversed by adenosine. Exogenous NO, but not adenosine, rescued expression of PGC-1 alpha in cells in which eNOS expression was knocked down by eNOS antisense treatment. Thus, TNF alpha elicits decreases in endothelial mitochondrial function and mass, and an increase in apoptosis. These effects were reversed by adenosine, an effect mediated by eNOS-synthesized NO, acting via soluble guanylate cyclase/cGMP to activate a mitochondrial biogenesis regulatory program under the control of PGC-1 alpha. These results support the existence of an adenosine-triggered, mito-and cytoprotective mechanism dependent upon an eNOS-PGC-1 alpha regulatory pathway, which acts to preserve endothelial mitochondrial function and mass during inflammatory challenge.	[Kalogeris, Theodore J.; Korthuis, Ronald J.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA; [Baines, Christopher] Univ Missouri, Dept Biomed Sci, Columbia, MO USA; [Baines, Christopher; Korthuis, Ronald J.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kalogeris, TJ (corresponding author), Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA.	kalogerist@health.missouri.edu		Baines, Christopher/0000-0002-4473-3869	National Institutes of Health (NIH) [AA014945, HL095486]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014945] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health (NIH) grants: AA014945, HL095486. http://www.niaaa.nih.gov/, http://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Anderson HDI, 2004, J BIOL CHEM, V279, P963, DOI 10.1074/jbc.M309552200; Bell C, 2013, MOL CELL PROTEOMICS, V12, P2394, DOI 10.1074/mcp.M112.025775; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; Bossy-Wetzel E, 2003, CELL DEATH DIFFER, V10, P757, DOI 10.1038/sj.cdd.4401244; Chen XH, 2010, MOL CELL ENDOCRINOL, V328, P63, DOI 10.1016/j.mce.2010.07.005; Chen XP, 2008, CURR HYPERTENS REV, V4, P245, DOI 10.2174/157340208786241336; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001; Dayton C, 2004, MICROCIRCULATION, V11, P709, DOI 10.1080/10739680490521014; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; Drabarek B, 2012, INT J BIOCHEM CELL B, V44, P1390, DOI 10.1016/j.biocel.2012.05.022; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Feelisch M, 1998, N-S ARCH PHARMACOL, V358, P113, DOI 10.1007/PL00005231; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Gaskin FS, 2007, AM J PHYSIOL-HEART C, V292, pH326, DOI 10.1152/ajpheart.00744.2006; Gonzalez-Fernandez F, 2001, ATHEROSCLEROSIS, V155, P61, DOI 10.1016/S0021-9150(00)00535-9; Groschner LN, 2012, PFLUG ARCH EUR J PHY, V464, P63, DOI 10.1007/s00424-012-1085-z; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hatoum OA, 2006, ANN NY ACAD SCI, V1072, P78, DOI 10.1196/annals.1326.003; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Kamada Kazuma, 2004, Pathophysiology, V10, P131, DOI 10.1016/j.pathophys.2003.10.010; Kavazis AN, 2009, AM J PHYSIOL-HEART C, V297, pH144, DOI 10.1152/ajpheart.01278.2008; Kim JJ, 2010, CELL DEATH DIFFER, V17, P1420, DOI 10.1038/cdd.2010.19; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lira VA, 2010, J PHYSIOL-LONDON, V588, P3551, DOI 10.1113/jphysiol.2010.194035; Liu YJ, 2012, AM J PHYSIOL-GASTR L, V302, pG44, DOI 10.1152/ajpgi.00413.2010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljubkovic M, 2007, AM J PHYSIOL-CELL PH, V292, pC1583, DOI 10.1152/ajpcell.00221.2006; Mariappan N, 2009, FREE RADICAL BIO MED, V46, P462, DOI 10.1016/j.freeradbiomed.2008.10.049; McLeod CJ, 2005, TRENDS CARDIOVAS MED, V15, P118, DOI 10.1016/j.tcm.2005.05.001; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Nisoli E, 2004, BIOCHEM PHARMACOL, V67, P1, DOI 10.1016/j.bcp.2003.10.015; Ozacmak VH, 2007, WORLD J GASTROENTERO, V13, P538, DOI 10.3748/wjg.v13.i4.538; Palomer X, 2009, CARDIOVASC RES, V81, P703, DOI 10.1093/cvr/cvn327; Paz Y, 2003, J AM COLL CARDIOL, V42, P1299, DOI 10.1016/S0735-1097(03)00992-6; Pias EK, 2002, CELL DEATH DIFFER, V9, P1007, DOI 10.1038/sj.cdd.4401064; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035; Spaulding HL, 2006, AM J PHYSIOL-CELL PH, V290, pC95, DOI 10.1152/ajpcell.00388.2005; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Yamaguchi T, 2007, AM J PHYSIOL-HEART C, V292, pH1435, DOI 10.1152/ajpheart.00282.2006; Yitzhaki S, 2009, BASIC RES CARDIOL, V104, P157, DOI 10.1007/s00395-009-0006-6; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200; Zhang X, 2002, J BIOL CHEM, V277, P48472, DOI 10.1074/jbc.M209130200; Zhu JH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.46	64	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98459	10.1371/journal.pone.0098459	http://dx.doi.org/10.1371/journal.pone.0098459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914683	Green Published, gold			2022-12-25	WOS:000340947700021
J	Zhou, M; Fu, J; Huang, W; Shen, LC; Xiao, L; Song, Y; Liu, Y				Zhou, Min; Fu, Jing; Huang, Wei; Shen, Licong; Xiao, Li; Song, Yong; Liu, Ying			Increased Cystic Fibrosis Transmembrane Conductance Regulators Expression and Decreased Epithelial Sodium Channel Alpha Subunits Expression in Early Abortion: Findings from a Mouse Model and Clinical Cases of Abortion	PLOS ONE			English	Article							CFTR GENE-EXPRESSION; MURINE ABORTION; NA+ CHANNEL; ENDOMETRIAL EPITHELIUM; INTERFERON-GAMMA; TNF-ALPHA; CELLS; PREGNANCY; ACTIVATION; REACTIVITY	The status of the maternal endometrium is vital in regulating humoral homeostasis and for ensuring embryo implantation. Cystic fibrosis transmembrane conductance regulators (CFTR) and epithelial sodium channel alpha subunits (ENaC-alpha) play an important role in female reproduction by maintaining humoral and cell homeostasis. However, it is not clear whether the expression levels of CFTR and ENaC-alpha in the decidual component during early pregnancy are related with early miscarriage. CBAxDBA/2 mouse mating has been widely accepted as a classical model of early miscarriage. The abortion rate associated with this mating was 33.33% in our study. The decidua of abortion-prone CBA female mice (DBA/2 mated) had higher CFTR mRNA and protein expression and lower ENaC-alpha mRNA and protein expression, compared to normal pregnant CBA mice (BLAB/C mated). Furthermore, increased CFTR expression and decreased ENaC-alpha expression were observed in the uterine tissue from women with early miscarriage, as compared to those with successful pregnancy. In conclusion, increased CFTR expression and decreased ENaC-alpha expression in the decidua of early abortion may relate with failure of early pregnancy.	[Zhou, Min; Fu, Jing; Huang, Wei; Shen, Licong; Xiao, Li; Song, Yong] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China; [Liu, Ying] Sichuan Univ, West China Univ Hosp 2, West China Inst Women & Childrens Hlth, Sichuan Univ Chinese Univ Hong Kong Joint Lab Rep, Chengdu 610064, Peoples R China	Sichuan University; Chinese University of Hong Kong; Sichuan University	Huang, W (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China.	weihuang64@163.com	Song, Yong/AAX-5509-2021					Ahmed A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013663; Arck PC, 1997, AM J REPROD IMMUNOL, V37, P262; Baek KH, 2007, TRENDS MOL MED, V13, P310, DOI 10.1016/j.molmed.2007.05.005; BESANCON F, 1994, AM J PHYSIOL-CELL PH, V267, pC1398, DOI 10.1152/ajpcell.1994.267.5.C1398; Braun C, 2005, J IMMUNOL, V175, P3402, DOI 10.4049/jimmunol.175.5.3402; Brouillard F, 2001, J BIOL CHEM, V276, P9486, DOI 10.1074/jbc.M006636200; Cafferata EG, 2000, BBA-MOL BASIS DIS, V1500, P241, DOI 10.1016/S0925-4439(99)00105-2; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chan LN, 2001, PFLUG ARCH EUR J PHY, V443, pS132; Chan LN, 2002, J MEMBRANE BIOL, V185, P165, DOI 10.1007/s00232-001-0117-y; CHAOUAT G, 1995, J IMMUNOL, V154, P4261; Chaouat G, 1988, 18 R C O G STUD GROU, P89, DOI DOI 10.1007/978-1-4471-1658-5_10; Chen MH, 2010, HUM REPROD, V25, P1744, DOI 10.1093/humrep/deq094; Chien LW, 2002, HUM REPROD, V17, P351, DOI 10.1093/humrep/17.2.351; Clark DA, 1999, AM J REPROD IMMUNOL, V41, P5; Cummins JM, 2001, HUM REPROD UPDATE, V7, P217, DOI 10.1093/humupd/7.2.217; Dagenais A, 2004, AM J PHYSIOL-LUNG C, V286, pL301, DOI 10.1152/ajplung.00326.2002; del Monaco SM, 2009, J MEMBRANE BIOL, V232, P1, DOI 10.1007/s00232-009-9206-0; Eisenhut Michael, 2006, J Inflamm (Lond), V3, P5, DOI 10.1186/1476-9255-3-5; Galietta LJV, 2000, AM J PHYSIOL-LUNG C, V278, pL1186, DOI 10.1152/ajplung.2000.278.6.L1186; HAMILTON MS, 1987, J REPROD IMMUNOL, V11, P237, DOI 10.1016/0165-0378(87)90060-X; Inagaki N, 2003, HUM REPROD, V18, P608, DOI 10.1093/humrep/deg139; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Lane M, 2005, REPROD FERT DEVELOP, V17, P371, DOI 10.1071/RD04102; Matthews CJ, 1998, J PHYSIOL-LONDON, V513, P443, DOI 10.1111/j.1469-7793.1998.443bb.x; Raghupathy R, 1999, CELL IMMUNOL, V196, P122, DOI 10.1006/cimm.1999.1532; Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4; Roth EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024445; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; TANGRI S, 1994, J IMMUNOL, V152, P4903; Yamamura H, 2004, J BIOL CHEM, V279, P44483, DOI 10.1074/jbc.M408929200; Yang JZ, 2004, CELL BIOL INT, V28, P433, DOI 10.1016/j.cellbi.2004.03.011; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4; Zenclussen AC, 2003, CYTOKINE, V24, P150, DOI 10.1016/j.cyto.2003.08.002	34	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99521	10.1371/journal.pone.0099521	http://dx.doi.org/10.1371/journal.pone.0099521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914548	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700110
J	Wang, GS; Yu, ZG; Zhen, Y; Mi, TZ; Shi, Y; Wang, JY; Wang, MX; Sun, S				Wang, Guoshan; Yu, Zhigang; Zhen, Yu; Mi, Tiezhu; Shi, Yan; Wang, Jianyan; Wang, Minxiao; Sun, Song			Molecular Characterisation, Evolution and Expression of Hypoxia-Inducible Factor in Aurelia sp.1	PLOS ONE			English	Article							FACTOR-I; STRIATED-MUSCLE; GENOME; HIF; TRANSCRIPTION; REPRODUCTION; JELLYFISH; CNIDARIA; REVEALS; HISTORY	The maintenance of physiological oxygen homeostasis is mediated by hypoxia-inducible factor (HIF), a key transcriptional factor of the PHD-HIF system in all metazoans. However, the molecular evolutionary origin of this central physiological regulatory system is not well characterized. As the earliest eumetazoans, Cnidarians can be served as an interesting model for exploring the HIF system from an evolutionary perspective. We identified the complete cDNA sequence of HIF-1 alpha (ASHIF) from the Aurelia sp.1, and the predicted HIF-1 alpha protein (pASHIF) was comprised of 674 amino acids originating from 2,025 bp nucleotides. A Pairwise comparison revealed that pASHIF not only possessed conserved basic helix-loop-helix (bHLH) and Per-Arnt-Sim (PAS) domains but also contained the oxygen dependent degradation (ODD) and the C-terminal transactivation domains (C-TAD), the key domains for hypoxia regulation. As indicated by sequence analysis, the ASHIF gene contains 8 exons interrupted by 7 introns. Western blot analysis indicated that pASHIF that existed in the polyps and medusa of Aurelia. sp.1 was more stable for a hypoxic response than normoxia.	[Wang, Guoshan; Wang, Jianyan] Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China; [Yu, Zhigang] Minist Educ, Key Lab Marine Chem Theory & Engn, Qingdao, Shandong, Peoples R China; [Yu, Zhigang] Ocean Univ China, Coll Chem & Chem Engn, Qingdao, Shandong, Peoples R China; [Zhen, Yu; Mi, Tiezhu] Minist Educ, Key Lab Marine Environm & Ecol, Qingdao, Shandong, Peoples R China; [Zhen, Yu; Mi, Tiezhu; Shi, Yan] Ocean Univ China, Coll Environm Sci & Engn, Qingdao, Shandong, Peoples R China; [Wang, Minxiao; Sun, Song] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Shandong, Peoples R China	Ocean University of China; Ocean University of China; Ocean University of China; Chinese Academy of Sciences; Institute of Oceanology, CAS	Zhen, Y (corresponding author), Minist Educ, Key Lab Marine Environm & Ecol, Qingdao, Shandong, Peoples R China.	zhenyu@ouc.edu.cn	ZHEN, YU/E-3247-2014	ZHEN, YU/0000-0003-1097-8179; Minxiao, Wang/0000-0002-6567-3295	National Basic Research Program of China (973 Program) [2011CB403602]; National Natural Science Foundation of China [41221004, 41076085]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (2011CB403602), and by the National Natural Science Foundation of China (41221004 and 41076085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Muller P, 2003, DEV BIOL, V255, P216, DOI 10.1016/S0012-1606(02)00091-X; Purcell JE, 2001, COAST EST S, V58, P77; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ruas JL, 2002, J BIOL CHEM, V277, P38723, DOI 10.1074/jbc.M205051200; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Rytkonen KT, 2011, EMBO REP, V12, P3, DOI 10.1038/embor.2010.192; Rytkonen KT, 2010, MOL EVOLUTION METAZO; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Seipel K, 2005, DEV BIOL, V282, P14, DOI 10.1016/j.ydbio.2005.03.032; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Tu Q, 2012, GENOME RES, V22, P2079, DOI 10.1101/gr.139170.112; [Вагелли А.А. Vagelli Alejandro A.], 2007, [Зоология беспозвоночных, Invertebrate Zoology, Zoologiya bespozvonochnykh], V4, P111; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510	31	7	8	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100057	10.1371/journal.pone.0100057	http://dx.doi.org/10.1371/journal.pone.0100057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926666	Green Submitted, Green Published, gold			2022-12-25	WOS:000338278100112
J	Sadakata, T; Kakegawa, W; Shinoda, Y; Hosono, M; Katoh-Semba, R; Sekine, Y; Sato, Y; Saruta, C; Ishizaki, Y; Yuzaki, M; Kojima, M; Furuichi, T				Sadakata, Tetsushi; Kakegawa, Wataru; Shinoda, Yo; Hosono, Mayu; Katoh-Semba, Ritsuko; Sekine, Yukiko; Sato, Yumi; Saruta, Chihiro; Ishizaki, Yasuki; Yuzaki, Michisuke; Kojima, Masami; Furuichi, Teiichi			Axonal Localization of Ca2+- Dependent Activator Protein for Secretion 2 Is Critical for Subcellular Locality of Brain-Derived Neurotrophic Factor and Neurotrophin-3 Release Affecting Proper Development of Postnatal Mouse Cerebellum	PLOS ONE			English	Article							CORE VESICLE TRAFFICKING; AUTISTIC-LIKE PHENOTYPES; DIFFERENTIAL REGULATION; CADPS2-KNOCKOUT MICE; SYNAPTIC PLASTICITY; CADPS2; BDNF; CALCIUM; CAPS1; EXOCYTOSIS	Ca2+-dependent activator protein for secretion 2 (CAPS2) is a protein that is essential for enhanced release of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) from cerebellar granule cells. We previously identified dex3, a rare alternative splice variant of CAPS2, which is overrepresented in patients with autism and is missing an exon 3 critical for axonal localization. We recently reported that a mouse model CAPS2(Delta ex3/Delta ex3) expressing dex3 showed autistic-like behavioral phenotypes including impaired social interaction and cognition and increased anxiety in an unfamiliar environment. Here, we verified impairment in axonal, but not somato-dendritic, localization of dex3 protein in cerebellar granule cells and demonstrated cellular and physiological phenotypes in postnatal cerebellum of CAPS2(Delta ex3/Delta ex3) mice. Interestingly, both BDNF and NT-3 were markedly reduced in axons of cerebellar granule cells, resulting in a significant decrease in their release. As a result, dex3 mice showed developmental deficits in dendritic arborization of Purkinje cells, vermian lobulation and fissurization, and granule cell precursor proliferation. Paired-pulse facilitation at parallel fiber-Purkinje cell synapses was also impaired. Together, our results indicate that CAPS2 plays an important role in subcellular locality (axonal vs. somato-dendritic) of enhanced BDNF and NT-3 release, which is indispensable for proper development of postnatal cerebellum.	[Sadakata, Tetsushi; Hosono, Mayu] Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma, Japan; [Sadakata, Tetsushi; Shinoda, Yo; Kojima, Masami; Furuichi, Teiichi] JST CREST, Kawaguchi, Saitama, Japan; [Kakegawa, Wataru; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Shinoda, Yo; Katoh-Semba, Ritsuko; Sekine, Yukiko; Sato, Yumi; Saruta, Chihiro; Furuichi, Teiichi] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Ishizaki, Yasuki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma, Japan; [Kojima, Masami] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Biointerface Res Grp, Ikeda, Osaka, Japan	Gunma University; Japan Science & Technology Agency (JST); Keio University; Tokyo University of Science; Gunma University; National Institute of Advanced Industrial Science & Technology (AIST)	Sadakata, T (corresponding author), Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma, Japan.	sadakata-1024@umin.ac.jp; tfuruichi@rs.tus.ac.jp	Ishizaki, Yasuki/AAB-1209-2020; Sadakata, Tetsushi/W-9324-2018; Kakegawa, Wataru/G-5569-2016; Shinoda, Yo/H-3091-2019; Yuzaki, Michisuke/K-5328-2013; Furuichi, Teiichi/B-5086-2014	Sadakata, Tetsushi/0000-0003-0276-4162; Shinoda, Yo/0000-0003-3253-2194; Yuzaki, Michisuke/0000-0002-5750-3544; Furuichi, Teiichi/0000-0002-9676-1888	Japan Foundation for Neuroscience and Mental Health; Uehara Memorial Foundation; Takeda Science Foundation; Nakajima Foundation; Yamada Science Foundation; Mother and Child Health Foundation; NOVARTIS Foundation for the Promotion of Science; Inamori Foundation; Scientific Research on Innovative Areas "Foundation of Synapse and Neurocircuit Pathology''; Japan Science and Technology Agency; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25110707]; Japan Society for the Promotion of Science (JSPS) [25430061]; Institute of Physical and Chemical Research (RIKEN); Program to Disseminate Tenure Tracking System of MEXT; Grants-in-Aid for Scientific Research [25110707, 25430061, 26250024] Funding Source: KAKEN	Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Nakajima Foundation; Yamada Science Foundation; Mother and Child Health Foundation(Mother and Child Health Foundation); NOVARTIS Foundation for the Promotion of Science; Inamori Foundation; Scientific Research on Innovative Areas "Foundation of Synapse and Neurocircuit Pathology''(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute of Physical and Chemical Research (RIKEN); Program to Disseminate Tenure Tracking System of MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Japan Foundation for Neuroscience and Mental Health, the Uehara Memorial Foundation, the Takeda Science Foundation, the Nakajima Foundation, the Yamada Science Foundation, the Mother and Child Health Foundation, the NOVARTIS Foundation for the Promotion of Science, the Inamori Foundation, Scientific Research on Innovative Areas "Foundation of Synapse and Neurocircuit Pathology'', the Japan Science and Technology Agency, the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT; grant number 25110707), the Japan Society for the Promotion of Science (JSPS; grant numbers 25430061), the Institute of Physical and Chemical Research (RIKEN), and the Program to Disseminate Tenure Tracking System of MEXT granted to Gunma University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Atluri PP, 1998, J NEUROSCI, V18, P8214; Bangash MA, 2011, CELL, V145, P758, DOI 10.1016/j.cell.2011.03.052; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Binda AV, 2005, BIOCHEM PHARMACOL, V69, P1451, DOI 10.1016/j.bcp.2005.02.015; Bonora E, 2014, EMBO MOL MED; Carter AR, 2002, J NEUROSCI, V22, P1316, DOI 10.1523/JNEUROSCI.22-04-01316.2002; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Christian SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/j.biopsych.2008.01.009; Cisternas FA, 2003, GENOMICS, V81, P279, DOI 10.1016/S0888-7543(02)00040-X; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Eran A, 2009, J CLIN INVEST, V119, P679, DOI 10.1172/JCI38620; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Kakegawa W, 2008, J NEUROSCI, V28, P1460, DOI 10.1523/JNEUROSCI.2553-07.2008; Katoh-Semba R, 2000, J NEUROCHEM, V74, P1923, DOI 10.1046/j.1471-4159.2000.0741923.x; KatohSemba R, 1996, J NEUROCHEM, V66, P330; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Okamoto N, 2011, AM J MED GENET A, V155A, P1568, DOI 10.1002/ajmg.a.34028; Palferman S, 2001, HUM MOL GENET, V10, P973; Pierce K, 2001, BIOL PSYCHIAT, V49, P655, DOI 10.1016/S0006-3223(00)01008-8; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Sadakata T, 2013, J NEUROSCI, V33, P17326, DOI 10.1523/JNEUROSCI.2777-13.2013; Sadakata T, 2012, P NATL ACAD SCI USA, V109, P21104, DOI 10.1073/pnas.1210055109; Sadakata T, 2010, J BIOL CHEM, V285, P38710, DOI 10.1074/jbc.M110.137414; Sadakata T, 2009, CEREBELLUM, V8, P312, DOI 10.1007/s12311-009-0097-5; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Shinoda Y, 2011, P NATL ACAD SCI USA, V108, P373, DOI 10.1073/pnas.1012220108; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99524	10.1371/journal.pone.0099524	http://dx.doi.org/10.1371/journal.pone.0099524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923991	Green Submitted, gold, Green Published			2022-12-25	WOS:000338701300071
J	Watari, K; Shibata, T; Kawahara, A; Sata, K; Nabeshima, H; Shinoda, A; Abe, H; Azuma, K; Murakami, Y; Izumi, H; Takahashi, T; Kage, M; Kuwano, M; Ono, M				Watari, Kosuke; Shibata, Tomohiro; Kawahara, Akihiko; Sata, Ken-ichi; Nabeshima, Hiroshi; Shinoda, Ai; Abe, Hideyuki; Azuma, Koichi; Murakami, Yuichi; Izumi, Hiroto; Takahashi, Takashi; Kage, Masayoshi; Kuwano, Michihiko; Ono, Mayumi			Tumor-Derived Interleukin-1 Promotes Lymphangiogenesis and Lymph Node Metastasis through M2-Type Macrophages	PLOS ONE			English	Article							GROWTH-FACTOR-C; CELL-LINE NCI-H460-LNM35; NF-KAPPA-B; CANCER-CELLS; LUNG-CANCER; INFLAMMATORY STIMULI; EMERGING MECHANISMS; VEGF-C; ANGIOGENESIS; ACTIVATION	Tumors formed by a highly metastatic human lung cancer cell line are characterized by activated signaling via vascular endothelial growth factor (VEGF)-C through its receptor (VEGFR-3) and aggressive lymph node metastasis. In this study, we examined how these highly metastatic cancers acquired aggressive lymph node metastasis. Compared with their lower metastatic counterparts, the highly metastatic tumors formed by this cell line expressed higher amounts of interleukin (IL)-1 alpha, with similarly augmented expression of IL-1 alpha and IL-1 beta by tumor stromal cells and of VEGF-A and VEGF-C by tumor-associated macrophages. These tumor-associated macrophages were mainly of the M2 type. Administration of a macrophage-targeting drug suppressed the production of these potent angiogenic and lymphangiogenic factors, resulting in decreased tumor growth, angiogenesis, lymphangiogenesis, and lymph node metastasis. In Matrigel plug assays, the highly metastatic cells formed tumors that were extensively infiltrated by M2-type macrophages and exhibited enhanced angiogenesis and lymphangiogenesis. All of these responses were suppressed by the IL-1 receptor (IL-1R) antagonist anakinra. Thus, the IL-1 alpha-driven inflammatory activation of angiogenesis and lymphangiogenesis seems to provide a highly metastatic tumor microenvironment favorable for lymph node metastasis through cross-talk with macrophages. Accordingly, the IL-1R/M2-type macrophage axis may be a good therapeutic target for patients with this form of lung cancer.	[Watari, Kosuke; Shibata, Tomohiro; Sata, Ken-ichi; Nabeshima, Hiroshi; Shinoda, Ai; Murakami, Yuichi; Ono, Mayumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 812, Japan; [Kawahara, Akihiko; Abe, Hideyuki; Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan; [Azuma, Koichi] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 830, Japan; [Murakami, Yuichi] St Marys Hosp, Kurume, Fukuoka, Japan; [Izumi, Hiroto] Univ Occupat & Environm Hlth, Dept Occupat Pneumol, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan; [Takahashi, Takashi] Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Ctr Neurol Dis & Canc, Nagoya, Aichi 4648601, Japan; [Kuwano, Michihiko] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Mol Canc Biol, Fukuoka 812, Japan	Kyushu University; Kurume University; Kurume University; University of Occupational & Environmental Health - Japan; Nagoya University; Kyushu University	Ono, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 812, Japan.	mono@phar.kyushu-u.ac.jp	Takahashi, Takashi/I-7262-2014	Takahashi, Takashi/0000-0003-0615-7001; Watari, Kosuke/0000-0003-0260-2323	JSPS KAKENHI [23112515, 23300350]; Grants-in-Aid for Scientific Research [221S0001, 23300350] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI Grant Numbers 23112515, 23300350 (to MO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Enholm B, 1997, ONCOGENE, V14, P2475, DOI 10.1038/sj.onc.1201090; Fujiwara T, 2011, AM J PATHOL, V179, P1157, DOI 10.1016/j.ajpath.2011.05.034; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Heckman CA, 2008, CANCER RES, V68, P4754, DOI 10.1158/0008-5472.CAN-07-5809; Hiraoka K, 2008, CANCER SCI, V99, P1595, DOI 10.1111/j.1349-7006.2008.00880.x; Holopainen T, 2012, J NATL CANCER I, V104, P461, DOI 10.1093/jnci/djs009; Kajita T, 2001, BRIT J CANCER, V85, P255, DOI 10.1054/bjoc.2001.1882; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Koukourakis MI, 1998, BRIT J CANCER, V77, P1696, DOI 10.1038/bjc.1998.280; Kozaki K, 2000, CANCER RES, V60, P2535; Kozaki K, 2001, ONCOGENE, V20, P4228, DOI 10.1038/sj.onc.1204561; Kuwano T, 2004, FASEB J, V18, P300, DOI 10.1096/fj.03-0473com; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Murakami Y, 2013, J BIOL CHEM, V288, P25025, DOI 10.1074/jbc.M113.472068; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Orlandini M, 2001, J BIOL CHEM, V276, P6576, DOI 10.1074/jbc.M009573200; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; Voronov E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00177; Watari K, 2008, BIOCHEM BIOPH RES CO, V377, P826, DOI 10.1016/j.bbrc.2008.10.077	41	49	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99568	10.1371/journal.pone.0099568	http://dx.doi.org/10.1371/journal.pone.0099568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924428	gold, Green Published, Green Submitted			2022-12-25	WOS:000338701300074
J	Favaron, PO; Mess, A; Will, SE; Maiorka, PC; de Oliveira, MF; Miglino, MA				Favaron, Phelipe Oliveira; Mess, Andrea; Will, Sonia Elisabete; Maiorka, Paulo Cesar; de Oliveira, Moacir Franco; Miglino, Maria Angelica			Yolk Sac Mesenchymal Progenitor Cells from New World Mice (Necromys lasiurus) with Multipotent Differential Potential	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; OSTEOGENIC DIFFERENTIATION; STROMAL CELLS; MOUSE; PLACENTA; BIOLOGY; IDENTIFICATION; PLURIPOTENCY; ANGIOGENESIS	Fetal membranes are abundant, ethically acceptable and readily accessible sources of stem cells. In particular, the yolk sac is a source of cell lineages that do not express MHCs and are mainly free from immunological incompatibles when transferred to a recipient. Although data are available especially for hematopoietic stem cells in mice and human, whereas other cell types and species are dramatically underrepresented. Here we studied the nature and differentiation potential of yolk sac derived mesenchymal stem cells from a New World mouse, Necromys lasiurus. Explants from mid-gestation were cultured in DMEM-High glucose medium with 10% defined fetal bovine serum. The cells were characterized by standard methods including immunophenotyping by fluorescence and flow cytometry, growth and differentiation potential and tumorigenicity assays. The first adherent cells were observed after 7 days of cell culture and included small, elongated fibroblast-like cells (92.13%) and large, round epithelial-like cells with centrally located nuclei (6.5%). Only the fibroblast-like cells survived the first passages. They were positive to markers for mesenchymal stem cells (Stro-1, CD90, CD105, CD73) and pluripotency (Oct3/4, Nanog) as well as precursors of hematopoietic stem cells (CD117). In differentiation assays, they were classified as a multipotent lineage, because they differentiated into osteogenic, adipogenic, and chondrogenic lineages and, finally, they did not develop tumors. In conclusion, mesenchymal progenitor cells with multipotent differentiation potential and sufficient growth and proliferation abilities were able to be obtained from Necromys yolk sacs, therefore, we inferred that these cells may be promising for a wide range of applications in regenerative medicine.	[Favaron, Phelipe Oliveira; Mess, Andrea; Will, Sonia Elisabete; Maiorka, Paulo Cesar; Miglino, Maria Angelica] Univ Sao Paulo, Sch Vet Med & Anim Sci, Sao Paulo, Brazil; [de Oliveira, Moacir Franco] Univ Fed Rural Semi Arido, Dept Anim Sci, Mossoro, RN, Brazil	Universidade de Sao Paulo; Universidade Federal Rural do Semi-Arido (UFERSA)	Favaron, PO (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Sao Paulo, Brazil.	Phelipe.favaron@yahoo.com.br	Maiorka, Paulo/ABG-1405-2020; Miglino, Maria Angelica/B-9519-2012	Miglino, Maria Angelica/0000-0003-4979-115X; Favaron, Phelipe/0000-0002-6431-6886	FAPESP [09/53392-8]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by a grant from FAPESP (Process number: 09/53392-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach R, 1998, DEV COMP IMMUNOL, V22, P333, DOI 10.1016/S0145-305X(98)00005-6; Auerbach R, 1996, STEM CELLS, V14, P269, DOI 10.1002/stem.140269; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; CARMICHAEL J, 1987, CANCER RES, V47, P936; Cooper GM, 2007, CELULA UMA ABORDAGEM; Corn BJ, 1991, CLIN BIOTECHNOL, V3, P15; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Favaron PO, 2012, PLACENTA, V33, P578, DOI 10.1016/j.placenta.2012.02.011; Fernandes R. A., 2012, Open Journal of Animal Sciences, V2, P166, DOI 10.4236/ojas.2012.23023; GLOBERSON A, 1987, DIFFERENTIATION, V36, P185, DOI 10.1111/j.1432-0436.1987.tb00192.x; Han JH, 2012, STEM CELLS, V30, P2746, DOI 10.1002/stem.1223; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jaffredo T, 2005, INT J DEV BIOL, V49, P269, DOI 10.1387/ijdb.041948tj; JOLLIE WP, 1990, TERATOLOGY, V41, P361, DOI 10.1002/tera.1420410403; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; MacArthur BD, 2013, CELL, V154, P484, DOI 10.1016/j.cell.2013.07.024; Mambelli LI, 2009, TISSUE ENG PART C-ME, V15, P87, DOI 10.1089/ten.tec.2008.0186; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; [那晓东 Na Xiaodong], 2003, [中国病理生理杂志, Chinese Journal of Pathophysiology], V19, P1316; [那晓东 Na Xiaodong], 2005, [中国病理生理杂志, Chinese Journal of Pathophysiology], V21, P636; Nakagawa S, 2000, ARCH HISTOL CYTOL, V63, P229, DOI 10.1679/aohc.63.229; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Parolini O, 2010, STEM CELLS DEV, V19, P143, DOI 10.1089/scd.2009.0404; Pessolato AGT, 2011, THESIS U SAO PAULO B; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; Sinowatz F., 2010, ESSENTIALS DOMESTIC, V1st ed., P317; VANDENHEUVEL RL, 1987, BRIT J HAEMATOL, V66, P15, DOI 10.1111/j.1365-2141.1987.tb06884.x; Wang XY, 2008, BLOOD, V111, P2436, DOI 10.1182/blood-2007-07-099333; Wenceslau CV, 2011, TISSUE ENG PT A, V17, P2165, DOI [10.1089/ten.TEA.2010.0678, 10.1089/ten.tea.2010.0678]; Wu GM, 2013, NAT CELL BIOL, V15, P1089, DOI 10.1038/ncb2816; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Zhao Zi-ping, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P41; Zhao ZP, 2003, THESIS CENTRAL S U C; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	43	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e95575	10.1371/journal.pone.0095575	http://dx.doi.org/10.1371/journal.pone.0095575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918429	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000005
J	Jackson, CR; Power, RJ; Groom, RJ; Masenga, EH; Mjingo, EE; Fyumagwa, RD; Roskaft, E; Davies-Mostert, H				Jackson, Craig R.; Power, R. John; Groom, Rosemary J.; Masenga, Emmanuel H.; Mjingo, Ernest E.; Fyumagwa, Robert D.; Roskaft, Eivin; Davies-Mostert, Harriet			Heading for the Hills: Risk Avoidance Drives Den Site Selection in African Wild Dogs	PLOS ONE			English	Article							NATAL DENS; PACK SIZE; COMPETITION; POPULATION; EXTINCTION; SOCIALITY; DYNAMICS; WOLVES	Compared to their main competitors, African wild dogs (Lycaon pictus) have inferior competitive abilities and interspecific competition is a serious fitness-limiting factor. Lions (Panthera leo) are the dominant large carnivore in African savannah ecosystems and wild dogs avoid them both spatially and temporally. Wild dog young are particularly vulnerable and suffer high rates of mortality from lions. Since lions do not utilize all parts of the landscape with an equal intensity, spatial variation in lion densities can be exploited by wild dogs both during their general ranging behaviour, but more specifically when they are confined to a den with vulnerable young. Since patches of rugged terrain are associated with lower lion densities, we hypothesized that these comparatively safe habitats should be selected by wild dogs for denning. We investigated the relationship between the distribution of 100 wild dog den sites and the occurrence of rugged terrain in four wild dog populations located in Tanzania, Zimbabwe and South Africa. A terrain ruggedness index was derived from a 90 m digital elevation model and used to map terrain ruggedness at each site. We compared characteristics of actual and potential (random) den sites to determine how wild dogs select den sites. The distributions of wild dog dens were strongly associated with rugged terrain and wild dogs actively selected terrain that was more rugged than that available on average. The likelihood of encountering lions is reduced in these habitats, minimizing the risk to both adults and pups. Our findings have important implications for the conservation management of the species, especially when assessing habitat suitability for potential reintroductions. The simple technique used to assess terrain ruggedness may be useful to investigate habitat suitability, and even predict highly suitable denning areas, across large landscapes.	[Jackson, Craig R.; Roskaft, Eivin] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway; [Power, R. John] North West Prov Govt, Dept Econ Dev Environm Conservat & Tourism, Mmabatho, South Africa; [Groom, Rosemary J.] Univ Johannesburg, Dept Zool, Johannesburg, South Africa; [Groom, Rosemary J.] African Wildlife Conservat Fund, Chishakwe Ranch, Zimbabwe; [Masenga, Emmanuel H.; Mjingo, Ernest E.; Fyumagwa, Robert D.] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Davies-Mostert, Harriet] Endangered Wildlife Trust, Johannesburg, South Africa; [Davies-Mostert, Harriet] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Oxford, England	Norwegian University of Science & Technology (NTNU); University of Johannesburg; University of Oxford	Jackson, CR (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway.	craig.jackson@bio.ntnu.no	Power, Richard John/AAT-2039-2021; Jackson, Craig/AAT-9335-2021; Røskaft, Eivin/N-7476-2019	Power, Richard John/0000-0002-0684-4007; Røskaft, Eivin/0000-0003-0262-8443; Davies-Mostert, Harriet/0000-0001-7824-4863; Jackson, Craig/0000-0002-3918-1721	Work in Zimbabwe: Rufford Small Grants Foundation [16.04.08, 50.10.09]; Columbus Zoo and Aquarium; Disney Worldwide Conservation Fund; National Geographic Conservation Trust [C183-10]; USFWS Wildlife Without Borders [96200-1-G236]; Sea World and Busch Gardens	Work in Zimbabwe: Rufford Small Grants Foundation; Columbus Zoo and Aquarium; Disney Worldwide Conservation Fund; National Geographic Conservation Trust(National Geographic Society); USFWS Wildlife Without Borders; Sea World and Busch Gardens	Financial support for work in the various study areas was received from the following: Work in Zimbabwe: Rufford Small Grants Foundation (1st and 2nd Rufford Small Grant; Reference: 16.04.08 and 50.10.09) (http://www.rufford.org/); Columbus Zoo and Aquarium (http://www.colszoo.org/); Disney Worldwide Conservation Fund (http://thewaltdisneycompany.com/citizenship/environmental-stewardship/disney-worldwide-conservation-fund); National Geographic Conservation Trust (Grant C183-10) (http://www.nationalgeographic.com/explorers/grants-programs/conservation-trust-application/); USFWS Wildlife Without Borders (Agreement number 96200-1-G236) (http://www.fws.gov/international/wildlife-without-borders/); and Sea World and Busch Gardens (www.swbg-conservationfund.org). Work in South Africa (Venetia Limpopo Nature Reserve): The Endangered Wildlife Trust (www.ewt.org.za); Land Rover Jaguar South Africa (www.jlrcorp.co.za); and De Beers Consolidated Mines (www.debeersgroup.com/operations/mining/mining-operations/de-beers-consolidated-mines). Work in Tanzania: Frankfurt Zoological Society (www.zgf.de/?id=8&language=en) and Vodacom Tanzania (www.vodacom.co.tz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjo WM, 2003, CAN J ZOOL, V81, P96, DOI 10.1139/Z02-232; Carbone C, 1997, J ANIM ECOL, V66, P318, DOI 10.2307/5978; Courchamp F, 2001, ANIM CONSERV, V4, P169, DOI 10.1017/S1367943001001196; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S, 1996, CONSERV BIOL, V10, P526, DOI 10.1046/j.1523-1739.1996.10020526.x; Creel S, 2001, CONSERV BIOL SER, V5, P35; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; Creel S., 2002, AFRICAN WILD DOG BEH; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Eide NE, 2001, POLAR BIOL, V24, P132; Hanby J. P., 1995, SERENGETI, P315; Homewood K, 2001, P NATL ACAD SCI USA, V98, P12544, DOI 10.1073/pnas.221053998; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Kaartinen S, 2010, J ZOOL, V281, P99, DOI 10.1111/j.1469-7998.2009.00678.x; MALCOLM JR, 1982, BEHAV ECOL SOCIOBIOL, V10, P1, DOI 10.1007/BF00296390; Manly BFJ, 2002, RESOURCE SELECTION A, DOI 10.1007/978-94-011-1558-2; Masenga E, 2011, THESIS SOKOINE U AGR; Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x; Mizutani F, 1999, AFR J ECOL, V37, P226, DOI 10.1046/j.1365-2028.1999.00171.x; Moehlmann PD, 1989, CARNIVORE BEHAV ECOL; Mucina Ladislav, 2006, V19, P2; Pruss SD, 1999, CAN J ZOOL, V77, P646, DOI 10.1139/cjz-77-4-646; Rasmussen GSA, 2008, AM NAT, V172, P508, DOI 10.1086/590965; Ruggiero LF, 1998, J WILDLIFE MANAGE, V62, P663, DOI 10.2307/3802342; Saleni P, 2007, CANID NEWS, V10, P2; Slough BG, 1999, CAN FIELD NAT, V113, P605; SMITS CMM, 1988, ARCTIC, V41, P12; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Steyn V, 2009, S AFR J WILDL RES, V39, P126, DOI 10.3957/056.039.0203; Theuerkauf J, 2003, CAN J ZOOL, V81, P163, DOI 10.1139/Z02-190; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; Trapp JR, 2008, CAN FIELD NAT, V122, P49, DOI 10.22621/cfn.v122i1.543; van der Meer E, 2013, MAMM BIOL, V78, P336, DOI 10.1016/j.mambio.2013.04.006; van Dyk G, 2003, AFR ZOOL, V38, P79; Viljoen R, 2007, GUIDE GEOLOGY MADIKW; Webster H, 2012, ETHOLOGY, V118, P147, DOI 10.1111/j.1439-0310.2011.01992.x; Woodroffe R, 1999, ORYX, V33, P132, DOI 10.1017/S0030605300030398; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	38	24	25	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99686	10.1371/journal.pone.0099686	http://dx.doi.org/10.1371/journal.pone.0099686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918935	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000104
J	Nava, E; Bottari, D; Villwock, A; Fengler, I; Buchner, A; Lenarz, T; Roder, B				Nava, Elena; Bottari, Davide; Villwock, Agnes; Fengler, Ineke; Buechner, Andreas; Lenarz, Thomas; Roeder, Brigitte			Audio-Tactile Integration in Congenitally and Late Deaf Cochlear Implant Users	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; RACE MODEL INEQUALITY; MULTISENSORY INTEGRATION; SPEECH-PERCEPTION; DEPRIVATION; FACILITATION; EXPERIENCE; ACTIVATION; CHILDREN; FUSION	Several studies conducted in mammals and humans have shown that multisensory processing may be impaired following congenital sensory loss and in particular if no experience is achieved within specific early developmental time windows known as sensitive periods. In this study we investigated whether basic multisensory abilities are impaired in hearing restored individuals with deafness acquired at different stages of development. To this aim, we tested congenitally and late deaf cochlear implant (CI) recipients, age-matched with two groups of hearing controls, on an audio-tactile redundancy paradigm, in which reaction times to unimodal and crossmodal redundant signals were measured. Our results showed that both congenitally and late deaf CI recipients were able to integrate audio-tactile stimuli, suggesting that congenital and acquired deafness does not prevent the development and recovery of basic multisensory processing. However, we found that congenitally deaf CI recipients had a lower multisensory gain compared to their matched controls, which may be explained by their faster responses to tactile stimuli. We discuss this finding in the context of reorganisation of the sensory systems following sensory loss and the possibility that these changes cannot be "rewired'' through auditory reafferentation.	[Nava, Elena; Bottari, Davide; Villwock, Agnes; Fengler, Ineke; Roeder, Brigitte] Univ Hamburg, Hamburg, Germany; [Buechner, Andreas; Lenarz, Thomas] Med Clin Hannover, German Hearing Ctr, Hannover, Germany	University of Hamburg	Nava, E (corresponding author), Univ Hamburg, Hamburg, Germany.	elena.nava@uni-hamburg.de	Bottari, Davide/H-1694-2018	Bottari, Davide/0000-0001-6843-1569; Nava, Elena/0000-0002-7496-9565	European Research Council [ERC-2009-AdG 249425-CriticalBrainChanges]	European Research Council(European Research Council (ERC)European Commission)	The study was supported by the European Research Council (ERC-2009-AdG 249425-CriticalBrainChanges) to BR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Buckley KA, 2011, EAR HEARING, V32, P2, DOI 10.1097/AUD.0b013e3181fa41bb; Carriere BN, 2007, J NEUROPHYSIOL, V98, P2858, DOI 10.1152/jn.00587.2007; Colonius H, 2006, PSYCHOL REV, V113, P148, DOI 10.1037/0033-295X.113.1.148; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gilley PM, 2010, RESTOR NEUROL NEUROS, V28, P207, DOI 10.3233/RNN-2010-0525; Gondan M, 2004, PSYCHON B REV, V11, P307, DOI 10.3758/BF03196575; Hotting K, 2004, PSYCHOL SCI, V15, P60, DOI 10.1111/j.0963-7214.2004.01501010.x; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; Landry SP, 2013, PSYCHOL SCI, V24, P1260, DOI 10.1177/0956797612471142; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; Lee HJ, 2007, CEREB CORTEX, V17, P909, DOI 10.1093/cercor/bhl001; Levanen S, 1998, CURR BIOL, V8, P869, DOI 10.1016/S0960-9822(07)00348-X; Levanen S, 2001, NEUROSCI LETT, V301, P75, DOI 10.1016/S0304-3940(01)01597-X; Lewkowicz D, 2011, NEW HDB MULTISENSORY; Lewkowicz DJ, 2009, TRENDS COGN SCI, V13, P470, DOI 10.1016/j.tics.2009.08.004; Lewkowicz DJ, 2000, PSYCHOL BULL, V126, P281, DOI 10.1037/0033-2909.126.2.281; Lewkowicz DJ, 2006, P NATL ACAD SCI USA, V103, P6771, DOI 10.1073/pnas.0602027103; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Occelli V, 2011, PSYCHON B REV, V18, P429, DOI 10.3758/s13423-011-0070-4; Pavani F., 2012, NEW HDB MULTISENSORY, P737; Putzar L, 2007, NAT NEUROSCI, V10, P1243, DOI 10.1038/nn1978; Putzar L, 2012, DEV NEUROPSYCHOL, V37, P697, DOI 10.1080/87565641.2012.696756; Putzar L, 2010, RESTOR NEUROL NEUROS, V28, P251, DOI 10.3233/RNN-2010-0526; RAAB DH, 1962, T NEW YORK ACAD SCI, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; Rouger J, 2007, P NATL ACAD SCI USA, V104, P7295, DOI 10.1073/pnas.0609419104; Sandmann P, 2012, BRAIN, V135, P555, DOI 10.1093/brain/awr329; Schorr EA, 2005, P NATL ACAD SCI USA, V102, P18748, DOI 10.1073/pnas.0508862102; Slater A, 1998, EXP BRAIN RES, V123, P90, DOI 10.1007/s002210050548; Tremblay C, 2010, RESTOR NEUROL NEUROS, V28, P283, DOI 10.3233/RNN-2010-0498; Ulrich R, 2007, BEHAV RES METHODS, V39, P291, DOI 10.3758/BF03193160; Wallace MT, 2007, J NEUROPHYSIOL, V97, P921, DOI 10.1152/jn.00497.2006; Wallace MT, 2004, J NEUROSCI, V24, P9580, DOI 10.1523/JNEUROSCI.2535-04.2004; Yu LP, 2010, J NEUROSCI, V30, P4904, DOI 10.1523/JNEUROSCI.5575-09.2010	35	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99606	10.1371/journal.pone.0099606	http://dx.doi.org/10.1371/journal.pone.0099606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24918766	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000097
J	Walton, AH; Muenzer, JT; Rasche, D; Boomer, JS; Sato, B; Brownstein, BH; Pachot, A; Brooks, TL; Deych, E; Shannon, WD; Green, JM; Storch, GA; Hotchkiss, RS				Walton, Andrew H.; Muenzer, Jared T.; Rasche, David; Boomer, Jonathan S.; Sato, Bryan; Brownstein, Bernard H.; Pachot, Alexandre; Brooks, Terrence L.; Deych, Elena; Shannon, William D.; Green, Jonathan M.; Storch, Gregory A.; Hotchkiss, Richard S.			Reactivation of Multiple Viruses in Patients with Sepsis	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CRITICALLY-ILL PATIENTS; EPSTEIN-BARR-VIRUS; STEM-CELL TRANSPLANTATION; TIME PCR ASSAY; CYTOMEGALOVIRUS REACTIVATION; TT VIRUS; IMMUNOCOMPETENT HOSTS; SURROGATE MARKER; HCMV INFECTION	A current controversy is whether patients with sepsis progress to an immunosuppressed state. We hypothesized that reactivation of latent viruses occurred with prolonged sepsis thereby providing evidence of clinically-relevant immunosuppression and potentially providing a means to serially-monitor patients' immune status. Secondly, if viral loads are markedly elevated, they may contribute to morbidity and mortality. This study determined if reactivation of herpesviruses, polyomaviruses, and the anellovirus TTV occurred in sepsis and correlated with severity. Serial whole blood and plasma samples from 560 critically-ill septic, 161 critically-ill non-septic, and 164 healthy age-matched patients were analyzed by quantitative-polymerase-chain-reaction for cytomegalovirus (CMV), Epstein-Barr (EBV), herpes-simplex (HSV), human herpes virus-6 (HHV-6), and TTV. Polyomaviruses BK and JC were quantitated in urine. Detectable virus was analyzed with respect to secondary fungal and opportunistic bacterial infections, ICU duration, severity of illness, and survival. Patients with protracted sepsis had markedly increased frequency of detectable virus. Cumulative viral DNA detection rates in blood were: CMV (24.2%), EBV (53.2%), HSV (14.1%), HHV-6 (10.4%), and TTV (77.5%). 42.7% of septic patients had presence of two or more viruses. The 50% detection rate for herpesviruses was 5-8 days after sepsis onset. A small subgroup of septic patients had markedly elevated viral loads (>10(4)-10(6) DNA copies/ml blood) for CMV, EBV, and HSV. Excluding TTV, DNAemia was uncommon in critically-ill non-septic patients and in age-matched healthy controls. Compared to septic patients without DNAemia, septic patients with viremia had increased fungal and opportunistic bacterial infections. Patients with detectable CMV in plasma had higher 90-day mortality compared to CMV-negative patients; p, 0.05. Reactivation of latent viruses is common with prolonged sepsis, with frequencies similar to those occurring in transplant patients on immunosuppressive therapy and consistent with development of an immunosuppressive state. Whether reactivated latent viruses contribute to morbidity and mortality in sepsis remains unknown.	[Walton, Andrew H.; Rasche, David; Brownstein, Bernard H.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Muenzer, Jared T.; Storch, Gregory A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Boomer, Jonathan S.; Brooks, Terrence L.; Deych, Elena; Shannon, William D.; Green, Jonathan M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Sato, Bryan] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Pachot, Alexandre] BioMerieux Inc, Med Diagnost Discovery Dept, Marcy Letoile, France	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); bioMerieux	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	hotch@wustl.edu		Walton, Andrew/0000-0003-2805-6666; Green, Jonathan/0000-0002-7449-4387	National Institutes of Health [GM 441181, GM 55194, GM09839, AI101530, HL 104985]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055194, R01GM098391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received financial support from the following National Institutes of Health grants: GM 441181, GM 55194, GM09839, AI101530, and HL 104985. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; Babel N, 2011, NAT REV NEPHROL, V7, P399, DOI 10.1038/nrneph.2011.59; Bakker NA, 2007, TRANSPLANTATION, V83, P433, DOI 10.1097/01.tp.0000252784.60159.96; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Beland K, 2013, J INFECT DIS; Beland K, 2014, J INFECT DIS, V209, P247, DOI 10.1093/infdis/jit423; Berrington WR, 2009, CLIN INFECT DIS, V49, P1295, DOI 10.1086/606053; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Boothpur R, 2010, J CLIN VIROL, V47, P306, DOI 10.1016/j.jcv.2009.12.006; Brennan DC, 2005, AM J TRANSPLANT, V5, P582, DOI 10.1111/j.1600-6143.2005.00742.x; Bruynseels P, 2003, LANCET, V362, P1536, DOI 10.1016/S0140-6736(03)14740-X; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Chen YP, 2009, NEW ENGL J MED, V361, P1067, DOI 10.1056/NEJMoa0904267; Cheng XXS, 2011, J AM SOC NEPHROL, V22, P825, DOI 10.1681/ASN.2010080877; Chiche L, 2011, CURR OPIN INFECT DIS, V24, P152, DOI 10.1097/QCO.0b013e328343b6e4; Cohen J, 2012, LANCET INFECT DIS, V12, P503, DOI 10.1016/S1473-3099(12)70136-6; Cook CH, 2003, CRIT CARE MED, V31, P1923, DOI 10.1097/01.CCM.0000070222.11325.C4; Cook CH, 2011, ANTIVIR RES, V90, P151, DOI 10.1016/j.antiviral.2011.03.179; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; De Vlieger G, 2012, CRIT CARE MED, V40, P36, DOI 10.1097/CCM.0b013e31822b50ae; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Dockrell DH, 2003, J MED MICROBIOL, V52, P5, DOI 10.1099/jmm.0.05074-0; Dolgin E, 2012, NAT MED, V18, P1000, DOI 10.1038/nm0712-1000; Espy MJ, 2000, J CLIN MICROBIOL, V38, P795, DOI 10.1128/JCM.38.2.795-799.2000; Focosi D, 2010, J CLIN VIROL, V47, P189, DOI 10.1016/j.jcv.2009.11.027; Gartner B, 2010, J CLIN VIROL, V48, P82, DOI 10.1016/j.jcv.2010.03.016; Hall MW, 2011, INTENS CARE MED, V37, P525, DOI 10.1007/s00134-010-2088-x; Hamprecht K, 1998, J CLIN VIROL, V11, P125, DOI 10.1016/S1386-6532(98)00046-4; Heininger A, 2001, CRIT CARE MED, V29, P541, DOI 10.1097/00003246-200103000-00012; Heininger A, 2011, CRIT CARE, V15, DOI 10.1186/cc10069; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Humar A, 2006, AM J TRANSPLANT, V6, P262, DOI 10.1111/j.1600-6143.2005.01207.x; Humar A, 2006, TRANSPLANTATION, V82, pS9, DOI 10.1097/01.tp.0000230432.39447.8b; Juvonen E, 2007, HAEMATOLOGICA, V92, P819, DOI 10.3324/haematol.10751; Kalil AC, 2011, CRIT CARE, V15, DOI 10.1186/cc10093; Kalil AC, 2009, CRIT CARE MED, V37, P2350, DOI 10.1097/CCM.0b013e3181a3aa43; Kutza AST, 1998, CLIN INFECT DIS, V26, P1076, DOI 10.1086/520307; Lee YJ, 2013, BIOL BLOOD MARROW TR, V19, P387, DOI 10.1016/j.bbmt.2012.10.014; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Linssen CFM, 2008, INTENS CARE MED, V34, P2202, DOI 10.1007/s00134-008-1231-4; Luyt CE, 2007, AM J RESP CRIT CARE, V175, P935, DOI 10.1164/rccm.200609-1322OC; Maggi F, 2003, J VIROL, V77, P2418, DOI 10.1128/JVI.77.4.2418-2425.2003; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Micek ST, 2010, ANTIMICROB AGENTS CH, V54, P1742, DOI 10.1128/AAC.01365-09; Munford RS, 2001, AM J RESP CRIT CARE, V163, P316, DOI 10.1164/ajrccm.163.2.2007102; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Pollock JL, 1997, VIROLOGY, V227, P168, DOI 10.1006/viro.1996.8303; Prosch S, 2000, VIROLOGY, V272, P357, DOI 10.1006/viro.2000.0367; Razonable RR, 2013, AM J TRANSPLANT, V13, P67, DOI 10.1111/ajt.12008; Razonable RR, 2002, J INFECT DIS, V185, P110, DOI 10.1086/324772; Sanchez JL, 2002, J CLIN MICROBIOL, V40, P2381, DOI 10.1128/JCM.40.7.2381-2386.2002; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shibayama T, 2001, AIDS, V15, P563, DOI 10.1097/00002030-200103300-00004; Touinssi M, 2001, J CLIN VIROL, V21, P135, DOI 10.1016/S1386-6532(01)00157-3; Venet F, 2013, CURR OPIN IMMUNOL; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Wada K, 2007, J CLIN MICROBIOL, V45, P1426, DOI 10.1128/JCM.01515-06; Wandinger KP, 2000, NEUROLOGY, V55, P178, DOI 10.1212/WNL.55.2.178; Wherry EJ, 2006, VIROLOGY, V353, P366, DOI 10.1016/j.virol.2006.06.017; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	66	222	230	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98819	10.1371/journal.pone.0098819	http://dx.doi.org/10.1371/journal.pone.0098819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919177	Green Published, gold			2022-12-25	WOS:000338631000028
J	Ghiani, A; Fumagalli, P; Van, TN; Gentili, R; Citterio, S				Ghiani, Alessandra; Fumagalli, Pietro; Tho Nguyen Van; Gentili, Rodolfo; Citterio, Sandra			The Combined Toxic and Genotoxic Effects of Cd and As to Plant Bioindicator Trifolium repens L	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; CADMIUM TOXICITY; HEAVY-METALS; MECHANISMS; RESPONSES; ARSENATE; MIXTURES; ARSENITE; SOILS; LEAD	This study was undertaken to investigate combined toxic and genotoxic effects of cadmium (Cd) and arsenic (As) on white clover, a pollutant sensitive plant frequently used as environmental bioindicator. Plants were exposed to soil spiked with increasing concentrations of cadmium sulfate (20, 40 and 60 mg Kg(-1)) or sodium arsenite (5, 10 and 20 mg Kg(-1)) as well as with their combinations. Metal(loid) bioavailability was assessed after soil contamination, whereas plant growth, metal(loid) concentration in plant organs and DNA damage were measured at the end of plant exposition. Results showed that individual and joint toxicity and genotoxicity were related to the concentration of Cd and As measured in plant organs, and that As concentration was the most relevant variable. Joint effects on plant growth were additive or synergistic, whereas joint genotoxic effects were additive or antagonistic. The interaction between Cd and As occurred at both soil and plant level. In soil the presence of As limited the bioavailability of Cd, whereas the presence of Cd increased the bioavailability of As. Nevertheless only As biovailability determined the amount of As absorbed by plants. The amount of Cd absorbed by plant was not linearly correlated with the fraction of bioavailable Cd in soil suggesting the involvement of additional factors, such as plant uptake mechanisms. These results reveal that the simultaneous presence in soil of Cd and As, although producing an additive or synergistic toxic effect on Trifolium repens L. growth, generates a lower DNA damage.	[Ghiani, Alessandra; Fumagalli, Pietro; Tho Nguyen Van; Gentili, Rodolfo; Citterio, Sandra] Univ Milano Bicocca, Dept Earth & Environm Sci, Milan, Italy	University of Milano-Bicocca	Citterio, S (corresponding author), Univ Milano Bicocca, Dept Earth & Environm Sci, Milan, Italy.	sandra.citterio@unimib.it	Gentili, Rodolfo/I-5613-2016	Gentili, Rodolfo/0000-0002-9332-7963	Ministry of University, Research, Science and Technology; Italian Lombardy Region	Ministry of University, Research, Science and Technology; Italian Lombardy Region	This work was supported by the Ministry of University, Research, Science and Technology and Italian Lombardy Region (Project: Soil mapping). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2005, CERCLA PRIOR LIST HA; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Dabt DEK, 2011, LABMEDICINE, V42, P735, DOI 10.1309/LMYKGUO5BEPE7IAW; Fayiga AO, 2006, SCI TOTAL ENVIRON, V359, P17, DOI 10.1016/j.scitotenv.2005.06.001; Gonzaga MIS, 2008, ENVIRON POLLUT, V154, P212, DOI 10.1016/j.envpol.2007.10.011; HAGHIRI F, 1973, Journal of Environmental Quality, V2, P93, DOI 10.2134/jeq1973.00472425000200010012x; Hartwig A, 2010, BIOMETALS, V23, P951, DOI 10.1007/s10534-010-9330-4; Heger TJ, 2012, EUR J SOIL BIOL, V49, P1, DOI 10.1016/j.ejsobi.2012.02.001; Huang M, 2009, J TOXICOL ENV HEAL A, V72, P1493, DOI 10.1080/15287390903213095; Ince NH, 1999, ARCH ENVIRON CON TOX, V36, P365, DOI 10.1007/PL00006607; Isayenkov SV, 2008, FEBS LETT, V582, P1625, DOI 10.1016/j.febslet.2008.04.022; Karak T, 2011, CHEMOSPHERE, V85, P948, DOI 10.1016/j.chemosphere.2011.06.061; Linsday W.L, 1969, AGRON ABSTR, V69, P87; Liu XL, 2007, J ENVIRON SCI, V19, P1221, DOI 10.1016/S1001-0742(07)60199-5; Luan ZQ, 2008, PLANT SOIL ENVIRON, V54, P403, DOI 10.17221/409-PSE; Lux A, 2011, J EXP BOT, V62, P21, DOI 10.1093/jxb/erq281; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Piraino F, 2006, SCI TOTAL ENVIRON, V372, P350, DOI 10.1016/j.scitotenv.2006.09.009; Polle A, 2003, TOP CURR GENET, V4, P187; Sharma P., 2012, J BOT, DOI DOI 10.1155/2012/650206; Smith E, 1999, J ENVIRON QUAL, V28, P1719, DOI 10.2134/jeq1999.00472425002800060005x; Sun YH, 2008, ENVIRON EXP BOT, V64, P264, DOI 10.1016/j.envexpbot.2008.05.009; Tkalec M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087582; Wang GS, 2008, TOXICOL APPL PHARM, V233, P92, DOI 10.1016/j.taap.2008.01.017; Zhou QX, 2006, J ENVIRON SCI-CHINA, V18, P741; Zhu XF, 2013, J HAZARD MATER, V263, P398, DOI 10.1016/j.jhazmat.2013.09.018	29	37	37	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99239	10.1371/journal.pone.0099239	http://dx.doi.org/10.1371/journal.pone.0099239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914541	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700074
J	Li, CQ; Zhou, Y; Wang, HW; Liu, J; Xiang, LB				Li, Changqing; Zhou, Yue; Wang, Hongwei; Liu, Jun; Xiang, Liangbi			Treatment of Unstable Thoracolumbar Fractures through Short Segment Pedicle Screw Fixation Techniques Using Pedicle Fixation at the Level of the Fracture: A Finite Element Analysis	PLOS ONE			English	Article							LUMBAR INTERBODY FUSION; BURST FRACTURES; TRANSPEDICULAR FIXATION; INSTRUMENTATION; ADJACENT; ANTERIOR; STABILIZATION; INSERTION; FAILURE; STRESS	Objective: To compare the von Mises stresses of the internal fixation devices among different short segment pedicle screw fixation techniques to treat thoracic 12 vertebral fractures, especially the mono-segment pedicle screw fixation and intermediate unilateral pedicle screw fixation techniques. Methods: Finite element methods were utilised to investigate the biomechanical comparison of the four posterior short segment pedicle screw fixation techniques (S4+2: traditional short-segment 4 pedicle screw fixation [SPSF]; M4+2: monosegment pedicle screw fixation; I6+2: intermediate bilateral pedicle screw fixation; and I5+2: intermediate unilateral pedicle screw fixation). Results: The range of motion (ROM) in flexion, axial rotation, and lateral bending was the smallest in the I6+2 fixation model, followed by the I5+2 and S4+2 fixation models, but lateral bending was the largest in the M4+2 fixation model. The maximal stress of the upper pedicle screw is larger than the lower pedicle screw in S4+2 and M4+2. The largest maximal von Mises stress was observed in the upper pedicle screw in the S4+2 and M4+2 fixation models and in the lower pedicle screw in the I6+2 and I5+2 fixation models. The values of the largest maximal von Mises stress of the pedicle screws and rods during all states of motion were 263.1 MPa and 304.5 MPa in the S4+2 fixation model, 291.6 MPa and 340.5 MPa in the M4+2 fixation model, 182.9 MPa and 263.2 MPa in the I6+2 fixation model, and 269.3 MPa and 383.7 MPa in the I5+2 fixation model, respectively. Comparing the stress between different spinal loadings, the maximal von Mises stress of the implants were observed in flexion in all implanted models. Conclusion: Additional bilateral pedicle screws at the level of the fracture to SPSF may result in a stiffer construct and less von Mises stress for pedicle screws and rods. The largest maximal von Mises stress of the pedicle screws during all states of motion were observed in the mono-segment pedicle screw fixation technique.	[Li, Changqing; Zhou, Yue] Third Mil Med Univ, Dept Orthoped, Xinqiao Hosp, Chongqing, Peoples R China; [Wang, Hongwei; Liu, Jun; Xiang, Liangbi] Gen Hosp Shenyang Mil Area Command Chinese PLA, Dept Orthoped, Shenyang, Liaoning, Peoples R China	Army Medical University	Wang, HW (corresponding author), Gen Hosp Shenyang Mil Area Command Chinese PLA, Dept Orthoped, Shenyang, Liaoning, Peoples R China.	cplawhw@163.com; xiangliangbi1963@163.com			Chinese National High Technology Research and Development program [2011AA030106]; Chinese Ministry of Health [201002018]; Foundation of the State Key Laboratory of Robotics [2011-O01]	Chinese National High Technology Research and Development program(National High Technology Research and Development Program of China); Chinese Ministry of Health; Foundation of the State Key Laboratory of Robotics	This work was supported by the Chinese National High Technology Research and Development program (No. 2011AA030106), the Key Project of the Chinese Ministry of Health (No. 201002018), and the Foundation of the State Key Laboratory of Robotics (No. 2011-O01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamaru T, 2005, SPINE, V30, P2783, DOI 10.1097/01.brs.0000192281.53603.3f; Alanay A, 2001, SPINE, V26, P213, DOI 10.1097/00007632-200101150-00017; Anekstein Y, 2007, J SPINAL DISORD TECH, V20, P72, DOI 10.1097/01.bsd.0000211240.98963.f6; Baaj AA, 2011, J NEUROSURG-SPINE, V14, P192, DOI 10.3171/2010.10.SPINE10222; Chen CS, 2005, MED ENG PHYS, V27, P487, DOI 10.1016/j.medengphy.2004.12.007; Chen CS, 2001, MED ENG PHYS, V23, P483; Chen SH, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-72; Dai LY, 2007, SURG NEUROL, V67, P221, DOI 10.1016/j.surneu.2006.08.081; Defino Helton L A, 2007, Indian J Orthop, V41, P337, DOI 10.4103/0019-5413.36998; Defino HL, 2005, INJURY, V36, P90, DOI 10.1016/j.injury.2005.06.019; Denoziere G, 2006, J BIOMECH, V39, P766, DOI 10.1016/j.jbiomech.2004.07.039; Guven O, 2009, J SPINAL DISORD TECH, V22, P417, DOI 10.1097/BSD.0b013e3181870385; Jahng TA, 2013, SPINE J, V13, P85, DOI 10.1016/j.spinee.2012.11.014; Kim HJ, 2012, SPINE, V37, P1637, DOI 10.1097/BRS.0b013e31823f2115; Kim HJ, 2010, MED BIOL ENG COMPUT, V48, P703, DOI 10.1007/s11517-010-0621-2; Kim Y, 2007, SPINE, V32, P2558, DOI 10.1097/BRS.0b013e318158cdd8; Kim Y, 2010, SPINE, V35, P599, DOI 10.1097/BRS.0b013e3181b6258a; KRAMER DL, 1995, J ORTHOP TRAUMA, V9, P499, DOI 10.1097/00005131-199509060-00007; Liu SY, 2009, J SPINAL DISORD TECH, V22, P38, DOI 10.1097/BSD.0b013e3181679ba3; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; Mahar A, 2007, SPINE, V32, P1503, DOI 10.1097/BRS.0b013e318067dd24; MCLAIN RF, 1993, J BONE JOINT SURG AM, V75A, P162, DOI 10.2106/00004623-199302000-00002; Pflugmacher R, 2004, SPINE, V29, P1413, DOI 10.1097/01.BRS.0000129895.90939.1E; Shen WJ, 2001, SPINE, V26, P1038, DOI 10.1097/00007632-200105010-00010; SUK SI, 1995, SPINE, V20, P1399, DOI 10.1097/00007632-199506000-00012; Tang SJ, 2011, TURK NEUROSURG, V21, P296, DOI 10.5137/1019-5149.JTN.4018-10.0; Tang SJ, 2011, J ORTHOP SCI, V16, P221, DOI 10.1007/s00776-011-0037-3; Tian JW, 2011, ORTHOPEDICS, V34, P594, DOI 10.3928/01477447-20110627-08; Wang HW, 2012, INDIAN J ORTHOP, V46, P395, DOI 10.4103/0019-5413.98827; Wei FX, 2010, SPINE, V35, pE714, DOI 10.1097/BRS.0b013e3181d7ad1d; Wood KB, 2005, J SPINAL DISORD TECH, V18, pS15, DOI 10.1097/01.bsd.0000132287.65702.8a; YAMAMOTO I, 1989, SPINE, V14, P1256, DOI 10.1097/00007632-198911000-00020; ZINDRICK MR, 1991, ORTHOP CLIN N AM, V22, P333	33	34	41	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99156	10.1371/journal.pone.0099156	http://dx.doi.org/10.1371/journal.pone.0099156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914815	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700067
J	Sun, YY; Morozov, YM; Yang, D; Li, YK; Dunn, RS; Rakic, P; Chan, PH; Abe, K; Lindquist, DM; Kuan, CY				Sun, Yu-Yo; Morozov, Yury M.; Yang, Dianer; Li, Yikun; Dunn, R. Scott; Rakic, Pasko; Chan, Pak H.; Abe, Koji; Lindquist, Diana M.; Kuan, Chia-Yi			Synergy of Combined tPA-Edaravone Therapy in Experimental Thrombotic Stroke	PLOS ONE			English	Article							FREE-RADICAL SCAVENGER; ACUTE ISCHEMIC-STROKE; PLASMINOGEN-ACTIVATOR; CEREBRAL-ISCHEMIA; BRAIN-INJURY; ANTIOXIDANT EDARAVONE; RAT MODEL; REPERFUSION; RECANALIZATION; THROMBOLYSIS	Edaravone, a potent antioxidant, may improve thrombolytic therapy because it benefits ischemic stroke patients on its own and mitigates adverse effects of tissue plasminogen activator (tPA) in preclinical models. However, whether the combined tPA-edaravone therapy is more effective in reducing infarct size than singular treatment is uncertain. Here we investigated this issue using a transient hypoxia-ischemia (tHI)-induced thrombotic stroke model, in which adult C57BL/6 mice were subjected to reversible ligation of the unilateral common carotid artery plus inhalation of 7.5% oxygen for 30 min. While unilateral occlusion of the common carotid artery suppressed cerebral blood flow transiently, the addition of hypoxia triggered reperfusion deficits, endogenous thrombosis, and attenuated tPA activity, leading up to infarction. We compared the outcomes of vehicle-controls, edaravone treatment, tPA treatment at 0.5, 1, or 4 h post-tHI, and combined tPA-edaravone therapies with mortality rate and infarct size as the primary end-points. The best treatment was further compared with vehicle-controls in behavioral, biochemical, and diffusion tensor imaging (DTI) analyses. We found that application of tPA at 0.5 or 1 h - but not at 4 h post-tHI - significantly decreased infarct size and showed synergistic (p, 0.05) or additive benefits with the adjuvant edaravone treatment, respectively. The acute tPA-edaravone treatment conferred >50% reduction of mortality, similar to 80% decline in infarct size, and strong white-matter protection. It also improved vascular reperfusion and decreased oxidative stress, inflammatory cytokines, and matrix metalloproteinase activities. In conclusion, edaravone synergizes with acute tPA treatment in experimental thrombotic stroke, suggesting that clinical application of the combined tPA-edaravone therapy merits investigation.	[Sun, Yu-Yo; Yang, Dianer; Li, Yikun; Kuan, Chia-Yi] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Sun, Yu-Yo; Yang, Dianer; Li, Yikun; Kuan, Chia-Yi] Childrens Healthcare Atlanta, Atlanta, GA USA; [Morozov, Yury M.; Rakic, Pasko] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Dunn, R. Scott; Lindquist, Diana M.] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Imaging Res Ctr, Cincinnati, OH 45229 USA; [Chan, Pak H.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Abe, Koji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama, Japan	Emory University; Children's Healthcare of Atlanta (CHOA); Yale University; Cincinnati Children's Hospital Medical Center; Stanford University; Okayama University	Kuan, CY (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	alex.kuan@emory.edu		Sun, Yu-Yo/0000-0002-6608-1347; Morozov, Yury/0000-0002-3679-6819	NIH [NS074559]; Children's Healthcare of Atlanta Research Centers Pilot Project grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023999] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Healthcare of Atlanta Research Centers Pilot Project grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the NIH grant NS074559 and a Children's Healthcare of Atlanta Research Centers Pilot Project grant (to CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1988, STROKE, V19, P480, DOI 10.1161/01.STR.19.4.480; Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Amaro S, 2011, STROKE, V42, P1495, DOI 10.1161/STROKEAHA.111.615039; Barreto AD, 2012, STROKE, V43, P591, DOI 10.1161/STROKEAHA.111.617902; Briers JD, 2001, PHYSIOL MEAS, V22, pR35, DOI 10.1088/0967-3334/22/4/201; Dalkara T, 2012, J CEREBR BLOOD F MET, V32, P2091, DOI 10.1038/jcbfm.2012.139; De Silva DA, 2009, STROKE, V40, P2872, DOI 10.1161/STROKEAHA.108.543595; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Garcia-Yebenes I, 2011, STROKE, V42, P196, DOI 10.1161/STROKEAHA.110.600452; Haelewyn B, 2010, J CEREBR BLOOD F MET, V30, P900, DOI 10.1038/jcbfm.2010.33; Heiss WD, 2011, CEREBROVASC DIS, V32, P307, DOI 10.1159/000330462; Hossmann KA, 2012, J CEREBR BLOOD F MET, V32, P1310, DOI 10.1038/jcbfm.2011.186; Kaste M, 2013, CEREBROVASC DIS, V36, P196, DOI 10.1159/000353680; Khatri P, 2005, STROKE, V36, P2400, DOI 10.1161/01.STR.0000185698.45720.58; Kimura K, 2012, J NEUROL SCI, V313, P132, DOI 10.1016/j.jns.2011.09.006; KORNINGER C, 1981, THROMB HAEMOSTASIS, V46, P561; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; Lapchak PA, 2009, EXP NEUROL, V215, P95, DOI 10.1016/j.expneurol.2008.09.004; Lee BJ, 2010, BRAIN RES, V1307, P22, DOI 10.1016/j.brainres.2009.10.026; Li PA, 1998, NEUROSCI LETT, V253, P191, DOI 10.1016/S0304-3940(98)00643-0; Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x; Margaill I, 2005, FREE RADICAL BIO MED, V39, P429, DOI 10.1016/j.freeradbiomed.2005.05.003; Martin A, 2010, J CEREBR BLOOD F MET, V30, P230, DOI 10.1038/jcbfm.2009.205; Matute C, 2013, STROKE, V44, P1204, DOI 10.1161/STROKEAHA.112.658328; Murakami K, 1998, J NEUROSCI, V18, P205; Niessen F, 2003, STROKE, V34, P2019, DOI 10.1161/01.STR.0000080941.73934.30; Orset C, 2007, STROKE, V38, P2771, DOI 10.1161/STROKEAHA.107.487520; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Romanos E, 2007, J CEREBR BLOOD F MET, V27, P14, DOI 10.1038/sj.jcbfm.9600312; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Shereen A, 2011, J CEREBR BLOOD F MET, V31, P1155, DOI 10.1038/jcbfm.2010.212; Sun YY, 2012, J NEUROSCI METH, V203, P122, DOI 10.1016/j.jneumeth.2011.09.029; Sun YY, 2010, J NEUROSCI, V30, P9621, DOI 10.1523/JNEUROSCI.2295-10.2010; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Watanabe T, 2008, CARDIOVASC THER, V26, P101, DOI 10.1111/j.1527-3466.2008.00041.x; Yagi K, 2009, STROKE, V40, P626, DOI 10.1161/STROKEAHA.108.520262; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Yamauchi H, 2012, BRAIN, V135, P2515, DOI 10.1093/brain/aws131; Yang D, 2013, CEREB CORTEX, V23, P1218, DOI 10.1093/cercor/bhs115; Yang D, 2009, J NEUROSCI, V29, P8669, DOI 10.1523/JNEUROSCI.1117-09.2009; Zhang N, 2005, STROKE, V36, P2220, DOI 10.1161/01.STR.0000182241.07096.06; Zhang WR, 2004, NEUROL RES, V26, P342, DOI 10.1179/016164104225014058	43	29	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98807	10.1371/journal.pone.0098807	http://dx.doi.org/10.1371/journal.pone.0098807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911517	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600015
J	Lee, YH; Morrison, BL; Bottaro, DP				Lee, Young H.; Morrison, Bethanie L.; Bottaro, Donald P.			Synergistic Signaling of Tumor Cell Invasiveness by Hepatocyte Growth Factor and Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CARCINOMA CELLS; BETA-CATENIN; MESENCHYMAL TRANSITION; CANCER CELLS; E-CADHERIN; IN-VITRO; C-JUN; AUTOPHAGY; ACTIVATION; MET	Hepatocyte growth factor (HGF) signaling promotes tumor invasiveness in renal cell carcinoma (RCC) and other cancers. In clear cell RCC, VHL loss generates pseudohypoxia that exacerbates HGF-driven invasion through beta-catenin deregulation. Hypoxia also enhances HGF-driven invasiveness by papillary RCC cells, but in the absence of VHL, loss signaling integration involves three parallel routes: 1) hypoxia-induced reactive oxygen species production and decreased DUSP2 expression, leading to enhanced mitogen-activated protein kinase (MAPK) cascade activation; 2) reactive oxygen species-induced diacylglycerol production by phospholipase C gamma, leading to protein kinase C activation and increased protein phosphatase-2A activity, thereby suppressing HGF-induced Akt activation; and 3) a profound shift from HGF-enhanced, proliferation-oriented metabolism to autophagy-dependent invasion and suppression of proliferation. This tripartite signaling integration was not unique to RCC or HGF; in RCC cells, invasive synergy induced by the combination of hypoxia and epidermal growth factor occurred through the same mechanism, and in estrogen receptor-positive breast cancer cells, this mechanism was suppressed in the absence of estrogen. These results define the molecular basis of growth factor and hypoxia invasive synergy in VHL-competent papillary RCC cells, illustrate the plasticity of invasive and proliferative tumor cell states, and provide signaling profiles by which they may be predicted.	[Lee, Young H.; Bottaro, Donald P.] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Morrison, Bethanie L.] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bottaro, DP (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bldg 10 CRC Rm 2-3952,10 Ctr Dr MSC 1107, Bethesda, MD 20892 USA.	dbottaro@helix.nih.gov	Bottaro, Donald P/F-8550-2010; Bottaro, Donald P/AAF-3853-2020	Bottaro, Donald P/0000-0002-5057-5334; Bottaro, Donald P/0000-0002-5057-5334	National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011124] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Asnaghi L., 2013, AM ASS CANC RES ANN; Athauda G, 2006, CLIN CANCER RES, V12, P4154, DOI 10.1158/1078-0432.CCR-06-0250; Ben-Ami I, 2011, J BIOL CHEM, V286, P31022, DOI 10.1074/jbc.M111.247726; Bernhardt WM, 2006, KIDNEY INT, V69, P114, DOI 10.1038/sj.ki.5000062; Chaudary N, 2013, RADIOTHER ONCOL, V108, P506, DOI 10.1016/j.radonc.2013.06.019; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Choueiri TK, 2013, J CLIN ONCOL, V31, P181, DOI 10.1200/JCO.2012.43.3383; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Gopalakrishna R, 1999, CANCER LETT, V136, P143, DOI 10.1016/S0304-3835(98)00315-2; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Ide T, 2006, INT J CANCER, V119, P2750, DOI 10.1002/ijc.22178; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim SD, 2005, BIOCHEM BIOPH RES CO, V328, P326, DOI 10.1016/j.bbrc.2004.11.173; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Koochekpour S, 1999, MOL CELL BIOL, V19, P5902; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Liao Y, 2010, AM J TRANSL RES, V2, P19; Linehan WM, 2010, ANNU REV MED, V61, P329, DOI 10.1146/annurev.med.042808.171650; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069485; Maina F, 2001, MOL CELL, V7, P1293, DOI 10.1016/S1097-2765(01)00261-1; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Monnier Y, 2008, CANCER RES, V68, P7323, DOI 10.1158/0008-5472.CAN-08-0841; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Peruzzi B, 2006, P NATL ACAD SCI USA, V103, P14531, DOI 10.1073/pnas.0606850103; Peruzzi B, 2006, CELL CYCLE, V5, P2839, DOI 10.4161/cc.5.24.3581; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Pursiheimo JP, 2009, ONCOGENE, V28, P334, DOI 10.1038/onc.2008.392; Rubin J. S., 2011, UCSD MOL PAGES, DOI [10.6072/H0.MP.A004032.01, DOI 10.6072/H0.MP.A004032.01]; Tai CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-95; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanimura S, 1998, ONCOGENE, V17, P57, DOI 10.1038/sj.onc.1201905; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Ueda K, 2013, ARTERIOSCL THROM VAS, V33, P1837, DOI 10.1161/ATVBAHA.112.300752; van Adelsberg J, 2001, J BIOL CHEM, V276, P15099, DOI 10.1074/jbc.M006634200; Wong VCL, 2012, INT J CANCER, V130, P83, DOI 10.1002/ijc.25970; Wu MZ, 2011, MOL CELL, V43, P811, DOI 10.1016/j.molcel.2011.07.012; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	49	18	18	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20448	20461		10.1074/jbc.M114.580597	http://dx.doi.org/10.1074/jbc.M114.580597			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24914205	Green Published, hybrid			2022-12-25	WOS:000339396600004
J	Lazado, CC; Kumaratunga, HPS; Nagasawa, K; Babiak, I; Giannetto, A; Fernandes, JMO				Lazado, Carlo C.; Kumaratunga, Hiruni P. S.; Nagasawa, Kazue; Babiak, Igor; Giannetto, Alessia; Fernandes, Jorge M. O.			Daily Rhythmicity of Clock Gene Transcripts in Atlantic Cod Fast Skeletal Muscle	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; TELEOST FISH GENOMES; GADUS-MORHUA L.; CIRCADIAN CLOCKS; CONTINUOUS LIGHT; TISSUE DISTRIBUTION; SOLEA-SENEGALENSIS; MOLECULAR-CLONING; PINEAL-GLAND; REV-ERB	The classical notion of a centralized clock that governs circadian rhythmicity has been challenged with the discovery of peripheral oscillators that enable organisms to cope with daily changes in their environment. The present study aimed to identify the molecular clock components in Atlantic cod (Gadus morhua) and to investigate their daily gene expression in fast skeletal muscle. Atlantic cod clock genes were closely related to their orthologs in teleosts and tetrapods. Synteny was conserved to varying degrees in the majority of the 18 clock genes examined. In particular, aryl hydrocarbon receptor nuclear translocator-like 2 (arntl2), RAR-related orphan receptor A (rora) and timeless (tim) displayed high degrees of conservation. Expression profiling during the early ontogenesis revealed that some transcripts were maternally transferred, namely arntl2, cryptochrome 1b and 2 (cry1b and cry2), and period 2a and 2b (per2a and per2b). Most clock genes were ubiquitously expressed in various tissues, suggesting the possible existence of multiple peripheral clock systems in Atlantic cod. In particular, they were all detected in fast skeletal muscle, with the exception of neuronal PAS (Per-Arnt-Single-minded) domain-containing protein (npas1) and rora. Rhythmicity analysis revealed 8 clock genes with daily rhythmic expression, namely arntl2, circadian locomotor output cycles kaput (clock), npas2, cry2, cry3 per2a, nuclear receptor subfamily 1, group D, member 1 (nr1d1), and nr1d2a. Transcript levels of the myogenic genes myogenic factor 5 (myf5) and muscleblind-like 1 (mbnl1) strongly correlated with clock gene expression. This is the first study to unravel the molecular components of peripheral clocks in Atlantic cod. Taken together, our data suggest that the putative clock system in fast skeletal muscle of Atlantic cod has regulatory implications on muscle physiology, particularly in the expression of genes related to myogenesis.	[Lazado, Carlo C.; Kumaratunga, Hiruni P. S.; Nagasawa, Kazue; Babiak, Igor; Giannetto, Alessia; Fernandes, Jorge M. O.] Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway; [Giannetto, Alessia] Univ Messina, Dept Biol & Environm Sci, Messina, Italy	Nord University; University of Messina	Fernandes, JMO (corresponding author), Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway.	jorge.fernandes@uin.no	Fernandes, Jorge MO/A-3526-2013; Giannetto, Alessia/AAA-6735-2019; Fernandes, Jorge/AAC-4632-2022; Lazado, Carlo C./H-7444-2019; Nagasawa, Kazue/ABH-6117-2020	Fernandes, Jorge MO/0000-0002-2550-1640; Giannetto, Alessia/0000-0002-5853-2881; Fernandes, Jorge/0000-0002-2550-1640; Nagasawa, Kazue/0000-0003-2819-3302; Babiak, Igor/0000-0002-1462-2690	Research Council of Norway [190350/S40]	Research Council of Norway(Research Council of Norway)	This research was supported by grant 190350/S40 from the Research Council of Norway (http://www.forskningsradet.no/en) to JMOF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral IPG, 2012, AM J PHYSIOL-REG I, V302, pR193, DOI 10.1152/ajpregu.00367.2011; Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Sanchez JA, 2010, CHRONOBIOL INT, V27, P19, DOI 10.3109/07420520903398633; Bayarri MJ, 2002, J PINEAL RES, V32, P34, DOI 10.1034/j.1600-079x.2002.10806.x; Bowden TJ, 2007, FISH SHELLFISH IMMUN, V22, P695, DOI 10.1016/j.fsi.2006.08.016; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Campos C, 2010, J EXP BIOL, V213, P200, DOI 10.1242/jeb.033126; Campos C, 2012, GENE, V500, P93, DOI 10.1016/j.gene.2012.03.041; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Cuesta IH, 2014, CHRONOBIOL INT, V31, P468, DOI 10.3109/07420528.2013.856316; Dardente H, 2007, CHRONOBIOL INT, V24, P195, DOI 10.1080/07420520701283693; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; del Pozo A, 2012, COMP BIOCHEM PHYS A, V163, P364, DOI 10.1016/j.cbpa.2012.07.004; Esteban MA, 2006, J PINEAL RES, V41, P261, DOI 10.1111/j.1600-079X.2006.00362.x; Falcon J, 1999, PROG NEUROBIOL, V58, P121, DOI 10.1016/S0301-0082(98)00078-1; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Giannetto A, 2014, DEV COMP IMMUNOL, V44, P30, DOI 10.1016/j.dci.2013.11.011; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Huang TS, 2010, CHRONOBIOL INT, V27, P1715, DOI 10.3109/07420528.2010.521272; Hughes AL, 2005, P NATL ACAD SCI USA, V102, P8791, DOI 10.1073/pnas.0503922102; Hughes AL, 2002, TRENDS GENET, V18, P433, DOI 10.1016/S0168-9525(02)02755-5; Kobayashi K, 1998, NUCLEIC ACIDS RES, V26, P5086, DOI 10.1093/nar/26.22.5086; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lefta M, 2011, CURR TOP DEV BIOL, V96, P231, DOI 10.1016/B978-0-12-385940-2.00009-7; Patino MAL, 2011, CHRONOBIOL INT, V28, P381, DOI 10.3109/07420528.2011.566398; Lopez-Olmeda JF, 2010, CHRONOBIOL INT, V27, P1380, DOI 10.3109/07420528.2010.501926; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martin-Robles AJ, 2012, J COMP PHYSIOL B, V182, P673, DOI 10.1007/s00360-012-0653-z; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Migaud H, 2010, J FISH BIOL, V76, P27, DOI 10.1111/j.1095-8649.2009.02500.x; Nagasawa K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036908; OHTA T, 1990, THEOR POPUL BIOL, V37, P213, DOI 10.1016/0040-5809(90)90036-U; Ptitsyn AA, 2006, PLOS COMPUT BIOL, V2, P126, DOI 10.1371/journal.pcbi.0020016; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Ruangsri J, 2012, FISH SHELLFISH IMMUN, V32, P396, DOI 10.1016/j.fsi.2011.11.022; Sharma VK, 2003, CHRONOBIOL INT, V20, P901, DOI 10.1081/CBI-120026099; Takahata S, 1998, BIOCHEM BIOPH RES CO, V248, P789, DOI 10.1006/bbrc.1998.9012; Taranger GL, 2006, ICES J MAR SCI, V63, P365, DOI 10.1016/j.icesjms.2005.10.014; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Velarde E, 2009, J BIOL RHYTHM, V24, P104, DOI 10.1177/0748730408329901; Wang H, 2008, J MOL EVOL, V67, P29, DOI 10.1007/s00239-008-9121-5; Wang H, 2008, MAR GENOM, V1, P69, DOI 10.1016/j.margen.2008.06.003; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Weger M, 2013, DEV BIOL, V380, P259, DOI 10.1016/j.ydbio.2013.04.035; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305	51	46	47	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99172	10.1371/journal.pone.0099172	http://dx.doi.org/10.1371/journal.pone.0099172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921252	Green Submitted, gold, Green Published			2022-12-25	WOS:000338701300039
J	Fischer, C; Roscher, C; Jensen, B; Eisenhauer, N; Baade, J; Attinger, S; Scheu, S; Weisser, WW; Schumacher, J; Hildebrandt, A				Fischer, Christine; Roscher, Christiane; Jensen, Britta; Eisenhauer, Nico; Baade, Jussi; Attinger, Sabine; Scheu, Stefan; Weisser, Wolfgang W.; Schumacher, Jens; Hildebrandt, Anke			How Do Earthworms, Soil Texture and Plant Composition Affect Infiltration along an Experimental Plant Diversity Gradient in Grassland?	PLOS ONE			English	Article							SATURATED HYDRAULIC CONDUCTIVITY; WATER INFILTRATION; PREFERENTIAL FLOW; TILLAGE; CLAY; MACROPORES; BURROWS; MOVEMENT; INFILTROMETERS; PRODUCTIVITY	Background: Infiltration is a key process in determining the water balance, but so far effects of earthworms, soil texture, plant species diversity and their interaction on infiltration capacity have not been studied. Methodology/Principal Findings: We measured infiltration capacity in subplots with ambient and reduced earthworm density nested in plots of different plant species (1, 4, and 16 species) and plant functional group richness and composition (1 to 4 groups; legumes, grasses, small herbs, tall herbs). In summer, earthworm presence significantly increased infiltration, whereas in fall effects of grasses and legumes on infiltration were due to plant-mediated changes in earthworm biomass. Effects of grasses and legumes on infiltration even reversed effects of texture. We propose two pathways: (i) direct, probably by modifying the pore spectrum and (ii) indirect, by enhancing or suppressing earthworm biomass, which in turn influenced infiltration capacity due to change in burrowing activity of earthworms. Conclusions/Significance: Overall, the results suggest that spatial and temporal variations in soil hydraulic properties can be explained by biotic processes, especially the presence of certain plant functional groups affecting earthworm biomass, while soil texture had no significant effect. Therefore biotic parameters should be taken into account in hydrological applications.	[Fischer, Christine; Attinger, Sabine; Hildebrandt, Anke] Univ Jena, Inst Geosci, Jena, Germany; [Fischer, Christine; Hildebrandt, Anke] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Roscher, Christiane] UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Jensen, Britta; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Eisenhauer, Nico] Univ Jena, Inst Ecol, Jena, Germany; [Baade, Jussi] Univ Jena, Dept Geog, Jena, Germany; [Attinger, Sabine] UFZ, Helmholtz Ctr Environm Res, Dept Computat Hydrosyst, Leipzig, Germany; [Weisser, Wolfgang W.] Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, Ctr Food & Life Sci Weihenstephan, Freising Weihenstephan, Germany; [Schumacher, Jens] Univ Jena, Inst Stochast, Jena, Germany	Friedrich Schiller University of Jena; Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Gottingen; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Munich; Friedrich Schiller University of Jena	Fischer, C (corresponding author), Univ Jena, Inst Geosci, Jena, Germany.	Fischer.christine@uni-jena.de	Weisser, Wolfgang W/B-9718-2014; Eisenhauer, Nico/I-3191-2019; Eisenhauer, Nico/I-5932-2012; Hildebrandt, Anke/J-7062-2012; Scheu, Stefan/H-7049-2015; Baade, Jussi/D-4281-2013	Weisser, Wolfgang W/0000-0002-2757-8959; Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720; Hildebrandt, Anke/0000-0001-8643-1634; Baade, Jussi/0000-0001-9878-7232	German Science Foundation (DFG) [FOR456/1451]; Friedrich Schiller University Jena; Max Planck Society; Helmholtz Impulse and Networking Fund through the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE); AquaDiv@Jena; initiative "ProExzellenz" of the German Federal State of Thuringia	German Science Foundation (DFG)(German Research Foundation (DFG)); Friedrich Schiller University Jena; Max Planck Society(Max Planck SocietyFoundation CELLEX); Helmholtz Impulse and Networking Fund through the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE); AquaDiv@Jena; initiative "ProExzellenz" of the German Federal State of Thuringia	The Jena Experiment was funded by the German Science Foundation (DFG, FOR456/1451, www.dfg.de, http://www.dfg.de.), with additional support from the Friedrich Schiller University Jena and the Max Planck Society. This specific research project was further supported by the Helmholtz Impulse and Networking Fund through the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE) and AquaDiv@Jena, a project funded by the initiative "ProExzellenz" of the German Federal State of Thuringia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT I, 1981, SOIL BIOL BIOCHEM, V13, P191, DOI 10.1016/0038-0717(81)90019-5; Alaoui A, 2011, SOIL TILL RES, V115, P1, DOI 10.1016/j.still.2011.06.002; Angers DA, 1998, BIOGEOCHEMISTRY, V42, P55, DOI 10.1023/A:1005944025343; Angulo-Jaramillo R, 2000, SOIL TILL RES, V55, P1, DOI 10.1016/S0167-1987(00)00098-2; Archer NAL, 2002, J ARID ENVIRON, V52, P535, DOI 10.1006/jare.2002.1011; Azooz RH, 1996, CAN J SOIL SCI, V76, P143, DOI 10.4141/cjss96-021; BARLEY KP, 1954, SOIL SCI, V78, P205, DOI 10.1097/00010694-195409000-00005; Bens O, 2007, EUR J FOREST RES, V126, P101, DOI 10.1007/s10342-006-0133-7; Bessler H, 2009, ECOLOGY, V90, P1520, DOI 10.1890/08-0867.1; BEVEN K, 1982, WATER RESOUR RES, V18, P1311, DOI 10.1029/WR018i005p01311; Beven K, 2013, WATER RESOUR RES, V49, P3071, DOI 10.1002/wrcr.20156; BLACKBURN WH, 1975, WATER RESOUR RES, V11, P929, DOI 10.1029/WR011i006p00929; Bodner G, 2008, GEODERMA, V146, P317, DOI 10.1016/j.geoderma.2008.06.012; BONSU M, 1992, HYDROLOG SCI J, V37, P599, DOI 10.1080/02626669209492626; Bouche MB, 1977, ECOL B STOCKHOLM, V25, P122, DOI DOI 10.2307/20112572; Bretz F., 2010, MULTIPLE COMP USING; Chan KY, 2004, APPL SOIL ECOL, V27, P89, DOI 10.1016/j.apsoil.2004.02.001; DEKKER LW, 1994, WATER RESOUR RES, V30, P2507, DOI 10.1029/94WR00749; DEXTER AR, 1988, SOIL TILL RES, V11, P199, DOI 10.1016/0167-1987(88)90002-5; Edwards C.A., 1996, BIOL ECOLOGY EARTHWO, V3rd; EDWARDS WM, 1990, GEODERMA, V46, P73, DOI 10.1016/0016-7061(90)90008-W; EHLERS W, 1975, SOIL SCI, V119, P242, DOI 10.1097/00010694-197503000-00010; Eisenhauer N, 2008, EUR J SOIL BIOL, V44, P141, DOI 10.1016/j.ejsobi.2007.10.002; Eisenhauer N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016055; Eisenhauer N, 2009, SOIL BIOL BIOCHEM, V41, P2430, DOI 10.1016/j.soilbio.2009.09.001; Eisenhauer N, 2009, OECOLOGIA, V161, P291, DOI 10.1007/s00442-009-1374-1; ELA SD, 1992, SOIL SCI SOC AM J, V56, P714, DOI 10.2136/sssaj1992.03615995005600030007x; FAO-UNESCO, 1997, SOIL MAP WORLD REV L; FLURY M, 1994, WATER RESOUR RES, V30, P1945, DOI 10.1029/94WR00871; GISH TJ, 1983, T ASAE, V26, P440; Grace J.B., 2006, STRUCT EQ MOD NAT; GREVERS MCJ, 1990, CAN J SOIL SCI, V70, P93, DOI 10.4141/cjss90-010; Hillel D, 1998, ENV SOIL PHYS; JARVIS NJ, 1995, SOIL SCI SOC AM J, V59, P27, DOI 10.2136/sssaj1995.03615995005900010004x; JARVIS NJ, 1987, J SOIL SCI, V38, P633, DOI 10.1111/j.1365-2389.1987.tb02160.x; JOSCHKO M, 1992, SOIL BIOL BIOCHEM, V24, P1545, DOI 10.1016/0038-0717(92)90148-Q; Kluge G, 2000, BERICHTE DTSCH WETTE, V213; Kordel W, 2008, PURE APPL CHEM, V80, P105, DOI 10.1351/pac200880010105; Kohler-Milleret R, 2013, PLANT SOIL, V370, P251, DOI 10.1007/s11104-013-1621-4; Kutilek M, 2004, SOIL TILL RES, V79, P175, DOI 10.1016/j.still.2004.07.006; Lachnicht SL, 1997, SOIL BIOL BIOCHEM, V29, P493, DOI 10.1016/S0038-0717(96)00106-X; LEE KE, 1991, AUST J SOIL RES, V29, P745, DOI 10.1071/SR9910745; Lin HS, 1999, SOIL SCI SOC AM J, V63, P948, DOI 10.2136/sssaj1999.634948x; Lipiec J, 2006, SOIL TILL RES, V89, P210, DOI 10.1016/j.still.2005.07.012; Logsdon SD, 2000, SOIL SCI SOC AM J, V64, P710, DOI 10.2136/sssaj2000.642710x; Masson-Delmotte V, 2018, SPEC REP GLOB WARM 1; MEEK BD, 1989, SOIL SCI SOC AM J, V53, P238, DOI 10.2136/sssaj1989.03615995005300010042x; MESSING I, 1990, J SOIL SCI, V41, P229, DOI 10.1111/j.1365-2389.1990.tb00059.x; Milcu A, 2008, ECOLOGY, V89, P1872, DOI 10.1890/07-1377.1; MITCHELL AR, 1995, COMMUN SOIL SCI PLAN, V26, P2655, DOI 10.1080/00103629509369475; MYTTON LR, 1993, GRASS FORAGE SCI, V48, P84, DOI 10.1111/j.1365-2494.1993.tb01840.x; NUUTINEN V, 1992, SOIL TILL RES, V23, P221, DOI 10.1016/0167-1987(92)90102-H; Obi ME, 1999, PLANT SOIL, V211, P165, DOI 10.1023/A:1004609104524; Ortlepp S, 2004, HOLOZANE FLUVIALE DY; Paoletti MG, 1999, AGR ECOSYST ENVIRON, V74, P137, DOI 10.1016/S0167-8809(99)00034-1; Peres G, 2013, PLANT SOIL, V373, P285, DOI 10.1007/s11104-013-1791-0; Peres G, 1998, BIOL FERT SOILS, V27, P417, DOI 10.1007/s003740050452; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Pucheta E, 2004, AUSTRAL ECOL, V29, P201, DOI 10.1111/j.1442-9993.2004.01337.x; Ravenek JM, 2014, OIKOS, V123, P1528, DOI 10.1111/oik.01502; RAWLS WJ, 1982, T ASAE, V25, P1316; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; SAXTON KE, 1986, SOIL SCI SOC AM J, V50, P1031, DOI 10.2136/sssaj1986.03615995005000040039x; Schwarzel K, 2007, SOIL SCI SOC AM J, V71, P1438, DOI 10.2136/sssaj2006.0104; SHIPITALO MJ, 1994, J ENVIRON QUAL, V23, P1345, DOI 10.2134/jeq1994.00472425002300060031x; SHIPITALO MJ, 1988, SOIL SCI SOC AM J, V52, P764, DOI 10.2136/sssaj1988.03615995005200030030x; Shipley B., 2000, CAUSE CORRELATIONS B; Shuster WD, 2002, APPL SOIL ECOL, V21, P159, DOI 10.1016/S0929-1393(02)00063-X; Simmonds LP, 1998, NUTR CYCL AGROECOSYS, V50, P65, DOI 10.1023/A:1009790803137; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; SLATER C. S., 1957, SOIL SCI SOC AMER PROC, V21, P457; Soto B., 1994, SOIL DEGRADATION DES, P91; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; STOCKDILL S. M. J., 1966, PROC N Z ECOL SOC, V13, P68; THIELEMANN U, 1986, PEDOBIOLOGIA, V29, P296; Thompson SE, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001134; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TIPPKOTTER R, 1983, GEODERMA, V29, P355, DOI 10.1016/0016-7061(83)90021-6; van Schaik L, 2014, ECOHYDROLOGY, V7, P401, DOI 10.1002/eco.1358; VEREECKEN H, 1995, GEODERMA, V65, P81, DOI 10.1016/0016-7061(95)92543-X; Ward A.D., 2004, ENV HYDROLOGY; WATSON KW, 1986, SOIL SCI SOC AM J, V50, P578, DOI 10.2136/sssaj1986.03615995005000030007x; Weiler M, 2003, HYDROL PROCESS, V17, P477, DOI 10.1002/hyp.1136; WOODING RA, 1968, WATER RESOUR RES, V4, P1259, DOI 10.1029/WR004i006p01259; WOSTEN JHM, 1988, SOIL SCI SOC AM J, V52, P1762, DOI 10.2136/sssaj1988.03615995005200060045x; Wuest SB, 2001, APPL SOIL ECOL, V18, P187, DOI 10.1016/S0929-1393(01)00145-7; Zacharias S, 2007, SOIL SCI SOC AM J, V71, P43, DOI 10.2136/sssaj2006.0098; ZACHMANN JE, 1987, SOIL SCI SOC AM J, V51, P1580, DOI 10.2136/sssaj1987.03615995005100060032x; ZACHMANN JE, 1989, SOIL SCI SOC AM J, V53, P1846, DOI 10.2136/sssaj1989.03615995005300060038x; Zartman R. E., 2012, Applied and Environmental Soil Science, V2012, P642791; Zehe E, 2001, J HYDROL, V247, P116, DOI 10.1016/S0022-1694(01)00371-7	91	74	78	5	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98987	10.1371/journal.pone.0098987	http://dx.doi.org/10.1371/journal.pone.0098987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918943	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000038
J	Heo, SK; Noh, EK; Yoon, DJ; Jo, JC; Park, JH; Kim, H				Heo, Sook-Kyoung; Noh, Eui-Kyu; Yoon, Dong-Joon; Jo, Jae-Cheol; Park, Jae-Hoo; Kim, Hawk			Dasatinib Accelerates Valproic Acid-Induced Acute Myeloid Leukemia Cell Death by Regulation of Differentiation Capacity	PLOS ONE			English	Article							KINASE INHIBITOR P21(WAF1/CIP1/MDA6); AML CELLS; IMATINIB MESYLATE; INDUCED APOPTOSIS; FUNCTIONAL-ROLE; RETINOIC ACID; IN-VITRO; PROLIFERATION; EXPRESSION; THERAPY	Dasatinib is a compound developed for chronic myeloid leukemia as a multi-targeted kinase inhibitor against wild-type BCR-ABL and SRC family kinases. Valproic acid (VPA) is an anti-epileptic drug that also acts as a class I histone deacetylase inhibitor. The aim of this research was to determine the anti-leukemic effects of dasatinib and VPA in combination and to identify their mechanism of action in acute myeloid leukemia (AML) cells. Dasatinib was found to exert potent synergistic inhibitory effects on VPA-treated AML cells in association with G1 phase cell cycle arrest and apoptosis induction involving the cleavage of poly (ADP-ribose) polymerase and caspase-3, -7 and -9. Dasatinib/VPA-induced cell death thus occurred via caspase-dependent apoptosis. Moreover, MEK/ERK and p38 MAPK inhibitors efficiently inhibited dasatinib/VPA-induced apoptosis. The combined effect of dasatinib and VPA on the differentiation capacity of AML cells was more powerful than the effect of each drug alone, being sufficiently strong to promote AML cell death through G(1) cell cycle arrest and caspasedependent apoptosis. MEK/ERK and p38 MAPK were found to control dasatinib/VPA-induced apoptosis as upstream regulators, and co-treatment with dasatinib and VPA to contribute to AML cell death through the regulation of differentiation capacity. Taken together, these results indicate that combined dasatinib and VPA treatment has a potential role in anti-leukemic therapy.	[Heo, Sook-Kyoung; Yoon, Dong-Joon; Kim, Hawk] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 680749, South Korea; [Noh, Eui-Kyu; Jo, Jae-Cheol; Park, Jae-Hoo; Kim, Hawk] Univ Ulsan, Coll Med, Div Hematol & Hematol Malignancies, Dept Hematol & Oncol,Ulsan Univ Hosp, Ulsan 680749, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Kim, H (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 680749, South Korea.	kimhawkmd@gmail.com	Jo, Jae-Cheol/CAE-9453-2022	Jo, Jae-Cheol/0000-0001-6014-7977	Priority Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0094050]	Priority Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by Priority Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0094050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 2006, ANTI-CANCER DRUG, V17, P1141, DOI 10.1097/01.cad.0000236302.89843.fc; Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Aurelius J, 2012, BLOOD, V119, P5832, DOI 10.1182/blood-2011-11-391722; Borriello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028555; Boufker HI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-298; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Cain K, 2003, DRUG METAB REV, V35, P337, DOI 10.1081/DMR-120026497; Chen XF, 2011, MOL CANCER RES, V9, P448, DOI 10.1158/1541-7786.MCR-10-0471; Chen Y, 2011, ANTICANCER RES, V31, P2231; Chevalier N, 2010, LEUKEMIA, V24, P1779, DOI 10.1038/leu.2010.151; Congleton J, 2012, LEUKEMIA, V26, P1180, DOI 10.1038/leu.2011.390; Deschesnes RG, 2001, MOL BIOL CELL, V12, P1569, DOI 10.1091/mbc.12.6.1569; Fang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066915; Fiskus W, 2006, CLIN CANCER RES, V12, P5869, DOI 10.1158/1078-0432.CCR-06-0980; Gianni' M, 2001, BLOOD, V97, P3234, DOI 10.1182/blood.V97.10.3234; Guerrouahen BS, 2010, CLIN CANCER RES, V16, P1149, DOI 10.1158/1078-0432.CCR-09-2416; Heo SK, 2009, J VASC RES, V46, P375, DOI 10.1159/000189798; Jonsson S, 2010, LEUKEMIA, V24, P1357, DOI 10.1038/leu.2010.84; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; Kircher B, 2009, EUR J HAEMATOL, V83, P48, DOI 10.1111/j.1600-0609.2009.01242.x; Kropf PL, 2010, LEUKEMIA, V24, P663, DOI 10.1038/leu.2009.267; Lee YC, 2010, ONCOGENE, V29, P3196, DOI 10.1038/onc.2010.73; Leiva M, 2012, LEUKEMIA, V26, P1630, DOI 10.1038/leu.2012.39; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Luo FR, 2006, CLIN CANCER RES, V12, P7180, DOI 10.1158/1078-0432.CCR-06-1112; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Mazharian A, 2011, BLOOD, V117, P5198, DOI 10.1182/blood-2010-12-326850; Miranda MB, 2008, LEUKEMIA, V22, P1624, DOI 10.1038/leu.2008.28; Noh EK, 2010, LEUKEMIA RES, V34, P1501, DOI 10.1016/j.leukres.2010.02.016; Peter ME, 2011, NATURE, V471, P310, DOI 10.1038/471310a; Rosato RR, 2004, MOL PHARMACOL, V65, P571, DOI 10.1124/mol.65.3.571; Schiffer CA, 2002, LEUKEMIA, V16, P745, DOI 10.1038/sj.leu.2402487; Schuchmann M, 2006, ONCOL REP, V15, P227; Shen WT, 2005, SURGERY, V138, P979, DOI 10.1016/j.surg.2005.09.019; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tang R, 2004, LEUKEMIA, V18, P1246, DOI 10.1038/sj.leu.2403390; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Torgersen ML, 2013, BLOOD, V122, P2467, DOI 10.1182/blood-2013-05-500629; Wang AH, 2011, ANN HEMATOL, V90, P917, DOI 10.1007/s00277-011-1175-6; Wang ZL, 1999, CANCER RES, V59, P1259; Wang ZL, 1998, EXP CELL RES, V244, P105, DOI 10.1006/excr.1998.4191; WHITE E, 1993, GENE DEV, V7, P2277, DOI 10.1101/gad.7.12a.2277; Woods WG, 1996, BLOOD, V87, P4979, DOI 10.1182/blood.V87.12.4979.bloodjournal87124979; Zurlo D, 2013, MOL CARCINOGEN, V52, P1, DOI 10.1002/mc.20872	45	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98859	10.1371/journal.pone.0098859	http://dx.doi.org/10.1371/journal.pone.0098859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918603	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000030
J	Malik, D; Hsu, T; Falatoonzadeh, P; Caceres-del-Carpio, J; Tarek, M; Chwa, M; Atilano, SR; Ramirez, C; Nesburn, AB; Boyer, DS; Kuppermann, BD; Jazwinski, SM; Miceli, MV; Wallace, DC; Udar, N; Kenney, MC				Malik, Deepika; Hsu, Tiffany; Falatoonzadeh, Payam; Caceres-del-Carpio, Javier; Tarek, Mohamed; Chwa, Marilyn; Atilano, Shari R.; Ramirez, Claudio; Nesburn, Anthony B.; Boyer, David S.; Kuppermann, Baruch D.; Jazwinski, S. Michal; Miceli, Michael V.; Wallace, Douglas C.; Udar, Nitin; Kenney, M. Cristina			Human Retinal Transmitochondrial Cybrids with J or H mtDNA Haplogroups Respond Differently to Ultraviolet Radiation: Implications for Retinal Diseases	PLOS ONE			English	Article							MITOCHONDRIAL-DNA HAPLOGROUPS; GROWTH-FACTOR-ALPHA; MACULAR DEGENERATION; PIGMENT EPITHELIUM; CELL-DEATH; ABERRANT ACCUMULATION; INFLAMMATORY CYTOKINE; NUCLEOTIDE EXCISION; COMPLEMENT-SYSTEM; OXIDATIVE STRESS	Background: It has been recognized that cells do not respond equally to ultraviolet (UV) radiation but it is not clear whether this is due to genetic, biochemical or structural differences of the cells. We have a novel cybrid (cytoplasmic hybrids) model that allows us to analyze the contribution of mitochondrial DNA (mtDNA) to cellular response after exposure to sub-lethal dose of UV. mtDNA can be classified into haplogroups as defined by accumulations of specific single nucleotide polymorphisms (SNPs). Recent studies have shown that J haplogroup is high risk for age-related macular degeneration while the H haplogroup is protective. This study investigates gene expression responses in J cybrids versus H cybrids after exposure to sub-lethal doses of UV-radiation. Methodology/Principal Findings: Cybrids were created by fusing platelets isolated from subjects with either H (n = 3) or J (n = 3) haplogroups with mitochondria-free (Rho 0) ARPE-19 cells. The H and J cybrids were cultured for 24 hours, treated with 10 mJ of UV-radiation and cultured for an additional 120 hours. Untreated and treated cybrids were analyzed for growth rates and gene expression profiles. The UV-treated and untreated J cybrids had higher growth rates compared to H cybrids. Before treatment, J cybrids showed lower expression levels for CFH, CD55, IL-33, TGF-A, EFEMP-1, RARA, BCL2L13 and BBC3. At 120 hours after UV-treatment, the J cybrids had decreased CFH, RARA and BBC3 levels but increased CD55, IL-33 and EFEMP-1 compared to UV-treated H cybrids. Conclusion/Significance: In cells with identical nuclei, the cellular response to sub-lethal UV-radiation is mediated in part by the mtDNA haplogroup. This supports the hypothesis that differences in growth rates and expression levels of complement, inflammation and apoptosis genes may result from population-specific, hereditary SNP variations in mtDNA. Therefore, when analyzing UV-induced damage in tissues, the mtDNA haplogroup background may be important to consider.	[Malik, Deepika; Hsu, Tiffany; Falatoonzadeh, Payam; Caceres-del-Carpio, Javier; Tarek, Mohamed; Chwa, Marilyn; Atilano, Shari R.; Ramirez, Claudio; Nesburn, Anthony B.; Kuppermann, Baruch D.; Udar, Nitin; Kenney, M. Cristina] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92697 USA; [Tarek, Mohamed] El Minya Univ, Dept Ophthalmol, El Minya, Egypt; [Nesburn, Anthony B.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Boyer, David S.] Retina Vitreous Associates Med Grp, Beverly Hills, CA USA; [Jazwinski, S. Michal; Miceli, Michael V.] Tulane Univ, Tulane Ctr Aging, New Orleans, LA 70118 USA; [Wallace, Douglas C.] Univ Penn, Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA; [Wallace, Douglas C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Kenney, M. Cristina] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	University of California System; University of California Irvine; Egyptian Knowledge Bank (EKB); Minia University; Cedars Sinai Medical Center; Retina Vitreous Associates Medical Group; Tulane University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of California System; University of California Irvine	Kenney, MC (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92697 USA.	mkenney@uci.edu		Udar, Nitin/0000-0001-8533-9190; CACERES DEL CARPIO, JAVIER/0000-0001-5673-5709; Moustafa, M. Tarek/0000-0003-4545-6012; Atilano, Shari/0000-0002-7729-7864	Discovery Eye Foundation; Guenther Foundation; Beckman Initiative for Macular Research; Polly and Michael Smith Foundation; Max Factor Family Foundation; Skirball Foundation; Lincy Foundation, Iris; B. Gerald Cantor Foundation; Research to Prevent Blindness;  [AG006168]; NATIONAL INSTITUTE ON AGING [R01AG006168, R37AG006168] Funding Source: NIH RePORTER	Discovery Eye Foundation; Guenther Foundation; Beckman Initiative for Macular Research; Polly and Michael Smith Foundation; Max Factor Family Foundation; Skirball Foundation; Lincy Foundation, Iris; B. Gerald Cantor Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Discovery Eye Foundation, Guenther Foundation, Beckman Initiative for Macular Research, Polly and Michael Smith Foundation, Max Factor Family Foundation, Skirball Foundation, Lincy Foundation, Iris and B. Gerald Cantor Foundation, and unrestricted grant from Research to Prevent Blindness. National Institute on Aging grant (AG006168) to SMJ and MVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimjongjun S, 2013, J PHOTOCH PHOTOBIO B, V124, P34, DOI 10.1016/j.jphotobiol.2013.04.003; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Andreozzi R, 2008, WATER RES, V42, P1684, DOI 10.1016/j.watres.2007.10.018; Artigas JM, 2013, J FR OPHTALMOL, V36, P23, DOI 10.1016/j.jfo.2012.03.018; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Baynes JW, 2002, ANN NY ACAD SCI, V959, P360, DOI 10.1111/j.1749-6632.2002.tb02107.x; Bellizzi D, 2009, CELL STRESS CHAPERON, V14, P265, DOI 10.1007/s12192-008-0081-x; Bellizzi D, 2006, GENES CELLS, V11, P883, DOI 10.1111/j.1365-2443.2006.00986.x; Blasiak J, 2013, INT J MOL SCI, V14, P2996, DOI 10.3390/ijms14022996; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; CHAKRABARTY S, 1994, CANCER LETT, V79, P157, DOI 10.1016/0304-3835(94)90254-2; Chien CH, 1997, GYNECOL ONCOL, V66, P405, DOI 10.1006/gyno.1997.4794; CORONEO MT, 1990, OPHTHALMIC SURG LAS, V21, P60; Cullen AP, 2002, INT J TOXICOL, V21, P455, DOI 10.1080/10915810290169882; D'Aquila P, 2012, GENE, V497, P323, DOI 10.1016/j.gene.2012.01.042; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Ding JD, 2008, VISION RES, V48, P339, DOI 10.1016/j.visres.2007.07.025; Doonan F, 2007, J NEUROSCI, V27, P10887, DOI 10.1523/JNEUROSCI.0903-07.2007; Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Felipe A, 2012, J REFRACT SURG, V28, P335, DOI 10.3928/1081597X-20120321-01; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Gomez-Vicente V, 2006, EUR J NEUROSCI, V24, P981, DOI 10.1111/j.1460-9568.2006.04990.x; Hain JHW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054340; Harman DG, 2006, CHEM COMMUN, P859, DOI 10.1039/b516408g; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Issa PC, 2011, GRAEF ARCH CLIN EXP, V249, P163, DOI 10.1007/s00417-010-1568-6; Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235; Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016; Kenney MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054339; Kenney MC, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-4; Kenney MC, 2014, HUM MOL GEN IN PRESS; Khaper N, 2010, ANTIOXID REDOX SIGN, V13, P1033, DOI 10.1089/ars.2009.2930; Klein BEK, 2011, ARCH OPHTHALMOL-CHIC, V129, P56, DOI 10.1001/archophthalmol.2010.322; Lau LI, 2011, INVEST OPHTH VIS SCI, V52, P6832, DOI 10.1167/iovs.11-7815; Liu XC, 2012, INFLAMMATION, V35, P776, DOI 10.1007/s10753-011-9379-4; Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Marti A, 1998, INVEST OPHTH VIS SCI, V39, P846; MOSKAL TL, 1995, CANCER EPIDEM BIOMAR, V4, P127; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030874; Nishikiori N, 2007, DIABETES, V56, P1333, DOI 10.2337/db06-1431; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; Pierron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021543; Pochampalli MR, 2007, CANCER RES, V67, P6591, DOI 10.1158/0008-5472.CAN-06-4518; Ramkumar HL, 2010, PROG RETIN EYE RES, V29, P169, DOI 10.1016/j.preteyeres.2010.02.002; Ratnapriya R, 2013, CLIN GENET, V84, P160, DOI 10.1111/cge.12206; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Roduit R, 2008, APOPTOSIS, V13, P343, DOI 10.1007/s10495-008-0179-8; Roybal CN, 2005, INVEST OPHTH VIS SCI, V46, P3973, DOI 10.1167/iovs.05-0070; Sacca SC, 2013, MUTAT RES-REV MUTAT, V752, P153, DOI 10.1016/j.mrrev.2013.01.001; SanGiovanni JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005508; Seeliger H, 2009, MOL CANCER RES, V7, P189, DOI 10.1158/1541-7786.MCR-08-0132; Simonelli F, 2006, BRIT J OPHTHALMOL, V90, P1142, DOI 10.1136/bjo.2006.096487; Sliney DH, 2005, PHOTOCHEM PHOTOBIOL, V81, P483, DOI 10.1562/2005-02-14-RA-439.1; Song EL, 2011, GYNECOL ONCOL, V121, P174, DOI 10.1016/j.ygyno.2010.11.004; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Wang QE, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-24; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Youn HY, 2011, MOL VIS, V17; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhou GM, 2001, MOL VIS, V7, P253	69	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99003	10.1371/journal.pone.0099003	http://dx.doi.org/10.1371/journal.pone.0099003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919117	Green Published, gold			2022-12-25	WOS:000338631000039
J	Mokshina, N; Gorshkova, T; Deyholos, MK				Mokshina, Natalia; Gorshkova, Tatyana; Deyholos, Michael K.			Chitinase-Like (CTL) and Cellulose Synthase (CESA) Gene Expression in Gelatinous-Type Cellulosic Walls of Flax (Linum usitatissimum L.) Bast Fibers	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; ARABINOGALACTAN PROTEINS; PLANT CHITINASES; PHLOEM FIBERS; TENSION WOOD; BIOSYNTHESIS; MECHANISM; FAMILY; TRANSCRIPTS; POPULUS	Plant chitinases (EC 3.2.1.14) and chitinase-like (CTL) proteins have diverse functions including cell wall biosynthesis and disease resistance. We analyzed the expression of 34 chitinase and chitinase-like genes of flax (collectively referred to as LusCTLs), belonging to glycoside hydrolase family 19 (GH19). Analysis of the transcript expression patterns of LusCTLs in the stem and other tissues identified three transcripts (LusCTL19, LusCTL20, LusCTL21) that were highly enriched in developing bast fibers, which form cellulose-rich gelatinous-type cell walls. The same three genes had low relative expression in tissues with primary cell walls and in xylem, which forms a xylan type of secondary cell wall. Phylogenetic analysis of the LusCTLs identified a flax-specific sub-group that was not represented in any of other genomes queried. To provide further context for the gene expression analysis, we also conducted phylogenetic and expression analysis of the cellulose synthase (CESA) family genes of flax, and found that expression of secondary wall-type LusCESAs (LusCESA4, LusCESA7 and LusCESA8) was correlated with the expression of two LusCTLs (LusCTL1, LusCTL2) that were the most highly enriched in xylem. The expression of LusCTL19, LusCTL20, and LusCTL21 was not correlated with that of any CESA subgroup. These results defined a distinct type of CTLs that may have novel functions specific to the development of the gelatinous (G-type) cellulosic walls.	[Mokshina, Natalia; Gorshkova, Tatyana] Russian Acad Sci, Kazan Inst Biochem & Biophys, Kazan, Russia; [Deyholos, Michael K.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Russian Academy of Sciences; Kazan Scientific Centre of the Russian Academy of Sciences; Kazan Institute of Biochemistry & Biophysics; University of Alberta	Deyholos, MK (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	deyholos@ualberta.ca	Gorshkova, Tatyana/C-4299-2014	Gorshkova, Tatyana/0000-0003-0342-8195; Mokshina, Natalia/0000-0002-6434-7404	Russian Foundation for Basic Research [12-04-31418]; President of the Russian Federation "Support of Leading Scientific Schools" [NSh_825.2012.4]; Genome Canada; Natural Sciences and Engineering Research Council (Canada)	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); President of the Russian Federation "Support of Leading Scientific Schools"; Genome Canada(Genome Canada); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was partially supported by the Russian Foundation for Basic Research (project no. 12-04-31418) and a grant of the President of the Russian Federation "Support of Leading Scientific Schools (NSh_825.2012.4)" and by Genome Canada and the Natural Sciences and Engineering Research Council (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageeva MV, 2005, PLANTA, V222, P565, DOI 10.1007/s00425-005-1536-2; Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; Aspeborg H, 2005, PLANT PHYSIOL, V137, P983, DOI 10.1104/pp.104.055087; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Brameld KA, 1998, P NATL ACAD SCI USA, V95, P4276, DOI 10.1073/pnas.95.8.4276; COLLINGE DB, 1993, PLANT J, V3, P31, DOI 10.1046/j.1365-313X.1993.t01-1-00999.x; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Gorshkova T, 2006, PLANTA, V223, P149, DOI 10.1007/s00425-005-0118-7; Gorshkova TA, 2010, RUSS J PLANT PHYSL+, V57, P328, DOI 10.1134/S1021443710030040; Gorshkova TA, 2003, IND CROP PROD, V18, P213, DOI 10.1016/S0926-6690(03)00043-8; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Grushetskaya ZE, 2010, CYTOL GENET+, V44, P195, DOI 10.3103/S0095452710040018; Haigler CH, 2005, PHYSIOL PLANTARUM, V124, P285, DOI 10.1111/j.1399-3054.2005.00480.x; Hamel F, 1997, J MOL EVOL, V44, P614, DOI 10.1007/PL00006184; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; Hermans C, 2010, PLANT PHYSIOL, V152, P904, DOI 10.1104/pp.109.149849; Hobson N, 2010, RUSS J PLANT PHYSL+, V57, P321, DOI 10.1134/S1021443710030039; Hong SW, 2003, PLANT PHYSIOL, V132, P757, DOI 10.1104/pp.102.017145; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jiang C, 2013, J GENET, V92, P121, DOI 10.1007/s12041-013-0222-6; Jitonnom J, 2011, BIOCHEMISTRY-US, V50, P4697, DOI 10.1021/bi101362g; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; KOMBRINK E, 1988, P NATL ACAD SCI USA, V85, P782, DOI 10.1073/pnas.85.3.782; Kumar M, 2009, TRENDS PLANT SCI, V14, P248, DOI 10.1016/j.tplants.2009.02.004; Lafarguette F, 2004, NEW PHYTOL, V164, P107, DOI 10.1111/j.1469-8137.2004.01175.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mellerowicz EJ, 2012, J EXP BOT, V63, P551, DOI 10.1093/jxb/err339; Mokshina NE, 2012, RUSS J PLANT PHYSL+, V59, P246, DOI 10.1134/S1021443712020082; Passarinho Paul A, 2002, Arabidopsis Book, V1, pe0023, DOI 10.1199/tab.0023; Roach MJ, 2007, MOL GENET GENOMICS, V278, P149, DOI 10.1007/s00438-007-0241-1; Roach MJ, 2011, PLANT PHYSIOL, V156, P1351, DOI 10.1104/pp.111.172676; Robert S, 2004, CELLULOSE, V11, P351, DOI 10.1023/B:CELL.0000046415.45774.80; Sanchez-Rodriguez C, 2012, PLANT CELL, V24, P589, DOI 10.1105/tpc.111.094672; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Takenaka Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1066, DOI 10.1271/bbb.80837; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang CM, 2004, PLANT MOL BIOL, V56, P285, DOI 10.1007/s11103-004-3382-1; Taylor NG, 2004, CELLULOSE, V11, P329, DOI 10.1023/B:CELL.0000046405.11326.a8; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; van Hengel AJ, 2001, PLANT PHYSIOL, V125, P1880, DOI 10.1104/pp.125.4.1880; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Witmer X, 2003, SEED SCI RES, V13, P167, DOI 10.1079/SSR2003134; WOJTASZEK P, 1995, PLANT PHYSIOL, V108, P1001, DOI 10.1104/pp.108.3.1001; Wu B, 2012, PLANT PHYSIOL, V159, P1440, DOI 10.1104/pp.112.195529; Zhang DS, 2004, PLANT MOL BIOL, V54, P353, DOI 10.1023/B:PLAN.0000036369.55253.dd; Zhong RQ, 2002, PLANT CELL, V14, P165, DOI 10.1105/tpc.010278	50	43	45	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e97949	10.1371/journal.pone.0097949	http://dx.doi.org/10.1371/journal.pone.0097949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918577	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000012
J	Tully, MA; Panter, J; Ogilvie, D				Tully, Mark A.; Panter, Jenna; Ogilvie, David			Individual Characteristics Associated with Mismatches between Self-Reported and Accelerometer-Measured Physical Activity	PLOS ONE			English	Article							HEALTH; CAMBRIDGE; ADULTS; MONITORS; TIME	Background: Accurate assessment tools are required for the surveillance of physical activity (PA) levels and the assessment of the effect of interventions. In addition, increasing awareness of PA is often used as the first step in pragmatic behavioural interventions, as discrepancies between the amount of activity an individual perceives they do and the amount actually undertaken may act as a barrier to change. Previous research has demonstrated differences in the amount of activity individuals report doing, compared to their level of physical activity when measured with an accelerometer. Understanding the characteristics of those whose PA level is ranked differently when measured with either self-report or accelerometry is important as it may inform the choice of instrument for future research. The aim of this project was to determine which individual characteristics are associated with differences between self-reported and accelerometer measured physical activity. Methods: Participant data from the 2009 wave of the Commuting and Health in Cambridge study were used. Quartiles of self-reported and accelerometer-measured PA were derived by ranking each measure from lowest to highest. These quartiles were compared to determine whether individuals' physical activity was ranked higher by either method. Multinomial logistic regression models were used to investigate the individual characteristics associated with different categories of mismatch. Results: Data from 486 participants (70% female) were included in the analysis. In adjusted analyses, the physical activity of overweight or obese individuals was significantly more likely to be ranked higher by self-report than by accelerometer than that of normal-weight individuals (OR = 2.07, 95%CI = 1.28-3.34), particularly among women (OR = 3.97, 95%CI = 2.11-7.47). Conclusions: There was a greater likelihood of mismatch between self-reported and accelerometer measured physical activity levels in overweight or obese adults. Future studies in overweight or obese adults should consider employing both methods of measurement.	[Tully, Mark A.] Royal Victoria Hosp, Inst Clin Sci B, Ctr Publ Hlth, UKCRC Ctr Excellence Publ Hlth NI, Belfast BT12 6BA, Antrim, North Ireland; [Panter, Jenna; Ogilvie, David] Univ Cambridge, Sch Clin Med, MRC, Epidemiol Unit, Cambridge, England; [Panter, Jenna; Ogilvie, David] Univ Cambridge, Sch Clin Med, Cambridge Biomed Campus, UKCRC Ctr Diet & Act Res CEDAR, Cambridge, England	University of Cambridge; University of Cambridge	Tully, MA (corresponding author), Royal Victoria Hosp, Inst Clin Sci B, Ctr Publ Hlth, UKCRC Ctr Excellence Publ Hlth NI, Belfast BT12 6BA, Antrim, North Ireland.	m.tully@qub.ac.uk	Tully, Mark/AAB-2939-2019	Tully, Mark/0000-0001-9710-4014; Ogilvie, David/0000-0002-0270-4672	Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust, under the UK Clinical Research Collaboration; National Institute for Health Research Public Health Research programme [09/3001/06]; Department for Employment and Learning, Northern Ireland; Medical Research Council [MC_UU_12015/6]; NIHR post-doctoral fellowship; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1, MR/K023241/1, MC_UP_1001/1] Funding Source: researchfish; National Institute for Health Research [PDF-2012-05-157, 09/3001/06] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UP_1001/1, MR/K023187/1, MC_UU_12015/6, MR/K023241/1] Funding Source: UKRI	Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust, under the UK Clinical Research Collaboration(Wellcome Trust); National Institute for Health Research Public Health Research programme; Department for Employment and Learning, Northern Ireland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR post-doctoral fellowship; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Commuting and Health in Cambridge study was developed by David Ogilvie, Simon Griffin, Andy Jones and Roger Mackett and initially funded under the auspices of the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Economic and Social Research Council, Medical Research Council, National Institute for Health Research and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The study is now funded by the National Institute for Health Research Public Health Research programme (project number 09/3001/06: see http://www.phr.nihr.ac.uk/funded_projects). Mark Tully's contribution to this study was funded by the Department for Employment and Learning, Northern Ireland, and is gratefully acknowledged. David Ogilvie supported by the Medical Research Council [Unit Programme number MC_UU_12015/6]. Jenna Panter is supported by an NIHR post-doctoral fellowship. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHR PHR programme or the Department of Health. The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Bauman Adrian, 2006, Promot Educ, V13, P92, DOI 10.1177/10253823060130020103; Beran Tanya N, 2010, BMC Res Notes, V3, P267, DOI 10.1186/1756-0500-3-267; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; Butte NF, 2012, MED SCI SPORT EXER, V44, pS5, DOI 10.1249/MSS.0b013e3182399c0e; Evenson KR, 2009, RES Q EXERCISE SPORT, V80, P355, DOI 10.1080/02701367.2009.10599570; Hallal PC, 2012, J PHYS ACT HEALTH, V9, pS88, DOI 10.1123/jpah.9.s1.s88; Hansen BH, 2013, J SPORTS SCI, V00, P1; Haskell WL, 2012, J PHYS ACT HEALTH, V9, pS5, DOI 10.1123/jpah.9.s1.s5; Hosmer D, 1989, MODEL BUILDING STRAT; Kaminsky LA, 2012, PHYSIOL MEAS, V33, P1869, DOI 10.1088/0967-3334/33/11/1869; Lechner L, 2006, HEALTH PROMOT INT, V21, P104, DOI 10.1093/heapro/dal011; Marcus BH, 2008, MOTIVATING PEOPLE BE; National Health Service, 2006, GEN PRACT PHYS ACT Q; Ogilvie D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-703; Panter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042202; Panter J, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-124; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Van Sluijs EM, 2007, INT J BEHAV NUTR PHY, V9, P1; VanderWeele TJ, 2012, AM J EPIDEMIOL, V176, P608, DOI 10.1093/aje/kws213; Walsh MC, 2004, AM J CLIN NUTR, V79, P1013; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Watkinson C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-68; Welk GJ, 2004, MED SCI SPORT EXER, V36, P1637, DOI 10.1249/01.MSS.0000074670.03001.98; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; WHO, 2009, GLOB HLTH RISKS PROG; Yang L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-841; Yang L, 2012, PREV MED, V55, P453, DOI 10.1016/j.ypmed.2012.08.019	30	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99636	10.1371/journal.pone.0099636	http://dx.doi.org/10.1371/journal.pone.0099636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919185	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000100
J	Becquart, P; Mahlakoiv, T; Nkoghe, D; Leroy, EM				Becquart, Pierre; Mahlakoiv, Tanel; Nkoghe, Dieudonne; Leroy, Eric M.			Identification of Continuous Human B-Cell Epitopes in the VP35, VP40, Nucleoprotein and Glycoprotein of Ebola Virus	PLOS ONE			English	Article							MATRIX PROTEIN VP40; HEMORRHAGIC-FEVER; MONOCLONAL-ANTIBODIES; ZAIRE-EBOLAVIRUS; PHYLOGENETIC CHARACTERIZATION; PROTECTIVE EFFICACY; INFECTED PATIENTS; IMMUNE-RESPONSES; RECEPTOR-BINDING; IMMUNOGLOBULIN-G	Ebola virus (EBOV) is a highly virulent human pathogen. Recovery of infected patients is associated with efficient EBOV-specific immunoglobulin G (IgG) responses, whereas fatal outcome is associated with defective humoral immunity. As B-cell epitopes on EBOV are poorly defined, we sought to identify specific epitopes in four EBOV proteins (Glycoprotein (GP), Nucleoprotein (NP), and matrix Viral Protein (VP)40 and VP35). For the first time, we tested EBOV IgG+ sera from asymptomatic individuals and symptomatic Gabonese survivors, collected during the early humoral response (seven days after the end of symptoms) and the late memory phase (7-12 years post-infection). We also tested sera from EBOV-seropositive patients who had never had clinical signs of hemorrhagic fever or who lived in non-epidemic areas (asymptomatic subjects). We found that serum from asymptomatic individuals was more strongly reactive to VP40 peptides than to GP, NP or VP35. Interestingly, anti-EBOV IgG from asymptomatic patients targeted three immunodominant regions of VP40 reported to play a crucial role in virus assembly and budding. In contrast, serum from most survivors of the three outbreaks, collected a few days after the end of symptoms, reacted mainly with GP peptides. However, in asymptomatic subjects the longest immunodominant domains were identified in GP, and analysis of the GP crystal structure revealed that these domains covered a larger surface area of the chalice bowl formed by three GP(1) subunits. The B-cell epitopes we identified in the EBOV VP35, VP40, NP and GP proteins may represent important tools for understanding the humoral response to this virus and for developing new antibody-based therapeutics or detection methods.	[Becquart, Pierre; Leroy, Eric M.] Inst Rech Dev, UMR MIVEGEC 264, Montpellier, France; [Becquart, Pierre; Mahlakoiv, Tanel; Nkoghe, Dieudonne; Leroy, Eric M.] Ctr Int Rech Med Franceville, Franceville, Gabon	Institut de Recherche pour le Developpement (IRD)	Becquart, P (corresponding author), Inst Rech Dev, UMR MIVEGEC 264, Montpellier, France.	pierre.becquart@ird.fr	LEROY, Eric M/I-4347-2016; Becquart, Pierre/GLT-0845-2022	LEROY, Eric M/0000-0003-0022-0890; Becquart, Pierre/0000-0002-0980-1678; Mahlakoiv, Tanel/0000-0001-9059-0486	Institut pour la Recherche et le Developpement; Total; Government of Gabon; Total-Fina-Elf Gabon; French Ministere des affaires Etrangeres et Europeennes, France	Institut pour la Recherche et le Developpement; Total(Total SA); Government of Gabon; Total-Fina-Elf Gabon; French Ministere des affaires Etrangeres et Europeennes, France	This work was supported by a special credits incitatifs grant from Institut pour la Recherche et le Developpement and by a grant from Total. CIRMF is supported by the Government of Gabon, Total-Fina-Elf Gabon, and the French Ministere des affaires Etrangeres et Europeennes, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, B WHO, V56, P247; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Becquart P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009126; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; Bradfute SB, 2008, J IMMUNOL, V180, P4058, DOI 10.4049/jimmunol.180.6.4058; Brindley MA, 2007, J VIROL, V81, P7702, DOI 10.1128/JVI.02433-06; Changula K, 2013, VIRUS RES, V176, P83, DOI 10.1016/j.virusres.2013.05.004; Dessen A, 2000, ACTA CRYSTALLOGR D, V56, P758, DOI 10.1107/S0907444900004388; Dessen A, 2000, EMBO J, V19, P4228, DOI 10.1093/emboj/19.16.4228; Dowling W, 2007, J VIROL, V81, P1821, DOI 10.1128/JVI.02098-06; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; ELLIOTT LH, 1985, VIROLOGY, V147, P169, DOI 10.1016/0042-6822(85)90236-3; Feldmann H, 1993, Arch Virol Suppl, V7, P81; Feldmann H, 2001, J GEN VIROL, V82, P2839, DOI 10.1099/0022-1317-82-12-2839; Francica JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001098; Francica JR, 2009, VIROLOGY, V383, P237, DOI 10.1016/j.virol.2008.10.029; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Geisbert TW, 1995, VIRUS RES, V39, P129, DOI 10.1016/0168-1702(95)00080-1; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; GeorgesCourbot MC, 1997, EMERG INFECT DIS, V3, P59, DOI 10.3201/eid0301.970107; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Johnson RF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-31; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Klenk Hans Dieter, 2001, Virus Research, V80, P117, DOI 10.1016/S0168-1702(01)00258-1; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Kuhn JH, 2010, ARCH VIROL, V155, P445, DOI 10.1007/s00705-010-0600-9; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2002, LANCET, V359, P712, DOI 10.1016/S0140-6736(02)07796-6; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Leroy EM, 2001, CLIN EXP IMMUNOL, V124, P453, DOI 10.1046/j.1365-2249.2001.01517.x; LINDE A, 1990, J CLIN MICROBIOL, V28, P211, DOI 10.1128/JCM.28.2.211-215.1990; Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005; Maruyama T, 1999, J INFECT DIS, V179, pS235, DOI 10.1086/514280; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Marzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036192; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Olal D, 2012, J VIROL, V86, P2809, DOI 10.1128/JVI.05549-11; Onyango CO, 2007, J INFECT DIS, V196, pS193, DOI 10.1086/520609; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Qiu XG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001575; Razumov IA, 1998, VOP VIRUSOL+, V43, P274; Reynard O, 2009, J VIROL, V83, P9596, DOI 10.1128/JVI.00784-09; Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Sanchez A, 2001, FIELDS VIROLOGY, P1279; Shahhosseini S, 2007, J VIROL METHODS, V143, P29, DOI 10.1016/j.jviromet.2007.02.004; Simmons G, 2002, J VIROL, V76, P2518, DOI 10.1128/JVI.76.5.2518-2528.2002; Sobarzo A, 2013, NEW ENGL J MED, V369, P492, DOI 10.1056/NEJMc1300266; Sobarzo A, 2013, J INFECT DIS, V208, P299, DOI 10.1093/infdis/jit162; Sullivan NJ, 2005, J VIROL, V79, P547, DOI 10.1128/JVI.79.1.547-553.2005; Takada A, 2007, J INFECT DIS, V196, pS347, DOI 10.1086/520581; Takada A, 2007, VACCINE, V25, P993, DOI 10.1016/j.vaccine.2006.09.076; Toyoda H, 2005, CLIN INFECT DIS, V40, pE49, DOI 10.1086/428128; Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054; Volchkov V, 1997, VIROLOGY, V232, P139, DOI 10.1006/viro.1997.8529; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wauquier N, 2009, EMERG INFECT DIS, V15, P1136, DOI 10.3201/eid1507.090402; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005	73	46	51	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e96360	10.1371/journal.pone.0096360	http://dx.doi.org/10.1371/journal.pone.0096360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914933	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700005
J	Qi, L; Meinel, FG; Zhou, CS; Zhao, YE; Schoepf, UJ; Zhang, LJ; Lu, GM				Qi, Li; Meinel, Felix G.; Zhou, Chang Sheng; Zhao, Yan E.; Schoepf, U. Joseph; Zhang, Long Jiang; Lu, Guang Ming			Image Quality and Radiation Dose of Lower Extremity CT Angiography Using 70 kVp, High Pitch Acquisition and Sinogram-Affirmed Iterative Reconstruction	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; DUAL-SOURCE CT; ANKLE-BRACHIAL INDEX; DIAGNOSTIC PERFORMANCE; OCCLUSIVE DISEASE; CHINESE PATIENTS; RISK-FACTORS; ACCURACY; CONTRAST; STENOSES	Objectives: The purpose of this study was to assess image quality and radiation dose of lower extremity CT angiography (CTA) with 70 kVp, high pitch acquisition and sinogram-affirmed iterative reconstruction (SAFIRE). Methods: Lower extremity CTAs were performed on 44 patients: 22 patients were examined using protocol A (120 kVp, pitch of 0.85 and 120 ml of contrast agent on a first-generation dual-source CT) (120 kVp group) and 22 patients were evaluated with protocol B (70 kVp, pitch of 2.2 and 80 ml of contrast agent on a second-generation dual-source CT) (70 kVp group). Images from the 120 kVp group were reconstructed with filtered back projection (FBP) and images from the 70 kVp group with SAFIRE. The attenuation, image noise, signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were calculated. Two radiologists subjectively assessed image quality of lower extremity arteries, plantar arterial enhancement and venous contamination of all patients. Radiation dose was compared between the two groups. Results: Higher mean intravascular attenuation was obtained in the 70 kVp group (70 vs. 120 kVp group, 555.4 +/- 83.4 HU vs. 300.9 +/- 81.4 HU, P<0.001), as well as image noise (20.0 +/- 2.8 HU vs. 17.5 +/- 3.2 HU, P = 0.010), SNR (32.0 +/- 7.0 vs. 19.1 +/- 6.9, P<0.001) and CNR (28.1 +/- 6.6 vs 15.9 +/- 6.3, P<0.001). No difference in subjective image quality and plantar arterial enhancement was found between 120 kVp group and 70 kVp group (all P>0.05). The venous contamination score was 1.5 +/- 0.8 for 120 kVp group while no venous contamination was found in 70 kVp group. The inter-observer agreement was moderate to good for both groups (0.515 similar to 1, P<0.001). The effective dose was lower in 70 kVp group (0.3 +/- 0.1 mSv) than in 120 kVp group (1.6 +/- 0.7 mSv)(P<0.001). Conclusions: Lower extremity CTA using 70 kVp, high pitch acquisition and SAFIRE, except increasing imaging noise, allows for lower radiation dose and contrast material volume without compromising image quality.	[Qi, Li; Zhou, Chang Sheng; Zhao, Yan E.; Schoepf, U. Joseph; Zhang, Long Jiang; Lu, Guang Ming] South Med Univ, Sch Clin, Jinling Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China; [Meinel, Felix G.; Schoepf, U. Joseph] Med Univ S Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA	Southern Medical University - China; Medical University of South Carolina	Zhang, LJ (corresponding author), South Med Univ, Sch Clin, Jinling Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China.	kevinzhlj@163.com; cjr.luguangming@vip.163.com		Meinel, Felix/0000-0002-3201-1033	Program for New Century Excellent Talents in University [NCET-12-0260]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was all supported by the Program for New Century Excellent Talents in University (NCET-12-0260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach S, 2011, JACC-CARDIOVASC IMAG, V4, P328, DOI 10.1016/j.jcmg.2011.01.012; Amacker NA, 2012, EUR J RADIOL, V81, pE392, DOI 10.1016/j.ejrad.2011.12.017; Baumueller S, 2012, EUR RADIOL, V22, P2597, DOI 10.1007/s00330-012-2524-0; Catalano C, 2004, RADIOLOGY, V231, P555, DOI 10.1148/radiol.2312020920; De Zordo T, 2012, EUR RADIOL, V22, P279, DOI 10.1007/s00330-011-2251-y; Duan YH, 2013, AM J ROENTGENOL, V201, pW906, DOI 10.2214/AJR.12.10209; Foley WD, 2010, RADIOL CLIN N AM, V48, P367, DOI 10.1016/j.rcl.2010.02.008; Fraioli F, 2006, EUR RADIOL, V16, P137, DOI 10.1007/s00330-005-2812-z; Grant K, 2013, SAFIRE SIMOGRAM AFFI; Gunn MLD, 2010, EMERG RADIOL, V17, P209, DOI 10.1007/s10140-009-0850-6; Han BK, 2012, J CARDIOVASC COMPUT, V6, P200, DOI 10.1016/j.jcct.2012.04.008; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Huang SY, 2012, ACAD RADIOL, V19, P1149, DOI 10.1016/j.acra.2012.04.014; Iezzi R, 2012, RADIOLOGY, V263, P287, DOI 10.1148/radiol.11110700; Li J, 2006, J HEALTH SCI, V52, P97, DOI 10.1248/jhs.52.97; Luo YY, 2007, J HUM HYPERTENS, V21, P461, DOI 10.1038/sj.jhh.1002177; Napoli A, 2011, RADIOLOGY, V261, P976, DOI 10.1148/radiol.11103564; Nie P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091123; Park CK, 2013, INT J CARDIOVAS IMAG, V29, P47, DOI 10.1007/s10554-013-0252-4; Redmond JM, 2008, ORTHOPEDICS, V31, P761, DOI 10.3928/01477447-20080801-27; Romano M, 2004, EUR J RADIOL, V50, P303, DOI 10.1016/S0720-048X(03)00118-9; Schuhbaeck A, 2013, EUR RADIOL, V23, P597, DOI 10.1007/s00330-012-2656-2; Shrimpton P., 2004, EUROPEAN COMMISSION; Utsunomiya D, 2010, EUR RADIOL, V20, P2758, DOI 10.1007/s00330-010-1841-4; von Spiczak J, 2013, J CARDIOVASC COMPUT, V7, P215, DOI 10.1016/j.jcct.2013.08.003; Yang WJ, 2013, J COMPUT ASSIST TOMO, V37, P301, DOI 10.1097/RCT.0b013e31827b8c66; Yang WJ, 2013, INT J CARDIOVAS IMAG, V29, P245, DOI 10.1007/s10554-012-0068-7	27	26	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99112	10.1371/journal.pone.0099112	http://dx.doi.org/10.1371/journal.pone.0099112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915439	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700063
J	Ryan, A; Kaplan, E; Nebel, JC; Polycarpou, E; Crescente, V; Lowe, E; Preston, GM; Sim, E				Ryan, Ali; Kaplan, Elise; Nebel, Jean-Christophe; Polycarpou, Elena; Crescente, Vincenzo; Lowe, Edward; Preston, Gail M.; Sim, Edith			Identification of NAD(P)H Quinone Oxidoreductase Activity in Azoreductases from P. aeruginosa: Azoreductases and NAD(P)H Quinone Oxidoreductases Belong to the Same FMN-Dependent Superfamily of Enzymes	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; N-ACETYLTRANSFERASE 1; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; HETEROLOGOUS EXPRESSION; SUBSTRATE-SPECIFICITY; STRESS RESISTANCE; DOWN-REGULATION	Water soluble quinones are a group of cytotoxic anti-bacterial compounds that are secreted by many species of plants, invertebrates, fungi and bacteria. Studies in a number of species have shown the importance of quinones in response to pathogenic bacteria of the genus Pseudomonas. Two electron reduction is an important mechanism of quinone detoxification as it generates the less toxic quinol. In most organisms this reaction is carried out by a group of flavoenzymes known as NAD(P)H quinone oxidoreductases. Azoreductases have previously been separate from this group, however using azoreductases from Pseudomonas aeruginosa we show that they can rapidly reduce quinones. Azoreductases from the same organism are also shown to have distinct substrate specificity profiles allowing them to reduce a wide range of quinones. The azoreductase family is also shown to be more extensive than originally thought, due to the large sequence divergence amongst its members. As both NAD(P)H quinone oxidoreductases and azoreductases have related reaction mechanisms it is proposed that they form an enzyme superfamily. The ubiquitous and diverse nature of azoreductases alongside their broad substrate specificity, indicates they play a wide role in cellular survival under adverse conditions.	[Ryan, Ali; Kaplan, Elise; Crescente, Vincenzo; Sim, Edith] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Ryan, Ali; Nebel, Jean-Christophe; Polycarpou, Elena; Crescente, Vincenzo; Sim, Edith] Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames KT1 2EE, Surrey, England; [Lowe, Edward] Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QT, England; [Preston, Gail M.] Univ Oxford, Dept Plant Sci, Oxford OX1 3QT, England	University of Oxford; Kingston University; University of Oxford; University of Oxford	Ryan, A (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	a.ryan@kingston.ac.uk	ryan, ali/AAB-1659-2022; Nebel, Jean-Christophe/B-5655-2009; Lowe, Edward/AAP-5381-2021; ryan, ali/J-5815-2012	Nebel, Jean-Christophe/0000-0003-1812-5269; Lowe, Edward/0000-0002-1757-0208; Preston, Gail/0000-0003-3882-4438; KAPLAN, Elise/0000-0003-4985-1482; ryan, ali/0000-0002-4627-8185				Ackerley DF, 2004, APPL ENVIRON MICROB, V70, P873, DOI 10.1128/AEM.70.2.873-882.2004; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal R, 2006, ACTA CRYSTALLOGR D, V62, P383, DOI [10.1107/S0907444906001600, 10.1107/S0904777906001600]; Ahn KS, 2007, CANCER RES, V67, P10004, DOI 10.1158/0008-5472.CAN-07-2213; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARCAMONE F, 1969, BIOTECHNOL BIOENG, V11, P1101, DOI 10.1002/bit.260110607; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Binter A, 2009, FEBS J, V276, P5263, DOI 10.1111/j.1742-4658.2009.07222.x; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Burger S, 2010, APPL MICROBIOL BIOT, V87, P2067, DOI 10.1007/s00253-010-2669-1; Butcher NJ, 2012, PHARMACOL REV, V64, P147, DOI 10.1124/pr.110.004275; Cai J, 1998, MICROBIOL-SGM, V144, P2705, DOI 10.1099/00221287-144-10-2705; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; CHATTERJEE PK, 1995, P NATL ACAD SCI USA, V92, P8950, DOI 10.1073/pnas.92.19.8950; Chen HZ, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-13; Chen HZ, 2005, MICROBIOL-SGM, V151, P1433, DOI 10.1099/mic.0.27805-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHESIS PL, 1984, P NATL ACAD SCI-BIOL, V81, P1696, DOI 10.1073/pnas.81.6.1696; Clark W. M., 1960, OXIDATION REDUCTION; Ding JL, 2005, GENES IMMUN, V6, P557, DOI 10.1038/sj.gene.6364240; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer TC, 2012, J AGR FOOD CHEM, V60, P12074, DOI 10.1021/jf303584r; Goncalves AMD, 2013, FEBS J, V280, P6643, DOI 10.1111/febs.12568; Gong X, 2007, CANCER RES, V67, P5380, DOI 10.1158/0008-5472.CAN-07-0323; Gooderham WJ, 2009, MICROBIOL-SGM, V155, P699, DOI 10.1099/mic.0.024554-0; Gorman J, 2005, PROTEIN SCI, V14, P3004, DOI 10.1110/ps.051680805; Green L, 2012, VITRO VIVO CHARACTER; Hayashi M, 1996, BBA-BIOENERGETICS, V1273, P165, DOI 10.1016/0005-2728(95)00138-7; Hervas M, 2012, BIOCHEMISTRY-US, V51, P1178, DOI 10.1021/bi201904p; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Ito K, 2008, J BIOL CHEM, V283, P13889, DOI 10.1074/jbc.M710070200; IYANAGI T, 1970, BIOCHIM BIOPHYS ACTA, V216, P282, DOI 10.1016/0005-2728(70)90220-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laurieri N, 2010, J AM CHEM SOC, V132, P3238, DOI 10.1021/ja909165u; Liu GF, 2008, APPL MICROBIOL BIOT, V80, P409, DOI 10.1007/s00253-008-1555-6; Liu GF, 2008, BIOTECHNOL LETT, V30, P869, DOI 10.1007/s10529-007-9627-8; Liu ZJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P68, DOI 10.1016/j.abb.2007.03.003; Lyngberg L, 2011, J BACTERIOL, V193, P4925, DOI 10.1128/JB.05272-11; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mendes S, 2011, APPL MICROBIOL BIOT, P1; Miseviciene L, 2006, ACTA BIOCHIM POL, V53, P569; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakanishi M, 2001, J BIOL CHEM, V276, P46394, DOI 10.1074/jbc.M104483200; Neyt C, 1997, J BACTERIOL, V179, P612, DOI 10.1128/jb.179.3.612-619.1997; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Prosser GA, 2010, BIOCHEM PHARMACOL, V79, P678, DOI 10.1016/j.bcp.2009.10.008; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rakhimova E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001685; Richter C, 2012, MOL PLANT MICROBE IN, V25, P200, DOI 10.1094/MPMI-04-11-0082; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; Rompel A, 1999, FEBS LETT, V445, P103, DOI 10.1016/S0014-5793(99)00106-4; Roosild TP, 2009, STRUCTURE, V17, P893, DOI 10.1016/j.str.2009.03.018; Ryan A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00063; Ryan A, 2010, PROTEIN CELL, V1, P780, DOI 10.1007/s13238-010-0090-2; Ryan A, 2010, J MOL BIOL, V400, P24, DOI 10.1016/j.jmb.2010.04.023; Salgado A, 2006, RAPID COMMUN MASS SP, V20, P512, DOI 10.1002/rcm.2330; Saravanakumar D, 2008, J APPL ENTOMOL, V132, P469, DOI 10.1111/j.1439-0418.2008.01278.x; Sedlacek V, 2009, ARCH BIOCHEM BIOPHYS, V483, P29, DOI 10.1016/j.abb.2008.12.016; Shiao SH, 2001, INSECT MOL BIOL, V10, P315, DOI 10.1046/j.0962-1075.2001.00268.x; Skelly JV, 1999, J MED CHEM, V42, P4325, DOI 10.1021/jm991060m; SolerRivas C, 1997, MYCOL RES, V101, P375, DOI 10.1017/S0953756296002729; Sparla F, 1999, FEBS LETT, V463, P382, DOI 10.1016/S0014-5793(99)01625-7; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; TEDESCHI G, 1995, J BIOL CHEM, V270, P2512, DOI 10.1074/jbc.270.6.2512; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; Thipyapong P, 2004, PLANTA, V220, P105, DOI 10.1007/s00425-004-1330-6; Turner KH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000779; Vasiliou Vasilis, 2006, Human Genomics, V2, P329; Wang CJ, 2007, J MOL BIOL, V373, P1213, DOI 10.1016/j.jmb.2007.08.048; Wang CJ, 2010, ACTA CRYSTALLOGR F, V66, P2, DOI 10.1107/S1744309109044741; Wang G, 2004, INFECT IMMUN, V72, P1391, DOI 10.1128/IAI.72.3.1391-1396.2004; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344; Xu JK, 2012, J BIOL CHEM, V287, P41608, DOI 10.1074/jbc.M112.387738; YANG WP, 1993, P NATL ACAD SCI USA, V90, P5796, DOI 10.1073/pnas.90.12.5796; Yang Z, 2007, J BACTERIOL, V189, P3945, DOI 10.1128/JB.00261-07; Ye J, 2007, FEBS LETT, V581, P3996, DOI 10.1016/j.febslet.2007.07.039	87	35	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98551	10.1371/journal.pone.0098551	http://dx.doi.org/10.1371/journal.pone.0098551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915188	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000340947700025
J	Xerri, C; Zennou-Azogui, Y				Xerri, Christian; Zennou-Azogui, Yoh'i			Early and Moderate Sensory Stimulation Exerts a Protective Effect on Perilesion Representations of Somatosensory Cortex after Focal Ischemic Damage	PLOS ONE			English	Article							INDUCED MOVEMENT THERAPY; TRAUMATIC BRAIN-INJURY; INDUCED CORTICAL INFARCTS; NEUROTROPHIC FACTOR; ENVIRONMENTAL ENRICHMENT; SENSORIMOTOR CORTEX; RECEPTIVE-FIELDS; FOREPAW REPRESENTATION; CEREBRAL INFARCTION; MOTOR RECOVERY	Previous studies have shown that intensive training within an early critical time window after focal cortical ischemia increases the area of damaged tissue and is detrimental to behavioral recovery. We postulated that moderate stimulation initiated soon after the lesion could have protective effects on peri-infarct cortical somatotopic representations. Therefore, we have assessed the effects of mild cutaneous stimulation delivered in an attention-demanding behavioral context on the functional organization of the perilesion somatosensory cortex using high-density electrophysiological mapping. We compared the effects of 6-day training initiated on the 3rd day postlesion (early training; ET) to those of same-duration training started on the 8th day (delayed training; DT). Our findings confirm previous work showing that the absence of training aggravates representational loss in the perilesion zone. In addition, ET was found to be sufficient to limit expansion of the ischemic lesion and reduce tissue loss, and substantially maintain the neuronal responsiveness to tactile stimulation, thereby preserving somatotopic map arrangement in the peri-infarct cortical territories. By contrast, DT did not prevent tissue loss and only partially reinstated lost representations in a use-dependent manner within the spared peri-infarct cortical area. This study differentiates the effects of early versus delayed training on perilesion tissue and cortical map reorganization, and underscores the neuroprotective influence of mild rehabilitative stimulation on neuronal response properties in the peri-infarct cortex during an early critical period.	[Xerri, Christian; Zennou-Azogui, Yoh'i] Aix Marseille Univ, CNRS, Unite Mixte Rech 7260, Federat Rech Comportement Cerveau Cognit 3512, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Xerri, C (corresponding author), Aix Marseille Univ, CNRS, Unite Mixte Rech 7260, Federat Rech Comportement Cerveau Cognit 3512, Marseille, France.	christian.xerri@univ-amu.fr			Ministere de l'Enseignement Superieur et de la Recherche; CNRS	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from Ministere de l'Enseignement Superieur et de la Recherche and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ADACHI H, 1995, INT J HYPERTHER, V11, P587, DOI 10.3109/02656739509022492; Back T, 2004, J NEUROL, V251, P388, DOI 10.1007/s00415-004-0399-y; Barbay S, 2006, EXP BRAIN RES, V169, P106, DOI 10.1007/s00221-005-0129-4; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; BROWN AG, 1989, J PHYSIOL-LONDON, V413, P119, DOI 10.1113/jphysiol.1989.sp017645; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; Burnett MG, 2006, STROKE, V37, P1327, DOI 10.1161/01.STR.0000217305.82123.d8; Burnett MG, 2005, BRAIN RES, V1047, P112, DOI 10.1016/j.brainres.2005.04.024; Carmichael ST, 2012, ARCH NEUROL-CHICAGO, V69, P161, DOI 10.1001/archneurol.2011.1175; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Chu CJ, 2000, EXP NEUROL, V166, P403, DOI 10.1006/exnr.2000.7509; Clarkson AN, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/708428; Clarkson AN, 2011, J NEUROSCI, V31, P3766, DOI 10.1523/JNEUROSCI.5780-10.2011; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Coq JO, 1998, EXP BRAIN RES, V121, P191, DOI 10.1007/s002210050452; Coq JO, 1999, EUR J NEUROSCI, V11, P2597, DOI 10.1046/j.1460-9568.1999.00673.x; Dalkara T, 2012, J CEREBR BLOOD F MET, V32, P2091, DOI 10.1038/jcbfm.2012.139; Davis MF, 2011, STROKE, V42, P792, DOI 10.1161/STROKEAHA.110.607135; DeBow SB, 2004, CAN J PHYSIOL PHARM, V82, P231, DOI 10.1139/Y04-013; DOETSCH GS, 1990, EXP NEUROL, V108, P162, DOI 10.1016/0014-4886(90)90024-M; DOMANN R, 1993, NEUROSCI LETT, V155, P69, DOI 10.1016/0304-3940(93)90675-B; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; DYKES RW, 1984, J NEUROPHYSIOL, V52, P1066, DOI 10.1152/jn.1984.52.6.1066; Enright LE, 2007, J CEREBR BLOOD F MET, V27, P1185, DOI 10.1038/sj.jcbfm.9600428; Eysel UT, 1997, ADV NEUROL, V73, P195; EYSEL UT, 1991, NEUROSCI LETT, V131, P45, DOI 10.1016/0304-3940(91)90333-O; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Friel KM, 1998, SOMATOSENS MOT RES, V15, P173, DOI 10.1080/08990229870745; Frostig RD, 2013, NEUROSCIENTIST, V19, P313, DOI 10.1177/1073858412462607; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Glazner GW, 2000, EXP NEUROL, V161, P442, DOI 10.1006/exnr.1999.7242; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Gottmann K, 2009, EXP BRAIN RES, V199, P203, DOI 10.1007/s00221-009-1994-z; Goubard V, 2011, J PHYSIOL-LONDON, V589, P2301, DOI 10.1113/jphysiol.2010.203125; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; Green AR, 2003, TRENDS PHARMACOL SCI, V24, P402, DOI 10.1016/S0165-6147(03)00192-5; Hata R, 2000, J CEREBR BLOOD F MET, V20, P306, DOI 10.1097/00004647-200002000-00012; HICKS TP, 1983, BRAIN RES, V274, P160, DOI 10.1016/0006-8993(83)90533-4; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jenkins WM, 1987, PROG BRAIN RES <D>, V71, P249; Johansson BB, 1996, EXP NEUROL, V139, P322, DOI 10.1006/exnr.1996.0106; Joo HW, 2012, EUR J NEUROSCI, V36, P3691, DOI 10.1111/ejn.12014; Perez-Alvarez MJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-157; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kesslak JP, 1998, BEHAV NEUROSCI, V112, P1012, DOI 10.1037/0735-7044.112.4.1012; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kundrotiene J, 2002, J NEUROTRAUM, V19, P69, DOI 10.1089/089771502753460259; LASKIN SE, 1979, J NEUROPHYSIOL, V42, P1061, DOI 10.1152/jn.1979.42.4.1061; Lay CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011270; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Lippert-Gruener M, 2007, EXP NEUROL, V203, P82, DOI 10.1016/j.expneurol.2006.07.025; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Mansoori BK, 2014, EXP NEUROL, V254, P18, DOI 10.1016/j.expneurol.2014.01.010; Martinez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016726; MITTMANN T, 1994, NEUROSCIENCE, V60, P891, DOI 10.1016/0306-4522(94)90270-4; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Neumann-Haefelin T, 1998, NEUROSCIENCE, V87, P871, DOI 10.1016/S0306-4522(98)00124-9; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Ohmoto Y, 1996, INT J HYPERTHER, V12, P321, DOI 10.3109/02656739609022521; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; PETERSON BE, 1995, J NEUROSCI METH, V57, P133, DOI 10.1016/0165-0270(94)00103-N; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Que M, 1999, NEUROSCIENCE, V93, P1233, DOI 10.1016/S0306-4522(99)00197-9; Risedal A, 1999, J CEREBR BLOOD F MET, V19, P997, DOI 10.1097/00004647-199909000-00007; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Sigler A, 2009, P NATL ACAD SCI USA, V106, P11759, DOI 10.1073/pnas.0812695106; Tang AC, 2002, BEHAV BRAIN RES, V131, P1, DOI 10.1016/S0166-4328(01)00330-8; Taub E, 1999, J REHABIL RES DEV, V36, P237; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; WATERS RS, 1995, EXP BRAIN RES, V103, P183; Winship IR, 2009, NEUROSCIENTIST, V15, P507, DOI 10.1177/1073858409333076; Xerri C, 2004, ARCH ITAL BIOL, V142, P217; Xerri C, 2003, NEUROSCIENCE, V118, P161, DOI 10.1016/S0306-4522(02)00911-9; Xerri C, 1999, CEREB CORTEX, V9, P264, DOI 10.1093/cercor/9.3.264; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119; Xerri C, 2010, BRAIN MAPPING NEURAL, P111; Zepeda A, 2004, J NEUROSCI, V24, P1812, DOI 10.1523/JNEUROSCI.3213-03.2004; Zepeda A, 2003, J CEREBR BLOOD F MET, V23, P811, DOI 10.1097/01.WCB.0000075010.31477.1E; Zhang F, 2007, NEUROSCIENCE, V150, P938, DOI 10.1016/j.neuroscience.2007.09.070	87	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99767	10.1371/journal.pone.0099767	http://dx.doi.org/10.1371/journal.pone.0099767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914807	Green Submitted, gold, Green Published			2022-12-25	WOS:000340947700130
J	Zupancic, T; Stojan, J; Lane, EB; Komel, R; Bedina-Zavec, A; Liovic, M				Zupancic, Tina; Stojan, Jure; Lane, Ellen Birgitte; Komel, Radovan; Bedina-Zavec, Apolonija; Liovic, Mirjana			Intestinal Cell Barrier Function In Vitro Is Severely Compromised by Keratin 8 and 18 Mutations Identified in Patients with Inflammatory Bowel Disease	PLOS ONE			English	Article							PATHOGENESIS; RESISTANCE; APOPTOSIS; MIGRATION; FILAMENTS; NETWORK; SKIN	Keratin 8 and 18 (K8/K18) mutations have been implicated in the aetiology of certain pathogenic processes of the liver and pancreas. While some K8 mutations (K8 G62C, K8 K464N) are also presumed susceptibility factors for inflammatory bowel disease (IBD), the only K18 mutation (K18 S230T) discovered so far in an IBD patient is thought to be a polymorphism. The aim of our study was to demonstrate that these mutations might also directly affect intestinal cell barrier function. Cell monolayers of genetically engineered human colonocytes expressing these mutations were tested for permeability, growth rate and resistance to heat-stress. We also calculated the change in dissociation constant (K-d, measure of affinity) each of these mutations introduces into the keratin protein, and present the first model of a keratin dimer L12 region with in silico clues to how the K18 S230T mutation may affect keratin function. Physiologically, these mutations cause up to 30% increase in paracellular permeability in vitro. Heat-stress induces little keratin clumping but instead cell monolayers peel off the surface suggesting a problem with cell junctions. K18 S230T has pronounced pathological effects in vitro marked by high K-d, low growth rate and increased permeability. The latter may be due to the altered distribution of tight junction components claudin-4 and ZO-1. This is the first time intestinal cells have been suggested also functionally impaired by K8/K18 mutations. Although an in vitro colonocyte model system does not completely mimic the epithelial lining of the intestine, nevertheless the data suggest that K8/K18 mutations may be also able to produce a phenotype in vivo.	[Zupancic, Tina; Komel, Radovan; Bedina-Zavec, Apolonija; Liovic, Mirjana] Natl Inst Chem, Ljubljana, Slovenia; [Stojan, Jure; Komel, Radovan; Liovic, Mirjana] Univ Ljubljana, Fac Med, Med Ctr Mol Biol, Ljubljana, Slovenia; [Lane, Ellen Birgitte] Inst Med Biol, Singapore, Singapore	National Institute of Chemistry - Slovenia; University of Ljubljana; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Liovic, M (corresponding author), Natl Inst Chem, Ljubljana, Slovenia.	mirjana.liovic@mf.uni-lj.si			Slovenian Research Agency [J3-2274, J3-3617, P1-0104]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency grants J3-2274 and J3-3617 to M. Liovic and P1-0104 to R. Komel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar J, 2013, J INVEST DERMATOL, DOI [10.1038/jid.2013.416, DOI 10.1038/JID.2013.416]; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Bevc S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022265; Buning C, 2004, DIGEST LIVER DIS, V36, P388, DOI 10.1016/S1590-8658(04)00086-6; Busch T, 2012, J CELL SCI, V125, P2148, DOI 10.1242/jcs.080127; Chernyatina AA, 2012, J STRUCT BIOL, V177, P46, DOI 10.1016/j.jsb.2011.11.014; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; Galarneau L, 2007, EXP CELL RES, V313, P179, DOI 10.1016/j.yexcr.2006.10.007; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; Habtezion A, 2011, P NATL ACAD SCI USA, V108, P1445, DOI 10.1073/pnas.1010833108; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Kolsch A, 2009, CELL MOTIL CYTOSKEL, V66, P976, DOI 10.1002/cm.20395; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Kucharzik T, 2006, INFLAMM BOWEL DIS, V12, P1068, DOI 10.1097/01.mib.0000235827.21778.d5; Kurokawa H, 2009, MOL CELL BIOL, V29, P6232, DOI 10.1128/MCB.00708-09; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LANE EB, 1982, EMBO J, V1, P1365, DOI 10.1002/j.1460-2075.1982.tb01324.x; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; Liovic M, 2003, J CELL SCI, V116, P1417, DOI 10.1242/jcs.00363; Liovic M, 2008, EXP CELL RES, V314, P2066, DOI 10.1016/j.yexcr.2008.02.020; Liovic M, 2009, EXP CELL RES, V315, P2995, DOI 10.1016/j.yexcr.2009.07.013; Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005; Majumdar D, 2012, INT J EXP PATHOL, V93, P305, DOI 10.1111/j.1365-2613.2012.00830.x; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Morley SM, 2003, BRIT J DERMATOL, V149, P46, DOI 10.1046/j.1365-2133.2003.05493.x; Owens DW, 2004, J CELL SCI, V117, P1989, DOI 10.1242/jcs.01043; Roth W, 2012, J CELL SCI, V125, P5269, DOI 10.1242/jcs.116574; Russell D, 2010, J INVEST DERMATOL, V130, P671, DOI 10.1038/jid.2009.327; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Tao GZ, 2007, CLIN GASTROENTEROL H, V5, P857, DOI 10.1016/j.cgh.2007.02.017; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; Valentin MD, 2012, BREAST CANCER RES TR, V134, P21, DOI 10.1007/s10549-011-1934-z; Wallace L, 2012, J CELL SCI, V125, P1750, DOI 10.1242/jcs.097139; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	38	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99398	10.1371/journal.pone.0099398	http://dx.doi.org/10.1371/journal.pone.0099398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915158	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700097
J	Jickling, GC; Ander, BP; Zhan, XH; Noblett, D; Stamova, B; Liu, DZ				Jickling, Glen C.; Ander, Bradley P.; Zhan, Xinhua; Noblett, Dylan; Stamova, Boryana; Liu, Dazhi			microRNA Expression in Peripheral Blood Cells following Acute Ischemic Stroke and Their Predicted Gene Targets	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; SUPPRESSOR; LET-7I; RNA	Background: microRNA (miRNA) are important regulators of gene expression. In patients with ischemic stroke we have previously shown that differences in immune cell gene expression are present. In this study we sought to determine the miRNA that are differentially expressed in peripheral blood cells of patients with acute ischemic stroke and thus may regulate immune cell gene expression. Methods: miRNA from peripheral blood cells of forty-eight patients with ischemic stroke and vascular risk factor controls were compared. Differentially expressed miRNA in patients with ischemic stroke were determined by microarray with qRT-PCR confirmation. The gene targets and pathways associated with ischemic stroke that may be regulated by the identified miRNA were characterized. Results: In patients with acute ischemic stroke, miR-122, miR-148a, let-7i, miR-19a, miR-320d, miR-4429 were decreased and miR-363, miR-487b were increased compared to vascular risk factor controls. These miRNA are predicted to regulate several genes in pathways previously identified by gene expression analyses, including toll-like receptor signaling, NF-kappa b signaling, leukocyte extravasation signaling, and the prothrombin activation pathway. Conclusions: Several miRNA are differentially expressed in blood cells of patients with acute ischemic stroke. These miRNA may regulate leukocyte gene expression in ischemic stroke including pathways involved in immune activation, leukocyte extravasation and thrombosis.	[Jickling, Glen C.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Jickling, GC (corresponding author), Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA.	gcjickling@ucdavis.edu	Jickling, Glen/J-8790-2019; Stamova, Boryana/ABA-2981-2020	Jickling, Glen/0000-0003-3543-0820; Stamova, Boryana/0000-0002-5440-8816; Noblett, Dylan/0000-0002-1328-5274	American Heart Association; National Institutes of Health [NS075035, NS079153]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075035, R01NS079153, R01NS101718] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the American Heart Association (GJ, DL) and the National Institutes of Health (NS075035, NS079153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of	Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Camaioni C, 2013, INTERN EMERG MED, V8, P291, DOI 10.1007/s11739-011-0705-5; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Dangwal S, 2013, HAMOSTASEOLOGIE, V33, P17, DOI 10.5482/HAMO-13-01-0002; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Diao S, 2010, PROTEOMICS, V10, P3723, DOI 10.1002/pmic.201000050; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Gan CS, 2012, GENET MOL RES, V11, P147, DOI 10.4238/2012.January.27.1; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Jickling GC, 2012, STROKE, V43, P1006, DOI 10.1161/STROKEAHA.111.638577; Jickling GC, 2010, ANN NEUROL, V68, P681, DOI 10.1002/ana.22187; Koutsis G, 2013, CURR TOP MED CHEM, V13, P1573, DOI 10.2174/15680266113139990106; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; O'Carroll D, 2012, NEUROPSYCHOPHARMACOL; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Philippe L, 2012, J IMMUNOL, V188, P454, DOI 10.4049/jimmunol.1102348; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Sharp FR, 2006, ARCH NEUROL-CHICAGO, V63, P1529, DOI 10.1001/archneur.63.11.1529; Stamova B, 2010, STROKE, V41, P2171, DOI 10.1161/STROKEAHA.110.588335; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tang Y, 2006, J CEREBR BLOOD F MET, V26, P1089, DOI 10.1038/sj.jcbfm.9600264; Tsai PC, 2013, J VASC RES, V50, P346, DOI 10.1159/000351767; Wu C, 2011, MOL CELL BIOL, V31, P4760, DOI 10.1128/MCB.05776-11; Zeng Lili, 2011, Front Biosci (Elite Ed), V3, P1265; Zhang MM, 2011, J IMMUNOL, V187, P1674, DOI 10.4049/jimmunol.1001937	33	137	143	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99283	10.1371/journal.pone.0099283	http://dx.doi.org/10.1371/journal.pone.0099283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911610	Green Published, gold			2022-12-25	WOS:000337165600066
J	Shanmugam, I; Abbas, M; Ayoub, F; Mirabal, S; Bsaili, M; Caulder, EK; Weinstock, DM; Tomkinson, AE; Hromas, R; Shaheen, M				Shanmugam, Ilanchezhian; Abbas, Mohammad; Ayoub, Farhan; Mirabal, Susan; Bsaili, Manal; Caulder, Erin K.; Weinstock, David M.; Tomkinson, Alan E.; Hromas, Robert; Shaheen, Monte			Ubiquitin-specific Peptidase 20 Regulates Rad17 Stability, Checkpoint Kinase 1 Phosphorylation and DNA Repair by Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; MAMMALIAN-CELLS; DAMAGE RESPONSE; ATR; ENDONUCLEASE; COMPLEXES; RECOVERY; REVEALS; FORK	Rad17 is a subunit of the Rad9-Hus1-Rad1 clamp loader complex, which is required for Chk1 activation after DNA damage. Rad17 has been shown to be regulated by the ubiquitin-proteasome system. We have identified a deubiquitylase, USP20 that is required for Rad17 protein stability in the steady-state and post DNA damage. We demonstrate that USP20 and Rad17 interact, and that this interaction is enhanced by UV exposure. We show that USP20 regulation of Rad17 is at the protein level in a proteasome-dependent manner. USP20 depletion results in poor activation of Chk1 protein by phosphorylation, consistent with Rad17 role in ATR-mediated phosphorylation of Chk1. Similar to other DNA repair proteins, USP20 is phosphorylated post DNA damage, and its depletion sensitizes cancer cells to damaging agents that form blocks ahead of the replication forks. Similar to Chk1 and Rad17, which enhance recombinational repair of collapsed replication forks, we demonstrate that USP20 depletion impairs DNA double strand break repair by homologous recombination. Together, our data establish a new function of USP20 in genome maintenance and DNA repair.	[Shanmugam, Ilanchezhian; Abbas, Mohammad; Ayoub, Farhan; Mirabal, Susan; Bsaili, Manal; Caulder, Erin K.; Tomkinson, Alan E.; Shaheen, Monte] Univ New Mexico, Dept Internal Med, Div Hematol Oncol, Albuquerque, NM 87131 USA; [Shanmugam, Ilanchezhian; Abbas, Mohammad; Ayoub, Farhan; Mirabal, Susan; Bsaili, Manal; Caulder, Erin K.; Tomkinson, Alan E.; Shaheen, Monte] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Hromas, Robert] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Weinstock, David M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	University of New Mexico; University of New Mexico; State University System of Florida; University of Florida; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Shaheen, M (corresponding author), Univ New Mexico, Ctr Canc, 1201 Camino de Salud NE, Albuquerque, NM 87131 USA.	moshaheen@salud.unm.edu			NIH [5K01HL103182-03]; UNM Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057479] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNM Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIH Grant 5K01HL103182-03 (to M. S.) and start-up funds from the UNM Cancer Center.	Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Budzowska M, 2004, EMBO J, V23, P3548, DOI 10.1038/sj.emboj.7600353; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nishino K, 2008, GENES GENET SYST, V83, P427, DOI 10.1266/ggs.83.427; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Yata K, 2012, MOL CELL, V45, P371, DOI 10.1016/j.molcel.2011.12.028; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	21	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22739	22748		10.1074/jbc.M114.550459	http://dx.doi.org/10.1074/jbc.M114.550459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24923443	hybrid, Green Published			2022-12-25	WOS:000341017200019
J	Ahn, BJ; Le, H; Shin, MW; Bae, SJ; Lee, EJ; Lee, SY; Yang, JH; Wee, HJ; Cha, JH; Seo, JH; Lee, HS; Lee, HJ; Arai, K; Lo, EH; Jeon, S; Oh, GT; Kim, WJ; Ryu, JK; Suh, JK; Kim, KW				Ahn, Bum Ju; Le, Hoang; Shin, Min Wook; Bae, Sung-Jin; Lee, Eun Ji; Lee, Sung Yi; Yang, Ju Hee; Wee, Hee-Jun; Cha, Jong-Ho; Seo, Ji Hae; Lee, Hye Shin; Lee, Hyo-Jong; Arai, Ken; Lo, Eng H.; Jeon, Sejin; Oh, Goo Taeg; Kim, Woo Jean; Ryu, Ji-Kan; Suh, Jun-Kyu; Kim, Kyu-Won			Ninjurin1 Enhances the Basal Motility and Transendothelial Migration of Immune Cells by Inducing Protrusive Membrane Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; LEUKOCYTE MIGRATION; ADHESION MOLECULE; ENDOTHELIAL-CELLS; MYELOID CELLS; RHO GTPASES; FILOPODIA; EXTRAVASATION; INFLAMMATION; DIAPEDESIS	Ninjurin1 is involved in the pathogenesis of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis, by mediating leukocyte extravasation, a process that depends on homotypic binding. However, the precise regulatory mechanisms of Ninjurin1 during inflammation are largely undefined. We therefore examined the pro-migratory function of Ninjurin1 and its regulatory mechanisms in macrophages. Interestingly, Ninjurin1-deficient bone marrow-derived macrophages exhibited reduced membrane protrusion formation and dynamics, resulting in the impairment of cell motility. Furthermore, exogenous Ninjurin1 was distributed at the membrane of filopodial structures in Raw264.7 macrophage cells. In Raw264.7 cells, RNA interference of Ninjurin1 reduced the number of filopodial projections, whereas overexpression of Ninjurin1 facilitated their formation and thus promoted cell motility. Ninjurin1-induced filopodial protrusion formation required the activation of Rac1. In Raw264.7 cells penetrating an MBEC4 endothelial cell monolayer, Ninjurin1 was localized to the membrane of protrusions and promoted their formation, suggesting that Ninjurin1-induced protrusive activity contributed to transendothelial migration. Taking these data together, we conclude that Ninjurin1 enhances macrophage motility and consequent extravasation of immune cells through the regulation of protrusive membrane dynamics. We expect these findings to provide insight into the understanding of immune responses mediated by Ninjurin1.	[Ahn, Bum Ju; Le, Hoang; Shin, Min Wook; Bae, Sung-Jin; Lee, Eun Ji; Lee, Sung Yi; Yang, Ju Hee; Wee, Hee-Jun; Cha, Jong-Ho; Seo, Ji Hae; Lee, Hye Shin; Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVasc Protect Res Ctr, Seoul 151742, South Korea; [Ahn, Bum Ju; Le, Hoang; Shin, Min Wook; Bae, Sung-Jin; Lee, Eun Ji; Lee, Sung Yi; Yang, Ju Hee; Wee, Hee-Jun; Cha, Jong-Ho; Seo, Ji Hae; Lee, Hye Shin; Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul 151742, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, Coll Med, Seoul 151742, South Korea; [Lee, Hyo-Jong] Inje Univ, Coll Pharm, Gimhae 621749, South Korea; [Arai, Ken; Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Boston, MA 02114 USA; [Arai, Ken; Lo, Eng H.] Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, Boston, MA 02114 USA; [Arai, Ken; Lo, Eng H.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Jeon, Sejin; Oh, Goo Taeg] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Jeon, Sejin; Oh, Goo Taeg] Ewha Womans Univ, Program GT5, Seoul 120750, South Korea; [Kim, Woo Jean; Ryu, Ji-Kan; Suh, Jun-Kyu] Inha Univ, Natl Res Ctr Sexual Med, Sch Med, Inchon 402751, South Korea; [Kim, Woo Jean; Ryu, Ji-Kan; Suh, Jun-Kyu] Inha Univ, Dept Urol, Sch Med, Inchon 402751, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inje University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Ewha Womans University; Ewha Womans University; Inha University; Inha University	Kim, KW (corresponding author), Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVasc Protect Res Ctr, Seoul 151742, South Korea.	qwonkim@snu.ac.kr	shin, minwook/HGA-4297-2022; Kim, Kyu Won/AAJ-7213-2020; Bae, Sung-Jin/AAX-9144-2021; Jeon, Sejin/GWU-7864-2022; Jeon, Sejin/GRJ-6826-2022; Oh, Goo Taeg/AAQ-9995-2021	Bae, Sung-Jin/0000-0001-8975-0876; Lee, Hyo-Jong/0000-0003-4826-7954; Le, Hoang/0000-0001-8427-3230	National Research Foundation of Korea; Ministry of Education, Science and Technology through the Global Research Laboratory Program [2011-0021874]; Brain Korea 21 Program; Global Core Research Center Program [2012-0001187]; Basic Science Research Program through the National Research Foundation - Ministry of Education, Science and Technology [2013R1A1A2058956]; National Institutes of Health [R37-NS37074, R01-76694, P01-NS55104]; National Research Foundation - Korean Government (Ministry of Education, Science and Technology) [2013003407]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs [A110076]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037074, P01NS055104] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology through the Global Research Laboratory Program; Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Global Core Research Center Program; Basic Science Research Program through the National Research Foundation - Ministry of Education, Science and Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation - Korean Government (Ministry of Education, Science and Technology); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from a National Research Foundation of Korea, a grant funded by the Ministry of Education, Science and Technology through the Global Research Laboratory Program (2011-0021874), Brain Korea 21 Program, and the Global Core Research Center Program Grant 2012-0001187.; Supported by Basic Science Research Program through the National Research Foundation funded by Ministry of Education, Science and Technology Grant 2013R1A1A2058956.; Supported by National Institutes of Health Grants R37-NS37074, R01-76694, and P01-NS55104 (to E. H. L.).; Supported by National Research Foundation Grant 2013003407 funded by the Korean Government (Ministry of Education, Science and Technology).; Supported by Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs Grant A110076.	Ahn BJ, 2014, J BIOL CHEM, V289, P3328, DOI 10.1074/jbc.M113.498212; Ahn BJ, 2012, BIOCHEM BIOPH RES CO, V428, P438, DOI 10.1016/j.bbrc.2012.10.099; Ahn BJ, 2009, BIOCHEM BIOPH RES CO, V387, P321, DOI 10.1016/j.bbrc.2009.07.019; Araki T, 1997, J BIOL CHEM, V272, P21373, DOI 10.1074/jbc.272.34.21373; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Dodelet-Devillers A, 2009, J MOL MED, V87, P765, DOI 10.1007/s00109-009-0488-6; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lee HJ, 2009, CELL DEATH DIFFER, V16, P1395, DOI 10.1038/cdd.2009.78; Ley K, 2008, J CELL BIOL, V183, P375, DOI 10.1083/jcb.200809173; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020	35	19	20	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21926	21936		10.1074/jbc.M113.532358	http://dx.doi.org/10.1074/jbc.M113.532358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24917672	hybrid, Green Published			2022-12-25	WOS:000340593500010
J	Purushotham, S; Deivanayagam, C				Purushotham, Sangeetha; Deivanayagam, Champion			The Calcium-induced Conformation and Glycosylation of Scavenger-rich Cysteine Repeat (SRCR) Domains of Glycoprotein 340 Influence the High Affinity Interaction with Antigen I/II Homologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-GORDONII SSPB; HUMAN SALIVARY AGGLUTININ; SURFACE-PLASMON RESONANCE; CRYSTAL-STRUCTURE; BACTERIA-BINDING; MEDIATED ADHERENCE; FAMILY ADHESINS; PROTEIN GP-340; DENTAL-CARIES; GENITAL-TRACT	Oral streptococci adhere to tooth-immobilized glycoprotein 340 (GP340) via the surface protein antigen I/II (AgI/II) and its homologs as the first step in pathogenesis. Studying this interaction using recombinant proteins, we observed that calcium increases the conformational stability of the scavenger-rich cysteine repeat (SRCRs) domains of GP340. Our results also show that AgI/II adheres specifically with nanomolar affinity to the calcium-induced SRCR conformation in an immobilized state and not in solution. This interaction is significantly dependent on the O-linked carbohydrates present on the SRCRs. This study also establishes that a single SRCR domain of GP340 contains the two surfaces to which the apical and C-terminal regions of AgI/II non-competitively adhere. Compared with the single SRCR domain, the three tandem SRCR domains displayed a collective/cooperative increase in their bacterial adherence and aggregation. The previously described SRCRP2 peptide that was shown to aggregate several oral streptococci displayed limited aggregation and also nonspecific adherence compared to SRCR domains. Finally, we show distinct species-specific adherence/aggregation between Streptococcus mutans AgI/II and Streptococcus gordonii SspB in their interaction with the SRCRs. This study concludes that identification of the metal ion and carbohydrate adherence motifs on both SRCRs and AgI/II homologs could lead to the development of anti-adhesive inhibitors that could deter the adherence of pathogenic oral streptococci and thereby prevent the onset of infections.	[Purushotham, Sangeetha; Deivanayagam, Champion] Univ Alabama Birmingham, Struct Biol Ctr, Dept Vis Sci, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Deivanayagam, C (corresponding author), Univ Alabama Birmingham, Struct Biol Ctr, Dept Vis Sci, 1025 18th St South,CBSE 100, Birmingham, AL 35294 USA.	champy@uab.edu		Deivanayagam, Champion/0000-0003-2972-1824	National Institutes of Health [R01DE017737]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE017737.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Bikker FJ, 2004, J BIOL CHEM, V279, P47699, DOI 10.1074/jbc.M406095200; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; BRADY LJ, 1992, INFECT IMMUN, V60, P1008, DOI 10.1128/IAI.60.3.1008-1017.1992; Christopeit T, 2009, ANAL BIOCHEM, V391, P39, DOI 10.1016/j.ab.2009.04.037; Chung WO, 2000, INFECT IMMUN, V68, P6758, DOI 10.1128/IAI.68.12.6758-6762.2000; Claudianos C, 2002, MOL MICROBIOL, V45, P1473, DOI 10.1046/j.1365-2958.2002.03118.x; Cummins JE, 2006, AIDS RES HUM RETROV, V22, P788, DOI 10.1089/aid.2006.22.788; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Demuth DR, 1996, MOL MICROBIOL, V20, P403, DOI 10.1111/j.1365-2958.1996.tb02627.x; DEMUTH DR, 1990, MICROB PATHOGENESIS, V9, P199, DOI 10.1016/0882-4010(90)90022-I; El-Sabaeny A, 2001, INFECT IMMUN, V69, P6520, DOI 10.1128/IAI.69.10.6520-6522.2001; ERICSON T, 1983, EUR J BIOCHEM, V133, P255, DOI 10.1111/j.1432-1033.1983.tb07456.x; Esberg A, 2012, INFECT IMMUN, V80, P3869, DOI 10.1128/IAI.00435-12; Hobb RI, 2010, MICROBES INFECT, V12, P476, DOI 10.1016/j.micinf.2010.02.009; Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; LAMONT RJ, 1991, INFECT IMMUN, V59, P3446, DOI 10.1128/IAI.59.10.3446-3450.1991; Lamont RJ, 2002, MICROBIOL-SGM, V148, P1627, DOI 10.1099/00221287-148-6-1627; Larson MR, 2011, J BIOL CHEM, V286, P21657, DOI 10.1074/jbc.M111.231100; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LEHNER T, 1980, LANCET, V1, P995; Leito JTD, 2011, MOL IMMUNOL, V49, P185, DOI 10.1016/j.molimm.2011.08.010; Ligtenberg AJM, 2007, BIOL CHEM, V388, P1275, DOI 10.1515/BC.2007.158; Ligtenberg AJM, 2010, INT J MOL SCI, V11, P5213, DOI 10.3390/ijms1112521; Ligtenberg TJM, 2001, BIOCHEM J, V359, P243, DOI 10.1042/0264-6021:3590243; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; Malamud D, 2011, Adv Dent Res, V23, P34, DOI 10.1177/0022034511399282; Mollenhauer J, 1997, NAT GENET, V17, P32, DOI 10.1038/ng0997-32; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Oho T, 1998, INFECT IMMUN, V66, P115, DOI 10.1128/IAI.66.1.115-121.1998; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; Oli MW, 2006, J MICROBIOL METH, V65, P503, DOI 10.1016/j.mimet.2005.09.011; Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200; Purushotham S, 2013, PROTEIN EXPRES PURIF, V90, P67, DOI 10.1016/j.pep.2013.05.003; Robinette RA, 2011, VACCINE, V29, P6292, DOI 10.1016/j.vaccine.2011.06.027; Rodamilans B, 2007, J BIOL CHEM, V282, P12669, DOI 10.1074/jbc.M611699200; Russell MW, 2004, CARIES RES, V38, P230, DOI 10.1159/000077759; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Somoza JR, 2003, STRUCTURE, V11, P1123, DOI 10.1016/S0969-2126(03)00148-5; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Stoddard E, 2009, J VIROL, V83, P8596, DOI 10.1128/JVI.00744-09; Wu ZW, 2006, AIDS RES HUM RETROV, V22, P508, DOI 10.1089/aid.2006.22.508; Wu ZW, 2004, AIDS RES HUM RETROV, V20, P600, DOI 10.1089/0889222041217400; Yang ZRW, 2004, PROTEIN SCI, V13, P830, DOI 10.1110/ps.03330104; Young A, 1997, EUR J ORAL SCI, V105, P485, DOI 10.1111/j.1600-0722.1997.tb00235.x	52	24	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21877	21887		10.1074/jbc.M114.565507	http://dx.doi.org/10.1074/jbc.M114.565507			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24923446	Green Published, hybrid			2022-12-25	WOS:000340593500006
J	Thompson, MD; Mei, Y; Weisbrod, RM; Silver, M; Shukla, PC; Bolotina, VM; Cohen, RA; Tong, XY				Thompson, Melissa D.; Mei, Yu; Weisbrod, Robert M.; Silver, Marcy; Shukla, Praphulla C.; Bolotina, Victoria M.; Cohen, Richard A.; Tong, Xiaoyong			Glutathione Adducts on Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase Cys-674 Regulate Endothelial Cell Calcium Stores and Angiogenic Function as Well as Promote Ischemic Blood Flow Recovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ENDOPLASMIC-RETICULUM; MIGRATION; HINDLIMB; SERCA2; MODEL	The sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) is key to Ca2+ homeostasis and is redox-regulated by reversible glutathione (GSH) adducts on the cysteine (C) 674 thiol that stimulate Ca2+ uptake activity and endothelial cell angiogenic responses in vitro. We found that mouse hind limb muscle ischemia induced S-glutathione adducts on SERCA in both whole muscle tissue and endothelial cells. To determine the role of S-glutathiolation, we used a SERCA 2 C674S heterozygote knock-in (SKI) mouse lacking half the key thiol. Following hind limb ischemia, SKI animals had decreased SERCA S-glutathione adducts and impaired blood flow recovery. We studied SKI microvascular endothelial cells in which total SERCA 2 expression was unchanged. Cultured SKI microvascular endothelial cells showed impaired migration and network formation compared with wild type (WT). Ca2+ studies showed decreased nitric oxide (center dot NO)-induced 45Ca(2+) uptake into the endoplasmic reticulum (ER) of SKI cells, while Fura-2 studies revealed lower Ca2+ stores and decreased vascular endothelial growth factor (VEGF)-and center dot NO-induced Ca2+ influx. Adenoviral overexpression of calreticulin, an ER Ca2+ binding protein, increased ionomycin-releasable stores, VEGF-induced Ca2+ influx and endo-thelial cell migration. Taken together, these data indicate that the redox-sensitive Cys-674 thiol on SERCA 2 is required for normal endothelial cell Ca2+ homeostasis and ischemia-induced angiogenic responses, revealing a novel redox control of angiogenesis via Ca2+ stores.	[Thompson, Melissa D.; Mei, Yu; Weisbrod, Robert M.; Silver, Marcy; Shukla, Praphulla C.; Cohen, Richard A.; Tong, Xiaoyong] Boston Univ, Sch Med, Dept Med, Vasc Biol Sect,Whitaker Cardiovasc Inst, 650 Albany St,X720, Boston, MA 02118 USA; [Bolotina, Victoria M.] Boston Univ, Sch Med, Ion Channel & Calcium Signaling Unit, Boston, MA 02118 USA; [Tong, Xiaoyong] Chongqing Univ, Innovat Drug Res Ctr, Chongqing 401331, Peoples R China	Boston University; Boston University; Chongqing University	Tong, XY (corresponding author), Boston Univ, Sch Med, Dept Med, Vasc Biol Sect,Whitaker Cardiovasc Inst, 650 Albany St,X720, Boston, MA 02118 USA.	racohen@bu.edu; xy_tong@yahoo.com	Tong, Xiaoyong/L-5791-2019; Shukla, Praphulla Chandra/GSO-1633-2022	Shukla, Praphulla Chandra/0000-0001-9031-1547; /0000-0002-1070-6408	National Institute of Health [HL031607-30, R37 HL104017, R01-HL071793]; NHLBI [HL07969, N01-HV-28178]; American Diabetes Association [7-09-JF-69]; Boston University; Calcium Affinity Research Collaborative of the Evans Center, Department of Medicine, Boston University Medical Center; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031607, R01HL028178, R37HL104017, T32HL007969, R01HL071793] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Diabetes Association(American Diabetes Association); Boston University; Calcium Affinity Research Collaborative of the Evans Center, Department of Medicine, Boston University Medical Center; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institute of Health Grants HL031607-30 (to R. A. C., X. T.), R37 HL104017 (to R. A. C.), and R01-HL071793 (to V. B.), NHLBI T32 Training Grant HL07969 (to M. D. T.) American Diabetes Association Award 7-09-JF-69 (to X. T.), and a Martin Luther King, Jr. Fellowship from Boston University (to M. D. T.), and the NHLBI-sponsored Boston University Cardiovascular Proteomics Center (Contract No. N01-HV-28178, to R. A. C.). These studies were also supported by the Calcium Affinity Research Collaborative of the Evans Center, Department of Medicine, Boston University Medical Center.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Adachi T, 2001, CIRCULATION, V104, P1040, DOI 10.1161/hc3501.093798; Adachi T, 2010, ADV PHARMACOL, V59, P165, DOI 10.1016/S1054-3589(10)59006-9; Carmeliet P, 1998, CARDIOVASC RES, V39, P8, DOI 10.1016/S0008-6363(98)00108-4; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; CORDA S, 1995, CIRC RES, V77, P927, DOI 10.1161/01.RES.77.5.927; Evangelista AM, 2012, ANTIOXID REDOX SIGN, V17, P1099, DOI 10.1089/ars.2011.4022; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Haeussler DJ, 2013, J BIOL CHEM, V288, P15380, DOI 10.1074/jbc.M112.427765; Khoo CP, 2011, TISSUE ENG PART C-ME, V17, P895, DOI [10.1089/ten.tec.2011.0150, 10.1089/ten.TEC.2011.0150]; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Lotfi S, 2013, ATHEROSCLEROSIS, V227, P1, DOI 10.1016/j.atherosclerosis.2012.10.060; Maulik N, 2002, ANTIOXID REDOX SIGN, V4, P805, DOI 10.1089/152308602760598963; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Neufeld Gera, 1994, Progress in Growth Factor Research, V5, P89, DOI 10.1016/0955-2235(94)90019-1; Tamarat R, 2002, HYPERTENSION, V39, P830, DOI 10.1161/hy0302.104671; Urano T, 2008, ARTERIOSCL THROM VAS, V28, P827, DOI 10.1161/ATVBAHA.107.149674; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zbinden S, 2007, AM J PHYSIOL-HEART C, V292, pH1891, DOI 10.1152/ajpheart.00537.2006; Ziegelstein RC, 2006, BIOCHEM BIOPH RES CO, V342, P153, DOI 10.1016/j.bbrc.2006.01.135	23	41	42	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19907	19916		10.1074/jbc.M114.554451	http://dx.doi.org/10.1074/jbc.M114.554451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24920669	Green Published, hybrid			2022-12-25	WOS:000339395200009
J	Riahi, Z; Bonnet, C; Zainine, R; Louha, M; Bouyacoub, Y; Laroussi, N; Chargui, M; Kefi, R; Jonard, L; Dorboz, I; Hardelin, JP; Salah, SB; Levilliers, J; Weil, D; McElreavey, K; Boespflug, OT; Besbes, G; Abdelhak, S; Petit, C				Riahi, Zied; Bonnet, Crystel; Zainine, Rim; Louha, Malek; Bouyacoub, Yosra; Laroussi, Nadia; Chargui, Mariem; Kefi, Rym; Jonard, Laurence; Dorboz, Imen; Hardelin, Jean-Pierre; Salah, Sihem Belhaj; Levilliers, Jacqueline; Weil, Dominique; McElreavey, Kenneth; Boespflug, Odile Tanguy; Besbes, Ghazi; Abdelhak, Sonia; Petit, Christine			Whole Exome Sequencing Identifies New Causative Mutations in Tunisian Families with Non-Syndromic Deafness	PLOS ONE			English	Article							NONSYNDROMIC HEARING-LOSS; PROFOUND DEAFNESS; GENE; ASSOCIATION; DOMINANT; HUMANS; DEFECT; CELLS; DFNB3	Identification of the causative mutations in patients affected by autosomal recessive non syndromic deafness (DFNB forms), is demanding due to genetic heterogeneity. After the exclusion of GJB2 mutations and other mutations previously reported in Tunisian deaf patients, we performed whole exome sequencing in patients affected with severe to profound deafness, from four unrelated consanguineous Tunisian families. Four biallelic non previously reported mutations were identified in three different genes: a nonsense mutation, c.208C>T (p.R70X), in LRTOMT, a missense mutation, c.5417T>C (p.L1806P), in MYO15A and two splice site mutations, c.7395+3G>A, and c.2260+2T>A, in MYO15A and TMC1 respectively. We thereby provide evidence that whole exome sequencing is a powerful, cost-effective screening tool to identify mutations causing recessive deafness in consanguineous families.	[Riahi, Zied; Bouyacoub, Yosra; Laroussi, Nadia; Chargui, Mariem; Kefi, Rym; Abdelhak, Sonia] Inst Pasteur Tunis, Lab Genom Biomed & Oncogenet, Tunis, Tunisia; [Riahi, Zied; Laroussi, Nadia; Abdelhak, Sonia] Univ Tunis El Manar, Fac Sci Tunis, Tunis, Tunisia; [Bonnet, Crystel; Petit, Christine] INSERM, UMRS 1120, Inst Vis, Paris, France; [Zainine, Rim; Salah, Sihem Belhaj; Besbes, Ghazi] CHU La Rabta, Serv ORL & Chirurg Maxillofaciale, Tunis, Tunisia; [Louha, Malek; Jonard, Laurence] Hop Trousseau, APHP, Ctr Reference Surdites Genet, F-75571 Paris, France; [Dorboz, Imen] INSERM, U931, Clermont Ferrand, France; [Hardelin, Jean-Pierre; Levilliers, Jacqueline; Weil, Dominique; Petit, Christine] Inst Pasteur Paris, Unite Genet & Physiol Audit, Paris, France; [McElreavey, Kenneth] Inst Pasteur Paris, Unite Genet Dev Humain, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Bordeaux; Universite de Tunis-El-Manar; Hopital La Rabta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Abdelhak, S (corresponding author), Inst Pasteur Tunis, Lab Genom Biomed & Oncogenet, Tunis, Tunisia.	sonia.abdelhak@pasteur.rns.tn	Bonnet, Crystel/AAN-5950-2021; Abdelhak, Sonia/L-2831-2013	Bonnet, Crystel/0000-0002-1916-9119; BOUYACOUB, Yosra/0000-0003-2423-199X; Jonard, Laurence/0000-0003-0369-0505; Abdelhak, Sonia/0000-0001-8466-5525; Petit, Christine/0000-0002-9069-002X	Tunisian Ministry of Public Health; Ministry of Higher Education and Scientific Research [LR11IPT05]; E.C. [295097]; BNP Paribas foundation	Tunisian Ministry of Public Health; Ministry of Higher Education and Scientific Research(Ministry of Higher Education & Scientific Research (MHESR)); E.C.(European CommissionEuropean Commission Joint Research Centre); BNP Paribas foundation	This work was supported by the Tunisian Ministry of Public Health, the Ministry of Higher Education and Scientific Research (LR11IPT05) and by the E.C. Grant agreement No 295097 for FP7 project GM-NCD-Inco and BNP Paribas foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2008, NAT GENET, V40, P1335, DOI 10.1038/ng.245; Belguith H, 2009, GENET TEST MOL BIOMA, V13, P147, DOI 10.1089/gtmb.2008.0077; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Ben Said M, 2010, GENET TEST MOL BIOMA, V14, P307, DOI 10.1089/gtmb.2009.0174; Bonnet C, 2013, GENE, V527, P537, DOI 10.1016/j.gene.2013.06.044; Charif M, 2012, MOL BIOL REP, V39, P11011, DOI 10.1007/s11033-012-2003-3; Delmaghani S, 2012, HUM MOL GENET, V21, P3835, DOI 10.1093/hmg/dds212; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Diaz-Horta O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050628; Du X, 2008, P NATL ACAD SCI USA, V105, P14609, DOI 10.1073/pnas.0807219105; Ishida S, 2013, NAT GENET, V45, P552, DOI 10.1038/ng.2601; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kitajiri SI, 2007, CLIN GENET, V72, P546, DOI 10.1111/j.1399-0004.2007.00895.x; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Riahi Z, 2013, INT J PEDIATR OTORHI, V77, P1485, DOI 10.1016/j.ijporl.2013.06.015; Riahi Z, 2013, INT J PEDIATR OTORHI, V77, P1481, DOI 10.1016/j.ijporl.2013.06.013; Riahi Z, 2013, GENE, V525, P1, DOI 10.1016/j.gene.2013.04.078; Romdhane L, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-52; Sirmaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032000; Sirmaci A, 2009, INT J PEDIATR OTORHI, V73, P699, DOI 10.1016/j.ijporl.2009.01.005; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Woo HM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-72; Yan D, 2013, GENET TEST MOL BIOMA, V17, P581, DOI 10.1089/gtmb.2012.0464; Yano T, 2013, J CLIN CASE REPORTS	25	20	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99797	10.1371/journal.pone.0099797	http://dx.doi.org/10.1371/journal.pone.0099797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926664	Green Submitted, Green Published, gold			2022-12-25	WOS:000338278100080
J	Wang, W; Ding, JH; Li, Y; Wang, CF; Zhou, LP; Zhu, H; Peng, WJ				Wang, Wei; Ding, Jianhui; Li, Yuan; Wang, Chaofu; Zhou, Liangping; Zhu, Hui; Peng, Weijun			Magnetic Resonance Imaging and Computed Tomography Characteristics of Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion	PLOS ONE			English	Article							MULTIPHASIC MULTIDETECTOR CT; OF-THE-LITERATURE; PATHOLOGICAL CORRELATION; HELICAL CT; ADULTS; NEOPLASMS; FEATURES; MASSES; DIFFERENTIATION; CLASSIFICATION	Purpose: To characterize Xp11.2 translocation renal cell carcinoma (RCC) using magnetic resonance imaging (MRI) and computed tomography (CT). Methods: This study retrospectively collected the MRI and CT data of twelve patients with Xp11.2 translocation RCC confirmed by pathology. Nine cases underwent dynamic contrast-enhanced MRI (DCE-MRI) and 6 cases underwent CT, of which 3 cases underwent MRI and CT simultaneously. The MRI and CT findings were analyzed in regard to tumor position, size, hemorrhagic, cystic or necrotic components, calcification, tumor density, signal intensity and enhancement features. Results: The age of the 12 patients ranged from 13 to 46 years (mean age: 23 years). T2WI revealed heterogeneous intensity, hyper-intensity, and slight hypo-intensity in 6 cases, 2 cases, and 1 case, respectively. On DCE-MR images, mild, moderate, and marked rim enhancement of the tumor in the corticomedullary phase (CMP) were observed in 1, 6, and 2 cases, respectively. The tumor parenchyma showed iso-attenuation (n = 4) or slight hyper-attenuation (n = 1) compared to the normal renal cortex on non-contrast CT images. Imaging findings were suggestive of hemorrhage (n = 4) or necrosis (n = 8) in the tumors, and there was evidence of calcification in 8 cases by CT (n = 3) and pathology (n = 8). On dynamic contrast-enhanced CT images, 3 cases and 1 case manifested moderate and strong CMP enhancement, respectively. Nine tumors by MRI and 4 tumors by CT showed prolonged enhancement. Three neoplasms presented at stage I, 2 at stage II, 3 at stage III, and 4 at stage IV according the 2010 AJCC staging criteria. Conclusions: XP11.2 translocation RCC should be considered when a child or young adult patient presents with a renal tumor with heterogeneous features such as hemorrhage, necrosis, cystic changes, and calcification on CT and MRI and/or is accompanied by metastatic evidence.	[Wang, Wei; Ding, Jianhui; Zhou, Liangping; Zhu, Hui; Peng, Weijun] Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai 200433, Peoples R China; [Wang, Wei; Ding, Jianhui; Li, Yuan; Wang, Chaofu; Zhou, Liangping; Zhu, Hui; Peng, Weijun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Li, Yuan; Wang, Chaofu] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Peng, WJ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai 200433, Peoples R China.	pengweijun601@163.com	Wang, Chao/GXF-8353-2022	Li, Yuan/0000-0001-5651-819X				Altinok G, 2005, PEDIATR DEVEL PATHOL, V8, P168, DOI 10.1007/s10024-004-9106-3; Amin MB, 2008, AM J SURG PATHOL, V32, P1822, DOI 10.1097/PAS.0b013e3181831e68; Aoyagi T, 2011, UROL INT, V86, P487, DOI 10.1159/000323866; Argani P, 2005, AM J SURG PATHOL, V29, P230, DOI 10.1097/01.pas.0000146007.54092.37; Argani P, 2005, CLIN LAB MED, V25, P363, DOI 10.1016/j.cll.2005.01.008; Argani P, 2003, ADV ANAT PATHOL, V10, P243, DOI 10.1097/00125480-200309000-00001; Argani P, 2003, ONCOGENE, V22, P5374, DOI 10.1038/sj.onc.1206686; Argani P, 2003, AM J SURG PATHOL, V27, P750, DOI 10.1097/00000478-200306000-00005; Argani P, 2001, AM J PATHOL, V159, P179, DOI 10.1016/S0002-9440(10)61684-7; Argani P, 2007, AM J SURG PATHOL, V31, P1149, DOI 10.1097/PAS.0b013e318031ffff; Argani P, 2006, AM J CLIN PATHOL, V126, P332, DOI 10.1309/EAEJTJGD5J4JB4F; Armah HB, 2008, PATHOLOGY, V40, P306, DOI 10.1080/00313020701816373; Armah HB, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-15; Camparo P, 2008, AM J SURG PATHOL, V32, P656, DOI 10.1097/PAS.0b013e3181609914; Dang TT, 2012, J COMPUT ASSIST TOMO, V36, P669, DOI 10.1097/RCT.0b013e3182680182; Delahunt B, 2001, HUM PATHOL, V32, P590, DOI 10.1053/hupa.2001.24984; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Vera-Badillo FE, 2012, INT J UROL, V19, P894, DOI 10.1111/j.1442-2042.2012.03079.x; Eren S, 2006, EUR J RADIOL, V59, P93, DOI 10.1016/j.ejrad.2006.01.003; Fujimoto H, 1999, JPN J CLIN ONCOL, V29, P198, DOI 10.1093/jjco/29.4.198; Herts BR, 2002, AM J ROENTGENOL, V178, P367, DOI 10.2214/ajr.178.2.1780367; Kato H, 2011, J MAGN RESON IMAGING, V33, P217, DOI 10.1002/jmri.22392; Kim JK, 2004, RADIOLOGY, V230, P677, DOI 10.1148/radiol.2303030003; Kondo T, 2004, INT J UROL, V11, P817, DOI 10.1111/j.1442-2042.2004.00907.x; Koo HJ, 2013, ACTA RADIOL, V54, P827, DOI 10.1177/0284185113484019; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Meyer PN, 2007, AM J CLIN PATHOL, V128, P70, DOI 10.1309/LR5G1VMXPY3G0CUK; Pedrosa I, 2008, RADIOGRAPHICS, V28, P985, DOI 10.1148/rg.284065018; Pedrosa I, 2008, EUR RADIOL, V18, P365, DOI 10.1007/s00330-007-0757-0; Rao Q, 2011, INT J SURG PATHOL, V19, P170, DOI 10.1177/1066896909354337; Rini BI, 2009, J CLIN ONCOL, V27, P4462, DOI 10.1200/JCO.2008.21.7034; Salles Paulo G. O., 2005, Int. braz j urol., V31, P251, DOI 10.1590/S1677-55382005000300009; Sasaguri K, 2010, JPN J RADIOL, V28, P453, DOI 10.1007/s11604-010-0450-0; Sasiwimonphan K, 2012, RADIOLOGY, V263, P160, DOI 10.1148/radiol.12111205; Sauk SC, 2011, RADIOLOGY, V261, P854, DOI 10.1148/radiol.11101508; Silverman SG, 2007, RADIOGRAPHICS, V27, P1131, DOI 10.1148/rg.274065147; STUDER UE, 1990, J UROLOGY, V144, P243, DOI 10.1016/S0022-5347(17)39422-3; SUSSMAN SK, 1990, RADIOLOGY, V177, P495, DOI 10.1148/radiology.177.2.2217790; Suzigan S, 2007, INT J SURG PATHOL, V15, P199, DOI 10.1177/1066896906295891; Winarti NW, 2008, INT J SURG PATHOL, V16, P66, DOI 10.1177/1066896907304994; Wu A, 2008, HISTOPATHOLOGY, V53, P533, DOI 10.1111/j.1365-2559.2008.03151.x; Yoshimitsu Kengo, 2004, Radiat Med, V22, P371; Young JR, 2013, RADIOLOGY, V267, P444, DOI 10.1148/radiol.13112617; Zhu QQ, 2013, ACTA RADIOL, V54, P355, DOI 10.1258/ar.2012.120255	44	24	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99990	10.1371/journal.pone.0099990	http://dx.doi.org/10.1371/journal.pone.0099990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926688	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100104
J	Chawes, BL; Bonnelykke, K; Jensen, PF; Schoos, AMM; Heickendorff, L; Bisgaard, H				Chawes, Bo L.; Bonnelykke, Klaus; Jensen, Pia F.; Schoos, Ann-Marie M.; Heickendorff, Lene; Bisgaard, Hans			Cord Blood 25(OH)-Vitamin D Deficiency and Childhood Asthma, Allergy and Eczema: The COPSAC(2000) Birth Cohort Study	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; BACTERIAL-COLONIZATION; NONALLERGIC RHINITIS; YOUNG-CHILDREN; RISK; INFANTS; PREGNANCY; WHEEZE; FOOD; SENSITIZATION	Background: Epidemiological studies have suggested an association between maternal vitamin D dietary intake during pregnancy and risk of asthma and allergy in the offspring. However, prospective clinical studies on vitamin D measured in cord blood and development of clinical end-points are sparse. Objective: To investigate the interdependence of cord blood 25-hydroxyvitamin D (25(OH)-Vitamin D) level and investigator-diagnosed asthma-and allergy-related conditions during preschool-age. Methods: Cord blood 25(OH)-Vitamin D level was measured in 257 children from the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC(2000)) at-risk mother-child cohort. Troublesome lung symptoms (TROLS), asthma, respiratory infections, allergic rhinitis, and eczema, at age 0-7 yrs were diagnosed exclusively by the COPSAC pediatricians strictly adhering to predefined algorithms. Objective assessments of lung function and sensitization were performed repeatedly from birth. Results: After adjusting for season of birth, deficient cord blood 25(OH)-Vitamin D level (<50 nmol/L) was associated with a 2.7-fold increased risk of recurrent TROLS (HR = 2.65; 95% CI = 1.02-6.86), but showed no association with respiratory infections or asthma. We saw no association between cord blood 25(OH)-Vitamin D level and lung function, sensitization, rhinitis or eczema. The effects were unaffected from adjusting for multiple lifestyle factors. Conclusion: Cord blood 25(OH)-Vitamin D deficiency associated with increased risk of recurrent TROLS till age 7 years. Randomized controlled trials of vitamin D supplementation during pregnancy are needed to prove causality.	[Chawes, Bo L.; Bonnelykke, Klaus; Jensen, Pia F.; Schoos, Ann-Marie M.; Bisgaard, Hans] Univ Copenhagen, Danish Pediat Asthma Ctr, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, Gentofte, Denmark; [Heickendorff, Lene] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark	University of Copenhagen; Aarhus University	Bisgaard, H (corresponding author), Univ Copenhagen, Danish Pediat Asthma Ctr, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, Gentofte, Denmark.	bisgaard@copsac.com	Schoos, Ann-Marie Malby/AAO-7677-2020; Bisgaard, Hans/N-4761-2016	Schoos, Ann-Marie Malby/0000-0002-5827-0885; Bisgaard, Hans/0000-0003-4131-7592; Bonnelykke, Klaus/0000-0003-2003-1018; Chawes, Bo/0000-0001-6846-6243	private and public research funds; Lundbeck Foundation; Danish Strategic Research Council; Pharmacy Foundation of 1991; Augustinus Foundation; Danish Medical Research Council; Lundbeck Foundation [R16-2007-1694] Funding Source: researchfish	private and public research funds; Lundbeck Foundation(Lundbeckfonden); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Pharmacy Foundation of 1991; Augustinus Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	COPSAC is funded by private and public research funds listed on www.copsac.com. The Lundbeck Foundation; The Danish Strategic Research Council; the Pharmacy Foundation of 1991; Augustinus Foundation; the Danish Medical Research Council and The Danish Pediatric Asthma Centre provided the core support for COPSAC research center. No pharmaceutical company was involved in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiz N., 2013, J ALLERGY CLIN IMMUN; Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2011, J ALLERGY CLIN IMMUN; Bisgaard H, 2012, AM J RESP CRIT CARE; Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2009, AM J RESP CRIT CARE, V179, P179, DOI 10.1164/rccm.200809-1436OC; BraunFahrlander C, 1997, PEDIATR ALLERGY IMMU, V8, P75, DOI 10.1111/j.1399-3038.1997.tb00147.x; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Chawes BLK, 2009, ALLERGY, V64, P1547, DOI 10.1111/j.1398-9995.2009.02085.x; Chawes BLK, 2012, J ALLERGY CLIN IMMUN, V130, P354, DOI 10.1016/j.jaci.2012.04.045; Chawes BLK, 2010, AM J RESP CRIT CARE, V182, P138, DOI 10.1164/rccm.200909-1377OC; Chawes BLK, 2010, J ALLERGY CLIN IMMUN, V126, P567, DOI 10.1016/j.jaci.2010.06.026; Chawes BLK, 2010, CHEST, V137, P1332, DOI 10.1378/chest.09-2601; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Halkjaer LB, 2006, ARCH DERMATOL, V142, P561, DOI 10.1001/archderm.142.5.561; Hojskov CS, 2010, CLIN CHIM ACTA, V411, P114, DOI 10.1016/j.cca.2009.10.010; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollams EM, 2012, CURR OPIN ALLERGY CL, V12, P228, DOI 10.1097/ACI.0b013e3283534a32; Jones AP, 2012, PEDIATRICS, V130, pE1128, DOI 10.1542/peds.2012-1172; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Litonjua AA, 2009, CURR OPIN ALLERGY CL, V9, P202, DOI 10.1097/ACI.0b013e32832b36cd; Liu X, 2013, PEDIATR RES, V74, P321, DOI 10.1038/pr.2013.110; Loland L, 2006, CHEST, V129, P669, DOI 10.1378/chest.129.3.669; Loland L, 2008, CHEST, V133, P115, DOI 10.1378/chest.07-1328; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; Miyake Y, 2010, EUR RESPIR J, V35, P1228, DOI 10.1183/09031936.00100609; Morales E, 2012, EPIDEMIOLOGY, V23, P64, DOI 10.1097/EDE.0b013e31823a44d3; Sichert-Hellert W, 2006, J NUTR, V136, P1329, DOI 10.1093/jn/136.5.1329; Sorensen M, 2007, BIOMARKERS, V12, P38, DOI 10.1080/13547500600943148; Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC; Wickman M, 2003, PEDIATR ALLERGY IMMU, V14, P441, DOI 10.1046/j.0905-6157.2003.00079.x; Wjst M, 2006, PEDIAT ALLERG IMM-UK, V17, P477, DOI 10.1111/j.1399-3038.2006.00456.x; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	39	77	81	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99856	10.1371/journal.pone.0099856	http://dx.doi.org/10.1371/journal.pone.0099856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925304	Green Submitted, Green Published, gold			2022-12-25	WOS:000338701300101
J	Shapovalov, MV; Wang, Q; Xu, QF; Andrake, M; Dunbrack, RL				Shapovalov, Maxim V.; Wang, Qiang; Xu, Qifang; Andrake, Mark; Dunbrack, Roland L., Jr.			BioAssemblyModeler (BAM): User-Friendly Homology Modeling of Protein Homo- and Heterooligomers	PLOS ONE			English	Article							PREDICTION; DATABASE; PISCES; SERVER	Many if not most proteins function in oligomeric assemblies of one or more protein sequences. The Protein Data Bank provides coordinates for biological assemblies for each entry, at least 60% of which are dimers or larger assemblies. BioAssemblyModeler (BAM) is a graphical user interface to the basic steps in homology modeling of protein homooligomers and heterooligomers from the biological assemblies provided in the PDB. BAM takes as input up to six different protein sequences and begins by assigning Pfam domains to the target sequences. The program utilizes a complete assignment of Pfam domains to sequences in the PDB, PDBfam (http://dunbrack2.fccc.edu/protcid/pdbfam), to obtain templates that contain any or all of the domains assigned to the target sequence(s). The contents of the biological assemblies of potential templates are provided, and alignments of the target sequences to the templates are produced with a profile-profile alignment algorithm. BAM provides for visual examination and mouse-editing of the alignments supported by target and template secondary structure information and a 3D viewer of the template biological assembly. Side-chain coordinates for a model of the biological assembly are built with the program SCWRL4. A built-in protocol navigation system guides the user through all stages of homology modeling from input sequences to a three-dimensional model of the target complex.	[Shapovalov, Maxim V.; Wang, Qiang; Xu, Qifang; Andrake, Mark; Dunbrack, Roland L., Jr.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Dunbrack, RL (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Roland.Dunbrack@fccc.edu	Dunbrack, Roland/ABG-7141-2020	Dunbrack, Roland/0000-0001-7674-6667	National Institutes of Health [R01 GM084453]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant R01 GM084453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Fukuhara N, 2008, NUCLEIC ACIDS RES, V36, pW185, DOI 10.1093/nar/gkn218; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hamp T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002623; Kittichotirat W, 2009, NUCLEIC ACIDS RES, V37, pW519, DOI 10.1093/nar/gkp306; Koh GCKW, 2012, J PROTEOME RES, V11, P2014, DOI 10.1021/pr201211w; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kundrotas PJ, 2012, P NATL ACAD SCI USA, V109, P9438, DOI 10.1073/pnas.1200678109; Li CQ, 2010, MOL CELL BIOL, V30, P116, DOI 10.1128/MCB.01876-08; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]; Mukherjee S, 2011, STRUCTURE, V19, P955, DOI 10.1016/j.str.2011.04.006; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Roberts JL, 2012, P NATL ACAD SCI USA, V109, P10456, DOI 10.1073/pnas.1202249109; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Soding J, 2011, CURR OPIN STRUC BIOL, V21, P404, DOI 10.1016/j.sbi.2011.03.005; TRAUT TW, 1994, CRIT REV BIOCHEM MOL, V29, P125, DOI 10.3109/10409239409086799; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang GL, 2004, PROTEIN SCI, V13, P1612, DOI 10.1110/ps.03601504; Wei Q, 2013, PROTEINS, V81, P199, DOI 10.1002/prot.24176; Wei QO, 2010, PROTEINS, V78, P2058, DOI 10.1002/prot.22722; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Xu QF, 2006, BIOINFORMATICS, V22, P2876, DOI 10.1093/bioinformatics/btl490; Xu QF, 2012, BIOINFORMATICS, V28, P2763, DOI 10.1093/bioinformatics/bts533; Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086	29	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98309	10.1371/journal.pone.0098309	http://dx.doi.org/10.1371/journal.pone.0098309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922057	Green Submitted, Green Published, gold			2022-12-25	WOS:000338701300007
J	Tao, DD; Deng, R; Jiang, Y; Galvin, JJ; Fu, QJ; Chen, B				Tao, Duoduo; Deng, Rui; Jiang, Ye; Galvin, John J., III; Fu, Qian-Jie; Chen, Bing			Contribution of Auditory Working Memory to Speech Understanding in Mandarin-Speaking Cochlear Implant Users	PLOS ONE			English	Article							SHORT-TERM-MEMORY; OF-THE-LITERATURE; CLINICAL EFFECTIVENESS; NORMAL-HEARING; DEAF-CHILDREN; DIGIT SPAN; LANGUAGE; RECOGNITION; PERFORMANCE; VOCABULARY	Purpose: To investigate how auditory working memory relates to speech perception performance by Mandarin-speaking cochlear implant (CI) users. Method: Auditory working memory and speech perception was measured in Mandarin-speaking CI and normal-hearing (NH) participants. Working memory capacity was measured using forward digit span and backward digit span; working memory efficiency was measured using articulation rate. Speech perception was assessed with: (a) word-in-sentence recognition in quiet, (b) word-in-sentence recognition in speech-shaped steady noise at +5 dB signal-to-noise ratio, (c) Chinese disyllable recognition in quiet, (d) Chinese lexical tone recognition in quiet. Self-reported school rank was also collected regarding performance in schoolwork. Results: There was large inter-subject variability in auditory working memory and speech performance for CI participants. Working memory and speech performance were significantly poorer for CI than for NH participants. All three working memory measures were strongly correlated with each other for both CI and NH participants. Partial correlation analyses were performed on the CI data while controlling for demographic variables. Working memory efficiency was significantly correlated only with sentence recognition in quiet when working memory capacity was partialled out. Working memory capacity was correlated with disyllable recognition and school rank when efficiency was partialled out. There was no correlation between working memory and lexical tone recognition in the present CI participants. Conclusions: Mandarin-speaking CI users experience significant deficits in auditory working memory and speech performance compared with NH listeners. The present data suggest that auditory working memory may contribute to CI users' difficulties in speech understanding. The present pattern of results with Mandarin-speaking CI users is consistent with previous auditory working memory studies with English-speaking CI users, suggesting that the lexical importance of voice pitch cues (albeit poorly coded by the CI) did not influence the relationship between working memory and speech perception.	[Tao, Duoduo; Deng, Rui; Jiang, Ye; Fu, Qian-Jie; Chen, Bing] Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otol & Skull Base Surg, Shanghai 200433, Peoples R China; [Tao, Duoduo; Galvin, John J., III; Fu, Qian-Jie] House Res Inst, Div Commun & Auditory Neurosci, Los Angeles, CA USA; [Galvin, John J., III; Fu, Qian-Jie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA	Fudan University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chen, B (corresponding author), Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otol & Skull Base Surg, Shanghai 200433, Peoples R China.	entdtao@gmail.com			Special Fund for Projects of Ministry of Health of China [201202005]; National Nature Science Foundation of China [81371087]; Shanghai Science and Technology Commission Medical Guide Project [134119a1800]; National Institutes of Health (NIH) [R01-DC004993]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004993] Funding Source: NIH RePORTER	Special Fund for Projects of Ministry of Health of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission Medical Guide Project; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded in part by the Special Fund for Projects of Ministry of Health of China (#201202005), the National Nature Science Foundation of China (#81371087), Shanghai Science and Technology Commission Medical Guide Project (#134119a1800), and by National Institutes of Health (NIH) grant R01-DC004993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2000, INT J LANG COMM DIS, V35, P95; Alloway TP, 2006, CHILD DEV, V77, P1698, DOI 10.1111/j.1467-8624.2006.00968.x; Alloway TP, 2009, CHILD DEV, V80, P606, DOI 10.1111/j.1467-8624.2009.01282.x; Andersson U, 2008, BRIT J EDUC PSYCHOL, V78, P181, DOI 10.1348/000709907X209854; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Berrettini S, 2011, ACTA OTORHINOLARYNGO, V31, P299; Bodmer D, 2007, LARYNGOSCOPE, V117, P1408, DOI 10.1097/MLG.0b013e318068b57e; Bruce I A, 2011, Cochlear Implants Int, V12 Suppl 1, pS82, DOI 10.1179/146701011X13001035752886; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Burkholder R, 2004, INT CONGR SER, V1273, P312, DOI 10.1016/j.ics.2004.08.030; Caplan D, 2013, PSYCHON B REV, V20, P243, DOI 10.3758/s13423-012-0369-9; Cleary M, 2000, VOLTA REV, V102, P259; Cowan N, 1998, J EXP PSYCHOL GEN, V127, P141, DOI 10.1037/0096-3445.127.2.141; Diller Gottfried, 2010, Cochlear Implants Int, V11 Suppl 1, P286, DOI 10.1179/146701010X12671177989273; Forli F, 2011, ACTA OTORHINOLARYNGO, V31, P281; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2011, J ACOUST SOC AM, V129, pEL267, DOI 10.1121/1.3590739; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 1997, DEV PSYCHOL, V33, P966, DOI 10.1037/0012-1649.33.6.966; Geers AE, 2013, OTOL NEUROTOL, V34, P396, DOI 10.1097/MAO.0b013e318277a0cb; Gupta P, 1997, BRAIN LANG, V59, P267, DOI 10.1006/brln.1997.1819; Harris MS, 2013, EAR HEARING, V34, P179, DOI 10.1097/AUD.0b013e318269ce50; Kronenberger WG, 2012, J SPEECH LANG HEAR R; Kronenberger WG, 2013, J SPEECH LANG HEAR R, V56, P805, DOI 10.1044/1092-4388(2012/11-0356); Lee CY, 2010, J ACOUST SOC AM, V127, P481, DOI 10.1121/1.3266683; Lenarz M, 2012, LARYNGOSCOPE, V122, P1361, DOI 10.1002/lary.23232; MCGARR NS, 1983, J SPEECH HEAR RES, V26, P451, DOI 10.1044/jshr.2603.451; Niparko JK, 2003, MENT RETARD DEV D R, V9, P267, DOI 10.1002/mrdd.10089; Nittrouer S, 2013, INT J PEDIATR OTORHI, V77, P1886, DOI 10.1016/j.ijporl.2013.09.001; Oba SI, 2013, J REHABIL RES DEV, V50, P99, DOI 10.1682/JRRD.2011.12.0229; Pickering SJ, 2001, MEMORY, V9, P423, DOI 10.1080/09658210143000182; Pisoni David B, 2011, Ear Hear, V32, p60S, DOI 10.1097/AUD.0b013e3181ffd58e; Pisoni DB, 2000, EAR HEARING, V21, P70, DOI 10.1097/00003446-200002000-00010; Pisoni DB, 2003, EAR HEARING, V24, p106S, DOI 10.1097/01.AUD.0000051692.05140.8E; Pisoni DB, 2000, ANN OTO RHINOL LARYN, V109, P92, DOI 10.1177/0003489400109S1240; Santarelli R, 2008, AUDIOL NEURO-OTOL, V13, P257, DOI 10.1159/000115435; Semenov YR, 2012, OTOLARYNG CLIN N AM, V45, P959, DOI 10.1016/j.otc.2012.06.003; Smyth MM, 1996, BRIT J PSYCHOL, V87, P179, DOI 10.1111/j.2044-8295.1996.tb02584.x; Stiles DJ, 2012, J SPEECH LANG HEAR R, V55, P154, DOI 10.1044/1092-4388(2011/11-0021); Wang RH, 1993, STANDARD CHINESE DAT; Watson DR, 2007, AUDIOL NEURO-OTOL, V12, P65, DOI 10.1159/000097793; Zhu MM, 2012, ACTA OTO-LARYNGOL, V132, P855, DOI 10.3109/00016489.2011.653668	44	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99096	10.1371/journal.pone.0099096	http://dx.doi.org/10.1371/journal.pone.0099096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24921934	gold, Green Published, Green Submitted			2022-12-25	WOS:000338701300027
J	Zenzeri, J; De Santis, D; Morasso, P				Zenzeri, Jacopo; De Santis, Dalia; Morasso, Pietro			Strategy Switching in the Stabilization of Unstable Dynamics	PLOS ONE			English	Article							MULTIJOINT ARM; MOTOR MEMORY; BODY SCHEMA; INVERTED PENDULUM; ANKLE STIFFNESS; SYSTEM; INSTABILITY; ADAPTATION; STABILITY; MOVEMENTS	In order to understand mechanisms of strategy switching in the stabilization of unstable dynamics, this work investigates how human subjects learn to become skilled users of an underactuated bimanual tool in an unstable environment. The tool, which consists of a mass and two hand-held non-linear springs, is affected by a saddle-like force-field. The non-linearity of the springs allows the users to determine size and orientation of the tool stiffness ellipse, by using different patterns of bimanual coordination: minimal stiffness occurs when the two spring terminals are aligned and stiffness size grows by stretching them apart. Tool parameters were set such that minimal stiffness is insufficient to provide stable equilibrium whereas asymptotic stability can be achieved with sufficient stretching, although at the expense of greater effort. As a consequence, tool users have two possible strategies for stabilizing the mass in different regions of the workspace: 1) high stiffness feedforward strategy, aiming at asymptotic stability and 2) low stiffness positional feedback strategy aiming at bounded stability. The tool was simulated by a bimanual haptic robot with direct torque control of the motors. In a previous study we analyzed the behavior of naive users and we found that they spontaneously clustered into two groups of approximately equal size. In this study we trained subjects to become expert users of both strategies in a discrete reaching task. Then we tested generalization capabilities and mechanism of strategy-switching by means of stabilization tasks which consist of tracking moving targets in the workspace. The uniqueness of the experimental setup is that it addresses the general problem of strategy-switching in an unstable environment, suggesting that complex behaviors cannot be explained in terms of a global optimization criterion but rather require the ability to switch between different sub-optimal mechanisms.	[Zenzeri, Jacopo; De Santis, Dalia; Morasso, Pietro] Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Zenzeri, J (corresponding author), Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Genoa, Italy.	jacopo.zenzeri@iit.it	Zenzeri, Jacopo/X-5206-2019	Zenzeri, Jacopo/0000-0001-5536-1960	RBCS Dept. of the Istituto Italiano di Tecnologia; ACIRAS (Ausili CIbernetici Riabilitativi per la diagnosi e la valutazione quantitativa della disabilita motoria dell'Arto Superiore nei bambini e negli adulti) Project; Regione Liguria; DARWIN EU Project [FP7-270138]	RBCS Dept. of the Istituto Italiano di Tecnologia; ACIRAS (Ausili CIbernetici Riabilitativi per la diagnosi e la valutazione quantitativa della disabilita motoria dell'Arto Superiore nei bambini e negli adulti) Project; Regione Liguria(Regione Liguria); DARWIN EU Project	This research was supported by the RBCS Dept. of the Istituto Italiano di Tecnologia, ACIRAS (Ausili CIbernetici Riabilitativi per la diagnosi e la valutazione quantitativa della disabilita motoria dell'Arto Superiore nei bambini e negli adulti) Project, Regione Liguria, and DARWIN EU Project (Grant No: FP7-270138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Berniker M, 2014, J NEUROPHYSIOL, V111, P1165, DOI 10.1152/jn.00493.2013; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; Casadio Maura, 2006, Technol Health Care, V14, P123; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; De Santis D, 2013, ADV INTELL SYST, V196, P109; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Gomi H, 1998, J NEUROSCI, V18, P8965; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; Hamilton AFD, 2004, EXP BRAIN RES, V157, P417, DOI 10.1007/s00221-004-1856-7; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Howard IS, 2010, J NEUROPHYSIOL, V104, P2082, DOI 10.1152/jn.00299.2010; Iriki A, 1996, NEUROREPORT, V7, P2325; Karniel A, 2002, EXP BRAIN RES, V143, P520, DOI 10.1007/s00221-002-1054-4; Lakie M, 2003, J PHYSIOL-LONDON, V551, P357, DOI 10.1113/jphysiol.2002.036939; Loram ID, 2007, J PHYSIOL-LONDON, V584, P661, DOI 10.1113/jphysiol.2007.140046; Loram ID, 2011, J PHYSIOL-LONDON, V589, P307, DOI 10.1113/jphysiol.2010.194712; Loram ID, 2002, J PHYSIOL-LONDON, V545, P1041, DOI 10.1113/jphysiol.2002.025049; Malfait N, 2002, J NEUROSCI, V22, P9656; Malfait N, 2005, J NEUROPHYSIOL, V93, P3327, DOI 10.1152/jn.00883.2004; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Mattar AAG, 2007, J NEUROPHYSIOL, V97, P220, DOI 10.1152/jn.00736.2006; McIntyre J, 1996, EXP BRAIN RES, V110, P248; Milner TE, 1998, IEEE T BIO-MED ENG, V45, P1363, DOI 10.1109/10.725333; Milton J, 2009, PHILOS T R SOC A, V367, P1181, DOI 10.1098/rsta.2008.0257; Mohan V, 2011, FRONTIERS NEUROROBOT, V5, P1, DOI DOI 10.3389/FNB0T.2011.00004); Morasso P., 2013, INT J MACH CONSCIOUS, V05, P75, DOI [10.1142/S1793843013400064, DOI 10.1142/S1793843013400064]; Perreault EJ, 2004, EXP BRAIN RES, V157, P507, DOI 10.1007/s00221-004-1864-7; Saha DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030301; Selen LPJ, 2009, J NEUROSCI, V29, P12606, DOI 10.1523/JNEUROSCI.2826-09.2009; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shadmehr R, 2000, J NEUROSCI, V20, P7807; Visalberghi E, 1998, BEHAV PROCESS, V42, P189, DOI 10.1016/S0376-6357(97)00076-4; VISALBERGHI E, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P138; Visalberghi Elisabetta, 1996, P57; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Zenzeri J, 2011, IEEE ENG MED BIO, P3115, DOI 10.1109/IEMBS.2011.6090850	46	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99087	10.1371/journal.pone.0099087	http://dx.doi.org/10.1371/journal.pone.0099087			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921254	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300025
J	Buj, I; Sanda, R; Marcic, Z; Caleta, M; Mrakovcic, M				Buj, Ivana; Sanda, Radek; Marcic, Zoran; Caleta, Marko; Mrakovcic, Milorad			Combining Morphology and Genetics in Resolving Taxonomy-A Systematic Revision of Spined Loaches (Genus Cobitis; Cypriniformes, Actinopterygii) in the Adriatic Watershed	PLOS ONE			English	Article							DNA-SEQUENCE DATA; PHYLOGENETIC-RELATIONSHIPS; EVOLUTIONARY HISTORY; STATISTICAL-METHOD; TELEOSTEI; DIVERSITY; MODEL; COALESCENT; PISCES; POPULATIONS	Taxonomic investigation of spined loaches from Dalmatia and Herzegovina was conducted on specimens from 14 localities. The results of the detailed morphological investigations were combined with genetic data (based on one mitochondrial and two nuclear genes) in order to resolve the taxonomic status of each Cobitis population. Among the investigated features of external morphology, the appearance of spots on the caudal fin base turned out to have the greatest diagnostic value. Furthermore, the number of branched fin rays enabled the discrimination of several species. No morphometric character alone could ensure determination of any Cobitis species. Nevertheless, groups of populations that are more similar in their body shapes correspond to mitochondrial phylogenetic lineages. Based on molecular genetic markers, Dalmatian and Herzegovinian spined loaches form independent lineages inside the Adriatic phylogenetic group. Mitochondrial DNA phylogenetic reconstruction revealed six monophyletic lineages, corresponding to six species distributed in the investigated area. The population distributed in Mostarsko blato karstic field in Bosnia and Herzegovina is described as a new species based on a unique combination of morphological characters: a single triangular Canestrini scale; usually 5(1)/(2) branched anal fin rays, 6(1)/(2) branched dorsal fin rays, 14 branched caudal fin rays; no spots in the surface pigmentation layer on the caudal fin base; scales on the body very small.	[Buj, Ivana; Marcic, Zoran; Mrakovcic, Milorad] Univ Zagreb, Fac Sci, Dept Zool, Zagreb 41000, Croatia; [Sanda, Radek] Natl Museum, Prague, Czech Republic; [Caleta, Marko] Univ Zagreb, Fac Teacher Educ, Zagreb 41000, Croatia	University of Zagreb; National Museum; University of Zagreb	Buj, I (corresponding author), Univ Zagreb, Fac Sci, Dept Zool, Zagreb 41000, Croatia.	ivaradic@biol.pmf.hr	Ćaleta, Marko/AGT-7655-2022	Ćaleta, Marko/0000-0002-4675-556X	Croatian Ministry of Science, Education and Sport [119-1782739-1233, 119-0000000-3184]; Czech Ministry of Culture [DF12P01OVV021]	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); Czech Ministry of Culture	This investigation was supported by the Croatian Ministry of Science, Education and Sport (project nos. 119-1782739-1233 and 119-0000000-3184) and by the Czech Ministry of Culture (project no. DF12P01OVV021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banarescu P., 1998, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V100, P405; Bernardi G, 2013, MOL ECOL, V22, P5487, DOI 10.1111/mec.12494; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bogutskaya N. G., 1999, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V101, P509; Bohlen J, 2006, MOL PHYLOGENET EVOL, V39, P552, DOI 10.1016/j.ympev.2005.12.007; Boron A, 2003, FOLIA BIOL-KRAKOW, V51, P49; Buj I, 2008, FOLIA ZOOL, V57, P71; Buj I, 2008, FOLIA ZOOL, V57, P100; Carstens BC, 2007, MOL ECOL, V16, P619, DOI 10.1111/j.1365-294X.2006.03167.x; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Chen X, 2014, MOL PHYLOGENET EVOL, V70, P130, DOI 10.1016/j.ympev.2013.09.003; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Doadrio I, 2005, MOL PHYLOGENET EVOL, V37, P484, DOI 10.1016/j.ympev.2005.07.009; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; ELLIOTT NG, 1995, J FISH BIOL, V46, P202, DOI 10.1111/j.1095-8649.1995.tb05962.x; Freyhof J, 2007, ICHTHYOL EXPLOR FRES, V18, P269; FU YX, 1993, GENETICS, V133, P693; Gambetta L., 1934, Bollettino dei Musei di Zoologia e di Anatomia Comparata Torino, V44, P297; Gamble T, 2008, MOL PHYLOGENET EVOL, V48, P112, DOI 10.1016/j.ympev.2008.03.015; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; Hey J, 1997, GENETICS, V145, P833; Hrbek T, 2004, MOL PHYLOGENET EVOL, V32, P297, DOI 10.1016/j.ympev.2003.12.017; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Janko K, 2005, FOLIA ZOOL, V54, P405; Karaman S, 1928, GLASNIK SKOPSKOG NAU, V6, P163; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Kottelat M, 2007, HDB EUROPEAN FRESHWA; Kottelat M, 2012, RAFFLES B ZOOL, P1; Kotusz J, 2000, FOLIA ZOOL, V49, P219; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Li WLS, 2012, MOL BIOL EVOL, V29, P751, DOI 10.1093/molbev/msr232; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Markova S, 2010, MOL PHYLOGENET EVOL, V55, P488, DOI 10.1016/j.ympev.2010.01.030; Mrakovic M., 2006, RED BOOK FRESHWATER; Mustafic P, 2008, FOLIA ZOOL, V57, P4; Perdices A, 2005, MOL PHYLOGENET EVOL, V37, P460, DOI 10.1016/j.ympev.2005.01.020; Perdices A, 2001, MOL PHYLOGENET EVOL, V19, P468, DOI 10.1006/mpev.2000.0900; Perdices A, 2008, MOL PHYLOGENET EVOL, V46, P382, DOI 10.1016/j.ympev.2007.05.007; Perea S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-265; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rab P, 2000, FOLIA ZOOL, V49, P55; Rambaut A., 2007, TRACER V1 4; SAITOH K, 1987, JPN J ICHTHYOL, V34, P334; Sanda R, 2008, FOLIA ZOOL, V57, P20; Sanda R, 2008, FOLIA ZOOL, V57, P42; Schneider D, 2000, FOLIA ZOOL, V49, P159; Schneider D, 2000, FOLIA ZOOL, V49, P227; Schulter D, 1996, PHIL T R SOC LOND B, V351; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Slechtova V, 2007, MOL PHYLOGENET EVOL, V44, P1358, DOI 10.1016/j.ympev.2007.02.019; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor EB, 1999, REV FISH BIOL FISHER, V9, P299, DOI 10.1023/A:1008955229420; TEMPLETON AR, 1992, GENETICS, V132, P619; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turan C, 2004, ICES J MAR SCI, V61, P774, DOI 10.1016/j.icesjms.2004.05.001; Vasil'eva ED, 2000, FOLIA ZOOL, V49, P23; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085	65	31	35	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99833	10.1371/journal.pone.0099833	http://dx.doi.org/10.1371/journal.pone.0099833			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918426	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000119
J	Hendrickx, A; Pierrot, N; Tasiaux, B; Schakman, O; Kienlen-Campard, P; De Smet, C; Octave, JN				Hendrickx, Aurelie; Pierrot, Nathalie; Tasiaux, Bernadette; Schakman, Olivier; Kienlen-Campard, Pascal; De Smet, Charles; Octave, Jean-Noel			Epigenetic Regulations of Immediate Early Genes Expression Involved in Memory Formation by the Amyloid Precursor Protein of Alzheimer Disease	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HISTONE ACETYLATION; MICE LACKING; C-FOS; TRANSCRIPTION FACTORS; NERVOUS-SYSTEM; SPATIAL MEMORY; INTRACELLULAR DOMAIN	We previously demonstrated that APP epigenetically regulates Egr1 expression both in cultured neurons and in vivo. Since Egr1 is an immediate early gene involved in memory formation, we wondered whether other early genes involved in memory were regulated by APP and we studied molecular mechanisms involved. By comparing prefrontal (PF) cortex from wild type (APP+/+) and APP knockout mice (APP-/-), we observed that APP down regulates expression of four immediate early genes, Egr1, c-Fos, Bdnf and Arc. Down regulation of Egr1, c-Fos and Bdnf transcription resulted from a decreased enrichment of acetylated histone H4 on the corresponding gene promoter. Further characterization of H4 acetylation at Egr1 and c-Fos promoters revealed increased acetylation of H4K5 and H4K12 residues in APP-/- mice. Whereas APP affected Egr1 promoter activity by reducing access of the CREB transcription factor, its effect on c-Fos appeared to depend on increased recruitment of HDAC2 histone deacetylase to the gene promoter. The physiological relevance of the epigenetic regulation of Egr1 and c-Fos gene transcription by APP was further analyzed following exposure of mice to novelty. Although transcription of Egr1 and c-Fos was increased following exposure of APP+/+ mice to novelty, such an induction was not possible in APP2/2 mice with a high basal level of expression of these immediate early genes. Altogether, these results demonstrate that APP-mediated regulation of c-Fos and Egr1 by different epigenetic mechanisms is needed for their induction during exposure to novelty.	[Hendrickx, Aurelie; Pierrot, Nathalie; Tasiaux, Bernadette; Schakman, Olivier; Kienlen-Campard, Pascal; Octave, Jean-Noel] Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium; [De Smet, Charles] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Octave, JN (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium.	jean-noel.octave@uclouvain.be		Kienlen-Campard, Pascal/0000-0003-1086-2942	FRIA of the Belgian Fonds pour la Recherche Scientifique (FNRS-FRS); Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy; Belgian Fonds de la Recherche Scientifique Medicale; Fondation pour la Recherche sur la Maladie d'Alzheimer (SAOFRA); Programme d'excellence Marshall Diane convention	FRIA of the Belgian Fonds pour la Recherche Scientifique (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy(Belgian Federal Science Policy Office); Belgian Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fondation pour la Recherche sur la Maladie d'Alzheimer (SAOFRA); Programme d'excellence Marshall Diane convention	This work was supported by FRIA funding of the Belgian Fonds pour la Recherche Scientifique (FNRS-FRS), by Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy, The Belgian Fonds de la Recherche Scientifique Medicale, the Fondation pour la Recherche sur la Maladie d'Alzheimer (SAOFRA) and the Programme d'excellence Marshall Diane convention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Aydin D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-160; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Bertaina-Anglade V, 2000, EUR J NEUROSCI, V12, P3803, DOI 10.1046/j.1460-9568.2000.00258.x; Bousiges O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057816; Bousiges O, 2010, NEUROPSYCHOPHARMACOL, V35, P2521, DOI 10.1038/npp.2010.117; Bozon B, 2002, HIPPOCAMPUS, V12, P570, DOI 10.1002/hipo.10100; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cortes-Mendoza J, 2013, INT J DEV NEUROSCI, V31, P359, DOI 10.1016/j.ijdevneu.2013.04.003; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; DeVito LM, 2010, LEARN MEMORY, V17, P161, DOI 10.1101/lm.1685710; Dias R, 2002, BEHAV NEUROSCI, V116, P498, DOI 10.1037//0735-7044.116.3.498; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hendrickx A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074305; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Koppel I, 2013, NEUROPHARMACOLOGY, V75, P106, DOI 10.1016/j.neuropharm.2013.07.015; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lubin FD, 2011, NEUROSCIENTIST, V17, P616, DOI 10.1177/1073858411386967; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Peixoto L, 2013, NEUROPSYCHOPHARMACOL, V38, P62, DOI 10.1038/npp.2012.86; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Renaudineau S, 2009, P NATL ACAD SCI USA, V106, P11771, DOI 10.1073/pnas.0900484106; Reul JMHM, 2014, FRONT PSYCHIATRY, V5, DOI [10.3389/fpsyt.2014.00005, 10.3389/fpsyt.2004.0005]; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Rinaldi A, 2010, NEUROBIOL LEARN MEM, V94, P373, DOI 10.1016/j.nlm.2010.08.004; Rowe A, 2008, NEOPLASIA, V10, P1421, DOI 10.1593/neo.08850; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Russell DL, 2003, MOL ENDOCRINOL, V17, P520, DOI 10.1210/me.2002-0066; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Veyrac A, 2013, P NATL ACAD SCI USA, V110, P7062, DOI 10.1073/pnas.1220558110; Yochiy A, 2012, BEHAV NEUROSCI, V126, P826, DOI 10.1037/a0030721	56	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99467	10.1371/journal.pone.0099467	http://dx.doi.org/10.1371/journal.pone.0099467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919190	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000088
J	Jiang, WZ; Yang, B; Weeks, DP				Jiang, WenZhi; Yang, Bing; Weeks, Donald P.			Efficient CRISPR/Cas9-Mediated Gene Editing in Arabidopsis thaliana and Inheritance of Modified Genes in the T2 and T3 Generations	PLOS ONE			English	Article							TARGETED MUTAGENESIS; RNA; CRISPR; CAS9; NUCLEASES; MULTIPLEX; TALEN	The newly developed CRISPR/Cas9 system for targeted gene knockout or editing has recently been shown to function in plants in both transient expression systems as well as in primary T1 transgenic plants. However, stable transmission of genes modified by the Cas9/single guide RNA (sgRNA) system to the T2 generation and beyond has not been demonstrated. Here we provide extensive data demonstrating the efficiency of Cas9/sgRNA in causing modification of a chromosomally integrated target reporter gene during early development of transgenic Arabidopsis plants and inheritance of the modified gene in T2 and T3 progeny. Efficient conversion of a nonfunctional, out-of-frame GFP gene to a functional GFP gene was confirmed in T1 plants by the observation of green fluorescent signals in leaf tissues as well as the presence of mutagenized DNA sequences at the sgRNA target site within the GFP gene. All GFP-positive T1 transgenic plants and nearly all GFP-negative plants examined contained mutagenized GFP genes. Analyses of 42 individual T2 generation plants derived from 6 different T1 progenitor plants showed that 50% of T2 plants inherited a single T-DNA insert. The efficiency of the Cas9/sgRNA system and stable inheritance of edited genes point to the promise of this system for facile editing of plant genes.	[Jiang, WenZhi; Weeks, Donald P.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Yang, Bing] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA	University of Nebraska System; University of Nebraska Lincoln; Iowa State University	Weeks, DP (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.	dweeks1@unl.edu	Yang, Bing/D-3628-2019	Yang, Bing/0000-0002-2293-3384	National Science Foundation [MCB-0952533, EPSCoR-1004094]; Department of Energy [DOE DE-EE0001052, DOE CAB-COMM DOE DE-EE0003373]; Iowa State University Plant Science Institute Innovation Grant	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Iowa State University Plant Science Institute Innovation Grant	Funding for this research was provided, in part, by the National Science Foundation (MCB-0952533 and EPSCoR-1004094 to D.P.W.) and the Department of Energy (DOE DE-EE0001052 and DOE CAB-COMM DOE DE-EE0003373 to D.P.W.) and Iowa State University Plant Science Institute Innovation Grant (to B.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen KL, 2013, J GENET GENOMICS, V40, P271, DOI 10.1016/j.jgg.2013.03.009; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Desfeux C, 2000, PLANT PHYSIOL, V123, P895, DOI 10.1104/pp.123.3.895; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Feng Z, 2013, P NATL ACAD SCI US; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gratz SJ, 2013, GENETICS; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xiao A, 2014, BIOINFORMATICS; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6	32	113	137	0	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99225	10.1371/journal.pone.0099225	http://dx.doi.org/10.1371/journal.pone.0099225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918588	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000060
J	Labrecque, MP; Takhar, MK; Jagdeo, JM; Tam, KJ; Chiu, C; Wang, TY; Prefontaine, GG; Cox, ME; Beischlag, TV				Labrecque, Mark P.; Takhar, Mandeep K.; Jagdeo, Julienne M.; Tam, Kevin J.; Chiu, Christina; Wang, Te-Yu; Prefontaine, Gratien G.; Cox, Michael E.; Beischlag, Timothy V.			A TRIP230-Retinoblastoma Protein Complex Regulates Hypoxia-Inducible Factor-1 alpha-Mediated Transcription and Cancer Cell Invasion	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; NUCLEAR TRANSLOCATOR ARNT; THYROID-HORMONE RECEPTOR; BREAST-CANCER; RETINOBLASTOMA PROTEIN; EXPRESSION; GENE; FAMILY; RECRUITMENT; CARCINOMA	Localized hypoxia in solid tumors activates transcriptional programs that promote the metastatic transformation of cells. Like hypoxia-inducible hyper-vascularization, loss of the retinoblastoma protein (Rb) is a trait common to advanced stages of tumor progression in many metastatic cancers. However, no link between the role of Rb and hypoxia-driven metastatic processes has been established. We demonstrated that Rb is a key mediator of the hypoxic response mediated by HIF1 alpha/beta, the master regulator of the hypoxia response, and its essential co-activator, the thyroid hormone receptor/retinoblastomainteracting protein (TRIP230). Furthermore, loss of Rb unmasks the full co-activation potential of TRIP230. Using small inhibitory RNA approaches in vivo, we established that Rb attenuates the normal physiological response to hypoxia by HIF1 alpha. Notably, loss of Rb results in hypoxia-dependent biochemical changes that promote acquisition of an invasive phenotype in MCF7 breast cancer cells. In addition, Rb is present in HIF1 alpha-ARNT/HIF1b transcriptional complexes associated with TRIP230 as determined by co-immuno-precipitation, GST-pull-down and ChIP assays. These results demonstrate that Rb is a negative modulator of hypoxia-regulated transcription by virtue of its direct effects on the HIF1 complex. This work represents the first link between the functional ablation of Rb in tumor cells and HIF1 alpha-dependent transcriptional activation and invasion.	[Labrecque, Mark P.; Takhar, Mandeep K.; Jagdeo, Julienne M.; Tam, Kevin J.; Chiu, Christina; Wang, Te-Yu; Prefontaine, Gratien G.; Beischlag, Timothy V.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Cox, Michael E.] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada	Simon Fraser University; University of British Columbia	Beischlag, TV (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	tvb@sfu.ca	Labrecque, Mark/GPP-4575-2022	Labrecque, Mark/0000-0001-7887-7599	Canadian Breast Cancer Foundation BC/Yukon; Natural Sciences and Engineering Research Council of Canada [RGPIN 356355]	Canadian Breast Cancer Foundation BC/Yukon; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by operating grants from the Canadian Breast Cancer Foundation BC/Yukon (http://www.cbcf.org/bc/Pages/default.aspx) and the Natural Sciences and Engineering Research Council, RGPIN 356355 (http://www.nserc-crsng.gc.ca/index_eng.asp) of Canada to TVB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bachelder RE, 2002, CANCER RES, V62, P7203; Beischlag TV, 2005, J BIOL CHEM, V280, P21607, DOI 10.1074/jbc.C500090200; Beischlag TV, 2004, J BIOL CHEM, V279, P54620, DOI 10.1074/jbc.M410456200; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; BOOKSTEIN R, 1990, P NATL ACAD SCI USA, V87, P7762, DOI 10.1073/pnas.87.19.7762; Brat DJ, 2002, ADV ANAT PATHOL, V9, P24, DOI 10.1097/00125480-200201000-00004; Chang KH, 1997, P NATL ACAD SCI USA, V94, P9040, DOI 10.1073/pnas.94.17.9040; Chen YH, 2006, J BIOL CHEM, V281, P12242, DOI 10.1074/jbc.M512537200; Chen YM, 1999, P NATL ACAD SCI USA, V96, P4443, DOI 10.1073/pnas.96.8.4443; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eisinger-Mathason TSK, 2010, CANCER CELL, V18, P3, DOI 10.1016/j.ccr.2010.06.007; Elferink CJ, 2001, MOL PHARMACOL, V59, P664, DOI 10.1124/mol.59.4.664; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gilkes DM, 2013, CANCER RES, V73, P3285, DOI 10.1158/0008-5472.CAN-12-3963; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Grandinetti KB, 2008, CELL CYCLE, V7, P1550, DOI 10.4161/cc.7.11.6052; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Honey K, 2009, J CLIN INVEST, V119, P1400, DOI 10.1172/JCI39834; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Jeon HW, 2010, MOL CANCER THER, V9, P1361, DOI 10.1158/1535-7163.MCT-09-0717; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Labrecque MP, 2013, CURR MOL MED, V13, P1047; Labrecque MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029545; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Laj A, 1999, MOL CELL BIOL, V19, P6632; LANGER R, 1980, P NATL ACAD SCI-BIOL, V77, P4331, DOI 10.1073/pnas.77.7.4331; Lee JH, 2009, MOL CANCER RES, V7, P1663, DOI 10.1158/1541-7786.MCR-09-0191; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; NISHIKAWA R, 1995, CANCER RES, V55, P1941; Partch CL, 2009, J BIOL CHEM, V284, P15184, DOI 10.1074/jbc.M808479200; Prefontaine GG, 1998, MOL CELL BIOL, V18, P3416, DOI 10.1128/MCB.18.6.3416; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Scambia G, 2006, ONCOGENE, V25, P5302, DOI 10.1038/sj.onc.1209620; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Simin K, 2004, PLOS BIOL, V2, P194, DOI 10.1371/journal.pbio.0020022; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Traina TA, 2009, ONCOLOGY-NY, V23, P327; Tricoli JV, 1996, GENE CHROMOSOME CANC, V15, P108, DOI 10.1002/(SICI)1098-2264(199602)15:2<108::AID-GCC5>3.0.CO;2-7; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Yokota J, 2003, CLIN EXP METASTAS, V20, P189, DOI 10.1023/A:1022978932215; Zia MK, 2007, INT J MOL MED, V20, P605	53	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99214	10.1371/journal.pone.0099214	http://dx.doi.org/10.1371/journal.pone.0099214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919196	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000058
J	Newman, S; Cheng, T; Ghahate, DM; Bobelu, J; Sandy, P; Faber, T; Shah, VO				Newman, Sara; Cheng, Terri; Ghahate, Donica M.; Bobelu, Jeanette; Sandy, Phillip; Faber, Thomas; Shah, Vallabh O.			Assessing Knowledge and Attitudes of Diabetes in Zuni Indians Using a Culture-Centered Approach	PLOS ONE			English	Article							AFRICAN-AMERICANS; HEALTH; CARE; PERCEPTIONS; BARRIERS; DISEASE; ADULTS	Introduction: The Zuni Pueblo, in collaboration with the University of New Mexico, have formed the Zuni Health Initiative (ZHI) engaged in community-based participatory research to plan and implement educational interventions to reduce health disparities. We conducted the first phase of ZHI study and identified barriers to healthcare. We concluded that the burden presented by these barriers ultimately translates into a lack of patient activation and engagement in their health care including for diabetes, effectively hindering adoption of healthy behaviors. Methods: Community health representatives (CHRs) led 10 one-hour focus group sessions to elicit information on diabetes knowledge and self-management strategies at which a total of 84 people participated. Audiotapes were translated and transcribed by bilingual ZHI staff. We reduced the text to thematic categories, constructed a coding dictionary and inserted the text into NVivo 9 program. Results: The focus groups revealed that despite extensive personal or family experiences with diabetes or complications, participants identified knowledge gaps in the disease progression and disease management. However, we gained insight into how many Zunis conceptualize the etiology of diabetes, risk factors associated with diabetes, sources of knowledge and self-management practices. Conclusion: We concluded that many of the Zuni diabetics experience significant impacts on their life when they were diagnosed with diabetes and suffered the plight of stigmatization. We further concluded that developing Zuni culture specific diabetes care should focus on family involvement with continued education.	[Newman, Sara] Univ Colorado, Denver, CO 80202 USA; [Cheng, Terri; Ghahate, Donica M.; Bobelu, Jeanette; Sandy, Phillip; Shah, Vallabh O.] Univ New Mexico, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Faber, Thomas] Indian Hlth Serv Comprehens Ctr Zuni Pueblo, Zuni, NM USA	University of Colorado System; University of Colorado Denver; University of New Mexico; University of New Mexico's Health Sciences Center	Shah, VO (corresponding author), Univ New Mexico, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA.	vshah@salud.unm.edu			National Center for research Resources [5P20RR016480-12]; National Institute of General Medical Sciences from NIH [8P20GM103451-12]; National Center for Research Resources; National Center for Advancing Translational Sciences of the National Institutes of Health [8UL1TR000041]; University of New Mexico Clinical and Translational Science Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER	National Center for research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from NIH; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of New Mexico Clinical and Translational Science Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported in full from the grants funded by the National Center for research Resources (5P20RR016480-12) and the National Institute of General Medical Sciences (8P20GM103451-12) from NIH. The authors would also like to acknowledge partial support from the pilot project grant funding from the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number 8UL1TR000041, The University of New Mexico Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maskari F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052857; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Anderson RM, 2000, DIABETES EDUCATOR, V26, P280, DOI 10.1177/014572170002600208; Bradshaw BG, 2007, DIABETES EDUCATOR, V33, P650, DOI 10.1177/0145721707303809; Burt RS, 2005, BROKERAGE CLOSURE IN; Downing-Matibag TM, 2009, QUAL HEALTH RES, V19, P1196, DOI 10.1177/1049732309344206; Dutta MJ, 2007, COMMUN THEORY, V17, P204; Fukunaga LL, 2011, PREV CHRONIC DIS, V8; Lautenschlager L, 2006, J NUTR EDUC BEHAV, V38, P307, DOI 10.1016/j.jneb.2006.04.004; Lukunaga LL, 2011, PREVENTING CHRONIC D, V8; Melkus GD, 2004, APPL NURS RES, V17, P10, DOI 10.1016/j.apnr.2003.10.009; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Norris SL, 2006, DIABETIC MED, V23, P544, DOI 10.1111/j.1464-5491.2006.01845.x; ONEIL JD, 1986, HUM ORGAN, V45, P119, DOI 10.17730/humo.45.2.q34m761r857km8lh; Sarkisian CA, 2005, ETHNIC DIS, V15, P283; Scavini M, 2003, DIABETES CARE, V26, P55, DOI 10.2337/diacare.26.1.55; Shah VO, 2014, CTS-CLIN TRANSL SCI, V7, P6, DOI 10.1111/cts.12127; Shah VN, 2009, INT J DIABETES DEV C, V29, P118, DOI 10.4103/0973-3930.54288; Shah VO, 2003, J AM SOC NEPHROL, V14, P1320, DOI 10.1097/01.ASN.0000059920.00228.A0; Stidley CA, 2003, J AM SOC NEPHROL, V14, pS139, DOI 10.1097/01.ASN.0000070151.95421.87; Thomas D.R., 2003, GEN INDUCTIVE APPROA; Tripp-Reimer T., 2001, DIABETES SPECTR, V14, P13, DOI 10.2337/diaspect.14.1.13; U.S. Department of Health and Human Services, 2007, OB AM IND AL NAT	24	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99614	10.1371/journal.pone.0099614	http://dx.doi.org/10.1371/journal.pone.0099614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24919064	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000099
J	Ryndock, EJ; Conway, MJ; Alam, S; Gul, S; Murad, S; Christensen, ND; Meyers, C				Ryndock, Eric J.; Conway, Michael J.; Alam, Samina; Gul, Sana; Murad, Sheeba; Christensen, Neil D.; Meyers, Craig			Roles for Human Papillomavirus Type 16 L1 Cysteine Residues 161, 229, and 379 in Genome Encapsidation and Capsid Stability	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; SIMIAN-VIRUS-40 VP1; BOVINE PAPILLOMAVIRUS; DISULFIDE BONDS; PROTEIN L1; MATURATION; INFECTION; L2; RECONSTRUCTION; NEUTRALIZATION	Human papillomavirus (HPV) capsids are formed through a network of inter-and intra-pentameric hydrophobic interactions and disulfide bonds. 72 pentamers of the major capsid protein, L1, and an unknown amount of the minor capsid protein, L2, form the structure of the capsid. There are 12 conserved L1 cysteine residues in HPV16. While C175, C185, and C428 have been implicated in the formation of a critical inter-pentameric disulfide bond, no structural or functional roles have been firmly attributed to any of the other conserved cysteine residues. Here, we show that substitution of cysteine residues C161, C229, and C379 for serine hinders the accumulation of endonuclease-resistant genomes as virions mature within stratifying and differentiating human epithelial tissue. C229S mutant virions form, but are non-infectious. These studies add detail to the differentiation-dependent assembly and maturation that occur during the HPV16 life cycle in human tissue.	[Ryndock, Eric J.; Conway, Michael J.; Alam, Samina; Meyers, Craig] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Christensen, Neil D.] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA USA; [Gul, Sana; Murad, Sheeba] Natl Univ Sci & Technol, Atta ur Rahman Sch Appl Biosci, Hlth Care Biotechnol Dept, Islamabad, Pakistan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National University of Sciences & Technology - Pakistan	Meyers, C (corresponding author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA.	cmm10@psu.edu	alam, samina/V-1599-2018		PHS Grant from the NIAID [R01AI57988]; NRSA Viruses and Cancer T32 Training Grants from the NIH [56JB, 5CJM]; NATIONAL CANCER INSTITUTE [T32CA060395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057988] Funding Source: NIH RePORTER	PHS Grant from the NIAID; NRSA Viruses and Cancer T32 Training Grants from the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a PHS Grant from the NIAID (www.niaid.nih.gov) R01AI57988 and NRSA Viruses and Cancer T32 Training Grants from the NIH (www.nih.gov) 56JB and 5CJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TS, 1989, BIOPHYS J, V55, P243, DOI 10.1016/S0006-3495(89)82799-7; BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; Belnap DM, 1996, J MOL BIOL, V259, P249, DOI 10.1006/jmbi.1996.0317; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Conway MJ, 2009, J DENT RES, V88, P307, DOI 10.1177/0022034509333446; Conway MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022427; Conway MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016405; Conway MJ, 2009, VIROLOGY, V393, P295, DOI 10.1016/j.virol.2009.08.010; Conway MJ, 2009, J VIROL, V83, P10515, DOI 10.1128/JVI.00731-09; Cruz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068379; Culp TD, 2006, J VIROL, V80, P11381, DOI 10.1128/JVI.01328-06; Finnen RL, 2003, J VIROL, V77, P4818, DOI 10.1128/JVI.77.8.4818-4826.2003; Fligge C, 2001, J VIROL, V75, P7727, DOI 10.1128/JVI.75.16.7727-7731.2001; Gharakhanian E, 2005, VIRUS RES, V107, P21, DOI 10.1016/j.virusres.2004.06.006; Ishii Y, 2005, VIRUS GENES, V31, P321, DOI 10.1007/s11262-005-3250-3; Ishii Y, 2003, VIROLOGY, V308, P128, DOI 10.1016/S0042-6822(02)00099-5; Ishii Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-110; Jao CC, 1999, J GEN VIROL, V80, P2481, DOI 10.1099/0022-1317-80-9-2481; Joshi A, 2006, J VIROL, V80, P7939, DOI 10.1128/JVI.00355-06; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Li ML, 1998, J VIROL, V72, P2160, DOI 10.1128/JVI.72.3.2160-2167.1998; Li PP, 2005, J VIROL, V79, P3859, DOI 10.1128/JVI.79.6.3859-3864.2005; Li PP, 2002, P NATL ACAD SCI USA, V99, P1353, DOI 10.1073/pnas.032668699; Li PP, 2000, J VIROL, V74, P11388, DOI 10.1128/JVI.74.23.11388-11393.2000; McLaughlin-Drubin ME, 2004, VIROLOGY, V322, P213, DOI 10.1016/j.virol.2004.02.011; McLaughlin-Drubin ME, 2003, VIROLOGY, V312, P1, DOI 10.1016/S0042-6822(03)00312-X; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Meyers C, 1997, J VIROL, V71, P7381, DOI 10.1128/JVI.71.10.7381-7386.1997; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Mukherjee S, 2008, J MOL BIOL, V381, P229, DOI 10.1016/j.jmb.2008.05.079; Ozbun MA, 1998, VIROLOGY, V248, P218, DOI 10.1006/viro.1998.9285; Perez-Berna AJ, 2012, J BIOL CHEM, V287, P31582, DOI 10.1074/jbc.M112.389957; Sapp M, 1998, J VIROL, V72, P6186, DOI 10.1128/JVI.72.7.6186-6189.1998; Trus BL, 1997, NAT STRUCT BIOL, V4, P413, DOI 10.1038/nsb0597-413; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107	39	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e994880	10.1371/journal.pone.0099488	http://dx.doi.org/10.1371/journal.pone.0099488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918586	Green Submitted, gold, Green Published			2022-12-25	WOS:000338631000090
J	Stark, JS; Kim, SL; Oliver, JS				Stark, Jonathan S.; Kim, Stacy L.; Oliver, John S.			Anthropogenic Disturbance and Biodiversity of Marine Benthic Communities in Antarctica: A Regional Comparison	PLOS ONE			English	Article							SOFT-SEDIMENT ASSEMBLAGES; MCMURDO-STATION; TAXONOMIC DISTINCTNESS; ORGANIC ENRICHMENT; EAST ANTARCTICA; CASEY STATION; MACROBENTHIC ASSEMBLAGES; MULTIVARIATE-ANALYSIS; SPATIAL VARIABILITY; METAL CONTAMINATION	The impacts of two Antarctic stations in different regions, on marine sediment macrofaunal communities were compared: McMurdo, a very large station in the Ross Sea; and Casey, a more typical small station in East Antarctica. Community structure and diversity were compared along a gradient of anthropogenic disturbance from heavily contaminated to uncontaminated locations. We examined some of the inherent problems in comparing data from unrelated studies, such as different sampling methods, spatial and temporal scales of sampling and taxonomic uncertainty. These issues generated specific biases which were taken into account when interpreting patterns. Control sites in the two regions had very different communities but both were dominated by crustaceans. Community responses to anthropogenic disturbance (sediment contamination by metals, oils and sewage) were also different. At McMurdo the proportion of crustaceans decreased in disturbed areas and polychaetes became dominant, whereas at Casey, crustaceans increased in response to disturbance, largely through an increase in amphipods. Despite differing overall community responses there were some common elements. Ostracods, cumaceans and echinoderms were sensitive to disturbance in both regions. Capitellid, dorvelleid and orbiniid polychaetes were indicative of disturbed sites. Amphipods, isopods and tanaids had different responses at each station. Biodiversity and taxonomic distinctness were significantly lower at disturbed locations in both regions. The size of the impact, however, was not related to the level of contamination, with a larger reduction in biodiversity at Casey, the smaller, less polluted station. The impacts of small stations, with low to moderate levels of contamination, can thus be as great as those of large or heavily contaminated stations. Regional broad scale environmental influences may be important in determining the composition of communities and thus their response to disturbance, but there are some generalizations regarding responses which will aid future management of stations.	[Stark, Jonathan S.] Australian Antarctic Div, Terr & Nearshore Ecosyst Program, Kingston, Tas, Australia; [Kim, Stacy L.; Oliver, John S.] Moss Landing Marine Labs, Moss Landing, CA 95039 USA	Australian Antarctic Division; Moss Landing Marine Laboratories	Stark, JS (corresponding author), Australian Antarctic Div, Terr & Nearshore Ecosyst Program, Kingston, Tas, Australia.	jonny.stark@aad.gov.au	Stark, Jonathan/ABF-4025-2020	Stark, Jonathan/0000-0002-4268-8072	Australian Antarctic Division under AAS project; National Science Foundation [DPP 8914858, OPP 97961111, OPP 9615849, OPP 59088, OPP 0126399]	Australian Antarctic Division under AAS project; National Science Foundation(National Science Foundation (NSF))	Work at Casey Station was supported by the Australian Antarctic Division (www.antarctica.gov.au/) under AAS project 2201. Work at McMurdo Station was supported by the National Science Foundation under Grant Nos. DPP 8914858, OPP 97961111, OPP 9615849, OPP 59088 and OPP 0126399. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aronson RB, 2011, ANN NY ACAD SCI, V1223, P82, DOI 10.1111/j.1749-6632.2010.05926.x; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Baird HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034363; Barnes DKA, 1999, J MAR BIOL ASSOC UK, V79, P401, DOI 10.1017/S0025315498000514; Barnes DKA, 2003, MAR ECOL PROG SER, V249, P145, DOI 10.3354/meps249145; BARRY JP, 1988, POLAR BIOL, V8, P377, DOI 10.1007/BF00442029; Bonar Scott A., 2011, P11; Borja A, 2008, ECOL INDIC, V8, P331, DOI 10.1016/j.ecolind.2007.05.004; Borja A, 2009, HYDROBIOLOGIA, V633, P181, DOI 10.1007/s10750-009-9881-y; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; BUSDOSH M, 1982, J EXP MAR BIOL ECOL, V62, P261, DOI 10.1016/0022-0981(82)90206-4; CEP, 2013, 15 CEP M HOB 36 ANT; Chapman PM, 2003, MAR POLLUT BULL, V46, P927, DOI 10.1016/S0025-326X(03)00252-2; Clark GF, 2013, GLOBAL CHANGE BIOL, V19, P3749, DOI 10.1111/gcb.12337; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; COMNAP, 2013, ANT FAC LIST 15 MAY; Conlan KE, 2010, MAR POLLUT BULL, V60, P419, DOI 10.1016/j.marpolbul.2009.10.009; Conlan KE, 2006, MAR POLLUT BULL, V52, P1695, DOI 10.1016/j.marpolbul.2006.06.010; Conlan Kathleen E., 2000, P315; Conlan KE, 1998, MAR ECOL PROG SER, V166, P1, DOI 10.3354/meps166001; Conlan KE, 2004, MAR POLLUT BULL, V49, P43, DOI 10.1016/j.marpolbul.2004.01.007; Corbera J, 1995, SCI MAR, V59, P63; COTTON JH, 1994, ANTARCT SCI, V6, P537, DOI 10.1017/S0954102094000799; Crockett AB, 1997, COMPREHENSIVE CHARAC; DAYTON PK, 1994, AM ZOOL, V34, P90; DAYTON PK, 1977, SCIENCE, V197, P55, DOI 10.1126/science.197.4298.55; de-la-Ossa-Carretero JA, 2011, ENVIRON MONIT ASSESS, V184, P2133; Dean HK, 2008, REV BIOL TROP, V56, P11, DOI DOI 10.15517/RBT.V56I4.27162; Duquesne S, 2002, POLAR BIOL, V25, P206, DOI 10.1007/s00300-001-0328-9; Durou C, 2005, ENVIRON TOXICOL, V20, P23, DOI 10.1002/tox.20074; Ellingsen KE, 2001, MAR ECOL PROG SER, V218, P1, DOI 10.3354/meps218001; Gasparon M, 2007, APPL GEOCHEM, V22, P888, DOI 10.1016/j.apgeochem.2006.12.018; Gibson G., 2000, ESTUARINE COASTAL MA; Gillies CL, 2013, MAR ECOL PROG SER, V478, P27, DOI 10.3354/meps10214; Gillies CL, 2012, ESTUAR COAST SHELF S, V97, P44, DOI 10.1016/j.ecss.2011.11.003; GOODMAN D, 1975, Q REV BIOL, V50, P237, DOI 10.1086/408563; Gotelli Nicholas J., 2011, P39; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GRAY JS, 1979, PHILOS T ROY SOC B, V286, P545, DOI 10.1098/rstb.1979.0045; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Grondahl F, 2009, POLAR RES, V28, P298, DOI 10.1111/j.1751-8369.2008.00056.x; Gutt J, 2004, ANTARCT SCI, V16, P11, DOI 10.1017/S0954102004001750; Hale RC, 2008, ENVIRON SCI TECHNOL, V42, P1452, DOI 10.1021/es702547a; Hall JA, 1997, MAR POLLUT BULL, V34, P527, DOI 10.1016/S0025-326X(97)00156-2; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Held C, 2005, SCI MAR, V69, P175, DOI 10.3989/scimar.2005.69s2175; Holte B, 1996, POLAR BIOL, V16, P549; HOWINGTON JP, 1992, MAR POLLUT BULL, V25, P324, DOI 10.1016/0025-326X(92)90690-8; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; *IUCN, 2004, 4 WORLD PARKS C; Kennicutt MC, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034010; KENNICUTT MC, 1995, ENVIRON SCI TECHNOL, V29, P1279, DOI 10.1021/es00005a600; Kim S, 2010, INTEGR COMP BIOL, V50, P1031, DOI 10.1093/icb/icq058; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Lande R, 2000, OIKOS, V89, P601, DOI 10.1034/j.1600-0706.2000.890320.x; LENIHAN HS, 1995, ECOL APPL, V5, P311, DOI 10.2307/1942024; LENIHAN HS, 1990, MAR POLLUT BULL, V21, P422, DOI 10.1016/0025-326X(90)90761-V; LENIHAN HS, 1992, MAR POLLUT BULL, V25, P318, DOI 10.1016/0025-326X(92)90689-4; Lenihan HS, 2003, MAR ECOL PROG SER, V261, P63, DOI 10.3354/meps261063; Leong LS, 1999, MAR POLLUT BULL, V38, P875, DOI 10.1016/S0025-326X(99)00013-2; Linse K, 2007, POLAR BIOL, V30, P1059, DOI 10.1007/s00300-007-0265-3; Lohrer AM, 2013, ECOSYSTEMS, V16, P224, DOI 10.1007/s10021-012-9610-7; Lundsten L, 2010, DEEP-SEA RES PT I, V57, P1573, DOI 10.1016/j.dsr.2010.09.003; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Magurran AE, 2011, BIOL DIVERSITY; May R.M., 1975, P81; Morrisey DJ, 1996, MAR BIOL, V125, P199, DOI 10.1007/BF00350774; MORRISEY DJ, 1992, J EXP MAR BIOL ECOL, V164, P233, DOI 10.1016/0022-0981(92)90177-C; Mouneyrac C, 2003, MAR BIOL, V143, P731, DOI 10.1007/s00227-003-1124-6; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Noren K, 2005, J EXP MAR BIOL ECOL, V317, P53, DOI 10.1016/j.jembe.2004.11.014; OAKDEN JM, 1984, MAR ECOL PROG SER, V14, P253, DOI 10.3354/meps014253; Oliver J, 2011, MAR ECOL-EVOL PERSP, V32, P278, DOI 10.1111/j.1439-0485.2011.00461.x; Osman RW, 1998, HYDROBIOLOGIA, V375-76, P113, DOI 10.1023/A:1017000820646; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; RISEBROUGH RW, 1990, MAR POLLUT BULL, V21, P523, DOI 10.1016/0025-326X(90)90300-W; Rosenberg R, 2001, SCI MAR, V65, P107, DOI 10.3989/scimar.2001.65s2107; Rosenberg R, 2004, MAR POLLUT BULL, V49, P728, DOI 10.1016/j.marpolbul.2004.05.013; Ruiz F, 2005, EARTH-SCI REV, V72, P89, DOI 10.1016/j.earscirev.2005.04.003; Scheiner SM, 2000, EVOL ECOL RES, V2, P791; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Schlacher TA, 1998, MAR ECOL PROG SER, V174, P159, DOI 10.3354/meps174159; Scouller RC, 2006, CHEMOSPHERE, V65, P294, DOI 10.1016/j.chemosphere.2006.02.062; SHULENBERGER E, 1974, MAR BIOL, V28, P185, DOI 10.1007/BF00387296; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Simpson SL, 2005, HDB SEDIMENT QUALITY; SLATTERY PN, 1986, POLAR BIOL, V6, P171, DOI 10.1007/BF00274880; Sleutel S, 2007, COMMUN SOIL SCI PLAN, V38, P2647, DOI 10.1080/00103620701662877; Smale DA, 2008, POLAR BIOL, V31, P189, DOI 10.1007/s00300-007-0346-3; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Snape I., 2001, POLAR REC, V37, P199; Stark Jonathan S., 2006, Ecological Management & Restoration, V7, P21, DOI 10.1111/j.1442-8903.2006.00243.x; Stark JS, 1998, MAR FRESHWATER RES, V49, P533, DOI 10.1071/MF97188; Stark JS, 1998, ECOTOXICOLOGY, V7, P161, DOI 10.1023/A:1014356327595; Stark JS, 2005, MAR POLLUT BULL, V50, P276, DOI 10.1016/j.marpolbul.2004.10.015; Stark JS, 2004, MAR ECOL PROG SER, V276, P53, DOI 10.3354/meps276053; Stark JS, 2003, AUSTRAL ECOL, V28, P287, DOI 10.1046/j.1442-9993.2003.01289.x; Stark JS, 2003, ESTUAR COAST SHELF S, V56, P717, DOI 10.1016/S0272-7714(02)00291-3; Stark JS, 2011, ENV IMPACT ASSESSMEN; STULL JK, 1986, MAR BIOL, V91, P539, DOI 10.1007/BF00392606; Sutherland RA, 1998, HYDROBIOLOGIA, V389, P153, DOI 10.1023/A:1003570219018; Thatje S, 2012, INTEGR COMP BIOL, V52, P470, DOI 10.1093/icb/ics105; Thomas DN, 2004, FROZEN OCEANS FLOATI; Thompson BW, 2003, MAR POLLUT BULL, V46, P232, DOI 10.1016/S0025-326X(02)00366-1; Thrush SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011899; Tin T., 2014, ANTARCTIC FUTURES; Tomassetti P, 2005, AQUACULT INT, V13, P109, DOI 10.1007/s10499-004-9026-2; United Nations, 2002, WORLD SUMMIT SUSTAIN; Van Gemerden BS, 2005, ECOL APPL, V15, P1747, DOI 10.1890/04-1791; Vanderklift MA, 1996, MAR ECOL PROG SER, V136, P137, DOI 10.3354/meps136137; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wang QR, 2011, ENVIRON MONIT ASSESS, V174, P241, DOI 10.1007/s10661-010-1454-z; Warwick RM, 1998, J APPL ECOL, V35, P532, DOI 10.1046/j.1365-2664.1998.3540532.x; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Warwick RM, 2001, OCEANOGR MAR BIOL, V39, P207; WARWICK RM, 1988, MAR POLLUT BULL, V19, P259, DOI 10.1016/0025-326X(88)90596-6; WARWICK RM, 1988, MAR ECOL PROG SER, V46, P167, DOI 10.3354/meps046167; Weimin Ying, 1992, Science of the Total Environment, V125, P67, DOI 10.1016/0048-9697(92)90383-4; Weisberg SB, 2008, ECOL INDIC, V8, P389, DOI 10.1016/j.ecolind.2007.04.001; WOODIN SA, 1974, ECOL MONOGR, V44, P171, DOI 10.2307/1942310	127	33	33	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98802	10.1371/journal.pone.0098802	http://dx.doi.org/10.1371/journal.pone.0098802			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919053	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000027
J	Sudenga, SL; Wiener, HW; King, CC; Rompalo, AM; Cu-Uvin, S; Klein, RS; Shah, KV; Sobel, JD; Jamieson, DJ; Shrestha, S				Sudenga, Staci L.; Wiener, Howard W.; King, Caroline C.; Rompalo, Anne M.; Cu-Uvin, Susan; Klein, Robert S.; Shah, Keerti V.; Sobel, Jack D.; Jamieson, Denise J.; Shrestha, Sadeep			Dense Genotyping of Immune-Related Loci Identifies Variants Associated with Clearance of HPV among HIV-Positive Women in the HIV Epidemiology Research Study (HERS)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL-CANCER; NATURAL-HISTORY; SUSCEPTIBILITY LOCI; G POLYMORPHISMS; YOUNG-WOMEN; RISK; E6; DNA	Persistent high-risk human papillomavirus (HR-HPV) is a necessary and causal factor of cervical cancer. Most women naturally clear HPV infections; however, the biological mechanisms related to HPV pathogenesis have not been clearly elucidated. Host genetic factors that specifically regulate immune response could play an important role. All HIV-positive women in the HIV Epidemiology Research Study (HERS) with a HR-HPV infection and at least one follow-up biannual visit were included in the study. Cervicovaginal lavage samples were tested for HPV using type-specific HPV hybridization assays. Type-specific HPV clearance was defined as two consecutive HPV-negative tests after a positive test. DNA from participants was genotyped for 196,524 variants within 186 known immune related loci using the custom ImmunoChip microarray. To assess the influence of each single-nucleotide polymorphism (SNP) with HR-HPV clearance, the Cox proportional hazards model with the Wei-Lin-Weissfeld approach was used, adjusting for CD4+ count, low risk HPV (LR-HPV) co-infection, and relevant confounders. Three analytical models were performed: race-specific (African Americans (n = 258), European Americans (n = 87), Hispanics (n = 55), race-adjusted combined analysis, and meta-analysis of pooled independent race-specific analyses. Women were followed for a median time of 1,617 days. Overall, three SNPs (rs1112085, rs11102637, and rs12030900) in the MAGI-3 gene and one SNP (rs8031627) in the SMAD3 gene were associated with HR-HPV clearance (p<10(-6)). A variant (rs1633038) in HLA-G were also significantly associated in African American. Results from this study support associations of immune-related genes, having potential biological mechanism, with differential cervical HR-HPV infection outcomes.	[Sudenga, Staci L.; Wiener, Howard W.; Shrestha, Sadeep] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35203 USA; [King, Caroline C.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA; [Rompalo, Anne M.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Cu-Uvin, Susan] Brown Univ, Dept Obstet & Gynecol & Med, Providence, RI 02912 USA; [Klein, Robert S.] Mt Sinai Sch Med, New York, NY USA; [Shah, Keerti V.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Sobel, Jack D.] Wayne State Univ, Sch Med, Detroit, MI USA	University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Brown University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wayne State University	Shrestha, S (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35203 USA.	sshrestha@uab.edu	Sudenga, Staci/A-7726-2015; Sudenga, Staci/O-1545-2019	Sudenga, Staci/0000-0001-7305-8738; Jamieson, Denise/0000-0003-2597-1201	Pilot Project Award from the Johns Hopkins Cervical Cancer SPORE [(2P50CA098252]; NIH Cancer Prevention and Control Training Program [R25CA47888]; Centers for Disease Control and Prevention [U64/CCU106795, U64/CCU206798, U64/CCU306802, U64/CCU506831]; NATIONAL CANCER INSTITUTE [R25CA047888, P50CA098252] Funding Source: NIH RePORTER	Pilot Project Award from the Johns Hopkins Cervical Cancer SPORE; NIH Cancer Prevention and Control Training Program; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Genotyping efforts were supported by the Pilot Project Award (PI: Sadeep Shrestha) from the Johns Hopkins Cervical Cancer SPORE (2P50CA098252 PI: TC Wu). The work was supported in part by the NIH Cancer Prevention and Control Training Program (R25CA47888 - fellowship of Staci Sudenga). The HIV Epidemiology Research Study (HERS) was funded through Centers for Disease Control and Prevention cooperative agreements U64/CCU106795, U64/CCU206798, U64/CCU306802, and U64/CCU506831. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth J, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-67; Bortolotti D, 2014, TISSUE ANTIGENS, V83, P113, DOI 10.1111/tan.12281; Bosch F Xavier, 2002, Curr Oncol Rep, V4, P175, DOI 10.1007/s11912-002-0079-y; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bosch FX, 2003, SALUD PUBLICA MEXICO, V45, pS326; Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662; Chen D, 2013, JNCI-J NATL CANCER I, V105, P624, DOI 10.1093/jnci/djt051; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Demeret C, 1995, NUCLEIC ACIDS RES, V23, P4777, DOI 10.1093/nar/23.23.4777; DONG XP, 1994, INT J CANCER, V58, P803, DOI 10.1002/ijc.2910580609; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Ferguson R, 2012, INT J CANCER, V131, pE312, DOI 10.1002/ijc.27356; Ferguson R, 2011, HUM IMMUNOL, V72, P337, DOI 10.1016/j.humimm.2011.01.010; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Hildesheim A, 1998, CANCER EPIDEM BIOMAR, V7, P1035; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Juran BD, 2012, HUM MOL GENET, V21, P5209, DOI 10.1093/hmg/dds359; Koshiol JE, 2006, INT J CANCER, V119, P1623, DOI 10.1002/ijc.22015; Lee DK, 2002, J BIOL CHEM, V277, P38557, DOI 10.1074/jbc.M206786200; Lee SJ, 2001, J IMMUNOL, V167, P497, DOI 10.4049/jimmunol.167.1.497; Mahmud SM, 2007, J INFECT DIS, V196, P82, DOI 10.1086/518612; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Metcalfe S, 2013, HUM IMMUNOL, V74, P1610, DOI 10.1016/j.humimm.2013.08.279; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; O'Brien PM, 2003, TRENDS MICROBIOL, V11, P300, DOI 10.1016/S0966-842X(03)00145-8; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi YY, 2013, NAT GENET, V45, P918, DOI 10.1038/ng.2687; Silva ID, 2013, HUM IMMUNOL, V74, P452, DOI 10.1016/j.humimm.2012.11.025; Simoes RT, 2009, MODERN PATHOL, V22, P1075, DOI 10.1038/modpathol.2009.67; Simonson SJS, 2005, CANCER RES, V65, P8266, DOI 10.1158/0008-5472.CAN-05-1651; Smith DK, 1997, AM J EPIDEMIOL, V146, P459, DOI 10.1093/oxfordjournals.aje.a009299; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Sudenga SL, 2013, INT J INFECT DIS; Sudenga SL, 2013, HUM IMMUNOL, V74, P1696, DOI 10.1016/j.humimm.2013.08.010; Sudenga SL, 2011, ADOLESC HEALTH MED T, V2, P63, DOI 10.2147/AHMT.S15941; Thomas M, 2002, ONCOGENE, V21, P5088, DOI 10.1038/sj.onc.1205668; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; Xue XN, 2010, CANCER EPIDEM BIOMAR, V19, P159, DOI 10.1158/1055-9965.EPI-09-0546; Yang YC, 2014, EUR J CANCER, V50, P469, DOI 10.1016/j.ejca.2013.10.018	46	10	10	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99109	10.1371/journal.pone.0099109	http://dx.doi.org/10.1371/journal.pone.0099109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918582	Green Published, gold			2022-12-25	WOS:000338631000048
J	Urasaki, Y; Pizzorno, G; Le, TT				Urasaki, Yasuyo; Pizzorno, Giuseppe; Le, Thuc T.			Uridine Affects Liver Protein Glycosylation, Insulin Signaling, and Heme Biosynthesis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HOMEOSTATIC REGULATION; TRANSLATIONAL CONTROL; EIF2-ALPHA KINASE; METABOLISM; PHOSPHORYLASE; DISEASE; RESISTANCE; GLUCOSE; CELLS	Purines and pyrimidines are complementary bases of the genetic code. The roles of purines and their derivatives in cellular signal transduction and energy metabolism are well-known. In contrast, the roles of pyrimidines and their derivatives in cellular function remain poorly understood. In this study, the roles of uridine, a pyrimidine nucleoside, in liver metabolism are examined in mice. We report that short-term uridine administration in C57BL/6J mice increases liver protein glycosylation profiles, reduces phosphorylation level of insulin signaling proteins, and activates the HRI-eIF-2 alpha-ATF4 heme-deficiency stress response pathway. Short-term uridine administration is also associated with reduced liver hemin level and reduced ability for insulin-stimulated blood glucose removal during an insulin tolerance test. Some of the short-term effects of exogenous uridine in C57BL/6J mice are conserved in transgenic UPase1(-/-) mice with long-term elevation of endogenous uridine level. UPase1(-/-) mice exhibit activation of the liver HRI-eIF-2 alpha-ATF4 heme-deficiency stress response pathway. UPase1(-/-) mice also exhibit impaired ability for insulin-stimulated blood glucose removal. However, other short-term effects of exogenous uridine in C57BL/6J mice are not conserved in UPase1(-/-) mice. UPase1(-/-) mice exhibit normal phosphorylation level of liver insulin signaling proteins and increased liver hemin concentration compared to untreated control C57BL/6J mice. Contrasting short-term and long-term consequences of uridine on liver metabolism suggest that uridine exerts transient effects and elicits adaptive responses. Taken together, our data support potential roles of pyrimidines and their derivatives in the regulation of liver metabolism.	[Urasaki, Yasuyo; Pizzorno, Giuseppe; Le, Thuc T.] Nevada Canc Inst, Las Vegas, NV 89135 USA; [Urasaki, Yasuyo; Pizzorno, Giuseppe; Le, Thuc T.] Desert Res Inst, Las Vegas, NV USA	University of California System; University of California San Diego; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Pizzorno, G (corresponding author), Nevada Canc Inst, Las Vegas, NV 89135 USA.	giuseppe.pizzorno@dri.edu; thuc@uchicago.edu			Nevada INBRE Program of the National Center for Research Resources [P20RR-016464]; American Cancer Society [IRG-08-062-04]; Vons Breast Cancer Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	Nevada INBRE Program of the National Center for Research Resources; American Cancer Society(American Cancer Society); Vons Breast Cancer Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partially supported by the Nevada INBRE Program of the National Center for Research Resources (P20RR-016464, TTL), the American Cancer Society (IRG-08-062-04, TTL), and the Vons Breast Cancer Research Award (TTL and GP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2010, MOL PHARMACOL, V77, P575, DOI 10.1124/mol.109.061259; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; ALBERTS B, 2007, MOL BIOL CELL GARLAN; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Cao DL, 2011, MOL CANCER THER, V10, P2330, DOI 10.1158/1535-7163.MCT-11-0202; Cao DL, 2005, J BIOL CHEM, V280, P21169, DOI 10.1074/jbc.M412343200; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; de Cabo R, 2009, CELL METAB, V9, P305, DOI 10.1016/j.cmet.2009.03.009; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Dudzinska W, 2013, PHYSIOL RES, V62, P163, DOI 10.33549/physiolres.932355; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Hawkins M, 1997, J BIOL CHEM, V272, P4889, DOI 10.1074/jbc.272.8.4889; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Le TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087179; Le TT, 2013, J LIPID RES, V54, P1044, DOI 10.1194/jlr.M034249; Le TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051092; Le TT, 2014, BMC PHARM T IN PRESS; Lebrecht D, 2007, HEPATOLOGY, V45, P72, DOI 10.1002/hep.21490; Li DS, 2005, CELL, V122, P487, DOI 10.1016/j.cell.2005.08.010; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Oliveri LM, 2012, BIOCHEM J, V442, P303, DOI 10.1042/BJ20111005; Pizzorno G, 2002, BBA-MOL BASIS DIS, V1587, P133, DOI 10.1016/S0925-4439(02)00076-5; Pooler AM, 2005, NEUROSCIENCE, V134, P207, DOI 10.1016/j.neuroscience.2005.03.050; Prado MAM, 2002, NEUROCHEM INT, V41, P291, DOI 10.1016/S0197-0186(02)00044-X; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Walker AK, 2013, FEBS J, V280, P233, DOI 10.1111/febs.12063; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037427; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Yamamoto T, 2010, NUCLEOS NUCLEOT NUCL, V29, P504, DOI 10.1080/15257771003740986; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang Y, 2004, MOL ENDOCRINOL, V18, P851, DOI 10.1210/me.2003-0285	45	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99728	10.1371/journal.pone.0099728	http://dx.doi.org/10.1371/journal.pone.0099728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918436	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000107
J	Yang, YX; Xu, SX; Xu, JX; Guo, Y; Yang, G				Yang, Yunxia; Xu, Shixia; Xu, Junxiao; Guo, Yan; Yang, Guang			Adaptive Evolution of Mitochondrial Energy Metabolism Genes Associated with Increased Energy Demand in Flying Insects	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; MUSCLE; FLIGHT; FLIGHTLESSNESS; SUBSTITUTION; PHYLOGENY; PRESSURE; MODELS; ORIGIN; OXYGEN	Insects are unique among invertebrates for their ability to fly, which raises intriguing questions about how energy metabolism in insects evolved and changed along with flight. Although physiological studies indicated that energy consumption differs between flying and non-flying insects, the evolution of molecular energy metabolism mechanisms in insects remains largely unexplored. Considering that about 95% of adenosine triphosphate (ATP) is supplied by mitochondria via oxidative phosphorylation, we examined 13 mitochondrial protein-encoding genes to test whether adaptive evolution of energy metabolism-related genes occurred in insects. The analyses demonstrated that mitochondrial DNA protein-encoding genes are subject to positive selection from the last common ancestor of Pterygota, which evolved primitive flight ability. Positive selection was also found in insects with flight ability, whereas no significant sign of selection was found in flightless insects where the wings had degenerated. In addition, significant positive selection was also identified in the last common ancestor of Neoptera, which changed its flight mode from direct to indirect. Interestingly, detection of more positively selected genes in indirect flight rather than direct flight insects suggested a stronger selective pressure in insects having higher energy consumption. In conclusion, mitochondrial protein-encoding genes involved in energy metabolism were targets of adaptive evolution in response to increased energy demands that arose during the evolution of flight ability in insects.	[Yang, Yunxia; Xu, Shixia; Xu, Junxiao; Guo, Yan; Yang, Guang] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Yang, G (corresponding author), Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	gyang@njnu.edu.cn			National Science Fund for Distinguished Young Scholars [31325025]; National Natural Science Foundation of China (NSFC) [31172069, 30830016]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Specialized Research Fund for the Doctoral Program of Higher Education [20113207130001]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was financially supported by the National Science Fund for Distinguished Young Scholars (grant no. 31325025, ULR: http://www.nsfc.gov.cn/) to GY, the National Natural Science Foundation of China (NSFC) (grant no. 31172069 and 30830016 to GY, and grant no. 31172069 to SXX, ULR: http://www.nsfc.gov.cn/), the Priority Academic Program Development of Jiangsu Higher Education Institutions to GY and SXX, and the Specialized Research Fund for the Doctoral Program of Higher Education to GY (grant no. 20113207130001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Carroll J, 2009, ANAL BIOCHEM, V395, P249, DOI 10.1016/j.ab.2009.08.006; CHAPMAN AD, 2009, NUMBERS LIVING SPECI; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144; Dudley R, 1998, J EXP BIOL, V201, P1043; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Goldsworthy G.J., 1989, INSECT FLIGHT; Goncalves RLS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007854; Grimaldi David, 2005, pi; HOCKING B., 1953, TRANS ROY ENT SOC LONDON, V104, P223; Hughes GM, 1974, LOCOMOTION TERRESTRI; Johnson KP, 2003, MOL PHYLOGENET EVOL, V26, P231, DOI 10.1016/S1055-7903(02)00342-1; JOSEPHSON RK, 1985, J EXP BIOL, V118, P185; Josephson RK, 2000, J EXP BIOL, V203, P2713; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; LEHNINGER A L, 1970, Biochemical Journal, V119, P129; Lindstedt SL, 1998, COMP BIOCHEM PHYS B, V120, P35, DOI 10.1016/S0305-0491(98)00021-2; MARSHALL AG, 1981, ECOLOGY ECTOPARASITI; Mayhew PJ, 2003, BIOL J LINN SOC, V80, P23, DOI 10.1046/j.1095-8312.2003.00217.x; McKenzie M, 2009, METHOD ENZYMOL, V456, P321, DOI 10.1016/S0076-6879(08)04418-2; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Mitterboeck TF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1128; Nei M., 2000, MOL EVOLUTION PHYLOG; Nielsen R, 1998, GENETICS, V148, P929; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; ROFF DA, 1990, ECOL MONOGR, V60, P389, DOI 10.2307/1943013; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Scheffler IE, 1998, PROG NUCLEIC ACID RE, V60, P267, DOI 10.1016/S0079-6603(08)60895-8; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; SMITH DS, 1965, SCI AM, V212, P77; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WAGNER DL, 1992, TRENDS ECOL EVOL, V7, P216, DOI 10.1016/0169-5347(92)90047-F; Wang ZJ, 2005, ANNU REV FLUID MECH, V37, P183, DOI 10.1146/annurev.fluid.36.050802.121940; Weibel ER, 2002, NATURE, V417, P131, DOI 10.1038/417131a; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]; WITHERS PC, 1981, J COMP PHYSIOL, V141, P433, DOI 10.1007/BF01101463; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	44	25	25	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99120	10.1371/journal.pone.0099120	http://dx.doi.org/10.1371/journal.pone.0099120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918926	Green Submitted, gold, Green Published			2022-12-25	WOS:000338631000050
J	Ammendola, M; Sacco, R; Sammarco, G; Donato, G; Montemurro, S; Ruggieri, E; Patruno, R; Marech, I; Cariello, M; Vacca, A; Gadaleta, CD; Ranieri, G				Ammendola, Michele; Sacco, Rosario; Sammarco, Giuseppe; Donato, Giuseppe; Montemurro, Severino; Ruggieri, Eustachio; Patruno, Rosa; Marech, Ilaria; Cariello, Marica; Vacca, Angelo; Gadaleta, Cosmo Damiano; Ranieri, Girolamo			Correlation between Serum Tryptase, Mast Cells Positive to Tryptase and Microvascular Density in Colo-Rectal Cancer Patients: Possible Biological-Clinical Significance	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; THYMIDINE PHOSPHORYLASE EXPRESSION; PROGNOSTIC-SIGNIFICANCE; MICROVESSEL DENSITY; CARCINOMA CELLS; ANGIOGENESIS; TUMOR; CHYMASE; METASTASIS; CONTRIBUTE	Background: Tryptase is a serin protease stored and released from mast cells (MCs) that plays a role in tumour angiogenesis. In this study we aimed to evaluate serum tryptase levels in colo-rectal cancer (CRC) patients before (STLBS) and after (STLAS) radical surgical resection. We also evaluated mast cell density positive to tryptase (MCDPT) and microvascular density (MVD) in primary tumour tissue. Methods: A series of 61 patients with stage B and C CRC (according to the Astler and Coller staging system) were selected. Serum blood samples were collected from patients one day before and one day after surgery. Tryptase levels were measured using the UniCAP Tryptase Fluoroenzymeimmunoassay (Pharmacia, Uppsala, Sweden). Tumour sections were immunostained with a primary anti-tryptase antibody (clone AA1; Dako, Glostrup, Denmark) and an anti CD-34 antibody (QB-END 10; Bio-Optica Milan, Italy) by means of immunohistochemistry and then evaluated by image analysis methods. Results: The mean +/- s.d. STLBS and STLAS was 5.63 +/- 2.61 mu g/L, and 3.39 +/- 1.47 mu g/L respectively and a significant difference between mean levels was found: p = 0.000 by t-test. The mean +/- s.d. of MCDPT and MVD was 8.13 +/- 3.28 and 29.16 +/- 7.39 respectively. A strong correlation between STLBS and MVD (r = 0.83, p = 0.000); STLBS and MCDPT (r = 0.60, p = 0.003); and MCDPT and MVD (r = 0.73; p = 0.001) was found. Conclusion: Results demonstrated higher STLBS in CRC patients, indicating an involvement of MC tryptase in CRC angiogenesis. Data also indicated lower STLAS, suggesting the release of tryptase from tumour-infiltrating MCs. Serum tryptase levels may therefore play a role as a novel bio-marker predictive of response to radical surgery. In this context tryptase inhibitors such as Gabexate and Nafamostat Mesilate might be evaluated in adjuvant clinical trials as a new anti-angiogenic approach.	[Ammendola, Michele; Sacco, Rosario; Sammarco, Giuseppe] Univ Catanzaro Magna Graecia, Sch Med, Clin Surg Unit, Dept Med & Surg Sci, Catanzaro, Italy; [Ammendola, Michele; Montemurro, Severino; Ruggieri, Eustachio] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Surg Unit, Bari, Italy; [Donato, Giuseppe] Univ Catanzaro Magna Graecia, Sch Med, Pathol Unit, Dept Med & Surg Sci, Catanzaro, Italy; [Patruno, Rosa] ASL BAT, Dept Hlth, Bari, Italy; [Marech, Ilaria; Cariello, Marica; Gadaleta, Cosmo Damiano; Ranieri, Girolamo] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Integrated Sect Translat Med Oncol, Intervent Radiol Unit, Bari, Italy; [Vacca, Angelo] Univ Bari, Sch Med, Dept Biomed Sci, Bari, Italy; [Vacca, Angelo] Univ Bari, Sch Med, Human Oncol Clin Med G Baccelli, Bari, Italy	Magna Graecia University of Catanzaro; IRCCS Istituto Tumori Bari Giovanni Paolo II; Magna Graecia University of Catanzaro; IRCCS Istituto Tumori Bari Giovanni Paolo II; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Ranieri, G (corresponding author), Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Integrated Sect Translat Med Oncol, Intervent Radiol Unit, Bari, Italy.	giroran@tiscalinet.it	Cariello, Marica/K-4064-2018; ruggieri, eustachio/AAJ-5531-2020; Vacca, Angelo/AAC-9558-2022; Sammarco, Giuseppe/ABG-8058-2020; Gadaleta, Cosmo Damiano/AAJ-8712-2020; Ranieri, Girolamo/AAJ-7929-2020; DONATO, GIUSEPPE/E-1080-2016; Marech, Ilaria/AAI-3779-2020	ruggieri, eustachio/0000-0002-0142-3289; Vacca, Angelo/0000-0002-4567-8216; Sammarco, Giuseppe/0000-0003-2898-9626; Ranieri, Girolamo/0000-0002-7952-694X; DONATO, GIUSEPPE/0000-0002-3065-5492; Gadaleta, Cosmo Damiano/0000-0003-2398-691X				Ammendola M, 2013, GASTROENT RES PRACT, V2013; Ammendola M, 2013, ONCOLOGY-BASEL, V85, P111, DOI 10.1159/000351145; Ammendola M, 2013, UPDATES SURG-ITALY, V65, P53, DOI 10.1007/s13304-012-0183-y; Angenete E, 2012, INT J COLORECTAL DIS, V27, P1267, DOI 10.1007/s00384-012-1463-1; ASTLER VB, 1954, ANN SURG, V139, P846, DOI 10.1097/00000658-195406000-00015; Attoub S, 2002, CANCER RES, V62, P4879; Bellone G, 2001, CANCER RES, V61, P2200; Bellone G, 1997, J CELL PHYSIOL, V172, P1, DOI 10.1002/(SICI)1097-4652(199707)172:1<1::AID-JCP1>3.0.CO;2-S; Ch'ng S, 2006, MODERN PATHOL, V19, P149, DOI 10.1038/modpathol.3800474; DETHLEFSEN SM, 1994, INVAS METAST, V14, P395; Elpek GO, 2001, J CLIN PATHOL, V54, P940, DOI 10.1136/jcp.54.12.940; Fajardo I, 2003, J IMMUNOL, V171, P1493, DOI 10.4049/jimmunol.171.3.1493; Garlipp B, 2012, BRIT J SURG, V99, P714, DOI 10.1002/bjs.8692; Gulubova M, 2009, J GASTROEN HEPATOL, V24, P1265, DOI 10.1111/j.1440-1746.2007.05009.x; Hallgren J, 2001, BIOCHEMISTRY-US, V40, P7342, DOI 10.1021/bi001988c; Hallgren J, 2006, FEBS J, V25, P234; Igarashi M, 1998, CANCER, V82, P1225, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1225::AID-CNCR3>3.0.CO;2-E; Kankkunen JP, 1997, INT J CANCER, V72, P385, DOI 10.1002/(SICI)1097-0215(19970729)72:3<385::AID-IJC1>3.0.CO;2-L; Khan JS, 2011, ANN ROY COLL SURG, V93, P603, DOI 10.1308/147870811X13137608455299; Kondo K, 2006, J SURG ONCOL, V93, P36, DOI 10.1002/jso.20394; Liu Y, 2006, BIOCHEM BIOPH RES CO, V344, P1263, DOI 10.1016/j.bbrc.2006.04.005; Mangia A, 2011, HISTOPATHOLOGY, V58, P1096, DOI 10.1111/j.1365-2559.2011.03842.x; Nakashima M, 2011, SURG LAPARO ENDO PER, V21, P415, DOI 10.1097/SLE.0b013e31823aca96; Nico B, 2008, STEM CELLS DEV, V17, P19, DOI 10.1089/scd.2007.0132; Patruno R, 2009, J CELL MOL MED, V13, P555, DOI 10.1111/j.1582-4934.2008.00355.x; Patruno R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/730246; Polverini PJ, 1996, EUR J CANCER, V32A, P2430, DOI 10.1016/S0959-8049(96)00386-3; Ranieri G, 2007, J CELL MOL MED, V11, P362, DOI 10.1111/j.1582-4934.2007.00007.x; Ranieri G, 2003, ONCOL REP, V10, P1189; Ranieri G, 2004, ONCOL REP, V12, P817; Ranieri G, 2013, CRIT REV ONCOL HEMAT, V88, P187, DOI 10.1016/j.critrevonc.2013.03.005; Ranieri G, 2004, ONCOL REP, V11, P435; Ranieri G, 2012, CURR MED CHEM, V19, P938, DOI 10.2174/092986712799320736; Ranieri G, 2001, Acta Otorhinolaryngol Ital, V21, P171; Ranieri G, 2002, INT J ONCOL, V21, P1317; Ranieri G, 2009, INT J ONCOL, V35, P115, DOI 10.3892/ijo_00000319; Ratto C, 2011, DIS COLON RECTUM, V54, pE232, DOI 10.1097/DCR.0b013e31821def52; Ribatti D, 1999, BRIT J CANCER, V79, P451, DOI 10.1038/sj.bjc.6690070; Ribatti D, 2011, INT J DEV BIOL, V55, P99, DOI 10.1387/ijdb.103138dr; SCHWARTZ LB, 1989, J CLIN INVEST, V83, P1551, DOI 10.1172/JCI114051; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; TAKAHASHI Y, 1995, CANCER RES, V55, P3964; Takanami I, 2000, CANCER, V88, P2686, DOI 10.1002/1097-0142(20000615)88:12<2686::AID-CNCR6>3.0.CO;2-6; Tonnesen MG, 1997, J CLIN INVEST, V99, P2691; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yano Hiroshi, 1999, Gastric Cancer, V2, P26, DOI 10.1007/s101200050017	46	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99512	10.1371/journal.pone.0099512	http://dx.doi.org/10.1371/journal.pone.0099512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915568	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700109
J	Everatt, KT; Andresen, L; Somers, MJ				Everatt, Kristoffer T.; Andresen, Leah; Somers, Michael J.			Trophic Scaling and Occupancy Analysis Reveals a Lion Population Limited by Top-Down Anthropogenic Pressure in the Limpopo National Park, Mozambique	PLOS ONE			English	Article							PANTHERA-LEO; SOCIAL-ORGANIZATION; PREY CHOICE; HABITAT; CONSERVATION; EXTINCTION; PROTECTION; CARNIVORES; PREDATORS; DENSITY	The African lion (Panthera Leo) has suffered drastic population and range declines over the last few decades and is listed by the IUCN as vulnerable to extinction. Conservation management requires reliable population estimates, however these data are lacking for many of the continent's remaining populations. It is possible to estimate lion abundance using a trophic scaling approach. However, such inferences assume that a predator population is subject only to bottom-up regulation, and are thus likely to produce biased estimates in systems experiencing top-down anthropogenic pressures. Here we provide baseline data on the status of lions in a developing National Park in Mozambique that is impacted by humans and livestock. We compare a direct density estimate with an estimate derived from trophic scaling. We then use replicated detection/non-detection surveys to estimate the proportion of area occupied by lions, and hierarchical ranking of covariates to provide inferences on the relative contribution of prey resources and anthropogenic factors influencing lion occurrence. The direct density estimate was less than 1/3 of the estimate derived from prey resources (0.99 lions/100 km(2) vs. 3.05 lions/100 km(2)). The proportion of area occupied by lions was Psi= 0.439 (SE = 0.121), or approximately 44% of a 2 400 km(2) sample of potential habitat. Although lions were strongly predicted by a greater probability of encountering prey resources, the greatest contributing factor to lion occurrence was a strong negative association with settlements. Finally, our empirical abundance estimate is approximately 1/3 of a published abundance estimate derived from opinion surveys. Altogether, our results describe a lion population held below resource-based carrying capacity by anthropogenic factors and highlight the limitations of trophic scaling and opinion surveys for estimating predator populations exposed to anthropogenic pressures. Our study provides the first empirical quantification of a population that future change can be measured against.	[Everatt, Kristoffer T.; Andresen, Leah; Somers, Michael J.] Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa; [Somers, Michael J.] Univ Pretoria, Ctr Invas Biol, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	Everatt, KT (corresponding author), Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa.	kteveratt@gmail.com	/A-1523-2008	/0000-0002-5836-8823	May and Stanley Smith Trust; Wipplinger KL Bursary Found; Wilderness Wildlife Trust; Canada National Student Grants	May and Stanley Smith Trust; Wipplinger KL Bursary Found; Wilderness Wildlife Trust; Canada National Student Grants	KTE and LA were supported by the May and Stanley Smith Trust, The Wipplinger KL Bursary Found, Wilderness Wildlife Trust and Canada National Student Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARD MS, 1993, HUM ECOL, V21, P355, DOI 10.1007/BF00891140; Barber-Meyer SM, 2013, J ZOOL, V289, P10, DOI 10.1111/j.1469-7998.2012.00956.x; Bauer H, 2003, CR BIOL, V326, pS112, DOI 10.1016/S1631-0691(03)00047-7; Bauer H, 2010, MAMMALIA, V74, P363, DOI 10.1515/MAMM.2010.048; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Chardonnet P, 2009, CONSERVATION S UNPUB; Ciarniello LM, 2007, ECOL APPL, V17, P1424, DOI 10.1890/06-1100.1; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Ferreira SM, 2010, WILDLIFE RES, V37, P194, DOI 10.1071/WR09030; Funston PJ, 2003, J ZOOL, V259, P131, DOI 10.1017/S0952836902003126; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Gertenbach W. P. D., 1980, Koedoe, V23, P35; Hanks John, 2000, Conservation Biology Series (Cambridge), V3, P239; Hatton J., 2001, BIODIVERSITY WAR CAS; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hebblewhite M, 2011, BIOL CONSERV, V144, P2403, DOI 10.1016/j.biocon.2011.03.020; Henschel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083500; Hines, 2017, OCCUPANCY ESTIMATION; Hines JE., 2006, PRESENCESOFTWARE EST; Huggins G., 2003, LIMPOPO NATL P UNPUB; Iucn Cat Specialist Group, 2006, REG CONS STRAT LION; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Kiffner C, 2009, ORYX, V43, P52, DOI 10.1017/S0030605307002335; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mills MGL, 2001, ANIM CONSERV, V4, P335, DOI 10.1017/S1367943001001391; Ogutu JO, 2005, J ZOOL, V265, P281, DOI 10.1017/S0952836904006302; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Ray J.C., 2005, 24 WILDL CONS SOC; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Rowcliffe JM, 2004, P ROY SOC B-BIOL SCI, V271, P2631, DOI 10.1098/rspb.2004.2915; Schaller G. B., 1972, SERENGETI LION STUDY; SMUTS GL, 1978, CARNIVORE, V1, P17; Stalmans M., 2004, Koedoe, V47, P61; Stephensen A., 2010, PARQUE NACL LI UNPUB; Treves A, 2009, ORYX, V43, P60, DOI 10.1017/S003060530700124X; VANORSDOL KG, 1985, J ZOOL, V206, P97; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1; Woodroffe R, 2005, ANIM CONSERV, V8, P91, DOI 10.1017/S1367943004001829; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	45	24	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99389	10.1371/journal.pone.0099389	http://dx.doi.org/10.1371/journal.pone.0099389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914934	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700095
J	Firdaus, R; Biswas, A; Saha, K; Mukherjee, A; Chaudhuri, S; Chandra, A; Konar, A; Sadhukhan, PC				Firdaus, Rushna; Biswas, Aritra; Saha, Kallol; Mukherjee, Anirban; Chaudhuri, Sujit; Chandra, Alok; Konar, Asokananda; Sadhukhan, Provash Chandra			Impact of Host IL28B rs12979860, rs8099917 in Interferon Responsiveness and Advanced Liver Disease in Chronic Genotype 3 Hepatitis C Patients	PLOS ONE			English	Article							PLUS RIBAVIRIN; VIRUS; POLYMORPHISM; ASSOCIATION; THERAPY; PATTERN	Background and Aims: Genetic polymorphisms near interleukin 28B gene are associated with spontaneous and treatment induced clearance of hepatitis C virus (HCV). Our objective was to evaluate the impact of interleukin 28B single nucleotide polymorphism (rs12979860, rs8099917) variability in HCV genotype 3 infected populations. Methods: 400 hepatitis C seroreactive patients from different population groups in Eastern and North Eastern part of India were assessed for host and viral genotypic analysis. 83 HCV genotype 3 infected patients were administered pegylated interferon-ribavirin therapy. Viral genotyping was performed using nested reverse transcriptase-PCR followed by direct sequencing methods. Host interleukin 28B genotyping was performed using real-time PCR based single nucleotide polymorphism analysis. Results: Out of 400 hepatitis C seroreactive individuals, 73.25% were found to be RNA positive. HCV genotype 3 (65.87%) was found to be the major circulating strain in this region followed by genotype 1 (32.08%). rs12979860 CC genotype was significantly associated with sustained virological response in HCV genotype 3 infected population. In patients achieving rapid virological response, favourable CC/TT allele at rs12979860, rs8099917 was found to be predominant at both the alleles at 77%, 73.2% respectively; whereas in case of patients with relapsed HCV infection CT, TG alleles were found to be predominant. Additionally, CC genotypes at rs12979860 were found to be associated with sustained virological response in patients with high viral load (OR = 6.75, 0.05<p). HCV unfavourable rs12979860 TT, rs8099917 GG alleles were present in 34%, 27.6% patients with relapsed HCV infection respectively. Also unfavourable CT, TG genotypes were found to be predominant in patients with advanced stages of liver disease. Conclusion: CC, TT the two favourable markers at SNPs rs12979860 and rs8099917 are strongly associated with sustained virological response in genotype 3 infected populations. This information will aid clinicians to effectively design response based treatment regimen.	[Firdaus, Rushna; Biswas, Aritra; Saha, Kallol; Mukherjee, Anirban; Sadhukhan, Provash Chandra] Indian Council Med Res, ICMR Virus Unit Kolkata, Kolkata, India; [Chaudhuri, Sujit] AMRI Hosp Salt Lake, Dept Gastroenterol, Kolkata, India; [Chandra, Alok] Command Hosp, Dept Med & Gastroenterol, Kolkata, India; [Konar, Asokananda] Peerless Hosp, Dept Gastroenterol, Kolkata, India; [Konar, Asokananda] BK Roy Res Ctr, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata	Sadhukhan, PC (corresponding author), Indian Council Med Res, ICMR Virus Unit Kolkata, Kolkata, India.	provash2000@gmail.com		chaudhuri, sujit/0000-0002-6637-2961; SAHA, KALLOL/0000-0002-2292-340X	Indian Council of Medical Research, India	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This work was supported by Indian Council of Medical Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2012, J HEPATOL, V52, P452; Bruno S, 1997, HEPATOLOGY, V25, P754, DOI 10.1002/hep.510250344; Castera L, 2004, GUT, V53, P420, DOI 10.1136/gut.2002.009936; Chakravarti A, 2011, INDIAN J MED RES, V133, P326; Das B R, 2002, Indian J Pathol Microbiol, V45, P323; Ezzikouri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054793; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gonzalez Stevan A, 2011, Gastroenterol Hepatol (N Y), V7, P366; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; Kiser JJ, 2013, ANNU REV PHARMACOL, V53, P427, DOI 10.1146/annurev-pharmtox-011112-140254; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lutz P, 2011, EUR J MED RES, V16, P335, DOI 10.1186/2047-783X-16-8-335; McHutchison JG, 2000, GASTROENTEROLOGY, V119, P1317, DOI 10.1053/gast.2000.19289; Omata M, 2012, HEPATOL INT, V6, P409, DOI 10.1007/s12072-012-9342-y; Rembeck K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029370; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Saha K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-116; Sivaprasad S, 2012, J CLIN EXP HEPATOL, V2, P112, DOI 10.1016/S0973-6883(12)60098-X; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Watson J C, 1998, MMWR Recomm Rep, V47, P1; WHO (World Health Organization), HEP C SURV CONTR	25	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99126	10.1371/journal.pone.0099126	http://dx.doi.org/10.1371/journal.pone.0099126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914551	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700065
J	Jacomy, M; Venturini, T; Heymann, S; Bastian, M				Jacomy, Mathieu; Venturini, Tommaso; Heymann, Sebastien; Bastian, Mathieu			ForceAtlas2, a Continuous Graph Layout Algorithm for Handy Network Visualization Designed for the Gephi Software	PLOS ONE			English	Article								Gephi is a network visualization software used in various disciplines (social network analysis, biology, genomics...). One of its key features is the ability to display the spatialization process, aiming at transforming the network into a map, and ForceAtlas2 is its default layout algorithm. The latter is developed by the Gephi team as an all-around solution to Gephi users' typical networks (scale-free, 10 to 10,000 nodes). We present here for the first time its functioning and settings. ForceAtlas2 is a force-directed layout close to other algorithms used for network spatialization. We do not claim a theoretical advance but an attempt to integrate different techniques such as the Barnes Hut simulation, degree-dependent repulsive force, and local and global adaptive temperatures. It is designed for the Gephi user experience (it is a continuous algorithm), and we explain which constraints it implies. The algorithm benefits from much feedback and is developed in order to provide many possibilities through its settings. We lay out its complete functioning for the users who need a precise understanding of its behaviour, from the formulas to graphic illustration of the result. We propose a benchmark for our compromise between performance and quality. We also explain why we integrated its various features and discuss our design choices.	[Jacomy, Mathieu; Venturini, Tommaso] Medialab, Sci Po, Paris, France; [Jacomy, Mathieu] Equipex DIME SHS, Paris, France; [Jacomy, Mathieu; Heymann, Sebastien; Bastian, Mathieu] Gephi Consortium, Paris, France; [Heymann, Sebastien] Univ Paris 06, CNRS, LIP6, Paris, France	Institut d'Etudes Politiques Paris (Sciences Po); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Jacomy, M (corresponding author), Medialab, Sci Po, Paris, France.	mathieu.jacomy@sciencespo.fr	Venturini, Tommaso/B-1472-2016; Jacomy, Mathieu/AAD-5386-2019	Venturini, Tommaso/0000-0003-0004-5308; Jacomy, Mathieu/0000-0002-6417-6895				Adar E., 2006, Conference on Human Factors in Computing Systems. CHI2006, P791; BARNES J, 1986, NATURE, V324, P446, DOI 10.1038/324446a0; Bastian M., 2009, P 3 INT C WEBLOGS SO, DOI DOI 10.13140/2.1.1341.1520; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Davidson R, 1996, ACM T GRAPHIC, V15, P301, DOI 10.1145/234535.234538; Diminescu D, 2008, SOC SCI INFORM, V47, P565, DOI 10.1177/0539018408096447; Eades P., 1984, C NUMERANTIUM, V42, P149; Frick A, 1994, FAST ADAPTIVE LAYOUT; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Hu Y, 2005, MATH J 10, V10, P37, DOI DOI 10.3402/QHW.V6I2.5918; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Krzywinski M, 2012, BRIEF BIOINFORM, V13, P627, DOI 10.1093/bib/bbr069; Martin S, 2011, SPIE C SERIES, V7868; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, ARXIVCONDMAT0407503; Noack Andreas, 2007, Journal of Graph Algorithms and Applications, V11, P453, DOI 10.7155/jgaa.00154; Noack A., 2007, THESIS BRANDENBURGIS; Noack Andreas, 2009, Phys Rev E Stat Nonlin Soft Matter Phys, V79, P026102, DOI 10.1103/PhysRevE.79.026102; Purchase HC, 2002, J VISUAL LANG COMPUT, V13, P501, DOI 10.1006/S1045-926X(02)00016-2; Walshaw C., 2001, Graph Drawing. 8th International Symposium, GD 2000. Proceedings (Lecture Notes in Computer Science Vol.1984), P171	21	1128	1158	27	182	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98679	10.1371/journal.pone.0098679	http://dx.doi.org/10.1371/journal.pone.0098679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914678	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700030
J	Mehaney, DA; Darwish, HA; Hegazy, RA; Nooh, MM; Tawdy, AM; Gawdat, HI; El-Sawalhi, MM				Mehaney, Dina A.; Darwish, Hebatallah A.; Hegazy, Rehab A.; Nooh, Mohammed M.; Tawdy, Amira M.; Gawdat, Heba I.; El-Sawalhi, Maha M.			Analysis of Oxidative Stress Status, Catalase and Catechol-O-Methyltransferase Polymorphisms in Egyptian Vitiligo Patients	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; GENE POLYMORPHISMS; ANTIOXIDANT STATUS; T/C EXON-9; ASSOCIATION; SUSCEPTIBILITY; BLOOD; COMT; IDENTIFICATION; EPIDERMIS	Vitiligo is the most common depigmentation disorder of the skin. Oxidative stress is implicated as one of the probable events involved in vitiligo pathogenesis possibly contributing to melanocyte destruction. Evidence indicates that certain genes including those involved in oxidative stress and melanin synthesis are crucial for development of vitiligo. This study evaluates the oxidative stress status, the role of catalase (CAT) and catechol-O-Methyltransferase (COMT) gene polymorphisms in the etiology of generalized vitiligo in Egyptians. Total antioxidant capacity (TAC) and malondialdehyde (MDA) levels as well as CAT exon 9 T/C and COMT 158 G/A polymorphisms were determined in 89 patients and 90 age and sex-matched controls. Our results showed significantly lower TAC along with higher MDA levels in vitiligo patients compared with controls. Meanwhile, genotype and allele distributions of CAT and COMT polymorphisms in cases were not significantly different from those of controls. Moreover, we found no association between both polymorphisms and vitiligo susceptibility. In conclusion, the enhanced oxidative stress with the lack of association between CAT and COMT polymorphisms and susceptibility to vitiligo in our patients suggest that mutations in other genes related to the oxidative pathway might contribute to the etiology of generalized vitiligo in Egyptian population.	[Mehaney, Dina A.] Cairo Univ, Fac Med, Clin & Chem Pathol Dept, Cairo, Egypt; [Darwish, Hebatallah A.; Nooh, Mohammed M.; El-Sawalhi, Maha M.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Hegazy, Rehab A.; Tawdy, Amira M.; Gawdat, Heba I.] Cairo Univ, Fac Med, Dept Dermatol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Nooh, MM (corresponding author), Cairo Univ, Fac Med, Clin & Chem Pathol Dept, Cairo, Egypt.	mohamed.nooh@pharma.cu.edu.eg		El-Sawalhi, Maha/0000-0002-6598-4392; Darwish, Hebatallah/0000-0001-5482-5559; Nooh, Mohammed/0000-0001-9794-4099	Medical Research Service of the Cairo University	Medical Research Service of the Cairo University(Cairo University)	This research was officially supported by the Medical Research Service of the Cairo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbas H, 2013, CLIN TER, V164, pE173, DOI 10.7417/CT.2013.1564; Andersen S, 2009, PHARMACOGENOMICS, V10, P669, DOI 10.2217/PGS.09.13; Arican O, 2008, ACTA DERMATOVEN ALP, V17, P12; Birlea SA, 2013, J INVEST DERMATOL, V133, P1369, DOI 10.1038/jid.2012.501; Birlea SA, 2011, J INVEST DERMATOL, V131, P371, DOI 10.1038/jid.2010.337; Boisseau-Garsaud AM, 2002, INT J DERMATOL, V41, P640, DOI 10.1046/j.1365-4362.2002.01472.x; Bulut H, 2011, GENET MOL RES, V10, P4126, DOI 10.4238/2011.October.31.12; Casp CB, 2002, PIGM CELL RES, V15, P62, DOI 10.1034/j.1600-0749.2002.00057.x; Dell'Anna ML, 2006, PIGM CELL RES, V19, P406, DOI 10.1111/j.1600-0749.2006.00333.x; Em S, 2007, PIGM CELL RES, V20, P405, DOI 10.1111/j.1600-0749.2007.00406.x; Erdal ME, 2003, DEPRESS ANXIETY, V18, P41, DOI 10.1002/da.10114; Foltynie T, 2004, MOVEMENT DISORD, V19, P885, DOI 10.1002/mds.20118; Gauthier Y, 2003, PIGM CELL RES, V16, P322, DOI 10.1034/j.1600-0749.2003.00070.x; Gavalas NG, 2006, BIOCHEM BIOPH RES CO, V345, P1586, DOI 10.1016/j.bbrc.2006.05.063; Goth L, 2000, LANCET, V356, P1820, DOI 10.1016/S0140-6736(00)03238-4; Goth L, 2001, ELECTROPHORESIS, V22, P49, DOI 10.1002/1522-2683(200101)22:1<49::AID-ELPS49>3.0.CO;2-W; Harrison PJ, 2008, NEUROPSYCHOPHARMACOL, V33, P3037, DOI 10.1038/sj.npp.1301543; Ines D, 2006, ARCH DERMATOL RES, V298, P147, DOI 10.1007/s00403-006-0680-2; Jain D, 2008, Indian J Physiol Pharmacol, V52, P297; Kawakami T, 2011, DERMAT RES PRACT, V2011, DOI 10.1155/2011/750342; Khan R, 2009, ARCH DERMATOL RES, V301, P731, DOI 10.1007/s00403-009-0964-4; Koracevic D, 2001, J CLIN PATHOL, V54, P356, DOI 10.1136/jcp.54.5.356; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Laddha NC, 2013, FREE RADICAL BIO MED, V65, P1110, DOI 10.1016/j.freeradbiomed.2013.08.189; Laddha NC, 2013, EXP DERMATOL, V22, P245, DOI 10.1111/exd.12103; LAHIRI DK, 1993, BIOCHEM GENET, V31, P321, DOI 10.1007/BF00553174; Li K, 2009, ARCH DERMATOL RES, V301, P681, DOI 10.1007/s00403-008-0920-8; Liu L, 2010, J INVEST DERMATOL, V130, P2647, DOI 10.1038/jid.2010.192; LUNDSTROM K, 1995, BBA-PROTEIN STRUCT M, V1251, P1, DOI 10.1016/0167-4838(95)00071-2; Malhotra N, 2013, J CUTAN MED SURG, V17, P153, DOI 10.2310/7750.2012.12005; Mandelcorn-Monson RL, 2003, J INVEST DERMATOL, V121, P550, DOI 10.1046/j.1523-1747.2003.12413.x; Maresca V, 1997, J INVEST DERMATOL, V109, P310, DOI 10.1111/1523-1747.ep12335801; Njoo MD, 1999, ARCH DERMATOL, V135, P407, DOI 10.1001/archderm.135.4.407; Park HH, 2006, EXP DERMATOL, V15, P377, DOI 10.1111/j.0906-6705.2006.00423.x; Passeron T, 2005, J AUTOIMMUN, V25, P63, DOI 10.1016/j.jaut.2005.10.001; PAVEL S, 1983, J CANCER RES CLIN, V105, P275, DOI 10.1007/BF00395758; Pichler R, 2009, WIEN MED WOCHENSCHR, V159, P337, DOI 10.1007/s10354-009-0699-z; Roberti JW, 2006, J COLL COUNS, V9, P135, DOI 10.1002/j.2161-1882.2006.tb00100.x; Schallreuter KU, 2007, BIOCHEM BIOPH RES CO, V360, P70, DOI 10.1016/j.bbrc.2007.05.218; Schallreuter KU, 2008, J INVEST DERMATOL, V128, P808, DOI 10.1038/sj.jid.5701100; Schallreuter KU, 2007, LIFE SCI, V80, P2221, DOI 10.1016/j.lfs.2007.01.028; SCHALLREUTER KU, 1991, J INVEST DERMATOL, V97, P1081, DOI 10.1111/1523-1747.ep12492612; Schallreuter KU, 2001, J INVEST DERMATOL, V116, P167, DOI 10.1046/j.1523-1747.2001.00220.x; Shajil E. M., 2006, Indian Journal of Experimental Biology, V44, P526; Singh A, 2012, J INVEST DERMATOL, V132, P124, DOI 10.1038/jid.2011.240; Singh S, 2011, EGYPTIAN DERMATOL ON, V7, P1; Spritz Richard A., 2008, V10, P244, DOI 10.1159/000131501; Spritz RA, 2011, J GENET GENOMICS, V38, P271, DOI 10.1016/j.jgg.2011.05.005; Sravani PV, 2009, INDIAN J DERMATOL VE, V75, P268, DOI 10.4103/0378-6323.48427; Tunbridge EM, 2010, INT REV NEUROBIOL, V95, P7, DOI [10.1016/B978-0-12-381326-8-00002-8, 10.1016/B978-0-12-381326-8.00002-8]; Tursen U, 2002, ARCH DERMATOL RES, V294, P143, DOI 10.1007/s00403-002-0295-1; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Westerhof W, 2011, EXP DERMATOL, V20, P92, DOI 10.1111/j.1600-0625.2010.01200.x; Zhang XJ, 2005, J DERMATOL SCI, V39, P137, DOI 10.1016/j.jdermsci.2005.06.004	54	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99286	10.1371/journal.pone.0099286	http://dx.doi.org/10.1371/journal.pone.0099286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915010	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700078
J	Mor, M; Mulla, W; Elyagon, S; Gabay, H; Dror, S; Etzion, Y; Liel-Cohen, N				Mor, Michal; Mulla, Wesam; Elyagon, Sigal; Gabay, Hovav; Dror, Shani; Etzion, Yoram; Liel-Cohen, Noah			Speckle-Tracking Echocardiography Elucidates the Effect of Pacing Site on Left Ventricular Synchronization in the Normal and Infarcted Rat Myocardium	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; REGIONAL GENE-EXPRESSION; HEART-FAILURE; STRAIN ANALYSIS; SCAR BURDEN; DYSSYNCHRONY; MOUSE; MODEL; MECHANISMS; PREDICTOR	Background: Right ventricular (RV) pacing generates regional disparities in electrical activation and mechanical function (ventricular dyssynchrony). In contrast, left ventricular (LV) or biventricular (BIV) pacing can improve cardiac efficiency in the setting of ventricular dyssynchrony, constituting the rationale for cardiac resynchronization therapy (CRT). Animal models of ventricular dyssynchrony and CRT currently relay on large mammals which are expensive and not readily available to most researchers. We developed a methodology for double-site epicardial pacing in conscious rats. Here, following postoperative recovery, we compared the effects of various pacing modes on LV dyssynchrony in normal rats and in rats with ischemic cardiomyopathy. Methods: Two bipolar electrodes were implanted in rats as follows: Group A (n = 6) right atrial (RA) and RV sites; Group B (n = 7) RV and LV sites; Group C (n = 8) as in group B in combination with left coronary artery ligation. Electrodes were exteriorized through the back. Following post-operative recovery, two-dimensional transthoracic echocardiography was performed during pacing through the different electrodes. Segmental systolic circumferential strain (Ecc) was used to evaluate LV dyssynchrony. Results: In normal rats, RV pacing induced marked LV dyssynchrony compared to RA pacing or sinus rhythm, as measured by the standard deviation (SD) of segmental time to peak Ecc, SD of peak Ecc, and the average delay between opposing ventricular segments. LV pacing and, to a greater extend BIV pacing diminished the LV dyssynchrony compared to RV pacing. In rats with extensive MI, the effects of LV and BIV pacing were markedly attenuated, and the response of individual animals was variable. Conclusions: Rodent cardiac pacing mimics important features seen in humans. This model may be developed as a simple new tool to study the pathophysiology of ventricular dyssynchrony and CRT.	[Mor, Michal; Mulla, Wesam; Elyagon, Sigal; Gabay, Hovav; Dror, Shani; Etzion, Yoram] Ben Gurion Univ Negev, Fac Hlth Sci, Cardiac Arrhythmia Res Lab, Dept Physiol & Cell Biol, Beer Sheva, Israel; [Gabay, Hovav] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Emergency Med, Recanati Sch Community Hlth Profess, Beer Sheva, Israel; [Gabay, Hovav] Ben Gurion Univ Negev, PREPARED Ctr Emergency Response Res, Beer Sheva, Israel; [Etzion, Yoram] Soroka Univ, Med Ctr, Div Internal Med, Beer Sheva, Israel; [Liel-Cohen, Noah] Soroka Univ, Med Ctr, Dept Cardiol, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Etzion, Y (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Cardiac Arrhythmia Res Lab, Dept Physiol & Cell Biol, Beer Sheva, Israel.	tzion@bgu.ac.il	Dror, Shani/ABE-4402-2021; ETZION, YORAM/F-2065-2012	ETZION, YORAM/0000-0002-9930-1035; dror, shani/0000-0002-9909-8110; Mulla, Wesam/0000-0002-7771-6096	Clalit Research Institute, Clalit health services, Israel	Clalit Research Institute, Clalit health services, Israel	This work was supported by a research grant from the Clalit Research Institute, Clalit health services, Israel (Yoram Etzion and Noah Liel-Cohen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein EC, 2011, EUR HEART J, V32, P93, DOI 10.1093/eurheartj/ehq389; Bachner-Hinenzon N, 2012, AM J PHYSIOL-HEART C, V303, pH549, DOI 10.1152/ajpheart.00294.2012; Bachner-Hinenzon N, 2010, AM J PHYSIOL-HEART C, V299, pH664, DOI 10.1152/ajpheart.00017.2010; Bader H, 2004, J AM COLL CARDIOL, V43, P248, DOI 10.1016/j.jacc.2003.08.038; Barth AS, 2009, CIRC-CARDIOVASC GENE, V2, P371, DOI 10.1161/CIRCGENETICS.108.832345; Bilchick KC, 2006, PHYSIOL GENOMICS, V26, P109, DOI 10.1152/physiolgenomics.00281.2005; Bleeker GB, 2006, NAT CLIN PRACT CARD, V3, P213, DOI 10.1038/ncpcardio0505; Bonios M, 2011, J AM SOC ECHOCARDIOG, V24, P808, DOI 10.1016/j.echo.2011.03.003; Chakir K, 2008, CIRCULATION, V117, P1369, DOI 10.1161/CIRCULATIONAHA.107.706291; Cho GY, 2005, J AM COLL CARDIOL, V46, P2237, DOI 10.1016/j.jacc.2004.11.074; Cho HN, 2012, CIRC-ARRHYTHMIA ELEC, V5, P594, DOI 10.1161/CIRCEP.111.962746; Dandel M, 2009, INT J CARDIOL, V132, P11, DOI 10.1016/j.ijcard.2008.06.091; Etzion Y, 2008, AM J PHYSIOL-HEART C, V295, pH1460, DOI 10.1152/ajpheart.00414.2008; Houser SR, 2012, CIRC RES, V111, P131, DOI 10.1161/RES.0b013e3182582523; Janousek J, 2013, CIRCULATION, V127, P613, DOI 10.1161/CIRCULATIONAHA.112.115428; Kaese S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00345; Kashani A, 2005, J AM COLL CARDIOL, V46, P2183, DOI 10.1016/j.jacc.2005.01.071; Kontogeorgis Andrianos, 2008, BMC Physiology, V8, P8, DOI 10.1186/1472-6793-8-8; Laughner JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076291; Leclercq C, 2011, EUR HEART J, V32, P1580, DOI 10.1093/eurheartj/ehr016; Ludwig DR, 2013, J CARDIOVASC TRANSL, V6, P425, DOI 10.1007/s12265-013-9457-0; Nerbonne JM, 2004, TRENDS CARDIOVAS MED, V14, P83, DOI 10.1016/j.tcm.2003.12.006; Popovic ZB, 2007, AM J PHYSIOL-HEART C, V292, pH2809, DOI 10.1152/ajpheart.01176.2006; Prinzen FW, 2011, HEART FAIL REV, V16, P215, DOI 10.1007/s10741-010-9205-3; Prinzen FW, 1999, J AM COLL CARDIOL, V33, P1735, DOI 10.1016/S0735-1097(99)00068-6; Rademakers LM, 2010, CIRC-ARRHYTHMIA ELEC, V3, P361, DOI 10.1161/CIRCEP.109.931865; Rappaport D, 2006, ULTRASOUND MED BIOL, V32, P1181, DOI 10.1016/j.ultrasmedbio.2006.05.005; Rickard J, 2013, HEART RHYTHM, V10, P55, DOI 10.1016/j.hrthm.2012.09.018; Saba S, 2010, CIRC-ARRHYTHMIA ELEC, V3, P79, DOI 10.1161/CIRCEP.109.889741; Salama G, 2007, J PHYSIOL-LONDON, V578, P43, DOI 10.1113/jphysiol.2006.118745; Strik M, 2013, CIRC-ARRHYTHMIA ELEC, V6, P682, DOI 10.1161/CIRCEP.111.000028; Tomaske M, 2009, EUROPACE, V11, P1168, DOI 10.1093/europace/eup178; Tomaske M, 2009, INT J CARDIOL, V136, P136, DOI 10.1016/j.ijcard.2008.04.048; Tops LF, 2009, J AM COLL CARDIOL, V54, P764, DOI 10.1016/j.jacc.2009.06.006; Ypenburg C, 2007, AM J CARDIOL, V99, P657, DOI 10.1016/j.amjcard.2006.09.115	35	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99191	10.1371/journal.pone.0099191	http://dx.doi.org/10.1371/journal.pone.0099191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915191	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700070
J	Rosazza, C; Aquino, D; D'Incerti, L; Cordella, R; Andronache, A; Zaca, D; Bruzzone, MG; Tringali, G; Minati, L				Rosazza, Cristina; Aquino, Domenico; D'Incerti, Ludovico; Cordella, Roberto; Andronache, Adrian; Zaca, Domenico; Bruzzone, Maria Grazia; Tringali, Giovanni; Minati, Ludovico			Preoperative Mapping of the Sensorimotor Cortex: Comparative Assessment of Task-Based and Resting-State fMRI	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; FUNCTIONAL CONNECTIVITY; BRAIN-TUMORS; INTRAOPERATIVE STIMULATION; SPONTANEOUS FLUCTUATIONS; CLINICAL-APPLICATIONS; HEALTHY-VOLUNTEERS; LANGUAGE AREAS; MRI; LOCALIZATION	Resting state fMRI (rs-fMRI) has recently been considered as a possible complement or alternative to task-based fMRI (tb-fMRI) for presurgical mapping. However, evidence of its usefulness remains scant, because existing studies have investigated relatively small samples and focused primarily on qualitative evaluation. The aim of this study is to investigate the clinical usefulness of rs-fMRI in the context of presurgical mapping of motor functions, and in particular to determine the degree of correspondence with tb-fMRI which, while not a gold-standard, is commonly used in preoperative setting. A group of 13 patients with lesions close to the sensorimotor cortex underwent rs-fMRI and tb-fMRI to localize the hand, foot and mouth motor areas. We assessed quantitatively the degree of correspondence between multiple rs-fMRI analyses (independent-component and seed-based analyses) and tb-fMRI, with reference to sensitivity and specificity of rs-fMRI with respect to tb-fMRI, and centre-of-mass distances. Agreement with electro-cortical stimulation (ECS) was also investigated, and a traditional map thresholding approach based on agreement between two experienced operators was compared to an automatic threshold determination method. Rs-fMRI can localize the sensorimotor cortex successfully, providing anatomical specificity for hand, foot and mouth motor subregions, in particular with seed-based analyses. Agreement with tb-fMRI was only partial and rs-fMRI tended to provide larger patterns of correlated activity. With respect to the ECS data available, rs-fMRI and tb-fMRI performed comparably, even though the shortest distance to stimulation points was observed for the latter. Notably, the results of both were on the whole robust to thresholding procedure. Localization performed by rs-fMRI is not equivalent to tb-fMRI, hence rs-fMRI cannot be considered as an outright replacement for tb-fMRI. Nevertheless, since there is significant agreement between the two techniques, rs-fMRI can be considered with caution as a potential alternative to tb-fMRI when patients are unable to perform the task.	[Rosazza, Cristina; Aquino, Domenico; D'Incerti, Ludovico; Andronache, Adrian; Bruzzone, Maria Grazia] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroradiol, Milan, Italy; [Rosazza, Cristina; Minati, Ludovico] Fdn IRCCS Ist Neurol Carlo Besta, Dept Sci, Milan, Italy; [Cordella, Roberto; Tringali, Giovanni] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neurosurg, Milan, Italy; [Zaca, Domenico; Minati, Ludovico] Univ Trento, Ctr Mind Brain Sci CIMeC, Trento, Trento, Italy	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; Italfarmaco; IRCCS Istituto Neurologico Besta; University of Trento	Rosazza, C (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroradiol, Milan, Italy.	cristina.rosazza@istituto-besta.it	Minati, Ludovico/R-1076-2017; zaca, domenico/AAM-4360-2020; Aquino, Domenico/AAK-3047-2021; Rosazza, Cristina/B-3959-2016; Bruzzone, Maria/AAM-4478-2021; Tringali, Giovanni/E-1834-2014	Minati, Ludovico/0000-0002-2532-1674; Aquino, Domenico/0000-0002-1289-9573; Rosazza, Cristina/0000-0002-7799-415X; Bruzzone, Maria/0000-0002-2786-1471; cordella, roberto/0000-0003-4803-2952; Tringali, Giovanni/0000-0003-1493-4034; D'Incerti, Ludovico/0000-0002-4092-9290	Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; Scienze Mente-Cervello (Rovereto, Italy)	Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; Scienze Mente-Cervello (Rovereto, Italy)	This study was funded by the Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy, without involvement of external funders in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors were funded by their respective institutions during the study period. LM gratefully acknowledges additional funding by Scienze Mente-Cervello (Rovereto, Italy).	Alkadhi H, 2002, AM J NEURORADIOL, V23, P1524; Andronache A, 2013, FRONT NEUROINFORM, V22, P7; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bizzi A, 2008, RADIOLOGY, V248, P579, DOI 10.1148/radiol.2482071214; Bizzi A, 2009, NEUROIMAG CLIN N AM, V19, P573, DOI 10.1016/j.nic.2009.08.010; Blatow M, 2011, J MAGN RESON IMAGING, V34, P429, DOI 10.1002/jmri.22629; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Churchill NW, 2013, NEUROIMAGE, V82, P306, DOI 10.1016/j.neuroimage.2013.05.102; Cordella R, 2013, CLIN NEUROPHYSIOL, V124, P1244, DOI 10.1016/j.clinph.2012.11.005; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Fandino J, 1999, J NEUROSURG, V91, P238, DOI 10.3171/jns.1999.91.2.0238; Fesl G, 2008, EUR RADIOL, V18, P1031, DOI 10.1007/s00330-008-0850-z; Francis S, 2009, NEUROIMAGE, V44, P469, DOI 10.1016/j.neuroimage.2008.09.017; Haberg A, 2004, NEUROSURGERY, V54, P902, DOI 10.1227/01.NEU.0000114510.05922.F8; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Kekhia H, 2011, NEUROSURG CLIN N AM, V22, P111, DOI 10.1016/j.nec.2011.01.004; Kokkonen SM, 2009, MAGN RESON IMAGING, V27, P733, DOI 10.1016/j.mri.2008.11.002; Kollndorfer K, 2013, FRONT HUM NEUROSCI, P7; Kristo G, 2014, HUM BRAIN MAPP, V35, P340, DOI 10.1002/hbm.22180; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lehericy S, 2000, J NEUROSURG, V92, P589, DOI 10.3171/jns.2000.92.4.0589; Leuthardt EC, 2013, NEUROSURGERY, V60, P64, DOI 10.1227/01.neu.0000430311.63702.77; Liu HS, 2009, J NEUROSURG, V111, P746, DOI 10.3171/2008.10.JNS08846; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Mannfolk P, 2011, J MAGN RESON IMAGING, V34, P511, DOI 10.1002/jmri.22654; Marshall I, 2004, RADIOLOGY, V233, P868, DOI 10.1148/radiol.2333031782; Mima T, 1999, BRAIN, V122, P1989, DOI 10.1093/brain/122.10.1989; Minati L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073746; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Orringer DA, 2012, SEMIN NEUROL, V32, P466, DOI 10.1055/s-0032-1331816; Otten ML, 2012, BRAIN, V135, P1017, DOI 10.1093/brain/aws041; Petrella JR, 2006, RADIOLOGY, V240, P793, DOI 10.1148/radiol.2403051153; Porro CA, 1996, J NEUROSCI, V16, P7688; Pouratian N, 2002, J NEUROSURG, V97, P21, DOI 10.3171/jns.2002.97.1.0021; Quigley M, 2001, AM J NEURORADIOL, V22, P294; Roessler K, 2005, J NEUROL NEUROSUR PS, V76, P1152, DOI 10.1136/jnnp.2004.050286; Rosazza C, 2012, AM J NEURORADIOL, V33, P180, DOI 10.3174/ajnr.A2733; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Roth R, 1996, NEUROREPORT, V7, P1280, DOI 10.1097/00001756-199605170-00012; Roux FE, 2003, NEUROSURGERY, V52, P1335, DOI 10.1227/01.NEU.0000064803.05077.40; Rutten GJ, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09251; Rutten GJM, 2002, ANN NEUROL, V51, P350, DOI 10.1002/ana.10117; Sanai N, 2008, NEW ENGL J MED, V358, P18, DOI 10.1056/NEJMoa067819; Sartorius CJ, 1998, J NEUROSURG, V88, P349, DOI 10.3171/jns.1998.88.2.0349; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Seibert TM, 2012, NEUROIMAGE, V59, P2452, DOI 10.1016/j.neuroimage.2011.08.105; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shimony JS, 2009, ACAD RADIOL, V16, P578, DOI 10.1016/j.acra.2009.02.001; Stippich C, 2002, NEUROSCI LETT, V331, P50, DOI 10.1016/S0304-3940(02)00826-1; Szameitat AJ, 2012, NEUROIMAGE, V62, P266, DOI 10.1016/j.neuroimage.2012.05.009; Tie YM, 2014, HUM BRAIN MAPP, V35, P1018, DOI 10.1002/hbm.22231; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Meulen M, 2014, HUM BRAIN MAPP, V35, P455, DOI 10.1002/hbm.22192; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Voyvodic JT, 2006, MAGN RESON IMAGING, V24, P1249, DOI 10.1016/j.mri.2006.04.020; Zaca D, 2013, J MAGN RESON IMAGING; Zaca D, 2011, WORLD J CLIN ONCOL, V2, P289, DOI 10.5306/wjco.v2.i7.289; Zhang DY, 2009, NEUROSURGERY, V65, P226, DOI 10.1227/01.NEU.0000350868.95634.CA	64	65	67	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98860	10.1371/journal.pone.0098860	http://dx.doi.org/10.1371/journal.pone.0098860			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914775	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700040
J	Serrao, NR; Steinke, D; Hanner, RH				Serrao, Natasha R.; Steinke, Dirk; Hanner, Robert H.			Calibrating Snakehead Diversity with DNA Barcodes: Expanding Taxonomic Coverage to Enable Identification of Potential and Established Invasive Species	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; CHANNA-ARGUS; EVOLUTIONARY GENETICS; POTOMAC RIVER; FISH; PERCIFORMES; PUNCTATUS; MACULATA	Detecting and documenting the occurrence of invasive species outside their native range requires tools to support their identification. This can be challenging for taxa with diverse life stages and/or problematic or unresolved morphological taxonomies. DNA barcoding provides a potent method for identifying invasive species, as it allows for species identification at all life stages, including fragmentary remains. It also provides an efficient interim taxonomic framework for quantifying cryptic genetic diversity by parsing barcode sequences into discontinuous haplogroup clusters (typical of reproductively isolated species) and labelling them with unique alphanumeric identifiers. Snakehead fishes are a diverse group of opportunistic predators endemic to Asia and Africa that may potentially pose significant threats as aquatic invasive species. At least three snakehead species (Channa argus, C. maculata, and C. marulius) are thought to have entered North America through the aquarium and live-food fish markets, and have established populations, yet their origins remain unclear. The objectives of this study were to assemble a library of DNA barcode sequences derived from expert identified reference specimens in order to determine the identity and aid invasion pathway analysis of the non-indigenous species found in North America using DNA barcodes. Sequences were obtained from 121 tissue samples representing 25 species and combined with public records from GenBank for a total of 36 putative species, which then partitioned into 49 discrete haplogroups. Multiple divergent clusters were observed within C. gachua, C. marulius, C. punctata and C. striata suggesting the potential presence of cryptic species diversity within these lineages. Our findings demonstrate that DNA barcoding is a valuable tool for species identification in challenging and under-studied taxonomic groups such as snakeheads, and provides a useful framework for inferring invasion pathway analysis.	[Serrao, Natasha R.; Steinke, Dirk; Hanner, Robert H.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Serrao, Natasha R.; Hanner, Robert H.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Serrao, NR (corresponding author), Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON K9J 7B8, Canada.	natasha.rosemary.serrao@gmail.com	Steinke, Dirk/D-4700-2009	Steinke, Dirk/0000-0002-8992-575X	OMAFRA EMergency Management program	OMAFRA EMergency Management program	The authors would like to acknowledge OMAFRA EMergency Management program for funding this project. This work is a contribution to FISH-BOL and the International Barcode of Life (iBOL.org) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson EAS, 2012, FRESHWATER BIOL, V57, P2211, DOI 10.1111/j.1365-2427.2012.02864.x; Adamson EAS, 2010, MOL PHYLOGENET EVOL, V56, P707, DOI 10.1016/j.ympev.2010.03.027; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Aquilino SVL, 2011, MOL ECOL RESOUR, V11, P612, DOI 10.1111/j.1755-0998.2011.03000.x; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Benziger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021272; Bhat AA, 2012, MOL BIOL REP, V39, P4267, DOI 10.1007/s11033-011-1213-4; Blagoev GA, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-44; Britz R, 2007, ICHTHYOL EXPLOR FRES, V18, P335; Bronnenhuber JE, 2013, CONSERV GENET RESOUR, V5, P971, DOI 10.1007/s12686-013-9946-0; CAMP, 1998, REP WORKSH CONS ASS, P1; Courtenay W.R., 2004, US GEOLOGICAL SURVEY; Courtenay WR, 2004, 77 BISH MUS; Cudmore B, 2006, 2006075 CSAS; Eschmeyer WN, CATALOG FISHES; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fuller PF, 2012, CHANNA ARGUS; Geetakumari Khangjrakpam, 2010, Journal of the Bombay Natural History Society, V107, P231; Haniffa MA, 2013, AM J RES BIOL, V1; Haniffa MA, 2007, BIOCHEM GENET, V45, P363, DOI 10.1007/s10528-007-9080-3; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helfman GS, 2007, FISH CONSERVATION GU; Herborg LM, 2007, CAN J FISH AQUAT SCI, V64, P1723, DOI 10.1139/F07-130; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; King TL, 2011, CONSERV GENET RESOUR, V3, P1, DOI 10.1007/s12686-010-9256-8; Lakra WS, 2010, BIOCHEM SYST ECOL, V38, P1212, DOI 10.1016/j.bse.2010.12.012; Lapointe NWR, 2013, HYDROBIOLOGIA, V709, P73, DOI 10.1007/s10750-012-1437-x; Lees DC, 2013, MOL ECOL RESOURC; Li X, 2006, ICHTHYOL RES, V53, P148, DOI 10.1007/s10228-005-0321-3; Lowenstein JH, 2011, MITOCHONDR DNA, V22, P52, DOI 10.3109/19401736.2010.537748; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Musikasinthorn P, 1998, ICHTHYOL RES, V45, P355, DOI 10.1007/BF02725188; Nagarajan M, 2006, AQUAC RES, V37, P1151, DOI 10.1111/j.1365-2109.2006.01539.x; Nwani CD, 2011, MITOCHONDR DNA, V22, P43, DOI 10.3109/19401736.2010.536537; Orrell TM, 2005, P BIOL SOC WASH, V118, P407, DOI 10.2988/0006-324X(2005)118[407:TNSCAA]2.0.CO;2; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Scott D, 2013, MANAGEMENT IN PRESS, V4; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Steinke D, 2011, MITOCHONDR DNA, V22, P10, DOI 10.3109/19401736.2010.536538; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052089; Victor BC, 2009, ZOOTAXA, P24; Wang JL, 2011, MITOCHONDR DNA, V22, P120, DOI 10.3109/19401736.2011.624599; Wang KX, 2013, MITOCHONDR DNA, V24, P362, DOI 10.3109/19401736.2012.762578; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Zhu L, 2011, HUMAN AGR SCI, V7; Zhu SR, 2013, BIOCHEM SYST ECOL, V51, P117, DOI 10.1016/j.bse.2013.08.011; Zhu SR, 2013, MITOCHONDR DNA, V24, P217, DOI 10.3109/19401736.2012.752469	58	25	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99546	10.1371/journal.pone.0099546	http://dx.doi.org/10.1371/journal.pone.0099546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915194	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700115
J	Shak, JR; Cremers, AJH; Gritzfeld, JF; de Jonge, MI; Hermans, PWM; Vidal, JE; Klugman, KP; Gordon, SB				Shak, Joshua R.; Cremers, Amelieke J. H.; Gritzfeld, Jenna F.; de Jonge, Marien I.; Hermans, Peter W. M.; Vidal, Jorge E.; Klugman, Keith P.; Gordon, Stephen B.			Impact of Experimental Human Pneumococcal Carriage on Nasopharyngeal Bacterial Densities in Healthy Adults	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; HAEMOPHILUS-INFLUENZAE; MORAXELLA-CATARRHALIS; COLONIZATION; PATHOGENS; CHILDREN; EPIDEMIOLOGY; ASSOCIATION; ACQUISITION	Colonization of the nasopharynx by Streptococcus pneumoniae is a necessary precursor to pneumococcal diseases that result in morbidity and mortality worldwide. The nasopharynx is also host to other bacterial species, including the common pathogens Staphylococcus aureus, Haemophilus influenzae, and Moraxella catarrhalis. To better understand how these bacteria change in relation to pneumococcal colonization, we used species-specific quantitative PCR to examine bacterial densities in 52 subjects 7 days before, and 2, 7, and 14 days after controlled inoculation of healthy human adults with S. pneumoniae serotype 6B. Overall, 33 (63%) of subjects carried S. pneumoniae post-inoculation. The baseline presence and density of S. aureus, H. influenzae, and M. catarrhalis were not statistically associated with likelihood of successful pneumococcal colonization at this study's sample size, although a lower rate of pneumococcal colonization in the presence of S. aureus (7/14) was seen compared to that in the presence of H. influenzae (12/16). Among subjects colonized with pneumococci, the number also carrying either H. influenzae or S. aureus fell during the study and at 14 days post-inoculation, the proportion carrying S. aureus was significantly lower among those who were colonized with S. pneumoniae (p = 0.008) compared to non-colonized subjects. These data on bacterial associations are the first to be reported surrounding experimental human pneumococcal colonization and show that co-colonizing effects are likely subtle rather than absolute.	[Shak, Joshua R.; Vidal, Jorge E.; Klugman, Keith P.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Cremers, Amelieke J. H.; de Jonge, Marien I.; Hermans, Peter W. M.] Radboudumc, Dept Pediat, Lab Pediat Infect Dis, Nijmegen, Netherlands; [Gritzfeld, Jenna F.; Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Resp Infect Grp, Liverpool L3 5QA, Merseyside, England	Emory University; Rollins School Public Health; Radboud University Nijmegen; Liverpool School of Tropical Medicine; University of Liverpool	Shak, JR (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	jshak@emory.edu; sbgordon@liverpool.ac.uk	Cremers, Amelieke/R-5197-2019; de Jonge, Marien I./P-5869-2015; Hermans, Peter W.M./H-8042-2014; Cremers, Amelieke J.H./A-5536-2016	Cremers, Amelieke/0000-0003-4704-4978; de Jonge, Marien I./0000-0003-2812-5895; Cremers, Amelieke J.H./0000-0003-4704-4978; Gordon, Stephen/0000-0001-6576-1116	Bill and Melinda Gates Foundation [OPP1035281]; Molecules to Mankind Program at Emory's Laney Graduate School; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; Medical Scientist Training Program at Emory University School of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Molecules to Mankind Program at Emory's Laney Graduate School; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Medical Scientist Training Program at Emory University School of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the financial support of the Bill and Melinda Gates Foundation (Experimental Human Pneumococcal Carriage model; OPP1035281). JRS acknowledges financial support from the Molecules to Mankind Program at Emory's Laney Graduate School and the Medical Scientist Training Program at Emory University School of Medicine. Statistical consultation at the ACTSI was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Bae S, 2012, J MED MICROBIOL, V61, P678, DOI 10.1099/jmm.0.040584-0; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Browall S, 2014, J INFECT DIS, V209, P377, DOI 10.1093/infdis/jit481; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; Das Bhattacharya S, 2012, INDIAN J PEDIATR, V79, P1447, DOI 10.1007/s12098-012-0762-4; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; Dunne EM, 2012, J CLIN MICROBIOL, V50, P1034, DOI 10.1128/JCM.06589-11; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferreira DM, 2013, AM J RESP CRIT CARE, V187, P855, DOI 10.1164/rccm.201212-2277OC; Ferreira DM, 2011, TRENDS MICROBIOL, V19, P464, DOI 10.1016/j.tim.2011.06.003; Gritzfeld JF, 2013, JOVE-J VIS EXP, DOI 10.3791/50115; Gritzfeld Jenna F, 2011, BMC Res Notes, V4, P122, DOI 10.1186/1756-0500-4-122; Jacoby P, 2007, VACCINE, V25, P2458, DOI 10.1016/j.vaccine.2006.09.020; Jourdain S, 2011, CLIN MICROBIOL INFEC, V17, P907, DOI 10.1111/j.1469-0691.2010.03410.x; Kilic A, 2010, DIAGN MICR INFEC DIS, V66, P349, DOI 10.1016/j.diagmicrobio.2009.11.010; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; Lijek RS, 2012, P NATL ACAD SCI USA, V109, P13823, DOI 10.1073/pnas.1208075109; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Madhi SA, 2007, J INFECT DIS, V196, P1662, DOI 10.1086/522164; McAvin JC, 2001, J CLIN MICROBIOL, V39, P3446, DOI 10.1128/JCM.39.10.3446-3451.2001; McCool TL, 2002, J EXP MED, V195, P359, DOI 10.1084/jem.20011576; Nizet V, 1996, J INFECT DIS, V173, P180, DOI 10.1093/infdis/173.1.180; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; van Gils EJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020229; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang X, 2011, INT J MED MICROBIOL, V301, P303, DOI 10.1016/j.ijmm.2010.11.004; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Wright AKA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002622	32	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98829	10.1371/journal.pone.0098829	http://dx.doi.org/10.1371/journal.pone.0098829			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915552	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000340947700037
J	Hanafi, LA; Gauchat, D; Godin-Ethier, J; Possamai, D; Duvignaud, JB; Leclerc, D; Grandvaux, N; Lapointe, R				Hanafi, Laila-Aicha; Gauchat, Dominique; Godin-Ethier, Jessica; Possamai, David; Duvignaud, Jean-Baptiste; Leclerc, Denis; Grandvaux, Nathalie; Lapointe, Rejean			Fludarabine Downregulates Indoleamine 2,3-Dioxygenase in Tumors via a Proteasome-Mediated Degradation Mechanism	PLOS ONE			English	Article							INTERFERON-GAMMA; DENDRITIC CELLS; EXPRESSION; CANCER; IDO; INHIBITION; TRYPTOPHAN; THERAPY; STAT1; CHEMOTHERAPY	Indoleamine 2,3-dioxygenase (IDO) is found in multiple malignancies and exerts immunosuppressive effects that are central in protecting tumors from host T lymphocyte rejection. IDO is an enzyme involved in the catabolism of tryptophan resulting in inhibition of T lymphocyte function. While inhibition of IDO enzymatic activity results in tumor rejection, it is still unknown how we can directly target IDO expression within tumors using drugs. We have chosen to interfere with IDO expression by targeting the key-signaling event signal transducer and activator of transcription 1 (STAT1). We evaluated the efficacy of fludarabine, previously described to inhibit STAT1 phosphorylation. Interestingly, fludarabine was efficient in suppressing protein expression and consequently IDO activity in two different cell lines derived from breast cancer and melanoma when IDO was activated with interferon-gamma (IFN-gamma) or supernatants prepared from activated T lymphocytes. However, fludarabine had no inhibitory effect on STAT1 phosphorylation. Other IFN-gamma-responsive genes were only marginally inhibited by fludarabine. The level of IDO transcript was unaffected by this inhibitor, suggesting the involvement of post-transcriptional control. Strikingly, we have found that the inhibition of proteasome partially protected IDO from fludarabine-induced degradation, indicating that fludarabine induces IDO degradation through a proteasome-dependent pathway. Currently used in the clinic to treat some malignancies, fludarabine has the potential for use in the treatment of human tumors through induction of IDO degradation and consequently, for the promotion of T cell-mediated anti-tumor response.	[Hanafi, Laila-Aicha; Gauchat, Dominique; Godin-Ethier, Jessica; Possamai, David; Grandvaux, Nathalie; Lapointe, Rejean] Univ Montreal, Res Ctr, Ctr Hosp Univ Montreal CRCHUM, Montreal, PQ, Canada; [Hanafi, Laila-Aicha; Gauchat, Dominique; Godin-Ethier, Jessica; Possamai, David; Lapointe, Rejean] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Duvignaud, Jean-Baptiste; Leclerc, Denis] Univ Laval, Ctr Rech & Infectiol, Ctr Hosp Univ Quebec, Quebec City, PQ, Canada; [Duvignaud, Jean-Baptiste; Leclerc, Denis] Univ Laval, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada; [Duvignaud, Jean-Baptiste] Univ Laval, PROTEO, Quebec City, PQ, Canada; [Grandvaux, Nathalie] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Laval University; Laval University; Laval University; Universite de Montreal	Lapointe, R (corresponding author), Univ Montreal, Res Ctr, Ctr Hosp Univ Montreal CRCHUM, Montreal, PQ, Canada.	rejean.lapointe@umontreal.ca	Leclerc, Denis/AAG-6112-2019; Leclerc, Denis/P-1604-2019	Grandvaux, Nathalie/0000-0003-0567-0284	Canadian Institutes of Health Research [MOP-89727]; Fonds de la recherche Quebec - Sante; Canada Research Chair Tier II	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Canada Research Chair Tier II(Canada Research Chairs)	This work was supported by an operating grant from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) [Grant number MOP-89727] and by fellowships from Fonds de la recherche Quebec - Sante (.qc.ca) [RL and LAH]. NG is supported by a Canada Research Chair Tier II (www.chairs-chaires.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Balachandran VP, 2011, NAT MED, V17, P1094, DOI 10.1038/nm.2438; CADY SG, 1991, ARCH BIOCHEM BIOPHYS, V291, P326, DOI 10.1016/0003-9861(91)90142-6; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Cheng CW, 2010, J AGR FOOD CHEM, V58, P887, DOI 10.1021/jf903377e; de Souza JA, 2009, BONE MARROW TRANSPL, V44, P81, DOI 10.1038/bmt.2009.101; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dudley ME, 2002, J IMMUNOTHER, V25, P243, DOI 10.1097/00002371-200205000-00007; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; Gamberale R, 2006, HAEMATOLOGICA, V91, P574; Godin-Ethier J, 2011, CLIN CANCER RES, V17, P6985, DOI 10.1158/1078-0432.CCR-11-1331; Godin-Ethier J, 2011, MOL IMMUNOL, V49, P253, DOI 10.1016/j.molimm.2011.08.017; Godin-Ethier J, 2009, J IMMUNOL, V183, P7752, DOI 10.4049/jimmunol.0901004; Heitger A, 2011, CURR MED CHEM, V18, P2222, DOI 0929-8673/11 $58.00+.00; Hernandez-Breijo B, 2011, WORLD J GASTROENTERO, V17, P3899, DOI 10.3748/wjg.v17.i34.3899; Hui ZG, 2009, INT J RADIAT ONCOL, V73, P288, DOI 10.1016/j.ijrobp.2008.08.043; Jeong YI, 2009, J BIOL CHEM, V284, P3700, DOI 10.1074/jbc.M807328200; Jiang GM, 2010, INT J BIOCHEM CELL B, V42, P1840, DOI 10.1016/j.biocel.2010.07.020; Lee HJ, 2007, BIOCHEM PHARMACOL, V73, P1412, DOI 10.1016/j.bcp.2006.12.018; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Lu K, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-55; Mailankot M, 2010, INT J BIOCHEM CELL B, V42, P1446, DOI 10.1016/j.biocel.2010.04.014; Mellor AL, 2005, J IMMUNOL, V175, P5601, DOI 10.4049/jimmunol.175.9.5601; Munn David H, 2012, Front Biosci (Elite Ed), V4, P734; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Noh KT, 2013, BIOCHEM BIOPH RES CO, V431, P348, DOI 10.1016/j.bbrc.2012.12.093; Novitskiy SV, 2012, CANCER DISCOV, V2, P673, DOI 10.1158/2159-8290.CD-12-0311; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; Pallotta MT, 2010, INT J TRYPTOPHAN RES, V3, P91, DOI 10.4137/IJTR.S3971; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Prendergast GC, 2011, CURR MED CHEM, V18, P2257, DOI 0929-8673/11 $58.00+.00; Rachakatla RS, 2008, CANCER INVEST, V26, P662, DOI 10.1080/07357900701871134; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; RIVOLTINI L, 1995, CANCER RES, V55, P3149; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Teicher BA, 1999, CLIN CANCER RES, V5, P2638; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Torella D, 2007, AM J PHYSIOL-HEART C, V292, pH2935, DOI 10.1152/ajpheart.00887.2006; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yuan BF, 2011, CANCER RES, V71, P1904, DOI 10.1158/0008-5472.CAN-10-3430	44	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99211	10.1371/journal.pone.0099211	http://dx.doi.org/10.1371/journal.pone.0099211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911872	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600057
J	Jurgens, TP; Sawatzki, A; Henrich, F; Magerl, W; May, A				Juergens, Tim P.; Sawatzki, Alexander; Henrich, Florian; Magerl, Walter; May, Arne			An Improved Model of Heat-Induced Hyperalgesia-Repetitive Phasic Heat Pain Causing Primary Hyperalgesia to Heat and Secondary Hyperalgesia to Pinprick and Light Touch	PLOS ONE			English	Article							LONG-TERM POTENTIATION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CENTRAL SENSITIZATION; C-FIBER; ELECTRICAL-STIMULATION; NOCICEPTIVE AFFERENTS; SEROTONERGIC SYSTEMS; EVOKED-POTENTIALS; NEUROPATHIC PAIN; CUTANEOUS PAIN	This study tested a modified experimental model of heat-induced hyperalgesia, which improves the efficacy to induce primary and secondary hyperalgesia and the efficacy-to-safety ratio reducing the risk of tissue damage seen in other heat pain models. Quantitative sensory testing was done in eighteen healthy volunteers before and after repetitive heat pain stimuli (60 stimuli of 48 degrees C for 6 s) to assess the impact of repetitive heat on somatosensory function in conditioned skin (primary hyperalgesia area) and in adjacent skin (secondary hyperalgesia area) as compared to an unconditioned mirror image control site. Additionally, areas of flare and secondary hyperalgesia were mapped, and time course of hyperalgesia determined. After repetitive heat pain conditioning we found significant primary hyperalgesia to heat, and primary and secondary hyperalgesia to pinprick and to light touch (dynamic mechanical allodynia). Acetaminophen (800 mg) reduced pain to heat or pinpricks only marginally by 11% and 8%, respectively (n.s.), and had no effect on heat hyperalgesia. In contrast, the areas of flare (-31%) and in particular of secondary hyperalgesia (-59%) as well as the magnitude of hyperalgesia (-59%) were significantly reduced (all p, 0.001). Thus, repetitive heat pain induces significant peripheral sensitization (primary hyperalgesia to heat) and central sensitization (punctate hyperalgesia and dynamic mechanical allodynia). These findings are relevant to further studies using this model of experimental heat pain as it combines pronounced peripheral and central sensitization, which makes a convenient model for combined pharmacological testing of analgesia and anti-hyperalgesia mechanisms related to thermal and mechanical input.	[Juergens, Tim P.; Sawatzki, Alexander; May, Arne] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Henrich, Florian; Magerl, Walter] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol, Chair Neurophysiol, Mannheim, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg	Jurgens, TP (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	t.juergens@uke.de			DFG [Ma1251/9-1, Ma1251/9-2]; German Research Foundation (Deutsche Forschungsgemeinschaft DFG)	DFG(German Research Foundation (DFG)); German Research Foundation (Deutsche Forschungsgemeinschaft DFG)(German Research Foundation (DFG))	This work was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG) "Sonderforschungsbereich 936'' (Project A5: Central networks in pain habituation). Part of this work was funded by a grant of the DFG to WM. (FOR926, grant Ma1251/9-1 and 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Ali Z, 1996, PAIN, V68, P401, DOI 10.1016/S0304-3959(96)03199-5; Baldwin A, 2012, J BURN CARE RES, V33, P176, DOI 10.1097/BCR.0b013e3182331cfe; Bandschapp O, 2010, ANESTHESIOLOGY, V113, P421, DOI 10.1097/ALN.0b013e3181e33ac8; Barriere DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070690; Bertolini A, 2006, CNS DRUG REV, V12, P250, DOI 10.1111/j.1527-3458.2006.00250.x; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Bingel U, 2007, PAIN, V131, P21, DOI 10.1016/j.pain.2006.12.005; Bjorkman R, 1995, Acta Anaesthesiol Scand Suppl, V103, P1; Breimhorst M, 2012, EUR J PAIN, V16, P1281, DOI 10.1002/j.1532-2149.2012.00133.x; CAMPBELL JN, 1979, J NEUROPHYSIOL, V42, P1669, DOI 10.1152/jn.1979.42.6.1669; CERVERO F, 1993, PAIN, V54, P181, DOI 10.1016/0304-3959(93)90207-6; Defrin R, 2006, CLIN J PAIN, V22, P130, DOI 10.1097/01.ajp.0000154048.68273.d8; Dirks J, 2003, J PAIN, V4, P122, DOI 10.1054/jpai.2003.10; Doganci B, 2011, EUR J PAIN, V15, P384, DOI 10.1016/j.ejpain.2010.09.003; Elia N, 2005, ANESTHESIOLOGY, V103, P1296, DOI 10.1097/00000542-200512000-00025; Filitz J, 2008, PAIN, V136, P262, DOI 10.1016/j.pain.2007.06.036; Fissmer I, 2011, ANESTHESIOLOGY, V115, P387, DOI 10.1097/ALN.0b013e318219509e; FORSTER C, 1992, AGENTS ACTIONS, V35, P112, DOI 10.1007/BF01990960; GREENSPAN JD, 1991, SOMATOSENS MOT RES, V8, P137, DOI 10.3109/08990229109144738; Greffrath W, 2007, PAIN, V132, P301, DOI 10.1016/j.pain.2007.04.026; Gustorff B, 2013, PAIN, V154, P586, DOI 10.1016/j.pain.2012.12.020; Hansen N, 2007, J NEUROPHYSIOL, V97, P2559, DOI 10.1152/jn.01125.2006; Hashmi JA, 2010, PAIN, V151, P737, DOI 10.1016/j.pain.2010.08.046; HENRIQUES FC, 1947, AM J PATHOL, V23, P531; Hoppe F, 1991, HAMBURGER SCHMERZ AD; Jurgens TP, 2012, EUR J PAIN, V16, P1251, DOI 10.1002/j.1532-2149.2012.00135.x; Klede M, 2003, J NEUROPHYSIOL, V90, P353, DOI 10.1152/jn.01136.2002; Klein T, 2004, J NEUROSCI, V24, P964, DOI 10.1523/JNEUROSCI.1222-03.2004; Klein T, 2008, PAIN, V139, P507, DOI 10.1016/j.pain.2008.06.001; Klein T, 2006, J NEUROPHYSIOL, V96, P3551, DOI 10.1152/jn.00755.2006; Koppert W, 2004, PAIN, V108, P148, DOI 10.1016/j.pain.2003.12.017; Koppert W, 2001, ANESTHESIOLOGY, V95, P395, DOI 10.1097/00000542-200108000-00022; Kuhtz-Buschbeck JP, 2010, ADV PHYSIOL EDUC, V34, P25, DOI 10.1152/advan.00002.2010; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190, DOI 10.1152/jn.1991.66.1.190; Lang S, 2007, PAIN, V128, P254, DOI 10.1016/j.pain.2006.09.026; LAUTENBACHER S, 1995, SOMATOSENS MOT RES, V12, P59, DOI 10.3109/08990229509063142; Liu XG, 1998, NEUROSCIENCE, V86, P1209, DOI 10.1016/S0306-4522(98)00107-9; Magerl W, 1996, J PHYSIOL-LONDON, V497, P837, DOI 10.1113/jphysiol.1996.sp021814; Magerl W, 2004, NEUROSCI LETT, V361, P136, DOI 10.1016/j.neulet.2003.12.001; MAGERL W, 1987, NEUROSCI LETT, V82, P349, DOI 10.1016/0304-3940(87)90281-3; Magerl W, 1998, PAIN, V74, P257, DOI 10.1016/S0304-3959(97)00177-2; Magerl W, 2001, BRAIN, V124, P1754, DOI 10.1093/brain/124.9.1754; Magerl W, 2006, HAND CLINIC, V81, P503, DOI 10.1016/S0072-9752(06)80037-0; Mallet C, 2008, PAIN, V139, P190, DOI 10.1016/j.pain.2008.03.030; Mallet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012748; May A, 2012, EUR J PAIN, V16, P401, DOI 10.1002/j.1532-2149.2011.00023.x; May A, 2011, EUR J PAIN IN PRESS; MORITZ AR, 1947, AM J PATHOL, V23, P695; Ong CKS, 2010, ANESTH ANALG, V110, P1170, DOI 10.1213/ANE.0b013e3181cf9281; Pedersen JL, 1998, PAIN, V76, P377, DOI 10.1016/S0304-3959(98)00070-0; Pedersen JL, 2000, DAN MED BULL, V47, P168; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Pfau DB, 2011, PAIN, V152, P1532, DOI 10.1016/j.pain.2011.02.037; Pickering G, 2008, CLIN PHARMACOL THER, V84, P47, DOI 10.1038/sj.clpt.6100403; Pini LA, 1996, EUR J PHARMACOL, V308, P31, DOI 10.1016/0014-2999(96)00261-0; RAJA SN, 1984, BRAIN, V107, P1179, DOI 10.1093/brain/107.4.1179; Rennefeld C, 2010, PAIN, V148, P503, DOI 10.1016/j.pain.2009.12.014; Rodriguez-Raecke R, 2010, J NEUROSCI, V30, P11363, DOI 10.1523/JNEUROSCI.2197-10.2010; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Schepers RJ, 2010, NEUROSCI BIOBEHAV R, V34, P177, DOI 10.1016/j.neubiorev.2009.10.003; Schmelz M, 2000, NEUROREPORT, V11, P645, DOI 10.1097/00001756-200002280-00041; Sinclair D, 1967, CATANEOUS SENSATION; Slugg RM, 2000, J NEUROPHYSIOL, V83, P2179, DOI 10.1152/jn.2000.83.4.2179; Stiasny-Kolster K, 2013, PAIN, V154, P1457, DOI 10.1016/j.pain.2013.05.007; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; THALHAMMER JG, 1982, BRAIN RES, V231, P257, DOI 10.1016/0006-8993(82)90364-X; TJOLSEN A, 1991, EUR J PHARMACOL, V193, P193, DOI 10.1016/0014-2999(91)90036-P; TREEDE RD, 1995, ANN MED, V27, P213, DOI 10.3109/07853899509031961; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Vaideanu D, 2006, BRIT J OPHTHALMOL, V90, P713, DOI 10.1136/bjo.2005.076091; Vo L, 2014, EUR J PAIN, V18, P376, DOI 10.1002/j.1532-2149.2013.00370.x; Vo L, 2013, EUR J PAIN, V17, P357, DOI 10.1002/j.1532-2149.2012.00208.x; Werner MU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062733; Ziegler EA, 1999, BRAIN, V122, P2245, DOI 10.1093/brain/122.12.2245	78	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99507	10.1371/journal.pone.0099507	http://dx.doi.org/10.1371/journal.pone.0099507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911787	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600097
J	Liu, J; Tong, CX; Liu, J; Jiang, Y; Zhao, XQ; Zhang, YY; Liu, HC; Lu, B; Wan, KL				Liu, Jie; Tong, Chongxiang; Liu, Jiao; Jiang, Yuan; Zhao, Xiuqin; Zhang, Yuanyuan; Liu, Haican; Lu, Bing; Wan, Kanglin			First Insight into the Genotypic Diversity of Clinical Mycobacterium tuberculosis Isolates from Gansu Province, China	PLOS ONE			English	Article							BEIJING GENOTYPE; MOLECULAR EPIDEMIOLOGY; DISCRIMINATORY ABILITY; GENETIC DIVERSITY; COMPLEX STRAINS; LOCI; POLYMORPHISM; FAMILY; SYSTEMS	Background:Investigations of Mycobacterium tuberculosis genetic diversity in China have indicated a significant regional distribution. The aim of this study was to characterize the genotypes of clinical M. tuberculosis isolates obtained from Gansu, which has a special geographic location in China. Methodology/Principal Findings: A total of 467 clinical M. tuberculosis strains isolated in Gansu Province were genotyped by 15-locus mycobacterial interspersed repetitive units-variable number tandem repeats (MIRU-VNTR) and spoligotyping. The results showed that 445 isolates belonged to six known spoligotype lineages, whereas 22 isolates were unknown. The Beijing genotype was the most prevalent (87.58%, n = 409), while the shared type 1 was the dominant genotype (80.94%, n = 378). The second most common lineage was the T lineage, with 25 isolates (5.35%), followed by the H lineage with 5 isolates (1.07%), the MANU family (0.64%, 3 isolates), the U family (0.43%, 2 isolates) and the CAS lineage with 1 isolate (0.21%). By using the VNTR15China method, we observed 15 groups and 228 genotypes among the 467 isolates. We found no association between the five larger groups (including the Beijing genotype) and sex, age, or treatment status, and there was no noticeable difference in the group analysis in different areas. In the present study, seven of the 15 MIRU-VNTR loci were highly or moderately discriminative according to their Hunter-Gaston discriminatory index. Conclusions/Significance: The Beijing genotype is the predominant genotype in Gansu province. We confirm that VNTR15China is suitable for typing Beijing strains in China and that it has a better discriminatory power than spoligotyping. Therefore, the use of both methods is the most suitable for genotyping analysis of M. tuberculosis.	[Liu, Jie; Liu, Jiao; Zhao, Xiuqin; Zhang, Yuanyuan; Liu, Haican; Lu, Bing; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Liu, Jie; Zhao, Xiuqin; Zhang, Yuanyuan; Liu, Haican; Lu, Bing; Wan, Kanglin] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Tong, Chongxiang; Jiang, Yuan] Lanzhou Pulm Hosp, Lanzhou, Gansu, Peoples R China; [Liu, Jie] Beijing Chaoyang Dist Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	wankanglin@icdc.cn			National Key Program of Mega Infectious Disease [2013ZX10003006-002-001, 2011ZX10004-001]	National Key Program of Mega Infectious Disease	This work was funded by the projects 2013ZX10003006-002-001 and 2011ZX10004-001 of the National Key Program of Mega Infectious Disease. The funders had no role in the study design, data collection and analysis, manuscript preparation, or decision to publish.	Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chai Li-Quan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P785; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Dong HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033904; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Fabre M, 2004, J CLIN MICROBIOL, V42, P3248, DOI 10.1128/JCM.42.7.3248-3255.2004; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Jiang Y, 2013, J BASIC MICROB, V53, P562, DOI 10.1002/jobm.201200230; Jiao WW, 2008, J CLIN MICROBIOL, V46, P1045, DOI 10.1128/JCM.01869-07; JUAN CP, 2007, TUBERCULOSIS 2007 BA; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Le Fleche P, 2001, BMC Microbiol, V1, P2; Li Wei-min, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P381; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Mokrousov I, 2008, J CLIN MICROBIOL, V46, P3576, DOI 10.1128/JCM.00414-08; Oota H, 2002, AM J PHYS ANTHROPOL, V118, P146, DOI 10.1002/ajpa.10056; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190; Wang JA, 2011, J CLIN MICROBIOL, V49, P1354, DOI 10.1128/JCM.02274-10; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yang SM, 2011, WEISHENG ZHIYE JIAOY, V29, P121; Yu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057660; Zhang L, 2011, CHINESE J ANTITUBERC, V33, P748; Zhang L, 2008, FEMS MICROBIOL LETT, V282, P22, DOI 10.1111/j.1574-6968.2008.01081.x	34	16	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99357	10.1371/journal.pone.0099357	http://dx.doi.org/10.1371/journal.pone.0099357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911588	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600076
J	Obrochta, KM; Kane, MA; Napoli, JL				Obrochta, Kristin M.; Kane, Maureen A.; Napoli, Joseph L.			Effects of Diet and Strain on Mouse Serum and Tissue Retinoid Concentrations	PLOS ONE			English	Article							VITAMIN-A HOMEOSTASIS; BINDING-PROTEIN; ACID; ACYLTRANSFERASE; QUANTIFICATION; LECITHIN; ESTERS; CELL	The relationship between dietary vitamin A and all-trans-retinoic acid levels in serum and tissues had not been quantified. We determined the impact of dietary vitamin A on retinoid levels in serum, liver, kidney, testis, and epididymal white adipose of five mouse strains: AKR/J; BALB/cByJ; C3H/HeJ; C57BL/6J; 129S1/SvImJ. Retinoids were quantified in mice fed copious vitamin A (lab chow, >= 20 IU/g) followed by one month feeding a vitamin A-sufficient diet (4 IU/g), or after three generations of feeding a vitamin A-sufficient diet. Retinol and retinyl esters were measured by high-performance liquid chromatography with ultraviolet absorbance detection. All-trans-retinoic acid was quantified by liquid chromatography tandem mass spectrometry. The amounts of dietary vitamin A had long-term strain-specific effects on tissue retinyl ester, retinol and all-trans-retinoic acid concentrations. Three generations of feeding a vitamin A-sufficient diet decreased all-transretinoic acid in most tissues of most strains, in some cases more than 60%, compared to a diet with copious vitamin A. With both diets, all-trans-retinoic acid concentrations maintained an order of liver approximate to testis. kidney. white adipose tissue approximate to serum. Neither retinol nor all-trans-retinoic acid in serum reflected all-trans-retinoic acid concentrations in tissues. Strain and tissue-specific differences in retinol and all-trans-retinoic acid altered by different amounts of dietary vitamin A could have profound effects on retinoid action. This would be the case especially with the increased all-trans-retinoic acid values associated with the amounts of vitamin A and its precursors (carotenoids) in chow diets.	[Obrochta, Kristin M.; Kane, Maureen A.; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Napoli, JL (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	jna@berkeley.edu			National Institutes of Health USA [DK090522, AA017927]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036870, R01DK090522, T32DK061918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017927] Funding Source: NIH RePORTER	National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health USA grants DK090522 and AA017927. JLN received this funding (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Benevenga NJ, 1995, NUTR REQUIREMENTS LA; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Hogarth CA, 2013, CURR OPIN ENDOCRINOL, V20, P217, DOI 10.1097/MED.0b013e32836067cf; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Liu LM, 2008, BIOCHEM PHARMACOL, V75, P2316, DOI 10.1016/j.bcp.2008.03.012; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; NAPOLI JL, 1986, METHOD ENZYMOL, V123, P112, DOI 10.1016/S0076-6879(86)23015-3; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nau H, 2001, J AM ACAD DERMATOL, V45, pS183, DOI 10.1067/mjd.2001.113720; Penniston KL, 2006, AM J CLIN NUTR, V83, P191; Pino-Lagos K, 2010, BIOFACTORS, V36, P430, DOI 10.1002/biof.117; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reeves PG, 1997, J NUTR, V127, pS838; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Ross AC, 2011, PHYSIOL GENOMICS, V43, P57, DOI 10.1152/physiolgenomics.00182.2010; Savenije B, 2010, NUTR FEEDING ANIMAL, P183; Schreiber R, 2012, BBA-MOL CELL BIOL L, V1821, P113, DOI 10.1016/j.bbalip.2011.05.001; Senoo H, 2010, CELL BIOL INT, V34, P1247, DOI 10.1042/CBI20100321; X E, 2002, J BIOL CHEM, V277, P36617, DOI [10.1074/jbc.M205519200, DOI 10.1074/JBC.M205519200]; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com	26	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99435	10.1371/journal.pone.0099435	http://dx.doi.org/10.1371/journal.pone.0099435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911926	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600088
J	Park, IW; Fan, Y; Luo, XY; Ryou, MG; Liu, JF; Green, L; He, JJ				Park, In-Woo; Fan, Yan; Luo, Xiaoyu; Ryou, Myoung-Gwi; Liu, Jinfeng; Green, Linden; He, Johnny J.			HIV-1 Nef Is Transferred from Expressing T Cells to Hepatocytic Cells through Conduits and Enhances HCV Replication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; KINASE-C-THETA; CHRONIC HEPATITIS-C; NF-KAPPA-B; RNA REPLICATION; LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; LIPID RAFTS; IMMUNOLOGICAL SYNAPSE; VIRAL REPLICATION	HIV-1 infection enhances HCV replication and as a consequence accelerates HCV-mediated hepatocellular carcinoma (HCC). However, the precise molecular mechanism by which this takes place is currently unknown. Our data showed that infectious HIV-1 failed to replicate in human hepatocytic cell lines. No discernible virus replication was observed, even when the cell lines transfected with HIV-1 proviral DNA were co-cultured with Jurkat T cells, indicating that the problem of liver deterioration in the co-infected patient is not due to the replication of HIV-1 in the hepatocytes of the HCV infected host. Instead, HIV-1 Nef protein was transferred from nef-expressing T cells to hepatocytic cells through conduits, wherein up to 16% (average 10%) of the cells harbored the transferred Nef, when the hepatocytic cells were co-cultured with nef-expressing Jurkat cells for 24 h. Further, Nef altered the size and numbers of lipid droplets (LD), and consistently upregulated HCV replication by 1.5 similar to 2.5 fold in the target subgenomic replicon cells, which is remarkable in relation to the initially indolent viral replication. Nef also dramatically augmented reactive oxygen species (ROS) production and enhanced ethanol-mediated up-regulation of HCV replication so as to accelerate HCC. Taken together, these data indicate that HIV-1 Nef is a critical element in accelerating progression of liver pathogenesis via enhancing HCV replication and coordinating modulation of key intra-and extra-cellular molecules for liver decay.	[Park, In-Woo; Fan, Yan; Luo, Xiaoyu; He, Johnny J.] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA; [Ryou, Myoung-Gwi] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX USA; [Park, In-Woo; Fan, Yan; Luo, Xiaoyu; Liu, Jinfeng; Green, Linden; He, Johnny J.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; Indiana University System; Indiana University Bloomington	Park, IW (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA.	inwoo.park@unthsc.edu	Fan, Yan/F-5107-2018	Luo, Xiaoyu/0000-0001-6059-0434	NIH/NIDDK [R01 DK099055]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099055] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by a grant from NIH/NIDDK R01 DK099055 (In- Woo Park). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.16; Acheampong EA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-183; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; ALLAN JS, 1985, SCIENCE, V230, P810, DOI 10.1126/science.2997921; Altavilla G, 2000, AM J PATHOL, V157, P1081, DOI 10.1016/S0002-9440(10)64622-6; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x; ASZTALOS BF, 2010, J INFECT DIS; Beld M, 1998, VIROLOGY, V244, P504, DOI 10.1006/viro.1998.9130; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Brugger B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-70; Caliceti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041246; CAO YZ, 1990, J VIROL, V64, P2553, DOI 10.1128/JVI.64.6.2553-2559.1990; CAO YZ, 1992, AIDS, V6, P65, DOI 10.1097/00002030-199201000-00008; Chang TH, 2012, VIROLOGY, V422, P205, DOI 10.1016/j.virol.2011.10.029; Choe EY, 2002, J BIOL CHEM, V277, P46079, DOI 10.1074/jbc.M204698200; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Chouteau P, 2012, J HEPATOL, V57, P499, DOI 10.1016/j.jhep.2012.04.019; Cubero FJ, 2008, HEPATOLOGY, V48, P2027, DOI 10.1002/hep.22592; Cui HL, 2012, J LIPID RES, V53, P696, DOI 10.1194/jlr.M023119; Daar ES, 2001, J ACQ IMMUN DEF SYND, V26, P466, DOI 10.1097/00126334-200104150-00011; Depla M, 2010, CELL MOL LIFE SCI, V67, P3151, DOI 10.1007/s00018-010-0373-z; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; El-Hage N, 2011, J VIROL, V85, P11601, DOI 10.1128/JVI.05239-11; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Fink T, 2011, METHODS MOL BIOL, V698, P243, DOI 10.1007/978-1-60761-999-4_19; Fournier M, 2010, MOL IMMUNOL, V47, P2594, DOI 10.1016/j.molimm.2010.06.010; FRANCHINI G, 1986, VIROLOGY, V155, P593, DOI 10.1016/0042-6822(86)90219-9; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Ghosn J, 2004, HIV MED, V5, P303, DOI 10.1111/j.1468-1293.2004.00225.x; Goedert JJ, 2001, J INFECT DIS, V184, P1202, DOI 10.1086/323665; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Hammer GP, 2003, SEX TRANSM DIS, V30, P919, DOI 10.1097/01.OLQ.0000091152.31366.E6; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Horton JD, 2003, J BIOL CHEM, V278, P36652, DOI 10.1074/jbc.M306540200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HOUSSET C, 1990, RES VIROLOGY, V141, P153, DOI 10.1016/0923-2516(90)90017-D; Hsieh MJ, 2011, J CELL BIOCHEM, V112, P233, DOI 10.1002/jcb.22926; Huang Y, 2006, HEPATOLOGY, V43, P81, DOI 10.1002/hep.21011; Iser DM, 2010, J VIROL, V84, P5860, DOI 10.1128/JVI.02594-09; Ivanov AV, 2013, VIRUSES-BASEL, V5, P439, DOI 10.3390/v5020439; Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957; Kang L, 2012, VIRUS RES, V163, P74, DOI 10.1016/j.virusres.2011.08.011; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Khabar KSA, 1997, J EXP MED, V186, P1077, DOI 10.1084/jem.186.7.1077; Khan KA, 2013, J INNATE IMMUN, V5, P639, DOI 10.1159/000350517; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Kusano F, 2000, LAB INVEST, V80, P415, DOI 10.1038/labinvest.3780046; Larbi A, 2004, EXP GERONTOL, V39, P551, DOI 10.1016/j.exger.2003.10.031; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Lin WY, 2011, J BIOL CHEM, V286, P2665, DOI 10.1074/jbc.M110.168286; Lin WY, 2010, GASTROENTEROLOGY, V138, P2509, DOI 10.1053/j.gastro.2010.03.008; Liu YH, 2000, J BIOL CHEM, V275, P3603, DOI 10.1074/jbc.275.5.3603; Masanetz S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-35; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Nobile C, 2010, J VIROL, V84, P2282, DOI 10.1128/JVI.02230-09; Okiyama W, 2009, J HEPATOL, V50, P1236, DOI 10.1016/j.jhep.2009.01.025; Olivetta E, 2005, BIOCHEM J, V390, P591, DOI 10.1042/BJ20042139; Olivetta E, 2009, J CELL BIOCHEM, V106, P812, DOI 10.1002/jcb.22041; Park IW, 2009, J LEUKOCYTE BIOL, V86, P1171, DOI 10.1189/jlb.0409261; Park IW, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-29; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Purohit V, 2013, LIFE SCI, V92, P3, DOI 10.1016/j.lfs.2012.10.009; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Rodger AJ, 2000, HEPATOLOGY, V32, P582, DOI 10.1053/jhep.2000.9714; Salmon-Ceron D, 2005, J HEPATOL, V42, P799, DOI 10.1016/j.jhep.2005.01.022; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; STEFFAN AM, 1992, P NATL ACAD SCI USA, V89, P1582, DOI 10.1073/pnas.89.5.1582; Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Vlahakis SR, 2003, J INFECT DIS, V188, P1455, DOI 10.1086/379738; VOGEL J, 1991, CANCER RES, V51, P6686; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Witte V, 2008, J IMMUNOL, V181, P8425, DOI 10.4049/jimmunol.181.12.8425; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Yoong KF, 1999, HEPATOLOGY, V30, P100, DOI 10.1002/hep.510300147; Zhang T, 2003, HEPATOLOGY, V38, P57, DOI 10.1053/jhep.2003.50295	86	18	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99545	10.1371/journal.pone.0099545	http://dx.doi.org/10.1371/journal.pone.0099545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911518	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600105
J	Himes, BE; Jiang, XF; Wagner, P; Hu, RX; Wang, QY; Klanderman, B; Whitaker, RM; Duan, QL; Lasky-Su, J; Nikolos, C; Jester, W; Johnson, M; Panettieri, RA; Tantisira, KG; Weiss, ST; Lu, Q				Himes, Blanca E.; Jiang, Xiaofeng; Wagner, Peter; Hu, Ruoxi; Wang, Qiyu; Klanderman, Barbara; Whitaker, Reid M.; Duan, Qingling; Lasky-Su, Jessica; Nikolos, Christina; Jester, William; Johnson, Martin; Panettieri, Reynold A., Jr.; Tantisira, Kelan G.; Weiss, Scott T.; Lu, Quan			RNA-Seq Transcriptome Profiling Identifies CRISPLD2 as a Glucocorticoid Responsive Gene that Modulates Cytokine Function in Airway Smooth Muscle Cells	PLOS ONE			English	Article							CHILDHOOD ASTHMA RESEARCH; C/EBP-BETA; DRUG-THERAPY; EXPRESSION; INFLAMMATION; ASSOCIATION; MECHANISMS; STEROIDS; RECEPTOR; AUGMENT	Asthma is a chronic inflammatory respiratory disease that affects over 300 million people worldwide. Glucocorticoids are a mainstay therapy for asthma because they exert anti-inflammatory effects in multiple lung tissues, including the airway smooth muscle (ASM). However, the mechanism by which glucocorticoids suppress inflammation in ASM remains poorly understood. Using RNA-Seq, a high-throughput sequencing method, we characterized transcriptomic changes in four primary human ASM cell lines that were treated with dexamethasone-a potent synthetic glucocorticoid (1 mu M for 18 hours). Based on a Benjamini-Hochberg corrected p-value < 0.05, we identified 316 differentially expressed genes, including both well known (DUSP1, KLF15, PER1, TSC22D3) and less investigated (C7, CCDC69, CRISPLD2) glucocorticoid-responsive genes. CRISPLD2, which encodes a secreted protein previously implicated in lung development and endotoxin regulation, was found to have SNPs that were moderately associated with inhaled corticosteroid resistance and bronchodilator response among asthma patients in two previously conducted genome-wide association studies. Quantitative RT-PCR and Western blotting showed that dexamethasone treatment significantly increased CRISPLD2 mRNA and protein expression in ASM cells. CRISPLD2 expression was also induced by the inflammatory cytokine IL1 beta, and small interfering RNA-mediated knockdown of CRISPLD2 further increased IL1 beta-induced expression of IL6 and IL8. Our findings offer a comprehensive view of the effect of a glucocorticoid on the ASM transcriptome and identify CRISPLD2 as an asthma pharmacogenetics candidate gene that regulates anti-inflammatory effects of glucocorticoids in the ASM.	[Himes, Blanca E.; Whitaker, Reid M.; Duan, Qingling; Lasky-Su, Jessica; Tantisira, Kelan G.; Weiss, Scott T.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Himes, Blanca E.; Whitaker, Reid M.; Duan, Qingling; Lasky-Su, Jessica; Tantisira, Kelan G.; Weiss, Scott T.] Harvard Univ, Sch Med, Boston, MA USA; [Himes, Blanca E.; Klanderman, Barbara; Weiss, Scott T.] Partners HealthCare Personalized Med, Boston, MA USA; [Himes, Blanca E.] Childrens Hosp Informat Program, Boston, MA USA; [Jiang, Xiaofeng; Wagner, Peter; Hu, Ruoxi; Wang, Qiyu; Lu, Quan] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Program Mol & Integrat Physiol Sci, Boston, MA 02115 USA; [Jiang, Xiaofeng; Wagner, Peter; Hu, Ruoxi; Wang, Qiyu; Lu, Quan] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Nikolos, Christina; Jester, William; Johnson, Martin; Panettieri, Reynold A., Jr.] Univ Penn, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania	Himes, BE (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	blanca.himes@channing.harvard.edu; qlu@hsph.harvard.edu	panettieri, reynold/AAG-9485-2019	Jester Jr., William/0000-0002-2872-6095; Lasky-Su, Jessica/0000-0001-6236-4705	National Institutes of Health (NIH) [U01 HL65899]; NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance [R01 HL097796, R01 HL114769, P30 ES013508]; NIH [K99 HL105663, T32 HL007118]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097796, R01HL114769, T32HL007118, R00HL105663, U01HL065899, P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by National Institutes of Health (NIH) U01 HL65899, an NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance, R01 HL097796, R01 HL114769, and P30 ES013508. BEH was funded by NIH K99 HL105663. XJ was supported by NIH training grant T32 HL007118. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami LJ, 2012, TRENDS ASTHMA PREVAL, P2001; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; [Anonymous], QUALITY CONTROL TOOL; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Berg T, 2005, BIOCHEM BIOPH RES CO, V334, P638, DOI 10.1016/j.bbrc.2005.06.146; Berg T, 2002, BIOCHEM BIOPH RES CO, V293, P907, DOI 10.1016/S0006-291X(02)00319-4; Burioka N, 2007, J PHARMACOL SCI, V103, P144, DOI 10.1254/jphs.FMJ06003X4; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Chiquet BT, 2007, HUM MOL GENET, V16, P2241, DOI 10.1093/hmg/ddm176; Cooper PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010235; Denlinger LC, 2007, J ALLERGY CLIN IMMUN, V119, P3, DOI 10.1016/j.jaci.2006.10.015; Doni A, 2008, J BIOL CHEM, V283, P29983, DOI 10.1074/jbc.M805631200; Doreswamy V, 2011, CLIN EXP ALLERGY, V41, P9, DOI 10.1111/j.1365-2222.2010.03628.x; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Global Initiative for Asthma (GINA), 2012, GLOB STR ASTHM MAN P; Guilbert TW, 2004, CONTROL CLIN TRIALS, V25, P286, DOI 10.1016/j.cct.2004.03.002; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; Himes BE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002824; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lakser OJ, 2008, EUR RESPIR J, V32, P1224, DOI 10.1183/09031936.00092908; LAMAS AM, 1991, J IMMUNOL, V147, P254; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Lu NZ, 2006, TRENDS CELL BIOL, V16, P301, DOI 10.1016/j.tcb.2006.04.005; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Masuno K, 2011, AM J RESP CELL MOL, V45, P642, DOI 10.1165/rcmb.2010-0369OC; McMaster A, 2007, EXP PHYSIOL, V92, P299, DOI 10.1113/expphysiol.2006.036194; Misior AM, 2009, AM J RESP CELL MOL, V41, P24, DOI 10.1165/rcmb.2008-0266OC; Moodley T, 2013, MOL PHARMACOL, V83, P894, DOI 10.1124/mol.112.083493; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NELSON HS, 1995, NEW ENGL J MED, V333, P499, DOI 10.1056/NEJM199508243330807; Oyewumi L, 2003, AM J RESP CELL MOL, V28, P232, DOI 10.1165/rcmb.4877; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Panettieri RA, 2008, AM J RESP CRIT CARE, V177, P248, DOI 10.1164/rccm.200708-1217PP; Patel GP, 2012, AM J RESP CRIT CARE, V185, P133, DOI 10.1164/rccm.201011-1897CI; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Roos AB, 2012, BIOCHEM BIOPH RES CO, V423, P134, DOI 10.1016/j.bbrc.2012.05.096; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Shore SA, 2003, RESP PHYSIOL NEUROBI, V137, P179, DOI 10.1016/S1569-9048(03)00146-0; Slats AM, 2006, CHEST, V130, P58, DOI 10.1378/chest.130.1.58; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trifilieff A, 2000, AM J PHYSIOL-LUNG C, V279, pL1120, DOI 10.1152/ajplung.2000.279.6.L1120; WALLEN N, 1991, J IMMUNOL, V147, P3490; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065743; Wang ZQ, 2009, J IMMUNOL, V183, P6646, DOI 10.4049/jimmunol.0802348; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yang HM, 2005, J CELL PHYSIOL, V204, P219, DOI 10.1002/jcp.20278; Yick CY, 2013, AM J RESP CRIT CARE, V187, P1076, DOI 10.1164/rccm.201210-1886OC	68	86	89	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99625	10.1371/journal.pone.0099625	http://dx.doi.org/10.1371/journal.pone.0099625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926665	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100056
J	Yan, F; Wang, Q; Xu, C; Cao, MF; Zhou, XM; Wang, TT; Yu, CX; Jing, F; Chen, WB; Gao, L; Zhao, JJ				Yan, Fang; Wang, Qi; Xu, Chao; Cao, Mingfeng; Zhou, Xiaoming; Wang, Tingting; Yu, Chunxiao; Jing, Fei; Chen, Wenbin; Gao, Ling; Zhao, Jiajun			Peroxisome Proliferator-Activated Receptor alpha Activation Induces Hepatic Steatosis, Suggesting an Adverse Effect	PLOS ONE			English	Article							FATTY LIVER-DISEASE; TYPE-2 DIABETES-MELLITUS; PPAR-ALPHA; NONALCOHOLIC STEATOHEPATITIS; LIPID-METABOLISM; MICE; FENOFIBRATE; EXPRESSION; ACID; RAT	Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic triglyceride accumulation, ranging from steatosis to steatohepatitis and cirrhosis. NAFLD is a risk factor for cardiovascular diseases and is associated with metabolic syndrome. Antihyperlipidemic drugs are recommended as part of the treatment for NAFLD patients. Although fibrates activate peroxisome proliferator-activated receptor alpha (PPAR alpha), leading to the reduction of serum triglyceride levels, the effects of these drugs on NAFLD remain controversial. Clinical studies have reported that PPAR alpha activation does not improve hepatic steatosis. In the present study, we focused on exploring the effect and mechanism of PPAR alpha activation on hepatic triglyceride accumulation and hepatic steatosis. Male C57BL/6J mice, Ppar alpha-null mice and HepG2 cells were treated with fenofibrate, one of the most commonly used fibrate drugs. Both low and high doses of fenofibrate were administered. Hepatic steatosis was detected through oil red O staining and electron microscopy. Notably, in fenofibrate-treated mice, the serum triglyceride levels were reduced and the hepatic triglyceride content was increased in a dose-dependent manner. Oil red O staining of liver sections demonstrated that fenofibrate-fed mice accumulated abundant neutral lipids. Fenofibrate also increased the intracellular triglyceride content in HepG2 cells. The expression of sterol regulatory element-binding protein 1c (SREBP-1c) and the key genes associated with lipogenesis were increased in fenofibrate-treated mouse livers and HepG2 cells in a dose-dependent manner. However, the effect was strongly impaired in Ppar alpha-null mice treated with fenofibrate. Fenofibrate treatment induced mature SREBP-1c expression via the direct binding of PPAR alpha to the DR1 motif of the SREBP-1c gene. Taken together, these findings indicate the molecular mechanism by which PPAR alpha activation increases liver triglyceride accumulation and suggest an adverse effect of fibrates on the pathogenesis of hepatic steatosis.	[Yan, Fang; Xu, Chao; Cao, Mingfeng; Yu, Chunxiao; Jing, Fei; Zhao, Jiajun] Shandong Univ, Shandong Prov Hosp, Dept Endocrinol & Metab, Jinan 250100, Shandong, Peoples R China; [Wang, Qi; Zhou, Xiaoming; Chen, Wenbin; Gao, Ling] Shandong Univ, Shandong Prov Hosp, Ctr Sci, Jinan 250100, Shandong, Peoples R China; [Yan, Fang; Xu, Chao; Wang, Tingting; Yu, Chunxiao; Jing, Fei; Gao, Ling; Zhao, Jiajun] Shandong Acad Clin Med, Inst Endocrinol, Jinan, Shandong, Peoples R China; [Wang, Qi] Shandong Univ, Inst Pharmacol, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Gao, L (corresponding author), Shandong Univ, Shandong Prov Hosp, Ctr Sci, Jinan 250100, Shandong, Peoples R China.	gaoling1@medmail.com.cn; jjzhao@medmail.com.cn	wang, tingting/AAK-2640-2020; Zhao, Jiajun/W-2963-2018; wang, qi/ABE-3782-2020	Zhao, Jiajun/0000-0003-3267-9292; 	National Basic Research Program [2012CB524900]; National Natural Science Foundation [30971409, 30901461, 81230018, 81170794, 81270869, 81370891]; Natural Science Foundation [ZR2009CZ009]; Shandong Province	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Province	This work was supported by grants from the National Basic Research Program (2012CB524900), the National Natural Science Foundation (30971409, 30901461, 81230018, 81170794, 81270869 and 81370891), the Natural Science Foundation (ZR2009CZ009), an international cooperation grant (2011) of Shandong Province and the Jinan self-renovation plan for colleges, universities and scientific research institutes (2012) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JC, 1997, DRUGS, V54, P615, DOI 10.2165/00003495-199754040-00007; Aguilera-Mendez A, 2013, MINI-REV MED CHEM, V13, P1691; Bajaj M, 2007, DIABETOLOGIA, V50, P1723, DOI 10.1007/s00125-007-0698-9; Chen Q, 2007, NAT PROTOC, V2, P1197, DOI 10.1038/nprot.2007.118; Cong WN, 2008, LIFE SCI, V82, P983, DOI 10.1016/j.lfs.2008.01.022; Damiano F, 2012, INT J BIOCHEM CELL B, V44, P659, DOI 10.1016/j.biocel.2012.01.003; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Delayre-Orthez C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-91; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Elijah IE, 2012, BURNS, V38, P481, DOI 10.1016/j.burns.2011.12.004; Fatani S, 2011, INT J GEN MED, V4, P211, DOI 10.2147/IJGM.S17376; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Fernandez-Alvarez A, 2011, J BIOL CHEM, V286, P21466, DOI 10.1074/jbc.M110.209973; Fernandez-Miranda C, 2008, DIGEST LIVER DIS, V40, P200, DOI 10.1016/j.dld.2007.10.002; Ferreira AVM, 2006, METABOLISM, V55, P731, DOI 10.1016/j.metabol.2006.01.020; Gao MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065641; Gibbons GF, 2002, ADV ENZYME REGUL, V42, P227, DOI 10.1016/S0065-2571(01)00033-4; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Karahashi M, 2013, J PHARMACOL SCI, V123, P356, DOI 10.1254/jphs.13149FP; Keating GM, 2011, AM J CARDIOVASC DRUG, V11, P227, DOI 10.2165/11207690-000000000-00000; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Knight BL, 2005, BIOCHEM J, V389, P413, DOI 10.1042/BJ20041896; Kostapanos MS, 2013, WORLD J HEPATOL, V5, P470, DOI 10.4254/wjh.v5.i9.470; Laurin J, 1996, HEPATOLOGY, V23, P1464; Le Jossic-Corcos C, 2004, BBA-MOL CELL BIOL L, V1683, P49, DOI 10.1016/j.bbalip.2004.04.004; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Luo ZD, 2012, CELL RES, V22, P551, DOI 10.1038/cr.2011.205; Martin PD, 2003, CLIN THER, V25, P459, DOI 10.1016/S0149-2918(03)80089-9; Nakajima T, 2010, REDOX REP, V15, P123, DOI 10.1179/174329210X12650506623807; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Pan SY, 2013, J PHARMACOL SCI, V123, P110, DOI 10.1254/jphs.13087FP; Pan SY, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-120; Panadero M. I., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P219; Pang SS, 2010, DIABETES, V59, P3041, DOI 10.2337/db10-0418; Patel DD, 2001, J LIPID RES, V42, P328; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Valasek MA, 2007, J LIPID RES, V48, P2725, DOI 10.1194/jlr.M700345-JLR200; Vecera R, 2011, BIOPHARM DRUG DISPOS, V32, P482, DOI 10.1002/bdd.774; Xue ZH, 2007, CLIN EXP PHARMACOL P, V34, P27, DOI 10.1111/j.1440-1681.2007.04547.x; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Zhang XQ, 2010, HEPATOLOGY, V51, P1190, DOI 10.1002/hep.23486	45	52	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99245	10.1371/journal.pone.0099245	http://dx.doi.org/10.1371/journal.pone.0099245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926685	Green Submitted, gold, Green Published			2022-12-25	WOS:000338278100032
J	Bao, R; Zhuang, K; Liu, JB; Wu, JG; Li, JL; Wang, X; Ho, WZ				Bao, Rong; Zhuang, Ke; Liu, Jinbiao; Wu, Jianguo; Li, Jieliang; Wang, Xu; Ho, Wen-Zhe			Lipopolysaccharide Induces Immune Activation and SIV Replication in Rhesus Macaques of Chinese Origin	PLOS ONE			English	Article							MICROBIAL TRANSLOCATION; T-CELLS; HIV-INFECTION; NATURAL HOSTS; VIRUS	Background: Chronic immune activation is a hallmark of progressive HIV infection and a key determinant of immunodeficiency in HIV-infected individuals. Bacterial lipopolysaccharide (LPS) in the circulation has been implicated as a key factor in HIV infection-related systemic immune activation. We thus investigate the impact of LPS on systemic immune activation in simian immunodeficiency virus (SIV)-infected rhesus macaques of Chinese origin. Methods: The animals were inoculated intravenously with SIVmac239. The levels of plasma viral load and host inflammatory cytokines in PBMC were measured by real-time RT-PCR. CD4/CD8 ratio and systemic immune activation markers were examined by flow cytometric analysis of PBMCs. White blood cell and neutrophil counts and C Reactive Protein levels were determined using biochemistry analyzer. The plasma levels of LPS were determined by Tachypleus Amebocyte Lysate (TAL) test. Results: The animals inoculated with SIVmac239 became infected as evidenced by the increased plasma levels of SIV RNA and decreased CD4/CD8 ratio. LPS administration of SIV-infected animals induced a transient increase of plasma SIV RNA and immune activation, which was indicated by the elevated expression of the inflammatory cytokines and CD4+HLA-DR+ T cells in PBMCs. Conclusions: These data support the concept that LPS is a driving factor in systemic immune activation of HIV disease.	[Bao, Rong; Zhuang, Ke; Liu, Jinbiao; Ho, Wen-Zhe] Wuhan Univ, Anim Biosafety Level Lab 3, Ctr Expt Anim, Wuhan 430072, Hubei, Peoples R China; [Wu, Jianguo; Ho, Wen-Zhe] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Li, Jieliang; Wang, Xu; Ho, Wen-Zhe] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA	Wuhan University; Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Ho, WZ (corresponding author), Wuhan Univ, Anim Biosafety Level Lab 3, Ctr Expt Anim, Wuhan 430072, Hubei, Peoples R China.	wenzheho@whu.edu.cn		Wu, Jianguo/0000-0002-8326-2895	National Natural Science Foundation of China [81271334]; Mega-Projects of Science Research for the 11th Five Year Plan, China [2013ZX10003009-003]; Translational Medical Research Fund of Wuhan University School of Medicine; NIDA [DA12815, DA22177, DA036163, DA27550]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mega-Projects of Science Research for the 11th Five Year Plan, China; Translational Medical Research Fund of Wuhan University School of Medicine; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This study was supported by the grants 81271334 from the National Natural Science Foundation of China, 2013ZX10003009-003 from the Mega-Projects of Science Research for the 11th Five Year Plan, China, theTranslational Medical Research Fund of Wuhan University School of Medicine and NIDA grants DA12815, DA22177, DA036163 and DA27550 (to WZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Boasso A, 2009, J IMMUNOL, V182, P4313, DOI 10.4049/jimmunol.0803314; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Campillo-Gimenez L, 2010, J IMMUNOL, V184, P984, DOI 10.4049/jimmunol.0902316; Cumont MC, 2007, CELL DEATH DIFFER, V14, P1747, DOI 10.1038/sj.cdd.4402192; Desrosiers R C, 1995, AIDS, V9 Suppl A, pS137; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Joag SV, 2000, MICROBES INFECT, V2, P223, DOI 10.1016/S1286-4579(00)00266-5; Kadoki M, 2010, INT IMMUNOL, V22, P469, DOI 10.1093/intimm/dxq032; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Mattapallil JJ, 2005, MASSIVE INFECT LOSS; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Paiardini M, 2008, AIDS REV, V10, P36; Paiardini M, 2009, ANNU REV MED, V60, P485, DOI 10.1146/annurev.med.60.041807.123753; Pallikkuth S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003471; Pandrea I, 2008, J IMMUNOL, V181, P6687, DOI 10.4049/jimmunol.181.10.6687; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Tanaka J, 2000, AIDS, V14, P1299, DOI 10.1097/00002030-200007070-00001; Ye L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009602; Zhou Y, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-89	26	10	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98636	10.1371/journal.pone.0098636	http://dx.doi.org/10.1371/journal.pone.0098636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918575	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000024
J	Chen, LH; Zhang, JQ; Chen, YF; Wang, WW; Zhou, XD; Yan, XC; Wang, J				Chen, Lihua; Zhang, Jiuquan; Chen, Yongfeng; Wang, Wenwei; Zhou, Xiangdong; Yan, Xiaochu; Wang, Jian			Relationship between Apparent Diffusion Coefficient and Tumour Cellularity in Lung Cancer	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; COMPLICATION RATE; WEIGHTED MRI; EXPERIENCE; LYMPHOMAS; GLIOMAS; BIOPSY	Background and objective: To prospectively investigate the relationship between the apparent diffusion coefficient (ADC) and cellularity in lung cancer. Methods: Sixty patients histopathologically confirmed with lung cancer (41 men, 19 women) underwent diffusion-weighted magnetic resonance imaging of the chest (with b values of 50 and 1000 s/mm(2)). The median mean ADC (ADCmean) value and median minimum ADC (ADCmin) value within each primary tumour were calculated and compared with the median nucleo-cytoplasmic ratio (NCR), which was selected to represent the cellularity. The correlation between the NCR and ADCmean/ADCmin was calculated with SPSS 18.0 software. Results: The mean ADCmean values, ADCmin values and median NCR were (1.07 +/- 0.12) x 10(-3) mm(2)/s, (0.86 +/- 0.14) x 10(-3) mm(2)/s, and (14.9 +/- 2.6) %, respectively, in adenocarcinoma; (0.88 +/- 0.10) x 10(-3) mm(2)/s, (0.73 +/- 0.12) x 10(-3) mm(2)/s, nd (20.6 +/- 4.4) %, respectively, in squamous cell carcinoma; and (0.89 +/- 0.13) x 10(-3) mm(2)/s, (0.67 +/- 0.13) x 10(-3) mm(2)/s, and (18.3 +/- 3.5) %, respectively in small cell lung cancer. The NCR of squamous cell carcinoma and small cell lung cancer is greater than that of adenocarcinoma (P<0.01 and P = 0.002, respectively). There was an inverse relationship between ADCmean/NCR and ADCmin/NCR (r = -0.60, P = 0.001 and r = -0.47, P<0.001, respectively). Conclusion: There is a significant inverse relationship between tumour cellularity and ADC in lung cancer. However, tumour cellularity most likely is not the sole determinant of the ADC.	[Chen, Lihua; Zhang, Jiuquan; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Chen, Lihua] PLA 101st Hosp, Dept Radiol, Wuxi, Jiangsu, Peoples R China; [Chen, Yongfeng; Wang, Wenwei; Zhou, Xiangdong] Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China; [Yan, Xiaochu] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Yan, XC (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China.	yanxiaochu2002@hotmail.com; wangjian_811@yahoo.com	ZHANG, JIUQUAN/X-8389-2019	Chen, Lihua/0000-0001-7249-2014; Chen, Lihua/0000-0001-5037-050X; Zhang, Jiuquan/0000-0003-0239-6988				Baysal T, 2009, MAGN RESON IMAGING, V27, P1447, DOI 10.1016/j.mri.2009.05.024; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; Chen LH, 2013, J MAGN RESON IMAGING, V37, P1351, DOI 10.1002/jmri.23939; Doskaliyev A, 2012, EUR J RADIOL, V81, P339, DOI 10.1016/j.ejrad.2010.11.005; Fan GG, 2005, ACAD RADIOL, V12, P640, DOI 10.1016/j.acra.2005.01.024; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Henzler T, 2010, EUR J RADIOL, V76, P329, DOI 10.1016/j.ejrad.2010.05.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kikuchi T, 2009, NEUROL RES, V31, P1102, DOI 10.1179/174313209X382539; Kosucu P, 2009, J MAGN RESON IMAGING, V30, P292, DOI 10.1002/jmri.21850; Koyama H, 2010, EUR RADIOL, V20, P790, DOI 10.1007/s00330-009-1615-z; Li Z, 2010, CHINESE GERMAN J CLI, V9, P388; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; Matoba M, 2007, RADIOLOGY, V243, P570, DOI 10.1148/radiol.2432060131; Matsumoto Y, 2009, ONCOL REP, V22, P641, DOI 10.3892/or_00000484; Park SH, 2012, EUR RADIOL, V22, P18, DOI 10.1007/s00330-011-2236-x; Poptani H, 1998, CANCER GENE THER, V5, P101; Priola AM, 2010, ACTA RADIOL, V51, P527, DOI 10.3109/02841851003691979; Razek AAKA, 2012, CANCER IMAGING, V12, P452, DOI 10.1102/1470-7330.2012.0041; Razek AAKA, 2011, J COMPUT ASSIST TOMO, V35, P248, DOI 10.1097/RCT.0b013e31820ccf73; Sadeghi N, 2003, AM J ROENTGENOL, V181, P235, DOI 10.2214/ajr.181.1.1810235; Shin HJ, 2012, NMR BIOMED, V25, P1349, DOI 10.1002/nbm.2807; Yabuuchi H, 2011, RADIOLOGY, V261, P598, DOI 10.1148/radiol.11101503; Yuan DM, 2011, CHINESE MED J-PEKING, V124, P3227, DOI 10.3760/cma.j.issn.0366-6999.2011.20.04	24	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99865	10.1371/journal.pone.0099865	http://dx.doi.org/10.1371/journal.pone.0099865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919055	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000123
J	Gao, B; Huang, Q; Lin, YS; Wei, BY; Guo, YS; Sun, Z; Wang, L; Fan, J; Zhang, HY; Han, YH; Li, XJ; Shi, J; Liu, J; Yang, L; Luo, ZJ				Gao, Bo; Huang, Qiang; Lin, Yan-Shui; Wei, Bo-Yuan; Guo, Yun-Shan; Sun, Zhen; Wang, Long; Fan, Jing; Zhang, Hong-Yang; Han, Yue-Hu; Li, Xiao-Jie; Shi, Jun; Liu, Jian; Yang, Liu; Luo, Zhuo-Jing			Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW; ADIPOCYTIC PHENOTYPE; GENE-EXPRESSION; ADIPOSE-TISSUE; BETA-CATENIN; DIFFERENTIATION; FAMILY; LRP5; PROLIFERATION	Fat infiltration within marrow cavity is one of multitudinous features of estrogen deficiency, which leads to a decline in bone formation functionality. The origin of this fat is unclear, but one possibility is that it is derived from osteoblasts, which transdifferentiate into adipocytes that produce bone marrow fat. We examined the dose-dependent effect of 17 beta-estradiol on the ability of MC3T3-E1 cells and murine bone marrow-derived mesenchymal stem cell (BMMSC)-derived osteoblasts to undergo osteo-adipogenic transdifferentiation. We found that 17 beta-estradiol significantly increased alkaline phosphatase activity (P<0.05); calcium deposition; and Alp, Col1a1, Runx2, and Ocn expression levels dose-dependently. By contrast, 17 beta-estradiol significantly decreased the number and size of lipid droplets, and Fabp4 and PPAR gamma expression levels during osteo-adipogenic transdifferentiation (P<0.05). Moreover, the expression levels of brown adipocyte markers (Myf5, Elovl3, and Cidea) and undifferentiated adipocyte markers (Dlk1, Gata2, and Wnt10b) were also affected by 17 beta-estradiol during osteo-adipogenic transdifferentiation. Western blotting and immunostaining further showed that canonical Wnt signaling can be activated by estrogen to exert its inhibitory effect of osteo-adipogenesis. This is the first study to demonstrate the dose-dependent effect of 17 beta-estradiol on the osteo-adipogenic transdifferentiation of MC3T3-E1 cells and BMMSCs likely via canonical Wnt signaling. In summary, our results indicate that osteo-adipogenic transdifferentiation modulated by canonical Wnt signaling pathway in bone metabolism may be a new explanation for the gradually increased bone marrow fat in estrogen-inefficient condition.	[Gao, Bo; Huang, Qiang; Wei, Bo-Yuan; Guo, Yun-Shan; Sun, Zhen; Wang, Long; Fan, Jing; Zhang, Hong-Yang; Han, Yue-Hu; Li, Xiao-Jie; Shi, Jun; Liu, Jian; Yang, Liu; Luo, Zhuo-Jing] Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped Surg, Xian 710032, Peoples R China; [Lin, Yan-Shui] Chengdu Med Coll, Affiliated Hosp 1, Dept Orthopaed, Chengdu, Peoples R China	Air Force Military Medical University; Chengdu Medical College	Liu, J (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped Surg, Xian 710032, Peoples R China.	liujianhq@sina.com; yangliufmmu@gmail.com; zjluogb@hotmail.com			Ministry of Science and Technology of China [2011CB964703]; National High Technology Research and Development Program 863 [2012AA020502]; China Postdoctoral Science Foundation [2012T50856]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1053]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Ministry of Science and Technology of China (2011CB964703), the National High Technology Research and Development Program 863 (2012AA020502), and the China Postdoctoral Science Foundation (2012T50856), and the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1053). No benefits in any form have been or will be received from a commercial party directly or indirectly by the authors of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2011, J BONE MINER RES, V26, P1457, DOI 10.1002/jbmr.346; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Burke ZD, 2005, CLIN SCI, V108, P309, DOI 10.1042/CS20040335; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ebeling PR, 2010, CURR OPIN ENDOCRINOL, V17, P284, DOI 10.1097/MED.0b013e328339658c; Foo C, 2007, GYNECOL ENDOCRINOL, V23, P535, DOI 10.1080/09513590701556483; Gambacciani M, 1997, J CLIN ENDOCR METAB, V82, P414, DOI 10.1210/jc.82.2.414; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Govindarajan P, 2014, AM J PATHOL, V184, P765, DOI 10.1016/j.ajpath.2013.11.011; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Guo YF, 2006, J MED GENET, V43, P798, DOI 10.1136/jmg.2006.041715; Gustafson B, 2010, J BIOL CHEM, V285, P14031, DOI 10.1074/jbc.M110.102855; Heim M, 2004, ENDOCRINOLOGY, V145, P848, DOI 10.1210/en.2003-1014; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kamiya Y, 2013, J BONE MINER RES, V28, P1127, DOI 10.1002/jbmr.1835; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Katoh M, 2005, ONCOL REP, V14, P1583; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2622, DOI 10.1210/en.139.5.2622; Kim MH, 2010, CELL PROLIFERAT, V43, P594, DOI 10.1111/j.1365-2184.2010.00709.x; Kim SW, 2005, BIOCHEM BIOPH RES CO, V327, P811, DOI 10.1016/j.bbrc.2004.12.076; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li Yongming, 2010, BMC Res Notes, V3, P309, DOI 10.1186/1756-0500-3-309; Li YM, 2013, J BIOMED MATER RES B, V101B, P9, DOI 10.1002/jbm.b.32803; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; McNeilly Thomas, 2013, Ulster Med J, V82, P89; Menagh PJ, 2010, J BONE MINER RES, V25, P757, DOI 10.1359/jbmr.091015; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Park SR, 1999, BONE, V24, P549, DOI 10.1016/S8756-3282(99)00084-8; Pierroz DD, 2009, J BONE MINER RES, V24, P775, DOI [10.1359/JBMR.081237, 10.1359/jbmr.081237]; Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; Ratti C, 2013, AGING CLIN EXP RES, V25, pS9, DOI 10.1007/s40520-013-0098-6; Rossini M, 2013, CALCIFIED TISSUE INT, V93, P121, DOI 10.1007/s00223-013-9749-z; Sadie-Van Gijsen H, 2013, CELL MOL LIFE SCI, V70, P2331, DOI 10.1007/s00018-012-1211-2; Santanam N, 1998, J LIPID RES, V39, P2111; Schiller PC, 2001, J BIOL CHEM, V276, P14133, DOI 10.1074/jbc.M011055200; Schilling T, 2008, J CELL BIOCHEM, V103, P413, DOI 10.1002/jcb.21415; Schilling T, 2007, MOL CELL ENDOCRINOL, V271, P1, DOI 10.1016/j.mce.2007.03.004; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; Song LG, 2013, EUR J PHARMACOL, V714, P15, DOI 10.1016/j.ejphar.2013.05.039; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Taipaleenmaki H, 2011, EXP CELL RES, V317, P745, DOI 10.1016/j.yexcr.2010.12.015; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Weaver CM, 2014, CURR OSTEOPOROS REP; Zhang JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057251	49	26	30	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99137	10.1371/journal.pone.0099137	http://dx.doi.org/10.1371/journal.pone.0099137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918446	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000053
J	Valiadi, M; Painter, SC; Allen, JT; Balch, WM; Iglesias-Rodriguez, MD				Valiadi, Martha; Painter, Stuart C.; Allen, John T.; Balch, William M.; Iglesias-Rodriguez, M. Debora			Molecular Detection of Bioluminescent Dinoflagellates in Surface Waters of the Patagonian Shelf during Early Austral Summer 2008	PLOS ONE			English	Article							BRAZIL-MALVINAS CONFLUENCE; TAMARENSE LEBOUR BALECH; PHYTOPLANKTON BLOOMS; GONYAULAX-EXCAVATA; ATLANTIC-OCEAN; ARGENTINE SEA; GOLFO-NUEVO; ALEXANDRIUM; CHLOROPHYLL; DIVERSITY	We investigated the distribution of bioluminescent dinoflagellates in the Patagonian Shelf region using "universal'' PCR primers for the dinoflagellate luciferase gene. Luciferase gene sequences and single cell PCR tests, in conjunction with taxonomic identification by microscopy, allowed us to identify and quantify bioluminescent dinoflagellates. We compared these data to coincidental discrete optical measurements of stimulable bioluminescence intensity. Molecular detection of the luciferase gene showed that bioluminescent dinoflagellates were widespread across the majority of the Patagonian Shelf region. Their presence was comparatively underestimated by optical bioluminescence measurements, whose magnitude was affected by interspecific differences in bioluminescence intensity and by the presence of other bioluminescent organisms. Molecular and microscopy data showed that the complex hydrography of the area played an important role in determining the distribution and composition of dinoflagellate populations. Dinoflagellates were absent south of the Falkland Islands where the cold, nutrient-rich, and well-mixed waters of the Falklands Current favoured diatoms instead. Diverse populations of dinoflagellates were present in the warmer, more stratified waters of the Patagonian Shelf and Falklands Current as it warmed northwards. Here, the dinoflagellate population composition could be related to distinct water masses. Our results provide new insight into the prevalence of bioluminescent dinoflagellates in Patagonian Shelf waters and demonstrate that a molecular approach to the detection of bioluminescent dinoflagellates in natural waters is a promising tool for ecological studies of these organisms.	[Valiadi, Martha; Iglesias-Rodriguez, M. Debora] Univ Southampton, Southampton, Hants, England; [Painter, Stuart C.; Allen, John T.] Natl Oceanog Ctr, Southampton, Hants, England; [Balch, William M.] Bigelow Lab Ocean Sci, East Boothbay, ME USA	University of Southampton; NERC National Oceanography Centre; Bigelow Laboratory for Ocean Sciences	Valiadi, M (corresponding author), Univ Southampton, Waterfront Campus, Southampton, Hants, England.	martha.valiadi@gmail.com	Allen, John Taylor/AHB-3419-2022; Valiadi, Martha/U-6718-2019; Painter, Stuart/F-1248-2010	Allen, John Taylor/0000-0001-7357-6623; Valiadi, Martha/0000-0003-0074-554X; Painter, Stuart/0000-0001-7934-7346	Luminescence and Marine Plankton project [1166]; Office of Naval Research (ONR) [N000140410180]; National Science Foundation cruise [OCE-0728582]; NSF [OCE-0961660]; NASA [NNX11AO72G, NNX11AL93G, NNX10AT67G]; NERC [noc010009] Funding Source: UKRI; Natural Environment Research Council [noc010009] Funding Source: researchfish; Directorate For Geosciences [0961660] Funding Source: National Science Foundation	Luminescence and Marine Plankton project; Office of Naval Research (ONR)(Office of Naval Research); National Science Foundation cruise; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding: Financial support for MV, SCP, JTA and DIR was provided by the Luminescence and Marine Plankton project (Defence Science and Technology Laboratory and Natural Environment Research Council joint grant scheme proposal. ref 1166). MV and DIR were additionally supported by the Office of Naval Research (ONR award number N000140410180, awarded to DIR). Support for WMB as well as the ship time for the project was provided by the National Science Foundation cruise (OCE-0728582). Additional support for WMB for this work was also provided by NSF (OCE-0961660) and NASA (NNX11AO72G; NNX11AL93G; NNX10AT67G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS MV, 1993, ECOLOGY, V74, P258, DOI 10.2307/1939521; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Baker A, 2008, J PHYCOL, V44, P419, DOI 10.1111/j.1529-8817.2008.00474.x; Balch WM, 2011, DEEP-SEA RES PT II, V58, P400, DOI 10.1016/j.dsr2.2010.08.004; Bianchi AA, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004854; BISBAL GA, 1995, MAR POLICY, V19, P21, DOI 10.1016/0308-597X(95)92570-W; Brandini FP, 2000, DEEP-SEA RES PT I, V47, P1015, DOI 10.1016/S0967-0637(99)00075-8; BUSKEY E, 1983, LIMNOL OCEANOGR, V28, P575, DOI 10.4319/lo.1983.28.3.0575; BUSKEY EJ, 1994, MAR BIOL, V121, P373, DOI 10.1007/BF00346747; BUSKEY EJ, 1992, J EXP MAR BIOL ECOL, V159, P37, DOI 10.1016/0022-0981(92)90256-A; CARRETO JI, 1986, J PLANKTON RES, V8, P15, DOI 10.1093/plankt/8.1.15; CARRETO JI, 1995, CONT SHELF RES, V15, P315, DOI 10.1016/0278-4343(94)E0001-3; Carreto JI, 2003, MAR BIOL, V143, P1013, DOI 10.1007/s00227-003-1147-z; Carreto JI, 2008, CONT SHELF RES, V28, P1589, DOI 10.1016/j.csr.2007.02.012; Cussatlegras AS, 2007, J EXP MAR BIOL ECOL, V343, P74, DOI 10.1016/j.jembe.2006.11.009; DESA R, 1968, J GEN PHYSIOL, V51, P105, DOI 10.1085/jgp.51.1.105; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Esaias WE, 1973, J CELL PHYSL, V82; Fleisher KJ, 1995, BIOL BULL, V189, P263, DOI 10.2307/1542143; Franco BC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032066; Garcia VMT, 2008, DEEP-SEA RES PT I, V55, P1150, DOI 10.1016/j.dsr.2008.04.011; Gayoso AM, 2006, HARMFUL ALGAE, V5, P233, DOI 10.1016/j.hal.2004.12.010; Gayoso AM, 1996, J PLANKTON RES, V18, P941, DOI 10.1093/plankt/18.6.941; Gayoso AM, 2001, J PLANKTON RES, V23, P463, DOI 10.1093/plankt/23.5.463; Gentile G, 2009, DEEP-SEA RES PT II, V56, P763, DOI 10.1016/j.dsr2.2008.07.023; Godhe A, 2001, MAR BIOTECHNOL, V3, P152, DOI 10.1007/s101260000052; GORDON AL, 1989, DEEP-SEA RES, V36, P359, DOI 10.1016/0198-0149(89)90042-3; Grasshoff K., 1999, METHODS SEAWATER ANA; Guillou L, 2002, PROTIST, V153, P223, DOI 10.1078/1434-4610-00100; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; KELLY MG, 1968, BIOL BULL, V135, P279, DOI 10.2307/1539782; LAPOTA D, 1992, MAR BIOL, V112, P665, DOI 10.1007/BF00346185; LAPOTA D, 1984, J EXP MAR BIOL ECOL, V77, P209, DOI 10.1016/0022-0981(84)90121-7; Levitus S., 1982, 13 NOAA; Li YQ, 1996, J PHYCOL, V32, P974, DOI 10.1111/j.0022-3646.1996.00974.x; Liu LY, 2007, P NATL ACAD SCI USA, V104, P696, DOI 10.1073/pnas.0607816103; Liu LY, 2004, P NATL ACAD SCI USA, V101, P16555, DOI 10.1073/pnas.0407597101; Lynch RV, 1978, OCCURENCE DISTRIBUTI, P49; Marcinko CLJ, 2013, PROG OCEANOGR, V109, P117, DOI 10.1016/j.pocean.2012.10.008; Marcinko CLJ, 2013, J PLANKTON RES, V35, P177, DOI 10.1093/plankt/fbs081; Moline MA, 2009, DEEP-SEA RES PT II, V56, P232, DOI 10.1016/j.dsr2.2008.08.002; NEGRI RM, 1992, J PLANKTON RES, V14, P261, DOI 10.1093/plankt/14.2.261; Olguin HF, 2006, J PLANKTON RES, V28, P1107, DOI 10.1093/plankt/fbl045; OLSON DB, 1988, DEEP-SEA RES, V35, P1971, DOI 10.1016/0198-0149(88)90120-3; Painter SC, 2010, CONT SHELF RES, V30, P1907, DOI 10.1016/j.csr.2010.08.013; PIOLA AR, 1989, DEEP-SEA RES, V36, P1, DOI 10.1016/0198-0149(89)90015-0; Poulton AJ, 2013, GLOBAL BIOGEOCHEM CY, V27, P1023, DOI 10.1002/2013GB004641; Poupin J, 1999, PLANCTON MARIN BIOLU, P83; Provost C, 1996, CONT SHELF RES, V16, P215, DOI 10.1016/0278-4343(95)00006-M; RAYMOND JA, 1976, LIMNOL OCEANOGR, V21, P599, DOI 10.4319/lo.1976.21.4.0599; Romero SI, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003244; Sabatini M, 2004, CONT SHELF RES, V24, P1359, DOI 10.1016/j.csr.2004.03.014; Schloss IR, 2007, MAR ECOL PROG SER, V332, P93, DOI 10.3354/meps332093; SCHMIDT RJ, 1978, J PHYCOL, V14, P5, DOI 10.1111/j.1529-8817.1978.tb00624.x; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1137, DOI 10.4319/lo.1997.42.5_part_2.1137; SOGIN ML, 1987, ANN NY ACAD SCI, V503, P125, DOI 10.1111/j.1749-6632.1987.tb40603.x; Steidinger Karen A., 1997, P387, DOI 10.1016/B978-012693018-4/50005-7; SWEENEY BM, 1959, J GEN PHYSIOL, V43, P285, DOI 10.1085/jgp.43.2.285; SWEENEY BM, 1963, BIOL BULL, V125, P177, DOI 10.2307/1539300; SWIFT E, 1985, J PLANKTON RES, V7, P831, DOI 10.1093/plankt/7.6.831; SWIFT E, 1995, J GEOPHYS RES-OCEANS, V100, P6527, DOI 10.1029/94JC01870; SWIFT E, 1973, J PHYCOL, V9, P420, DOI 10.1111/j.1529-8817.1973.tb04115.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TETT PB, 1971, J MAR BIOL ASSOC UK, V51, P183, DOI 10.1017/S002531540000655X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uribe P, 2008, MAR BIOTECHNOL, V10, P692, DOI 10.1007/s10126-008-9107-8; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; Valiadi Martha, 2013, Microorganisms, V1, P3; Valiadi M, 2012, J PHYCOL, V48, P826, DOI 10.1111/j.1529-8817.2012.01144.x; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Willson HR, 2000, PROG OCEANOGR, V45, P415, DOI 10.1016/S0079-6611(00)00011-2; Zhang H, 2002, APPL ENVIRON MICROB, V68, P989, DOI 10.1128/AEM.68.2.989-994.2002	74	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98849	10.1371/journal.pone.0098849	http://dx.doi.org/10.1371/journal.pone.0098849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918444	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000338631000029
J	Ziska, LH				Ziska, Lewis H.			Increasing Minimum Daily Temperatures Are Associated with Enhanced Pesticide Use in Cultivated Soybean along a Latitudinal Gradient in the Mid-Western United States	PLOS ONE			English	Article							CLIMATE-CHANGE; FOOD SECURITY; ELEVATED CO2; AGRICULTURE; TRENDS; IMPACT; YIELDS	Assessments of climate change and food security often do not consider changes to crop production as a function of altered pest pressures. Evaluation of potential changes may be difficult, in part, because management practices are routinely utilized in situ to minimize pest injury. If so, then such practices, should, in theory, also change with climate, although this has never been quantified. Chemical (pesticide) applications remain the primary means of managing pests in industrialized countries. While a wide range of climate variables can influence chemical use, minimum daily temperature (lowest 24 h recorded temperature in a given year) can be associated with the distribution and thermal survival of many agricultural pests in temperate regions. The current study quantifies average pesticide applications since 1999 for commercial soybean grown over a 2100 km North-South latitudinal transect for seven states that varied in minimum daily temperature (1999-2013) from -28.6 degrees C (Minnesota) to -5.1 degrees C (Louisiana). Although soybean yields (per hectare) did not vary by state, total pesticide applications (kg of active ingredient, ai, per hectare) increased from 4.3 to 6.5 over this temperature range. Significant correlations were observed between minimum daily temperatures and kg of ai for all pesticide classes. This suggested that minimum daily temperature could serve as a proxy for pesticide application. Longer term temperature data (1977-2013) indicated greater relative increases in minimum daily temperatures for northern relative to southern states. Using these longer-term trends to determine short-term projections of pesticide use (to 2023) showed a greater comparative increase in herbicide use for soybean in northern; but a greater increase in insecticide and fungicide use for southern states in a warmer climate. Overall, these data suggest that increases in pesticide application rates may be a means to maintain soybean production in response to rising minimum daily temperatures and potential increases in pest pressures.	ARS, Crop Syst & Global Change Lab, USDA, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA)	Ziska, LH (corresponding author), ARS, Crop Syst & Global Change Lab, USDA, Beltsville, MD 20705 USA.	l.ziska@ars.usda.gov						ADAMS RM, 1990, NATURE, V345, P219, DOI 10.1038/345219a0; [Anonymous], 2012, MAN RISKS EXTR EV DI; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; CAMMELL ME, 1992, ADV ECOL RES, V22, P117, DOI 10.1016/S0065-2504(08)60135-X; Carpenter J., 1999, AgBioForum, V2, P1; Chen CC, 2001, CLIMATIC CHANGE, V50, P475, DOI 10.1023/A:1010655503471; Delye C, 2013, TRENDS GENET, V29, P649, DOI 10.1016/j.tig.2013.06.001; Fuhrer J, 2003, AGR ECOSYST ENVIRON, V97, P1, DOI 10.1016/S0167-8809(03)00125-7; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Tran JK, 2007, ECOL APPL, V17, P882, DOI 10.1890/06-0512; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; LOUGH JM, 1983, J CLIM APPL METEOROL, V22, P1673, DOI 10.1175/1520-0450(1983)022<1673:CACISF>2.0.CO;2; Malloch G, 2006, B ENTOMOL RES, V96, P573, DOI 10.1017/BER2006459; McDonald A, 2009, AGR ECOSYST ENVIRON, V130, P131, DOI 10.1016/j.agee.2008.12.007; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Patterson DT, 1999, CLIMATIC CHANGE, V43, P711, DOI 10.1023/A:1005549400875; PORTER JH, 1991, AGR FOREST METEOROL, V57, P221, DOI 10.1016/0168-1923(91)90088-8; Reilly J, 2003, CLIMATIC CHANGE, V57, P43, DOI 10.1023/A:1022103315424; Robinson EA, 2012, NEW PHYTOL, V194, P321, DOI 10.1111/j.1469-8137.2012.04074.x; Scherm H, 2004, CAN J PLANT PATHOL, V26, P267; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Southern Weed Science Society (SWSS), 2013, SWSS P, V66, P275; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; TREHARNE K, 1989, CAS PAPER, V19, P67; Vose RS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024379; Yang Y, 2010, COMPUT ELECTRON AGR, V71, P77, DOI 10.1016/j.compag.2009.12.006; Zimdahl RL., 2007, WEED CROP COMPETITIO, V2; Ziska L. H., 2010, HDB CLIMATE CHANGE A, P191; Ziska LH, 2012, P ROY SOC B-BIOL SCI, V279, P4097, DOI 10.1098/rspb.2012.1005; Ziska LH, 2007, AGROECOSYSTEMS CHANG, P262	36	16	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98516	10.1371/journal.pone.0098516	http://dx.doi.org/10.1371/journal.pone.0098516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918585	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000018
J	Brander, S; Mikkelsen, JD; Kepp, KP				Brander, Soren; Mikkelsen, Jorn D.; Kepp, Kasper P.			Characterization of an Alkali- and Halide-Resistant Laccase Expressed in E-coli: CotA from Bacillus clausii	PLOS ONE			English	Article							PH ACTIVITY PROFILE; BILIRUBIN OXIDASE; MULTICOPPER OXIDASE; BACTERIAL LACCASE; TOLERANT LACCASE; FUNGAL LACCASE; REDOX; SUBTILIS; INHIBITION; SUBSTRATE	The limitations of fungal laccases at higher pH and salt concentrations have intensified the search for new extremophilic bacterial laccases. We report the cloning, expression, and characterization of the bacterial cotA from Bacillus clausii, a supposed alkalophilic ortholog of cotA from B. subtilis. Both laccases were expressed in E. coli strain BL21(DE3) and characterized fully in parallel for strict benchmarking. We report activity on ABTS, SGZ, DMP, caffeic acid, promazine, phenyl hydrazine, tannic acid, and bilirubin at variable pH. Whereas ABTS, promazine, and phenyl hydrazine activities vs. pH were similar, the activity of B. clausii cotA was shifted upwards by similar to 0.5-2 pH units for the simple phenolic substrates DMP, SGZ, and caffeic acid. This shift is not due to substrate affinity (K-M) but to pH dependence of catalytic turnover: The k(cat) of B. clausii cotA was 1 s(-1) at pH 6 and 5 s(-1) at pH 8 in contrast to 6 s(-1) at pH 6 and 2 s(-1) at pH 8 for of B. subtilis cotA. Overall, k(cat)/K-M was 10-fold higher for B. subtilis cotA at pH(opt). While both proteins were heat activated, activation increased with pH and was larger in cotA from B. clausii. NaCl inhibited activity at acidic pH, but not up to 500-700 mM NaCl in alkaline pH, a further advantage of the alkali regime in laccase applications. The B. clausii cotA had similar to 20 minutes half-life at 80 degrees C, less than the similar to 50 minutes at 80 degrees C for cotA from B. subtilis. While cotA from B. subtilis had optimal stability at pH similar to 8, the cotA from B. clausii displayed higher combined salt-and alkali-resistance. This resistance is possibly caused by two substitutions (S427Q and V110E) that could repel anions to reduce anion-copper interactions at the expense of catalytic proficiency, a trade-off of potential relevance to laccase optimization.	[Brander, Soren; Mikkelsen, Jorn D.] Tech Univ Denmark, DTU Chem Engn, DK-2800 Lyngby, Denmark; [Brander, Soren; Kepp, Kasper P.] Tech Univ Denmark, DTU Chem, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Kepp, KP (corresponding author), Tech Univ Denmark, DTU Chem, DK-2800 Lyngby, Denmark.	kpj@kemi.dtu.dk	Kepp, Kasper Planeta/G-1748-2013; Kepp, Kasper P./AAA-4626-2021	Kepp, Kasper Planeta/0000-0002-6754-7348; Kepp, Kasper P./0000-0002-6754-7348; Brander, Soren/0000-0002-6294-6331	Danish Council for Independent Research | Technology and Production Sciences (FTP) [10-082488]	Danish Council for Independent Research | Technology and Production Sciences (FTP)(Det Frie Forskningsrad (DFF))	The authors wish to thank The Danish Council for Independent Research | Technology and Production Sciences (FTP) (grant # 10-082488) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abari AH, 2012, AFR J MICROBIOL RES, V6, P393, DOI 10.5897/AJMR11.1155; Anwar A, 1998, BIORESOURCE TECHNOL, V64, P175, DOI 10.1016/S0960-8524(97)00182-X; Baril E, 2012, FOOD MICROBIOL, V32, P79, DOI 10.1016/j.fm.2012.04.011; BOND AM, 1988, ANAL CHEM, V60, P1023, DOI 10.1021/ac00161a015; Brissos Vania, 2009, Biotechnology Journal, V4, P558, DOI 10.1002/biot.200800248; Chen CY, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-49; Claus H, 2003, ARCH MICROBIOL, V179, P145, DOI 10.1007/s00203-002-0510-7; Costadinnova L, 2012, J U CHEM TECHNOL MET, V47, P289; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Daassi D, 2013, WORLD J MICROB BIOT, V29, P1; Dawkar VV, 2008, J APPL MICROBIOL, V105, P14, DOI 10.1111/j.1365-2672.2008.03738.x; Durand F, 2012, BIOSENS BIOELECTRON, V35, P140, DOI 10.1016/j.bios.2012.02.033; Durao P, 2008, BIOCHEM J, V412, P339, DOI 10.1042/BJ20080166; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; Enguita FJ, 2004, J BIOL CHEM, V279, P23472, DOI 10.1074/jbc.M314000200; Fawole OA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-200; Fernandes AT, 2011, J BIOL INORG CHEM, V16, P641, DOI 10.1007/s00775-011-0768-9; Fernandes AT, 2010, FEBS J, V277, P3176, DOI 10.1111/j.1742-4658.2010.07725.x; Ferner-Ortner-Bleckmann J, 2011, BIOINTERPHASES, V6, P63, DOI 10.1116/1.3589284; Giacomelli C, 2002, J BRAZIL CHEM SOC, V13, P332, DOI 10.1590/S0103-50532002000300007; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HAPIOT P, 1993, J ELECTROANAL CHEM, V353, P225, DOI 10.1016/0022-0728(93)80299-W; Held C, 2005, ENVIRON CHEM LETT, V3, P74, DOI 10.1007/s10311-005-0006-1; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Jia HH, 2013, CHEMPLUSCHEM, V78, P451, DOI 10.1002/cplu.201300066; Kageyama Y, 2007, EXTREMOPHILES, V11, P597, DOI 10.1007/s00792-007-0074-1; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kittl R, 2012, J BIOTECHNOL, V157, P304, DOI 10.1016/j.jbiotec.2011.11.021; KOBAYASHI T, 1995, APPL MICROBIOL BIOT, V43, P473; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kudanga T, 2009, J MOL CATAL B-ENZYM, V61, P143, DOI 10.1016/j.molcatb.2009.06.003; Kunamneni Adinarayana, 2008, Recent Pat Biotechnol, V2, P10, DOI 10.2174/187220808783330965; Liu YH, 2011, APPL MICROBIOL BIOT, V91, P667, DOI 10.1007/s00253-011-3292-5; Madzak C, 2006, PROTEIN ENG DES SEL, V19, P77, DOI 10.1093/protein/gzj004; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Mate DM, 2013, CHEM BIOL, V20, P223, DOI 10.1016/j.chembiol.2013.01.001; Mohammadian M, 2010, J IND MICROBIOL BIOT, V37, P863, DOI 10.1007/s10295-010-0734-5; Mollania N, 2011, ENZYME MICROB TECH, V49, P446, DOI 10.1016/j.enzmictec.2011.08.001; NAQUI A, 1980, FEBS LETT, V113, P157, DOI 10.1016/0014-5793(80)80581-3; Olukanni OD, 2013, J MICROBIOL BIOTECHN, V23, P843, DOI 10.4014/jmb.1211.11077; Pan JB, 2011, ADV MATER RES-SWITZ, V183-185, P773, DOI 10.4028/www.scientific.net/AMR.183-185.773; Reiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065633; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Riva S, 2006, TRENDS BIOTECHNOL, V24, P219, DOI 10.1016/j.tibtech.2006.03.006; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Sakasegawa S, 2006, APPL ENVIRON MICROB, V72, P972, DOI 10.1128/AEM.72.1.972-975.2006; Santhanam N, 2011, TRENDS BIOTECHNOL, V29, P480, DOI 10.1016/j.tibtech.2011.04.005; Singh G, 2007, ENZYME MICROB TECH, V41, P794, DOI 10.1016/j.enzmictec.2007.07.001; Solomon EI, 2008, DALTON T, P3921, DOI 10.1039/b800799c; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sulistyaningdyah WT, 2004, FEMS MICROBIOL LETT, V230, P209, DOI 10.1016/S0378-1097(03)00892-9; Sung YM, 2013, APPL BIOCHEM BIOTECH, V169, P2420, DOI 10.1007/s12010-013-0165-7; Telke AA, 2011, BIORESOURCE TECHNOL, V102, P1752, DOI 10.1016/j.biortech.2010.08.086; Torres-Salas P, 2013, CHEMBIOCHEM, V14, P934, DOI 10.1002/cbic.201300102; Xu F, 1997, J BIOL CHEM, V272, P924, DOI 10.1074/jbc.272.2.924; Xu F, 1996, BBA-PROTEIN STRUCT M, V1292, P303, DOI 10.1016/0167-4838(95)00210-3; Xu F, 1998, BIOCHEM J, V334, P63, DOI 10.1042/bj3340063; Zhang C, 2012, BIORESOURCE TECHNOL, V126, P80, DOI 10.1016/j.biortech.2012.09.055	60	79	85	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99402	10.1371/journal.pone.0099402	http://dx.doi.org/10.1371/journal.pone.0099402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915287	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700098
J	Chen, HM; Zhang, JH; Yuan, G; Liu, C				Chen, Haimei; Zhang, Jianhui; Yuan, George; Liu, Chang			Complex Interplay among DNA Modification, Noncoding RNA Expression and Protein-Coding RNA Expression in Salvia miltiorrhiza Chloroplast Genome	PLOS ONE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; GENE-EXPRESSION; EPIGENETIC INHERITANCE; SINGLE-MOLECULE; METHYLATION; SEQ; DANSHEN; PLANTS; SENSE; PCR	Salvia miltiorrhiza is one of the most widely used medicinal plants. As a first step to develop a chloroplast-based genetic engineering method for the over-production of active components from S. miltiorrhiza, we have analyzed the genome, transcriptome, and base modifications of the S. miltiorrhiza chloroplast. Total genomic DNA and RNA were extracted from fresh leaves and then subjected to strand-specific RNA-Seq and Single-Molecule Real-Time (SMRT) sequencing analyses. Mapping the RNA-Seq reads to the genome assembly allowed us to determine the relative expression levels of 80 protein-coding genes. In addition, we identified 19 polycistronic transcription units and 136 putative antisense and intergenic noncoding RNA (ncRNA) genes. Comparison of the abundance of protein-coding transcripts (cRNA) with and without overlapping antisense ncRNAs (asRNA) suggest that the presence of asRNA is associated with increased cRNA abundance (p<0.05). Using the SMRT Portal software (v1.3.2), 2687 potential DNA modification sites and two potential DNA modification motifs were predicted. The two motifs include a TATA box-like motif (CPGDMM1, "TATANNNATNA''), and an unknown motif (CPGDMM2 "WNYANTGAW''). Specifically, 35 of the 97 CPGDMM1 motifs (36.1%) and 91 of the 369 CPGDMM2 motifs (24.7%) were found to be significantly modified (p<0.01). Analysis of genes downstream of the CPGDMM1 motif revealed the significantly increased abundance of ncRNA genes that are less than 400 bp away from the significantly modified CPGDMM1motif (p<0.01). Taking together, the present study revealed a complex interplay among DNA modifications, ncRNA and cRNA expression in chloroplast genome.	[Chen, Haimei; Zhang, Jianhui; Liu, Chang] Chinese Acad Med Sci, Inst Med Plant Dev, IMPLAD PacBio Adv Genom Anal Lab, Beijing 100730, Peoples R China; [Chen, Haimei; Zhang, Jianhui; Liu, Chang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yuan, George] Pacific Biosci, Menlo Pk, CA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, C (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, IMPLAD PacBio Adv Genom Anal Lab, Beijing 100730, Peoples R China.	cliu@implad.ac.cn	Zhang, Jianhui/K-8793-2019; Zhang, Jianhui/ABD-5476-2020; Liu, Chang/A-1148-2014	Zhang, Jianhui/0000-0002-6362-4027; Zhang, Jianhui/0000-0002-6362-4027; 	Chinese Academy of Medical Science [431118]; Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives [YZ-12-04]; Ministry of Human Resources [431207]; Program for Changjiang Scholars and Innovative Research Team in University of the Ministry of Education of China [IRT1150]; National Science Foundation [81202859, 81373912]	Chinese Academy of Medical Science; Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives; Ministry of Human Resources; Program for Changjiang Scholars and Innovative Research Team in University of the Ministry of Education of China; National Science Foundation(National Science Foundation (NSF))	This work was supported by a start fund from the Chinese Academy of Medical Science (No. 431118) granted to C. Liu, as well as by the Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives (No. YZ-12-04 granted to C. Liu), the research grant for returned Overseas Chinese Scholars, Ministry of Human Resources (No. 431207) granted to C. Liu, the Program for Changjiang Scholars and Innovative Research Team in University of the Ministry of Education of China (IRT1150), and grants from the National Science Foundation, No. 81202859 to HMC and No. 81373912 to C. Liu. Pacific Biosciences provided support in the form of a salary for author GY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahlert D, 2009, MOL GENET GENOMICS, V282, P17, DOI 10.1007/s00438-009-0440-z; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Daniell H, 2005, TRENDS BIOTECHNOL, V23, P238, DOI 10.1016/j.tibtech.2005.03.008; Ding JH, 2012, P NATL ACAD SCI USA, V109, P2654, DOI 10.1073/pnas.1121374109; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Georg J, 2010, NEW PHYTOL, V186, P615, DOI 10.1111/j.1469-8137.2010.03203.x; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Grigoriadis A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-324; He GM, 2011, ANNU REV PLANT BIOL, V62, P411, DOI 10.1146/annurev-arplant-042110-103806; Hegeman CE, 2005, NUCLEIC ACIDS RES, V33, P1454, DOI 10.1093/nar/gki286; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hotto AM, 2011, G3-GENES GENOM GENET, V1, P559, DOI 10.1534/g3.111.000752; Hotto AM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-213; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Ling MHT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-243; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; Sharwood RE, 2011, RNA, V17, P2165, DOI 10.1261/rna.028043.111; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Stern DB, 1997, TRENDS PLANT SCI, V2, P308, DOI 10.1016/S1360-1385(97)89953-0; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Sultan M, 2012, BIOCHEM BIOPH RES CO, V422, P643, DOI 10.1016/j.bbrc.2012.05.043; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zghidi-Abouzid O, 2011, NUCLEIC ACIDS RES, V39, P5379, DOI 10.1093/nar/gkr143; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	43	16	18	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99314	10.1371/journal.pone.0099314	http://dx.doi.org/10.1371/journal.pone.0099314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914614	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700084
J	Grantham, JP; Henneberg, M				Grantham, James P.; Henneberg, Maciej			The Estrogen Hypothesis of Obesity	PLOS ONE			English	Article							URBAN; MENARCHE; WOMEN; FAT; AGE	The explanation of obesity as a simple result of positive energy balance fails to account for the scope of variable responses to diets and lifestyles. It is postulated that individual physiological and anatomical variation may be responsible for developing obesity. Girls in poor families develop greater adiposity than their male siblings, a trend not present in richer environments. This indicates strong influence of estrogen on fat accumulation irrespective of poor socioeconomic conditions. Obesity rates in males and females of developed nations are similar, while in poorer nations obesity is much more prevalent in females. Female to male ratio of obesity correlates inversely with gross domestic product. Therefore, the parity of male and female obesity in developed countries may result from male exposure to environmental estrogen-like substances associated with affluence. These hormonally driven mechanisms may be equally active within both sexes in more developed areas, thereby increasing overall obesity.	[Grantham, James P.; Henneberg, Maciej] Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia	University of Adelaide	Henneberg, M (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia.	maciej.henneberg@adelaide.edu.au		Henneberg, Maciej/0000-0003-1941-2286	Medical Research Council of South Africa	Medical Research Council of South Africa(South African Medical Research Council)	Collection of the data on the growth of children was funded by the Medical Research Council of South Africa. The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler GK, 2012, MEDSCAPE; [Anonymous], 2013, OB OV; Bharaktiya S, 2011, MEDSCAPE; Caballero B, 2005, NEW ENGL J MED, V352, P1514, DOI 10.1056/NEJMp048310; Digate Muth N, 2009, ACE FIT; European Commission, 2004, LIF CYCL ASS PVC PRI; Eurostat, 2011, OV OB BMI STAT; FRISCH RE, 1971, ARCH DIS CHILD, V46, P695, DOI 10.1136/adc.46.249.695; FRISCH RE, 1987, HUM REPROD, V2, P521, DOI 10.1093/oxfordjournals.humrep.a136582; GUO SS, 1994, AM J CLIN NUTR, V59, P810, DOI 10.1093/ajcn/59.4.810; Henneberg M, 1998, AM J HUM BIOL, V10, P73, DOI 10.1002/(SICI)1520-6300(1998)10:1<73::AID-AJHB9>3.0.CO;2-D; HENNEBERG M, 1995, AM J PHYS ANTHROPOL, V96, P1, DOI 10.1002/ajpa.1330960102; HENNEBERG M, 1995, AM J PHYS ANTHROPOL, V96, P329, DOI 10.1002/ajpa.1330960402; HENNEBERG M, 1976, J HUM EVOL, V5, P41, DOI 10.1016/0047-2484(76)90098-1; Henneberg M, 1992, S AFR MED J, V82, P196; Hennenberg R., 1999, PERSPECTIVES HUMAN B, V4, P177; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Kaltsas GA, 2000, CLIN ENDOCRINOL, V53, P493, DOI 10.1046/j.1365-2265.2000.01117.x; McDermott MT, 2001, J CLIN ENDOCR METAB, V86, P4585, DOI 10.1210/jc.86.10.4585; Mutha NH, 2006, RESOUR CONSERV RECY, V47, P222, DOI 10.1016/j.resconrec.2005.09.003; PVC, 2013, PVC HLTH; Roccisano D., 2012, Food and Nutrition Sciences, V3, P260, DOI 10.4236/fns.2012.32038; Ruhli FJ, 2004, EUR SPINE J, V13, P733, DOI 10.1007/s00586-004-0682-8; Santin AP, 2011, J THROID RES, V2011, DOI 10.4061/2011/875125; Schiller JS, 2010, VITAL HLTH STAT, V10, P2012; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E; Soy Connection, 2012, SOYB OIL US OV; Soyfoods Association of North America, 2013, SOY DAIR FREE PROD; Stephan CN, 2001, MED HYPOTHESES, V57, P633, DOI 10.1054/mehy.2001.1431; Turner L, 2012, FIND HORMONAL HARMON; United Nations, 2012, NAT ACC MAIN AGGR DA; Vanderpump MPJ, 2002, THYROID, V12, P839, DOI 10.1089/105072502761016458; Vinyl in Design, 2013, US VIN; Westerbacka J, 2004, DIABETOLOGIA, V47, P1360, DOI 10.1007/s00125-004-1460-1; WHO, 2013, OB SIT TRENDS; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization (WHO), 2013, GLOB DAT BOD MASS IN; Yadav K, 2008, OBES REV, V9, P400, DOI 10.1111/j.1467-789X.2008.00505.x	38	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99776	10.1371/journal.pone.0099776	http://dx.doi.org/10.1371/journal.pone.0099776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915457	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700135
J	Greer, AM; Matthay, MA; Kukreja, J; Bhakta, NR; Nguyen, CP; Wolters, PJ; Woodruff, PG; Fahy, JV; Shin, JS				Greer, Alexandra M.; Matthay, Michael A.; Kukreja, Jasleen; Bhakta, Nirav R.; Nguyen, Christine P.; Wolters, Paul J.; Woodruff, Prescott G.; Fahy, John V.; Shin, Jeoung-Sook			Accumulation of BDCA1(+) Dendritic Cells in Interstitial Fibrotic Lung Diseases and Th2-High Asthma	PLOS ONE			English	Article							HUMAN BRONCHOALVEOLAR LAVAGE; EPIDERMAL LANGERHANS CELLS; PULMONARY-FIBROSIS; BRONCHIAL-MUCOSA; MAST-CELLS; IGE; EXPRESSION; RECEPTOR; INDUCTION; FEATURES	Dendritic cells (DCs) significantly contribute to the pathology of several mouse lung disease models. However, little is known of the contribution of DCs to human lung diseases. In this study, we examined infiltration with BDCA1(+) DCs of human lungs in patients with interstitial lung diseases or asthma. Using flow cytometry, we found that these DCs increased by 5,6 fold in the lungs of patients with idiopathic pulmonary fibrosis or hypersensitivity pneumonitis, which are both characterized by extensive fibrosis in parenchyma. The same DC subset also significantly increased in the lung parenchyma of patients with chronic obstructive pulmonary disease, although the degree of increase was relatively modest. By employing immunofluorescence microscopy using Fc epsilon RI and MHCII as the specific markers for BDCA1(+) DCs, we found that the numbers of BDCA1(+) DCs also significantly increased in the airway epithelium of Th2 inflammation-associated asthma. These findings suggest a potential contribution of BDCA1(+) DCs in human lung diseases associated with interstitial fibrosis or Th2 airway inflammation.	[Greer, Alexandra M.; Shin, Jeoung-Sook] Univ Calif San Francisco, Dept Microbiol & Immunol, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; [Matthay, Michael A.] Univ Calif San Francisco, Dept Med & Anesthesia, San Francisco, CA 94143 USA; [Kukreja, Jasleen] Univ Calif San Francisco, Div Cardiothorac Surg, San Francisco, CA 94143 USA; [Bhakta, Nirav R.; Nguyen, Christine P.; Wolters, Paul J.; Woodruff, Prescott G.; Fahy, John V.] Univ Calif San Francisco, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shin, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA.	Jeoung-Sook.Shin@ucsf.edu			National Heart, Lung, and Blood Institute [HL51854]; National Institutes of Health [F32 1F32HL110720, T32 5T32HL007185]; UCSF Nina Ireland Lung Disease Program; NIH [HL095372]; American Thoracic Society; UCSF Sandler Asthma Basic Research Center; Genentech; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202, F32HL110720, T32HL007185, R01HL095372, R01HL051854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Nina Ireland Lung Disease Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society; UCSF Sandler Asthma Basic Research Center; Genentech(Roche HoldingGenentech); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MAM was supported by National Heart, Lung, and Blood Institute grant #HL51854. NRB was supported by National Institutes of Health grants F32 1F32HL110720 and T32 5T32HL007185. PJW was supported by the UCSF Nina Ireland Lung Disease Program. PGW was supported by a grant from Genentech and from the NIH (HL095372). AMG and JS were supported by the American Thoracic Society and the UCSF Sandler Asthma Basic Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042066; Bantsimba-Malanda C, 2010, AM J RESP CRIT CARE, V182, P385, DOI 10.1164/rccm.200907-1164OC; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; Burkhardt AM, 2012, J IMMUNOL, V188, P6399, DOI 10.4049/jimmunol.1102903; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Dehlink E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012204; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Dougherty RH, 2010, J ALLERGY CLIN IMMUN, V125, P1046, DOI 10.1016/j.jaci.2010.03.003; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Foster B, 2003, J ALLERGY CLIN IMMUN, V112, P1132, DOI 10.1016/j.jaci.2003.09.011; Freeman CM, 2009, AM J RESP CRIT CARE, V180, P1179, DOI 10.1164/rccm.200904-0552OC; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; GRUSCHWITZ MS, 1992, J INVEST DERMATOL, V99, P114, DOI 10.1111/1523-1747.ep12611890; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hanak V, 2007, MAYO CLIN PROC, V82, P812, DOI 10.4065/82.7.812; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Jahnsen FL, 2006, J IMMUNOL, V177, P5861, DOI 10.4049/jimmunol.177.9.5861; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Luppi F, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002880; Masten BJ, 2006, J IMMUNOL, V177, P7784, DOI 10.4049/jimmunol.177.11.7784; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Moller GM, 1996, CLIN EXP ALLERGY, V26, P517, DOI 10.1111/j.1365-2222.1996.tb00571.x; NELSON DJ, 1995, AM J RESP CRIT CARE, V151, P475, DOI 10.1164/ajrccm.151.2.7842209; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; Pisabarro MT, 2006, J IMMUNOL, V176, P2069, DOI 10.4049/jimmunol.176.4.2069; Sallmann E, 2011, J IMMUNOL, V187, P164, DOI 10.4049/jimmunol.1003392; SCADDING JG, 1967, THORAX, V22, P291, DOI 10.1136/thx.22.4.291; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Selman M, 2012, AM J RESP CRIT CARE, V186, P314, DOI 10.1164/rccm.201203-0513CI; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Tsoumakidou M, 2009, RESPIRATION, V78, P446, DOI 10.1159/000226244; Tsoumakidou M, 2008, AM J RESP CRIT CARE, V177, P1180, DOI 10.1164/rccm.200711-1727PP; TunonDeLara JM, 1996, CLIN EXP ALLERGY, V26, P648, DOI 10.1046/j.1365-2222.1996.1095481.x; Van Pottelberge GR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-35; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; VANHAARST JMW, 1994, AM J RESP CELL MOL, V11, P344, DOI 10.1165/ajrcmb.11.3.8086170; vanHaarst JMW, 1996, AM J RESP CELL MOL, V15, P752, DOI 10.1165/ajrcmb.15.6.8969270; Vasudev M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032556; Veres TZ, 2013, J IMMUNOL, V190, P897, DOI 10.4049/jimmunol.1200220; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; ZHOU LJ, 1995, BLOOD, V86, P3295, DOI 10.1182/blood.V86.9.3295.bloodjournal8693295	50	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99084	10.1371/journal.pone.0099084	http://dx.doi.org/10.1371/journal.pone.0099084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915147	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700061
J	Simon, AM; Ingraham, KA; Fey, NP; Finucane, SB; Lipschutz, RD; Young, AJ; Hargrove, LJ				Simon, Ann M.; Ingraham, Kimberly A.; Fey, Nicholas P.; Finucane, Suzanne B.; Lipschutz, Robert D.; Young, Aaron J.; Hargrove, Levi J.			Configuring a Powered Knee and Ankle Prosthesis for Transfemoral Amputees within Five Specific Ambulation Modes	PLOS ONE			English	Article							FOOT PROSTHESIS; STAIR ASCENT; DESCENT; WALKING; GENERATION; AMPUTATION; GAIT	Lower limb prostheses that can generate net positive mechanical work may restore more ambulation modes to amputees. However, configuration of these devices imposes an additional burden on clinicians relative to conventional prostheses; devices for transfemoral amputees that require configuration of both a knee and an ankle joint are especially challenging. In this paper, we present an approach to configuring such powered devices. We developed modified intrinsic control strategies-which mimic the behavior of biological joints, depend on instantaneous loads within the prosthesis, or set impedance based on values from previous states, as well as a set of starting configuration parameters. We developed tables that include a list of desired clinical gait kinematics and the parameter modifications necessary to alter them. Our approach was implemented for a powered knee and ankle prosthesis in five ambulation modes (level-ground walking, ramp ascent/descent, and stair ascent/descent). The strategies and set of starting configuration parameters were developed using data from three individuals with unilateral transfemoral amputations who had previous experience using the device; this approach was then tested on three novice unilateral transfemoral amputees. Only 17% of the total number of parameters (i.e., 24 of the 140) had to be independently adjusted for each novice user to achieve all five ambulation modes and the initial accommodation period (i.e., time to configure the device for all modes) was reduced by 56%, to 5 hours or less. This approach and subsequent reduction in configuration time may help translate powered prostheses into a viable clinical option where amputees can more quickly appreciate the benefits such devices can provide.	[Simon, Ann M.; Ingraham, Kimberly A.; Fey, Nicholas P.; Finucane, Suzanne B.; Lipschutz, Robert D.; Young, Aaron J.; Hargrove, Levi J.] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Simon, Ann M.; Fey, Nicholas P.; Lipschutz, Robert D.; Hargrove, Levi J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Young, Aaron J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Shirley Ryan AbilityLab; Northwestern University; Northwestern University	Simon, AM (corresponding author), Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA.	annie-simon@northwestern.edu		Simon, Ann/0000-0002-6431-0329	US Army's Telemedicine and Advanced Technology Research Center [81XWH-09-2-0020]	US Army's Telemedicine and Advanced Technology Research Center	This work was supported by the US Army's Telemedicine and Advanced Technology Research Center, grant number 81XWH-09-2-0020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JM, 2012, GAIT POSTURE, V36, P291, DOI 10.1016/j.gaitpost.2012.03.013; Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Au SK, 2009, IEEE T ROBOT, V25, P51, DOI 10.1109/TRO.2008.2008747; Bellman R. D., 2008, IEEE RAS EMBS INT C; Datta D, 1996, CLIN REHABIL, V10, P227, DOI DOI 10.1177/026921559601000307; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; Fey N. P., 2013, ANN M AM SOC BIOM OM; Gailey RS, 2002, ARCH PHYS MED REHAB, V83, P613, DOI 10.1053/ampr.2002.32309; Goldfarb M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007312; Herr HM, 2012, P ROY SOC B-BIOL SCI, V279, P457, DOI 10.1098/rspb.2011.1194; Lawson B., 2012, IEEE T NEURAL SYST R; MCFADYEN BJ, 1988, J BIOMECH, V21, P733, DOI 10.1016/0021-9290(88)90282-5; Riener R, 2002, GAIT POSTURE, V15, P32, DOI 10.1016/S0966-6362(01)00162-X; Rouse E. J., 2012, IEEE INT C BIOM ROB; Schmalz T, 2002, GAIT POSTURE, V16, P255, DOI 10.1016/S0966-6362(02)00008-5; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; Sup F, 2011, IEEE T NEUR SYS REH, V19, P71, DOI 10.1109/TNSRE.2010.2087360; Sup Frank, 2009, IEEE Int Conf Rehabil Robot, V2009, P638, DOI 10.1109/ICORR.2009.5209625; Sup F, 2009, IEEE-ASME T MECH, V14, P667, DOI 10.1109/TMECH.2009.2032688; Vallery H, 2009, IEEE T NEUR SYS REH, V17, P23, DOI 10.1109/TNSRE.2008.2008278; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	23	119	120	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99387	10.1371/journal.pone.0099387	http://dx.doi.org/10.1371/journal.pone.0099387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914674	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700093
J	Usubuchi, H; Kawase, T; Kanno, A; Yahata, I; Miyazaki, H; Nakasato, N; Kawashima, R; Katori, Y				Usubuchi, Hajime; Kawase, Tetsuaki; Kanno, Akitake; Yahata, Izumi; Miyazaki, Hiromitsu; Nakasato, Nobukazu; Kawashima, Ryuta; Katori, Yukio			Effects of Contralateral Noise on the 20-Hz Auditory Steady State Response - Magnetoencephalography Study	PLOS ONE			English	Article							MODULATION-FOLLOWING RESPONSE; REPETITION RATES PROFILE; EVOKED-POTENTIALS; TEMPORAL ENVELOPE; BRAIN-STEM; WIDE-RANGE; 40-HZ; FREQUENCY; CORTEX; MASKING	The auditory steady state response (ASSR) is an oscillatory brain response, which is phase locked to the rhythm of an auditory stimulus. ASSRs have been recorded in response to a wide frequency range of modulation and/or repetition, but the physiological features of the ASSRs are somewhat different depending on the modulation frequency. Recently, the 20-Hz ASSR has been emphasized in clinical examinations, especially in the area of psychiatry. However, little is known about the physiological properties of the 20-Hz ASSR, compared to those of the 40-Hz and 80-Hz ASSRs. The effects of contralateral noise on the ASSR are known to depend on the modulation frequency to evoke ASSR. However, the effects of contralateral noise on the 20-Hz ASSR are not known. Here we assessed the effects of contralateral white noise at a level of 70 dB SPL on the 20-Hz and 40-Hz ASSRs using a helmet-shaped magnetoencephalography system in 9 healthy volunteers (8 males and 1 female, mean age 31.2 years). The ASSRs were elicited by monaural 1000-Hz 5-s tone bursts amplitude-modulated at 20 and 39 Hz and presented at 80 dB SPL. Contralateral noise caused significant suppression of both the 20-Hz and 40-Hz ASSRs, although suppression was significantly smaller for the 20-Hz ASSRs than the 40-Hz ASSRs. Moreover, the greatest suppression of both 20-Hz and 40-Hz ASSRs occurred in the right hemisphere when stimuli were presented to the right ear with contralateral noise. The present study newly showed that 20-Hz ASSRs are suppressed by contralateral noise, which may be important both for characterization of the 20-Hz ASSR and for interpretation in clinical situations. Physicians must be aware that the 20-Hz ASSR is significantly suppressed by sound (e. g. masking noise or binaural stimulation) applied to the contralateral ear.	[Usubuchi, Hajime; Kawase, Tetsuaki; Yahata, Izumi; Miyazaki, Hiromitsu; Katori, Yukio] Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 980, Japan; [Kawase, Tetsuaki] Tohoku Univ, Grad Sch Biomed Engn, Lab Rehabil Auditory Sci, Sendai, Miyagi 980, Japan; [Kawase, Tetsuaki] Tohoku Univ, Grad Sch Med, Dept Audiol, Sendai, Miyagi 980, Japan; [Kanno, Akitake; Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Nakasato, Nobukazu] Tohoku Univ, Grad Sch Med, Dept Epileptol, Sendai, Miyagi 980, Japan; [Nakasato, Nobukazu] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Dept Electromagnet Neurophysiol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kawase, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 980, Japan.	kawase@orl.med.tohoku.ac.jp	Nakasato, Nobukazu/AAC-3650-2019		Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a management grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology for fiscal 2011-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi M, 1999, AUDIOL NEURO-OTOL, V4, P28, DOI 10.1159/000013817; AOYAGI M, 1993, HEARING RES, V65, P253, DOI 10.1016/0378-5955(93)90218-P; COHEN LT, 1991, J ACOUST SOC AM, V90, P2467, DOI 10.1121/1.402050; Cunningham MO, 2004, J PHYSIOL-LONDON, V559, P347, DOI 10.1113/jphysiol.2004.068973; Draganova R, 2008, CEREB CORTEX, V18, P1193, DOI 10.1093/cercor/bhm153; GALAMBOS R, 1992, J ACOUST SOC AM, V92, P2683, DOI 10.1121/1.404383; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; HARI R, 1988, EXP BRAIN RES, V71, P87; Herdman AT, 2002, BRAIN TOPOGR, V15, P69, DOI 10.1023/A:1021470822922; John MS, 2002, EAR HEARING, V23, P106, DOI 10.1097/00003446-200204000-00004; JOHNSON B W, 1988, Brain Topography, V1, P117, DOI 10.1007/BF01129176; Kawase T, 2012, NEUROIMAGE, V59, P1037, DOI 10.1016/j.neuroimage.2011.08.108; Kuriki S, 1995, HEARING RES, V92, P47, DOI 10.1016/0378-5955(95)00195-6; KUWADA S, 1986, HEARING RES, V21, P179, DOI 10.1016/0378-5955(86)90038-9; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; LINDEN RD, 1985, EAR HEARING, V6, P167, DOI 10.1097/00003446-198505000-00008; Maki A, 2009, EAR HEARING, V30, P584, DOI 10.1097/AUD.0b013e3181acfb57; Millman RE, 2010, NEUROIMAGE, V49, P745, DOI 10.1016/j.neuroimage.2009.08.029; Oda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039955; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parkkonen L, 2009, HUM BRAIN MAPP, V30, P1772, DOI 10.1002/hbm.20788; Pastor MA, 2002, J NEUROSCI, V22, P10501; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; PLOURDE G, 1990, ANESTH ANALG, V71, P460; Rass O, 2012, SCHIZOPHR RES, V136, P143, DOI 10.1016/j.schres.2012.01.003; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Ross B, 2000, J ACOUST SOC AM, V108, P679, DOI 10.1121/1.429600; Ross B, 2005, J NEUROPHYSIOL, V94, P4082, DOI 10.1152/jn.00469.2005; Ross B, 2003, HEARING RES, V186, P57, DOI 10.1016/S0378-5955(03)00299-5; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Tlumak AI, 2012, INT J AUDIOL, V51, P480, DOI 10.3109/14992027.2012.664289; Tlumak AI, 2011, INT J AUDIOL, V50, P448, DOI 10.3109/14992027.2011.560903; Tsuchimoto R, 2011, SCHIZOPHR RES, V133, P99, DOI 10.1016/j.schres.2011.07.020; Wong WYS, 2004, EAR HEARING, V25, P57, DOI 10.1097/01.AUD.0000111257.11898.64	36	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99457	10.1371/journal.pone.0099457	http://dx.doi.org/10.1371/journal.pone.0099457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915061	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700105
J	Vieira, N; Deng, FM; Liang, FX; Liao, Y; Chang, J; Zhou, G; Zheng, WY; Simon, JP; Ding, MX; Wu, XR; Romih, R; Kreibich, G; Sun, TT				Vieira, Neide; Deng, Fang-Ming; Liang, Feng-Xia; Liao, Yi; Chang, Jennifer; Zhou, Ge; Zheng, Weiyue; Simon, Jean-Pierre; Ding, Mingxiao; Wu, Xue-Ru; Romih, Rok; Kreibich, Gert; Sun, Tung-Tien			SNX31: A Novel Sorting Nexin Associated with the Uroplakin-Degrading Multivesicular Bodies in Terminally Differentiated Urothelial Cells	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; URINARY-BLADDER EPITHELIUM; ASYMMETRIC UNIT MEMBRANE; TRANSITIONAL EPITHELIUM; UMBRELLA CELLS; PROTEIN TRAFFICKING; SUPERFICIAL CELLS; BARRIER FUNCTION; APICAL MEMBRANE; PLAQUE PARTICLE	Uroplakins (UP), a group of integral membrane proteins, are major urothelial differentiation products that form 2D crystals of 16-nm particles (urothelial plaques) covering the apical surface of mammalian bladder urothelium. They contribute to the urothelial barrier function and, one of them, UPIa, serves as the receptor for uropathogenic Escherichia coli. It is therefore important to understand the mechanism by which these surface-associated uroplakins are degraded. While it is known that endocytosed uroplakin plaques are targeted to and line the multivesicular bodies (MVBs), it is unclear how these rigid-looking plaques can go to the highly curved membranes of intraluminal vesicles (ILVs). From a cDNA subtraction library, we identified a highly urothelium-specific sorting nexin, SNX31. SNX31 is expressed, like uroplakins, in terminally differentiated urothelial umbrella cells where it is predominantly associated with MVBs. Apical membrane proteins including uroplakins that are surface biotin-tagged are endocytosed and targeted to the SNX31-positive MVBs. EM localization demonstrated that SNX31 and uroplakins are both associated not only with the limiting membranes of MVBs containing uroplakin plaques, but also with ILVs. SNX31 can bind, on one hand, the PtdIns3P-enriched lipids via its N-terminal PX-domain, and, on the other hand, it binds uroplakins as demonstrated by co-immunoprecipitation and proximity ligation assay, and by its reduced membrane association in uroplakin II-deficient urothelium. The fact that in urothelial umbrella cells MVBs are the only major intracellular organelles enriched in both PtdIns3P and uroplakins may explain SNX31's MVB-specificity in these cells. However, in MDCK and other cultured cells transfected SNX31 can bind to early endosomes possibly via lipids. These data support a model in which SNX31 mediates the endocytic degradation of uroplakins by disassembling/collapsing the MVB-associated uroplakin plaques, thus enabling the uroplakin-containing (but 'softened') membranes to bud and form the ILVs for lysosomal degradation and/or exosome formation.	[Vieira, Neide; Liao, Yi; Chang, Jennifer; Zheng, Weiyue; Simon, Jean-Pierre; Kreibich, Gert; Sun, Tung-Tien] NYU, Dept Cell Biol, Langone Med Ctr, Inst Canc, New York, NY 10016 USA; [Deng, Fang-Ming; Wu, Xue-Ru] NYU, Langone Med Ctr, Inst Canc, Dept Pathol, New York, NY 10016 USA; [Liang, Feng-Xia; Sun, Tung-Tien] NYU, Langone Med Ctr, Inst Canc, Dept Dermatol, New York, NY 10016 USA; [Zhou, Ge; Sun, Tung-Tien] NYU, Langone Med Ctr, Inst Canc, Dept Mol Pharmacol & Biochem, New York, NY 10016 USA; [Ding, Mingxiao] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Wu, Xue-Ru; Sun, Tung-Tien] NYU, Langone Med Ctr, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru; Sun, Tung-Tien] NYU, Langone Med Ctr, Inst Canc, New York, NY 10016 USA; [Wu, Xue-Ru] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Romih, Rok] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Peking University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Ljubljana	Sun, TT (corresponding author), NYU, Dept Cell Biol, Langone Med Ctr, Inst Canc, 550 1St Ave, New York, NY 10016 USA.	sunt01@nyumc.org	Vieira, Neide/K-7702-2015; Sun, Tung-Tien/J-4425-2015	Vieira, Neide/0000-0002-7166-4336; Sun, Tung-Tien/0000-0002-6841-1063; Liang, Fengxia/0000-0003-0037-4590; Wu, Xue-Ru/0000-0001-6058-6291	National Institutes of Health [DK52206, DK39753]; NYU Center of Excellence for Urological Diseases; Goldstein Fund for Urological Research of the New York University School of Medicine; NATIONAL CANCER INSTITUTE [P01CA165980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056903, P01DK052206, R01DK039753] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU Center of Excellence for Urological Diseases; Goldstein Fund for Urological Research of the New York University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants DK52206 (T. T. S. and G. K.) and DK39753 (T. T. S.), the NYU Center of Excellence for Urological Diseases, and the Goldstein Fund for Urological Research of the New York University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO O, 1991, ANAT RECORD, V229, P9, DOI 10.1002/ar.1092290103; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Burden JJ, 2004, J BIOL CHEM, V279, P16237, DOI 10.1074/jbc.M313689200; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Davies BA, 2009, CHEM REV, V109, P1575, DOI 10.1021/cr800473s; Deng FM, 2001, P NATL ACAD SCI USA, V98, P154, DOI 10.1073/pnas.98.1.154; Derganc J, 2013, TRENDS BIOCHEM SCI, V38, P576, DOI 10.1016/j.tibs.2013.08.006; DeSalle R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-13; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Guo XM, 2009, TRAFFIC, V10, P1350, DOI 10.1111/j.1600-0854.2009.00950.x; Hannan TJ, 2012, FEMS MICROBIOL REV, V36, P616, DOI 10.1111/j.1574-6976.2012.00339.x; Hanson PI, 2012, ANN REV CELL DEV BIO; Hayashi H, 2012, J BIOL CHEM, V287, P15054, DOI 10.1074/jbc.M111.337931; HICKS RM, 1966, J CELL BIOL, V30, P623, DOI 10.1083/jcb.30.3.623; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Hu CCA, 2005, MOL BIOL CELL, V16, P3937, DOI 10.1091/mbc.E05-02-0136; Hu CCA, 2008, BIOCHEM J, V414, P195, DOI 10.1042/BJ20080550; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Hudoklin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032935; Hudoklin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023636; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; JEZERNIK K, 1992, CELL BIOL INT REP, V16, P1219, DOI 10.1016/S0309-1651(06)80038-X; Kachar B, 1999, J MOL BIOL, V285, P595, DOI 10.1006/jmbi.1998.2304; Katzmann DJ, 2006, DEV CELL, V10, P278, DOI 10.1016/j.devcel.2006.02.005; Khandelwal P, 2010, EMBO J, V29, P1961, DOI 10.1038/emboj.2010.91; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Knauth P, 2005, J MOL BIOL, V347, P813, DOI 10.1016/j.jmb.2005.02.004; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Kreft ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038509; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Leuchowius K., 2011, CURR PROTOC CYTOM, V56, P9, DOI [10.1002/0471142956.cy0936s56, DOI 10.1002/0471142956.CY0936S56]; LEWIS SA, 1982, NATURE, V297, P685, DOI 10.1038/297685a0; Lewis SA, 2000, AM J PHYSIOL-RENAL, V278, pF867; Liang FX, 1999, DIFFERENTIATION, V65, P59, DOI 10.1046/j.1432-0436.1999.6510059.x; Liang FX, 2001, BIOCHEM J, V355, P13, DOI 10.1042/0264-6021:3550013; LIN JH, 1994, J BIOL CHEM, V269, P1775; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Min GW, 2002, J MOL BIOL, V317, P697, DOI 10.1006/jmbi.2002.5442; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886, DOI 10.1152/ajprenal.1996.271.4.F886; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; ROMIH R, 1994, CELL BIOL INT, V18, P663, DOI 10.1006/cbir.1994.1093; Romih R, 2005, CELL TISSUE RES, V320, P259, DOI 10.1007/s00441-004-1005-4; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; SEVERS NJ, 1979, J ULTRA MOL STRUCT R, V69, P279, DOI 10.1016/S0022-5320(79)90117-5; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Sun TT, 2006, AM J PHYSIOL-RENAL, V291, pF9, DOI 10.1152/ajprenal.00035.2006; SURYA B, 1990, J CELL SCI, V97, P419; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Truschel ST, 1999, J BIOL CHEM, V274, P15020, DOI 10.1074/jbc.274.21.15020; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; Tu LY, 2002, MOL BIOL CELL, V13, P4221, DOI 10.1091/mbc.E02-04-0211; Valdes JL, 2011, J BIOL CHEM, V286, P39403, DOI 10.1074/jbc.M111.260802; Veranic P, 2002, CELL MOTIL CYTOSKEL, V53, P317, DOI 10.1002/cm.10077; Wang HB, 2009, J MOL BIOL, V392, P352, DOI 10.1016/j.jmb.2009.06.077; WU XR, 1993, J CELL SCI, V106, P31; WU XR, 1995, J BIOL CHEM, V270, P29752; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; WU XR, 1994, J BIOL CHEM, V269, P13716; WU XR, 1990, J BIOL CHEM, V265, P19170; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; YU J, 1994, J CELL BIOL, V125, P171, DOI 10.1083/jcb.125.1.171; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; ZHANG SX, 1994, HISTOL HISTOPATHOL, V9, P315; Zhou G, 2001, J CELL SCI, V114, P4095; Zhou G, 2012, MOL BIOL CELL, V23, P1354, DOI 10.1091/mbc.E11-09-0823	75	17	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99644	10.1371/journal.pone.0099644	http://dx.doi.org/10.1371/journal.pone.0099644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914955	gold, Green Submitted, Green Published			2022-12-25	WOS:000340947700122
J	Zheng, MH; Seto, WK; Shi, KQ; Wong, DKH; Fung, J; Hung, IFN; Fong, DYT; Yuen, JCH; Tong, T; Lai, CL; Yuen, MF				Zheng, Ming-Hua; Seto, Wai-Kay; Shi, Ke-Qing; Wong, Danny Ka-Ho; Fung, James; Hung, Ivan Fan-Ngai; Fong, Daniel Yee-Tak; Yuen, John Chi-Hang; Tong, Teresa; Lai, Ching-Lung; Yuen, Man-Fung			Artificial Neural Network Accurately Predicts Hepatitis B Surface Antigen Seroclearance	PLOS ONE			English	Article							HBSAG SEROCLEARANCE; MORTALITY; QUANTIFICATION; DETERMINANTS; OUTCOMES	Background & Aims: Hepatitis B surface antigen (HBsAg) seroclearance and seroconversion are regarded as favorable outcomes of chronic hepatitis B (CHB). This study aimed to develop artificial neural networks (ANNs) that could accurately predict HBsAg seroclearance or seroconversion on the basis of available serum variables. Methods: Data from 203 untreated, HBeAg-negative CHB patients with spontaneous HBsAg seroclearance (63 with HBsAg seroconversion), and 203 age-and sex-matched HBeAg-negative controls were analyzed. ANNs and logistic regression models (LRMs) were built and tested according to HBsAg seroclearance and seroconversion. Predictive accuracy was assessed with area under the receiver operating characteristic curve (AUROC). Results: Serum quantitative HBsAg (qHBsAg) and HBV DNA levels, qHBsAg and HBV DNA reduction were related to HBsAg seroclearance (P<0.001) and were used for ANN/LRM-HBsAg seroclearance building, whereas, qHBsAg reduction was not associated with ANN-HBsAg seroconversion (P = 0.197) and LRM-HBsAg seroconversion was solely based on qHBsAg (P = 0.01). For HBsAg seroclearance, AUROCs of ANN were 0.96, 0.93 and 0.95 for the training, testing and genotype B subgroups respectively. They were significantly higher than those of LRM, qHBsAg and HBV DNA (all P<0.05). Although the performance of ANN-HBsAg seroconversion (AUROC 0.757) was inferior to that for HBsAg seroclearance, it tended to be better than those of LRM, qHBsAg and HBV DNA. Conclusions: ANN identifies spontaneous HBsAg seroclearance in HBeAg-negative CHB patients with better accuracy, on the basis of easily available serum data. More useful predictors for HBsAg seroconversion are still needed to be explored in the future.	[Zheng, Ming-Hua; Shi, Ke-Qing] Wenzhou Med Univ, Affiliated Hosp 1, Liver Res Ctr, Dept Infect & Liver Dis, Wenzhou, Zhejiang, Peoples R China; [Zheng, Ming-Hua; Seto, Wai-Kay; Wong, Danny Ka-Ho; Fung, James; Hung, Ivan Fan-Ngai; Yuen, John Chi-Hang; Tong, Teresa; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Fong, Daniel Yee-Tak] Univ Hong Kong, Queen Mary Hosp, Dept Nursing Studies, Hong Kong, Hong Kong, Peoples R China; [Seto, Wai-Kay; Wong, Danny Ka-Ho; Fung, James; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China	Wenzhou Medical University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yuen, MF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Wong, Danny/H-6819-2016; SETO, Wai-Kay/H-4452-2012; Shi, KeQing/A-3411-2009; Fung, James/AAG-4832-2020; Zheng, Ming-Hua/H-5584-2019; Hung, Ivan FN/ABD-5916-2021; Wong, Danny/S-6230-2019; Fong, Daniel YT/C-4269-2009	SETO, Wai-Kay/0000-0002-9012-313X; Shi, KeQing/0000-0002-5070-3834; Zheng, Ming-Hua/0000-0003-4984-2631; Hung, Ivan FN/0000-0002-1556-2538; Fong, Daniel YT/0000-0001-7365-9146; /0000-0001-9078-5005; Lai, Ching-Lung/0000-0002-5927-2436; Fung, James/0000-0002-1286-8902	Roche Diagnostics	Roche Diagnostics	The assays used to determine serum hepatitis B virus DNA level (Cobas Taqman assay) and hepatitis B surface antigen level (Elecsys HBsAg II assay) performed in our laboratory were supported by an unrestricted grant from Roche Diagnostics. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2005, J HEPATOL, V42, P188, DOI 10.1016/j.jhep.2004.10.026; Arai M, 2012, EUR J GASTROEN HEPAT, V24, P414, DOI 10.1097/MEG.0b013e328350594d; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chan HLY, 2011, J INFECT DIS, V204, P408, DOI 10.1093/infdis/jir283; Chen YC, 2012, CLIN GASTROENTEROL H, V10, P297, DOI 10.1016/j.cgh.2011.08.029; CROSS SS, 1995, LANCET, V346, P1075, DOI 10.1016/S0140-6736(95)91746-2; Cucchetti A, 2007, GUT, V56, P253, DOI 10.1136/gut.2005.084434; Cucchetti A, 2010, J HEPATOL, V52, P880, DOI 10.1016/j.jhep.2009.12.037; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ho WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029179; Howes P, 1999, NEUROCOMPUTING, V24, P191, DOI 10.1016/S0925-2312(98)00102-7; Idilman R, 2012, J VIRAL HEPATITIS, V19, P220, DOI 10.1111/j.1365-2893.2011.01542.x; Ikeda K, 2006, AM J MED, V119, P977, DOI 10.1016/j.amjmed.2005.02.033; Kobayashi M, 2014, J GASTROENTEROL, V49, P538, DOI 10.1007/s00535-013-0821-2; Kwak MS, 2011, DIGESTION, V84, P23, DOI 10.1159/000333211; Liu J, 2014, GUT, V63, P1648, DOI 10.1136/gutjnl-2013-305785; Liu J, 2013, J HEPATOL, V58, P853, DOI 10.1016/j.jhep.2012.12.006; Liu J, 2010, GASTROENTEROLOGY, V139, P474, DOI 10.1053/j.gastro.2010.04.048; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Seto WK, 2012, HEPATOLOGY, V56, P812, DOI 10.1002/hep.25718; Tai DI, 2010, AM J GASTROENTEROL, V105, P1102, DOI 10.1038/ajg.2009.669; Tseng TC, 2013, HEPATOLOGY, V57, P441, DOI 10.1002/hep.26041; Tseng TC, 2011, GASTROENTEROLOGY, V141, P517, DOI 10.1053/j.gastro.2011.04.046; Tseng TC, 2009, GASTROENTEROLOGY, V136, P1842, DOI 10.1053/j.gastro.2008.12.074; Wursthorn K, 2011, J CLIN VIROL, V50, P292, DOI 10.1016/j.jcv.2010.12.008; Zheng MH, 2013, J VIRAL HEPATITIS, V20, P248, DOI 10.1111/j.1365-2893.2012.01647.x	28	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99422	10.1371/journal.pone.0099422	http://dx.doi.org/10.1371/journal.pone.0099422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914537	gold, Green Submitted, Green Published			2022-12-25	WOS:000340947700101
J	Derycke, L; Eyerich, S; Van Crombruggen, K; Perez-Novo, C; Holtappels, G; Deruyck, N; Gevaert, P; Bachert, C				Derycke, Lara; Eyerich, Stefanie; Van Crombruggen, Koen; Perez-Novo, Claudina; Holtappels, Gabriele; Deruyck, Natalie; Gevaert, Philippe; Bachert, Claus			Mixed T Helper Cell Signatures In Chronic Rhinosinusitis with and without Polyps	PLOS ONE			English	Article							NASAL POLYPS; IFN-GAMMA; DIFFERENTIATION; INTERLEUKIN-10; PATHOGENESIS; CYTOKINES; RESPONSES; DISEASE; PROTEIN; PRODUCE	In chronic rhinosinusitis (CRS) different phenotypes have been reported based on cytokine profile and inflammatory cell patterns. The aim of this study was to characterize the intracytoplasmatic cytokines ofTcells infiltrating theinflamed sinonasal mucosa. Methods: Infiltrated T cells and tissue homogenates from sinonasal mucosal samples of 7 healthy subjects, 9 patients with CRS without nasal polyp (CRSsNP), 15 with CRS with nasal polyps (CRSwNP) and 5cystic fibrosis patients (CF-NP) were analyzed for cytokine expression using flow cytometry and multiplex analysis respectively. Intracytoplasmic cytokinesin T cells were analyzed after stimulation of nasal polyps with Staphylococcus aureus enterotoxin B for 24 hours. Results: The number of T cellsper total living cells was significantly higher in patients with CRSwNP vs. CRSsNP and controls. 85% of the CD4+ Tcells showed to be memory T cells. The effector T cells present in all tissues have apredominantTh1 phenotype. Only in CRSwNP, a significantfraction of T cellsproduced the Th2 cytokinesIL-4 and IL-5, while nasal polyps from CF patients were characterized by a higher CD4/CD8 T cell ratio and an increased number of Th17 cells. 24 h stimulation with SEB resulted in a significant induction of CD4+ T cells producing IL-10 (Tr1 cells). Conclusion: T cell cytokine patternsin healthy and inflamed sinonasal mucosa revealed that Th2 cells (IL-4 and IL-5 producing cells) are significantly increased in CRSwNP mucosal inflammation. Exposure to SEB stimulates Tr1 cellsthat may contribute to the Th2 bias in CRSwNP.	[Derycke, Lara; Van Crombruggen, Koen; Perez-Novo, Claudina; Holtappels, Gabriele; Deruyck, Natalie; Gevaert, Philippe; Bachert, Claus] Ghent Univ Hosp, Upper Airway Res Lab URL, Ghent, Belgium; [Bachert, Claus] Karolinska Inst, Div ENT Dis, Stockholm, Sweden; [Eyerich, Stefanie] ZAUM Zentrum Allergie & Umwelt, Munich, Germany	Ghent University; Ghent University Hospital; Karolinska Institutet	Bachert, C (corresponding author), Ghent Univ Hosp, Upper Airway Res Lab URL, Ghent, Belgium.	claus.bachert@Ugent.be	Novo, Claudina Angela Perez/H-9697-2016; Gevaert, Philippe/ABA-4588-2021; Novo, Claudina A Perez/E-6098-2011; Bachert, Claus/J-8825-2012; Gevaert, Philippe/AAP-1892-2020	Novo, Claudina A Perez/0000-0003-4562-4346; Gevaert, Philippe/0000-0002-1629-8468	Scientific Research Flanders [3G.0489.08, G.0642.10N]; Interuniversity Attraction Poles Program (IUAP) - Belgian state - Belgian Science Policy [P6/35, P7/30]	Scientific Research Flanders(FWO); Interuniversity Attraction Poles Program (IUAP) - Belgian state - Belgian Science Policy	This project was supported by the Fund for Scientific Research Flanders (FWO-Vlaanderen - Projects 3G.0489.08 to C.B., G.0642.10N to C.B) and The Interuniversity Attraction Poles Program (IUAP) - Belgian state - Belgian Science Policy P6/35 and P7/30. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Annunziato F, 2013, SEMIN IMMUNOL, V25, P299, DOI 10.1016/j.smim.2013.10.011; Annunziato F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2843; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Cheng W, 2007, J INVEST ALLERG CLIN, V17, P297; Derycke L, 2012, J CYST FIBROS, V11, P193, DOI 10.1016/j.jcf.2011.11.007; Faith A, 2012, ALLERGY, V67, P1007, DOI 10.1111/j.1398-9995.2012.02852.x; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Hirahara K, 2011, IMMUNOLOGY, V134, P235, DOI 10.1111/j.1365-2567.2011.03483.x; Kemeny DM, 1999, AM J RESP CRIT CARE, V160, pS33, DOI 10.1164/ajrccm.160.supplement_1.10; Li ZH, 2011, PROTEIN CELL, V2, P604, DOI 10.1007/s13238-011-1083-5; Lin YT, 2011, CLIN EXP ALLERGY, V41, P516, DOI 10.1111/j.1365-2222.2010.03681.x; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Noel C, 2001, INT IMMUNOL, V13, P431, DOI 10.1093/intimm/13.4.431; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Prussin C, 2010, J ALLERGY CLIN IMMUN, V126, P1094, DOI 10.1016/j.jaci.2010.08.031; Riechelmann H, 2005, CLIN EXP ALLERGY, V35, P1186, DOI 10.1111/j.1365-2222.2005.02316.x; Rowe J, 2004, J ALLERGY CLIN IMMUN, V113, P710, DOI 10.1016/j.jaci.2003.12.585; Rutz S, 2011, CURR OPIN IMMUNOL, V23, P605, DOI 10.1016/j.coi.2011.07.018; Sanchez-Segura A, 1998, J ALLERGY CLIN IMMUN, V102, P953, DOI 10.1016/S0091-6749(98)70333-1; Tang YF, 2012, J ALLERGY CLIN IMMUN, V129, P1611, DOI 10.1016/j.jaci.2011.12.976; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Van Crombruggen K, 2011, J ALLERGY CLIN IMMUN, V128, P728, DOI 10.1016/j.jaci.2011.07.049; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Weiss E, 2004, J AM ACAD DERMATOL, V50, P657, DOI 10.1016/j.jaad.2003.11.075; Zygmunt B, 2011, ADV IMMUNOL, V109, P159, DOI 10.1016/B978-0-12-387664-5.00005-4	28	99	102	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e97581	10.1371/journal.pone.0097581	http://dx.doi.org/10.1371/journal.pone.0097581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911279	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600124
J	Kuznetsov, NA; Kuznetsova, AA; Vorobjev, YN; Krasnoperov, LN; Fedorova, OS				Kuznetsov, Nikita A.; Kuznetsova, Alexandra A.; Vorobjev, Yuri N.; Krasnoperov, Lev N.; Fedorova, Olga S.			Thermodynamics of the DNA Damage Repair Steps of Human 8-Oxoguanine DNA Glycosylase	PLOS ONE			English	Article							CONFORMATIONAL DYNAMICS; SUBSTRATE RECOGNITION; LESION RECOGNITION; ENZYME; FLUORESCENCE; BINDING; PYRROLOCYTOSINE; 2-AMINOPURINE; COMPONENTS; MECHANISM	Human 8-oxoguanine DNA glycosylase (hOGG1) is a key enzyme responsible for initiating the base excision repair of 7,8dihydro- 8-oxoguanosine (oxoG). In this study a thermodynamic analysis of the interaction of hOGG1 with specific and nonspecific DNA-substrates is performed based on stopped-flow kinetic data. The standard Gibbs energies, enthalpies and entropies of specific stages of the repair process were determined via kinetic measurements over a temperature range using the van't Hoff approach. The three steps which are accompanied with changes in the DNA conformations were detected via 2-aminopurine fluorescence in the process of binding and recognition of damaged oxoG base by hOGG1. The thermodynamic analysis has demonstrated that the initial step of the DNA substrates binding is mainly governed by energy due to favorable interactions in the process of formation of the recognition contacts, which results in negative enthalpy change, as well as due to partial desolvation of the surface between the DNA and enzyme, which results in positive entropy change. Discrimination of non-specific G base versus specific oxoG base is occurring in the second step of the oxoG-substrate binding. This step requires energy consumption which is compensated by the positive entropy contribution. The third binding step is the final adjustment of the enzyme/substrate complex to achieve the catalytically competent state which is characterized by large endothermicity compensated by a significant increase of entropy originated from the dehydration of the DNA grooves.	[Kuznetsov, Nikita A.; Kuznetsova, Alexandra A.; Vorobjev, Yuri N.; Fedorova, Olga S.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia; [Kuznetsov, Nikita A.; Kuznetsova, Alexandra A.; Vorobjev, Yuri N.; Fedorova, Olga S.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia; [Krasnoperov, Lev N.] New Jersey Inst Technol, Dept Chem & Environm Sci, Newark, NJ 07102 USA	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; New Jersey Institute of Technology	Fedorova, OS (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia.	fedorova@niboch.nsc.ru	Kuznetsov, Nikita A/F-3245-2011; Kuznetsov, Nikita/AFU-9897-2022; Fedorova, Olga/ABE-6637-2020; Fedorova, Olga S./E-1291-2013; Kuznetsov, Nikita/CAA-3889-2022; Kuznetsova, Aleksandra A/G-5119-2013	Kuznetsov, Nikita A/0000-0002-4016-198X; Kuznetsov, Nikita/0000-0002-4016-198X; Fedorova, Olga/0000-0002-4001-7187; Fedorova, Olga S./0000-0002-4001-7187; Kuznetsov, Nikita/0000-0002-4016-198X; Kuznetsova, Aleksandra/0000-0002-9805-7050	Program of the Russian Academy of Sciences "Molecular and Cell Biology'' [6.11]; President Grants [SS-1205.2014.4, SP-4012.2013.4]; Russian Scientific Foundation [14-14-00063]; Russian Foundation for Basic Research [13-04-00013, 14-04-31174, 14-04-00531, 12-04-00135]; Russian Science Foundation [14-14-00063] Funding Source: Russian Science Foundation	Program of the Russian Academy of Sciences "Molecular and Cell Biology''; President Grants; Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Program of the Russian Academy of Sciences "Molecular and Cell Biology'' (6.11); President Grants (nos. SS-1205.2014.4 and SP-4012.2013.4); the Grant from Russian Scientific Foundation (14-14-00063); O.S.F., A.A.K.,N.A.K. and Y.N.V. are supported by Russian Foundation for Basic Research (nos. 13-04-00013, 14-04-31174, 14-04-00531 and 12-04-00135, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins P., 2006, PHYS CHEM; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Bjoras M, 2002, J MOL BIOL, V317, P171, DOI 10.1006/jmbi.2002.5400; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; CHENG KC, 1992, J BIOL CHEM, V267, P166; Crenshaw CM, 2012, J BIOL CHEM, V287, P24916, DOI 10.1074/jbc.M111.316497; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Fromme JC, 2003, NAT STRUCT BIOL, V10, P204, DOI 10.1038/nsb902; Hardman SJO, 2006, BIOCHEMISTRY-US, V45, P9145, DOI 10.1021/bi060479t; Jen-Jacobson L, 2000, STRUCTURE, V8, P1015, DOI 10.1016/S0969-2126(00)00501-3; Koval VV, 2010, MUTAT RES-FUND MOL M, V685, P3, DOI 10.1016/j.mrfmmm.2009.08.018; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Kuznetsov NA, 2012, DNA REPAIR, V11, P884, DOI 10.1016/j.dnarep.2012.08.004; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; Kuznetsov NA, 2009, BIOCHEMISTRY-US, V48, P11335, DOI 10.1021/bi901100b; Kuznetsova AA, 2009, RUSS CHEM REV+, V78, P659, DOI 10.1070/RC2009v078n07ABEH004038; Kuznetsova AA, 2014, BBA-GEN SUBJECTS, V1840, P387, DOI 10.1016/j.bbagen.2013.09.035; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Norman DPG, 2003, BIOCHEMISTRY-US, V42, P1564, DOI 10.1021/bi026823d; Privalov PL, 2011, NUCLEIC ACIDS RES, V39, P2483, DOI 10.1093/nar/gkq984; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Radom CT, 2007, J BIOL CHEM, V282, P9182, DOI 10.1074/jbc.M608989200; RAGONE R, 1995, J PHYS CHEM-US, V99, P13050, DOI 10.1021/j100034a054; ROSE GD, 1993, ANNU REV BIOPH BIOM, V22, P381, DOI 10.1146/annurev.bb.22.060193.002121; RUMYANTSEVA GV, 1989, FEBS LETT, V242, P397, DOI 10.1016/0014-5793(89)80509-5; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Vorobjev YN, 1997, BIOPHYS J, V73, P722, DOI 10.1016/S0006-3495(97)78105-0; Vorobjev YN, 2011, ADV PROTEIN CHEM STR, V85, P281, DOI 10.1016/B978-0-12-386485-7.00008-9; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	36	26	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98495	10.1371/journal.pone.0098495	http://dx.doi.org/10.1371/journal.pone.0098495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911585	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600007
J	Li, L; Men, WW; Chang, YK; Fan, MX; Ji, L; Wei, GX				Li, Lin; Men, Wei-Wei; Chang, Yu-Kai; Fan, Ming-Xia; Ji, Liu; Wei, Gao-Xia			Acute Aerobic Exercise Increases Cortical Activity during Working Memory: A Functional MRI Study in Female College Students	PLOS ONE			English	Article							OLDER-ADULTS; RESISTANCE EXERCISE; EXECUTIVE FUNCTIONS; COGNITIVE FUNCTION; TEST-PERFORMANCE; TASK-DIFFICULTY; BRAIN; ACTIVATION; FMRI; FITNESS	There is increasing evidence that acute aerobic exercise is associated with improved cognitive function. However, neural correlates of its cognitive plasticity remain largely unknown. The present study examined the effect of a session of acute aerobic exercise on working memory task-evoked brain activity as well as task performance. A within-subjects design with a counterbalanced order was employed. Fifteen young female participants (M = 19.56, SD = 0.81) were scanned using functional magnetic resonance imaging while performing a working memory task, the N-back task, both following an acute exercise session with 20 minutes of moderate intensity and a control rest session. Although an acute session of exercise did not improve behavioral performance, we observed that it had a significant impact on brain activity during the 2-back condition of the N-back task. Specifically, acute exercise induced increased brain activation in the right middle prefrontal gyrus, the right lingual gyrus, and the left fusiform gyrus as well as deactivations in the anterior cingulate cortexes, the left inferior frontal gyrus, and the right paracentral lobule. Despite the lack of an effect on behavioral measures, significant changes after acute exercise with activation of the prefrontal and occipital cortexes and deactivation of the anterior cingulate cortexes and left frontal hemisphere reflect the improvement of executive control processes, indicating that acute exercise could benefit working memory at a macro-neural level. In addition to its effects on reversing recent obesity and disease trends, our results provide substantial evidence highlighting the importance of promoting physical activity across the lifespan to prevent or reverse cognitive and neural decline.	[Li, Lin; Ji, Liu] Minist Educ, Key Lab Adolescent Hlth Assessment & Exercise Int, Shanghai, Peoples R China; [Li, Lin; Ji, Liu] E China Normal Univ, Phys Educ & Hlth Sch, Shanghai 200062, Peoples R China; [Men, Wei-Wei; Fan, Ming-Xia] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai, Peoples R China; [Chang, Yu-Kai] Natl Taiwan Sport Univ, Grad Inst Athlet & Coaching Sci, Guishan Township, Taoyuan County, Taiwan; [Wei, Gao-Xia] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Wei, Gao-Xia] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China	East China Normal University; East China Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Ji, L (corresponding author), Minist Educ, Key Lab Adolescent Hlth Assessment & Exercise Int, Shanghai, Peoples R China.	lji@tyxx.ecnu.edu.cn; weigx@psych.ac.cn	Meijer, Anna/K-5118-2016		Open Research Fund of the Key Laboratory of Adolescent Health Assessment and Exercise Intervention [7823005E]; Research Fund for the Doctoral Program of Higher Education [20110076120029]; large instruments Open Foundation of East China Normal University [2013-46]; National Natural Science Foundation of China [31200794, 91132728]; Open Research Fund of the Key Laboratory of Mental Health of the Chinese Academy of Sciences	Open Research Fund of the Key Laboratory of Adolescent Health Assessment and Exercise Intervention; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); large instruments Open Foundation of East China Normal University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund of the Key Laboratory of Mental Health of the Chinese Academy of Sciences	This work was supported by grants from Open Research Fund of the Key Laboratory of Adolescent Health Assessment and Exercise Intervention (7823005E), the Research Fund for the Doctoral Program of Higher Education (20110076120029), large instruments Open Foundation of East China Normal University (2013-46), the National Natural Science Foundation of China (31200794, 91132728 to GXW), the Open Research Fund of the Key Laboratory of Mental Health of the Chinese Academy of Sciences (to GXW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chang YK, 2014, J SCI MED SPORT, V17, P51, DOI 10.1016/j.jsams.2013.02.007; Chang YK, 2011, J SPORT EXERCISE PSY, V33, P847, DOI 10.1123/jsep.33.6.847; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Coles K, 2008, J SPORT SCI, V26, P333, DOI 10.1080/02640410701591417; DEMB JB, 1995, J NEUROSCI, V15, P5870; Erickson KI, 2007, CEREB CORTEX, V17, P192, DOI 10.1093/cercor/bhj137; Etnier JL, 2009, J SPORT EXERCISE PSY, V31, P469, DOI 10.1123/jsep.31.4.469; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Gothe N, 2012, J PHYS ACT HLTH; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2005, CONSCIOUS COGN, V14, P679, DOI 10.1016/j.concog.2005.04.004; Haller S, 2005, MAGN RESON MATER PHY, V18, P263, DOI 10.1007/s10334-005-0010-2; Hillman CH, 2009, NEUROSCIENCE, V159, P1044, DOI 10.1016/j.neuroscience.2009.01.057; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Hyodo K, 2012, NEUROBIOL AGING, V33, P2621, DOI 10.1016/j.neurobiolaging.2011.12.022; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kamijo K, 2007, INT J PSYCHOPHYSIOL, V65, P114, DOI 10.1016/j.ijpsycho.2007.04.001; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lowe PA, 2003, ARCH CLIN NEUROPSYCH, V18, P865, DOI 10.1016/S0887-6177(02)00162-2; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pontifex MB, 2007, CLIN NEUROPHYSIOL, V118, P570, DOI 10.1016/j.clinph.2006.09.029; Pontifex MB, 2009, MED SCI SPORT EXER, V41, P927, DOI 10.1249/MSS.0b013e3181907d69; Sibley BA, 2007, J SPORT EXERCISE PSY, V29, P783, DOI 10.1123/jsep.29.6.783; Stratta P, 2001, PSYCHIAT RES, V102, P39, DOI 10.1016/S0165-1781(01)00230-X; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; TOMPOROWSKI PD, 1986, PSYCHOL BULL, V99, P338, DOI 10.1037/0033-2909.99.3.338; Tsujii T, 2013, ADV EXP MED BIOL, V765, P293, DOI 10.1007/978-1-4614-4989-8_41; Voss B, 2012, EUR ARCH PSY CLIN N, V262, P329, DOI 10.1007/s00406-011-0267-6; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; Voss MW, 2010, NEUROPSYCHOLOGIA, V48, P1394, DOI 10.1016/j.neuropsychologia.2010.01.005; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	43	115	118	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99222	10.1371/journal.pone.0099222	http://dx.doi.org/10.1371/journal.pone.0099222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI8LF	24911975	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600058
J	Nelson, MC; Reynolds, JD				Nelson, Michelle C.; Reynolds, John D.			Time-Delayed Subsidies: Interspecies Population Effects in Salmon	PLOS ONE			English	Article							JUVENILE COHO SALMON; MARINE-DERIVED NUTRIENTS; ANADROMOUS SOCKEYE-SALMON; FRESH-WATER ECOSYSTEMS; COPPER RIVER DELTA; ONCORHYNCHUS-KISUTCH; PACIFIC SALMON; CARCASS ADDITION; RIPARIAN CANOPY; GROWTH	Cross-boundary nutrient inputs can enhance and sustain populations of organisms in nutrient-poor recipient ecosystems. For example, Pacific salmon (Oncorhynchus spp.) can deliver large amounts of marine-derived nutrients to freshwater ecosystems through their eggs, excretion, or carcasses. This has led to the question of whether nutrients from one generation of salmon can benefit juvenile salmon from subsequent generations. In a study of 12 streams on the central coast of British Columbia, we found that the abundance of juvenile coho salmon was most closely correlated with the abundance of adult pink salmon from previous years. There was a secondary role for adult chum salmon and watershed size, followed by other physical characteristics of streams. Most of the coho sampled emerged in the spring, and had little to no direct contact with spawning salmon nutrients at the time of sampling in the summer and fall. A combination of techniques suggest that subsidies from spawning salmon can have a strong, positive, time-delayed influence on the productivity of salmon-bearing streams through indirect effects from previous spawning events. This is the first study on the impacts of nutrients from naturally-occurring spawning salmon on juvenile population abundance of other salmon species.	[Nelson, Michelle C.; Reynolds, John D.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Nelson, Michelle C.] Raincoast Conservat Fdn, Sidney, BC, Canada	Simon Fraser University	Nelson, MC (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada.	mcnelson@sfu.ca	Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074	RIX Family Leading Edge student award; Raincoast Conservation Foundation; NSERC; Pacific Salmon Foundation; BC Leading Edge Fund; Simon Fraser University	RIX Family Leading Edge student award; Raincoast Conservation Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Pacific Salmon Foundation; BC Leading Edge Fund; Simon Fraser University	This work was supported by RIX Family Leading Edge student award and NSERC Industrial Post-graduate Scholarship to MN with industrial funding from Raincoast Conservation Foundation (www.raincoast.org); and NSERC Discovery and Accelerator Grants to JDR, and and the Tom Buell Research Chair partnership between the Pacific Salmon Foundation (www.psf.ca), the BC Leading Edge Fund, and Simon Fraser University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM PUBL HLTH ASS, 1989, STAND METH EX WAST W; Anderson D.R., 2008, MODEL BASED INFERENC; Armstrong JB, 2010, ECOLOGY, V91, P1445, DOI 10.1890/09-0790.1; Bain M.B., 1999, AQUATIC HABITAT ASSE; Barton K., 2012, MULTI MODEL INFERENC; Bilby RE, 1998, CAN J FISH AQUAT SCI, V55, P1909, DOI 10.1139/cjfas-55-8-1909; Bilby RE, 2001, FISHERIES, V26, P6, DOI 10.1577/1548-8446(2001)026<0006:PEOTUO>2.0.CO;2; Bradford M, 1997, T AM FISH SOC, V126, P59, DOI DOI 10.1577/1548-8659(1997)126%; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P677, DOI 10.1139/cjfas-57-4-677; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; DEGERMAN E, 1986, WATER AIR SOIL POLL, V30, P665, DOI 10.1007/BF00303330; Dorazio RM, 2005, BIOMETRICS, V61, P1093, DOI 10.1111/j.1541-0420.2005.00360.x; ENGLISH KK, 1992, CAN J FISH AQUAT SCI, V49, P1982, DOI 10.1139/f92-220; Field RD, 2011, P ROY SOC B-BIOL SCI, V278, P3081, DOI 10.1098/rspb.2010.2731; Garcia EA, 2011, OECOLOGIA, V166, P1111, DOI 10.1007/s00442-011-1952-x; Graham MD, 2006, LIMNOL OCEANOGR, V51, P1524, DOI 10.4319/lo.2006.51.3.1524; Gresh T, 2000, FISHERIES, V25, P15, DOI 10.1577/1548-8446(2000)025<0015:AEOHAC>2.0.CO;2; Groot C, 1991, PACIFIC SALMON LIFE; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Harding JN, 2014, FRESHWATER BIOL, V59, P1361, DOI 10.1111/fwb.12351; Harding JN, 2014, NUTR SUBSIDIES UNPUB; Harvey BC, 2010, N AM J FISH MANAGE, V30, P1445, DOI 10.1577/M10-022.1; HAWKINS CP, 1983, CAN J FISH AQUAT SCI, V40, P1173, DOI 10.1139/f83-134; Hicks BJ, 2005, OECOLOGIA, V144, P558, DOI 10.1007/s00442-005-0035-2; Hocking MD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2433; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; HOLTBY LB, 1988, CAN J FISH AQUAT SCI, V45, P502, DOI 10.1139/f88-060; HUNTER JG, 1959, J FISH RES BOARD CAN, V16, P835, DOI 10.1139/f59-061; IRVINE JR, 1992, CAN J FISH AQUAT SCI, V49, P1972, DOI 10.1139/f92-219; Janetski DJ, 2009, OECOLOGIA, V159, P583, DOI 10.1007/s00442-008-1249-x; Kershner JL, 1992, IMPORTANCE HABITAT L, P179; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Lang DW, 2006, CAN J FISH AQUAT SCI, V63, P917, DOI 10.1139/F05-268; Levi PS, 2011, CAN J FISH AQUAT SCI, V68, P1316, DOI [10.1139/F2011-067, 10.1139/f2011-067]; Levi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001303; Marczak LB, 2008, OECOLOGIA, V156, P249, DOI 10.1007/s00442-008-0989-y; MCGARIGAL LS, 2000, MULTIVARIATE STAT WI; MICHAEL JH, 1995, NORTHWEST SCI, V69, P228; Moore JW, 2007, ECOLOGY, V88, P1278, DOI 10.1890/06-0782; Moore JW, 2004, CAN J FISH AQUAT SCI, V61, P1582, DOI [10.1139/f04-103, 10.1139/F04-103]; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Nelson MC, 2014, EFFECT SUBSIDE UNPUB; Piovia-Scott J, 2011, SCIENCE, V331, P461, DOI 10.1126/science.1200282; POJAR J, 1987, FOREST ECOL MANAG, V22, P119, DOI 10.1016/0378-1127(87)90100-9; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; R Development Core Team, 2009, R FDN STAT COMP; Reisinger AJ, 2013, FRESHWATER BIOL, V58, P938, DOI 10.1111/fwb.12098; Richardson JS, 2010, RIVER RES APPL, V26, P55, DOI 10.1002/rra.1283; Rinella DJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00112.1; Roni P, 2001, CAN J FISH AQUAT SCI, V58, P282, DOI 10.1139/cjfas-58-2-282; Rosenfeld J, 2000, CAN J FISH AQUAT SCI, V57, P766, DOI 10.1139/cjfas-57-4-766; Ruckelshaus MH, 2002, ANNU REV ECOL SYST, V33, P665, DOI 10.1146/annurev.ecolsys.33.010802.150504; Scheuerell MD, 2007, FRESHWATER BIOL, V52, P1944, DOI 10.1111/j.1365-2427.2007.01823.x; Scheuerell MD, 2005, CAN J FISH AQUAT SCI, V62, P961, DOI 10.1139/F05-113; SCHNUTE J, 1983, CAN J FISH AQUAT SCI, V40, P2153, DOI 10.1139/f83-250; Sharma R, 2001, CAN J FISH AQUAT SCI, V58, P1453, DOI 10.1139/cjfas-58-7-1453; SWAIN DP, 1989, CAN J FISH AQUAT SCI, V46, P1406, DOI 10.1139/f89-180; Tiegs SD, 2008, ECOL APPL, V18, P4, DOI 10.1890/07-0655.1; Tiegs SD, 2011, ECOSYSTEMS, V14, P598, DOI 10.1007/s10021-011-9431-0; Verspoor JJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00011.1; Verspoor JJ, 2010, ECOSYSTEMS, V13, P1020, DOI 10.1007/s10021-010-9371-0; Wilzbach MA, 2005, CAN J FISH AQUAT SCI, V62, P58, DOI 10.1139/F04-177; Wipfli MS, 1998, CAN J FISH AQUAT SCI, V55, P1503, DOI 10.1139/cjfas-55-6-1503; Wipfli MS, 2003, T AM FISH SOC, V132, P371, DOI 10.1577/1548-8659(2003)132<0371:MSIFES>2.0.CO;2; Wolman M. G., 1954, T AM GEOPHYS UNION, V35, P951, DOI DOI 10.1029/TR035I006P00951; ZIPPIN C, 1956, BIOMETRICS, V12, P163, DOI 10.2307/3001759; Zuur Alain F., 2009, P1	69	8	9	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98951	10.1371/journal.pone.0098951	http://dx.doi.org/10.1371/journal.pone.0098951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911974	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600028
J	Shestopaloff, YK; Sbalzarini, IF				Shestopaloff, Yuri K.; Sbalzarini, Ivo F.			A Method for Modeling Growth of Organs and Transplants Based on the General Growth Law: Application to the Liver in Dogs and Humans	PLOS ONE			English	Article							REGENERATION; MECHANISM; MAMMALS; DONORS	Understanding biological phenomena requires a systemic approach that incorporates different mechanisms acting on different spatial and temporal scales, since in organisms the workings of all components, such as organelles, cells, and organs interrelate. This inherent interdependency between diverse biological mechanisms, both on the same and on different scales, provides the functioning of an organism capable of maintaining homeostasis and physiological stability through numerous feedback loops. Thus, developing models of organisms and their constituents should be done within the overall systemic context of the studied phenomena. We introduce such a method for modeling growth and regeneration of livers at the organ scale, considering it a part of the overall multi-scale biochemical and biophysical processes of an organism. Our method is based on the earlier discovered general growth law, postulating that any biological growth process comprises a uniquely defined distribution of nutritional resources between maintenance needs and biomass production. Based on this law, we introduce a liver growth model that allows to accurately predicting the growth of liver transplants in dogs and liver grafts in humans. Using this model, we find quantitative growth characteristics, such as the time point when the transition period after surgery is over and the liver resumes normal growth, rates at which hepatocytes are involved in proliferation, etc. We then use the model to determine and quantify otherwise unobservable metabolic properties of livers.	[Shestopaloff, Yuri K.] Segmentsoft Inc, Res & Dev Lab, Toronto, ON, Canada; [Sbalzarini, Ivo F.] Max Planck Inst Mol Cell Biol & Genet, Ctr Syst Biol Dresden, MOSAIC Grp, Dresden, Germany	Max Planck Society	Shestopaloff, YK (corresponding author), Segmentsoft Inc, Res & Dev Lab, Toronto, ON, Canada.	shes169@yahoo.ca		Sbalzarini, Ivo Fabian/0000-0003-4414-4340				Arias I M, 2008, LIVER BIOL PATHOBIOL; Furchtgott LA, 2009, BIOPHYS J, V96, P3926, DOI 10.1016/j.bpj.2009.01.061; Haga J, 2008, LIVER TRANSPLANT, V14, P1718, DOI 10.1002/lt.21622; Holzhutter HG, 2012, WIRES SYST BIOL MED, V4, P221, DOI 10.1002/wsbm.1158; Hunter PJ, 2008, BRIEF BIOINFORM, V9, P333, DOI 10.1093/bib/bbn024; Jones GW, 2012, SIAM REV, V54, P52, DOI 10.1137/080731785; KAM I, 1987, HEPATOLOGY, V7, P362, DOI 10.1002/hep.1840070225; Krauss M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002750; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Lui JC, 2011, ENDOCR REV, V32, P422, DOI 10.1210/er.2011-0001; MaalOe O, 1966, CONTROL MACROMOLECUL; Maher B, 2013, NATURE, V499, P20, DOI 10.1038/499020a; Netter FH, 2019, ATLAS HUMAN ANATOMY, VSeventh; Pomfret EA, 2003, TRANSPLANTATION, V76, P5, DOI 10.1097/01.TP.0000079064.08263.8E; Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669; Shestopaloff Y. K., 2012, Biophysical Reviews and Letters, V7, P177, DOI 10.1142/S1793048012500075; Shestopaloff YK, 2010, PHYS GROWTH REPLICAT; Shestopaloff YK, 2012, LAW REPLICATION GROW; Shestopaloff YK, 2014, GROWTH UNION FORM BI; Shestopaloff Yuri K., 2012, Biophysical Reviews and Letters, V7, P71, DOI 10.1142/S1793048012500051; Shestopaloff YK, 2011, INT J BIOMATH, V4, P35, DOI 10.1142/S1793524511001180; Shestopaloff Yuri K., 2010, Biophysical Reviews and Letters, V5, P43, DOI 10.1142/S1793048010001111; SKALAK R, 1982, J THEOR BIOL, V94, P555, DOI 10.1016/0022-5193(82)90301-0; Stewart I, 1998, LIFES OTHER SECRET N; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thompson d'Arcy W., 1992, GROWTH FORM; Wambaugh J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000756; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799	29	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99275	10.1371/journal.pone.0099275	http://dx.doi.org/10.1371/journal.pone.0099275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911324	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600064
J	Ude, CC; Sulaiman, SB; Ng, MH; Chen, HC; Ahmad, J; Yahaya, NM; Saim, AB; Idrus, RBH				Ude, Chinedu C.; Sulaiman, Shamsul B.; Ng Min-Hwei; Chen Hui-Cheng; Ahmad, Johan; Yahaya, Norhamdan M.; Saim, Aminuddin B.; Idrus, Ruszymah B. H.			Cartilage Regeneration by Chondrogenic Induced Adult Stem Cells in Osteoarthritic Sheep Model	PLOS ONE			English	Article							DEGENERATIVE JOINT DISEASE; BONE-MARROW; ADIPOSE-TISSUE; IN-VITRO; DIFFERENTIATION; THERAPIES; MEDICINE; REPAIR; YIELD	Objectives: In this study, Adipose stem cells (ADSC) and bone marrow stem cells (BMSC), multipotent adult cells with the potentials for cartilage regenerations were induced to chondrogenic lineage and used for cartilage regenerations in surgically induced osteoarthritis in sheep model. Methods: Osteoarthritis was induced at the right knee of sheep by complete resection of the anterior cruciate ligament and medial meniscus following a 3-weeks exercise regimen. Stem cells from experimental sheep were culture expanded and induced to chondrogenic lineage. Test sheep received a single dose of 2610 7 autologous PKH26-labelled, chondrogenically induced ADSCs or BMSCs as 5 mls injection, while controls received 5 mls culture medium. Results: The proliferation rate of ADSCs 34.4 +/- 1.6 hr was significantly higher than that of the BMSCs 48.8 +/- 5.3 hr (P = 0.008). Chondrogenic induced BMSCs had significantly higher expressions of chondrogenic specific genes (Collagen II, SOX9 and Aggrecan) compared to chondrogenic ADSCs (P = 0.031, 0.010 and 0.013). Grossly, the treated knee joints showed regenerated de novo cartilages within 6 weeks post-treatment. On the International Cartilage Repair Society grade scores, chondrogenically induced ADSCs and BMSCs groups had significantly lower scores than controls (P = 0.0001 and 0.0001). Fluorescence of the tracking dye (PKH26) in the injected cells showed that they had populated the damaged area of cartilage. Histological staining revealed loosely packed matrixes of de novo cartilages and immunostaining demonstrated the presence of cartilage specific proteins, Collagen II and SOX9. Conclusion: Autologous chondrogenically induced ADSCs and BMSCs could be promising cell sources for cartilage regeneration in osteoarthritis.	[Ude, Chinedu C.; Sulaiman, Shamsul B.; Ng Min-Hwei; Idrus, Ruszymah B. H.] Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Cheras, Selangor, Malaysia; [Chen Hui-Cheng] Univ Putra Malaysia, Fac Vet Med, Dept Clin Vet, Serdang 43400, Selangor, Malaysia; [Ahmad, Johan; Yahaya, Norhamdan M.] Univ Kebangsaan Malaysia, Med Ctr, Dept Orthoped & Traumatol, Cheras, Selangor, Malaysia; [Saim, Aminuddin B.] Ampang Putri Specialist Hosp, ENT Consultant Clin, Ampang, Selangor, Malaysia; [Ude, Chinedu C.; Idrus, Ruszymah B. H.] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Idrus, RBH (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Cheras, Selangor, Malaysia.	ruszyidrus@gmail.com	Ng, Angela Min Hwei/ABC-6726-2020; Sulaiman, Shamsul/AFW-2819-2022	Ng, Angela Min Hwei/0000-0002-5791-639X; Sulaiman, Shamsul/0000-0003-2148-6575; Chen, Hui Cheng/0000-0003-3717-0831; Saim, Aminuddin Bin/0000-0002-8090-0855	Malaysian Ministry of Education [UKM-AP-2011-26, DPP-2013-084]; Universiti Kebangsaan Malaysia Medical Center (Tissue Engineering Center Chemical) [50-67-01-001]	Malaysian Ministry of Education; Universiti Kebangsaan Malaysia Medical Center (Tissue Engineering Center Chemical)	This study was supported by grants from the Malaysian Ministry of Education (UKM-AP-2011-26), (DPP-2013-084) and the grant from the Universiti Kebangsaan Malaysia Medical Center (Tissue Engineering Center Chemical grant: 50-67-01-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICHROTH PM, 1991, INT ORTHOP, V15, P351; Al Faqeh H, 2012, EXP GERONTOL, V47, P458, DOI 10.1016/j.exger.2012.03.018; Alfaqeh H, 2008, Med J Malaysia, V63 Suppl A, P37; Alfaqeh HH, 2011, SAUDI MED J, V32, P640; Aubin PP, 2007, CLIN ORTHOP REL S391, pS318; Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; Brian OD, 2010, TISSUE ENG A, V16; Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343; Chen K, 2013, INT J ORAL MAX SURG, V42, P240, DOI 10.1016/j.ijom.2012.05.030; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dragoo JL, 2007, TISSUE ENG, V13, P1615, DOI 10.1089/ten.2006.0249; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Guilak F, 2010, CLIN ORTHOP RELAT R, V468, P2530, DOI 10.1007/s11999-010-1410-9; Hamid AA, 2012, CLINICS, V67, P99, DOI 10.6061/clinics/2012(02)03; Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; Kim HJ, 2009, J ORTHOP RES, V27, P612, DOI 10.1002/jor.20766; Maumus M, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt55; Mehlhorn AT, 2006, TISSUE ENG, V12, P2853, DOI 10.1089/ten.2006.12.2853; Mifune Y, 2013, OSTEOARTHR CARTILAGE, V21, P175, DOI 10.1016/j.joca.2012.09.018; Munirah S, 2005, TISSUE ENG REGEN MED, V2, P347; Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Oedayrajsingh-Varma MJ, 2006, CYTOTHERAPY, V8, P166, DOI 10.1080/14653240600621125; Pak Jaewoo, 2011, J Med Case Rep, V5, P296, DOI 10.1186/1752-1947-5-296; Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480; Saw KY, 2010, J ARTHRO, V11, DOI 10.1016/; Sha'ban M, 2011, TISSUE ENG REGEN MED, V8, P32; Sigma, 1993, RESEARCH, V53, P2360; Tew SR, 2000, ARTHRITIS RHEUM-US, V43, P215, DOI 10.1002/1529-0131(200001)43:1<215::AID-ANR26>3.0.CO;2-X; Ude CC, 2012, TISSUE CELL, V44, P156, DOI 10.1016/j.tice.2012.02.001; Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca	38	75	77	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98770	10.1371/journal.pone.0098770	http://dx.doi.org/10.1371/journal.pone.0098770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911365	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000337165600014
J	Young, PG; Proft, T; Harris, PWR; Brimble, MA; Baker, EN				Young, Paul G.; Proft, Thomas; Harris, Paul W. R.; Brimble, Margaret A.; Baker, Edward N.			Structure and Activity of Streptococcus pyogenes SipA: A Signal Peptidase-Like Protein Essential for Pilus Polymerisation	PLOS ONE			English	Article							ACUTE RHEUMATIC-FEVER; CRYSTAL-STRUCTURE; STABILIZING ISOPEPTIDE; EXPRESSION; SEQUENCE; ADHESION; GENE; DETERMINANTS; SCATTERING; MUTATIONS	The pili expressed on the surface of the human pathogen Streptococcus pyogenes play an important role in host cell attachment, colonisation and pathogenesis. These pili are built from two or three components, an adhesin subunit at the tip, a major pilin that forms a polymeric shaft, and a basal pilin that is attached to the cell wall. Assembly is carried out by specific sortase (cysteine transpeptidase) enzyme. These components are encoded in a small gene cluster within the S. pyogenes genome, often together with another protein, SipA, whose function is unknown. We show through functional assays, carried out by expressing the S. pyogenes pilus components in Lactococcus lactis, SipA from the clinically important M1T1 strain is essential for pilus assembly, and that SipA function is likely to be conserved in all S. pyogenes. From the crystal structure of SipA we confirm that SipA belongs to the family of bacterial signal peptidases (SPases), which process the signal-peptides of secreted proteins. In contrast to a previous arm-swapped SipA dimer, this present structure shows that its principal domain closely resembles the catalytic domain of SPases and has a very similar peptide-binding cleft, but it lacks the catalytic Ser and Lys residues characteristic of SPases. In SipA these are replaced by Asp and Gly residues, which play no part in activity. We propose that SipA functions by binding a key component at the bacterial cell surface, in a conformation that facilitates pilus assembly.	[Young, Paul G.; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Proft, Thomas] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med, Auckland 1, New Zealand; [Harris, Paul W. R.; Brimble, Margaret A.] Univ Auckland, Sch Chem Sci, Auckland 1, New Zealand; [Proft, Thomas; Harris, Paul W. R.; Brimble, Margaret A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	Young, PG (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	p.young@auckland.ac.nz	Proft, Thomas/H-4686-2019	Proft, Thomas/0000-0002-9275-5042; Brimble, Margaret/0000-0002-7086-4096; Baker, Edward/0000-0003-2456-7661	Health Research Council of New Zealand; New Zealand Synchrotron Group Ltd.	Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Synchrotron Group Ltd.	This work was supported by the Health Research Council of New Zealand. Access to the Australian Synchrotron was funded by the New Zealand Synchrotron Group Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Bell CE, 2000, CELL, V101, P801, DOI 10.1016/S0092-8674(00)80891-0; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Carlos JL, 2000, J BIOL CHEM, V275, P38813, DOI 10.1074/jbc.M007093200; Carlos JL, 2000, BIOCHEMISTRY-US, V39, P7276, DOI 10.1021/bi000301l; Carrere-Kremer S, 2004, J BIOL CHEM, V279, P41384, DOI 10.1074/jbc.M406315200; Chauleau M, 2011, J BIOL CHEM, V286, P29397, DOI 10.1074/jbc.M111.242354; Choo KH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S15; Cozzi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049048; Cregg KM, 1996, J BACTERIOL, V178, P5712, DOI 10.1128/jb.178.19.5712-5718.1996; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; Dubuisson J, 2000, J BIOL CHEM, V275, P30605, DOI 10.1074/jbc.M004326200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Fischer R, 2003, BIOCONJUGATE CHEM, V14, P653, DOI 10.1021/bc025658b; Fittipaldi N, 2007, APPL ENVIRON MICROB, V73, P4359, DOI 10.1128/AEM.00258-07; Fittipaldi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008426; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Harris PWR, 2008, INT J PEPT RES THER, V14, P387, DOI 10.1007/s10989-008-9149-9; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; INADA T, 1989, J BACTERIOL, V171, P585, DOI 10.1128/jb.171.1.585-587.1989; Jaine R, 2008, J PAEDIATR CHILD H, V44, P564, DOI 10.1111/j.1440-1754.2008.01384.x; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015969; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Luo CY, 2009, BIOCHEMISTRY-US, V48, P8976, DOI 10.1021/bi9009538; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Maguire GP, 2012, MED J AUSTRALIA, V197, P133, DOI 10.5694/mja12.10980; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; OCHMAN H, 1988, GENETICS, V120, P621; Paetzel M, 1997, J BIOL CHEM, V272, P9994; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Paetzel M, 2000, PHARMACOL THERAPEUT, V87, P27, DOI 10.1016/S0163-7258(00)00064-4; Que YA, 2000, INFECT IMMUN, V68, P3516, DOI 10.1128/IAI.68.6.3516-3522.2000; Quigley BR, 2010, INFECT IMMUN, V78, P1294, DOI 10.1128/IAI.01037-09; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; van Roosmalen ML, 2004, BBA-MOL CELL RES, V1694, P279, DOI 10.1016/j.bbamcr.2004.05.006; Winzor DJ, 2004, J CHROMATOGR A, V1037, P351, DOI 10.1016/j.chroma.2003.11.092; Young PG, 2013, J STRUCT BIOL, V183, P99, DOI 10.1016/j.jsb.2013.05.021; Zahner D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025124; Zahner D, 2008, J BACTERIOL, V190, P527, DOI 10.1128/JB.01520-07	62	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99135	10.1371/journal.pone.0099135	http://dx.doi.org/10.1371/journal.pone.0099135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911348	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600044
J	Lin, SX; Zhang, Q; Cao, ZG; Lu, YB; Zhang, H; Yan, K; Liu, Y; McKee, MD; Qin, CL; Chen, Z; Feng, JQ				Lin, Shuxian; Zhang, Qi; Cao, Zhengguo; Lu, Yongbo; Zhang, Hua; Yan, Kevin; Liu, Ying; McKee, Marc D.; Qin, Chunlin; Chen, Zhi; Feng, Jian Q.			Constitutive Nuclear Expression of Dentin Matrix Protein 1 Fails to Rescue the Dmp1-null Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIA; IN-VITRO; SIBLING PROTEINS; ACIDIC PHOSPHOPROTEIN; DMP1-DEFICIENT MICE; DMP1; GENE; BONE; OSTEOCYTES; VIVO	Dentin matrix protein 1 (DMP1) plays multiple roles in bone, tooth, phosphate homeostasis, kidney, salivary gland, reproductive cycles, and the development of cancer. In vitro studies have indicated two different biological mechanisms: 1) as a matrix protein, DMP1 interacts with alpha v beta 3 integrin and activates MAP kinase signaling; and 2) DMP1 serves as a transcription co-factor. In vivo studies have demonstrated its key role in osteocytes. This study attempted to determine whether DMP1 functions as a transcription co-factor and regulates osteoblast functions. For gene expression comparisons using adenovirus constructs, we targeted the expression of DMP1 either to the nucleus only by replacing the endogenous signal peptide with a nuclear localization signal (NLS) sequence (referred to as (NLS)DMP1) or to the extracellular matrix as the WT type (referred to as (SP)DMP1) in MC3T3 osteoblasts. High levels of DMP1 in either form greatly increased osteogenic gene expression in an identical manner. However, the targeted (NLS)DMP1 transgene driven by a 3.6-kb rat Col 1 alpha 1 promoter in the nucleus of osteoblasts and osteocytes failed to rescue the phenotyope of Dmp1-null mice, whereas the (SP)DMP1 transgene rescued the rickets defect. These studies support the notion that DMP1 functions as an extracellular matrix protein, rather than as a transcription cofactor in vivo. We also show that DMP1 continues its expression in osteoblasts during postnatal development and that the deletion of Dmp1 leads to an increase in osteoblast proliferation. However, poor mineralization in the metaphysis indicates a critical role for DMP1 in both osteoblasts and osteocytes.	[Lin, Shuxian; Lu, Yongbo; Zhang, Hua; Liu, Ying; Qin, Chunlin; Feng, Jian Q.] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA; [Lin, Shuxian; Cao, Zhengguo; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Hubei, Peoples R China; [Lin, Shuxian; Cao, Zhengguo; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430079, Hubei, Peoples R China; [Zhang, Qi] Tongji Univ, Sch Stomatol, Dept Endodont, Lab Oral Biomed Sci & Translat Med, Shanghai 200092, Peoples R China; [Yan, Kevin] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [McKee, Marc D.] McGill Univ, Fac Dent, Montreal, PQ H3A 0G4, Canada; [McKee, Marc D.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0G4, Canada	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Wuhan University; Wuhan University; Tongji University; Columbia University; McGill University; McGill University	Chen, Z (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, 237 Luoyu Rd, Wuhan 430079, Hubei, Peoples R China.	zhichen@whu.edu.cn; jfeng@bcd.tamhsc.edu	Chen, Zhi/V-2214-2017; McKee, Marc D/E-2187-2011	Chen, Zhi/0000-0003-2095-1324; McKee, Marc D/0000-0001-8349-965X; Lu, Yongbo/0000-0003-3692-1736; Cao, Zhengguo/0000-0002-4261-9034; Zhang, Hua/0000-0002-6789-9343	National Institutes of Health [DE018486, R56DE022789]; NSF under the State Scholarship Fund of China [2010627108]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE022789, R01DE018486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF under the State Scholarship Fund of China; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants DE018486 and R56DE022789 (to J. Q. F.) and Scholarship NSF 2010627108 under the State Scholarship Fund of China (to S. L.).	Barron MJ, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001162; Braut A, 2002, CONNECT TISSUE RES, V43, P216, DOI 10.1080/03008200290001078; Bucciarelli E, 2007, BREAST CANCER RES TR, V105, P95, DOI 10.1007/s10549-006-9436-0; Burra S, 2010, P NATL ACAD SCI USA, V107, P13648, DOI 10.1073/pnas.1009382107; Chaplet M, 2003, J BONE MINER RES, V18, P1506, DOI 10.1359/jbmr.2003.18.8.1506; Corsi A, 2001, ARCH PATHOL LAB MED, V125, P1375; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Eapen A, 2011, CELLS TISSUES ORGANS, V194, P255, DOI 10.1159/000324258; Farrow EG, 2009, BONE, V44, P287, DOI 10.1016/j.bone.2008.10.040; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; GEORGE A, 1993, J BIOL CHEM, V268, P12624; He G, 2003, CONNECT TISSUE RES, V44, P240, DOI 10.1080/03008200390181726; Hirst KL, 1997, J DENT RES, V76, P754, DOI 10.1177/00220345970760030701; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Jiang BC, 2010, J BONE MINER RES, V25, P2155, DOI 10.1002/jbmr.117; Kaartinen MT, 2005, J DENT RES, V84, P607, DOI 10.1177/154405910508400705; Koshida R, 2010, J BONE MINER METAB, V28, P585, DOI 10.1007/s00774-010-0169-0; Kucka M, 2013, MOL ENDOCRINOL, V27, P1840, DOI 10.1210/me.2013-1068; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Lu YB, 2011, J BONE MINER RES, V26, P331, DOI 10.1002/jbmr.226; Lu YB, 2009, CELLS TISSUES ORGANS, V189, P175, DOI 10.1159/000151727; Lv K, 2010, INT J BIOL SCI, V6, P537; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Maciejewska I, 2009, CELLS TISSUES ORGANS, V189, P186, DOI 10.1159/000151372; Makitie O, 2010, J BONE MINER RES, V25, P2165, DOI 10.1002/jbmr.105; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Rangiani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042329; Ravindran S, 2008, J BIOL CHEM, V283, P29658, DOI 10.1074/jbc.M800786200; Sato S, 2008, ARTHRITIS RHEUM, V58, P2764, DOI 10.1002/art.23805; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Siyam A, 2012, BIOCHEM BIOPH RES CO, V424, P641, DOI 10.1016/j.bbrc.2012.07.037; Sun Y, 2011, J DENT RES, V90, P619, DOI 10.1177/0022034510397839; Sun Y, 2011, CELLS TISSUES ORGANS, V194, P199, DOI 10.1159/000324672; Sun Y, 2010, J BIOL CHEM, V285, P31713, DOI 10.1074/jbc.M110.137059; Sun Y, 2010, J HISTOCHEM CYTOCHEM, V58, P1033, DOI 10.1369/jhc.2010.956771; Tartaix PH, 2004, J BIOL CHEM, V279, P18115, DOI 10.1074/jbc.M314114200; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Turan S, 2010, BONE, V46, P402, DOI 10.1016/j.bone.2009.09.016; Wu H, 2011, J BIOL CHEM, V286, P29462, DOI 10.1074/jbc.M110.194746; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zhang R, 2011, J BONE MINER RES, V26, P1047, DOI 10.1002/jbmr.294	49	13	13	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21533	21543		10.1074/jbc.M113.543330	http://dx.doi.org/10.1074/jbc.M113.543330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24917674	hybrid, Green Published			2022-12-25	WOS:000340558300029
J	Carson, JM; Okamura, K; Wakashin, H; McFann, K; Dobrinskikh, E; Kopp, JB; Blaine, J				Carson, John M.; Okamura, Kayo; Wakashin, Hidefumi; McFann, Kim; Dobrinskikh, Evgenia; Kopp, Jeffrey B.; Blaine, Judith			Podocytes Degrade Endocytosed Albumin Primarily in Lysosomes	PLOS ONE			English	Article							PROTEIN ACCUMULATION; GLOMERULAR PROTEIN; AUTOPHAGY; CELLS; REABSORPTION; DEFICIENCY; APOPTOSIS; SEGMENTS; REVEALS; NEPHRON	Albuminuria is a strong, independent predictor of chronic kidney disease progression. We hypothesize that podocyte processing of albumin via the lysosome may be an important determinant of podocyte injury and loss. A human urine derived podocyte-like epithelial cell (HUPEC) line was used for in vitro experiments. Albumin uptake was quantified by Western blot after loading HUPECs with fluorescein-labeled (FITC) albumin. Co-localization of albumin with lysosomes was determined by confocal microscopy. Albumin degradation was measured by quantifying FITC-albumin abundance in HUPEC lysates by Western blot. Degradation experiments were repeated using HUPECs treated with chloroquine, a lysosome inhibitor, or MG-132, a proteasome inhibitor. Lysosome activity was measured by fluorescence recovery after photo bleaching (FRAP). Cytokine production was measured by ELISA. Cell death was determined by trypan blue staining. In vivo, staining with lysosome-associated membrane protein-1 (LAMP-1) was performed on tissue from a Denys-Drash trangenic mouse model of nephrotic syndrome. HUPECs endocytosed albumin, which co-localized with lysosomes. Choloroquine, but not MG-132, inhibited albumin degradation, indicating that degradation occurs in lysosomes. Cathepsin B activity, measured by FRAP, significantly decreased in HUPECs exposed to albumin (12.5% of activity in controls) and chloroquine (12.8%), and declined further with exposure to albumin plus chloroquine (8.2%, p < 0.05). Cytokine production and cell death were significantly increased in HUPECs exposed to albumin and chloroquine alone, and these effects were potentiated by exposure to albumin plus chloroquine. Compared to wild-type mice, glomerular staining of LAMP-1 was significantly increased in Denys-Drash mice and appeared to be most prominent in podocytes. These data suggest lysosomes are involved in the processing of endocytosed albumin in podocytes, and lysosomal dysfunction may contribute to podocyte injury and glomerulosclerosis in albuminuric diseases. Modifiers of lysosomal activity may have therapeutic potential in slowing the progression of glomerulosclerosis by enhancing the ability of podocytes to process and degrade albumin.	[Carson, John M.; Okamura, Kayo; McFann, Kim; Dobrinskikh, Evgenia; Blaine, Judith] Univ Colorado, Hlth Sci Ctr, Aurora, CO 80045 USA; [Wakashin, Hidefumi; Kopp, Jeffrey B.] NIDDK, Kidney Dis Sect, NIH, Bethesda, MD USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Carson, JM (corresponding author), Univ Colorado, Hlth Sci Ctr, Aurora, CO 80045 USA.	john.m.carson@ucdenver.edu	Kopp, Jeffrey B/O-2681-2015	Kopp, Jeffrey B/0000-0001-9052-186X	NIH [K08DK080989]; Intramural Research program, NIDDK, NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research program, NIDDK, NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by NIH grant K08DK080989 to Judith Blaine and the Intramural Research program, NIDDK, NIH to Jeffrey B. Kopp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2008, J AM SOC NEPHROL, V19, P1158, DOI 10.1681/ASN.2007060686; Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; APPELMANS F, 1955, BIOCHEM J, V59, P438, DOI 10.1042/bj0590438; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Bahr BA, 2012, REJUV RES, V15, P189, DOI 10.1089/rej.2011.1282; Bechtel W, 2013, J AM SOC NEPHROL, V24, P727, DOI 10.1681/ASN.2012070700; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Bracamonte ER, 2006, AM J KIDNEY DIS, V48, P844, DOI 10.1053/j.ajkd.2006.05.034; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Chatterjee PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035361; Chen JC, 2013, J AM SOC NEPHROL, V24, P198, DOI 10.1681/ASN.2012010101; Cina DP, 2012, J AM SOC NEPHROL, V23, P412, DOI 10.1681/ASN.2011070690; DAVIES DJ, 1985, PATHOLOGY, V17, P412, DOI 10.3109/00313028509105494; Dobrinskikh E, 2014, AM J PHYSL RENAL PHY; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Eddy AA, 2000, KIDNEY INT, V58, P618, DOI 10.1046/j.1523-1755.2000.00208.x; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; FARQUHAR MG, 1961, J EXP MED, V113, P47, DOI 10.1084/jem.113.1.47; Gekle M, 2005, ANNU REV PHYSIOL, V67, P573, DOI 10.1146/annurev.physiol.67.031103.154845; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Haymann JP, 2000, J AM SOC NEPHROL, V11, P632, DOI 10.1681/ASN.V114632; He FF, 2011, CELL BIOL INT, V35, P827, DOI 10.1042/CBI20100411; He FF, 2011, GENE, V484, P18, DOI 10.1016/j.gene.2011.05.025; HORY B, 1994, CLIN NEPHROL, V42, P327; Karnovsky M J, 1972, Adv Nephrol Necker Hosp, V2, P35; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kobayashi N, 2002, AM J PHYSIOL-RENAL, V282, pF358, DOI 10.1152/ajprenal.0164.2001; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Liebau MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063506; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MAACK T, 1971, AM J PHYSIOL, V221, P1609, DOI 10.1152/ajplegacy.1971.221.6.1609; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Okamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054817; OLBRICHT CJ, 1986, AM J PHYSIOL, V250, P1055; Pryor PR, 2012, METHOD ENZYMOL, V505, P145, DOI 10.1016/B978-0-12-388448-0.00016-4; Ratelade J, 2010, HUM MOL GENET, V19, P1, DOI 10.1093/hmg/ddp462; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Saito A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/403272; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sakairi T, 2010, AM J PHYSIOL-RENAL, V298, pF557, DOI 10.1152/ajprenal.00509.2009; Sakamoto KM, 2002, MOL GENET METAB, V77, P44, DOI 10.1016/S1096-7192(02)00146-4; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; STRAUS W, 1957, J BIOPHYS BIOCHEM CY, V3, P933, DOI 10.1083/jcb.3.6.933; STRAUS W, 1964, J CELL BIOL, V21, P295, DOI 10.1083/jcb.21.3.295; TOJO A, 1992, AM J PHYSIOL, V263, pF601, DOI 10.1152/ajprenal.1992.263.4.F601; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Tryggvason K, 2005, PHYSIOLOGY, V20, P96, DOI 10.1152/physiol.00045.2004; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Weide T, 2011, CELL TISSUE RES, V343, P467, DOI 10.1007/s00441-010-1115-0; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yadav A, 2010, AM J PHYSIOL-CELL PH, V299, pC488, DOI 10.1152/ajpcell.00424.2009; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Yoshida S, 2008, NEPHRON EXP NEPHROL, V108, pE57, DOI 10.1159/000124236; YOSHIKAWA N, 1986, ARCH PATHOL LAB MED, V110, P394	59	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99771	10.1371/journal.pone.0099771	http://dx.doi.org/10.1371/journal.pone.0099771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924335	gold, Green Submitted, Green Published			2022-12-25	WOS:000338701300092
J	Choi, HY; Kim, SW; Kim, B; Lee, HN; Kim, SJ; Song, M; Kim, S; Kim, J; Kim, YB; Kim, JH; Cho, SG				Choi, Hye Yeon; Kim, Seung Woo; Kim, BongWoo; Lee, Hae Na; Kim, Su-Jeong; Song, Minjung; Kim, Sol; Kim, Jungho; Kim, Young Bong; Kim, Jin-Hoi; Cho, Ssang-Goo			Alpha-Fetoprotein, Identified as a Novel Marker for the Antioxidant Effect of Placental Extract, Exhibits Synergistic Antioxidant Activity in the Presence of Estradiol	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; NITRIC-OXIDE; HYDROGEN-PEROXIDE; ESTROGEN-BINDING; FREE-RADICALS; DNA-DAMAGE; SKIN; FETAL; EXPRESSION	Placenta, as a reservoir of nutrients, has been widely used in medical and cosmetic materials. Here, we focused on the antioxidant properties of placental extract and attempted to isolate and identify the main antioxidant factors. Porcine placental extracts were prepared through homogenization or acid hydrolysis, and their antioxidant activity was investigated in the human keratinocyte HaCaT cell line. Treatment with homogenized placental extract (H-PE) increased the cell viability of H2O2-treated HaCaT cells more than two-fold. H-PE treatment suppressed H2O2-induced apoptotic and necrotic cell death and decreased intracellular ROS levels in H2O2-treated HaCaT cells. The antioxidant factors in H-PE were found to be thermounstable and were thus expected to include proteins. The candidate antioxidant proteins were fractionated with cation-exchange, anion-exchange, and size-exclusion chromatography, and the antioxidant properties of the chromatographic fractions were investigated. We obtained specific antioxidant fractions that suppressed ROS generation and ROS-induced DNA strand breaks. From silver staining and MALDI-TOF analyses, alpha-fetoprotein (AFP) precursor was identified as a main marker for the antioxidant effect of H-PE. Purified AFP or ectopically expressed AFP exhibited synergistic antioxidant activity in the presence of estradiol. Taken together, our data suggest that AFP, a serum glycoprotein produced at high levels during fetal development, is a novel marker protein for the antioxidant effect of the placenta that exhibits synergistic antioxidant activity in the presence of estradiol.	[Choi, Hye Yeon; Kim, Seung Woo; Kim, BongWoo; Lee, Hae Na; Kim, Su-Jeong; Song, Minjung; Kim, Young Bong; Kim, Jin-Hoi; Cho, Ssang-Goo] Konkuk Univ, Dept Anim Biotechnol, Anim Resources Res Ctr, Seoul, South Korea; [Choi, Hye Yeon; Kim, Seung Woo; Kim, BongWoo; Lee, Hae Na; Kim, Su-Jeong; Song, Minjung; Kim, Young Bong; Kim, Jin-Hoi; Cho, Ssang-Goo] Konkuk Univ, Incurable Dis Anim Model & Stem Cell Inst IDASI, Seoul, South Korea; [Kim, Sol; Kim, Jungho] Sogang Univ, Dept Life Sci, Seoul, South Korea	Konkuk University; Konkuk University; Sogang University	Cho, SG (corresponding author), Konkuk Univ, Dept Anim Biotechnol, Anim Resources Res Ctr, Seoul, South Korea.	ssangoo@konkuk.ac.kr	CHOI, HYEYEON/O-1234-2019	kim, jin-hoi/0000-0003-1232-5307; Cho, Ssang-Goo/0000-0002-0968-7932	National Research Foundation (NRF) - Korean government (MEST) [2010-0020348]; Bio-Industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs [312062-05];  [2013M3A9D3045880]	National Research Foundation (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Bio-Industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs; 	This work was supported by grants from the National Research Foundation (NRF) funded by the Korean government (MEST) (No. 2010-0020348) (No. 2013M3A9D3045880) and by the Bio-Industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs (No. 312062-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS GK, 1982, J BIOL CHEM, V257, P5148; Angelucci C, 1999, ANTICANCER RES, V19, P429; AVISSAR N, 1994, AM J PHYSIOL, V267, pE68, DOI 10.1152/ajpendo.1994.267.1.E68; Baker ME, 1998, P SOC EXP BIOL MED, V217, P317; Banerjee K K, 1992, Riv Eur Sci Med Farmacol, V14, P361; Barbouti A, 2002, FREE RADICAL BIO MED, V33, P691, DOI 10.1016/S0891-5849(02)00967-X; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Black HS, 2004, J INVEST DERMATOL, V122, pXIII, DOI 10.1111/j.0022-202X.2004.22625.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Briganti S, 2003, J EUR ACAD DERMATOL, V17, P663, DOI 10.1046/j.1468-3083.2003.00751.x; Chakraborty PD, 2006, INT IMMUNOPHARMACOL, V6, P100, DOI 10.1016/j.intimp.2005.07.018; Cianfarani F, 2006, AM J PATHOL, V169, P1167, DOI 10.2353/ajpath.2006.051314; CUCKLE HS, 1984, LANCET, V1, P926; De D, 2011, J CELL PHYSIOL, V226, P2033, DOI 10.1002/jcp.22535; DEUTSCH HF, 1991, ADV CANCER RES, V56, P253; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI [10.1517/14728220802517901, 10.1517/14728220802517901 ]; Gabant P, 2002, P NATL ACAD SCI USA, V99, P12865, DOI 10.1073/pnas.202215399; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hedley SJ, 2002, PIGM CELL RES, V15, P49, DOI 10.1034/j.1600-0749.2002.00067.x; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; HISHIKAWA K, 1995, FEBS LETT, V360, P291, DOI 10.1016/0014-5793(95)00124-R; HOGG N, 1995, J LIPID RES, V36, P1756; HOGG N, 1993, FEBS LETT, V326, P199, DOI 10.1016/0014-5793(93)81790-7; Hong JW, 2010, ANN PLAS SURG, V65, P96, DOI 10.1097/SAP.0b013e3181b0bb67; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Jayaprakasha GK, 2004, BIOORGAN MED CHEM, V12, P5141, DOI 10.1016/j.bmc.2004.07.028; Jung TJ CH, 2006, METHOD MANUFACTURING; Kim SY, 2007, J NUTR BIOCHEM, V18, P31, DOI 10.1016/j.jnutbio.2006.02.006; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; LEIGHTON PC, 1975, LANCET, V2, P1012; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; Liu KX, 1998, BIOL PHARM BULL, V21, P44; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Mizejewski GJ, 2001, EXP BIOL MED, V226, P377, DOI 10.1177/153537020122600503; MONTANO MM, 1995, BIOL REPROD, V53, P1198, DOI 10.1095/biolreprod53.5.1198; MOORADIAN AD, 1993, J STEROID BIOCHEM, V45, P509, DOI 10.1016/0960-0760(93)90166-T; NIKI E, 1990, METHOD ENZYMOL, V186, P330; NISHI S, 1991, P NATL ACAD SCI USA, V88, P3102, DOI 10.1073/pnas.88.8.3102; Parvez S, 2006, TOXICOLOGY, V225, P109, DOI 10.1016/j.tox.2006.05.009; Rahman K, 2007, CLIN INTERV AGING, V2, P219; Santanam N, 1998, J LIPID RES, V39, P2111; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; SUBBIAH MTR, 1993, J CLIN ENDOCR METAB, V77, P1095, DOI 10.1210/jc.77.4.1095; TAKEHARA Y, 1990, ACTA MED OKAYAMA, V44, P103; TILGHMAN SM, 1982, P NATL ACAD SCI-BIOL, V79, P5254, DOI 10.1073/pnas.79.17.5254; Togashi SI, 2002, PLACENTA, V23, P497, DOI 10.1053/plac.2002.0833; Trouba KJ, 2002, ANTIOXID REDOX SIGN, V4, P665, DOI 10.1089/15230860260220175; Wu CH, 2003, BRIT J DERMATOL, V148, P236, DOI 10.1046/j.1365-2133.2003.05164.x; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Yamashita H, 1999, J BIOL CHEM, V274, P29897, DOI 10.1074/jbc.274.42.29897; Zhou Q, 2009, FREE RADICAL BIO MED, V47, P891, DOI 10.1016/j.freeradbiomed.2009.06.033	51	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99421	10.1371/journal.pone.0099421	http://dx.doi.org/10.1371/journal.pone.0099421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922551	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300060
J	Sadio, A; Gustafsson, JK; Pereira, B; Gomes, CP; Hansson, GC; David, L; Pego, AP; Almeida, R				Sadio, Ana; Gustafsson, Jenny K.; Pereira, Bruno; Gomes, Carla Pereira; Hansson, Gunnar C.; David, Leonor; Pego, Ana Paula; Almeida, Raquel			Modified-Chitosan/siRNA Nanoparticles Downregulate Cellular CDX2 Expression and Cross the Gastric Mucus Barrier	PLOS ONE			English	Article							TRIMETHYL CHITOSAN; IN-VITRO; POLYMERIC NANOPARTICLES; INTESTINAL METAPLASIA; RNA INTERFERENCE; CANCER-THERAPY; DRUG-DELIVERY; CELLS; VIVO; COLON	Development of effective non-viral vectors is of crucial importance in the implementation of RNA interference in clinical routine. The localized delivery of siRNAs to the gastrointestinal mucosa is highly desired but faces specific problems such as the stability in gastric acidity conditions and the presence of the mucus barrier. CDX2 is a transcription factor critical for intestinal differentiation being involved in the initiation and maintenance of gastrointestinal diseases. Specifically, it is the trigger of gastric intestinal metaplasia which is a precursor lesion of gastric cancer. Its expression is also altered in colorectal cancer, where it may constitute a lineage-survival oncogene. Our main objective was to develop a nanoparticle-delivery system of siRNA targeting CDX2 using modified chitosan as a vector. CDX2 expression was assessed in gastric carcinoma cell lines and nanoparticles behaviour in gastrointestinal mucus was tested in mouse explants. We show that imidazole-modified chitosan and trimethylchitosan/siRNA nanoparticles are able to downregulate CDX2 expression and overpass the gastric mucus layer but not colonic mucus. This system might constitute a potential therapeutic approach to treat CDX2-dependent gastric lesions.	[Sadio, Ana; Pereira, Bruno; David, Leonor; Almeida, Raquel] Univ Porto, IPATIMUP Inst Patol & Imunol Mol, P-4100 Oporto, Portugal; [Sadio, Ana; Gomes, Carla Pereira; Pego, Ana Paula] Univ Porto, INEB Inst Engn Biomed, P-4100 Oporto, Portugal; [Sadio, Ana] Unidade Local Saude Guarda, Dept Gastroenterol, Guarda, Portugal; [Sadio, Ana] Gulbenkian Programme Adv Med Educ, Lisbon, Portugal; [Sadio, Ana; David, Leonor; Almeida, Raquel] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Gustafsson, Jenny K.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden; [Gomes, Carla Pereira; Pego, Ana Paula] Univ Porto, Fac Engn, P-4100 Oporto, Portugal; [Pego, Ana Paula] Univ Porto, ICBAS, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; University of Gothenburg; Universidade do Porto; Universidade do Porto	Almeida, R (corresponding author), Univ Porto, IPATIMUP Inst Patol & Imunol Mol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ralmeida@ipatimup.pt	Hansson, Gunnar C./AAF-7324-2019; David, Leonor/A-4829-2008; Pêgo, Ana Paula/C-6942-2012; Almeida, Raquel/B-9647-2012; Pereira, Bruno/H-5614-2019; Hansson, Gunnar C/A-1236-2009; Gomes, Carla/K-8690-2013	Hansson, Gunnar C./0000-0002-1900-1869; David, Leonor/0000-0003-4207-9258; Pêgo, Ana Paula/0000-0001-5169-328X; Almeida, Raquel/0000-0002-5622-1633; Hansson, Gunnar C/0000-0002-1900-1869; Gomes, Carla/0000-0002-1483-4079; Sadio, Ana/0000-0002-6575-4781; Pereira, Bruno/0000-0003-2460-6720	Sociedade Portuguesa de Gastrenterologia (SPG) [NORTE - 07-0124-FEDER-000024]; Programa Operacional Regional do Norte, under Quadro de Referencia Estrategico Nacional (QREN) [2 - O Novo Norte]; Fundo Europeu de Desenvolvimento Regional (FEDER); Swedish Research Council; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; Inga Britt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUA-ALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Sociedade Portuguesa de Gastrenterologia (SPG); Programa Operacional Regional do Norte, under Quadro de Referencia Estrategico Nacional (QREN); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga Britt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUA-ALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Sociedade Portuguesa de Gastrenterologia (SPG), Project NORTE - 07-0124-FEDER-000024 co-financed by Programa Operacional Regional do Norte (ON. 2 - O Novo Norte), under Quadro de Referencia Estrategico Nacional (QREN) by Fundo Europeu de Desenvolvimento Regional (FEDER), the Swedish Research Council; The Swedish Cancer Foundation, The Knut and Alice Wallenberg Foundation, Inga Britt and Arne Lundberg Foundation, Sahlgren's University Hospital (LUA-ALF), Wilhelm and Martina Lundgren's Foundation, Torsten och Ragnar Soderbergs Stiftelser, The Sahlgrenska Academy, and The Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program. IPATIMUP and INEB are Associated Laboratories of Ministerio da Educacao e Ciencia and are partially supported by Fundacao para a Ciencia e a Tecnologia (FCT). The Gulbenkian Programme for Advanced Medical Education is sponsored by Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude and FCT. The authors would like to thank Vania Camilo (IPATIMUP) for all the support with cell experiments and Anna Ermund (Gothenburg) for the help with stomach dissection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alameh M, 2010, INT J NANOMED, V5, P473; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Ballarin-Gonzalez B, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.2; Barros R, 2012, TRENDS MOL MED, V18, P555, DOI 10.1016/j.molmed.2012.07.006; Barros R, 2011, GUT, V60, P290, DOI 10.1136/gut.2010.222323; Barros R, 2010, BIOCHEM SOC T, V38, P358, DOI 10.1042/BST0380358; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Breunig M, 2007, P NATL ACAD SCI USA, V104, P14454, DOI 10.1073/pnas.0703882104; Caldara M, 2012, CURR BIOL, V22, P2325, DOI 10.1016/j.cub.2012.10.028; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Ensign LM, 2012, ADV DRUG DELIVER REV, V64, P557, DOI 10.1016/j.addr.2011.12.009; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gartner F, 1996, VIRCHOWS ARCH, V428, P91; Gavrilov Kseniya, 2012, Yale Journal of Biology and Medicine, V85, P187; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kotze AF, 1997, PHARMACEUT RES, V14, P1197, DOI 10.1023/A:1012106907708; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mallo GV, 1998, J BIOL CHEM, V273, P14030, DOI 10.1074/jbc.273.22.14030; Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004; Miele E, 2012, INT J NANOMED, V7, P3637, DOI 10.2147/IJN.S23696; Mittnacht U, 2010, NANO LETT, V10, P3933, DOI 10.1021/nl1016909; Moreira C, 2009, ACTA BIOMATER, V5, P2995, DOI 10.1016/j.actbio.2009.04.021; Mourya VK, 2009, J MATER SCI-MATER M, V20, P1057, DOI 10.1007/s10856-008-3659-z; Salari K, 2012, P NATL ACAD SCI USA, V109, pE3196, DOI 10.1073/pnas.1206004109; Sandri G, 2010, AAPS PHARMSCITECH, V11, P362, DOI 10.1208/s12249-010-9390-3; Vias M, 2008, TRENDS MOL MED, V14, P486, DOI 10.1016/j.molmed.2008.09.002	31	19	19	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99449	10.1371/journal.pone.0099449	http://dx.doi.org/10.1371/journal.pone.0099449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925340	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300061
J	Herrera, C; Vance, DJ; Eisele, LE; Shoemaker, CB; Mantis, NJ				Herrera, Cristina; Vance, David J.; Eisele, Leslie E.; Shoemaker, Charles B.; Mantis, Nicholas J.			Differential Neutralizing Activities of a Single Domain Camelid Antibody (VHH) Specific for Ricin Toxin's Binding Subunit (RTB)	PLOS ONE			English	Article							B-CHAIN; PROTECTIVE IMMUNITY; A-CHAIN; GALACTOSE; SURFACE; MICE; RETROTRANSLOCATION; MECHANISM; LECTINS; VACCINE	Ricin, a member of the A-B family of ribosome-inactivating proteins, is classified as a Select Toxin by the Centers for Disease Control and Prevention because of its potential use as a biothreat agent. In an effort to engineer therapeutics for ricin, we recently produced a collection of alpaca-derived, heavy-chain only antibody V-H domains (VHH or "nanobody'') specific for ricin's enzymatic (RTA) and binding (RTB) subunits. We reported that one particular RTB-specific VHH, RTB-B7, when covalently linked via a peptide spacer to different RTA-specific V(H)Hs, resulted in heterodimers like VHH D10/B7 that were capable of passively protecting mice against a lethal dose challenge with ricin. However, RTB-B7 itself, when mixed with ricin at a 1: 10 toxin: antibody ratio did not afford any protection in vivo, even though it had demonstrable toxin-neutralizing activity in vitro. To better define the specific attributes of antibodies associated with ricin neutralization in vitro and in vivo, we undertook a more thorough characterization of RTB-B7. We report that RTB-B7, even at 100-fold molar excess (toxin:antibody) was unable to alter the toxicity of ricin in a mouse model. On the other hand, in two well-established cytotoxicity assays, RTB-B7 neutralized ricin with a 50% inhibitory concentration (IC50) that was equivalent to that of 24B11, a well-characterized and potent RTB-specific murine monoclonal antibody. In fact, RTB-B7 and 24B11 were virtually identical when compared across a series of in vitro assays, including adherence to and neutralization of ricin after the toxin was pre-bound to cell surface receptors. RTB-B7 differed from both 24B11 and VHH D10/B7 in that it was relatively less effective at blocking ricin attachment to receptors on host cells and was not able to form high molecular weight toxin:antibody complexes in solution. Whether either of these activities is important in ricin toxin neutralizing activity in vivo remains to be determined.	[Herrera, Cristina; Vance, David J.; Mantis, Nicholas J.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12229 USA; [Herrera, Cristina; Mantis, Nicholas J.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Eisele, Leslie E.] New York State Dept Hlth, Sci Cores, Wadsworth Ctr, Albany, NY USA; [Shoemaker, Charles B.] Tufts Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center	Mantis, NJ (corresponding author), New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12229 USA.	nmantis@wadsworth.org	Vance, David/ABF-5998-2020	Vance, David/0000-0002-9913-7722; Mantis, Nicholas/0000-0002-5083-8640	Carson Carr Diversity Scholarship from the University at Albany; National Institutes of Health [AI097688]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI097688] Funding Source: NIH RePORTER	Carson Carr Diversity Scholarship from the University at Albany; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CH gratefully acknowledges the support of a Carson Carr Diversity Scholarship from the University at Albany. This project was supported in part by a grant from the National Institutes of Health (AI097688) to NJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GP, 2007, BIOTECHNIQUES, V43, P806, DOI 10.2144/000112600; Anderson GP, 2013, ANAL CHIM ACTA, V786, P132, DOI 10.1016/j.aca.2013.05.010; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; COLOMBATTI M, 1986, HYBRIDOMA, V5, P9, DOI 10.1089/hyb.1986.5.9; COLOMBATTI M, 1987, J IMMUNOL, V138, P3339; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; FOXWELL BMJ, 1985, TOXICOLOGY, V34, P79, DOI 10.1016/0300-483X(85)90080-0; FRENOY JP, 1986, BIOCHEM J, V240, P221, DOI 10.1042/bj2400221; Gage E, 2011, TOXINS, V3, P1131, DOI 10.3390/toxins3091131; Goldman ER, 2009, SENSORS-BASEL, V9, P542, DOI 10.3390/s90100542; Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053; Greene CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069678; KATZIN BJ, 1991, PROTEINS, V10, P251, DOI 10.1002/prot.340100309; KIMURA Y, 1988, J BIOCHEM-TOKYO, V103, P944, DOI 10.1093/oxfordjournals.jbchem.a122391; Korcheva V, 2007, MOL IMMUNOL, V44, P2761, DOI 10.1016/j.molimm.2006.10.025; LEWIS MS, 1986, J BIOL CHEM, V261, P1571; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; Marconescu PS, 2010, VACCINE, V28, P5315, DOI 10.1016/j.vaccine.2010.05.045; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; NEWTON DL, 1992, J BIOL CHEM, V267, P11917; O'Hara JM, 2012, CURR TOP MICROBIOL, V357, P209, DOI 10.1007/82_2011_193; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Prigent J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020166; Reisler Ronald B, 2012, Adv Prev Med, V2012, P149737, DOI 10.1155/2012/149737; ROBERTS LM, 1985, J BIOL CHEM, V260, P5682; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; Sandvig K, 2013, HISTOCHEM CELL BIOL; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sepulveda J, 2010, INFECT IMMUN, V78, P756, DOI 10.1128/IAI.01084-09; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Stirpe F, 2004, TOXICON, V44, P371, DOI 10.1016/j.toxicon.2004.05.004; Tremblay JM, 2010, TOXICON, V56, P990, DOI 10.1016/j.toxicon.2010.07.003; Tremblay JM, 2013, INFECT IMMUN; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; Vance DJ, 2012, TOXICON, V60, P874, DOI 10.1016/j.toxicon.2012.06.014; VILLAFRANCA JE, 1981, J BIOL CHEM, V256, P554; Vitetta ES, 2006, P NATL ACAD SCI USA, V103, P2268, DOI 10.1073/pnas.0510893103; Vitetta ES, 2012, CLIN VACCINE IMMUNOL; WALES R, 1991, J BIOL CHEM, V266, P19172; Wolfe DN, 2013, HUM VACCIN IMMUNOTHE, V9; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13; Yermakova A, 2013, TOXICON, V72, P29, DOI 10.1016/j.toxicon.2013.04.005; Yermakova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044317; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8; Zhan JB, 1997, FEBS LETT, V407, P271, DOI 10.1016/S0014-5793(97)00341-4	55	10	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99788	10.1371/journal.pone.0099788	http://dx.doi.org/10.1371/journal.pone.0099788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918772	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000109
J	Janowski, M; Walczak, P; Kropiwnicki, T; Jurkiewicz, E; Domanska-Janik, K; Bulte, JWM; Lukomska, B; Roszkowski, M				Janowski, Miroslaw; Walczak, Piotr; Kropiwnicki, Tomasz; Jurkiewicz, Elzbieta; Domanska-Janik, Krystyna; Bulte, Jeff W. M.; Lukomska, Barbara; Roszkowski, Marcin			Long-Term MRI Cell Tracking after Intraventricular Delivery in a Patient with Global Cerebral Ischemia and Prospects for Magnetic Navigation of Stem Cells within the CSF	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD-INJURY; PARKINSONS-DISEASE; TRANSPLANTATION; SAFETY; BLOOD; NEUROTRANSPLANTATION; THERAPY; GRAFTS; STROKE	Background: The purpose of the study was to evaluate the long-term clinical tracking of magnetically labeled stem cells after intracerebroventricular transplantation as well as to investigate in vitro feasibility for magnetic guidance of cell therapy within large fluid compartments. Method: After approval by our Institutional Review Board, an 18-month-old patient, diagnosed as being in a vegetative state due to global cerebral ischemia, underwent cell transplantation to the frontal horn of the lateral ventricle, with umbilical cord blood-derived stem cells labeled with superparamagnetic iron oxide (SPIO) contrast agent. The patient was followed over 33 months with clinical examinations and MRI. To evaluate the forces governing the distribution of cells within the fluid compartment of the ventricular system in vivo, a gravity-driven sedimentation assay and a magnetic field-driven cell attraction assay were developed in vitro. Results: Twenty-four hours post-transplantation, MR imaging (MRI) was able to detect hypointense cells in the occipital horn of the lateral ventricle. The signal gradually decreased over 4 months and became undetectable at 33 months. In vitro, no significant difference in cell sedimentation between SPIO-labeled and unlabeled cells was observed (p = NS). An external magnet was effective in attracting cells over distances comparable to the size of human lateral ventricles. Conclusions: MR imaging of SPIO-labeled cells allows monitoring of cells within lateral ventricles. While the initial biodistribution is governed by gravity-driven sedimentation, an external magnetic field may possibly be applied to further direct the distribution of labeled cells within large fluid compartments such as the ventricular system.	[Janowski, Miroslaw; Domanska-Janik, Krystyna; Lukomska, Barbara] Polish Acad Sci, Mossakowski Med Res Ctr, NeuroRepair Dept, Warsaw, Poland; [Janowski, Miroslaw] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurosurg, Warsaw, Poland; [Janowski, Miroslaw; Walczak, Piotr; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Magnet Resonance Res, Baltimore, MD USA; [Janowski, Miroslaw; Walczak, Piotr; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Cellular Imaging Sect, Baltimore, MD USA; [Janowski, Miroslaw; Walczak, Piotr; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Biol Program, Baltimore, MD USA; [Walczak, Piotr] Univ Warmia & Mazury, Fac Med Sci, Dept Radiol, Olsztyn, Poland; [Kropiwnicki, Tomasz; Roszkowski, Marcin] Childrens Mem Hlth Inst, Dept Neurosurg, Warsaw, Poland; [Jurkiewicz, Elzbieta] Childrens Mem Hlth Inst, Dept Radiol, Magnet Resonance Unit, Warsaw, Poland; [Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Chem & Biomol Engn, Baltimore, MD USA; [Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Warmia & Mazury; Children's Memorial Health Institute; Children's Memorial Health Institute; Johns Hopkins University; Johns Hopkins University	Roszkowski, M (corresponding author), Childrens Mem Hlth Inst, Dept Neurosurg, Warsaw, Poland.	marcroszkowski@gmail.com		Janowski, Miroslaw/0000-0001-5261-7975; Domanska-Janik, Krystyna/0000-0003-0514-7776; Bulte, Jeff/0000-0003-1202-1610; Jurkiewicz, Elzbieta/0000-0003-4505-8815; Walczak, Piotr/0000-0002-3733-3322; Roszkowski, Marcin/0000-0002-8735-8296	Mobility Plus Fellowship from the Polish Ministry of Science and Education [R21NS081544, RO1 NS076573, MSCRFII0193, MSCRFII190, MSCRFE0178]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081544, R01NS076573] Funding Source: NIH RePORTER	Mobility Plus Fellowship from the Polish Ministry of Science and Education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	R21NS081544, RO1 NS076573, MSCRFII0193, MSCRFII190, MSCRFE0178, MJ was supported by a Mobility Plus Fellowship from the Polish Ministry of Science and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwal S, 2009, PEDIATR NEUROL, V40, P227, DOI 10.1016/j.pediatrneurol.2008.09.025; Bates D, 2005, NEUROPSYCHOL REHABIL, V15, P175, DOI 10.1080/09602010443000399; Battistella V, 2011, REGEN MED, V6, P45, DOI 10.2217/RME.10.97; Berman SC, 2011, MAGN RESON MED, V65, P564, DOI 10.1002/mrm.22613; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Bulte JWM, 2004, METHOD ENZYMOL, V386, P275; Buzanska L, 2006, STEM CELLS DEV, V15, P391, DOI 10.1089/scd.2006.15.391; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Deda H, 2009, CYTOTHERAPY, V11, P18, DOI 10.1080/14653240802549470; Farin A, 2009, NEUROSURGERY, V64, P15, DOI 10.1227/01.NEU.0000337580.02706.DC; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; Gorelik M, 2012, CELL TRANSP IN PRESS; Habich A, 2006, EXP HEMATOL, V34, P914, DOI 10.1016/j.exphem.2006.03.010; Hess DC, 2008, CELL PROLIFERAT, V41, P94, DOI 10.1111/j.1365-2184.2008.00486.x; Huang HY, 2008, CLIN TRANSPLANT, V22, P710, DOI 10.1111/j.1399-0012.2008.00865.x; Huang Hongyun, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P14; Janowski M, 2008, NEUROSCI LETT, V430, P169, DOI 10.1016/j.neulet.2007.10.050; Janowski M, 2010, STEM CELLS DEV, V19, P5, DOI 10.1089/scd.2009.0271; Janowski M, 2009, REV NEUROSCIENCE, V20, P39; Jozwiak S, 2010, CELL MED, V1, P71, DOI 10.3727/215517910X536618; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Lin TCY, 2008, CHINESE J PHYSIOL, V51, P197; LINDVALL O, 1988, LANCET, V2, P1483; Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Placzek MR, 2009, J R SOC INTERFACE, V6, P209, DOI 10.1098/rsif.2008.0442; Richards JMJ, 2012, CIRC-CARDIOVASC IMAG, V5, P509, DOI 10.1161/CIRCIMAGING.112.972596; Saberi H, 2008, NEUROSCI LETT, V443, P46, DOI 10.1016/j.neulet.2008.07.041; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; Tupitsyn NN, 2006, J BIOL REG HOMEOS AG, V20, P36; Walczak P, 2007, MAGN RESON MED, V58, P261, DOI 10.1002/mrm.21280; Weller R. O., 2005, Morphologie, V89, P22, DOI 10.1016/S1286-0115(05)83235-7; WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	36	49	52	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e97631	10.1371/journal.pone.0097631	http://dx.doi.org/10.1371/journal.pone.0097631			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919061	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000009
J	Kreifelts, B; Bruck, C; Ritter, J; Ethofer, T; Domin, M; Lotze, M; Jacob, H; Schlipf, S; Wildgruber, D				Kreifelts, Benjamin; Bruck, Carolin; Ritter, Jan; Ethofer, Thomas; Domin, Martin; Lotze, Martin; Jacob, Heike; Schlipf, Sarah; Wildgruber, Dirk			They Are Laughing at Me: Cerebral Mediation of Cognitive Biases in Social Anxiety	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; ATTENTIONAL CONTROL; BEHAVIORAL THERAPY; PREFRONTAL CORTEX; ANGRY FACES; PHOBIA; DISORDER; INDIVIDUALS; ACTIVATION; SEVERITY	The fear of embarrassment and humiliation is the central element of social anxiety. This frequent condition is associated with cognitive biases indicating increased sensitivity to signals of social threat, which are assumed to play a causal role in the maintenance of social anxiety. Here, we employed laughter, a potent medium for the expression of acceptance and rejection, as an experimental stimulus in participants selected for varying degrees of social anxiety to identify cerebral mediators of cognitive biases in social anxiety using functional magnetic resonance imaging in combination with mediation analysis. We directly demonstrated that cerebral activation patterns within the dorsal attention network including the left dorsolateral and dorsomedial prefrontal cortex mediate the influence of social anxiety on laughter perception. This mediation proved to be specific for social anxiety after correction for measures of general state and trait anxiety and occurred most prominently under bimodal audiovisual laughter presentation when compared with monomodal auditory or visual laughter cues. Considering the possibility to modulate cognitive biases and cerebral activity by neuropsychological trainings, non-invasive electrophysiological stimulation and psychotherapy, this study represents a starting point for a whole line of translational research projects and identifies promising targets for electrophysiological interventions aiming to alleviate cognitive biases and symptom severity in social anxiety.	[Kreifelts, Benjamin; Bruck, Carolin; Ritter, Jan; Ethofer, Thomas; Jacob, Heike; Schlipf, Sarah; Wildgruber, Dirk] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Ethofer, Thomas] Univ Tubingen, Dept Biomed Magnet Resonance, Tubingen, Germany; [Domin, Martin; Lotze, Martin] Ernst Moritz Arndt Univ Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Ernst Moritz Arndt Universitat Greifswald	Schlipf, S (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany.	sarahschlipf@gmx.de	Lotze, Martin/D-2964-2012	Lotze, Martin/0000-0003-4519-4956; Kreifelts, Benjamin/0000-0002-9233-3800	Fortune-Program of the University of Tubingen [1997-0-0, 2140-0-0]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tubingen University	Fortune-Program of the University of Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tubingen University	This work was supported by grants of the Fortune-Program of the University of Tubingen (fortune 1997-0-0, and fortune 2140-0-0), by the Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir N, 2005, BIOL PSYCHIAT, V57, P975, DOI 10.1016/j.biopsych.2005.01.044; Amir N, 2008, J ABNORM PSYCHOL, V117, P860, DOI 10.1037/a0013445; Browning M, 2010, BIOL PSYCHIAT, V67, P919, DOI 10.1016/j.biopsych.2009.10.031; Clark D. M., 1995, SOCIAL PHOBIA DIAGNO, P69, DOI DOI 10.1017/S1352465808004487; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dresler T, 2012, J PSYCHIATR RES, V46, P1627, DOI 10.1016/j.jpsychires.2012.09.004; Edwards K., 2010, PSYCHOL TEST ASSESSM, P52; Eibl-Eibesfeldt I., 1970, ETHOLOGY BIOL BEHAV; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fani N, 2012, BIOL PSYCHOL, V90, P134, DOI 10.1016/j.biopsycho.2012.03.001; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gilboa-Schechtman E, 1999, COGNITION EMOTION, V13, P305, DOI 10.1080/026999399379294; Goldin PR, 2012, J CONSULT CLIN PSYCH, V80, P1034, DOI 10.1037/a0028555; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Heimberg RG, 1999, PSYCHOL MED, V29, P199, DOI 10.1017/S0033291798007879; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hofmann SG, 2012, COGNITION EMOTION, V26, P282, DOI 10.1080/02699931.2011.579414; Kalu UG, 2012, PSYCHOL MED, V42, P1791, DOI 10.1017/S0033291711003059; Laux L., 1981, STATE TRAIT ANGSTINV; Lehrl S., 2005, MANUAL ZUM MWT B MEH; Lipshitz JD, 2000, PHARMACOECONOMICS, V18, P23, DOI 10.2165/00019053-200018010-00003; Machado-de-Sousa JP, 2010, J NEUROSCI METH, V193, P1, DOI 10.1016/j.jneumeth.2010.08.013; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Mendlowicz MV, 2000, AM J PSYCHIAT, V157, P669, DOI 10.1176/appi.ajp.157.5.669; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Monk CS, 2006, AM J PSYCHIAT, V163, P1091, DOI 10.1176/appi.ajp.163.6.1091; Moritz Steffen, 2007, Cogn Neuropsychiatry, V12, P381, DOI 10.1080/13546800601119982; Nitsche M A, 2012, Front Psychiatry, V3, P58, DOI 10.3389/fpsyt.2012.00058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8; Pena-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022812; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Price RB, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.46; Provine RR, 2013, TRENDS COGN SCI, V17, P9, DOI 10.1016/j.tics.2012.11.001; Quadflieg S, 2008, BIOL PSYCHOL, V78, P129, DOI 10.1016/j.biopsycho.2008.01.014; Quadflieg S, 2007, BEHAV RES THER, V45, P3096, DOI 10.1016/j.brat.2007.08.003; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Ross MD, 2009, CURR BIOL, V19, P1106, DOI 10.1016/j.cub.2009.05.028; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Stein DJ, 2010, DEPRESS ANXIETY, V27, P390, DOI 10.1002/da.20639; Stein MB, 2000, ARCH GEN PSYCHIAT, V57, P1046, DOI 10.1001/archpsyc.57.11.1046; Stein MB, 2002, ARCH GEN PSYCHIAT, V59, P1027, DOI 10.1001/archpsyc.59.11.1027; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Straube T, 2004, BIOL PSYCHIAT, V56, P921, DOI 10.1016/j.biopsych.2004.09.024; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Szameitat DP, 2010, NEUROIMAGE, V53, P1264, DOI 10.1016/j.neuroimage.2010.06.028; Szameitat DP, 2009, EMOTION, V9, P397, DOI 10.1037/a0015692; Taylor CT, 2010, J ANXIETY DISORD, V24, P403, DOI 10.1016/j.janxdis.2010.02.004; Telzer EH, 2008, BIOL PSYCHOL, V79, P216, DOI 10.1016/j.biopsycho.2008.05.004; Tobon JI, 2011, J COGN PSYCHOTHER, V25, P114, DOI 10.1891/0889-8391.25.2.114; Vriends N, 2007, J ANXIETY DISORD, V21, P59, DOI 10.1016/j.janxdis.2006.05.002; WAGNER HL, 1993, J NONVERBAL BEHAV, V17, P3, DOI 10.1007/BF00987006; Weaver B, 2013, BEHAV RES METHODS, V45, P880, DOI 10.3758/s13428-012-0289-7; Weinstein S, 2007, NEUROIMAGE, V36, P188, DOI 10.1016/j.neuroimage.2007.02.030; Wildgruber D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063441; WITTCHEN HU, 1997, STRUKTURIERTES KLIN, V4; Wolkenstein L, 2013, BIOL PSYCHIAT, V73, P646, DOI 10.1016/j.biopsych.2012.10.010	61	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99815	10.1371/journal.pone.0099815	http://dx.doi.org/10.1371/journal.pone.0099815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24918625	Green Published, gold			2022-12-25	WOS:000338631000114
J	Singh, P; Indi, SS; Savithri, HS				Singh, Pratibha; Indi, Shantinath S.; Savithri, Handanahal S.			Groundnut Bud Necrosis Virus Encoded NSm Associates with Membranes via Its C-Terminal Domain	PLOS ONE			English	Article							SPOTTED-WILT-VIRUS; CELL-TO-CELL; COMPLETE NUCLEOTIDE-SEQUENCE; RNA SILENCING SUPPRESSOR; MOVEMENT PROTEIN NSM; ALFALFA MOSAIC-VIRUS; ENDOPLASMIC-RETICULUM; COILED-COIL; NUCLEOCAPSID PROTEIN; GENOME ORGANIZATION	Groundnut Bud Necrosis Virus (GBNV) is a tripartite ambisense RNA plant virus that belongs to serogroup IV of Tospovirus genus. Non-Structural protein-m (NSm), which functions as movement protein in tospoviruses, is encoded by the M RNA. In this communication, we demonstrate that despite the absence of any putative transmembrane domain, GBNV NSm associates with membranes when expressed in E. coli as well as in N. benthamiana. Incubation of refolded NSm with liposomes ranging in size from 200-250 nm resulted in changes in the secondary and tertiary structure of NSm. A similar behaviour was observed in the presence of anionic and zwitterionic detergents. Furthermore, the morphology of the liposomes was found to be modified in the presence of NSm. Deletion of coiled coil domain resulted in the inability of in planta expressed NSm to interact with membranes. Further, when the C-terminal coiled coil domain alone was expressed, it was found to be associated with membrane. These results demonstrate that NSm associates with membranes via the C-terminal coiled coil domain and such an association may be important for movement of viral RNA from cell to cell.	[Singh, Pratibha; Savithri, Handanahal S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Indi, Shantinath S.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Savithri, HS (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	bchss@biochem.iisc.ernet.in		Singh, Pratibha/0000-0003-2190-6576	Indian Institute of Science; JC Bose Fellowship from the Department of Science and Technology; Department of Biotechnology, Government of India	Indian Institute of Science(Indian Institute of Science (IISC) - Bangalore); JC Bose Fellowship from the Department of Science and Technology; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The funding agencies are Indian Institute of Science, JC Bose Fellowship from the Department of Science and Technology and funding from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins S, 2000, MOL PLANT PATHOL, V1, P151, DOI 10.1046/j.1364-3703.2000.00022.x; Akram M, 2004, ANN APPL BIOL, V145, P285, DOI 10.1111/j.1744-7348.2004.tb00385.x; Andika IB, 2013, VIROLOGY, V435, P493, DOI 10.1016/j.virol.2012.10.024; Bhat AI, 2002, CURR SCI INDIA, V82, P1389; Bhat AS, 2011, ARCH VIROL, V156, P2163, DOI 10.1007/s00705-011-1110-0; Brill LM, 2000, P NATL ACAD SCI USA, V97, P7112, DOI 10.1073/pnas.130187897; Brill LM, 2004, J VIROL, V78, P3372, DOI 10.1128/JVI.78.5.3372-3377.2004; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chowdhury SR, 2011, FEBS J, V278, P257, DOI 10.1111/j.1742-4658.2010.07943.x; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Goswami S, 2012, VIRUS RES, V163, P368, DOI 10.1016/j.virusres.2011.08.016; Govind K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031190; Haupt S, 2005, PLANT CELL, V17, P164, DOI 10.1105/tpc.104.027821; Heinlein M, 1998, PLANT CELL, V10, P1107, DOI 10.1105/tpc.10.7.1107; Huang M, 1999, MOL PLANT MICROBE IN, V12, P680, DOI 10.1094/MPMI.1999.12.8.680; JANCSO A, 1991, J BIOL CHEM, V266, P5891; Ju HJ, 2005, PLANT PHYSIOL, V138, P1877, DOI 10.1104/pp.105.066019; Kaido M, 2009, VIROLOGY, V395, P232, DOI 10.1016/j.virol.2009.09.022; KINSKY SC, 1969, BIOCHEMISTRY-US, V8, P4149, DOI 10.1021/bi00838a036; Kormelink R, 2011, VIRUS RES, V162, P184, DOI 10.1016/j.virusres.2011.09.028; Kozlov MM, 1998, BIOPHYS J, V75, P1384, DOI 10.1016/S0006-3495(98)74056-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Laporte C, 2003, PLANT CELL, V15, P2058, DOI 10.1105/tpc.013896; Lewandowski DJ, 2005, VIROLOGY, V342, P26, DOI 10.1016/j.virol.2005.06.050; Li W, 2009, VIROLOGY, V390, P110, DOI 10.1016/j.virol.2009.04.027; Lokesh B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009757; Main G D, 1995, Methods Mol Biol, V44, P405; Makarov VV, 2009, J GEN VIROL, V90, P3022, DOI 10.1099/vir.0.013862-0; Martinez-Gil L, 2009, J VIROL, V83, P5535, DOI 10.1128/JVI.00393-09; Nichol S. T., 2005, 8 INT COMM TAX VIR, P695; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; PARADIES HH, 1980, J PHYS CHEM-US, V84, P599, DOI 10.1021/j100443a008; Peremyslov VV, 2004, J VIROL, V78, P3704, DOI 10.1128/JVI.78.7.3704-3709.2004; Perraki A, 2012, PLANT PHYSIOL, V160, P624, DOI 10.1104/pp.112.200519; Reichel C, 1998, P NATL ACAD SCI USA, V95, P11169, DOI 10.1073/pnas.95.19.11169; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Satyanarayana T, 1996, J GEN VIROL, V77, P2347, DOI 10.1099/0022-1317-77-9-2347; Satyanarayana T, 1996, ARCH VIROL, V141, P85, DOI 10.1007/BF01718590; Schaad MC, 1997, EMBO J, V16, P4049, DOI 10.1093/emboj/16.13.4049; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Scholthof HB, 2005, TRENDS PLANT SCI, V10, P376, DOI 10.1016/j.tplants.2005.07.002; Schroedel Andrea, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-10; Soellick TR, 2000, P NATL ACAD SCI USA, V97, P2373, DOI 10.1073/pnas.030548397; Stavolone L, 2005, P NATL ACAD SCI USA, V102, P6219, DOI 10.1073/pnas.0407731102; Storms MMH, 1995, VIROLOGY, V214, P485, DOI 10.1006/viro.1995.0059; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; van der Wel NN, 1998, VIROLOGY, V244, P322, DOI 10.1006/viro.1998.9117; Verchot-Lubicz J, 2010, MOL PLANT MICROBE IN, V23, P1231, DOI 10.1094/MPMI-04-10-0086; Vilar M, 2001, J BIOL CHEM, V276, P18122, DOI 10.1074/jbc.M100706200; Whyte JRC, 2002, J CELL SCI, V115, P2627; WOLF S, 1989, SCIENCE, V246, P377, DOI 10.1126/science.246.4928.377; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; ZHOU NE, 1992, BIOPOLYMERS, V32, P419, DOI 10.1002/bip.360320419	55	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99370	10.1371/journal.pone.0099370	http://dx.doi.org/10.1371/journal.pone.0099370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919116	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000338631000081
J	Sevane, N; Bialade, F; Velasco, S; Rebole, A; Rodriguez, ML; Ortiz, LT; Canon, J; Dunner, S				Sevane, Natalia; Bialade, Federica; Velasco, Susana; Rebole, Almudena; Luisa Rodriguez, Maria; Ortiz, Luis T.; Canon, Javier; Dunner, Susana			Dietary Inulin Supplementation Modifies Significantly the Liver Transcriptomic Profile of Broiler Chickens	PLOS ONE			English	Article							INTESTINAL MICROFLORA; GROWTH-PERFORMANCE; OLIGOFRUCTOSE; INFLAMMATION; METABOLISM; PROBIOTICS; MORPHOLOGY; INFECTION; HEALTH; TARGET	Inclusion of prebiotics in the diet is known to be advantageous, with positive influences both on health and growth. The current study investigated the differences in the hepatic transcriptome profiles between chickens supplemented with inulin (a storage carbohydrate found in many plants) and controls. Liver is a major metabolic organ and has been previously reported to be involved in the modification of the lipid metabolism in chickens fed with inulin. A nutrigenomic approach through the analysis of liver RNA hybridized to the Affymetrix GeneChip Chicken Genome Array identified 148 differentially expressed genes among both groups: 104 up-regulated (>= 1.4-fold) and 44 down-regulated (<= 0.6-fold). Quantitative real-time PCR analysis validated the microarray expression results for five out of seven genes tested. The functional annotation analyses revealed a number of genes, processes and pathways with putative involvement in chicken growth and performance, while reinforcing the immune status of animals, and fostering the production of long chain fatty acids in broilers supplemented with 5 g of inulin kg(-1) diet. As far as we are aware, this is the first report of a microarray based gene expression study on the effect of dietary inulin supplementation, supporting further research on the use of this prebiotic on chicken diets as a useful alternative to antibiotics for improving performance and general immunity in poultry farming, along with a healthier meat lipid profile.	[Sevane, Natalia; Bialade, Federica; Velasco, Susana; Rebole, Almudena; Luisa Rodriguez, Maria; Ortiz, Luis T.; Canon, Javier; Dunner, Susana] Univ Complutense Madrid, Fac Vet, Dept Anim Prod, Madrid, Spain	Complutense University of Madrid	Dunner, S (corresponding author), Univ Complutense Madrid, Fac Vet, Dept Anim Prod, Madrid, Spain.	dunner@ucm.es	Sevane, Natalia/R-1920-2018; Cañón, Javier/M-5704-2018; Rebolé, Almudena/AAH-6536-2021; Ortiz, Luis/A-7247-2010; Velasco, Susana/C-7064-2012; Dunner, Susana/H-3124-2015	Sevane, Natalia/0000-0003-4766-6291; Cañón, Javier/0000-0003-1137-0958; Ortiz, Luis/0000-0002-1685-7768; Velasco, Susana/0000-0001-6835-2967; REBOLE GARRIGOS, ALMUDENA/0000-0002-9210-2084	UCM-Santander [GR35/10-A-920323]	UCM-Santander	This work has been supported by a grant to Research Group Nutrigenomica Animal from UCM-Santander GR35/10-A-920323. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERMANI E, 1989, Poultry Science, V68, P167; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anveden A, 2012, OBESITY, V20, P708, DOI 10.1038/oby.2011.268; Barnes MJ, 2010, J IMMUNOL, V184, P3743, DOI 10.4049/jimmunol.0903164; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bosscher D, 2006, INT DAIRY J, V16, P1092, DOI 10.1016/j.idairyj.2005.10.028; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Dalman MR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S2-S11; Delzenne NM, 2002, BRIT J NUTR, V87, pS255, DOI 10.1079/BJN/2002545; Galton VA, 2005, THYROID, V15, P823, DOI 10.1089/thy.2005.15.823; Gervois P, 2012, EXPERT OPIN THER TAR, V16, P1113, DOI 10.1517/14728222.2012.715633; Glibowski P, 2011, ACTA SCI POLON-TECHN, V10, P189; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hume ME, 2011, POULTRY SCI, V90, P2663, DOI 10.3382/ps.2010-01030; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Letexier D, 2003, AM J CLIN NUTR, V77, P559, DOI 10.1093/ajcn/77.3.559; Lomax AR, 2009, CURR PHARM DESIGN, V15, P1428, DOI 10.2174/138161209788168155; Mastrangelo L, 2012, P NATL ACAD SCI USA, V109, P3377, DOI 10.1073/pnas.1118067109; Mateo H, 2007, THESIS U GRANADA; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; NRC, 1994, NUTR REQ POULTR; Ortiz LT, 2013, AQUACULT NUTR, V19, P475, DOI 10.1111/j.1365-2095.2012.00981.x; Pelicano ERL, 2005, Rev. Bras. Cienc. Avic., V7, P221, DOI 10.1590/S1516-635X2005000400005; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rebole A, 2010, POULTRY SCI, V89, P276, DOI 10.3382/ps.2009-00336; Rehman H, 2007, POULTRY SCI, V86, P118, DOI 10.1093/ps/86.1.118; Roberfroid M B, 2001, J Pharm Belg, V56, P43; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; *SAS I INC, 2009, STAT AN SAS STAT SOF; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tacchi L, 2011, FISH SHELLFISH IMMUN, V31, P704, DOI 10.1016/j.fsi.2011.02.023; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velasco S, 2010, POULTRY SCI, V89, P1651, DOI 10.3382/ps.2010-00687; Wammes LJ, 2013, J INFECT DIS, V207, P1590, DOI 10.1093/infdis/jit058; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xu ZR, 2003, POULTRY SCI, V82, P1030, DOI 10.1093/ps/82.6.1030; Yusrizal, 2003, International Journal of Poultry Science, V2, P214	42	32	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98942	10.1371/journal.pone.0098942	http://dx.doi.org/10.1371/journal.pone.0098942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915441	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000340947700045
J	Steele, LD; Muir, WM; Seong, KM; Valero, MC; Rangesa, M; Sun, WL; Clark, JM; Coates, B; Pittendrigh, BR				Steele, Laura D.; Muir, William M.; Seong, Keon Mook; Valero, M. Carmen; Rangesa, Madhumitha; Sun, Weilin; Clark, John M.; Coates, Brad; Pittendrigh, Barry R.			Genome-Wide Sequencing and an Open Reading Frame Analysis of Dichlorodiphenyltrichloroethane (DDT) Susceptible (91-C) and Resistant (91-R) Drosophila melanogaster Laboratory Populations	PLOS ONE			English	Article							CROSS-RESISTANCE; DIPTERA; STRAINS; ASSOCIATION; PERMETHRIN; SELECTION; GENE	The Drosophila melanogaster 91-R and 91-C strains are of common origin, however, 91-R has been intensely selected for dichlorodiphenyltrichloroethane (DDT) resistance over six decades while 91-C has been maintained as the non-selected control strain. These fly strains represent a unique genetic resource to understand the accumulation and fixation of mutations under laboratory conditions over decades of pesticide selection. Considerable research has been done to investigate the differential expression of genes associated with the highly DDT resistant strain 91-R, however, with the advent of whole genome sequencing we can now begin to develop an in depth understanding of the genomic changes associated with this intense decades-long xenobiotic selection pressure. Here we present the first whole genome sequencing analysis of the 91-R and 91-C fly strains to identify genome-wide structural changes within the open reading frames. Between-strain changes in allele frequencies revealed a higher percent of new alleles going to fixation for the 91-R strain, as compared to 91-C (P<0.0001). These results suggest that resistance to DDT in the 91-R laboratory strain could potentially be due primarily to new mutations, as well as being polygenic rather than the result of a few major mutations, two hypotheses that remain to be tested.	[Steele, Laura D.; Seong, Keon Mook; Valero, M. Carmen; Rangesa, Madhumitha; Sun, Weilin; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Muir, William M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Clark, John M.] Univ Massachusetts, Amherst, MA 01003 USA; [Coates, Brad] Iowa State Univ, USDA, Agr Res Serv, Corn Insects & Crop Genet Res Unit, Ames, IA USA	University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Massachusetts System; University of Massachusetts Amherst; Iowa State University; United States Department of Agriculture (USDA)	Steele, LD (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	steele11@illinois.edu		Coates, Brad/0000-0001-8908-1529; Rangesa, Madhumitha/0000-0002-5825-2775	United States Department of Agriculture, Agricultural Research Service (USDA-ARS) [3625-22000-017-00]; Iowa State University Agriculture and Home Economics Experiment Station, Ames, IA [3543]	United States Department of Agriculture, Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)); Iowa State University Agriculture and Home Economics Experiment Station, Ames, IA	This work was primarily funded by the C. W. Kearns, C. L. Metcalf and W. P. Flint Endowment. Additional funding support came from the United States Department of Agriculture, Agricultural Research Service (USDA-ARS; Appropriated CRIS Project 3625-22000-017-00) and the Iowa State University Agriculture and Home Economics Experiment Station, Ames, IA (Project 3543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Barnola F V, 1971, Int J Neurosci, V1, P309, DOI 10.3109/00207457109147430; Branca A, 2011, P NATL ACAD SCI USA, V108, pE864, DOI 10.1073/pnas.1104032108; Busvine J R, 1957, Bull World Health Organ, V16, P206; Carson Rachel, 1994, SILENT SPRING; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; Conis E, 2010, PUBLIC HEALTH REP, V125, P337, DOI 10.1177/003335491012500224; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; DAPKUS D, 1992, J ECON ENTOMOL, V85, P340, DOI 10.1093/jee/85.2.340; DAPKUS D, 1977, GENETICS, V87, P685; Deus KM, 2012, J MED ENTOMOL, V49, P356, DOI 10.1603/ME11164; Feachem RGA, 2007, JAMA-J AM MED ASSOC, V297, P2281, DOI 10.1001/jama.297.20.2281; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Greenberg D S, 1963, Science, V140, P878, DOI 10.1126/science.140.3569.878; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jaga Kushik, 2003, Int J Occup Med Environ Health, V16, P7; Krupke CH, 2007, AM ENTOMOLOGIST; Linheiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030008; McCart C, 2005, CURR BIOL, V15, pR587, DOI 10.1016/j.cub.2005.07.054; MERRELL DAVID J., 1965, AMER NATUR, V99, P411, DOI 10.1086/282383; MERRELL DJ, 1956, J ECON ENTOMOL, V49, P300, DOI 10.1093/jee/49.3.300; MERRELL DJ, 1959, GENETICS, V44, P527; Pedra JHF, 2005, PROTEOMICS, V5, P258, DOI 10.1002/pmic.200400914; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; PRASITTISUK C, 1977, PESTIC SCI, V8, P527, DOI 10.1002/ps.2780080516; Rost S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-4; Sackton TB, 2009, GENOME BIOL EVOL, V1, P449, DOI 10.1093/gbe/evp048; SCOTT JG, 1981, PESTIC BIOCHEM PHYS, V16, P21, DOI 10.1016/0048-3575(81)90068-7; SHEPANSKI MC, 1977, J ECON ENTOMOL, V70, P539, DOI 10.1093/jee/70.5.539; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Yang Y, 2012, MOL PHYLOGENET EVOL, V62, P214, DOI [10.1016/j.ympev.2011.09.018, 10.1016/j.ympev.2011.04.008]	36	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98584	10.1371/journal.pone.0098584	http://dx.doi.org/10.1371/journal.pone.0098584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915415	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700026
J	Wang, X; Wang, HL; Li, HY; Li, T; Yu, X				Wang, Xiao; Wang, Huali; Li, Huiying; Li, Tao; Yu, Xin			Frequency of the Apolipoprotein E epsilon 4 Allele in a Memory Clinic Cohort in Beijing: A Naturalistic Descriptive Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; SPORADIC ALZHEIMERS-DISEASE; APOE GENOTYPE; DIAGNOSTIC-CRITERIA; VASCULAR DEMENTIA; TYPE-4 ALLELE; DECLINE; ASSOCIATION; ONSET; RISK	Objectives: To describe the distribution of apolipoprotein E (APOE) genotypes among an elderly Chinese patient population with memory complaints treated in a memory clinic in Beijing and to compare the epsilon 4 allele frequency among individuals with subjective cognitive impairment (SCI), mild cognitive impairment (MCI) and Alzheimer's disease (AD). Methods: A total of 385 subjects with memory complaints participated in the study, including 216 patients with AD, 56 with MCI, 17 with SCI, and 96 with other types of cognitive impairment. A total of 75 healthy elderly control subjects were also recruited. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique was used to investigate the APOE genotypes. Results: The frequency of the epsilon 4 allele was 19.6 percent for the entire sample of patients who had memory complaints. The APOE allele distribution differed between women and men (22.6% and 14.9%, respectively; p<0.05) in the individuals with memory complaints. Compared with the control group (7.3%), the prevalence of the APOE epsilon 4 allele was significantly higher in the AD (23.6%) and MCI (21.4%) groups and was slightly increased in the SCI (14.7%) group. Conclusions: In the memory clinic, we observed a higher prevalence of the APOE epsilon 4 allele among Chinese AD and MCI patients. A similar trend was observed in patients with SCI. These findings suggest that nondemented APOE epsilon 4 allele carriers with memory complaints may have a greater genetic risk for AD and should be monitored more closely.	[Wang, Xiao; Wang, Huali; Li, Huiying; Li, Tao; Yu, Xin] Peking Univ, Inst Mental Hlth, Dementia Care & Res Ctr, Hosp 6, Beijing 100871, Peoples R China; [Wang, Xiao; Wang, Huali; Li, Huiying; Li, Tao; Yu, Xin] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100871, Peoples R China; [Li, Huiying] Chaoyang Dist Third Hosp, Beijing, Peoples R China	Peking University; Peking University	Wang, HL (corresponding author), Peking Univ, Inst Mental Hlth, Dementia Care & Res Ctr, Hosp 6, Beijing 100871, Peoples R China.	huali_wang@hsc.pku.edu.cn	Wang, Huali/S-9848-2018		Natural Science Foundation of China [30971044, 81171018]; National Key RD 863 Project [2007AA02Z421]; Fogarty International Center [R21AG028180-01A2]; Alzheimer's Association [NIRG-04-1184]; National Institute on Aging; NATIONAL INSTITUTE ON AGING [R21AG028180] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key RD 863 Project(National High Technology Research and Development Program of China); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Alzheimer's Association(Alzheimer's Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Natural Science Foundation of China (30971044, HW; 81171018, HW) and National Key R&D 863 Project (2007AA02Z421, HW). The infrastructure of Dementia Care and Research Center was in part supported by National Institute on Aging and the Fogarty International Center (R21AG028180-01A2) and Alzheimer's Association (NIRG-04-1184, HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom ES, 2009, DEMENT GERIATR COGN, V27, P458, DOI 10.1159/000216841; Borenstein AR, 2010, AM J ALZHEIMERS DIS, V25, P233, DOI 10.1177/1533317509357736; Bretsky PM, 1999, ALZ DIS ASSOC DIS, V13, P216, DOI 10.1097/00002093-199910000-00007; Corder EH, 2004, ANN NY ACAD SCI, V1019, P24, DOI 10.1196/annals.1297.005; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Craft S, 1998, NEUROLOGY, V51, P149, DOI 10.1212/WNL.51.1.149; Dik MG, 2000, NEUROLOGY, V54, P1492, DOI 10.1212/WNL.54.7.1492; Dik MG, 2001, NEUROLOGY, V57, P2217, DOI 10.1212/WNL.57.12.2217; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; Engelborghs S, 2003, J NEUROL NEUROSUR PS, V74, P1148, DOI 10.1136/jnnp.74.8.1148; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; FESKENS EJM, 1994, BRIT MED J, V309, P1202, DOI 10.1136/bmj.309.6963.1202; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hejl A, 2002, J NEUROL NEUROSUR PS, V73, P390, DOI 10.1136/jnnp.73.4.390; Herukka SK, 2007, NEUROBIOL AGING, V28, P507, DOI 10.1016/j.neurobiolaging.2006.02.001; HIXSON JE, 1990, J LIPID RES, V31, P545; Hsiung GYR, 2004, CAN MED ASSOC J, V171, P863, DOI 10.1503/cmaj.1031789; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Johnson JK, 1999, ARCH NEUROL-CHICAGO, V56, P1233, DOI 10.1001/archneur.56.10.1233; Katzman R, 1997, NEUROLOGY, V49, P779, DOI 10.1212/WNL.49.3.779; Lehtovirta M, 1996, NEUROLOGY, V46, P413, DOI 10.1212/WNL.46.2.413; Li G., 1989, CHIN MENTAL HLTH J, V4, P148; Li X, 2003, J CAPITAL U MED SCI, V3, P268; Liao J, 2010, ALZ DIS ASSOC DIS, V24, P317, DOI 10.1097/WAD.0b013e3181df1c7b; Marra C, 2004, DEMENT GERIATR COGN, V18, P125, DOI 10.1159/000079191; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Murphy GM, 1997, AM J PSYCHIAT, V154, P603; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Payami H, 1996, AM J HUM GENET, V58, P803; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Ramakers IHGB, 2008, DEMENT GERIATR COGN, V26, P101, DOI 10.1159/000144072; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Sasaki M, 2009, INT J GERIATR PSYCH, V24, P1119, DOI 10.1002/gps.2234; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; Small GW, 1999, AM J PSYCHIAT, V156, P1035; Smith GE, 1998, NEUROLOGY, V50, P355, DOI 10.1212/WNL.50.2.355; Stewart R, 2012, CURR OPIN PSYCHIATR, V25, P445, DOI 10.1097/YCO.0b013e3283586fd8; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Van der Flier WM, 2008, DEMENT GERIATR COGN, V25, P433, DOI 10.1159/000124750; van der Flier WM, 2006, NEUROLOGY, V67, P526, DOI 10.1212/01.wnl.0000228222.17111.2a; van der Vlies AE, 2007, DEMENT GERIATR COGN, V24, P98, DOI 10.1159/000104467; Vina J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501; Wang PN, 2006, NEUROBIOL AGING, V27, P1797, DOI 10.1016/j.neurobiolaging.2005.10.002; Wang QS, 2002, BRAIN RES, V951, P77, DOI 10.1016/S0006-8993(02)03137-2; Wilson RS, 2002, J NEUROL NEUROSUR PS, V73, P672, DOI 10.1136/jnnp.73.6.672; World Health Organization, 1999, INT CLASS DIS 10 REV; Xu SL, 1984, CLIN MEMORY SCALE; Zhang ZX, 2005, ARCH NEUROL-CHICAGO, V62, P447, DOI 10.1001/archneur.62.3.447; Zhao X, 2003, CHINESE J CLIN REHAB, V31, P4262	53	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99130	10.1371/journal.pone.0099130	http://dx.doi.org/10.1371/journal.pone.0099130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914687	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700066
J	Yea, SS; So, L; Mallya, S; Lee, J; Rajasekaran, K; Malarkannan, S; Fruman, DA				Yea, Sung Su; So, Lomon; Mallya, Sharmila; Lee, Jongdae; Rajasekaran, Kamalakannan; Malarkannan, Subramaniam; Fruman, David A.			Effects of Novel Isoform-Selective Phosphoinositide 3-Kinase Inhibitors on Natural Killer Cell Function	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; TERMINAL MATURATION; ADAPTIVE IMMUNITY; SOLID TUMORS; NK CELLS; PI3K; CANCER; KINASE; P110-DELTA; GAMMA	Phosphoinositide 3-kinases (PI3Ks) are promising targets for therapeutic development in cancer. The class I PI3K isoform p110 alpha has received considerable attention in oncology because the gene encoding p110 alpha (PIK3CA) is frequently mutated in human cancer. However, little is known about the function of p110 alpha in lymphocyte populations that modulate tumorigenesis. We used recently developed investigational inhibitors to compare the function of p110 alpha and other isoforms in natural killer (NK) cells, a key cell type for immunosurveillance and tumor immunotherapy. Inhibitors of all class I isoforms (pan-PI3K) significantly impaired NK cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity against tumor cells, whereas p110 alpha-selective inhibitors had no effect. In NK cells stimulated through NKG2D, p110 alpha inhibition modestly reduced PI3K signaling output as measured by AKT phosphorylation. Production of IFN-gamma and NK cell-derived chemokines was blocked by a pan-PI3K inhibitor and partially reduced by a p110 delta inhibitor, with lesser effects of p110 alpha inhibitors. Oral administration of mice with MLN1117, a p110 alpha inhibitor in oncology clinical trials, had negligible effects on NK subset maturation or terminal subset commitment. Collectively, these results support the targeting of PIK3CA mutant tumors with selective p110 alpha inhibitors to preserve NK cell function.	[Yea, Sung Su; So, Lomon; Mallya, Sharmila; Lee, Jongdae; Fruman, David A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Yea, Sung Su; So, Lomon; Mallya, Sharmila; Lee, Jongdae; Fruman, David A.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92717 USA; [Yea, Sung Su] Inje Univ, Coll Med, Dept Biochem, Pusan, South Korea; [Rajasekaran, Kamalakannan; Malarkannan, Subramaniam] Blood Res Inst, Lab Mol Immunol & Immunotherapy, Milwaukee, WI USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Inje University; Versiti Blood Center of Wisconsin	Yea, SS (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	ssyea@inje.ac.kr; dfruman@uci.edu	Malarkannan, Subramaniam/AAQ-3934-2020; Malarkannan, Subra/AAQ-9617-2020; RAJASEKARAN, KAMALAKANNAN/F-7350-2015	Malarkannan, Subramaniam/0000-0002-7511-2731; RAJASEKARAN, KAMALAKANNAN/0000-0001-5634-9007; Lee, Jongdae/0000-0002-6270-4658	Intellikine, Inc.; National Research Foundation of Korea (NRF) - Korea government (MSIP) [R13-2007-023-00000-0]; National Institutes of Health [R21-AI099656]; Immunology Research Training Program [T32 AI 60573]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099656, R01AI102893, T32AI060573] Funding Source: NIH RePORTER	Intellikine, Inc.; National Research Foundation of Korea (NRF) - Korea government (MSIP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immunology Research Training Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Sponsored Research Agreement with Intellikine, Inc., the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NO. R13-2007-023-00000-0) (to SSY), and by National Institutes of Health research grant R21-AI099656 (to DAF) and Immunology Research Training Program grant T32 AI 60573 (to LS). Intellikine, Inc. was involved in study design, data collection and analysis. Intellikine was acquired by Millennium Pharmaceuticals, and this company approved of the decision to publish and the final manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. Millennium would be prepared to supply MLN1117 or MLN1316 subject to the normal process of MTA approval & compound availability.	Aoukaty A, 2002, J BIOL CHEM, V277, P13331, DOI 10.1074/jbc.M112029200; Awasthi A, 2008, GENES IMMUN, V9, P522, DOI 10.1038/gene.2008.45; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; BONNEMA JD, 1994, J EXP MED, V180, P1427, DOI 10.1084/jem.180.4.1427; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Edgar KA, 2010, CANCER RES, V70, P1164, DOI 10.1158/0008-5472.CAN-09-2525; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Fruman DA, 2011, CANCER DISCOV, V1, P562, DOI 10.1158/2159-8290.CD-11-0249; Furet P, 2013, BIOORG MED CHEM LETT, V23, P3741, DOI 10.1016/j.bmcl.2013.05.007; Guo HL, 2008, J EXP MED, V205, P2419, DOI 10.1084/jem.20072327; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Jessen K, 2011, MOL CANC THER, V10; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; KANAKARAJ P, 1994, J EXP MED, V179, P551, DOI 10.1084/jem.179.2.551; Kim JM, 2013, J EXP MED, V210, P1647, DOI 10.1084/jem.20131625; Kim N, 2007, BLOOD, V110, P3202, DOI 10.1182/blood-2007-02-075366; Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x; Ligresti G, 2009, CELL CYCLE, V8, P1352, DOI 10.4161/cc.8.9.8255; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Puri KD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00256; Putz EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040852; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Regunathan J, 2005, BLOOD, V105, P233, DOI 10.1182/blood-2004-03-1075; Rewcastle GW, 2011, J MED CHEM, V54, P7105, DOI 10.1021/jm200688y; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Saudemont A, 2009, P NATL ACAD SCI USA, V106, P5795, DOI 10.1073/pnas.0808594106; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; So LM, 2013, J BIOL CHEM, V288, P5718, DOI 10.1074/jbc.M112.379446; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Tassi I, 2007, IMMUNITY, V27, P214, DOI 10.1016/j.immuni.2007.07.014; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Zebedin E, 2008, BLOOD, V112, P4655, DOI 10.1182/blood-2008-02-139105; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99486	10.1371/journal.pone.0099486	http://dx.doi.org/10.1371/journal.pone.0099486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915189	Green Published, gold			2022-12-25	WOS:000340947700106
J	Zheng, QQ; Jiang, DQ; Zhang, W; Zhang, QQ; Zhao, Q; Jin, J; Li, X; Yang, HT; Bartlam, M; Shaw, N; Zhou, WH; Rao, ZH				Zheng, Qianqian; Jiang, Dunquan; Zhang, Wei; Zhang, Qingqing; Zhao, Qi; Jin, Jin; Li, Xin; Yang, Haitao; Bartlam, Mark; Shaw, Neil; Zhou, Weihong; Rao, Zihe			Mechanism of Dephosphorylation of Glucosyl-3-phosphoglycerate by a Histidine Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; METHYLGLUCOSE LIPOPOLYSACCHARIDE; MYCOBACTERIAL POLYSACCHARIDES; BACILLUS-STEAROTHERMOPHILUS; COMPLEX-FORMATION; BIOSYNTHESIS; BACTERIAL; PATHWAY; GLUCOSYLGLYCERATE; THERMOPHILUS	Mycobacterium tuberculosis (Mtb) synthesizes polymethylated polysaccharides that form complexes with long chain fatty acids. These complexes, referred to as methylglucose lipopolysaccharides (MGLPs), regulate fatty acid biosynthesis in vivo, including biosynthesis of mycolic acids that are essential for building the cell wall. Glucosyl-3-phosphoglycerate phosphatase (GpgP, EC 5.4.2.1), encoded by Rv2419c gene, catalyzes the second step of the pathway for the biosynthesis of MGLPs. The molecular basis for this dephosphorylation is currently not understood. Here, we describe the crystal structures of apo-, vanadate-bound, and phosphate-bound MtbGpgP, depicting unliganded, reaction intermediate mimic, and product-bound views of MtbGpgP, respectively. The enzyme consists of a single domain made up of a central beta-sheet flanked by alpha-helices on either side. The active site is located in a positively charged cleft situated above the central beta-sheet. Unambiguous electron density for vanadate covalently bound to His(11), mimicking the phosphohistidine intermediate, was observed. The role of residues interacting with the ligands in catalysis was probed by site-directed mutagenesis. Arg(10), His(11), Asn(17), Gln(23), Arg(60), Glu(84), His(159), and Leu(209) are important for enzymatic activity. Comparison of the structures of MtbGpgP revealed conformational changes in a key loop region connecting beta 1 with alpha 1. This loop regulates access to the active site. MtbGpgP functions as dimer. L209E mutation resulted in monomeric GpgP, rendering the enzyme incapable of dephosphorylation. The structures of GpgP reported here are the first crystal structures for histidine-phosphatase-type GpgPs. These structures shed light on a key step in biosynthesis of MGLPs that could be targeted for development of anti-tuberculosis therapeutics.	[Zheng, Qianqian; Jiang, Dunquan; Zhang, Wei; Zhang, Qingqing; Zhao, Qi; Li, Xin; Yang, Haitao; Shaw, Neil; Zhou, Weihong; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Yang, Haitao] Tianjin Univ, Coll Life Sci, Tianjin 300073, Peoples R China; [Shaw, Neil; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100101, Peoples R China; [Rao, Zihe] Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China; [Zhao, Qi] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Nankai University; Tianjin University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Tsinghua University; Yale University	Zhou, WH (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	zhouwh@nankai.edu.cn; raozh@xtal.tsinghua.edu.cn	Yang, Haitao/G-9116-2012; li, xin/HHS-9461-2022; Rao, Zihe/HCH-6944-2022; Li, Lambert LL/F-7146-2015; zhang, qingqing/GXF-2381-2022; Jiang, Quan/GQA-6586-2022	Zhang, Wei/0000-0001-8693-6747; Bartlam, Mark/0000-0001-5173-5080; Zheng, Qianqian/0000-0002-1760-4906; Shaw, Neil/0000-0003-2722-9967	Ministry of Science and Technology of China Project 973 [2013CB733904, 2014CB542800]; National Science Foundation of China [813300237]	Ministry of Science and Technology of China Project 973; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 2013CB733904 and 2014CB542800 from the Ministry of Science and Technology of China Project 973 and by National Science Foundation of China Grant 813300237.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BERGERON R, 1975, J BIOL CHEM, V250, P1223; Bond CS, 2001, J BIOL CHEM, V276, P3247, DOI 10.1074/jbc.M007318200; Bond CS, 2002, J MOL BIOL, V316, P1071, DOI 10.1006/jmbi.2002.5418; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiba Y, 2013, J BIOL CHEM, V288, P11448, DOI 10.1074/jbc.M112.449561; Costa J, 2006, J BACTERIOL, V188, P1022, DOI 10.1128/JB.188.3.1022-1030.2006; Costa J, 2007, J BACTERIOL, V189, P1648, DOI 10.1128/JB.00841-06; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Davies DR, 2011, ACTA CRYSTALLOGR F, V67, P1044, DOI 10.1107/S1744309111030405; Empadinhas N, 2003, APPL ENVIRON MICROB, V69, P3272, DOI 10.1128/AEM.69.6.3272-3279.2003; Empadinhas N, 2001, J BIOL CHEM, V276, P43580, DOI 10.1074/jbc.M108054200; Empadinhas N, 2008, FEMS MICROBIOL LETT, V280, P195, DOI 10.1111/j.1574-6968.2007.01064.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fothergill-Gilmore L. A., 1989, ADV ENZYMOLOGY RELAT, V62, P227; Garg SK, 2007, PROTEIN EXPRES PURIF, V51, P198, DOI 10.1016/j.pep.2006.08.005; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; ILTON M, 1971, P NATL ACAD SCI USA, V68, P87, DOI 10.1073/pnas.68.1.87; KAMISANGO K, 1987, J BIOL CHEM, V262, P4580; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee YH, 1996, BIOCHEMISTRY-US, V35, P6010, DOI 10.1021/bi9600613; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MACHIDA Y, 1973, P NATL ACAD SCI USA, V70, P1146, DOI 10.1073/pnas.70.4.1146; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendes V, 2012, NAT PROD REP, V29, P834, DOI 10.1039/c2np20014g; Mendes V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00177; Mendes V, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-21; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Rigden DJ, 2002, J MOL BIOL, V315, P1129, DOI 10.1006/jmbi.2001.5290; Rigden DJ, 2003, J MOL BIOL, V325, P411, DOI 10.1016/S0022-2836(02)01229-9; Riley LW, 2006, J CLIN INVEST, V116, P1475, DOI 10.1172/JCI28734; SAIER MH, 1968, J BIOL CHEM, V243, P4332; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Some Daniel, 2013, Biophys Rev, V5, P147, DOI 10.1007/s12551-013-0107-1; Stadthagen G, 2007, J BIOL CHEM, V282, P27270, DOI 10.1074/jbc.M702676200; Syson K, 2011, J BIOL CHEM, V286, P38298, DOI 10.1074/jbc.M111.279315; TAKAI A, 1991, BIOCHEM J, V275, P233, DOI 10.1042/bj2750233; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; Tuffal G, 1998, GLYCOBIOLOGY, V8, P675, DOI 10.1093/glycob/8.7.675; TUFFAL G, 1995, EUR J BIOCHEM, V233, P377, DOI 10.1111/j.1432-1033.1995.377_1.x; Yuen MH, 1999, J BIOL CHEM, V274, P2176, DOI 10.1074/jbc.274.4.2176	47	8	9	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21242	21251		10.1074/jbc.M114.569913	http://dx.doi.org/10.1074/jbc.M114.569913			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24914210	hybrid, Green Published			2022-12-25	WOS:000340558300004
J	Das, S; Ghosal, S; Sen, R; Chakrabarti, J				Das, Shaoli; Ghosal, Suman; Sen, Rituparno; Chakrabarti, Jayprokas			InCeDB: Database of Human Long Noncoding RNA Acting as Competing Endogenous RNA	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CLIP-SEQ; EVOLUTION; CERNA; DIFFERENTIATION; CONSERVATION; EXPRESSION; NETWORKS; POLYCOMB; STARBASE	Long noncoding RNA (lncRNA) influences post-transcriptional regulation by interfering with the microRNA (miRNA) pathways, acting as competing endogenous RNA (ceRNA). These lncRNAs have miRNA responsive elements (MRE) in them, and control endogenous miRNAs available for binding with their target mRNAs, thus reducing the repression of these mRNAs. lnCeDB provides a database of human lncRNAs (from GENCODE 19 version) that can potentially act as ceRNAs. The putative mRNA targets of human miRNAs and the targets mapped to AGO clipped regions are collected from TargetScan and StarBase respectively. The lncRNA targets of human miRNAs (up to GENCODE 11) are downloaded from miRCode database. miRNA targets on the rest of the GENCODE 19 lncRNAs are predicted by our algorithm for finding seed-matched target sites. These putative miRNA-lncRNA interactions are mapped to the Ago interacting regions within lncRNAs. To find out the likelihood of an lncRNA-mRNA pair for actually being ceRNA we take recourse to two methods. First, a ceRNA score is calculated from the ratio of the number of shared MREs between the pair with the total number of MREs of the individual candidate gene. Second, the P-value for each ceRNA pair is determined by hypergeometric test using the number of shared miRNAs between the ceRNA pair against the number of miRNAs interacting with the individual RNAs. Typically, in a pair of RNAs being targeted by common miRNA(s), there should be a correlation of expression so that the increase in level of one ceRNA results in the increased level of the other ceRNA. Near-equimolar concentration of the competing RNAs is associated with more profound ceRNA effect. In lnCeDB one can not only browse for lncRNA-mRNA pairs having common targeting miRNAs, but also compare the expression of the pair in 22 human tissues to estimate the chances of the pair for actually being ceRNAs. Availability: Downloadable freely from http://gyanxet-beta. com/ lncedb/.	[Das, Shaoli; Ghosal, Suman; Chakrabarti, Jayprokas] Indian Assoc Cultivat Sci, Computat Biol Grp, Kolkata, W Bengal, India; [Sen, Rituparno; Chakrabarti, Jayprokas] Gyanxet, Kolkata, W Bengal, India	Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Chakrabarti, J (corresponding author), Indian Assoc Cultivat Sci, Computat Biol Grp, Kolkata, W Bengal, India.	j.chakrabarti@gyanxet.com	Das, Shaoli/AAE-6879-2020; Sen, Rituparno/AAX-9937-2021; Ghosal, Suman/AAW-9012-2020	Das, Shaoli/0000-0002-3428-1862; Sen, Rituparno/0000-0001-5980-5565; Ghosal, Suman/0000-0002-3772-2336	intramural funds of their host institutes; Indian Association for the Cultivation of Science; Gyanxet	intramural funds of their host institutes; Indian Association for the Cultivation of Science(Department of Science & Technology (India)Indian Association for the Cultivation of Science (IACS) - Jadavpur); Gyanxet	The authors received financial support from the intramural funds of their host institutes. SD, SG and JC received financial support from the Indian Association for the Cultivation of Science. RS was hosted by Gyanxet, an independent non-profit body. Funds for the website were contributed by Gyanxet. The fund giving organizations, namely, the Indian Association for the Cultivation of Science and Gyanxet, had no role in the design, data collection and analysis, the decision to publish, or in the preparation of the manuscript.	Aguilo F, 2011, CANCER RES, V71, P5365, DOI 10.1158/0008-5472.CAN-10-4379; Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Bhartiya D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat034; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Enright AJ, 2004, GENOME BIOL, V5; Fan M, 2013, EXP THER MED, V5, P1143, DOI 10.3892/etm.2013.933; Ghosal Suman, 2013, Frontiers in Genetics, V4, P283, DOI 10.3389/fgene.2013.00283; Ghosal S, 2013, STEM CELLS DEV, V22, P2240, DOI 10.1089/scd.2013.0014; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hawkins PG, 2010, TRANSCR-AUSTIN, V1, P165, DOI 10.4161/trns.1.3.13332; Jalali S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053823; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Karolchik D., 2012, CURR PROTOC BIOINFOR, V40; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Lam LT, 2010, MOL CANCER THER, V9, P2943, DOI 10.1158/1535-7163.MCT-10-0427; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Lv XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063516; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Menigatti M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.21; Meola N, 2012, RNA, V18, P111, DOI 10.1261/rna.029454.111; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Paralkar VR, 2011, GENE DEV, V25, P2555, DOI 10.1101/gad.183020.111; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pD239, DOI 10.1093/nar/gks1246; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sarver AL, 2012, BIOINFORMATION, V8, P731, DOI 10.6026/97320630008731; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	44	126	129	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98965	10.1371/journal.pone.0098965	http://dx.doi.org/10.1371/journal.pone.0098965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926662	gold, Green Submitted, Green Published			2022-12-25	WOS:000338278100024
J	Singhal, V; Lawson, EA; Ackerman, KE; Fazeli, PK; Clarke, H; Lee, H; Eddy, K; Marengi, DA; Derrico, NP; Bouxsein, ML; Misra, M				Singhal, Vibha; Lawson, Elizabeth A.; Ackerman, Kathryn E.; Fazeli, Pouneh K.; Clarke, Hannah; Lee, Hang; Eddy, Kamryn; Marengi, Dean A.; Derrico, Nicholas P.; Bouxsein, Mary L.; Misra, Madhusmita			Irisin Levels Are Lower in Young Amenorrheic Athletes Compared with Eumenorrheic Athletes and Non-Athletes and Are Associated with Bone Density and Strength Estimates	PLOS ONE			English	Article							GROWTH-FACTOR 21; BROWN ADIPOSE-TISSUE; ANOREXIA-NERVOSA; MINERAL DENSITY; EXERCISE; OBESITY; SERUM; WOMEN; FGF21; MICROARCHITECTURE	Irisin and FGF21 are novel hormones implicated in the "browning'' of white fat, thermogenesis, and energy homeostasis. However, there are no data regarding these hormones in amenorrheic athletes (AA) (a chronic energy deficit state) compared with eumenorrheic athletes (EA) and non-athletes. We hypothesized that irisin and FGF21 would be low in AA, an adaptive response to low energy stores. Furthermore, because (i) brown fat has positive effects on bone, and (ii) irisin and FGF21 may directly impact bone, we hypothesized that bone density, structure and strength would be positively associated with these hormones in athletes and non-athletes. To test our hypotheses, we studied 85 females, 14-21 years [38 AA, 24 EA and 23 non-athletes (NA)]. Fasting serum irisin and FGF21 were measured. Body composition and bone density were assessed using dual energy X-ray absorptiometry, bone microarchitecture using high resolution peripheral quantitative CT, strength estimates using finite element analysis, resting energy expenditure (REE) using indirect calorimetry and time spent exercising/week by history. Subjects did not differ for pubertal stage. Fat mass was lowest in AA. AA had lower irisin and FGF21 than EA and NA, even after controlling for fat and lean mass. Across subjects, irisin was positively associated with REE and bone density Z-scores, volumetric bone mineral density (total and trabecular), stiffness and failure load. FGF21 was negatively associated with hours/week of exercise and cortical porosity, and positively with fat mass and cortical volumetric bone density. Associations of irisin (but not FGF21) with bone parameters persisted after controlling for potential confounders. In conclusion, irisin and FGF21 are low in AA, and irisin (but not FGF21) is independently associated with bone density and strength in athletes.	[Singhal, Vibha; Lawson, Elizabeth A.; Ackerman, Kathryn E.; Fazeli, Pouneh K.; Clarke, Hannah; Eddy, Kamryn; Marengi, Dean A.; Misra, Madhusmita] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; [Singhal, Vibha; Lawson, Elizabeth A.; Ackerman, Kathryn E.; Fazeli, Pouneh K.; Clarke, Hannah; Lee, Hang; Eddy, Kamryn; Marengi, Dean A.; Derrico, Nicholas P.; Bouxsein, Mary L.; Misra, Madhusmita] Harvard Univ, Sch Med, Boston, MA USA; [Singhal, Vibha; Misra, Madhusmita] Massachusetts Gen Hosp Children, Pediat Endocrine Unit, Boston, MA USA; [Ackerman, Kathryn E.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Lee, Hang] Massachusetts Gen Hosp, Dept Biostat, Boston, MA 02114 USA; [Eddy, Kamryn] Massachusetts Gen Hosp, Harris Ctr, Boston, MA 02114 USA; [Derrico, Nicholas P.; Bouxsein, Mary L.] Massachusetts Gen Hosp, Div Endocrine, Boston, MA 02114 USA; [Bouxsein, Mary L.] Beth Israel Deaconess Med Ctr, Dept Orthoped Surg, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center	Misra, M (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA.	mmisra@partners.org	Singhal, Vibha/AAP-3792-2020; Singhal, Vibha/AAN-1432-2021; Misra, Madhusmita/X-8807-2018	Misra, Madhusmita/0000-0002-9405-2981; Lawson, Elizabeth/0000-0001-8619-3349	NIH [UL1 RR025758, R01 HD060827, K23 MH092560, K24HD071843]; Massachusetts General Hospital Claflin Distinguished Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060827, K24HD071843] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, K23DK094820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092560] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Claflin Distinguished Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by NIH Grants UL1 RR025758, R01 HD060827, K23 MH092560; K24HD071843; and Massachusetts General Hospital Claflin Distinguished Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN K, 2012, BONE IN PRESS; Ackerman KE, 2011, J CLIN ENDOCR METAB, V96, P3123, DOI 10.1210/jc.2011-1614; Anastasilakis AD, 2014, OSTEOPOROSIS INT, V25, P1633, DOI 10.1007/s00198-014-2673-x; BLUHER S, 2014, OBESITY SILVER SPRIN; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bredella MA, 2012, J CLIN ENDOCR METAB, V97, pE584, DOI 10.1210/jc.2011-2246; Colaianni G, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/902186; Cuevas-Ramos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038022; Cuevas-Ramos D, 2010, EUR J ENDOCRINOL, V163, P469, DOI 10.1530/EJE-10-0454; Dostalova I, 2008, J CLIN ENDOCR METAB, V93, P3627, DOI 10.1210/jc.2008-0746; Fazeli PK, 2013, OSTEOPOROSIS INT, V24, P2433, DOI 10.1007/s00198-013-2353-2; FISHER FM, GENES DEV, V26, P271; Fletcher JA, 2012, APPL PHYSIOL NUTR ME, V37, P1054, DOI [10.1139/H2012-091, 10.1139/h2012-091]; Gorar S, 2010, GYNECOL ENDOCRINOL, V26, P819, DOI 10.3109/09513590.2010.487587; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Hofmann T, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2013.00202; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Ishida K, 2013, BIOCHEM BIOPH RES CO, V432, P677, DOI 10.1016/j.bbrc.2013.02.019; Kim KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063517; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lawson EA, 2013, EUR J ENDOCRINOL, V168, P457, DOI 10.1530/EJE-12-0869; Lee P, 2013, OSTEOPOROSIS INT, V24, P1513, DOI 10.1007/s00198-012-2110-y; LEE P, 2013, OSTEOPOROS INT; LEE P, J CLIN ENDOCRINOL ME, V98, pE98; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Miller KK, 2004, J CLIN ENDOCR METAB, V89, P525, DOI 10.1210/jc.2003-030680; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Peter PR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094463; Ponrartana S, 2012, J CLIN ENDOCR METAB, V97, P2693, DOI 10.1210/jc.2012-1589; REINEHR T, J CLIN ENDOCRINOL ME, V97, P2143; SAHIN SB, 2014, SCAND J CLIN LAB INV; Shen Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-124; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Yang SJ, 2011, CLIN ENDOCRINOL, V75, P464, DOI 10.1111/j.1365-2265.2011.04078.x; ZHANG J, 2013, ASBMR 2013; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	41	72	74	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100218	10.1371/journal.pone.0100218	http://dx.doi.org/10.1371/journal.pone.0100218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926783	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100121
J	Stamellou, E; Fontana, J; Wedel, J; Ntasis, E; Sticht, C; Becker, A; Pallavi, P; Wolf, K; Kramer, BK; Hafner, M; van Son, WJ; Yard, BA				Stamellou, Eleni; Fontana, Johann; Wedel, Johannes; Ntasis, Emmanouil; Sticht, Carsten; Becker, Anja; Pallavi, Prama; Wolf, Kerstin; Kraemer, Bernhard K.; Hafner, Mathias; van Son, Willem J.; Yard, Benito A.			N-Octanoyl Dopamine Treatment of Endothelial Cells Induces the Unfolded Protein Response and Results in Hypometabolism and Tolerance to Hypothermia	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER-STRESS; IN-VITRO; MOLECULAR CHAPERONES; PHENOLIC-COMPOUNDS; KINASE; ATF6; ADAPTATION; APOPTOSIS; INJURY	Aim: N-acyl dopamines (NADD) are gaining attention in the field of inflammatory and neurological disorders. Due to their hydrophobicity, NADD may have access to the endoplasmic reticulum (ER). We therefore investigated if NADD induce the unfolded protein response (UPR) and if this in turn influences cell behaviour. Methods: Genome wide gene expression profiling, confirmatory qPCR and reporter assays were employed on human umbilical vein endothelial cells (HUVEC) to validate induction of UPR target genes and UPR sensor activation by N-octanoyl dopamine (NOD). Intracellular ATP, apoptosis and induction of thermotolerance were used as functional parameters to assess adaptation of HUVEC. Results: NOD, but not dopamine dose dependently induces the UPR. This was also found for other synthetic NADD. Induction of the UPR was dependent on the redox activity of NADD and was not caused by selective activation of a particular UPR sensor. UPR induction did not result in cell apoptosis, yet NOD strongly impaired cell proliferation by attenuation of cells in the S-G2/M phase. Long-term treatment of HUVEC with low NOD concentration showed decreased intracellular ATP concentration paralleled with activation of AMPK. These cells were significantly more resistant to cold inflicted injury. Conclusions: We provide for the first time evidence that NADD induce the UPR in vitro. It remains to be assessed if UPR induction is causally associated with hypometabolism and thermotolerance. Further pharmacokinetic studies are warranted to address if the NADD concentrations used in vitro can be obtained in vivo and if this in turn shows therapeutic efficacy.	[Stamellou, Eleni; Wedel, Johannes; Ntasis, Emmanouil; Pallavi, Prama; Kraemer, Bernhard K.; Yard, Benito A.] Heidelberg Univ, Med Fac Mannheim, Med Dept 5, Mannheim, Germany; [Fontana, Johann] Ruhr Univ Bochum, Dept Neurosurg, Bochum, Germany; [Sticht, Carsten] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr ZMF, Mannheim, Germany; [Becker, Anja; Wolf, Kerstin; Hafner, Mathias] Mannheim Univ Appl Sci, Inst Mol & Cellular Biol, Mannheim, Germany; [van Son, Willem J.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	Ruprecht Karls University Heidelberg; Ruhr University Bochum; Ruprecht Karls University Heidelberg; University of Groningen	Stamellou, E (corresponding author), Heidelberg Univ, Med Fac Mannheim, Med Dept 5, Mannheim, Germany.	stamellou.eleni@googlemail.com		Stamellou, Eleni/0000-0001-7472-4907; Wedel, Johannes/0000-0002-3490-8477	Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wuerttemberg ("Innovative Projekte'')	Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wuerttemberg ("Innovative Projekte'')	The work was partially supported by a grant from the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wuerttemberg ("Innovative Projekte'') to M.H. and B.Y. No additional funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar MB, 2012, INT J MOL SCI, V13, P15054, DOI 10.3390/ijms131115054; Achard CS, 2012, ENDOCRINOLOGY, V153, P2164, DOI 10.1210/en.2011-1881; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Ait-Hsiko L, 2013, PLATELETS, V24, P428, DOI 10.3109/09537104.2012.715217; Almasi R, 2008, LIFE SCI, V82, P644, DOI 10.1016/j.lfs.2007.12.022; Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; Bisogno T, 2000, BIOCHEM J, V351, P817, DOI 10.1042/0264-6021:3510817; Bouma HR, 2010, TRANSPLANTATION, V90, P353, DOI 10.1097/TP.0b013e3181e7a3aa; Cojocari D, 2013, RADIOTHER ONCOL, V108, P541, DOI 10.1016/j.radonc.2013.06.005; Connor M, 2010, BRIT J PHARMACOL, V160, P1857, DOI 10.1111/j.1476-5381.2010.00862.x; Cybulsky AV, 2005, J BIOL CHEM, V280, P24396, DOI 10.1074/jbc.M500729200; Graf PCF, 2002, CELL MOL LIFE SCI, V59, P1624, DOI 10.1007/PL00012489; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hottenrott MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073122; Janicke B, 2011, NUTR CANCER, V63, P611, DOI 10.1080/01635581.2011.538486; Kawabata T, 1996, BIOCHEM PHARMACOL, V51, P1569, DOI 10.1016/0006-2952(96)00101-3; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Losel RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009713; Mamady H, 2008, ARCH BIOCHEM BIOPHYS, V477, P77, DOI 10.1016/j.abb.2008.05.006; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Papp E, 2003, BIOFACTORS, V17, P249, DOI 10.1002/biof.5520170124; Peralta C, 2001, HEPATOLOGY, V34, P1164, DOI 10.1053/jhep.2001.29197; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubio C, 2011, J CELL BIOL, V193, P171, DOI 10.1083/jcb.201007077; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Siveen KS, 2011, J ENVIRON PATHOL TOX, V30, P301, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i4.30; Suh DH, 2012, ANN NY ACAD SCI, V1271, P20, DOI 10.1111/j.1749-6632.2012.06739.x; Tabata K, 2012, ANTICANCER RES, V32, P4781; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; TAKAHASHI K, 1995, BIOL PHARM BULL, V18, P1401; Tsagogiorgas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043525; Tsang KY, 2010, J CELL SCI, V123, P2145, DOI 10.1242/jcs.068833; TSENG CF, 1992, CHEM PHARM BULL, V40, P396, DOI 10.1248/cpb.40.396; Vettel C, 2013, J PHARM EXP THER; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	46	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99298	10.1371/journal.pone.0099298	http://dx.doi.org/10.1371/journal.pone.0099298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926788	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100033
J	Hema, R; Vemanna, RS; Sreeramulu, S; Reddy, CP; Senthil-Kumar, M; Udayakumar, M				Hema, Ramanna; Vemanna, Ramu S.; Sreeramulu, Shivakumar; Reddy, Chandrasekhara P.; Senthil-Kumar, Muthappa; Udayakumar, Makarla			Stable Expression of mtlD Gene Imparts Multiple Stress Tolerance in Finger Millet	PLOS ONE			English	Article							ELEUSINE-CORACANA-GAERTN; TRANSGENIC INDICA RICE; WATER-USE EFFICIENCY; SALT-TOLERANCE; FUNCTIONAL VALIDATION; OSMOLYTE ACCUMULATION; MANNITOL; L.; DROUGHT; SALINITY	Finger millet is susceptible to abiotic stresses, especially drought and salinity stress, in the field during seed germination and early stages of seedling development. Therefore developing stress tolerant finger millet plants combating drought, salinity and associated oxidative stress in these two growth stages is important. Cellular protection through osmotic adjustment and efficient free radical scavenging ability during abiotic stress are important components of stress tolerance mechanisms in plants. Mannitol, an osmolyte, is known to scavenge hydroxyl radicals generated during various abiotic stresses and thereby minimize stress damage in several plant species. In this study transgenic finger millet plants expressing the mannitol biosynthetic pathway gene from bacteria, mannitol-1-phosphate dehydrogenase (mtlD), were developed through Agrobacterium tumefaciens-mediated genetic transformation. mtlD gene integration in the putative transgenic plants was confirmed by Southern blot. Further, performance of transgenic finger millet under drought, salinity and oxidative stress was studied at plant level in T-1 generation and in T-1 and T-2 generation seedlings. Results from these experiments showed that transgenic finger millet had better growth under drought and salinity stress compared to wild-type. At plant level, transgenic plants showed better osmotic adjustment and chlorophyll retention under drought stress compared to the wildtype. However, the overall increase in stress tolerance of transgenics for the three stresses, especially for oxidative stress, was only marginal compared to other mtlD gene expressing plant species reported in the literature. Moreover, the Agrobacterium-mediated genetic transformation protocol developed for finger millet in this study can be used to introduce diverse traits of agronomic importance in finger millet.	[Hema, Ramanna; Vemanna, Ramu S.; Sreeramulu, Shivakumar; Reddy, Chandrasekhara P.; Senthil-Kumar, Muthappa; Udayakumar, Makarla] Univ Agr Sci, GKVK, Dept Crop Physiol, Bangalore, Karnataka, India; [Senthil-Kumar, Muthappa] Natl Inst Plant Genome Res, New Delhi, India	University of Agricultural Sciences Bangalore; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Senthil-Kumar, M (corresponding author), Univ Agr Sci, GKVK, Dept Crop Physiol, Bangalore, Karnataka, India.	skmuthappa@nipgr.ac.in	Senthil-Kumar, Muthappa/A-6699-2009; Mysore, Kirankumar/AAG-7112-2020	Senthil-Kumar, Muthappa/0000-0003-1502-1659; Mysore, Kirankumar/0000-0002-9805-5741; Vemanna, Ramu/0000-0002-9729-8768	Indian council of agricultural research, New Delhi; department of crop physiology; council of scientific and industrial research, New Delhi [9/271(86)/2004/EMR-1]; international foundation for science (IFS), Sweden [C/4066-1/Ac/17341R]	Indian council of agricultural research, New Delhi(Indian Council of Agricultural Research (ICAR)); department of crop physiology; council of scientific and industrial research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); international foundation for science (IFS), Sweden(International Foundation for Science)	This work was supported by grants from Indian council of agricultural research, New Delhi. HR acknowledges the financial assistance from department of crop physiology towards her PhD research. MS-K thanks the council of scientific and industrial research, New Delhi for the senior research fellowship award (No. 9/271(86)/2004/EMR-1) for his PhD research and also international foundation for science (IFS), Sweden (C/4066-1/Ac/17341R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarati P, 2003, PLANT SCI, V164, P25, DOI 10.1016/S0168-9452(02)00321-7; Abebe T, 2003, PLANT PHYSIOL, V131, P1748, DOI 10.1104/pp.102.003616; Adhikari R. K., 2012, Journal of Development and Agricultural Economics, V4, P151; Anjaneyulu E., 2011, World Applied Sciences Journal, V12, P919; Bhatt D, 2013, MOL BIOL REP, V40, P1155, DOI 10.1007/s11033-012-2157-z; Bhatt Deepesh, 2011, Physiology and Molecular Biology of Plants, V17, P347, DOI 10.1007/s12298-011-0084-4; Borges AA, 2003, PLANT PATHOL, V52, P429, DOI 10.1046/j.1365-3059.2003.00877.x; Ceasar SA, 2011, PLANT CELL REP, V30, P1759, DOI 10.1007/s00299-011-1084-0; Chan ZL, 2011, J EXP BOT, V62, P4787, DOI 10.1093/jxb/err130; Chandrashekar A, 2010, ADV FOOD NUTR RES, V59, P215, DOI 10.1016/S1043-4526(10)59006-5; Chiang YJ, 2005, J AM SOC HORTIC SCI, V130, P605, DOI 10.21273/JASHS.130.4.605; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1766, DOI 10.1093/pcp/pcr121; CORCORAN AC, 1947, J BIOL CHEM, V170, P165; Dinesh-Kumar S P, 1987, PLANT CELL ENVIRON, V10, P661; DODGE AD, 1970, BIOCHEM J, V118, pP43, DOI 10.1042/bj1180043P; EAPEN S, 1989, PLANT SCI, V61, P127, DOI 10.1016/0168-9452(89)90126-X; Gelvin SB, 2006, METH MOL B, V343, P77; Gopalakrishna R, 2001, BIOCHEM BIOPH RES CO, V284, P574, DOI 10.1006/bbrc.2001.4992; Govind G, 2009, MOL GENET GENOMICS, V281, P591, DOI 10.1007/s00438-009-0432-z; Gowda BTS, 2000, CURR SCI INDIA, V79, P366; Gupta P., 2001, PLANT BIOTECHNOL, V18, P275, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.18.275; Hamza NB, 2009, PROGR PROSPECTS MILL, P260; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; Hebbar S. Shankar, 1992, Crop Research (Hisar), V5, P92; Hema R, 2007, PLANTA, V226, P655, DOI 10.1007/s00425-007-0514-2; Hema R, 2001, THESIS U AGR SCI BAN; Hema R, 2006, RELEVANCE MANNITAL D; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Hu L, 2005, TREE PHYSIOL, V25, P1273, DOI 10.1093/treephys/25.10.1273; Ignacimuthu S, 2012, J BIOSCIENCES, V37, P135, DOI 10.1007/s12038-011-9178-y; Jagga-Chugh S, 2012, PLANT CELL TISS ORG, V109, P401, DOI 10.1007/s11240-011-0104-7; James VA, 2002, THEOR APPL GENET, V104, P553, DOI 10.1007/s001220100745; Jayaprakash T. L., 1992, Plant Physiology & Biochemistry (New Delhi), V19, P49; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kalarani M. K., 2001, Madras Agricultural Journal, V88, P509; Kalarani M. K., 2001, Indian Journal of Plant Physiology, V6, P435; KANDPAL RP, 1985, BIOCHEM INT, V11, P365; KANDPAL RP, 1985, PLANT SCI, V40, P73, DOI 10.1016/0168-9452(85)90044-5; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kathuria H, 2009, PLANT BIOTECHNOL J, V7, P512, DOI 10.1111/j.1467-7652.2009.00420.x; Khare N, 2010, PLANT CELL TISS ORG, V103, P267, DOI 10.1007/s11240-010-9776-7; Kumar S, 2001, CURR SCI INDIA, V81, P1482; Latha AM, 2005, PLANT SCI, V169, P657, DOI 10.1016/j.plantsci.2005.05.009; Liu J, 1995, Chin J Biotechnol, V11, P275; Macaluso L, 2007, J HORTIC SCI BIOTECH, V82, P979, DOI 10.1080/14620316.2007.11512336; Mahalakshmi S, 2006, PLANTA, V224, P347, DOI 10.1007/s00425-005-0218-4; Maheswari M, 2010, BIOL PLANTARUM, V54, P647, DOI 10.1007/s10535-010-0115-y; Mbithi-Mwikya S, 2002, J AGR FOOD CHEM, V50, P3030, DOI 10.1021/jf011008a; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagaraja A., 2008, Journal of Mycopathological Research, V46, P109; Nandini B., 2010, International Journal of Plant Sciences (Muzaffarnagar), V5, P602; Oghbaei M, 2012, J SCI FOOD AGR, V92, P2281, DOI 10.1002/jsfa.5622; Oltmanns H, 2010, PLANT PHYSIOL, V152, P1158, DOI 10.1104/pp.109.148585; Prabhavathi V, 2007, PLANT SCI, V173, P50, DOI 10.1016/j.plantsci.2007.04.004; Prabhavathi V, 2002, MOL BREEDING, V9, P137, DOI 10.1023/A:1026765026493; PRASAD SV, 1980, P INDIAN AS-PLANT SC, V89, P481; Pujni D, 2007, J PLANT BIOCHEM BIOT, V16, P1; Radchuk V, 2012, J EXP BOT, V63, P5497, DOI 10.1093/jxb/ers200; Rahnama H, 2011, ACTA PHYSIOL PLANT, V33, P1521, DOI 10.1007/s11738-010-0690-8; Rai Srubha, 2009, Indian Journal of Plant Physiology, V14, P82; Ramegowda V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040397; Rathinasabapathi B, 2000, ANN BOT-LONDON, V86, P709, DOI 10.1006/anbo.2000.1254; REDDY V C, 1983, Mysore Journal of Agricultural Sciences, V17, P325; SASHIDHAR VR, 1986, FIELD CROP RES, V13, P133, DOI 10.1016/0378-4290(86)90016-X; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Seckin B, 2009, J PLANT GROWTH REGUL, V28, P12, DOI 10.1007/s00344-008-9068-1; Senthil-Kumar M, 2003, J EXP BOT, V54, P2569, DOI 10.1093/jxb/erg278; Serraj R, 2002, PLANT CELL ENVIRON, V25, P333, DOI 10.1046/j.1365-3040.2002.00754.x; Shailaja HB, 2007, INDIAN J AGR SCI, V77, P672; Sharma M, 2011, PLANT CELL TISS ORG, V105, P93, DOI 10.1007/s11240-010-9846-x; Shen B, 1997, PLANT PHYSIOL, V115, P527, DOI 10.1104/pp.115.2.527; Shet RM, 2009, ENV ECOLOGY, V27, P1013; Sheveleva EV, 2000, J EXP BOT, V51, P115, DOI 10.1093/jexbot/51.342.115; SHI MM, 1994, J BIOL CHEM, V269, P26512; Shivakumar S, 2006, OVEREXPRESSION P5CS; Shivkumar B. G., 1996, Indian Journal of Agricultural Research, V30, P173; SIVADAS P, 1990, PLANT CELL REP, V9, P93, DOI 10.1007/BF00231557; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; TARCZYNSKI MC, 1992, P NATL ACAD SCI USA, V89, P2600, DOI 10.1073/pnas.89.7.2600; THOMAS JC, 1995, PLANT CELL ENVIRON, V18, P801, DOI 10.1111/j.1365-3040.1995.tb00584.x; TOWILL LE, 1975, CAN J BOT, V53, P1097, DOI 10.1139/b75-129; UMA S, 1995, ANN BOT-LONDON, V76, P43, DOI 10.1006/anbo.1995.1076; Vasantha KM, 2013, TARGETING GENES ION; Vijayalakshmi D., 2012, Journal of Dairying, Foods and Home Sciences, V31, P223; Yadav D. S., 1999, Journal of Potassium Research, V15, P131; Yamada M, 2009, PLANT CELL PHYSIOL, V50, P1736, DOI 10.1093/pcp/pcp116; Yamunarani BR, 2009, MOL CHARACTERIZATION; Zhifang G, 2003, PLANT CELL ENVIRON, V26, P275, DOI 10.1046/j.1365-3040.2003.00958.x	89	46	49	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99110	10.1371/journal.pone.0099110	http://dx.doi.org/10.1371/journal.pone.0099110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922513	Green Submitted, Green Published, gold			2022-12-25	WOS:000338701300030
J	Lang, LW; Liu, XY; Li, Y; Zhou, Q; Xie, P; Yan, CH; Chen, XG				Lang, Liwei; Liu, Xiaoyu; Li, Yan; Zhou, Qing; Xie, Ping; Yan, Chunhong; Chen, Xiaoguang			A Synthetic Manassantin A Derivative Inhibits Hypoxia-Inducible Factor 1 and Tumor Growth	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; SAURURUS-CHINENSIS; ACTIVATION; RESISTANCE; ARYLATION; LIGNANS; ALPHA	The dineolignan manassantin A from Saururaceae was recently identified as a hypoxia-inducible factor 1 (HIF-1) inhibitor, but its in-vivo anti-tumor effect has not been explored. We synthesized a series of manassantin A derivatives, and found that replacing the central tetrahydrofuran moiety with a cyclopentane ring yielded a compound (LXY6006) with increased HIF-1-inhibitory activity yet decreased stereochemically complexity amenable to a simplified synthesis scheme. LXY6006 inhibited HIF-1 alpha nuclear accumulation induced by hypoxia, and inhibited cancer cell growth as a consequence of G2/M arrest. Oral administration of LXY6006 significantly inhibited growth of breast, lung, and pancreatic tumors implanted in nude mice. These results indicate that LXY6006 represents a novel class of agents targeting a broad range of human cancers.	[Lang, Liwei; Li, Yan; Zhou, Qing; Chen, Xiaoguang] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Dept Pharmacol, Beijing 100050, Peoples R China; [Lang, Liwei; Liu, Xiaoyu; Li, Yan; Zhou, Qing; Xie, Ping; Chen, Xiaoguang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Xiaoyu; Xie, Ping] Chinese Acad Med Sci, Inst Mat Med, Dept Synthet Med Chem, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Lang, Liwei; Yan, Chunhong] Georgia Regents Univ, GRU Canc Ctr, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA 30901 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; University System of Georgia; Augusta University	Yan, CH (corresponding author), Georgia Regents Univ, GRU Canc Ctr, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA 30901 USA.	cyan@gru.edu; chxg@imm.ac.cn	Lang, Liwei/I-7744-2019	Yan, Chunhong/0000-0002-3974-7991; Lang, Liwei/0000-0002-2374-645X	Beijing Natural Science Foundation [7121010]; National Science and Technology Major Project [2012ZX09301002-006]; NIH/NCI [R01CA164006]; NATIONAL CANCER INSTITUTE [R01CA164006] Funding Source: NIH RePORTER	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Science and Technology Major Project; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the grants from Beijing Natural Science Foundation (7121010) and National Science and Technology Major Project (2012ZX09301002-006) to XC, and a NIH/NCI grant R01CA164006 to CY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JS, 2011, J PHARMACOL SCI, V115, P84, DOI 10.1254/jphs.10239SC; Chou TC, 2005, CANCER CHEMOTH PHARM, V56, P379, DOI 10.1007/s00280-005-1019-y; Hahm JC, 2005, PLANTA MED, V71, P464, DOI 10.1055/s-2005-864143; Hanessian S, 2006, ORG LETT, V8, P5477, DOI 10.1021/ol0621710; Hossain CF, 2005, BIOCHEM BIOPH RES CO, V333, P1026, DOI 10.1016/j.bbrc.2005.05.191; Hu YZ, 2013, J CELL BIOCHEM, V114, P498, DOI 10.1002/jcb.24390; Hwang BY, 2003, PHYTOCHEMISTRY, V64, P765, DOI 10.1016/S0031-9422(03)00391-1; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JEFFERY T, 1984, J CHEM SOC CHEM COMM, P1287, DOI 10.1039/c39840001287; Kasper AC, 2009, BIOORG MED CHEM LETT, V19, P3783, DOI 10.1016/j.bmcl.2009.04.071; Kim JY, 2009, J PHARMACOL SCI, V109, P583, DOI 10.1254/jphs.08299FP; Kim SJ, 2011, BIOL PHARM BULL, V34, P1769, DOI 10.1248/bpb.34.1769; Kwon OE, 2005, ARCH PHARM RES, V28, P55, DOI 10.1007/BF02975136; LAROCK RC, 1988, TETRAHEDRON LETT, V29, P905, DOI 10.1016/S0040-4039(00)82478-8; Lee HD, 2011, EXP DERMATOL, V20, P761, DOI 10.1111/j.1600-0625.2011.01296.x; Liu Wei, 2012, Int J Biochem Mol Biol, V3, P165; Lu CW, 2013, BIOCHEM PHARMACOL, V85, P1246, DOI 10.1016/j.bcp.2013.02.003; Oladipupo S, 2011, P NATL ACAD SCI USA, V108, P13264, DOI 10.1073/pnas.1101321108; PRASHAD M, 1989, TETRAHEDRON LETT, V30, P2877, DOI 10.1016/S0040-4039(00)99147-0; Rapisarda A, 2002, CANCER RES, V62, P4316; Rho MC, 2003, PLANTA MED, V69, P1147, DOI 10.1055/s-2003-818007; Rohwer N, 2013, ONCOGENE, V32, P3569, DOI 10.1038/onc.2012.510; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Zhou Q, 2012, BIOL PHARM BULL, V35, P2170, DOI 10.1248/bpb.b12-00513	25	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99584	10.1371/journal.pone.0099584	http://dx.doi.org/10.1371/journal.pone.0099584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925080	gold, Green Published, Green Submitted			2022-12-25	WOS:000338701300079
J	Olchanheski, LR; Dourado, MN; Beltrame, FL; Zielinski, AAF; Demiate, IM; Pileggi, SAV; Azevedo, RA; Sadowsky, MJ; Pileggi, M				Olchanheski, Luiz R.; Dourado, Manuella N.; Beltrame, Flavio L.; Zielinski, Acacio A. F.; Demiate, Ivo M.; Pileggi, Sonia A. V.; Azevedo, Ricardo A.; Sadowsky, Michael J.; Pileggi, Marcos			Mechanisms of Tolerance and High Degradation Capacity of the Herbicide Mesotrione by Escherichia coli Strain DH5-alpha	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; ETHYL DIPROPYLTHIOCARBAMATE; ANTIOXIDANT ENZYMES; DEGRADING BACTERIA; DEFICIENT MUTANT; SOIL; MICROORGANISMS; METABOLISM; PARAQUAT; ATRAZINE	The intensive use of agrochemicals has played an important role in increasing agricultural production. One of the impacts of agrochemical use has been changes in population structure of soil microbiota. The aim of this work was to analyze the adaptive strategies that bacteria use to overcome oxidative stress caused by mesotrione, which inhibits 4-hydroxyphenylpyruvate dioxygenase. We also examined antioxidative stress systems, saturation changes of lipid membranes, and the capacity of bacteria to degrade mesotrione. Escherichia coli DH5-a was chosen as a non-environmental strain, which is already a model bacterium for studying metabolism and adaptation. The results showed that this bacterium was able to tolerate high doses of the herbicide (10 x field rate), and completely degraded mesotrione after 3 h of exposure, as determined by a High Performance Liquid Chromatography. Growth rates in the presence of mesotrione were lower than in the control, prior to the period of degradation, showing toxic effects of this herbicide on bacterial cells. Changes in the saturation of the membrane lipids reduced the damage caused by reactive oxygen species and possibly hindered the entry of xenobiotics in the cell, while activating glutathione-S-transferase enzyme in the antioxidant system and in the metabolizing process of the herbicide. Considering that E. coli DH5-alpha is a non-environmental strain and it had no previous contact with mesotrione, the defense system found in this strain could be considered non-specific. This bacterium system response may be a general adaptation mechanism by which bacterial strains resist to damage from the presence of herbicides in agricultural soils.	[Olchanheski, Luiz R.; Pileggi, Sonia A. V.; Pileggi, Marcos] Univ Estadual Ponta Grossa, Dept Biol Estrutural Mol & Genet, Ponta Grossa, PR, Brazil; [Dourado, Manuella N.; Azevedo, Ricardo A.] Univ Sao Paulo, ESALQ, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Beltrame, Flavio L.] Univ Estadual Ponta Grossa, Dept Ciencias Farmaceut, Ponta Grossa, PR, Brazil; [Zielinski, Acacio A. F.] Univ Fed Parana, Programa Posgrad Engn & Alimentos, BR-80060000 Curitiba, Parana, Brazil; [Demiate, Ivo M.] Univ Estadual Ponta Grossa, Dept Engn Alimentos, Ponta Grossa, PR, Brazil; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA	Universidade Estadual de Ponta Grossa; Universidade de Sao Paulo; Universidade Estadual de Ponta Grossa; Universidade Federal do Parana; Universidade Estadual de Ponta Grossa; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Pileggi, M (corresponding author), Univ Estadual Ponta Grossa, Dept Biol Estrutural Mol & Genet, Ponta Grossa, PR, Brazil.	marcos.pileggi@pq.cnpq.br	Pileggi, Marcos/H-2695-2017; Dourado, Manuella N/P-2337-2018; Zielinski, Acácio AF/L-5868-2016; Beltrame, Flavio Luis/H-8505-2015; Sadowsky, Michael/J-2507-2016; Zielinski, Acácio AF/N-4432-2013; Pileggi, Marcos/B-8651-2012; Azevedo, Ricardo Antunes/F-8863-2011; Demiate, Ivo M/C-3859-2008	Pileggi, Marcos/0000-0003-1633-8295; Dourado, Manuella N/0000-0002-2152-0246; Zielinski, Acácio AF/0000-0002-6184-9628; Beltrame, Flavio Luis/0000-0001-7067-5802; Sadowsky, Michael/0000-0001-8779-2781; Zielinski, Acácio AF/0000-0002-6184-9628; Pileggi, Marcos/0000-0003-1633-8295; Azevedo, Ricardo Antunes/0000-0001-7316-125X; Demiate, Ivo M/0000-0002-5609-0186	National Council of Technological and Scientific Development [221/2007, 473438/2010-0]; Foundation for Research Support of the State of Sao Paulo [2009/54676-6]; Foundation for Research Support of the State of Parana [21724]	National Council of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the State of Sao Paulo; Foundation for Research Support of the State of Parana	The authors would like to thank the Brazilian funding agencies Coordination for the Improvement of Higher Level Personnel (www.capes.gov.br), Grant no. 221/2007, National Council of Technological and Scientific Development (www.cnpq.br), Grant no. 473438/2010-0, Foundation for Research Support of the State of Sao Paulo (www.fapesp.br), Grant no. 2009/54676-6, and Foundation for Research Support of the State of Parana (www.fundacaoaraucaria.org.br), Grant no. 21724, for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alferness P, 2002, J AGR FOOD CHEM, V50, P3926, DOI 10.1021/jf011696y; Allocati N, 2003, BIOCHEM J, V373, P305, DOI 10.1042/BJ20030184; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Araujo ASF, 2003, CHEMOSPHERE, V52, P799, DOI 10.1016/S0045-6535(03)00266-2; Armas Eduardo Dutra de, 2007, Quím. Nova, V30, P1119, DOI 10.1590/S0100-40422007000500013; Azevedo RA, 1998, PHYSIOL PLANTARUM, V104, P280, DOI 10.1034/j.1399-3054.1998.1040217.x; Balague C, 2001, ENVIRON TOXICOL, V16, P43, DOI 10.1002/1522-7278(2001)16:1<43::AID-TOX50>3.0.CO;2-R; Barrett Michael, 1995, Drug Metabolism and Drug Interactions, V12, P299; Batisson I, 2009, ENVIRON POLLUT, V157, P1195, DOI 10.1016/j.envpol.2008.12.009; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boger P, 2000, PEST MANAG SCI, V56, P497; Bonnet JL, 2008, ARCH ENVIRON CON TOX, V55, P576, DOI 10.1007/s00244-008-9145-2; Botelho RG, 2012, BRAZ J BIOL, V72, P141, DOI 10.1590/S1519-69842012000100016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; Cia MC, 2012, ANN APPL BIOL, V161, P313, DOI 10.1111/j.1744-7348.2012.00575.x; Crouzet O, 2010, SOIL BIOL BIOCHEM, V42, P193, DOI 10.1016/j.soilbio.2009.10.016; Cummins I, 2011, DRUG METAB REV, V43, P266, DOI 10.3109/03602532.2011.552910; Cycon M, 2013, APPL SOIL ECOL, V72, P242, DOI 10.1016/j.apsoil.2013.07.015; Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046; DESOUZA ML, 1995, APPL ENVIRON MICROB, V61, P3373, DOI 10.1128/AEM.61.9.3373-3378.1995; Durand S, 2006, LETT APPL MICROBIOL, V43, P222, DOI 10.1111/j.1472-765X.2006.01923.x; Durand S, 2010, CHEMOSPHERE, V81, P372, DOI 10.1016/j.chemosphere.2010.07.017; Fournier J, 1997, SOIL ECOTOXICOLOGY, P85; Garcia JS, 2006, J AGR FOOD CHEM, V54, P8623, DOI 10.1021/jf061593l; GAUDU P, 1994, EUR J BIOCHEM, V226, P459, DOI 10.1111/j.1432-1033.1994.tb20070.x; Ghelfi A, 2011, ANN APPL BIOL, V159, P267, DOI 10.1111/j.1744-7348.2011.00491.x; Gratao PL, 2008, ANN APPL BIOL, V153, P321, DOI 10.1111/j.1744-7348.2008.00299.x; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; Hatzios KK, 2004, WEED SCI, V52, P454, DOI 10.1614/P2002-168C; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hernandez M, 2011, FEMS MICROBIOL ECOL, V78, P511, DOI 10.1111/j.1574-6941.2011.01180.x; IIZUKA M, 1989, J BACTERIOL, V171, P6039, DOI 10.1128/jb.171.11.6039-6042.1989; Isarankura-Na-Ayudhya P, 2010, EXCLI J, V9, P108; Jiang L, 2008, J AGR FOOD CHEM, V56, P11933, DOI 10.1021/jf8023134; Jung IL, 2003, BIOCHEM BIOPH RES CO, V301, P915, DOI 10.1016/S0006-291X(03)00064-0; Kiely T, 2004, PESTICIDES IND SALES, P1; KRAUS TE, 1995, J PLANT PHYSIOL, V145, P570, DOI 10.1016/S0176-1617(11)81790-6; Lima E.S., 2001, BRAZ J PHARM SCI, V37, P293; Lopez-Perez GC, 2006, J AGR FOOD CHEM, V54, P1797, DOI 10.1021/jf0525737; Ma XX, 2009, EMBO REP, V10, P1320, DOI 10.1038/embor.2009.216; Martins PF, 2011, PROCESS BIOCHEM, V46, P1186, DOI 10.1016/j.procbio.2011.02.014; Martins PF, 2007, BRAZ ARCH BIOL TECHN, V50, P153, DOI 10.1590/S1516-89132007000100019; McGuinness MC, 2007, ENG LIFE SCI, V7, P611, DOI 10.1002/elsc.200720218; Medici LO, 2004, FUNCT PLANT BIOL, V31, P1, DOI 10.1071/FP03130; Mitchell G, 2001, PEST MANAG SCI, V57, P120, DOI 10.1002/1526-4998(200102)57:2<120::AID-PS254>3.0.CO;2-E; Monteiro CC, 2011, ENVIRON EXP BOT, V71, P306, DOI 10.1016/j.envexpbot.2010.12.020; NAGY I, 1995, APPL ENVIRON MICROB, V61, P2056, DOI 10.1128/AEM.61.5.2056-2060.1995; Nordby JN, 2008, WEED SCI, V56, P376, DOI 10.1614/WS-07-145.1; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Penna TCV, 2004, AFR J BIOTECHNOL, V3, P105; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; Pileggi M, 2012, CHEMOSPHERE, V86, P1127, DOI 10.1016/j.chemosphere.2011.12.041; Sanchez M, 2005, APPL MICROBIOL BIOT, V66, P589, DOI 10.1007/s00253-004-1735-y; Sands DC, 2009, PLANT SCI, V177, P377, DOI 10.1016/j.plantsci.2009.07.011; SHAO ZQ, 1995, APPL ENVIRON MICROB, V61, P2061, DOI 10.1128/AEM.61.5.2061-2065.1995; Sharma D, 2010, TALANTA, V82, P1077, DOI 10.1016/j.talanta.2010.06.043; Silva TM, 2007, BRAZ J MICROBIOL, V38, P522, DOI 10.1590/S1517-83822007000300026; Skopelitou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034263; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Van Eerd LL, 2003, WEED SCI, V51, P472, DOI 10.1614/0043-1745(2003)051[0472:PMIPAM]2.0.CO;2; Williams JA, 2009, BIOTECHNOL ADV, V27, P353, DOI 10.1016/j.biotechadv.2009.02.003; ZABLOTOWICZ RM, 1995, APPL ENVIRON MICROB, V61, P1054, DOI 10.1128/AEM.61.3.1054-1060.1995; Zhang Y, 2012, J HAZARD MATER, V229, P434, DOI 10.1016/j.jhazmat.2012.05.054	67	23	23	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99960	10.1371/journal.pone.0099960	http://dx.doi.org/10.1371/journal.pone.0099960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924203	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300110
J	Sun, P; Guo, JF; Guo, SC; Chen, JY; He, L; Fu, SM				Sun, Pei; Guo, Jianfei; Guo, Shichun; Chen, Jingyi; He, Le; Fu, Shimin			BOLD Signal Change and Contrast Reversing Frequency: An Event-Related fMRI Study in Human Primary Visual Cortex	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; CEREBRAL-BLOOD-FLOW; TEMPORAL-FREQUENCY; SPATIOTEMPORAL FREQUENCY; STIMULUS FREQUENCY; CORTICAL RESPONSE; RATE DEPENDENCE; BRAIN ACTIVITY; STRIATE; NEURONS	It is believed that human primary visual cortex (V1) increases activity with increasing temporal frequency of a visual stimulus. Two kinds of visual stimulus were used in the previous studies, one is patterned-flash stimulus with a fixed onset period and an increasing average luminance with the increase of temporal frequency, the other is contrast reversing flickering checkerboard or grating with a constant average luminance across different temporal frequencies. That hemodynamic responses change as a function of reversal frequency of contrast reversing checkerboard is at odds with neurophysiological studies in animals and neuroimaging studies in humans. In the present study, we addressed the relationship between reversal frequency of contrast reversing checkerboard and hemodynamic response in human V1 using an event-related experimental paradigm and found that the transient characteristics of blood oxygenation level dependent response in human V1 depended very little on the reversal frequency of a contrast reversing checkerboard.	[Sun, Pei; Guo, Jianfei; Guo, Shichun; Fu, Shimin] Tsinghua Univ, Dept Psychol, Sch Social Sci, Beijing 100084, Peoples R China; [Sun, Pei] RIKEN Brain Sci Inst, Lab Cognit Brain Mapping, Wako, Saitama, Japan; [Guo, Shichun] Tsinghua Univ, Dept Comp Sci, Beijing 100084, Peoples R China; [Chen, Jingyi] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [He, Le] Tsinghua Univ, Ctr Biomed Imaging Res, Beijing 100084, Peoples R China	Tsinghua University; RIKEN; Tsinghua University; Tsinghua University; Tsinghua University	Sun, P (corresponding author), Tsinghua Univ, Dept Psychol, Sch Social Sci, Beijing 100084, Peoples R China.	peisun@tsinghua.edu.cn	Fu, Shimin/A-6438-2008; Fu, Shimin/ABD-7806-2021		Natural Science Foundation of China [31371142]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	The project supported by the Natural Science Foundation of China (31371142) and sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; Bouvier SE, 2011, NEUROIMAGE, V57, P1177, DOI 10.1016/j.neuroimage.2011.04.012; BRUDER H, 1992, MAGNET RESON MED, V23, P311, DOI 10.1002/mrm.1910230211; D'Souza DV, 2011, J VISION, V11, DOI 10.1167/11.8.8; Emir UE, 2008, NEUROSCI LETT, V436, P185, DOI 10.1016/j.neulet.2008.03.021; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Fawcett IP, 2004, NEUROIMAGE, V21, P1542, DOI 10.1016/j.neuroimage.2003.10.045; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; FOX PT, 1985, ANN NEUROL, V17, P303, DOI 10.1002/ana.410170315; Hagenbeek RE, 2002, HUM BRAIN MAPP, V17, P244, DOI 10.1002/hbm.10067; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; IKEDA H, 1975, EXP BRAIN RES, V22, P363; Issa NP, 2008, J NEUROPHYSIOL, V99, P2745, DOI 10.1152/jn.90211.2008; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Kaufmann C, 2001, HUM BRAIN MAPP, V14, P28, DOI 10.1002/hbm.1039; Kim SG, 1996, MAGNET RESON MED, V35, P895, DOI 10.1002/mrm.1910350618; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Law I, 2001, J CEREBR BLOOD F MET, V21, P1003, DOI 10.1097/00004647-200108000-00013; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; Maas LC, 1997, MAGNET RESON MED, V37, P131, DOI 10.1002/mrm.1910370119; Mentis MJ, 1997, NEUROIMAGE, V5, P116, DOI 10.1006/nimg.1997.0256; Mirzajani A, 2007, PHYSIOL MEAS, V28, P547, DOI 10.1088/0967-3334/28/5/008; Moore Iv BD, 2005, J NEUROPHYSIOL; Moradi F, 2003, NEUROIMAGE, V18, P595, DOI 10.1016/S1053-8119(02)00053-8; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Mullen KT, 2010, J VISION, V10, DOI 10.1167/10.13.13; Muthukumaraswamy SD, 2008, NEUROIMAGE, V40, P1552, DOI 10.1016/j.neuroimage.2008.01.052; Norcia AM, 2005, J VISION, V5, P34, DOI 10.1167/5.1.4; Ozus B, 2001, MAGN RESON IMAGING, V19, P21, DOI 10.1016/S0730-725X(01)00219-3; Parkes LM, 2004, NEUROIMAGE, V21, P236, DOI 10.1016/j.neuroimage.2003.08.025; Pastor MA, 2003, J NEUROSCI, V23, P11621; REID RC, 1992, VISUAL NEUROSCI, V9, P39, DOI 10.1017/S0952523800006350; SAUL AB, 1992, VISUAL NEUROSCI, V8, P365, DOI 10.1017/S0952523800005101; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Singh M, 2003, MAGNET RESON MED, V49, P108, DOI 10.1002/mrm.10335; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Srinivasan R, 2007, EXP BRAIN RES, V180, P677, DOI 10.1007/s00221-007-0886-3; Sun P, 2007, NAT NEUROSCI, V10, P1404, DOI 10.1038/nn1983; Thomas CG, 1998, MAGNET RESON MED, V40, P203, DOI 10.1002/mrm.1910400206; To L, 2013, VISION RES, V90, P15, DOI 10.1016/j.visres.2013.04.011; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Toronov VY, 2006, NEUROIMAGE; Yen CCC, 2011, NEUROIMAGE, V58, P82, DOI 10.1016/j.neuroimage.2011.06.022; Zhu XH, 1998, MAGN RESON MED, V40, P703, DOI 10.1002/mrm.1910400510	47	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99547	10.1371/journal.pone.0099547	http://dx.doi.org/10.1371/journal.pone.0099547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924221	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300072
J	Wosnitzer, MS; Mielnik, A; Dabaja, A; Robinson, B; Schlegel, PN; Paduch, DA				Wosnitzer, Matthew S.; Mielnik, Anna; Dabaja, Ali; Robinson, Brian; Schlegel, Peter N.; Paduch, Darius A.			Ubiquitin Specific Protease 26 (USP26) Expression Analysis in Human Testicular and Extragonadal Tissues Indicates Diverse Action of USP26 in Cell Differentiation and Tumorigenesis	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; CARCINOMA-IN-SITU; RAT LEYDIG-CELLS; ANDROGEN-RECEPTOR; GENE-EXPRESSION; PROSTATE-CANCER; HUMAN SPERM; GERM-CELLS; TESTIS; LOCALIZATION	Ubiquitin specific protease 26 (USP26), a deubiquitinating enzyme, is highly expressed early during murine spermatogenesis, in round spermatids, and at the blood-testis barrier. USP26 has also been recognized as a regulator of androgen receptor (AR) hormone-induced action involved in spermatogenesis and steroid production in in vitro studies. Prior mutation screening of USP26 demonstrated an association with human male infertility and low testosterone production, but protein localization and expression in the human testis has not been characterized previously. USP26 expression analysis of mRNA and protein was completed using murine and human testis tissue and human tissue arrays. USP26 and AR mRNA levels in human testis were quantitated using multiplex qRT-PCR. Immunofluorescence colocalization studies were performed with formalin-fixed/paraffin-embedded and frozen tissues using primary and secondary antibodies to detect USP26 and AR protein expression. Human microarray dot blots were used to identify protein expression in extra-gonadal tissues. For the first time, expression of USP26 and colocalization of USP26 with androgen receptor in human testis has been confirmed predominantly in Leydig cell nuclei, with less in Leydig cell cytoplasm, spermatogonia, primary spermatocytes, round spermatids, and Sertoli cells. USP26 likely affects regulatory proteins of early spermatogenesis, including androgen receptor with additional activity in round spermatids. This X-linked gene is not testis-specific, with USP26 mRNA and protein expression identified in multiple other human organ tissues (benign and malignant) including androgen-dependent tissues such as breast (myoepithelial cells and secretory luminal cells) and thyroid tissue (follicular cells). USP26/AR expression and interaction in spermatogenesis and androgen-dependent cancer warrants additional study and may prove useful in diagnosis and management of male infertility.	[Wosnitzer, Matthew S.; Mielnik, Anna; Dabaja, Ali; Schlegel, Peter N.; Paduch, Darius A.] Weill Cornell Med Coll, Dept Urol, New York, NY 10065 USA; [Robinson, Brian] Weill Cornell Med Coll, Dept Pathol, New York, NY USA	Cornell University; Cornell University	Wosnitzer, MS (corresponding author), Weill Cornell Med Coll, Dept Urol, New York, NY 10065 USA.	maw7011@med.cornell.edu	Wosnitzer, Matthew/O-4398-2019; Wosnitzer, Matthew/ABA-2308-2021; Paduch, Darius/AAD-9734-2020	Wosnitzer, Matthew/0000-0001-5379-9678; Paduch, Darius/0000-0003-1105-3493	Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust; New York Academy of Medicine - Ferdinand C. Valentine Fellowship in Urology; Society for the Study of Male Reproduction (SSMR) Research Grant	Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust; New York Academy of Medicine - Ferdinand C. Valentine Fellowship in Urology; Society for the Study of Male Reproduction (SSMR) Research Grant	This work was supported by The Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust (http://issuu.com/nyct/docs/nyct_ar12_final_5.22/52), the New York Academy of Medicine - Ferdinand C. Valentine Fellowship in Urology 2013-2014 (http://www.nyam.org/grants/valentine.html) ,and the Society for the Study of Male Reproduction (SSMR) Research Grant (http://ssmr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGELL N, 1988, BIOCHEM J, V250, P883, DOI 10.1042/bj2500883; Akimoto C, 2010, P NATL ACAD SCI USA, V107, P19891, DOI 10.1073/pnas.1010307107; Andersson AM, 2004, J CLIN ENDOCR METAB, V89, P3161, DOI 10.1210/jc.2003-031786; Aquila S, 2007, HUM REPROD, V22, P2594, DOI 10.1093/humrep/dem243; Aston KI, 2010, HUM REPROD, V25, P1383, DOI 10.1093/humrep/deq081; Baarends WM, 2000, J ENDOCRINOL INVEST, V23, P597, DOI 10.1007/BF03343782; Black BE, 2004, MOL ENDOCRINOL, V18, P834, DOI 10.1210/me.2003-0145; BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227; BRYAN RM, 1984, CANCER, V54, P2436, DOI 10.1002/1097-0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO;2-H; Cardozo CP, 2003, ARCH BIOCHEM BIOPHYS, V410, P134, DOI 10.1016/S0003-9861(02)00680-X; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Davis-Dao CA, 2011, CARCINOGENESIS, V32, P1238, DOI 10.1093/carcin/bgr104; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; de Vries M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031485; DEMEYTS ER, 1992, J ENDOCRINOL, V135, pR1, DOI 10.1677/joe.0.135R001; Dirac AMG, 2010, MOL CANCER RES, V8, P844, DOI 10.1158/1541-7786.MCR-09-0424; Finley Daniel, 2004, Cell, VS116, pS29, DOI 10.1016/S0092-8674(03)00971-1; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2004, NAT CELL BIOL, V6, P571, DOI 10.1038/ncb0704-571; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Jacobsen R, 2000, BMJ-BRIT MED J, V321, P789, DOI 10.1136/bmj.321.7264.789; JANSSEN PJ, 1994, J HISTOCHEM CYTOCHEM, V42, P1169, DOI 10.1177/42.8.8027537; Joensen UN, 2007, NAT CLIN PRACT UROL, V4, P402, DOI 10.1038/ncpuro0859; Johnson L, 2001, HUM REPROD, V16, P1575, DOI 10.1093/humrep/16.8.1575; Kawate H, 2005, J CLIN ENDOCR METAB, V90, P6162, DOI 10.1210/jc.2005-0179; Lee IW, 2008, ASIAN J ANDROL, V10, P896, DOI 10.1111/j.1745-7262.2008.00439.x; Lin YW, 2011, INT J ANDROL, V34, pE368, DOI 10.1111/j.1365-2605.2010.01130.x; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Mancini M, 2007, HUM REPROD, V22, P1042, DOI 10.1093/humrep/del500; Merlet J, 2007, P NATL ACAD SCI USA, V104, P3615, DOI 10.1073/pnas.0611421104; Miyajima N, 2008, CANCER RES, V68, P3486, DOI 10.1158/0008-5472.CAN-07-6059; ORTEGO LS, 1994, BIOTECH HISTOCHEM, V69, P317, DOI 10.3109/10520299409106312; Paduch DA, 2005, REPROD BIOMED ONLINE, V10, P747; Pelletier G, 2000, J ENDOCRINOL, V165, P359, DOI 10.1677/joe.0.1650359; Petersen PM, 1999, J CLIN ONCOL, V17, P173, DOI 10.1200/JCO.1999.17.1.173; Sciarra A, 2013, EUR UROL, V64, P722, DOI 10.1016/j.eururo.2013.04.020; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Solakidi S, 2005, HUM REPROD, V20, P3481, DOI 10.1093/humrep/dei267; Stanleya JA, 2010, STEROIDS, V75, P1058, DOI 10.1016/j.steroids.2010.06.009; Steger K, 1998, MOL HUM REPROD, V4, P227, DOI 10.1093/molehr/4.3.227; Stouffs K, 2005, EUR J HUM GENET, V13, P336, DOI 10.1038/sj.ejhg.5201335; Suarez-Quian CA, 1999, J CLIN ENDOCR METAB, V84, P350, DOI 10.1210/jc.84.1.350; TOBIAS JW, 1991, J BIOL CHEM, V266, P12021; van den Driesche S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030111; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Weissman BA, 2005, J ANDROL, V26, P369, DOI 10.2164/jandrol.04178; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wong YC, 2001, MARC MALPIG SYMP SER, V7, P111; Wrobel KH, 2000, ANAT EMBRYOL, V202, P209, DOI 10.1007/s004290000111; Zhang J, 2007, ASIAN J ANDROL, V9, P809, DOI 10.1111/j.1745-7262.2007.00305.x; Zhang J, 2009, ASIAN J ANDROL, V11, P478, DOI 10.1038/aja.2009.31; Zhou Q, 2002, J ANDROL, V23, P870	58	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98638	10.1371/journal.pone.0098638	http://dx.doi.org/10.1371/journal.pone.0098638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922532	Green Submitted, Green Published, gold			2022-12-25	WOS:000338701300010
J	Zhao, DB; Ning, NN; Lei, Z; Sun, H; Wei, CF; Chen, DW; Li, JX				Zhao, Dongbo; Ning, Nannan; Lei, Zhen; Sun, Hua; Wei, Chuanfei; Chen, Dawei; Li, Jingxin			Identification of a Novel Protein Complex Containing ASIC1a and GABA(A) Receptors and Their Interregulation	PLOS ONE			English	Article							PROTON MODULATION; CONTRIBUTES; EXPRESSION; CHANNELS; CALCIUM	Acid-sensing ion channels (ASICs) belong to the family of the epithelial sodium channel/degenerin (ENaC/DEG) and are activated by extracellular protons. They are widely distributed within both the central and peripheral nervous systems. ASICs were modified by the activation of gamma-aminobutyric acid receptors (GABA(A)), a ligand-gated chloride channels, in hippocampal neurons. In contrast, the activity of GABA(A) receptors were also modulated by extracellular pH. However so far, the mechanisms underlying this intermodulation remain obscure. We hypothesized that these two receptors-GABA(A) receptors and ASICs channels might form a novel protein complex and functionally interact with each other. In the study reported here, we found that ASICs were modified by the activation of GABA(A) receptors either in HEK293 cells following transient co-transfection of GABA(A) and ASIC1a or in primary cultured dorsal root ganglia (DRG) neurons. Conversely, activation of ASIC1a also modifies the GABA(A) receptor-channel kinetics. Immunoassays showed that both GABA(A) and ASIC1a proteins were co-immunoprecipitated mutually either in HEK293 cells co-transfected with GABA(A) and ASIC1a or in primary cultured DRG neurons. Our results indicate that putative GABA(A) and ASIC1a channels functionally interact with each other, possibly via an inter-molecular association by forming a novel protein complex.	[Zhao, Dongbo; Sun, Hua] Shandong Canc Hosp & Inst, Dept Thorac Surg, Jinan, Peoples R China; [Ning, Nannan; Wei, Chuanfei; Chen, Dawei; Li, Jingxin] Shandong Univ, Dept Physiol, Sch Med, Jinan 250100, Peoples R China; [Lei, Zhen] Shandong Univ, Dept Anesthesiol, Qilu Hosp, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Li, JX (corresponding author), Shandong Univ, Dept Physiol, Sch Med, Jinan 250100, Peoples R China.	ljingxin@sdu.edu.cn		Chen, Dawei/0000-0002-2541-4512	Promotive Research Fund for Excellent Young and Middle-Aged Scientists of Shandong Province [BS2010SW029]; National Natural Science Foundation of China [31171108]	Promotive Research Fund for Excellent Young and Middle-Aged Scientists of Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Promotive Research Fund for Excellent Young and Middle-Aged Scientists of Shandong Province (No. BS2010SW029) and the National Natural Science Foundation of China (No. 31171108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chen X, PLOS ONE, V6; Chen XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021970; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; Dietrich CJ, 2010, J NEUROSCI, V30, P16044, DOI 10.1523/JNEUROSCI.6364-09.2010; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Huang RQ, 2004, J NEUROPHYSIOL, V92, P883, DOI 10.1152/jn.01040.2003; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; Mamet J, 2002, J NEUROSCI, V22, P10662; ROBELLO M, 1994, NEUROSCIENCE, V61, P833, DOI 10.1016/0306-4522(94)90406-5; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Wilkins ME, 2005, J PHYSIOL-LONDON, V567, P365, DOI 10.1113/jphysiol.2005.088823; Wilkins ME, 2002, J NEUROSCI, V22, P5328; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zhou CY, 2007, BRAIN RES, V1145, P213, DOI 10.1016/j.brainres.2007.01.121; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	24	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99735	10.1371/journal.pone.0099735	http://dx.doi.org/10.1371/journal.pone.0099735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923912	Green Submitted, gold, Green Published			2022-12-25	WOS:000338701300090
J	Leng, YP; Qiu, N; Fang, WJ; Zhang, M; He, ZM; Xiong, Y				Leng, Yi-Ping; Qiu, Ni; Fang, Wei-jin; Zhang, Mei; He, Zhi-Min; Xiong, Yan			Involvement of Increased Endogenous Asymmetric Dimethylarginine in the Hepatic Endoplasmic Reticulum Stress of Type 2 Diabetic Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INDUCED INSULIN-RESISTANCE; ENDOTHELIAL DYSFUNCTION; ER STRESS; KINASE; INHIBITION; APOPTOSIS; HOMEOSTASIS; ACTIVATION; EXPRESSION	Objective: Increasing evidence suggested that endoplasmic reticulum (ER) stress contributes to insulin resistance, which plays an important role in the development of type 2 diabetes mellitus (T2DM). Accumulation of endogenous nitric oxide synthase (NOS) inhibitor, asymmetric dimethylarginine (ADMA), is associated with insulin resistance, T2DM, and diabetic cardiovascular complications, although the mechanisms have not been elucidated. This study was to determine whether elevated endogenous ADMA is involved in hepatic ER stress of type 2 diabetic rats, verify their causal relationship, and elucidate the potential mechanism underlying ADMA induced ER stress in rat hepatocytes. Methods: Immunoglobulin binding protein (Bip) transcription, eukaryotic initiation factor 2 alpha kinase (eIF2 alpha) phosphorylation, X box-binding protein-1 (XBP-1) mRNA splicing and C/EBP homologues protein (CHOP) expression were measured to reflect ER stress. Contents of ADMA and nitrite/nitrate as well as activities or expression of NOS and dimethylarginine dimethylaminohydrolase (DDAH) were detected to show the changes in DDAH/ADMA/NOS/NO pathway. The lipid peroxidation product malondialdehyde content and antioxidant enzyme superoxide dismutase activity were analyzed to evaluate oxidative stress. Results: ER stress was provoked in the liver of type 2 diabetic rats, as expressed by increases of Bip transcription, eIF2a phosphorylation, XBP-1 splicing and CHOP expression, all of which were in parallel with the elevation of serum ADMA, suppression of NO generation, NOS and DDAH activities in the liver. Exposure of hepatocytes to ADMA or hydrogen peroxide also induced ER stress, which was associated with the inhibition of NO production and increase of oxidative stress. Treatment of hepatocytes with antioxidant pyrrolidine dithiocarbamate not only decreased ADMA-induced oxidative stress and inhibition of NO production but also reduced ADMA-triggered ER stress. Conclusions: These results indicate that increased endogenous ADMA contributes to hepatic ER stress in type 2 diabetic rats, and the mechanism underlying ADMA-induced ER stress may relate to oxidative stress via NOS uncoupling.	[Qiu, Ni; Fang, Wei-jin; Zhang, Mei; Xiong, Yan] Guangzhou Med Univ, Guangzhou Res Inst Snake Venom, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China; [Qiu, Ni; Fang, Wei-jin; Zhang, Mei; Xiong, Yan] Guangzhou Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Leng, Yi-Ping; Xiong, Yan] Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha, Hunan, Peoples R China; [He, Zhi-Min] Guangzhou Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [He, Zhi-Min] Guangzhou Med Univ, Canc Hosp, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Central South University; Guangzhou Medical University; Guangzhou Medical University	Xiong, Y (corresponding author), Guangzhou Med Univ, Guangzhou Res Inst Snake Venom, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China.	Xiongyan2001@yahoo.com	Fang, Weijin/J-3449-2014		Natural Science Research Foundation of China [30873062, 81170778]; Guangzhou Municipal Science and Technology and Information Bureau	Natural Science Research Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Municipal Science and Technology and Information Bureau	This study was supported by the grants from the Natural Science Research Foundation of China (No. 30873062 & 81170778) and from Guangzhou Municipal Science and Technology and Information Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chao PL, 2007, ANN NY ACAD SCI, V1122, P276, DOI 10.1196/annals.1403.020; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Fu YF, 2005, EUR J PHARMACOL, V508, P167, DOI 10.1016/j.ejphar.2004.11.063; Guo WK, 2014, INT J MOL SCI, V15, P484, DOI 10.3390/ijms15010484; Han KL, 2008, DIABETES, V57, P737, DOI 10.2337/db07-0972; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Ji YL, 2013, ASIAN J ANDROL, V15, P290, DOI 10.1038/aja.2012.129; Juan CC, 2005, ENDOCRINOLOGY, V146, P2246, DOI 10.1210/en.2004-1136; Jung TW, 2014, MOL CELL ENDOCRINOL, V382, P66, DOI 10.1016/j.mce.2013.09.013; Kaneto H, 2005, INT J BIOCHEM CELL B, V37, P1595, DOI 10.1016/j.biocel.2005.04.003; Kim SH, 2001, BIOCHEM BIOPH RES CO, V281, P367, DOI 10.1006/bbrc.2001.4376; Lee EK, 2012, NEPHRON EXP NEPHROL, V121, pE38, DOI 10.1159/000342802; Li Y, 2013, J BIOL CHEM, V288, P9583, DOI 10.1074/jbc.M112.431627; Lim SK, 2013, FOOD CHEM TOXICOL, V62, P763, DOI 10.1016/j.fct.2013.10.014; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Lu CW, 2007, NITRIC OXIDE-BIOL CH, V16, P94, DOI 10.1016/j.niox.2006.07.006; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Nakamura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060517; Nakatani Y, 2006, DIABETIC MED, V23, P216, DOI 10.1111/j.1464-5491.2005.01766.x; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rodionov RN, 2010, J BIOL CHEM, V285, P5385, DOI 10.1074/jbc.M109.091280; Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046; Sheikh-Ali M, 2010, NUTRITION, V26, P1146, DOI 10.1016/j.nut.2009.08.019; Solovyova N, 2002, EMBO J, V21, P622, DOI 10.1093/emboj/21.4.622; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Stuhlinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420, DOI 10.1001/jama.287.11.1420; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Taniguchi Y, 2006, DIABETES, V55, P2371, DOI 10.2337/db06-0268; Tyra HM, 2012, MOL BIOL CELL, V23, P811, DOI 10.1091/mbc.E11-12-1011; Watanabe Y, 2003, J CELL BIOCHEM, V89, P244, DOI 10.1002/jcb.10501; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Xiong Y, 2005, LIFE SCI, V77, P149, DOI 10.1016/j.lfs.2004.10.062; Xiong Y, 2003, J CARDIOVASC PHARM, V42, P191, DOI 10.1097/00005344-200308000-00006; Xiong Y, 1997, ACTA PHARMACOL SIN, V18, P511; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yin QF, 2005, J CARDIOVASC PHARM, V45, P525, DOI 10.1097/01.fjc.0000159642.44523.7f; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zhou QG, 2009, AM J PHYSIOL-ENDOC M, V296, pE869, DOI 10.1152/ajpendo.91011.2008	44	14	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e97125	10.1371/journal.pone.0097125	http://dx.doi.org/10.1371/journal.pone.0097125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918756	gold, Green Submitted, Green Published			2022-12-25	WOS:000338631000007
J	Rong, XZ; Chen, C; Zhou, P; Zhou, YM; Li, Y; Lu, L; Liu, YZ; Zhou, JF; Duan, CM				Rong, Xiaozhi; Chen, Chen; Zhou, Pin; Zhou, Yumei; Li, Yun; Lu, Ling; Liu, Yunzhang; Zhou, Jianfeng; Duan, Cunming			R-Spondin 3 Regulates Dorsoventral and Anteroposterior Patterning by Antagonizing Wnt/beta-Catenin Signaling in Zebrafish Embryos	PLOS ONE			English	Article							BETA-CATENIN; SPEMANN ORGANIZER; GASTRULATION MOVEMENTS; GENE-EXPRESSION; AXIS FORMATION; WNT PATHWAY; RECEPTORS; MESODERM; FAMILY; LRP6	The Wnt/beta-catenin or canonical Wnt signaling pathway plays fundamental roles in early development and in maintaining adult tissue homeostasis. R-spondin 3 (Rspo3) is a secreted protein that has been implicated in activating the Wnt/beta-catenin signaling in amphibians and mammals. Here we report that zebrafish Rspo3 plays a negative role in regulating the zygotic Wnt/beta-catenin signaling. Zebrafish Rspo3 has a unique domain structure. It contains a third furin-like (FU3) domain. This FU3 is present in other four ray-finned fish species studied but not in elephant shark. In zebrafish, rspo3 mRNA is maternally deposited and has a ubiquitous expression in early embryonic stages. After 12 hpf, its expression becomes tissue-specific. Forced expression of rspo3 promotes dorsoanterior patterning and increases the expression of dorsal and anterior marker genes. Knockdown of rspo3 increases ventral-posterior development and stimulates ventral and posterior marker genes expression. Forced expression of rspo3 abolishes exogenous Wnt3a action and reduces the endogenous Wnt signaling activity. Knockdown of rspo3 results in increased Wnt/beta-catenin signaling activity. Further analyses indicate that Rspo3 does not promote maternal Wnt signaling. Human RSPO3 has similar action when tested in zebrafish embryos. These results suggest that Rspo3 regulates dorsoventral and anteroposterior patterning by negatively regulating the zygotic Wnt/beta-catenin signaling in zebrafish embryos.	[Rong, Xiaozhi; Chen, Chen; Zhou, Pin; Zhou, Yumei; Li, Yun; Lu, Ling; Liu, Yunzhang; Zhou, Jianfeng] Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China; [Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Ocean University of China; University of Michigan System; University of Michigan	Zhou, JF (corresponding author), Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China.	jfzhou@ouc.edu.cn; cduan@umich.edu	Zhou, Yu/HHN-3071-2022		Major Science Programs of China [2011CB943800]; National Science Foundation of China [30972238, 40876064, 30970357, 30928021]; US National Science Foundation (NSF) Research Grant [IOS-1051034]; Division Of Integrative Organismal Systems [1051034] Funding Source: National Science Foundation	Major Science Programs of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation (NSF) Research Grant(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from Major Science Programs of China (#2011CB943800) and the National Science Foundation of China (Grant #30972238, #40876064, #30970357 and #30928021). C. D. was supported by US National Science Foundation (NSF) Research Grant IOS-1051034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Baker KD, 2010, DEV DYNAM, V239, P2828, DOI 10.1002/dvdy.22419; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Birchmeier W, 2011, NATURE, V476, P287, DOI 10.1038/476287a; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; Erter CE, 2001, DEVELOPMENT, V128, P3571; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Feng Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052674; Furthauer M, 2004, DEVELOPMENT, V131, P2853, DOI 10.1242/dev.01156; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; Hikasa H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007955; Kagermeier-Schenk B, 2011, DEV CELL, V21, P1129, DOI 10.1016/j.devcel.2011.10.015; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kelly C, 2000, DEVELOPMENT, V127, P3899; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; MacDonald BT, 2012, CELL RES, V22, P1410, DOI 10.1038/cr.2012.91; Maures TJ, 2002, ENDOCRINOLOGY, V143, P2722, DOI 10.1210/en.143.7.2722; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nojima H, 2004, MECH DEVELOP, V121, P371, DOI 10.1016/j.mod.2004.02.003; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Pelegri F, 1998, MECH DEVELOP, V77, P63, DOI 10.1016/S0925-4773(98)00132-4; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Reifers F, 1998, DEVELOPMENT, V125, P2381; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Ryu SL, 2001, DEV BIOL, V231, P397, DOI 10.1006/dbio.2000.0150; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; Shinya M, 2000, MECH DEVELOP, V98, P3, DOI 10.1016/S0925-4773(00)00433-0; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Tsang M, 2004, DEVELOPMENT, V131, P2769, DOI 10.1242/dev.01157; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Wu CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4149; Xie Y, 2013, EMBO REP; Yamamoto A, 2005, CELL, V120, P223, DOI 10.1016/j.cell.2004.11.051; Yamanaka Y, 1998, GENE DEV, V12, P2345, DOI 10.1101/gad.12.15.2345; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023	60	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99514	10.1371/journal.pone.0099514	http://dx.doi.org/10.1371/journal.pone.0099514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918770	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000091
J	Yu, ZY; Tan, JC; McMahon, AC; Iismaa, SE; Xiao, XH; Kesteven, SH; Reichelt, ME; Mohl, MC; Smith, NJ; Fatkin, D; Allen, D; Head, SI; Graham, RM; Feneley, MP				Yu, Ze-Yan; Tan, Ju-Chiat; McMahon, Aisling C.; Iismaa, Siiri E.; Xiao, Xiao-Hui; Kesteven, Scott H.; Reichelt, Melissa E.; Mohl, Marion C.; Smith, Nicola J.; Fatkin, Diane; Allen, David; Head, Stewart I.; Graham, Robert M.; Feneley, Michael P.			RhoA/ROCK Signaling and Pleiotropic alpha(1A)-Adrenergic Receptor Regulation of Cardiac Contractility	PLOS ONE			English	Article							RHO-KINASE; HEART-FAILURE; ACTIVATION; MICE; OVEREXPRESSION; DYSFUNCTION; INHIBITION; PHOSPHORYLATION; HYPERTROPHY; PROTEINS	Aims: To determine the mechanisms by which the alpha(1A)-adrenergic receptor (AR) regulates cardiac contractility. Background: We reported previously that transgenic mice with cardiac-restricted alpha(1A)-AR overexpression (alpha(1A)-TG) exhibit enhanced contractility but not hypertrophy, despite evidence implicating this G alpha(q/11)-coupled receptor in hypertrophy. Methods: Contractility, calcium (Ca2+) kinetics and sensitivity, and contractile proteins were examined in cardiomyocytes, isolated hearts and skinned fibers from alpha(1A)-TG mice (170-fold overexpression) and their non-TG littermates (NTL) before and after alpha(1A)-AR agonist stimulation and blockade, angiotensin II (AngII), and Rho kinase (ROCK) inhibition. Results: Hypercontractility without hypertrophy with alpha(1A)-AR overexpression is shown to result from increased intracellular Ca2+ release in response to agonist, augmenting the systolic amplitude of the intracellular Ca2+ concentration [Ca2+](i) transient without changing resting [Ca2+](i). In the absence of agonist, however, alpha(1A)-AR overexpression reduced contractility despite unchanged [Ca2+](i). This hypocontractility is not due to heterologous desensitization: the contractile response to AngII, acting via its G alpha(q/11)-coupled receptor, was unaltered. Rather, the hypocontractility is a pleiotropic signaling effect of the alpha(1A)-AR in the absence of agonist, inhibiting RhoA/ROCK activity, resulting in hypophosphorylation of both myosin phosphatase targeting subunit 1 (MYPT1) and cardiac myosin light chain 2 (cMLC2), reducing the Ca2+ sensitivity of the contractile machinery: all these effects were rapidly reversed by selective alpha(1A)-AR blockade. Critically, ROCK inhibition in normal hearts of NTLs without alpha(1A)-AR overexpression caused hypophosphorylation of both MYPT1 and cMLC2, and rapidly reduced basal contractility. Conclusions: We report for the first time pleiotropic alpha(1A)-AR signaling and the physiological role of RhoA/ROCK signaling in maintaining contractility in the normal heart.	[Yu, Ze-Yan; Tan, Ju-Chiat; McMahon, Aisling C.; Iismaa, Siiri E.; Xiao, Xiao-Hui; Kesteven, Scott H.; Reichelt, Melissa E.; Mohl, Marion C.; Smith, Nicola J.; Fatkin, Diane; Graham, Robert M.; Feneley, Michael P.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Yu, Ze-Yan; McMahon, Aisling C.; Fatkin, Diane; Graham, Robert M.; Feneley, Michael P.] St Vincents Hosp, Dept Cardiol, Darlinghurst, NSW 2010, Australia; [Yu, Ze-Yan; Iismaa, Siiri E.; Smith, Nicola J.; Fatkin, Diane; Graham, Robert M.; Feneley, Michael P.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Allen, David] Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia; [Head, Stewart I.] Univ New S Wales, Dept Physiol, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney	Feneley, MP (corresponding author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia.	mfeneley@stvincents.com.au	Reichelt, Melissa E/C-9579-2014; Head, Stewart/O-7016-2019; Iismaa, Siiri/C-9300-2013	Reichelt, Melissa E/0000-0002-5059-2046; Head, Stewart/0000-0002-6891-7590; Smith, Nicola J/0000-0002-7247-9562; Iismaa, Siiri/0000-0003-2409-7356	National Health and Medical Research Council of Australia Program [354400, 573732, 526622]	National Health and Medical Research Council of Australia Program(National Health and Medical Research Council (NHMRC) of Australia)	National Health and Medical Research Council of Australia Program Grants #354400, 573732, 526622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Chaulet H, 2006, J MOL CELL CARDIOL, V40, P540, DOI 10.1016/j.yjmcc.2006.01.015; Chu L, 2005, N-S ARCH PHARMACOL, V371, P185, DOI 10.1007/s00210-005-1032-z; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Du XJ, 2006, CARDIOVASC RES, V71, P735, DOI 10.1016/j.cardiores.2006.06.015; Du XJ, 2004, J MOL CELL CARDIOL, V37, P979, DOI 10.1016/j.yjmcc.2004.07.010; Hamid SA, 2007, AM J PHYSIOL-HEART C, V292, pH2598, DOI 10.1152/ajpheart.01393.2006; Hattori T, 2004, CIRCULATION, V109, P2234, DOI 10.1161/01.CIR.0000127939.16111.58; HEAD SI, 1990, J PHYSIOL-LONDON, V422, P351, DOI 10.1113/jphysiol.1990.sp017988; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KNOWLTON KU, 1993, J BIOL CHEM, V268, P15374; Kobayashi N, 2002, CARDIOVASC RES, V55, P757, DOI 10.1016/S0008-6363(02)00457-1; Lin G, 2001, CIRC RES, V89, P343, DOI 10.1161/hh1601.095912; Lin GR, 2007, CARDIOVASC RES, V75, P51, DOI 10.1016/j.cardiores.2007.03.009; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Mohl MC, 2011, CARDIOVASC RES, V91, P310, DOI 10.1093/cvr/cvr081; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Perez DM, 1996, MOL PHARMACOL, V49, P112; Satoh N, 2000, CIRCULATION, V102, P2249; Smith NJ, 2011, HYPERTENSION, V57, P973, DOI 10.1161/HYPERTENSIONAHA.110.166710; Solaro RJ, 2008, CARDIOVASC RES, V77, P616, DOI 10.1093/cvr/cvn004; van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5; Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202; Zhao X, 2012, AM J PHYSIOL-HEART C, V302, pH1614, DOI 10.1152/ajpheart.01072.2011	25	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99024	10.1371/journal.pone.0099024	http://dx.doi.org/10.1371/journal.pone.0099024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919197	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000040
J	Jesudasan, SJB; Todd, KG; Winship, IR				Jesudasan, Sam Joshva Baskar; Todd, Kathryn G.; Winship, Ian R.			Reduced Inflammatory Phenotype in Microglia Derived from Neonatal Rat Spinal Cord versus Brain	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE; INDUCED NEUROTOXICITY; CYTOKINE EXPRESSION; MICE DEFICIENT; TNF-ALPHA; IN-VIVO; INJURY	Microglia are the primary immune cells of the central nervous system (CNS). Membrane bound sensors on their processes monitor the extracellular environment and respond to perturbations of the CNS such as injury or infection. Once activated, microglia play a crucial role in determining neuronal survival. Recent studies suggest that microglial functional response properties vary across different regions of the CNS. However, the activation profiles of microglia derived from the spinal cord have not been evaluated against brain microglia in vitro. Here, we studied the morphological properties and secretion of inflammatory and trophic effectors by microglia derived from the brain or spinal cord of neonatal rats under basal culture conditions and after activation with lipopolysaccharide (LPS). Our results demonstrate that spinal microglia assume a less inflammatory phenotype after LPS activation, with reduced release of the inflammatory effectors tumor necrosis factor alpha, interleukin-1 beta, and nitric oxide, a less amoeboid morphology, and reduced phagocytosis relative to brain-derived microglia. Phenotypic differences between brain and spinal microglia are an important consideration when evaluating anti-inflammatory or immunomodulatory therapies for brain versus spinal injury.	[Jesudasan, Sam Joshva Baskar; Todd, Kathryn G.; Winship, Ian R.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Jesudasan, Sam Joshva Baskar; Todd, Kathryn G.; Winship, Ian R.] Univ Alberta, Dept Psychiat, Neurochem Res Unit, Edmonton, AB, Canada	University of Alberta; University of Alberta	Winship, IR (corresponding author), Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada.	iwinship@ualberta.ca			Alberta Innovates Health Solutions; Heart and Stroke Foundation of Canada; Natural Science and Engineering Research Council; Canadian Institutes of Health Research; George and Dorthy Davey Endowment Fund for Brain Injury Research	Alberta Innovates Health Solutions; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); George and Dorthy Davey Endowment Fund for Brain Injury Research	This research is funded by Alberta Innovates Health Solutions [IRW], the Heart and Stroke Foundation of Canada [IRW], the Natural Science and Engineering Research Council [IRW], Canadian Institutes of Health Research [KGT, IRW] and George and Dorthy Davey Endowment Fund for Brain Injury Research [KGT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERKA D, 1989, J IMMUNOL, V143, P3517; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Araki E, 2001, STROKE, V32, P2370, DOI 10.1161/hs1001.096057; Armstrong L, 1996, THORAX, V51, P143, DOI 10.1136/thx.51.2.143; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Broderick C, 2000, INVEST OPHTH VIS SCI, V41, P2613; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Castillo J, 2000, STROKE, V31, P852, DOI 10.1161/01.STR.31.4.852; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Clausen BH, 2005, NEUROSCIENCE, V132, P879, DOI 10.1016/j.neuroscience.2005.01.031; Diab A, 1997, J NEUROPATH EXP NEUR, V56, P641; Downes N, 2013, DEV MYELIN BRAIN JUV; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Gingras M, 2007, J NEUROSCI METH, V163, P111, DOI 10.1016/j.jneumeth.2007.02.024; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hill JK, 1999, BRAIN RES, V820, P45, DOI 10.1016/S0006-8993(98)01140-8; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Hua K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052728; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; KADER A, 1993, STROKE, V24, P1709, DOI 10.1161/01.STR.24.11.1709; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kurpius D, 2007, GLIA, V55, P873, DOI 10.1002/glia.20509; Lai AY, 2013, NEUROSCIENCE, V254, P185, DOI 10.1016/j.neuroscience.2013.09.010; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Lai AY, 2011, NEURON GLIA BIOL, V7, P5, DOI 10.1017/S1740925X12000154; Lai AY, 2006, CAN J PHYSIOL PHARM, V84, P49, DOI 10.1139/y05-143; Lai AY, 2006, GLIA, V53, P809, DOI 10.1002/glia.20335; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Lambertsen KL, 2009, J NEUROSCI, V29, P1319, DOI 10.1523/JNEUROSCI.5505-08.2009; Ledeboer A, 2002, EUR J NEUROSCI, V16, P1175, DOI 10.1046/j.1460-9568.2002.02200.x; Ma TC, 2000, ARZNEIMITTELFORSCH, V50, P512; Matsui T, 2010, ANESTH ANALG, V111, P554, DOI 10.1213/ANE.0b013e3181e3a2a2; Nakamura Y, 1999, NEUROSCI RES, V35, P95, DOI 10.1016/S0168-0102(99)00071-1; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Olson JK, 2010, ANN NY ACAD SCI, V1198, P271, DOI 10.1111/j.1749-6632.2010.05536.x; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Rezaie P, 1999, MICROSC RES TECHNIQ, V45, P359, DOI 10.1002/(SICI)1097-0029(19990615)45:6<359::AID-JEMT4>3.3.CO;2-4; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Siao CJ, 2002, J NEUROSCI, V22, P3352; Smith PD, 2012, CIRCULATION, V126, pS110, DOI 10.1161/CIRCULATIONAHA.111.080275; Sriram K, 2002, FASEB J, V16, P1474, DOI 10.1096/fj.02-0216fje; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Taoufik E, 2007, J NEUROSCI, V27, P6633, DOI 10.1523/JNEUROSCI.1091-07.2007; TARKOWSKI E, 1995, STROKE, V26, P1393, DOI 10.1161/01.STR.26.8.1393; Taylor DL, 2005, J NEUROSCI, V25, P2952, DOI 10.1523/JNEUROSCI.4456-04.2005; von Zahn J, 1997, NEUROREPORT, V8, P3851, DOI 10.1097/00001756-199712220-00003; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang XK, 2004, MOL PHARMACOL, V65, P890, DOI 10.1124/mol.65.4.890; Werry EL, 2011, NEUROSCIENCE, V175, P93, DOI 10.1016/j.neuroscience.2010.10.080; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yip PK, 2009, J NEUROSCI METH, V183, P223, DOI 10.1016/j.jneumeth.2009.07.002	59	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99443	10.1371/journal.pone.0099443	http://dx.doi.org/10.1371/journal.pone.0099443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914808	gold, Green Submitted, Green Published			2022-12-25	WOS:000340947700103
J	Mangia, AL; Pirini, M; Simoncini, L; Cappello, A				Mangia, Anna Lisa; Pirini, Marco; Simoncini, Laura; Cappello, Angelo			A Feasibility Study of an Improved Procedure for Using EEG to Detect Brain Responses to Imagery Instruction in Patients with Disorders of Consciousness	PLOS ONE			English	Article							VEGETATIVE STATE; MOTOR IMAGERY; COMPUTER INTERFACE; CHANNEL SELECTION; AWARENESS; CLASSIFICATION; RELIABILITY; MODULATION; ACTIVATION; MOVEMENTS	One of the major concerns of recent studies is the correct discrimination between vegetative and minimally conscious state as the distinction between these two conditions has major implications for subsequent patient rehabilitation. In particular, it would be advantageous to establish communication with these patients. This work describes a procedure using EEG to detect brain responses to imagery instruction in patients with disorders of consciousness. Five healthy subjects and five patients with different disorders of consciousness took part in the study. A support vector machine classifier applied to EEG data was used to distinguish two mental tasks (Imagery Trial) and to detect answers to simple yes or no questions (pre-Communication Trial). The proposed procedure uses feature selection based on a nested-leave-one-out algorithm to reduce the number of electrodes required. We obtained a mean classification accuracy of 82.0% (SD 5.1%) for healthy subjects and 84.6% (SD 9.1%) for patients in the Imagery Trial, and a mean classification accuracy of 80.7% (SD 11.5%) for healthy subjects and 91.7% (SD 7.4%) for patients in the pre-Communication Trial. The subset of electrodes selected was subject and session dependent.	[Mangia, Anna Lisa; Pirini, Marco; Cappello, Angelo] Univ Bologna, Dept Elect Elect & Informat Engn DEI, Cesena, Italy; [Simoncini, Laura] Maggiore Hosp, Rehabil Unit, Bologna, Italy	University of Bologna; AUSL di Bologna	Mangia, AL (corresponding author), Univ Bologna, Dept Elect Elect & Informat Engn DEI, Cesena, Italy.	annalisa.mangia2@unibo.it	Simoncini, Laura/AAB-9410-2022	Simoncini, Laura/0000-0002-8853-1791				Arvaneh M, 2011, IEEE T BIO-MED ENG, V58, P1865, DOI 10.1109/TBME.2011.2131142; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Brunner Clemens, 2008, INT J BIOELEKTROMAGN, V10, P52, DOI DOI 10.1.1.330.3349; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chungki L, 2012, P ANN INT C IEEE EMB, P5290; Congedo M, 2008, CLIN NEUROPHYSIOL, V119, P2677, DOI 10.1016/j.clinph.2008.09.007; Cruse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049933; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; De Massari D, 2013, BRAIN, V136, P1989, DOI 10.1093/brain/awt102; De Massari D, 2013, BIOL PSYCHOL, V92, P267, DOI 10.1016/j.biopsycho.2012.10.015; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goldfine AM, 2013, LANCET, V381, P289, DOI 10.1016/S0140-6736(13)60125-7; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gudmundsson S, 2007, CLIN NEUROPHYSIOL, V118, P2162, DOI 10.1016/j.clinph.2007.06.018; Guillot A, 2005, J MOTOR BEHAV, V37, P10, DOI 10.3200/JMBR.37.1.10-20; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; Ishizu T, 2009, NEUROSCI LETT, V465, P85, DOI 10.1016/j.neulet.2009.08.079; John ER, 2011, BRAIN INJURY, V25, P426, DOI 10.3109/02699052.2011.558045; Kamrunnahar M, 2009, IEEE ENG MED BIO, P6477, DOI 10.1109/IEMBS.2009.5333585; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kotchoubey B, 2003, NEUROSCI LETT, V352, P129, DOI 10.1016/j.neulet.2003.08.045; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kurita T, 2004, JACIII, V8; Lal TN, 2004, IEEE T BIO-MED ENG, V51, P1003, DOI 10.1109/TBME.2004.827827; Lebon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037850; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Li Y, 2009, NEUROSCI RES, V65, P44, DOI 10.1016/j.neures.2009.05.004; Lule D, 2013, CLIN NEUROPHYSIOL, V124, P101, DOI 10.1016/j.clinph.2012.04.030; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Munzert J, 2008, EXP BRAIN RES, V188, P437, DOI 10.1007/s00221-008-1376-y; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Popescu F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000637; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Szameitat AJ, 2007, NEUROIMAGE, V34, P702, DOI 10.1016/j.neuroimage.2006.09.033; Tam WK, 2011, IEEE T NEUR SYS REH, V19, P617, DOI 10.1109/TNSRE.2011.2168542; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	41	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99289	10.1371/journal.pone.0099289	http://dx.doi.org/10.1371/journal.pone.0099289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915148	gold, Green Submitted, Green Published			2022-12-25	WOS:000340947700079
J	Srinivasan, P; Zervantonakis, IK; Kothapalli, CR				Srinivasan, Parthasarathy; Zervantonakis, Ioannis K.; Kothapalli, Chandrasekhar R.			Synergistic Effects of 3D ECM and Chemogradients on Neurite Outgrowth and Guidance: A Simple Modeling and Microfluidic Framework	PLOS ONE			English	Article							GROWTH-FACTOR-I; SIGNALING MECHANISMS; STOCHASTIC-MODEL; RANDOM MOTILITY; GRADIENTS; CHEMOTAXIS; DIFFUSION; MIGRATION; DYNAMICS; CELLS	During nervous system development, numerous cues within the extracellular matrix microenvironment (ECM) guide the growing neurites along specific pathways to reach their intended targets. Neurite motility is controlled by extracellular signal sensing through the growth cone at the neurite tip, including chemoattractive and repulsive cues. However, it is difficult to regenerate and restore neurite tracts, lost or degraded due to an injury or disease, in the adult central nervous system. Thus, it is important to evaluate the dynamic interplay between ECM and the concentration gradients of these cues, which would elicit robust neuritogenesis. Such information is critical in understanding the processes involved in developmental biology, and in developing high-fidelity neurite regenerative strategies post-injury, and in drug discovery and targeted therapeutics for neurodegenerative conditions. Here, we quantitatively investigated this relationship using a combination of mathematical modeling and in vitro experiments, and determined the synergistic role of guidance cues and ECM on neurite outgrowth and turning. Using a biomimetic microfluidic system, we have shown that cortical neurite outgrowth and turning under chemogradients (IGF-1 or BDNF) within 3D scaffolds is highly regulated by the source concentration of the guidance cue and the physical characteristics of the scaffold. A mechanistic-driven partial differential equation model of neurite outgrowth has been proposed, which could also be used prospectively as a predictive tool. The parameters for the chemotaxis term in the model are determined from the experimental data using our microfluidic assay. Resulting model simulations demonstrate how neurite outgrowth was critically influenced by the experimental variables, which was further supported by experimental data on cell-surface-receptor expressions. The model results are in excellent agreement with the experimental findings. This integrated approach represents a framework for further elucidation of biological mechanisms underlying neuronal responses of specialized cell types, during various stages of development, and under healthy or diseased conditions.	[Srinivasan, Parthasarathy] Cleveland State Univ, Dept Math, Cleveland, OH 44115 USA; [Zervantonakis, Ioannis K.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Kothapalli, Chandrasekhar R.] Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; Harvard University; Harvard Medical School; University System of Ohio; Cleveland State University	Kothapalli, CR (corresponding author), Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA.	c.kothapalli@csuohio.edu	Zervantonakis, Ioannis/C-2890-2011; Zervantonakis, Ioannis/ADS-2519-2022; Zervantonakis, Ioannis/N-9717-2019	Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553	Cleveland State University	Cleveland State University	C. K. would like to express his gratitude for the startup funds, Faculty Research Development Award (2012-2013), and Provost Undergraduate Research and Creative Achievement Award (2012) from the Cleveland State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletti G, 2008, IET SYST BIOL, V2, P150, DOI 10.1049/iet-syb:20070059; Bagnard D, 2000, J NEUROSCI, V20, P1030, DOI 10.1523/JNEUROSCI.20-03-01030.2000; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; BUETTNER HM, 1994, DEV BIOL, V163, P407, DOI 10.1006/dbio.1994.1158; BUETTNER HM, 1994, ANN NY ACAD SCI, V745, P210; BUETTNER HM, 1995, CELL MOTIL CYTOSKEL, V32, P187, DOI 10.1002/cm.970320304; Crank J., 1975, MATH DIFFUSION; De Smedt A, 2011, STROKE, V42, P2180, DOI 10.1161/STROKEAHA.110.600783; DECHANT G, 1993, DEVELOPMENT, V119, P545; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; Deumens R, 2006, NEUROSCI LETT, V407, P268, DOI 10.1016/j.neulet.2006.08.059; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dontchev V, 2011, CR ACAD BULG SCI, V64, P1347; DUNN GA, 1987, J CELL SCI, P81; Dupraz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054462; FORD RM, 1991, BIOTECHNOL BIOENG, V37, P661, DOI 10.1002/bit.260370708; Gates MA, 2004, EUR J NEUROSCI, V19, P831, DOI 10.1111/j.1460-9568.2004.03213.x; Gisladottir S, 2009, GRAEF ARCH CLIN EXP, V247, P1677, DOI 10.1007/s00417-009-1141-3; Goodhill GJ, 1998, TRENDS NEUROSCI, V21, P226, DOI 10.1016/S0166-2236(97)01203-4; Goodhill GJ, 1998, NEURAL COMPUT, V10, P521, DOI 10.1162/089976698300017638; Goodhill GJ, 1997, EUR J NEUROSCI, V9, P1414, DOI 10.1111/j.1460-9568.1997.tb01496.x; Goodhill GJ, 1999, J NEUROBIOL, V41, P230, DOI 10.1002/(SICI)1097-4695(19991105)41:2<230::AID-NEU6>3.0.CO;2-9; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; GUO YS, 1992, GASTROENTEROLOGY, V102, P1101; Helm CLE, 2005, P NATL ACAD SCI USA, V102, P15779, DOI 10.1073/pnas.0503681102; Horstmann D, 2004, JAHRESBER DEUTSCH MA, V106, P51; Horstmann D., 2003, JAHRESBERICHTE DMV, V105, P103; Isbister CM, 2003, J NEUROSCI, V23, P193; KATZ MJ, 1984, CELL MOTIL CYTOSKEL, V4, P351, DOI 10.1002/cm.970040505; KELLER EF, 1970, J THEOR BIOL, V26, P399, DOI 10.1016/0022-5193(70)90092-5; Kobayashi T, 2010, J THEOR BIOL, V266, P712, DOI 10.1016/j.jtbi.2010.07.036; Kothapalli CR, 2013, BIOMATERIALS, V34, P5995, DOI 10.1016/j.biomaterials.2013.04.042; Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI 10.1039/c01c00240b; Koulakov AA, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-30; Kunze A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026187; Kunze A, 2011, BIOMATERIALS, V32, P2088, DOI 10.1016/j.biomaterials.2010.11.047; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LAPIDUS IR, 1976, BIOPHYS J, V16, P779, DOI 10.1016/S0006-3495(76)85728-1; Li GN, 2008, TISSUE ENG PART B-RE, V14, P33, DOI 10.1089/teb.2007.0181; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Loschinger J, 2000, PHILOS T ROY SOC B, V355, P971, DOI 10.1098/rstb.2000.0633; Manns RPC, 2012, J NEUROSCI, V32, P8554, DOI 10.1523/JNEUROSCI.5964-11.2012; Maskery S, 2005, ANNU REV BIOMED ENG, V7, P187, DOI 10.1146/annurev.bioeng.7.060804.100446; Maskery SM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-22; Meinhardt H, 1999, J CELL SCI, V112, P2867; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mortimer D, 2008, TRENDS NEUROSCI, V31, P90, DOI 10.1016/j.tins.2007.11.008; NOWAKOWSKI RS, 1992, BRAIN RES, V576, P152, DOI 10.1016/0006-8993(92)90622-G; Othmer HG, 1997, SIAM J APPL MATH, V57, P1044, DOI 10.1137/S0036139995288976; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P311, DOI 10.1007/BF02476407; Pearson YE, 2011, B MATH BIOL, V73, P2837, DOI 10.1007/s11538-011-9648-2; Pettet GJ, 1996, MATH BIOSCI, V136, P35, DOI 10.1016/0025-5564(96)00044-2; Polleux F, 2002, DEVELOPMENT, V129, P3147; Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.3.CO;2-C; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; Rusu L, 2010, MACROMOL BIOSCI, V10, P1465, DOI 10.1002/mabi.201000033; Salie R, 2005, INT J DEV NEUROSCI, V23, P587, DOI 10.1016/j.ijdevneu.2005.07.003; Sawonik MA, 2013, ADV MICROFLUIDICS NA; Schugart RC, 2008, P NATL ACAD SCI USA, V105, P2628, DOI 10.1073/pnas.0711642105; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STOKES CL, 1991, J THEOR BIOL, V152, P377, DOI 10.1016/S0022-5193(05)80201-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tharin S, 2012, INTEGR BIOL-UK, V4, P1398, DOI 10.1039/c2ib20019h; Tsaneva-Atanasova K, 2009, BIOPHYS J, V96, P840, DOI 10.1016/j.bpj.2008.10.036; Urbach JS, 1999, NEUROCOMPUTING, V26-7, P39, DOI 10.1016/S0925-2312(99)00086-7; von Philipsborn AC, 2006, DEVELOPMENT, V133, P2487, DOI 10.1242/dev.02412; Wang CJ, 2008, LAB CHIP, V8, P227, DOI 10.1039/b713945d; Wang FS, 2003, BIOPHYS J, V85, P3319, DOI 10.1016/S0006-3495(03)74751-1; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xiang YJ, 2011, INT J NEUROSCI, V121, P101, DOI 10.3109/00207454.2010.535935; Xu J, 2005, DEVELOPMENT, V132, P4545, DOI 10.1242/dev.02029; Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035; Zervantonakis IK, 2010, INT J MICRONANOSCALE, V1, P27, DOI DOI 10.1260/1759-3093.1.1.27	81	14	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99640	10.1371/journal.pone.0099640	http://dx.doi.org/10.1371/journal.pone.0099640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914812	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700121
J	Greiman, SE; Tkach, VV; Pulis, E; Fayton, TJ; Curran, SS				Greiman, Stephen E.; Tkach, Vasyl V.; Pulis, Eric; Fayton, Thomas J.; Curran, Stephen S.			Large Scale Screening of Digeneans for Neorickettsia Endosymbionts Using Real-Time PCR Reveals New Neorickettsia Genotypes, Host Associations and Geographic Records	PLOS ONE			English	Article							FLUORESCENT-ANTIBODY TEST; SALMON POISONING DISEASE; RISTICII GENOMIC DNA; TREMATODES; AGENT; FLUKE; FISH; MICROBIOTA; DIVERSITY; SENNETSU	Digeneans are endoparasitic flatworms with complex life cycles including one or two intermediate hosts (first of which is always a mollusk) and a vertebrate definitive host. Digeneans may harbor intracellular endosymbiotic bacteria belonging to the genus Neorickettsia (order Rickettsiales, family Anaplasmataceae). Some Neorickettsia are able to invade cells of the digenean's vertebrate host and are known to cause diseases of wildlife and humans. In this study we report the results of screening 771 digenean samples for Neorickettsia collected from various vertebrates in terrestrial, freshwater, brackish, and marine habitats in the United States, China and Australia. Neorickettsia were detected using a newly designed real-time PCR protocol targeting a 152 bp fragment of the heat shock protein coding gene, GroEL, and verified with nested PCR and sequencing of a 1371 bp long region of 16S rRNA. Eight isolates of Neorickettsia have been obtained. Sequence comparison and phylogenetic analysis demonstrated that 7 of these isolates, provisionally named Neorickettsia sp. 1-7 (obtained from allocreadiid Crepidostomum affine, haploporids Saccocoelioides beauforti and Saccocoelioides lizae, faustulid Bacciger sprenti, deropegid Deropegus aspina, a lecithodendriid, and a pleurogenid) represent new genotypes and one (obtained from Metagonimoides oregonensis) was identical to a published sequence of Neorickettsia known as SF agent. All digenean species reported in this study represent new host records. Three of the 6 digenean families (Haploporidae, Pleurogenidae, and Faustulidae) are also reported for the first time as hosts of Neorickettsia. We have detected Neorickettsia in digeneans from China and Australia for the first time based on PCR and sequencing evidence. Our findings suggest that further surveys from broader geographic regions and wider selection of digenean taxa are likely to reveal new Neorickettsia lineages as well as new digenean host associations.	[Greiman, Stephen E.; Tkach, Vasyl V.] Univ N Dakota, Dept Biol, Grand Forks, ND 58202 USA; [Pulis, Eric; Fayton, Thomas J.; Curran, Stephen S.] Univ So Mississippi, Dept Coastal Sci, Ocean Springs, MS USA	University of North Dakota Grand Forks; University of Southern Mississippi	Greiman, SE (corresponding author), Univ N Dakota, Dept Biol, Grand Forks, ND 58202 USA.	stephen.greiman@my.und.edu	Pulis, Eric/AAF-4312-2020	Pulis, Eric/0000-0002-1695-7953; Tkach, Vasyl/0000-0001-5084-7566	National Institutes of Health, USA [R15AI092622]; US Fish and Wildlife Service/Mississippi Department of Marine Resources; MSCIAP [MS.R.798, M10AF20151]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI092622] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Fish and Wildlife Service/Mississippi Department of Marine Resources; MSCIAP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the grant R15AI092622 from the National Institutes of Health, USA, and US Fish and Wildlife Service/Mississippi Department of Marine Resources MSCIAP MS.R.798 Award M10AF20151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlough JE, 1997, VET PARASITOL, V68, P367, DOI 10.1016/S0304-4017(96)01083-7; BRAY RA, 1982, J NAT HIST, V16, P23, DOI 10.1080/00222938200770031; BURCH JB, 1989, N AM FRESHWATER SNAI; CHAPIN E. A., 1926, N AM VET, V7, P42; Coimbra H.S., 2005, Arq. Inst. Biol., V72, P325, DOI 10.1590/1808-1657v72p3252005; Cribb TH, 1999, SYST PARASITOL, V44, P119, DOI 10.1023/A:1006248418404; Cribb Thomas H., 2001, Systematics Association Special Volume Series, V60, P168; Donham CR, 1925, SCIENCE, V61, P341, DOI 10.1126/science.61.1578.341; FARRELL RK, 1973, AM J VET RES, V34, P919; FUKUDA T, 1981, JPN J MED SCI BIOL, V34, P103, DOI 10.7883/yoken1952.34.103; Fukuda T, 1973, Kansenshogaku Zasshi, V47, P474; Fukuda T., 1954, MED BIOL, V32, P200; Gibson D. I., 2008, KEYS TREMATODA, V3; Gibson DI, 2005, KEYS TREMATODA, V2; Gibson DI, 2002, KEYS TREMATODA, V1; Gibson KE, 2005, ENVIRON MICROBIOL, V7, P203, DOI 10.1111/j.1462-2920.2004.00683.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Headley SA, 2011, VET J, V187, P165, DOI 10.1016/j.tvjl.2009.11.019; Hirai K, 1966, Kumamoto Igakkai Zasshi, V40, P1159; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUNTER WANDA SANBORN, 1961, TRANS AMER MICROS SOC, V80, P176, DOI 10.2307/3223906; KATSUTA I, 1931, TAIWAN IGAKKAI ZASSH, V30, P1404; Larsen A, 2013, FEMS MICROBIOL ECOL, V85, P483, DOI 10.1111/1574-6941.12136; Liu Sheng-fa, 2002, Journal of Oceanography in Taiwan Strait, V21, P37; MADDISON D. R., 2005, MACCLADE 4 ANAL PHYL; MADIGAN JE, 1995, J AM VET MED ASSOC, V207, P1448; Madigan JE, 2000, VET CLIN N AM-EQUINE, V16, P487, DOI 10.1016/S0749-0739(17)30091-3; McCAULEY JAMES E., 1961, TRANS AMER MICROSC, V80, P373, DOI 10.2307/3223651; Mott J, 1997, J CLIN MICROBIOL, V35, P2215, DOI 10.1128/JCM.35.9.2215-2219.1997; Newton PN, 2009, AM J TROP MED HYG, V81, P190, DOI 10.4269/ajtmh.2009.81.190; OVERSTRE.RM, 1971, J PARASITOL, V57, P967, DOI 10.2307/3277846; Philip CB., 1953, 6TH INT C MICR REP P, V2, P256; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pusterla N, 2000, VET PARASITOL, V90, P129, DOI 10.1016/S0304-4017(00)00227-2; Pusterla N, 2003, J HELMINTHOL, V77, P335, DOI 10.1079/JOH2003181; Pusterla N, 2000, VET PARASITOL, V92, P199, DOI 10.1016/S0304-4017(00)00287-9; RIKIHISA Y, 1985, INFECT IMMUN, V49, P513, DOI 10.1128/IAI.49.3.513-517.1985; RIKIHISA Y, 1991, CLIN MICROBIOL REV, V4, P286, DOI 10.1128/CMR.4.3.286-308.1991; Seng P, 2009, CLIN MICROBIOL INFEC, V15, P88, DOI 10.1111/j.1469-0691.2008.02252.x; SHISHIDO A, 1965, JPN J MED SCI BIOL, V18, P73, DOI 10.7883/yoken1952.18.73; Tachibana N., 1986, MICROBIOLOGY 1986, P205; Tkach V, 1999, ACTA PARASITOL, V44, P147; Tkach VV, 2012, ACTA PARASITOL, V57, P285, DOI 10.2478/s11686-012-0043-4; Tkach VV, 2012, J PARASITOL, V99, P1114; Vaughan JA, 2012, ADV PARASIT, V79, P253, DOI 10.1016/B978-0-12-398457-9.00003-2; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; Ward NL, 2009, EXTREMOPHILES, V13, P679, DOI 10.1007/s00792-009-0252-4; Wen BH, 1996, INT J SYST BACTERIOL, V46, P149, DOI 10.1099/00207713-46-1-149	49	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98453	10.1371/journal.pone.0098453	http://dx.doi.org/10.1371/journal.pone.0098453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911315	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600005
J	Hawley, J; Simpson, SJ; Wilder, SM				Hawley, Jesse; Simpson, Stephen J.; Wilder, Shawn M.			Effects of Prey Macronutrient Content on Body Composition and Nutrient Intake in a Web-Building Spider	PLOS ONE			English	Article							PREDATORS; HOMEOSTASIS; INSECTS	The nutritional composition of diets can vary widely in nature and have large effects on the growth, reproduction and survival of animals. Many animals, especially herbivores, will tightly regulate the nutritional composition of their body, which has been referred to as nutritional homeostasis. We tested how experimental manipulation of the lipid and protein content of live prey affected the nutrient reserves and subsequent diet regulation of web-building spiders, Argiope keyserlingi. Live locusts were injected with experimental solutions containing specific amounts of lipid and protein and then fed to spiders. The nutrient composition of the spiders' bodies was directly related to the nutrient composition of the prey on which they fed. We then conducted an experiment where spiders were fed either high lipid or high protein prey and subsequently provided with two large unmanipulated locusts. Prior diet did not affect the amount or ratio of lipid and protein ingested by spiders when feeding on unmanipulated prey. Argiope keyserlingi were flexible in the storage of lipid and protein in their bodies and did not bias their extraction of nutrients from prey to compensate for previously biased diets. Some carnivores, especially those that experience frequent food limitation, may be less likely to strictly regulate their body composition than herbivores because food limitation may encourage opportunistic ingestion and assimilation of nutrients.	[Wilder, Shawn M.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Wilder, SM (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	shawn.wilder@sydney.edu.au		Simpson, Stephen J./0000-0003-0256-7687; Wilder, Shawn/0000-0003-0359-7220	Australian Research Council; University of Sydney	Australian Research Council(Australian Research Council); University of Sydney(University of Sydney)	The Australian Research Council and the University of Sydney funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry KL, 2013, OIKOS, V122, P1058, DOI 10.1111/j.1600-0706.2012.00164.x; BELL WJ, 1975, BIOL REV, V50, P373, DOI 10.1111/j.1469-185X.1975.tb01058.x; Bilde T, 1998, OECOLOGIA, V115, P54, DOI 10.1007/s004420050490; Clissold FJ, 2010, P ROY SOC B-BIOL SCI, V277, P1751, DOI 10.1098/rspb.2009.2045; Jensen K, 2011, ANIM BEHAV, V81, P993, DOI 10.1016/j.anbehav.2011.01.035; Jensen K, 2010, J INSECT PHYSIOL, V56, P1095, DOI 10.1016/j.jinsphys.2010.03.001; Kim KW, 2012, BEHAV ECOL SOCIOBIOL, V66, P1569, DOI 10.1007/s00265-012-1410-8; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Overgaard J, 2012, COMP PHYSL FASTING S; Pekar S, 2010, ANIM BEHAV, V79, P1301, DOI 10.1016/j.anbehav.2010.03.002; Persson J, 2010, OIKOS, V119, P741, DOI 10.1111/j.1600-0706.2009.18545.x; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; SIMPSON SJ, 1993, PHILOS T R SOC B, V342, P381, DOI 10.1098/rstb.1993.0166; Simpson SJ, 2012, NATURE NUTR UNIFYING; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Toft S, 2010, PHYSIOL ENTOMOL, V35, P317, DOI 10.1111/j.1365-3032.2010.00746.x; Venner S, 2005, P ROY SOC B-BIOL SCI, V272, P1587, DOI 10.1098/rspb.2005.3114; Wang H, 2012, ECOL MODEL, V243, P81, DOI 10.1016/j.ecolmodel.2012.06.003; Wilder SM, 2013, ECOL LETT, V16, P895, DOI 10.1111/ele.12116; Wilder SM, 2011, ADV INSECT PHYSIOL, V40, P87, DOI 10.1016/B978-0-12-387668-3.00002-7; Wilder SM, 2010, OIKOS, V119, P350, DOI 10.1111/j.1600-0706.2009.17819.x; Wise DH, 1993, SPIDERS ECOLOGICAL W	24	12	12	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99165	10.1371/journal.pone.0099165	http://dx.doi.org/10.1371/journal.pone.0099165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911958	gold, Green Submitted, Green Published			2022-12-25	WOS:000337165600048
J	Hur, H; Paik, MJ; Xuan, Y; Nguyen, DT; Ham, IH; Yun, J; Cho, YK; Lee, G; Han, SU				Hur, Hoon; Paik, Man Jeong; Xuan, Yi; Duc-Toan Nguyen; Ham, In-Hye; Yun, Jisoo; Cho, Yong Kwan; Lee, Gwang; Han, Sang-Uk			Quantitative Measurement of Organic Acids in Tissues from Gastric Cancer Patients Indicates Increased Glucose Metabolism in Gastric Cancer	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; POSITRON-EMISSION-TOMOGRAPHY; BREAST-CANCER; CELLS; SPECTROSCOPY; CHEMOTHERAPY; METASTASIS; EXPRESSION; PREDICTION; PHENOTYPE	The levels of organic acids representing metabolic pathway end products are important indicators of physiological status, and may be associated with metabolic changes in cancer. The aim of this study is to investigate the levels of organic acids in cancerous and normal tissues from gastric cancer patients and to confirm the role of metabolic alterations in gastric carcinogenesis. Organic acids in normal and cancerous tissues from forty-five patients with gastric adenocarcinoma were investigated by gas chromatography-mass spectrometry in selected ion monitoring mode as methoxime/ tert-butyldimethylsilyl derivatives. We analysed the significant differences in the levels of organic acids in normal and cancer tissues and investigated the correlation of these levels in cancer tissues with clinicopathological features. The levels of Krebs cycle components, including alpha-ketoglutaric acid, succinic acid, fumaric acid, malic acid and oxaloacetic acid, were significantly increased in cancer tissues compared to normal tissues. In addition, the levels of glycolytic products, including pyruvic acid and lactic acid, as well as the levels of ketone bodies, including 3-hydroxybutyric acid, were also significantly increased in cancer tissues compared to normal tissues. The levels of ketone bodies in cancer tissues with differentiated histology and in intestinal-type cancer tissues were significantly increased. The organic acid profiling analysis described here may be a generally useful clinical tool for understanding the complexity of metabolic events in gastric adenocarcinoma, and organic acids may have potential as metabolic markers for the future discovery of diagnostic and therapeutic modalities.	[Hur, Hoon; Xuan, Yi; Ham, In-Hye; Yun, Jisoo; Cho, Yong Kwan; Han, Sang-Uk] Ajou Univ, Sch Med, Dept Surg, Suwon 441749, South Korea; [Hur, Hoon; Ham, In-Hye; Yun, Jisoo; Lee, Gwang; Han, Sang-Uk] Ajou Univ, Sch Med, Inst Gastr Canc Mech, Suwon 441749, South Korea; [Paik, Man Jeong] Suncheon Natl Univ, Coll Pharm, Sunchon, South Korea; [Xuan, Yi] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China; [Duc-Toan Nguyen] Natl Inst Drug Qual Control, Hanoi, Vietnam; [Lee, Gwang] Ajou Univ, Sch Med, Dept Physiol, Suwon 441749, South Korea	Ajou University; Ajou University; Sunchon National University; Fudan University; Ajou University	Lee, G (corresponding author), Ajou Univ, Sch Med, Inst Gastr Canc Mech, Suwon 441749, South Korea.	glee@ajou.ac.kr; hansu@ajou.ac.kr	Hur, Hoon/AAI-1396-2019; Ham, in-hye/ABI-7969-2020; Nguyen, Duc Toan/B-3536-2010	Hur, Hoon/0000-0002-5435-5363; Ham, in-hye/0000-0002-3168-5597; Nguyen, Duc Toan/0000-0002-3283-3504	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A1012602]; Priority Research Centres Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0093826]	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Priority Research Centres Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science and Technology (2012R1A1A1012602), and the Priority Research Centres Program through the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science and Technology (2009-0093826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Fujii M, 2010, SURG TODAY, V40, P295, DOI 10.1007/s00595-009-4148-9; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; Gribbestad IS, 1999, ANTICANCER RES, V19, P1737; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; KALLINOWSKI F, 1988, CANCER RES, V48, P7264; Kang H, 2011, CURR TREAT OPTION ON, V12, P96, DOI 10.1007/s11864-010-0135-z; Kawamura T, 2001, CANCER-AM CANCER SOC, V92, P634, DOI 10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lin LL, 2012, J PROTEOMICS, V75, P3081, DOI 10.1016/j.jprot.2012.03.046; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P1271, DOI 10.4161/cc.10.8.15330; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Noguchi Y, 1999, HEPATO-GASTROENTEROL, V46, P2683; Paik MJ, 2008, BIOMED CHROMATOGR, V22, P450, DOI 10.1002/bmc.966; Paik MJ, 2010, CLIN CHIM ACTA, V411, P1532, DOI 10.1016/j.cca.2010.05.034; Paik MJ, 2005, J CHROMATOGR B, V821, P94, DOI 10.1016/j.jchromb.2005.04.011; RICHTSMEIER WJ, 1987, CANCER RES, V47, P5230; Sano T, 2011, GASTRIC CANCER, V14, P97, DOI 10.1007/s10120-011-0040-6; Shin A, 2011, J GASTRIC CANCER, V11, P135, DOI 10.5230/jgc.2011.11.3.135; Song H, 2011, ONCOL REP, V26, P431, DOI 10.3892/or.2011.1302; Tian JH, 2004, NUCL MED COMMUN, V25, P825, DOI 10.1097/01.mnm.0000135042.54461.f6; WARBURG O, 1956, SCIENCE, V124, P269; Weber WA, 2003, J CLIN ONCOL, V21, P2651, DOI 10.1200/JCO.2003.12.004; Wieder HA, 2004, J CLIN ONCOL, V22, P900, DOI 10.1200/JCO.2004.07.122; Yamashita K, 2011, SURG TODAY, V41, P24, DOI 10.1007/s00595-010-4370-5; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141	31	30	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98581	10.1371/journal.pone.0098581	http://dx.doi.org/10.1371/journal.pone.0098581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911788	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600001
J	Jang, HC; Choi, OJ; Kim, GS; Jang, MO; Kang, SJ; Jung, SI; Shin, JH; Chun, BJ; Park, KH				Jang, Hee-Chang; Choi, Ok-Ja; Kim, Gwang-Sook; Jang, Mi-Ok; Kang, Seung-Ji; Jung, Sook-In; Shin, Jong-Hee; Chun, Byeong Jo; Park, Kyung-Hwa			Active Surveillance of the Trachea or Throat for MRSA Is More Sensitive than Nasal Surveillance and a Better Predictor of MRSA Infections among Patients in Intensive Care	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; VENTILATOR-ASSOCIATED PNEUMONIA; COLONIZATION; CULTURES; UNIT; SWABS; ADMISSION; BACTEREMIA; CARRIAGE; THERAPY	Background: Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common causes of infection in the intensive care unit (ICU). Although surveillance culture for MRSA is recommended for ICU patients, no comparative study investigating the optimal sites and frequency of culture has been performed in this population. Methods: A prospective observational cohort study was performed in an 18-bed emergency intensive care unit (EICU) in a tertiary teaching hospital. A total of 282 patients were included. Samples for MRSA detection were obtained at the time of admission, 48 h after admission, and then weekly thereafter. All subjects were routinely monitored for the development of MRSA infection during their stay in the ICU. Results: MRSA colonization was detected in 129 (46%) patients over the course of the study. The sensitivity of MRSA surveillance culture was significantly higher in throat or tracheal aspirates (82%; 106/129) than in anterior nares (47%; 61/ 129) (P < 0.001). The sensitivity of MRSA surveillance culture for subsequent MRSA infection and MRSA pneumonia was also higher in the throat/trachea (69 and 93%, respectively) than in the anterior nares (48 and 50%, respectively). The area under the curve for subsequent MRSA infection was higher in trachea/throat (0.675) than in the anterior nares (0.648); however, this difference was not significant (P > 0.05). The area under the curve for MRSA pneumonia was significantly higher in trachea/throat (0.791; 95% CI, 0.739-0.837) than anterior nares (0.649; 95% CI, 0.590-0.705) (P = 0.044). Conclusion: MRSA colonization was more common in the trachea/throat than in the anterior nares in ICU patients. Cultures from throat or tracheal aspirates were more sensitive and predictive of subsequent MRSA pneumonia than cultures from the anterior nares in this population.	[Jang, Hee-Chang; Jang, Mi-Ok; Kang, Seung-Ji; Jung, Sook-In; Park, Kyung-Hwa] Chonnam Natl Univ, Sch Med, Dept Infect Dis, Kwangju, South Korea; [Choi, Ok-Ja; Kim, Gwang-Sook; Park, Kyung-Hwa] Chonnam Natl Univ Hosp, Off Infect Control, Kwangju, South Korea; [Shin, Jong-Hee] Chonnam Natl Univ, Sch Med, Dept Lab Med, Kwangju, South Korea; [Chun, Byeong Jo] Chonnam Natl Univ, Sch Med, Dept Emergency Med, Kwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University	Park, KH (corresponding author), Chonnam Natl Univ, Sch Med, Dept Infect Dis, Kwangju, South Korea.	iammedkid@naver.com		Kang, Seung ji/0000-0002-3298-0520; Jang, Hee-Chang/0000-0002-3407-8493; jeon, byeongjo/0000-0002-5240-4213	Chonnam National University Hospital [CRI 10087-1]	Chonnam National University Hospital	This study was supported by research funds from Chonnam National University Hospital, 2010 (CRI 10087-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydiner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043935; Baker SE, 2010, INFECT CONT HOSP EP, V31, P42, DOI 10.1086/649222; Batra R, 2008, INTENS CARE MED, V34, P1703, DOI 10.1007/s00134-008-1153-1; Bignardi GE, 2009, J HOSP INFECT, V71, P373, DOI 10.1016/j.jhin.2009.01.003; Bitterman Y, 2010, EUR J CLIN MICROBIOL, V29, P391, DOI 10.1007/s10096-009-0869-3; Boyce JM, 2013, ANTIMICROB AGENTS CH, V57, P1163, DOI 10.1128/AAC.01965-12; Chan JD, 2012, CRIT CARE MED, V40, P1437, DOI 10.1097/CCM.0b013e318243168e; Depuydt P, 2008, INTENS CARE MED, V34, P675, DOI 10.1007/s00134-007-0953-z; Depuydt PO, 2006, CRIT CARE MED, V34, P653, DOI 10.1097/01.CCM.0000201405.16525.34; Harbarth S, 2007, J CLIN MICROBIOL, V45, P1072, DOI 10.1128/JCM.02121-06; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Jang HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049136; Jang HC, 2009, CLIN INFECT DIS, V49, P395, DOI 10.1086/600295; Kyaw WM, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-33; Lloyd-Smith E, 2012, EPIDEMIOL INFECT, V140, P1721, DOI 10.1017/S0950268811002421; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malhotra-Kumar S, 2010, J CLIN MICROBIOL, V48, P1040, DOI 10.1128/JCM.01745-09; Matheson A, 2012, INFECT CONT HOSP EP, V33, P803, DOI 10.1086/666639; McKinnell JA, 2013, INFECT CONT HOSP EP, V34, P161, DOI 10.1086/669095; Mertz D, 2009, ARCH INTERN MED, V169, P172, DOI 10.1001/archinternmed.2008.536; Mertz D, 2007, CLIN INFECT DIS, V45, P475, DOI 10.1086/520016; Nilsson P, 2006, J CLIN MICROBIOL, V44, P3334, DOI 10.1128/JCM.00880-06; Papadomichelakis E, 2008, INTENS CARE MED, V34, P2169, DOI 10.1007/s00134-008-1247-9; Sarikonda KV, 2010, CRIT CARE MED, V38, P1991, DOI 10.1097/CCM.0b013e3181eeda3f; Senn L, 2012, CLIN MICROBIOL INFEC, V18, pE31, DOI 10.1111/j.1469-0691.2011.03724.x; Toschlog EA, 2012, CRIT CARE MED, V40, P1651, DOI 10.1097/CCM.0b013e3182474b27; Widmer AF, 2008, J CLIN MICROBIOL, V46, P835, DOI 10.1128/JCM.02276-07	29	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99192	10.1371/journal.pone.0099192	http://dx.doi.org/10.1371/journal.pone.0099192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911358	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600054
J	Garyali, P; Segvich, DM; DePaoli-Roach, AA; Roach, PJ				Garyali, Punitee; Segvich, Dyann M.; DePaoli-Roach, Anna A.; Roach, Peter J.			Protein Degradation and Quality Control in Cells from Laforin and Malin Knockout Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; E3 UBIQUITIN LIGASE; GLYCOGEN ACCUMULATION; ENDOPLASMIC-RETICULUM; DISEASE; AUTOPHAGY; PHOSPHATASE; METABOLISM; BODIES; BINDING	Lafora disease is a progressive myoclonus epilepsy caused by mutations in the EPM2A or EPM2B genes that encode a glycogen phosphatase, laforin, and an E3 ubiquitin ligase, malin, respectively. Lafora disease is characterized by accumulation of insoluble, poorly branched, hyperphosphorylated glycogen in brain, muscle, heart, and liver. The laforinmalin complex has been proposed to play a role in the regulation of glycogen metabolism and protein quality control. We evaluated three arms of the protein degradation/quality control process (the autophago-lysosomal pathway, the ubiquitin-proteasomal pathway, and the endoplasmic reticulum (ER) stress response) in mouse embryonic fibroblasts from Epm2a(-/-), Epm2b(-/-), and Epm2a(-/-) Epm2b(-/-) mice. The levels of LC3-II, a marker of autophagy, were decreased in all knock-out cells as compared with wild type even though they still showed a slight response to starvation and rapamycin. Furthermore, ribosomal protein S6 kinase and S6 phosphorylation were increased. Under basal conditions there was no effect on the levels of ubiquitinated proteins in the knock-out cells, but ubiquitinated protein degradation was decreased during starvation or stress. Lack of malin (Epm2b(-/-) and Epm2a(-/-) Epm2b(-/-) cells) but not laforin (Epm2a(-/-) cells) decreased LAMP1, a lysosomal marker. CHOP expression was similar in wild type and knock-out cells under basal conditions or with ER stress-inducing agents. In conclusion, both laforin and malin knock-out cells display mTOR-dependent autophagy defects and reduced proteasomal activity but no defects in the ER stress response. We speculate that these defects may be secondary to glycogen overaccumulation. This study also suggests a malin function independent of laforin, possibly in lysosomal biogenesis and/or lysosomal glycogen disposal.	[Garyali, Punitee; Segvich, Dyann M.; DePaoli-Roach, Anna A.; Roach, Peter J.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Roach, PJ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	proach@iu.edu			National Institutes of Health [DK27221, NS056454]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK027221, R37DK027221, R01DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK27221 and NS056454.	Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Criado O, 2012, HUM MOL GENET, V21, P1521, DOI 10.1093/hmg/ddr590; DePaoli-Roach AA, 2012, HUM MOL GENET, V21, P1604, DOI 10.1093/hmg/ddr598; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; Freie B, 2003, BLOOD, V102, P4146, DOI 10.1182/blood-2003-03-0971; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; HARRIMAN DGF, 1955, BRAIN, V78, P325, DOI 10.1093/brain/78.3.325; Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; Kannourakis G, 2002, SEMIN HEMATOL, V39, P103, DOI 10.1053/shem.2002.31920; Knecht E, 2012, AUTOPHAGY, V8, P701, DOI 10.4161/auto.19522; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Pederson BA, 2013, ANN NEUROL, V74, P297, DOI 10.1002/ana.23899; Puri R, 2012, HUM MOL GENET, V21, P175, DOI 10.1093/hmg/ddr452; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Sharma J, 2011, NEUROBIOL DIS, V44, P133, DOI 10.1016/j.nbd.2011.06.013; Shin Yoon S, 2006, Semin Pediatr Neurol, V13, P115, DOI 10.1016/j.spen.2006.06.007; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Turnbull J, 2014, ANN NEUROL, V75, P442, DOI 10.1002/ana.24104; Turnbull J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002037; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Wang W, 2006, BIOCHEM BIOPH RES CO, V350, P588, DOI 10.1016/j.bbrc.2006.09.091; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	46	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20606	20614		10.1074/jbc.M114.580167	http://dx.doi.org/10.1074/jbc.M114.580167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24914213	Green Published, hybrid			2022-12-25	WOS:000339396600020
J	Smith, ED; Prieto, GA; Tong, LQ; Sears-Kraxberger, I; Rice, JD; Steward, O; Cotman, CW				Smith, Erica D.; Prieto, G. Aleph; Tong, Liqi; Sears-Kraxberger, Ilse; Rice, Jeffrey D.; Steward, Oswald; Cotman, Carl W.			Rapamycin and Interleukin-1 beta Impair Brain-derived Neurotrophic Factor-dependent Neuron Survival by Modulating Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTENDS LIFE-SPAN; CELL-DEATH; MAMMALIAN TARGET; SIGNALING PATHWAY; SYNAPTIC PLASTICITY; INSULIN-RESISTANCE; IN-VITRO; MTOR; GROWTH; KINASE	The mammalian target of rapamycin (mTOR) pathway has multiple important physiological functions, including regulation of protein synthesis, cell growth, autophagy, and synaptic plasticity. Activation of mTOR is necessary for the many beneficial effects of brain-derived neurotrophic factor (BDNF), including dendritic translation and memory formation in the hippocampus. At present, however, the role of mTOR in BDNF's support of survival is not clear. We report that mTOR activation is necessary for BDNF-dependent survival of primary rat hippocampal neurons, as either mTOR inhibition by rapamycin or genetic manipulation of the downstream molecule p70S6K specifically blocked BDNF rescue. Surprisingly, however, BDNF did not promote neuron survival by up-regulating mTOR-dependent protein synthesis or through mTOR-dependent suppression of caspase-3 activation. Instead, activated mTOR was responsible for BDNF's suppression of autophagic flux. shRNA against the autophagic machinery Atg7 or Atg5 prolonged the survival of neurons co-treated with BDNF and rapamycin, suggesting that suppression of mTORin BDNF-treated cells resulted in excessive autophagy. Finally, acting as a physiological analog of rapamycin, IL-1 beta impaired BDNF signaling by way of inhibiting mTOR activation as follows: the cytokine induced caspase-independent neuronal death and accelerated autophagic flux in BDNF-treated cells. These findings reveal a novel mechanism of BDNF neuroprotection; BDNF not only prevents apoptosis through inhibiting caspase activation but also promotes neuron survival through modulation of autophagy. This protection mechanism is vulnerable under chronic inflammation, which deregulates autophagy through impairing mTOR signaling. These results may be relevant to age-related changes observed in neurodegenerative diseases.	[Smith, Erica D.; Prieto, G. Aleph; Tong, Liqi; Rice, Jeffrey D.; Cotman, Carl W.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Sears-Kraxberger, Ilse; Steward, Oswald] Univ Calif Irvine, Reeve Irvine Res Ctr, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Cotman, CW (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	cwcotman@uci.edu		Smith, Erica/0000-0002-5424-580X; Prieto, G. Aleph/0000-0001-9517-6989; Steward, Oswald/0000-0001-7069-8756	National Institutes of Health [P01-AG000538, RO1-NS073857]; NRSA from the NIMH [MH14599-29]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG000538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA from the NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-AG000538 (to C. W. C.) and by NRSA Award MH14599-29 (to E. D. S.) from the NIMH.; Supported by National Institutes of Health Grant RO1-NS073857.	Alirezaei M, 2010, AUTOPHAGY, V6, P702, DOI 10.4161/auto.6.6.12376; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Bains M, 2009, J BIOL CHEM, V284, P20398, DOI 10.1074/jbc.M109.011791; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; CACERES A, 1984, J NEUROSCI, V4, P394; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Pastor MD, 2009, J BIOL CHEM, V284, P22067, DOI 10.1074/jbc.M109.033100; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Dziedzic SA, 2012, AUTOPHAGY, V8, P731, DOI 10.4161/auto.19314; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; Francis BM, 2012, NEUROBIOL AGING, V33, P555, DOI 10.1016/j.neurobiolaging.2010.04.003; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; He CC, 2012, AUTOPHAGY, V8, P1548, DOI 10.4161/auto.21327; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Higgins GC, 2011, CELL MOL LIFE SCI, V68, P3725, DOI 10.1007/s00018-011-0667-9; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hyman BT, 2011, NAT NEUROSCI, V14, P5, DOI 10.1038/nn0111-5; Jaeger PA, 2010, ARCH NEUROL-CHICAGO, V67, P1181, DOI 10.1001/archneurol.2010.258; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klionsky DJ, 2005, AUTOPHAGY, V1, P59, DOI 10.4161/auto.1.1.1536; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Mitra S, 2009, AUTOPHAGY, V5, P1037, DOI 10.4161/auto.5.7.9291; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Neely KM, 2011, J NEUROSCI, V31, P2781, DOI 10.1523/JNEUROSCI.5156-10.2010; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Park HYL, 2012, BRAIN RES, V1469, P10, DOI 10.1016/j.brainres.2012.06.006; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Petralia RS, 2013, BIOL OPEN, V2, P499, DOI 10.1242/bio.20134275; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Sekulic A, 2000, CANCER RES, V60, P3504; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shehata M, 2012, J NEUROSCI, V32, P10413, DOI 10.1523/JNEUROSCI.4533-11.2012; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Snigdha S, 2012, NEUROSCI BULL, V28, P14, DOI 10.1007/s12264-012-1057-5; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Sun J, 2011, J BIOL CHEM, V286, P6791, DOI 10.1074/jbc.M110.172882; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tong LQ, 2008, NEUROBIOL AGING, V29, P1380, DOI 10.1016/j.neurobiolaging.2007.02.027; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Vega F, 2006, CANCER RES, V66, P6589, DOI 10.1158/0008-5472.CAN-05-3018; Walls KC, 2010, J BIOL CHEM, V285, P10497, DOI 10.1074/jbc.M110.103747; Wu XH, 2004, J BIOL CHEM, V279, P9167, DOI 10.1074/jbc.M312397200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamada M, 1997, J BIOL CHEM, V272, P30334, DOI 10.1074/jbc.272.48.30334; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhao P, 2010, BIOCHEM BIOPH RES CO, V395, P219, DOI 10.1016/j.bbrc.2010.03.165	86	67	74	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20615	20629		10.1074/jbc.M114.568659	http://dx.doi.org/10.1074/jbc.M114.568659			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24917666	Green Published, hybrid			2022-12-25	WOS:000339396600021
J	Nielsen, RO; Ronnow, L; Rasmussen, S; Lind, M				Nielsen, Rasmus Oestergaard; Ronnow, Lotte; Rasmussen, Sten; Lind, Martin			A Prospective Study on Time to Recovery in 254 Injured Novice Runners	PLOS ONE			English	Article							LOWER-EXTREMITY INJURIES; OVERUSE INJURIES; RISK-FACTORS; FOOT	Objectives: Describe the diagnoses and the time to recovery of running-related injuries in novice runners. Design: Prospective cohort study on injured runners. Method: This paper is a secondary data analysis of a 933-person cohort study (DANO-RUN) aimed at characterizing risk factors for injury in novice runners. Among those sustaining running-related injuries, the types of injuries and time to recovery is described in the present paper. All injured runners were diagnosed after a thorough clinical examination and then followed prospectively during their recovery. If they recovered completely from injury, time to recovery of each injury was registered. Results: A total of 254 runners were injured. The proportion of runners diagnosed with medial tibial stress syndrome was 15%, 10% for patellofemoral pain, 9% for medial meniscal injury, 7% for Achilles tendinopathy and 5% for plantar fasciitis. Among the 220 runners (87%) recovering from their injury, the median time to recovery was 71 days (minimum = 9 days, maximum = 617 days). Conclusions: Medial tibial stress syndrome was the most common injury followed by patellofemoral pain, medial meniscal injury and Achilles tendinopathy. Half of the injured runners were unable to run 26500 meters without pain after 10 weeks. Almost 5% of the injured runners received surgical treatment.	[Nielsen, Rasmus Oestergaard] Aarhus Univ, Dept Publ Hlth, Sect Sports Sci, Aarhus, Denmark; [Nielsen, Rasmus Oestergaard; Rasmussen, Sten] Aalborg Univ Hosp, Sci & Innovat Ctr, Orthopaed Surg Res Unit, Aalborg, Denmark; [Ronnow, Lotte; Lind, Martin] Aarhus Univ Hosp, Dept Orthopaed, DK-8000 Aarhus, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Nielsen, RO (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Sports Sci, Aarhus, Denmark.	roen@sport.au.dk	Rasmussen, Sten/N-3916-2013; Nielsen, Rasmus Oestergaard/O-1288-2013	Rasmussen, Sten/0000-0002-8664-352X; Nielsen, Rasmus Oestergaard/0000-0001-5757-1806				Bertelsen ML, 2013, GAIT POSTURE, V38, P354, DOI 10.1016/j.gaitpost.2012.11.022; Buist I, 2010, BRIT J SPORT MED, V44, P598, DOI 10.1136/bjsm.2007.044677; Buist I, 2008, AM J SPORT MED, V36, P35, DOI 10.1177/0363546507307505; Buist I, 2010, AM J SPORT MED, V38, P273, DOI 10.1177/0363546509347985; Khan KM, 1998, CLIN J SPORT MED, V8, P1, DOI 10.1097/00042752-199801000-00001; Knobloch K, 2008, FOOT ANKLE INT, V29, P671, DOI 10.3113/FAI.2008.0671; KOPLAN JP, 1995, MED SCI SPORT EXER, V27, P1180; Lopes AD, 2012, SPORTS MED, V42, P891, DOI [10.2165/11631170-000000000-00000, 10.1007/BF03262301]; McKean KA, 2006, CLIN J SPORT MED, V16, P149, DOI 10.1097/00042752-200603000-00011; Moen MH, 2012, SCAND J MED SCI SPOR, V22, P34, DOI 10.1111/j.1600-0838.2010.01144.x; Nielsen RO, 2012, INT J SPORTS PHYS TH, V7, P58; Nielsen RO, 2014, BRIT J SPORT MED, V48, P440, DOI 10.1136/bjsports-2013-092202; Nielsen RO, 2011, BRIT J SPORT MED, V45, P365; Rasmussen CH, 2013, INT J SPORTS PHYS TH, V8, P111; Schneiders AG, 2012, J ORTHOP SPORT PHYS, V42, P760, DOI 10.2519/jospt.2012.4000; Taunton JE, 2003, BRIT J SPORT MED, V37, P239, DOI 10.1136/bjsm.37.3.239; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Teh J, 2011, SEMIN MUSCULOSKEL R, V15, P101, DOI 10.1055/s-0031-1271962; Van Middelkoop M, 2008, SCAND J MED SCI SPOR, V18, P691, DOI 10.1111/j.1600-0838.2007.00768.x; van Middelkoop M, 2007, CLIN J SPORT MED, V17, P25, DOI 10.1097/JSM.0b013e3180305e4d; Wen Dennis Y, 2007, Curr Sports Med Rep, V6, P307	22	51	52	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99877	10.1371/journal.pone.0099877	http://dx.doi.org/10.1371/journal.pone.0099877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923269	gold, Green Published			2022-12-25	WOS:000338701300103
J	Sarkisova, SA; Lotlikar, SR; Guragain, M; Kubat, R; Cloud, J; Franklin, MJ; Patrauchan, MA				Sarkisova, Svetlana A.; Lotlikar, Shalaka R.; Guragain, Manita; Kubat, Ryan; Cloud, John; Franklin, Michael J.; Patrauchan, Marianna A.			A Pseudomonas aeruginosa EF-Hand Protein, EfhP (PA4107), Modulates Stress Responses and Virulence at High Calcium Concentration	PLOS ONE			English	Article							BINDING PROTEIN; SUPEROXIDE-DISMUTASE; OXYGEN LIMITATION; OXIDATIVE STRESS; SIGNAL PEPTIDES; CYSTIC-FIBROSIS; ENDOCARDITIS; EXPRESSION; MULTIPLE; ALGINATE	Pseudomonas aeruginosa is a facultative human pathogen, and a major cause of nosocomial infections and severe chronic infections in endocarditis and in cystic fibrosis (CF) patients. Calcium (Ca2+) accumulates in pulmonary fluids of CF patients, and plays a role in the hyperinflamatory response to bacterial infection. Earlier we showed that P. aeruginosa responds to increased Ca2+ levels, primarily through the increased production of secreted virulence factors. Here we describe the role of putative Ca2+-binding protein, with an EF-hand domain, PA4107 (EfhP), in this response. Deletion mutations of efhP were generated in P. aeruginosa strain PAO1 and CF pulmonary isolate, strain FRD1. The lack of EfhP abolished the ability of P. aeruginosa PAO1 to maintain intracellular Ca2+ homeostasis. Quantitative high-resolution 2D-PAGE showed that the efhP deletion also affected the proteomes of both strains during growth with added Ca2+. The greatest proteome effects occurred when the pulmonary isolate was cultured in biofilms. Among the proteins that were significantly less abundant or absent in the mutant strains were proteins involved in iron acquisition, biosynthesis of pyocyanin, proteases, and stress response proteins. In support, the phenotypic responses of FRD1 DefhP showed that the mutant strain lost its ability to produce pyocyanin, developed less biofilm, and had decreased resistance to oxidative stress (H2O2) when cultured at high [Ca2+]. Furthermore, the mutant strain was unable to produce alginate when grown at high [Ca2+] and no iron. The effect of the DefhP mutations on virulence was determined in a lettuce model of infection. Growth of wild-type P. aeruginosa strains at high [Ca2+] causes an increased area of disease. In contrast, the lack of efhP prevented this Ca2+-induced increase in the diseased zone. The results indicate that EfhP is important for Ca2+ homeostasis and virulence of P. aeruginosa when it encounters host environments with high [Ca2+].	[Sarkisova, Svetlana A.; Lotlikar, Shalaka R.; Guragain, Manita; Kubat, Ryan; Cloud, John; Patrauchan, Marianna A.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA; [Franklin, Michael J.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Franklin, Michael J.] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Patrauchan, MA (corresponding author), Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA.	m.patrauchan@okstate.edu	Guragain, Manita/AAW-9237-2021	Guragain, Manita/0000-0002-5266-1746; Kubat, Ryan/0000-0001-5899-2418	Public Health Service from the National Institute of Allergy and Infectious Diseases [AI-094268]; American Heart Association [09BGIA2330036]; OCAST [HR12-167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094268] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); OCAST; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant AI-094268 from the National Institute of Allergy and Infectious Diseases (M.J.F.), and research grants 09BGIA2330036 from American Heart Association and HR12-167 from OCAST (M.A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Bicanic TA, 2002, J INFECTION, V44, P137, DOI 10.1053/jinf.2001.0926; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Bredenbruch F, 2006, ENVIRON MICROBIOL, V8, P1318, DOI 10.1111/j.1462-2920.2006.01025.x; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Campbell AK S-NG, 1993, BIOLUMINESCENT CHEMI, P58; Campbell AK, 2007, ARCH BIOCHEM BIOPHYS, V468, P107, DOI 10.1016/j.abb.2007.09.006; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Carty NL, 2006, MOL MICROBIOL, V61, P782, DOI 10.1111/j.1365-2958.2006.05269.x; Chazin WJ, 2011, ACCOUNTS CHEM RES, V44, P171, DOI 10.1021/ar100110d; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FRANKLIN MJ, 1993, J BACTERIOL, V175, P5057, DOI 10.1128/JB.175.16.5057-5065.1993; Guragain M, 2013, CELL CALCIUM, V54, P350, DOI 10.1016/j.ceca.2013.08.004; Halmerbauer G, 2000, CLIN EXP ALLERGY, V30, P1771, DOI 10.1046/j.1365-2222.2000.00988.x; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hassett DJ, 1997, J BACTERIOL, V179, P1452, DOI 10.1128/jb.179.5.1452-1459.1997; Herbaud ML, 1998, BBA-MOL CELL RES, V1448, P212, DOI 10.1016/S0167-4889(98)00145-1; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Irani VR, 1997, BIOTECHNIQUES, V22, P54, DOI 10.2144/97221bm09; Ishiwada N, 2005, CIRC J, V69, P1266, DOI 10.1253/circj.69.1266; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; Jones HE, 1999, CELL CALCIUM, V25, P265, DOI 10.1054/ceca.1999.0028; Kaye KS, 2006, ANTIMICROB AGENTS CH, V50, P2192, DOI 10.1128/AAC.00060-06; Kim EJ, 2003, MICROBIOL-SGM, V149, P2627, DOI 10.1099/mic.0.26276-0; KOMSHIAN SV, 1990, REV INFECT DIS, V12, P693; KRETSINGER RH, 1976, ANNU REV BIOCHEM, V45, P239, DOI 10.1146/annurev.bi.45.070176.001323; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Lau ATY, 2004, BIOCHEM J, V382, P641, DOI 10.1042/BJ20040224; Leganes F, 2009, MICROBIOL-SGM, V155, P25, DOI 10.1099/mic.0.022251-0; LORIN MI, 1976, J LAB CLIN MED, V88, P114; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; Patrauchan MA, 2007, MICROBIOL-SGM, V153, P3838, DOI 10.1099/mic.0.2007/010371-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rada B, 2008, J IMMUNOL, V181, P4883, DOI 10.4049/jimmunol.181.7.4883; Rada B, 2010, FEBS LETT, V584, P917, DOI 10.1016/j.febslet.2010.01.025; Ran HM, 2003, P NATL ACAD SCI USA, V100, P14315, DOI 10.1073/pnas.2332354100; Redly GA, 2003, J BACTERIOL, V185, P1261, DOI 10.1128/JB.185.4.1261-1265.2003; Sarkisova S, 2005, J BACTERIOL, V187, P4327, DOI 10.1128/JB.187.13.4327-4337.2005; Sauer K, 2001, J BACTERIOL, V183, P6579, DOI 10.1128/JB.183.22.6579-6589.2001; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Starkey M, 2009, NAT PROTOC, V4, P117, DOI 10.1038/nprot.2008.224; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Takase H, 2000, INFECT IMMUN, V68, P1834, DOI 10.1128/IAI.68.4.1834-1839.2000; Tossavainen H, 2003, EUR J BIOCHEM, V270, P2505, DOI 10.1046/j.1432-1033.2003.03623.x; van Asselt EJ, 1999, FEBS LETT, V458, P429, DOI 10.1016/S0014-5793(99)01198-9; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; VONRUECKER AA, 1984, PEDIATR RES, V18, P594, DOI 10.1203/00006450-198407000-00005; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Wang SL, 2008, J BACTERIOL, V190, P4061, DOI 10.1128/JB.01954-07; Wiens JR, 2014, MBIO, V5, DOI 10.1128/mBio.01010-13; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Xi CW, 2000, P NATL ACAD SCI USA, V97, P11114, DOI 10.1073/pnas.210181097; Yonekawa T, 2005, FEMS MICROBIOL LETT, V244, P315, DOI 10.1016/j.femsle.2005.02.003; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102; Zhou Y, 2006, PROTEINS, V65, P643, DOI 10.1002/prot.21139	67	25	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98985	10.1371/journal.pone.0098985	http://dx.doi.org/10.1371/journal.pone.0098985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918783	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000037
J	Guo, J; Zhang, X; Chen, Z; Wen, Y; Li, JL				Guo, Jia; Zhang, Xuan; Chen, Zhi; Wen, Ying; Li, Jilun			Two Adjacent and Similar TetR Family Transcriptional Regulator Genes, SAV577 and SAV576, Co-Regulate Avermectin Production in Streptomyces avermitilis	PLOS ONE			English	Article							ANTIBIOTIC PRODUCTION; SECONDARY METABOLISM; BIOSYNTHESIS; COELICOLOR; EXPRESSION; SEQUENCE; HOMOLOG; CLONING; DNA	Streptomyces avermitilis is an important bacterial species used for industrial production of avermectins, a family of broadspectrum anthelmintic agents. We previously identified the protein SAV576, a TetR family transcriptional regulator (TFR), as a downregulator of avermectin biosynthesis that acts by controlling transcription of its major target gene SAV575 (which encodes cytochrome P450/NADPH-ferrihemoprotein reductase) and ave genes. SAV577, another TFR gene, encodes a SAV577 protein that displays high amino acid homology with SAV576. In this study, we examined the effect of SAV577 on avermectin production and the relationships between SAV576 and SAV577. SAV577 downregulated avermectin biosynthesis indirectly, similarly to SAV576. SAV576 and SAV577 both directly repressed SAV575 transcription, and reciprocally repressed each other's expression. SAV575 transcription levels in various S. avermitilis strains were correlated with avermectin production levels. DNase I footprinting and electrophoretic mobility shift assays indicated that SAV576 and SAV577 compete for the same binding regions, and that DNA-binding affinity of SAV576 is much stronger than that of SAV577. GST pull-down assays revealed no direct interaction between the two proteins. Taken together, these findings suggest that SAV577 regulates avermectin production in S. avermitilis by a mechanism similar to that of SAV576, and that the role of SAV576 is dominant over that of SAV577. This is the first report of two adjacent and similar TFR genes that co-regulate antibiotic production in Streptomyces.	[Guo, Jia; Zhang, Xuan; Chen, Zhi; Wen, Ying; Li, Jilun] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Guo, Jia; Zhang, Xuan; Chen, Zhi; Wen, Ying; Li, Jilun] China Agr Univ, Coll Biol Sci, MOA Key Lab Soil Microbiol, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Wen, Y (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.; Wen, Y (corresponding author), China Agr Univ, Coll Biol Sci, MOA Key Lab Soil Microbiol, Beijing 100094, Peoples R China.	wen@cau.edu.cn			National Natural Science Foundation of China [31170045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31170045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Chen Z, 2007, CHINESE SCI BULL, V52, P616, DOI 10.1007/s11434-007-0119-y; Choi KY, 2012, FEBS J, V279, P1650, DOI 10.1111/j.1742-4658.2011.08462.x; Craney A, 2013, J ANTIBIOT, V66, P387, DOI 10.1038/ja.2013.25; Demain AL, 2002, NAT BIOTECHNOL, V20, P331, DOI 10.1038/nbt0402-331; Duong CTP, 2009, J MICROBIOL BIOTECHN, V19, P136, DOI 10.4014/jmb.0806.387; Guo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071330; Guo J, 2010, MOL GENET GENOMICS, V283, P123, DOI 10.1007/s00438-009-0502-2; He F, 2014, APPL MICROBIOL BIOT, V98, P399, DOI 10.1007/s00253-013-5348-1; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; IKEDA H, 1988, ANTIMICROB AGENTS CH, V32, P282, DOI 10.1128/AAC.32.2.282; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Ikeda H, 1997, CHEM REV, V97, P2591, DOI 10.1021/cr960023p; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Liu YP, 2013, J BACTERIOL, V195, P4365, DOI 10.1128/JB.00716-13; MACNEIL DJ, 1987, J IND MICROBIOL, V2, P209, DOI 10.1007/BF01569542; Martin JF, 2012, APPL MICROBIOL BIOT, V95, P61, DOI 10.1007/s00253-012-4129-6; McCormick JR, 2012, FEMS MICROBIOL REV, V36, P206, DOI 10.1111/j.1574-6976.2011.00317.x; Miyamoto KT, 2011, MICROBIOL-SGM, V157, P2266, DOI 10.1099/mic.0.048371-0; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Yu Z, 2010, J MOL BIOL, V400, P847, DOI 10.1016/j.jmb.2010.05.062; Zhao JL, 2007, CHINESE SCI BULL, V52, P623, DOI 10.1007/s11434-007-0105-4; Zianni Michael, 2006, J Biomol Tech, V17, P103	29	12	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99224	10.1371/journal.pone.0099224	http://dx.doi.org/10.1371/journal.pone.0099224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915523	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700072
J	Rudolf, AF; Skovgaard, T; Knapp, S; Jensen, LJ; Berthelsen, J				Rudolf, Amalie Frederikke; Skovgaard, Tine; Knapp, Stefan; Jensen, Lars Juhl; Berthelsen, Jens			A Comparison of Protein Kinases Inhibitor Screening Methods Using Both Enzymatic Activity and Binding Affinity Determination	PLOS ONE			English	Article							INTERACTION MAP; ASSAYS	Binding assays are increasingly used as a screening method for protein kinase inhibitors; however, as yet only a weak correlation with enzymatic activity-based assays has been demonstrated. We show that the correlation between the two types of assays can be improved using more precise screening conditions. Furthermore a marked improvement in the correlation was found by using kinase constructs containing the catalytic domain in presence of additional domains or subunits.	[Rudolf, Amalie Frederikke; Skovgaard, Tine; Jensen, Lars Juhl; Berthelsen, Jens] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, Copenhagen, Denmark; [Berthelsen, Jens] Univ Copenhagen, Fac Hlth Sci, Costerton Biofilm Ctr, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England	University of Copenhagen; University of Copenhagen; University of Oxford	Jensen, LJ (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, Copenhagen, Denmark.	lars.juhl.jensen@gmail.com; jb@sund.ku.dk	Knapp, Stefan/AAG-2347-2019; Jensen, Lars Juhl/C-6492-2008	Knapp, Stefan/0000-0001-5995-6494; Jensen, Lars Juhl/0000-0001-7885-715X	Novo Nordisk Foundation; FOBI (Research School for Biotechnology); Danish Strategic Research Council; Novo Nordisk Foundation Center for Protein Research [PI Lars Juhl Jensen] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); FOBI (Research School for Biotechnology); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Novo Nordisk Foundation Center for Protein Research	This work was funded by an Institutional core grant from the Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en). AFR was supported by a grant from FOBI (Research School for Biotechnology). JB is funded from a grant from the Danish Strategic Research Council rewarded to Prof Givskov at ISIM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Blackwell LJ, 2009, METHODS MOL BIOL, V565, P225, DOI 10.1007/978-1-60327-258-2_11; Card A, 2009, J BIOMOL SCREEN, V14, P31, DOI 10.1177/1087057108326663; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Fabbro D, 2012, METHODS MOL BIOL, V795, P1, DOI 10.1007/978-1-61779-337-0_1; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Gao YH, 2013, BIOCHEM J, V451, P313, DOI 10.1042/BJ20121418; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Grant S, 2009, CELL MOL LIFE SCI, V66, P1163, DOI 10.1007/s00018-008-8539-7; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Ma HC, 2008, EXPERT OPIN DRUG DIS, V3, P607, DOI 10.1517/17460441.3.6.607; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Posy SL, 2011, J MED CHEM, V54, P54, DOI 10.1021/jm101195a; Smyth Lynette A, 2009, J Chem Biol, V2, P131, DOI 10.1007/s12154-009-0023-9; Sutherland JJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1425, DOI 10.1016/j.bbapap.2012.12.023; Williams KP, 2009, METHODS MOL BIOL, V565, P107, DOI 10.1007/978-1-60327-258-2_5; Zhang C, 2011, NAT BIOTECHNOL, V29, P981, DOI 10.1038/nbt.2021	26	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98800	10.1371/journal.pone.0098800	http://dx.doi.org/10.1371/journal.pone.0098800			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915177	Green Submitted, gold, Green Published			2022-12-25	WOS:000340947700034
J	Somme, L; Mayer, C; Jacquemart, AL				Somme, Laurent; Mayer, Carolin; Jacquemart, Anne-Laure			Multilevel Spatial Structure Impacts on the Pollination Services of Comarum palustre (Rosaceae)	PLOS ONE			English	Article							POLLEN-LIMITATION; PLANT REPRODUCTION; HABITAT FRAGMENTATION; CONNECTIVITY MEASURES; BEE POLLINATORS; LANDSCAPE SCALE; POPULATION-SIZE; SEED PRODUCTION; DENSITY; BUMBLEBEES	Habitat destruction and fragmentation accelerate pollinator decline, consequently disrupting ecosystem processes such as pollination. To date, the impacts of multilevel spatial structure on pollination services have rarely been addressed. We focused on the effects of population spatial structure on the pollination services of Comarum palustre at three levels (i.e. within-population, between-populations and landscape). For three years, we investigated 14 Belgian populations, which differed in their within-population flower density, population surface, closure (i.e. proportion of the population edge that consisted of woody elements) and isolation (i.e. percentage of woody area cover within a 500 m radius from the population centre). We tested whether these spatial characteristics impact on pollinator abundance and visitation rate and thus, reproductive success of C. palustre. Insects were observed in 15 randomly-chosen plots in each population. We tested for pollen limitation with supplemental hand-cross pollination. Bumble bees and solitary bees were the major pollinators through all populations. Within populations, plots with high flower densities attracted high numbers of bumble bees and other insects. High bumble bee and solitary bee abundance was observed in populations presenting high proportions of woody edges and in populations within landscapes presenting high proportions of woody areas. Seed set resulting from open pollination varied with bumble bee and solitary bee visitation rate, leading to increased pollen limitation when pollinators were scarce. Since the reproductive success depended on the visitation rate of the main pollinators, which depended on multilevel spatial structure, wetland management plans should pay special attention to favour a mosaic of biotopes, including nesting sites and food resources for insects. This study particularly supports the relevance of a mix wetlands and woody habitats to bees.	[Somme, Laurent; Mayer, Carolin; Jacquemart, Anne-Laure] Catholic Univ Louvain, Earth & Life Inst Agron, Res Team Genet, Louvain La Neuve, Belgium	Universite Catholique Louvain	Somme, L (corresponding author), Catholic Univ Louvain, Earth & Life Inst Agron, Res Team Genet, Louvain La Neuve, Belgium.	laurent.somme@uclouvain.be			Belgian Fund for Scientific Research (FNRS) [2.4540.09]	Belgian Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	The Belgian Fund for Scientific Research (FNRS contract 2.4540.09) funded this research. website: http://www.frs-fnrs.be/. L. Somme holds a FRIA fellowship (Funds for training in Industry and Agriculture Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Aiken SG, 2003, FLORA CANADIAN ARCTI; Aizen MA, 2007, ECOLOGY, V88, P271, DOI 10.1890/06-1017; Albert T, 2008, PLANT BIOLOGY, V10, P643, DOI 10.1111/j.1438-8677.2008.00067.x; Artz DR, 2006, J ECOL, V94, P597, DOI 10.1111/j.1365-2745.2006.01109.x; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Bailey S, 2014, ECOL EVOL, V4, P370, DOI 10.1002/ece3.924; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Burel F., 2003, LANDSCAPE ECOLOGY CO; Cane J, 2001, CONSERV ECOL, V5, P149; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Dauber J, 2010, J ECOL, V98, P188, DOI 10.1111/j.1365-2745.2009.01590.x; Diaz-Forero I, 2011, BALT FOR, V17, P235; Eckert CG, 2000, ECOLOGY, V81, P532, DOI 10.1890/0012-9658(2000)081[0532:COAAGT]2.0.CO;2; Elliott SE, 2009, AM J BOT, V96, P912, DOI 10.3732/ajb.0800260; Ewers RM, 2013, INSECT CONSERV DIVER, V6, P598, DOI 10.1111/icad.12014; Fabian Y, 2013, J ANIM ECOL, V82, P1203, DOI 10.1111/1365-2656.12103; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; Frankard Philippe, 1998, Suo (Helsinki), V49, P33; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gibbs JP, 2000, CONSERV BIOL, V14, P314, DOI 10.1046/j.1523-1739.2000.98608.x; Gonzalez-Varo JP, 2009, BIOL CONSERV, V142, P1058, DOI 10.1016/j.biocon.2009.01.017; Goulson D, 2006, J INSECT CONSERV, V10, P95, DOI 10.1007/s10841-006-6286-3; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Goverde M, 2002, BIOL CONSERV, V104, P293, DOI 10.1016/S0006-3207(01)00194-X; Grindeland JM, 2005, FUNCT ECOL, V19, P383, DOI 10.1111/j.1365-2435.2005.00988.x; Guillen A., 2005, REPROD BIOL, V62, P9; Hadley AS, 2012, BIOL REV, V87, P526, DOI 10.1111/j.1469-185X.2011.00205.x; Jha S, 2013, P NATL ACAD SCI USA, V110, P555, DOI 10.1073/pnas.1208682110; Joosten H, 2002, WISE USE MIRES PEATL; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Kindlmann P, 2008, LANDSCAPE ECOL, V23, P879, DOI 10.1007/s10980-008-9245-4; KINDVALL O, 1995, BIOL CONSERV, V73, P51, DOI 10.1016/0006-3207(95)90063-2; Klank C, 2010, J ECOL, V98, P1389, DOI 10.1111/j.1365-2745.2010.01720.x; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Knight TM, 2003, OECOLOGIA, V137, P557, DOI 10.1007/s00442-003-1371-8; Korosi A, 2012, INSECT CONSERV DIVER, V5, P118, DOI 10.1111/j.1752-4598.2011.00138.x; Kreyer D, 2004, BIOL CONSERV, V116, P111, DOI 10.1016/S0006-3207(03)00182-4; KWAK MM, 1991, OECOLOGIA, V86, P99, DOI 10.1007/BF00317395; Lamers LPM, 2002, HYDROBIOLOGIA, V478, P107, DOI 10.1023/A:1021022529475; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1111/j.1095-8312.2000.tb01221.x; Lienert Judit, 2004, Journal for Nature Conservation (Jena), V12, P53, DOI 10.1016/j.jnc.2003.07.002; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Macek P, 2008, EVOL ECOL, V22, P419, DOI 10.1007/s10682-007-9235-z; Mayer C, 2012, BASIC APPL ECOL, V13, P690, DOI 10.1016/j.baae.2012.09.012; Mayer C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050353; Michener C.D., 2007, BEES WORLD, Vsecond; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.1890/0012-9658(2002)083[1131:SCMISE]2.0.CO;2; Moron D, 2008, WETLANDS, V28, P975, DOI 10.1672/08-83.1; Murren CJ, 2002, J ECOL, V90, P100, DOI 10.1046/j.0022-0477.2001.00638.x; Nielsen A, 2012, BASIC APPL ECOL, V13, P489, DOI 10.1016/j.baae.2012.08.008; Ockinger E, 2012, ECOGRAPHY, V35, P259, DOI 10.1111/j.1600-0587.2011.06870.x; OLESEN I, 1992, NORD J BOT, V12, P373, DOI 10.1111/j.1756-1051.1992.tb01318.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PYKE GH, 1980, THEOR POPUL BIOL, V17, P232, DOI 10.1016/0040-5809(80)90008-8; R Development Core Team, 2012, R LANG ENV STAT COMP; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schleuning M, 2009, BASIC APPL ECOL, V10, P61, DOI 10.1016/j.baae.2007.12.002; Schuepp C, 2011, OECOLOGIA, V165, P713, DOI 10.1007/s00442-010-1746-6; Sepp K, 2004, LANDSCAPE URBAN PLAN, V67, P173, DOI 10.1016/S0169-2046(03)00037-9; Shao JW, 2008, J INTEGR PLANT BIOL, V50, P1151, DOI 10.1111/j.1744-7909.2008.00655.x; Soderstrom B, 2001, BIODIVERS CONSERV, V10, P1839, DOI 10.1023/A:1013153427422; Somme L, 2014, ANN BOT-LONDON, V113, P477, DOI 10.1093/aob/mct280; Somme L, 2012, MOL ECOL RESOUR, V12, P91, DOI 10.1111/j.1755-0998.2011.03072.x; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Stevens VM, 2010, BIOL REV, V85, P625, DOI 10.1111/j.1469-185X.2009.00119.x; Strijker D, 2005, BASIC APPL ECOL, V6, P99, DOI 10.1016/j.baae.2005.01.001; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Verte P., 2007, ECHO RESERVES, V3, P4; Vervoort A, 2011, INT J PLANT SCI, V172, P366, DOI 10.1086/658152; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Wesselingh RA, 2007, NEW PHYTOL, V174, P26, DOI 10.1111/j.1469-8137.2007.01997.x; Westrich P., 1996, The conservation of bees., P1; WILLIAMS PH, 1988, ECOL ENTOMOL, V13, P223, DOI 10.1111/j.1365-2311.1988.tb00350.x; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x; Zurbuchen A, 2010, APIDOLOGIE, V41, P497, DOI 10.1051/apido/2009084; Zuur Alain F., 2009, P1	89	10	10	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99295	10.1371/journal.pone.0099295	http://dx.doi.org/10.1371/journal.pone.0099295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915450	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700081
J	Zhao, FZ; Yang, GH; Han, XH; Feng, YZ; Ren, GX				Zhao, Fazhu; Yang, Gaihe; Han, Xinhui; Feng, Yongzhong; Ren, Guangxin			Stratification of Carbon Fractions and Carbon Management Index in Deep Soil Affected by the Grain-to-Green Program in China	PLOS ONE			English	Article							ORGANIC-CARBON; LOESS PLATEAU; TILLAGE CHRONOSEQUENCE; SEQUESTRATION; GRASSLAND; STOCKS; RATIO; AFFORESTATION; CONSERVATION; INDICATOR	Conversion of slope cropland to perennial vegetation has a significant impact on soil organic carbon (SOC) stock in A horizon. However, the impact on SOC and its fraction stratification is still poorly understood in deep soil in Loess Hilly Region (LHR) of China. Samples were collected from three typical conversion lands, Robinia psendoacacia (RP), Caragana Korshinskii Kom (CK), and abandoned land (AB), which have been converted from slope croplands (SC) for 30 years in LHR. Contents of SOC, total nitrogen (TN), particulate organic carbon (POC), and labile organic carbon (LOC), and their stratification ratios (SR) and carbon management indexes (CMI) were determined on soil profiles from 0 to 200 cm. Results showed that the SOC, TN, POC and LOC stocks of RP were significantly higher than that of SC in soil layers of 0-10, 10-40, 40-100 and 100-200 cm (P<0.05). Soil layer of 100-200 cm accounted for 27.38-36.62%, 25.10-32.91%, 21.59-31.69% and 21.08-26.83% to SOC, TN, POC and LOC stocks in lands of RP, CK and AB. SR values were >2.0 in most cases of RP, CK and AB. Moreover, CMI values of RP, CK, and AB increased by 11.61-61.53% in soil layer of 100-200 cm compared with SC. Significant positive correlations between SOC stocks and CMI or SR values of both surface soil and deep soil layers indicated that they were suitable indicators for soil quality and carbon changes evaluation. The Grain-to-Green Program (GTGP) had strong influence on improving quantity and activity of SOC pool through all soil layers of converted lands, and deep soil organic carbon should be considered in C cycle induced by GTGP. It was concluded that converting slope croplands to RP forestlands was the most efficient way for sequestering C in LHR soils.	[Yang, Gaihe] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Yang, GH (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	ygh@nwsuaf.edu.cn; hanxinhui@nwsuaf.edu.cn	Zhao, Fazhu/CAG-5988-2022; Ren, Chengjie/CAF-2259-2022; Feng, Yongzhong/F-5090-2012; ren, guangxin/Q-1234-2015	Zhao, Fazhu/0000-0003-4758-3277; Feng, Yongzhong/0000-0002-5202-4368; ren, guangxin/0000-0001-9895-2680	Special Fund for forest-scientific Research in the Public Interest [201304312]	Special Fund for forest-scientific Research in the Public Interest	This work was supported by Special Fund for forest-scientific Research in the Public Interest (201304312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; Bai ZG, 2009, AMBIO, V38, P150, DOI 10.1579/0044-7447-38.3.150; Bao S.D., 2000, SOIL AGR CHEM ANAL, P355; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Chen LD, 2007, ECOL RES, V22, P641, DOI 10.1007/s11284-006-0065-1; [陈奇伯 Chen Qibo], 2003, [生态学报, Acta Ecologica Sinica], V23, P1463; Cole CV, 1997, NUTR CYCL AGROECOSYS, V49, P221, DOI 10.1023/A:1009731711346; Davis M, 2007, GLOBAL CHANGE BIOL, V13, P1414, DOI 10.1111/j.1365-2486.2007.01372.x; Diekow J, 2005, PLANT SOIL, V268, P319, DOI 10.1007/s11104-004-0330-4; Eaton J, 2008, CLIMATIC CHANGE, V91, P317, DOI 10.1007/s10584-008-9412-2; Franzluebbers AJ, 1997, SOIL SCI SOC AM J, V61, P1382, DOI 10.2136/sssaj1997.03615995006100050014x; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P197, DOI 10.1016/S0167-1987(02)00027-2; Fu XL, 2010, GEODERMA, V155, P31, DOI 10.1016/j.geoderma.2009.11.020; Gong ZT, 1999, CHINESE SOIL TAXONOM, P36; Groenendijk FM, 2002, GEODERMA, V108, P91, DOI 10.1016/S0016-7061(02)00125-8; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; Jiao JY, 2012, RESTOR ECOL, V20, P240, DOI 10.1111/j.1526-100X.2010.00756.x; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Li FM, 2004, SOIL BIOL BIOCHEM, V36, P1893, DOI 10.1016/j.soilbio.2004.04.040; Liu GB, 1999, AMBIO, V28, P663; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Moreno F, 2006, SOIL TILL RES, V85, P86, DOI 10.1016/j.still.2004.12.001; PRESCOTT CE, 1995, CARBON FORMS AND FUNCTIONS IN FOREST SOILS, P377; Qiu LP, 2010, PLANT SOIL, V332, P207, DOI 10.1007/s11104-010-0286-5; Raiesi F, 2012, PLANT SOIL, V351, P161, DOI 10.1007/s11104-011-0941-5; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Sa JCD, 2001, SOIL SCI SOC AM J, V65, P1486, DOI 10.2136/sssaj2001.6551486x; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Schnabel RR, 2001, POTENTIAL OF U.S. GRAZING LANDS TO SEQUESTER CARBON AND MITIGATE THE GREENHOUSE EFFECT, P291; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sparling G. P., 1997, P97; Strahm BD, 2009, FOREST ECOL MANAG, V258, P2347, DOI 10.1016/j.foreco.2009.03.014; VandenBygaart AJ, 2011, SOIL SCI SOC AM J, V75, P226, DOI 10.2136/sssaj2010.0099; VANLEAR DH, 1995, CARBON FORMS AND FUNCTIONS IN FOREST SOILS, P489; Wang YF, 2010, QUATERNARY RES, V73, P70, DOI 10.1016/j.yqres.2008.11.006; Wang Z, 2012, CATENA, V99, P26, DOI 10.1016/j.catena.2012.07.003; [王征 Wang Zheng], 2010, [生态学报, Acta Ecologica Sinica], V30, P3947; Wei J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040123; Wei XR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032054; Xue Sha, 2009, Scientia Agricultura Sinica, V42, P1458; ZB Jia, 2009, INVESTIGATION REPORT, P267; Zhang CS, 2004, GEODERMA, V119, P261, DOI 10.1016/j.geoderma.2003.08.004; Zhang Feng, 2007, Acta Ecologica Sinica, V27, P4555; Zhao YT, 2010, ECOLOGICAL EC, V7, P81	46	54	59	5	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99657	10.1371/journal.pone.0099657	http://dx.doi.org/10.1371/journal.pone.0099657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915425	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700125
J	Aebischer, D; Willrodt, AH; Halin, C				Aebischer, David; Willrodt, Ann-Helen; Halin, Cornelia			Oxazolone-Induced Contact Hypersensitivity Reduces Lymphatic Drainage but Enhances the Induction of Adaptive Immunity	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DENDRITIC CELL-MIGRATION; CHRONIC SKIN INFLAMMATION; IFN-GAMMA PRODUCTION; IN-VIVO; STEADY-STATE; TRANSGENIC MICE; T-CELLS; PSORIASIS; VESSELS	Contact hypersensitivity (CHS) induced by topical application of haptens is a commonly used model to study dermal inflammatory responses in mice. Several recent studies have indicated that CHS-induced skin inflammation triggers lymphangiogenesis but may negatively impact the immune-function of lymphatic vessels, namely fluid drainage and dendritic cell (DC) migration to draining lymph nodes (dLNs). On the other hand, haptens have been shown to exert immune-stimulatory activity by inducing DC maturation. In this study we investigated how the presence of pre-established CHS-induced skin inflammation affects the induction of adaptive immunity in dLNs. Using a mouse model of oxazolone-induced skin inflammation we observed that lymphatic drainage was reduced and DC migration from skin to dLNs was partially compromised. At the same time, a significantly stronger adaptive immune response towards ovalbumin (OVA) was induced when immunization had occurred in CHS-inflamed skin as compared to uninflamed control skin. In fact, immunization with sterile OVA in CHS-inflamed skin evoked a delayed-type hypersensitivity (DTH) response comparable to the one induced by conventional immunization with OVA and adjuvant in uninflamed skin. Striking phenotypic and functional differences were observed when comparing DCs from LNs draining uninflamed or CHS-inflamed skin. DCs from LNs draining CHS-inflamed skin expressed higher levels of co-stimulatory molecules and MHC molecules, produced higher levels of the interleukin-12/23 p40 subunit (IL-12/23-p40) and more potently induced T cell activation in vitro. Immunization experiments revealed that blockade of IL-12/23-p40 during the priming phase partially reverted the CHS-induced enhancement of the adaptive immune response. Collectively, our findings indicate that CHS-induced skin inflammation generates an overall immune-stimulatory milieu, which outweighs the potentially suppressive effect of reduced lymphatic vessel function.	[Aebischer, David; Willrodt, Ann-Helen; Halin, Cornelia] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland	ETH Zurich	Halin, C (corresponding author), Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland.	cornelia.halin@pharma.ethz.ch		Halin, Cornelia/0000-0002-7899-2850	Swiss National Fund [310030_138330]; Swisslife Jubilaumsstiftung; ETH Zurich	Swiss National Fund(Swiss National Science Foundation (SNSF)); Swisslife Jubilaumsstiftung; ETH Zurich(ETH Zurich)	This work was supported by the Swiss National Fund (grant 310030_138330), the Swisslife Jubilaumsstiftung and ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 2010, J IMMUNOL, V184, P545, DOI 10.4049/jimmunol.0900397; Bianchi R, 1999, J IMMUNOL, V163, P2517; Bouta EM, 2014, J PHYSIOL-LONDON, V592, P1213, DOI 10.1113/jphysiol.2013.266700; Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x; Chu CC, 2011, SEMIN IMMUNOL, V23, P28, DOI 10.1016/j.smim.2011.01.006; Cliff S, 1999, BRIT J DERMATOL, V140, P61; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Esser PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041340; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Halin C, 2008, METHOD ENZYMOL, V445, P1, DOI 10.1016/S0076-6879(08)03001-2; Heinzel K, 2007, P NATL ACAD SCI USA, V104, P8421, DOI 10.1073/pnas.0608274104; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Hvid H, 2008, INT IMMUNOL, V20, P1097, DOI 10.1093/intimm/dxn068; Iolyeva M, 2013, BLOOD, V122, P2271, DOI 10.1182/blood-2013-01-478073; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Johnson-Huang LM, 2012, DIS MODEL MECH, V5, P423, DOI 10.1242/dmm.009092; Kim YS, 2009, J IMMUNOL, V183, P5113, DOI 10.4049/jimmunol.0901566; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Kratky W, 2011, P NATL ACAD SCI USA, V108, P17414, DOI 10.1073/pnas.1108945108; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Lachance PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076078; Liao S, 2006, J IMMUNOL, V177, P3369, DOI 10.4049/jimmunol.177.5.3369; Liao S, 2011, P NATL ACAD SCI USA, V108, P18784, DOI 10.1073/pnas.1116152108; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Manome H, 1999, IMMUNOLOGY, V98, P481, DOI 10.1046/j.1365-2567.1999.00916.x; Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; McFadden JP, 2013, BRIT J DERMATOL, V168, P692, DOI 10.1111/bjd.12145; Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NESTLE FO, 1994, J CLIN INVEST, V94, P202, DOI 10.1172/JCI117308; Nitschke M, 2012, BLOOD, V120, P2249, DOI 10.1182/blood-2012-03-417923; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Shin JY, 2009, CELL IMMUNOL, V256, P72, DOI 10.1016/j.cellimm.2009.01.006; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; THOMAS R, 1994, J IMMUNOL, V152, P2613; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Van Kruiningen HJ, 2008, GUT, V57, P1; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; von der Weid PY, 2010, ANN NY ACAD SCI, V1207, pE69, DOI 10.1111/j.1749-6632.2010.05715.x; von Moos S, 2012, ALLERGY, V67, P638, DOI 10.1111/j.1398-9995.2012.02802.x; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793	51	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99297	10.1371/journal.pone.0099297	http://dx.doi.org/10.1371/journal.pone.0099297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911791	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600067
J	Cui, YL; Qin, S; Jiang, P				Cui, Yulin; Qin, Song; Jiang, Peng			Chloroplast Transformation of Platymonas (Tetraselmis) subcordiformis with the bar Gene as Selectable Marker	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; PLASTID TRANSFORMATION; HIGHER-PLANTS; TRANSGENIC CHLOROPLASTS; CHLAMYDOMONAS-REINHARDTII; HERBICIDE RESISTANCE; GLUTAMINE-SYNTHETASE; EXPRESSION; BOMBARDMENT; BIOTECHNOLOGY	The objective of this research was to establish a chloroplast transformation technique for Platymonas (Tetraselmis) subcordiformis. Employing the gfp gene as a reporter and the bar gene as a selectable marker, transformation vectors of P. subcordiformis chloroplast were constructed with endogenous fragments rrn16S-trnl (left) and trnA-rrn23S (right) as a recombination site of the chloroplast genome. The plasmids were transferred into P. subcordiformis via particle bombardment. Confocal laser scanning microscopy indicated that the green fluorescence protein was localized in the chloroplast of P. subcordiformis, confirming the activity of the Chlamydomonas reinhardtii promoter. Cells transformed with the bar gene were selected using the herbicide Basta. Resistant colonies were analyzed by PCR and Southern blotting, and the results indicated that the bar gene was successfully integrated into the chloroplast genome via homologous recombination. The technique will improve genetic engineering of this alga.	[Cui, Yulin; Qin, Song] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Biol & Biol Resource Utilizat, Yantai, Shandong, Peoples R China; [Cui, Yulin; Jiang, Peng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Qin, S (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Biol & Biol Resource Utilizat, Yantai, Shandong, Peoples R China.	sqin@yic.ac.cn; jiangpeng@ms.qdio.ac.cn	Jiang, Peng/B-8061-2011	Jiang, Peng/0000-0001-9867-8386	Ocean Public Welfare Scientific Research Project, State Oceanic Administration of China [201205027]; National Natural Science Foundation of China [41176144]	Ocean Public Welfare Scientific Research Project, State Oceanic Administration of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ocean Public Welfare Scientific Research Project, State Oceanic Administration of China (201205027), National Natural Science Foundation of China (41176144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOWERS AD, 1989, PLANT CELL, V1, P123, DOI 10.1105/tpc.1.1.123; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; CARRER H, 1993, MOL GEN GENET, V241, P49, DOI 10.1007/BF00280200; Cui YL, 2012, CHIN J OCEANOL LIMN, V30, P471, DOI 10.1007/s00343-012-1093-z; Daniell H, 2002, TRENDS PLANT SCI, V7, P84, DOI 10.1016/S1360-1385(01)02193-8; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; Doetsch NA, 2001, CURR GENET, V39, P49, DOI 10.1007/s002940000174; Ghoshroy S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-198; GOLDSCHMIDTCLERMONT M, 1991, NUCLEIC ACIDS RES, V19, P4083, DOI 10.1093/nar/19.15.4083; Guo Z, 2008, BIOTECHNOL LETT, V30, P877, DOI 10.1007/s10529-008-9637-1; Hibberd JM, 1998, PLANT J, V16, P627, DOI 10.1046/j.1365-313x.1998.00328.x; HIREL B, 1982, PHYSIOL PLANTARUM, V55, P197, DOI 10.1111/j.1399-3054.1982.tb02287.x; Hou BK, 2003, TRANSGENIC RES, V12, P111, DOI 10.1023/A:1022180315462; Kohler RH, 1997, SCIENCE, V276, P2039, DOI 10.1126/science.276.5321.2039; Lapidot M, 2002, PLANT PHYSIOL, V129, P7, DOI 10.1104/pp.011023; Lee SM, 2006, MOL CELLS, V21, P401; Lee SB, 2003, MOL BREEDING, V11, P1, DOI 10.1023/A:1022100404542; Lelivelt CLC, 2005, PLANT MOL BIOL, V58, P763, DOI 10.1007/s11103-005-7704-8; Limaye A, 2006, FASEB J, V20, P959, DOI 10.1096/fj.05-5134fje; Lutz KA, 2001, PLANT PHYSIOL, V125, P1585, DOI 10.1104/pp.125.4.1585; Maliga P, 2004, ANNU REV PLANT BIOL, V55, P289, DOI 10.1146/annurev.arplant.55.031903.141633; Maliga P, 2002, CURR OPIN PLANT BIOL, V5, P164, DOI 10.1016/S1369-5266(02)00248-0; MCNALLY SF, 1983, PLANT PHYSIOL, V72, P22, DOI 10.1104/pp.72.1.22; Quesada-Vargas T, 2005, PLANT PHYSIOL, V138, P1746, DOI 10.1104/pp.105.063040; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; Rieseberg M, 2001, APPL MICROBIOL BIOT, V56, P350, DOI 10.1007/s002530100673; SALISBURY JL, 1981, PROTOPLASMA, V107, P1, DOI 10.1007/BF01275602; Sidorov VA, 1999, PLANT J, V19, P209, DOI 10.1046/j.1365-313X.1999.00508.x; Su ZL, 2005, ACTA BIOCH BIOPH SIN, V37, P709, DOI 10.1111/j.1745-7270.2005.00092.x; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; SVAB Z, 1990, P NATL ACAD SCI USA, V87, P8526, DOI 10.1073/pnas.87.21.8526; Tan CP, 2005, J MICROBIOL, V43, P361; WHITE J, 1990, NUCLEIC ACIDS RES, V18, P1062, DOI 10.1093/nar/18.4.1062; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yang TT, 1998, J BIOL CHEM, V273, P8212, DOI 10.1074/jbc.273.14.8212; Ye GN, 2003, PLANT PHYSIOL, V133, P402, DOI 10.1104/pp.103.021949; Zhang YC, 2008, SCI CHINA SER C, V51, P1116, DOI 10.1007/s11427-008-0143-4	37	36	36	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98607	10.1371/journal.pone.0098607	http://dx.doi.org/10.1371/journal.pone.0098607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911932	Green Submitted, gold, Green Published			2022-12-25	WOS:000337165600008
J	Lin, WL; Seak, CJ; Wu, JY; Weng, YM; Chen, HC				Lin, Wen-Ling; Seak, Chen-June; Wu, Jiunn-Yih; Weng, Yi-Ming; Chen, Hang-Cheng			Risk Factors for Development of Chronic Kidney Disease following Renal Infarction: Retrospective Evaluation of Emergency Room Patients from a Single Center	PLOS ONE			English	Article							CLASSIFICATION; PREDICTION; SCORE	Background: Previous studies have analyzed factors associated with renal infarction so that patients can be provided with earlier diagnosis and treatment. However, the factors associated with development of chronic kidney disease (CKD) following renal infarction are unknown. Methods: We retrospectively reviewed the records of patients with a diagnosis of renal infarction based on enhanced computed tomography. All patients were admitted to a single emergency department in Taiwan from 1999 to 2008. Univariate and multivariate analysis were used to assess the effect of different factors on development of CKD based on estimates of the glomerular filtration rate (eGFR) at admission and at 3-12 months after discharge. Results: Univariate analysis indicated significantly increased risk of CKD in patients older than 50 years, with symptoms for 24 h or less before admission, lower eGFR at admission, APACHE II score greater than 7, SOFA score greater than 1, ASA score greater than 2, and SAPS II score greater than 15. Multivariate analysis indicated that only SOFA score greater than 1 was significantly and independently associated with CKD at follow-up (p < 0.001). Conclusions: A total of 32.5% of patients admitted for renal infarction over a ten-year period developed CKD at 3-12 months after discharge. A SOFA score greater than 1 was significantly and independently associated with development of CKD in these patients.	[Lin, Wen-Ling; Seak, Chen-June; Weng, Yi-Ming] Chang Gung Mem Hosp, Dept Emergency Med, Taoyuan, Taiwan; [Lin, Wen-Ling; Seak, Chen-June; Wu, Jiunn-Yih; Weng, Yi-Ming; Chen, Hang-Cheng] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Wu, Jiunn-Yih; Chen, Hang-Cheng] Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chen, HC (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan.	ezn2002@gmail.com		SEAK, CHEN-JUNE/0000-0003-0984-8385				Bolderman R, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.06.049; Ceriotti F, 2008, CLIN CHEM, V54, P559, DOI 10.1373/clinchem.2007.099648; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Domanovits H, 1999, MEDICINE, V78, P386, DOI 10.1097/00005792-199911000-00004; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Huang CC, 2007, AM J EMERG MED, V25, P164, DOI 10.1016/j.ajem.2006.06.010; KEATS AS, 1978, ANESTHESIOLOGY, V49, P233, DOI 10.1097/00000542-197810000-00001; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Korzets Z, 2002, ISRAEL MED ASSOC J, V4, P781; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1995, INTENS CARE MED, V21, P770, DOI 10.1007/BF01704747; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Piffaretti G, 2008, VASC ENDOVASC SURG, V42, P375, DOI 10.1177/1538574408314445; Suzer O, 2002, EUR J RADIOL, V44, P59, DOI 10.1016/S0720-048X(01)00476-4; Tsai SH, 2007, INT J CLIN PRACT, V61, P62, DOI 10.1111/j.1742-1241.2006.01136.x	15	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98880	10.1371/journal.pone.0098880	http://dx.doi.org/10.1371/journal.pone.0098880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911965	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600018
J	Nada, O; Marian, A; Tran-Khanh, N; Buschmann, M; Podtetenev, M; Vidal, F; Costantino, S; Brunette, I				Nada, Ossama; Marian, Anca; Tran-Khanh, Nicolas; Buschmann, Michael; Podtetenev, Michel; Vidal, Francois; Costantino, Santiago; Brunette, Isabelle			Effect of Corneal Hydration on the Quality of the Femtosecond Laser Anterior Lamellar Cut	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; ENDOTHELIAL KERATOPLASTY; INTRALASE; THICKNESS; DONOR; MICROKERATOME; TRANSPARENCY; CREATION; LASIK; DISSECTION	The goal of this study was to assess the effect of corneal hydration on the quality of the femtosecond laser (FSL) anterior lamellar cut. The Visumax FSL was used to dissect an 8-mm-diameter corneal flap in 22 eye bank corneas showing various levels of hydration. The intended ablation depth was 220 mm in all eyes, which corresponded to the maximal depth available with this laser. After the cut, the achieved ablation depth was measured using optical coherence tomography images, flap separability was assessed by measuring the mean force generated to detach the flap, and stromal bed roughness was assessed by measuring the Haralick contrast level on the 1000 x scanning electron microscopy images of the ablated surfaces. The preoperative central corneal thickness ranged from 547 to 1104 mu m (mean +/- SEM: 833 +/- 30 mu m). A negative correlation was found between the level of corneal hydration and the ablation depth measured in the midperipheral cornea (r = -0.626, p = 0.003), the ablation being more superficial in more edematous corneas. The Haralick contrast also tended to increase as a function of corneal hydration ( r = 0.416, p = 0.061), suggesting that laser ablation in edematous corneas results in rougher stromal surfaces. These results support the hypothesis that the quality of the FSL lamellar cut decreases as the level of corneal hydration increases. Although FSL is still considered in the field as the tool of the future for corneal dissection, a better understanding of the limits of this tool will be needed before it can replace manual or automated stromal dissection techniques in hydrated corneas.	[Nada, Ossama; Marian, Anca; Podtetenev, Michel; Costantino, Santiago; Brunette, Isabelle] Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada; [Tran-Khanh, Nicolas; Buschmann, Michael] Ecole Polytech, Montreal, PQ H3C 3A7, Canada; [Tran-Khanh, Nicolas; Buschmann, Michael] Ecole Polytech, Grp Rech Sci & Technol Biomed, Montreal, PQ H3C 3A7, Canada; [Vidal, Francois] Inst Natl Rech Sci Energie Varennes, Ctr Energie Mat Telecommun, Varennes, PQ J3X 1S2, Canada; [Podtetenev, Michel; Costantino, Santiago; Brunette, Isabelle] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada; [Podtetenev, Michel] Focus Vis Clin, Verdun, PQ, Canada; [Nada, Ossama] Ain Shams Univ, Cairo, Egypt	Universite de Montreal; Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Polytechnique Montreal; University of Quebec; Universite de Montreal; Egyptian Knowledge Bank (EKB); Ain Shams University	Brunette, I (corresponding author), Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada.	i.brunett@videotron.ca	Costantino, Santiago/ABD-5472-2020; Vidal, François/A-3112-2010	Costantino, Santiago/0000-0002-2454-2635; Buschmann, Michael/0000-0002-2242-6198	Canadian Institutes of Health Research, Ottawa, ON, Canada; CNIB, Toronto, ON, Canada; FROUM, University of Montreal, Montreal, QC, Canada; FRQS Research in Vision Network, Montreal, QC, Canada	Canadian Institutes of Health Research, Ottawa, ON, Canada(Canadian Institutes of Health Research (CIHR)); CNIB, Toronto, ON, Canada; FROUM, University of Montreal, Montreal, QC, Canada; FRQS Research in Vision Network, Montreal, QC, Canada	This work was supported by: Canadian Institutes of Health Research, Ottawa, ON, Canada; CNIB, Toronto, ON, Canada; FROUM, University of Montreal, Montreal, QC, Canada; and FRQS Research in Vision Network, Montreal, QC, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn H, 2011, J CATARACT REFR SURG, V37, P349, DOI 10.1016/j.jcrs.2010.08.042; Bahar I, 2009, BRIT J OPHTHALMOL, V93, P73, DOI 10.1136/bjo.2008.148346; BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Brunette I, 2011, INVEST OPHTH VIS SCI, V52, P206, DOI 10.1167/iovs.09-4101; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Chan CC, 2010, CORNEA, V29, P290, DOI 10.1097/ICO.0b013e3181b77873; Cheng YYY, 2009, TRANSPLANTATION, V88, P1294, DOI 10.1097/TP.0b013e3181bc419c; Cheng YYY, 2009, CORNEA, V28, P73, DOI 10.1097/ICO.0b013e318183a379; Durrie DS, 2005, J CATARACT REFR SURG, V31, P120, DOI 10.1016/j.jcrs.2004.09.046; EBAA, 2011, EYE BANK STAT REP 20; Farid M, 2010, CURR OPIN OPHTHALMOL, V21, P288, DOI 10.1097/ICU.0b013e32833a8dbc; FARRELL RA, 1973, J PHYSIOL-LONDON, V233, P589, DOI 10.1113/jphysiol.1973.sp010325; GOLDMAN JN, 1968, INVEST OPHTH VISUAL, V7, P501; Hahn S, 2003, INVEST OPHTH VIS SCI, V44, P1508, DOI 10.1167/iovs.02-0641; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hoffart L, 2007, J FR OPHTALMOL, V30, P689, DOI 10.1016/S0181-5512(07)91356-X; Javaloy J, 2007, J REFRACT SURG, V23, P178; Jones YJ, 2008, CORNEA, V27, P88, DOI 10.1097/ICO.0b013e31815771f5; Kim JY, 2011, JPN J OPHTHALMOL, V55, P423, DOI 10.1007/s10384-011-0042-2; Kim JH, 2008, J CATARACT REFR SURG, V34, P132, DOI 10.1016/j.jcrs.2007.08.036; Kim P, 2011, CURR OPIN OPHTHALMOL, V22, P238, DOI 10.1097/ICU.0b013e3283477c9c; Kopani KR, 2014, BRIT J OPHTHALMOL, V98, DOI 10.1136/bjophthalmol-2013-304546; Leonard DW, 1997, BIOPHYS J, V72, P1382, DOI 10.1016/S0006-3495(97)78784-8; Letko E, 2009, J REFRACT SURG, V25, P1039, DOI 10.3928/1081597X-20090617-13; Maier PC, 2010, KLIN MONATSBL AUGENH, V227, P453, DOI 10.1055/s-0029-1245351; Marian A, 2013, J CATARACT REFR SURG, V39, P118, DOI 10.1016/j.jcrs.2012.08.050; MCCAREY BE, 1977, INVEST OPHTH VIS SCI, V16, P743; Meek KM, 2003, EYE, V17, P927, DOI 10.1038/sj.eye.6700574; Meek KM, 2003, BIOPHYS J, V85, P2205, DOI 10.1016/S0006-3495(03)74646-3; Mehta JS, 2008, J CATARACT REFR SURG, V34, P1970, DOI 10.1016/j.jcrs.2008.07.028; Mehta JS, 2008, CORNEA, V27, P706, DOI 10.1097/QAI.0b013e31815ee267; Montes-Mico R, 2007, OPHTHALMOLOGY, V114, P62, DOI 10.1016/j.ophtha.2006.07.019; Nuzzo V, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2811951; Prasad A, 2011, CORNEA, V30, P553, DOI 10.1097/ICO.0b013e3181fb880c; Proust H, 2011, AM J OPHTHALMOL, V151, P29, DOI 10.1016/j.ajo.2010.07.016; Salomao MQ, 2009, J CATARACT REFR SURG, V35, P1756, DOI 10.1016/j.jcrs.2009.05.032; Sarayba MA, 2007, CORNEA, V26, P446, DOI 10.1097/ICO.0b013e318033e7cc; Sarayba MA, 2007, J REFRACT SURG, V23, P58; Singh K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083185; Soong HK, 2005, OPHTHALMOLOGY, V112, P44, DOI 10.1016/j.ophtha.2004.06.037; Sutton G, 2008, J REFRACT SURG, V24, P802, DOI 10.3928/1081597X-20081001-06; Terry MA, 2005, CORNEA, V24, P453, DOI 10.1097/01.ico.0000151509.57189.6f; Yoo SH, 2011, AM J OPHTHALMOL, V151, P189, DOI 10.1016/j.ajo.2010.10.008; Zhou YH, 2011, J REFRACT SURG, V27, P408, DOI 10.3928/1081597X-20101029-01	44	2	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98852	10.1371/journal.pone.0098852	http://dx.doi.org/10.1371/journal.pone.0098852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911840	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000337165600017
J	Newman, LE; Zhou, CJ; Mudigonda, S; Mattheyses, AL; Paradies, E; Marobbio, CMT; Kahn, RA				Newman, Laura E.; Zhou, Cheng-jing; Mudigonda, Samatha; Mattheyses, Alexa L.; Paradies, Eleonora; Marobbio, Carlo Marya Thomas; Kahn, Richard A.			The ARL2 GTPase Is Required for Mitochondrial Morphology, Motility, and Maintenance of ATP Levels	PLOS ONE			English	Article							MEMBRANE ORGANIZATION; ARF FAMILY; COFACTOR-D; FUNCTIONAL-CHARACTERIZATION; S-ADENOSYLMETHIONINE; MITOFILIN COMPLEXES; ACTIVATING PROTEIN; STRUCTURAL BASIS; TRANSPORT; MUTANTS	ARF-like 2 (ARL2) is a member of the ARF family and RAS superfamily of regulatory GTPases, predicted to be present in the last eukaryotic common ancestor, and essential in a number of model genetic systems. Though best studied as a regulator of tubulin folding, we previously demonstrated that ARL2 partially localizes to mitochondria. Here, we show that ARL2 is essential to a number of mitochondrial functions, including mitochondrial morphology, motility, and maintenance of ATP levels. We compare phenotypes resulting from ARL2 depletion and expression of dominant negative mutants and use these to demonstrate that the mitochondrial roles of ARL2 are distinct from its roles in tubulin folding. Testing of current models for ARL2 actions at mitochondria failed to support them. Rather, we found that knockdown of the ARL2 GTPase activating protein (GAP) ELMOD2 phenocopies two of three phenotypes of ARL2 siRNA, making it a likely effector for these actions. These results add new layers of complexity to ARL2 signaling, highlighting the need to deconvolve these different cell functions. We hypothesize that ARL2 plays essential roles inside mitochondria along with other cellular functions, at least in part to provide coupling of regulation between these essential cell processes.	[Newman, Laura E.; Mudigonda, Samatha; Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Zhou, Cheng-jing] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Mattheyses, Alexa L.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Paradies, Eleonora] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy; [Marobbio, Carlo Marya Thomas] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy	Emory University; Emory University; Emory University; Consiglio Nazionale delle Ricerche (CNR); Universita degli Studi di Bari Aldo Moro	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	rkahn@emory.edu	MAROBBIO, Carlo/G-5775-2015; Paradies, Eleonora/K-4606-2014; Kahn, Richard/ABD-2666-2020	MAROBBIO, Carlo/0000-0002-2516-0321; Paradies, Eleonora/0000-0002-1668-7148; Kahn, Richard/0000-0002-0259-0601; Newman, Laura/0000-0001-5559-713X; Mattheyses, Alexa L/0000-0002-5119-7750	National Institutes of Health [GM090158]; American Heart Association predoctoral fellowship [14PRE18840040]; Microscopy Core of the Emory Neuroscience Core Facilities grant from National Institutes of Health [P30NS055077];  [5T32GM008367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM090158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral fellowship(American Heart Association); Microscopy Core of the Emory Neuroscience Core Facilities grant from National Institutes of Health; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health (http://www.nih.gov/) GM090158 to RAK, American Heart Association predoctoral fellowship (http://www.heart.org/) 14PRE18840040 to LEN, Microscopy Core of the Emory Neuroscience Core Facilities grant P30NS055077 from National Institutes of Health (http://www.nih.gov/), L. Newman was supported by a training grant 5T32GM008367 while performing some of the work in this manuscript. As with the other funding sources, the funders had no role in the design or execution of the study, or the decision to publish or preparation of the manuscript.	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; Antoshechkin I, 2002, DEV CELL, V2, P579, DOI 10.1016/S1534-5807(02)00146-6; Beghin A, 2008, CELL CYCLE, V7, P3074, DOI 10.4161/cc.7.19.6777; Behin A, 2007, EXP CELL RES, V313, P473, DOI 10.1016/j.yexcr.2006.10.024; Beltran-Parrazal L, 2006, AM J PHYSIOL-CELL PH, V291, pC1193, DOI 10.1152/ajpcell.00230.2006; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; BOLLAG G, 1991, ANNU REV CELL BIOL, V7, P601, DOI 10.1146/annurev.cellbio.7.1.601; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Bowzard JB, 2005, METHOD ENZYMOL, V404, P453, DOI 10.1016/S0076-6879(05)04040-1; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; Cunningham LA, 2008, J BIOL CHEM, V283, P7155, DOI 10.1074/jbc.M706753200; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dong JH, 2007, GENE, V396, P116, DOI 10.1016/j.gene.2007.03.001; East MP, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.417477; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hanzal-Bayer M, 2005, J MOL BIOL, V350, P1074, DOI 10.1016/j.jmb.2005.05.036; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Ivanova AA, 2014, J BIOL CHEM; Jaworek TJ, AM J HUM GE IN PRESS; Jeyaraju DV, 2006, P NATL ACAD SCI USA, V103, P18562, DOI 10.1073/pnas.0604983103; Johnson KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036074; Kahn RA, 2009, FEBS LETT, V583, P3872, DOI 10.1016/j.febslet.2009.10.066; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Fanarraga ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008846; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574; McElver J, 2000, PLANT CELL, V12, P1379, DOI 10.1105/tpc.12.8.1379; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Muromoto R, 2008, INT IMMUNOL, V20, P395, DOI 10.1093/intimm/dxm154; Nishi H, 2010, J BIOL CHEM, V285, P4920, DOI 10.1074/jbc.M109.082610; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 1979, Methods Enzymol, V56, P279; Phillips D, 2010, J BIOL CHEM, V285, P23532, DOI 10.1074/jbc.C110.152652; Price HP, 2010, MOL BIOCHEM PARASIT, V173, P123, DOI 10.1016/j.molbiopara.2010.05.016; Radcliffe PA, 2000, FEBS LETT, V468, P84, DOI 10.1016/S0014-5793(00)01202-3; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Sharer JD, 2005, IUBMB LIFE, V57, P607, DOI 10.1080/15216540500217735; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; STEARNS T, 1990, GENETICS, V124, P251; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tian GL, 2010, CYTOSKELETON, V67, P706, DOI 10.1002/cm.20480; Tsai PC, 2013, P NATL ACAD SCI USA, V110, pE668, DOI 10.1073/pnas.1221484110; van der Laan M, 2012, TRENDS CELL BIOL, V22, P185, DOI 10.1016/j.tcb.2012.01.004; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Wang KH, 2011, J BIOL CHEM, V286, P9468, DOI 10.1074/jbc.M110.178335; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343; Zerbes RM, 2012, BIOL CHEM, V393, P1247, DOI 10.1515/hsz-2012-0239; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	75	24	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99270	10.1371/journal.pone.0099270	http://dx.doi.org/10.1371/journal.pone.0099270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911211	gold, Green Submitted, Green Published			2022-12-25	WOS:000337165600063
J	Shiina, N; Nakayama, K				Shiina, Nobuyuki; Nakayama, Kei			RNA Granule Assembly and Disassembly Modulated by Nuclear Factor Associated with Double-stranded RNA 2 and Nuclear Factor 45	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE FORMATION; STRESS GRANULES; MESSENGER-RNA; BINDING PROTEINS; ENDORIBONUCLEASE G3BP; TRANSLATIONAL CONTROL; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; NFAR PROTEINS; NF90	RNA granules are large messenger ribonucleoprotein complexes that regulate translation and mRNA translocation to control the timing and location of protein synthesis. The regulation of RNA granule assembly and disassembly is a structural basis of translational control, and its disorder is implicated in degenerative disease. Here, we used proteomic analysis to identify proteins associated with RNA granule protein 105 (RNG105)/caprin1, an RNA-binding protein in RNA granules. Among the identified proteins, we focused on nuclear factor (NF) 45 and its binding partner, nuclear factor associated with dsRNA 2 (NFAR2), and we demonstrated that NF45 promotes disassembly of RNA granules, whereas NFAR2 enhances the assembly of RNA granules in cultured cells. The GQSY domain of NFAR2 was required to associate with messenger ribonucleoprotein complexes containing RNG105/caprin1, and it was structurally and functionally related to the low complexity sequence domain of the fused in sarcoma protein, which drives the assembly of RNA granules. Another domain of NFAR2, the DZF domain, was dispensable for association with the RNG105 complex, but it was involved in positive and negative regulation of RNA granule assembly by being phosphorylated at double-stranded RNA-activated kinase sites and by association with NF45, respectively. These results suggest a novel molecular mechanism for the modulation of RNA granule assembly and disassembly by NFAR2, NF45, and phosphorylation at double-stranded RNA-activated kinase PKR sites.	[Shiina, Nobuyuki; Nakayama, Kei] Okazaki Inst Integrat Biosci, Lab Neuronal Cell Biol, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki; Nakayama, Kei] Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki; Nakayama, Kei] Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Shiina, N (corresponding author), Okazaki Inst Integrat Biosci, Lab Neuronal Cell Biol, Nishigonaka 38, Okazaki, Aichi 4448585, Japan.	nshiina@nibb.ac.jp	Nakayama, Kei/C-1182-2009	Shiina, Nobuyuki/0000-0002-1854-4239; Nakayama, Kei/0000-0001-8032-7940	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Uehara Memorial Foundation (to N. S.).	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Bentmann E, 2013, FEBS J, V280, P4348, DOI 10.1111/febs.12287; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Duchange N, 2000, GENE, V261, P345, DOI 10.1016/S0378-1119(00)00495-9; El Fatimy R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039338; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Katsafanas GC, 2004, J BIOL CHEM, V279, P52210, DOI 10.1074/jbc.M411033200; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kotani T, 2013, J CELL BIOL, V202, P1041, DOI 10.1083/jcb.201302139; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Larcher JC, 2004, FASEB J, V18, P1761, DOI 10.1096/fj.04-1763fje; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Orford RL, 1998, MOL CELL BIOL, V18, P5557, DOI 10.1128/MCB.18.9.5557; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; Saunders LR, 2001, GENOMICS, V71, P256, DOI 10.1006/geno.2000.6423; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Shiina N, 1999, MOL BIOL CELL, V10, P597, DOI 10.1091/mbc.10.3.597; Shiina N, 2010, J NEUROSCI, V30, P12816, DOI 10.1523/JNEUROSCI.6386-09.2010; Shiina N, 2010, J BIOL CHEM, V285, P24260, DOI 10.1074/jbc.M110.108944; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wolkowicz UM, 2012, NUCLEIC ACIDS RES, V40, P9356, DOI 10.1093/nar/gks696; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zekri L, 2005, MOL CELL BIOL, V25, P8703, DOI 10.1128/MCB.25.19.8703-8716.2005; Zhang JW, 2011, J CELL SCI, V124, P4087, DOI 10.1242/jcs.090951	61	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21163	21180		10.1074/jbc.M114.556365	http://dx.doi.org/10.1074/jbc.M114.556365			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24920670	hybrid, Green Published			2022-12-25	WOS:000339396600066
J	Lee, MHH; Chen, SJ; Tsao, CM; Wu, CC				Lee, Michelle Hui-Hsin; Chen, Shiu-Jen; Tsao, Cheng-Ming; Wu, Chin-Chen			Perivascular Adipose Tissue Inhibits Endothelial Function of Rat Aortas via Caveolin-1	PLOS ONE			English	Article							NITRIC-OXIDE; VASCULAR FUNCTION; MUSCLE; FAT; ATHEROSCLEROSIS; INFLAMMATION; DYSFUNCTION; ENDOCRINE; ARTERIES; ALPHA	Perivascular adipose tissue (PVAT)-derived factors have been proposed to play an important role in the pathogenesis of atherosclerosis. Caveolin-1 (Cav-1), occupying the calcium/calmodulin binding site of endothelial NO synthase (eNOS) and then inhibiting nitric oxide (NO) production, is also involved in the development of atherosclerosis. Thus, we investigated whether PVAT regulated vascular tone via Cav-1 and/or endothelial NO pathways. Isometric tension studies were carried out in isolated thoracic aortas from Wistar rats in the presence and absence of PVAT. Concentration-response curves of phenylephrine, acetylcholine, and sodium nitroprusside were illustrated to examine the vascular reactivity and endothelial function. The protein expressions of eNOS and Cav-1 were also examined in aortic homogenates. Our results demonstrated that PVAT significantly enhanced vasoconstriction and inhibited vasodilatation via endothelium-dependent mechanism. The aortic NO production was diminished after PVAT treatment, whereas protein expression and activity of eNOS were not significantly affected. In addition, Cav-1 protein expression was significantly increased in aortas with PVAT transfer. Furthermore, a caveolae depleter methyl-beta-cyclodextrin abolished the effect of PVAT on the enhancement of vasoconstriction, and reversed the impairment of aortic NO production. In conclusion, unknown factor(s) released from PVAT may inhibit endothelial NO production and induce vasocontraction via an increase of Cav-1 protein expression.	[Lee, Michelle Hui-Hsin] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Shiu-Jen] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Tsao, Cheng-Ming] Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan; [Wu, Chin-Chen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Chen, Shiu-Jen] Kang Ning Jr Coll Med Care & Management, Dept Nursing, Taipei, Taiwan; [Tsao, Cheng-Ming] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Tsao, Cheng-Ming] Natl Yang Ming Univ, Taipei 112, Taiwan; [Wu, Chin-Chen] Taipei Med Univ, Dept Pharmacol, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University	Tsao, CM (corresponding author), Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan.	cm.cmtsao@gmail.com; ccwu@office365.ndmctsgh.edu.tw			National Science Council, Taiwan, ROC [NSC 101-2314-B-075-004, NSC 101-2320-B-345-001, NSC 101-2320-B-016-014]; Taipei Veterans General Hospital, Taiwan [VGH-V120C-143]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This study was supported by the Grants of NSC 101-2314-B-075-004 (CMT), NSC 101-2320-B-345-001 (SJC), and NSC 101-2320-B-016-014 (CCW) from the National Science Council, Taiwan, ROC, and by the Grant of VGH-V120C-143 (CMT) from Taipei Veterans General Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasier AR, 1996, HYPERTENSION, V27, P1009, DOI 10.1161/01.HYP.27.4.1009; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Dubrovska G, 2004, AM J PHYSIOL-HEART C, V286, pH1107, DOI 10.1152/ajpheart.00656.2003; Fang LP, 2009, J HYPERTENS, V27, P2174, DOI 10.1097/HJH.0b013e328330a900; Fruhbeck G, 1999, DIABETES, V48, P903, DOI 10.2337/diabetes.48.4.903; Gao YJ, 2007, BRIT J PHARMACOL, V151, P323, DOI 10.1038/sj.bjp.0707228; Gao YJ, 2005, J THORAC CARDIOV SUR, V130, P1130, DOI 10.1016/j.jtcvs.2005.05.028; Gao YJ, 2006, CARDIOVASC RES, V71, P363, DOI 10.1016/j.cardiores.2006.03.013; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Iacobellis G, 2008, CURR DIABETES REP, V8, P20, DOI 10.1007/s11892-008-0005-2; KRAUSE BR, 1984, J LIPID RES, V25, P97; Lee YC, 2011, CIRCULATION, V124, P1160, DOI 10.1161/CIRCULATIONAHA.111.027375; Li R, 2013, EUR J PHARMACOL, V698, P310, DOI 10.1016/j.ejphar.2012.09.026; Lohn M, 2002, FASEB J, V16, P1057, DOI 10.1096/fj.02-0024com; Maenhaut N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-25; Marchesi C, 2009, HYPERTENSION, V54, P1384, DOI 10.1161/HYPERTENSIONAHA.109.138305; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Meijer RI, 2013, DIABETES, V62, P590, DOI 10.2337/db11-1603; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; MULVANY MJ, 1976, NATURE, V260, P617, DOI 10.1038/260617a0; Owen MK, 2013, CIRCULATION, V128, P9, DOI 10.1161/CIRCULATIONAHA.112.001238; Pavlides S, 2012, ADV EXP MED BIOL, V729, P127, DOI 10.1007/978-1-4614-1222-9_9; Payne GA, 2008, MICROCIRCULATION, V15, P417, DOI 10.1080/10739680701858447; Payne GA, 2009, AM J PHYSIOL-HEART C, V297, pH460, DOI 10.1152/ajpheart.00116.2009; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Scotland RS, 2001, HYPERTENSION, V38, P833, DOI 10.1161/hy1001.092651; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; SOLTIS EE, 1991, CLIN EXP HYPERTENS A, V13, P277, DOI 10.3109/10641969109042063; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Vanhoutte PM, 1997, EUR HEART J, V18, pE19, DOI 10.1016/S0195-668X(97)90005-1; Verhagen SN, 2011, ATHEROSCLEROSIS, V214, P3, DOI 10.1016/j.atherosclerosis.2010.05.034; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Wort SJ, 2009, J BIOL CHEM, V284, P24297, DOI 10.1074/jbc.M109.032524; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Zavaritskaya O, 2013, HYPERTENSION, V61, P151, DOI 10.1161/HYPERTENSIONAHA.112.197566; Zhang DX, 2002, AM J PHYSIOL-HEART C, V283, pH1785, DOI 10.1152/ajpheart.00318.2002	42	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99947	10.1371/journal.pone.0099947	http://dx.doi.org/10.1371/journal.pone.0099947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926683	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100096
J	Chiang, CF; Albarino, CG; Lo, MK; Spiropoulou, CF				Chiang, Cheng-Feng; Albarino, Cesar G.; Lo, Michael K.; Spiropoulou, Christina F.			Small Interfering RNA Inhibition of Andes Virus Replication	PLOS ONE			English	Article							HANTAVIRUS CARDIOPULMONARY SYNDROME; PULMONARY SYNDROME; NUCLEOCAPSID PROTEIN; ANTIVIRAL IMMUNITY; MOSQUITO CELLS; DOUBLE-BLIND; TRANSMISSION; INFECTIONS; RESISTANCE; RIBAVIRIN	Andes virus (ANDV) is the most common causative agent of hantavirus pulmonary syndrome (HPS) in the Americas, and is the only hantavirus associated with human-to-human transmission. Case fatality rates of ANDV-induced HPS are approximately 40%. There are currently no effective vaccines or antivirals against ANDV. Since HPS severity correlates with viral load, we tested small interfering RNA (siRNA) directed against ANDV genes as a potential antiviral strategy. We designed pools of 4 siRNAs targeting each of the ANDV genome segments (S, M, and L), and tested their efficacy in reducing viral replication in vitro. The siRNA pool targeting the S segment reduced viral transcription and replication in Vero-E6 cells more efficiently than those targeting the M and L segments. In contrast, siRNAs targeting the S, M, or L segment were similar in their ability to reduce viral replication in human lung microvascular endothelial cells. Importantly, these siRNAs inhibit ANDV replication even if given after infection. Taken together, our findings indicate that siRNAs targeting the ANDV genome efficiently inhibit ANDV replication, and show promise as a strategy for developing therapeutics against ANDV infection.	[Chiang, Cheng-Feng; Albarino, Cesar G.; Lo, Michael K.; Spiropoulou, Christina F.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Spiropoulou, CF (corresponding author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.	cspiropoulou@cdc.gov		Lo, Michael/0000-0002-0409-7896; Chiang, Cheng-Feng/0000-0002-3617-9124	Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by Centers for Disease Control and Prevention (CDC) core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljofan M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-187; Alminaite A, 2006, J VIROL, V80, P9073, DOI 10.1128/JVI.00515-06; Billecocq A, 2000, J GEN VIROL, V81, P2161, DOI 10.1099/0022-1317-81-9-2161; Borges AA, 2006, MICROBES INFECT, V8, P2324, DOI 10.1016/j.micinf.2006.04.019; Chaparro J, 1998, J HOSP INFECT, V40, P281, DOI 10.1016/S0195-6701(98)90304-8; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Doyle TJ, 1998, INFECT DIS CLIN N AM, V12, P95, DOI 10.1016/S0891-5520(05)70411-6; Dykxhoorn DM, 2006, PLOS MED, V3, P1000, DOI 10.1371/journal.pmed.0030242; Enria DA, 2001, CURR TOP MICROBIOL, V256, P117; Ferres M, 2007, J INFECT DIS, V195, P1563, DOI 10.1086/516786; Flusin O, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-249; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Hutchinson KL, 1996, VIROLOGY, V224, P139, DOI 10.1006/viro.1996.0515; Jeang KT, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-58; Jonsson CB, 2008, ANTIVIR RES, V78, P162, DOI 10.1016/j.antiviral.2007.10.012; Kariwa H, 2003, ARCH VIROL, V148, P1671, DOI 10.1007/s00705-003-0141-6; Levin A, 2006, VIRUS RES, V120, P121, DOI 10.1016/j.virusres.2006.02.009; McNulty S, 2013, J VIROL, V87, P912, DOI 10.1128/JVI.02415-12; Mertz GJ, 2004, CLIN INFECT DIS, V39, P1307, DOI 10.1086/425007; Mir MA, 2004, J VIROL, V78, P8281, DOI 10.1128/jvi.78.15.8281-8288.2004; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; Muller S, 2007, ANTIMICROB AGENTS CH, V51, P2215, DOI 10.1128/AAC.01368-06; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Powers AM, 1996, P NATL ACAD SCI USA, V93, P4187, DOI 10.1073/pnas.93.9.4187; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; SCHMALJOHN CS, 2001, HANTAVIRUSES; Severson WE, 2001, J VIROL, V75, P2646, DOI 10.1128/JVI.75.6.2646-2652.2001; Soldan SS, 2005, J VIROL, V79, P234, DOI 10.1128/JVI.79.1.234-244.2005; Spiropoulou CF, 2003, VIROLOGY, V308, P48, DOI 10.1016/S0042-6822(02)00092-2; Spiropoulou CF, 2007, J VIROL, V81, P2769, DOI 10.1128/JVI.02402-06; Terajima M, 1999, J INFECT DIS, V180, P2030, DOI 10.1086/315153; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Wells RM, 1997, EMERG INFECT DIS, V3, P361, DOI 10.3201/eid0303.970314; Xiao RB, 2006, J INFECT DIS, V194, P1403, DOI 10.1086/508494; Zhou JH, 2011, METHODS MOL BIOL, V721, P67, DOI 10.1007/978-1-61779-037-9_4	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99764	10.1371/journal.pone.0099764	http://dx.doi.org/10.1371/journal.pone.0099764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924189	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300091
J	DeBarry, JD; Kissinger, JC				DeBarry, Jeremy D.; Kissinger, Jessica C.			A Survey of Innovation through Duplication in the Reduced Genomes of Twelve Parasites	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; SEGMENTAL DUPLICATIONS; TOXOPLASMA-GONDII; CRYPTOSPORIDIUM-PARVUM; GENE DUPLICATION; APICOMPLEXAN PARASITES; ORTHOLOG GROUPS; EVOLUTION; PLASMODIUM; SEQUENCE	We characterize the prevalence, distribution, divergence, and putative functions of detectable two-copy paralogs and segmental duplications in the Apicomplexa, a phylum of parasitic protists. Apicomplexans are mostly obligate intracellular parasites responsible for human and animal diseases (e. g. malaria and toxoplasmosis). Gene loss is a major force in the phylum. Genomes are small and protein-encoding gene repertoires are reduced. Despite this genomic streamlining, duplications and gene family amplifications are present. The potential for innovation introduced by duplications is of particular interest. We compared genomes of twelve apicomplexans across four lineages and used orthology and genome cartography to map distributions of duplications against genome architectures. Segmental duplications appear limited to five species. Where present, they correspond to regions enriched for multi-copy and species-specific genes, pointing toward roles in adaptation and innovation. We found a phylum-wide association of duplications with dynamic chromosome regions and syntenic breakpoints. Trends in the distribution of duplicated genes indicate that recent, species-specific duplicates are often tandem while most others have been dispersed by genome rearrangements. These trends show a relationship between genome architecture and gene duplication. Functional analysis reveals: proteases, which are vital to a parasitic lifecycle, to be prominent in putative recent duplications; a pair of paralogous genes in Toxoplasma gondii previously shown to produce the rate-limiting step in dopamine synthesis in mammalian cells, a possible link to the modification of host behavior; and phylum-wide differences in expression and subcellular localization, indicative of modes of divergence. We have uncovered trends in multiple modes of duplicate divergence including sequence, intron content, expression, subcellular localization, and functions of putative recent duplicates that highlight the role of duplications in the continuum of forces that have shaped these genomes.	[DeBarry, Jeremy D.; Kissinger, Jessica C.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [DeBarry, Jeremy D.; Kissinger, Jessica C.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Kissinger, Jessica C.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	DeBarry, JD (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	debarryj@gmail.com	Kissinger, Jessica C/E-9610-2010; Kissinger, Jessica/M-9920-2019	Kissinger, Jessica C/0000-0002-6413-1101; Kissinger, Jessica/0000-0002-6413-1101; DeBarry, Jeremy/0000-0001-5718-2675	National Institutes of Health [R01AI068908]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant number R01AI068908 to J.C.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson TJC, 2009, TRENDS PARASITOL, V25, P336, DOI 10.1016/j.pt.2009.04.005; Aurrecoechea C, 2009, NUCLEIC ACIDS RES; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; DeBarry J, 2011, MOL BIOL EVOLUTION, V28; Delwiche CF, 2004, BIOSCIENCE, V54, P991, DOI 10.1641/0006-3568(2004)054[0991:TGPGIE]2.0.CO;2; Durand PM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-282; Emes RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002295; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Guerzoni D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002381; Heiges M, 2006, NUCLEIC ACIDS RES, V34, pD419, DOI 10.1093/nar/gkj078; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Jelenska J, 2001, P NATL ACAD SCI USA, V98, P2723, DOI 10.1073/pnas.051629998; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r28; Kissinger JC, 2011, TRENDS PARASITOL, V27, P345, DOI 10.1016/j.pt.2011.03.006; Kondrashov FA, 2012, P ROY SOC B-BIOL SCI, V279, P5048, DOI 10.1098/rspb.2012.1108; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; Kuo C-H, 2008, MOL BIOL EVOL; Kuo CH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-108; Li H, 2012, BBA-PROTEINS PROTEOM, V1824, P177, DOI 10.1016/j.bbapap.2011.06.002; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; McConkey GA, 2013, J EXP BIOL, V216, P113, DOI 10.1242/jeb.074153; MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133; Menard D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002489; Nair S, 2007, MOL BIOL EVOL, V24, P562, DOI 10.1093/molbev/msl185; Nguyen HD, 2007, MOL BIOL EVOL, V24, P1093, DOI 10.1093/molbev/msm037; Oberstaller J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-516; Okamoto N, 2008, FUTURE MICROBIOL, V3, P391, DOI 10.2217/17460913.3.4.391; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Reid AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002567; Saffo MB, 2010, P NATL ACAD SCI USA, V107, P16190, DOI 10.1073/pnas.1002335107; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Sankoff D, 2001, CURR OPIN GENET DEV, V11, P681, DOI 10.1016/S0959-437X(00)00253-7; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Sun J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-49; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Templeton TJ, 2009, MOL BIOL EVOL; Van de Peer Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-250; Wasmuth J, 2009, GENOME RES, V19, P1202, DOI 10.1101/gr.083386.108; Xu JH, 2012, MOL BIOL EVOL, V29, P861, DOI 10.1093/molbev/msr261; Yang ZF, 2011, FEBS LETT, V585, P641, DOI 10.1016/j.febslet.2011.01.017; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhu G, 2002, GENE, V298, P79, DOI 10.1016/S0378-1119(02)00931-9; Zhu G, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-46; Zuther E, 1999, P NATL ACAD SCI USA, V96, P13387, DOI 10.1073/pnas.96.23.13387	67	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99213	10.1371/journal.pone.0099213	http://dx.doi.org/10.1371/journal.pone.0099213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919110	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000057
J	Masuda, T; Maruyama, H; Honda, A; Arai, F				Masuda, Taisuke; Maruyama, Hisataka; Honda, Ayae; Arai, Fumihito			Virus Enrichment for Single Virus Infection by Using 3D Insulator Based Dielectrophoresis	PLOS ONE			English	Article							DIFFRACTIVE-OPTICS FABRICATION; GRAY-SCALE LITHOGRAPHY; CONTINUOUS SEPARATION; MICROFLUIDIC DEVICES; CELLS; MANIPULATION; ELECTRODES; EFFICIENCY; PARTICLES; MASKS	We developed an active virus filter (AVF) that enables virus enrichment for single virus infection, by using insulator-based dielectrophoresis (iDEP). A 3D-constricted flow channel design enabled the production of an iDEP force in the microfluidic chip. iDEP using a chip with multiple active virus filters (AVFs) was more accurate and faster than using a chip with a single AVF, and improved the efficiency of virus trapping. We utilized maskless photolithography to achieve the precise 3D gray-scale exposure required for fabrication of constricted flow channel. Influenza virus (A PR/8) was enriched by a negative DEP force when sinusoidal wave was applied to the electrodes within an amplitude range of 20 Vp-p and a frequency of 10 MHz. AVF-mediated virus enrichment can be repeated simply by turning the current ON or OFF. Furthermore, the negative AVF can inhibit virus adhesion onto the glass substrate. We then trapped and transported one of the enriched viruses by using optical tweezers. This microfluidic chip facilitated the effective transport of a single virus from AVFs towards the cell-containing chamber without crossing an electrode. We successfully transported the virus to the cell chamber (v = 10 mu m/s) and brought it infected with a selected single H292 cell.	[Masuda, Taisuke; Maruyama, Hisataka; Arai, Fumihito] Nagoya Univ, Grad Sch Engn, Dept Micronano Syst Engn, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Honda, Ayae] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan	Nagoya University; Hosei University	Masuda, T (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Micronano Syst Engn, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	masuda@mech.nagoya-u.ac.jp			Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST)	Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was partially supported by Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Akin D, 2004, NANO LETT, V4, P257, DOI 10.1021/nl034987p; Albrecht DR, 2004, BIOPHYS J, V87, P2131, DOI 10.1529/biophysj.104.039511; Aldaeus F, 2005, ELECTROPHORESIS, V26, P4252, DOI 10.1002/elps.200500068; Arai F, 2001, ELECTROPHORESIS, V22, P283, DOI 10.1002/1522-2683(200101)22:2<283::AID-ELPS283>3.0.CO;2-C; Demierre N, 2008, SENSOR ACTUAT B-CHEM, V132, P388, DOI 10.1016/j.snb.2007.09.078; Fiedler S, 1998, ANAL CHEM, V70, P1909, DOI 10.1021/ac971063b; Gadish N, 2006, ANAL CHEM, V78, P7870, DOI 10.1021/ac061170i; Honda A, 2008, J BIOTECHNOL, V133, P208, DOI 10.1016/j.jbiotec.2007.08.019; HUANG Y, 1991, MEAS SCI TECHNOL, V2, P1142, DOI 10.1088/0957-0233/2/12/005; Hughes MP, 1998, BBA-GEN SUBJECTS, V1425, P119, DOI 10.1016/S0304-4165(98)00058-0; Ino K, 2009, ELECTROPHORESIS, V30, P3406, DOI 10.1002/elps.200900244; Itoga K, 2008, ANAL CHEM, V80, P1323, DOI 10.1021/ac702208d; Lapizco-Encinas BH, 2005, J MICROBIOL METH, V62, P317, DOI 10.1016/j.mimet.2005.04.027; Li HB, 2002, SENSOR ACTUAT B-CHEM, V86, P215, DOI 10.1016/S0925-4005(02)00172-7; MARKX GH, 1995, BIOTECHNOL BIOENG, V45, P337, DOI 10.1002/bit.260450408; Markx GH, 1997, J PHYS D APPL PHYS, V30, P2470, DOI 10.1088/0022-3727/30/17/013; Maruyama H, 2011, MICROFLUID NANOFLUID, V10, P1109, DOI 10.1007/s10404-010-0739-4; MASUDA S, 1989, IEEE T IND APPL, V25, P732, DOI 10.1109/28.31255; Masuda T, 2011, PROC IEEE MICR ELECT, P1099, DOI 10.1109/MEMSYS.2011.5734621; Mittal N, 2007, LAB CHIP, V7, P1146, DOI 10.1039/b706342c; Morgan H, 2001, J PHYS D APPL PHYS, V34, P1553, DOI 10.1088/0022-3727/34/10/316; OSHEA DC, 1995, APPL OPTICS, V34, P7518, DOI 10.1364/AO.34.007518; PETHIG R, 1992, J PHYS D APPL PHYS, V25, P881, DOI 10.1088/0022-3727/25/5/022; Pethig R, 2010, BIOMICROFLUIDICS, V4; POHL HA, 1971, BIOPHYS J, V11, P711, DOI 10.1016/S0006-3495(71)86249-5; POHL HA, 1951, J APPL PHYS, V22, P869, DOI 10.1063/1.1700065; Pohl HA, 1978, DIELECTROPHRESIS; Regtmeier J, 2011, ELECTROPHORESIS, V32, P2253, DOI 10.1002/elps.201100055; Rosenthal A, 2006, LAB CHIP, V6, P508, DOI 10.1039/b600280n; Sabounchi P, 2008, BIOMED MICRODEVICES, V10, P661, DOI 10.1007/s10544-008-9177-4; Schnelle T, 1996, NATURWISSENSCHAFTEN, V83, P172, DOI 10.1007/BF01143058; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; SULESKI TJ, 1995, APPL OPTICS, V34, P7507, DOI 10.1364/AO.34.007507; Totsu K, 2006, SENSOR ACTUAT A-PHYS, V130, P387, DOI 10.1016/j.sna.2005.12.008; Ueda R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067011; Waits CM, 2005, SENSOR ACTUAT A-PHYS, V119, P245, DOI 10.1016/j.sna.2004.03.024	36	22	22	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e94083	10.1371/journal.pone.0094083	http://dx.doi.org/10.1371/journal.pone.0094083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918921	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000002
J	Sugi, H; Chaen, S; Kobayashi, T; Abe, T; Kimura, K; Saeki, Y; Ohnuki, Y; Miyakawa, T; Tanokura, M; Sugiura, S				Sugi, Haruo; Chaen, Shigeru; Kobayashi, Takakazu; Abe, Takahiro; Kimura, Kazushige; Saeki, Yasutake; Ohnuki, Yoshiki; Miyakawa, Takuya; Tanokura, Masaru; Sugiura, Seiryo			Definite Differences between In Vitro Actin-Myosin Sliding and Muscle Contraction as Revealed Using Antibodies to Myosin Head	PLOS ONE			English	Article							ATP HYDROLYSIS; STEP-SIZE; FILAMENTS; MOVEMENT; MECHANISM; FIBERS; STROKE; SITE	Muscle contraction results from attachment-detachment cycles between myosin heads extending from myosin filaments and actin filaments. It is generally believed that a myosin head first attaches to actin, undergoes conformational changes to produce force and motion in muscle, and then detaches from actin. Despite extensive studies, the molecular mechanism of myosin head conformational changes still remains to be a matter for debate and speculation. The myosin head consists of catalytic (CAD), converter (CVD) and lever arm (LD) domains. To give information about the role of these domains in the myosin head performance, we have examined the effect of three site-directed antibodies to the myosin head on in vitro ATP-dependent actin-myosin sliding and Ca2+-activated contraction of muscle fibers. Antibody 1, attaching to junctional peptide between 50K and 20K heavy chain segments in the CAD, exhibited appreciable effects neither on in vitro actin-myosin sliding nor muscle fiber contraction. Since antibody 1 covers actin-binding sites of the CAD, one interpretation of this result is that rigor actin-myosin linkage is absent or at most a transient intermediate in physiological actin-myosin cycling. Antibody 2, attaching to reactive lysine residue in the CVD, showed a marked inhibitory effect on in vitro actin-myosin sliding without changing actin-activated myosin head (S1) ATPase activity, while it showed no appreciable effect on muscle contraction. Antibody 3, attaching to two peptides of regulatory light chains in the LD, had no significant effect on in vitro actin-myosin sliding, while it reduced force development in muscle fibers without changing MgATPase activity. The above definite differences in the effect of antibodies 2 and 3 between in vitro actin-myosin sliding and muscle contraction can be explained by difference in experimental conditions; in the former, myosin heads are randomly oriented on a glass surface, while in the latter myosin heads are regularly arranged within filament-lattice structures.	[Sugi, Haruo] Teikyo Univ, Sch Med, Dept Physiol, Tokyo 173, Japan; [Chaen, Shigeru] Nihon Univ, Coll Humanities & Sci, Dept Integrated Sci Phys & Biol, Tokyo, Japan; [Kobayashi, Takakazu; Abe, Takahiro; Kimura, Kazushige] Shibaura Inst Technol, Dept Elect Engn, Tokyo 108, Japan; [Saeki, Yasutake; Ohnuki, Yoshiki] Tsurumi Univ, Sch Dent, Dept Physiol, Yokohama, Kanagawa, Japan; [Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biochem, Tokyo, Japan; [Sugiura, Seiryo] Univ Tokyo, Grad Sch Frontier Sci, Tokyo, Japan	Teikyo University; Nihon University; Shibaura Institute of Technology; Tsurumi University; University of Tokyo; University of Tokyo	Sugi, H (corresponding author), Teikyo Univ, Sch Med, Dept Physiol, Tokyo 173, Japan.	sugi@kyf.biglobe.ne.jp		Tanokura, Masaru/0000-0001-5072-2480				Bagshaw CR., 1993, MUSCLE CONTRACTION, DOI 10.1007/978-94-015-6839-5; Brenner B, 1998, CURRENT METHODS MUSC, P33, DOI DOI 10.1093/ACPROF:OSO/9780198523970.003.0002; CHAEN S, 1986, J BIOL CHEM, V261, P3632; EDMAN KAP, 1988, J PHYSIOL-LONDON, V404, P301, DOI 10.1113/jphysiol.1988.sp017291; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1954, NATURE, V173, P971, DOI 10.1038/173971a0; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; IWAMOTO H, 1990, J PHYSIOL-LONDON, V422, P185, DOI 10.1113/jphysiol.1990.sp017979; Kobayashi H, 2013, IUPS 2013 ABSTRACT B; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; KRAFT T, 1995, BIOPHYS J, V69, P1246, DOI 10.1016/S0006-3495(95)80018-4; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Minoda H, 2011, BIOCHEM BIOPH RES CO, V405, P651, DOI 10.1016/j.bbrc.2011.01.087; MORNET D, 1980, FEBS LETT, V117, P183, DOI 10.1016/0014-5793(80)80941-0; Muhlrad A, 2003, BIOPHYS J, V84, P1047, DOI 10.1016/S0006-3495(03)74921-2; PERRY SV, 1955, METHOD ENZYMOL, V2, P582, DOI 10.1016/S0076-6879(55)02258-1; Radocaj A, 2009, BIOPHYS J, V96, P1430, DOI 10.1016/j.bpj.2008.11.023; SAITO K, 1994, BIOPHYS J, V66, P769, DOI 10.1016/S0006-3495(94)80853-7; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SUGI H, 1992, P NATL ACAD SCI USA, V89, P6134, DOI 10.1073/pnas.89.13.6134; Sugi H, 1997, P NATL ACAD SCI USA, V94, P4378, DOI 10.1073/pnas.94.9.4378; Sugi H, 2011, J MUSCLE RES CELL M, V32, P34; Sugi H, 2014, ABSTR BIOPH IN PRESS; Sugi H, 2008, P NATL ACAD SCI USA, V105, P17396, DOI 10.1073/pnas.0809581105; Sugi H, 2013, J PHYSIOL SCI, V63, pS35; SUTOH K, 1989, J MOL BIOL, V206, P357, DOI 10.1016/0022-2836(89)90485-3; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; YAMADA T, 1993, J PHYSIOL-LONDON, V466, P229	34	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e93272	10.1371/journal.pone.0093272	http://dx.doi.org/10.1371/journal.pone.0093272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918754	gold, Green Submitted, Green Published			2022-12-25	WOS:000338631000001
J	Alexander, NM; Harper, DM; Comes, JC; Smith, MS; Heutinck, MA; Handley, SM; Ahern, DA				Alexander, Natalie Marya; Harper, Diane Medved; Comes, Johanna Claire; Smith, Melissa Smith; Heutinck, Melinda Ann; Handley, Sandra Martin; Ahern, Debra Ann			Intent to Participate in Future Cervical Cancer Screenings Is Lower when Satisfaction with the Decision to Be Vaccinated Is Neutral	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; GUIDELINES; INCREASE; ERA	Background: HPV vaccination programs have adversely affected participation in future cervical cancer screening. The purpose of this study is to determine the influence of decision satisfaction with accepting/rejecting the HPV vaccine, as well as traditional clinical factors, on the intent to participate in future screening. Methods and Findings: From January 2011 through August 2012 women 18-26 years old presenting for health care in an urban college student health and wellness clinic in the US Midwest were asked to complete a descriptive and medical history survey including a six element decisional satisfaction survey scored on 5-point Likert scales, where the intent to participate in future cervical cancer screening was measured. Of the 568 women who completed the decisional satisfaction survey, 17% of those <21 years and 7% >= 21 years indicated no intent to participate in future cervical cancer screenings. Among women of current screening age, the univariate risk factors of race/ethnicity, contraceptive use, number of lifetime sexual partners, and receipt of HPV vaccine were not predictors of intent for future cervical cancer screening. Instead, only a history of a prior Pap test was a significant positive predictor and only a decisional satisfaction of 'neutral' (Likert score = 3) for any of the four decisional satisfaction elements was a significant negative predictor. For the decisional satisfaction element "best for me personally'', there was a 78% decreased likelihood of intending to participate in future screening if the satisfaction was neutral rather than firm (aOR = 0.22, 95% CI: 0.05-0.91) and a 26 fold increased likelihood if she had had a prior Pap test (aOR = 26, 95% CI: 5-133). Conclusions: HPV vaccination implementation programs must help women be the owner of their decision around HPV vaccination and understand the importance of future participation in cervical cancer screening.	[Alexander, Natalie Marya; Harper, Diane Medved; Ahern, Debra Ann] Univ Missouri, Sch Med, Dept Community & Family Med, Kansas City, MO 64110 USA; [Harper, Diane Medved] Univ Missouri, Sch Med, Dept Obstet & Gynecol, Kansas City, MO 64110 USA; [Harper, Diane Medved] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA; Kansas City Univ Med & Biosci, Dept Family Med, Kansas City, MO USA; [Harper, Diane Medved; Comes, Johanna Claire; Smith, Melissa Smith; Heutinck, Melinda Ann; Handley, Sandra Martin; Ahern, Debra Ann] Univ Missouri, Univ Missouri Kansas City Student Hlth & Wellness, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Kansas City University of Medicine & Biosciences; University of Missouri System; University of Missouri Kansas City	Harper, DM (corresponding author), Univ Missouri, Sch Med, Dept Community & Family Med, Kansas City, MO 64110 USA.	diane.m.harper@gmail.com						Ahluwalia IB, 2007, J WOMENS HEALTH, V16, P935, DOI 10.1089/jwh.2007.CDC8; American College of Obstetricians and Gynecologists (ACOG), 2012, OBSTET GYNECOL, V120, P1222, DOI DOI 10.1097/AOG.0B013E318277C92A; [Anonymous], 2012, AHRQ PUBLICATION; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Bauch CT, 2010, LANCET INFECT DIS, V10, P133, DOI 10.1016/S1473-3099(10)70004-9; Beebe TJ, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-19; Beer H, 2014, VACCINE, V32, P1828, DOI 10.1016/j.vaccine.2014.01.087; Blank PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045450; Brotherton JML, 2013, SS224 EUROGIN; Budd AC, 2010, SEX HEALTH, V7, P328, DOI 10.1071/SH09133; Camilloni L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-464; Cuzick J, 2013, CANCER EPIDEM BIOMAR; Engeland A, 1993, APMIS Suppl, V38, P1; Franco EL, 2006, VACCINE, V24, P171, DOI 10.1016/j.vaccine.2006.05.061; Franco EL, 2009, PUBLIC HEALTH GENOM, V12, P352, DOI 10.1159/000214925; Goldie SJ, 2006, VACCINE, V24, P164, DOI 10.1016/j.vaccine.2006.05.114; Harper DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088493; Harper Diane M, 2010, J Vaccines Vaccin, V1; Harper DM, 2010, DISCOV MED, V10, P7; Harper Diane M, 2011, ISRN Obstet Gynecol, V2011, P457204, DOI 10.5402/2011/457204; Harper DM, 2010, LANCET INFECT DIS, V10, P594, DOI 10.1016/S1473-3099(10)70182-1; Harper DM, 1999, J FAM PRACTICE, V48, P531; HolmesRovner M, 1996, MED DECIS MAKING, V16, P58, DOI 10.1177/0272989X9601600114; Hou SI, 2011, ASIAN PAC J CANCER P, V12, P3133; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Ogilvie GS, 2013, INT J CANCER, V133, P2934, DOI 10.1002/ijc.28324; Paiva AL, 2014, J AM COLL HEALTH, V62, P32, DOI 10.1080/07448481.2013.843534; Sancho-Garnier H, 2013, INT J CANCER, V133, P2681, DOI 10.1002/ijc.28283; Sasieni P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2968; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schmeink CE, 2011, REV MED VIROL, V21, P139, DOI 10.1002/rmv.686; Sforzo Gary A, 2013, Glob Adv Health Med, V2, P58, DOI 10.7453/gahmj.2013.040; StatSoft Inc, 2010, STATISTICA DAT AN SO; The National Committee for Quality Assurance (NCQA), HEALTHC EFF DAT INF; Tota J, 2010, SEX HEALTH, V7, P376, DOI 10.1071/SH10022; Vadaparampil ST, 2014, AM J PREV MED, V46, P80, DOI 10.1016/j.amepre.2013.07.009	37	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98665	10.1371/journal.pone.0098665	http://dx.doi.org/10.1371/journal.pone.0098665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914536	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700029
J	Delimont, D; Dufek, BM; Meehan, DT; Zallocchi, M; Gratton, MA; Phillips, G; Cosgrove, D				Delimont, Duane; Dufek, Brianna M.; Meehan, Daniel T.; Zallocchi, Marisa; Gratton, Michael Anne; Phillips, Grady; Cosgrove, Dominic			Laminin alpha 2-Mediated Focal Adhesion Kinase Activation Triggers Alport Glomerular Pathogenesis	PLOS ONE			English	Article							NF-KAPPA-B; BASEMENT-MEMBRANE; MOUSE MODEL; TRANSFORMING GROWTH-FACTOR-BETA-1; MATRIX METALLOPROTEINASES; MESANGIAL CELLS; RENAL-DISEASE; INTEGRIN; FAK; ALPHA-1-BETA-1	It has been known for some time that laminins containing alpha 1 and alpha 2 chains, which are normally restricted to the mesangial matrix, accumulate in the glomerular basement membranes (GBM) of Alport mice, dogs, and humans. We show that laminins containing the alpha 2 chain, but not those containing the alpha 1 chain activates focal adhesion kinase (FAK) on glomerular podocytes in vitro and in vivo. CD151-null mice, which have weakened podocyte adhesion to the GBM rendering these mice more susceptible to biomechanical strain in the glomerulus, also show progressive accumulation of alpha 2 laminins in the GBM, and podocyte FAK activation. Analysis of glomerular mRNA from both models demonstrates significant induction of MMP-9, MMP-10, MMP-12, MMPs linked to GBM destruction in Alport disease models, as well as the pro-inflammatory cytokine IL-6. SiRNA knockdown of FAK in cultured podocytes significantly reduced expression of MMP-9, MMP-10 and IL-6, but not MMP-12. Treatment of Alport mice with TAE226, a small molecule inhibitor of FAK activation, ameliorated fibrosis and glomerulosclerosis, significantly reduced proteinuria and blood urea nitrogen levels, and partially restored GBM ultrastructure. Glomerular expression of MMP-9, MMP-10 and MMP-12 mRNAs was significantly reduced in TAE226 treated animals. Collectively, this work identifies laminin alpha 2-mediated FAK activation in podocytes as an important early event in Alport glomerular pathogenesis and suggests that FAK inhibitors, if safe formulations can be developed, might be employed as a novel therapeutic approach for treating Alport renal disease in its early stages.	[Delimont, Duane; Dufek, Brianna M.; Meehan, Daniel T.; Zallocchi, Marisa; Cosgrove, Dominic] Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA; [Cosgrove, Dominic] Univ Nebraska Med Ctr, Dept Biochem, Omaha, NE USA; [Gratton, Michael Anne; Phillips, Grady] St Louis Univ, Dept Otolaryngol, St Louis, MO 63103 USA	Boys Town National Research Hospital; University of Nebraska System; University of Nebraska Medical Center; Saint Louis University	Cosgrove, D (corresponding author), Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA.	Dominic.cosgrove@boystown.org	Zallocchi, Marisa/HHS-7445-2022		 [NIH R01 DK055000];  [NIH R01 DC006442]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006442] Funding Source: NIH RePORTER	; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding provided by NIH R01 DK055000 to DC, NIH R01 DC006442 to MAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2007, J AM SOC NEPHROL, V18, P2465, DOI 10.1681/ASN.2007030328; Abrahamson DR, 2003, KIDNEY INT, V63, P826, DOI 10.1046/j.1523-1755.2003.00800.x; Andrews KL, 2000, AM J PATHOL, V157, P303, DOI 10.1016/S0002-9440(10)64541-5; Baleato RM, 2008, AM J PATHOL, V173, P927, DOI 10.2353/ajpath.2008.071149; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; Chen YJ, 2009, J CELL PHYSIOL, V221, P98, DOI 10.1002/jcp.21835; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Cosgrove D, 2000, AM J PATHOL, V157, P1649, DOI 10.1016/S0002-9440(10)64802-X; Cosgrove D, 2008, AM J PATHOL, V172, P761, DOI 10.2353/ajpath.2008.070473; Dennis J, 2010, AM J PATHOL, V177, P2527, DOI 10.2353/ajpath.2010.100017; Fischer E, 2000, NEPHROL DIAL TRANSPL, V15, P1956, DOI 10.1093/ndt/15.12.1956; Gunwar S, 1998, J BIOL CHEM, V273, P8767, DOI 10.1074/jbc.273.15.8767; Hansen K, 2003, KIDNEY INT, V64, P110, DOI 10.1046/j.1523-1755.2003.00039.x; Horikoshi S, 1999, NEPHRON, V81, P284, DOI 10.1159/000045294; Kashtan CE, 2001, J AM SOC NEPHROL, V12, P252, DOI 10.1681/ASN.V122252; Koepke ML, 2007, NEPHROL DIAL TRANSPL, V22, P1062, DOI 10.1093/ndt/gfl810; Kruegel J, 2013, NAT REV NEPHROL, V9, P170, DOI 10.1038/nrneph.2012.259; Li X, 1998, J BIOL CHEM, V273, P9361, DOI 10.1074/jbc.273.16.9361; Ma H, 2010, J AM SOC NEPHROL, V21, P1145, DOI 10.1681/ASN.2009090991; Meehan DT, 2009, KIDNEY INT, V76, P968, DOI 10.1038/ki.2009.324; Nagase H, 2001, SUBSTRATE SPECIFICIT, P39; Oh JH, 2009, GYNECOL ONCOL, V114, P509, DOI 10.1016/j.ygyno.2009.05.027; Rao VH, 2006, AM J PATHOL, V169, P32, DOI 10.2353/ajpath.2006.050896; Sampson NS, 2001, J BIOL CHEM, V276, P34182, DOI 10.1074/jbc.M102859200; SANCHEZLOPEZ R, 1993, J BIOL CHEM, V268, P7238; Sayers R, 1999, KIDNEY INT, V56, P1662, DOI 10.1046/j.1523-1755.1999.00744.x; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tseng WP, 2010, J CELL PHYSIOL, V223, P389, DOI 10.1002/jcp.22047; Van Slambrouck S, 2007, INT J ONCOL, V31, P1501; Zallocchi M, 2013, AM J PATHOL, V183, P1269, DOI 10.1016/j.ajpath.2013.06.015; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100; Zeng ZZ, 2006, CANCER RES, V66, P8091, DOI 10.1158/0008-5472.CAN-05-4400	33	37	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99083	10.1371/journal.pone.0099083	http://dx.doi.org/10.1371/journal.pone.0099083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915008	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700060
J	Han, XZ; Hui, C				Han, Xiaozhuo; Hui, Cang			Niche Construction on Environmental Gradients: The Formation of Fitness Valley and Stratified Genotypic Distributions	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; EVOLUTIONARY CONSEQUENCES; POLYMORPHISM MAINTENANCE; METAPOPULATION DYNAMICS; EGG SIZE; PLANTS; POPULATION; STRATEGIES; SPECIATION; DIVERSITY	The process of niche construction can alter the trajectory of natural selection through organism-environment feedback. As such, the mechanism and impact of niche construction can be better investigated along environmental gradients. Here we investigate how the process of niche construction affects the distribution of genotypes and fitness landscape along an environmental gradient under three selection regimes, namely heterozygote superiority, genetic loci which dictates niche construction ability being either selectively neutral or non-neutral. Using a spatially explicit cellular automaton, we show that niche construction can stratify genetic diversity by forming band-like distributions consisting of different genotypic compositions and promote reproduction isolation by forming a divide with reduced average fitness along the gradients, termed a fitness valley. The band structure and the presence of a fitness valley depend on heterogeneous environments, resource-dependent fitness and the selection acting on the gene loci affecting the niche-constructing ability. Our work adds to the growing body of evidence on criticizing species distribution models which assume that the environment alone can determine species distributions. Based on the results, we argue that conservation planning should target preserving or restoring environmental gradients.	[Han, Xiaozhuo] Guangdong Univ Technol, Sch Appl Math, Guangzhou, Peoples R China; [Hui, Cang] Univ Stellenbosch, Dept Math Sci, Ctr Invas Biol, Matieland, South Africa; [Hui, Cang] African Inst Math Sci, Muizenberg, South Africa	Guangdong University of Technology; Stellenbosch University	Han, XZ (corresponding author), Guangdong Univ Technol, Sch Appl Math, Guangzhou, Peoples R China.	hanxzh03@163.com	Hui, Cang/A-1781-2008	Hui, Cang/0000-0002-3660-8160	National Natural Science Foundation of China [31100308]; National Research Foundation [76912, 81825]; University of Stellenbosch	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation; University of Stellenbosch	This work was supported by the National Natural Science Foundation of China (31100308). C.H. also received support from the National Research Foundation (Grants 76912 and 81825) and the University of Stellenbosch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo RBR, 1996, EVOLUTION, V50, P2338, DOI [10.2307/2410702, 10.1111/j.1558-5646.1996.tb03621.x]; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Berthouly-Salazar C, 2013, MOL ECOL, V22, P5793, DOI 10.1111/mec.12538; Berthouly-Salazar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038145; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Bridle JR, 2001, J EVOLUTION BIOL, V14, P878, DOI 10.1046/j.1420-9101.2001.00344.x; BULLOCK J, 1994, TRENDS ECOL EVOL, V9, P299, DOI [10.1016/0169-5347(94)90037-X, 10.1016/0169-5347(94)90038-8]; Caplat P, 2014, BIOL INVASIONS, V16, P677, DOI 10.1007/s10530-013-0608-7; Corenblit D, 2009, GLOBAL ECOL BIOGEOGR, V18, P507, DOI 10.1111/j.1466-8238.2009.00461.x; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Coyne JA, 2004, SPECIATION, V37; Dassonville N, 2011, BIOL INVASIONS, V13, P1115, DOI 10.1007/s10530-011-9954-5; Davies SJ, 2013, AUSTRAL ECOL, V38, P851, DOI 10.1111/aec.12022; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Donaldson JE, 2014, GLOBAL CHANGE BIOL, V20, P1527, DOI 10.1111/gcb.12486; Donohue K, 2005, NEW PHYTOL, V166, P83, DOI 10.1111/j.1469-8137.2005.01357.x; Donohue K, 2009, PHILOS T R SOC B, V364, P1059, DOI 10.1098/rstb.2008.0291; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Erwin DH, 2008, TRENDS ECOL EVOL, V23, P304, DOI 10.1016/j.tree.2008.01.013; Fogarty L, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525911003311; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; Gaertner M, 2014, DIVERS DISTRIB, V20, P733, DOI 10.1111/ddi.12182; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2014, TRENDS ECOL IN PRESS; Han XZ, 2009, APPL MATH COMPUT, V215, P449, DOI 10.1016/j.amc.2009.05.015; Han XZ, 2006, ECOL MODEL, V192, P160, DOI 10.1016/j.ecolmodel.2005.07.019; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Horak J, 2013, NATURWISSENSCHAFTEN, V100, P327, DOI 10.1007/s00114-013-1029-2; Hui C, 2006, ECOL COMPLEX, V3, P148, DOI 10.1016/j.ecocom.2005.12.003; Hui C, 2005, ECOL RES, V20, P115, DOI 10.1007/s11284-004-0020-y; Hui C, 2004, ECOL MODEL, V177, P107, DOI 10.1016/j.ecolmodel.2003.11.016; Hui C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3454; Hui C, 2012, ECOGRAPHY, V35, P1024, DOI 10.1111/j.1600-0587.2012.07697.x; In Meffe G. K., 1997, PRINCIPLES CONSERVAT, VSecond, P3; Izsak J, 2000, ECOL MODEL, V130, P151, DOI 10.1016/S0304-3800(00)00203-9; Johnston TA, 2002, ECOLOGY, V83, P1777, DOI 10.2307/3071764; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Kylafis G, 2008, ECOL LETT, V11, P1072, DOI 10.1111/j.1461-0248.2008.01220.x; Kylafis G, 2011, ECOL LETT, V14, P82, DOI 10.1111/j.1461-0248.2010.01551.x; Laland KN, 2006, EVOLUTION, V60, P1751; Laland KN, 1996, J EVOLUTION BIOL, V9, P293, DOI 10.1046/j.1420-9101.1996.9030293.x; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lewontin R., 1972, EVOL BIOL, V6, P391; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; MYERS N, 1997, PRINCIPLES CONSERVAT, P123; Odling-Smee F.J., 1988, P73; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Roura-Pascual N, 2009, GLOBAL CHANGE BIOL, V15, P2101, DOI 10.1111/j.1365-2486.2009.01907.x; Schmidt PS, 2008, ECOLOGY, V89, pS91, DOI 10.1890/07-1162.1; Schroder B, 2006, ECOL MODEL, V199, P505, DOI 10.1016/j.ecolmodel.2006.05.036; Silver M, 2006, THEOR POPUL BIOL, V70, P387, DOI 10.1016/j.tpb.2006.08.003; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Taylor T, 2004, Artificial Life IX, P375; Wcislo WT, 2009, BIOL REV, V84, P19, DOI 10.1111/j.1469-185X.2008.00059.x; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Yue DX, 2004, ISR J PLANT SCI, V52, P235, DOI 10.1560/XBQW-L1WH-1Q3X-DJHR; Zhang F, 2013, EVOLUTION, V67, P548, DOI 10.1111/j.1558-5646.2012.01796.x; Zhang F, 2012, MATH BIOSCI, V240, P260, DOI 10.1016/j.mbs.2012.08.006	63	8	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99775	10.1371/journal.pone.0099775	http://dx.doi.org/10.1371/journal.pone.0099775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915290	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700134
J	Knight, JM; Moynihan, JA; Lyness, JM; Xia, YL; Tu, X; Messing, S; Hunter, BC; Huang, LS; Obi, RO; Gaisser, D; Liesveld, JL; Sahler, OJZ				Knight, Jennifer M.; Moynihan, Jan A.; Lyness, Jeffrey M.; Xia, Yinglin; Tu, Xin; Messing, Susan; Hunter, Bryan C.; Huang, Li-Shan; Obi, Rosemary O.; Gaisser, D'Arcy; Liesveld, Jane L.; Sahler, Olle Jane Z.			Peri-Transplant Psychosocial Factors and Neutrophil Recovery following Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							IMMUNE-SYSTEM; TRAIT ANXIETY; SURVIVAL; STRESS; LIFE; REDISTRIBUTION; RESPONSES; VALIDITY; OPTIMISM; SUPPORT	Objective: Multiple psychosocial factors appear to affect cancer progression in various populations; however, research investigating the relationship between psychosocial factors and outcomes following hematopoietic stem cell transplantation (HCT) is scarce. Subject to adverse immunological and psychological conditions, HCT patients may be especially vulnerable to psychosomatic health sequelae; therefore, we studied whether optimism and anxiety influence the pertinent clinical outcome of days to neutrophil engraftment (DTE). Method: 54 adults undergoing either autologous or allogeneic HCT completed self-report questionnaires measuring optimism and anxiety. We assessed the association between these psychosocial variables and DTE. Results: Greater optimism and less anxiety were associated with the favorable outcome of fewer DTE in autologous HCT recipients, though this relationship was no longer significant when reducing the sample size to only subjects who filled out their baseline survey by the time of engraftment. Conclusion: Our findings are suggestive that optimism and anxiety may be associated with time to neutrophil recovery in autologous, but not allogeneic, adult HCT recipients. Further investigation in larger, more homogeneous subjects with consistent baseline sampling is warranted.	[Knight, Jennifer M.; Moynihan, Jan A.; Lyness, Jeffrey M.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester Ctr Mind Body Res, Rochester, NY 14642 USA; [Xia, Yinglin; Tu, Xin; Messing, Susan; Huang, Li-Shan] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Hunter, Bryan C.] Nazareth Coll, Dept Mus Therapy, Rochester, NY USA; [Obi, Rosemary O.; Sahler, Olle Jane Z.] Univ Rochester, Med Ctr, Dept Pediat, Div Hematol Oncol, Rochester, NY 14642 USA; [Gaisser, D'Arcy] Univ Rochester, Med Ctr, Dept Cardiol, Rochester, NY 14642 USA; [Liesveld, Jane L.; Sahler, Olle Jane Z.] Univ Rochester, Med Ctr, Dept Med, Div Hematol Oncol, Rochester, NY 14642 USA; [Sahler, Olle Jane Z.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [Sahler, Olle Jane Z.] Univ Rochester, Med Ctr, Dept Med Humanities, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Knight, JM (corresponding author), Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA.	jmknight@mcw.edu		Knight, Jennifer/0000-0002-9140-3109; Huang, Li-Shan/0000-0001-8297-2804	National Institutes of Health [5R24 AG031089-02, T32 073452, R21 AT000895]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT000895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R24AG031089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (5R24 AG031089-02, T32 073452, R21 AT000895). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsar FS, 2010, J CUTAN MED SURG, V14, P13, DOI 10.2310/7750.2010.09021; ANDRYKOWSKI MA, 1994, PSYCHOSOM MED, V56, P432, DOI 10.1097/00006842-199409000-00008; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Barker LA, 2005, BRIT J PHARMACOL, V145, P872, DOI 10.1038/sj.bjp.0706257; Bensinger W I, 2001, Rev Clin Exp Hematol, V5, P67, DOI 10.1046/j.1468-0734.2001.00033.x; Burke KL, 2000, CURR PSYCHOL, V19, P129, DOI 10.1007/s12144-000-1009-5; Cecilio CA, 1997, MEDIAT INFLAMM, V6, P46, DOI 10.1080/09629359791929; Chang G, 2004, PSYCHOSOMATICS, V45, P378, DOI 10.1176/appi.psy.45.5.378; Costanzo ES, 2013, BRAIN BEHAV IMMUN, V30, pS68, DOI 10.1016/j.bbi.2012.07.005; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; Elsenbruch S, 2006, AM J GASTROENTEROL, V101, P2300, DOI 10.1111/j.1572-0241.2006.00837.x; Gregurek R, 1996, BONE MARROW TRANSPL, V18, P585; Hashizume H, 2005, BRIT J DERMATOL, V152, P1161, DOI 10.1111/j.1365-2133.2005.06449.x; Hochhausen N, 2007, J PSYCHOSOC ONCOL, V25, P87, DOI 10.1300/J077v25n01_05; Hoodin F, 2006, BONE MARROW TRANSPL, V38, P255, DOI 10.1038/sj.bmt.1705419; Hoodin F, 2003, PSYCHOSOMATICS, V44, P181, DOI 10.1176/appi.psy.44.3.181; JENKINS PL, 1994, PSYCHOSOMATICS, V35, P361, DOI 10.1016/S0033-3182(94)71757-6; Katsuura S, 2011, INT J PSYCHOPHYSIOL, V81, P38, DOI 10.1016/j.ijpsycho.2011.04.004; Kaufmann I, 2007, CLIN IMMUNOL, V125, P103, DOI 10.1016/j.clim.2007.07.004; Knight JM, 2013, PSYCHONEUROENDOCRINO, V38, P2383, DOI 10.1016/j.psyneuen.2013.06.016; Lee SJ, 2003, BIOL BLOOD MARROW TR, V9, P389, DOI 10.1016/S1083-8791(03)00103-4; LEKANDER M, 1995, INT J BEHAV MED, V2, P1, DOI 10.1207/s15327558ijbm0201_1; Matzner P, 2013, NEUROIMMUNOMODULAT, V20, P194, DOI 10.1159/000348698; McGregor BA, 2013, BRAIN BEHAV IMMUN, V30, pS142, DOI 10.1016/j.bbi.2012.07.020; Mouthon MA, 1999, INT J RADIAT ONCOL, V43, P867, DOI 10.1016/S0360-3016(98)00477-5; Norkin M, 2012, SEMIN HEMATOL, V49, P104, DOI 10.1053/j.seminhematol.2011.10.004; Pasquini MC, 2012, CURRENT USE OUTCOME; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Saito T, 2003, BONE MARROW TRANSPL, V32, P601, DOI 10.1038/sj.bmt.1704205; Salome N, 2008, NEUROSCIENCE, V151, P1112, DOI 10.1016/j.neuroscience.2007.12.010; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Thaker PH, 2008, SEMIN CANCER BIOL, V18, P164, DOI 10.1016/j.semcancer.2007.12.005; Trabold B, 2007, SCAND CARDIOVASC J, V41, P59, DOI 10.1080/14017430601085948; Trigg ME, 2002, INT J HEMATOL, V76, P199, DOI 10.1007/BF03165245; Watson D, 1996, J PERS SOC PSYCHOL, V70, P567, DOI 10.1037/0022-3514.70.3.567	36	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99778	10.1371/journal.pone.0099778	http://dx.doi.org/10.1371/journal.pone.0099778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24915544	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700136
J	Qi, HW; Nakka, P; Chen, C; Radhakrishnan, ML				Qi, Helena W.; Nakka, Priyanka; Chen, Connie; Radhakrishnan, Mala L.			The Effect of Macromolecular Crowding on the Electrostatic Component of Barnase-Barstar Binding: A Computational, Implicit Solvent-Based Study	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; NATIVE-STATE STABILITY; HUMAN TELOMERIC DNA; PROTEIN STABILITY; G-QUADRUPLEX; CELL; DYNAMICS; SURFACE; ENVIRONMENT; ASSOCIATION	Macromolecular crowding within the cell can impact both protein folding and binding. Earlier models of cellular crowding focused on the excluded volume, entropic effect of crowding agents, which generally favors compact protein states. Recently, other effects of crowding have been explored, including enthalpically-related crowder-protein interactions and changes in solvation properties. In this work, we explore the effects of macromolecular crowding on the electrostatic desolvation and solvent-screened interaction components of protein-protein binding. Our simple model enables us to focus exclusively on the electrostatic effects of water depletion on protein binding due to crowding, providing us with the ability to systematically analyze and quantify these potentially intuitive effects. We use the barnase-barstar complex as a model system and randomly placed, uncharged spheres within implicit solvent to model crowding in an aqueous environment. On average, we find that the desolvation free energy penalties incurred by partners upon binding are lowered in a crowded environment and solvent-screened interactions are amplified. At a constant crowder density ( fraction of total available volume occupied by crowders), this effect generally increases as the radius of model crowders decreases, but the strength and nature of this trend can depend on the water probe radius used to generate the molecular surface in the continuum model. In general, there is huge variation in desolvation penalties as a function of the random crowder positions. Results with explicit model crowders can be qualitatively similar to those using a lowered "effective'' solvent dielectric to account for crowding, although the "best'' effective dielectric constant will likely depend on multiple system properties. Taken together, this work systematically demonstrates, quantifies, and analyzes qualitative intuition-based insights into the effects of water depletion due to crowding on the electrostatic component of protein binding, and it provides an initial framework for future analyses.	[Qi, Helena W.; Nakka, Priyanka; Chen, Connie; Radhakrishnan, Mala L.] Wellesley Coll, Dept Chem, Wellesley, MA 02181 USA	Wellesley College	Radhakrishnan, ML (corresponding author), Wellesley Coll, Dept Chem, Wellesley, MA 02181 USA.	mradhakr@wellesley.edu	Radhakrishnan, Mala/X-1062-2019	Radhakrishnan, Mala/0000-0002-5434-3696	Wellesley College Staley Fellowship	Wellesley College Staley Fellowship	This work was funded by a Wellesley College Staley Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriata LA, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/045006; Altman MD, 2006, THESIS; Batra J, 2009, BIOPHYS J, V97, P906, DOI 10.1016/j.bpj.2009.05.032; Bhat S, 2006, PROTEINS, V62, P244, DOI 10.1002/prot.20682; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brown CJ, 2008, CELL CYCLE, V7, P608, DOI 10.4161/cc.7.5.5488; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; BUCKLE AM, 1994, BIOCHEMISTRY-US, V33, P8878, DOI 10.1021/bi00196a004; Busby B, 2011, J MOL BIOL, V408, P321, DOI 10.1016/j.jmb.2011.01.053; Carrascal N, 2010, J PHYS CHEM B, V114, P5096, DOI 10.1021/jp910540z; Chen E, 2012, BIOCHEMISTRY-US, V51, P9836, DOI 10.1021/bi301324y; Chen Z, 2009, J AM CHEM SOC, V131, P10430, DOI 10.1021/ja9010749; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; Christ CD, 2010, J COMPUT CHEM, V31, P1569, DOI 10.1002/jcc.21450; Christiansen A, 2010, BIOCHEMISTRY-US, V49, P6519, DOI 10.1021/bi100578x; Cortines JR, 2011, VIROLOGY, V421, P1, DOI 10.1016/j.virol.2011.09.005; de Ruiter A, 2011, CURR OPIN CHEM BIOL, V15, P547, DOI 10.1016/j.cbpa.2011.05.021; Despa F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228104; Despa F, 2004, PHYS REV LETT, V93; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Elcock AH, 2010, CURR OPIN STRUC BIOL, V20, P196, DOI 10.1016/j.sbi.2010.01.008; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Feig M, 2012, J PHYS CHEM B, V116, P599, DOI 10.1021/jp209302e; GERSTEIN M, 1995, J MOL BIOL, V249, P955, DOI 10.1006/jmbi.1995.0351; Ghosh S, 2013, LANGMUIR, V29, P7975, DOI 10.1021/la400840n; Giordano S, 2003, J ELECTROSTAT, V58, P59, DOI 10.1016/S0304-3886(02)00199-7; Green DF, 2005, PROTEINS, V60, P644, DOI 10.1002/prot.20540; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; Harada R, 2013, J AM CHEM SOC, V135, P3696, DOI 10.1021/ja3126992; Harada R, 2012, J AM CHEM SOC, V134, P4842, DOI 10.1021/ja211115q; Hassan SA, 2011, J PHYS CHEM B, V115, P14668, DOI 10.1021/jp208184e; Heddi B, 2011, J AM CHEM SOC, V133, P9824, DOI 10.1021/ja200786q; Hendsch ZS, 1999, PROTEIN SCI, V8, P1381, DOI 10.1110/ps.8.7.1381; Homouz D, 2008, P NATL ACAD SCI USA, V105, P11754, DOI 10.1073/pnas.0803672105; Homouz D, 2009, J MOL BIOL, V391, P933, DOI 10.1016/j.jmb.2009.06.073; Homouz D, 2009, BIOPHYS J, V96, P671, DOI 10.1016/j.bpj.2008.10.014; Hong JA, 2010, J AM CHEM SOC, V132, P10445, DOI 10.1021/ja103166y; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim JS, 2009, BIOPHYS J, V96, P1333, DOI 10.1016/j.bpj.2008.11.030; Kim YC, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3516589; Lee LP, 2001, PROTEIN SCI, V10, P362, DOI 10.1110/ps.40001; Lee LP, 2001, NAT STRUCT BIOL, V8, P73; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; Li W, 2006, FEBS LETT, V580, P4905, DOI 10.1016/j.febslet.2006.08.007; Ma Q, 2012, PLOS ONE, V7; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Midelfort KS, 2004, J MOL BIOL, V343, P685, DOI 10.1016/j.jmb.2004.08.019; Mikaelsson T, 2013, BIOPHYS J, V104, P694, DOI 10.1016/j.bpj.2012.12.020; Miklos AC, 2011, J AM CHEM SOC, V133, P7116, DOI 10.1021/ja200067p; Miklos AC, 2010, BIOCHEMISTRY-US, V49, P6984, DOI 10.1021/bi100727y; Minkara MS, 2012, PROTEINS, V80, P573, DOI 10.1002/prot.23221; Minton AP, 2005, J PHARM SCI-US, V94, P1668, DOI 10.1002/jps.20417; Mittal J, 2010, BIOPHYS J, V98, P315, DOI 10.1016/j.bpj.2009.10.009; Phillip Y, 2013, FEBS LETT, V587, P1046, DOI 10.1016/j.febslet.2013.01.007; Phillip Y, 2012, BIOPHYS J, V103, P1011, DOI 10.1016/j.bpj.2012.08.009; Phillip Y, 2009, BIOPHYS J, V97, P875, DOI 10.1016/j.bpj.2009.05.026; Predeus AV, 2012, J PHYS CHEM B, V116, P8610, DOI 10.1021/jp300129u; Qin SB, 2013, J CHEM THEORY COMPUT, V9, P4633, DOI 10.1021/ct4005195; Qin SB, 2009, BIOPHYS J, V97, P12, DOI 10.1016/j.bpj.2009.03.066; Radhakrishnan ML, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1252-5; Rincon V, 2011, BIOPHYS J, V100, P738, DOI 10.1016/j.bpj.2010.12.3714; Rosen J, 2011, J PHYS CHEM B, V115, P2683, DOI 10.1021/jp200625k; Sanfelice D, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/045002; Sasmal DK, 2013, LANGMUIR, V29, P2289, DOI 10.1021/la3043473; Sheinerman FB, 2002, J MOL BIOL, V318, P161, DOI 10.1016/S0022-2836(02)00030-X; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Talley Kemper, 2008, PMC Biophys, V1, P2, DOI 10.1186/1757-5036-1-2; Tanizaki S, 2008, BIOPHYS J, V94, P747, DOI 10.1529/biophysj.107.116236; Tjong H, 2008, BIOPHYS J, V95, P2601, DOI 10.1529/biophysj.107.127746; Verma PK, 2011, BIOCHIMIE, V93, P1424, DOI 10.1016/j.biochi.2011.04.017; Wang YQ, 2012, J AM CHEM SOC, V134, P16614, DOI 10.1021/ja305300m; Wang YQ, 2010, J AM CHEM SOC, V132, P9392, DOI 10.1021/ja102296k; Wieczorek G, 2008, BIOPHYS J, V95, P5030, DOI 10.1529/biophysj.108.136291; Xue Y, 2007, J AM CHEM SOC, V129, P11185, DOI 10.1021/ja0730462; Zheng KW, 2010, NUCLEIC ACIDS RES, V38, P327, DOI 10.1093/nar/gkp898; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou HX, 2013, FEBS LETT, V587, P1053, DOI 10.1016/j.febslet.2013.01.064; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	82	11	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98618	10.1371/journal.pone.0098618	http://dx.doi.org/10.1371/journal.pone.0098618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915485	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700027
J	Richard, AJ; Fuller, S; Fedorcenco, V; Beyl, R; Burris, TP; Mynatt, R; Ribnicky, DM; Stephens, JM				Richard, Allison J.; Fuller, Scott; Fedorcenco, Veaceslav; Beyl, Robbie; Burris, Thomas P.; Mynatt, Randall; Ribnicky, David M.; Stephens, Jacqueline M.			Artemisia scoparia Enhances Adipocyte Development and Endocrine Function In Vitro and Enhances Insulin Action In Vivo	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; SKELETAL-MUSCLE; PPAR-GAMMA; METABOLIC SYNDROME; DIABETES-MELLITUS; 3T3-L1 ADIPOCYTES; HEPATIC INSULIN; GENE-EXPRESSION	Background: Failure of adipocytes to expand during periods of energy excess can result in undesirable metabolic consequences such as ectopic fat accumulation and insulin resistance. Blinded screening studies have indicated that Artemisia scoparia (SCO) extracts can enhance adipocyte differentiation and lipid accumulation in cultured adipocytes. The present study tested the hypothesis that SCO treatment modulates fat cell development and function in vitro and insulin sensitivity in adipose tissue in vivo. Methods: In vitro experiments utilized a Gal4-PPAR gamma ligand binding domain (LBD) fusion protein-luciferase reporter assay to examine PPAR gamma activation. To investigate the ability of SCO to modulate adipogenesis and mature fat cell function in 3T3-L1 cells, neutral lipid accumulation, gene expression, and protein secretion were measured by Oil Red O staining, qRT-PCR, and immunoblotting, respectively. For the in vivo experiments, diet-induced obese (DIO) C57BL/6J mice were fed a high-fat diet (HFD) or HFD containing 1% w/w SCO for four weeks. Body weight and composition, food intake, and fasting glucose and insulin levels were measured. Phospho-activation and expression of insulin-sensitizing proteins in epididymal adipose tissue (eWAT) were measured by immunoblotting. Results: Ethanolic extracts of A. scoparia significantly activated the PPAR gamma LBD and enhanced lipid accumulation in differentiating 3T3-L1 cells. SCO increased the transcription of several PPAR gamma target genes in differentiating 3T3-L1 cells and rescued the negative effects of tumor necrosis factor alpha on production and secretion of adiponectin and monocyte chemoattractant protein-1 in fully differentiated fat cells. DIO mice treated with SCO had elevated adiponectin levels and increased phosphorylation of AMPK alpha in eWAT when compared to control mice. In SCO-treated mice, these changes were also associated with decreased fasting insulin and glucose levels. Conclusion: SCO has metabolically beneficial effects on adipocytes in vitro and adipose tissue in vivo, highlighting its potential as a metabolically favorable botanical supplement.	[Richard, Allison J.; Fuller, Scott; Fedorcenco, Veaceslav; Beyl, Robbie; Mynatt, Randall; Stephens, Jacqueline M.] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Burris, Thomas P.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Ribnicky, David M.] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Saint Louis University; Rutgers State University New Brunswick	Stephens, JM (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	jsteph1@lsu.edu	Burris, Thomas P/B-3886-2016; Beyl, Robbie Albert/N-1951-2017; Mynatt, Randall L/N-1980-2017; Stephens, Jacqueline M/R-5217-2018; Fuller, Scott/GWM-5641-2022; Richard, Allison/N-1987-2017	Burris, Thomas P/0000-0003-2922-4449; Mynatt, Randall L/0000-0003-4399-0019; Fuller, Scott/0000-0002-2677-1677	NCAAM; ODS - NIH [2P50AT002776-06]; NIH [T32 AT004094]; COBRE [NIH 8 P20 GM103528]; NORC from the National Institutes of Health [NIH 2P30DK072476]; National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]; National Center for Complementary & Integrative Health [P50AT002776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528, U54GM104940] Funding Source: NIH RePORTER	NCAAM; ODS - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE; NORC from the National Institutes of Health; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research project was supported by an NCAAM and ODS funded NIH grant (2P50AT002776-06) awarded to the PBRC Botanical Research Center. AJR and SF were supported by an NIH T-32 postdoctoral training fellowship in botanicals granted to PBRC (T32 AT004094). This research project used PBRC Genomics Core facilities that are supported in part by COBRE (NIH 8 P20 GM103528) and NORC (NIH 2P30DK072476) center grants from the National Institutes of Health. Statistical analysis for this project was supported by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds the Louisiana Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Busby SA, 2011, ACS CHEM BIOL, V6, P618, DOI 10.1021/cb100396s; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Chopra I, 2012, DIABETOLOGIA, V55, P783, DOI 10.1007/s00125-011-2407-y; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; Frosig C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062338; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hamza N, 2010, J ETHNOPHARMACOL, V128, P513, DOI 10.1016/j.jep.2010.01.004; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huang JV, 2012, J LIPID RES, V53, P1738, DOI 10.1194/jlr.R024505; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; KURIHARCUCH W, 1978, P NATL ACAD SCI USA, V75, P6107, DOI 10.1073/pnas.75.12.6107; Lim DW, 2013, MOLECULES, V18, P9241, DOI 10.3390/molecules18089241; Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Obanda DN, 2012, DIABETES, V61, P597, DOI 10.2337/db11-0396; Ribnicky DM, 2006, PHYTOMEDICINE, V13, P550, DOI 10.1016/j.phymed.2005.09.007; Richard AJ, 2012, BBA-MOL BASIS DIS, V1822, P557, DOI 10.1016/j.bbadis.2011.12.005; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Rubenstrunk A, 2007, BBA-MOL CELL BIOL L, V1771, P1065, DOI 10.1016/j.bbalip.2007.02.003; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Shibata T, 2013, J PHARMACOL SCI, V122, P93, DOI 10.1254/jphs.12270FP; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tripathy D, 2013, DIABETOLOGIA, V56, P2153, DOI 10.1007/s00125-013-2976-z; Wang ZQ, 2008, METABOLISM, V57, pS58, DOI 10.1016/j.metabol.2008.04.003; Wang ZQ, 2013, METABOLISM, V62, P1239, DOI 10.1016/j.metabol.2013.03.004; Wang ZQ, 2011, J NUTR BIOCHEM, V22, P71, DOI 10.1016/j.jnutbio.2009.11.015; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; Xing XH, 2009, J ETHNOPHARMACOL, V125, P410, DOI 10.1016/j.jep.2009.07.021; Yamamoto N, 2011, FOOD FUNCT, V2, P45, DOI 10.1039/c0fo00129e; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	47	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98897	10.1371/journal.pone.0098897	http://dx.doi.org/10.1371/journal.pone.0098897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915004	Green Published, gold			2022-12-25	WOS:000340947700042
J	Tamayo, T; Claessen, H; Ruckert, IM; Maier, W; Schunk, M; Meisinger, C; Mielck, A; Holle, R; Thorand, B; Narres, M; Moebus, S; Mahabadi, AA; Pundt, N; Krone, B; Slomiany, U; Erbel, R; Jockel, KH; Rathmann, W; Icks, A				Tamayo, Teresa; Claessen, Heiner; Rueckert, Ina-Maria; Maier, Werner; Schunk, Michaela; Meisinger, Christine; Mielck, Andreas; Holle, Rolf; Thorand, Barbara; Narres, Maria; Moebus, Susanne; Mahabadi, Amir-Abbas; Pundt, Noreen; Krone, Bastian; Slomiany, Uta; Erbel, Raimund; Joeckel, Karl-Heinz; Rathmann, Wolfgang; Icks, Andrea			Treatment Pattern of Type 2 Diabetes Differs in Two German Regions and with Patients' Socioeconomic Position	PLOS ONE			English	Article							HEINZ NIXDORF RECALL; EUROPEAN COUNTRIES; SOUTHERN GERMANY; HOUSEHOLD INCOME; PREVALENCE; HEALTH; CARE; INEQUALITIES; MANAGEMENT; MELLITUS	Background: Diabetes treatment may differ by region and patients' socioeconomic position. This may be particularly true for newer drugs. However, data are highly limited. Methods: We examined pooled individual data of two population-based German studies, KORA F4 (Cooperative Health Research in the Region of Augsburg, south), and the HNR (Heinz Nixdorf Recall study, west) both carried out 2006 to 2008. To ascertain the association between region and educational level with anti-hyperglycemic medication we fitted poisson regression models with robust error variance for any and newer anti-hyperglycemic medication, adjusting for age, sex, diabetes duration, BMI, cardiovascular disease, lifestyle, and insurance status. Results: The examined sample comprised 662 participants with self-reported type 2 diabetes (KORA F4: 83 women, 111 men; HNR: 183 women, 285 men). The probability to receive any anti-hyperglycemic drug as well as to be treated with newer anti-hyperglycemic drugs such as insulin analogues, thiazolidinediones, or glinides was significantly increased in southern compared to western Germany (prevalence ratio (PR); 95% CI: 1.12; 1.02-1.22, 1.52; 1.10-2.11 respectively). Individuals with lower educational level tended to receive anti-hyperglycemic drugs more likely than their better educated counterparts (PR; 95% CI univariable: 1.10; 0.99-1.22; fully adjusted: 1.10; 0.98-1.23). In contrast, lower education was associated with a lower estimated probability to receive newer drugs among those with any anti-hyperglycemic drugs (PR low vs. high education: 0.66; 0.48-0.91; fully adjusted: 0.68; 0.47-0.996). Conclusions: We found regional and individual social disparities in overall and newer anti-hyperglycemic medication which were not explained by other confounders. Further research is needed.	[Tamayo, Teresa; Claessen, Heiner; Narres, Maria; Rathmann, Wolfgang; Icks, Andrea] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Rueckert, Ina-Maria; Meisinger, Christine; Thorand, Barbara] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Maier, Werner; Schunk, Michaela; Mielck, Andreas; Holle, Rolf] Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Thorand, Barbara] German Ctr Diabet Res DZD EV, Neuherberg, Germany; [Moebus, Susanne; Pundt, Noreen; Krone, Bastian; Slomiany, Uta; Joeckel, Karl-Heinz] Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Mahabadi, Amir-Abbas; Erbel, Raimund] Univ Duisburg Essen, West German Heart Ctr, Dept Cardiol, Essen, Germany; [Icks, Andrea] Univ Dusseldorf, Dept Publ Hlth, Fac Med, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Duisburg Essen; University of Duisburg Essen; Heinrich Heine University Dusseldorf	Icks, A (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany.	andrea.icks@ddz.uni-duesseldorf.de	Holle, Rolf/D-9333-2013; Thorand, Barbara/B-5349-2014; Meisinger, Christine/B-5358-2014; Mahabadi, Amir/ABE-6057-2020	Holle, Rolf/0000-0001-5395-2695; Thorand, Barbara/0000-0002-8416-6440; Moebus, Susanne/0000-0002-0072-5410; Maier, Werner/0000-0003-4356-7296; Schunk, Michaela/0000-0002-1200-1903; Meisinger, Christa/0000-0002-9026-6544	Competence Network Diabetes mellitus of the German Federal Ministry of Education and Research (BMBF) [01GI0816]; Heinz Nixdorf Foundation (Germany); German Ministry of Education and Science; Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; German Research Foundation from the German Diabetes Center; German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westfalia	Competence Network Diabetes mellitus of the German Federal Ministry of Education and Research (BMBF); Heinz Nixdorf Foundation (Germany); German Ministry of Education and Science; Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; German Research Foundation from the German Diabetes Center; German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westfalia	This work was supported by the Competence Network Diabetes mellitus of the German Federal Ministry of Education and Research (BMBF, grant 01GI0816). Andrea Icks is guarantor of this work. The authors thank the Heinz Nixdorf Foundation (Germany) for the generous support of the Heinz Nixdorf Recall Study (HNR). The study is also supported by the German Ministry of Education and Science. The KORA F4 research platform (KORA F4, Cooperative Health Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. The KORA Diabetes Study was partly funded by a German Research Foundation project grant to W. R. from the German Diabetes Center. The German Diabetes Center is funded by the German Federal Ministry of Health, and the Ministry of School, Science and Research of the State of North-Rhine-Westfalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busse R, 2004, HEALTH AFFAIR, V23, P56, DOI 10.1377/hlthaff.23.3.56; Dorais Marc, 2008, Can J Clin Pharmacol, V15, pe15; Gude D, 2012, J PHARMACOL PHARMACO, V3, P127, DOI 10.4103/0976-500X.95507; Hagen B, 2012, 52012 DMP PROJ ZENTR; Icks A, 2006, AM J PUBLIC HEALTH, V96, P1656, DOI 10.2105/AJPH.2005.063339; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Koller D, 2013, INFECTION, V41, P121, DOI 10.1007/s15010-012-0302-1; Kraus L, 2001, ADDICTION, V96, P459, DOI 10.1046/j.1360-0443.2001.9634599.x; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Meisinger C, 2010, DIABETIC MED, V27, P360, DOI 10.1111/j.1464-5491.2009.02905.x; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Mielck A, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-52; Moebus S, 2009, DIABETOLOGIA, V52, P81, DOI 10.1007/s00125-008-1173-y; Nordin M, 2013, SOC SCI MED, V77, P106, DOI 10.1016/j.socscimed.2012.11.013; Oduncu FS, 2013, MED HEALTH CARE PHIL, V16, P237; Ozegowski S, 2014, HEALTH POLICY, V114, P54, DOI 10.1016/j.healthpol.2013.08.005; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Rabi DM, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-11; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Rosenthal T, 2012, ANNU REV MED, V63, P493, DOI 10.1146/annurev-med-050710-134438; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Schipf S, 2012, DIABETIC MED, V29, pE88, DOI 10.1111/j.1464-5491.2012.03578.x; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Stang A, 2005, EUR J EPIDEMIOL, V20, P489, DOI 10.1007/s10654-005-5529-z; Sundmacher L, 2011, GESUNDHEITSWESEN, V73, P229, DOI 10.1055/s-0030-1254154; Vonneilich N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-285; WAUGH N, 2010, HEALTH TECHNOL ASSES, V14, P1; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	32	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99773	10.1371/journal.pone.0099773	http://dx.doi.org/10.1371/journal.pone.0099773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24915157	Green Submitted, gold, Green Published			2022-12-25	WOS:000340947700133
J	Xue, HL; Zhong, M; Xu, JH; Xu, LX				Xue, Huiliang; Zhong, Min; Xu, Jinhui; Xu, Laixiang			Geographic Distance Affects Dispersal of the Patchy Distributed Greater Long-Tailed Hamster (Tscherskia triton)	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; GENETIC DIVERSITY; MICROSATELLITE MARKERS; HABITAT FRAGMENTATION; POPULATION-STRUCTURE; DEPENDENT DISPERSAL; LANDSCAPE GENETICS; VOLE POPULATIONS; CLIMATE-CHANGE; SMALL MAMMALS	Dispersal is a fundamental process in ecology influencing the genetic structure and the viability of populations. Understanding how variable factors influence the dispersal of the population is becoming an important question in animal ecology. To date, geographic distance and geographic barriers are often considered as main factors impacting dispersal, but their effects are variable depending on different conditions. In general, geographic barriers affect more significantly than geographic distance on dispersal. In rapidly expanding populations, however, geographic barriers have less effect on dispersal than geographic distance. The effects of both geographic distance and geographic barriers in low-density populations with patchy distributions are poorly understood. By using a panel of 10 microsatellite loci we investigated the genetic structure of three patchy-distributed populations of the Greater long-tailed hamster (Tscherskia triton) from Raoyang, Guan and Shunyi counties of the North China Plain. The results showed that (i) high genetic diversity and differentiation exist in three geographic populations with patchy distributions; (ii) gene flow occurs among these three populations with physical barriers of Beijing city and Hutuo River, which potentially restricted the dispersal of the animal; (iii) the gene flow is negatively correlated with the geographic distance, while the genetic distance shows the positive correlation. Our results suggest that the effect of the physical barriers is conditional-dependent, including barrier capacity or individual potentially dispersal ability. Geographic distance also acts as an important factor affecting dispersal for the patchy distributed geographic populations. So, gene flow is effective, even at relatively long distances, in balancing the effect of geographic barrier in this study.	[Xue, Huiliang; Xu, Jinhui; Xu, Laixiang] Qufu Normal Univ, Coll Life Sci, Qufu, Shandong, Peoples R China; [Zhong, Min] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Qufu Normal University; Auburn University System; Auburn University	Xu, LX (corresponding author), Qufu Normal Univ, Coll Life Sci, Qufu, Shandong, Peoples R China.	xulx@mail.qfnu.edu.cn			National Natural Science Foundation of China [31270417, 31300304]; Shandong Provincial Natural Science Foundation [ZR2010CL013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This study was supported by National Natural Science Foundation of China (31270417 and 31300304) and the Shandong Provincial Natural Science Foundation (ZR2010CL013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alda F, 2013, J HERED, V104, P36, DOI 10.1093/jhered/ess071; An HS, 2013, MOL BIOL REP, V40, P3445, DOI 10.1007/s11033-012-2044-7; Andreassen HP, 2001, ECOLOGY, V82, P2911, DOI 10.2307/2679970; AYRES MP, 1994, ECOL MONOGR, V64, P465, DOI 10.2307/2937146; Berthier K, 2006, MOL ECOL, V15, P2665, DOI 10.1111/j.1365-294X.2006.02959.x; Billot C, 2003, MAR ECOL PROG SER, V253, P111, DOI 10.3354/meps253111; Boonstra R, 1998, ECOLOGY, V79, P1479; Bowler DE, 2009, J ANIM ECOL, V78, P1234, DOI 10.1111/j.1365-2656.2009.01580.x; Casgrain P, 2001, DEV RELEASE R PACKAG; Chaves JA, 2012, J EVOLUTION BIOL, V25, P509, DOI 10.1111/j.1420-9101.2011.02447.x; Conradt L, 2001, OIKOS, V95, P416, DOI 10.1034/j.1600-0706.2001.950306.x; da Rocha LC, 2013, GENETICA, V141, P65, DOI 10.1007/s10709-013-9706-9; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; DENNO RF, 1989, ECOL ENTOMOL, V14, P31, DOI 10.1111/j.1365-2311.1989.tb00751.x; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Dong JP, 2010, J MAMMAL, V91, P200, DOI 10.1644/09-MAMM-A-098R1.1; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Frankham R., 2002, INTRO CONSERVATION G; GAINES MS, 1980, ANNU REV ECOL SYST, V11, P163, DOI 10.1146/annurev.es.11.110180.001115; Gerlach G, 2000, CONSERV BIOL, V14, P1066, DOI 10.1046/j.1523-1739.2000.98519.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Gunter LE, 2000, GLOBAL CHANGE BIOL, V6, P335, DOI 10.1046/j.1365-2486.2000.00313.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hedin M, 2013, MOL ECOL, V22, P508, DOI 10.1111/mec.12130; Hellmann JJ, 2007, BIOL CONSERV, V137, P599, DOI 10.1016/j.biocon.2007.03.018; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hoffmann AA, 2001, EVOLUTION, V55, P1621, DOI 10.1111/j.0014-3820.2001.tb00681.x; Igawa T, 2013, HEREDITY, V110, P46, DOI 10.1038/hdy.2012.59; Ims RA, 2005, P ROY SOC B-BIOL SCI, V272, P913, DOI 10.1098/rspb.2004.3025; Irene K, 2003, P ROYAL SOC B, V270, P417; Jensen H, 2013, MOL ECOL, V22, P1792, DOI 10.1111/mec.12226; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; Keller I, 2004, MOL ECOL, V13, P2983, DOI 10.1111/j.1365-294X.2004.02310.x; Krebs CJ, 1996, J MAMMAL, V77, P8, DOI 10.2307/1382705; Kupper C, 2012, MOL ECOL, V21, P5864, DOI 10.1111/mec.12064; Kuussaari M, 1996, J ANIM ECOL, V65, P791, DOI 10.2307/5677; Leonardi S, 2012, J HERED, V103, P408, DOI 10.1093/jhered/ess004; Li Jing, 2010, Acta Entomologica Sinica, V53, P1135; Lin YTK, 2001, ECOL MONOGR, V71, P245, DOI 10.1890/0012-9615(2001)071[0245:TIOHQO]2.0.CO;2; Luo ZX, 2000, FAUNA SINICA MAMMALI, P63; MADER HJ, 1984, BIOL CONSERV, V29, P81, DOI 10.1016/0006-3207(84)90015-6; Magnus W, 2001, HEREDITY, V86, P703; Massot M, 2002, J ANIM ECOL, V71, P253, DOI 10.1046/j.1365-2656.2002.00592.x; Michaux JR, 2005, HEREDITY, V94, P52, DOI 10.1038/sj.hdy.6800561; Nangong Zi-Yan, 2008, Acta Entomologica Sinica, V51, P417; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M, 1978, GENETICS, V89, P538; Nei M., 1987, MOL EVOLUTIONARY GEN; Nichols J., 2001, DISPERSAL; Nielsen O, 1996, ARCTIC, V49, P383; Niemiller ML, 2013, EVOLUTION, V67, P1011, DOI 10.1111/evo.12017; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; Parada R, 2012, MOL BIOL REP, V39, P5291, DOI 10.1007/s11033-011-1327-8; Perez-Espona S, 2008, MOL ECOL, V17, P981, DOI 10.1111/j.1365-294X.2007.03629.x; Perez-Espona S, 2012, MOL ECOL, V21, P5969, DOI 10.1111/mec.12088; Piel AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058965; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Robinson SJ, 2012, MOL ECOL, V21, P4190, DOI 10.1111/j.1365-294X.2012.05681.x; Ronce Ophelie, 2001, P341; RYMAN N, 1983, AQUACULTURE, V33, P1, DOI 10.1016/0044-8486(83)90382-4; Schmitt T, 2004, MOL ECOL, V13, P21, DOI 10.1046/j.1365-294X.2004.02020.x; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Serrano D, 2003, J ANIM ECOL, V72, P400, DOI 10.1046/j.1365-2656.2003.00707.x; Song MJ, 2005, CAN J ZOOL, V83, P773, DOI 10.1139/Z05-060; Wang YH, 2013, MAR GENOM, V9, P63, DOI 10.1016/j.margen.2012.06.003; WASER PM, 1994, BEHAV ECOL, V5, P135; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wright S., 1978, EVOLUTION GENETICS P, V4; Xie JY, 2006, INTEGR ZOOL, V1, P188, DOI 10.1111/j.1749-4877.2006.00035.x; Xu Lai-Xiang, 2002, Acta Zoologica Sinica, V48, P264; Xu LX, 2007, MOL ECOL NOTES, V7, P617, DOI 10.1111/j.1471-8286.2006.01651.x; Xu LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054171; Zakharov EV, 2008, MOL ECOL, V17, P189, DOI 10.1111/j.1365-294X.2007.03488.x; Zhao Hui-Ting, 2008, Acta Zootaxonomica Sinica, V33, P89	81	6	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99540	10.1371/journal.pone.0099540	http://dx.doi.org/10.1371/journal.pone.0099540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911266	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600103
J	Park, JD; Kang, HJ; Kim, YA; Jo, M; Lee, ES; Shin, HY; Yun, YH				Park, June Dong; Kang, Hyoung Jin; Kim, Young Ae; Jo, MinKyoung; Lee, Eun Sook; Shin, Hee Young; Yun, Young Ho			Trends in the Aggressiveness of End-of-Life Care for Korean Pediatric Cancer Patients Who Died in 2007-2010	PLOS ONE			English	Article							CHILDREN; QUALITY; PERSPECTIVES; INDICATORS; SYMPTOMS	Background: In light of the Korean Supreme Court's 2009 ruling favoring a patient's right to die with dignity, we evaluated trends in aggressive care in a cohort of pediatric cancer patients. Methods We conducted a population-based retrospective study that used administrative data for patients who died in 2007-2010 among the 5,203 pediatric cancer patients registered at the Korean Cancer Central Registry (KCCR) during 2007-2009. Results: In the time period covered, 696 patients died. The proportion who had received chemotherapy in the last 30 days of life decreased from 58.1% to 28.9% (P<0.001), those who received new chemotherapy in the same time period decreased from 55.2% to 15.1% (P<0.001), and those who received treatment in the last 2 weeks of life decreased from 51.4% to 21.7% (P<0.001). In the last 30 days of life, the proportion of patients whose hospital admission period was over 14 days increased from 70.5% to 82.5% (P = 0.03), the proportion who received cardiopulmonary resuscitation decreased from 28.6% to 9.6% (P<0.001), and we found no statistically significant trends in the proportion of emergency department visits, intensive care unit admissions, or mechanical ventilation. Conclusions: In this study, in contrast with earlier ones, the aggressiveness of end-of-life care of Korean pediatric cancer patients decreased dramatically.	[Park, June Dong; Kang, Hyoung Jin; Shin, Hee Young] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Kang, Hyoung Jin; Shin, Hee Young; Yun, Young Ho] Seoul Natl Univ, Coll Med, Inst Canc, Seoul, South Korea; [Kim, Young Ae; Jo, MinKyoung; Lee, Eun Sook] Natl Canc Ctr, Hosp & Res Inst, Goyang, South Korea; [Yun, Young Ho] Seoul Natl Univ Hosp, Dept Biomed Sci, Seoul 110744, South Korea; [Yun, Young Ho] Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University Hospital	Yun, YH (corresponding author), Seoul Natl Univ, Coll Med, Inst Canc, Seoul, South Korea.	lawyun@snu.ac.kr		Park, June Dong/0000-0001-8113-1384	National Cancer Center [1010081];  [1310250-1]	National Cancer Center; 	This study was supported by National Cancer Center 1010081 grants and 1310250-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beretta S, 2010, PEDIATR BLOOD CANCER, V54, P88, DOI 10.1002/pbc.22284; Bradshaw Glenna, 2005, J Palliat Med, V8, P86, DOI 10.1089/jpm.2005.8.86; Earle CC, 2005, INT J QUAL HEALTH C, V17, P505, DOI 10.1093/intqhc/mzi061; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Fujii Y, 2003, PEDIATR INT, V45, P54, DOI 10.1046/j.1442-200X.2003.01664.x; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Mack JW, 2005, J CLIN ONCOL, V23, P9155, DOI 10.1200/JCO.2005.04.010; Meert KL, 2009, PEDIATR CRIT CARE ME, V10, P544, DOI 10.1097/PCC.0b013e3181a7045c; Pui CH, 2011, NAT REV CLIN ONCOL, V8, P540, DOI 10.1038/nrclinonc.2011.95; Sato K, 2008, SUPPORT CARE CANCER, V16, P113, DOI 10.1007/s00520-007-0332-x; Ser MJ, 2009, JOONGANG DAILY  0522; Shin Hai-Rim, 2005, Cancer Res Treat, V37, P325, DOI 10.4143/crt.2005.37.6.325; Tang ST, 2011, J CLIN ONCOL, V29, P890, DOI 10.1200/JCO.2010.32.5639; Tang ST, 2009, J CLIN ONCOL, V27, P4613, DOI 10.1200/JCO.2008.20.5096; von Lutzau P, 2012, J PALLIAT CARE, V28, P274, DOI 10.1177/082585971202800406; Wolfe J, 2000, NEW ENGL J MED, V342, P326, DOI 10.1056/NEJM200002033420506; Wolfe J, 2008, J CLIN ONCOL, V26, P1717, DOI 10.1200/JCO.2007.14.0277; Yun YH, 2007, ONCOLOGY-BASEL, V72, P164, DOI 10.1159/000112802; Yun YH, 2011, CAN MED ASSOC J, V183, pE673, DOI 10.1503/cmaj.110020	21	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99888	10.1371/journal.pone.0099888	http://dx.doi.org/10.1371/journal.pone.0099888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923320	Green Submitted, gold, Green Published			2022-12-25	WOS:000338701300104
J	Wang, J; Qu, XF; Qi, YF; Li, JH; Song, XL; Li, L; Yin, DH; Xu, K; Li, J				Wang, Juan; Qu, Xiaofeng; Qi, Yanfei; Li, Jinhua; Song, Xiuling; Li, Li; Yin, Dehui; Xu, Kun; Li, Juan			Pharmacokinetics of Anti-HBV Polyoxometalate in Rats	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; BIOLOGICAL-ACTIVITY; IN-VITRO; INFECTION; TITANIUM; TYPE-1	Polyoxometalates are non-nucleoside analogs that have been proven to exhibit broad-spectrum antiviral activity. In particular, Cs2K4Na[SiW9Nb3O40].H2O 1 shows low toxicity and high activity against HBV. The preclinical pharmacokinetics of Compound 1 in rats were characterized by establishing and applying inductively coupled plasma-mass spectrometry method to determine the concentration of W in plasma, urine, feces, bile and organ samples. The quantitative ICP-MS method demonstrated good sensitivity and application in the pharmacokinetics study of polyoxometalates. The pharmacokinetic behavior of Compound 1 after intravenous or oral administration fit a two-compartment model. T-max ranges from 0.1 h to 3 h and the T-1/2 of Compound 1 is between 20 h and 30 h. The absolute bioavailability of Compound 1 at 45, 180 and 720 mg/kg groups were 23.68%, 14.67% and 11.93%, respectively. The rates of plasma protein binding of Compound 1 at 9, 18 and 36 mg/ml of Compound 1 are 62.13 +/- 69.41%, 71.20 +/- 624.98% and 49.00 +/- 625.59%, respectively. Compound 1 was widely distributed throughout the body, and high levels of compound 1 were found in the kidney and liver. The level of Compound 1 in excretion was lower: 30% for urine, 0.28% for feces and 0.42% for bile, respectively. For elaborate pharmacokinetic characteristics to be fully understood, the metabolism of Compound 1 needs to be studied further.	[Wang, Juan; Qu, Xiaofeng; Qi, Yanfei; Li, Jinhua; Song, Xiuling; Li, Li; Yin, Dehui; Xu, Kun; Li, Juan] Jilin Univ, Sch Publ Hlth, Changchun 130023, Jilin, Peoples R China	Jilin University	Xu, K (corresponding author), Jilin Univ, Sch Publ Hlth, Changchun 130023, Jilin, Peoples R China.	xukun@jlu.edu.cn; li_juan@jlu.edu.cn		Li, Li/0000-0002-6789-2328	National S & T Major Project of China [2009ZX09103-105]; National Natural Science Foundation of China [81072337]; Talents Ph.D. Project of Bethune College of Medicine in Jilin University	National S & T Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talents Ph.D. Project of Bethune College of Medicine in Jilin University	This work was financially supported by the National S & T Major Project of China (2009ZX09103-105) and the National Natural Science Foundation of China (Nos. 81072337). The authors acknowledge support from The Talents Ph.D. Project of Bethune College of Medicine in Jilin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; BOUDINOT FD, 1984, J PHARM SCI, V73, P774, DOI 10.1002/jps.2600730617; De Clercq E, 1999, INT J ANTIMICROB AG, V12, P81, DOI 10.1016/S0924-8579(99)00060-6; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; IKEDA S, 1993, J MED VIROL, V41, P191, DOI 10.1002/jmv.1890410304; Judd DA, 2001, J AM CHEM SOC, V123, P886, DOI 10.1021/ja001809e; JUDD DA, 1994, ANTIVIR CHEM CHEMOTH, V5, P410, DOI 10.1177/095632029400500609; Keita B, 2007, J MOL CATAL A-CHEM, V262, P190, DOI 10.1016/j.molcata.2006.08.066; KIM GS, 1994, J MED CHEM, V37, P816, DOI 10.1021/jm00032a016; Kogerler P, 2010, DALTON T, V39, P21, DOI 10.1039/b910716a; Liu J, 2000, ANTIVIR CHEM CHEMOTH, V11, P367, DOI 10.1177/095632020001100603; Long DL, 2007, CHEM SOC REV, V36, P105, DOI 10.1039/b502666k; Nguyen MH, 2009, J VIRAL HEPATITIS, V16, P149, DOI 10.1111/j.1365-2893.2009.01078.x; NI L, 1995, EUR J DRUG METAB PH, V20, P209, DOI 10.1007/BF03189672; NI L, 1994, ANTIMICROB AGENTS CH, V38, P504, DOI 10.1128/AAC.38.3.504; Pramoolsinsup C, 2002, J GASTROEN HEPATOL, V17, pS125, DOI 10.1046/j.1440-1746.17.s1.3.x; Qi YF, 2012, ANTIVIR RES, V93, P118, DOI 10.1016/j.antiviral.2011.11.003; Rhule JT, 1998, CHEM REV, V98, P327, DOI 10.1021/cr960396q; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Shigeta S, 2003, ANTIVIR RES, V58, P265, DOI 10.1016/S0166-3542(03)00009-3; Shigeta S, 1997, ANTIMICROB AGENTS CH, V41, P1423, DOI 10.1128/AAC.41.7.1423; Shigeta S, 2006, BIOMED PHARMACOTHER, V60, P211, DOI 10.1016/j.biopha.2006.03.009; TAKE Y, 1991, ANTIVIR RES, V15, P113, DOI 10.1016/0166-3542(91)90029-Q; Witvrouw M, 2000, J MED CHEM, V43, P778, DOI 10.1021/jm980263s; Yamase T, 2005, J MATER CHEM, V15, P4773, DOI 10.1039/b504585a; [原野 Yuan Ye], 2012, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V38, P28; Zhang H, 2012, BIOORG MED CHEM LETT, V22, P1664, DOI 10.1016/j.bmcl.2011.12.115; Zou L, 2010, J THEOR BIOL, V262, P330, DOI 10.1016/j.jtbi.2009.09.035	28	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98292	10.1371/journal.pone.0098292	http://dx.doi.org/10.1371/journal.pone.0098292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921932	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300006
J	Jahangirzadeh, A; Basser, H; Akib, S; Karami, H; Naji, S; Shamshirband, S				Jahangirzadeh, Afshin; Basser, Hossein; Akib, Shatirah; Karami, Hojat; Naji, Sareh; Shamshirband, Shahaboddin			Experimental and Numerical Investigation of the Effect of Different Shapes of Collars on the Reduction of Scour around a Single Bridge Pier	PLOS ONE			English	Article							LOCAL SCOUR; RIPRAP; SCALE; FIELD	The scour phenomenon around bridge piers causes great quantities of damages annually all over the world. Collars are considered as one of the substantial methods for reducing the depth and volume of scour around bridge piers. In this study, the experimental and numerical methods are used to investigate two different shapes of collars, i.e, rectangular and circular, in terms of reducing scour around a single bridge pier. The experiments were conducted in hydraulic laboratory at university of Malaya. The scour around the bridge pier and collars was simulated numerically using a three-dimensional, CFD model namely SSIIM 2.0, to verify the application of the model. The results indicated that although, both types of collars provides a considerable decrease in the depth of the scour, the rectangular collar, decreases scour depth around the pier by 79 percent, and has better performance compared to the circular collar. Furthermore, it was observed that using collars under the stream's bed, resulted in the most reduction in the scour depth around the pier. The results also show the SSIIM 2.0 model could simulate the scour phenomenon around a single bridge pier and collars with sufficient accuracy. Using the experimental and numerical results, two new equations were developed to predict the scour depth around a bridge pier exposed to circular and rectangular collars.	[Jahangirzadeh, Afshin; Basser, Hossein; Akib, Shatirah; Naji, Sareh] Univ Malaya, Dept Civil Engn, Kuala Lumpur, Malaysia; [Karami, Hojat] Semnan Univ, Dept Civil Engn, Semnan, Iran; [Shamshirband, Shahaboddin] Islamic Azad Univ, Dept Comp Sci, Chalous, Mazandaran, Iran	Universiti Malaya; Semnan University; Islamic Azad University	Akib, S (corresponding author), Univ Malaya, Dept Civil Engn, Kuala Lumpur, Malaysia.	shatirahakib@yahoo.co.uk	Akib, Shatirah/C-5165-2011; S.Band, Shahab/ABI-7388-2020; S.Band, Shahab/AAD-3311-2021; Karami, Hojat/AAU-1618-2020	Akib, Shatirah/0000-0002-6538-0716; S.Band, Shahab/0000-0002-8963-731X; Basser, Hossein/0000-0001-8744-1869	High Impact Research Grant [UM.C/625/1/HIR/61];  [H-16001-00-D000061]	High Impact Research Grant; 	High Impact Research Grant, project number: UM.C/625/1/HIR/61, account number: H-16001-00-D000061: A Fundamental Research on Sustainable Scouring Countermeasure and Innovative Scouring Monitoring Systems with Smart Sensor Technologies. The funder (high impact research) has provided all expenses in project, also it will support all fees of publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akib S., 2014, WORLD ACAD SCI ENG T, V8, P56, DOI [10.5281/zenodo.1336432, DOI 10.5281/ZENODO.1336432]; Akib S, 2014, J HYDROL HYDROMECH, V62, P108, DOI 10.2478/johh-2014-0015; Akib S, 2011, BALT J ROAD BRIDGE E, V6, P107, DOI 10.3846/bjrbe.2011.15; Alabi P.D., 2006, THESIS U SASKATCHEWA; Bertoldi D, 1993, P NAT C HYDR ENG ASC, P121; Breusers H. N. C., 1991, SCOURING HYDRAULIC S; CHIEW YM, 1992, J HYDRAUL ENG-ASCE, V118, P1260, DOI 10.1061/(ASCE)0733-9429(1992)118:9(1260); CHIEW YM, 1987, J HYDRAUL RES, V25, P15, DOI 10.1080/00221688709499285; Christensen Z. M., 2009, REDUCTION LOCAL SCOU; DARGAHI B, 1990, J HYDRAUL ENG-ASCE, V116, P1197, DOI 10.1061/(ASCE)0733-9429(1990)116:10(1197); Dey S, 1997, INT J SEDIMENT RES, V12, P23; Duan JG, 2006, J HYDROL, V327, P426, DOI 10.1016/j.jhydrol.2005.11.055; Euler T, 2012, CATENA, V91, P35, DOI 10.1016/j.catena.2010.11.002; Ghodsian M, 2009, INT J SEDIMENT RES, V24, P145, DOI 10.1016/S1001-6279(09)60022-6; Jahangirzadeh A, 2014, NEUROCOMPUT IN PRESS; Karami H, 2012, WATER ENVIRON J, V28, P124, DOI DOI 10.1111/WEJ.12019; Kattell J, 1998, 9877 USDA FOREST SER; Kumar A, 2012, J HYDRO-ENVIRON RES, V6, P251, DOI 10.1016/j.jher.2012.05.006; Kumar V, 1999, J HYDRAUL ENG-ASCE, V125, P1302, DOI 10.1061/(ASCE)0733-9429(1999)125:12(1302); Lagasse PF, 1997, 396 NAT COOP HIGHW R; Link O, 2008, INT J SEDIMENT RES, V23, P258, DOI 10.1016/S1001-6279(08)60023-2; Melville B, 2008, P 4 INT C SCOUR ER T, P2838; Melville BW, 1999, J HYDRAUL ENG-ASCE, V125, P1221, DOI 10.1061/(ASCE)0733-9429(1999)125:11(1221); Melville BW, 1999, J HYDRAUL ENG-ASCE, V125, P59, DOI 10.1061/(ASCE)0733-9429(1999)125:1(59); MELVILLE BW, 1977, J HYDRAUL RES, V15, P373, DOI 10.1080/00221687709499641; Moncada-M AT, 2009, J HYDRAUL RES, V47, P119, DOI 10.3826/jhr.2009.3244; Muzzammil M, 2003, J HYDRAUL RES, V41, P285, DOI 10.1080/00221680309499973; Neill C. R., 1973, GUIDE BRIDGE HYDRAUL; Odgaard AJ, 1987, P NAT C HYDR ENG; Olsen N.R.B., 2009, 3 DIMENSIONAL NUMERI; PARKER G, 1998, COUNTERMEASURES PROT; PAROLA AC, 1993, J HYDRAUL ENG-ASCE, V119, P1080, DOI 10.1061/(ASCE)0733-9429(1993)119:10(1080); RAUDKIVI A. J., 1983, J HYDRAUL ENG-ASCE, V109, P339; SaniKhani H, 2008, P 4 NAT C CIV ENG TE; Schneible DE, 1951, THESIS STATE U IOWA; Sheppard DM, 2004, J HYDRAUL ENG, V130, P957, DOI 10.1061/(ASCE)0733-9429(2004)130:10(957); Shirhole A.M., 1991, TRANSPORTATION RES R; Tanaka S, 1967, P 12 IAHR C DELFT; Termini D, 2011, CATENA, V84, P125, DOI 10.1016/j.catena.2010.10.008; Thomas Z, 1967, P 12 IAHR C DELFT; van Rijn L.C., 1987, THESIS DELFT U TECHN; Zarrati AR, 2006, J HYDRAUL ENG, V132, P154, DOI 10.1061/(ASCE)0733-9429(2006)132:2(154); Zarrati AR, 2004, J HYDRAUL RES, V42, P97, DOI 10.1080/00221686.2004.9641188	43	18	18	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98592	10.1371/journal.pone.0098592	http://dx.doi.org/10.1371/journal.pone.0098592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919065	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000021
J	Jorgensen, CF; Powell, LA; Lusk, JJ; Bishop, AA; Fontaine, JJ				Jorgensen, Christopher F.; Powell, Larkin A.; Lusk, Jeffery J.; Bishop, Andrew A.; Fontaine, Joseph J.			Assessing Landscape Constraints on Species Abundance: Does the Neighborhood Limit Species Response to Local Habitat Conservation Programs?	PLOS ONE			English	Article							RING-NECKED PHEASANTS; BIRD POPULATIONS; BREEDING BIRDS; NEST PREDATORS; SPATIAL SCALE; AGRICULTURAL LANDSCAPES; PHASIANUS-COLCHICUS; RESERVE-PROGRAM; GRASSLAND BIRDS; LAND-USE	Landscapes in agricultural systems continue to undergo significant change, and the loss of biodiversity is an ever-increasing threat. Although habitat restoration is beneficial, management actions do not always result in the desired outcome. Managers must understand why management actions fail; yet, past studies have focused on assessing habitat attributes at a single spatial scale, and often fail to consider the importance of ecological mechanisms that act across spatial scales. We located survey sites across southern Nebraska, USA and conducted point counts to estimate Ring-necked Pheasant abundance, an economically important species to the region, while simultaneously quantifying landscape effects using a geographic information system. To identify suitable areas for allocating limited management resources, we assessed land cover relationships to our counts using a Bayesian binomial-Poisson hierarchical model to construct predictive Species Distribution Models of relative abundance. Our results indicated that landscape scale land cover variables severely constrained or, alternatively, facilitated the positive effects of local land management for Ring-necked Pheasants.	[Jorgensen, Christopher F.; Powell, Larkin A.] Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA; [Jorgensen, Christopher F.] Univ Nebraska, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE USA; [Lusk, Jeffery J.] Nebraska Game & Parks Commiss, Lincoln, NE USA; [Bishop, Andrew A.] US Fish & Wildlife Serv, Rainwater Basin Joint Venture, Grand Isl, NE USA; [Fontaine, Joseph J.] Univ Nebraska, Nebraska Cooperat Fish & Wildlife Res Unit, US Geol Survey, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln	Jorgensen, CF (corresponding author), Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA.	jorgensen.chris@gmail.com	Fontaine, Joseph J/F-6557-2010	Fontaine, Joseph J/0000-0002-7639-9156	Federal Aid in Wildlife Restoration [W-89-R]; U.S. Geological Survey; Nebraska Game and Parks Commission; University of Nebraska; U.S. Fish and Wildlife Service; Wildlife Management Institute	Federal Aid in Wildlife Restoration; U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission; University of Nebraska; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute	Funding for this project was received from Federal Aid in Wildlife Restoration projects W-89-R, administered by the Nebraska Game and Parks Commission. Any use of trade names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The Nebraska Cooperative Fish and Wildlife Research Unit is supported by a cooperative agreement among the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska, the U.S. Fish and Wildlife Service, and the Wildlife Management Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 1956, PHEASANTS N AM; Baxter WL, 1973, LIFE HIST ECOLOGY RI; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; BEST LB, 1995, AM MIDL NAT, V134, P1, DOI 10.2307/2426479; Best LB, 2001, J WILDLIFE MANAGE, V65, P442, DOI 10.2307/3803096; Blondel J., 1981, Studies in Avian Biology, P414; BOGENSCHUTZ TR, 1995, J WILDLIFE MANAGE, V59, P776, DOI 10.2307/3801956; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bremner A, 2007, BIOL CONSERV, V139, P306, DOI 10.1016/j.biocon.2007.07.005; Brier G.W., 1950, MON WEATHER REV, V78, P1, DOI [DOI 10.1175/1520-0493(1950)0782.0.CO;2, DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2]; BRING J, 1994, AM STAT, V48, P209, DOI 10.2307/2684719; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Buckland S.T., 2001, pi; Caruana R, 2004, P 10 ACM SIGKDD INT; Chalfoun AD, 2002, ECOL APPL, V12, P858, DOI 10.1890/1051-0761(2002)012[0858:SNPIFP]2.0.CO;2; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Chalfoun AD, 2007, J APPL ECOL, V44, P983, DOI 10.1111/j.1365-2664.2007.01352.x; Clark WR, 1999, J WILDLIFE MANAGE, V63, P976, DOI 10.2307/3802812; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; COWARDIN LM, 1995, WILDLIFE SOC B, V23, P48; Cozzi G, 2008, LANDSCAPE ECOL, V23, P269, DOI 10.1007/s10980-007-9178-3; Cunningham MA, 2006, ECOL APPL, V16, P1062, DOI 10.1890/1051-0761(2006)016[1062:PALFIG]2.0.CO;2; Didier KA, 1999, WILDLIFE SOC B, V27, P409; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Drake JF, 2006, GAMEBIRD 2006 QUAIL, P302; Eggebo SL, 2003, WILDLIFE SOC B, V31, P779; Emmering QC, 2011, J ANIM ECOL, V80, P1305, DOI 10.1111/j.1365-2656.2011.01869.x; Errington PL, 1937, J WILDLIFE MANAGE, V1, P3; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Fisher RJ, 2010, J WILDLIFE MANAGE, V74, P265, DOI 10.2193/2009-020; Fletcher Jr RJ, 2010, PREDICTIVE MODELING, P91; Fletcher RJ, 2002, J WILDLIFE MANAGE, V66, P1011, DOI 10.2307/3802933; Franklin J, 2009, MAPPING SPECIES DIST; FRIED LOUIS A., 1940, JOUR WILDLIFE MANAGEMENT, V4, P27, DOI 10.2307/3796264; Garrettson PR, 2001, J WILDLIFE MANAGE, V65, P445; GATES JM, 1966, J WILDLIFE MANAGE, V30, P735, DOI 10.2307/3798280; Gelman A., 2007, DATA ANAL USING REGR; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Gibeau ML, 1998, URSUS-SERIES, V10, P235; Giudice JH, 2007, J FIELD ORNITHOL, V78, P140, DOI 10.1111/j.1557-9263.2007.00097.x; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Heath RG, 1961, 2273 MICH DEP CONS G, V2273, P38; Henningsen JC, 2005, J WILDLIFE MANAGE, V69, P198, DOI 10.2193/0022-541X(2005)069&lt;0198:GBUORF&gt;2.0.CO;2; Herkert JR, 2009, CONSERV BIOL, V23, P1036, DOI 10.1111/j.1523-1739.2009.01234.x; HILDEN OLAVL, 1965, ANN ZOOL FEN NICI, V2, P53; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Hutto R.L., 1985, P455; HUTTO RL, 1986, AUK, V103, P593, DOI 10.1093/auk/103.3.593; JAMES FC, 1971, WILSON BULL, V83, P215; Kery M., 2010, INTRO WINBUGS ECOLOG; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kimball JW, 1949, J WILDLIFE MANAGE, V16, P429; Knight AT, 2007, CONSERV BIOL, V21, P1124, DOI 10.1111/j.1523-1739.2007.00690.x; Kusak J, 1998, URSUS-SERIES, V10, P281; Latimer AM, 2006, ECOL APPL, V16, P33, DOI 10.1890/04-0609; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Leif AP, 2005, WILDLIFE SOC B, V33, P130, DOI 10.2193/0091-7648(2005)33[130:SEAHSO]2.0.CO;2; LEIF AP, 1994, J WILDLIFE MANAGE, V58, P501, DOI 10.2307/3809322; Leopold A., 1933, GAME MANAGEMENT; Liu C, 2009, 18TH WORLD IMACS CONGRESS AND MODSIM09 INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P4241; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Luukkonen DR, 1997, J WILDLIFE MANAGE, V61, P1338, DOI 10.2307/3802135; LYON LJ, 1954, J WILDLIFE MANAGE, V18, P179, DOI 10.2307/3797712; MANKIN PC, 1992, AM MIDL NAT, V128, P281, DOI 10.2307/2426462; MARTIN TE, 1988, P NATL ACAD SCI USA, V85, P2196, DOI 10.1073/pnas.85.7.2196; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; McCoy TD, 1999, J WILDLIFE MANAGE, V63, P530, DOI 10.2307/3802639; MCGARIGAL K, 1995, PNWGTR351 US FOR SER; Miller DA, 2003, WILDLIFE SOC B, V31, P30; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Murray LD, 2008, CONDOR, V110, P747, DOI 10.1525/cond.2008.8610; Newburn D, 2005, CONSERV BIOL, V19, P1411, DOI 10.1111/j.1523-1739.2005.00199.x; Nielson RM, 2008, AUK, V125, P434, DOI 10.1525/auk.2008.07002; Patterson MP, 1996, AM MIDL NAT, V135, P153, DOI 10.2307/2426881; Perkins AL, 1997, J WILDLIFE MANAGE, V61, P634, DOI 10.2307/3802171; Peterjohn BG, 2003, AUK, V120, P14, DOI 10.1642/0004-8038(2003)120[0014:ALCTSH]2.0.CO;2; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; Powell LA, 2012, ANIM BIODIV CONSERV, V35, P295; R Core Team, 2021, R LANG ENV STAT COMP; Rahmig CJ, 2009, CONSERV BIOL, V23, P420, DOI 10.1111/j.1523-1739.2008.01118.x; Renfrew RB, 2003, AUK, V120, P371, DOI 10.1642/0004-8038(2003)120[0371:GPNPNP]2.0.CO;2; Ricklefs R. E., 1969, ANAL NESTING MORTALI, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; RILEY TZ, 1995, WILDLIFE SOC B, V23, P386; Riley TZ, 1998, J WILDLIFE MANAGE, V62, P36, DOI 10.2307/3802262; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; ROBERTSON PA, 1993, J APPL ECOL, V30, P465, DOI 10.2307/2404187; Robertson PA, 1996, WILDLIFE SOC B, V24, P98; Rodgers RD, 1999, WILDLIFE SOC B, V27, P654; Rohwer FC, 2004, TRANS N AM WILDL NAT, V69, P129; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Saab V, 1999, ECOL APPL, V9, P135, DOI 10.1890/1051-0761(1999)009[0135:IOSSTH]2.0.CO;2; SAUER JR, 2011, N AM BREEDING BIRD S; Schmitz RA, 1999, J WILDLIFE MANAGE, V63, P147, DOI 10.2307/3802495; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Smith SA, 1999, AM MIDL NAT, V141, P185, DOI 10.1674/0003-0031(1999)141[0185:HRHSAM]2.0.CO;2; SNYDER WD, 1984, J WILDLIFE MANAGE, V48, P878, DOI 10.2307/3801434; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stephens SE, 2008, CONSERV BIOL, V22, P1320, DOI 10.1111/j.1523-1739.2008.01022.x; Stephens SE, 2004, BIOL CONSERV, V115, P101, DOI 10.1016/S0006-3207(03)00098-3; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; TAYLOR M W, 1978, Wildlife Society Bulletin, V6, P226; Thogmartin WE, 2006, CONDOR, V108, P25, DOI 10.1650/0010-5422(2006)108[0025:PRAORG]2.0.CO;2; Tuffery S., 2011, DATA MINING STAT DEC; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Ward EJ, 2008, ECOL MODEL, V211, P1, DOI 10.1016/j.ecolmodel.2007.10.030; WARNER RE, 1982, J WILDLIFE MANAGE, V46, P923, DOI 10.2307/3808225; WIENS JA, 1973, ECOLOGY, V54, P877, DOI 10.2307/1935683; WIENS JA, 1995, IBIS, V137, pS97, DOI 10.1111/j.1474-919X.1995.tb08464.x; Wrbka T, 2008, COMMUNITY ECOL, V9, P217, DOI 10.1556/ComEc.9.2008.2.11; Zinn HC, 1998, SOC NATUR RESOUR, V11, P649, DOI 10.1080/08941929809381109; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	115	8	10	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99339	10.1371/journal.pone.0099339	http://dx.doi.org/10.1371/journal.pone.0099339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918779	gold, Green Published			2022-12-25	WOS:000338631000079
J	Schuster, R; Martin, TG; Arcese, P				Schuster, Richard; Martin, Tara G.; Arcese, Peter			Bird Community Conservation and Carbon Offsets in Western North America	PLOS ONE			English	Article							BETA-DIVERSITY; PAYMENTS; LAND; FORESTS; COSTS; OPPORTUNITY; STRATEGIES; MANAGEMENT; EASEMENTS; ECOSYSTEM	Conservation initiatives to protect and restore valued species and communities in human-dominated landscapes face huge challenges linked to the cost of acquiring habitat. We ask how the sale of forest carbon offsets could reduce land acquisition costs, and how the alternate goals of maximizing alpha or beta-diversity in focal communities could affect the prioritization land parcels over a range of conservation targets. Maximizing total carbon storage and carbon sequestration potential reduced land acquisition costs by up to 48%. Maximizing beta rather than alpha-diversity within forest and savannah bird communities reduced acquisition costs by up to 15%, and when these solutions included potential carbon credit revenues, acquisition cost reductions up to 32% were achieved. However, the total cost of conservation networks increased exponentially as area targets increased in all scenarios. Our results indicate that carbon credit sales have the potential to enhance conservation outcomes in human-dominated landscapes by reducing the net acquisition costs of land conservation in old and maturing forests essential for the persistence of old forest plant and animal communities. Maximizing beta versus alpha-diversity may further reduce costs by reducing the total area required to meet conservation targets and enhancing landscape heterogeneity. Although the potential value of carbon credit sales declined as a fraction of total acquisition costs, even conservative scenarios using a carbon credit value of $12.5/T suggest reductions in acquisition cost of up to $235 M, indicating that carbon credit sales could substantially reduce the costs of conservation.	[Schuster, Richard; Martin, Tara G.; Arcese, Peter] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada; [Martin, Tara G.] CSIRO Ecosyst Sci, Ecosci Precinct, Brisbane, Qld, Australia	University of British Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schuster, R (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada.	mail@richard-schuster.com	Martin, Tara/M-1897-2016; Schuster, Richard/E-1619-2011	Martin, Tara/0000-0001-7165-9812; Schuster, Richard/0000-0003-3191-7869	Natural Sciences and Engineering Research Council Canada Discovery Grant; University of British Columbia	Natural Sciences and Engineering Research Council Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of British Columbia	The Natural Sciences and Engineering Research Council Canada Discovery Grant (PA, http://www.nserc-crsng.gc.ca/), W. and H. Hesse (RS, http://hess-eaward.sites.olt.ubc.ca/) and the University of British Columbia (RS, PA, http://ubc.ca/) kindly funded our work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, ANNU REV ENV RESOUR, V36, P373, DOI 10.1146/annurev-environ-042009-094508; Anderson K, 2008, ECOL ECON, V68, P437, DOI 10.1016/j.ecolecon.2008.04.015; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; [Anonymous], 1991, SPECIAL REPORT SERIE; Arcese P, 2014, DIVERS DIST IN PRESS; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Armsworth PR, 2008, CONSERV LETT, V1, P182, DOI 10.1111/j.1755-263X.2008.00028.x; Arponen A, 2008, J APPL ECOL, V45, P1436, DOI 10.1111/j.1365-2664.2008.01513.x; Austin M.A., 2008, TAKING NATURES PULSE; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bayon R, 2010, NATURE, V466, P184, DOI 10.1038/466184a; Bennett JR, 2013, CONSERV BIOL, V27, P417, DOI 10.1111/cobi.12015; Bennett JR, 2013, BIOL INVASIONS, V15, P707, DOI 10.1007/s10530-012-0320-z; Beyer H. L, 2012, GEOSPATIAL MODELLING; Bivand RS, 2013, APPL SPATIAL DATA AN, DOI [10.1111/j.1541-0420.2009.012471.x, DOI 10.1111/J.1541-0420.2009.01247_1.X]; Bradshaw CJA, 2013, BIOL CONSERV, V161, P71, DOI 10.1016/j.biocon.2013.02.012; Bunn D, 2013, CALIF AGR, V67, P86, DOI 10.3733/ca.v067n02p86; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carwardine J, 2010, CONSERV BIOL, V24, P1529, DOI 10.1111/j.1523-1739.2010.01535.x; Chan KMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024378; Climate Commission, 2013, CRIT DEC GLOB ACT BU; Convention on Biological Diversity, 2010, SECR CONV BIOL DIV M; Crossman ND, 2011, CONSERV BIOL, V25, P835, DOI 10.1111/j.1523-1739.2011.01649.x; Douglass LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023843; Drechsler M, 2007, BIOL CONSERV, V140, P174, DOI 10.1016/j.biocon.2007.08.013; Dunwiddie PW, 2011, NORTHWEST SCI, V85, P83, DOI 10.3955/046.085.0201; Ehrlich PR, 2008, P NATL ACAD SCI USA, V105, P11579, DOI 10.1073/pnas.0801911105; Environmental Systems Research Institute (ESRI), 2012, ARCGIS 10 1; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Evans MC, 2014, GLOB ENV CH IN PRESS; Fairbanks DHK, 2001, BIOL CONSERV, V98, P365, DOI 10.1016/S0006-3207(00)00179-8; Ferraro PJ, 2003, J POLICY ANAL MANAG, V22, P27, DOI 10.1002/pam.10094; Fishburn IS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004996; Gonzales EK, 2008, ECOLOGY, V89, P3282, DOI 10.1890/08-0435.1; Gordon A, 2011, BIOL CONSERV, V144, P558, DOI 10.1016/j.biocon.2010.10.011; Kimmins JP, 1999, ECOL MODEL, V122, P195, DOI 10.1016/S0304-3800(99)00138-6; Klimek S, 2008, BIOL CONSERV, V141, P2888, DOI 10.1016/j.biocon.2008.08.025; Knight AT, 2011, BIOL CONSERV, V144, P2623, DOI 10.1016/j.biocon.2011.07.013; Knight AT, 2010, CONSERV BIOL, V24, P1348, DOI 10.1111/j.1523-1739.2010.01494.x; Lea T., 2006, DAVIDSONIA, V17, P34; Lo AY, 2013, ECOL ECON, V87, P84, DOI 10.1016/j.ecolecon.2012.12.014; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; MacDougall AS, 2004, CONSERV BIOL, V18, P455, DOI 10.1111/j.1523-1739.2004.00483.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Marsh CJ, 2010, BIOL CONSERV, V143, P1364, DOI 10.1016/j.biocon.2010.03.010; Martin TG, 2011, BIOL CONSERV, V144, P459, DOI 10.1016/j.biocon.2010.09.033; McCune JL, 2013, BIOL CONSERV, V166, P293, DOI 10.1016/j.biocon.2013.08.004; Meidinger D, 1998, FIELD MANUAL DESCRIB; MES, 2008, TERR EC MAPP COAST D; Ministry of Environment BC, 2011, PROT CREAT FOR CARB; Mokany K, 2011, ECOL LETT, V14, P1043, DOI 10.1111/j.1461-0248.2011.01675.x; Moon K, 2011, J RURAL STUD, V27, P331, DOI 10.1016/j.jrurstud.2011.04.001; Mosseler A., 2003, Environmental Reviews, V11, pS1, DOI 10.1139/a03-018; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Newell RG, 2013, J ECON PERSPECT, V27, P123, DOI 10.1257/jep.27.1.123; Nickerson CJ, 2001, AM J AGR ECON, V83, P341, DOI 10.1111/0002-9092.00160; Noss RF, 2012, CONSERV BIOL, V26, P1, DOI 10.1111/j.1523-1739.2011.01738.x; Parker DP, 2004, NAT RESOUR J, V44, P483; PCT, 2013, PAC CARB TRUST CARB; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pellatt MG, 2012, ENVIRON MANAGE, V49, P802, DOI 10.1007/s00267-012-9815-8; Phelps J, 2012, NAT CLIM CHANGE, V2, P497, DOI [10.1038/NCLIMATE1462, 10.1038/nclimate1462]; Polasky S, 2001, LAND ECON, V77, P68, DOI 10.2307/3146981; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; R Development Core Team, 2012, R LANG ENV STAT COMP; Rissman AR, 2013, ENVIRON CONSERV, V40, P222, DOI 10.1017/S0376892913000015; Rissman AR, 2011, CONSERV LETT, V4, P31, DOI 10.1111/j.1755-263X.2010.00136.x; Schilling BJ, 2013, J AGR RESOUR EC, V38; Schuster R, 2013, ECOGRAPHY, V36, P499, DOI 10.1111/j.1600-0587.2012.07681.x; Seely B, 2004, FOREST ECOL MANAG, V199, P283, DOI 10.1016/j.foreco.2004.05.048; Turner Nancy J., 2014, ANCIENT PATHWAYS ANC; Vellend M, 2008, BIOL CONSERV, V141, P2576, DOI 10.1016/j.biocon.2008.07.019; Venter O, 2009, SCIENCE, V326, P1368, DOI 10.1126/science.1180289; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Wang Q, 2013, NATURE, V493, P273, DOI 10.1038/493273a; Wiersma YF, 2005, CONSERV BIOL, V19, P1262, DOI 10.1111/j.1523-1739.2005.00099.x; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x	79	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99292	10.1371/journal.pone.0099292	http://dx.doi.org/10.1371/journal.pone.0099292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918621	Green Published, gold			2022-12-25	WOS:000338631000072
J	Du, F; Shi, HJ; Zhang, XC; Xu, XX				Du, Feng; Shi, Huijun; Zhang, Xingchang; Xu, Xuexuan			Responses of Reactive Oxygen Scavenging Enzymes, Proline and Malondialdehyde to Water Deficits among Six Secondary Successional Seral Species in Loess Plateau	PLOS ONE			English	Article							DROUGHT STRESS; MECHANISMS; OSMOTOLERANCE; SUPPRESSION; GENOTYPES; BETAINE	Drought can impact local vegetation dynamics in a long term. In order to predict the possible successional pathway of local community under drought, the responses of some drought resistance indices of six successional seral species in the semiarid Loss Hilly Region of China were illustrated and compared on three levels of soil water deficits along three growing months (7, 8 and 9). The results showed that: 1) the six species had significant differences in SOD, POD activities and MDA content. The rank correlations between SOD, POD activities and the successional niche positions of the six species were positive, and the correlation between MDA content and the niche positions was negative; 2) activities of SOD, CAT and POD, and content of proline and MDA had significant differences among the three months; 3) there existed significant interactions of SOD, CAT, POD activities and MDA content between months and species. With an exception, no interaction of proline was found. Proline in leaves had a general decline in reproductive month; 4) SOD, CAT, POD activities and proline content had negative correlations with MDA content. Among which, the correlation between SOD activity and MDA content was significant. The results implied that, in arid or semiarid region, the species at later successional stage tend to have strong drought resistance than those at early stage. Anti-drought indices can partially interpret the pathway of community succession in the drought impacted area. SOD activity is more distinct and important on the scope of protecting membrane damage through the scavenging of ROS on exposure to drought.	[Du, Feng; Shi, Huijun; Zhang, Xingchang; Xu, Xuexuan] Northwest Sci Tech Univ Agr & Forestry, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Du, Feng; Zhang, Xingchang; Xu, Xuexuan] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Du, Feng; Zhang, Xingchang] State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Du, F (corresponding author), Northwest Sci Tech Univ Agr & Forestry, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China.	dufeng@ms.iswc.ac.cn			National Natural Science Foundation of China [41271526, 41171421]; Northwest Agriculture and Forestry University [2109021121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest Agriculture and Forestry University	This research was supported jointly by the National Natural Science Foundation of China (41271526 and 41171421), basic scientific fund of Northwest Agriculture and Forestry University (2109021121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AA, 2006, ACTIVITIES ANTIOXIDA, P187; Anderson-Teixeira KJ, 2013, GLOBAL CHANGE BIOL, V19, P2001, DOI 10.1111/gcb.12194; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; Chutipaijit S, 2011, AUST J CROP SCI, V5, P1191; Chutipaijit S, 2009, PAK J BOT, V41, P2497; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Du F, 2005, J NATURAL RESOURCES, V20, P33; Du F, 2007, COLLOID SURFACE B, V58, P278, DOI 10.1016/j.colsurfb.2007.04.002; Elizamar CDS, 2013, RESPONSES ORG WATER; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI [10.1007/978-90-481-2666-8_12, 10.1051/agro:2008021]; Gao JF, 2006, GUIDE BOT PHYSL EXPT; Grene Ruth, 2002, Arabidopsis Book, V1, pe0036, DOI 10.1199/tab.0036.1; HS Li, 2006, THEORY TECHNIQUES BO; Igarashi Y, 2000, PLANT CELL PHYSIOL, V41, P750, DOI 10.1093/pcp/41.6.750; Jiang M.Y., 1991, ACTA U AGR BOREALI O, V19, P88; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Ledger ME, 2011, GLOBAL CHANGE BIOL, V17, P2288, DOI 10.1111/j.1365-2486.2011.02420.x; Lemos JM, 2011, J AGR SCI TECHNOL B, V1, P22; LUDLOW MM, 1990, ADV AGRON, V43, P107; MacDougall AS, 2004, J ECOL, V92, P422, DOI 10.1111/j.0022-0477.2004.00886.x; Nanjo T, 1999, PLANT J, V18, P185, DOI 10.1046/j.1365-313X.1999.00438.x; Ning T., 2013, AGR SCI REV, V04, P100, DOI [10.4236/as.2013.45B019, DOI 10.4236/AS.2013.45B019]; Okuma E, 2004, SOIL SCI PLANT NUTR, V50, P1301, DOI 10.1080/00380768.2004.10408608; Okuma E, 2002, SOIL SCI PLANT NUTR, V48, P753, DOI 10.1080/00380768.2002.10409266; Ostle NJ, 2009, J ECOL, V97, P851, DOI 10.1111/j.1365-2745.2009.01547.x; Ozden M, 2009, SCI HORTIC-AMSTERDAM, V119, P163, DOI 10.1016/j.scienta.2008.07.031; PICKETT STA, 1987, BOT REV, V53, P335, DOI 10.1007/BF02858321; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; Shabala S, 2011, ADV BOT RES PLANT RE, V57, p[165, 505]; Shao HB, 2005, COLLOID SURFACE B, V42, P107, DOI 10.1016/j.colsurfb.2005.01.011; Shao HB, 2008, CR BIOL, V331, P433, DOI 10.1016/j.crvi.2008.03.011; Shao HB, 2007, COLLOID SURFACE B, V54, P143, DOI 10.1016/j.colsurfb.2006.09.004; Shipley B, 2010, PLANT TRAITS VEGETAT, P275; Sivakumar P, 2000, BIOCHEM BIOPH RES CO, V279, P512, DOI 10.1006/bbrc.2000.4005; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Tang Q., 2007, DPS DATA PROCESSING; van der Molen MK, 2011, AGR FOREST METEOROL, V151, P765, DOI 10.1016/j.agrformet.2011.01.018; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WU B-G, 1985, Acta Botanica Sinica, V27, P152; Yong T, 2006, COLLOID SURFACE B, V49, P60, DOI 10.1016/j.colsurtb.2006.02.014	44	15	22	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98872	10.1371/journal.pone.0098872	http://dx.doi.org/10.1371/journal.pone.0098872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914928	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700041
J	Honge, BL; Jespersen, S; Medina, C; Te, DD; da Silva, ZJ; Lewin, S; Ostergaard, L; Erikstrup, C; Wejse, C; Laursen, AL; Krarup, H				Honge, Bo Langhoff; Jespersen, Sanne; Medina, Candida; Te, David da Silva; da Silva, Zacarias Jose; Lewin, Sharon; Ostergaard, Lars; Erikstrup, Christian; Wejse, Christian; Laursen, Alex Lund; Krarup, Henrik		Bissau HIV Cohort Study Grp	Hepatitis B and Delta Virus Are Prevalent but Often Subclinical Co-Infections among HIV Infected Patients in Guinea-Bissau, West Africa: A Cross-Sectional Study	PLOS ONE			English	Article							CLINICAL-IMPLICATIONS; NATURAL-HISTORY; PREGNANT-WOMEN; DISEASE BURDEN; COTE-DIVOIRE; GENOTYPE-E; C VIRUS; HBV; EPIDEMIOLOGY; SEROPREVALENCE	Background: Co-infection with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) may lead to accelerated hepatic disease progression with higher rates of liver cirrhosis and liver-related mortality compared with HBV mono-infection. Co or super-infection with hepatitis Delta virus (HDV) may worsen the liver disease and complicate treatment possibilities. Methods: In this cross-sectional study we included HIV-infected individuals who had a routine blood analysis performed at an HIV clinic in Bissau, Guinea-Bissau between the 28th of April and 30th of September 2011. All patients were interviewed, had a clinical exam performed and had a blood sample stored. The patients' samples were tested for HBV and HDV serology, and HBV/HDV viral loads were analyzed using in-house real-time PCR methods. Results: In total, 576 patients (417 HIV-1, 104 HIV-2 and 55 HIV-1/2) were included in this study. Ninety-four (16.3%) patients were HBsAg positive of whom 16 (17.0%) were HBeAg positive. In multivariable logistic regression analysis, CD4 cell count <200 cells/mu l and animist religion were significantly associated with HBsAg positivity. Due to scarcity of available plasma, virological analyses were not performed for eight patients. HBV DNA was detected in 42 of 86 samples (48.8%) positive for HBsAg and genotyping was performed in 26 patients; 25 of whom had genotype E and one genotype D. Among 9 patients on antiretroviral treatment (ART), one patient had the [L180M, M204V] mutation associated with lamivudine resistance. Among the HBsAg positive patients 25.0% were also positive for anti-HDV and 4/9 (44.4%) had detectable HDV RNA. Conclusion: HBV and HDV were frequent co-infections among HIV positive patients in Guinea-Bissau and chronic infection was associated with severe immunosuppression. Lamivudine was widely used among HBsAg positive patients with the risk of developing resistant HBV.	[Honge, Bo Langhoff; Jespersen, Sanne; da Silva, Zacarias Jose; Wejse, Christian] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Honge, Bo Langhoff; Jespersen, Sanne; Ostergaard, Lars; Wejse, Christian; Laursen, Alex Lund] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Medina, Candida; Te, David da Silva] Minist Hlth, Natl HIV Programme, Bissau, Guinea Bissau; [da Silva, Zacarias Jose] Natl Publ Hlth Lab, Bissau, Guinea Bissau; [Lewin, Sharon] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Lewin, Sharon] Monash Univ, Melbourne, Vic 3004, Australia; [Lewin, Sharon] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark; [Wejse, Christian] Aarhus Univ, Sch Publ Hlth, Ctr Global Hlth, GloHAU, Aarhus, Denmark; [Krarup, Henrik] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark	Aarhus University; Florey Institute of Neuroscience & Mental Health; Monash University; Burnet Institute; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital	Honge, BL (corresponding author), Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau.	bohonge@gmail.com	Ostergaard, Lars/AAA-3020-2020; Wejse, Christian/C-8468-2014; Lewin, Sharon/Z-3297-2019	Ostergaard, Lars/0000-0003-2459-0511; Wejse, Christian/0000-0002-2534-2942; Fomsgaard, Anders/0000-0003-4304-0603; Laursen, Alex Lund/0000-0002-1206-156X; Erikstrup, Christian/0000-0001-6551-6647; Eugen-Olsen, Jesper/0000-0002-4630-4275; Sodemann, Morten/0000-0001-8992-2500; Ostergaard, Lars/0000-0002-7619-605X; Jespersen, Sanne/0000-0001-8493-2064	Bandim health project; 'Overlaege Johan Boserup og Lise Boserups Legat'; 'Aage og Johanne Louis-Hansens Fond'; 'Jacob og Olga Madsens Fond'; 'Aase og Ejnar Danielsens Fond'; Global Fund through the 'Secretariado National de Luta contra o Sida' in Guinea-Bissau; Ministry of foreign Affairs of Denmark (DANIDA); Aarhus University, Denmark; WAPHIR; IeDEA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919] Funding Source: NIH RePORTER; Lundbeck Foundation [R5-2006-359] Funding Source: researchfish	Bandim health project; 'Overlaege Johan Boserup og Lise Boserups Legat'; 'Aage og Johanne Louis-Hansens Fond'; 'Jacob og Olga Madsens Fond'; 'Aase og Ejnar Danielsens Fond'; Global Fund through the 'Secretariado National de Luta contra o Sida' in Guinea-Bissau; Ministry of foreign Affairs of Denmark (DANIDA); Aarhus University, Denmark; WAPHIR; IeDEA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Lundbeck Foundation(Lundbeckfonden)	The study was supported by the Bandim health project, 'Overlaege Johan Boserup og Lise Boserups Legat', 'Aage og Johanne Louis-Hansens Fond', 'Jacob og Olga Madsens Fond' and 'Aase og Ejnar Danielsens Fond'. The Global Fund to Fight AIDS, TB and Malaria (Global Fund) supported the data collection during 2009-2013 through the 'Secretariado National de Luta contra o Sida' in Guinea-Bissau. The Ministry of foreign Affairs of Denmark (DANIDA) provided a travel grant for BLH. Aarhus University, Denmark supported a one year scholarship for BLH. Abbott provided serology reagents. WAPHIR and IeDEA supported data collection in Bissau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; BACHA A, 1990, J INFECT DIS, V161, P150, DOI 10.1093/infdis/161.1.150; Bado G, 2013, MED MALADIES INFECT, V43, P202, DOI 10.1016/j.medmal.2013.04.001; Bani-Sadr F, 2003, AM J MED, V114, P768, DOI 10.1016/S0002-9343(03)00156-6; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; BODSWORTH N, 1989, J INFECT DIS, V160, P577, DOI 10.1093/infdis/160.4.577; Borresen ML, 2010, J VIRAL HEPATITIS, V17, P162, DOI 10.1111/j.1365-2893.2009.01159.x; Boyd A, 2010, J VIRAL HEPATITIS, V17, P65, DOI 10.1111/j.1365-2893.2009.01153.x; da Silva ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0b013e328300a33d; Diop-Ndiaye H, 2008, J MED VIROL, V80, P1332, DOI 10.1002/jmv.21236; Dumpis U, 2001, J HEPATOL, V35, P99, DOI 10.1016/S0168-8278(01)00064-2; Dupinay T, 2010, J MED VIROL, V82, P1515, DOI 10.1002/jmv.21865; Farci P, 2003, J HEPATOL, V39, pS212, DOI 10.1016/S0168-8278(03)00331-3; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hamers RL, 2013, JAIDS-J ACQ IMM DEF, V64, P174, DOI 10.1097/QAI.0b013e3182a60f7d; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Honge BL, 2013, J ACQ IMMUN DEF SYND, V65, P87; Honge BL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003499; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Idoko J, 2009, CLIN INFECT DIS, V49, P1268, DOI 10.1086/605675; Jobarteh M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-230; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Krarup H, 2011, SCAND J GASTROENTERO, V46, P1484, DOI 10.3109/00365521.2011.619273; Krarup HB, 2008, SCAND J GASTROENTERO, V43, P334, DOI 10.1080/00365520701712198; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Le Gal F, 2006, EMERG INFECT DIS, V12, P1447, DOI 10.3201/eid1209.060112; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Lunel-Fabiani F, 2013, J INFECTION, V67, P448, DOI 10.1016/j.jinf.2013.06.008; Mansour W, 2012, J MED VIROL, V84, P1186, DOI 10.1002/jmv.23336; Matthews GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061297; Mirandola S, 2011, J VIRAL HEPATITIS, V18, pE212, DOI 10.1111/j.1365-2893.2011.01435.x; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; Nguyen T, 2010, J HEPATOL, V52, P508, DOI 10.1016/j.jhep.2010.01.007; Onyekwere CA, 2012, INDIAN J GASTROENTER, V31, P34, DOI 10.1007/s12664-011-0158-9; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pastor R, 2009, WORLD J GASTROENTERO, V15, P753, DOI 10.3748/wjg.15.753; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; Rouet F, 2004, J MED VIROL, V74, P34, DOI 10.1002/jmv.20143; Rowland-Jones SL, 2007, NAT IMMUNOL, V8, P329, DOI 10.1038/ni0407-329; Sagoe KWC, 2012, J MED VIROL, V84, P6, DOI 10.1002/jmv.22262; Soriano V, 2005, AIDS, V19, P221, DOI 10.1097/01.aids.0000192093.46506.e5; Stewart Balint, 2011, BMC Res Notes, V4, P561, DOI 10.1186/1756-0500-4-561; Suzuki S, 2003, J MED VIROL, V69, P459, DOI 10.1002/jmv.10331; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205	47	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99971	10.1371/journal.pone.0099971	http://dx.doi.org/10.1371/journal.pone.0099971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915064	Green Submitted, gold, Green Published			2022-12-25	WOS:000340947700141
J	Le Roux, C; Del Prete, S; Boutet-Mercey, S; Perreau, F; Balague, C; Roby, D; Fagard, M; Gaudin, V				Le Roux, Clementine; Del Prete, Stefania; Boutet-Mercey, Stephanie; Perreau, Francois; Balague, Claudine; Roby, Dominique; Fagard, Mathilde; Gaudin, Valerie			The hnRNP-Q Protein LIF2 Participates in the Plant Immune Response	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; SALICYLIC-ACID; ARABIDOPSIS-THALIANA; BOTRYTIS-CINEREA; SCLEROTINIA-SCLEROTIORUM; DEFENSE RESPONSES; SIGNALING PATHWAYS; DISEASE RESISTANCE; III EFFECTOR; BINDING	Eukaryotes have evolved complex defense pathways to combat invading pathogens. Here, we investigated the role of the Arabidopsis thaliana heterogeneous nuclear ribonucleoprotein (hnRNP-Q) LIF2 in the plant innate immune response. We show that LIF2 loss-of-function in A. thaliana leads to changes in the basal expression of the salicylic acid (SA)- and jasmonic acid (JA)- dependent defense marker genes PR1 and PDF1.2, respectively. Whereas the expression of genes involved in SA and JA biosynthesis and signaling was also affected in the lif2-1 mutant, no change in SA and JA hormonal contents was detected. In addition, the composition of glucosinolates, a class of defense-related secondary metabolites, was altered in the lif2-1 mutant in the absence of pathogen challenge. The lif2-1 mutant exhibited reduced susceptibility to the hemi-biotrophic pathogen Pseudomonas syringae and the necrotrophic ascomycete Botrytis cinerea. Furthermore, the lif2-1 sid2-2 double mutant was less susceptible than the wild type to P. syringae infection, suggesting that the lif2 response to pathogens was independent of SA accumulation. Together, our data suggest that lif2-1 exhibits a basal primed defense state, resulting from complex deregulation of gene expression, which leads to increased resistance to pathogens with various infection strategies. Therefore, LIF2 may function as a suppressor of cell-autonomous immunity. Similar to its human homolog, NSAP1/SYNCRIP, a trans-acting factor involved in both cellular processes and the viral life cycle, LIF2 may regulate the conflicting aspects of development and defense programs, suggesting that a conserved evolutionary trade-off between growth and defense pathways exists in eukaryotes.	[Le Roux, Clementine; Del Prete, Stefania; Boutet-Mercey, Stephanie; Perreau, Francois; Fagard, Mathilde; Gaudin, Valerie] INRA AgroParisTech, UMR1318, Inst JP Bourgin, Ctr Versailles Grignon, Versailles, France; [Balague, Claudine; Roby, Dominique] INRA, Lab Interact Plantes Microorganismes, UMR441, F-31326 Castanet Tolosan, France; [Balague, Claudine; Roby, Dominique] CNRS, Lab Interact Plantes Microorganismes, UMR2594, Castanet Tolosan, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse	Gaudin, V (corresponding author), INRA AgroParisTech, UMR1318, Inst JP Bourgin, Ctr Versailles Grignon, Versailles, France.	valerie.gaudin@versailles.inra.fr	Del Prete, Stefania/AAS-4710-2020; Le Roux, Clementine/B-4761-2018	Del Prete, Stefania/0000-0002-1806-1819; Perreau, Francois/0000-0001-7873-9866; Gaudin, Valerie/0000-0002-1356-5567; Le Roux, Clementine/0000-0003-1689-6211	INRA CJS; European Commission [316965]; ANR from the French Research Ministry [ANR/08/BLAN-0200]; INRA	INRA CJS; European Commission(European CommissionEuropean Commission Joint Research Centre); ANR from the French Research Ministry(French National Research Agency (ANR)); INRA	CLR was supported by an INRA CJS PhD fellowship. SDP was supported by PhD fellowships provided by the European Commission Seventh Framework-People-2012-ITN project EpiTRAITS (Epigenetic regulation of economically important plant traits, no-316965). Furthermore, this work was supported by the ANR (ANR/08/BLAN-0200) from the French Research Ministry and by INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Alcazar R, 2011, CURR OPIN PLANT BIOL, V14, P378, DOI 10.1016/j.pbi.2011.04.001; Alvarez-Venegas R, 2007, EPIGENETICS-US, V2, P106, DOI 10.4161/epi.2.2.4404; Ambrosone A, 2012, PLANT SCI, V182, P12, DOI 10.1016/j.plantsci.2011.02.004; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Antico Christopher J, 2012, [Frontiers in Biology, 生物学前沿], V7, P48; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Berr A, 2010, PLANT PHYSIOL, V154, P1403, DOI 10.1104/pp.110.161497; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Busch A, 2012, WIRES RNA, V3, P1, DOI 10.1002/wrna.100; Chaouch S, 2010, PLANT PHYSIOL, V153, P1692, DOI 10.1104/pp.110.153957; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen ZX, 2009, PLANT SIGNAL BEHAV, V4, P493, DOI 10.4161/psb.4.6.8392; Choi KC, 2004, J VIROL, V78, P13153, DOI 10.1128/JVI.78.23.13153-13162.2004; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; DEBENER T, 1991, PLANT J, V1, P289, DOI 10.1046/j.1365-313X.1991.t01-7-00999.x; DeFraia CT, 2010, PLANT J, V64, P511, DOI 10.1111/j.1365-313X.2010.04345.x; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Denance N, 2013, PLANT J, V73, P225, DOI 10.1111/tpj.12027; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Durrant WE, 2007, P NATL ACAD SCI USA, V104, P4223, DOI 10.1073/pnas.0609357104; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Guo XM, 2007, MOL PLANT MICROBE IN, V20, P1384, DOI 10.1094/MPMI-20-11-1384; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Jeong BR, 2011, J BIOL CHEM, V286, P43272, DOI 10.1074/jbc.M111.290122; Jirage D, 2001, PLANT J, V26, P395, DOI 10.1046/j.1365-313X.2001.2641040.x; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kim JH, 2004, PLANT MOL BIOL, V54, P671, DOI 10.1023/B:PLAN.0000040897.49151.98; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; La Camera S, 2011, PLANT J, V68, P507, DOI 10.1111/j.1365-313X.2011.04706.x; Latrasse D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016592; Lee DH, 2012, PLANT J, V72, P235, DOI 10.1111/j.1365-313X.2012.05063.x; Lee KC, 2006, ANAL BIOANAL CHEM, V386, P2225, DOI 10.1007/s00216-006-0882-7; Liu HM, 2009, VIROLOGY, V386, P249, DOI 10.1016/j.virol.2009.01.018; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Ludwig-Muller J, 1999, PLANTA, V208, P409, DOI 10.1007/s004250050576; Ma KW, 2011, PLANT PHYSIOL, V157, P535, DOI 10.1104/pp.111.182295; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; March-Diaz R, 2008, PLANT J, V53, P475, DOI 10.1111/j.1365-313X.2007.03361.x; McCarty MF, 2006, INTEGR CANCER THER, V5, P252, DOI 10.1177/1534735406291499; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Morcx S, 2013, FUNGAL GENET BIOL, V52, P1, DOI 10.1016/j.fgb.2012.11.011; Moumen A, 2013, CELL CYCLE, V12, P698, DOI 10.4161/cc.23592; Nakaminami K, 2012, BBA-GENE REGUL MECH, V1819, P149, DOI 10.1016/j.bbagrm.2011.07.015; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Palma K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001137; Park SM, 2011, NUCLEIC ACIDS RES, V39, P7791, DOI 10.1093/nar/gkr509; Perchepied L, 2010, MOL PLANT MICROBE IN, V23, P846, DOI 10.1094/MPMI-23-7-0846; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qi YP, 2010, MOL PLANT MICROBE IN, V23, P1573, DOI 10.1094/MPMI-05-10-0106; Ramirez V, 2011, PLANT PHYSIOL, V155, P1920, DOI 10.1104/pp.110.171843; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Schweizer F, 2013, PLANT CELL, V25, P3117, DOI 10.1105/tpc.113.115139; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Staiger D, 2013, NEW PHYTOL, V197, P394, DOI 10.1111/nph.12022; Stotz HU, 2011, PLANT CELL PHYSIOL, V52, P1941, DOI 10.1093/pcp/pcr127; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Wang CZ, 2010, PLANT CELL PHYSIOL, V51, P1291, DOI 10.1093/pcp/pcq087; Ward JL, 2010, PLANT J, V63, P443, DOI 10.1111/j.1365-313X.2010.04254.x; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Winter CM, 2011, DEV CELL, V20, P430, DOI 10.1016/j.devcel.2011.03.019; Wittstock U., 2010, Arabidopsis Book, V8, pe0134, DOI 10.1199/tab.0134; Woloshen V, 2011, J PATHOG, V2011, DOI 10.4061/2011/278697; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yang HJ, 2007, PLANT PHYSIOL, V145, P135, DOI 10.1104/pp.107.100800; Zhang A, 2013, CELL RES, V23, P340, DOI 10.1038/cr.2012.164; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zhang YL, 2005, CURR BIOL, V15, P1936, DOI 10.1016/j.cub.2005.09.038; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	92	35	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99343	10.1371/journal.pone.0099343	http://dx.doi.org/10.1371/journal.pone.0099343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914891	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700086
J	Xiong, G; Zhang, B; Huang, MY; Zhou, HF; Chen, LZ; Feng, QS; Luo, X; Lin, HJ; Zeng, YX				Xiong, Geng; Zhang, Bo; Huang, Mu-yun; Zhou, Hufeng; Chen, Li-Zhen; Feng, Qi-Sheng; Luo, Xi; Lin, Hui-jia; Zeng, Yi-xin			Epstein-Barr Virus (EBV) Infection in Chinese Children: A Retrospective Study of Age-Specific Prevalence	PLOS ONE			English	Article								Background: Epstein-Barr Virus (EBV) is a globally prevalent herpesvirus associated with infectious mononucleosis and many malignancies. The survey on EBV prevalence appears to be important to study EBV-related diseases and determine when to administer prophylactic vaccine. The purpose of this retrospective study was to collect baseline information about the prevalence of EBV infection in Chinese children. Methodology/Principal Finding: We collected 1778 serum samples from healthy children aged 0 to 10, who were enrolled in conventional health and nutrition examinations without any EBV-related symptom in 2012 and 2013 in North China (n = 973) and South China (n = 805). We detected four EBV-specific antibodies, i.e., anti-VCA-IgG and IgM, anti-EBNA-IgG and anti-EA-IgG, by ELISA, representing all of the phases of EBV infection. The overall EBV seroprevalence in samples from North and South China were 80.78% and 79.38% respectively. The EBV seropositivity rates dropped slightly at age 2, and then increased gradually with age. The seroprevalence became stabilized at over 90% after age 8. In this study, the seroprevalence trends between North and South China showed no difference (P > 0.05), and the trends of average antibody concentrations were similar as well (P > 0.05). Conclusions/Significance: EBV seroprevalence became more than 50% before age 3 in Chinese children, and exceed 90% after age 8. This study can be helpful to study the relationship between EBV and EBV-associated diseases, and supportive to EBV vaccine development and implementation.	[Xiong, Geng; Huang, Mu-yun; Chen, Li-Zhen; Feng, Qi-Sheng; Zeng, Yi-xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Bo] Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China; [Zhou, Hufeng] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Zhou, Hufeng] Harvard Univ, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Luo, Xi] Guangzhou Women & Childrens Med Ctr, Dept Otorhinolaryngol, Guangzhou, Guangdong, Peoples R China; [Lin, Hui-jia] Guangdong Women & Childrens Hosp, Neonatal Intens Care Unit, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Harvard University; Brigham & Women's Hospital; Harvard University	Xiong, G (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China.	xionggeng@sysucc.org.cn; zengyix@mail.sysu.edu.cn	Zhou, Hufeng/M-1307-2014	Zhou, Hufeng/0000-0001-9382-5674				Adams M, 2007, VACCINE, V25, P3007, DOI 10.1016/j.vaccine.2007.01.016; Bagni R, 2012, J INFECT DIS, V205, P873, DOI 10.1093/infdis/jir871; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Balfour HH, 2013, J INFECT DIS, V207, P1787, DOI 10.1093/infdis/jit096; Bauer G, 2001, Clin Lab, V47, P223; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Cohen JI, 2013, VACCINE, V31, pB194, DOI 10.1016/j.vaccine.2012.09.041; de The G, 1975, Bibl Haematol, P216; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; Dowd JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064921; Gao YN, 2002, ONCOGENE, V21, P825, DOI 10.1038/sj.onc.1205130; Hess RD, 2004, J CLIN MICROBIOL, V42, P3381, DOI 10.1128/JCM.42.8.3381-3387.2004; Hjalgrim H, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P929; Huang Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-55; Koidl C, 2011, WIEN KLIN WOCHENSCHR, V123, P230, DOI 10.1007/s00508-011-1561-z; Liu P, 2011, J VIROL, V85, P11291, DOI 10.1128/JVI.00823-11; Macsween KF, 2003, LANCET INFECT DIS, V3, P131, DOI 10.1016/S1473-3099(03)00543-7; Morris MC, 2002, J MED VIROL, V67, P522, DOI 10.1002/jmv.10132; Murata T, 2014, REV MED VIROLOGY; PEARSON GR, 1988, J VIROL METHODS, V21, P97, DOI 10.1016/0166-0934(88)90056-0; Raab-Traub N, 1997, Oral Dis, V3 Suppl 1, pS164; Rea TD, 2002, AM J CLIN PATHOL, V117, P156; Robertson P, 2003, J MED VIROL, V70, P617, DOI 10.1002/jmv.10439; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Wang X, 1998, J VIROL, V72, P5552, DOI 10.1128/JVI.72.7.5552-5558.1998; Zeng MS, 2005, J VIROL, V79, P15323, DOI 10.1128/JVI.79.24.15323-15330.2005; Zou Xiaonong, 1992, Chinese Medical Sciences Journal, V7, P201; ZOU XN, 1994, INT J CANCER, V59, P155, DOI 10.1002/ijc.2910590202	28	44	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99857	10.1371/journal.pone.0099857	http://dx.doi.org/10.1371/journal.pone.0099857			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914816	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700139
J	Zhang, GH; Yuan, ZJ; Zhang, CX; Yin, KS; Tang, MJ; Guo, HW; Fu, JY; Xiao, Q				Zhang, Gui-Hua; Yuan, Zhi-Jun; Zhang, Chuan-Xi; Yin, Kun-Shan; Tang, Mei-Jun; Guo, Hua-Wei; Fu, Jian-Yu; Xiao, Qiang			Detecting Deep Divergence in Seventeen Populations of Tea Geometrid (Ectropis obliqua Prout) in China by COI mtDNA and Cross-Breeding	PLOS ONE			English	Article							DNA; LEPIDOPTERA; INSECT; ALEYRODIDAE; APHELINIDAE; HYMENOPTERA; RESISTANCE; HEMIPTERA; SEQUENCES; SOFTWARE	The tea geometrid (Ectropis obliqua Prout, Lepidoptera: Geometridae) is a dominant chewing insect endemic in most tea-growing areas in China. Recently some E. obliqua populations have been found to be resistant to the nucleopolyhedrovirus (EoNPV), a host-specific virus that has so far been found only in E. obliqua. Although the resistant populations are morphologically indistinguishable from susceptible populations, we conducted a nationwide collection and examined the genetic divergence in the COI region of the mtDNA in E. obliqua. Phylogenetic analyses of mtDNA in 17 populations revealed two divergent clades with genetic distance greater than 3.7% between clades and less than 0.7% within clades. Therefore, we suggest that E. obliqua falls into two distinct groups. Further inheritance analyses using reciprocal single-pair mating showed an abnormal F-1 generation with an unbalanced sex ratio and the inability to produce fertile eggs (or any eggs) through F1 self-crossing. These data revealed a potential cryptic species complex with deep divergence and reproductive isolation within E. obliqua. Uneven distribution of the groups suggests a possible geographic effect on the divergence. Future investigations will be conducted to examine whether EoNPV selection or other factors prompted the evolution of resistance.	[Zhang, Gui-Hua; Yuan, Zhi-Jun; Yin, Kun-Shan; Tang, Mei-Jun; Guo, Hua-Wei; Fu, Jian-Yu; Xiao, Qiang] Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Plants Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China; [Zhang, Chuan-Xi] Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Zhejiang University	Fu, JY (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Plants Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China.	mybatigoal@mail.tricaas.com; xqtea@mail.tricaas.com	zhang, guihua/GVU-4494-2022; Zhang, Chuan-Xi/K-7978-2019	Zhang, Chuan-Xi/0000-0002-7784-1188	National Science and Technology Support Program Projects [2011BAD01B02]; Fundamental Research Funds of National Science and Technology [2013FY113200]; Key Innovation Team of Zhejiang Province [2011R09027-13]; National Natural Science Foundation of China [31100503]; public technology application research of Zhejiang Province [2013C32086]	National Science and Technology Support Program Projects; Fundamental Research Funds of National Science and Technology; Key Innovation Team of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); public technology application research of Zhejiang Province	This work was supported by the National Science and Technology Support Program Projects (2011BAD01B02), the Fundamental Research Funds of National Science and Technology (2013FY113200), the Key Innovation Team of Zhejiang Province (Grant No. 2011R09027-13), the National Natural Science Foundation of China (Grant No. 31100503) and the public technology application research of Zhejiang Province (2013C32086). The funders had no role in study design, samples collection and data analysis, decision to publish, or manuscript preparation.	Asser-Kaiser S, 2007, SCIENCE, V317, P1916, DOI 10.1126/science.1146542; Behere Gajanan T., 2007, BMC Evolutionary Biology, V7; Beltran M, 2002, MOL BIOL EVOL, V19, P2176, DOI 10.1093/oxfordjournals.molbev.a004042; Blair CP, 2005, EVOLUTION, V59, P304; Boykin LM, 2006, B ENTOMOL RES, V96, P457, DOI 10.1079/BER2006438; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Doak P, 2000, ECOLOGY, V81, P1828, DOI 10.1890/0012-9658(2000)081[1828:PCORDF]2.0.CO;2; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Hazarika LK, 2009, ANNU REV ENTOMOL, V54, P267, DOI 10.1146/annurev.ento.53.103106.093359; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Monti MM, 2005, B ENTOMOL RES, V95, P401, DOI 10.1079/BER2005371; Navajas M, 2001, B ENTOMOL RES, V91, P117; Ndo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058862; Pages N, 2009, VET PARASITOL, V165, P298, DOI 10.1016/j.vetpar.2009.07.020; Polaszek A, 2004, ZOOL SCR, V33, P403, DOI 10.1111/j.0300-3256.2004.00161.x; Prout LB, 1912, MACROLEPIDOPTERA WOR, V4, P1; PROUT LOUIS B., 1930, NOVITATES ZOOL [TRING], V35, P289; Qin Li, 2013, Acta Entomologica Sinica, V56, P186; Saha D, 2013, INT J TROP INSECT SC, V33, P46, DOI 10.1017/S1742758412000380; Scoble M, ONLINE LIST VALID AV; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Sourassou NF, 2012, EXP APPL ACAROL, V57, P15, DOI 10.1007/s10493-012-9534-0; Sperling FAH, 1999, INSECT MOL BIOL, V8, P97, DOI 10.1046/j.1365-2583.1999.810097.x; Warren W., 1894, Novitates Zoologicae, Vi, P366; Xi Yu, 2011, Journal of Tea Science, V31, P100; Ye GY, 2014, BIOL CONTROL, V68, P73, DOI 10.1016/j.biocontrol.2013.06.013; Yin Xian-Bing, 2007, Acta Entomologica Sinica, V50, P1263; Zhang HH, 2004, TEA PESTS NONPOLLUTI, P3	34	33	50	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99373	10.1371/journal.pone.0099373	http://dx.doi.org/10.1371/journal.pone.0099373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915522	gold, Green Submitted, Green Published			2022-12-25	WOS:000340947700091
J	Baboo, S; Bhushan, B; Jiang, HB; Grovenor, CRM; Pierre, P; Davis, BG; Cook, PR				Baboo, Sabyasachi; Bhushan, Bhaskar; Jiang, Haibo; Grovenor, Chris R. M.; Pierre, Philippe; Davis, Benjamin G.; Cook, Peter R.			Most Human Proteins Made in Both Nucleus and Cytoplasm Turn Over within Minutes	PLOS ONE			English	Article							TRANSLATION INITIATION; MASS-SPECTROMETRY; IN-VIVO; TRANSCRIPTION; DEGRADATION; CELLS; VISUALIZATION; MECHANISM; PEPTIDES; REVEALS	In bacteria, protein synthesis can be coupled to transcription, but in eukaryotes it is believed to occur solely in the cytoplasm. Using pulses as short as 5 s, we find that three analogues -L-azidohomoalanine, puromycin (detected after attaching fluors using 'click' chemistry or immuno-labeling), and amino acids tagged with 'heavy' N-15 and C-13 (detected using secondary ion mass spectrometry) -are incorporated into the nucleus and cytoplasm in a process sensitive to translational inhibitors. The nuclear incorporation represents a significant fraction of the total, and labels in both compartments have half-lives of less than a minute; results are consistent with most newly-made peptides being destroyed soon after they are made. As nascent RNA bearing a premature termination codon (detected by fluorescence in situ hybridization) is also eliminated by a mechanism sensitive to a translational inhibitor, the nuclear turnover of peptides is probably a by-product of proof-reading the RNA for stop codons (a process known as nonsense-mediated decay). We speculate that the apparently-wasteful turnover of this previously-hidden ('dark-matter') world of peptide is involved in regulating protein production.	[Baboo, Sabyasachi; Cook, Peter R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Bhushan, Bhaskar; Davis, Benjamin G.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Jiang, Haibo; Grovenor, Chris R. M.] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Pierre, Philippe] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France; [Pierre, Philippe] INSERM, U1104, F-13258 Marseille, France; [Pierre, Philippe] CNRS, Unites Mixtes Rech 7280, Marseille, France	University of Oxford; University of Oxford; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Cook, PR (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	peter.cook@path.ox.ac.uk	Davis, Benjamin G/C-5281-2011; Jiang, Haibo/E-6623-2015	Davis, Benjamin G/0000-0002-5056-407X; Jiang, Haibo/0000-0002-2384-4826; Bhushan, Bhaskar/0000-0001-6136-8616; pierre, philippe/0000-0003-0863-8255; Cook, Peter/0000-0002-6639-188X; Baboo, Sabyasachi/0000-0002-4547-5160	Felix Scholarship Trust of Oxford University; Sir William Dunn School of Pathology; Rhodes Scholarship; China Scholarship Council; BBSRC [BB/E004350/1] Funding Source: UKRI; EPSRC [EP/G026688/1, EP/E000614/1, EP/E036384/1, EP/I500200/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C510824/1, BB/E004350/1, EGA17763] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I500200/1, GR/T19797/01, EP/G026688/1, GR/T26542/01, EP/E000614/1, EP/E036384/1, EP/D023343/1, EP/D023335/1] Funding Source: researchfish	Felix Scholarship Trust of Oxford University; Sir William Dunn School of Pathology; Rhodes Scholarship; China Scholarship Council(China Scholarship Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	SB was supported by the Felix Scholarship Trust of Oxford University and The Sir William Dunn School of Pathology, BB is supported by a Rhodes Scholarship, and HJ by The China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Jubran K, 2013, RNA, V19, P1669, DOI 10.1261/rna.038356.113; Apcher S, 2013, P NATL ACAD SCI USA, V110, P17951, DOI 10.1073/pnas.1309956110; Apcher S, 2012, CURR OPIN IMMUNOL, V24, P71, DOI 10.1016/j.coi.2012.01.007; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Boxer SG, 2009, ANNU REV BIOPHYS, V38, P53, DOI 10.1146/annurev.biophys.050708.133634; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Catic A, 2013, CELL, V155, P1380, DOI 10.1016/j.cell.2013.11.016; Dahlberg J, 2012, NUCLEUS-PHILA, V3, P320, DOI 10.4161/nucl.20754; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; GOIDL JA, 1978, TRENDS BIOCHEM SCI, V3, pN225; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; GREENBERG NA, 1979, J FOOD SCI, V44, P735, DOI 10.1111/j.1365-2621.1979.tb08487.x; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; HARRIS H, 1994, TRENDS BIOCHEM SCI, V19, P303, DOI 10.1016/0968-0004(94)90011-6; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hinz FI, 2012, ACS CHEM NEUROSCI, V3, P40, DOI 10.1021/cn2000876; Iborra FJ, 2004, J CELL SCI, V117, P899, DOI 10.1242/jcs.00933; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kapranov Philipp, 2012, Frontiers in Genetics, V3, P60, DOI 10.3389/fgene.2012.00060; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Maquat LE, 2002, GENE DEV, V16, P1743, DOI 10.1101/gad.1014502; McMahon G, 2006, J AM SOC MASS SPECTR, V17, P1181, DOI 10.1016/j.jasms.2006.04.031; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; NIELSEN PJ, 1980, J CELL PHYSIOL, V104, P269, DOI 10.1002/jcp.1041040302; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Papantonis A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000419; REDMAN CM, 1966, P NATL ACAD SCI USA, V56, P608, DOI 10.1073/pnas.56.2.608; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; SIUTAMANGANO P, 1981, J BIOL CHEM, V256, P2094; Szychowski J, 2010, J AM CHEM SOC, V132, P18351, DOI 10.1021/ja1083909; Tom Dieck Susanne, 2012, Curr Protoc Cell Biol, VChapter 7, DOI 10.1002/0471143030.cb0711s56; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; van Kasteren SI, 2007, NATURE, V446, P1105, DOI 10.1038/nature05757; WHEATLEY DN, 1980, CELL BIOL INT REP, V4, P1081, DOI 10.1016/0309-1651(80)90045-4; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 2013, P NATL ACAD SCI USA, V110, P17612, DOI 10.1073/pnas.1318259110	50	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99346	10.1371/journal.pone.0099346	http://dx.doi.org/10.1371/journal.pone.0099346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911415	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600075
J	Williams-Bey, Y; Boularan, C; Vural, A; Huang, NN; Hwang, IY; Shan-Shi, C; Kehrl, JH				Williams-Bey, Yolanda; Boularan, Cedric; Vural, Ali; Huang, Ning-Na; Hwang, Il-Young; Shan-Shi, Chong; Kehrl, John H.			Omega-3 Free Fatty Acids Suppress Macrophage Inflammasome Activation by Inhibiting NF-kappa B Activation and Enhancing Autophagy	PLOS ONE			English	Article							RECEPTORS; SIGNALS; CELLS; GPR120	The omega-3 (omega 3) fatty acid docosahexaenoic acid (DHA) can suppress inflammation, specifically IL-1 beta production through poorly understood molecular mechanisms. Here, we show that DHA reduces macrophage IL-1 beta production by limiting inflammasome activation. Exposure to DHA reduced IL-1 beta production by ligands that stimulate the NLRP3, AIM2, and NAIP5/NLRC4 inflammasomes. The inhibition required Free Fatty Acid Receptor (FFAR) 4 (also known as GPR120), a G-protein coupled receptor (GPR) known to bind DHA. The exposure of cells to DHA recruited the adapter protein beta-arrestin1/2 to FFAR4, but not to a related lipid receptor. DHA treatment reduced the initial inflammasome priming step by suppressing the nuclear translocation of NF-kB. DHA also reduced IL-1 beta levels by enhancing autophagy in the cells. As a consequence macrophages derived from mice lacking the essential autophagy protein ATG7 were partially resistant to suppressive effects of DHA. Thus, DHA suppresses inflammasome activation by two distinct mechanisms, inhibiting the initial priming step and by augmenting autophagy, which limits inflammasome activity.	[Williams-Bey, Yolanda; Boularan, Cedric; Vural, Ali; Huang, Ning-Na; Hwang, Il-Young; Shan-Shi, Chong; Kehrl, John H.] NIAID, B Cell Mol Immunol Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kehrl, JH (corresponding author), NIAID, B Cell Mol Immunol Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA.	jkehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	Intramural Research Program of the National Institutes of Health [National Institute of Allergy and Infectious Diseases]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000739] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health [National Institute of Allergy and Infectious Diseases](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health [National Institute of Allergy and Infectious Diseases]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Decuypere JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061020; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Jing K, 2011, AUTOPHAGY, V7, P1348, DOI 10.4161/auto.7.11.16658; Kiecolt-Glaser JK, 2012, BRAIN BEHAV IMMUN, V26, P988, DOI 10.1016/j.bbi.2012.05.011; Luttrell LM, 2002, J CELL SCI, V115, P455; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Nasti TH, 2012, PHOTOCHEM PHOTOBIOL, V88, P1111, DOI 10.1111/j.1751-1097.2012.01182.x; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shin S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/568671; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; Yonezawa T, 2013, CURR MED CHEM, V20, P3855	18	148	155	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e97957	10.1371/journal.pone.0097957	http://dx.doi.org/10.1371/journal.pone.0097957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911523	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600126
J	Liu, X; Song, ZW; Huo, YD; Zhang, JH; Zhu, TG; Wang, JY; Zhao, XN; Aikhionbare, F; Zhang, JC; Duan, HQ; Wu, JH; Dou, Z; Shi, YY; Yao, XB				Liu, Xing; Song, Zhenwei; Huo, Yuda; Zhang, Jiahai; Zhu, Tongge; Wang, Jianyu; Zhao, Xuannv; Aikhionbare, Felix; Zhang, Jiancun; Duan, Hequan; Wu, Jihui; Dou, Zhen; Shi, Yunyu; Yao, Xuebiao			Chromatin Protein HP1 alpha Interacts with the Mitotic Regulator Borealin Protein and Specifies the Centromere Localization of the Chromosomal Passenger Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE AURORA B; CELL-DIVISION; PHOSPHORYLATION; SURVIVIN; SPINDLE; HP1; INCENP; HETEROCHROMATIN; MITOSIS; KINETOCHORE	Accurate mitosis requires the chromosomal passenger protein complex (CPC) containing Aurora B kinase, borealin, INCENP, and survivin, which orchestrates chromosome dynamics. However, the chromatin factors that specify the CPC to the centromere remain elusive. Here we show that borealin interacts directly with heterochromatin protein 1 alpha (HP1 alpha) and that this interaction is mediated by an evolutionarily conserved PXVXL motif in the C-terminal borealin with the chromo shadow domain of HP1 alpha. This borealin-HP1 alpha interaction recruits the CPC to the centromere and governs an activation of Aurora B kinase judged by phosphorylation of Ser-7 in CENP-A, a substrate of Aurora B. Consistently, modulation of the motif PXVXL leads to defects in CPC centromere targeting and aberrant Aurora B activity. On the other hand, the localization of the CPC in the midzone is independent of the borealin-HP1 alpha interaction, demonstrating the spatial requirement of HP1 alpha in CPC localization to the centromere. These findings reveal a previously unrecognized but direct link between HP1 alpha and CPC localization in the centromere and illustrate the critical role of borealin-HP1 alpha interaction in orchestrating an accurate cell division.	[Liu, Xing; Huo, Yuda; Zhu, Tongge; Wang, Jianyu; Zhao, Xuannv; Duan, Hequan; Dou, Zhen; Yao, Xuebiao] Univ Sci & Technol China, Sch Life Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Anhui, Peoples R China; [Liu, Xing; Song, Zhenwei; Huo, Yuda; Zhang, Jiahai; Zhu, Tongge; Zhao, Xuannv; Wu, Jihui; Dou, Zhen; Shi, Yunyu; Yao, Xuebiao] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Nanoscale, Hefei 230026, Anhui, Peoples R China; [Liu, Xing; Zhu, Tongge; Aikhionbare, Felix; Duan, Hequan] Morehouse Sch Med, Mol Imaging Ctr, Atlanta, GA 30310 USA; [Zhang, Jiancun] Guangzhou Inst Biomed Hlth, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Yao, XB (corresponding author), Univ Sci & Technol China, Sch Life Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Anhui, Peoples R China.	yaoxb@ustc.edu.cn	Song, Zhenwei/W-6191-2019; Liu, Xing/H-2989-2018; Yao, Xuebiao/P-5771-2014; DOU, ZHEN/N-2022-2013	Liu, Xing/0000-0002-7480-5085; DOU, ZHEN/0000-0003-3303-9393; Song, Zhenwei/0000-0002-9679-5113	National Institutes of Health [DK56292, CA164133, 8G12MD007602, G12RR03034]; Chinese 973 Project [2010CB912103, 2012CB917204, 2013CB911203]; Chinese Academy of Sciences [KSCX1-YW-R-65, KSCX2-YW-R-195]; Chinese Natural Science Foundation [91313303, 31320103904, 90508002, 91129714, 81270466, 31271518, 31371363, 90913016]; China Fellowship [2012M510210]; Fundamental Research Funds for Central Universities [WK2340000032, WK2060190018];  [MOST 2009DFA31010];  [MOE 20113402130010];  [IRT13038]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007602, S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Fellowship; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, 8G12MD007602, and G12RR03034. This work was also supported by Chinese 973 Project Grants 2010CB912103, 2012CB917204, and 2013CB911203; by Chinese Academy of Sciences Grants KSCX1-YW-R-65 and KSCX2-YW-R-195; by Grant MOST 2009DFA31010; by Grants MOE 20113402130010 and IRT13038; by Chinese Natural Science Foundation Grants 91313303, 31320103904, 90508002, 91129714, 81270466, 31271518, 31371363, and 90913016; by China Fellowship 2012M510210; and by Fundamental Research Funds for Central Universities Grants WK2340000032 and WK2060190018.	Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; Chu LL, 2012, J MOL CELL BIOL, V4, P331, DOI 10.1093/jmcb/mjs023; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kang J, 2011, MOL BIOL CELL, V22, P1181, DOI 10.1091/mbc.E11-01-0009; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Qiu Y, 2012, GENE DEV, V26, P1376, DOI 10.1101/gad.188359.112; Ren J, 2010, NUCLEIC ACIDS RES, V38, pD155, DOI 10.1093/nar/gkp784; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Tsukahara T, 2010, NATURE, V467, P719, DOI 10.1038/nature09390; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200; Yuan K, 2009, J BIOL CHEM, V284, P23072, DOI 10.1074/jbc.M109.001990; Zhu TG, 2013, J BIOL CHEM, V288, P36149, DOI 10.1074/jbc.M113.507970	40	26	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20638	20649		10.1074/jbc.M114.572842	http://dx.doi.org/10.1074/jbc.M114.572842			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24917673	hybrid, Green Published			2022-12-25	WOS:000339396600023
J	Kittaka, H; Akimoto, H; Takeshita, H; Funaoka, H; Hazui, H; Okamoto, M; Kobata, H; Ohishi, Y				Kittaka, Hirotada; Akimoto, Hiroshi; Takeshita, Hitoshi; Funaoka, Hiroyuki; Hazui, Hiroshi; Okamoto, Masao; Kobata, Hitoshi; Ohishi, Yasuo			Usefulness of Intestinal Fatty Acid-Binding Protein in Predicting Strangulated Small Bowel Obstruction	PLOS ONE			English	Article							CREATINE-PHOSPHOKINASE; DIAGNOSTIC-ACCURACY; ISCHEMIA; SERUM; CT; LACTATE; MARKER; TRANSLOCATION; CRITERIA; SYSTEM	Background: The level of intestinal fatty acid-binding protein (I-FABP) is considered to be useful diagnostic markers of small bowel ischemia. The purpose of this retrospective study was to investigate whether the serum I-FABP level is a predictive marker of strangulation in patients with small bowel obstruction (SBO). Methods: A total of 37 patients diagnosed with SBO were included in this study. The serum I-FABP levels were retrospectively compared between the patients with strangulation and those with simple obstruction, and cut-off values for the diagnosis of strangulation were calculated using a receiver operating characteristic curve. In addition, the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated. Results: Twenty-one patients were diagnosed with strangulated SBO. The serum I-FABP levels were significantly higher in the patients with strangulation compared with those observed in the patients with simple obstruction (18.5 vs. 1.6 ng/ml p<0.001). Using a cut-off value of 6.5 ng/ml, the sensitivity, specificity, PPV and NPV were 71.4%, 93.8%, 93.8% and 71.4%, respectively. An I-FABP level greater than 6.5 ng/ml was found to be the only independent significant factor for a higher likelihood of strangulated SBO (P = 0.02; odds ratio: 19.826; 95% confidence interval: 2.1560 - 488.300). Conclusions: The I-FABP level is a useful marker for discriminating between strangulated SBO and simple SBO in patients with SBO.	[Kittaka, Hirotada; Akimoto, Hiroshi; Hazui, Hiroshi; Okamoto, Masao; Kobata, Hitoshi; Ohishi, Yasuo] Osaka Mishima Emergency Crit Care Ctr, Dept Emergency, Takatsuki, Osaka, Japan; [Takeshita, Hitoshi] Osaka Mishima Emergency Crit Care Ctr, Dept Inspect, Takatsuki, Osaka, Japan; [Funaoka, Hiroyuki] DS Pharma Biomed CO Ltd, Suita, Osaka, Japan		Kittaka, H (corresponding author), Osaka Mishima Emergency Crit Care Ctr, Dept Emergency, Takatsuki, Osaka, Japan.	kittaka142@osaka-mishima.jp	Takeshita, Hitoshi/AAC-4593-2019	Takeshita, Hitoshi/0000-0002-8444-2193				Akimoto Teruyuki, 2006, Int J Biomed Sci, V2, P160; ALPERS DH, 1984, P NATL ACAD SCI-BIOL, V81, P313, DOI 10.1073/pnas.81.2.313; Balthazar EJ, 1997, RADIOLOGY, V205, P519, DOI 10.1148/radiology.205.2.9356638; Bass K N, 1997, Adv Surg, V31, P1; Biondo S, 2003, BRIT J SURG, V90, P542, DOI 10.1002/bjs.4150; BIZER LS, 1981, SURGERY, V89, P407; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Cronk Daniel R, 2006, Curr Surg, V63, P322, DOI 10.1016/j.cursur.2006.05.006; DEITCH EA, 1989, ARCH SURG-CHICAGO, V124, P699; DELAURIER GA, 1989, AM J SURG, V158, P32, DOI 10.1016/0002-9610(89)90311-5; Di Saverio S, 2008, WORLD J SURG, V32, P2293, DOI 10.1007/s00268-008-9694-6; Evennett NJ, 2009, WORLD J SURG, V33, P1374, DOI 10.1007/s00268-009-0074-7; Fall Pamela J, 2005, J Intensive Care Med, V20, P255, DOI 10.1177/0885066605278644; Firoozmand E, 2001, AM SURGEON, V67, P1145; Fuller BM, 2012, CURR OPIN CRIT CARE, V18, P267, DOI 10.1097/MCC.0b013e3283532b8a; Funaoka H, 2010, IMMUNOL INVEST, V39, P54, DOI 10.3109/08820130903428283; GOLLIN G, 1993, SURGERY, V113, P545; GRAEBER GM, 1983, ARCH SURG-CHICAGO, V118, P837; GRAEBER GM, 1981, ANN SURG, V193, P499; Ha HK, 1997, RADIOLOGY, V204, P507, DOI 10.1148/radiology.204.2.9240545; Hayakawa K, 2013, EMERG RADIOL, V20, P3, DOI 10.1007/s10140-012-1070-z; KANDA T, 1992, DIGEST DIS SCI, V37, P1362, DOI 10.1007/BF01296004; Kanda T, 1996, GASTROENTEROLOGY, V110, P339, DOI 10.1053/gast.1996.v110.pm8566578; Kanda T, 2011, J GASTROENTEROL, V46, P492, DOI 10.1007/s00535-011-0373-2; Kim JH, 2004, WORLD J SURG, V28, P63, DOI 10.1007/s00268-003-6899-6; LAWS HL, 1976, SOUTHERN MED J, V69, P733, DOI 10.1097/00007611-197606000-00021; LEFFALL LD, 1965, ARCH SURG-CHICAGO, V91, P592; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Markogiannakis H, 2011, SURGERY, V149, P394, DOI 10.1016/j.surg.2010.08.007; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Miller G, 2000, AM J SURG, V180, P33, DOI 10.1016/S0002-9610(00)00407-4; MURRAY MJ, 1994, AM J SURG, V167, P575, DOI 10.1016/0002-9610(94)90101-5; OCKNER RK, 1974, J CLIN INVEST, V54, P326, DOI 10.1172/JCI107768; Okorie ON, 2011, CRIT CARE CLIN, V27, P299, DOI 10.1016/j.ccc.2010.12.013; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; SAGAR PM, 1995, DIS COLON RECTUM, V38, P640, DOI 10.1007/BF02054126; SHATILA AH, 1976, AM J SURG, V132, P299, DOI 10.1016/0002-9610(76)90379-2; Sheedy SP, 2006, RADIOLOGY, V241, P729, DOI 10.1148/radiol.2413050965; SHIELDS HM, 1986, J LIPID RES, V27, P549; SILEN W, 1962, ARCH SURG-CHICAGO, V85, P121; SNYDER EN, 1966, AM J SURG, V111, P398, DOI 10.1016/S0002-9610(66)80018-1; Tanaka K, 2012, AM SURGEON, V78, P86; Thuijls G, 2011, ANN SURG, V253, P303, DOI 10.1097/SLA.0b013e318207a767; van Wijck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022366; Yamamoto T, 2005, DIS COLON RECTUM, V48, P1451, DOI 10.1007/s10350-005-0019-7; Zalcman M, 2000, AM J ROENTGENOL, V175, P1601, DOI 10.2214/ajr.175.6.1751601; ZOLLINGER R M, 1964, Am Surg, V30, P1	47	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99915	10.1371/journal.pone.0099915	http://dx.doi.org/10.1371/journal.pone.0099915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926782	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100089
J	Gomes, GM; Dalmolin, GD; Bar, J; Karpova, A; Mello, CF; Kreutz, MR; Rubin, MA				Gomes, Guilherme Monteiro; Dalmolin, Gerusa Duarte; Baer, Julia; Karpova, Anna; Mello, Carlos Fernando; Kreutz, Michael R.; Rubin, Maribel Antonello			Inhibition of the Polyamine System Counteracts beta-Amyloid Peptide-Induced Memory Impairment in Mice: Involvement of Extrasynaptic NMDA Receptors	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ORNITHINE-DECARBOXYLASE; NEURONAL DYSFUNCTION; DENDRITIC SPINES; MOLECULAR-BASIS; SYNAPSE LOSS; MEMANTINE; GLUTAMATE; OLIGOMERS; BRAIN	In Alzheimer's disease (AD), the beta-amyloid peptide (A beta) has been causally linked to synaptic dysfunction and cognitive impairment. Several studies have shown that N-Methyl-D-Aspartate receptors (NMDAR) activation is involved in the detrimental actions of A beta. Polyamines, like spermidine and spermine, are positive modulators of NMDAR function and it has been shown that their levels are regulated by A beta. In this study we show here that interruption of NMDAR modulation by polyamines through blockade of its binding site at NMDAR by arcaine (0.02 nmol/site), or inhibition of polyamine synthesis by DFMO (2.7 nmol/site), reverses A beta(25-35)-induced memory impairment in mice in a novel object recognition task. Incubation of hippocampal cell cultures with A beta(25-35) (10 mu M) significantly increased the nuclear accumulation of Jacob, which is a hallmark of NMDAR activation. The A beta-induced nuclear translocation of Jacob was blocked upon application of traxoprodil (4 nM), arcaine (4 mu M) or DFMO (5 mu M), suggesting that activation of the polyamine binding site at NMDAR located probably at extrasynaptic sites might underlie the cognitive deficits of A beta(25-35)-treated mice. Extrasynaptic NMDAR activation in primary neurons results in a stripping of synaptic contacts and simplification of neuronal cytoarchitecture. A beta(25-35) application in hippocampal primary cell cultures reduced dendritic spine density and induced alterations on spine morphology. Application of traxoprodil (4 nM), arcaine (4 mu M) or DFMO (5 mu M) reversed these effects of A beta(25-35). Taken together these data provide evidence that polyamine modulation of extrasynaptic NMDAR signaling might be involved in A beta pathology.	[Gomes, Guilherme Monteiro; Dalmolin, Gerusa Duarte; Rubin, Maribel Antonello] Univ Fed Santa Maria, Nat & Exact Sci Ctr, Biochem & Mol Biol Dept, BR-97119900 Santa Maria, RS, Brazil; [Gomes, Guilherme Monteiro; Baer, Julia; Karpova, Anna; Kreutz, Michael R.] Leibniz Inst Neurobiol, Res Grp Neuroplast, Magdeburg, Germany; [Mello, Carlos Fernando] Univ Fed Santa Maria, Dept Physiol & Pharmacol, BR-97119900 Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Leibniz Institut fur Neurobiologie (LIN); Universidade Federal de Santa Maria (UFSM)	Rubin, MA (corresponding author), Univ Fed Santa Maria, Nat & Exact Sci Ctr, Biochem & Mol Biol Dept, BR-97119900 Santa Maria, RS, Brazil.	maribel.rubin@gmail.com	Mello, Carlos/C-7188-2013	Mello, Carlos/0000-0002-1326-1045; rubin, maribel/0000-0002-2763-9619	CNPq [306164/2010-8, 481664/2010-6, 476551/2009-9]; CNPq fellowships; DAAD/CAPES cooperation program fellowship; DFG [SFB 779]; DIP grant; German Center for Neurodegenerative Diseases (DZNE), Location Magdeburg, Germany; federal state of Saxony-Anhalt; Vorhaben: Center for Behavioral Brain Sciences (CBBS)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DAAD/CAPES cooperation program fellowship; DFG(German Research Foundation (DFG)); DIP grant; German Center for Neurodegenerative Diseases (DZNE), Location Magdeburg, Germany; federal state of Saxony-Anhalt; Vorhaben: Center for Behavioral Brain Sciences (CBBS)	This study was supported by CNPq (306164/2010-8, 481664/2010-6, 476551/2009-9). C.F. Mello and M.A. Rubin are recipients of CNPq fellowships. G.M. Gomes is recipient of DAAD/CAPES cooperation program fellowship. M.R. Kreutz is supported by the DFG (SFB 779 TP B8), DIP grant, and the German Center for Neurodegenerative Diseases (DZNE), Location Magdeburg, Germany. A. Karpova is supported by the federal state of Saxony-Anhalt, Vorhaben: Center for Behavioral Brain Sciences (CBBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; Behnisch T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017276; BERNSTEIN HG, 1995, NEUROSCI LETT, V186, P123, DOI 10.1016/0304-3940(95)11301-C; Buisson B, 1998, MOL PHARMACOL, V53, P555, DOI 10.1124/mol.53.3.555; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Dalmolin GD, 2011, PAIN, V152, P2224, DOI 10.1016/j.pain.2011.04.015; Danysz W, 2012, BRIT J PHARMACOL, V167, P324, DOI 10.1111/j.1476-5381.2012.02057.x; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dickerson BC, 2010, NEUROPSYCHOPHARMACOL, V35, P86, DOI 10.1038/npp.2009.126; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gomes GM, 2010, NEUROBIOL LEARN MEM, V93, P589, DOI 10.1016/j.nlm.2010.02.007; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Inoue K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02364; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kaminsky YG, 2010, EXP NEUROL, V221, P26, DOI 10.1016/j.expneurol.2009.09.005; Karpova A, 2013, CELL, V152, P1119, DOI 10.1016/j.cell.2013.02.002; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kew JNC, 1998, J PHYSIOL-LONDON, V512, P17, DOI 10.1111/j.1469-7793.1998.017bf.x; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lison H, 2014, NEUROBIOL DIS, V63, P62, DOI 10.1016/j.nbd.2013.11.014; Lo D, 2011, EXPERT REV NEUROTHER, V11, P1359, DOI [10.1586/ern.11.132, 10.1586/ERN.11.132]; Makitie LT, 2010, BRAIN PATHOL, V20, P571, DOI 10.1111/j.1750-3639.2009.00334.x; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; MORRISON LD, 1995, NEUROSCI LETT, V197, P5, DOI 10.1016/0304-3940(95)11881-V; Morrison LD, 1998, J NEUROCHEM, V71, P288; Mota SI, 2014, NEUROPHARMACOLOGY, V76, P16, DOI 10.1016/j.neuropharm.2013.08.013; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Perfecto K, 2013, J PSYCHOSOC NURS MEN, V51, P17, DOI 10.3928/02793695-20130731-01; Price M, 2009, WORLD ALZHEIMERS REP; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Ronicke R, 2011, NEUROBIOL AGING, V32, P2219, DOI 10.1016/j.neurobiolaging.2010.01.011; Rubin MA, 2004, J NEUROSCI, V24, P2328, DOI 10.1523/JNEUROSCI.1622-03.2004; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Silva MA, 2011, BIOCHEM PHARMACOL, V82, P269, DOI 10.1016/j.bcp.2011.04.015; Small DH, 2008, TRENDS MOL MED, V14, P103, DOI 10.1016/j.molmed.2007.12.006; Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang DY, 2007, NEUROPSYCHOPHARMACOL, V32, P1261, DOI 10.1038/sj.npp.1301256; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yatin SM, 2001, J NEUROSCI RES, V63, P395, DOI 10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q; Yatin SM, 1997, E NEUROSCI LETT, V263, P17	50	34	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99184	10.1371/journal.pone.0099184	http://dx.doi.org/10.1371/journal.pone.0099184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921942	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300041
J	Huynen, L; Gill, BJ; Doyle, A; Millar, CD; Lambert, DM				Huynen, Leon; Gill, Brian J.; Doyle, Anthony; Millar, Craig D.; Lambert, David M.			Identification, Classification, and Growth of Moa Chicks (Aves: Dinornithiformes) from the Genus Euryapteryx	PLOS ONE			English	Article							ANCIENT DNA; NEW-ZEALAND; CLIMATE; DIET	Background: The analysis of growth in extinct organisms is difficult. The general lack of skeletal material from a range of developmental states precludes determination of growth characteristics. For New Zealand's extinct moa we have available to us a selection of rare femora at different developmental stages that have allowed a preliminary determination of the early growth of this giant flightless bird. We use a combination of femora morphometrics, ancient DNA, and isotope analysis to provide information on the identification, classification, and growth of extinct moa from the genus Euryapteryx. Results: Using ancient DNA, we identify a number of moa chick bones for the species Euryapteryx curtus, Dinornis novaezealandiae, and Anomalopteryx didiformis, and the first chick bone for Pachyornis geranoides. Isotope analysis shows that partial derivative N-15 levels vary between the two known size classes of Euryapteryx, with the larger size class having reduced levels of partial derivative N-15. A growth series for femora of the two size classes of Euryapteryx shows that early femora growth characteristics for both classes are almost identical. Morphometric, isotopic, and radiographic analysis of the smallest Euryapteryx bones suggests that one of these femora is from a freshly hatched moa at a very early stage of development. Conclusion: Using morphometric, isotopic, and ancient DNA analyses have allowed the determination of a number of characteristics of rare moa chick femora. For Euryapteryx the analyses suggest that the smaller sized class II Euryapteryx is identical in size and growth to the extant Darwin's rhea.	[Huynen, Leon; Lambert, David M.] Griffith Univ, Environm Futures Ctr, Nathan, Qld 4111, Australia; [Gill, Brian J.] Auckland War Mem Museum, Auckland, New Zealand; [Doyle, Anthony] Univ Auckland, Fac Hlth & Med Sci, Auckland 1, New Zealand; [Millar, Craig D.] Univ Auckland, Sch Biol Sci, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 1, New Zealand	Griffith University; University of Auckland; Massey University; University of Auckland	Lambert, DM (corresponding author), Griffith Univ, Environm Futures Ctr, Nathan, Qld 4111, Australia.	d.lambert@griffith.edu.au	Gill, Brian/I-9553-2019	Gill, Brian/0000-0003-4026-2905; Lambert, David/0000-0002-5821-3637	Australian Research Council [DP110101364]	Australian Research Council(Australian Research Council)	The authors thank the Australian Research Council for support (Grant number DP110101364; The molecular evolution of wings in ratites). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; Applegate TJ, 2002, POULTRY SCI, V81, P1289, DOI 10.1093/ps/81.9.1289; BRUNING D, 1970, WILSON BULL, V82, P219; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Cooper A, 2000, SCIENCE, V289, P1139; Davies S., 2003, GRZIMEKS ANIMAL LIFE; Dickison MJ., 2007, THESIS DUKE U; Gill BJ, 2010, REC AUST MUS, V62, P115, DOI 10.3853/j.0067-1975.62.2010.1535; Hassan SM, 2004, POULTRY SCI, V83, P495, DOI 10.1093/ps/83.3.495; Hector J., 1872, T P NZ I, V4, P110; Holdaway Richard N., 2011, Notornis, V58, P1; Huynen L, 2010, P NATL ACAD SCI USA, V107, P16201, DOI 10.1073/pnas.0914096107; McCallum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050732; McMeans BC, 2009, J FISH BIOL, V75, P2464, DOI 10.1111/j.1095-8649.2009.02402.x; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Rawlence NJ, 2012, QUATERNARY SCI REV, V50, P141, DOI 10.1016/j.quascirev.2012.07.004; REECE RL, 1984, AUST VET J, V61, P403, DOI 10.1111/j.1751-0813.1984.tb07174.x; Rogers KM, 2009, J AGR FOOD CHEM, V57, P4236, DOI 10.1021/jf803760s; Roots C., 2006, FLIGHTLESS BIRDS; STEADMAN D W, 1980, Contributions in Science (Los Angeles), P131; Turvey ST, 2005, J MORPHOL, V265, P70, DOI 10.1002/jmor.10341; Turvey ST, 2005, NATURE, V435, P940, DOI 10.1038/nature03635; Tykot RH, 2004, P INT SCH PHYS E FER; Wood Jamie R., 2007, Records of the Canterbury Museum, V21, P27; WORTHY T H, 1987, National Museum of New Zealand Records, V3, P59; Worthy TH, 2012, NEW ZEAL J ZOOL, V39, P87, DOI 10.1080/03014223.2012.665060; Worthy T. H., 2002, LOST WORLD MOA PREHI; Worthy TH, 1988, NATL MUSEUM NZ MISC, V17, P3	28	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99929	10.1371/journal.pone.0099929	http://dx.doi.org/10.1371/journal.pone.0099929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923666	Green Published, gold			2022-12-25	WOS:000338701300107
J	Jhaveri, DJ; Nanavaty, I; Prosper, BW; Marathe, S; Husain, BFA; Kernie, SG; Bartlett, PF; Vaidya, VA				Jhaveri, Dhanisha J.; Nanavaty, Ishira; Prosper, Boris W.; Marathe, Swanand; Husain, Basma F. A.; Kernie, Steven G.; Bartlett, Perry F.; Vaidya, Vidita A.			Opposing Effects of alpha 2-and beta-Adrenergic Receptor Stimulation on Quiescent Neural Precursor Cell Activity and Adult Hippocampal Neurogenesis	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CHRONIC ANTIDEPRESSANT TREATMENT; RAT HIPPOCAMPUS; DENTATE GYRUS; 5-HYDROXYTRYPTAMINE RELEASE; NORADRENERGIC SYSTEM; NEUROTROPHIC FACTOR; BRAIN; ALPHA(2)-ADRENOCEPTORS; NOREPINEPHRINE	Norepinephrine regulates latent neural stem cell activity and adult hippocampal neurogenesis, and has an important role in modulating hippocampal functions such as learning, memory and mood. Adult hippocampal neurogenesis is a multi-stage process, spanning from the activation and proliferation of hippocampal stem cells, to their differentiation into neurons. However, the stage-specific effects of noradrenergic receptors in regulating adult hippocampal neurogenesis remain poorly understood. In this study, we used transgenic Nestin-GFP mice and neurosphere assays to show that modulation of alpha 2-and beta-adrenergic receptor activity directly affects Nestin-GFP/GFAP-positive precursor cell population albeit in an opposing fashion. While selective stimulation of alpha 2-adrenergic receptors decreases precursor cell activation, proliferation and immature neuron number, stimulation of beta-adrenergic receptors activates the quiescent precursor pool and enhances their proliferation in the adult hippocampus. Furthermore, our data indicate no major role for alpha 1-adrenergic receptors, as we did not observe any change in either the activation and proliferation of hippocampal precursors following selective stimulation or blockade of alpha 1-adrenergic receptors. Taken together, our data suggest that under physiological as well as under conditions that lead to enhanced norepinephrine release, the balance between alpha 2-and beta-adrenergic receptor activity regulates precursor cell activity and hippocampal neurogenesis.	[Jhaveri, Dhanisha J.; Prosper, Boris W.; Bartlett, Perry F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Nanavaty, Ishira; Marathe, Swanand; Husain, Basma F. A.; Vaidya, Vidita A.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Kernie, Steven G.] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Kernie, Steven G.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	University of Queensland; Tata Institute of Fundamental Research (TIFR); Columbia University; Columbia University	Bartlett, PF (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	p.bartlett@uq.edu.au; vvaidya@tifr.res.in	Kernie, Steven/AAT-9912-2020; Jhaveri, Dhanisha/D-2640-2009; Bartlett, Perry/F-3813-2012	Jhaveri, Dhanisha/0000-0002-5615-3546; Kernie, Steven/0000-0003-1371-0549; Vaidya, Vidita/0000-0002-3907-8580; Marathe, Swananda/0000-0002-2539-366X	Queensland Government; Estate of Dr. Clem Jones AO; Department of Biotechnology, Government of India; TIFR intramural funds	Queensland Government; Estate of Dr. Clem Jones AO; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); TIFR intramural funds	This work was supported by an Indo-Queensland Biotechnology Project Fund Award from the Queensland Government and the Estate of Dr. Clem Jones AO to PFB and the Department of Biotechnology, Government of India to VAV and by TIFR intramural funds (VAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bortolozzi A, 2003, NEUROPSYCHOPHARMACOL, V28, P421, DOI 10.1038/sj.npp.1300061; Brunello N, 2003, INT CLIN PSYCHOPHARM, V18, P191, DOI 10.1097/00004850-200307000-00001; Doze VA, 2011, MOL PHARMACOL, V80, P747, DOI 10.1124/mol.111.073734; DURSUN SM, 1993, BRIT J PHARMACOL, V109, P1046, DOI 10.1111/j.1476-5381.1993.tb13727.x; Dworkin S, 2009, STEM CELLS, V27, P1347, DOI 10.1002/stem.56; Esteban S, 1999, N-S ARCH PHARMACOL, V360, P135, DOI 10.1007/s002109900045; Flugge G, 2003, EUR J NEUROSCI, V17, P917, DOI 10.1046/j.1460-9568.2003.02510.x; Garcia-Vallejo P, 1998, BRAIN RES, V801, P72, DOI 10.1016/S0006-8993(98)00547-2; GLAVIN GB, 1985, LIFE SCI, V37, P461, DOI 10.1016/0024-3205(85)90408-4; Gobert A, 2003, J PHARMACOL EXP THER, V305, P338, DOI 10.1124/jpet.102.046383; Gupta MK, 2009, MOL PHARMACOL, V76, P314, DOI 10.1124/mol.109.057307; Harley CW, 2007, PROG BRAIN RES, V163, P299, DOI 10.1016/S0079-6123(07)63018-0; HEIN L, 1995, NEUROPHARMACOLOGY, V34, P357, DOI 10.1016/0028-3908(95)00018-2; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Jhaveri DJ, 2012, DEV NEUROBIOL, V72, P1044, DOI 10.1002/dneu.22027; Jhaveri DJ, 2010, J NEUROSCI, V30, P2795, DOI 10.1523/JNEUROSCI.3780-09.2010; Kulkarni VA, 2002, EUR J NEUROSCI, V16, P2008, DOI 10.1046/j.1460-9568.2002.02268.x; LOY R, 1980, SCIENCE, V208, P1282, DOI 10.1126/science.7375941; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mantamadiotis T, 2012, BIOESSAYS, V34, P293, DOI 10.1002/bies.201100133; Marien MR, 2004, BRAIN RES REV, V45, P38, DOI 10.1016/j.brainresrev.2004.02.002; Masuda T, 2012, PROG NEURO-PSYCHOPH, V36, P44, DOI 10.1016/j.pnpbp.2011.08.019; Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nair A, 2007, NEUROPSYCHOPHARMACOL, V32, P1504, DOI 10.1038/sj.npp.1301276; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Nicholas AP, 1996, TRENDS PHARMACOL SCI, V17, P245, DOI 10.1016/S0165-6147(96)10022-5; O'Malley SS, 1998, EUR J PHARMACOL, V348, P287, DOI 10.1016/S0014-2999(98)00149-6; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Philipp M, 2004, PHARMACOL THERAPEUT, V101, P65, DOI 10.1016/j.pharmthera.2003.10.004; Ribas C, 2001, BRIT J PHARMACOL, V132, P1467, DOI 10.1038/sj.bjp.0703963; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Sanacora G, 2004, NEUROPSYCHOPHARMACOL, V29, P1166, DOI 10.1038/sj.npp.1300418; Subhash MN, 2003, NEUROCHEM INT, V43, P603, DOI 10.1016/S0197-0186(03)00097-4; Vaidya Vidita A, 2007, Expert Rev Neurother, V7, P853, DOI 10.1586/14737175.7.7.853; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; Yanpallewar SU, 2010, J NEUROSCI, V30, P1096, DOI 10.1523/JNEUROSCI.2309-09.2010; Yoshioka M, 1995, EUR J PHARMACOL, V294, P565, DOI 10.1016/0014-2999(95)00582-X; Yu TS, 2005, GENESIS, V41, P147, DOI 10.1002/gene.20110	42	25	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98736	10.1371/journal.pone.0098736	http://dx.doi.org/10.1371/journal.pone.0098736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922313	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300015
J	Rowehl, RA; Burke, S; Bialkowska, AB; Pettet, DW; Rowehl, L; Li, E; Antoniou, E; Zhang, YH; Bergamaschi, R; Shroyer, KR; Ojima, I; Botchkina, GI				Rowehl, Rebecca A.; Burke, Stephanie; Bialkowska, Agnieszka B.; Pettet, Donald W., III; Rowehl, Leahana; Li, Ellen; Antoniou, Eric; Zhang, Yuanhao; Bergamaschi, Roberto; Shroyer, Kenneth R.; Ojima, Iwao; Botchkina, Galina I.			Establishment of Highly Tumorigenic Human Colorectal Cancer Cell Line (CR4) with Properties of Putative Cancer Stem Cells	PLOS ONE			English	Article							Y-CHROMOSOME; CD133(+)CD44(+) POPULATION; INITIATING CELLS; SIDE POPULATION; POOR-PROGNOSIS; TUMOR-GROWTH; CD133; CD44; RESISTANCE; EXPRESSION	Background: Colorectal cancer (CRC) has the third highest mortality rates among the US population. According to the most recent concept of carcinogenesis, human tumors are organized hierarchically, and the top of it is occupied by malignant stem cells (cancer stem cells, CSCs, or cancer-initiating cells, CICs), which possess unlimited self-renewal and tumor-initiating capacities and high resistance to conventional therapies. To reflect the complexity and diversity of human tumors and to provide clinically and physiologically relevant cancer models, large banks of characterized patient-derived low-passage cell lines, and especially CIC-enriched cell lines, are urgently needed. Principal Findings: Here we report the establishment of a novel CIC-enriched, highly tumorigenic and clonogenic colon cancer cell line, CR4, derived from liver metastasis. This stable cell line was established by combining 3D culturing and 2D culturing in stem cell media, subcloning of cells with particular morphology, co-culture with carcinoma associated fibroblasts (CAFs) and serial transplantation to NOD/SCID mice. Using RNA-Seq complete transcriptome profiling of the tumorigenic fraction of the CR4 cells in comparison to the bulk tumor cells, we have identified about 360 differentially expressed transcripts, many of which represent stemness, pluripotency and resistance to treatment. Majority of the established CR4 cells express common markers of stemness, including CD133, CD44, CD166, EpCAM, CD24 and Lgr5. Using immunocytochemical, FACS and western blot analyses, we have shown that a significant ratio of the CR4 cells express key markers of pluripotency markers, including Sox-2, Oct3/4 and c-Myc. Constitutive overactivation of ABC transporters and NFkB and absence of tumor suppressors p53 and p21 may partially explain exceptional drug resistance of the CR4 cells. Conclusions: The highly tumorigenic and clonogenic CIC-enriched CR4 cell line may provide an important new tool to support the discovery of novel diagnostic and/or prognostic biomarkers as well as the development of more effective therapeutic strategies.	[Rowehl, Rebecca A.; Burke, Stephanie; Shroyer, Kenneth R.; Botchkina, Galina I.] SUNY Stony Brook, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA; [Bialkowska, Agnieszka B.; Pettet, Donald W., III; Rowehl, Leahana; Li, Ellen] SUNY Stony Brook, Dept Med, Med Ctr, Stony Brook, NY 11794 USA; [Antoniou, Eric] Cold Spring Harbor Lab, Genome Res Ctr, Cold Spring Harbor, NY 11724 USA; [Zhang, Yuanhao] SUNY Stony Brook, CEWIT, Stony Brook, NY 11794 USA; [Bergamaschi, Roberto] SUNY Stony Brook, Med Ctr, Dept Surg Surg Oncol, Stony Brook, NY 11794 USA; [Ojima, Iwao; Botchkina, Galina I.] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Ojima, Iwao] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Botchkina, GI (corresponding author), SUNY Stony Brook, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA.	gbotchkina@stonybrookmedicine.edu		Ojima, Iwao/0000-0002-3628-1161	Fusion TRO grant [1104347-5-37298]; SBU Cancer Center; SBU Vice President for Research (RSR) [1111963-3-63845]; Department of Pathology; Institute of Chemical Biology & Drug Discovery (ICBDD); Simons Foundation	Fusion TRO grant; SBU Cancer Center; SBU Vice President for Research (RSR); Department of Pathology; Institute of Chemical Biology & Drug Discovery (ICBDD); Simons Foundation	This study was supported by Fusion TRO grant (P.I. Dr. Botchkina; 1104347-5-37298), SBU Cancer Center, and SBU Vice President for Research (RSR 1111963-3-63845). According to the Fusion TRO conditions, the Department of Pathology, the Institute of Chemical Biology & Drug Discovery (ICB&DD) and the Simons Foundation have also partially contributed to this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamdani MSS, 2012, J PROTEOMICS, V75, P3747, DOI 10.1016/j.jprot.2012.04.042; Amsterdam A, 2013, ACTA HISTOCHEM, V115, P320, DOI 10.1016/j.acthis.2012.09.003; Antoniou E, 2012, METHODS MOL BIOL, V825, P237, DOI 10.1007/978-1-61779-436-0_18; Attard G, 2009, PROSTATE, V69, P1507, DOI 10.1002/pros.20997; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Becker L, 2008, THESCIENTIFICWORLDJO, V8, P1168, DOI 10.1100/tsw.2008.148; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Botchkina GI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069884; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Dirks PB, 2006, NATURE, V444, P687, DOI 10.1038/444687a; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Failli A, 2009, TUMORI J, V95, P343; Fredebohm J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048503; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Gaiser T, 2011, AM J PATHOL, V178, P1478, DOI 10.1016/j.ajpath.2010.12.036; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034219; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Horst D, 2009, CANCER INVEST, V27, P844, DOI 10.1080/07357900902744502; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Jiang XH, 2002, ONCOGENE, V21, P6113, DOI 10.1038/sj.onc.1205778; Kirkland SC, 2009, BRIT J CANCER, V101, P320, DOI 10.1038/sj.bjc.6605143; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kobayashi S, 2012, STEM CELLS, V30, P2631, DOI 10.1002/stem.1257; Luo Jian-Hua, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006057; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsuda Y, 2011, CANCER BIOL THER, V11, P512, DOI 10.4161/cbt.11.5.14673; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mimeault M, 2010, HISTOL HISTOPATHOL, V25, P1057, DOI 10.14670/HH-25.1057; Muraro MG, 2012, STEM CELL TRANSL MED, V1, P592, DOI 10.5966/sctm.2012-0003; Nielander I, 2008, HAEMATOLOGICA, V93, P949, DOI 10.3324/haematol.12656; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohata H, 2012, CANCER RES, V72, P5101, DOI 10.1158/0008-5472.CAN-11-3812; Park JG, 1996, J CELL BIOCHEM, P131; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Peehl DM, 2004, J CELL BIOCHEM, V91, P185, DOI 10.1002/jcb.10691; Perez-Escuredo J, 2011, CELL ONCOL, V34, P23, DOI 10.1007/s13402-010-0002-8; Perinchery G, 2000, J UROLOGY, V163, P1339, DOI 10.1016/S0022-5347(05)67774-9; Puglisi MA, 2009, EUR REV MED PHARMACO, V13, P55; Rao GH, 2013, ACTA PHARMACOL SIN, V34, P793, DOI 10.1038/aps.2013.56; Ray S, 2012, J CANCER, V3, P196, DOI 10.7150/jca.4484; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rowehl Rebecca A., 2008, Cancer Genomics & Proteomics, V5, P301; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Streppel MM, 2013, ONCOGENE, V2013, P1; Takeda K, 2011, ANTICANCER RES, V31, P263; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tortoreto M, 2009, P NATL ACAD SCI USA, V106; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vijayakumar S, 2005, GENE CHROMOSOME CANC, V44, P365, DOI 10.1002/gcc.20250; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wang CX, 2012, ONCOL REP, V28, P1301, DOI 10.3892/or.2012.1951; Wong BCY, 2003, ONCOGENE, V22, P1189, DOI 10.1038/sj.onc.1206234; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Wu YG, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/537531; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193; Zhang NH, 2012, EXP THER MED, V3, P973, DOI 10.3892/etm.2012.527; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85; Zhang WH, 2011, CANCER-AM CANCER SOC, V117, P4092, DOI 10.1002/cncr.26021; Zheng XS, 2011, ONCOL RES, V19, P555, DOI 10.3727/096504012X13340632812631; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	78	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99091	10.1371/journal.pone.0099091	http://dx.doi.org/10.1371/journal.pone.0099091			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921652	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000338701300026
J	Su, WR; Li, ZH; Jia, Y; Zhuo, YH				Su, Wenru; Li, Zuohong; Jia, Yu; Zhuo, Yehong			Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model	PLOS ONE			English	Article							GANGLION-CELL DEATH; MOUSE MODEL; TRANSCRIPTION FACTOR; AUTOPHAGY PATHWAY; PROTEIN-KINASE; IN-VITRO; KAPPA-B; ACTIVATION; MICROGLIA; SURVIVAL	Glaucoma is a leading cause of irreversible blindness. Injury of retinal ganglion cells (RGCs) accounts for visual impairment of glaucoma. Here, we report rapamycin protects RGCs from death in experimental glaucoma model and the underlying mechanisms. Our results showed that treatment with rapamycin dramatically promote RGCs survival in a rat chronic ocular hypertension model. This protective action appears to be attributable to inhibition of neurotoxic mediators release and/or direct suppression of RGC apoptosis. In support of this mechanism, in vitro, rapamycin significantly inhibits the production of NO, TNF-alpha in BV2 microglials by modulating NF-kappa B signaling. In experimental animals, treatment with rapamycin also dramatically inhibited the activation of microglials. In primary RGCs, rapamycin was capable of direct suppression the apoptosis of primary RGCs induced by glutamate. Mechanistically, rapamycin-mediated suppression of RGCs apoptosis is by sparing phosphorylation of Akt at a site critical for maintenance of its survival-promoting activity in cell and animal model. These results demonstrate that rapamycin is neuroprotective in experimental glaucoma, possibly via decreasing neurotoxic releasing and suppressing directly apoptosis of RGCs.	[Su, Wenru; Li, Zuohong; Jia, Yu; Zhuo, Yehong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhuo, YH (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhuoyh@mail.sysu.edu.cn		Su, Wenru/0000-0002-0506-6362	Natural Science Foundation of China [81270992, 81300740]; Natural Science Foundation of Guangdong Province [10251008901000028]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was funded by Natural Science Foundation of China (81270992), Natural Science Foundation of Guangdong Province (10251008901000028) and Natural Science Foundation of China (81300740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P4722, DOI 10.1167/iovs.09-5032; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Berg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059647; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Deng SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077100; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Greenstein RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002496; Grisham MB, 1996, METHOD ENZYMOL, V268, P237; Han HE, 2013, BIOMOL THER, V21, P21, DOI 10.4062/biomolther.2012.089; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jung WK, 2010, BRIT J PHARMACOL, V159, P1274, DOI 10.1111/j.1476-5381.2009.00615.x; Kaur C, 2013, J PINEAL RES, V54, P190, DOI 10.1111/jpi.12016; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Kim HS, 2005, BRAIN RES, V1057, P17, DOI 10.1016/j.brainres.2005.07.005; Kitaoka Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.391; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Lebrun-Julien F, 2009, MOL CELL NEUROSCI, V40, P410, DOI 10.1016/j.mcn.2008.12.005; Levkovitch-Verbin H, 2007, EXP EYE RES, V85, P250, DOI 10.1016/j.exer.2007.04.011; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Muller YD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010352; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; Piras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022514; Prevel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074450; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ratai EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010523; Rodriguez-Muela N, 2012, CELL DEATH DIFFER, V19, P162, DOI 10.1038/cdd.2011.88; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Shi ZH, 2008, J BIOL CHEM, V283, P29156, DOI 10.1074/jbc.M802365200; Shi Z, 2007, DEV NEUROBIOL, V67, P884, DOI 10.1002/dneu.20360; Sirohi K, 2013, AUTOPHAGY, V9, P510, DOI 10.4161/auto.23458; Sivakumar V, 2011, J PATHOL, V224, P245, DOI 10.1002/path.2858; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Su WR, 2013, INVEST OPHTH VIS SCI, V54, P783, DOI 10.1167/iovs.12-10323; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104; Zhu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035125; Zhu JL, 1999, GASTROENTEROLOGY, V117, P1198, DOI 10.1016/S0016-5085(99)70406-3	54	64	69	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99719	10.1371/journal.pone.0099719	http://dx.doi.org/10.1371/journal.pone.0099719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923557	Green Submitted, Green Published, gold			2022-12-25	WOS:000338701300087
J	Gallant, AL; Euliss, NH; Browning, Z				Gallant, Alisa L.; Euliss, Ned H., Jr.; Browning, Zac			Mapping Large-Area Landscape Suitability for Honey Bees to Assess the Influence of Land-Use Change on Sustainability of National Pollination Services	PLOS ONE			English	Article							THEMATIC ACCURACY; CONSERVATION PROGRAMS; ECOSYSTEM SERVICES; COLONY LOSSES; UNITED-STATES; HABITAT LOSS; COVER DATA; WETLANDS; PLAINS	Pollination is a critical ecosystem service affected by various drivers of land-use change, such as policies and programs aimed at land resources, market values for crop commodities, local land-management decisions, and shifts in climate. The United States is the world's most active market for pollination services by honey bees, and the Northern Great Plains provide the majority of bee colonies used to meet the Nation's annual pollination needs. Legislation requiring increased production of biofuel crops, increasing commodity prices for crops of little nutritional value for bees in the Northern Great Plains, and reductions in government programs aimed at promoting land conservation are converging to alter the regional landscape in ways that challenge beekeepers to provide adequate numbers of hives for national pollination services. We developed a spatially explicit model that identifies sites with the potential to support large apiaries based on local-scale land-cover requirements for honey bees. We produced maps of potential apiary locations for North Dakota, a leading producer of honey, based on land-cover maps representing (1) an annual time series compiled from existing operational products and (2) a realistic scenario of land change. We found that existing land-cover products lack sufficient local accuracy to monitor actual changes in landscape suitability for honey bees, but our model proved informative for evaluating effects on suitability under scenarios of land change. The scenario we implemented was aligned with current drivers of land-use change in the Northern Great Plains and highlighted the importance of conservation lands in landscapes intensively and extensively managed for crops.	[Gallant, Alisa L.] US Geol Survey, Earth Resources Observat & Sci Ctr, Sioux Falls, SD 57198 USA; [Euliss, Ned H., Jr.] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND USA; [Browning, Zac] Brownings Honey Co Inc, Jamestown, ND USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Gallant, AL (corresponding author), US Geol Survey, Earth Resources Observat & Sci Ctr, Sioux Falls, SD 57198 USA.	gallant@usgs.gov	BITOUN, RACHEL Elisabeth/AAC-9538-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910	United States Geological Survey; United States Department of Agriculture, Farm Service Agency; United States Department of Agriculture, Natural Resources Conservation Service, Conservation Effects Assessment Project-Wetlands	United States Geological Survey(United States Geological Survey); United States Department of Agriculture, Farm Service Agency; United States Department of Agriculture, Natural Resources Conservation Service, Conservation Effects Assessment Project-Wetlands	The United States Geological Survey; the United States Department of Agriculture, Farm Service Agency; and the United States Department of Agriculture, Natural Resources Conservation Service, Conservation Effects Assessment Project-Wetlands jointly supported this project. Other than policy review by the United States Geological Survey and a general editorial review the authors solicited from a colleague at the United States Department of Agriculture's Farm Service Agency, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alaux Cedric, 2010, Biol Lett, V6, P562, DOI 10.1098/rsbl.2009.0986; [Anonymous], 1986, CRP ENR RENT PAYM CO; Auch R.F., 2012, REMOTE SENSING LAND, P351; Auch Roger F., 2011, Great Plains Research, V21, P231; Balas CJ, 2012, WETLANDS, V32, P333, DOI 10.1007/s13157-012-0269-9; Batt B.D.J., 1989, P204; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Boryan C, 2011, GEOCARTO INT, V26, P341, DOI 10.1080/10106049.2011.562309; Broome FR, 2003, PHOTOGRAMM ENG REM S, V69, P1119, DOI 10.14358/PERS.69.10.1119; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Claassen R., 2011, ERR120 USDA EC RES S; Cowan T, 2010, 75700 C RES SERV; Dadant MG, 1946, HIVE HONEYBEE NEW BO, P290; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Euliss NH, 2008, WETLANDS, V28, P553, DOI 10.1672/07-154.1; Euliss NH, 2006, SCI TOTAL ENVIRON, V361, P179, DOI 10.1016/j.scitotenv.2005.06.007; Euliss NH, 2011, ECOL APPL, V21, pS128, DOI 10.1890/09-0285.1; Euliss NH, 2010, ENVIRON SCI TECHNOL, V44, P7761, DOI 10.1021/es102761c; Farm Service Agency, 2008, CONS RES PROGR CRP B; Fernandez-Cornejo J, 2012, EC INFORM B, V98, P18; Gallant AL, 2007, COPEIA, P967, DOI 10.1643/0045-8511(2007)7[967:GROHLA]2.0.CO;2; Gallant AL, 2009, J WILDLIFE MANAGE, V73, P796, DOI 10.2193/2007-509; Gleason RA, 2008, 1745 US GEOL SURV; Gutmann MP, 2005, POPULATION LAND USE, P84; Hagler J, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.14301; Hartman MD, 2011, ECOL APPL, V21, P1105, DOI 10.1890/10-0036.1; Haufler J.B., 2005, FISH WILDLIFE BENEFI; Hellerstein D., 2011, Economic Research Report - Economic Research Service, USDA; Johnson, 2013, R43191 C RES SERV; Johnson R, 2007, RL33938 C RES SERV; Manuel J, 2007, ENVIRON HEALTH PERSP, V115, pA92, DOI 10.1289/ehp.115-a92; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Multi-Resolution Land Characteristics Consortium (MRLC), NAT LAND COV DAT FRE; National Agricultural Statistics Service, 2012, HON REP; National Agricultural Statistics Service, QUICK STATS; National Agricultural Statistics Service, 2011, AGR PRIC; National Agricultural Statistics Service, 2009, GEOGR AR SER 51, V1; National Research Council, 2007, STAT POLL N AM; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Pettis JS, 2010, APIDOLOGIE, V41, P256, DOI 10.1051/apido/2010013; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Roy DP, 2010, REMOTE SENS ENVIRON, V114, P35, DOI 10.1016/j.rse.2009.08.011; Rucker RR, 2012, AM J AGR ECON, V94, P956, DOI 10.1093/ajae/aas031; Schnepf R, 2010, 75700 C RES SERV; Skokstad E, 2007, SCIENCE, V316, P970; Smith A. J., 1964, WATERFOWL TOMORROW, P39; Sohl TL, 2012, AGR ECOSYST ENVIRON, V153, P1, DOI 10.1016/j.agee.2012.02.019; Sohl TL, 2004, PHOTOGRAMM ENG REM S, V70, P439, DOI 10.14358/PERS.70.4.439; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Stehman SV, 2003, REMOTE SENS ENVIRON, V86, P500, DOI 10.1016/S0034-4257(03)00128-7; Stewart LO., 1935, PUBLIC LAND SURVEYS; Strong LL, 2005, GAP ANAL N DAKOTA FI; Stubbs M, 2009, AGR CONS ISS 111 C; Stubbs M, 2007, C RES SERV C; Sylvester KM, 2013, AGR ECOSYST ENVIRON, V168, P7, DOI 10.1016/j.agee.2013.01.014; Thogmartin WE, 2004, WILDLIFE SOC B, V32, P970, DOI 10.2193/0091-7648(2004)032[0970:CACTRU]2.0.CO;2; Thompson W, 2010, BIOMASS BIOENERG, V34, P883, DOI 10.1016/j.biombioe.2010.01.033; Tuvendal M, 2011, ECOL SOC, V16, DOI 10.5751/ES-04456-160421; U.S. Department of Agriculture, 1980, AGR HDB, V335; U.S. Department of Agriculture Census of Agriculture, 2007, 2007 CENS AG ATL MAP; U.S. Department of Agriculture Farm Service Agency, CONS PROGR; U.S. Department of Agriculture National Agricultural Statistics Service, 2005, 2002 AGR ATL US 1, V2; U.S. Department of Agriculture National Agricultural Statistics Service, 2009, 2006 N DAK CROPL DAT; U.S. Department of Agriculture National Agricultural Statistics Service, 2009, HON REP 2009; U.S. Department of Agriculture National Agricultural Statistics Service, 2013, HON REP 2013; U.S. Department of Agriculture National Agricultural Statistics Service, 2012, HON REP 2012; U.S. Department of Agriculture National Agricultural Statistics Service, 2002, ACR REP; U.S. Department of Agriculture National Agricultural Statistics Service, 2011, HON REP 2011; U.S. Department of Agriculture National Agricultural Statistics Service, STAT B; U.S. Department of Agriculture National Agricultural Statistics Service, 2010, HON REP 2010; U.S. Department of Agriculture National Agricultural Statistics Service, STAT B; U.S. Department of Agriculture National Agricultural Statistics Service, STAT B; U.S. Department of Agriculture National Agricultural Statistics Service, STAT B; U.S. Department of Agriculture National Agricultural Statistics Service, GROPL DAT LAYER MET; U.S. Department of Agriculture National Agricultural Statistics Service, 1992, 1992 CENS AGR AGR AT; U.S. Department of Commerce Bureau of the Census, 1990, 1987 CENS AGR 1, V2; U.S. Department of Commerce Bureau of the Census, 1985, 1982 CENS AGR, V2; U.S. Geological Survey, 2008, IM EV US GEOL SURV T; U.S. Geological Survey, WELD WEB EN LANDS DA; Undersander D, 2004, N CENTRAL REGION EXT; United States Department of Agriculture National Agricultural Statistics Service (NASS), 2012, ACR REP; US Governmental Accountability Office, 2009, GAO09446; USDA, CROPSCAPE CROPL DAT; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; Watts RD, 2007, SCIENCE, V316, P736, DOI 10.1126/science.1138141; Watts RD, 2005, DISTANCE NEAREST ROA; Wickham JD, 2010, REMOTE SENS ENVIRON, V114, P1286, DOI 10.1016/j.rse.2010.01.018; Wickham JD, 2004, REMOTE SENS ENVIRON, V91, P452, DOI 10.1016/j.rse.2004.04.002; WILEN BO, 1995, VEGETATIO, V118, P153, DOI 10.1007/BF00045197; Wu JJ, 2010, LAND ECON, V86, P1, DOI 10.1007/s10980-009-9444-7; Zhu Z, 2014, REMOTE SENS ENVIRON, V144, P152, DOI 10.1016/j.rse.2014.01.011; Zhu Z, 2012, REMOTE SENS ENVIRON, V122, P75, DOI 10.1016/j.rse.2011.10.030	97	52	52	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99268	10.1371/journal.pone.0099268	http://dx.doi.org/10.1371/journal.pone.0099268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919181	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000070
J	Gupta, MR; Kolli, D; Molteni, C; Casola, A; Garofalo, RP				Gupta, Meera R.; Kolli, Deepthi; Molteni, Claudio; Casola, Antonella; Garofalo, Roberto P.			Paramyxovirus Infection Regulates T Cell Responses by BDCA-1(+) and BDCA-3(+) Myeloid Dendritic Cells	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; HUMAN METAPNEUMOVIRUS INFECTION; IMPORTANT RISK-FACTOR; NF-KAPPA-B; IMMUNE-RESPONSE; DIFFERENTIAL RESPONSE; RSV BRONCHIOLITIS; INTERFERON-ALPHA; CUTTING EDGE; ASTHMA	Respiratory syncytial virus (RSV) and human Metapneumovirus (hMPV), viruses belonging to the family Paramyxoviridae, are the most important causes of lower respiratory tract infection in young children. Infections with RSV and hMPV are clinically indistinguishable, and both RSV and hMPV infection have been associated with aberrant adaptive immune responses. Myeloid Dendritic cells (mDCs) play a pivotal role in shaping adaptive immune responses during infection; however, few studies have examined how interactions of RSV and hMPV with individual mDC subsets (BDCA-1(+) and BDCA-3(+) mDCs) affect the outcome of anti-viral responses. To determine whether RSV and hMPV induce virus-specific responses from each subset, we examined co-stimulatory molecules and cytokines expressed by BDCA-1(+) and BDCA-3(+) mDCs isolated from peripheral blood after infection with hMPV and RSV, and examined their ability to stimulate T cell proliferation and differentiation. Our data show that RSV and hMPV induce virus-specific and subset-specific patterns of co-stimulatory molecule and cytokine expression. RSV, but not hMPV, impaired the capacity of infected mDCs to stimulate T cell proliferation. Whereas hMPV-infected BDCA-1(+) and BDCA-3(+) mDCs induced expansion of Th17 cells, in response to RSV, BDCA-1+ mDCs induced expansion of Th1 cells and BDCA-3(+) mDCs induced expansion of Th2 cells and Tregs. These results demonstrate a virusspecific and subset-specific effect of RSV and hMPV infection on mDC function, suggesting that these viruses may induce different adaptive immune responses.	[Gupta, Meera R.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Gupta, Meera R.; Kolli, Deepthi; Casola, Antonella; Garofalo, Roberto P.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Kolli, Deepthi; Casola, Antonella; Garofalo, Roberto P.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Casola, Antonella; Garofalo, Roberto P.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Molteni, Claudio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Gupta, MR (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	megupta@utmb.edu	Garofalo, Roberto P./ABL-2322-2022; Garofalo, Roberto P./AAF-7385-2022		National Center for Research Resources [UL1RR029876]; National Institutes of Health [NO1-HV-00245]; Universita degli Studi di Milano, Italy;  [KL2RR029875];  [AI062885];  [AI07924602]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR029875, UL1RR029876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885, R01AI079246] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universita degli Studi di Milano, Italy; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project described was supported by award number KL2RR029875 (to Meera Gupta) and UL1RR029876 (to Allan Brasier) from the National Center for Research Resources and by award number AI062885 (to Roberto Garofalo/Allan Brasier) and AI07924602 (to Antonella Casola) and NO1-HV-00245 (to Alexander Kurosky/Roberto Garofalo) from the National Institutes of Health. Claudio Molteni was supported by a fellowship from Universita degli Studi di Milano, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2005, J VIROL, V79, P5971, DOI 10.1128/JVI.79.10.5971-5978.2005; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bacher N, 2013, CANCER RES; Bao XY, 2008, J VIROL, V82, P8224, DOI 10.1128/JVI.02584-07; Barnaba V, 2013, EUR J IMMUNOL, V43, P318, DOI 10.1002/eji.201243265; Benwell RK, 2010, CELL IMMUNOL, V264, P119, DOI 10.1016/j.cellimm.2010.05.008; Borderia AV, 2008, J IMMUNOL, V181, P6872, DOI 10.4049/jimmunol.181.10.6872; Braciale Thomas J, 2005, Proc Am Thorac Soc, V2, P141, DOI 10.1513/pats.200503-022AW; Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; de Bree GJ, 2007, J INFECT DIS, V195, P1718, DOI 10.1086/517612; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Demedts IK, 2006, AM J RESP CELL MOL, V35, P387, DOI 10.1165/rcmb.2005-0382OC; Douville RN, 2006, J IMMUNOL, V176, P5848, DOI 10.4049/jimmunol.176.10.5848; Faber TE, 2012, J MED VIROL, V84, P1084, DOI 10.1002/jmv.23291; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Freeman CM, 2009, AM J RESP CRIT CARE, V180, P1179, DOI 10.1164/rccm.200904-0552OC; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Garcia-Garcia ML, 2007, PEDIATR PULM, V42, P458, DOI 10.1002/ppul.20597; Garofalo RP, 2001, J INFECT DIS, V184, P393, DOI 10.1086/322788; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; Guerrero-Plata A, 2009, J IMMUNOL, V182, P3072, DOI 10.4049/jimmunol.0802262; Gupta MR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-71; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hayashi Y, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-29; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Heymann PW, 2004, J ALLERGY CLIN IMMUN, V114, P239, DOI 10.1016/j.jaci.2004.04.006; Johnson TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016458; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Jyonouchi H, 2010, EUR J PEDIATR, V169, P1233, DOI 10.1007/s00431-010-1210-y; Kassianos AJ, 2012, EUR J IMMUNOL, V42, P1512, DOI 10.1002/eji.201142098; Kayserova J, 2012, SCAND J IMMUNOL, V75, P305, DOI 10.1111/j.1365-3083.2011.02649.x; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; King IL, 2005, J IMMUNOL, V175, P641, DOI 10.4049/jimmunol.175.2.641; Kolli D, 2011, J IMMUNOL, V187, P47, DOI 10.4049/jimmunol.1002589; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Laham FR, 2004, J INFECT DIS, V189, P2047, DOI 10.1086/383350; Larranaga CL, 2009, PEDIATR INFECT DIS J, V28, P867, DOI 10.1097/INF.0b013e3181a3ea71; Le Nouen C, 2009, VIROLOGY, V385, P169, DOI 10.1016/j.virol.2008.11.043; Le Nouen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015017; Lebre MC, 2005, IMMUNOL CELL BIOL, V83, P525, DOI 10.1111/j.1440-1711.2005.01365.x; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Loebbermann J, 2012, MUCOSAL IMMUNOL, V5, P161, DOI 10.1038/mi.2011.62; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Munir S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001336; Murtaza A, 1999, INT IMMUNOL, V11, P407, DOI 10.1093/intimm/11.3.407; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Osugi Y, 2002, BLOOD, V100, P2858, DOI 10.1182/blood.V100.8.2858; Papenburg J, 2010, REV MED VIROL, V20, P245, DOI 10.1002/rmv.651; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Pulendran B, 2005, J IMMUNOL, V174, P2457, DOI 10.4049/jimmunol.174.5.2457; Ren JP, 2011, J GEN VIROL, V92, P2153, DOI 10.1099/vir.0.032987-0; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Rogge L, 1998, J IMMUNOL, V161, P6567; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Spears M, 2011, CLIN EXPT ALLERGY J, P1; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; Sung RYT, 2001, EUR J PEDIATR, V160, P117, DOI 10.1007/s004310000676; Tan MC, 2007, VIROLOGY, V357, P1, DOI 10.1016/j.virol.2006.08.004; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Vermaelen K, 2005, AM J RESP CRIT CARE, V172, P530, DOI 10.1164/rccm.200410-1384SO; Williams JV, 2005, J INFECT DIS, V192, P1149, DOI 10.1086/444392; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Wissinger EL, 2008, J IMMUNOL, V180, P2957, DOI 10.4049/jimmunol.180.5.2957; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Zhao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046241; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778	84	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99227	10.1371/journal.pone.0099227	http://dx.doi.org/10.1371/journal.pone.0099227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918929	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000062
J	Mallon, JC; Anderson, JS				Mallon, Jordan C.; Anderson, Jason S.			The Functional and Palaeoecological Implications of Tooth Morphology and Wear for the Megaherbivorous Dinosaurs from the Dinosaur Park Formation (Upper Campanian) of Alberta, Canada	PLOS ONE			English	Article							JUDITH RIVER FORMATION; DENTAL MICROWEAR; PROVINCIAL-PARK; JAW MECHANICS; BRACHYLOPHOSAURUS-CANADENSIS; ORNITHISCHIA ANKYLOSAURIA; QUANTITATIVE-ANALYSIS; INTRACRANIAL JOINTS; FEEDING MECHANISMS; EVOLUTION	Megaherbivorous dinosaurs were exceptionally diverse on the Late Cretaceous island continent of Laramidia, and a growing body of evidence suggests that this diversity was facilitated by dietary niche partitioning. We test this hypothesis using the fossil megaherbivore assemblage from the Dinosaur Park Formation (upper Campanian) of Alberta as a model. Comparative tooth morphology and wear, including the first use of quantitative dental microwear analysis in the context of Cretaceous palaeosynecology, are used to infer the mechanical properties of the foods these dinosaurs consumed. The phylliform teeth of ankylosaurs were poorly adapted for habitually processing high-fibre plant matter. Nevertheless, ankylosaur diets were likely more varied than traditionally assumed: the relatively large, bladed teeth of nodosaurids would have been better adapted to processing a tougher, more fibrous diet than the smaller, cusp-like teeth of ankylosaurids. Ankylosaur microwear is characterized by a preponderance of pits and scratches, akin to modern mixed feeders, but offers no support for interspecific dietary differences. The shearing tooth batteries of ceratopsids are much better adapted to high-fibre herbivory, attested by their scratch-dominated microwear signature. There is tentative microwear evidence to suggest differences in the feeding habits of centrosaurines and chasmosaurines, but statistical support is not significant. The tooth batteries of hadrosaurids were capable of both shearing and crushing functions, suggestive of a broad dietary range. Their microwear signal overlaps broadly with that of ankylosaurs, and suggests possible dietary differences between hadrosaurines and lambeosaurines. Tooth wear evidence further indicates that all forms considered here exhibited some degree of masticatory propaliny. Our findings reveal that tooth morphology and wear exhibit different, but complimentary, dietary signals that combine to support the hypothesis of dietary niche partitioning. The inferred mechanical and dietary patterns appear constant over the 1.5 Myr timespan of the Dinosaur Park Formation megaherbivore chronofauna, despite continual species turnover.	[Mallon, Jordan C.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Anderson, Jason S.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	University of Calgary; University of Calgary	Mallon, JC (corresponding author), Canadian Museum Nat, POB 3443 Stn D, Ottawa, ON K1P 6P4, Canada.	jmallon@mus-nature.ca		Mallon, Jordan/0000-0002-8209-8827	NSERC Alexander Graham Bell Canada Graduate Scholarship; Alberta Innovates Technology Futures graduate student scholarship; Queen Elizabeth II Graduate Scholarship; Jurassic Foundation grant; NSERC Discovery grant	NSERC Alexander Graham Bell Canada Graduate Scholarship; Alberta Innovates Technology Futures graduate student scholarship; Queen Elizabeth II Graduate Scholarship; Jurassic Foundation grant; NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding to JCM was provided by an NSERC Alexander Graham Bell Canada Graduate Scholarship, Alberta Innovates Technology Futures graduate student scholarship, Queen Elizabeth II Graduate Scholarship, and Jurassic Foundation grant. Funding to JSA was provided by an NSERC Discovery grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O., 1922, PALAEONTOL Z, V4, P87; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ager Derek V, 1963, PRINCIPLES PALEOECOL; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arbour VM, 2009, J VERTEBR PALEONTOL, V29, P1117, DOI 10.1671/039.029.0405; Archer D, 2002, J ZOOL, V257, P13, DOI 10.1017/S0952836902000614; ARCHIBALD JD, 1996, DINOSAUR EXTINCTION, P237; BAKKER RT, 1978, NATURE, V274, P661, DOI 10.1038/274661a0; Barrett Paul M., 2000, P42, DOI 10.1017/CBO9780511549717.004; Barrett PM, 2001, LIFE O PAST, P25; Barrett PM, 1998, THESIS U CAMBRIDGE C; Behrensmeyer Anna K., 1992, P15; BELAND P, 1978, CAN J EARTH SCI, V15, P1012, DOI 10.1139/e78-109; Brinkman DB, 1998, PALAIOS, V13, P160, DOI 10.2307/3515487; BRINKMAN DB, 1990, PALAEOGEOGR PALAEOCL, V78, P37, DOI 10.1016/0031-0182(90)90203-J; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; Calvo Jorge O., 1994, Gaia, V10, P183; Carpenter K., 1990, P281, DOI 10.1017/CBO9780511608377.024; Carpenter Kenneth, 1997, P307; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; Chin K, 2007, PALAIOS, V22, P554, DOI 10.2110/palo.2006.p06-087r; Coe M.J., 1987, P225; Coombs W.P. Jr, 1990, P456; COOMBS W P JR, 1978, Palaeontology (Oxford), V21, P143; Coombs W.P. Jr, 1990, P269, DOI 10.1017/CBO9780511608377.023; COSTA RL, 1981, J PALEONTOL, V55, P635; CROMPTON A W, 1970, Zoological Journal of the Linnean Society, V49, P21, DOI 10.1111/j.1096-3642.1970.tb00728.x; Currie Philip J., 1995, P111; Currie PJ, 1984, 3 S MES TERR EC, P52; Cuthbertson RS, 2012, ANAT REC, V295, P968, DOI 10.1002/ar.22458; Dodson P., 1983, Mosasaur, V1, P89; DODSON P, 1971, PALAEOGEOGR PALAEOCL, V10, P21, DOI 10.1016/0031-0182(71)90044-7; DODSON P, 1993, AM J SCI, V293A, P200, DOI 10.2475/ajs.293.A.200; Dodson P., 1996, HORNED DINOSAURS NAT; Dodson P, 1997, ENCY DINOSAURS, P473; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Dodson Peter, 1997, P393; EBERTH DA, 2001, GUIDEBOOK FIELD TRIP, P49; Eberth David A., 2010, P495; Edmund A.G., 1960, CONTR LIFE SCI DIV R, V52, P1, DOI DOI 10.5962/BHL.TITLE.52196; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Erickson GM, 2012, SCIENCE, V338, P98, DOI 10.1126/science.1224495; Evans AR, 2003, BIOL J LINN SOC, V78, P173, DOI 10.1046/j.1095-8312.2003.00146.x; Farke AA, 2011, ACTA PALAEONTOL POL, V56, P691, DOI 10.4202/app.2010.0121; Fiorillo A.R., 2011, PALAEONTOL ELECTRON, V14, P7; Fiorillo A. R, 1991, 5 S MES TERR ECOS BI, P23; Fiorillo Anthony R., 2008, P104; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fortelius Mikael, 2000, American Museum Novitates, V3301, P1, DOI 10.1206/0003-0082(2000)301<0001:FCOUMU>2.0.CO;2; Fraser D, 2011, J MORPHOL, V272, P1513, DOI 10.1002/jmor.11001; Fraser D, 2009, PALAIOS, V24, P818, DOI 10.2110/palo.2009.p09-064r; Freeman PW, 2000, EVOL ECOL RES, V2, P317; Fritz H, 2002, OECOLOGIA, V131, P620, DOI 10.1007/s00442-002-0919-3; Fujiwara S, 2009, J VERTEBR PALEONTOL, V29, P1136, DOI 10.1671/039.029.0406; Funston GF, 2014, CAN J EARTH SCI, V51, P156, DOI 10.1139/cjes-2013-0186; Galton P.M., 1986, P203; Godfrey SJ, 1995, J VERTEBR PALEONTOL, V15, P726, DOI 10.1080/02724634.1995.10011258; GORDON KD, 1984, AM J PHYS ANTHROPOL, V63, P77, DOI 10.1002/ajpa.1330630110; GORDON KD, 1984, J DENT RES, V63, P1043, DOI 10.1177/00220345840630080601; GORDON KD, 1984, ARCH ORAL BIOL, V29, P783, DOI 10.1016/0003-9969(84)90007-4; GORDON KD, 1982, AM J PHYS ANTHROPOL, V59, P195, DOI 10.1002/ajpa.1330590208; GORNIAK GC, 1982, J MORPHOL, V171, P321, DOI 10.1002/jmor.1051710307; Goswami A, 2005, J VERTEBR PALEONTOL, V25, P320, DOI 10.1671/0272-4634(2005)025[0320:DMITAI]2.0.CO;2; GREAVES W S, 1974, Forma et Functio, V7, P363; GREAVES WS, 1978, J ZOOL, V184, P271, DOI 10.1111/j.1469-7998.1978.tb03282.x; GREAVES WS, 1980, AM NAT, V116, P432, DOI 10.1086/283636; GREAVES WS, 1973, J PALEONTOL, V47, P1000; Green JL, 2009, ZOOL J LINN SOC-LOND, V156, P201, DOI 10.1111/j.1096-3642.2008.00486.x; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Haas G., 1969, American Museum Novitates, VNo. 2399, P1; HAAS GEORG, 1955, AMER MUS NOVITATES, V1729, P1; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; Hiiemae K.M., 1985, P262; Hiiemae KM, 1976, MASTICATION, P105; Holliday CM, 2008, J VERTEBR PALEONTOL, V28, P1073, DOI 10.1671/0272-4634-28.4.1073; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hunt Rebecca K., 2010, P447; Hwang SH, 2005, J MORPHOL, V266, P208, DOI 10.1002/jmor.10372; JANIS C M, 1990, Memoirs of the Queensland Museum, V28, P349; JANIS CM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P76; Jernvall J., 2000, P269, DOI 10.1017/CBO9780511542626.019; JOHNSON RE, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P205; Kaiser TM, 2010, J ZOOL, V281, P12, DOI 10.1111/j.1469-7998.2009.00674.x; Kay R.F., 1978, P173; Kay R.F., 1978, P309; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; King G.M., 1996, REPTILES HERBIVORY; King T, 1999, AM J PHYS ANTHROPOL, V108, P359, DOI 10.1002/(SICI)1096-8644(199903)108:3<359::AID-AJPA10>3.0.CO;2-9; Kraeusel R., 1922, Palaeontologische Zeitschrift, V4, P80; KRASSILOV VA, 1981, PALAEOGEOGR PALAEOCL, V34, P207, DOI 10.1016/0031-0182(81)90065-1; Lambe L.M., 1920, GEOLOGICAL SURVEY CA, V120, P1, DOI [DOI 10.4095/101655, 10.4095/101655]; Lamprey H. F., 1963, East African Wildlife Journal, V1, P63; Landman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069771; Lehman T. M., 1997, DINOFEST INT, P223; Lehman Thomas M., 2001, P310; Losos Jonathan B., 1994, P60; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas P.W., 2000, P282, DOI 10.1017/CBO9780511542626.020; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; LUCAS PW, 1995, PHILOS T R SOC B, V348, P363, DOI 10.1098/rstb.1995.0074; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; LULL RICHARD SWANN, 1933, MEM PEABODY MUS NAT HIST, V3, P1; Lull RS, 1908, AM J SCI, V25, P387; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mallon JC, J VERT PALE IN PRESS; Mallon JC, 2014, PALAEOGEOGR PALAEOCL, V394, P29, DOI 10.1016/j.palaeo.2013.11.014; Mallon JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067182; Mallon JC, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-14; Mallon JC, 2012, PALAEOGEOGR PALAEOCL, V350, P124, DOI 10.1016/j.palaeo.2012.06.024; Manchester SR, 2010, INT J PLANT SCI, V171, P679, DOI 10.1086/653688; MCNAUGHTON SJ, 1986, ANNU REV ECOL SYST, V17, P39, DOI 10.1146/annurev.es.17.110186.000351; Merceron G, 2006, NATURWISSENSCHAFTEN, V93, P329, DOI 10.1007/s00114-006-0107-0; MILLS JRE, 1972, P ROY SOC MED, V65, P392, DOI 10.1177/003591577206500440; Morris W. J., 1970, Contr. Sci., VNo. 193, P1; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nopcsa F, 1900, DINOSAURIERRESTE SIE, V68, P555; Nopcsa F., 1928, GEOLOGICA HUNGARIA S, V1, P3; Norman D.B., 1984, Symposia of the Zoological Society of London, P521; NORMAN DB, 1985, AM NAT, V126, P151, DOI 10.1086/284406; Norman DB., 1991, BIOMECHANICS EVOLUTI, P161; OLSON EC, 1952, EVOLUTION, V6, P181, DOI 10.2307/2405622; OSTROM JH, 1966, EVOLUTION, V20, P290, DOI 10.1111/j.1558-5646.1966.tb03367.x; Ostrom JH., 1961, B AM MUS NAT HIST, V122, P39; OSTROM JOHN H., 1964, POSTILLA [YALE PEABODY MUS], V88, P1; Owen-Smith N., 1988, MEGAHERBIVORES INFLU; Parks W. A., 1924, University of Toronto Studies Geological Series, V18, P1; Paul GS, 2000, PALEOBIOLOGY, V26, P450, DOI 10.1666/0094-8373(2000)026<0450:FPINDI>2.0.CO;2; Peng J-H, 2001, PROV MUS ALBERTA NAT, V25, P1, DOI DOI 10.5962/BHL.TITLE.115853; Penkalski P, 2013, CAN J EARTH SCI, V50, P171, DOI 10.1139/cjes-2012-0098; PREGILL G, 1984, J HERPETOL, V18, P186, DOI 10.2307/1563747; Reilly SM, 2001, COMP BIOCHEM PHYS A, V128, P397, DOI 10.1016/S1095-6433(00)00326-3; RENSBERGER JM, 1973, J PALEONTOL, V47, P515; Russell D.A., 1977, Natural Hist ser natn Mus Can, VNo. 4, P1; Russell L. S., 1940, University of Toronto Studies Geological Series, V43, P1; RUSSELL LORIS S., 1935, BULL NAT MUS CANADA, V77, P39; RYAN AS, 1979, AM J PHYS ANTHROPOL, V50, P155, DOI 10.1002/ajpa.1330500204; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Rybczynski N, 2001, LIFE O PAST, P299; Rybczynski N, 2008, PALAEONTOL ELECTRON, V11; Sampson Scott D., 2001, P263; Sampson SD, 1993, THESIS U TORONTO TOR; Sander P. M., 1997, ENCY DINOSAURS, P717; Sander PM., 2010, PLANTS MESOZOIC TIME, P331; Sanson G, 2006, AM J BOT, V93, P1531, DOI 10.3732/ajb.93.10.1531; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Semprebon GM, 2004, J HUM EVOL, V47, P115, DOI 10.1016/j.jhevol.2004.06.004; SERENO PC, 1986, NATL GEOGR RES, V2, P234; SINCLAIR ARE, 1975, J ANIM ECOL, V44, P497, DOI 10.2307/3608; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Smith J. M., 1959, School Science Review, V40, P289; Smith JB, 2003, J VERTEBR PALEONTOL, V23, P1, DOI 10.1671/0272-4634(2003)23[1:APFAST]2.0.CO;2; Sokal R. R., 2012, BIOMETRY; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; SOLOUNIAS N, 1988, PALEOBIOLOGY, V14, P287, DOI 10.1017/S009483730001201X; Sternberg C. M., 1936, Journal of Paleontology Menasha, V10, P652; STRAIT SG, 1993, J HUM EVOL, V25, P471, DOI 10.1006/jhev.1993.1062; Strait Suzanne G., 1997, Evolutionary Anthropology, V5, P199, DOI 10.1002/(SICI)1520-6505(1997)5:6<199::AID-EVAN2>3.0.CO;2-8; TAIT JOHN, 1928, TRANS ROY SOC CANADA SECT V, V22, P13; Tanoue K, 2009, ANAT REC, V292, P1352, DOI 10.1002/ar.20979; Teaford M. F., 2007, EVOLUTION HOMININ DI, P106; Teaford Mark F., 1994, Evolutionary Anthropology, V3, P17, DOI 10.1002/evan.1360030107; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1167; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Thompson S, 2007, PALAEONTOL ELECTRON, V10; THROCKMORTON GS, 1976, J MORPHOL, V148, P363, DOI 10.1002/jmor.1051480307; Turner Derek, 2011, PALEONTOLOGY PHILOS; Tweet JS, 2008, PALAIOS, V23, P624, DOI 10.2110/palo.2007.p07-044r; UNGAR PS, 1994, AM J PHYS ANTHROPOL, V94, P339, DOI 10.1002/ajpa.1330940305; Ungar PS, 2003, SCANNING, V25, P185, DOI 10.1002/sca.4950250405; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Varriale FJ, 2011, THESIS J HOPKINS U B; Varriale F, 2004, J VERTEBR PALEONTOL, V24, p124A; Versluys J., 1923, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V38, P1; Versluys J, 1922, PALAEONTOL Z, V4, P80; Versluys J., 1910, ZOOLOGISCHE JB ABTEI, V30, P175; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Vickaryous MK, 2003, ZOOL J LINN SOC-LOND, V137, P157, DOI 10.1046/j.1096-3642.2003.00045.x; von Kripp D, 1933, PALAEOBIOLOGICA, V5, P409; WALKER PL, 1976, AM J PHYS ANTHROPOL, V45, P299, DOI 10.1002/ajpa.1330450215; WEISHAMPEL D B, 1983, Acta Palaeontologica Polonica, V28, P271; Weishampel D.B., 1987, Occasional Paper of the Tyrrell Museum of Palaeontology, P167; Weishampel D.B., 1984, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V167, P224; Weishampel David B., 2000, P123, DOI 10.1017/CBO9780511549717.006; WEISHAMPEL DB, 1984, ADV ANAT EMBRYOL CEL, V87, P1; Weishampel DB, 1989, GEOL SOC AM SPEC PAP, V238, P87, DOI DOI 10.1130/SPE238-P87; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Williams VS, 2009, P NATL ACAD SCI USA, V106, P11194, DOI 10.1073/pnas.0812631106; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; You Hailu, 2004, P478	196	48	51	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98605	10.1371/journal.pone.0098605	http://dx.doi.org/10.1371/journal.pone.0098605			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918431	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000023
J	Menghini, R; Campia, U; Tesauro, M; Marino, A; Rovella, V; Rodia, G; Schinzari, F; Tolusso, B; di Daniele, N; Federici, M; Zoli, A; Ferraccioli, G; Cardillo, C				Menghini, Rossella; Campia, Umberto; Tesauro, Manfredi; Marino, Arianna; Rovella, Valentina; Rodia, Giuseppe; Schinzari, Francesca; Tolusso, Barbara; di Daniele, Nicola; Federici, Massimo; Zoli, Angelo; Ferraccioli, Gianfranco; Cardillo, Carmine			Toll-Like Receptor 4 Mediates Endothelial Cell Activation Through NF-kappa B but Is Not Associated with Endothelial Dysfunction in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; REDUCES ATHEROSCLEROSIS; METALLOPROTEINASE 3; AMERICAN-COLLEGE; TISSUE INHIBITOR; APOLIPOPROTEIN-E; INNATE IMMUNITY; TLR4; MICE; DISEASE	Objective: To investigate the effects of TLR4 antagonism on human endothelial cells activation and cytokine expression, and whether the Asp299Gly TLR4 polymorphism is associated with better endothelial function in patients with rheumatoid arthritis (RA). Methods: Human aortic endothelial cells (HAECs) were treated with lipopolysaccharide (LPS), OxPAPC, and free fatty acids (FFA) at baseline and after incubation with the TLR4 antagonist eritoran (E5564). Cytokine expression was assessed by quantitative real-time PCR. In vivo endothelial function was assessed as brachial artery flow-mediated dilation (FMD) in RA patients with the wild type gene (aa) and with the Asp299Gly TLR4 polymorphic variant (ag). Results: In HAEC, TLR4 antagonism with eritoran inhibited LPS-induced mRNA expression of IL-6, IL-8, TNF alpha, CCL-2, VCAM and ICAM (P < 0.05 for all) and inhibited Ox-PAPC-induced mRNA expression of IL-8 (P < 0.05) and IL-6, albeit not to a statistically significant level (p = 0.07). In contrast, eritoran did not affect FFA-induced mRNA expression of IL-6 (P > 0.05). In 30 patients with RA (15 with the ag allele) undergoing measurement of FMD, no differences in FMD and plasma levels of IL6, IL-8, VCAM, and ICAM were found between the aa and the ag phenotype (P > 0.05 for all). Conclusions: TLR4 signaling in endothelial cells may be triggered by LPS and oxidized phospholipids, leading to endothelial activation and inflammation, which are inhibited by eritoran. Our in vivo investigation, however, does not support an association between the Asp299Gly TLR4 polymorphism and improved endothelium-dependent vasodilator function in patients with RA. Further study is needed to better understand the potential role of TLR4 on endothelial dysfunction in this and other patient populations.	[Menghini, Rossella; Tesauro, Manfredi; Marino, Arianna; Rovella, Valentina; Rodia, Giuseppe; di Daniele, Nicola; Federici, Massimo] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Campia, Umberto] MedStar Heart Inst, Div Cardiol, Washington, DC 20010 USA; [Schinzari, Francesca; Cardillo, Carmine] Univ Cattolica Sacro Cuore, Sch Med, Dept Internal Med, Rome, Italy; [Tolusso, Barbara; Zoli, Angelo; Ferraccioli, Gianfranco] Univ Cattolica Sacro Cuore, Sch Med, Dept Rheumatol, Rome, Italy; [Federici, Massimo] Policlin Tor Vergata, Ctr Atherosclerosis, Rome, Italy	University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Rome Tor Vergata; Policlin Tor Vergata	Campia, U (corresponding author), MedStar Heart Inst, Div Cardiol, Washington, DC 20010 USA.	umberto.campia@medstar.net	schinzari, francesca/AAB-9982-2019; Tolusso, Barbara/K-8995-2018; Federici, Massimo/G-9940-2012; menghini, rossella/I-3485-2012; Rovella, Valentina/AAB-9727-2019	Tolusso, Barbara/0000-0002-9108-6609; Federici, Massimo/0000-0003-4989-5194; menghini, rossella/0000-0001-8397-2355; Rovella, Valentina/0000-0002-3311-486X; Cardillo, Carmine/0000-0001-5182-3005; Ferraccioli, Gianfranco/0000-0002-6884-4301	intramural grant of Tor Vergata University	intramural grant of Tor Vergata University	This work as supported by an intramural grant of Tor Vergata University to Dr. Menghini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Barochia A, 2011, EXPERT OPIN DRUG MET, V7, P479, DOI 10.1517/17425255.2011.558190; Casagrande V, 2012, ARTERIOSCL THROM VAS, V32, P74, DOI 10.1161/ATVBAHA.111.238402; Chen L, 1997, J LIPID RES, V38, P546; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Dvoracek LA, 2010, ATHEROSCLEROSIS, V208, P50, DOI 10.1016/j.atherosclerosis.2009.06.013; He M, 2013, ARTERIOSCL THROM VAS, V33, P1384, DOI 10.1161/ATVBAHA.113.301490; Hollan I, 2013, AUTOIMMUNITY REV; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Lorenz E, 2001, BIOTECHNIQUES, V31, P22, DOI 10.2144/01311bm01; Lu ZY, 2013, J ENDOCRINOL, V216, P61, DOI 10.1530/JOE-12-0338; Lu ZY, 2012, ARTERIOSCL THROM VAS, V32, P1696, DOI 10.1161/ATVBAHA.112.251181; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Michelsen KS, 2004, J IMMUNOL, V173, P5901, DOI 10.4049/jimmunol.173.10.5901; Murdaca G, 2012, ATHEROSCLEROSIS, V224, P309, DOI 10.1016/j.atherosclerosis.2012.05.013; Netea MG, 2004, EUR J CLIN INVEST, V34, P94, DOI 10.1111/j.1365-2362.2004.01303.x; O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802; Prevoo MLL, 1996, BRIT J RHEUMATOL, V35, P1101; Protogerou AD, 2011, ATHEROSCLEROSIS, V219, P734, DOI 10.1016/j.atherosclerosis.2011.09.015; Radstake TRDJ, 2004, ARTHRITIS RHEUM, V50, P999, DOI 10.1002/art.20114; Rizza S, 2011, ATHEROSCLEROSIS, V215, P180, DOI 10.1016/j.atherosclerosis.2010.12.021; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sun RJ, 2012, CELL BIOL INT, V36, P475, DOI 10.1042/CBI20110535; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Zhang K, 2012, THROMB RES, V130, pE203, DOI 10.1016/j.thromres.2012.07.008	34	33	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99053	10.1371/journal.pone.0099053	http://dx.doi.org/10.1371/journal.pone.0099053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918924	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000044
J	Yang, Y; Fu, L; Zhang, JL; Hu, LH; Xu, MJ; Xu, J				Yang, Yong; Fu, Ling; Zhang, Jinlong; Hu, Linghan; Xu, Minjuan; Xu, Jun			Characterization of the Xiamenmycin Biosynthesis Gene Cluster in Streptomyces xiamenensis 318	PLOS ONE			English	Article							MEMBRANE-BOUND PRENYLTRANSFERASE; CHORISMATE PYRUVATE-LYASE; CHALCONE-ISOMERASE; ESCHERICHIA-COLI; LITHOSPERMUM-ERYTHRORHIZON; REACTION-MECHANISM; CLONING; 4-HYDROXYBENZOATE; PURIFICATION; ENZYME	Xiamenmycin (1) is a prenylated benzopyran derivative with anti-fibrotic activity. To investigate the genetic basis of xiamenmycin biosynthesis, we performed genome mining in the xiamenmycin-producing Streptomyces xiamenensis wildtype strain 318 to identify a candidate gene cluster. The complete gene cluster, consisting of five genes, was confirmed by a series of gene inactivations and heterologous expression. Based on bioinformatics analyses of each gene and feeding experiments, we found that the structure of an intermediate xiamenmycin B (3) accumulated in a ximA inactivation mutant, allowing us to propose a biosynthetic pathway. All five of the genes in the pathway were genetically and biochemically characterized. XimA was biochemically characterized as an ATP-dependent amide synthetase, catalyzing an amide bond formation in the presence of ATP as the final step in Xiamenmycin biosynthesis. The Km value of XimA was determined to be 474.38 mM for the substrate xiamenmycin B. These studies provide opportunities to use genetic and chemo-enzymatic methods to create new benzopyran derivatives as potential therapeutic agents.	[Yang, Yong; Fu, Ling; Zhang, Jinlong; Hu, Linghan; Xu, Jun] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Yang, Yong; Fu, Ling; Zhang, Jinlong; Hu, Linghan; Xu, Jun] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Ocean Engn, Shanghai 200030, Peoples R China; [Xu, Minjuan] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Key Lab Syst Biomed, Shanghai 200030, Peoples R China; [Xu, Jun] Shanghai Jiao Tong Univ, Inst Oceanol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, MJ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Key Lab Syst Biomed, Shanghai 200030, Peoples R China.	minjuanxu@sjtu.edu.cn; xujunn@sjtu.edu.cn	zhang, jin/GXV-9154-2022		National Basic Research Program of China "973'' [2012CB721001]; NSFC [81273404]	National Basic Research Program of China "973''(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	The work was supported by the National Basic Research Program of China "973'' 2012CB721001 and NSFC 81273404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BEDNAR RA, 1988, J BIOL CHEM, V263, P9582; BLACK PN, 1992, J BIOL CHEM, V267, P25513; BOLAND MJ, 1975, EUR J BIOCHEM, V50, P383, DOI 10.1111/j.1432-1033.1975.tb09814.x; Brauer L, 2008, CHEMBIOCHEM, V9, P982, DOI 10.1002/cbic.200700575; Chen YH, 2010, J BIOL CHEM, V285, P38853, DOI 10.1074/jbc.M110.147744; Gensheimer M, 2004, PROTEIN SCI, V13, P540, DOI 10.1110/ps.03395404; He YL, 2010, J MICROBIOL BIOTECHN, V20, P678, DOI 10.4014/jmb.0910.10031; Holden MJ, 2002, BBA-PROTEIN STRUCT M, V1594, P160, DOI 10.1016/S0167-4838(01)00302-8; Hur S, 2003, J AM CHEM SOC, V125, P1472, DOI 10.1021/ja0293047; Jez JM, 2002, BIOCHEMISTRY-US, V41, P5168, DOI 10.1021/bi0255266; Jez JM, 2002, J BIOL CHEM, V277, P1361, DOI 10.1074/jbc.M109224200; Kawamura N., 2000, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2000072766 A 20000307, 2000072766]; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h; LAWRENCE J, 1974, J BACTERIOL, V118, P41, DOI 10.1128/JB.118.1.41-45.1974; LWaB Sontag, 1996, ANGEW CHEM INT EDIT, V1996, P3; Macone A, 2009, BIOORGAN MED CHEM, V17, P6003, DOI 10.1016/j.bmc.2009.06.061; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Muhlenweg A, 1998, PLANTA, V205, P407, DOI 10.1007/s004250050337; Ngaki MN, 2012, NATURE, V485, P530, DOI 10.1038/nature11009; NICHOLS BP, 1992, J BACTERIOL, V174, P5309, DOI 10.1128/JB.174.16.5309-5316.1992; Ohara K, 2009, BIOCHEM J, V421, P231, DOI 10.1042/BJ20081968; Peer WA, 2012, NAT CHEM BIOL, V8, P607, DOI 10.1038/nchembio.1006; Ruiz-Pernia JJ, 2007, J AM CHEM SOC, V129, P9117, DOI 10.1021/ja071720+; Sandmann A, 2007, ANGEW CHEM INT EDIT, V46, P2712, DOI 10.1002/anie.200603513; SCHREUDER HA, 1988, J MOL BIOL, V199, P637, DOI 10.1016/0022-2836(88)90307-5; SIEBERT M, 1992, FEBS LETT, V307, P347, DOI 10.1016/0014-5793(92)80710-X; SIEBERT M, 1994, MICROBIOL-SGM, V140, P897, DOI 10.1099/00221287-140-4-897; Smith L, 2008, CHEMBIOCHEM, V9, P2967, DOI 10.1002/cbic.200800585; Sultana A, 2004, EMBO J, V23, P1911, DOI 10.1038/sj.emboj.7600201; WU GH, 1993, J GEN MICROBIOL, V139, P1795, DOI 10.1099/00221287-139-8-1795; Xu J, 2009, INT J SYST EVOL MICR, V59, P472, DOI 10.1099/ijs.0.000497-0; Xu MJ, 2012, MAR DRUGS, V10, P639, DOI 10.3390/md10030639; Yazaki K, 2002, J BIOL CHEM, V277, P6240, DOI 10.1074/jbc.M106387200	36	16	18	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99537	10.1371/journal.pone.0099537	http://dx.doi.org/10.1371/journal.pone.0099537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919072	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000093
J	Caron, V; Ede, FJ; Sunnucks, P				Caron, Valerie; Ede, Fiona J.; Sunnucks, Paul			Unravelling the Paradox of Loss of Genetic Variation during Invasion: Superclones May Explain the Success of a Clonal Invader	PLOS ONE			English	Article							OLIGOSPILUS FORSTER HYMENOPTERA; PARTHENOGENETIC SITOBION APHIDS; ADAPTIVE EVOLUTION; MOLECULAR EVIDENCE; REPRODUCTIVE MODE; RANGE EXPANSION; INSECT PEST; TENTHREDINIDAE; MICROSATELLITE; DISPERSAL	Clonality is a common characteristic of successful invasive species, but general principles underpinning the success of clonal invaders are not established. A number of mechanisms could contribute to invasion success including clones with broad tolerances and preferences, specialist clones and adaptation in situ. The majority of studies to date have been of plants and some invertebrate parthenogens, particularly aphids, and have not necessarily caught invasion at very early stages. Here we describe the early stages of an invasion by a Northern Hemisphere Hymenopteran model in three different land masses in the Southern Hemisphere. Nematus oligospilus Forster (Hymenoptera: Tenthredinidae), a sawfly feeding on willows (Salix spp.), was recently introduced to the Southern Hemisphere where it has become invasive and is strictly parthenogenetic. In this study, the number of N. oligospilus clones, their distribution in the landscape and on different willow hosts in South Africa, New Zealand and Australia were assessed using 25 microsatellite markers. Evidence is presented for the presence of two very common and widespread multilocus genotypes (MLGs) or 'superclones' dominating in the three countries. Rarer MLGs were closely related to the most widespread superclone; it is plausible that all N. oligospilus individuals were derived from a single clone. A few initial introductions to Australia and New Zealand seemed to have occurred. Our results point towards a separate introduction in Western Australia, potentially from South Africa. Rarer clones that were dominant locally putatively arose in situ, and might be locally favoured, or simply have not yet had time to spread. Data presented represent rare baseline data early in the invasion process for insights into the mechanisms that underlie the success of a global invader, and develop Nematus oligospilus as a valuable model to understand invasion genetics of clonal pests.	[Caron, Valerie; Sunnucks, Paul] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Ede, Fiona J.] Dept Environm & Primary Ind, Biosci Res Div, Bundoora, Vic, Australia	Monash University	Caron, V (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	valerie.caron@monash.edu		Ede, Fiona/0000-0003-4553-7314; Sunnucks, Paul/0000-0002-8139-7059	Holsworth Endowment; Department of Primary Industries Nancy Millis Postgraduate Award; North East Catchment Management Agency; West Gippsland Catchment Management Agency; North Central Catchment Management Agency; Melbourne Water; Victorian Department of Primary Industries Nancy Millis Postgraduate Award	Holsworth Endowment; Department of Primary Industries Nancy Millis Postgraduate Award; North East Catchment Management Agency; West Gippsland Catchment Management Agency; North Central Catchment Management Agency; Melbourne Water; Victorian Department of Primary Industries Nancy Millis Postgraduate Award	This research was funded by Holsworth Endowment, the Department of Primary Industries Nancy Millis Postgraduate Award, North East Catchment Management Agency, West Gippsland Catchment Management Agency, North Central Catchment Management Agency, Melbourne Water and the Victorian Department of Primary Industries Nancy Millis Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2008, AQUAT BOT, V88, P113, DOI 10.1016/j.aquabot.2007.08.015; Benson R. B., 1950, Transactions of the Society for British Entomology, V10, P45; Berry Jocelyn A., 1997, New Zealand Entomologist, V20, P51; Bruzzese E., 2006, Plant Protection Quarterly, V21, P43; Budde KB, 2011, BIOL INVASIONS, V13, P45, DOI 10.1007/s10530-010-9785-9; Caron V, 2013, B ENTOMOL RES, V103, P74, DOI 10.1017/S0007485312000429; Caron V, 2014, AUSTRAL ENTOMOL, V53, P175, DOI 10.1111/aen.12067; Carr G., 1996, FLORA VICTORIA, P385; Carr GW, 2005, PROVISIONAL KEY NATU; Castaneda LE, 2010, J INSECT PHYSIOL, V56, P1058, DOI 10.1016/j.jinsphys.2010.02.019; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Colautti RI, 2005, MOL ECOL, V14, P1869, DOI 10.1111/j.1365-294X.2005.02565.x; Dapoto G., 1994, Bosque, V15, P27; Digweed SC, 2009, CAN ENTOMOL, V141, P201, DOI 10.4039/n09-003; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Dybdahl MF, 2005, ECOLOGY, V86, P1592, DOI 10.1890/04-0898; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Figueroa CC, 2005, HEREDITY, V95, P24, DOI 10.1038/sj.hdy.6800662; Figueroa CC, 2004, J CHEM ECOL, V30, P2515, DOI 10.1007/s10886-004-7947-x; Fisher D, 2001, BULLETIN, V4500; Frantz A, 2006, J EVOLUTION BIOL, V19, P392, DOI 10.1111/j.1420-9101.2005.01025.x; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Harrison JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017524; Hoffmann AA, 2008, P ROY SOC B-BIOL SCI, V275, P2473, DOI 10.1098/rspb.2008.0685; Koch F, 2000, P ENTOMOL SOC WASH, V102, P292; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Liston A. D., 1995, COMPENDIUM EUROPEAN; Marrs RA, 2008, BIOL INVASIONS, V10, P561, DOI 10.1007/s10530-007-9153-6; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; Muirhead JR, 2006, DIVERS DISTRIB, V12, P71, DOI 10.1111/j.1366-9516.2006.00218.x; Naumann ID, 2002, AUST J ENTOMOL, V41, P1, DOI 10.1046/j.1440-6055.2002.00260.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peccoud J, 2008, MOL ECOL, V17, P4608, DOI 10.1111/j.1365-294X.2008.03949.x; Perez JE, 2006, BIOL INVASIONS, V8, P1115, DOI 10.1007/s10530-005-8281-0; Pichancourt JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032323; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schmid-Hempel P, 2007, HEREDITY, V99, P414, DOI 10.1038/sj.hdy.6801017; SCOTT JK, 1993, J BIOGEOGR, V20, P87, DOI 10.2307/2845742; Shannon C., 1964, MATH THEORY COMMUNIC; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Smith D.R, 1979, CATALOG HYMENOPTERA, V1, P3; Spencer R, 1997, HORTICULTURAL FLOR 1; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Sunnucks P, 1996, GENETICS, V144, P747; Sunnucks P, 1998, HEREDITY, V81, P638, DOI 10.1046/j.1365-2540.1998.00444.x; Urban AJ, 1995, AFR ENTOMOL, V3, P23; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Vorburger C, 2003, ECOL LETT, V6, P1091, DOI 10.1046/j.1461-0248.2003.00536.x; Vorburger C, 2003, MOL ECOL, V12, P3493, DOI 10.1046/j.1365-294X.2003.01998.x; Vorwerk S, 2006, GENOME, V49, P678, DOI 10.1139/G06-028; Weeks AR, 1998, EVOLUTION, V52, P1325, DOI [10.2307/2411302, 10.1111/j.1558-5646.1998.tb02014.x]; Weetman D, 2002, GENETICS, V162, P813; Wilson ACC, 1999, MOL ECOL, V8, P1655, DOI 10.1046/j.1365-294x.1999.00751.x; Wilson ACC, 2003, BIOL J LINN SOC, V79, P115, DOI 10.1046/j.1095-8312.2003.00176.x; Wilson ACC, 2006, GENET RES, V87, P175, DOI 10.1017/S0016672306008202; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x; Zhang YY, 2010, MOL ECOL, V19, P1774, DOI 10.1111/j.1365-294X.2010.04609.x	64	19	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e97744	10.1371/journal.pone.0097744	http://dx.doi.org/10.1371/journal.pone.0097744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914550	Green Published, gold			2022-12-25	WOS:000340947700011
J	Phan, HT; Hause, B; Hause, G; Arcalis, E; Stoger, E; Maresch, D; Altmann, F; Joensuu, J; Conrad, U				Hoang Trong Phan; Hause, Bettina; Hause, Gerd; Arcalis, Elsa; Stoger, Eva; Maresch, Daniel; Altmann, Friedrich; Joensuu, Jussi; Conrad, Udo			Influence of Elastin-Like Polypeptide and Hydrophobin on Recombinant Hemagglutinin Accumulations in Transgenic Tobacco Plants	PLOS ONE			English	Article							PROTEIN BODY FORMATION; NEUTRALIZING ANTIBODIES; ENDOPLASMIC-RETICULUM; FUSION PROTEIN; IN-VITRO; PURIFICATION; EXPRESSION; VIRUS; BIOCOMPATIBILITY; INDUCTION	Fusion protein strategies are useful tools to enhance expression and to support the development of purification technologies. The capacity of fusion protein strategies to enhance expression was explored in tobacco leaves and seeds. C-terminal fusion of elastin-like polypeptides (ELP) to influenza hemagglutinin under the control of either the constitutive CaMV 35S or the seed-specific USP promoter resulted in increased accumulation in both leaves and seeds compared to the unfused hemagglutinin. The addition of a hydrophobin to the C-terminal end of hemagglutinin did not significantly increase the expression level. We show here that, depending on the target protein, both hydrophobin fusion and ELPylation combined with endoplasmic reticulum (ER) targeting induced protein bodies in leaves as well as in seeds. The N-glycosylation pattern indicated that KDEL sequence-mediated retention of leaf-derived hemagglutinins and hemagglutinin-hydrophobin fusions were not completely retained in the ER. In contrast, hemagglutinin-ELP from leaves contained only the oligomannose form, suggesting complete ER retention. In seeds, ER retention seems to be nearly complete for all three constructs. An easy and scalable purification method for ELPylated proteins using membrane-based inverse transition cycling could be applied to both leaf- and seed-expressed hemagglutinins.	[Hoang Trong Phan; Conrad, Udo] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Mol Genet, Gatersleben, Germany; [Hause, Bettina] Leibniz Inst Plant Biochem IPB, Halle, Germany; [Hause, Gerd] Univ Halle Wittenberg, Bioctr, Microscopy Unit, D-06108 Halle, Germany; [Arcalis, Elsa; Stoger, Eva] Univ Nat Resources & Appl Life Sci, Vienna, Austria; [Maresch, Daniel; Altmann, Friedrich] Univ Nat Resources & Appl Life Sci, Dept Chem, Vienna, Austria; [Hoang Trong Phan] Vietnam Acad Sci & Technol, Inst Biotechnol IBT, Dept Plant Cell Biotechnol, Hanoi, Vietnam; [Joensuu, Jussi] VTT Tech Res Ctr Finland, Espoo, Finland	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Leibniz Institut fur Pflanzenbiochemie; Martin Luther University Halle Wittenberg; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Vietnam Academy of Science & Technology (VAST); VTT Technical Research Center Finland	Conrad, U (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Mol Genet, Gatersleben, Germany.	conradu@ipk-gatersleben.de		Phan, Hoang Trong/0000-0001-7580-5776; Stoeger, Eva/0000-0002-7651-7992; Altmann, Friedrich/0000-0002-0112-7877; Arcalis, Elsa/0000-0001-9883-465X	Vietnam Ministry of Education and Training (MoET); BMBF (DLR), Germany	Vietnam Ministry of Education and Training (MoET); BMBF (DLR), Germany	This research was supported by the Vietnam Ministry of Education and Training (MoET) and by the BMBF (DLR), Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcalis E, 2004, PLANT PHYSIOL, V136, P3457, DOI 10.1104/pp.104.050153; Christensen T, 2007, ANAL BIOCHEM, V360, P166, DOI 10.1016/j.ab.2006.09.020; Conley AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-48; Conley AJ, 2009, BIOTECHNOL BIOENG, V103, P562, DOI 10.1002/bit.22278; Conrad U, 2011, PLANT BIOTECHNOL J, V9, P22, DOI 10.1111/j.1467-7652.2010.00523.x; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; Davoodi-Semiromi A, 2009, HUM VACCINES, V5, P488, DOI 10.4161/hv.8247; Duvenage L, 2013, J VIROL METHODS, V191, P55, DOI 10.1016/j.jviromet.2013.03.028; Egelkrout E, 2012, PLANT SCI, V184, P83, DOI 10.1016/j.plantsci.2011.12.005; Evangelista RL, 1998, BIOTECHNOL PROGR, V14, P607, DOI 10.1021/bp980047c; Fischer R, 2004, PLANT MADE PHARM TEC; Floss DM, 2012, ENCY SUSTAINABILITY, P8073; Floss DM, 2013, FUSION PROTEIN TECHN, P211; Floss DM, 2008, PLANT BIOTECHNOL J, V6, P379, DOI 10.1111/j.1467-7652.2008.00326.x; Floss DM, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P489, DOI 10.1007/978-3-642-01144-3_31; Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004; Floss DM, 2009, PLANT BIOTECHNOL J, V7, P899, DOI 10.1111/j.1467-7652.2009.00452.x; Floss DM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/274346; Gahrtz Manfred, 2009, V483, P289, DOI 10.1007/978-1-59745-407-0_17; Ge X, 2006, BIOTECHNOL BIOENG, V95, P424, DOI 10.1002/bit.21046; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Gutierrez SP, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-40; Phan HT, 2013, CURR PHARM DESIGN, V19, P5601, DOI 10.2174/1381612811319310014; Phan HT, 2011, INT J MOL SCI, V12, P2808, DOI 10.3390/ijms12052808; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Isayenkov S, 2005, PLANT PHYSIOL, V139, P1401, DOI 10.1104/pp.105.069054; Joensuu JJ, 2009, TRANSGENIC RES, V18, P685, DOI 10.1007/s11248-009-9257-0; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; KEIL W, 1985, EMBO J, V4, P2711, DOI 10.1002/j.1460-2075.1985.tb03991.x; Kolarich D, 2000, ANAL BIOCHEM, V285, P64, DOI 10.1006/abio.2000.4737; Landry N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015559; Lin M, 2006, BIOCHEM J, V398, P577, DOI 10.1042/BJ20060544; Linder MB, 2004, BIOCHEMISTRY-US, V43, P11873, DOI 10.1021/bi0488202; Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NakariSetala T, 1996, EUR J BIOCHEM, V235, P248, DOI 10.1111/j.1432-1033.1996.00248.x; Patel J, 2007, TRANSGENIC RES, V16, P239, DOI 10.1007/s11248-006-9026-2; Phan HT, 2013, PLANT BIOTECHNOL J, V11, P582, DOI 10.1111/pbi.12049; Rincon AC, 2006, J BIOMED MATER RES A, V78A, P343, DOI 10.1002/jbm.a.30702; Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a; Sharma AK, 2009, BIOTECHNOL ADV, V27, P811, DOI 10.1016/j.biotechadv.2009.06.004; Shoji Y, 2012, INFLUENZA OTHER RESP, V6, P204, DOI 10.1111/j.1750-2659.2011.00295.x; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Thieme F, 2007, MOL PLANT MICROBE IN, V20, P1250, DOI 10.1094/MPMI-20-10-1250; Torrent Margarita, 2009, V483, P193, DOI 10.1007/978-1-59745-407-0_11; Torrent M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-5; URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306; Veit M, 2011, ADV VIROL, V2011, DOI 10.1155/2011/370606; WANDELT CI, 1992, PLANT J, V2, P181; Watanabe Y, 2012, TRENDS MICROBIOL, V20, P11, DOI 10.1016/j.tim.2011.10.003; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; [WHO] World Health Organization, INFL HUM AN INT HAI; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yusibov V, 2008, EXPERT REV VACCINES, V7, P1173, DOI 10.1586/14760584.7.8.1173; Zhang S, 2012, PROTEOMICS, V12, P1269, DOI 10.1002/pmic.201100474	57	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99347	10.1371/journal.pone.0099347	http://dx.doi.org/10.1371/journal.pone.0099347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914995	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700087
J	Yao, X; Jia, WQ; Si, HY; Guo, ZQ; Tian, YC; Liu, XJ; Cao, WX; Zhu, Y				Yao, Xia; Jia, Wenqing; Si, Haiyang; Guo, Ziqing; Tian, Yongchao; Liu, Xiaojun; Cao, Weixing; Zhu, Yan			Exploring Novel Bands and Key Index for Evaluating Leaf Equivalent Water Thickness in Wheat Using Hyperspectra Influenced by Nitrogen	PLOS ONE			English	Article							SPECTRAL REFLECTANCE; VEGETATION; MOISTURE; STRESS; GROWTH; MODEL; RISK; CORN	Leaf equivalent water thickness (LEWT) is an important indicator of crop water status. Effectively monitoring the water status of wheat under different nitrogen treatments is important for effective water management in precision agriculture. Trends in the variation of LEWT in wheat plants during plant growth were analyzed based on field experiments in which wheat plants under various water and nitrogen treatments in two consecutive growing seasons. Two-band spectral indices [ normalized difference spectral indices (NDSI), ratio spectral indices (RSI), different spectral indices (DSI)], and then three-band spectral indices were established based on the best two-band spectral index within the range of 350-2500 nm to reduce the noise caused by nitrogen and saturation. Then, optimal spectral indices were selected to construct models of LEWT monitoring in wheat. The results showed that the two-band spectral index NDSI(R-1204, R-1318) could be used for LEWT monitoring throughout the wheat growth season, but the model performed differently before and after anthesis. Therefore, further two-band spectral indices NDSIb(R-1445, R-487), NDSIa(R-1714, R-1395), and NDSI(R-1429, R-416), were constructed for the two developmental phases, with NDSI(R-1429, R-416) considered to be the best index. Finally, a three-band index (R-1429-R-416- R-1865)/(R-1429+R-416+R-1865), which was superior for monitoring LEWT and reducing the noise caused by nitrogen, was formed on the best two-band spectral index NDSI(R-1429, R-416) by adding the 1,865 nm wavelenght as the third band. This produced more uniformity and stable performance compared with the two-band spectral indices in the LEWT model. The results are of technical significance for monitoring the water status of wheat under different nitrogen treatments in precision agriculture.	[Yao, Xia; Jia, Wenqing; Si, Haiyang; Guo, Ziqing; Tian, Yongchao; Liu, Xiaojun; Cao, Weixing; Zhu, Yan] Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhu, Y (corresponding author), Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Nanjing, Jiangsu, Peoples R China.	yanzhu@njau.edu.cn	Zhu, Yan/AAK-6927-2020	Zhu, Yan/0000-0002-8912-3888; Yao, Xia/0000-0002-1093-1736	National High-tech Research and Development Program of China (863 Program) [2013AA102404, 2011AA100703]; National Natural Science Foundation of China [31201130, 31201131]; Special Program for Agriculture Science and Technology from Ministry of Agriculture in China [201303109]; Science and Technology Support Plan of Jiangsu Province [BE2011351, BE2012302]; Jiangsu agriculture science and technology innovation fund [SCX(12)3272]; Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National High-tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Agriculture Science and Technology from Ministry of Agriculture in China; Science and Technology Support Plan of Jiangsu Province; Jiangsu agriculture science and technology innovation fund; Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National High-tech Research and Development Program of China (863 Program) (2013AA102404,2011AA100703), National Natural Science Foundation of China (31201130, 31201131), Special Program for Agriculture Science and Technology from Ministry of Agriculture in China (201303109), Science and Technology Support Plan of Jiangsu Province (BE2011351, BE2012302), Jiangsu agriculture science and technology innovation fund, SCX(12)3272, and Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Li, 2008, Scientia Agricultura Sinica, V41, P2499; CARTER GA, 1991, AM J BOT, V78, P916, DOI 10.2307/2445170; Ceccato P, 2001, REMOTE SENS ENVIRON, V77, P22, DOI 10.1016/S0034-4257(01)00191-2; Champagne CM, 2003, REMOTE SENS ENVIRON, V87, P148, DOI 10.1016/S0034-4257(03)00137-8; Chen HB, 2010, WATER SAVING IRRIGAT, V8, P69; Cheng T, 2011, REMOTE SENS ENVIRON, V115, P659, DOI 10.1016/j.rse.2010.11.001; Dong JingJing, 2006, Acta Agriculturae Universitatis Jiangxiensis, V28, P587; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; HARDISKY MA, 1983, PHOTOGRAMM ENG REM S, V49, P77; Hou XJ, 2008, REMOTE SENSING INFOR, V2, P10; HUNT ER, 1989, REMOTE SENS ENVIRON, V30, P43, DOI 10.1016/0034-4257(89)90046-1; Jackson TJ, 2004, REMOTE SENS ENVIRON, V92, P475, DOI 10.1016/j.rse.2003.10.021; [刘良云 LIU Liangyun], 2007, [遥感学报, Journal of Remote Sensing], V11, P289; Liu XiaoJun, 2012, Scientia Agricultura Sinica, V45, P435; Maki M, 2004, REMOTE SENS ENVIRON, V90, P441, DOI 10.1016/j.rse.2004.02.002; PENUELAS J, 1993, INT J REMOTE SENS, V14, P1887, DOI 10.1080/01431169308954010; Pu RL, 2000, HYPERSPECTRAL REMOTE, P194; Schneider P, 2008, REMOTE SENS ENVIRON, V112, P1151, DOI 10.1016/j.rse.2007.07.010; Seelig HD, 2008, REMOTE SENS ENVIRON, V112, P445, DOI 10.1016/j.rse.2007.05.002; [沈艳 Shen Yan], 2005, [地理与地理信息科学, Geography and geo-information science], V21, P16; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Stow D, 2005, INT J REMOTE SENS, V26, P3867, DOI 10.1080/01431160500185342; Tian Yong-chao, 2010, Yingyong Shengtai Xuebao, V21, P966; Tian YongChao, 2005, Acta Phytoecologica Sinica, V29, P318; Tilling AK, 2007, FIELD CROP RES, V104, P77, DOI 10.1016/j.fcr.2007.03.023; VERASAN V, 1978, AGRON J, V70, P613, DOI 10.2134/agronj1978.00021962007000040021x; Verbesselt J, 2007, REMOTE SENS ENVIRON, V108, P357, DOI 10.1016/j.rse.2006.11.019; Wang JiHua, 2001, Scientia Agricultura Sinica, V34, P104; Wang P, 2010, REMOTE SENSING LAND, V3, P97; Wang W, 2012, FIELD CROP RES, V129, P90, DOI 10.1016/j.fcr.2012.01.014; Yao X, 2010, INT J APPL EARTH OBS, V12, P89, DOI 10.1016/j.jag.2009.11.008; Yilmaz MT, 2008, REMOTE SENS ENVIRON, V112, P2514, DOI 10.1016/j.rse.2007.11.014; Zarco-Tejada PJ, 2003, REMOTE SENS ENVIRON, V85, P109, DOI 10.1016/S0034-4257(02)00197-9; [张佳华 ZHANG Jiahua], 2007, [应用基础与工程科学学报, Journal of Basic Science and Engineering], V15, P45; Zhang L, 2012, EUR J AGRON, V41, P103, DOI 10.1016/j.eja.2012.04.003; [赵全志 ZHAO Quanzhi], 2006, [干旱地区农业研究, Agricultural Research in the Arid Areas], V24, P61; Zhu Y, 2007, AUST J AGR RES, V58, P1077, DOI 10.1071/AR06413; Ziadi N, 2008, AGRON J, V100, P1264, DOI 10.2134/agronj2008.0016	38	21	23	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e96352	10.1371/journal.pone.0096352	http://dx.doi.org/10.1371/journal.pone.0096352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914778	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700004
J	Esmaeelpour, M; Kajic, V; Zabihian, B; Othara, R; Ansari-Shahrezaei, S; Kellner, L; Krebs, I; Nemetz, S; Kraus, MF; Hornegger, J; Fujimoto, JG; Drexler, W; Binder, S				Esmaeelpour, Marieh; Kajic, Vedran; Zabihian, Behrooz; Othara, Richu; Ansari-Shahrezaei, Siamak; Kellner, Lukas; Krebs, Ilse; Nemetz, Susanne; Kraus, Martin F.; Hornegger, Joachim; Fujimoto, James G.; Drexler, Wolfgang; Binder, Susanne			Choroidal Haller's and Sattler's Layer Thickness Measurement Using 3-Dimensional 1060-nm Optical Coherence Tomography	PLOS ONE			English	Article							MACULAR DEGENERATION; NM; CHORIOCAPILLARIS; OCT; REPRODUCIBILITY; VISUALIZATION; SEGMENTATION; PENETRATION; CIRCULATION; EYES	Objectives: To examine the feasibility of automatically segmented choroidal vessels in three-dimensional (3D) 1060-nmOCT by testing repeatability in healthy and AMD eyes and by mapping Haller's and Sattler's layer thickness in healthy eyes Methods: Fifty-five eyes (from 45 healthy subjects and 10 with non-neovascular age-related macular degeneration (AMD) subjects) were imaged by 3D-1060- nmOCT over a 36 degrees x36 degrees field of view. Haller's and Sattler's layer were automatically segmented, mapped and averaged across the Early Treatment Diabetic Retinopathy Study grid. For ten AMD eyes and ten healthy eyes, imaging was repeated within the same session and on another day. Outcomes were the repeatability agreement of Haller's and Sattler's layer thicknesses in healthy and AMD eyes, the validation with ICGA and the statistical analysis of the effect of age and axial eye length ( AL) on both healthy choroidalsublayers. Conclusions: Automated Sattler's and Haller's thickness segmentation generates rapid 3D measurements with a repeatability correspondingto reported manual segmentation. Sublayers in healthy eyes thinnedsignificantly with increasing AL. In the presence of the thinned Sattler's layer in AMD, careful measurement interpretation is needed. Automatic choroidal vascular layer mapping may help to explain if pathological choroidal thinning affects medium and large choroidal vasculature in addition to choriocapillaris loss.	[Esmaeelpour, Marieh; Ansari-Shahrezaei, Siamak; Kellner, Lukas; Krebs, Ilse; Binder, Susanne] Rudolf Fdn Clin, Dept Ophthalmol, Ludwig Boltzmann Inst Retinol & Biomicroscop Lase, Vienna, Austria; [Esmaeelpour, Marieh; Kajic, Vedran; Zabihian, Behrooz; Othara, Richu; Drexler, Wolfgang] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Nemetz, Susanne] OptikNemetz, Vienna, Austria; [Kraus, Martin F.; Hornegger, Joachim] Univ Erlangen Nurnberg, Pattern Recognit Lab, D-91054 Erlangen, Bavaria, Germany; [Kraus, Martin F.; Hornegger, Joachim] Univ Erlangen Nurnberg, Sch Adv Opt Technol SATO, D-91054 Erlangen, Bavaria, Germany; [Fujimoto, James G.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Ludwig Boltzmann Institute; Medical University of Vienna; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Massachusetts Institute of Technology (MIT)	Esmaeelpour, M (corresponding author), Rudolf Fdn Clin, Dept Ophthalmol, Ludwig Boltzmann Inst Retinol & Biomicroscop Lase, Vienna, Austria.	marieh.esmaeelpour@meduniwien.ac.at	Hornegger, Joachim/H-2465-2017	Hornegger, Joachim/0000-0002-1834-8844; Drexler, Wolfgang/0000-0002-3557-6398	Medical University Vienna, Macular Vision Research Foundation (MVRF, USA); European Union [201880]; FAMOS [ICT 317744]; FWF-NFN [14294]; National Institutes of Health [NIH R01-EY011289-27]; Deutsche Forschungsgesellschaft [DFG-GSC80-SAOT]; German Research Foundation [DFG-GSC80-SAOT, DFG-HO-1791/11-1]; NATIONAL EYE INSTITUTE [R01EY011289] Funding Source: NIH RePORTER	Medical University Vienna, Macular Vision Research Foundation (MVRF, USA); European Union(European Commission); FAMOS; FWF-NFN(Austrian Science Fund (FWF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by Medical University Vienna, Macular Vision Research Foundation (MVRF, USA), European Union project FUN OCT (FP7 HEALTH, contract no. 201880) and FAMOS (FP7 ICT 317744), FWF-NFN 'Photoacoustic imaging in biology and Medicine', Oesterreichische Nationalbank Jubilaumsfondsprojekt (14294), National Institutes of Health (NIH R01-EY011289-27), Deutsche Forschungsgesellschaft (DFG-GSC80-SAOT), CARL ZEISS Meditec Inc., Femtolasers GmbH and the Christian Doppler Society (Christian Doppler Laboratory ' Laser development and their application in medicine'). German Research Foundation DFG-GSC80-SAOT, DFG-HO-1791/11-1. Optik Nemetz provided support in the form of a salary for author SN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANSI, 2000, SAF US LAS SAF US OP; BILL A, 1983, INT OPHTHALMOL, V6, P101, DOI 10.1007/BF00127638; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; de Bruin DM, 2008, INVEST OPHTH VIS SCI, V49, P4545, DOI 10.1167/iovs.07-1553; Esmaeelpour M, 2010, INVEST OPHTH VIS SCI, V51, P5260, DOI 10.1167/iovs.10-5196; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; HAYREH SS, 1974, A GRAEF ARCH KLIN EX, V192, P165; Hayreh SS, 2004, INVEST OPHTH VIS SCI, V45, P749, DOI 10.1167/iovs.03-0469; HAYREH SS, 1990, EYE, V4, P273, DOI 10.1038/eye.1990.39; Hogan MJ, 1971, SAUNDERS, P322; ICNIRP, 2000, REV GUID LIM EXP LAS; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V51, P2173; Ikuno Y, 2011, INVEST OPHTH VIS SCI, V52, P5536, DOI 10.1167/iovs.10-6811; Kajic V, 2013, BIOMED OPT EXPRESS, V4, P134, DOI 10.1364/BOE.4.000134; Kajic V, 2012, BIOMED OPT EXPRESS, V3, P86, DOI 10.1364/BOE.3.000086; Kim JH, 2013, EYE, V27, P809, DOI 10.1038/eye.2013.78; Koizumi H, 2011, GRAEF ARCH CLIN EXP, V249, P1123, DOI 10.1007/s00417-011-1620-1; Kraus MF, 2012, BIOMED OPT EXPRESS, V3, P1182, DOI 10.1364/BOE.3.001182; Lee JY, 2013, INVEST OPHTH VIS SCI, V54, P7812, DOI 10.1167/iovs.13-12284; Linsenmeier RA, 2000, INVEST OPHTH VIS SCI, V41, P3117; Manjunath V, 2011, AM J OPHTHALMOL, V152, P663, DOI 10.1016/j.ajo.2011.03.008; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; McLeod DS, 2002, INVEST OPHTH VIS SCI, V43, P1986; Motaghiannezam R, 2012, INVEST OPHTH VIS SCI, V53, P2337, DOI 10.1167/iovs.11-7823; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Nishiyama Y, 2001, RETINA-J RET VIT DIS, V21, P237, DOI 10.1097/00006982-200106000-00007; Querques G, 2012, INVEST OPHTH VIS SCI, V53, P1258, DOI 10.1167/iovs.11-8907; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Sim DA, 2013, INVEST OPHTH VIS SCI, V54, P2893, DOI 10.1167/iovs.12-11085; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010; Unterhuber A, 2005, OPT EXPRESS, V13, P3252, DOI 10.1364/OPEX.13.003252; Young M, 2014, RETINA-J RET VIT DIS, V34, P1308, DOI 10.1097/IAE.0000000000000081; ZHANG HR, 1994, PROG RETIN EYE RES, V13, P243, DOI 10.1016/1350-9462(94)90012-4; Zhang L, 2012, INVEST OPHTH VIS SCI, V53, P7510, DOI 10.1167/iovs.12-10311	36	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99690	10.1371/journal.pone.0099690	http://dx.doi.org/10.1371/journal.pone.0099690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911446	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600115
J	Liefhebber, JMP; Hague, CV; Zhang, QF; Wakelam, MJO; McLauchlan, J				Liefhebber, Jolanda M. P.; Hague, Charlotte V.; Zhang, Qifeng; Wakelam, Michael J. O.; McLauchlan, John			Modulation of Triglyceride and Cholesterol Ester Synthesis Impairs Assembly of Infectious Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE PEPTIDASE; DIFFERENTIATION-RELATED PROTEIN; LIPID DROPLET-BINDING; LOW-DENSITY LIPOPROTEINS; RNA-CONTAINING PARTICLES; CORE PROTEIN; FATTY-ACID; POSTTRANSLATIONAL REGULATION; INTRAMEMBRANE PROTEOLYSIS; NORDIHYDROGUAIARETIC ACID	In hepatitis C virus infection, replication of the viral genome and virion assembly are linked to cellular metabolic processes. In particular, lipid droplets, which store principally triacylglycerides (TAGs) and cholesterol esters (CEs), have been implicated in production of infectious virus. Here, we examine the effect on productive infection of triacsin C and YIC-C8-434, which inhibit synthesis of TAGs and CEs by targeting long-chain acyl-CoA synthetase and acyl-CoA: cholesterol acyltransferase, respectively. Our results present high resolution data on the acylglycerol and cholesterol ester species that were affected by the compounds. Moreover, triacsin C, which blocks both triglyceride and cholesterol ester synthesis, cleared most of the lipid droplets in cells. By contrast, YIC-C8-434, which only abrogates production of cholesterol esters, induced an increase in size of droplets. Although both compounds slightly reduced viral RNA synthesis, they significantly impaired assembly of infectious virions in infected cells. In the case of triacsin C, reduced stability of the viral core protein, which forms the virion nucleocapsid and is targeted to the surface of lipid droplets, correlated with lower virion assembly. In addition, the virus particles that were released from cells had reduced specific infectivity. YIC-C8-434 did not alter the association of core with lipid droplets but appeared to decrease production of infectious virus particles, suggesting a block in virion assembly. Thus, the compounds have antiviral properties, indicating that targeting synthesis of lipids stored in lipid droplets might be an option for therapeutic intervention in treating chronic hepatitis C virus infection.	[Liefhebber, Jolanda M. P.; Hague, Charlotte V.; McLauchlan, John] Univ Glasgow, Ctr Virus Res, Med Res Council, Glasgow G11 5JR, Lanark, Scotland; [Zhang, Qifeng; Wakelam, Michael J. O.] Babraham Inst, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Glasgow; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	McLauchlan, J (corresponding author), Univ Glasgow, Ctr Virus Res, Med Res Council, 8 Church St, Glasgow G11 5JR, Lanark, Scotland.	john.mclauchlan@glasgow.ac.uk		Hague, Charlotte/0000-0003-2625-102X; Wakelam, Michael/0000-0003-4059-9276	Seventh Framework Program of the European Union [202272]; United Kingdom Medical Research Council Grant [4050295596]; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415, BBS/E/B/0000S227] Funding Source: researchfish; Medical Research Council [MC_UU_12014/1] Funding Source: researchfish; BBSRC [BBS/E/B/0000S227, BBS/E/B/000C0415] Funding Source: UKRI; MRC [MC_UU_12014/1] Funding Source: UKRI	Seventh Framework Program of the European Union(European Commission); United Kingdom Medical Research Council Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Seventh Framework Program of the European Union-funded "LipidomicNet" (Proposal 202272) United Kingdom Medical Research Council Grant 4050295596 (to J. M. P. L., C. V. H., and J. M.) and the Biotechnology and Biological Sciences Research Council(to Q. Z. and M. J. O. W.).	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Bemlih S, 2010, CANCER BIOL THER, V9, P1025, DOI 10.4161/cbt.9.12.11875; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Fazio S, 2006, NEW ENGL J MED, V354, P1307, DOI 10.1056/NEJMe068012; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; Gross DN, 2006, MOL ENDOCRINOL, V20, P459, DOI 10.1210/me.2005-0323; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Iro M, 2009, ANTIVIR RES, V83, P148, DOI 10.1016/j.antiviral.2009.04.007; Kaddai V, 2011, EXPERT REV GASTROENT, V5, P503, DOI [10.1586/EGH.11.43, 10.1586/egh.11.43]; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lee MS, 2010, BIOCHEM BIOPH RES CO, V401, P92, DOI 10.1016/j.bbrc.2010.09.016; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; Leu GZ, 2004, BIOCHEM BIOPH RES CO, V318, P275, DOI 10.1016/j.bbrc.2004.04.019; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meuwese MC, 2009, JAMA-J AM MED ASSOC, V301, P1131, DOI 10.1001/jama.301.11.1131; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nchoutmboube JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003401; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Nielsen SU, 2008, J GEN VIROL, V89, P2507, DOI 10.1099/vir.0.2008/000083-0; Oehler V, 2012, J VIROL, V86, P7818, DOI 10.1128/JVI.00457-12; Ohishi K, 2003, BIOL PHARM BULL, V26, P1125; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Rainero E, 2012, J CELL BIOL, V196, P277, DOI 10.1083/jcb.201109112; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Suzuki M, 2012, MOL BIOL CELL, V23, P800, DOI 10.1091/mbc.E11-11-0950; Syed GH, 2011, HEPATOLOGY, V54, P1936, DOI 10.1002/hep.24619; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Targett-Adams P, 2010, VIRUSES-BASEL, V2, P1195, DOI 10.3390/v2051195; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Vauloup-Fellous C, 2006, J BIOL CHEM, V281, P27679, DOI 10.1074/jbc.M602587200; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	73	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21276	21288		10.1074/jbc.M114.582999	http://dx.doi.org/10.1074/jbc.M114.582999			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24917668	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000340558300007
J	Stein, KC; Bengoechea, R; Harms, MB; Weihl, CC; True, HL				Stein, Kevin C.; Bengoechea, Rocio; Harms, Matthew B.; Weihl, Conrad C.; True, Heather L.			Myopathy-causing Mutations in an HSP40 Chaperone Disrupt Processing of Specific Client Conformers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; RNQ(+) PRION; PROTEIN AGGREGATION; AMYLOID STRUCTURES; DNAJB6 MYOPATHY; RICH DOMAIN; YEAST; PROPAGATION; SIS1; DISEASE	The molecular chaperone network protects against the toxic misfolding and aggregation of proteins. Disruption of this network leads to a variety of protein conformational disorders. One such example recently discovered is limb-girdle muscular dystrophy type 1D (LGMD1D), which is caused by mutation of the HSP40 chaperone DNAJB6. All LGMD1D-associated mutations localize to the conserved G/F domain of DNAJB6, but the function of this domain is largely unknown. Here, we exploit the yeast HSP40 Sis1, which has known aggregation-prone client proteins, to gain insight into the role of the G/F domain and its significance in LGMD1D pathogenesis. Strikingly, we demonstrate that LGMD1D mutations in a Sis1-DNAJB6 chimera differentially impair the processing of specific conformers of two yeast prions, [RNQ+] and [PSI+]. Importantly, these differences do not simply correlate to the sensitivity of these prion strains to changes in chaperone levels. Additionally, we analyzed the effect of LGMD1D-associated DNAJB6 mutations on TDP-43, a protein known to form inclusions in LGMD1D. We show that the DNAJB6 G/F domain mutants disrupt the processing of nuclear TDP-43 stress granules in mammalian cells. These data suggest that the G/F domain mediates chaperone-substrate interactions in a manner that extends beyond recognition of a particular client and to a subset of client conformers. We propose that such selective chaperone disruption may lead to the accumulation of toxic aggregate conformers and result in the development of LGMD1D and perhaps other protein conformational disorders.	[Stein, Kevin C.; True, Heather L.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Bengoechea, Rocio; Harms, Matthew B.; Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Weihl, CC (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	weihlc@neuro.wustl.edu; heather.true@wustl.edu		Stein, Kevin/0000-0002-0622-8319	National Institutes of Health [F31AG040899, T32GM007067, GM072778, AG031867, AG042095]; Muscular Dystrophy Association; Hope Center for Neurological Disorders; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067, R01GM072778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031867, K02AG042095, F31AG040899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Hope Center for Neurological Disorders; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants F31AG040899 and T32GM007067 (to K. C. S.), GM072778 (to H. L. T.), and AG031867 and AG042095 (to C. C. W.). This work was also supported by the Muscular Dystrophy Association (to C. C. W.) and the Hope Center for Neurological Disorders (to C. C. W., M. B. H., and H. L. T.).	Aron R, 2007, EMBO J, V26, P3794, DOI 10.1038/sj.emboj.7601811; Bardill JP, 2009, PRION, V3, P151, DOI 10.4161/pri.3.3.9662; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Couthouis J, 2014, NEUROMUSCULAR DISORD, V24, P431, DOI 10.1016/j.nmd.2014.01.014; Derkatch IL, 1996, GENETICS, V144, P1375; Dulle JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087521; Durrenberger PF, 2009, J NEUROSCI RES, V87, P238, DOI 10.1002/jnr.21819; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Harms MB, 2012, ANN NEUROL, V71, P407, DOI 10.1002/ana.22683; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Hines JK, 2011, PRION, V5, P238, DOI [10.4161/pri.5.4.17818, 10.4161/pri.17818]; Huang VJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079582; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kakkar V, 2012, CURR TOP MED CHEM, V12, P2479; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lopez N, 2003, MOL BIOL CELL, V14, P1172, DOI 10.1091/mbc.E02-09-0593; Perales-Calvo J, 2010, J BIOL CHEM, V285, P34231, DOI 10.1074/jbc.M110.144642; Pereira C, 2012, FEBS J, V279, P697, DOI 10.1111/j.1742-4658.2012.08477.x; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Sato T, 2013, NEUROMUSCULAR DISORD, V23, P269, DOI 10.1016/j.nmd.2012.12.010; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Stein KC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004337; Stein KC, 2011, PRION, V5, P291, DOI [10.4161/pri.5.4.18213, 10.4161/pri.18213]; Suarez-Cedeno G, 2014, MUSCLE NERVE, V49, P607, DOI 10.1002/mus.24106; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tenreiro S, 2013, J NEUROCHEM, V127, P438, DOI 10.1111/jnc.12271; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; True HL, 2006, TRENDS GENET, V22, P110, DOI 10.1016/j.tig.2005.12.004; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Udan-Johns M, 2014, HUM MOL GENET, V23, P157, DOI 10.1093/hmg/ddt408; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Walker AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081170; Watson ED, 2007, DEVELOPMENT, V134, P1809, DOI 10.1242/dev.02843; Westergard L, 2014, MOL MICROBIOL, V92, P698, DOI 10.1111/mmi.12579; Westergard L, 2014, MOL MICROBIOL, V92, P183, DOI 10.1111/mmi.12543; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643	48	33	34	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21120	21130		10.1074/jbc.M114.572461	http://dx.doi.org/10.1074/jbc.M114.572461			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24920671	hybrid, Green Published			2022-12-25	WOS:000339396600062
J	King, T; Kocharunchitt, C; Gobius, K; Bowman, JP; Ross, T				King, Thea; Kocharunchitt, Chawalit; Gobius, Kari; Bowman, John P.; Ross, Tom			Global Genome Response of Escherichia coli O157:H7 Sakai during Dynamic Changes in Growth Kinetics Induced by an Abrupt Temperature Downshift	PLOS ONE			English	Article							LAG PHASE DURATION; GENE-EXPRESSION; STRESS-RESPONSE; SIGMA(S)-DEPENDENT GENES; TRANSCRIPTIONAL ANALYSIS; MICROARRAY ANALYSIS; PROTEOMIC ANALYSES; STATISTICAL-MODEL; STATIONARY-PHASE; GLYCINE BETAINE	Escherichia coli O157:H7 is a mesophilic food-borne pathogen. We investigated the growth kinetics of E. coli O157: H7 Sakai during an abrupt temperature downshift from 35 degrees C to either 20 degrees C, 17 degrees C, 14 degrees C or 10 degrees C; as well as the molecular mechanisms enabling growth after cold stress upon an abrupt downshift from 35 degrees C to 14 degrees C in an integrated transcriptomic and proteomic analysis. All downshifts caused a lag period of growth before growth resumed at a rate typical of the post-shift temperature. Lag and generation time increased with the magnitude of the shift or with the final temperature, while relative lag time displayed little variation across the test range. Analysis of time-dependent molecular changes revealed, in keeping with a decreased growth rate at lower temperature, repression of genes and proteins involved in DNA replication, protein synthesis and carbohydrate catabolism. Consistent with cold-induced remodelling of the bacterial cell envelope, alterations occurred in the expression of genes and proteins involved in transport and binding. The RpoS regulon exhibited sustained induction confirming its importance in adaptation and growth at 14 degrees C. The RpoE regulon was transiently induced, indicating a potential role for this extracytoplasmic stress response system in the early phase of low temperature adaptation during lag phase. Interestingly, genes previously reported to be amongst the most highly up-regulated under oxidative stress were consistently down-regulated. This comprehensive analysis provides insight into the molecular mechanisms operating during adaptation of E. coli to growth at low temperature and is relevant to its physiological state during chilling in foods, such as carcasses.	[King, Thea] Commonwealth Sci & Ind Res Org, Anim Food & Hlth Sci, N Ryde, NSW, Australia; [Kocharunchitt, Chawalit; Bowman, John P.; Ross, Tom] Univ Tasmania, Food Safety Ctr, Tasmanian Inst Agr, Hobart, Tas, Australia; [Gobius, Kari] Commonwealth Sci & Ind Res Org, Anim Food & Hlth Sci, Werribee, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	King, T (corresponding author), Commonwealth Sci & Ind Res Org, Anim Food & Hlth Sci, N Ryde, NSW, Australia.	Thea.King@csiro.au	Gobius, Kari/I-4700-2013; Bowman, John P./ABF-5108-2020; Bowman, John P/C-2414-2014	Gobius, Kari/0000-0002-3653-2581; Bowman, John P./0000-0002-4528-9333; Bowman, John P/0000-0002-4528-9333; Kocharunchitt, Chawalit/0000-0003-3919-2401; Ross, Tom/0000-0001-9916-7772	Meat and Livestock Australia; CSIRO; Food Safety Centre	Meat and Livestock Australia(Meat and Livestock Australia); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Food Safety Centre	This study was funded by Meat and Livestock Australia (http://www.mla.com.au), the CSIRO and the Food Safety Centre. The funder Meat and Livestock Australia had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders CSIRO and the Food Safety Centre were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Allen KJ, 2008, FOODBORNE PATHOG DIS, V5, P437, DOI 10.1089/fpd.2008.0100; Angelidis AS, 2003, APPL ENVIRON MICROB, V69, P7492, DOI 10.1128/AEM.69.12.7492-7498.2003; Beckering CL, 2002, J BACTERIOL, V184, P6395, DOI 10.1128/JB.184.22.6395-6402.2002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Budde I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/mic.0.28530-0; Cagney C, 2004, FOOD MICROBIOL, V21, P203, DOI 10.1016/S0740-0020(03)00052-2; Cairrao F, 2003, MOL MICROBIOL, V50, P1349, DOI 10.1046/j.1365-2958.2003.03766.x; Carty SM, 1999, J BIOL CHEM, V274, P9677, DOI 10.1074/jbc.274.14.9677; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Choi H, 2008, J PROTEOME RES, V7, P47, DOI 10.1021/pr700747q; CLARK DP, 1983, BIOCHEMISTRY-US, V22, P5897, DOI 10.1021/bi00294a032; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Etchegaray JP, 1996, GENES CELLS, V1, P171, DOI 10.1046/j.1365-2443.1996.d01-231.x; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Free A, 1997, J BACTERIOL, V179, P909, DOI 10.1128/jb.179.3.909-918.1997; Gadgil M, 2005, BIOTECHNOL PROGR, V21, P689, DOI 10.1021/bp049630l; Giuliodori AM, 2007, ANN NY ACAD SCI, V1113, P95, DOI 10.1196/annals.1391.008; Golovlev EL, 2003, MICROBIOLOGY+, V72, P1, DOI 10.1023/A:1022276318653; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gustavsson N, 2002, MOL MICROBIOL, V43, P107, DOI 10.1046/j.1365-2958.2002.02720.x; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Ichikawa JK, 2000, P NATL ACAD SCI USA, V97, P9659, DOI 10.1073/pnas.160140297; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ingraham J. L., 1996, ESCHERICHIA COLI SAL, V2, P1570; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jonas K, 2008, MOL MICROBIOL, V70, P236, DOI 10.1111/j.1365-2958.2008.06411.x; Jones PG, 1996, P NATL ACAD SCI USA, V93, P76, DOI 10.1073/pnas.93.1.76; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; KATO M, 1992, EUR J BIOCHEM, V210, P1007, DOI 10.1111/j.1432-1033.1992.tb17506.x; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; King T, 2010, APPL ENVIRON MICROB, V76, P6514, DOI 10.1128/AEM.02392-09; Ko R, 1999, APPL ENVIRON MICROB, V65, P4040; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; Kocharunchitt C, 2014, GLOBAL GENOME RESPON, VO157, pH7; Kocharunchitt C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009019; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Li BG, 2003, MICROBIOL-SGM, V149, P1323, DOI 10.1099/mic.0.26213-0; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; MACKEY BM, 1986, J APPL BACTERIOL, V60, P501, DOI 10.1111/j.1365-2672.1986.tb01089.x; McClure P, 2000, WORLD J MICROB BIOT, V16, P749, DOI 10.1023/A:1008997310966; Mellefont LA, 2003, INT J FOOD MICROBIOL, V83, P281, DOI 10.1016/S0168-1605(02)00377-X; Mellefont LA, 2003, INT J FOOD MICROBIOL, V83, P295, DOI 10.1016/S0168-1605(02)00378-1; Moen B, 2009, CAN J MICROBIOL, V55, P714, DOI [10.1139/W09-016, 10.1139/w09-016]; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; Nakashima K, 1996, J BACTERIOL, V178, P2994, DOI 10.1128/jb.178.10.2994-2997.1996; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Overgaard M, 2009, MOL MICROBIOL, V74, P1289, DOI 10.1111/j.1365-2958.2009.06943.x; Ozcan N, 2005, J BACTERIOL, V187, P4752, DOI 10.1128/JB.187.14.4752-4759.2005; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Polissi A, 2003, RES MICROBIOL, V154, P573, DOI 10.1016/S0923-2508(03)00167-0; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Raivio TL, 1999, CURR OPIN MICROBIOL, V2, P159, DOI 10.1016/S1369-5274(99)80028-9; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Robinson TP, 1998, INT J FOOD MICROBIOL, V44, P83, DOI 10.1016/S0168-1605(98)00120-2; Rock CO, 1996, J BACTERIOL, V178, P5382, DOI 10.1128/jb.178.18.5382-5387.1996; Rodrigues DF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-547; Ross T, 2003, INT J FOOD MICROBIOL, V82, P33, DOI 10.1016/S0168-1605(02)00252-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell NJ, 2002, INT J FOOD MICROBIOL, V79, P27, DOI 10.1016/S0168-1605(02)00176-9; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Strocchi M, 2006, PROTEOMICS, V6, P193, DOI 10.1002/pmic.200500031; Thieringer HA, 1998, BIOESSAYS, V20, P49; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Tsui HCT, 1997, J BACTERIOL, V179, P7476, DOI 10.1128/jb.179.23.7476-7487.1997; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Watanabe H, 1996, LANCET, V348, P831, DOI 10.1016/S0140-6736(05)65257-9; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Weber Michael H. W., 2003, Science Progress, V86, P9, DOI 10.3184/003685003783238707; White-Ziegler CA, 2008, MICROBIOL-SGM, V154, P148, DOI 10.1099/mic.0.2007/012021-0; Liu XX, 2008, J BACTERIOL, V190, P972, DOI 10.1128/JB.01590-07; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Yamanaka Kunitoshi, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P193; Yang L, 2009, FEMS MICROBIOL LETT, V291, P50, DOI 10.1111/j.1574-6968.2008.01434.x; Yohannes E, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-59; Zheng JM, 2007, MOL MICROBIOL, V63, P1360, DOI 10.1111/j.1365-2958.2007.05611.x; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	93	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99627	10.1371/journal.pone.0099627	http://dx.doi.org/10.1371/journal.pone.0099627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926786	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100057
J	Lu, X; Wang, YL; Meng, HY; Chen, PS; Huang, YQ; Wang, ZM; Zhou, NT; Li, CJ; Wang, LS; Jia, EZ; Yang, ZJ				Lu, Xin; Wang, Yunle; Meng, Haoyu; Chen, Pengsheng; Huang, Yaqing; Wang, Zemu; Zhou, Ningtian; Li, Chunjian; Wang, Liansheng; Jia, Enzhi; Yang, Zhijian			Association of Admission Serum Calcium Levels and In-Hospital Mortality in Patients with Acute ST-Elevated Myocardial Infarction: An Eight-Year, Single-Center Study in China	PLOS ONE			English	Article							CORONARY INTERVENTION; INTRACELLULAR CALCIUM; IONIZED HYPOCALCEMIA; CRITICALLY-ILL; RISK-FACTORS; TASK-FORCE; INFLAMMATION; GUIDELINES; PREDICTOR	Objective: The relationship between admission serum calcium levels and in-hospital mortality in patients with acute ST-segment elevation myocardial infarction (STEMI) has not been well definitively explored. The objective was to assess the predictive value of serum calcium levels on in-hospital mortality in STEMI patients. Methods: From 2003 to 2010, 1431 consecutive STEMI patients admitted to the First Affiliated Hospital of Nanjing Medical University were enrolled in the present study. Patients were stratified according to quartiles of serum calcium from the blood samples collected in the emergency room after admission. Between the aforementioned groups, the baseline characteristics, in-hospital management, and in-hospital mortality were analyzed. The association of serum calcium level with in-hospital mortality was calculated by a multivariable Cox regression analysis. Results: Among 1431 included patients, 79% were male and the median age was 65 years (range, 55-74). Patients in the lower quartiles of serum calcium, as compared to the upper quartiles of serum calcium, were older, had more cardiovascular risk factors, lower rate of emergency revascularization and higher in-hospital mortality. According to univariate Cox proportional analysis, patients with lower serum calcium level (hazard ratio 0.267, 95% confidence interval 0.164-0.433, p<0.001) was associated with higher in-hospital mortality. The result of multivariable Cox proportional hazard regression analyses showed that the Killip's class >= 3 (HR = 2.192, p = 0.026), aspartate aminotransferase (HR = 1.001, p<0.001), neutrophil count (HR = 1.123, p<0.001), serum calcium level (HR = 0.255, p = 0.001), and emergency revascularization (HR = 0.122, p<0.001) were significantly and independently associated with in-hospital mortality in STEMI patients. Conclusions: Serum calcium was an independent predictor for in-hospital mortality in patients with STEMI. This widely available serum biochemical index may be incorporated into the current established risk stratification model of STEMI patients. Further studies are required to determine the actual mechanism and whether patients with hypocalcaemia could benefit from calcium supplement.	[Lu, Xin; Wang, Yunle; Meng, Haoyu; Chen, Pengsheng; Wang, Zemu; Zhou, Ningtian; Li, Chunjian; Wang, Liansheng; Jia, Enzhi; Yang, Zhijian] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Huang, Yaqing] Nanjing Med Univ, Drum Tower Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Yang, Zhijian] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University; Nanjing Medical University	Yang, ZJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	zhijianyangnj@njmu.edu.cn	Jia, Enzhi/AGX-9137-2022; Wang, Ze-Mu/F-8243-2010	Wang, Ze-Mu/0000-0003-2517-7382	National Natural Science Foundation of China [81170102/H0203]; Priority Academic Program Development of Jiangsu Higher Education Institutions [BL2012011]; Chinese Medical Association of the Sunlight Foundation [SCRFCMDA201217]; Fourth Period Progect "333'' of Jiangsu Province [BRA2012207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Chinese Medical Association of the Sunlight Foundation; Fourth Period Progect "333'' of Jiangsu Province	Project supported by the National Natural Science Foundation of China (No. 81170102/H0203), the Priority Academic Program Development of Jiangsu Higher Education Institutions (BL2012011), the Chinese Medical Association of the Sunlight Foundation (SCRFCMDA201217), the Fourth Period Progect "333'' of Jiangsu Province (BRA2012207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter GF, 2002, BASIC RES CARDIOL, V97, P268, DOI 10.1007/s00395-002-0366-7; Boya P, 2001, EMBO J, V20, P4325, DOI 10.1093/emboj/20.16.4325; Campillo-Soto A, 2009, CIR ESPAN, V86, P391, DOI 10.1016/j.ciresp.2009.03.029; Cherry RA, 2006, J TRAUMA, V61, P774, DOI 10.1097/01.ta.0000239516.49799.63; Choi YC, 2008, J KOREAN MED SCI, V23, P700, DOI 10.3346/jkms.2008.23.4.700; CHULKOVA TM, 1989, VOP MED KHIM, V35, P2; Clunn GF, 1997, BRIT J PHARMACOL, V121, P1789, DOI 10.1038/sj.bjp.0701299; Cross KML, 2000, IN VITRO CELL DEV-AN, V36, P50; Eisner D, 2013, J MOL CELL CARDIOL, V58, P110, DOI 10.1016/j.yjmcc.2012.11.017; Frick TW, 2012, SURGERY, V152, pS157, DOI 10.1016/j.surg.2012.05.013; HADJIS T, 1993, CLIN NEPHROL, V39, P22; Hastbacka J, 2003, ACTA ANAESTH SCAND, V47, P1264, DOI 10.1046/j.1399-6576.2003.00236.x; HOVIS JG, 1993, ENDOCRINOLOGY, V132, P1931, DOI 10.1210/en.132.5.1931; Jorde R, 1999, HYPERTENSION, V34, P484, DOI 10.1161/01.HYP.34.3.484; Kaya MG, 2013, INT J CARDIOL, V168, P1154, DOI 10.1016/j.ijcard.2012.11.074; Kushner FG, 2009, CATHETER CARDIO INTE, V74, pE25, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Lazzeri C, 2010, MED SCI MONITOR, V16, pCR567; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Lind L, 1997, J CLIN EPIDEMIOL, V50, P967, DOI 10.1016/S0895-4356(97)00104-2; LIND L, 1988, BMJ-BRIT MED J, V297, P960, DOI 10.1136/bmj.297.6654.960; Lundgren E, 2001, SURGERY, V130, P978, DOI 10.1067/msy.2001.118377; Meissner J, 2011, AM J MED, V124, P534, DOI 10.1016/j.amjmed.2010.10.023; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Muller B, 2000, EUR J CLIN INVEST, V30, P823; Pettit EJ, 1998, PHYSIOL REV, V78, P949, DOI 10.1152/physrev.1998.78.4.949; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; SZYFELBEIN SK, 1981, CRIT CARE MED, V9, P454, DOI 10.1097/00003246-198106000-00004; Tantry US, 2010, PLATELETS, V21, P360, DOI 10.3109/09537100903548903; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Van Hemelrijck M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061037; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; VINCENT JL, 1995, INTENS CARE MED, V21, P838, DOI 10.1007/BF01700968; WALKER BE, 1979, J CLIN PATHOL, V32, P488, DOI 10.1136/jcp.32.5.488	33	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99895	10.1371/journal.pone.0099895	http://dx.doi.org/10.1371/journal.pone.0099895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926660	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100088
J	De Angelis, M; Montemurno, E; Piccolo, M; Vannini, L; Lauriero, G; Maranzano, V; Gozzi, G; Serrazanetti, D; Dalfino, G; Gobbetti, M; Gesualdo, L				De Angelis, Maria; Montemurno, Eustacchio; Piccolo, Maria; Vannini, Lucia; Lauriero, Gabriella; Maranzano, Valentina; Gozzi, Giorgia; Serrazanetti, Diana; Dalfino, Giuseppe; Gobbetti, Marco; Gesualdo, Loreto			Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TERM-FOLLOW-UP; HIGH-FAT DIET; GUT MICROBIOTA; FECAL MICROBIOTA; GASTROINTESTINAL MICROBIOTA; INTESTINAL MICROBIOTA; CHILDREN; INFLAMMATION; PATHOGENESIS	This study aimed at investigating the fecal microbiota, and the fecal and urinary metabolome of non progressor (NP) and progressor (P) patients with immunoglobulin A nephropathy (IgAN). Three groups of volunteers were included in the study: (i) sixteen IgAN NP patients; (ii) sixteen IgAN P patients; and (iii) sixteen healthy control (HC) subjects, without known diseases. Selective media were used to determine the main cultivable bacterial groups. Bacterial tag-encoded FLX-titanium amplicon pyrosequencing of the 16S rDNA and 16S rRNA was carried out to determine total and metabolically active bacteria, respectively. Biochrom 30 series amino acid analyzer and gas-chromatography mass spectrometry/solid-phase microextraction (GC-MS/SPME) analyses were mainly carried out for metabolomic analyses. As estimated by rarefaction, Chao and Shannon diversity index, the lowest microbial diversity was found in P patients. Firmicutes increased in the fecal samples of NP and, especially, P patients due to the higher percentages of some genera/species of Ruminococcaceae, Lachnospiraceae, Eubacteriaceae and Streptococcaeae. With a few exceptions, species of Clostridium, Enterococcus and Lactobacillus genera were found at the highest levels in HC. Bacteroidaceae, Porphyromonadaceae, Prevotellaceae and Rikenellaceae families differed among NP, P and HC subjects. Sutterellaceae and Enterobacteriaceae species were almost the highest in the fecal samples of NP and/or P patients. Compared to HC subjects, Bifidobacterium species decreased in the fecal samples of NP and P. As shown by multivariate statistical analyses, the levels of metabolites (free amino acids and organic volatile compounds) from fecal and urinary samples markedly differentiated NP and, especially, P patients.	[De Angelis, Maria; Piccolo, Maria; Gobbetti, Marco] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy; [Montemurno, Eustacchio; Lauriero, Gabriella; Maranzano, Valentina; Dalfino, Giuseppe; Gesualdo, Loreto] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Nephrol Unit, Bari, Italy; [Vannini, Lucia; Gozzi, Giorgia] Univ Bologna, Dept Agr & Food Sci, Bologna, Italy; [Serrazanetti, Diana] Univ Cesena, Interdept Ctr Ind Agri Food Res, Cesena, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Bologna	De Angelis, M (corresponding author), Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy.	maria.deangelis@uniba.it	De Angelis, Maria/AAA-9909-2019; Dalfino, Giuseppe G/I-8125-2018; Serrazanetti, Diana Isabella/K-2606-2016; Gesualdo, Loreto/K-7751-2016; Gobbetti, Marco/K-4138-2014	Dalfino, Giuseppe G/0000-0002-6381-6985; Serrazanetti, Diana Isabella/0000-0002-6796-4053; Gesualdo, Loreto/0000-0002-4861-0911; GOZZI, Giorgia/0000-0001-6015-6144; Vannini, Lucia/0000-0002-9417-8410; Gobbetti, Marco/0000-0003-0869-2737; De Angelis, Maria/0000-0002-2010-884X	University of Bari Aldo Moro; University of Bologna	University of Bari Aldo Moro; University of Bologna	This work was founded by the University of Bari Aldo Moro and the University of Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8; Anders HJ, 2013, KIDNEY INT, V83, P1010, DOI 10.1038/ki.2012.440; Bajaj JS, 2012, AM J GASTROENTEROL S, V1, P9, DOI DOI 10.1038/ajgsup.2012.3; Bammens B, 2003, KIDNEY INT, V64, P2196, DOI 10.1046/j.1523-1755.2003.00314.x; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; Boyd JK, 2010, KIDNEY INT, V78, P1211, DOI 10.1038/ki.2010.365; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chang JH, 2009, NEPHROL DIAL TRANSPL, V24, P2406, DOI 10.1093/ndt/gfp091; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cho SB, 2013, BRIT J DERMATOL, V168, P977, DOI 10.1111/bjd.12128; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DAMICO G, 1985, MEDICINE, V64, P49, DOI 10.1097/00005792-198501000-00004; De Angelis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076993; Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219; Di Cagno R, 2009, APPL ENVIRON MICROB, V75, P3963, DOI 10.1128/AEM.02793-08; Di Mauro A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-15; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elgaali H, 2002, J BASIC MICROB, V42, P373, DOI 10.1002/1521-4028(200212)42:6<373::AID-JOBM373>3.0.CO;2-4; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Fox-Orenstein A. E, 2012, AM J GASTROENTEROL S, V1, P41, DOI DOI 10.1038/AJGSUP.2012.8; Francavilla R, 2012, PEDIAT ALLERG IMM-UK, V23, P420, DOI 10.1111/j.1399-3038.2012.01286.x; Fukuuchi F., 2002, CLIN EXP NEPHROL, V6, P99, DOI [10.1007/s101570200016, DOI 10.1007/S101570200016]; Glassock RJ, 2009, TREATMENT PRIMARY GL, P313; Gondalia SV, 2012, AUTISM RES, V5, P419, DOI 10.1002/aur.1253; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Gowen CM, 2010, BIOTECHNOL J, V5, P759, DOI 10.1002/biot.201000084; Hansen J, 2010, CURR OPIN GASTROEN, V26, P564, DOI 10.1097/MOG.0b013e32833f1195; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; JOHNSTON PA, 1992, Q J MED, V84, P619; KATAFUCHI R, 1994, CLIN NEPHROL, V41, P191; Kiryluk K, 2013, ANNU REV MED, V64, P339, DOI 10.1146/annurev-med-041811-142014; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Manno C, 2007, AM J KIDNEY DIS, V49, P763, DOI 10.1053/j.ajkd.2007.03.013; Manno C, 2009, NEPHROL DIAL TRANSPL, V24, P3694, DOI 10.1093/ndt/gfp356; McCarthy DD, 2011, J CLIN INVEST, V121, P3991, DOI 10.1172/JCI45563; Medina M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-19; Meijers BKI, 2011, NEPHROL DIAL TRANSPL, V26, P759, DOI 10.1093/ndt/gfq818; Meng H, 2012, J CLIN EXP HEMATOP, V52, P161, DOI 10.3960/jslrt.52.161; Ndagijimana M, 2009, INT J FOOD MICROBIOL, V134, P147, DOI 10.1016/j.ijfoodmicro.2009.04.016; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Otani M, 2012, J AM SOC NEPHROL, V23, P438, DOI 10.1681/ASN.2011070701; Prakash S, 2011, BIOL-TARGETS THER, V5, P71, DOI 10.2147/BTT.S19099; Ranganathan N, 2009, CURR MED RES OPIN, V25, P1919, DOI 10.1185/03007990903069249; Ringel Y, 2012, AM J GASTROENTEROL S, V1, P34, DOI DOI 10.1038/AJGSUP.2012.7; Rocchetti MT, 2008, PROTEOMICS, V8, P206, DOI 10.1002/pmic.200700492; Rocchetti MT, 2013, CLIN J AM SOC NEPHRO, V8, P1115, DOI 10.2215/CJN.05950612; Salazar N, 2008, APPL ENVIRON MICROB, V74, P4737, DOI 10.1128/AEM.00325-08; Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P789, DOI 10.1111/j.1462-2920.2007.01503.x; Schmitt R, 2010, AM J PATHOL, V176, P608, DOI 10.2353/ajpath.2010.090428; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Serrazanetti DI, 2011, APPL ENVIRON MICROB, V77, P2656, DOI 10.1128/AEM.01826-10; Shannon CE, 1949, AT&T TECH J, V27, P359; Smith AC, 2006, J AM SOC NEPHROL, V17, P1192, DOI 10.1681/ASN.2005101115; Soylu A, 2007, PEDIATR NEPHROL, V22, P1040, DOI 10.1007/s00467-007-0433-2; Stachowicz N, 2013, POSTEP HIG MED DOSW, V67, P288, DOI 10.5604/17322693.1044746; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Sui WG, 2012, CLINICS, V67, P363, DOI 10.6061/clinics/2012(04)10; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Vaziri ND, 2012, CURR OPIN NEPHROL HY, V21, P587, DOI 10.1097/MNH.0b013e328358c8d5; Vitali B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-4; Wang FQ, 2012, NEPHROLOGY, V17, P733, DOI 10.1111/j.1440-1797.2012.01647.x; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Zhang ZG, 2013, AM J GASTROENTEROL, V108, P1601, DOI 10.1038/ajg.2013.221; Zhao YY, 2013, CLIN CHIM ACTA, V422, P59, DOI 10.1016/j.cca.2013.03.033	69	134	139	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99006	10.1371/journal.pone.0099006	http://dx.doi.org/10.1371/journal.pone.0099006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922509	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300023
J	Huguet, A; Hatton, A; Villot, R; Quenault, H; Blanchard, Y; Fessard, V				Huguet, Antoine; Hatton, Aurelie; Villot, Romain; Quenault, Helene; Blanchard, Yannick; Fessard, Valerie			Modulation of Chromatin Remodelling Induced by the Freshwater Cyanotoxin Cylindrospermopsin in Human Intestinal Caco-2 Cells	PLOS ONE			English	Article							CYANOBACTERIAL TOXIN CYLINDROSPERMOPSIN; PROTEIN-SYNTHESIS INHIBITION; CULTURED RAT HEPATOCYTES; OXIDATIVE STRESS; DNA-DAMAGE; ALKALOID CYLINDROSPERMOPSIN; HEPG2 CELLS; IN-VITRO; RACIBORSKII; TOXICITY	Cylindrospermopsin (CYN) is a cyanotoxin that has been recognised as an emerging potential public health risk. Although CYN toxicity has been demonstrated, the mechanisms involved have not been fully characterised. To identify some key pathways related to this toxicity, we studied the transcriptomic profile of human intestinal Caco-2 cells exposed to a sub-toxic concentration of CYN (1.6 mu M for 24hrs) using a non-targeted approach. CYN was shown to modulate different biological functions which were related to growth arrest (with down-regulation of cdkn1a and uhrf1 genes), and DNA recombination and repair (with up-regulation of aptx and pms2 genes). Our main results reported an increased expression of some histone-modifying enzymes (histone acetyl and methyltransferases MYST1, KAT5 and EHMT2) involved in chromatin remodelling, which is essential for initiating transcription. We also detected greater levels of acetylated histone H2A (Lys5) and dimethylated histone H3 (Lys4), two products of these enzymes. In conclusion, CYN overexpressed proteins involved in DNA damage repair and transcription, including modifications of nucleosomal histones. Our results highlighted some new cell processes induced by CYN.	[Huguet, Antoine; Hatton, Aurelie; Villot, Romain; Fessard, Valerie] Anses, Fougeres Lab, Contaminant Toxicol Unit, Fougeres, France; [Quenault, Helene; Blanchard, Yannick] Anses, Ploufragan Plouzane Lab, Viral Genet & Biosecur Unit, Ploufragan, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Fougeres; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Huguet, A (corresponding author), Anses, Fougeres Lab, Contaminant Toxicol Unit, Fougeres, France.	antoine.huguet@anses.fr		Huguet, Antoine/0000-0001-5399-0907; Fessard, Valerie/0000-0001-9046-9117	AFSSET [EST 2009/1/58]	AFSSET	Financial support was provided by the AFSSET EST 2009/1/58 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour M, 2009, BIOCHEM BIOPH RES CO, V390, P523, DOI 10.1016/j.bbrc.2009.09.131; Bain P, 2007, J TOXICOL ENV HEAL A, V70, P1687, DOI 10.1080/15287390701434877; Baken KA, 2007, TOXICOLOGY, V237, P35, DOI 10.1016/j.tox.2007.04.018; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bazin E, 2012, ENVIRON TOXICOL, V27, P277, DOI 10.1002/tox.20640; Bazin E, 2010, ENVIRON MOL MUTAGEN, V51, P251, DOI 10.1002/em.20539; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chai XR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003778; Chiswell RK, 1999, ENVIRON TOXICOL, V14, P155, DOI 10.1002/(SICI)1522-7278(199902)14:1<155::AID-TOX20>3.0.CO;2-Z; Chong MWK, 2002, TOXICON, V40, P205, DOI 10.1016/S0041-0101(01)00228-8; Chorus I, 2012, CURRENT APPROACHES C; Dmitriev RI, 2008, BIOCHEMISTRY-MOSCOW+, V73, P839, DOI 10.1134/S0006297908080014; Falconer IR, 2006, ENVIRON TOXICOL, V21, P299, DOI 10.1002/tox.20194; Falconer IR, 2001, ENVIRON TOXICOL, V16, P192, DOI 10.1002/tox.1024; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Froscio SM, 2008, TOXICON, V51, P191, DOI 10.1016/j.toxicon.2007.09.001; Froscio SM, 2009, TOXICON, V54, P862, DOI 10.1016/j.toxicon.2009.06.019; Froscio SM, 2003, ENVIRON TOXICOL, V18, P243, DOI 10.1002/tox.10121; Froscio SM, 2001, ENVIRON TOXICOL, V16, P408, DOI 10.1002/tox.1050; Froscio SM, 2009, J TOXICOL ENV HEAL A, V72, P345, DOI 10.1080/15287390802529906; Fuller-Pace FV, 2007, BIOCHEM SOC T, V35, P1427, DOI 10.1042/BST0351427; Funari E, 2008, CRIT REV TOXICOL, V38, P97, DOI 10.1080/10408440701749454; Griffiths DJ, 2003, ENVIRON TOXICOL, V18, P78, DOI 10.1002/tox.10103; Gutierrez-Praena D, 2012, WATER RES, V46, P1566, DOI 10.1016/j.watres.2011.12.044; Gutierrez-Praena D, 2011, ECOTOX ENVIRON SAFE, V74, P1567, DOI 10.1016/j.ecoenv.2011.04.030; HAWKINS PR, 1985, APPL ENVIRON MICROB, V50, P1292, DOI 10.1128/AEM.50.5.1292-1295.1985; Humpage AR, 2005, J TOXICOL ENV HEAL A, V68, P739, DOI 10.1080/15287390590925465; Humpage AR, 2000, MUTAT RES-GEN TOX EN, V472, P155, DOI 10.1016/S1383-5718(00)00144-3; Kinnear S, 2010, MAR DRUGS, V8, P542, DOI 10.3390/md8030542; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Lopez-Alonso H, 2013, CHEM RES TOXICOL, V26, P203, DOI 10.1021/tx3003438; Merel S, 2010, SCI TOTAL ENVIRON, V408, P3433, DOI 10.1016/j.scitotenv.2010.04.033; Miyamoto N, 2008, J BIOL CHEM, V283, P18218, DOI 10.1074/jbc.M802332200; OHTANI I, 1992, J AM CHEM SOC, V114, P7941, DOI 10.1021/ja00046a067; Rucker J, 2007, TOXICON, V50, P800, DOI 10.1016/j.toxicon.2007.06.019; RUNNEGAR MT, 1995, BIOCHEM PHARMACOL, V49, P219, DOI 10.1016/S0006-2952(94)00466-8; RUNNEGAR MT, 1994, BIOCHEM BIOPH RES CO, V201, P235, DOI 10.1006/bbrc.1994.1694; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Shaw GR, 2000, THER DRUG MONIT, V22, P89, DOI 10.1097/00007691-200002000-00019; Shen XY, 2002, TOXICON, V40, P1499, DOI 10.1016/S0041-0101(02)00151-4; Sparfel L, 2010, TOXICOL SCI, V114, P247, DOI 10.1093/toxsci/kfq007; Straser A, 2013, TOXICOL IN VITRO; Straser A, 2013, MAR DRUGS, V11, P3077, DOI 10.3390/md11083077; Straser A, 2013, CHEMOSPHERE, V92, P24, DOI 10.1016/j.chemosphere.2013.03.023; Straser A, 2011, ARCH TOXICOL, V85, P1617, DOI 10.1007/s00204-011-0716-z; TERAO K, 1994, TOXICON, V32, P833, DOI 10.1016/0041-0101(94)90008-6; van Apeldoorn ME, 2007, MOL NUTR FOOD RES, V51, P7, DOI 10.1002/mnfr.200600185; Venneti S, 2013, J NEUROPATH EXP NEUR, V72, P298, DOI 10.1097/NEN.0b013e3182898113; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Young FM, 2012, TOXICOL IN VITRO, V26, P656, DOI 10.1016/j.tiv.2012.03.001; Zegura B, 2011, TOXICON, V58, P471, DOI 10.1016/j.toxicon.2011.08.005	53	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99121	10.1371/journal.pone.0099121	http://dx.doi.org/10.1371/journal.pone.0099121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921660	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300033
J	Brandstedt, J; Wangefjord, S; Nodin, B; Eberhard, J; Sundstrom, M; Manjer, J; Jirstrom, K				Brandstedt, Jenny; Wangefjord, Sakarias; Nodin, Bjorn; Eberhard, Jakob; Sundstrom, Magnus; Manjer, Jonas; Jirstrom, Karin			Associations of Anthropometric Factors with KRAS and BRAF Mutation Status of Primary Colorectal Cancer in Men and Women: A Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; ISLAND METHYLATOR PHENOTYPE; BETA-CATENIN ALTERATIONS; LIFE-STYLE FACTORS; KI-RAS MUTATIONS; COLON-CANCER; MICROSATELLITE INSTABILITY; PHYSICAL-ACTIVITY; CIGARETTE-SMOKING; TUMOR-DEVELOPMENT	Obesity is a well-established risk factor for colorectal cancer (CRC), and accumulating evidence suggests a differential influence of sex and anthropometric factors on the molecular carcinogenesis of the disease. The aim of the present study was to investigate the relationship between height, weight, bodyfat percentage, waist-and hip circumference, waist-hip ratio (WHR), body mass index (BMI) and CRC risk according to KRAS and BRAF mutation status of the tumours, with particular reference to potential sex differences. KRAS and BRAF mutations were analysed by pyrosequencing in tumours from 494 incident CRC cases in the Malmo Diet and Cancer Study. Hazard ratios of CRC risk according to anthropometric factors and mutation status were calculated using multivariate Cox regression models. While all anthropometric measures except height were associated with an increased risk of KRAS-mutated tumours, only BMI was associated with an increased risk of KRAS wild type tumours overall. High weight, hip, waist, WHR and BMI were associated with an increased risk of BRAF wild type tumours, but none of the anthropometric factors were associated with risk of BRAF-mutated CRC, neither in the overall nor in the sex-stratified analysis. In men, several anthropometric measures were associated with both KRAS-mutated and KRAS wild type tumours. In women, only a high WHR was significantly associated with an increased risk of KRA-Smutated CRC. A significant interaction was found between sex and BMI with respect to risk of KRAS-mutated tumours. In men, all anthropometric factors except height were associated with an increased risk of BRAF wild type tumours, whereas in women, only bodyfat percentage was associated with an increased risk of BRAF wild type tumours. The results from this prospective cohort study further support an influence of sex and lifestyle factors on different pathways of colorectal carcinogenesis, defined by KRAS and BRAF mutation status of the tumours.	[Brandstedt, Jenny; Wangefjord, Sakarias; Nodin, Bjorn; Eberhard, Jakob; Jirstrom, Karin] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden; [Brandstedt, Jenny; Wangefjord, Sakarias] Skane Univ Hosp, Dept Surg, Malmo, Sweden; [Sundstrom, Magnus] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Manjer, Jonas] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Manjer, Jonas] Skane Univ Hosp, Dept Plast Surg, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Uppsala University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Brandstedt, J (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden.	Jenny.brandstedt@med.lu.se			Knut and Alice Wallenberg Foundation; Swedish Cancer Society; Gunnar Nilsson Cancer Foundation, Region Skane; Research Funds of Skane University Hospital	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Society(Swedish Cancer Society); Gunnar Nilsson Cancer Foundation, Region Skane; Research Funds of Skane University Hospital	This study was supported by grants from the Knut and Alice Wallenberg Foundation, the Swedish Cancer Society, the Gunnar Nilsson Cancer Foundation, Region Skane and the Research Funds of Skane University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19; Bazan V, 2002, ANN ONCOL, V13, P1438, DOI 10.1093/annonc/mdf226; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Bond CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047483; Brandstedt J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-293; Brandstedt J, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-23; Chen K, 2005, EUR J EPIDEMIOL, V20, P149, DOI 10.1007/s10654-004-2953-4; Cho EY, 2004, ANN INTERN MED, V140, P603, DOI 10.7326/0003-4819-140-8-200404200-00007; Deng G, 2008, EUR J CANCER, V44, P1290, DOI 10.1016/j.ejca.2008.03.014; Farina-Sarasqueta A, 2010, ANN ONCOL, V21, P2396, DOI 10.1093/annonc/mdq258; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P192, DOI 10.1093/jnci/86.3.192; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Hughes LAE, 2012, INT J EPIDEMIOL, V41, P1060, DOI 10.1093/ije/dys055; Hughes LAE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018571; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Kalady MF, 2012, DIS COLON RECTUM, V55, P128, DOI 10.1097/DCR.0b013e31823c08b3; KATZ MH, 1993, J GEN INTERN MED, V8, P702, DOI 10.1007/BF02598295; Kim GP, 2007, J CLIN ONCOL, V25, P767, DOI 10.1200/JCO.2006.05.8172; Kim IJ, 2006, CARCINOGENESIS, V27, P392, DOI 10.1093/carcin/bgi237; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Larsson A, 2011, BRIT J CANCER, V105, P666, DOI 10.1038/bjc.2011.295; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; MacInnis RJ, 2006, INT J CANCER, V118, P1496, DOI 10.1002/ijc.21508; MacInnis RJ, 2004, CANCER EPIDEM BIOMAR, V13, P553; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Nash GM, 2010, ANN SURG ONCOL, V17, P416, DOI 10.1245/s10434-009-0713-0; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Palmer RC, 2005, CANCER CAUSE CONTROL, V16, P55, DOI 10.1007/s10552-004-1253-3; Pancione Massimo, 2012, Patholog Res Int, V2012, P509348, DOI 10.1155/2012/509348; Phipps AI, 2013, BRIT J CANCER, V108, P1757, DOI 10.1038/bjc.2013.118; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rosenberg DW, 2007, CANCER RES, V67, P3551, DOI 10.1158/0008-5472.CAN-07-0343; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Russo A, 2009, ONCOLOGY-BASEL, V77, P57, DOI 10.1159/000258497; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Samowitz WS, 2000, CANCER EPIDEM BIOMAR, V9, P1193; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Slattery ML, 2010, CANCER CAUSE CONTROL, V21, P1237, DOI 10.1007/s10552-010-9551-4; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Slattery ML, 2003, CANCER CAUSE CONTROL, V14, P75, DOI 10.1023/A:1022545017867; Slattery ML, 2001, MUTAT RES-FUND MOL M, V483, P73, DOI 10.1016/S0027-5107(01)00228-7; Steen B, 1987, Compr Gerontol A, V1, P102; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wangefjord S, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-17; Wangefjord S, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-10; Wangefjord Sakarias, 2011, Biol Sex Differ, V2, P10, DOI 10.1186/2042-6410-2-10; Yokota T, 2011, BRIT J CANCER, V104, P856, DOI 10.1038/bjc.2011.19; Zlobec I, 2010, INT J CANCER, V127, P2569, DOI 10.1002/ijc.25265	56	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98964	10.1371/journal.pone.0098964	http://dx.doi.org/10.1371/journal.pone.0098964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918610	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000036
J	McCabe, RM; Grutsch, JF; Nutakki, SB; Braun, DP; Markman, M				McCabe, Ryan M.; Grutsch, James F.; Nutakki, Swetha B.; Braun, Donald P.; Markman, Maurie			Can Quality of Life Assessments Differentiate Heterogeneous Cancer Patients?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; EORTC QLQ-C30; LUNG-CANCER; HEALTH; ONCOLOGY; SCORES; OUTCOMES; INSTRUMENTS; VARIABLES; DISTRESS	Purpose: This research conducted a face validation study of patient responses to the application of an HRQOL assessment research tool in a comprehensive community cancer program setting across a heterogeneous cohort of cancer patients throughout the natural history of diagnosed malignant disease, many of whom would not be considered candidates for clinical research trial participation. Methods: Cancer registries at two regional cancer treatment centers identified 11072 cancer patients over a period of nine years. The EORTC QLQ-C30 was administered to patients at the time of their initial clinical presentation to these centers. To determine the significance of differences between patient subgroups, two analytic criteria were used. The Mann-Whitney test was used to determine statistical significance; clinical relevance defined a range of point differences that could be perceived by patients with different health states. Results: Univariate analyses were conducted across stratification variables for population, disease severity and demographic characteristics. The largest differences were associated with cancer diagnosis and recurrence of disease. Large differences were also found for site of origin, mortality and stage; minimal differences were observed for gender and age. Consistently sensitive QoL scales were appetite loss, fatigue and pain symptoms, and role (work-related), social and physical functions. Conclusions: 1) The EORTC QLQ-C30 collected meaningful patient health assessments in the context of non-research based clinical care, 2) patient assessment differences are manifested disparately across 15 QoL domains, and 3) in addition to indicating how a patient may feel at a point in time, QoL indicators may also reveal information about underlying biological responses to disease progression, treatments, and prospective survival.	[McCabe, Ryan M.; Grutsch, James F.; Nutakki, Swetha B.; Braun, Donald P.] Midwestern Reg Med Ctr, Canc Treatment Ctr Amer, Zion, IL USA; [Grutsch, James F.] Univ Illinois, Sch Publ Hlth, Dept Epidemiol, Chicago, IL USA; [Markman, Maurie] Eastern Reg Med Ctr, Canc Treatment Ctr Amer, Philadelphia, PA USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	McCabe, RM (corresponding author), Amer Coll Surg, Chicago, IL 60611 USA.	rmccabe@facs.org			Cancer Treatment Centers of America	Cancer Treatment Centers of America	The research program is funded by Cancer Treatment Centers of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Bjordal K, 2000, EUR J CANCER, V36, P1796, DOI 10.1016/S0959-8049(00)00186-6; Bottomley A, 2002, ONCOLOGIST, V7, P120, DOI 10.1634/theoncologist.7-2-120; Bowling A, 2001, SOCIOLOGY HLTH ILLNE, V18, P395; Cella D, 2002, QUAL LIFE RES, V11, P207, DOI 10.1023/A:1015276414526; Cocks K, 2008, EUR J CANCER, V44, P1793, DOI 10.1016/j.ejca.2008.05.008; Cocks K, 2011, J CLIN ONCOL, V29, P89, DOI 10.1200/JCO.2010.28.0107; Cohen S, 2006, CURR DIR PSYCHOL SCI, V15, P122, DOI 10.1111/j.0963-7214.2006.00420.x; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Du-Quiton J, 2010, PSYCHO-ONCOLOGY, V19, P180, DOI 10.1002/pon.1539; Ferrans Carol Estwing, 2007, J Natl Cancer Inst Monogr, P22, DOI 10.1093/jncimonographs/lgm008; Gordon JS, 2008, HEMATOL ONCOL CLIN N, V22, P683, DOI 10.1016/j.hoc.2008.04.010; Grutsch JF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-193; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Halyard Michele Y, 2008, J Support Oncol, V6, P221; Hjermstad MJ, 1998, EUR J CANCER, V34, P1381, DOI 10.1016/S0959-8049(98)00136-1; Jordhoy MS, 2001, BRIT J CANCER, V85, P1478, DOI 10.1054/bjoc.2001.2116; KATZ JN, 1992, MED CARE, V30, P917, DOI 10.1097/00005650-199210000-00004; King MT, 1996, QUAL LIFE RES, V5, P555, DOI 10.1007/BF00439229; LEE YTNM, 1983, J SURG ONCOL, V23, P175, DOI 10.1002/jso.2930230311; Lis CG, 2009, PATIENT PREFER ADHER, V3, P287; Maringwa JT, 2011, SUPPORT CARE CANCER, V19, P1753, DOI 10.1007/s00520-010-1016-5; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Osoba D, 1997, QUAL LIFE RES, V6, P103; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Pickard AS, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-4; Quinten C, 2011, JNCI-J NATL CANCER I, V103, P1851, DOI 10.1093/jnci/djr485; Rabkin JG, 2009, PSYCHO-ONCOLOGY, V18, P79, DOI 10.1002/pon.1386; Scott N., 2008, EORTC QLQ C30 REFERE; Sloan J. A., 2003, SOCRA SOURCE, V38, P23; Sprangers MAG, 2010, QUAL LIFE RES, V19, P1395, DOI 10.1007/s11136-010-9759-5; Tishelman C, 2007, J CLIN ONCOL, V25, P5381, DOI 10.1200/JCO.2006.08.7874; UNGER JM, 2014, J NATL CANC I; van de Poll-Franse LV, 2011, EUR J CANCER, V47, P667, DOI 10.1016/j.ejca.2010.11.004; Velikova G, 1999, EUR J CANCER, V35, P1571, DOI 10.1016/S0959-8049(99)00193-8; Velikova G, 2010, EUR J CANCER, V46, P2381, DOI 10.1016/j.ejca.2010.04.030; Visser M, 2005, QUAL LIFE RES, V14, P2109, DOI 10.1007/s11136-004-2577-x; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59	38	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99445	10.1371/journal.pone.0099445	http://dx.doi.org/10.1371/journal.pone.0099445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24919068	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000087
J	Kelly, CM; van Oosterhout, JJ; Ngwalo, C; Stewart, RC; Benjamin, L; Robertson, KR; Khoo, S; Allain, TJ; Solomon, T				Kelly, Christine M.; van Oosterhout, Joep J.; Ngwalo, Chisomo; Stewart, Robert C.; Benjamin, Laura; Robertson, Kevin R.; Khoo, Saye; Allain, Theresa J.; Solomon, Tom			HIV Associated Neurocognitive Disorders (HAND) in Malawian Adults and Effect on Adherence to Combination Anti-Retroviral Therapy: A Cross Sectional Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; MEDICATION ADHERENCE; RISK-FACTORS; INFECTED PATIENTS; DEMENTIA; IMPAIRMENT; PERFORMANCE; INDIVIDUALS; PREVALENCE; DEPRESSION	Background: Little is known about the prevalence and burden of HIV associated neurocognitive disorder (HAND) among patients on combination antiretroviral therapy (cART) in sub-Saharan Africa. We estimated the prevalence of HAND in adult Malawians on cART and investigated the relationship between HAND and adherence to cART. Methods: HIV positive adults in Blantyre, Malawi underwent a full medical history, neurocognitive test battery, depression score, Karnofsky Performance Score and adherence assessment. The Frascati criteria were used to diagnose HAND and the Global Deficit Score (GDS) was also assessed. Blood was drawn for CD4 count and plasma nevirapine and efavirenz concentrations. HIV negative adults were recruited from the HIV testing clinic to provide normative scores for the neurocognitive battery. Results: One hundred and six HIV positive patients, with median (range) age 39 (18-71) years, 73% female and median (range) CD4 count 323.5 (68-1039) cells/mu l were studied. Symptomatic neurocognitive impairment was present in 15% (12% mild neurocognitive disorder [MND], 3% HIV associated dementia [HAD]). A further 55% fulfilled Frascati criteria for asymptomatic neurocognitive impairment (ANI); however factors other than neurocognitive impairment could have confounded this estimate. Neither the symptomatic (MND and HAD) nor asymptomatic (ANI) forms of HAND were associated with subtherapeutic nevirapine/efavirenz concentrations, adjusted odds ratio 1.44 (CI. 0.234, 8.798; p = 0.696) and aOR 0.577 (CI. 0.09, 3.605; p = 0.556) respectively. All patients with subtherapeutic nevirapine/efavirenz levels had a GDS of less than 0.6, consistent with normal neurocognition. Discussion/Conclusion: Fifteen percent of adult Malawians on cART had a diagnosis of MND or HAD. Subtherapeutic drug concentrations were found exclusively in patients with normal neurocognitive function suggesting HAND did not affect cART adherence. Further study of HAND requires more robust locally derived normative neurocognitive values and determination of the clinical relevance of ANI.	[Kelly, Christine M.; Benjamin, Laura; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Brain Infect Grp, Liverpool L69 3BX, Merseyside, England; [Kelly, Christine M.] Queen Elizabeth Cent Hosp, Coll Med, Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi; [van Oosterhout, Joep J.; Ngwalo, Chisomo; Allain, Theresa J.] Coll Med, Dept Med, Blantyre, Malawi; [Stewart, Robert C.] Coll Med, Dept Mental Hlth, Blantyre, Malawi; [Robertson, Kevin R.] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA; [Khoo, Saye] Univ Liverpool, Inst Translat Med, HIV Pharmacol Grp, Liverpool L69 3BX, Merseyside, England; [van Oosterhout, Joep J.] Dignitas Int, Zomba, Malawi; [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England; [Solomon, Tom] Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England	University of Liverpool; University of Malawi; University of Malawi; University of Malawi; University of North Carolina; University of North Carolina Chapel Hill; University of Liverpool; Walton Centre	Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Brain Infect Grp, Liverpool L69 3BX, Merseyside, England.	tsolomon@liverpool.ac.uk		Solomon, Tom/0000-0001-7266-6547; Kelly, Christine/0000-0002-3239-7714; Benjamin, Laura/0000-0002-9685-1664	Liverpool Glasgow Wellcome Centre for Global Health Research [099934/Z/12/A]; Medical Research Council [G0901364] Funding Source: researchfish; MRC [G0901364] Funding Source: UKRI	Liverpool Glasgow Wellcome Centre for Global Health Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CMK is a Wellcome Trust Training Fellow supported by the Liverpool Glasgow Wellcome Centre for Global Health Research. Grant number 099934/Z/12/A, http://www.wellcome.ac.uk/Funding. TS is an MRC Senior Clinical Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abers MS, 2014, CNS DRUGS, V28, P131, DOI 10.1007/s40263-013-0132-4; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bonnet F, 2013, AIDS, V27, P391, DOI 10.1097/QAD.0b013e32835b1019; Braganca M, 2011, AIDS BEHAV, V15, P1879, DOI 10.1007/s10461-011-9973-3; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Else L, 2010, J CHROMATOGR B, V878, P1455, DOI 10.1016/j.jchromb.2010.03.036; Ettenhofer ML, 2009, AM J GERIAT PSYCHIAT, V17, P281, DOI 10.1097/JGP.0b013e31819431bd; Fabbiani M, 2013, HIV MED, V14, P136, DOI 10.1111/j.1468-1293.2012.01044.x; Garvey L, 2011, HIV CLIN TRIALS, V12, P333, DOI 10.1310/hct1206-333; Gisslen M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-356; Gutierrez F, 2005, CLIN INFECT DIS, V41, P1648, DOI 10.1086/497835; Haddow LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061826; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hinkin CH, 2002, NEUROLOGY, V59, P1944, DOI 10.1212/01.WNL.0000038347.48137.67; HO DD, 1985, NEW ENGL J MED, V313, P1493, DOI 10.1056/NEJM198512123132401; Joska JA, 2011, AIDS PATIENT CARE ST, V25, P95, DOI 10.1089/apc.2010.0292; Karnofsky D. A., 1949, EVALUATION CHEMOTHER, P196; Kim DH, 2001, CAN J NEUROL SCI, V28, P228, DOI 10.1017/S0317167100001372; Lawler K, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-15; Lawler K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017233; Fernandes SM, 2012, INT PSYCHOGERIATR, V24, P1648, DOI 10.1017/S1041610212000944; McArthur JC, 2010, AIDS, V24, P1367, DOI 10.1097/QAD.0b013e3283391d56; Nakasujja N, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-44; Nakku J, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-126; Nanzigu S, 2012, HIV MED, V13, P193, DOI 10.1111/j.1468-1293.2011.00952.x; Njamnshi AK, 2008, JAIDS-J ACQ IMM DEF, V49, P393, DOI 10.1097/QAI.0b013e318183a9df; Oshinaike OO, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/581531; Parsons TD, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-11; Patel VN, 2010, INT J STD AIDS, V21, P356, DOI 10.1258/ijsa.2010.009554; Robbins RN, 2011, AIDS PATIENT CARE ST, V25, P587, DOI 10.1089/apc.2011.0154; Robertson K, 2011, J NEUROVIROL, V17, P438, DOI 10.1007/s13365-011-0044-3; Robertson K, 2009, NEUROPSYCHOL REV, V19, P232, DOI 10.1007/s11065-009-9096-z; Robertson KR, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-8; Rodriguez-Penney AT, 2013, AIDS PATIENT CARE ST, V27, P5, DOI 10.1089/apc.2012.0329; Rueda S, 2011, AIDS CARE, V23, P435, DOI 10.1080/09540121.2010.507952; Sacktor NC, 2005, AIDS, V19, P1367; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; Selnes OA, 2002, JAIDS-J ACQ IMM DEF, V31, pS132, DOI 10.1097/00126334-200212153-00009; Stewart RC, 2009, J AFFECT DISORDERS, V112, P126, DOI 10.1016/j.jad.2008.04.001; Tozzi V, 2004, INT J STD AIDS, V15, P254, DOI 10.1258/095646204773557794; Wong MH, 2007, NEUROLOGY, V68, P350, DOI 10.1212/01.wnl.0000252811.48891.6d; Wright EJ, 2010, NEUROLOGY, V75, P864, DOI 10.1212/WNL.0b013e3181f11bd8	44	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98962	10.1371/journal.pone.0098962	http://dx.doi.org/10.1371/journal.pone.0098962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24915530	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700046
J	Niyompanich, S; Jaresitthikunchai, J; Srisanga, K; Roytrakul, S; Tungpradabkul, S				Niyompanich, Suthamat; Jaresitthikunchai, Janthima; Srisanga, Kitima; Roytrakul, Sittiruk; Tungpradabkul, Sumalee			Source-Identifying Biomarker Ions between Environmental and Clinical Burkholderia pseudomallei Using Whole-Cell Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS)	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; NORTHERN AUSTRALIA; IDENTIFICATION; MELIOIDOSIS; BACTERIA; INSIGHTS; DISCRIMINATION; CLASSIFICATION; EPIDEMIOLOGY; STRAINS	Burkholderia pseudomallei is the causative agent of melioidosis, which is an endemic disease in Northeast Thailand and Northern Australia. Environmental reservoirs, including wet soils and muddy water, serve as the major sources for contributing bacterial infection to both humans and animals. The whole-cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (whole-cell MALDI-TOF MS) has recently been applied as a rapid, accurate, and high-throughput tool for clinical diagnosis and microbiological research. In this present study, we employed a whole-cell MALDI-TOF MS approach for assessing its potency in clustering a total of 11 different B. pseudomallei isolates (consisting of 5 environmental and 6 clinical isolates) with respect to their origins and to further investigate the source-identifying biomarker ions belonging to each bacterial group. The cluster analysis demonstrated that six out of eleven isolates were grouped correctly to their sources. Our results revealed a total of ten source-identifying biomarker ions, which exhibited statistically significant differences in peak intensity between average environmental and clinical mass spectra using ClinProTools software. Six out of ten mass ions were assigned as environmental-identifying biomarker ions (EIBIs), including, m/z 4,056, 4,214, 5,814, 7,545, 7,895, and 8,112, whereas the remaining four mass ions were defined as clinical-identifying biomarker ions (CIBIs) consisting of m/z 3,658, 6,322, 7,035, and 7,984. Hence, our findings represented, for the first time, the source-specific biomarkers of environmental and clinical B. pseudomallei.	[Niyompanich, Suthamat; Srisanga, Kitima; Tungpradabkul, Sumalee] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Jaresitthikunchai, Janthima; Roytrakul, Sittiruk] Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Tungpradabkul, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand.	sumalee.tan@mahidol.ac.th			Thailand Research Fund; RGJ (the Royal Golden Jubilee) [PHD/0341/2551]; Faculty of Science Mahidol University	Thailand Research Fund(Thailand Research Fund (TRF)); RGJ (the Royal Golden Jubilee); Faculty of Science Mahidol University	This work was supported by the Thailand Research Fund and Faculty of Science Mahidol University. S. Niyompanich received the Ph. D. scholarship from RGJ (the Royal Golden Jubilee) No. PHD/0341/2551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker A, 2013, J CLIN MICROBIOLOGY; Bartpho T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037762; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Chen YS, 2010, J CLIN MICROBIOL, V48, P1432, DOI 10.1128/JCM.01720-09; Cheng AC, 2004, J CLIN MICROBIOL, V42, P5477, DOI 10.1128/JCM.42.12.5477-5483.2004; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; CURRIE B, 1994, EPIDEMIOL INFECT, V113, P307, DOI 10.1017/S0950268800051736; Dance DAB, 2000, ACTA TROP, V74, P159, DOI 10.1016/S0001-706X(99)00066-2; Demirev PA, 2008, J MASS SPECTROM, V43, P1441, DOI 10.1002/jms.1474; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Donohue MJ, 2006, J MICROBIOL METH, V65, P380, DOI 10.1016/j.mimet.2005.08.005; Eddabra R, 2012, MICROBIOL RES, V167, P226, DOI 10.1016/j.micres.2011.09.002; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Giebel RA, 2008, WATER RES, V42, P931, DOI 10.1016/j.watres.2007.09.005; Haase A, 1997, J MED MICROBIOL, V46, P557, DOI 10.1099/00222615-46-7-557; HAASE A, 1995, J CLIN MICROBIOL, V33, P1687, DOI 10.1128/JCM.33.7.1687-1690.1995; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Inglis TJJ, 2000, EMERG INFECT DIS, V6, P56; Intelicato-Young J, 2013, J MICROBIOL METH, V92, P381, DOI 10.1016/j.mimet.2013.01.004; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Karger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-229; Ketterlinus Ralf, 2005, Biotechniques, VSuppl, P37; Krasny L, 2013, INT J MASS SPECTROM, V353, P67, DOI 10.1016/j.ijms.2013.04.016; Leelayuwat C, 2000, ACTA TROP, V77, P229, DOI 10.1016/S0001-706X(00)00137-6; Liew SM, 2012, TROP BIOMED, V29, P160; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Niumsup P, 2002, J ANTIMICROB CHEMOTH, V50, P445, DOI 10.1093/jac/dkf165; Norton R, 1998, FEMS IMMUNOL MED MIC, V20, P37, DOI 10.1016/S0928-8244(97)00104-1; Rajakaruna L, 2009, INFECT GENET EVOL, V9, P507, DOI 10.1016/j.meegid.2009.01.012; Rattanavong S, 2011, APPL ENVIRON MICROB, V77, P532, DOI 10.1128/AEM.01822-10; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Sandrin TR, 2013, MASS SPECTROM REV, V32, P188, DOI 10.1002/mas.21359; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Sermswan RW, 2001, ACTA TROP, V80, P237, DOI 10.1016/S0001-706X(01)00176-0; Siegrist TJ, 2007, J MICROBIOL METH, V68, P554, DOI 10.1016/j.mimet.2006.10.012; Subsin B, 2003, J BACTERIOL, V185, P7008, DOI 10.1128/JB.185.23.7008-7014.2003; Tanigawa K, 2010, APPL ENVIRON MICROB, V76, P4055, DOI 10.1128/AEM.02698-09; Trakulsomboon Suwanna, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P756; Tungpradabkul S, 1999, MOL CELL PROBE, V13, P99, DOI 10.1006/mcpr.1999.0221; Ulett GC, 2001, MICROBES INFECT, V3, P621, DOI 10.1016/S1286-4579(01)01417-4; Valentine N, 2005, APPL ENVIRON MICROB, V71, P58, DOI 10.1128/AEM.71.1.58-64.2005; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Vuddhakul V, 1999, AM J TROP MED HYG, V60, P458, DOI 10.4269/ajtmh.1999.60.458; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Winstanley C, 1998, J MED MICROBIOL, V47, P689, DOI 10.1099/00222615-47-8-689; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002	52	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99160	10.1371/journal.pone.0099160	http://dx.doi.org/10.1371/journal.pone.0099160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914956	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700068
J	Wang, XF; Wahl, R				Wang, Xiaofei; Wahl, Richard			Responses of the Insulin Signaling Pathways in the Brown Adipose Tissue of Rats following Cold Exposure	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER GLUT-4; IN-VIVO; F-18-FDG PET/CT; USA-FAT; ACCLIMATION; ADIPOCYTES; EXPRESSION; PKA; THERMOGENESIS; METABOLISM	The insulin signaling pathway is critical for the control of blood glucose levels. Brown adipose tissue (BAT) has also been implicated as important in glucose homeostasis. The effect of short-term cold exposure on this pathway in BAT has not been explored. We evaluated the effect of 4 hours of cold exposure on the insulin pathway in the BAT of rats. Whole genomic microarray chips were used to examine the transcripts of the pathway in BAT of rats exposed to 4 degrees C and 22 degrees C for 4 hours. The 4 most significantly altered pathways following 4 hours of cold exposure were the insulin signaling pathway, protein kinase A, PI3K/AKT and ERK/MAPK signaling. The insulin signaling pathway was the most affected. In the documented 142 genes of the insulin pathway, 42 transcripts (29.6%) responded significantly to this cold exposure with the least false discovery rate (Benjamini-Hochberg Multiple Testing: -log10 (p-value) = 7.18). Twenty-seven genes (64%) were up-regulated, including the insulin receptor (Insr), insulin substrates 1 and 2 (Irs1 and Irs2). Fifteen transcripts (36%) were down-regulated. Multiple transcripts of the primary target and secondary effector targets for the insulin signaling were also up-regulated, including those for carbohydrate metabolism. Using western blotting, we demonstrated that the cold induced higher Irs2, Irs1, and Akt-p protein levels in the BAT than in the BAT of controls maintained at room temperature, and higher Akt-p protein level in the muscle. Conclusion: this study demonstrated that 4 hours of cold exposure stimulated the insulin signaling pathway in the BAT and muscle of overnight fasted rats. This raises the possibility that acute cold stimulation may have potential to improve glucose clearance and insulin sensitivity.	[Wang, Xiaofei; Wahl, Richard] Johns Hopkins Univ, Sch Med, Div Nucl Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA	Johns Hopkins University	Wang, XF (corresponding author), Johns Hopkins Univ, Sch Med, Div Nucl Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	xfwang2002@yahoo.com; rwahl@jhmi.edu		WAHL, RICHARD L./0000-0002-7306-2590	Ruth L. Kirschstein-National Service Research Award from NIH [T32EB006351]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	Ruth L. Kirschstein-National Service Research Award from NIH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Ruth L. Kirschstein-National Service Research Award from NIH (T32EB006351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2007, J NUCL MED, V48, P1715, DOI 10.2967/jnumed.107.041715; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; CAMERON IL, 1964, J CELL BIOL, V23, P89, DOI 10.1083/jcb.23.1.89; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Chernogubova E, 2004, ENDOCRINOLOGY, V145, P269, DOI 10.1210/en.2003-0857; Cohade C, 2003, J NUCL MED, V44, P1267; Cohade C, 2003, J NUCL MED, V44, P170; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Dallner OS, 2006, ENDOCRINOLOGY, V147, P5730, DOI 10.1210/en.2006-0242; Farese RV, 2005, EXP BIOL MED, V230, P593; Gasparetti AL, 2005, PFLUG ARCH EUR J PHY, V449, P537, DOI 10.1007/s00424-004-1359-1; Gasparetti AL, 2003, J PHYSIOL-LONDON, V552, P149, DOI 10.1113/jphysiol.2003.050369; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; HARDMAN MJ, 1970, J PHYSIOL-LONDON, V206, P263, DOI 10.1113/jphysiol.1970.sp009012; HAUSDORFF SF, 1994, J BIOL CHEM, V269, P21391; HIMMSHAGEN J, 1972, LIPIDS, V7, P310, DOI 10.1007/BF02532649; HIMMSHAGEN J, 1995, OBES RES, V3, P361, DOI 10.1002/j.1550-8528.1995.tb00162.x; LOPEZSORIANO FJ, 1988, BIOCHEM J, V252, P843, DOI 10.1042/bj2520843; McKnight GS, 1998, RECENT PROG HORM RES, V53, P139; Mizuma H, 2010, J NUCL MED, V51, P1068, DOI 10.2967/jnumed.110.075184; OLICHONBERTHE C, 1992, MOL CELL ENDOCRINOL, V89, P11, DOI 10.1016/0303-7207(92)90205-K; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; SHIBATA H, 1989, AM J PHYSIOL, V257, pR96, DOI 10.1152/ajpregu.1989.257.1.R96; SHIMIZU Y, 1993, AM J PHYSIOL, V264, pE890, DOI 10.1152/ajpendo.1993.264.6.E890; SUTER ER, 1969, J ULTRA MOL STRUCT R, V26, P216, DOI 10.1016/S0022-5320(69)80003-1; Taha C, 1997, AM J PHYSIOL-ENDOC M, V273, pE68, DOI 10.1152/ajpendo.1997.273.1.E68; Tatsumi M, 2004, J NUCL MED, V45, P1189; Valladares A, 2000, J CELL PHYSIOL, V185, P324, DOI 10.1002/1097-4652(200012)185:3<324::AID-JCP2>3.0.CO;2-Q; VALLERAND AL, 1983, AM J PHYSIOL, V245, pE575, DOI 10.1152/ajpendo.1983.245.6.E575; VALLERAND AL, 1987, AM J PHYSIOL, V253, pE179, DOI 10.1152/ajpendo.1987.253.2.E179; VALLERAND AL, 1990, AM J PHYSIOL, V259, pR1043, DOI 10.1152/ajpregu.1990.259.5.R1043; Wang X, 2012, J VIS EXP, DOI [10.3791/e4060, DOI 10.3791/E4060]; Wu S, 2012, DIABETES, V61, P114, DOI 10.2337/db11-0956	34	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99772	10.1371/journal.pone.0099772	http://dx.doi.org/10.1371/journal.pone.0099772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915042	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700132
J	Lee, BG; Qiao, LP; Kinney, B; Feng, GS; Shao, JH				Lee, Bonggi; Qiao, Liping; Kinney, Brice; Feng, Gen-Sheng; Shao, Jianhua			Macrophage Depletion Disrupts Immune Balance and Energy Homeostasis	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; COLONY-STIMULATING FACTOR; CELL-LINEAGE-ABLATION; ADIPOSE-TISSUE; FOOD-INTAKE; STROMAL CELLS; ACTIVATION; OBESITY; INFLAMMATION; NEUTROPHILS	Increased macrophage infiltration in tissues including white adipose tissue and skeletal muscle has been recognized as a pro-inflammatory factor that impairs insulin sensitivity in obesity. However, the relationship between tissue macrophages and energy metabolism under non-obese physiological conditions is not clear. To study a homeostatic role of macrophages in energy homeostasis, we depleted tissue macrophages in adult mice through conditional expression of diphtheria toxin (DT) receptor and DT-induced apoptosis. Macrophage depletion robustly reduced body fat mass due to reduced energy intake. These phenotypes were reversed after macrophage recovery. As a potential mechanism, severe hypothalamic and systemic inflammation was induced by neutrophil (NE) infiltration in the absence of macrophages. In addition, macrophage depletion dramatically increased circulating granulocyte colony-stimulating factor (G-CSF) which is indispensable for NE production and tissue infiltration. Our in vitro study further revealed that macrophages directly suppress G-CSF gene expression. Therefore, our study indicates that macrophages may play a critical role in integrating immune balance and energy homeostasis under physiological conditions.	[Lee, Bonggi; Qiao, Liping; Kinney, Brice; Shao, Jianhua] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Shao, JH (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	jishao@ucsd.edu			NIH [DK080418, HD069634, DK095132, R01DK075916]; American Diabetes Association [1-13-BS-048]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075916, R01DK095132, R01DK080418] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by grants DK080418 (J.S.), HD069634 (J.S.), DK095132 (J.S.) and R01DK075916 (G. F.) from the NIH, as well as 1-13-BS-048 (G.F.) from the American Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2003, EXP TOXICOL PATHOL, V55, P21, DOI 10.1078/0940-2993-00297; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Buchanan JB, 2007, NEUROENDOCRINOLOGY, V86, P183, DOI 10.1159/000108280; Butera PC, 2004, PHYSIOL BEHAV, V82, P777, DOI 10.1016/j.physbeh.2004.06.018; Chadzinska M, 2004, FOLIA BIOL-KRAKOW, V52, P225, DOI 10.3409/1734916044527557; Cloutier A, 2009, J IMMUNOL, V182, P563, DOI 10.4049/jimmunol.182.1.563; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; DORSHKIND K, 1990, ANNU REV IMMUNOL, V8, P111, DOI 10.1146/annurev.iy.08.040190.000551; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordy C, 2011, BLOOD, V117, P618, DOI 10.1182/blood-2010-01-265959; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Hierholzer C, 1998, J LEUKOCYTE BIOL, V63, P169, DOI 10.1002/jlb.63.2.169; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pang C, 2008, AM J PHYSIOL-ENDOC M, V295, pE313, DOI 10.1152/ajpendo.90296.2008; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; PlataSalaman CR, 1996, PHYSIOL BEHAV, V60, P867, DOI 10.1016/S0031-9384(96)00148-5; RENNICK D, 1987, BLOOD, V69, P682; Romanatto T, 2007, PEPTIDES, V28, P1050, DOI 10.1016/j.peptides.2007.03.006; SAWADA M, 1990, BRAIN RES, V509, P119, DOI 10.1016/0006-8993(90)90317-5; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002; WATARI K, 1994, STEM CELLS, V12, P416, DOI 10.1002/stem.5530120409; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	39	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99575	10.1371/journal.pone.0099575	http://dx.doi.org/10.1371/journal.pone.0099575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911652	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600106
J	Arvidsson, E; Viereckel, T; Mikulovic, S; Wallen-Mackenzie, A				Arvidsson, Emma; Viereckel, Thomas; Mikulovic, Sanja; Wallen-Mackenzie, Asa			Age- and Sex-Dependence of Dopamine Release and Capacity for Recovery Identified in the Dorsal Striatum of C57/BI6J Mice	PLOS ONE			English	Article							FAST CYCLIC VOLTAMMETRY; PARKINSONS-DISEASE; GENDER-DIFFERENCES; BASAL GANGLIA; TRANSPORTER; RAT; BRAIN; NEURONS	The dorsal striatum is the main input structure of the basal ganglia and the major target area of dopaminergic projections originating in the substantia nigra pars compacta. Heavily involved in the regulation of voluntary movement and habit formation, this structure is of strong importance in Parkinson's disease, obsessive-compulsive disorder, Tourette's syndrome and addiction. The C57/Bl6J mouse strain, the most commonly used strain in preclinical research today, is frequently used as a model organism for analysis of dopaminergic parameters implicated in human pathophysiology. Several components of the dopamine system have been shown to vary with age and sex, however knowledge of the contribution of these factors for dopamine release kinetics in the C57/Bl6J mouse strain is lacking. In the present study, we used an intracranial KCl-stimulation challenge paradigm to provoke release from dopaminergic terminals in the dorsal striatum of anaesthetized C57/Bl6J mice. By high-speed in vivo chronoamperometric recordings, we analyzed DA release parameters in male and female mice of two different ages. Our experiments demonstrate elevated DA amplitudes in adult compared to young mice of both sexes and higher DA amplitudes in females compared to males at both ages. Adult mice exhibited higher recovery capabilities after repeated stimulation than did young mice and also showed a lower variability in the kinetic parameters t(rise) and t(80) between stimulations. These results identified age- and sex-dimorphisms in DA release parameters and point to the importance of taking these dimorphisms into account when utilizing the C57/Bl6J mouse strain as model for neurological and neuropsychiatric disorders.	[Arvidsson, Emma; Viereckel, Thomas; Wallen-Mackenzie, Asa] Uppsala Univ, Unit Funct Neurobiol, Dept Neurosci, Uppsala, Sweden; [Mikulovic, Sanja] Uppsala Univ, Unit Dev Genet, Dept Neurosci, Uppsala, Sweden	Uppsala University; Uppsala University	Wallen-Mackenzie, A (corresponding author), Uppsala Univ, Unit Funct Neurobiol, Dept Neurosci, Uppsala, Sweden.	asa.mackenzie@neuro.uu.se	Wallén-Mackenzie, Åsa/B-9105-2017	Wallén-Mackenzie, Åsa/0000-0002-8713-070X; Viereckel, Thomas/0000-0001-9039-7707	Swedish Medical Research Council (SMRC) [2007-5742, 2011-4747]; Uppsala University; Parkinsonfonden; Swedish Brain Foundation; foundations of Bertil Hallsten, Major Gosta Lind, Ahlen; Ake Wiberg	Swedish Medical Research Council (SMRC)(Swedish Medical Research Council (SMRC)); Uppsala University; Parkinsonfonden; Swedish Brain Foundation; foundations of Bertil Hallsten, Major Gosta Lind, Ahlen; Ake Wiberg	The work was supported by grants from the Swedish Medical Research Council (SMRC 2007-5742, 2011-4747), Uppsala University, the Swedish Brain Foundation, Parkinsonfonden, and the foundations of Bertil Hallsten, Major Gosta Lind, Ahlen and Ake Wiberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsio J, 2011, J NEUROSCI, V31, P12593, DOI 10.1523/JNEUROSCI.2397-11.2011; ANDEN NE, 1964, LIFE SCI, V3, P523, DOI 10.1016/0024-3205(64)90161-4; Bruun RD, 1997, NEUROL CLIN, V15, P291, DOI 10.1016/S0733-8619(05)70313-3; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Dluzen DE, 2008, ANN NY ACAD SCI, V1139, P140, DOI 10.1196/annals.1432.010; Elsworth JD, 1997, EXP NEUROL, V144, P4, DOI 10.1006/exnr.1996.6379; FRIEDEMANN MN, 1992, NEUROBIOL AGING, V13, P325, DOI 10.1016/0197-4580(92)90046-Z; GERHARDT GA, 1986, J NEUROCHEM, V46, P842, DOI 10.1111/j.1471-4159.1986.tb13048.x; GERHARDT GA, 1984, BRAIN RES, V290, P390, DOI 10.1016/0006-8993(84)90963-6; Hafner H, 2003, PSYCHONEUROENDOCRINO, V28, P17, DOI 10.1016/S0306-4530(02)00125-7; Ji J, 2007, J NEUROENDOCRINOL, V19, P725, DOI 10.1111/j.1365-2826.2007.01581.x; Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572; Kumar V, 2013, SCIENCE, V342, P1508, DOI 10.1126/science.1245503; Laakso A, 2002, BIOL PSYCHIAT, V52, P759, DOI 10.1016/S0006-3223(02)01369-0; Lavalaye J, 2000, EUR J NUCL MED, V27, P867, DOI 10.1007/s002590000279; MICHAEL AC, 1987, BRAIN RES, V421, P325, DOI 10.1016/0006-8993(87)91302-3; Michael AC, 2007, FRONT NEUROENG, V1, P1; Nakano M, 1995, GERONTOLOGY, V41, P69; Obeso JA, 2008, MOVEMENT DISORD, V23, pS548, DOI 10.1002/mds.22062; Paxinos G, 2004, MOUSE BRAIN STEREOTA; PETER D, 1995, J NEUROSCI, V15, P6179; Ramsey LCB, 2011, NEUROSCIENCE, V180, P222, DOI 10.1016/j.neuroscience.2011.01.041; Reith MEA, 1997, EUR J PHARMACOL, V324, P1, DOI 10.1016/S0014-2999(97)00065-4; Riccardi P, 2006, NEUROPSYCHOPHARMACOL, V31, P1016, DOI 10.1038/sj.npp.1300916; Shulman LM, 2007, GENDER MED, V4, P8, DOI 10.1016/S1550-8579(07)80003-9; STAMFORD JA, 1989, J NEUROCHEM, V52, P1582, DOI 10.1111/j.1471-4159.1989.tb09212.x; Walker QD, 2000, NEUROSCIENCE, V95, P1061; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	30	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99592	10.1371/journal.pone.0099592	http://dx.doi.org/10.1371/journal.pone.0099592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925086	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300080
J	Gilani, SZ; Rooney, K; Shafait, F; Walters, M; Mian, A				Gilani, Syed Zulqarnain; Rooney, Kathleen; Shafait, Faisal; Walters, Mark; Mian, Ajmal			Geometric Facial Gender Scoring: Objectivity of Perception	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; HUMAN FACES; ATTRACTIVENESS; MASCULINITY; MEN; CLASSIFICATION; DIFFERENCE; TESTOSTERONE; PREFERENCES; SYMMETRY	Gender score is the cognitive judgement of the degree of masculinity or femininity of a face which is considered to be a continuum. Gender scores have long been used in psychological studies to understand the complex psychosocial relationships between people. Perceptual scores for gender and attractiveness have been employed for quality assessment and planning of cosmetic facial surgery. Various neurological disorders have been linked to the facial structure in general and the facial gender perception in particular. While, subjective gender scoring by human raters has been a tool of choice for psychological studies for many years, the process is both time and resource consuming. In this study, we investigate the geometric features used by the human cognitive system in perceiving the degree of masculinity/femininity of a 3D face. We then propose a mathematical model that can mimic the human gender perception. For our experiments, we obtained 3D face scans of 64 subjects using the 3dMDface scanner. The textureless 3D face scans of the subjects were then observed in different poses and assigned a gender score by 75 raters of a similar background. Our results suggest that the human cognitive system employs a combination of Euclidean and geodesic distances between biologically significant landmarks of the face for gender scoring. We propose a mathematical model that is able to automatically assign an objective gender score to a 3D face with a correlation of up to 0.895 with the human subjective scores.	[Gilani, Syed Zulqarnain; Shafait, Faisal; Mian, Ajmal] Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA 6009, Australia; [Rooney, Kathleen] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Walters, Mark] Princess Margaret Hosp Children, CraniomaxilloFacial Unit, Perth, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Gilani, SZ (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA 6009, Australia.	zulqarnain.gilani@uwa.edu.au	Gilani, Syed Zulqarnain/AAJ-8482-2021	Gilani, Syed Zulqarnain/0000-0002-7448-2327; Mian, Ajmal/0000-0002-5206-3842	Australian Research Council [DP110102399, LP110201008]; UWA Faculty of Engineering, Computing and Mathematics Development Grant; International Postgraduate Research Scholarship	Australian Research Council(Australian Research Council); UWA Faculty of Engineering, Computing and Mathematics Development Grant; International Postgraduate Research Scholarship(Australian Government)	This research was partly supported by Australian Research Council Discovery Grant DP110102399 and UWA Faculty of Engineering, Computing and Mathematics Development Grant. Syed Zulqarnain Gilani is supported by International Postgraduate Research Scholarship, and Faisal Shafait was supported by Australian Research Council grant LP110201008. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDI H, 1995, PERCEPTION, V24, P539, DOI 10.1068/p240539; Aldridge K, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-15; Armann R, 2012, VISION RES, V63, P69, DOI 10.1016/j.visres.2012.05.005; BARDIN CW, 1981, SCIENCE, V211, P1285, DOI 10.1126/science.7010603; Bejerot S, 2012, BRIT J PSYCHIAT, V201, P116, DOI 10.1192/bjp.bp.111.097899; Ben Hamza A, 2006, IEEE T IMAGE PROCESS, V15, P2249, DOI 10.1109/TIP.2006.875250; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blanz V, 2003, IEEE T PATTERN ANAL, V25, P1063, DOI 10.1109/TPAMI.2003.1227983; Boothroyd LG, 2008, EVOL HUM BEHAV, V29, P211, DOI 10.1016/j.evolhumbehav.2007.12.009; Bracaglia R, 2005, AESTHET PLAST SURG, V29, P230, DOI 10.1007/s00266-005-0034-z; Bronstein AM, 2005, INT J COMPUT VISION, V64, P5, DOI 10.1007/s11263-005-1085-y; BRUCE V, 1993, PERCEPTION, V22, P131, DOI 10.1068/p220131; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; BURTON AM, 1993, PERCEPTION, V22, P153, DOI 10.1068/p220153; Chung EH, 2013, INT J PEDIAT OTORHIN; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; DErico J., 2008, SURFACE FITTING USIN; Dey JK, 2013, LARYNGOSCOPE; Duda R.O., 2006, PATTERN CLASSIFICATI; Farkas Leslie G., 1994, P71; FARKAS LG, 1987, CLIN PLAST SURG, V14, P599; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Gao JL, 2002, IEEE SYS MAN CYBERN, P2016; Graf ABA, 2006, NEURAL COMPUT, V18, P143, DOI 10.1162/089976606774841611; Gupta S, 2010, INT J COMPUT VISION, V90, P331, DOI 10.1007/s11263-010-0360-8; Hoss RA, 2005, PERCEPTION, V34, P1459, DOI 10.1068/p5154; Jones BC, 2013, BEHAV ECOL, V24, P373, DOI 10.1093/beheco/ars173; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Lee AJ, 2013, BEHAV ECOL, V24, P779, DOI 10.1093/beheco/ars199; Leopold DA, 2010, J COMP PSYCHOL, V124, P233, DOI 10.1037/a0019460; Little AC, 2002, BRIT J PSYCHOL, V93, P451, DOI 10.1348/000712602761381349; Little AC, 2011, PHILOS T R SOC B, V366, P1634, DOI 10.1098/rstb.2010.0386; OToole AJ, 1997, PERCEPTION, V26, P75, DOI 10.1068/p260075; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Peters M, 2008, J EVOLUTION BIOL, V21, P572, DOI 10.1111/j.1420-9101.2007.01477.x; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rhodes G, 2000, BRIT J PSYCHOL, V91, P125, DOI 10.1348/000712600161718; Rieger G, 2010, ARCH SEX BEHAV, V39, P124, DOI 10.1007/s10508-008-9405-2; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Stephen ID, 2012, EVOL HUM BEHAV, V33, P260, DOI 10.1016/j.evolhumbehav.2011.10.003; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Weinberg SM, 2006, J CRANIOFAC SURG, V17, P477, DOI 10.1097/00001665-200605000-00015	48	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99483	10.1371/journal.pone.0099483	http://dx.doi.org/10.1371/journal.pone.0099483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24923319	Green Published, gold			2022-12-25	WOS:000338701300065
J	Lu, F; Guan, HJ; Gong, B; Liu, XQ; Zhu, RR; Wang, Y; Qian, JJ; Zhou, TQ; Lan, XY; Wang, P; Lin, Y; Ma, S; Lin, H; Zhu, X; Chen, R; Zhu, XJ; Shi, Y; Yang, ZL				Lu, Fang; Guan, Huaijin; Gong, Bo; Liu, Xiaoqi; Zhu, Rongrong; Wang, Yong; Qian, Jingjing; Zhou, Tianqiu; Lan, Xiaoyan; Wang, Pu; Lin, Ying; Ma, Shi; Lin, He; Zhu, Xiong; Chen, Rong; Zhu, Xianjun; Shi, Yi; Yang, Zhenglin			Genetic Variants in PVRL2-TOMM40-APOE Region Are Associated with Human Longevity in a Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; COGNITIVE DECLINE; SURVIVAL; APOE; HERITABILITY; FOXO3A; GENOTYPES; HOMOLOG; PROTEIN	Purpose: Human longevity results from a number of factors, including genetic background, favorable environmental, social factors and chance. In this study, we aimed to elucidate the association of human longevity with genetic variations in several major candidate genes in a Han Chinese population. Methods: A case-control association study of 1015 long-lived individuals (aged 90 years or older) and 1725 younger controls (30-70 years old) was undertaken. Rs2075650 in TOMM40 was firstly genotyped using the ABI SNaPshot method in an initial cohort consisted of 597 unrelated long-lived individuals and 1275 younger controls enrolled from Sichuan. Secondly, eighteen tag single-nucleotide polymorphisms (SNPs) in the PVRL2-TOMM40-APOE locus were genotyped for extensive study in the same cohort. Finally, 5 associated SNPs were genotyped in a replication cohort including 418 older individuals and 450 younger controls. The genotype and allele frequencies were evaluated using the chi(2) tests. The linkage disequilibrium (LD) block structure was examined using the program Haploview. Results: The case-control study of rs2075650 in TOMM40 showed significant difference in allele frequencies between cases and controls (P = 0.006) in an initial study. Of the 18 SNPs genotyped, rs405509 in APOE and another three SNPs (rs12978931, rs519825 and rs395908) in the PVRL2 gene also showed significant association with human longevity in extensive study in the same cohort. Rs2075650 in TOMM40, rs405509 in APOE and rs519825 in PVRL2 showed a significant association with human longevity in a replication cohort. Conclusion: These results suggested that PVRL2, TOMM40 and APOE might be associated with human longevity. However, further research is needed to identify the causal variants and determine which of these genes are involved in the progress of human longevity.	[Lu, Fang; Gong, Bo; Liu, Xiaoqi; Lan, Xiaoyan; Wang, Pu; Lin, Ying; Ma, Shi; Lin, He; Zhu, Xiong; Chen, Rong; Zhu, Xianjun; Shi, Yi; Yang, Zhenglin] Sichuan Acad Med Sci, Sichuan Key Lab Dis Gene Study, Chengdu, Sichuan, Peoples R China; [Lu, Fang; Gong, Bo; Liu, Xiaoqi; Lan, Xiaoyan; Wang, Pu; Lin, Ying; Ma, Shi; Lin, He; Zhu, Xiong; Chen, Rong; Zhu, Xianjun; Shi, Yi; Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Guan, Huaijin; Zhu, Rongrong; Wang, Yong; Qian, Jingjing; Zhou, Tianqiu] Nantong Univ, Inst Eye, Affiliated Hosp, Nantong, Jiangsu, Peoples R China; [Lu, Fang; Gong, Bo; Liu, Xiaoqi; Lan, Xiaoyan; Wang, Pu; Lin, Ying; Ma, Shi; Lin, He; Zhu, Xiong; Chen, Rong; Zhu, Xianjun; Shi, Yi; Yang, Zhenglin] Chinese Acad Sci, Sichuan Translat Med Res Hosp, Chengdu, Sichuan, Peoples R China; [Lu, Fang; Gong, Bo; Liu, Xiaoqi; Lan, Xiaoyan; Wang, Pu; Lin, Ying; Ma, Shi; Lin, He; Zhu, Xiong; Chen, Rong; Zhu, Xianjun; Shi, Yi; Yang, Zhenglin] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Nantong University; Chinese Academy of Sciences; University of Electronic Science & Technology of China	Shi, Y (corresponding author), Sichuan Acad Med Sci, Sichuan Key Lab Dis Gene Study, Chengdu, Sichuan, Peoples R China.	shiyi197911@gmail.com; zliny@yahoo.com		Zhu, Xianjun/0000-0002-2531-7552	natural Science Foundation of China [81371048, 81241001, 81070761, 81070718]; Department of Science and Technology of Sichuan Province [2011JTD0020, 2012JQ0023]; Medical key foundation of Jiangsu Province [XK200724]; Department of Sichuan Provincial Health [130167, 130193]	natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province; Medical key foundation of Jiangsu Province; Department of Sichuan Provincial Health	This study was supported by grants from the natural Science Foundation of China (81371048 to B. G., 81241001 and 81070761 to F. L.); the Department of Science and Technology of Sichuan Province (2011JTD0020 to Z.Y. and 2012JQ0023 to Y.S.); the Natural Science Foundation of China (81070718 to H. G.); the Medical key foundation of Jiangsu Province (XK200724 to H. G.); and the Department of Sichuan Provincial Health (130167 to B. G., 130193 to X. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2012, J GERONTOL A-BIOL, V67, P395, DOI 10.1093/gerona/glr223; Asada T, 1996, NEUROLOGY, V47, P603, DOI 10.1212/WNL.47.2.603; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bathum L, 2006, J AM GERIATR SOC, V54, P654, DOI 10.1111/j.1532-5415.2005.53554.x; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; de Magalhaes JP, 2010, AGEING RES REV, V9, P315, DOI 10.1016/j.arr.2009.10.006; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; EBERLE F, 1995, GENE, V159, P267, DOI 10.1016/0378-1119(95)00180-E; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Fossel M, 2000, J PEDIATR ENDOCR MET, V13, P1477; Gerdes LU, 2000, GENET EPIDEMIOL, V19, P202, DOI 10.1002/1098-2272(200010)19:3<202::AID-GEPI2>3.0.CO;2-Q; Gogele M, 2011, J GERONTOL A-BIOL, V66, P26, DOI 10.1093/gerona/glq163; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; KERVINEN K, 1994, ATHEROSCLEROSIS, V105, P89, DOI 10.1016/0021-9150(94)90011-6; Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459; MCGUE M, 1993, J GERONTOL, V48, pB237, DOI 10.1093/geronj/48.6.B237; McKay GJ, 2011, AM J EPIDEMIOL, V173, P1357, DOI 10.1093/aje/kwr015; Nebel A, 2011, MECH AGEING DEV, V132, P324, DOI 10.1016/j.mad.2011.06.008; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls T, 2002, J MOL NEUROSCI, V19, P233, DOI 10.1007/s12031-002-0039-x; Reed T, 2003, TWIN RES, V6, P227, DOI 10.1375/136905203765693889; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Schupf N, 2012, NEUROBIOL AGING; Sebastiani Paola, 2013, Front Public Health, V1, P38, DOI 10.3389/fpubh.2013.00038; Sebastiani P, 2013, AGING-US, V5, P653, DOI 10.18632/aging.100594; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Shukla D, 1999, J VIROL, V73, P4493, DOI 10.1128/JVI.73.5.4493-4497.1999; Skytthe A, 2003, TWIN RES, V6, P448, DOI 10.1375/twin.6.5.448; Soerensen M, 2012, AGE DORDR; Soerensen M, 2010, AGING CELL, V9, P1010, DOI 10.1111/j.1474-9726.2010.00627.x; Terry DF, 2008, ARCH INTERN MED, V168, P277, DOI 10.1001/archinternmed.2007.75; Tindale LC, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.010; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yu CE, 2007, GENOMICS, V89, P655, DOI 10.1016/j.ygeno.2007.02.002; Zhao L, 2012, AGING CELL, V11, P1094, DOI 10.1111/acel.12011	43	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99580	10.1371/journal.pone.0099580	http://dx.doi.org/10.1371/journal.pone.0099580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924924	gold, Green Submitted, Green Published			2022-12-25	WOS:000338701300078
J	Buxton, JL; Das, S; Rodriguez, A; Kaakinen, M; Alves, AC; Sebert, S; Millwood, IY; Laitinen, J; O'Reilly, PF; Jarvelin, MR; Blakemore, AIF				Buxton, Jessica L.; Das, Shikta; Rodriguez, Alina; Kaakinen, Marika; Alves, Alexessander Couto; Sebert, Sylvain; Millwood, Iona Y.; Laitinen, Jaana; O'Reilly, Paul F.; Jarvelin, Marjo-Riitta; Blakemore, Alexandra I. F.			Multiple Measures of Adiposity Are Associated with Mean Leukocyte Telomere Length in the Northern Finland Birth Cohort 1966	PLOS ONE			English	Article							BODY-MASS INDEX; EARLY-LIFE; OBESITY; ADULTHOOD; MORTALITY; DISEASE; GENDER; HEART; AGE	Studies of leukocyte telomere length (LTL) and adiposity have produced conflicting results, and the relationship between body mass index (BMI) and telomere length throughout life remains unclear. We therefore tested association of adult LTL measured in 5,598 participants with: i) childhood growth measures (BMI and age at adiposity rebound (AR)); ii) change in BMI from childhood to adulthood and iii) adult BMI, waist-to-hip ratio (WHR), body adiposity index (BAI). Childhood BMI at AR was positively associated with LTL at 31 years in women (P = 0.041). Adult BMI and WHR in both men (P = 0.025 and P = 0.049, respectively) and women (P = 0.029 and P = 0.008, respectively), and BAI in women (P = 0.021) were inversely associated with LTL at 31 years. An increase in standardised BMI between early childhood and adulthood was associated with shorter adult LTL in women (P = 0.008). We show that LTL is inversely associated with multiple measures of adiposity in both men and women. Additionally, BMI increase in women from childhood to adulthood is associated with shorter telomeres at age 31, potentially indicating accelerated biological ageing.	[Buxton, Jessica L.; Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Investigat Med, London, England; [Das, Shikta; Rodriguez, Alina; Kaakinen, Marika; Alves, Alexessander Couto; Millwood, Iona Y.; O'Reilly, Paul F.; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Ctr Environm & Hlth, MRC,Publ Hlth England,Dept Epidemiol & Biostat, London, England; [Das, Shikta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England; [Rodriguez, Alina] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden; [Kaakinen, Marika; Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Millwood, Iona Y.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Millwood, Iona Y.] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Helsinki, Finland; [O'Reilly, Paul F.] Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Psychiat Ctr, London, England; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children & Young People & Families, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Unit Primary Care, Oulu, Finland	Imperial College London; Imperial College London; Public Health England; Imperial College London; Mid-Sweden University; University of Oulu; University of Oulu; University of Oxford; University of Oxford; Finnish Institute of Occupational Health; University of London; King's College London; Finland National Institute for Health & Welfare; University of Oulu	Buxton, JL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Investigat Med, London, England.	j.buxton@imperial.ac.uk	Buxton, Jessica/L-9849-2019; Rodriguez, Alina/B-3541-2015	Rodriguez, Alina/0000-0003-1209-8802; Couto Alves, Alex/0000-0001-8519-7356; Sebert, Sylvain/0000-0001-6681-6983; O'Reilly, Paul/0000-0001-7515-0845; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Kaakinen, Marika/0000-0002-9228-0462	Wellcome Trust Fellowship [WT088431MA]; Medical Research Council (MRC) UK [G0500539]; National Institute for Health Research (NIHR); Imperial College Health Care NHS Trust, Biomedical Research Centre; Academy of Finland (Center of Excellence in Complex Disease Genetics and SALVE) [104781, 120315, 129269, 1114194]; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; European Commission (EURO-BLCS) [QLG1-CT-2000-01643]; NHLBI through the STAMPEED program [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706:02]; Medical Research Council, UK [G0500539, G0600705]; Wellcome Trust, UK [GR069224]; ENGAGE project; Academy of Finland and Biocentrum Helsinki;  [HEALTH-F4-2007-201413]; MRC [MR/K014536/1, G0600705] Funding Source: UKRI; Medical Research Council [G0600705, MR/K014536/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER	Wellcome Trust Fellowship(Wellcome Trust); Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Imperial College Health Care NHS Trust, Biomedical Research Centre; Academy of Finland (Center of Excellence in Complex Disease Genetics and SALVE); University Hospital Oulu, Biocenter, University of Oulu, Finland; European Commission (EURO-BLCS)(European CommissionEuropean Commission Joint Research Centre); NHLBI through the STAMPEED program; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust, UK(Wellcome Trust); ENGAGE project(General Electric); Academy of Finland and Biocentrum Helsinki(Academy of Finland); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JLB was supported by Wellcome Trust (http://www.wellcome.ac.uk/) Fellowship Grant WT088431MA; SD was supported by the Medical Research Council (MRC) UK (http://www.mrc.ac.uk/), (G0500539) and PFO was supported by the National Institute for Health Research (NIHR) (http://www.nihr.ac.uk/), Imperial College Health Care NHS Trust, Biomedical Research Centre. Financial support for the Northern Finland Birth Cohort 1966 (NFBC1966) was received from the Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics and SALVE), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), NIH/NIMH (5R01MH63706:02), the Medical Research Council, UK (G0500539, G0600705, PrevMetSyn/SALVE) and the Wellcome Trust (project grant GR069224), UK., ENGAGE project and grant agreement HEALTH-F4-2007-201413. The DNA extractions, sample quality controls, biobank upkeep and aliquotting were performed in the National Public Health Institute, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Adaikalakoteswari A, 2005, DIABETIC MED, V22, P1151, DOI 10.1111/j.1464-5491.2005.01574.x; Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; Aviv A, 2006, J CLIN ENDOCR METAB, V91, P635, DOI 10.1210/jc.2005-1814; Aviv A, 2009, INT J EPIDEMIOL, V38, P1735, DOI 10.1093/ije/dyp298; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Cui Y, 2013, OBESITY, V21, P2582, DOI 10.1002/oby.20321; Drury S S, 2012, Mol Psychiatry, V17, P719, DOI 10.1038/mp.2011.53; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Garcia-Calzon S, 2014, INT J OBESITY, V38, P177, DOI 10.1038/ijo.2013.68; Garcia-Calzon S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089828; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Ludlow Andrew T, 2011, J Aging Res, V2011, P790378, DOI 10.4061/2011/790378; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Muezzinler A, 2014, OBES REV, V15, P192, DOI 10.1111/obr.12126; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Oeseburg Hisko, 2010, Pflugers Arch, V459, P259, DOI 10.1007/s00424-009-0728-1; Rantakallio P, 1988, Paediatr Perinat Epidemiol, V2, P59, DOI 10.1111/j.1365-3016.1988.tb00180.x; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Rolland-Cachera MF, 2005, ADV EXP MED BIOL, V569, P35; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Schulze MB, 2012, DIABETOLOGIA, V55, P1660, DOI 10.1007/s00125-012-2499-z; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; Sovio U, 2014, INT J OBESITY, V38, P53, DOI 10.1038/ijo.2013.165; Tzanetakou IP, 2012, AGEING RES REV, V11, P220, DOI 10.1016/j.arr.2011.12.003; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; World Health Organisation, 1995, PHYS STAT USE INT AN	43	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99133	10.1371/journal.pone.0099133	http://dx.doi.org/10.1371/journal.pone.0099133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919187	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000338631000052
J	Martin, SAL; Jameson, CH; Allan, SM; Lawrence, CB				Martin, Sarah A. L.; Jameson, Christine H.; Allan, Stuart M.; Lawrence, Catherine B.			Maternal High-Fat Diet Worsens Memory Deficits in the Triple-Transgenic (3xTgAD) Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							FEMALE MICE LEADS; EARLY-LIFE; INSULIN-RESISTANCE; INDUCED OBESITY; INCIDENT DEMENTIA; AMYLOID-BETA; RISK-FACTORS; BEHAVIOR; PREGNANCY; ACIDS	Alzheimer's disease (AD) is not normally diagnosed until later in life, although evidence suggests that the disease starts at a much earlier age. Risk factors for AD, such as diabetes, hypertension and obesity, are known to have their affects during mid-life, though events very early in life, including maternal over-nutrition, can predispose offspring to develop these conditions. This study tested whether over-nutrition during pregnancy and lactation affected the development of AD in offspring, using a transgenic AD mouse model. Female triple-transgenic AD dam mice (3xTgAD) were exposed to a high-fat (60% energy from fat) or control diet during pregnancy and lactation. After weaning (at 3 weeks of age), female offspring were placed on a control diet and monitored up until 12 months of age during which time behavioural tests were performed. A transient increase in body weight was observed in 4-week-old offspring 3xTgAD mice from dams fed a highfat diet. However, by 5 weeks of age the body weight of 3xTgAD mice from the maternal high-fat fed group was no different when compared to control-fed mice. A maternal high-fat diet led to a significant impairment in memory in 2-and 12monthold 3xTgAD offspring mice when compared to offspring from control fed dams. These effects of a maternal high-fat diet on memory were accompanied by a significant increase (50%) in the number of tau positive neurones in the hippocampus. These data demonstrate that a high-fat diet during pregnancy and lactation increases memory impairments in female 3xTgAD mice and suggest that early life events during development might influence the onset and progression of AD later in life.	[Martin, Sarah A. L.; Jameson, Christine H.; Allan, Stuart M.; Lawrence, Catherine B.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Lawrence, CB (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	catherine.lawrence@manchester.ac.uk	Allan, Stuart/AAL-1245-2020	Allan, Stuart/0000-0001-9646-4456; Lawrence, Catherine/0000-0002-2372-2968	capacity-building award to Manchester's Centre for Integrative Mammalian Biology	capacity-building award to Manchester's Centre for Integrative Mammalian Biology	SALM and CHJ were Masters of Research students, supported by a capacity-building award to Manchester's Centre for Integrative Mammalian Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebakin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045179; Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; BARKER DJP, 1986, LANCET, V1, P1077; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Breteler MMB, 2001, EPIDEMIOLOGY, V12, P378; Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017; Eskelinen MH, 2008, INT J GERIATR PSYCH, V23, P741, DOI 10.1002/gps.1969; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Freeman DJ, 2010, SEMIN FETAL NEONAT M, V15, P113, DOI 10.1016/j.siny.2009.09.001; Grant W B, 1999, J Alzheimers Dis, V1, P197; Grant W.B., 1997, ALZHEIMERS DIS REV, V2, P42; Gustafson D, 2008, EUR J PHARMACOL, V585, P163, DOI 10.1016/j.ejphar.2008.01.052; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Herculano B, 2013, J ALZHEIMERS DIS, V33, P983, DOI 10.3233/JAD-2012-121324; Herring A, 2012, FASEB J, V26, P117, DOI 10.1096/fj.11-193193; Hiramatsu M, 1997, PHARMACOL BIOCHEM BE, V56, P73, DOI 10.1016/S0091-3057(96)00159-1; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Jones KL, 2013, BEHAV BRAIN RES, V238, P193, DOI 10.1016/j.bbr.2012.10.028; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Kajantie E, 2008, HORM-INT J ENDOCRINO, V7, P101, DOI 10.1007/BF03401501; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Knight EM, 2012, NEUROBIOL AGING, V33, P187, DOI 10.1016/j.neurobiolaging.2010.02.003; Knight EM, 2014, NEUROBIOL AGING, DOI 10.1016; Lahiri DK, 2008, BIOGERONTOLOGY, V9, P375, DOI 10.1007/s10522-008-9162-6; Laitinen MH, 2006, DEMENT GERIATR COGN, V22, P99, DOI 10.1159/000093478; Leboucher A, 2013, DIABETES, V62, P1681, DOI 10.2337/db12-0866; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Liang C, 2009, BIRTH DEFECTS RES B, V86, P377, DOI 10.1002/bdrb.20206; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Maesako M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.028; McMillen IC, 2005, J PHYSIOL-LONDON, V565, P9, DOI 10.1113/jphysiol.2004.081992; Miller DB, 2008, METABOLISM, V57, pS44, DOI 10.1016/j.metabol.2008.07.011; Naef L, 2008, PSYCHOPHARMACOLOGY, V197, P83, DOI 10.1007/s00213-007-1008-4; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Panza F, 2004, PUBLIC HEALTH NUTR, V7, P959, DOI 10.1079/PHN2004561; Park SH, 2013, INT J MOL MED, V31, P577, DOI 10.3892/ijmm.2013.1233; Patil S, 2005, NEUROSCI LETT, V384, P288, DOI 10.1016/j.neulet.2005.05.003; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pedrini S, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-40; Peleg-Raibstein D, 2012, BEHAV BRAIN RES, V233, P398, DOI 10.1016/j.bbr.2012.05.027; Phivilay A, 2009, NEUROSCIENCE, V159, P296, DOI 10.1016/j.neuroscience.2008.12.006; Polidori MC, 2012, J ALZHEIMERS DIS, V32, P521, DOI 10.3233/JAD-2012-120871; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Rahman A, 2005, FEBS LETT, V579, P6411, DOI 10.1016/j.febslet.2005.10.024; Raygada M, 1998, J NUTR, V128, P2505; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Rodriguez A, 2010, J CHILD PSYCHOL PSYC, V51, P134, DOI 10.1111/j.1469-7610.2009.02133.x; Rodriguez JS, 2012, INT J DEV NEUROSCI, V30, P75, DOI 10.1016/j.ijdevneu.2011.12.012; Ross MG, 2007, CURR ALZHEIMER RES, V4, P213, DOI 10.2174/156720507780362056; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sullivan EL, 2010, J NEUROSCI, V30, P3826, DOI 10.1523/JNEUROSCI.5560-09.2010; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wall PM, 2002, PSYCHOPHARMACOLOGY, V160, P233, DOI 10.1007/s00213-001-0979-9; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Yu HL, 2010, INT J DEV NEUROSCI, V28, P271, DOI 10.1016/j.ijdevneu.2009.12.001	60	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99226	10.1371/journal.pone.0099226	http://dx.doi.org/10.1371/journal.pone.0099226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918775	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000061
J	Takahashi, K; Raska, M; Horynova, MS; Hall, SD; Poulsen, K; Kilian, M; Hiki, Y; Yuzawa, Y; Moldoveanu, Z; Julian, BA; Renfrow, MB; Novak, J				Takahashi, Kazuo; Raska, Milan; Horynova, Milada Stuchlova; Hall, Stacy D.; Poulsen, Knud; Kilian, Mogens; Hiki, Yoshiyuki; Yuzawa, Yukio; Moldoveanu, Zina; Julian, Bruce A.; Renfrow, Matthew B.; Novak, Jan			Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; GALACTOSE-DEFICIENT IGA1; HUMAN SERUM IGA1; ABERRANTLY GLYCOSYLATED IGA1; CIRCULATING IMMUNE-COMPLEXES; RESONANCE MASS-SPECTROMETRY; BREAST-CANCER PATIENTS; N-GLYCOSYLATION; MESANGIAL CELLS; HINGE REGION	Patients with IgA nephropathy (IgAN) have elevated circulating levels of IgA1 with some O-glycans consisting of galactose (Gal)-deficient N-acetylgalactosamine (GalNAc) with or without N-acetylneuraminic acid (NeuAc). We have analyzed O-glycosylation heterogeneity of naturally asialo-IgA1 (Ale) myeloma protein that mimics Gal-deficient IgA1 (Gd-IgA1) of patients with IgAN, except that IgA1 O-glycans of IgAN patients are frequently sialylated. Specifically, serum IgA1 of healthy controls has more alpha 2,3-sialylated O-glycans (NeuAc attached to Gal) than alpha 2,6-sialylated O-glycans (NeuAc attached to GalNAc). As IgA1-producing cells from IgAN patients have an increased activity of alpha 2,6-sialyltransferase (ST6GalNAc), we hypothesize that such activity may promote premature sialylation of GalNAc and, thus, production of Gd-IgA1, as sialylation of GalNAc prevents subsequent Gal attachment. Distribution of NeuAc in IgA1 O-glycans may play an important role in the pathogenesis of IgAN. To better understand biological functions of NeuAc in IgA1, we established protocols for enzymatic sialylation leading to alpha 2,3- or alpha 2,6-sialylation of IgA1 O-glycans. Sialylation of Gal-deficient asialo-IgA1 (Ale) myeloma protein by an ST6GalNAc enzyme generated sialylated IgA1 that mimics the Gal-deficient IgA1 glycoforms in patients with IgAN, characterized by alpha 2,6-sialylated Gal-deficient GalNAc. In contrast, sialylation of the same myeloma protein by an alpha 2,3-sialyltransferase yielded IgA1 typical for healthy controls, characterized by alpha 2,3-sialylated Gal. The GalNAc-specific lectin from Helix aspersa (HAA) is used to measure levels of Gd-IgA1. We assessed HAA binding to IgA1 sialylated at Gal or GalNAc. As expected, alpha 2,6-sialylation of IgA1 markedly decreased reactivity with HAA. Notably, alpha 2,3-sialylation also decreased reactivity with HAA. Neuraminidase treatment recovered the original HAA reactivity in both instances. These results suggest that binding of a GalNAc-specific lectin is modulated by sialylation of GalNAc as well as Gal in the clustered IgA1 O-glycans. Thus, enzymatic sialylation offers a useful model to test the role of NeuAc in reactivities of the clustered O-glycans with lectins.	[Takahashi, Kazuo; Raska, Milan; Horynova, Milada Stuchlova; Hall, Stacy D.; Moldoveanu, Zina; Julian, Bruce A.; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Julian, Bruce A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Renfrow, Matthew B.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, UAB Biomed FT ICR MS Lab, Birmingham, AL 35203 USA; [Takahashi, Kazuo; Yuzawa, Yukio] Fujita Hlth Univ, Sch Med, Dept Nephrol, Toyoake, Aichi 47011, Japan; [Raska, Milan; Horynova, Milada Stuchlova] Palacky Univ, Fac Med & Dent, Dept Immunol, CR-77147 Olomouc, Czech Republic; [Poulsen, Knud; Kilian, Mogens] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Hiki, Yoshiyuki] Fujita Hlth Univ, Sch Hlth Sci, Toyoake, Aichi, Japan	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Fujita Health University; Palacky University Olomouc; Aarhus University; Fujita Health University	Renfrow, MB (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, UAB Biomed FT ICR MS Lab, Birmingham, AL 35203 USA.	renfrow@uab.edu; jannovak@uab.edu	Raska, Milan/E-9813-2013	Raska, Milan/0000-0002-8572-7246; Stuchlova Horynova, Milada/0000-0001-6375-4406; Kilian, Mogens/0000-0002-5861-0472; Renfrow, Matthew B./0000-0002-4193-7305	NIH [DK078244, GM098539, DK082753]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082753, R56DK078244, R01DK078244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098539] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24591219] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the NIH grants DK078244, GM098539, and DK082753, and by a gift from the IGA Nephropathy Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; Amore A, 2001, J AM SOC NEPHROL, V12, P1862, DOI 10.1681/ASN.V1291862; BAENZIGER J, 1974, J BIOL CHEM, V249, P7270; Basset C, 1999, SCAND J IMMUNOL, V50, P572; Berger J, 1968, UROL NEPHROL PARIS, V74, P694; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Bresalier RS, 1996, GASTROENTEROLOGY, V110, P1354, DOI 10.1053/gast.1996.v110.pm8613039; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; CONLEY ME, 1980, J CLIN INVEST, V66, P1432, DOI 10.1172/JCI109998; COPPO R, 1984, CLIN EXP IMMUNOL, V57, P583; COPPO R, 1993, CONTRIB NEPHROL, V104, P162; CORFIELD T, 1992, GLYCOBIOLOGY, V2, P509, DOI 10.1093/glycob/2.6.509; CZERKINSKY C, 1986, J CLIN INVEST, V77, P1931, DOI 10.1172/JCI112522; Ding JX, 2007, CLIN IMMUNOL, V125, P268, DOI 10.1016/j.clim.2007.08.009; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Hastings Margaret Colleen, 2013, Expert Opin Med Diagn, V7, P615, DOI 10.1517/17530059.2013.856878; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; Hiki Y, 2009, CLIN EXP NEPHROL, V13, P415, DOI 10.1007/s10157-009-0173-7; Horie A, 2003, AM J KIDNEY DIS, V42, P486, DOI 10.1016/S0272-6386(03)00743-1; Horynova M, 2012, PROTEIN EXPRES PURIF, V81, P175, DOI 10.1016/j.pep.2011.10.006; Horynova MS, 2013, CELL MOL LIFE SCI, V70, P829, DOI 10.1007/s00018-012-1082-6; JULIAN BA, 1988, AM J MED, V84, P129, DOI 10.1016/0002-9343(88)90019-8; Julien S, 2005, BREAST CANCER RES TR, V90, P77, DOI 10.1007/s10549-004-3137-3; Kilian M, 1996, APMIS, V104, P321, DOI 10.1111/j.1699-0463.1996.tb00724.x; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; Kokubo T, 1998, J AM SOC NEPHROL, V9, P2048; LAI KN, 1994, NEPHRON, V66, P38, DOI 10.1159/000187763; Leung JCK, 2002, J CLIN LAB ANAL, V16, P11, DOI 10.1002/jcla.2035; Leung JCK, 1999, J LAB CLIN MED, V133, P152, DOI 10.1016/S0022-2143(99)90008-2; Leung JCK, 2001, KIDNEY INT, V59, P277, DOI 10.1046/j.1523-1755.2001.00489.x; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Maenuma K, 2009, J PROTEOME RES, V8, P3617, DOI 10.1021/pr800816w; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; MESTECKY J, 1989, IMMUNOL INVEST, V18, P313, DOI 10.3109/08820138909112245; MESTECKY J, 1986, MONOGR ALLERGY, V19, P277; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; Mestecky J, 2013, ANNU REV PATHOL-MECH, V8, P217, DOI 10.1146/annurev-pathol-011110-130216; Mistry D, 2006, INT J BIOCHEM CELL B, V38, P1244, DOI 10.1016/j.biocel.2005.10.005; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; MOLDOVEANU Z, 1988, J IMMUNOL, V141, P208; MONTEIRO RC, 1985, KIDNEY INT, V28, P666, DOI 10.1038/ki.1985.181; Moore JS, 2007, MOL IMMUNOL, V44, P2598, DOI 10.1016/j.molimm.2006.12.011; Moore JS, 2005, AIDS, V19, P381, DOI 10.1097/01.aids.0000161767.21405.68; Mungul A, 2004, INT J ONCOL, V25, P937; Novak J, 2005, KIDNEY INT, V67, P504, DOI 10.1111/j.1523-1755.2005.67107.x; Novak J, 2001, J CLIN IMMUNOL, V21, P310, DOI 10.1023/A:1012284402054; Novak J, 2008, SEMIN NEPHROL, V28, P78, DOI 10.1016/j.semnephrol.2007.10.009; Novak J, 2013, CURR OPIN NEPHROL HY, V22, P287, DOI 10.1097/MNH.0b013e32835fef54; Odani H, 2000, BIOCHEM BIOPH RES CO, V271, P268, DOI 10.1006/bbrc.2000.2613; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; RADEMACHER TW, 1994, P NATL ACAD SCI USA, V91, P6123, DOI 10.1073/pnas.91.13.6123; Raska M, 2007, J MOL BIOL, V369, P69, DOI 10.1016/j.jmb.2007.03.002; REINHOLDT J, 1990, INFECT IMMUN, V58, P1186, DOI 10.1128/IAI.58.5.1186-1194.1990; Renfrow MB, 2007, ANAL BIOANAL CHEM, V389, P1397, DOI 10.1007/s00216-007-1500-z; Renfrow MB, 2005, J BIOL CHEM, V280, P19136, DOI 10.1074/jbc.M411368200; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sano T, 2002, NEPHROL DIAL TRANSPL, V17, P50, DOI 10.1093/ndt/17.1.50; SCHENA FP, 1989, CLIN EXP IMMUNOL, V77, P15; Schindlbeck C, 2005, HISTOCHEM CELL BIOL, V123, P631, DOI 10.1007/s00418-005-0781-6; SCHMITT FC, 1995, VIRCHOWS ARCH, V427, P251; Scott DW, 2013, GLYCOBIOLOGY, V23, P622, DOI 10.1093/glycob/cwt014; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Steirer LM, 2009, J BIOL CHEM, V284, P3777, DOI 10.1074/jbc.M808689200; Stephenson AE, 2002, MOL MICROBIOL, V43, P147, DOI 10.1046/j.1365-2958.2002.02725.x; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Storr SJ, 2008, GLYCOBIOLOGY, V18, P456, DOI 10.1093/glycob/cwn022; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2014, J BIOL CHEM, V289, P5330, DOI 10.1074/jbc.M113.512277; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Takahashi K, 2012, J PROTEOME RES, V11, P692, DOI 10.1021/pr200608q; Takahashi K, 2010, MOL CELL PROTEOMICS, V9, P2545, DOI 10.1074/mcp.M110.001834; Tarelli E, 2004, CARBOHYD RES, V339, P2329, DOI 10.1016/j.carres.2004.07.011; TOMANA M, 1988, GASTROENTEROLOGY, V94, P762, DOI 10.1016/0016-5085(88)90252-1; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Tomana M, 1997, KIDNEY INT, V52, P509, DOI 10.1038/ki.1997.361; Troelsen LN, 2007, ARTHRITIS RHEUM, V56, P21, DOI 10.1002/art.22302; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Xu LX, 2005, KIDNEY INT, V68, P167, DOI 10.1111/j.1523-1755.2005.00390.x; Xue J, 2013, GLYCOCONJUGATE J, V30, P735, DOI 10.1007/s10719-013-9481-y	85	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99026	10.1371/journal.pone.0099026	http://dx.doi.org/10.1371/journal.pone.0099026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918438	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000041
J	Yeghiazaryan, M; Rutkowska-Wlodarczyk, I; Konopka, A; Wilczynski, GM; Melikyan, A; Korkotian, E; Kaczmarek, L; Figiel, I				Yeghiazaryan, Marine; Rutkowska-Wlodarczyk, Izabela; Konopka, Anna; Wilczynski, Grzegorz M.; Melikyan, Armenuhi; Korkotian, Eduard; Kaczmarek, Leszek; Figiel, Izabela			DP-b99 Modulates Matrix Metalloproteinase Activity and Neuronal Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ACUTE ISCHEMIC-STROKE; SYNAPTIC PLASTICITY; STATUS EPILEPTICUS; MOUSE MODEL; MATRIX-METALLOPROTEINASE-9; EPILEPSY; MEMBRANE; CHELATOR; MMP-9	DP-b99 is a membrane-activated chelator of zinc and calcium ions, recently proposed as a therapeutic agent. Matrix metalloproteinases (MMPs) are zinc-dependent extracellularly operating proteases that might contribute to synaptic plasticity, learning and memory under physiological conditions. In excessive amounts these enzymes contribute to a number of neuronal pathologies ranging from the stroke to neurodegeneration and epileptogenesis. In the present study, we report that DP-b99 delays onset and severity of PTZ-induced seizures in mice, as well as displays neuroprotective effect on kainate excitotoxicity in hippocampal organotypic slices and furthermore blocks morphological reorganization of the dendritic spines evoked by a major neuronal MMP, MMP-9. Taken together, our findings suggest that DP-b99 may inhibit neuronal plasticity driven by MMPs, in particular MMP-9, and thus may be considered as a therapeutic agent under conditions of aberrant plasticity, such as those subserving epileptogenesis.	[Yeghiazaryan, Marine; Konopka, Anna; Wilczynski, Grzegorz M.] M Nencki Inst Expt Biol, Dept Neurophysiol, PL-02093 Warsaw, Poland; [Rutkowska-Wlodarczyk, Izabela; Kaczmarek, Leszek; Figiel, Izabela] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland; [Melikyan, Armenuhi] D Pharm Ltd, Rehovot, Israel; [Korkotian, Eduard] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Weizmann Institute of Science	Figiel, I (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland.	i.figiel@nencki.gov.pl	Korkotian, Eduard/K-1744-2012; Kaczmarek, Leszek/B-6171-2008; Korkotian, Eduard/P-4559-2019; Kaczmarek, Leszek/AHA-0076-2022	Korkotian, Eduard/0000-0001-5515-3387; Kaczmarek, Leszek/0000-0002-7207-3490; Kaczmarek, Leszek/0000-0002-7207-3490; Wilczynski, Grzegorz/0000-0001-6667-0291; Figiel, Izabela/0000-0001-5028-0168; Konopka, Anna/0000-0002-5487-6003	7FP EU; ERANET NEURON; National Science Centre Poland [N N301 665140]	7FP EU(European Commission); ERANET NEURON; National Science Centre Poland(National Science Centre, Poland)	This work has been supported by the 7FP EU grant Plasticise, ERANET NEURON grant TBI Epi, and grant no. N N301 665140 from National Science Centre Poland (IF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Angel A, 2002, DRUG DEVELOP RES, P300; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; BarKalifa R, 2009, EUR J PHARMACOL, V618, P15, DOI 10.1016/j.ejphar.2009.07.019; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Buckmaster PS, 2002, J NEUROSCI, V22, P6650; Chaturvedi M, 2012, NEUROCHEM INT, V61, P1065, DOI 10.1016/j.neuint.2012.07.023; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Conant K, 2010, NEUROSCIENCE, V166, P508, DOI 10.1016/j.neuroscience.2009.12.061; Diener HC, 2008, STROKE, V39, P1774, DOI 10.1161/STROKEAHA.107.506378; Dziembowska M, 2012, INT J BIOCHEM CELL B, V44, P709, DOI 10.1016/j.biocel.2012.01.023; Friedman J, 2010, INT J STROKE S2, V5, P142; Friedman J, 2010, INT J STROKE S2, V5, P141; Huntley GW, 2012, HIPPOCAMPUS, V22, P17, DOI 10.1002/hipo.20859; Jourquin J, 2003, EUR J NEUROSCI, V18, P1507, DOI 10.1046/j.1460-9568.2003.02876.x; Knapska E, 2013, J NEUROSCI, V33, P14591, DOI 10.1523/JNEUROSCI.5239-12.2013; Lees KR, 2013, STROKE, V44, P580, DOI 10.1161/STROKEAHA.111.000013; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Michaluk P, 2011, J CELL SCI, V124, P3369, DOI 10.1242/jcs.090852; Mioduszewska B, 2008, J NEUROSCI RES, V86, P61, DOI 10.1002/jnr.21469; Mizoguchi H, 2011, J NEUROSCI, V31, P12963, DOI 10.1523/JNEUROSCI.3118-11.2011; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; OKAZAKI MM, 1995, J COMP NEUROL, V352, P515, DOI 10.1002/cne.903520404; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Rosenberg G, 2005, BRIT J CLIN PHARMACO, V60, P7, DOI 10.1111/j.1365-2125.2005.02378.x; Rosenberg G, 2011, INT J STROKE, V6, P362, DOI 10.1111/j.1747-4949.2011.00608.x; Ruszczycki B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-213; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Vezzani A, 2000, P NATL ACAD SCI USA, V97, P11534, DOI 10.1073/pnas.190206797; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Walker L, 2012, EPILEPSY CURR, V12, P8, DOI 10.5698/1535-7511-12.1.8; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Wiera G, 2013, HIPPOCAMPUS, V23, P529, DOI 10.1002/hipo.22112; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Zagulska-Szymczak S, 2001, NEUROCHEM INT, V38, P485, DOI 10.1016/S0197-0186(00)00101-7; Zhou L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-15	47	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99789	10.1371/journal.pone.0099789	http://dx.doi.org/10.1371/journal.pone.0099789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918931	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000110
J	Chrostek, E; Marialva, MSP; Yamada, R; O'Neill, SL; Teixeira, L				Chrostek, Ewa; Marialva, Marta S. P.; Yamada, Ryuichi; O'Neill, Scott L.; Teixeira, Luis			High Anti-Viral Protection without Immune Upregulation after Interspecies Wolbachia Transfer	PLOS ONE			English	Article							SEQUENCE TYPING SYSTEM; CYTOPLASMIC INCOMPATIBILITY; DROSOPHILA-MELANOGASTER; MITOCHONDRIAL GENOTYPE; ENDOSYMBIONT WOLBACHIA; DENGUE VIRUS; EXPRESSION; SYMBIONT; DENSITY; ACTIVATION	Wolbachia, endosymbionts that reside naturally in up to 40-70% of all insect species, are some of the most prevalent intracellular bacteria. Both Wolbachia wAu, naturally associated with Drosophila simulans, and wMel, native to Drosophila melanogaster, have been previously described to protect their hosts against viral infections. wMel transferred to D. simulans was also shown to have a strong antiviral effect. Here we directly compare one of the most protective wMel variants and wAu in D. melanogaster in the same host genetic background. We conclude that wAu protects better against viral infections, it grows exponentially and significantly shortens the lifespan of D. melanogaster. However, there is no difference between wMel and wAu in the expression of selected antimicrobial peptides. Therefore, neither the difference in anti-viral effect nor the life-shortening could be attributed to the immune stimulation by exogenous Wolbachia. Overall, we prove that stable transinfection with a highly protective Wolbachia is not necessarily associated with general immune activation.	[Chrostek, Ewa; Marialva, Marta S. P.; Teixeira, Luis] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Yamada, Ryuichi] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL USA; [O'Neill, Scott L.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [O'Neill, Scott L.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Instituto Gulbenkian de Ciencia; Scripps Research Institute; University of Queensland; Monash University	Chrostek, E (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	e.chrostek@gmail.com	Teixeira, Luis/H-6106-2013; O'Neill, Scott L/B-3568-2009; O'Neill, Scott/R-9560-2019; Chrostek, Ewa/AAA-4218-2022	Teixeira, Luis/0000-0001-8326-6645; O'Neill, Scott L/0000-0002-4131-3615; O'Neill, Scott/0000-0002-4131-3615; Chrostek, Ewa/0000-0003-1825-372X; Yamada, Ryuichi/0000-0002-8344-5499	Fundacao para a Ciencia e Tecnologia [PTDC/BIA-MIC/108327/2008, SFRH/BD/51625/2011]; Wellcome Trust [094664/Z/10/Z]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-MIC/108327/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia (http://www.fct.pt) grants PTDC/BIA-MIC/108327/2008 and the Wellcome Trust (http://www.wellcome.ac.uk) grant 094664/Z/10/Z. EC is supported by the PhD fellowship from Fundacao para a Ciencia e Tecnologia SFRH/BD/51625/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; Brun G, 1978, GENET BIOL DROSOPHIL, P625; Charlat S, 2004, EVOLUTION, V58, P1901, DOI 10.1111/j.0014-3820.2004.tb00478.x; Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896; Clancy DJ, 2008, AGING CELL, V7, P795, DOI 10.1111/j.1474-9726.2008.00428.x; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; Fenton A, 2011, AM NAT, V178, P333, DOI 10.1086/661247; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; HOFFMANN AA, 1994, GENETICS, V136, P993; Ilinsky YY, 2007, RUSS J GENET+, V43, P748, DOI 10.1134/S102279540707006X; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; James AC, 2003, GENETICS, V164, P187; Johnson KN, 1999, J INVERTEBR PATHOL, V73, P248, DOI 10.1006/jipa.1998.4830; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kapun M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012421; Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607; Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x; Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Paraskevopoulos C, 2006, CURR MICROBIOL, V53, P388, DOI 10.1007/s00284-006-0054-1; Poinsot D, 1998, GENETICS, V150, P227; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Richardson MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003129; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Siozios S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055390; SOLIGNAC M, 1994, CR ACAD SCI III-VIE, V317, P461; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Teixeira L, 2012, BRIEF FUNCT GENOMICS, V11, P375, DOI 10.1093/bfgp/els043; Verspoor RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026318; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430; Woolfit M, 2013, GENOME BIOL EVOL, V5, P2189, DOI 10.1093/gbe/evt169; Yamada R, 2011, INSECT MOL BIOL, V20, P75, DOI 10.1111/j.1365-2583.2010.01042.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	50	44	45	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99025	10.1371/journal.pone.0099025	http://dx.doi.org/10.1371/journal.pone.0099025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911519	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600035
J	Dordevic, AL; Konstantopoulos, N; Cameron-Smith, D				Dordevic, Aimee L.; Konstantopoulos, Nicky; Cameron-Smith, David			3T3-L1 Preadipocytes Exhibit Heightened Monocyte-Chemoattractant Protein-1 Response to Acute Fatty Acid Exposure	PLOS ONE			English	Article							FACTOR-KAPPA-B; NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE CELLS; ADIPOSE-TISSUE; TNF-ALPHA; ADIPOCYTE DIFFERENTIATION; INNATE IMMUNITY; KINASE-C; EXPRESSION	Preadipocytes contribute to the inflammatory responses within adipose tissue. Whilst fatty acids are known to elicit an inflammatory response within adipose tissue, the relative contribution of preadipocytes and mature adipocytes to this is yet to be determined. We aimed to examine the actions of common dietary fatty acids on the acute inflammatory and adipokine response in 3T3-L1 preadipocytes and differentiated mature adipocytes. Gene expression levels of key adipokines in 3T3-L1 preadipocytes and adipocytes were determined following incubation with palmitic acid, myristic acid or oleic acid and positive inflammatory control, lipopolysaccharide for 2 and 4 h. Inflammatory kinase signalling was assessed by analysis of nuclear factor-kappa B, p38-mitogen-activated protein kinase and c-jun amino-terminal kinase phosphorylation. Under basal conditions, intracellular monocyte chemoattractant protein-1 and interleukin-6 gene expression levels were increased in preadipocytes, whereas mature adipocytes expressed increased gene expression levels of leptin and adiponectin. Fatty acid exposure at 2 and 4 h increased both monocyte chemoattractant protein-1 and interleukin-6 gene expression levels in preadipocytes to greater levels than in mature adipocytes. There was an accompanying increase of inhibitor of kappa B-a degradation and nuclear factor-kB (p65) (Ser536) phosphorylation with fatty acid exposure in the preadipocytes only. The current study points to preadipocytes rather than the adipocytes as the contributors to both immune cell recruitment and inflammatory adipokine secretion with acute increases in fatty acids.	[Dordevic, Aimee L.; Cameron-Smith, David] Deakin Univ, Sch Exercise & Nutr Sci, Melbourne, Vic, Australia; [Dordevic, Aimee L.] Monash Univ, Dept Nutr & Dietet, Notting Hill, Vic, Australia; [Konstantopoulos, Nicky] Deakin Univ, Sch Med, Metab Res Unit, Geelong, Vic 3217, Australia; [Cameron-Smith, David] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	Deakin University; Monash University; Deakin University; University of Auckland	Cameron-Smith, D (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Melbourne, Vic, Australia.	d.cameron-smith@auckland.ac.nz		Dordevic, Aimee/0000-0002-0405-3164; Cameron-Smith, David/0000-0002-0144-5816	Strategic Priorities grant	Strategic Priorities grant	Funding was received through a Strategic Priorities grant to DCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Annuzzi G, 2010, METABOLISM, V59, P567, DOI 10.1016/j.metabol.2009.08.020; Berg AH, 2004, AM J PHYSIOL-ENDOC M, V287, pE1178, DOI 10.1152/ajpendo.00002.2004; Bradley RL, 2008, OBESITY, V16, P938, DOI 10.1038/oby.2008.39; Chai WD, 2007, ENDOCRINOLOGY, V148, P1622, DOI 10.1210/en.2006-1068; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; Gao D, 2012, INT J OBES LOND; Granados N, 2011, BRIT J NUTR, V105, P1226, DOI 10.1017/S0007114510004885; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; Hudak Carolyn S, 2013, Front Endocrinol (Lausanne), V4, P79, DOI 10.3389/fendo.2013.00079; Hunter JE, 2010, AM J CLIN NUTR, V91, P46, DOI 10.3945/ajcn.2009.27661; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Jove M, 2006, ENDOCRINOLOGY, V147, P552, DOI 10.1210/en.2005-0440; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Konstantopoulos N, 2007, ENDOCRINOLOGY, V148, P374, DOI 10.1210/en.2006-0446; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V368, P81, DOI 10.1016/j.bbrc.2008.01.035; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Lamers D, 2012, MOL CELL ENDOCRINOL, V362, P194, DOI 10.1016/j.mce.2012.06.010; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Manning PJ, 2008, OBESITY, V16, P2046, DOI 10.1038/oby.2008.334; Masson CJ, 2011, J NUTR, V141, P816, DOI 10.3945/jn.110.136432; Melloni E, 2013, NUTRITION, V29, P332, DOI 10.1016/j.nut.2012.07.013; Meneses ME, 2011, MOL NUTR FOOD RES, V55, P1759, DOI 10.1002/mnfr.201100200; Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2; Neacsu O, 2013, OBESITY, V21, P1843, DOI 10.1002/oby.20329; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; O'Hara A, 2012, MOL CELL ENDOCRINOL, V349, P239, DOI 10.1016/j.mce.2011.10.031; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Peairs AD, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-122; Poulain-Godefroy O, 2007, BIOCHEM BIOPH RES CO, V356, P662, DOI 10.1016/j.bbrc.2007.03.053; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Shang Z, 2014, BIOSCI REP; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Stehno-Bittel L, 2008, PHYS THER, V88, P1265, DOI 10.2522/ptj.20080034; Stuart AAV, 2012, J CLIN ENDOCR METAB, V97, P463, DOI 10.1210/jc.2011-1858; Tardif N, 2011, CLIN NUTR, V30, P799, DOI 10.1016/j.clnu.2011.05.009; Thompson GM, 2004, ANAL BIOCHEM, V330, P21, DOI 10.1016/j.ab.2004.03.061; van Dijk SJ, 2009, AM J CLIN NUTR, V90, P1656, DOI 10.3945/ajcn.2009.27792; Voon PT, 2011, AM J CLIN NUTR, V94, P1451, DOI 10.3945/ajcn.111.020107; Wang BH, 2005, AM J PHYSIOL-ENDOC M, V288, pE731, DOI 10.1152/ajpendo.00475.2004; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	56	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99382	10.1371/journal.pone.0099382	http://dx.doi.org/10.1371/journal.pone.0099382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911931	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600078
J	Karampampa, K; Andersson, T; Drefahl, S; Ahlbom, A; Modig, K				Karampampa, Korinna; Andersson, Tomas; Drefahl, Sven; Ahlbom, Anders; Modig, Karin			Does Improved Survival Lead to a More Fragile Population: Time Trends in Second and Third Hospital Admissions among Men and Women above the Age of 60 in Sweden	PLOS ONE			English	Article							MORTALITY; EUROPE; DISEASES; HEALTH; OLD	Background:Life expectancy and time to first hospitalization have been prolonged, indicating that people live longer without needing hospital care. Life expectancy increased partially due to improved survival from severe diseases, which, however, could lead to a more fragile population. If so, time to a subsequent hospitalization could decrease. Alternatively, the overall trend of improved health could continue after the first hospitalization, prolonging also the time to subsequent hospitalizations. This study analyzes trends in subsequent hospitalizations among Swedish men and women above the age of 60, relating them to first hospitalization. It also looks at trends in the proportion of never hospitalized. Methods: Individuals were followed in national registers for hospital admissions and deaths between 1972 and 2010. The proportion of never hospitalized individuals at given ages and time points, and the annual change in the risks of first and subsequent hospitalizations, were calculated. Findings: An increase in the proportion of never hospitalized was seen over time. The risks of first as well as subsequent hospitalizations were reduced by almost 10% per decade for both men and women. Improvements were observed mainly for individuals below the ages of 90 and up to the year 2000. Conclusions: The reduction in annual risk of both first and subsequent hospitalizations up to 90 years of age speaks in favor of a postponement of the overall morbidity among the elderly and provides no support for the hypothesis that the population becomes more fragile due to increased survival from severe diseases.	[Karampampa, Korinna; Andersson, Tomas; Drefahl, Sven; Ahlbom, Anders; Modig, Karin] Karolinska Inst, Inst Environm Med, Epidemiol Unit, S-10401 Stockholm, Sweden; [Andersson, Tomas] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Drefahl, Sven] Stockholm Univ, Dept Sociol, Demog Unit, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm County Council; Stockholm University	Karampampa, K (corresponding author), Karolinska Inst, Inst Environm Med, Epidemiol Unit, S-10401 Stockholm, Sweden.	korinna.karampampa@ki.se	Modig, Karin/H-1542-2014	Drefahl, Sven/0000-0003-4533-7558; Modig, Karin/0000-0002-5151-4867	Swedish Research Council for Health; Working Life and Social Research (Forskningsradet for halsa, arbetsliv och valfard, FAS) [2011-0843]; Swedish Society of Medicine (Svenska Lakaresallskapet)	Swedish Research Council for Health; Working Life and Social Research (Forskningsradet for halsa, arbetsliv och valfard, FAS); Swedish Society of Medicine (Svenska Lakaresallskapet)	Funding was received from the Swedish Research Council for Health, Working Life and Social Research (Forskningsradet for halsa, arbetsliv och valfard, FAS) grant number: 2011-0843), and the Swedish Society of Medicine (Svenska Lakaresallskapet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CAUS DEATH REG; Bosetti C, 2013, ANN ONCOLOGY OFFICIA; Bronnum-Hansen H, 2009, AGE AGEING, V38, P47, DOI 10.1093/ageing/afn239; Cooper R, 2000, CIRCULATION, V102, P3137; Drefahl S, 2012, J INTERN MED, V272, P100, DOI 10.1111/j.1365-2796.2012.02518.x; Herberts P., 2011, ANN REPORT; Holosko MJ, 2009, SOC WORK PUBLIC HLTH, V24, P210, DOI 10.1080/19371910802595299; Karampampa K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003447; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Kesteloot H, 2006, EUR HEART J, V27, P107, DOI 10.1093/eurheartj/ehi511; Larsson K, 2006, SCAND J PUBLIC HEALT, V34, P185, DOI 10.1080/14034950600677253; Levi F, 2009, EUR J CARDIOV PREV R, V16, P333, DOI 10.1097/HJR.0b013e328325d67d; Modig K, 2013, INT J EPIDEMIOLOGY; Modig K, 2013, INT J EPIDEMIOL, V42, P914, DOI 10.1093/ije/dyt035; Modig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064928; National Board of Health and Welfare [Socialstyrelsen], 2011, INP DIS SWED 1987 20; National Board of Health and Welfare [Socialstyrelsen], 2013, PAT REG; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Rasmussen Lene Juel, 2011, Mech Ageing Dev, V132, P522, DOI 10.1016/j.mad.2011.07.004; Socialstyrelsen [National Board of Health and Welfare], 2012, PAT 2010 DRG PERSP; Statistics Sweden, 2013, LONG INT DAT HLTH IN; Statistics Sweden [Statistika Centralbyran], 2013, TOT POP REG; Vaupel JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000128	23	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99034	10.1371/journal.pone.0099034	http://dx.doi.org/10.1371/journal.pone.0099034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911650	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600036
J	Lavigne, AC; Castells, M; Mermet, J; Kocanova, S; Dalvai, M; Bystricky, K				Lavigne, Anne-Claire; Castells, Magali; Mermet, Jerome; Kocanova, Silvia; Dalvai, Mathieu; Bystricky, Kerstin			Increased macroH2A1.1 Expression Correlates with Poor Survival of Triple-Negative Breast Cancer Patients	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE MACROH2A1; STEM-CELLS; MOLECULAR SUBTYPES; CLAUDIN-LOW; METASTASIS; SIGNATURE; GENES; LUNG; IDENTIFICATION	Purpose: Epithelial-Mesenchymal Transition (EMT) features appear to be key events in development and progression of breast cancer. Epigenetic modifications contribute to the establishment and maintenance of cancer subclasses, as well as to the EMT process. Whether histone variants contribute to these transformations is not known. We investigated the relative expression levels of histone macroH2A1 splice variants and correlated it with breast cancer status/prognosis/types. Methods: To detect differential expression of macroH2A1 variant mRNAs in breast cancer cells and tumor samples, we used the following databases: GEO, EMBL-EBI and publisher databases (may-august 2012). We extracted macroH2A1.1/macroH2A1 mRNA ratios and performed correlation studies on intrinsic molecular subclasses of breast cancer and on molecular characteristics of EMT. Associations between molecular and survival data were determined. Results: We found increased macroH2A1.1/macroH2A1 mRNA ratios to be associated with the claudin-low intrinsic subtype in breast cancer cell lines. At the molecular level this association translates into a positive correlation between macroH2A1 ratios and molecular characteristics of the EMT process. Moreover, untreated Triple Negative Breast Cancers presenting a high macroH2A1.1 mRNA ratio exhibit a poor outcome. Conclusion: These results provide first evidence that macroH2A1.1 could be exploited as an actor in the maintenance of a transient cellular state in EMT progress towards metastatic development of breast tumors.	[Lavigne, Anne-Claire; Castells, Magali; Mermet, Jerome; Kocanova, Silvia; Dalvai, Mathieu; Bystricky, Kerstin] Univ Toulouse, Lab Biol Mol Eucaryote, F-31062 Toulouse, France; [Lavigne, Anne-Claire; Castells, Magali; Mermet, Jerome; Kocanova, Silvia; Dalvai, Mathieu; Bystricky, Kerstin] CNRS, LBME, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Lavigne, AC (corresponding author), Univ Toulouse, Lab Biol Mol Eucaryote, F-31062 Toulouse, France.	lavigne@ibcg.biotoul.fr	Bystricky, Kerstin/AAA-3003-2020; Lavigne, Anne-Claire/O-8805-2015; BYSTRICKY, Kerstin/B-8670-2009	Bystricky, Kerstin/0000-0001-6717-3721; BYSTRICKY, Kerstin/0000-0001-6717-3721; Mermet, Jerome/0000-0001-8623-7380	Institut National du Cancer [TRANSLA11-73]	Institut National du Cancer(Institut National du Cancer (INCA) France)	Funding provided by Institut National du Cancer - noTRANSLA11-73 -URL:http://www.e-cancer.fr/and Fondation pour la Recherche Medicale - URL: http://www.frm.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Barrero MJ, 2013, J BIOL CHEM; Barrero MJ, 2013, CELL REP; Belguise K, 2012, ONCOGENE, V31, P4889, DOI 10.1038/onc.2011.659; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carmody LC, 2012, J BIOMOL SCREEN, V17, P1204, DOI 10.1177/1087057112458317; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Creppe C, 2012, MOL CELL BIOL, V32, P1442, DOI 10.1128/MCB.06323-11; Dardenne E, 2012, NAT STRUCT MOL BIOL, V19, P1139, DOI 10.1038/nsmb.2390; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dittmar KA, 2012, MOL CELL BIOL, V32, P1468, DOI 10.1128/MCB.06536-11; Gaspar-Maia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2582; Germain AR, 2012, BIOORG MED CHEM LETT, V22, P3571, DOI 10.1016/j.bmcl.2012.01.035; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Lapuk A, 2010, MOL CANCER RES, V8, P961, DOI 10.1158/1541-7786.MCR-09-0528; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Novikov L, 2011, MOL CELL BIOL, V31, P4244, DOI 10.1128/MCB.05244-11; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pasque V, 2012, J CELL SCI, V125, P6094, DOI 10.1242/jcs.113019; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rasmussen TP, 2000, J CELL BIOL, V150, P1189, DOI 10.1083/jcb.150.5.1189; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rody A, 2007, BREAST, V16, P235, DOI 10.1016/j.breast.2007.02.006; Rody A, 2007, CLIN CANCER RES, V13, P1115, DOI 10.1158/1078-0432.CCR-06-2433; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rody A, 2009, EUR J CANCER, V45, P405, DOI 10.1016/j.ejca.2008.10.016; Ruckhaberle E, 2010, EUR J CANCER, V46, P549, DOI 10.1016/j.ejca.2009.11.020; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Sporn JC, 2012, AM J PATHOL, V180, P2516, DOI 10.1016/j.ajpath.2012.02.027; Stadler SC, 2012, SEMIN CANC BIOL; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Wang Y, 2012, EXP CELL RES; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Warzecha CC, 2012, SEMIN CANC BIOL; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2	63	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98930	10.1371/journal.pone.0098930	http://dx.doi.org/10.1371/journal.pone.0098930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911873	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600027
J	Yoon, YK; Yang, KS; Lee, SE; Kim, HJ; Sohn, JW; Kim, MJ				Yoon, Young Kyung; Yang, Kyung Sook; Lee, Seung Eun; Kim, Hyun Jeong; Sohn, Jang Wook; Kim, Min Ja			Effects of Group 1 versus Group 2 Carbapenems on the Susceptibility of Acinetobacter baumannii to Carbapenems: A Before and After Intervention Study of Carbapenem-Use Stewardship	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ERTAPENEM USE; ANTIMICROBIAL RESISTANCE; MULTIDRUG-RESISTANCE; IMPACT; IMIPENEM; CONSUMPTION; RATES	Objective: Antimicrobial stewardship programs have been proposed for reducing bacterial resistance in the hospital environment. The purpose of this study was to investigate the impact of a carbapenem-use stewardship program on the susceptibility of Acinetobacter baumannii to Group 2 carbapenems. Methods: A before and after intervention study was conducted at a university hospital from September 2008 to February 2013. Three study periods were defined: Phase I, pre-intervention (months 1-18); Phase II, a postintervention period during which ertapenem use was mandated but carbapenem use was not restricted (months 19-36); and Phase III, a postintervention period during which Group 2 carbapenem use was restricted (months 37-54). Results: During the study period, intervention resulted in diminished consumption of Group 2 carbapenems (antimicrobial use density (AUD): 21.3 +/- 6.0 in Phase I, 18.8 +/- 6.0 in Phase II, 16.1 +/- 4.4 in Phase III; P = 0.028) and increased consumption of ertapenem (AUD: 2.7 +/- 1.7 in Phase I, 7.2 +/- 4.5 in Phase II, 9.1 +/- 5.3 in Phase III; P<0.001). The use of autoregressive-error models showed that in contrast with ertapenem use, the use of Group 2 carbapenem during the previous one month was positively and significantly associated with a subsequent increase in the proportion of carbapenem-resistant A. baumannii (CRAB) (P = 0.031). Conclusions: Implementing a carbapenem-use stewardship program featuring the preferential use of ertapenem for treating appropriate indications of infection resulted in reduced use of Group 2 carbapenems and had a positive impact on the susceptibility of A. baumannii to carbapenems. This approach could be integrated into CRAB-control strategies in hospitals.	[Yoon, Young Kyung; Sohn, Jang Wook; Kim, Min Ja] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 136705, South Korea; [Yoon, Young Kyung; Sohn, Jang Wook; Kim, Min Ja] Korea Univ, Coll Med, Inst Emerging Infect Dis, Seoul 136705, South Korea; [Yang, Kyung Sook] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea; [Yoon, Young Kyung; Lee, Seung Eun; Kim, Hyun Jeong; Sohn, Jang Wook; Kim, Min Ja] Korea Univ, Anam Hosp, Infect Control Unit, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, MJ (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 136705, South Korea.	macropha@korea.ac.kr	Kyung, Yoon Young/AAS-3428-2020	Yoon, Young Kyung/0000-0001-8435-935X; KIM, MIN JA/0000-0002-2125-7521	Merck Sharp Dohme	Merck Sharp Dohme(Merck & Company)	This study was financially supported by Merck Sharp & Dohme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beovic B, 2011, J CHEMOTHERAPY, V23, P216, DOI 10.1179/joc.2011.23.4.216; Cao J, 2013, J CLIN PHARMACOL, V53, P96, DOI 10.1177/0091270011435988; Chen IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065621; D'Agata EMC, 2000, INFECT CONT HOSP EP, V21, P588, DOI 10.1086/501808; Dortch MJ, 2011, SURG INFECT, V12, P15, DOI 10.1089/sur.2009.059; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Falagas ME, 2013, EXPERT REV ANTI-INFE, V11, P69, DOI [10.1586/eri.12.149, 10.1586/ERI.12.149]; Fishbain J, 2010, CLIN INFECT DIS, V51, P79, DOI 10.1086/653120; Goff DA, 2008, J INFECTION, V57, P123, DOI 10.1016/j.jinf.2008.06.001; Kim JY, 2008, J ANTIMICROB CHEMOTH, V62, P416, DOI 10.1093/jac/dkn164; Kuo HY, 2012, INT J ANTIMICROB AG, V39, P33, DOI 10.1016/j.ijantimicag.2011.08.016; Lee CM, 2013, DIAGN MICR INFEC DIS, V75, P94, DOI 10.1016/j.diagmicrobio.2012.09.018; Lee K, 2011, YONSEI MED J, V52, P879, DOI 10.3349/ymj.2011.52.6.879; Lee NY, 2007, INFECT CONT HOSP EP, V28, P713, DOI 10.1086/517954; Lee NY, 2011, DIAGN MICR INFEC DIS, V70, P150, DOI 10.1016/j.diagmicrobio.2010.12.008; Lima ALM, 2008, BRAZ J INFECT DIS, V12, P105, DOI 10.1590/S1413-86702008000200001; Lima ALLM, 2011, BRAZ J INFECT DIS, V15, P1, DOI [10.1016/S1413-8670(11)70131-3, 10.1590/S1413-86702011000100001]; Lima ALL, 2009, INFECT CONT HOSP EP, V30, P487, DOI 10.1086/596781; McDougall DAJ, 2013, J ANTIMICROB CHEMOTH, V68, P457, DOI 10.1093/jac/dks385; Nicolau DP, 2012, INT J ANTIMICROB AG, V39, P11, DOI 10.1016/j.ijantimicag.2011.08.018; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Sousa D, 2013, J ANTIMICROB CHEMOTH, V68, P1917, DOI 10.1093/jac/dkt091; Su CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037788; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Xu JC, 2013, INT J ENV RES PUB HE, V10, P1462, DOI 10.3390/ijerph10041462; Yoon YK, 2011, J MICROBIOL, V49, P363, DOI 10.1007/s12275-011-0491-9	27	14	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99101	10.1371/journal.pone.0099101	http://dx.doi.org/10.1371/journal.pone.0099101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911244	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600043
J	Maehama, T; Kawahara, K; Nishio, M; Suzuki, A; Hanada, K				Maehama, Tomohiko; Kawahara, Kohichi; Nishio, Miki; Suzuki, Akira; Hanada, Kentaro			Nucleolar Stress Induces Ubiquitination-independent Proteasomal Degradation of PICT1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR CANDIDATE; C-MYC; RIBOSOME BIOGENESIS; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; P53 ACTIVATION; GENE-PRODUCT; IN-VIVO; L11; PREDICTION; STABILITY	The nucleolar protein PICT1 regulates tumor suppressor p53 by tethering ribosomal protein L11 within the nucleolus to repress the binding of L11 to the E3 ligase MDM2. PICT1 depletion results in the release of L11 to the nucleoplasm to inhibit MDM2, leading to p53 activation. Here, we demonstrate that nucleolar stress induces proteasome-mediated degradation of PICT1 in a ubiquitin-independent manner. Treatment of H1299 cells with nucleolar stress inducers, such as actinomycin D, 5-fluorouridine, or doxorubicin, induced the degradation of PICT1 protein. The proteasome inhibitors MG132, lactacystin, and epoxomicin blocked PICT1 degradation, whereas the inhibition of E1 ubiquitin-activating enzyme by a specific inhibitor and genetic inactivation fail to repress PICT1 degradation. In addition, the 20 S proteasome was able to degrade purified PICT1 protein in vitro. We also found a PICT1 mutant showing nucleoplasmic localization did not undergo nucleolar stress-induced degradation, although the same mutant underwent in vitro degradation by the 20 S proteasome, suggesting that nucleolar localization is indispensable for the stress-induced PICT1 degradation. These results suggest that PICT1 employs atypical proteasome-mediated degradation machinery to sense nucleolar stress within the nucleolus.	[Maehama, Tomohiko; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo 1628640, Japan; [Kawahara, Kohichi; Nishio, Miki; Suzuki, Akira] Kyushu Univ, Med Inst Bioregulat, Div Canc Genet, Fukuoka 8128582, Japan	National Institute of Infectious Diseases (NIID); Kyushu University	Maehama, T (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	tmaehama@niid.go.jp	Maehama, Tomohiko/HGB-4896-2022; Kawahara, Kohichi/AAQ-5381-2021; Maehama, Tomohiko/AAX-8926-2020; Suzuki, Akira/GYD-6697-2022	Maehama, Tomohiko/0000-0002-9685-2317; Suzuki, Akira/0000-0002-5950-8808; Hanada, Kentaro/0000-0003-1383-2781	Ministry of Education, Culture, Sports, and Technology of Japan; Grants-in-Aid for Scientific Research [23592132] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research (KAKENHI) from the Ministry of Education, Culture, Sports, and Technology of Japan.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Arabi A, 2003, J CELL SCI, V116, P1707, DOI 10.1242/jcs.00370; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Bursac S, 2012, P NATL ACAD SCI USA, V109, P20467, DOI 10.1073/pnas.1218535109; Challagundla KB, 2011, MOL CELL BIOL, V31, P4007, DOI 10.1128/MCB.05810-11; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2010, J BIOL CHEM, V285, P12587, DOI 10.1074/jbc.M109.056259; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Donati G, 2013, CELL REP, V4, P87, DOI 10.1016/j.celrep.2013.05.045; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Gautam AKS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034864; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalt I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030825; Kalt I, 2010, J VIROL, V84, P2935, DOI 10.1128/JVI.00757-09; Lee S, 2012, CELL DEATH DIFFER, V19, P1613, DOI 10.1038/cdd.2012.40; Lo D, 2012, J BIOL CHEM, V287, P10013, DOI 10.1074/jbc.M111.335141; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Mattsson K, 2001, P NATL ACAD SCI USA, V98, P1012, DOI 10.1073/pnas.031566998; Melo SP, 2011, J BIOL CHEM, V286, P36559, DOI 10.1074/jbc.M111.274258; Okahara F, 2005, ANAL BIOCHEM, V336, P138, DOI 10.1016/j.ab.2004.09.018; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Pena MMO, 2009, J BIOL CHEM, V284, P31597, DOI 10.1074/jbc.M109.038455; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Sloan KE, 2013, CELL REP, V5, P237, DOI 10.1016/j.celrep.2013.08.049; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yamauchi T, 2008, GENES CELLS, V13, P27, DOI 10.1111/j.1365-2443.2007.01148.x; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	47	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20802	20812		10.1074/jbc.M114.571893	http://dx.doi.org/10.1074/jbc.M114.571893			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24923447	hybrid, Green Published			2022-12-25	WOS:000339396600035
J	Padilla-Benavides, T; Thompson, AMG; McEvoy, MM; Arguello, JM				Padilla-Benavides, Teresita; Thompson, Alayna M. George; McEvoy, Megan M.; Argueello, Jose M.			Mechanism of ATPase-mediated Cu+ Export and Delivery to Periplasmic Chaperones THE INTERACTION OF ESCHERICHIA COLI CopA AND CusF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER HOMEOSTASIS; FUNCTIONAL ROLES; TRANSPORT; EFFLUX; METALLOCHAPERONES; REQUIREMENT; DIVERSITY; DOCKING	Cellular copper homeostasis requires transmembrane transport and compartmental trafficking while maintaining the cell essentially free of uncomplexed Cu2+/+. In bacteria, soluble cytoplasmic and periplasmic chaperones bind and deliver Cu+ to target transporters or metalloenzymes. Transmembrane Cu+-ATPases couple the hydrolysis of ATP to the efflux of cytoplasmic Cu+. Cytosolic Cu+ chaperones (CopZ) interact with a structural platform in Cu+-ATPases (CopA) and deliver copper into the ion permeation path. CusF is a periplasmic Cu+ chaperone that supplies Cu+ to the CusCBA system for efflux to the extracellular milieu. In this report, using Escherichia coli CopA and CusF, direct Cu+ transfer from the ATPase to the periplasmic chaperone was observed. This required the specific interaction of the Cu+-bound form of CopA with apo-CusF for subsequent metal transfer upon ATP hydrolysis. As expected, the reverse Cu+ transfer from CusF to CopA was not observed. Mutation of CopA extracellular loops or the electropositive surface of CusF led to a decrease in Cu+ transfer efficiency. On the other hand, mutation of Met and Glu residues proposed to be part of the metal exit site in the ATPase yielded enzymes with lower turnover rates, although Cu+ transfer was minimally affected. These results show how soluble chaperones obtain Cu+ from transmembrane transporters. Furthermore, by explaining the movement of Cu+ from the cytoplasmic pool to the extracellular milieu, these data support a mechanism by which cytoplasmic Cu+ can be precisely directed to periplasmic targets via specific transporter-chaperone interactions.	[Padilla-Benavides, Teresita; Argueello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA; [Thompson, Alayna M. George; McEvoy, Megan M.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	Worcester Polytechnic Institute; University of Arizona	McEvoy, MM (corresponding author), Univ Arizona, Dept Chem & Biochem, 1041 E Lowell St, Tucson, AZ 85721 USA.	mcevoy@arizona.edu; arguello@wpi.edu	Padilla-Benavides, Teresita/K-1968-2012; Arguello, Jose/D-1997-2012	Padilla-Benavides, Teresita/0000-0002-4624-0822; Arguello, Jose/0000-0003-3940-6297	National Institutes of Health [GM079192, T32 GM008659]; National Science Foundation [MCB-0743901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079192, T32GM008659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079192 (to M. M. M.) and T32 GM008659 (for support of A. M. G. T.). This work was supported by the National Science Foundation Grant MCB-0743901 (to J. M. A.).	Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Banci L, 2010, NAT PROD REP, V27, P695, DOI 10.1039/b906678k; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2010, MOL MICROBIOL, V78, P1246, DOI 10.1111/j.1365-2958.2010.07402.x; Gonzalez-Guerrero M, 2009, J BIOL CHEM, V284, P20804, DOI 10.1074/jbc.M109.016329; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Hernandez-Montes G, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-249; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kershaw CJ, 2005, MICROBIOL-SGM, V151, P1187, DOI 10.1099/mic.0.27650-0; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim EH, 2011, J BACTERIOL, V193, P2381, DOI 10.1128/JB.01323-10; Kim EH, 2010, NAT PROD REP, V27, P711, DOI 10.1039/b906681k; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Loftin IR, 2005, BIOCHEMISTRY-US, V44, P10533, DOI 10.1021/bi050827b; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; Mealman TD, 2011, BIOCHEMISTRY-US, V50, P2559, DOI 10.1021/bi102012j; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Otoikhian A, 2012, J AM CHEM SOC, V134, P10458, DOI 10.1021/ja301221s; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P69, DOI 10.1074/jbc.M112.420810; Patel SJ, 2014, MICROBIOL-SGM, V160, P1237, DOI 10.1099/mic.0.079137-0; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Raimunda D, 2012, MOL MICROBIOL, V84, P1139, DOI 10.1111/j.1365-2958.2012.08082.x; Raimunda D, 2011, BIOMETALS, V24, P467, DOI 10.1007/s10534-010-9404-3; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Rensing C, 2013, METAL IONS LIFE SCI, V12, P417, DOI 10.1007/978-94-007-5561-1_12; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635	46	49	50	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20492	20501		10.1074/jbc.M114.577668	http://dx.doi.org/10.1074/jbc.M114.577668			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24917681	hybrid, Green Published			2022-12-25	WOS:000339396600011
J	Mesti, T; Savarin, P; Triba, MN; Le Moyec, L; Ocvirk, J; Banissi, C; Carpentier, AF				Mesti, Tanja; Savarin, Philippe; Triba, Mohamed N.; Le Moyec, Laurence; Ocvirk, Janja; Banissi, Claire; Carpentier, Antoine F.			Metabolic Impact of Anti-Angiogenic Agents on U87 Glioma Cells	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; GROWTH-FACTOR VEGF; IN-VIVO; H-1-NMR SPECTROSCOPY; MELANOMA-CELLS; GLIOBLASTOMA; THERAPY; BEVACIZUMAB; AUTOCRINE; INVASION	Background: Glioma cells not only secrete high levels of vascular endothelial growth factor (VEGF) but also express VEGF receptors (VEGFR), supporting the existence of an autocrine loop. The direct impact on glioma cells metabolism of drugs targeting the VEGF pathway, such as Bevacizumab (Bev) or VEGFR Tyrosine Kinase Inhibitor (TKI), is poorly known. Material and Methods: U87 cells were treated with Bev or SU1498, a selective VEGFR2 TKI. VEGFR expression was checked with FACS flow cytometry and Quantitative Real-Time PCR. VEGF secretion into the medium was assessed with an ELISA kit. Metabolomic studies on cells were performed using High Resolution Magic Angle Spinning Spectroscopy (HR-MAS). Results: U87 cells secreted VEGF and expressed low level of VEGFR2, but no detectable VEGFR1. Exposure to SU1498, but not Bev, significantly impacted cell proliferation and apoptosis. Metabolomic studies with HR MAS showed that Bev had no significant effect on cell metabolism, while SU1498 induced a marked increase in lipids and a decrease in glycerophosphocholine. Accordingly, accumulation of lipid droplets was seen in the cytoplasm of SU1498-treated U87 cells. Conclusion: Although both drugs target the VEGF pathway, only SU1498 showed a clear impact on cell proliferation, cell morphology and metabolism. Bevacizumab is thus less likely to modify glioma cells phenotype due to a direct therapeutic pressure on the VEGF autocrine loop. In patients treated with VEGFR TKI, monitoring lipids with magnetic resonance spectroscopic (MRS) might be a valuable marker to assess drug cytotoxicity.	[Mesti, Tanja; Banissi, Claire] Univ Paris 05, Hop Europeen Georges Pompidou, Lab Rech Biochirurg, Paris, France; [Savarin, Philippe; Triba, Mohamed N.] Univ Paris 13, CNRS, UMR 7244, Bobigny, France; [Le Moyec, Laurence] Univ Evry, INSERM, U902, Unite Biol Integrat Adaptat Exercice, Evry, France; [Ocvirk, Janja] Inst Oncol Ljubljana, Div Med Oncol, Ljubljana, Slovenia; [Carpentier, Antoine F.] Univ Paris 13, Unite Format & Rech Sante Med & Biol Humaine, Bobigny, France; [Carpentier, Antoine F.] Hop Avicenne, AP HP, F-93009 Bobigny, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institute of Oncology - Slovenia; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Carpentier, AF (corresponding author), Univ Paris 13, Unite Format & Rech Sante Med & Biol Humaine, Bobigny, France.	antoine.carpentier@avc.aphp.fr		Carpentier, Antoine/0000-0003-2926-0060	European Association for Neuro Oncology (EANO) fellowship; Association Oligocyte; EANO; Association pour le Developpement des Neurosciences a Avicenne (ADNA)	European Association for Neuro Oncology (EANO) fellowship; Association Oligocyte; EANO; Association pour le Developpement des Neurosciences a Avicenne (ADNA)	TM was the recipient of the 2012 European Association for Neuro Oncology (EANO) fellowship. The study was supported by the Association Oligocyte (assoligocyte.wordpress.com), the EANO (wwww.eano.eu), and the Association pour le Developpement des Neurosciences a Avicenne (ADNA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcic U, 2012, NEOPLASIA, V14, P612, DOI 10.1593/neo.11948; Batchelor TT, 2013, J CLIN ONCOL, V31, P3212, DOI 10.1200/JCO.2012.47.2464; Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Chahal M, 2010, NEURO-ONCOLOGY, V12, P822, DOI 10.1093/neuonc/noq017; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; Cloughesy T, 2010, LANCET ONCOL, V11, P1120, DOI 10.1016/S1470-2045(10)70269-2; Cuperlovic-Culf M, 2010, DRUG DISCOV TODAY, V15, P610, DOI 10.1016/j.drudis.2010.06.012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delikatny EJ, 2002, CANCER RES, V62, P1394; Francescone R, 2012, J BIOL CHEM, V287, P24821, DOI 10.1074/jbc.M111.334540; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Grau S, 2011, J NEURO-ONCOL, V104, P103, DOI 10.1007/s11060-010-0480-6; Griffin JL, 2006, ANAL CHEM, V78, P1546, DOI 10.1021/ac051418o; Griffin JL, 2003, CANCER RES, V63, P3195; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; Henriksson R, 2013, J CLIN ONCOL S; Huang HG, 2005, NEUROL RES, V27, P371, DOI 10.1179/016164105X39833; Jeon JY, 2012, AM J NEURORADIOL, V33, P2095, DOI 10.3174/ajnr.A3091; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kim H, 2011, CANCER RES, V71, P3745, DOI 10.1158/0008-5472.CAN-10-2991; Knizetova P, 2008, CELL CYCLE, V7, P2553, DOI 10.4161/cc.7.16.6442; Kronthaler J, 2012, OMICS, V16, P90, DOI 10.1089/omi.2011.0048; Kunkel P, 2001, CANCER RES, V61, P6624; Law M, 2003, AM J NEURORADIOL, V24, P1989; Lehtimaki KK, 2003, J BIOL CHEM, V278, P45915, DOI 10.1074/jbc.M306209200; Lucio-Eterovic AK, 2009, CLIN CANCER RES, V15, P4589, DOI 10.1158/1078-0432.CCR-09-0575; Martinho O, 2013, TRANSL ONCOL, V6, P187, DOI 10.1593/tlo.12400; Mentlein R, 2004, J NEURO-ONCOL, V67, P9, DOI 10.1023/B:NEON.0000021737.89357.cc; Mirbahai L, 2012, NMR BIOMED, V25, P1253, DOI 10.1002/nbm.2796; Morvan D, 2003, MAGN RESON MED, V49, P241, DOI 10.1002/mrm.10368; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pan XY, 2013, METABOLOMICS, V9, P722, DOI 10.1007/s11306-012-0483-8; Ratai EM, 2013, NEURO-ONCOLOGY, V15, P936, DOI 10.1093/neuonc/not044; Reardon DA, 2011, J NATL COMPR CANC NE, V9, P414, DOI 10.6004/jnccn.2011.0038; Robinson CJ, 2001, J CELL SCI, V114, P853; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Triba MN, 2010, NMR BIOMED, V23, P1009, DOI 10.1002/nbm.1516; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Vink H, 2000, AM J PHYSIOL-HEART C, V278, pH285, DOI 10.1152/ajpheart.2000.278.1.H285; von Baumgarten L, 2011, CLIN CANCER RES, V17, P6192, DOI 10.1158/1078-0432.CCR-10-1868; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wick A, 2011, ANN NEUROL, V69, P586, DOI 10.1002/ana.22336; Xu CS, 2013, SCI WORLD J, DOI 10.1155/2013/417413	47	29	29	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99198	10.1371/journal.pone.0099198	http://dx.doi.org/10.1371/journal.pone.0099198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922514	Green Published, gold			2022-12-25	WOS:000338701300044
J	Neogi, U; Haggblom, A; Santacatterina, M; Bratt, G; Gisslen, M; Albert, J; Sonnerborg, A				Neogi, Ujjwal; Haggblom, Amanda; Santacatterina, Michele; Bratt, Goran; Gisslen, Magnus; Albert, Jan; Sonnerborg, Anders			Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; INFECTION; EUROPE; TYPE-1; TRANSMISSION; DYNAMICS; BRAZIL	Background: HIV-1 subtype B (HIV-1B) still dominates in resource-rich countries but increased migration contributes to changes in the global subtype distribution. Also, spread of non-B subtypes within such countries occurs. The trend of the subtype distribution from the beginning of the epidemic in the country has earlier not been reported in detail. Thus the primary objective of this study is to describe the temporal trend of the subtype distribution from the beginning of the HIV-1 epidemic in Sweden over three decades. Methods: HIV-1 pol sequences from patients (n = 3967) diagnosed in Sweden 1983-2012, corresponding to >40% of patients ever diagnosed, were re-subtyped using several automated bioinformatics tools. The temporal trends of subtypes and recombinants during three decades were described by a multinomial logistic regression model. Results: All eleven group M HIV-1 subtypes and sub-subtypes (78%), 17 circulating recombinant forms (CRFs) (19%) and 32 unique recombinants forms (URF) (3%) were identified. When all patients were analysed, there was an increase of newly diagnosed HIV-1C (RR, 95% CI: 1.10, 1.06-1.14), recombinants (1.20, 1.17-1.24) and other pure subtypes (1.11, 1.07-1.16) over time compared to HIV-1B. The same pattern was found when all patients infected in Sweden (n = 1165) were analysed. Also, for MSM patients infected in Sweden (n = 921), recombinant forms and other pure subtypes increased. Significance: Sweden exhibits one of the most diverse subtype epidemics outside Africa. The increase of non-B subtypes is due to migration and to a spread among heterosexually infected patients and MSM within the country. This viral heterogeneity may become a hotspot for development of more diverse and complex recombinant forms if the epidemics converge.	[Neogi, Ujjwal; Sonnerborg, Anders] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Haggblom, Amanda; Sonnerborg, Anders] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden; [Haggblom, Amanda] Cty Council Gavleborg, Dept Infect Dis, Gavle, Sweden; [Santacatterina, Michele] Karolinska Inst, Inst Environm Med, Unit Biostat, S-10401 Stockholm, Sweden; [Bratt, Goran] Stockholm South Gen Hosp, Dept Clin Sci & Educ, Venhalsan, Stockholm, Sweden; [Gisslen, Magnus] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Karolinska Institutet	Neogi, U (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	ujjwal.neogi@ki.se	Neogi, Ujjwal/E-4274-2012; Santacatterina, Michele/AAL-5050-2020; Sönnerborg, Anders/W-2011-2019; Neogi, Ujjwal/ABF-1172-2021; Gisslen, Magnus/D-7454-2015	Santacatterina, Michele/0000-0003-0599-3876; Sönnerborg, Anders/0000-0001-8928-3374; Neogi, Ujjwal/0000-0002-0844-3338; Gisslen, Magnus/0000-0002-2357-1020	Swedish International Developing Agency; CHAIN FP7 EU; Swedish Civil Contingencies Agency [SWE-2009-151]; Swedish Research Council [521-2012-3476, 2007-7092]	Swedish International Developing Agency; CHAIN FP7 EU; Swedish Civil Contingencies Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding provided by Swedish International Developing Agency, CHAIN FP7 EU, the Swedish Civil Contingencies Agency [SWE-2009-151], and the Swedish Research Council [521-2012-3476 and 2007-7092]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Alcantara KC, 2013, J MED VIROL, V85, P396, DOI 10.1002/jmv.23474; Almeida SEM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-306; [Anonymous], INFECT GENET EVOL; Bontell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059337; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Delatorre EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041904; Foster GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083337; Fox J, 2010, AIDS, V24, P2397, DOI 10.1097/QAD.0b013e32833cbb5b; Frange P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-69; Frentz D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-36; Helleberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072257; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Karlsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033484; Kassu A, 2007, AIDS RES HUM RETROV, V23, P564, DOI 10.1089/aid.2006.0270; Lee K, 2013, J BIOPHARM STAT, V23, P681, DOI 10.1080/10543406.2012.756500; Lihana RW, 2012, AIDS REV, V14, P83; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pyne MT, 2013, J CLIN MICROBIOL; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Sandstrom E, 2003, SCAND J INFECT DIS, V35, P155, DOI 10.1080/00365540310006395; Sonnerborg A, 1997, AIDS RES HUM RETROV, V13, P343, DOI 10.1089/aid.1997.13.343; Vangroenweghe D, 2001, PHILOS T ROY SOC B, V356, P923, DOI 10.1098/rstb.2001.0876; von Wyl V, 2011, J INFECT DIS, V204, P1095, DOI 10.1093/infdis/jir491; VONKROGH G, 1987, SCAND J INFECT DIS, V19, P285, DOI 10.3109/00365548709018471	28	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99390	10.1371/journal.pone.0099390	http://dx.doi.org/10.1371/journal.pone.0099390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922326	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300057
J	Arndt, A; Hoffacker, P; Zellmer, K; Goecer, O; Recks, MS; Kuerten, S				Arndt, Andreas; Hoffacker, Peter; Zellmer, Konstantin; Goecer, Oktay; Recks, Mascha S.; Kuerten, Stefanie			Conventional Housing Conditions Attenuate the Development of Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ANTIGEN-SPECIFIC T; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; CELL; MICROBIOTA; POLYSACCHARIDE; POPULATION; RESPONSES; DISEASE	Background: The etiology of multiple sclerosis (MS) has remained unclear, but a causative contribution of factors outside the central nervous system (CNS) is conceivable. It was recently suggested that gut bacteria trigger the activation of CNS-reactive T cells and the development of demyelinative disease. Methods: C57BL/6 (B6) mice were kept either under specific pathogen free or conventional housing conditions, immunized with the myelin basic protein (MBP)-proteolipid protein (PLP) fusion protein MP4 and the development of EAE was clinically monitored. The germinal center size of the Peyer's patches was determined by immunohistochemistry in addition to the level of total IgG secretion which was assessed by ELISPOT. ELISPOT assays were also used to measure MP4-specific T cell and B cell responses in the Peyer's patches and the spleen. Ear swelling assays were performed to determine the extent of delayed-type hypersensitivity reactions in specific pathogen free and conventionally housed mice. Results: In B6 mice that were actively immunized with MP4 and kept under conventional housing conditions clinical disease was significantly attenuated compared to specific pathogen free mice. Conventionally housed mice displayed increased levels of IgG secretion in the Peyer's patches, while the germinal center formation in the gut and the MP4-specific T(H)17 response in the spleen were diminished after immunization. Accordingly, these mice displayed an attenuated delayed type hypersensitivity (DTH) reaction in ear swelling assays. Conclusions: The data corroborate the notion that housing conditions play a substantial role in the induction of murine EAE and suggest that the presence of gut bacteria might be associated with a decreased immune response to antigens of lower affinity. This concept could be of importance for MS and calls for caution when considering the therapeutic approach to treat patients with antibiotics.	[Arndt, Andreas; Hoffacker, Peter; Zellmer, Konstantin; Goecer, Oktay; Recks, Mascha S.] Univ Cologne, Dept Anat 1, D-50931 Cologne, Germany; [Kuerten, Stefanie] Univ Wurzburg, Dept Anat & Cell Biol, D-97070 Wurzburg, Germany	University of Cologne; University of Wurzburg	Kuerten, S (corresponding author), Univ Wurzburg, Dept Anat & Cell Biol, D-97070 Wurzburg, Germany.	stefanie.kuerten@uni-wuerzburg.de			German Research Foundation (DFG) [KU 2760/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a research grant from the German Research Foundation (DFG), project KU 2760/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Berer K, 2012, ACTA NEUROPATHOL, V123, P639, DOI 10.1007/s00401-012-0949-9; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; HEMPEL K, 1985, INT ARCH ALLER A IMM, V76, P193, DOI 10.1159/000233691; Hundgeburth LC, 2013, CLIN IMMUNOL, V146, P155, DOI 10.1016/j.clim.2012.12.007; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Kuerten S, 2008, CLIN IMMUNOL, V129, P256, DOI 10.1016/j.clim.2008.07.016; Kuerten S, 2006, J NEUROIMMUNOL, V177, P99, DOI 10.1016/j.jneuroim.2006.03.021; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; LEIBOWITZ U, 1966, J NEUROL NEUROSUR PS, V29, P60, DOI 10.1136/jnnp.29.1.60; LIKE AA, 1991, DIABETES, V40, P259, DOI 10.2337/diabetes.40.2.259; Loh G, 2012, GUT MICROBES, V3, P544, DOI 10.4161/gmic.22156; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Patterson CC, 1996, DIABETOLOGIA, V39, P1063, DOI 10.1007/BF00400655; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; SCHECHTER I, 1968, J EXP MED, V127, P237, DOI 10.1084/jem.127.2.237; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Shim JO, 2013, PEDIATR GASTROENTERO, V16, P17, DOI 10.5223/pghn.2013.16.1.17; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Stromnes IM, 2006, NAT PROTOC, V1, P1952, DOI 10.1038/nprot.2006.284; Stys PK, 2012, NAT REV NEUROSCI, V13, P507, DOI 10.1038/nrn3275; Tigno-Aranjuez JT, 2009, J IMMUNOL, V183, P5654, DOI 10.4049/jimmunol.0900645; Tkach K, 2013, CURR OPIN IMMUNOL, V25, P120, DOI 10.1016/j.coi.2012.12.001; Vaghef-Mehrabany E, 2014, NUTRITION, V30, P430, DOI 10.1016/j.nut.2013.09.007; von Geldern G, 2012, NAT REV NEUROL, V8, P678, DOI 10.1038/nrneurol.2012.194; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Westall FC, 2006, J CLIN MICROBIOL, V44, P2099, DOI 10.1128/JCM.02532-05; Wong FS, 2008, ANN NY ACAD SCI, V1150, P123, DOI 10.1196/annals.1447.063	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99794	10.1371/journal.pone.0099794	http://dx.doi.org/10.1371/journal.pone.0099794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919069	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000111
J	Wang, HZ; Liu, X; Lv, B; Yang, F; Hong, YZ				Wang, Huazhen; Liu, Xin; Lv, Bing; Yang, Fan; Hong, Yanzhu			Reliable Multi-Label Learning via Conformal Predictor and Random Forest for Syndrome Differentiation of Chronic Fatigue in Traditional Chinese Medicine	PLOS ONE			English	Article							CLASSIFICATION; DIAGNOSIS	Objective: Chronic Fatigue (CF) still remains unclear about its etiology, pathophysiology, nomenclature and diagnostic criteria in the medical community. Traditional Chinese medicine (TCM) adopts a unique diagnostic method, namely 'bian zheng lun zhi' or syndrome differentiation, to diagnose the CF with a set of syndrome factors, which can be regarded as the Multi-Label Learning (MLL) problem in the machine learning literature. To obtain an effective and reliable diagnostic tool, we use Conformal Predictor (CP), Random Forest (RF) and Problem Transformation method (PT) for the syndrome differentiation of CF. Methods and Materials: In this work, using PT method, CP-RF is extended to handle MLL problem. CP-RF applies RF to measure the confidence level (p-value) of each label being the true label, and then selects multiple labels whose p-values are larger than the pre-defined significance level as the region prediction. In this paper, we compare the proposed CP-RF with typical CP-NBC(Naive Bayes Classifier), CP-KNN(K-Nearest Neighbors) and ML-KNN on CF dataset, which consists of 736 cases. Specifically, 95 symptoms are used to identify CF, and four syndrome factors are employed in the syndrome differentiation, including 'spleen deficiency', 'heart deficiency', 'liver stagnation' and 'qi deficiency'. The Results: CP-RF demonstrates an outstanding performance beyond CP-NBC, CP-KNN and ML-KNN under the general metrics of subset accuracy, hamming loss, one-error, coverage, ranking loss and average precision. Furthermore, the performance of CP-RF remains steady at the large scale of confidence levels from 80% to 100%, which indicates its robustness to the threshold determination. In addition, the confidence evaluation provided by CP is valid and wellcalibrated. Conclusion: CP-RF not only offers outstanding performance but also provides valid confidence evaluation for the CF syndrome differentiation. It would be well applicable to TCM practitioners and facilitate the utilities of objective, effective and reliable computer-based diagnosis tool.	[Wang, Huazhen; Liu, Xin; Lv, Bing] Huaqiao Univ, Coll Comp Sci & Technol, Xiamen, Peoples R China; [Yang, Fan] Xiamen Univ, Sch Informat Sci & Engn, Xiamen, Peoples R China; [Hong, Yanzhu] Xiamen Univ, Dept Tradit Chinese Med, Xiamen, Peoples R China	Huaqiao University; Xiamen University; Xiamen University	Yang, F (corresponding author), Xiamen Univ, Sch Informat Sci & Engn, Xiamen, Peoples R China.	yang@xmu.edu.cn			National Natural Science Fundation of China [61202144, 61203282, 61300138]; Natural Science Foundation of Fujian Province China [2012J01274, 2012J05125]; Research Grant Council of Huaqiao University [09BS515]	National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province China(Natural Science Foundation of Fujian Province); Research Grant Council of Huaqiao University	The work is supported by National Natural Science Fundation of China under Grant No. 61202144, No. 61203282 and No. 61300138, Natural Science Foundation of Fujian Province China, under Grant No. 2012J01274 and No. 2012J05125, The Research Grant Council of Huaqiao University under Grant No. 09BS515. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alraek T, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-87; Boutell MR, 2004, PATTERN RECOGN, V37, P1757, DOI 10.1016/j.patcog.2004.03.009; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen R, 2010, EVID-BASED COMPL ALT, V7, P3, DOI 10.1093/ecam/nen017; Chen RQ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-73; Dai J, 2012, EVID-BASED COMPL ALT, V2012, P1; Duan YX, 2010, J MATH MED, V23, P65; Elisseeff A, 2002, ADV NEUR IN, V14, P681; Fedorova V., 2012, P 29 INT C MACH LEAR; Feng Y, 2006, ARTIF INTELL MED, V38, P219, DOI 10.1016/j.artmed.2006.07.005; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gammerman, 2005, ALGORITHMIC LEARNING; [洪燕珠 HONG Yanzhu], 2009, [中医杂志, Journal of Traditional Chinese Medicine], V50, P1114; Jiang M, 2012, J ETHNOPHARMACOL, V140, P634, DOI 10.1016/j.jep.2012.01.033; Li FF, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-127; Li GZ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/837245; Liu GP, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/135387; Liu GP, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-37; Lukman S, 2007, COMPUT METH PROG BIO, V88, P283, DOI 10.1016/j.cmpb.2007.09.008; Luo H, 2007, CHINA J TRADITIONAL, V22, P399; Madjarov G, 2012, PATTERN RECOGN, V45, P3084, DOI 10.1016/j.patcog.2012.03.004; McCrone P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040808; Mei SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037716; Melluish T., 2001, PROC EUR C MACH LEAR, P360; Nouretdinov I, 2011, NEUROIMAGE, V56, P809, DOI 10.1016/j.neuroimage.2010.05.023; Pillai I, 2013, PATTERN RECOGN, V46, P2055, DOI 10.1016/j.patcog.2013.01.012; Prasko J, 2010, ACT NERV SUPER REDIV, V52, P104; Schapire RE, 2000, MACH LEARN, V39, P135, DOI 10.1023/A:1007649029923; Shafer G, 2008, J MACH LEARN RES, V9, P371; Song YM, 2011, CHINESE ARCH TRADITI, V8, P072; Song YN, 2013, EVID-BASED COMPL ALT, V2013, P1; Streich AP, 2008, LECT NOTES ARTIF INT, V5212, P390, DOI 10.1007/978-3-540-87481-2_26; Su SB, 2013, INT J INTEGR MED, V1, P1; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1, DOI DOI 10.4018/JDWM.2007070101; Vanderlooy S, 2007, LECT NOTES ARTIF INT, V4571, P310, DOI 10.1007/978-3-540-73499-4_24; Vovk V, 2012, 12092673 ARXIV; Vovk V, 2006, THEOR COMPUT SCI, V364, P10, DOI 10.1016/j.tcs.2006.07.038; Vovk V, 2013, MACH LEARN, V92, P349, DOI 10.1007/s10994-013-5355-6; Wang H, 2009, J INFORM COMPUTATION, V6, P305; Wang HZ, 2009, COMPUT BIOL MED, V39, P425, DOI 10.1016/j.compbiomed.2009.02.002; Wang J, 2008, P 1 ACM INT C MULT I, P298, DOI DOI 10.1145/1460096.1460145; Wang J, 2012, EURASIP J ADV SIG PR, DOI [10.1186/1687-6180-2012-8, 10.1155/2012/268542]; Wang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036317; Wang YQ, 2011, INT J DATA MIN BIOIN, V5, P369, DOI 10.1504/IJDMB.2011.041554; Yang E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-55; Yang Y, 2001, P 24 ANN INT ACM SIG, P137, DOI DOI 10.1145/383952.383975; Zhang ML, 2014, IEEE T KNOWL DATA EN, V26, P1819, DOI 10.1109/TKDE.2013.39; Zhang ML, 2005, 2005 IEEE INTERNATIONAL CONFERENCE ON GRANULAR COMPUTING, VOLS 1 AND 2, P718; Zhou WF, 2002, GIANJIN J TRADITIONA, V19, P1; Zhu Wen-feng, 2007, Zhong Xi Yi Jie He Xue Bao, V5, P607	50	20	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99565	10.1371/journal.pone.0099565	http://dx.doi.org/10.1371/journal.pone.0099565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918430	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000095
J	Jin, SK; Cheng, TC; Jiang, L; Lin, P; Yang, Q; Xiao, Y; Kusakabe, T; Xia, QY				Jin, Shengkai; Cheng, Tingcai; Jiang, Liang; Lin, Ping; Yang, Qiong; Xiao, Yang; Kusakabe, Takahiro; Xia, Qingyou			Identification of a New Sprouty Protein Responsible for the Inhibition of the Bombyx mori Nucleopolyhedrovirus Reproduction	PLOS ONE			English	Article							POSTERIOR SILK GLAND; TYROSINE KINASE; SIGNALING PATHWAYS; DROSOPHILA-SPROUTY; ERK ACTIVATION; RAS ACTIVATION; GROWTH; GENES; FGF; PHOSPHORYLATION	The rat sarcoma-extracellular signal regulated kinase mitogen-activated protein kinases pathway, one of the most ancient signaling pathways, is crucial for the defense against Bombyx mori nucleopolyhedrovirus (BmNPV) infection. Sprouty (Spry) proteins can inhibit the activity of this pathway by receptor tyrosine kinases. We cloned and identified a new B. mori gene with a Spry domain similar to the Spry proteins of other organisms, such as fruitfly, mouse, human, chicken, Xenopus and zebrafish, and named it BmSpry. The gene expression analysis showed that BmSpry was transcribed in all of the examined tissues and in all developmental stages from embryo to adult. BmSpry also induced expression of BmNPV in the cells. Our results indicated: (1) the knock-down of BmSpry led to increased BmNPV replication and silkworm larvae mortality; (2) overexpression of BmSpry led to reduced BmNPV replication; and (3) BmSpry regulated the activation of ERK and inhibited BmNPV replication. These results showed that BmSpry plays a crucial role in the antiviral defense of the silkworm both in vitro and in vivo.	[Jin, Shengkai; Cheng, Tingcai; Jiang, Liang; Lin, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Yang, Qiong; Xiao, Yang] Guangdong Acad Agr Sci, Sericulture & Farm Prod Proc Res Inst, Guangzhou, Guangdong, Peoples R China; [Kusakabe, Takahiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan	Southwest University - China; Guangdong Academy of Agricultural Sciences; Kyushu University	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn		cheng, tingcai/0000-0002-3862-0817	National Hi-Tech Research and Development Program of China [2011AA100306]; National Basic Research Program of China [2012CB114600]; Resistance Breeding Center of State Key Laboratory of Silkworm Genome Biology [2012B090600049]	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Resistance Breeding Center of State Key Laboratory of Silkworm Genome Biology	This work was funded by the National Hi-Tech Research and Development Program of China (No. 2011AA100306, http://www.most.gov.cn/), the National Basic Research Program of China (No. 2012CB114600, http://www.most.gov.cn/), Resistance Breeding Center of State Key Laboratory of Silkworm Genome Biology (No. 2012B090600049, http://sklsgb.swu.edu.cn/cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BUDAY L, 1995, ONCOGENE, V11, P1327; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chambers D, 2000, MOL CELL NEUROSCI, V15, P22, DOI 10.1006/mcne.1999.0801; de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Deng HM, 2012, P NATL ACAD SCI USA, V109, P12598, DOI 10.1073/pnas.1203149109; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Gao XR, 2004, J VIROL, V78, P11798, DOI 10.1128/JVI.78.21.11798-11806.2004; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Gual P, 2001, ONCOGENE, V20, P156, DOI 10.1038/sj.onc.1204047; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Ikeda M, 1999, VIROLOGY, V258, P176, DOI 10.1006/viro.1999.9706; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Ishida M, 2007, CANCER SCI, V98, P815, DOI 10.1111/j.1349-7006.2007.00457.x; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041838; Jiang L, 2012, ARCH VIROL, V157, P1323, DOI 10.1007/s00705-012-1309-8; Jiang XJ, 2009, BIOCHEM BIOPH RES CO, V378, P269, DOI 10.1016/j.bbrc.2008.11.046; Katsuma S, 1999, J GEN VIROL, V80, P783, DOI 10.1099/0022-1317-80-3-783; Katsuma S, 2007, J VIROL, V81, P13700, DOI 10.1128/JVI.01683-07; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kramer S, 1999, DEVELOPMENT, V126, P2515; Krysan K, 2004, CANCER RES, V64, P6359, DOI 10.1158/0008-5472.CAN-04-1681; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Ma L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-182; Ma L, 2013, J PROTEOME RES, V12, P1924, DOI 10.1021/pr400005g; Ma L, 2011, CELL RES, V21, P934, DOI 10.1038/cr.2011.36; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Minowada G, 1999, DEVELOPMENT, V126, P4465; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Moriya K, 2010, INSECT MOL BIOL, V19, P291, DOI 10.1111/j.1365-2583.2009.00982.x; Mortensen AS, 2006, AQUAT TOXICOL, V79, P99, DOI 10.1016/j.aquatox.2006.05.009; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; Nutt SL, 2001, GENE DEV, V15, P1152, DOI 10.1101/gad.191301; Ogura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008030; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Ozaki K, 2001, BIOCHEM BIOPH RES CO, V285, P1084, DOI 10.1006/bbrc.2001.5295; Pan MH, 2007, IN VITRO CELL DEV-AN, V43, P101, DOI 10.1007/s11626-006-9009-x; Panteva M, 2003, VIRUS RES, V92, P131, DOI 10.1016/S0168-1702(02)00356-8; Payungporn S, 2006, J VIROL METHODS, V131, P143, DOI 10.1016/j.jviromet.2005.08.004; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Reich A, 1999, DEVELOPMENT, V126, P4139; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Soejima K, 2001, J BIOCHEM-TOKYO, V130, P475, DOI 10.1093/oxfordjournals.jbchem.a003009; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tyler KL, 2001, TRENDS MICROBIOL, V9, P560, DOI 10.1016/S0966-842X(01)02103-5; UEKI K, 1994, J BIOL CHEM, V269, P15756; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xiao W, 2009, VIROLOGY, V391, P83, DOI 10.1016/j.virol.2009.06.007; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zaremba A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-192; Zhang YZ, 2008, PROTEOMICS, V8, P4178, DOI 10.1002/pmic.200800133	73	27	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99200	10.1371/journal.pone.0099200	http://dx.doi.org/10.1371/journal.pone.0099200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915434	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700071
J	Kaneko, K; Yamaguchi, H; Saito, T; Yano, T; Oono, Y; Ikematsu, H; Nomura, S; Sato, A; Kojima, M; Esumi, H; Ochiai, A				Kaneko, Kazuhiro; Yamaguchi, Hiroshi; Saito, Takaaki; Yano, Tomonori; Oono, Yasuhiro; Ikematsu, Hiroaki; Nomura, Shogo; Sato, Akihiro; Kojima, Motohiro; Esumi, Hiroyasu; Ochiai, Atsushi			Hypoxia Imaging Endoscopy Equipped with Laser Light Source from Preclinical Live Animal Study to First-In-Human Subject Research	PLOS ONE			English	Article							TUMOR HYPOXIA; MALIGNANT-PROGRESSION; CANCER; FLOW	A goal in next-generation endoscopy is to develop functional imaging techniques to open up new opportunities for cancer diagnosis. Although spatial and temporal information on hypoxia is crucial for understanding cancer physiology and expected to be useful for cancer diagnosis, existing techniques using fluorescent indicators have limitations due to low spatial resolution and invasive administration. To overcome these problems, we developed an imaging technology based on hemoglobin oxygen saturation in both the tumor and surrounding mucosa using a laser endoscope system, and conducted the first human subject research for patients with aero-digestive tract cancer. The oxygen saturation map overlapped the images of cancerous lesions and indicated highly heterogeneous features of oxygen supply in the tumor. The hypoxic region of the tumor surface was found in both early cancer and cancer precursors. This technology illustrates a novel aspect of cancer biology as a potential biomarker and can be widely utilized in cancer diagnosis.	[Kaneko, Kazuhiro; Yano, Tomonori; Oono, Yasuhiro; Ikematsu, Hiroaki] Natl Canc Ctr Hosp East, Endoscopy Div, Dept Gastroenterol, Kashiwa, Chiba, Japan; [Kaneko, Kazuhiro] Natl Canc Ctr Hosp East, Div Sci & Technol Endoscopy & Surg, Kashiwa, Chiba, Japan; [Yamaguchi, Hiroshi; Saito, Takaaki] FUJIFILM Corp, Imaging Technol Ctr, Kaisei, Kanagawa, Japan; [Nomura, Shogo; Sato, Akihiro] Natl Canc Ctr, Clin Trial Sect, Kashiwa, Chiba, Japan; [Kojima, Motohiro; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Dept Pathol, Kashiwa, Chiba, Japan; [Esumi, Hiroyasu] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 278, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Fujifilm Corporation; National Cancer Center - Japan; National Cancer Center - Japan; Tokyo University of Science	Kaneko, K (corresponding author), Natl Canc Ctr Hosp East, Endoscopy Div, Dept Gastroenterol, Kashiwa, Chiba, Japan.	kkaneko@east.ncc.go.jp; hiroshi.mm.yamaguchi@fujifilm.com	/AAM-6970-2020	/0000-0002-8387-0372; Nomura, Shogo/0000-0001-8734-6984	National Cancer Center Research and Development Fund [23-A-45, 23-A-15]; Ministry of Health, Labour and Welfare; Accelerating Regulatory Science Initiative [H-24]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Accelerating Regulatory Science Initiative	This work was supported in part by the National Cancer Center Research and Development Fund (23-A-45) and (23-A-15) and the 3rd-term comprehensive 10-Year strategy for Cancer Control by the Ministry of Health, Labour and Welfare, and Accelerating Regulatory Science Initiative (H-24) [http://www.ncc.go.jp/en/index.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Benaron DA, 2004, ANESTHESIOLOGY, V100, P1469, DOI 10.1097/00000542-200406000-00019; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chitneni SK, 2011, J NUCL MED, V52, P165, DOI 10.2967/jnumed.110.075663; Goh V, 2012, J NUCL MED, V53, P687, DOI 10.2967/jnumed.111.098525; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada H, 2005, MOL IMAGING, V4, P182; Hockel M, 1996, CANCER RES, V56, P4509; Jordan BF, 2005, NEOPLASIA, V7, P475, DOI 10.1593/neo.04628; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Maxim PG, 2005, TECHNOL CANCER RES T, V4, P227, DOI 10.1177/153303460500400301; Moy AJ, 2011, MICROVASC RES, V82, P199, DOI 10.1016/j.mvr.2011.07.004; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Sutherland RM, 1998, ACTA ONCOL, V37, P567, DOI 10.1080/028418698430278; Zhang GQ, 2009, NAT MATER, V8, P747, DOI [10.1038/nmat2509, 10.1038/NMAT2509]	19	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99055	10.1371/journal.pone.0099055	http://dx.doi.org/10.1371/journal.pone.0099055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915532	gold, Green Submitted, Green Published			2022-12-25	WOS:000340947700055
J	Maekawa, N; Konnai, S; Ikebuchi, R; Okagawa, T; Adachi, M; Takagi, S; Kagawa, Y; Nakajima, C; Suzuki, Y; Murata, S; Ohashi, K				Maekawa, Naoya; Konnai, Satoru; Ikebuchi, Ryoyo; Okagawa, Tomohiro; Adachi, Mami; Takagi, Satoshi; Kagawa, Yumiko; Nakajima, Chie; Suzuki, Yasuhiko; Murata, Shiro; Ohashi, Kazuhiko			Expression of PD-L1 on Canine Tumor Cells and Enhancement of IFN-gamma Production from Tumor-Infiltrating Cells by PD-L1 Blockade	PLOS ONE			English	Article							PROGRAMMED DEATH-1; UP-REGULATION; MOLECULAR-CLONING; B7-H1 EXPRESSION; CARCINOMA; MELANOMA; DOGS; ESTABLISHMENT; ANTIBODY; SAFETY	Programmed death 1 (PD-1), an immunoinhibitory receptor, and programmed death ligand 1 (PD-L1), its ligand, together induce the "exhausted'' status in antigen-specific lymphocytes and are thus involved in the immune evasion of tumor cells. In this study, canine PD-1 and PD-L1 were molecularly characterized, and their potential as therapeutic targets for canine tumors was discussed. The canine PD-1 and PD-L1 genes were conserved among canine breeds. Based on the sequence information obtained, the recombinant canine PD-1 and PD-L1 proteins were constructed; they were confirmed to bind each other. Antibovine PD-L1 monoclonal antibody effectively blocked the binding of recombinant PD-1 with PD-L1-expressing cells in a dose-dependent manner. Canine melanoma, mastocytoma, renal cell carcinoma, and other types of tumors examined expressed PD-L1, whereas some did not. Interestingly, anti-PD-L1 antibody treatment enhanced IFN-gamma production from tumor-infiltrating cells. These results showed that the canine PD-1/PD-L1 pathway is also associated with T-cell exhaustion in canine tumors and that its blockade with antibody could be a new therapeutic strategy for canine tumors. Further investigations are needed to confirm the ability of anti-PD-L1 antibody to reactivate canine antitumor immunity in vivo, and its therapeutic potential has to be further discussed.	[Maekawa, Naoya; Konnai, Satoru; Ikebuchi, Ryoyo; Okagawa, Tomohiro; Murata, Shiro; Ohashi, Kazuhiko] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido, Japan; [Adachi, Mami; Takagi, Satoshi; Kagawa, Yumiko] Hokkaido Univ, Vet Teaching Hosp, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Kagawa, Yumiko] North Lab, Sapporo, Hokkaido, Japan; [Nakajima, Chie; Suzuki, Yasuhiko] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Ohashi, K (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido, Japan.	okazu@vetmed.hokudai.ac.jp	Okagawa, Tomohiro/AAX-1284-2021; Suzuki, Yasuhiko/F-6890-2012; Nakajima, Chie/A-5020-2012; Ikebuchi, Ryoyo/AAG-1138-2019	Ikebuchi, Ryoyo/0000-0003-0231-7733; TAKAGI, Satoshi/0000-0001-6653-5890; Satoru, Konnai/0000-0002-3230-7109	Japan Science and Technology Agency (JST); Akiyama Life Science Foundation of Japan	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Akiyama Life Science Foundation of Japan	This work was supported by a special grant for the Adaptable and Seamless Technology transfer Program (A-Step) through target driven R&D from the Japan Science and Technology Agency (JST) and Grants for Scientific Research from the Akiyama Life Science Foundation of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Barroga EF, 1999, J VET MED SCI, V61, P361; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Bolton B, 1990, VET PATHOL, V27, P96; Boria PA, 2004, JAVMA-J AM VET MED A, V224, P388, DOI 10.2460/javma.2004.224.388; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Chapon M, 2011, J INVEST DERMATOL, V131, P1300, DOI 10.1038/jid.2011.30; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; de Haij S, 2005, KIDNEY INT, V68, P2091, DOI 10.1111/j.1523-1755.2005.00665.x; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Duncan B, 2003, J AM ANIM HOSP ASSOC, V39, P294; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Geng L, 2008, J CANCER RES CLIN, V134, P1021, DOI 10.1007/s00432-008-0364-8; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HARVEY HJ, 1981, J AM VET MED ASSOC, V178, P580; Ikebuchi R, IMMUNOLOGY IN PRESS; Ikebuchi R, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-59; Ikebuchi R, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-103; Ikebuchi R, 2010, MICROBIOL IMMUNOL, V54, P291, DOI 10.1111/j.1348-0421.2010.00208.x; Inman BA, 2007, CANCER-AM CANCER SOC, V109, P1499, DOI 10.1002/cncr.22588; Ishiguro T, 2001, J VET MED SCI, V63, P1031, DOI 10.1292/jvms.63.1031; KADOSAWA T, 1994, J VET MED SCI, V56, P1167, DOI 10.1292/jvms.56.1167; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Konnai S, 2013, COMP IMMUNOL MICROB, V36, P63, DOI 10.1016/j.cimid.2012.09.005; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ohashi E, 2002, J VET MED SCI, V64, P169, DOI 10.1292/jvms.64.169; Ohashi E, 2001, J VET MED SCI, V63, P83, DOI 10.1292/jvms.63.83; Okagawa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-45; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Proulx DR, 2003, VET RADIOL ULTRASOUN, V44, P352, DOI 10.1111/j.1740-8261.2003.tb00468.x; Rassnick KM, 2001, J AM VET MED ASSOC, V218, P1444, DOI 10.2460/javma.2001.218.1444; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Shirai T, 2011, VET IMMUNOL IMMUNOP, V144, P462, DOI 10.1016/j.vetimm.2011.08.018; Spangler WL, 2006, VET PATHOL, V43, P136, DOI 10.1354/vp.43-2-136; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Takahashi T, 2001, INT ARCH ALLERGY IMM, V125, P228, DOI 10.1159/000053820; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Welle MM, 2008, VET DERMATOL, V19, P321, DOI 10.1111/j.1365-3164.2008.00694.x; Wong RM, 2007, INT IMMUNOL, V19, P1223, DOI 10.1093/intimm/dxm091; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003; Ye YF, 2009, J SURG ONCOL, V100, P500, DOI 10.1002/jso.21376; ZETTLMEISSL G, 1990, DNA CELL BIOL, V9, P347, DOI 10.1089/dna.1990.9.347	52	68	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98415	10.1371/journal.pone.0098415	http://dx.doi.org/10.1371/journal.pone.0098415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915569	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700019
J	Dall'Olio, GM; Bertranpetit, J; Wagner, A; Laayouni, H				Marco Dall'Olio, Giovanni; Bertranpetit, Jaume; Wagner, Andreas; Laayouni, Hafid			Human Genome Variation and the Concept of Genotype Networks	PLOS ONE			English	Article							ADAPTATION; INNOVATION; EVOLUTION; SEQUENCE; FEATURES; SPACE	Genotype networks are a concept used in systems biology to study sets of genotypes having the same phenotype, and the ability of these to bring forth novel phenotypes. In the past they have been applied to determine the genetic heterogeneity, and stability to mutations, of systems such as metabolic networks and RNA folds. Recently, they have been the base for reconciling the neutralist and selectionist views on evolution. Here, we adapted this concept to the study of population genetics data. Specifically, we applied genotype networks to the human 1000 genomes dataset, and analyzed networks composed of short haplotypes of Single Nucleotide Variants (SNV). The result is a scan of how properties related to genetic heterogeneity and stability to mutations are distributed along the human genome. We found that genes involved in acquired immunity, such as some HLA and MHC genes, tend to have the most heterogeneous and connected networks, and that coding regions tend to be more heterogeneous and stable to mutations than non-coding regions. We also found, using coalescent simulations, that regions under selection have more extended and connected networks. The application of the concept of genotype networks can provide a new opportunity to understand the evolutionary processes that shaped our genome. Learning how the genotype space of each region of our genome has been explored during the evolutionary history of the human species can lead to a better understanding on how selective pressures and neutral factors have shaped genetic diversity within populations and among individuals. Combined with the availability of larger datasets of sequencing data, genotype networks represent a new approach to the study of human genetic diversity that looks to the whole genome, and goes beyond the classical division between selection and neutrality methods.	[Marco Dall'Olio, Giovanni; Bertranpetit, Jaume; Laayouni, Hafid] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Catalonia, Spain; [Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Wagner, Andreas] Swiss Inst Bioinformat, Lausanne, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA; [Laayouni, Hafid] Univ Autonoma Barcelona, E-08193 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute; Autonomous University of Barcelona	Dall'Olio, GM (corresponding author), Kings Coll London, Div Canc Studies, London, England.	giovanni.dallolio@kcl.ac.uk	Laayouni, Hafid/AAA-9254-2019; Bertranpetit, Jaume/F-8550-2012	Laayouni, Hafid/0000-0003-1297-5078; Bertranpetit, Jaume/0000-0003-0100-0590; Dall'Olio, Giovanni Marco/0000-0001-9057-2480	Ministerio de Ciencia y Tecnologia (Spain) [BFU2010-19443]; Direccio General de Recerca, Generalitat de Catalunya [SGR 1101]; FPI [BES-2009-01773]; Swiss National Science Foundation; URPP Evolutionary Biology at the University of Zurich	Ministerio de Ciencia y Tecnologia (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Direccio General de Recerca, Generalitat de Catalunya(Generalitat de Catalunya); FPI(Spanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); URPP Evolutionary Biology at the University of Zurich	This work was supported by grants BFU2010-19443 (subprogram BMC) awarded to JB by Ministerio de Ciencia y Tecnologia (Spain) and by the Direccio General de Recerca, Generalitat de Catalunya (Grup de Recerca Consolidat 2009 SGR 1101). GMD is supported by a FPI fellowship BES-2009-017731. AW would like to acknowledge support by the Swiss National Science Foundation and by the URPP Evolutionary Biology at the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026324; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alves I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002837; Barve A, 2013, NATURE, V500, P203, DOI 10.1038/nature12301; Cao HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069388; Csardi G, 2006, INTERJOURNAL; Dall'Olio GM, 2014, ARXIV14012016; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dhar R, 2011, J EVOLUTION BIOL, V24, P1135, DOI 10.1111/j.1420-9101.2011.02249.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferrada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014172; Fontana W, 1998, J THEOR BIOL, V194, P491, DOI 10.1006/jtbi.1998.0771; Greenbury SF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0249; Habegger L, 2012, BIOINFORMATICS, V28, P2267, DOI 10.1093/bioinformatics/bts368; Khurana E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002886; LIPMAN DJ, 1991, P ROY SOC B-BIOL SCI, V245, P7, DOI 10.1098/rspb.1991.0081; Manrubia SC, 2010, ARBOR, V186, P1051, DOI 10.3989/arbor.2010.746n1253; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Nei M., 1987, MOL EVOLUTIONARY GEN; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Noble JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007732; Payne JL, 2014, ARTIF LIFE, V20, P111, DOI 10.1162/ARTL_a_00099; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rodrigues JFM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000613; Samal A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-30; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Wagner A, 2011, ORIGINS OF EVOLUTIONARY INNOVATIONS: A THEORY OF TRANSFORMATIVE CHANGE IN LIVING SYSTEMS, P1, DOI 10.1093/acprof:oso/9780199692590.001.0001; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Wagner A, 2012, P ROY SOC B-BIOL SCI, V279, P1249, DOI 10.1098/rspb.2011.2293; Wagner A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-231; Wagner A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-33; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	36	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99424	10.1371/journal.pone.0099424	http://dx.doi.org/10.1371/journal.pone.0099424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911413	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000337165600085
J	Pysz, MA; Hao, F; Hizli, AA; Lum, MA; Swetzig, WM; Black, AR; Black, JD				Pysz, Marybeth A.; Hao, Fang; Hizli, A. Asli; Lum, Michelle A.; Swetzig, Wendy M.; Black, Adrian R.; Black, Jennifer D.			Differential Regulation of Cyclin D1 Expression by Protein Kinase C alpha and epsilon Signaling in Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BREAST-CANCER CELLS; PKC-EPSILON; GENE-EXPRESSION; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTORS; DEPENDENT PATHWAY; POTENTIAL ROLE; ACTIVATION; GROWTH	Cellular accumulation of cyclin D1, a key regulator of cell proliferation and tumorigenesis, is subject to tight control. Our previous studies have identified PKC alpha as a negative regulator of cyclin D1 in the intestinal epithelium. However, treatment of non-transformed IEC-18 ileal crypt cells with PKC agonists has a biphasic effect on cyclin D1 expression. Initial PKC alpha-mediated down-regulation is followed by recovery and subsequent accumulation of the cyclin to levels markedly higher than those seen in untreated cells. Using protein overexpression strategies, siRNA, and pharmacological inhibitors, we now demonstrate that the recovery and hyperinduction of cyclin D1 reflect the combined effects of (a) loss of negative signals from PKC alpha due to agonist-induced PKC alpha down-regulation and (b) positive effects of PKC epsilon. PKC epsilon-mediated up-regulation of cyclin D1 requires sustained ERK stimulation and transcriptional activation of the proximal cyclin D1 (CCDN1) promoter, without apparent involvement of changes in protein stability or translation. PKC epsilon also up-regulates cyclin D1 expression in colon cancer cells, through mechanisms that parallel those in IEC-18 cells. Although induction of cyclin D1 by PKC epsilon is dependent on non-canonical NF-kappa B activation, the NF-kappa B site in the proximal promoter is not required. Instead, cyclin D1 promoter activity is regulated by a novel interaction between NF-kappa B and factors that associate with the cyclic AMP-response element adjacent to the NF-kappa B site. The differential effects of PKC alpha and PKC epsilon on cyclin D1 accumulation are likely to contribute to the opposing tumor-suppressive and tumor-promoting activities of these PKC family members in the intestinal epithelium.	[Lum, Michelle A.; Black, Adrian R.; Black, Jennifer D.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Lum, Michelle A.; Black, Adrian R.; Black, Jennifer D.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Pysz, Marybeth A.; Hao, Fang; Hizli, A. Asli; Swetzig, Wendy M.; Black, Adrian R.; Black, Jennifer D.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Roswell Park Cancer Institute	Black, JD (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.			HIZLI DENIZ, AYSEN ASLI/0000-0003-0490-7737	National Institutes of Health [DK60632, DK54909, CA16056, CA036727]; National Institutes of Health Postdoctoral Fellowship [CA113048]; National Science Foundation [DBI-0353490]; NATIONAL CANCER INSTITUTE [P30CA036727, F32CA113048, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054909, R56DK060632, R01DK060632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK60632, DK54909, CA16056, and CA036727 and National Institutes of Health Postdoctoral Fellowship CA113048 (to M. A. P.). This work was also supported by National Science Foundation Grant DBI-0353490.	Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Benavides F, 2011, CELL CYCLE, V10, P268, DOI 10.4161/cc.10.2.14469; Besson A, 2001, ONCOGENE, V20, P7398, DOI 10.1038/sj.onc.1204899; Black AR, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00423; Cavicchi M, 1999, GUT, V45, P367, DOI 10.1136/gut.45.3.367; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Cheng JJ, 2001, J BIOL CHEM, V276, P31368, DOI 10.1074/jbc.M011317200; Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200; De Plaen IG, 2006, IMMUNOLOGY, V118, P153, DOI 10.1111/j.1365-2567.2006.02344.x; Faisal A, 2008, J BIOL CHEM, V283, P18591, DOI 10.1074/jbc.M710330200; Fasanaro P, 2006, FASEB J, V20, P1242, DOI 10.1096/fj.05-4695fje; Frey MR, 2000, J CELL BIOL, V151, P763, DOI 10.1083/jcb.151.4.763; Frey MR, 1997, J BIOL CHEM, V272, P9424; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Garg R, 2012, J BIOL CHEM, V287, P37570, DOI 10.1074/jbc.M112.398925; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Guo Xiaoling, 2011, Genes Cancer, V2, P818, DOI 10.1177/1947601911431082; Guo Y, 2005, ONCOGENE, V24, P1032, DOI 10.1038/sj.onc.1208299; Guo ZY, 2011, CLIN EPIGENETICS, V2, P63, DOI 10.1007/s13148-010-0018-y; Hao F, 2011, J BIOL CHEM, V286, P18104, DOI 10.1074/jbc.M110.208488; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Hellmuth M, 2002, CARCINOGENESIS, V23, P1273, DOI 10.1093/carcin/23.8.1273; Hizli AA, 2006, J BIOL CHEM, V281, P14596, DOI 10.1074/jbc.M601959200; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Hong DH, 1999, AM J PHYSIOL-GASTR L, V277, pG1041, DOI 10.1152/ajpgi.1999.277.5.G1041; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Kang DW, 2008, J BIOL CHEM, V283, P4094, DOI 10.1074/jbc.M707416200; Kazanietz MG, 2010, PROTEIN KINASE C IN CANCER SIGNALING AND THERAPY, P1, DOI 10.1007/978-1-60761-543-9; Kilker RL, 2006, CANCER RES, V66, P11478, DOI 10.1158/0008-5472.CAN-06-1755; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Li XY, 2011, J CELL BIOCHEM, V112, P211, DOI 10.1002/jcb.22925; Lim JH, 2008, CANCER SCI, V99, P1798, DOI 10.1111/j.1349-7006.2008.00892.x; Lum MA, 2013, J BIOL CHEM, V288, P27112, DOI 10.1074/jbc.M112.437095; Morais C, 2006, NEPHROL DIAL TRANSPL, V21, P3377, DOI 10.1093/ndt/gfl543; Murray NR, 2009, CANCER RES, V69, P656, DOI 10.1158/0008-5472.CAN-08-3001; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Ng R, 2012, J CLIN INVEST, V122, P1097, DOI 10.1172/JCI46039; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Page K, 2002, AM J RESP CELL MOL, V27, P204, DOI 10.1165/ajrcmb.27.2.20010016oc; Perletti GP, 1998, ONCOGENE, V16, P3345, DOI 10.1038/sj.onc.1201871; Pervin S, 2001, P NATL ACAD SCI USA, V98, P3583, DOI 10.1073/pnas.041603998; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; Rao VU, 2004, AM J PHYSIOL-HEART C, V286, pH2195, DOI 10.1152/ajpheart.00475.2003; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; SAXON ML, 1994, J CELL BIOL, V126, P747, DOI 10.1083/jcb.126.3.747; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Tanaka M, 2004, BIOORG MED CHEM LETT, V14, P5171, DOI 10.1016/j.bmcl.2004.07.061; Tang J, 2010, J BIOL CHEM, V285, P34072, DOI 10.1074/jbc.M110.137380; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Toncheva D, 2004, TUMOR BIOL, V25, P157, DOI 10.1159/000081097; Toualbi-Abed K, 2008, CARCINOGENESIS, V29, P536, DOI 10.1093/carcin/bgm293; Wang BB, 2012, MOL ENDOCRINOL, V26, P1356, DOI 10.1210/me.2012-1035; Wang F, 2010, TOXICOLOGY, V273, P12, DOI 10.1016/j.tox.2010.04.009; Wang XF, 2004, ONCOGENE, V23, P1885, DOI 10.1038/sj.onc.1207312; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Wilding J, 2002, CANCER RES, V62, P4562; Wilson L, 1999, GASTROENTEROLOGY, V117, P106, DOI 10.1016/S0016-5085(99)70556-1; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Yan SC, 2001, J CELL PHYSIOL, V186, P338, DOI 10.1002/1097-4652(2000)9999:9999<000::AID-JCP1032>3.0.CO;2-B; Zhang JP, 2007, ENDOCRINOLOGY, V148, P268, DOI 10.1210/en.2006-0500	70	17	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22268	22283		10.1074/jbc.M114.571554	http://dx.doi.org/10.1074/jbc.M114.571554			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24914206	hybrid, Green Published			2022-12-25	WOS:000340593500040
J	Lu, YX; Zhang, Q; Xu, WH				Lu, Yu-Xuan; Zhang, Qi; Xu, Wei-Hua			Global Metabolomic Analyses of the Hemolymph and Brain during the Initiation, Maintenance, and Termination of Pupal Diapause in the Cotton Bollworm, Helicoverpa armigera	PLOS ONE			English	Article							AMINO-ACID POOLS; RICE STEM BORER; BOMBYX-MORI; SHONAI ECOTYPE; COLD-HARDINESS; FAT-BODY; SILKWORM; GLYCEROL; SORBITOL; EGGS	A strategy known as diapause (developmental arrest) has evolved in insects to increase their survival rate under harsh environmental conditions. Diapause causes a dramatic reduction in the metabolic rate and drastically extends lifespan. However, little is known about the mechanisms underlying the metabolic changes involved. Using gas chromatography-mass spectrometry, we compared the changes in the metabolite levels in the brain and hemolymph of nondiapause- and diapause-destined cotton bollworm, Helicoverpa armigera, during the initiation, maintenance, and termination of pupal diapause. A total of 55 metabolites in the hemolymph and 52 metabolites in the brain were detected. Of these metabolites, 21 and 12 metabolite levels were altered in the diapause pupal hemolymph and brain, respectively. During diapause initiation and maintenance, the number of metabolites with increased levels in the hemolymph of the diapausing pupae is far greater than the number in the nondiapause pupae. These increased metabolites function as an energy source, metabolic intermediates, and cryoprotectants. The number of metabolites with decreased levels in the brain of diapausing pupae is far greater than the number in the nondiapause pupae. Low metabolite levels are likely to directly or indirectly repress the brain metabolic activity. During diapause termination, most of the metabolite levels in the hemolymph of the diapausing pupae rapidly decrease because they function as energy and metabolic sources that promote pupa-adult development. In conclusion, the metabolites with altered levels in the hemolymph and brain serve as energy and metabolic resources and help to maintain a low brain metabolic activity during diapause.	[Lu, Yu-Xuan; Zhang, Qi; Xu, Wei-Hua] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xu, WH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	xuweihua@mail.sysu.edu.cn	Lu, Yu-Xuan/GYU-8582-2022; Lu, Yu-Xuan/AHE-5003-2022; Xu, Weihua/GYJ-6124-2022	Lu, Yu-Xuan/0000-0001-6751-5250; Xu, wei-hua/0000-0003-1696-3330	Natural Scientific Foundation of China [31230066]; National Basic Research Program of China, Ministry of Science and Technology [2012CB114101]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China, Ministry of Science and Technology	This study was supported by a Grant-in-Aid from the Natural Scientific Foundation of China (31230066) and the National Basic Research Program of China, Ministry of Science and Technology (2012CB114101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bemani M, 2012, J INSECT PHYSIOL, V58, P897, DOI 10.1016/j.jinsphys.2012.04.003; CHINO H, 1958, J INSECT PHYSIOL, V2, P1, DOI 10.1016/0022-1910(58)90024-6; Colinet H, 2013, METABOLOMICS, V9, P608, DOI 10.1007/s11306-012-0471-z; Davis DJ, 2001, ARCH INSECT BIOCHEM, V48, P199, DOI 10.1002/arch.1072; Denlinger D.L., 2005, P615; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Goto M, 2001, J INSECT PHYSIOL, V47, P709, DOI 10.1016/S0022-1910(00)00164-5; Goto Michiyo, 1998, Journal of Insect Physiology, V44, P87, DOI 10.1016/S0022-1910(97)00098-X; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Horie Y, 2000, J INSECT PHYSIOL, V46, P1009, DOI 10.1016/S0022-1910(99)00212-7; Kostal V, 2007, J INSECT PHYSIOL, V53, P580, DOI 10.1016/j.jinsphys.2007.02.009; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2011, P NATL ACAD SCI USA, V108, P13041, DOI 10.1073/pnas.1107060108; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Li YP, 2002, J INSECT PHYSIOL, V48, P303, DOI 10.1016/S0022-1910(01)00177-9; Li YP, 2002, ARCH INSECT BIOCHEM, V50, P53, DOI 10.1002/arch.10024; Lu YX, 2010, J PROTEOME RES, V9, P5053, DOI 10.1021/pr100356t; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; Nelson CJ, 2010, COMP BIOCHEM PHYS D, V5, P265, DOI 10.1016/j.cbd.2010.07.002; Nelson D.L., 2008, PRINCIPLES BIOCH; OSANAI M, 1986, INSECT BIOCHEM, V16, P373, DOI 10.1016/0020-1790(86)90050-8; SUZUKI K, 1984, INSECT BIOCHEM, V14, P557, DOI 10.1016/0020-1790(84)90012-X; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Xu J, 2009, GLYCOBIOLOGY, V19, P250, DOI 10.1093/glycob/cwn127; Xu WH, 2012, P NATL ACAD SCI USA, V109, P14687, DOI 10.1073/pnas.1212879109; YAGINUMA T, 1978, J INSECT PHYSIOL, V24, P347, DOI 10.1016/0022-1910(78)90074-4; Yaginuma T, 1999, J INSECT PHYSIOL, V45, P621, DOI 10.1016/S0022-1910(98)00150-4; Yang J, 2010, J INSECT PHYSIOL, V56, P1992, DOI 10.1016/j.jinsphys.2010.08.023; Zhang Q, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-751; Zhang Q, 2012, J PROTEOME RES, V11, P1042, DOI 10.1021/pr200796a	32	20	24	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99948	10.1371/journal.pone.0099948	http://dx.doi.org/10.1371/journal.pone.0099948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926789	gold, Green Published, Green Submitted			2022-12-25	WOS:000338278100097
J	Sarr, O; Thompson, JA; Zhao, L; Lee, TY; Regnault, TRH				Sarr, Ousseynou; Thompson, Jennifer A.; Zhao, Lin; Lee, Ting-Yim; Regnault, Timothy R. H.			Low Birth Weight Male Guinea Pig Offspring Display Increased Visceral Adiposity in Early Adulthood	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; PPAR-GAMMA; GENE-EXPRESSION; IN-VIVO; TRIGLYCERIDE LIPASE; FAT-CELLS; TISSUE; ADIPOCYTE; INSULIN; OBESITY	Uteroplacental insufficiency (UPI)-induced intrauterine growth restriction (IUGR) predisposes individuals to adult visceral obesity. We postulated that low birth weight (LBW) offspring, from UPI-induced IUGR pregnancies, would display a visceral adipose lipogenic molecular signature involving altered gene expression, phosphorylation status of proteins of the lipid synthesis pathway and microRNA (miR) expression profile, occurring in association with increased visceral adiposity. Normal birth weight (NBW) and LBW (obtained by uterine artery ablation) male guinea pig pups were fed a control diet from weaning to 145 days and sacrificed. Despite being lighter at birth, LBW pups displayed body weights similar to NBW offspring at 145 days. At this age, which represents young adulthood, the relative weights of LBW epididymal white adipose tissue (EWAT) and lipid content were increased; which was consistent with adipocyte hypertrophy in the LBW offspring. Additionally, the mRNA expression of lipid synthesis-related genes including acetyl-CoA carboxylase 1 (ACC1), diglyceride acyltransferase 2 (DGAT2) and peroxisome proliferator-activated receptor gamma 1 (PPAR gamma 1), was increased in LBW EWAT. Further, LBW EWAT displayed decreased phospho-ACC (Ser79) and phospho-PPAR gamma (Ser273) proteins. Moreover, the mRNA expression of hormone-sensitive lipase (HSL) and fatty acid binding protein 4 (FABP4), both involved in promoting adipose lipid storage, was increased in LBW EWAT. Finally, miR-24 and miR-103-2, miRs related to adipocyte development, were both increased in LBW EWAT. These findings indicate that, following an adverse in utero environment, lipid synthesis-related genes and miR expression, along with phosphorylation status of key regulators of lipid synthesis, appear to be chronically altered and occur in association with increased visceral adiposity in young adult IUGR male offspring.	[Sarr, Ousseynou; Zhao, Lin; Regnault, Timothy R. H.] Univ Western Ontario, Childrens Hlth Res Inst, Dept Obstet & Gynecol, Lawson Hlth Res Inst, London, ON, Canada; [Thompson, Jennifer A.] Georgia Regents Univ, Dept Physiol, Augusta, GA USA; [Lee, Ting-Yim] Univ Western Ontario, Dept Med Imaging, London, ON, Canada; [Lee, Ting-Yim] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Lee, Ting-Yim] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Lee, Ting-Yim] Lawson Hlth Res Inst, London, ON, Canada; [Lee, Ting-Yim] Robarts Res Inst, London, ON N6A 5C1, Canada; [Regnault, Timothy R. H.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); University System of Georgia; Augusta University; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Sarr, O (corresponding author), Univ Western Ontario, Childrens Hlth Res Inst, Dept Obstet & Gynecol, Lawson Hlth Res Inst, London, ON, Canada.	osarr@uwo.ca	Regnault, Timothy RH/AAE-3168-2021; Regnault, Timothy/J-8902-2014; Regnault, Timothy RH/GVS-9382-2022; Lee, Ting-Yim/M-1721-2013	Regnault, Timothy/0000-0003-1930-8358; Regnault, Timothy RH/0000-0003-1930-8358; Thompson, Jennifer/0000-0003-0421-3719	Canadian Institutes of Health Research [MOP-209113]; Whaley Postdoctoral Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Whaley Postdoctoral Fellowship	This work was supported by the Canadian Institutes of Health Research (Operating Grant #MOP-209113). Ousseynou Sarr was supported by the Whaley Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER P, 1988, DIABETES METAB REV, V4, P507; Baschat AA, 2004, SEMIN PERINATOL, V28, P67, DOI 10.1053/j.semperi.2003.10.014; BJORNTORP P, 1972, EUR J CLIN INVEST, V2, P78, DOI 10.1111/j.1365-2362.1972.tb00573.x; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; CARTER AM, 1990, J DEV PHYSIOL, V13, P261; Castaneda-Gutierrez E, 2011, AM J CLIN NUTR, V94, p1838S, DOI 10.3945/ajcn.110.000794; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Darimont C, 1997, ENDOCRINOLOGY, V138, P1092, DOI 10.1210/en.138.3.1092; Desai M, 2008, REPROD SCI, V15, P785, DOI 10.1177/1933719108318597; Emanuela F, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/476380; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gathercole LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026223; Gerin I, 2010, AM J PHYSIOL-ENDOC M, V299, pE198, DOI 10.1152/ajpendo.00179.2010; Gomez-Pinilla PJ, 2007, J UROLOGY, V177, P1558, DOI 10.1016/j.juro.2006.11.071; Granton PV, 2010, J APPL PHYSIOL, V109, P1162, DOI 10.1152/japplphysiol.00016.2010; Gruffat D, 1996, REPROD NUTR DEV, V36, P375, DOI 10.1051/rnd:19960404; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; HORUK R, 1983, J BIOL CHEM, V258, P7425; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Joss-Moore LA, 2010, EARLY HUM DEV, V86, P179, DOI 10.1016/j.earlhumdev.2010.02.006; Kalderon B, 2000, AM J PHYSIOL-ENDOC M, V279, pE221, DOI 10.1152/ajpendo.2000.279.1.E221; Kang M, 2013, GENET MOL RES, V12, P5267, DOI 10.4238/2013.November.7.1; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Large V, 1999, J LIPID RES, V40, P2059; Le Lay S, 2002, J BIOL CHEM, V277, P35625, DOI 10.1074/jbc.M203913200; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Lie S, 2013, J DEV ORIG HLTH DIS, V4, P421, DOI 10.1017/S2040174413000202; Lim KI, 2010, CLIN ENDOCRINOL, V73, P588, DOI 10.1111/j.1365-2265.2010.03841.x; Lin XZ, 2013, GENE EXPRESSION, V16, P1, DOI 10.3727/105221613X13776146743262; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012; Lukaszewski MA, 2011, AM J PHYSIOL-ENDOC M, V301, pE548, DOI 10.1152/ajpendo.00011.2011; Luu YK, 2009, MED ENG PHYS, V31, P34, DOI 10.1016/j.medengphy.2008.03.006; MacLaren RE, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-3; Mandard S., 2006, Nutritional genomics: impact on health and disease, P208, DOI 10.1002/3527608109.ch12; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Nguyen LT, 2010, PLACENTA, V31, P902, DOI 10.1016/j.placenta.2010.07.014; Nuesken KD, 2008, ENDOCRINOLOGY, V149, P1056, DOI 10.1210/en.2007-0891; Rasmussen EL, 2005, DIABETES CARE, V28, P151, DOI 10.2337/diacare.28.1.151; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; SAGGERSON ED, 1974, BIOCHEM J, V140, P211, DOI 10.1042/bj1400211; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Takekoshi K, 2006, METABOLISM, V55, P1122, DOI 10.1016/j.metabol.2006.04.007; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Tse MCL, 2013, MOL CELL BIOL, V33, P1797, DOI 10.1128/MCB.01410-12; Turner AJ, 2009, PLACENTA, V30, P236, DOI 10.1016/j.placenta.2008.11.023; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Xie HM, 2009, EXPERT OPIN THER TAR, V13, P1227, DOI 10.1517/14728220903190707; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yajima H, 2007, BIOCHEM BIOPH RES CO, V352, P526, DOI 10.1016/j.bbrc.2006.11.054; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	64	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98433	10.1371/journal.pone.0098433	http://dx.doi.org/10.1371/journal.pone.0098433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926663	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100016
J	Gimenes, F; Medina, FS; de Abreu, ALP; Irie, MMT; Esquicati, IB; Malagutti, N; Vasconcellos, VRB; Discacciati, MG; Bonini, MG; Maria-Engler, SS; Consolaro, MEL				Gimenes, Fabricia; Medina, Fabiana Soares; Pimenta de Abreu, Andre Luelsdorf; Taguti Irie, Mary Mayumi; Esquicati, Isis Baroni; Malagutti, Natalia; Bulla Vasconcellos, Vinicius Rodrigo; Discacciati, Michele Garcia; Bonini, Marcelo Gialluisi; Maria-Engler, Silvya Stuchi; Lopes Consolaro, Marcia Edilaine			Sensitive Simultaneous Detection of Seven Sexually Transmitted Agents in Semen by Multiplex-PCR and of HPV by Single PCR	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; MALE GENITAL-TRACT; MYCOPLASMA-GENITALIUM; UREAPLASMA-UREALYTICUM; TRICHOMONAS-VAGINALIS; RAPID DETECTION; MEN; DISEASE; IMPACT; URETHRITIS	Sexually transmitted diseases (STDs) may impair sperm parameters and functions thereby promoting male infertility. To date limited molecular studies were conducted to evaluate the frequency and type of such infections in semen Thus, we aimed at conceiving and validating a multiplex PCR (M-PCR) assay for the simultaneous detection of the following STD pathogens in semen: Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis, Herpes virus simplex (HSV) -1 and -2, and Treponema pallidum; We also investigated the potential usefulness of this M-PCR assay in screening programs for semen pathogens. In addition, we aimed: to detect human Papillomavirus (HPV) and genotypes by single PCR (sPCR) in the same semen samples; to determine the prevalence of the seven STDs, HPV and co-infections; to assess the possibility that these infections affect semen parameters and thus fertility. The overall validation parameters of M-PCR were extremely high including agreement (99.2%), sensitivity (100.00%), specificity (99.70%), positive (96.40%) and negative predictive values (100.00%) and accuracy (99.80%). The prevalence of STDs was very high (55.3%). Furthermore, associations were observed between STDs and changes in semen parameters, highlighting the importance of STD detection in semen. Thus, this M-PCR assay has great potential for application in semen screening programs for pathogens in infertility and STD clinics and in sperm banks.	[Gimenes, Fabricia; Medina, Fabiana Soares; Pimenta de Abreu, Andre Luelsdorf; Taguti Irie, Mary Mayumi; Esquicati, Isis Baroni; Malagutti, Natalia; Bulla Vasconcellos, Vinicius Rodrigo; Lopes Consolaro, Marcia Edilaine] Univ Estadual Maringa, Sect Clin Cytol, Dept Clin Anal & Biomed, Maringa, Parana, Brazil; [Discacciati, Michele Garcia; Maria-Engler, Silvya Stuchi] Univ Sao Paulo, Clin Chem & Toxicol Dept, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Bonini, Marcelo Gialluisi] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA	Universidade Estadual de Maringa; Universidade de Sao Paulo; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Consolaro, MEL (corresponding author), Univ Estadual Maringa, Sect Clin Cytol, Dept Clin Anal & Biomed, Maringa, Parana, Brazil.	melconsolaro@gmail.com	Consolaro, Marcia EL/I-4932-2014; Engler, Silvya Stuchi Maria/K-5936-2016; Maria-Engler, Silvya/ABC-2016-2020; Discacciati, Michelle Garcia/B-4608-2014	Consolaro, Marcia EL/0000-0001-9102-4865; Engler, Silvya Stuchi Maria/0000-0003-4771-6041; Maria-Engler, Silvya/0000-0003-4771-6041; Discacciati, Michelle Garcia/0000-0003-3660-3826	Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), Brazilian Government [AUX-PE-PRODOC 2571/2010]	Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), Brazilian Government(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), AUX-PE-PRODOC 2571/2010, Brazilian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghistani HI, 2010, MIDDLE EAST FERTIL S, V15, P29, DOI 10.1016/j.mefs.2010.03.003; Bezold G, 2007, FERTIL STERIL, V87, P1087, DOI 10.1016/j.fertnstert.2006.08.109; BOLAN G, 1999, SEXUALLY TRANSMITTED, P117; Brookings C, 2013, KOREAN J UROL, V54, P149, DOI 10.4111/kju.2013.54.3.149; Chen LH, 2013, J MED VIROL, V85, P1229, DOI 10.1002/jmv.23582; Cheng L, 2002, ESSENTIALS ANATOMIC; Cunningham KA, 2008, BIOL REPROD, V79, P180, DOI 10.1095/biolreprod.108.067835; Edwards JL, 2004, CLIN MICROBIOL REV, V17, P965, DOI 10.1128/CMR.17.4.965-981.2004; Elder K, 2005, INFECTIONS, INFERTILITY, AND ASSISTED REPRODUCTION, P1; Eley A, 2005, LANCET INFECT DIS, V5, P53, DOI 10.1016/S1473-3099(04)01254-X; Foresta C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015036; Foresta C, 2010, FERTIL STERIL, V94, P1723, DOI 10.1016/j.fertnstert.2009.11.012; Furuya R, 2004, J UROLOGY, V171, P1550, DOI 10.1097/01.ju.0000116288.59223.e9; Garolla A, 2013, J REPROD IMMUNOL, V100, P20, DOI 10.1016/j.jri.2013.03.004; Gdoura R, 2008, ANDROLOGIA, V40, P209, DOI 10.1111/j.1439-0272.2008.00845.x; Gonzales GF, 2004, ANDROLOGIA, V36, P1, DOI 10.1046/j.0303-4569.2003.00594.x; Gore-Felton C, 2003, INT J STD AIDS, V14, P539, DOI 10.1258/095646203767869156; Hobbs MM, 2006, J CLIN MICROBIOL, V44, P3994, DOI 10.1128/JCM.00952-06; Hobbs MM, 1999, SEX TRANSM DIS, V26, P381, DOI 10.1097/00007435-199908000-00003; Hook E. W., 1999, SEXU LLY TRANSMITTED, P451; Jensen JS, 2004, J EUR ACAD DERMATOL, V18, P1, DOI 10.1111/j.1468-3083.2004.00923.x; Kalwij S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-802; Kaspersen MD, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-226; Kaspersen MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018095; Kotronias D, 1998, IN VIVO, V12, P391; Krieger JN, 2002, INT J ANTIMICROB AG, V19, P475, DOI 10.1016/S0924-8579(02)00086-9; LaMontagne DS, 2004, SEX TRANSM INFECT, V80, P335, DOI 10.1136/sti.2004.012856; Lee JS, 2013, UROLOGY, V81, P1219, DOI 10.1016/j.urology.2013.02.044; MANOS MM, 1994, J INFECT DIS, V170, P1096, DOI 10.1093/infdis/170.5.1096; McIver CJ, 2009, J CLIN MICROBIOL, V47, P1358, DOI 10.1128/JCM.01873-08; McKechnie ML, 2009, J CLIN MICROBIOL, V47, P1871, DOI 10.1128/JCM.00120-09; Monavari SH, 2013, J BIOMED RES, V27, P56, DOI 10.7555/JBR.27.20110139; Muller, 1990, SEXUALLY TRANSMITTED, P481; Muvunyi CM, 2011, DIAGN MICR INFEC DIS, V71, P29, DOI 10.1016/j.diagmicrobio.2011.06.005; Nadala Elpidio-Cesar, 2009, BMJ, V339, pb2655, DOI 10.1136/bmj.b2655; Neofytou E, 2009, FERTIL STERIL, V91, P2487, DOI 10.1016/j.fertnstert.2008.03.074; Ochsendorf FR, 2008, ANDROLOGIA, V40, P72, DOI 10.1111/j.1439-0272.2007.00825.x; Olatunbosun O A, 1998, West Afr J Med, V17, P19; Mackern-Oberti JP, 2013, J REPROD IMMUNOL, V100, P37, DOI 10.1016/j.jri.2013.05.002; Peeling Rw, 2005, Can J Infect Dis Med Microbiol, V16, P73; Pellati D, 2008, EUR J OBSTET GYN R B, V140, P3, DOI 10.1016/j.ejogrb.2008.03.009; Rowe PJ., 1993, WHO MANUAL STANDARDI, V83; Rusz A, 2012, WORLD J UROL, V30, P23, DOI 10.1007/s00345-011-0726-8; Sankuntaw N, 2011, MOL CELL PROBE, V25, P114, DOI 10.1016/j.mcp.2011.03.004; Santiago E, 2006, J CLIN VIROL, V37, P38, DOI 10.1016/j.jcv.2006.06.001; Simms I, 2003, SEX TRANSM INFECT, V79, P491, DOI 10.1136/sti.79.6.491; Sleha R, 2013, EPIDEMIOL MIKROBI IM, V62, P26; Souza RP, 2013, AM J TROP MED HYG, V89, P1199, DOI 10.4269/ajtmh.13-0315; Svenstrup HF, 2003, HUM REPROD, V18, P2103, DOI 10.1093/humrep/deg392; Uuskula A, 2002, INT J STD AIDS, V13, P79, DOI 10.1258/0956462021924695; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Wang Y, 2006, ASIAN J ANDROL, V8, P562, DOI 10.1111/j.1745-7262.2006.00190.x; Wikstrom A, 2006, SEX TRANSM INFECT, V82, P276, DOI 10.1136/sti.2005.018598; World Health Organization, 2007, GLOB STRAT PREV CONT; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wu Kun-He, 2007, Zhonghua Nan Ke Xue, V13, P1075; Yoshida T, 2003, J CLIN MICROBIOL, V41, P1850, DOI 10.1128/JCM.41.5.1850-1855.2003; Zuckerman RA, 2009, AIDS, V23, P479, DOI 10.1097/QAD.0b013e328326ca62	58	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98862	10.1371/journal.pone.0098862	http://dx.doi.org/10.1371/journal.pone.0098862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921247	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300018
J	Kuznetsova, AA; Kuznetsov, NA; Vorobjev, YN; Barthes, NPF; Michel, BY; Burger, A; Fedorova, OS				Kuznetsova, Alexandra A.; Kuznetsov, Nikita A.; Vorobjev, Yuri N.; Barthes, Nicolas P. F.; Michel, Benoit Y.; Burger, Alain; Fedorova, Olga S.			New Environment-Sensitive Multichannel DNA Fluorescent Label for Investigation of the Protein-DNA Interactions	PLOS ONE			English	Article							COLI ENDONUCLEASE-VIII; CONFORMATIONAL DYNAMICS; ANALOGS TC; RECOGNITION; NUCLEOSIDE; MECHANISM; REPAIR; GLYCOSYLASE; COMPLEXES; KINETICS	Here, we report the study of a new multichannel DNA fluorescent base analogue 3-hydroxychromone (3HC) to evaluate its suitability as a fluorescent reporter probe of structural transitions during protein-DNA interactions and its comparison with the current commercially available 2-aminopurine (aPu), pyrrolocytosine (C-py) and 1,3-diaza-2-oxophenoxazine (tC(O)). For this purpose, fluorescent base analogues were incorporated into DNA helix on the opposite or on the 5'-side of the damaged nucleoside 5,6-dihydrouridine (DHU), which is specifically recognized and removed by Endonuclease VIII. These fluorophores demonstrated different sensitivities to the DNA helix conformational changes. The highest sensitivity and the most detailed information about the conformational changes of DNA induced by protein binding and processing were obtained using the 3HC probe. The application of this new artificial fluorescent DNA base is a very useful tool for the studies of complex mechanisms of protein-DNA interactions. Using 3HC biosensor, the kinetic mechanism of Endonuclease VIII action was specified.	[Kuznetsova, Alexandra A.; Kuznetsov, Nikita A.; Vorobjev, Yuri N.; Fedorova, Olga S.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia; [Kuznetsova, Alexandra A.; Kuznetsov, Nikita A.; Vorobjev, Yuri N.; Fedorova, Olga S.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia; [Barthes, Nicolas P. F.; Michel, Benoit Y.; Burger, Alain] Univ Nice Sophia Antipolis, CNRS, UMR 7272, Inst Chim Nice, F-06189 Nice, France	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Cote d'Azur	Burger, A (corresponding author), Univ Nice Sophia Antipolis, CNRS, UMR 7272, Inst Chim Nice, F-06189 Nice, France.	burger@unice.fr; fedorova@niboch.nsc.ru	Kuznetsov, Nikita/AFU-9897-2022; Kuznetsov, Nikita A/F-3245-2011; Kuznetsova, Aleksandra A/G-5119-2013; Fedorova, Olga/ABE-6637-2020; Burger, Alain F/B-9586-2009; Kuznetsov, Nikita/CAA-3889-2022; Fedorova, Olga S./E-1291-2013; BARTHES, Nicolas P F/C-7948-2016	Kuznetsov, Nikita/0000-0002-4016-198X; Kuznetsov, Nikita A/0000-0002-4016-198X; Fedorova, Olga/0000-0002-4001-7187; Kuznetsov, Nikita/0000-0002-4016-198X; Fedorova, Olga S./0000-0002-4001-7187; Kuznetsova, Aleksandra/0000-0002-9805-7050; BARTHES, Nicolas P F/0000-0002-5102-3056	Russian Academy of Sciences "Molecular & Cell Biology" [6.11]; Russian Foundation for Basic Research [12-04-00135, 14-04-00531, 13-04-00013, 14-04-31174]; Russian Ministry of Education and Science [SS-1205.2014.4, SP-4012.2013.4]; Russian Scientific Foundation [14-14-00063]; ANR [ANR-12-BS08-0003-02]; FRM [DCM20111223038]; Russian Science Foundation [14-14-00063] Funding Source: Russian Science Foundation	Russian Academy of Sciences "Molecular & Cell Biology"; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Russian Scientific Foundation(Russian Science Foundation (RSF)); ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported by the Program of the Russian Academy of Sciences '' Molecular & Cell Biology '' (No 6.11), the Grants from Russian Foundation for Basic Research (12-04-00135, 14-04-00531, 13-04-00013 and 14-04-31174) and Russian Ministry of Education and Science (SS-1205.2014.4 and SP-4012.2013.4), the Grant from Russian Scientific Foundation (14-14-00063). The ANR (ANR-12-BS08-0003-02) and the FRM (DCM20111223038) are thanked for financial support and grant for N.P.F.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess S, 2002, J BIOL CHEM, V277, P2938, DOI 10.1074/jbc.M110499200; Das R, 2009, PHOTOCH PHOTOBIO SCI, V8, P1583, DOI 10.1039/b906710h; Demchenko AP, 2006, FEBS LETT, V580, P2951, DOI 10.1016/j.febslet.2006.03.091; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Dziuba D, 2012, J AM CHEM SOC, V134, P10209, DOI 10.1021/ja3030388; Golan G, 2005, NUCLEIC ACIDS RES, V33, P5006, DOI 10.1093/nar/gki796; Jiang DY, 1997, J BIOL CHEM, V272, P32230, DOI 10.1074/jbc.272.51.32230; Kanazhevskaya LY, 2012, BIOCHEMISTRY-US, V51, P1306, DOI 10.1021/bi201444m; Kim KT, 2013, ORG BIOMOL CHEM, V11, P5605, DOI 10.1039/c3ob41222a; Koval VV, 2010, MUTAT RES-FUND MOL M, V685, P3, DOI 10.1016/j.mrfmmm.2009.08.018; Koval VV, 2004, NUCLEIC ACIDS RES, V32, P926, DOI 10.1093/nar/gkh237; Kropachev KY, 2006, BIOCHEMISTRY-US, V45, P12039, DOI 10.1021/bi060663e; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Kuznetsov NA, 2007, BIOCHEMISTRY-US, V46, P424, DOI 10.1021/bi060787r; Kuznetsov NA, 2012, DNA REPAIR, V11, P884, DOI 10.1016/j.dnarep.2012.08.004; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; Kuznetsov NA, 2009, BIOCHEMISTRY-US, V48, P11335, DOI 10.1021/bi901100b; Kuznetsova AA, 2014, BBA-GEN SUBJECTS, V1840, P387, DOI 10.1016/j.bbagen.2013.09.035; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4]; Liu W, 2013, ACS CHEM BIOL, V8, P2017, DOI 10.1021/cb400256h; MELAMEDE RJ, 1994, BIOCHEMISTRY-US, V33, P1255, DOI 10.1021/bi00171a028; Ono T, 2012, ANGEW CHEM INT EDIT, V51, P1689, DOI 10.1002/anie.201108135; Pawar MG, 2013, J PHYS CHEM B, V117, P14273, DOI 10.1021/jp4071168; Pawar MG, 2013, BIOCONJUG CHEM; Popov A V, 2010, Mol Biol (Mosk), V44, P735; Reddy CK, 2001, J MOL BIOL, V314, P619, DOI 10.1006/jmbi.2001.5154; Rodgers BJ, 2014, CHEM-EUR J, V20, P2010, DOI 10.1002/chem.201303410; Sandin P, 2009, NUCLEIC ACIDS RES, V37, P3924, DOI 10.1093/nar/gkp266; Segal M, 2013, J MED CHEM, V56, P4860, DOI 10.1021/jm301838y; Shynkar VV, 2007, J AM CHEM SOC, V129, P2187, DOI 10.1021/ja068008h; Sinkeldam RW, 2010, CHEM REV, V110, P2579, DOI 10.1021/cr900301e; Sowers LC, 2000, BIOCHEMISTRY-US, V39, P7613, DOI 10.1021/bi992388k; Spadafora M, 2009, TETRAHEDRON, V65, P7809, DOI 10.1016/j.tet.2009.07.021; Stengel G, 2009, ANAL CHEM, V81, P9079, DOI 10.1021/ac9017555; Stengel G, 2009, BIOCHEMISTRY-US, V48, P7547, DOI 10.1021/bi9006995; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; Suzuki A, 2013, BIOORG MED CHEM LETT, V23, P886, DOI 10.1016/j.bmcl.2012.11.029; Wilhelmsson LM, 2010, Q REV BIOPHYS, V43, P159, DOI 10.1017/S0033583510000090; Yang KS, 2008, PHOTOCHEM PHOTOBIOL, V84, P741, DOI 10.1111/j.1751-1097.2007.00251.x; Zang Z, 2005, J BIOL CHEM, V280, P30873, DOI 10.1074/jbc.M505283200; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789	42	37	37	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e100007	10.1371/journal.pone.0100007	http://dx.doi.org/10.1371/journal.pone.0100007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925085	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300118
J	Buccigrossi, V; Laudiero, G; Russo, C; Miele, E; Sofia, M; Monini, M; Ruggeri, FM; Guarino, A				Buccigrossi, Vittoria; Laudiero, Gabriella; Russo, Carla; Miele, Erasmo; Sofia, Morena; Monini, Marina; Ruggeri, Franco Maria; Guarino, Alfredo			Chloride Secretion Induced by Rotavirus Is Oxidative Stress-Dependent and Inhibited by Saccharomyces boulardii in Human Enterocytes	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; ION-TRANSPORT; DISEASE; CHILDREN; DIARRHEA; METABOLITES; ARTICLE; PROTEIN; NSP4; VIVO	Rotavirus (RV) infection causes watery diarrhea via multiple mechanisms, primarily chloride secretion in intestinal epithelial cell. The chloride secretion largely depends on non-structural protein 4 (NSP4) enterotoxic activity in human enterocytes through mechanisms that have not been defined. Redox imbalance is a common event in cells infected by viruses, but the role of oxidative stress in RV infection is unknown. RV SA11 induced chloride secretion in association with an increase in reactive oxygen species (ROS) in Caco-2 cells. The ratio between reduced (GSH) and oxidized (GSSG) glutathione was decreased by RV. The same effects were observed when purified NSP4 was added to Caco-2 cells. N-acetylcysteine (NAC), a potent antioxidant, strongly inhibited the increase in ROS and GSH imbalance. These results suggest a link between oxidative stress and RV-induced diarrhea. Because Saccharomyces boulardii (Sb) has been effectively used to treat RV diarrhea, we tested its effects on RV-infected cells. Sb supernatant prevented RV-induced oxidative stress and strongly inhibited chloride secretion in Caco-2 cells. These results were confirmed in an organ culture model using human intestinal biopsies, demonstrating that chloride secretion induced by RV-NSP4 is oxidative stress-dependent and is inhibited by Sb, which produces soluble metabolites that prevent oxidative stress. The results of this study provide novel insights into RV-induced diarrhea and the efficacy of probiotics.	[Buccigrossi, Vittoria; Laudiero, Gabriella; Russo, Carla; Miele, Erasmo; Sofia, Morena; Guarino, Alfredo] Univ Naples Federico II, Sect Pediat, Dept Translat Med Sci, Naples, Italy; [Monini, Marina; Ruggeri, Franco Maria] Ist Super Sanita, Viral Zoonoses Unit, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy	University of Naples Federico II; Istituto Superiore di Sanita (ISS)	Guarino, A (corresponding author), Univ Naples Federico II, Sect Pediat, Dept Translat Med Sci, Naples, Italy.	alfguari@unina.it	MONINI, MARINA/C-9949-2015; Buccigrossi, Vittoria/AAA-1226-2020; Ruggeri, Franco M/B-5707-2013; Guarino, Alfredo/AAC-4812-2022	MONINI, MARINA/0000-0002-5874-2221; Guarino, Alfredo/0000-0003-0199-0336	Biocodex Laboratories, Gentilly, France	Biocodex Laboratories, Gentilly, France	This work was supported in part by Biocodex Laboratories, Gentilly, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agrawal L, 2011, NEUROBIOL DIS, P1; Albano F, 2007, EUR J PEDIATR, V166, P241, DOI 10.1007/s00431-006-0237-6; Allen S, 2001, METHODS CELL SCI, V22, P305; Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; Buccigrossi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029436; Buts JP, 2010, SCAND J GASTROENTERO, V45, P175, DOI 10.3109/00365520903453141; Canani RB, 2003, GASTROENTEROLOGY, V124, P368, DOI 10.1053/gast.2003.50056; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Correa NBO, 2011, J PEDIATR GASTR NUTR, V53, P497, DOI 10.1097/MPG.0b013e31822b7ab0; De Marco G, 2009, J INFECT DIS, V200, P813, DOI 10.1086/605125; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Forster J, 2009, PEDIATRICS, V123, pe393, DOI 10.1542/peds.2008-2088; Gac M, 2010, VIROLOGY, V404, P293, DOI 10.1016/j.virol.2010.05.018; GRISHAM MB, 1990, INFLAMMATION, V14, P531, DOI 10.1007/BF00914274; Guarino A, 2012, J PEDIATR GASTR NUTR, V55, P621, DOI 10.1097/MPG.0b013e318272b5e2; Guarino A, 2009, CURR OPIN GASTROEN, V25, P18, DOI 10.1097/MOG.0b013e32831b4455; Hagbom M, 2012, CURR OPIN VIROL, V2, P408, DOI 10.1016/j.coviro.2012.05.006; Hosakote YM, 2009, AM J RESP CELL MOL, V41, P348, DOI 10.1165/rcmb.2008-0330OC; Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957; Lorrot M, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-31; Morris AP, 1999, AM J PHYSIOL-GASTR L, V277, pG431, DOI 10.1152/ajpgi.1999.277.2.G431; NGUYEN TD, 1994, BIOCHEM PHARMACOL, V47, P403, DOI 10.1016/0006-2952(94)90032-9; Ousingsawat J, 2011, PFLUG ARCH EUR J PHY, V461, P579, DOI 10.1007/s00424-011-0947-0; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Piescik-Lech M, 2013, ALIMENT PHARM THER, V37, P289, DOI 10.1111/apt.12163; Pothoulakis C, 2009, ALIMENT PHARM THER, V30, P826, DOI 10.1111/j.1365-2036.2009.04102.x; Rooj AK, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-16; Schultheiss G, 2008, BRIT J PHARMACOL, V154, P991, DOI 10.1038/bjp.2008.162; Sodhi CP, 1996, INDIAN J MED RES, V104, P245; Szajewska H, 2007, ALIMENT PHARM THER, V25, P257, DOI 10.1111/j.1365-2036.2006.03202.x; TAMAI H, 1992, J CLIN INVEST, V89, P301, DOI 10.1172/JCI115576; Tanaka G, 2007, PEDIATR INFECT DIS J, V26, P1014, DOI 10.1097/INF.0b013e318125721c; Tsilingiri K, 2013, BENEF MICROBES, V4, P101, DOI 10.3920/BM2012.0046; Tsilingiri K, 2012, GUT, V61, P1007, DOI 10.1136/gutjnl-2011-300971	35	40	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99830	10.1371/journal.pone.0099830	http://dx.doi.org/10.1371/journal.pone.0099830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918938	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000116
J	Nakanishi, M; Wang, YJ; Wang, YT; Mitsukura, Y; Jung, TP				Nakanishi, Masaki; Wang, Yijun; Wang, Yu-Te; Mitsukura, Yasue; Jung, Tzyy-Ping			Generating Visual Flickers for Eliciting Robust Steady-State Visual Evoked Potentials at Flexible Frequencies Using Monitor Refresh Rate	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; CANONICAL CORRELATION-ANALYSIS; FEATURE-SELECTIVE ATTENTION; SSVEP; BCI; RESPONSES; TOOLBOX; DESIGN; PHASE; TIME	In the study of steady-state visual evoked potentials (SSVEPs), it remains a challenge to present visual flickers at flexible frequencies using monitor refresh rate. For example, in an SSVEP-based brain-computer interface (BCI), it is difficult to present a large number of visual flickers simultaneously on a monitor. This study aims to explore whether or how a newly proposed frequency approximation approach changes signal characteristics of SSVEPs. At 10 Hz and 12 Hz, the SSVEPs elicited using two refresh rates (75 Hz and 120 Hz) were measured separately to represent the approximation and constantperiod approaches. This study compared amplitude, signal-to-noise ratio (SNR), phase, latency, scalp distribution, and frequency detection accuracy of SSVEPs elicited using the two approaches. To further prove the efficacy of the approximation approach, this study implemented an eight-target BCI using frequencies from 8-15 Hz. The SSVEPs elicited by the two approaches were found comparable with regard to all parameters except amplitude and SNR of SSVEPs at 12 Hz. The BCI obtained an averaged information transfer rate (ITR) of 95.0 bits/min across 10 subjects with a maximum ITR of 120 bits/min on two subjects, the highest ITR reported in the SSVEP-based BCIs. This study clearly showed that the frequency approximation approach can elicit robust SSVEPs at flexible frequencies using monitor refresh rate and thereby can largely facilitate various SSVEP-related studies in neural engineering and visual neuroscience.	[Nakanishi, Masaki; Mitsukura, Yasue] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 223, Japan; [Nakanishi, Masaki; Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping] Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA; [Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping] Univ Calif San Diego, Inst Engn Med, Ctr Adv Neurol Engn, La Jolla, CA 92093 USA	Keio University; University of California System; University of California San Diego; University of California System; University of California San Diego	Wang, YJ (corresponding author), Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA.	yijun@sccn.ucsd.edu	Mitsukura, Yasue/ABI-2277-2020; Mitsukura, Yasue/F-8149-2014; Mitsukura, Yasue/AAF-1449-2021; Nakanishi, Masaki/S-9251-2019; Wang, Yijun/F-3547-2012; Wang, Yijun/GXW-1763-2022	Mitsukura, Yasue/0000-0001-5575-8589; Mitsukura, Yasue/0000-0001-5575-8589; Jung, Tzyy-Ping/0000-0002-8377-2166	Swartz Foundation; Office of Naval Research [N00014-08-1215]; Army Research Office [W911NF-09-1-0510]; Army Research Laboratory [W911NF-10-2-0022]; DARPA [USDI D11PC20183]; Japan Society for the Promotion of Science	Swartz Foundation; Office of Naval Research(Office of Naval Research); Army Research Office; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Research is supported in part by a gift fund from Swartz Foundation, Office of Naval Research (N00014-08-1215), Army Research Office (W911NF-09-1-0510), Army Research Laboratory (W911NF-10-2-0022), and DARPA (USDI D11PC20183). M. Nakanishi is also supported by Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SK, 2010, P NATL ACAD SCI USA, V107, P13878, DOI 10.1073/pnas.1002436107; Bakardjian H, 2010, NEUROSCI LETT, V469, P34, DOI 10.1016/j.neulet.2009.11.039; Bin GY, 2009, IEEE COMPUT INTELL M, V4, P22, DOI 10.1109/MCI.2009.934562; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cao T, 2011, I IEEE EMBS C NEUR E, P465, DOI 10.1109/NER.2011.5910587; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Chi YM, 2012, IEEE T NEUR SYS REH, V20, P228, DOI 10.1109/TNSRE.2011.2174652; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Diez PF, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-39; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Gao XR, 2003, IEEE T NEUR SYS REH, V11, P137, DOI 10.1109/TNSRE.2003.814449; Gergondet P., 2011, 2011 IEEE International Conference on Robotics and Biomimetics (ROBIO), P192, DOI 10.1109/ROBIO.2011.6181284; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hwang HJ, 2012, J NEUROSCI METH, V208, P59, DOI 10.1016/j.jneumeth.2012.04.011; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Kluge T, 2007, 2007 3RD INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, VOLS 1 AND 2, P425, DOI 10.1109/CNE.2007.369700; Lalor EC, 2005, EURASIP J APPL SIG P, V2005, P3156, DOI 10.1155/ASP.2005.3156; Lee PL, 2010, ANN BIOMED ENG, V38, P2383, DOI 10.1007/s10439-010-9964-y; Lin YP, 2013, IEEE ENG MED BIO, P1350, DOI 10.1109/EMBC.2013.6609759; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Lopez-Gordo MA, 2010, NEURAL PROCESS LETT, V32, P1, DOI 10.1007/s11063-010-9139-8; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Nakanishi M, 2013, I IEEE EMBS C NEUR E, P1092, DOI 10.1109/NER.2013.6696127; Nan WY, 2011, I IEEE EMBS C NEUR E, P469, DOI 10.1109/NER.2011.5910588; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; REGAN D, 1966, ELECTROEN CLIN NEURO, V20, P238, DOI 10.1016/0013-4694(66)90088-5; Regan D., 1989, HUMAN BRAIN ELECTROP; Russo FD, 1999, VISION RES, V39, P2975, DOI DOI 10.1016/S0042-6989(99)00031-; Shyu KK, 2010, NEUROSCI LETT, V483, P28, DOI 10.1016/j.neulet.2010.07.043; SPEKREIJSE H, 1977, VISUAL EVOKED POTENT, P16; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang Y, 2010, ELECTRON LETT, V46, P1057, DOI 10.1049/el.2010.0923; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576; Wang YJ, 2008, IEEE ENG MED BIOL, V27, P64, DOI 10.1109/MEMB.2008.923958; Wang YJ, 2005, 2005 FIRST INTERNATIONAL CONFERENCE ON NEURAL INTERFACE AND CONTROL PROCEEDINGS, P37; Wang YT, 2013, IEEE ENG MED BIO, P5271, DOI 10.1109/EMBC.2013.6610738; Wang YT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025018; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	43	67	68	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99235	10.1371/journal.pone.0099235	http://dx.doi.org/10.1371/journal.pone.0099235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918435	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000065
J	Araya, RE; Jury, J; Bondar, C; Verdu, EF; Chirdo, FG				Araya, Romina E.; Jury, Jennifer; Bondar, Constanza; Verdu, Elena F.; Chirdo, Fernando G.			Intraluminal Administration of Poly I:C Causes an Enteropathy That Is Exacerbated by Administration of Oral Dietary Antigen	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; DOUBLE-STRANDED-RNA; NONOBESE DIABETIC MICE; CELIAC-DISEASE; BACTERIAL DYSENTERY; GLUTEN SENSITIVITY; TRANSGLUTAMINASE 2; BARRIER FUNCTION; RESPONSES; GLIADIN	Systemic administration of polyinosinic: polycytidylic acid (poly I:C), mimics virally-induced activation of TLR3 signalling causing acute small intestine damage, but whether and how mucosal administration of poly I:C causes enteropathy is less clear. Our aim was to investigate the inflammatory pathways elicited after intraluminal administration of poly I:C and determine acute and delayed consequences of this locally induced immune activation. Intraluminal poly I:C induced rapid mucosal immune activation in C57BL/6 mice involving IFN beta and the CXCL10/CXCR3 axis, that may drive inflammation towards a Th1 profile. Intraluminal poly I:C also caused enteropathy and gut dysfunction in gliadin-sensitive NOD-DQ8 mice, and this was prolonged by concomitant oral administration of gliadin. Our results indicate that small intestine pathology can be induced in mice by intraluminal administration of poly I:C and that this is exacerbated by subsequent oral delivery of a relevant dietary antigen.	[Araya, Romina E.; Bondar, Constanza; Chirdo, Fernando G.] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Lab Invest Sistema Inmune LISIN, La Plata, Buenos Aires, Argentina; [Jury, Jennifer; Verdu, Elena F.] McMaster Univ, Farncombe Family Digest Hlth Inst, Div Gastroenterol, Hamilton, ON, Canada	National University of La Plata; McMaster University	Chirdo, FG (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Lab Invest Sistema Inmune LISIN, La Plata, Buenos Aires, Argentina.	fchirdo@biol.unlp.edu.ar	Chirdo, Fernando/AAL-7928-2020	Araya, Romina Elizabeth/0000-0001-9787-2670; Chirdo, Fernando/0000-0002-7099-9142	CONICET [PIP 719]; CIHR [MOP-123282]; Canadian Association of Gastroenterology (CAG) - Latin American Student Research Opportunity	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology (CAG) - Latin American Student Research Opportunity	This work was supported by a grant to F.Ch. from CONICET PIP 719 and a CIHR grant to E. F. V. (MOP-123282). R. E. A. received a travel grant from Canadian Association of Gastroenterology (CAG) - Latin American Student Research Opportunity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017039; Bayardo M, 2012, CLIN EXP IMMUNOL, V168, P95, DOI 10.1111/j.1365-2249.2011.04545.x; Biagi F, 2004, J CLIN PATHOL, V57, P835, DOI 10.1136/jcp.2003.013607; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; Bondar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089068; Broquet AH, 2011, J IMMUNOL, V186, P1618, DOI 10.4049/jimmunol.1002862; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; de Kauwe AL, 2009, J IMMUNOL, V182, P7440, DOI 10.4049/jimmunol.0900233; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Galipeau HJ, 2011, J IMMUNOLOGY; GARSIDE P, 1991, IMMUNOLOGY, V74, P279; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Heyman M, 2012, GUT, V61, P1355, DOI 10.1136/gutjnl-2011-300327; Honda K, 2009, MUCOSAL IMMUNOL, V2, P187, DOI 10.1038/mi.2009.8; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kolodziej LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026352; Marietta E, 2004, J CLIN INVEST, V114, P1090, DOI 10.1172/JCI200421055; Marshall JK, 2007, CLIN GASTROENTEROL H, V5, P457, DOI 10.1016/j.cgh.2006.11.025; Marshall JK, 2006, GASTROENTEROLOGY, V131, P445, DOI 10.1053/j.gastro.2006.05.053; Marshall JK, 2010, GUT, V59, P605, DOI 10.1136/gut.2009.202234; McAllister CS, 2013, J IMMUNOL, V190, P418, DOI 10.4049/jimmunol.1202756; Nanayakkara M, 2013, AM J CLIN NUTR, V98, P1123, DOI 10.3945/ajcn.112.054544; Natividad JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006472; Ostvik AE, 2013, INFLAMM BOWEL DIS, V19, P265, DOI 10.1002/ibd.23034; Quaedackers JSLT, 2000, TRANSPLANT P, V32, P1307, DOI 10.1016/S0041-1345(00)01238-0; Rajagopalan G, 2003, DIABETES, V52, P342, DOI 10.2337/diabetes.52.2.342; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Suwanai H, 2010, P NATL ACAD SCI USA, V107, P9305, DOI 10.1073/pnas.1004492107; Troncone R, 2007, J PEDIATR GASTR NUTR, V44, P527, DOI 10.1097/MPG.0b013e31804ca0ec; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Verdu EF, 2008, AM J PHYSIOL-GASTR L, V294, pG217, DOI 10.1152/ajpgi.00225.2007; Verdu EF, 2007, CAN J GASTROENTEROL, V21, P453, DOI 10.1155/2007/169591; Verdu EF, 2012, AM J GASTROENTEROL, V107, P1752, DOI 10.1038/ajg.2012.291; Verdu EF, 2009, AM J GASTROENTEROL, V104, P1587, DOI 10.1038/ajg.2009.188; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Zhou RB, 2007, P NATL ACAD SCI USA, V104, P7512, DOI 10.1073/pnas.0700822104; Zhou RB, 2007, J IMMUNOL, V178, P4548, DOI 10.4049/jimmunol.178.7.4548	40	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99236	10.1371/journal.pone.0099236	http://dx.doi.org/10.1371/journal.pone.0099236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915573	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700073
J	Armstead, J; Morris, J; Denning, DW				Armstead, Joanne; Morris, Julie; Denning, David W.			Multi-Country Estimate of Different Manifestations of Aspergillosis in Cystic Fibrosis	PLOS ONE			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; LUNG-FUNCTION; FUMIGATUS; SENSITIZATION; PREVALENCE; CLASSIFICATION; BRONCHITIS; FREQUENCY; DIAGNOSIS; CHILDREN	Aspergillus spp. can lead to allergic bronchopulmonary aspergillosis (ABPA), Aspergillus sensitisation and Aspergillus bronchitis in CF. The relative frequencies of these entities have recently been ascertained in a large UK adult CF cohort. We have used this data to estimate the burden of aspergillosis and ABPA cases in adult CF patients in 30 countries reporting CF. National and international CF registry data was accessed and assessed for completeness and age distribution. Published proportions of ABPA (17.7%), Aspergillus sensitisation (14.6%) and Aspergillus bronchitis (30%) in CF were applied to those >18 years and compared with notified ABPA cases. Of the 76,201 estimated CF patients worldwide (not including India), 37,714 were >18 years. The proportion of adults to children varied from 63% in Norway to 20% in Brazil. ABPA caseload in adults is anticipated to be 6,675 cases of which only 2,221 cases (33%) are currently recorded, indicating substantial underdiagnosis. The ABPA diagnosis rate compared with estimated rates varies by country from 101% (France) to 14.5% (Greece), although genetic variation could account for genuine differences compared with the UK. Aspergillus bronchitis is not currently recognised or recorded in CF registries but there are an anticipated 10,988 adult cases. Aspergillus sensitisation, associated with increased bronchiectasis and reduced FEV1, affects an anticipated 5,506 patients without ABPA or Aspergillus bronchitis. Together ABPA and Aspergillus bronchitis are estimated to affect 17,989 adults, 47.7% of the adult CF population. ABPA also occurs in children and teenagers and 984 cases were documented in registries. Diagnosed ABPA rates by age were available for the ECFS registry, USA, UK, Ireland, Belgium and Netherlands. The rate was <1% under 4 years, and increased throughout childhood and adolescence, with marked variation between countries. Newly published diagnostic criteria and methods should facilitate better recognition of aspergillosis in CF, allowing better CF disease control.	[Denning, David W.] Univ Manchester, Univ S Manchester Hosp, Natl Aspergillosis Ctr, Manchester, Lancs, England; Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester	Denning, DW (corresponding author), Univ Manchester, Univ S Manchester Hosp, Natl Aspergillosis Ctr, Manchester, Lancs, England.	ddenning@manchester.ac.uk	Denning, David/AAC-6931-2019	Denning, David/0000-0001-5626-2251	University Hospital of South Manchester	University Hospital of South Manchester	This work was funded by the University Hospital of South Manchester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2013, CLIN EXP ALLERGY, V43, P850, DOI 10.1111/cea.12141; Agarwal R, 2006, CHEST, V130, P442, DOI 10.1378/chest.130.2.442; Agarwal R, 2010, ASPERGILLOSIS: FROM DIAGNOSIS TO PREVENTION, P671, DOI 10.1007/978-90-481-2408-4_39; Amin R, 2010, CHEST, V137, P171, DOI 10.1378/chest.09-1103; [Anonymous], 2011, IN FRENCH CYST FIBR; [Anonymous], 2011, CYSTIC FIBROSIS FDN; Av Norsk senter for cystisk fibrose Oslo universitetssykehus, 2011, CYST FIBR POP NORG P; Barton RC, 2008, DIAGN MICR INFEC DIS, V62, P287, DOI 10.1016/j.diagmicrobio.2008.06.018; Baxter CG, 2013, J ALLERGY CLIN IMMUN, V132, P560, DOI 10.1016/j.jaci.2013.04.007; BEAUMONT F, 1984, ALLERGY, V39, P183, DOI 10.1111/j.1398-9995.1984.tb02623.x; Belgische Mucoviscidose Register Registre Belge de la Mucoviscidose Scientific Institute of Public Health, 2010, BELG CYST FIBR REG S; Burgel PR, 2012, ANTIMICROB AGENTS CH, V56, P869, DOI 10.1128/AAC.05077-11; Carneiro Ana Cláudia Costa, 2008, J. bras. pneumol., V34, P900, DOI 10.1590/S1806-37132008001100003; Chakrabarti A, 2002, MYCOSES, V45, P295, DOI 10.1046/j.1439-0507.2002.00738.x; Chrdle A, 2012, ANN NY ACAD SCI, V1272, P73, DOI 10.1111/j.1749-6632.2012.06816.x; Cordero CV, 2008, REGISTRO EUROPEO FQ; Cystic Fibrosis Association of New Zealand, 2011, PORT CFNZ 2011 NAT D; Cystic Fibrosis Australia, 2012, CYST FIBR AUSTR 2011; Cystic Fibrosis Canada, 2013, CAN CYST FIBR REG 20; de Vrankrijker AMM, 2011, CLIN MICROBIOL INFEC, V17, P1381, DOI 10.1111/j.1469-0691.2010.03429.x; Denning DW, 2013, MED MYCOL, V51, P361, DOI 10.3109/13693786.2012.738312; Dutch Cystic Fibrosis Registry, 2012, ANN DAT REP 2011; ELDAHR JM, 1994, AM J RESP CRIT CARE, V150, P1513, DOI 10.1164/ajrccm.150.6.7952609; European Cystic Fibrosis Society, 2009, EUR CYST FIBR SOC PA; Fillaux J, 2012, SCAND J INFECT DIS, V44, P842, DOI 10.3109/00365548.2012.695454; Geller DE, 1999, CHEST, V116, P639, DOI 10.1378/chest.116.3.639; Greenberger PA, 2001, FRONTIERS BIOSCIENCE, V8, ps119; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Grupo Brasileiro De Estudos De Fibrose Cistica, 2010, REG BRAS FIBR CIST A; Hedayati MT, 2010, ENVIRON MONIT ASSESS, V168, P481, DOI 10.1007/s10661-009-1128-x; HENDERSON AH, 1968, THORAX, V23, P501, DOI 10.1136/thx.23.5.501; Howard SJ, 2011, MED MYCOL, V49, pS90, DOI 10.3109/13693786.2010.508469; Hutcheson PS, 1996, CHEST, V110, P363, DOI 10.1378/chest.110.2.363; Kanthan SK, 2007, PEDIATR PULM, V42, P785, DOI 10.1002/ppul.20656; Kapoor V, 2006, J CYST FIBROS, V5, P43, DOI 10.1016/j.jcf.2005.10.002; KIRSTEN D, 1993, MED KLIN, V88, P353; Kopacz E, 2009, KONF V4 CF ZBORN PRE; MARCHANT JL, 1994, THORAX, V49, P1002, DOI 10.1136/thx.49.10.1002; Marshall B, 2013, US CYSTIC FIBROSIS F; Mastella G, 2000, EUR RESPIR J, V16, P464, DOI 10.1034/j.1399-3003.2000.016003464.x; MEARNS M, 1965, THORAX, V20, P385, DOI 10.1136/thx.20.5.385; Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06; Milla CE, 1996, PEDIATR PULM, V21, P6, DOI 10.1002/(SICI)1099-0496(199601)21:1&lt;6::AID-PPUL1&gt;3.0.CO;2-R; Paugam A, 2010, MED MYCOL, V48, pS32, DOI 10.3109/13693786.2010.503665; Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604; Prasad R, 2010, INDIAN J CLIN BIOCHE, V25, P335, DOI 10.1007/s12291-010-0091-1; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sens B, 2011, QUALITATSSICHERUNG M; Shah JR, 1997, J ASSOC PHYSICIAN I, V19, P835; Shoseyov D, 2006, CHEST, V130, P222, DOI 10.1378/chest.130.1.222; SIMMONDS EJ, 1990, ARCH DIS CHILD, V65, P507, DOI 10.1136/adc.65.5.507; Skov M, 2005, RESP MED, V99, P887, DOI 10.1016/j.rmed.2004.11.018; Spagna F, 2010, FIBROSIS QUISTICA UR; State Social Security Institution Uruguay (BPS), 2012, FIBR QUIST UR SIT PE; Stevens DA, 2003, CLIN INFECT DIS, V37, pS225, DOI 10.1086/376525; The Cystic Fibrosis Registry of Ireland, 2011, ANN REPORT; Tudela Juan Luis Rodriguez, 2013, BURDEN SERIOUS FUNGA; UK CF Registry, 2013, ANN DAT REP 2011; Viviani L, 2012, EUROPEAN CYSTIC FIBR, P1; Wojnarowski C, 1997, AM J RESP CRIT CARE, V155, P1902, DOI 10.1164/ajrccm.155.6.9196093; Woodcock AA, 2006, ALLERGY, V61, P140, DOI 10.1111/j.1398-9995.2005.00941.x	61	75	75	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98502	10.1371/journal.pone.0098502	http://dx.doi.org/10.1371/journal.pone.0098502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914809	gold, Green Submitted, Green Published			2022-12-25	WOS:000340947700022
J	Avilov, S; Berardozzi, R; Gunewardene, MS; Adam, V; Hess, ST; Bourgeois, D				Avilov, Sergiy; Berardozzi, Romain; Gunewardene, Mudalige S.; Adam, Virgile; Hess, Samuel T.; Bourgeois, Dominique			In cellulo Evaluation of Phototransformation Quantum Yields in Fluorescent Proteins Used As Markers for Single-Molecule Localization Microscopy	PLOS ONE			English	Article							TO-RED PHOTOCONVERSION; SUPERRESOLUTION MICROSCOPY; CORRELATION SPECTROSCOPY; STRUCTURAL BASIS; DYNAMICS; PHOTOSTABILITY; FLUOROPHORES; CONVERSION; BLINKING; STATE	Single-molecule localization microscopy of biological samples requires a precise knowledge of the employed fluorescent labels. Photoactivation, photoblinking and photobleaching of phototransformable fluorescent proteins influence the data acquisition and data processing strategies to be used in (Fluorescence) Photoactivation Localization Microscopy ((F)-PALM), notably for reliable molecular counting. As these parameters might depend on the local environment, they should be measured in cellulo in biologically relevant experimental conditions. Here, we measured phototransformation quantum yields for Dendra2 fused to actin in fixed mammalian cells in typical (F)-PALM experiments. To this aim, we developed a data processing strategy based on the clustering optimization procedure proposed by Lee et al (PNAS 109, 17436-17441, 2012). Using simulations, we estimated the range of experimental parameters (molecular density, molecular orientation, background level, laser power, frametime) adequate for an accurate determination of the phototransformation yields. Under illumination at 561 nm in PBS buffer at pH 7.4, the photobleaching yield of Dendra2 fused to actin was measured to be (2.5 +/- 0.4) x 10(-5), whereas the blinking-off yield and thermally-activated blinking-on rate were measured to be (2.3 +/- 0.2) x 10(-5) and 11.7 +/- 0.5 s(-1), respectively. These phototransformation yields differed from those measured in polyvinyl alcohol (PVA) and were strongly affected by addition of the antifading agent 1,4-diazabicyclo[2.2.2] octane (DABCO). In the presence of DABCO, the photobleaching yield was reduced 2-fold, the blinking-off yield was decreased more than 3-fold, and the blinking-on rate was increased 2-fold. Therefore, DABCO largely improved Dendra2 photostability in fixed mammalian cells. These findings are consistent with redox-based bleaching and blinking mechanisms under (F)-PALM experimental conditions. Finally, the green-to-red photoconversion quantum yield of Dendra2 was estimated to be (1.4 +/- 0.6) x 10(-5) in cellulo under 405 nm illumination.	[Avilov, Sergiy; Berardozzi, Romain; Adam, Virgile; Bourgeois, Dominique] Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France; [Avilov, Sergiy; Berardozzi, Romain; Adam, Virgile; Bourgeois, Dominique] CNRS, IBS, Grenoble, France; [Avilov, Sergiy; Berardozzi, Romain; Adam, Virgile; Bourgeois, Dominique] CEA, DSV, IBS, Grenoble, France; [Gunewardene, Mudalige S.; Hess, Samuel T.] Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Maine System; University of Maine Orono	Hess, ST (corresponding author), Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA.	sam.hess@umit.maine.edu; dominique.bourgeois@ibs.fr	Adam, Virgile/B-9359-2009; , Bourgeois/AAI-2337-2020	Adam, Virgile/0000-0003-2209-7846; 	ANR [ANR-2011-BSV5-012-01 NOBLEACH]; U.S. National Institutes of Health [K25-AI65459, R15-GM094713]; U.S. National Science Foundation [CHE0722759]; Maine Technology Institute [MTAF 1106, MTAF 2061]; Maine Economic Improvement Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI065459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094713] Funding Source: NIH RePORTER	ANR(French National Research Agency (ANR)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); Maine Technology Institute; Maine Economic Improvement Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.B. acknowledges financial support by the ANR (ANR-2011-BSV5-012-01 NOBLEACH). S.T.H. and M.S.G. were supported by U.S. National Institutes of Health grants K25-AI65459 and R15-GM094713, U.S. National Science Foundation grant CHE0722759, Maine Technology Institute grants MTAF 1106 and MTAF 2061, and the Maine Economic Improvement Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2011, CHEM BIOL, V18, P1241, DOI 10.1016/j.chembiol.2011.08.007; Adam V, 2009, J AM CHEM SOC, V131, P18063, DOI 10.1021/ja907296v; Adam V, 2009, BIOCHEMISTRY-US, V48, P4905, DOI 10.1021/bi900383a; Altman RB, 2012, NAT METHODS, V9, P428, DOI 10.1038/nmeth.1988; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Baldini G, 2005, SCIENCE, V309, P1096, DOI 10.1126/science.1115001; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bogdanov AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053004; Bogdanov AM, 2009, NAT METHODS, V6, P859, DOI 10.1038/nmeth1209-859; Bogdanov AM, 2009, NAT CHEM BIOL, V5, P459, DOI 10.1038/nchembio.174; Coltharp C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051725; DAVID CC, 2012, PHOTOCH PHOTOBIO SCI, V11, P358, DOI DOI 10.1039/C1PP05292F; Dean KM, 2011, BIOPHYS J, V101, P961, DOI 10.1016/j.bpj.2011.06.055; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Dittrich PS, 2005, BIOPHYS J, V89, P3446, DOI 10.1529/biophysj.105.061713; Duan CX, 2013, J AM CHEM SOC, V135, P15841, DOI 10.1021/ja406860e; Durisic N., 2014, NAT METHODS; Endesfelder U, 2011, MOLECULES, V16, P3106, DOI 10.3390/molecules16043106; Fourkas JT, 2001, OPT LETT, V26, P211, DOI 10.1364/OL.26.000211; Furstenberg A, 2013, PHYS CHEM CHEM PHYS, V15, P14919, DOI 10.1039/c3cp52289j; Ganguly S, 2011, BIOCHEM BIOPH RES CO, V405, P234, DOI 10.1016/j.bbrc.2011.01.016; Gunzenhauser J, 2012, NANO LETT, V12, P4705, DOI 10.1021/nl3021076; Gurskaya NG, 2006, NAT BIOTECHNOL; Ha T, 2012, ANNU REV PHYS CHEM, V63, P595, DOI 10.1146/annurev-physchem-032210-103340; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Harms GS, 2001, BIOPHYS J, V80, P2396, DOI 10.1016/S0006-3495(01)76209-1; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hoi HF, 2010, J MOL BIOL, V401, P776, DOI 10.1016/j.jmb.2010.06.056; JOHNSON GD, 1982, J IMMUNOL METHODS, V55, P231, DOI 10.1016/0022-1759(82)90035-7; Kao YT, 2012, P NATL ACAD SCI USA, V109, P3220, DOI 10.1073/pnas.1115311109; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; Lando D, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120078; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Lelimousin M, 2009, J AM CHEM SOC; Liu YX, 2006, J PHYS CHEM B, V110, P24138, DOI 10.1021/jp062164t; Makarov NS, 2014, J PHOTOCH PHOTOBIO A, V280, P5, DOI 10.1016/j.jphotochem.2014.02.001; Malkani N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018586; McEvoy AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051314; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Moeyaert B, 2014, ACS NANO; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Nanguneri S, 2014, MICROSC RES TECH; Ono M, 2001, J HISTOCHEM CYTOCHEM, V49, P305, DOI 10.1177/002215540104900304; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Peterman EJG, 1999, J PHYS CHEM A, V103, P10553, DOI 10.1021/jp991968o; Puchner EM, 2013, P NATL ACAD SCI USA, V110, P16015, DOI 10.1073/pnas.1309676110; Roy A, 2011, J AM CHEM SOC, V133, P18586, DOI 10.1021/ja2085355; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saha R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01580; Schenk A, 2004, BIOPHYS J, V86, P384, DOI 10.1016/S0006-3495(04)74114-4; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Tsutsui H, 2009, CHEM BIOL, V16, P1140, DOI 10.1016/j.chembiol.2009.10.010; VALNES K, 1985, J HISTOCHEM CYTOCHEM, V33, P755, DOI 10.1177/33.8.3926864; van de Linde S, 2014, CHEM SOC REV, V43, P1076, DOI 10.1039/c3cs60195a; van de Linde S, 2012, ANNU REV PHYS CHEM, V63, P519, DOI 10.1146/annurev-physchem-032811-112012; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Widengren J, 2007, J PHYS CHEM A, V111, P429, DOI 10.1021/jp0646325; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wolter S, 2011, OPT EXPRESS, V19, P7020, DOI 10.1364/OE.19.007020; Wong FHC, 2007, J AM CHEM SOC, V129, P10302, DOI 10.1021/ja0715905; Yeow EKL, 2006, J PHYS CHEM A, V110, P1726, DOI 10.1021/jp055496r; Zhao ZQW, 2014, P NATL ACAD SCI USA, V111, P681, DOI 10.1073/pnas.1318496111; Zondervan R, 2003, J PHYS CHEM A, V107, P6770, DOI 10.1021/jp034723r	73	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98362	10.1371/journal.pone.0098362	http://dx.doi.org/10.1371/journal.pone.0098362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915511	Green Submitted, gold, Green Published			2022-12-25	WOS:000340947700018
J	Odaka, H; Numakawa, T; Adachi, N; Ooshima, Y; Nakajima, S; Katanuma, Y; Inoue, T; Kunugi, H				Odaka, Haruki; Numakawa, Tadahiro; Adachi, Naoki; Ooshima, Yoshiko; Nakajima, Shingo; Katanuma, Yusuke; Inoue, Takafumi; Kunugi, Hiroshi			Cabergoline, Dopamine D2 Receptor Agonist, Prevents Neuronal Cell Death under Oxidative Stress via Reducing Excitotoxicity	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; MITOCHONDRIAL DYSFUNCTION; GLUTAMATE TRANSPORTERS; GLUTATHIONE SYSTEM; INDUCED APOPTOSIS; STEM-CELLS; ACTIVATION; ERK; PROTEIN; KINASE	Several lines of evidence demonstrate that oxidative stress is involved in the pathogenesis of neurodegenerative diseases, including Parkinson's disease. Potent antioxidants may therefore be effective in the treatment of such diseases. Cabergoline, a dopamine D2 receptor agonist and antiparkinson drug, has been studied using several cell types including mesencephalic neurons, and is recognized as a potent radical scavenger. Here, we examined whether cabergoline exerts neuroprotective effects against oxidative stress through a receptor-mediated mechanism in cultured cortical neurons. We found that neuronal death induced by H2O2 exposure was inhibited by pretreatment with cabergoline, while this protective effect was eliminated in the presence of a dopamine D2 receptor inhibitor, spiperone. Activation of ERK1/2 by H2O2 was suppressed by cabergoline, and an ERK signaling pathway inhibitor, U0126, similarly protected cortical neurons from cell death. This suggested the ERK signaling pathway has a critical role in cabergoline-mediated neuroprotection. Furthermore, increased extracellular levels of glutamate induced by H2O2, which might contribute to ERK activation, were reduced by cabergoline, while inhibitors for NMDA receptor or L-type Ca2+ channel demonstrated a survival effect against H2O2. Interestingly, we found that cabergoline increased expression levels of glutamate transporters such as EAAC1. Taken together, these results suggest that cabergoline has a protective effect on cortical neurons via a receptor-mediated mechanism including repression of ERK1/2 activation and extracellular glutamate accumulation induced by H2O2.	[Odaka, Haruki; Numakawa, Tadahiro; Adachi, Naoki; Ooshima, Yoshiko; Nakajima, Shingo; Katanuma, Yusuke; Kunugi, Hiroshi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan; [Odaka, Haruki; Katanuma, Yusuke; Inoue, Takafumi] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan; [Numakawa, Tadahiro; Adachi, Naoki; Nakajima, Shingo; Kunugi, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol Program, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; Waseda University; Japan Science & Technology Agency (JST)	Numakawa, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan.	numakawa@ncnp.go.jp	Odaka, Haruki/AAQ-4448-2020; Inoue, Takafumi/AAM-9533-2020; Kunugi, Hiroshi/ABC-5260-2021	Odaka, Haruki/0000-0001-5632-2680; Inoue, Takafumi/0000-0002-2728-0060; Adachi, Naoki/0000-0002-4850-1467; Kunugi, Hiroshi/0000-0002-7209-3790	NCNP [24-11]; JST [08062571]; Takeda Science Foundation; JSPS KAKENHI [24300139]; JSPS KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [25640019]	NCNP; JST(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Intramural Research Grant (No. 24-11) for Neurological and Psychiatric Disorders of NCNP (http://www.ncnp.go.jp/) and CREST program "creation of a novel technology towards diagnosis and treatment based on understanding of molecular pathogenesis of psychiatric and neurological disorders'' (No. 08062571) of JST (http://www.sss.jst.go.jp/info/index.html) (T.N., N.A. and H.K.). This project was also supported by Takeda Science Foundation (http://www.takeda-sci.or.jp/) (T.N.), a grant from Grant-in-Aid for Scientific Research (B) (JSPS KAKENHI Grant Number 24300139) (http://www.jsps.go. jp/english/index.html) (T.N.), and Grant-in-Aid for Challenging Exploratory Research (JSPS KAKENHI Grant Number 25640019) (http://www.jsps.go.jp/english/ index.html) (T.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Baas HKJ, 2001, EUR NEUROL, V46, P18, DOI 10.1159/000058049; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chau KY, 2009, J NEUROL SCI, V278, P44, DOI 10.1016/j.jns.2008.11.012; Chiba S, 2010, PSYCHOPHARMACOLOGY, V211, P291, DOI 10.1007/s00213-010-1894-8; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Crossthwaite AJ, 2002, J NEUROCHEM, V80, P24, DOI 10.1046/j.0022-3042.2001.00637.x; Curran MP, 2004, DRUGS, V64, P2125, DOI 10.2165/00003495-200464180-00015; Duxon MS, 1997, NEUROSCIENCE, V76, P323, DOI 10.1016/S0306-4522(96)00480-0; Feelders RA, 2013, J CLIN ENDOCR METAB, V98, P425, DOI 10.1210/jc.2012-3126; Feng Y, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/472932; Guillet B, 2002, NEUROCHEM INT, V40, P661, DOI 10.1016/S0197-0186(01)00110-3; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Himi T, 2003, J NEURAL TRANSM, V110, P1337, DOI 10.1007/s00702-003-0049-z; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Johri A, 2012, BBA-MOL BASIS DIS, V1822, P664, DOI 10.1016/j.bbadis.2011.11.014; Kalampokas T, 2013, GYNECOL ENDOCRINOL, V29, P98, DOI 10.3109/09513590.2012.730578; Kaneko T, 2002, NEUROSCI RES, V42, P243, DOI 10.1016/S0168-0102(02)00009-3; Kitamura Y, 2003, NEUROCHEM RES, V28, P1035, DOI 10.1023/A:1023207222944; Kvernmo T, 2006, CLIN THER, V28, P1065, DOI 10.1016/j.clinthera.2006.08.004; Lee Y, 2004, NEUROCHEM INT, V44, P107, DOI 10.1016/S0197-0186(03)00112-8; Leysen JE, 2004, CNS NEUROL DISORD-DR, V3, P11, DOI 10.2174/1568007043482598; Lim JY, 2008, J NEUROSCI RES, V86, P2168, DOI 10.1002/jnr.21669; Lombardi G, EUR J PHARM, V457, P95; Mailly F, 1999, J NEUROCHEM, V73, P1181, DOI 10.1046/j.1471-4159.1999.0731181.x; Miglio G, 2004, EUR J PHARMACOL, V489, P157, DOI 10.1016/j.ejphar.2004.03.006; Numakawa T, 2013, NEUROSCIENCE, V239, P157, DOI 10.1016/j.neuroscience.2012.09.073; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; Pradeep H, 2012, FOLIA NEUROPATHOL, V50, P219, DOI 10.5114/fn.2012.30522; RESINK A, 1995, EUR J NEUROSCI, V7, P1700, DOI 10.1111/j.1460-9568.1995.tb00691.x; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Samanta S, 1998, J NEUROCHEM, V70, P2082; Sawada H, 1998, ANN NEUROL, V44, P110, DOI 10.1002/ana.410440117; Schinder AF, 1996, J NEUROSCI, V16, P6125; Scholz H, 2011, COCHRANE DB SYST REV, V16; Schroeter H, 2002, NEUROBIOL AGING, V23, P861, DOI 10.1016/S0197-4580(02)00075-1; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Tanaka K, 2001, NEUROCHEM RES, V26, P31, DOI 10.1023/A:1007672414239; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Wang AT, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-33; Wang W, 2003, J NEUROCYTOL, V32, P143, DOI 10.1023/B:NEUR.0000005599.10952.33; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Yang L, 2013, TOXICOL IN VITRO, V27, P908, DOI 10.1016/j.tiv.2013.01.001; Yoshioka M, 2002, NEUROSCI RES, V43, P259, DOI 10.1016/S0168-0102(02)00040-8; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006	51	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99271	10.1371/journal.pone.0099271	http://dx.doi.org/10.1371/journal.pone.0099271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914776	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700076
J	Szczesny, SE; Edelstein, RS; Elliott, DM				Szczesny, Spencer E.; Edelstein, Rachel S.; Elliott, Dawn M.			DTAF Dye Concentrations Commonly Used to Measure Microscale Deformations in Biological Tissues Alter Tissue Mechanics	PLOS ONE			English	Article							COLLAGEN FIBRILS; TENDON COLLAGEN; SYNCHROTRON-RADIATION; ANNULUS FIBROSUS; STRAIN TRANSFER; IN-VITRO; STRESS; LEVEL; MULTISCALE; NANOSCALE	Identification of the deformation mechanisms and specific components underlying the mechanical function of biological tissues requires mechanical testing at multiple levels within the tissue hierarchical structure. Dichlorotriazinylaminofluorescein (DTAF) is a fluorescent dye that is used to visualize microscale deformations of the extracellular matrix in soft collagenous tissues. However, the DTAF concentrations commonly employed in previous multiscale experiments (>= 2000 mu g/ml) may alter tissue mechanics. The objective of this study was to determine whether DTAF affects tendon fascicle mechanics and if a concentration threshold exists below which any observed effects are negligible. This information is valuable for guiding the continued use of this fluorescent dye in future experiments and for interpreting the results of previous work. Incremental strain testing demonstrated that high DTAF concentrations >= 100 mu g/ml) increase the quasistatic modulus and yield strength of rat tail tendon fascicles while reducing their viscoelastic behavior. Subsequent multiscale testing and modeling suggests that these effects are due to a stiffening of the collagen fibrils and strengthening of the interfibrillar matrix. Despite these changes in tissue behavior, the fundamental deformation mechanisms underlying fascicle mechanics appear to remain intact, which suggests that conclusions from previous multiscale investigations of strain transfer are still valid. The effects of lower DTAF concentrations (<= 10 mu g/ml) on tendon mechanics were substantially smaller and potentially negligible; nevertheless, no concentration was found that did not at least slightly alter the tissue behavior. Therefore, future studies should either reduce DTAF concentrations as much as possible or use other dyes/techniques for measuring microscale deformations.	[Szczesny, Spencer E.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Edelstein, Rachel S.; Elliott, Dawn M.] Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA	University of Pennsylvania; University of Delaware	Elliott, DM (corresponding author), Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA.	delliott@udel.edu	Elliott, Dawn/U-8375-2019; Szczesny, Spencer/AAL-9217-2021	Elliott, Dawn/0000-0003-4792-1029; Szczesny, Spencer/0000-0002-7691-949X	NIH COBRE grant [NIH/NCRR P20 RR016458]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016458] Funding Source: NIH RePORTER	NIH COBRE grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by an NIH COBRE grant (NIH/NCRR P20 RR016458) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoczky SP, 2002, J ORTHOPAED RES, V20, P29, DOI 10.1016/S0736-0266(01)00080-8; BLAKESLEE D, 1976, J IMMUNOL METHODS, V13, P305, DOI 10.1016/0022-1759(76)90078-8; Bruehlmann SB, 2004, SPINE, V29, P2612, DOI 10.1097/01.brs.0000146465.05972.56; Buckley MR, 2010, J BIOMECH, V43, P796, DOI 10.1016/j.jbiomech.2009.10.012; Cheng VWT, 2007, J MATER SCI, V42, P8957, DOI 10.1007/s10853-007-1653-3; Clemmer J, 2010, J BIOMECH, V43, P2785, DOI 10.1016/j.jbiomech.2010.06.009; DAVISON PF, 1985, INVEST OPHTH VIS SCI, V26, P1202; Desrochers J, 2010, J BIOMECH, V43, P2141, DOI 10.1016/j.jbiomech.2010.03.045; Duncan NA, 2014, COMPUT METHOD BIOMEC, V17, P39, DOI 10.1080/10255842.2012.742075; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Granath K, 1973, CARBOHYDRATE RES, V2, P375, DOI DOI 10.1016/S0008-6215(00)81824-8; Gupta HS, 2010, J STRUCT BIOL, V169, P183, DOI 10.1016/j.jsb.2009.10.002; Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103; Hagenau A, 2011, J STRUCT BIOL, V175, P339, DOI 10.1016/j.jsb.2011.05.016; Han WM, 2013, BIOPHYS J, V105, P807, DOI 10.1016/j.bpj.2013.06.023; Hansen P, 2009, CONNECT TISSUE RES, V50, P211, DOI 10.1080/03008200802610040; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1; Huyghe JM, 2012, BIOMECH MODEL MECHAN, V11, P161, DOI 10.1007/s10237-011-0300-8; Jayyosi C, 2014, ACTA BIOMATER, V10, P2591, DOI 10.1016/j.actbio.2014.02.031; KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283; Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013; Li YF, 2013, MATRIX BIOL, V32, P169, DOI 10.1016/j.matbio.2013.01.003; Liao J, 2007, J BIOMECH ENG-T ASME, V129, P78, DOI 10.1115/1.2401186; Masic A, 2011, BIOMACROMOLECULES, V12, P3989, DOI 10.1021/bm201008b; Michalek AJ, 2009, J BIOMECH, V42, P2279, DOI 10.1016/j.jbiomech.2009.06.047; MOSLER E, 1985, J MOL BIOL, V182, P589, DOI 10.1016/0022-2836(85)90244-X; NEMETSCHEK T, 1983, J MOL BIOL, V167, P461, DOI 10.1016/S0022-2836(83)80345-3; Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033; Rigozzi S, 2013, J BIOMECH, V46, P813, DOI 10.1016/j.jbiomech.2012.11.017; ROWE RWD, 1985, CONNECT TISSUE RES, V14, P9, DOI 10.3109/03008208509089839; Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3; Sasaki N, 1999, J BIOMECH, V32, P285, DOI 10.1016/S0021-9290(98)00174-2; Screen HRC, 2013, MED ENG PHYS, V35, P96, DOI 10.1016/j.medengphy.2012.04.004; Screen HRC, 2004, P I MECH ENG H, V218, P109, DOI 10.1243/095441104322984004; Shen ZLL, 2010, BIOPHYS J, V99, P1986, DOI 10.1016/j.bpj.2010.07.021; Smolin E. M., 1959, S TRIAZINES DERIVATI; Stella JA, 2008, BIOMATERIALS, V29, P3228, DOI 10.1016/j.biomaterials.2008.04.029; Svensson RB, 2013, BIOPHYS J, V104, P2476, DOI 10.1016/j.bpj.2013.04.033; Szczesny SE, 2014, ACTA BIOMATER, V10, P2582, DOI 10.1016/j.actbio.2014.01.032; Tanaka ML, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004412; Thorpe CT, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1058; Thorpe CT, 2013, ACTA BIOMATER, V9, P7948, DOI 10.1016/j.actbio.2013.05.004; Thorpe CT, 2012, J R SOC INTERFACE, V9, P3108, DOI 10.1098/rsif.2012.0362; Upton ML, 2008, BIOPHYS J, V95, P2116, DOI 10.1529/biophysj.107.126938; van der Rijt JAJ, 2006, MACROMOL BIOSCI, V6, P697, DOI 10.1002/mabi.200600063; Wall ME, 2007, J BIOMECH, V40, P173, DOI 10.1016/j.jbiomech.2005.10.032; Wood ML, 1998, J ORTHOPAED RES, V16, P438, DOI 10.1002/jor.1100160407; Yang L, 2012, J MECH BEHAV BIOMED, V6, P148, DOI 10.1016/j.jmbbm.2011.11.008	48	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99588	10.1371/journal.pone.0099588	http://dx.doi.org/10.1371/journal.pone.0099588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915570	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700118
J	Karbanova, J; Laco, J; Marzesco, AM; Janich, P; Vobornikova, M; Mokry, J; Fargeas, CA; Huttner, WB; Corbeil, D				Karbanova, Jana; Laco, Jan; Marzesco, Anne-Marie; Janich, Peggy; Vobornikova, Magda; Mokry, Jaroslav; Fargeas, Christine A.; Huttner, Wieland B.; Corbeil, Denis			Human PROMININ-1 (CD133) Is Detected in Both Neoplastic and Non-Neoplastic Salivary Gland Diseases and Released into Saliva in a Ubiquitinated Form	PLOS ONE			English	Article							STEM-CELL MARKER; CARCINOEMBRYONIC ANTIGEN CEA; APICAL PLASMA-MEMBRANE; BREAST-CANCER PATIENTS; EPITHELIAL-CELLS; MONOCLONAL-ANTIBODIES; HEMATOPOIETIC STEM; COLORECTAL-CANCER; PROGENITOR CELLS; MUCINS MUC1	Prominin-1 (CD133) is physiologically expressed at the apical membranes of secretory (serous and mucous) and duct cells of major salivary glands. We investigated its expression in various human salivary gland lesions using two distinct antiprominin- 1 monoclonal antibodies (80B258 and AC133) applied on paraffin-embedded sections and characterized its occurrence in saliva. The 80B258 epitope was extensively expressed in adenoid cystic carcinoma, in lesser extent in acinic cell carcinoma and pleomorphic adenoma, and rarely in mucoepidermoid carcinoma. The 80B258 immunoreactivity was predominately detected at the apical membrane of tumor cells showing acinar or intercalated duct cell differentiation, which lined duct-or cyst-like structures, and in luminal secretions. It was observed on the whole cell membrane in nonluminal structures present in the vicinity of thin-walled blood vessels and hemorrhagic areas in adenoid cystic carcinoma. Of note, AC133 labeled only a subset of 80B258-positive structures. In peritumoral salivary gland tissues as well as in obstructive sialadenitis, an up-regulation of prominin-1 (both 80B258 and AC133 immunoreactivities) was observed in intercalated duct cells. In most tissues, prominin-1 was partially co-expressed with two cancer markers: carcinoembryonic antigen (CEA) and mucin-1 (MUC1). Differential centrifugation of saliva followed by immunoblotting indicated that all three markers were released in association with small membrane vesicles. Immuno-isolated prominin-1-positive vesicles contained CEA and MUC1, but also exosome-related proteins CD63, flotillin-1, flotillin-2 and the adaptor protein syntenin-1. The latter protein was shown to interact with prominin-1 as demonstrated by its co-immunoisolation. A fraction of salivaassociated prominin-1 appeared to be ubiquitinated. Collectively, our findings bring new insights into the biochemistry and trafficking of prominin-1 as well as its immunohistochemical profile in certain types of salivary gland tumors and inflammatory diseases.	[Karbanova, Jana; Janich, Peggy; Fargeas, Christine A.; Corbeil, Denis] Tech Univ Dresden, BIOTEC, Tissue Engn Labs, D-01062 Dresden, Germany; [Karbanova, Jana; Vobornikova, Magda; Mokry, Jaroslav] Charles Univ Prague, Fac Med, Dept Histol & Embryol, Prague, Czech Republic; [Karbanova, Jana; Laco, Jan; Vobornikova, Magda; Mokry, Jaroslav] Univ Hosp Hradec Kralove, Prague, Czech Republic; [Laco, Jan] Charles Univ Prague, Fac Med, Fingerland Dept Pathol, Prague, Czech Republic; [Marzesco, Anne-Marie; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; Max Planck Society	Karbanova, J (corresponding author), Tech Univ Dresden, BIOTEC, Tissue Engn Labs, D-01062 Dresden, Germany.	jana.karbanova@biotec.tu-dresden.de; corbeil@biotec.tu-dresden.de	Laco, Jan/L-9715-2017; Corbeil, Denis/L-2340-2019; Mokry, Jaroslav/B-5088-2017; Huttner, Wieland B./P-4080-2018; Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/A-6519-2010	Laco, Jan/0000-0002-9602-7501; Corbeil, Denis/0000-0003-1181-3659; Mokry, Jaroslav/0000-0001-5769-9973; Karbanova, Jana/0000-0001-7687-0983; Janich, Peggy/0000-0003-1045-7365	Grant Agency of the Czech Republic [GACR 304/07/P307]; PRVOUK [P37/11, P37/6]; Deutsche Forschungsgemeinschaft [SFB655 A2, TRR83 TP6, SFB 655 B3, CO298/5-1]; Sachsisches Staatsministerium fur Wissenschaft und Kunst;  [LM2010004]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); PRVOUK; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sachsisches Staatsministerium fur Wissenschaft und Kunst; 	JK was supported by Grant Agency of the Czech Republic (GACR 304/07/P307). JL was supported by the programme PRVOUK P37/11 and the project LM2010004. JM and MV were supported by the programme PRVOUK P37/6. WBH was supported by Deutsche Forschungsgemeinschaft (SFB655 A2; TRR83 TP6) and DC (SFB 655 B3; TRR83 TP6; CO298/5-1). Sachsisches Staatsministerium fur Wissenschaft und Kunst supported JK, CAF and DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha-Hosseini F, 2009, MED ORAL PATOL ORAL, V14, pE521; Al Dhaybi R, 2010, MODERN PATHOL, V23, P376, DOI 10.1038/modpathol.2009.163; Alos L, 2005, AM J SURG PATHOL, V29, P806, DOI 10.1097/01.pas.0000155856.84553.c9; Angelov Angel, 1996, General and Diagnostic Pathology, V141, P229; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BARANOV V, 1994, CANCER RES, V54, P3305; Barnes L., 2005, WHO CLASSIFICATION T; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; Berckmans RJ, 2011, BLOOD, V117, P3172, DOI 10.1182/blood-2010-06-290460; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Bon GG, 1997, CLIN CHEM, V43, P585; BOSHELL M, 1992, BIOCHEM BIOPH RES CO, V185, P1, DOI 10.1016/S0006-291X(05)80946-5; Brooks MN, 2008, MOL MED REP, V1, P375; CASELITZ J, 1981, VIRCHOWS ARCH A, V394, P49, DOI 10.1007/BF00431664; CASELITZ J, 1981, J CANCER RES CLIN, V100, P205, DOI 10.1007/BF00403366; Chen KH, 2010, CHILD NERV SYST, V26, P1605, DOI 10.1007/s00381-010-1190-2; Corbeil D, 2001, BIOCHEM BIOPH RES CO, V285, P939, DOI 10.1006/bbrc.2001.5271; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Corbeil D, 2014, P NATL ACAD SCI USA, V111, pE1451, DOI 10.1073/pnas.1400195111; Corbeil D, 2013, ADV EXP MED BIOL, V777, P3, DOI 10.1007/978-1-4614-5894-4_1; Dai SM, 2005, CLIN CANCER RES, V11, P7554, DOI 10.1158/1078-0432.CCR-05-0810; Das SK, 2012, FRONT BIOSCI-LANDMRK, V17, P1, DOI 10.2741/3911; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Ellis GLA., 2008, AFIP ATLAS TUMOR PAT, P301; Fan LN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-320; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Fargeas CA, 2003, J BIOL CHEM, V278, P8586, DOI 10.1074/jbc.M210640200; Fargeas CA, 2006, FUTURE LIPIDOL, V1, P213, DOI 10.2217/17460875.1.2.213; Fargeas CA, 2013, ADV EXP MED BIOL, V777, P25, DOI 10.1007/978-1-4614-5894-4_2; Fargeas CA, 2011, WORLD J GASTROENTERO, V17, P4149, DOI 10.3748/wjg.v17.i36.4149; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Goldstein MJ, 2005, CANCER INVEST, V23, P338, DOI 10.1081/CNV-200058878; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Hamada T, 2004, J CLIN PATHOL, V57, P813, DOI 10.1136/jcp.2003.014043; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Handra-Luca A, 2005, AM J SURG PATHOL, V29, P881, DOI 10.1097/01.pas.0000159103.95360.e8; HAYES DF, 1985, J CLIN INVEST, V75, P1671, DOI 10.1172/JCI111875; He H, 2009, J CANCER RES CLIN, V135, P1315, DOI 10.1007/s00432-009-0572-x; Hilbe W, 2004, J CLIN PATHOL, V57, P965, DOI 10.1136/jcp.2004.016444; HILKENS J, 1984, INT J CANCER, V34, P197, DOI 10.1002/ijc.2910340210; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; Huttner HB, 2012, EPILEPSY RES, V99, P101, DOI 10.1016/j.eplepsyres.2011.10.029; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Jaszai J, 2007, HISTOCHEM CELL BIOL, V128, P409, DOI 10.1007/s00418-007-0334-2; Julian J, 2002, BIOCHEM BIOPH RES CO, V293, P1183, DOI 10.1016/S0006-291X(02)00352-2; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; Kojima M, 2008, CANCER SCI, V99, P1578, DOI 10.1111/j.1349-7006.2008.00849.x; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Lardon J, 2008, PANCREAS, V36, pE1, DOI 10.1097/mpa.0b013e318149f2dc; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Liu B, 2002, J HISTOCHEM CYTOCHEM, V50, P811, DOI 10.1177/002215540205000607; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Lonnroth C, 2012, INT J ONCOL, V41, P15, DOI 10.3892/ijo.2012.1460; Ma HI, 2011, J NEUROSURG, V114, P651, DOI 10.3171/2009.11.JNS091396; Mahomed F, 2011, ORAL ONCOL, V47, P797, DOI 10.1016/j.oraloncology.2011.06.008; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Mall AS, 2008, J CLIN PATHOL, V61, P1018, DOI 10.1136/jcp.2008.058057; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Marzesco AM, 2013, ADV EXP MED BIOL, V777, P41, DOI 10.1007/978-1-4614-5894-4_3; Marzesco AM, 2009, FEBS LETT, V583, P897, DOI 10.1016/j.febslet.2009.01.048; Missol-Kolka E, 2011, PROSTATE, V71, P254, DOI 10.1002/pros.21239; Ogawa Y, 2011, BIOL PHARM BULL, V34, P13, DOI 10.1248/bpb.34.13; Okumura F, 2011, MOL CELL BIOCHEM, V352, P163, DOI 10.1007/s11010-011-0750-4; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Price MR, 1998, TUMOR BIOL, V19, P1, DOI 10.1159/000056500; Pringle S, 2013, STEM CELLS, V31, P613, DOI 10.1002/stem.1327; Rajesh S, 2011, J BIOL CHEM, V286, P39606, DOI 10.1074/jbc.M111.262402; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Rappa G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-62; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; SEKINE H, 1985, J CLIN ONCOL, V3, P1355, DOI 10.1200/JCO.1985.3.10.1355; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Soares AB, 2011, HISTOPATHOLOGY, V58, P377, DOI 10.1111/j.1365-2559.2011.03758.x; Staubach S, 2009, PROTEOMICS, V9, P2820, DOI 10.1002/pmic.200800793; Streckfus C, 2000, CANCER INVEST, V18, P101, DOI 10.3109/07357900009038240; Sussman LK, 2003, CANCER BIOL THER, V2, P255, DOI 10.4161/cbt.2.3.363; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P587, DOI 10.1074/mcp.M112.021303; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; VERSTIJNEN CPHJ, 1986, ANTICANCER RES, V6, P97; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang K, 1996, J CELL BIOCHEM, V60, P538, DOI 10.1002/(SICI)1097-4644(19960315)60:4<538::AID-JCB10>3.3.CO;2-A	94	23	24	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98927	10.1371/journal.pone.0098927	http://dx.doi.org/10.1371/journal.pone.0098927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911657	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600026
J	Long, R; Niruban, S; Heffernan, C; Cooper, R; Fisher, D; Ahmed, R; Egedahl, ML; Fur, R				Long, Richard; Niruban, Selvanayagam; Heffernan, Courtney; Cooper, Ryan; Fisher, Dina; Ahmed, Rabia; Egedahl, Mary Lou; Fur, Rhonda			A 10-Year Population Based Study of 'Opt-Out' HIV Testing of Tuberculosis Patients in Alberta, Canada: National Implications	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SAN-FRANCISCO; INFECTION; RECOMMENDATIONS; TRANSMISSION; COINFECTION; EXPERIENCES; INITIATION; SUPPORT; CARE	Introduction: Compliance with the recommendation that all tuberculosis (TB) patients be tested for human immunodeficiency virus (HIV) has not yet been achieved in Canada or globally. Methods:The experience of "opt-out" HIV testing of TB patients in the Province of Alberta, Canada is described over a 10-year period, 2003-2012. Testing rates are reported before and after the introduction of the "opt-out" approach. Risk factors for HIV seropositivity are described and demographic, clinical and laboratory characteristics of TB patients who were newly diagnosed versus previously diagnosed with HIV are compared. Genotypic clusters, defined as groups of two or more cases whose isolates of Mycobacterium tuberculosis had identical DNA fingerprints over the 10-year period or within 2 years of one another, were analyzed for their ability to predict HIV co-infection. Results: HIV testing rates were 26% before and 90% after the introduction of "opt-out" testing. During the "opt-out" testing years those <15 or >64 years of age at diagnosis were less likely to have been tested. In those tested the prevalence of HIV was 5.6%. In the age group 15-64 years, risk factors for HIV were: age (35-64 years), Canadian-born Aboriginal or foreign-born sub-Saharan African origin, and combined respiratory and non-respiratory disease. Compared to TB patients previously known to be HIV positive, TB patients newly discovered to be HIV positive had more advanced HIV disease (lower CD4 counts; higher viral loads) at diagnosis. Large duster size was associated with Aboriginal ancestry. Cluster size predicted HIV co-infection in Aboriginal peoples when clusters included all cases reported over 10 years but not when clusters included cases reported within 2 years of one another. Conclusion: "Opt-out" HIV testing of TB patients is effective and well received. Universal HIV testing of TB patients (>80% of patients tested) has immediate (patients) and longer-term (TB/HIV program planning) benefits.	[Long, Richard; Heffernan, Courtney; Cooper, Ryan; Ahmed, Rabia; Egedahl, Mary Lou] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Long, Richard; Niruban, Selvanayagam] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada; [Fisher, Dina] Univ Calgary, Dept Med, Calgary, AB, Canada; [Fur, Rhonda] Alberta Hlth Serv, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Calgary; Alberta Health Services (AHS)	Long, R (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	richard.long@ualberta.ca	Heffernan, Courtney E/G-5296-2016					Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; [Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], 2013, ANN INTERN MED; [Anonymous], 2010, POL COLL TB HIV ACT; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Canadian Thoracic Society Tuberculosis Directors of Canada Department of National Health and Welfare in consultation with the provincial and territorial epidemiologists AIDS coordinators and HIV caregivers, 1992, CCDR, V18, P155; Centers for Disease Control, 1994, MMWR-MORBID MORTAL W, V50, P1; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P236; Centers for Disease Control (CDC), 1989, MMWR-MORBID MORTAL W, V38, P243; Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; DeRiemer K, 2007, AM J RESP CRIT CARE, V176, P936, DOI 10.1164/rccm.200603-440OC; Gardner A, 2012, INT J TUBERC LUNG D, V16, P1241, DOI 10.5588/ijtld.11.0628; Giordano TP, 2004, CLIN INFECT DIS, V38, P10, DOI 10.1086/380454; Horsburgh CR, 2000, CLIN INFECT DIS, V31, P633, DOI 10.1086/314007; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Houben RMGJ, 2011, INT J TUBERC LUNG D, V15, P24; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; Jayaraman GC, 2003, CAN MED ASSOC J, V168, P679; Jensen M, 2012, INT J TUBERC LUNG D, V16, P43, DOI 10.5588/ijtld.11.0374; Kunimoto D, 2004, INT J TUBERC LUNG D, V8, P1213; Langlois-Klassen D, 2013, PLOS ONE, V7, DOI [10.1371/journal.pone.ee38431, DOI 10.1371/JOURNAL.PONE.EE38431]; Langlois-Klassen D, 2013, EMERG INFECT DIS, V19, P701, DOI 10.3201/eid1905.121578; Long R, 2013, CAN MED ASSOC J, V185, P587, DOI 10.1503/cmaj.113-2113; Long R, 2010, CAN J PUBLIC HEALTH, V101, P202, DOI 10.1007/BF03404374; Manabe YC, 2009, J INFECT DIS, V199, P437, DOI 10.1086/595985; Menzies D, 2013, CAN RESPIR J SA, V20, p1A; Mohtashemi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008851; Person AK, 2010, AIDS PATIENT CARE ST, V24, P539, DOI 10.1089/apc.2010.0102; Pope DS, 2008, JAIDS-J ACQ IMM DEF, V48, P190, DOI 10.1097/QAI.0b013e3181775926; Pope DS, 2010, AIDS CARE, V22, P238, DOI 10.1080/09540120903040594; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; Shah S., 2010, Morbidity and Mortality Weekly Report, V59, P1509; Staples CT, 1999, CLIN INFECT DIS, V29, P150, DOI 10.1086/520144; Sturtevant D, 2009, CAN J PUBLIC HEALTH, V100, P116, DOI 10.1007/BF03405519; The Canadian Tuberculosis Committee of the Centre for Infectious Disease Prevention and Control Population and Public Health Branch Health Canada, 2002, CCDR, V28, P1; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; WHO, 2009, GLOB TUB CONTR 2009; Word Health Organization, GLOB TUB REP 2012; World Health Organization, 2012, 20121 WHO HTM TB; Zencovich M, 2006, INT J STD AIDS, V17, P813, DOI 10.1258/095646206779307469	45	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98993	10.1371/journal.pone.0098993	http://dx.doi.org/10.1371/journal.pone.0098993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI8LF	24911262	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600033
J	Zhang, YH; Wu, YC; Zhang, Q; Su, DD; Zou, FS				Zhang, Yanhua; Wu, Yuchun; Zhang, Qiang; Su, Dongdong; Zou, Fasheng			Prevalence Patterns of Avian Plasmodium and Haemoproteus Parasites and the Influence of Host Relative Abundance in Southern China	PLOS ONE			English	Article							BLOOD PARASITES; MALARIA PARASITES; EVOLUTIONARY RELATIONSHIPS; HAEMOSPORIDIAN PARASITES; MIST NETS; DIVERSITY; BIRDS; ASSEMBLAGES; INFECTION; PHYLOGENY	Infectious diseases threaten the health and survival of wildlife populations. Consequently, relationships between host diversity, host abundance, and parasite infection are important aspects of disease ecology and conservation research. Here, we report on the prevalence patterns of avian Plasmodium and Haemoproteus infections and host relative abundance influence based on sampling 728 wild-caught birds representing 124 species at seven geographically widespread sites in southern China. The overall prevalence of two haemoprotozoan parasites, Plasmodium and Haemoproteus, was 29.5%, with 22.0% attributable to Haemoproteus and 7.8% to Plasmodium. Haemoproteus prevalence differed significantly among different avian host families, with the highest prevalence in Nectariniidae, Pycnonotidae and Muscicapidae, whereas Plasmodium prevalence varied significantly among host species. Seventy-nine mitochondrial lineages including 25 from Plasmodium and 54 from Haemoproteus were identified, 80% of which were described here for the first time. The phylogenetic relationships among these parasites indicated stronger host-species specificity for Haemoproteus than Plasmodium. Well-supported host-family (Timaliidae) specific clades were found in both Plasmodium and Haemoproteus. The Haemoproteus tree shows regional subclades, whereas the Plasmodium clades are "scattered'' among different geographical regions. Interestingly, there were statistically significant variations in the prevalence of Plasmodium and Haemoproteus among the geographical regions. Furthermore, the prevalence of Plasmodium and Haemoproteus were not significantly correlated with host relative abundance. Further efforts will focus on exploring the relationships between parasite prevalence and sex, age, and immune defense of the host.	[Zhang, Yanhua] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Zhang, Yanhua] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wu, Yuchun; Zhang, Qiang; Su, Dongdong; Zou, Fasheng] Guangdong Entomol Inst, South China Inst Endangered Anim, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Zou, FS (corresponding author), Guangdong Entomol Inst, South China Inst Endangered Anim, Guangzhou, Guangdong, Peoples R China.	zoufs@gdei.gd.cn			National Natural Science Foundation of China [31172067, 31200327, 31201709]; Guangdong Natural Science Foundation [S2013010012976]; Wildlife survey in Nanling National Nature Reserve [RYCG12-14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Wildlife survey in Nanling National Nature Reserve	This study was funded by National Natural Science Foundation of China (31172067, 31200327, 31201709), Guangdong Natural Science Foundation (S2013010012976) and Wildlife survey in Nanling National Nature Reserve (RYCG12-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Beadell JS, 2009, INT J PARASITOL, V39, P257, DOI 10.1016/j.ijpara.2008.06.005; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Belo NO, 2012, PARASITOLOGY, V139, P1021, DOI 10.1017/S003118201200039X; BENNETT GF, 1993, SYST PARASITOL, V26, P171, DOI 10.1007/BF00009724; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Blake JG, 2001, AUK, V118, P304, DOI 10.1642/0004-8038(2001)118[0304:BAISGA]2.0.CO;2; Brown CR, 2001, P ROY SOC B-BIOL SCI, V268, P1833, DOI 10.1098/rspb.2001.1749; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; Cibois A, 2003, AUK, V120, P35, DOI 10.1642/0004-8038(2003)120[0035:MDPOBT]2.0.CO;2; Cornuault J, 2012, MOL ECOL, V21, P1438, DOI 10.1111/j.1365-294X.2012.05483.x; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dunn Erica H., 2004, Studies in Avian Biology, P1; Durrant KL, 2006, ORNITHOL MONOGR, P98; Fredensborg BL, 2006, MAR BIOL, V149, P275, DOI 10.1007/s00227-005-0184-1; Galvani AP, 2003, TRENDS ECOL EVOL, V18, P132, DOI 10.1016/S0169-5347(02)00050-2; Garamszegi LZ, 2006, ECOL LETT, V9, P933, DOI 10.1111/j.1461-0248.2006.00936.x; Hechinger RF, 2005, P ROY SOC B-BIOL SCI, V272, P1059, DOI 10.1098/rspb.2005.3070; Hellgren O, 2005, J ORNITHOL, V146, P55, DOI 10.1007/s10336-004-0055-4; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2007, MOL ECOL, V16, P1281, DOI 10.1111/j.1365-294X.2007.03227.x; Hellgren O, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-381; Hellgren O, 2009, ECOLOGY, V90, P2840, DOI 10.1890/08-1059.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishtiaq F, 2007, J WILDLIFE DIS, V43, P382, DOI 10.7589/0090-3558-43.3.382; Jenkins T, 2012, EVOLUTION, V66, P740, DOI 10.1111/j.1558-5646.2011.01470.x; Johnson KP, 1998, MOL PHYLOGENET EVOL, V10, P82, DOI 10.1006/mpev.1997.0481; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Karr J.R., 1981, Studies in Avian Biology, P62; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kimura M, 2006, J PARASITOL, V92, P1043, DOI 10.1645/GE-639R.1; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Lacorte GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057770; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; Loiseau C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01126; Loiseau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044729; Loiseau C, 2012, MOL ECOL, V21, P431, DOI 10.1111/j.1365-294X.2011.05341.x; MACARTHUR RH, 1974, P NATL ACAD SCI USA, V71, P3230, DOI 10.1073/pnas.71.8.3230; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Marzal A, 2008, J EVOLUTION BIOL, V21, P979, DOI 10.1111/j.1420-9101.2008.01545.x; Moller AP, 2007, ECOLOGY, V88, P871, DOI 10.1890/06-0747; Moyle RG, 2012, SYST BIOL, V61, P631, DOI 10.1093/sysbio/sys027; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Perez-Tris J, 2005, PARASITOLOGY, V131, P15, DOI 10.1017/S003118200500733X; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Remsen JV, 1996, AUK, V113, P381, DOI 10.2307/4088905; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Ricklefs RE, 2005, ECOL MONOGR, V75, P543, DOI 10.1890/04-1820; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Silva-Iturriza A, 2012, PARASITOL INT, V61, P650, DOI 10.1016/j.parint.2012.07.003; Slater LB, 2005, B HIST MED, V79, P261, DOI 10.1353/bhm.2005.0092; Srinivasan U, 2013, J APPL ECOL, V50, P920, DOI 10.1111/1365-2664.12123; Svensson-Coelho M., 2013, ORNITHOLOGICAL MONOG, V76, P1, DOI [10.1525/om.2013.76.1.1, DOI 10.1525/OM.2013.76.1.1]; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; Tomas G, 2007, FUNCT ECOL, V21, P125, DOI 10.1111/j.1365-2435.2006.01214.x; Tracy CR, 2006, INTEGR COMP BIOL, V46, P1191, DOI 10.1093/icb/icl054; Valkiunas G, 2004, J WILDLIFE DIS, V40, P555, DOI 10.7589/0090-3558-40.3.555; Valkiunas G, 2005, AVIAN MALARIA PARASI; Valkiunas G, 2006, J PARASITOL, V92, P1123, DOI 10.1645/GE-3564-RN.1; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Wonham MJ, 2004, P ROY SOC B-BIOL SCI, V271, P501, DOI 10.1098/rspb.2003.2608; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Zhang Qiang, 2010, Acta Zootaxonomica Sinica, V35, P135; Zou FS, 2012, ZOOL STUD, V51, P362	68	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99501	10.1371/journal.pone.0099501	http://dx.doi.org/10.1371/journal.pone.0099501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911323	Green Submitted, gold, Green Published			2022-12-25	WOS:000337165600094
J	Slevin, LK; Romes, EM; Dandulakis, MG; Slep, KC				Slevin, Lauren K.; Romes, Erin M.; Dandulakis, Mary G.; Slep, Kevin C.			The Mechanism of Dynein Light Chain LC8-mediated Oligomerization of the Ana2 Centriole Duplication Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE CHAIN; STRUCTURAL-CHARACTERIZATION; CENTROSOME DUPLICATION; PROTEIN; SAS-6; ELEGANS; COMPLEX; BINDING; PLK4; SIL	Centrioles play a key role in nucleating polarized microtubule networks. In actively dividing cells, centrioles establish the bipolar mitotic spindle and are essential for genomic stability. Drosophila anastral spindle-2 (Ana2) is a conserved centriole duplication factor. Although recent work has demonstrated that an Ana2-dynein light chain (LC8) centriolar complex is critical for proper spindle positioning in neuroblasts, how Ana2 and LC8 interact is yet to be established. Here we examine the Ana2-LC8 interaction and map two LC8-binding sites within the central region of Ana2, Ana2M (residues 156-251). Ana2 LC8-binding site 1 contains a signature TQT motif and robustly binds LC8 (K-D of 1.1 mu M), whereas site 2 contains a TQC motif and binds LC8 with lower affinity (K-D of 13 mu M). Both LC8-binding sites flank a predicted similar to 34-residue alpha-helix. We present two independent atomic structures of LC8 dimers in complex with Ana2 LC8-binding site 1 and site 2 peptides. The Ana2 peptides form beta-strands that extend a central composite LC8 beta-sandwich. LC8 recognizes the signature TQT motif in the first LC8 binding site of Ana2, forming extensive van der Waals contacts and hydrogen bonding with the peptide, whereas the Ana2 site 2 TQC motif forms a uniquely extended beta-strand, not observed in other dynein light chain-target complexes. Size exclusion chromatography coupled with multiangle static light scattering demonstrates that LC8 dimers bind Ana2M sites and induce Ana2 tetramerization, yielding an Ana2M(4)-LC8(8) complex. LC8-mediated Ana2 oligomerization probably enhances Ana2 avidity for centriole-binding factors and may bridge multiple factors as required during spindle positioning and centriole biogenesis.	[Slevin, Lauren K.; Dandulakis, Mary G.; Slep, Kevin C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Romes, Erin M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Slep, KC (corresponding author), Univ N Carolina, Dept Biol, 402 Fordham Hall,Campus Box 3280, Chapel Hill, NC 27599 USA.	kslep@bio.unc.edu			National Institutes of Health [R01GM094415, T32GM008570]; National Science Foundation [DGE-0646083]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094415, T32GM008570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM094415 (to K. C. S.) and T32GM008570 (to the University of North Carolina Program in Molecular and Cellular Biophysics). This work was also supported by a National Science Foundation Graduate Research Fellowship under Grant DGE-0646083 (to L. K. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; APLAN PD, 1991, MOL CELL BIOL, V11, P5462, DOI 10.1128/MCB.11.11.5462; Arquint C, 2012, J CELL SCI, V125, P1342, DOI 10.1242/jcs.099887; Asthana J, 2012, J BIOL CHEM, V287, P40793, DOI 10.1074/jbc.M112.394353; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chaudhury A, 2008, AM J PHYSIOL-GASTR L, V295, pG442, DOI 10.1152/ajpgi.90280.2008; Cottee MA, 2013, ELIFE, V2, DOI 10.7554/eLife.01071; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erez A, 2004, ONCOGENE, V23, P5371, DOI 10.1038/sj.onc.1207685; Gallego P, 2013, J BIOL CHEM, V288, P12283, DOI 10.1074/jbc.M113.459149; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Guichard P, 2013, CURR BIOL, V23, P1620, DOI 10.1016/j.cub.2013.06.061; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hatzopoulos GN, 2013, STRUCTURE, V21, P2069, DOI 10.1016/j.str.2013.08.019; Hilbert M, 2013, P NATL ACAD SCI USA, V110, P11373, DOI 10.1073/pnas.1302721110; Izraeli S, 1997, CELL GROWTH DIFFER, V8, P1171; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Lerit DA, 2013, J CELL BIOL, V202, P1013, DOI 10.1083/jcb.201303141; Lettman MM, 2013, DEV CELL, V25, P284, DOI 10.1016/j.devcel.2013.03.011; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; Nyarko A, 2013, J BIOL CHEM, V288, P2614, DOI 10.1074/jbc.M112.432831; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Qiao RP, 2012, EMBO J, V31, P4334, DOI 10.1038/emboj.2012.280; Rao L, 2013, MOL BIOL CELL, V24, P2362, DOI 10.1091/mbc.E13-03-0166; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Rapali P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018818; Romes EM, 2012, J BIOL CHEM, V287, P15862, DOI 10.1074/jbc.M111.336172; Shimanovskaya Ekaterina, 2013, Worm, V2, pe25214, DOI 10.4161/worm.25214; Slevin LK, 2012, STRUCTURE, V20, P1905, DOI 10.1016/j.str.2012.08.025; Stevens NR, 2010, DEV CELL, V19, P913, DOI 10.1016/j.devcel.2010.11.010; Stevens NR, 2010, J CELL BIOL, V188, P313, DOI 10.1083/jcb.200910016; Stuchell-Brereton MD, 2011, MOL BIOL CELL, V22, P2690, DOI 10.1091/mbc.E11-01-0075; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; Wang C, 2011, DEV CELL, V21, P520, DOI 10.1016/j.devcel.2011.08.002; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S	53	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20727	20739		10.1074/jbc.M114.576041	http://dx.doi.org/10.1074/jbc.M114.576041			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24920673	Green Published, hybrid			2022-12-25	WOS:000339396600030
J	Ames, RM; Money, D; Lovell, SC				Ames, Ryan M.; Money, Daniel; Lovell, Simon C.			Inferring Gene Family Histories in Yeast Identifies Lineage Specific Expansions	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; TREE RECONCILIATION; SACCHAROMYCES-CEREVISIAE; EVOLUTIONARY ANALYSIS; DUPLICATION; DEATH; SCALE; PHYLOGENIES; DIVERGENCE; TREHALOSE	The complement of genes found in the genome is a balance between gene gain and gene loss. Knowledge of the specific genes that are gained and lost over evolutionary time allows an understanding of the evolution of biological functions. Here we use new evolutionary models to infer gene family histories across complete yeast genomes; these models allow us to estimate the relative genome-wide rates of gene birth, death, innovation and extinction (loss of an entire family) for the first time. We show that the rates of gene family evolution vary both between gene families and between species. We are also able to identify those families that have experienced rapid lineage specific expansion/contraction and show that these families are enriched for specific functions. Moreover, we find that families with specific functions are repeatedly expanded in multiple species, suggesting the presence of common adaptations and that these family expansions/contractions are not random. Additionally, we identify potential specialisations, unique to specific species, in the functions of lineage specific expanded families. These results suggest that an important mechanism in the evolution of genome content is the presence of lineage-specific gene family changes.	[Ames, Ryan M.; Lovell, Simon C.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Money, Daniel] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	University of Manchester; University of Kansas	Ames, RM (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	ryan.ames@manchester.ac.uk	Money, Daniel/W-3401-2019	Money, Daniel/0000-0001-5151-3648; Ames, Ryan/0000-0002-1432-5629; Lovell, Simon/0000-0002-4092-8458	BBSRC [BB/I020489/1]; Biotechnology and Biological Sciences Research Council [BB/I020489/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is funded by BBSRC grant BB/I020489/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerborg O, 2009, P NATL ACAD SCI USA, V106, P5714, DOI 10.1073/pnas.0806251106; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Peral FJ, 2002, MICROBIOL-SGM, V148, P2599, DOI 10.1099/00221287-148-8-2599; Ames RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062670; Ames RM, 2012, BIOINFORMATICS, V28, P48, DOI 10.1093/bioinformatics/btr592; Ames RM, 2010, GENOME BIOL EVOL, V2, P591, DOI 10.1093/gbe/evq043; Arvestad L, 2003, BIOINFORMATICS, V19, pi7, DOI 10.1093/bioinformatics/btg1000; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashby SF, 1926, ANN BOT-LONDON, V40, P69, DOI 10.1093/oxfordjournals.aob.a090018; Balzer M, 2005, VIS SOFTW UND AN 200, P1; Balzer M., 2005, P 2005 ACM S SOFTW V, P165, DOI DOI 10.1145/1056018.1056041; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown C, 1998, MULTIPLE DUPLICATION; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Carvunis AR, 2012, NATURE IN PRESS; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; COHEN G, 1985, MOL GEN GENET, V200, P74, DOI 10.1007/BF00383315; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Csuros M, 2010, BIOINFORMATICS, V26, P1910, DOI 10.1093/bioinformatics/btq315; DAMORE T, 1991, J IND MICROBIOL, V7, P191, DOI 10.1007/BF01575882; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Demuth JP, 2009, BIOESSAYS, V31, P29, DOI 10.1002/bies.080085; Despons L, 2006, TRENDS GENET, V22, P10, DOI 10.1016/j.tig.2005.10.001; Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811; DUNLOP PC, 1978, J BIOL CHEM, V253, P1297; Durand D, 2006, RES COMP MOL BIOL 9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; FELSENSTEIN J, 1992, EVOLUTION, V46, P159, DOI [10.2307/2409811, 10.1111/j.1558-5646.1992.tb01991.x]; FLEET GH, 1990, J APPL BACTERIOL, V68, P199, DOI 10.1111/j.1365-2672.1990.tb02566.x; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Gorecki P, 2004, P 8 ANN INT C RES CO, P316; Hahn MW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r141; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Hakes L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r209; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Han MV, 2013, MOL BIOL EV IN PRESS; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Karev GP, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-18; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Kunin V, 2003, GENETRACE RECONSTRUC; Kwon HB, 2003, FEMS YEAST RES, V3, P433, DOI 10.1016/S1567-1356(03)00035-7; LAGUNAS R, 1993, FEMS MICROBIOL LETT, V104, P229, DOI 10.1016/0378-1097(93)90598-V; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Librado P, 2012, BIOINFORMATICS, V28, P279, DOI 10.1093/bioinformatics/btr623; Lin ZG, 2011, MOL BIOL EVOL, V28, P131, DOI 10.1093/molbev/msq184; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2; Nikolski M, 2007, BIOINFORMATICS, V23, pE71, DOI 10.1093/bioinformatics/btl314; Nobre A, 1999, APPL ENVIRON MICROB, V65, P3594; Novozhilov AS, 2006, BRIEF BIOINFORM, V7, P70, DOI 10.1093/bib/bbk006; Ohno S., 1970, EVOLUTION GENE DUPLI; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; ONISHI H, 1960, B AGR CHEM SOC JAPAN, V24, P126; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Page RDM, 1998, BIOINFORMATICS, V14, P819, DOI 10.1093/bioinformatics/14.9.819; Rasmussen MD, 2011, MOL BIOL EVOL, V28, P273, DOI 10.1093/molbev/msq189; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; SINCLAIR K, 1994, GENE, V144, P37, DOI 10.1016/0378-1119(94)90200-3; Smits GJ, 2005, CURR OPIN BIOTECH, V16, P225, DOI 10.1016/j.copbio.2005.02.005; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wehe A, 2008, BIOINFORMATICS, V24, P1540, DOI 10.1093/bioinformatics/btn230; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	75	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99480	10.1371/journal.pone.0099480	http://dx.doi.org/10.1371/journal.pone.0099480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921666	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300064
J	Lood, C; Tyden, H; Gullstrand, B; Sturfelt, G; Jonsen, A; Truedsson, L; Bengtsson, AA				Lood, Christian; Tyden, Helena; Gullstrand, Birgitta; Sturfelt, Gunnar; Jonsen, Andreas; Truedsson, Lennart; Bengtsson, Anders A.			Platelet Activation and Anti-Phospholipid Antibodies Collaborate in the Activation of the Complement System onle Platelets in Systemic Lupus Erythematosus	PLOS ONE			English	Article							RABBIT ANTICARDIOLIPIN ANTIBODIES; RISK-FACTORS; THROMBOSIS; AGGREGATION; DISEASE; MANIFESTATIONS; INFARCTION; COLLAGEN; BINDING; DAMAGE	Anti-phospholipid (aPL) antibodies are important contributors to development of thrombosis in patients with the autoimmune rheumatic disease systemic lupus erythematosus (SLE). The underlying mechanism of aPL antibody-mediated thrombosis is not fully understood but existing data suggest that platelets and the complement system are key components. Complement activation on platelets is seen in SLE patients, especially in patients with aPL antibodies, and has been related to venous thrombosis and stroke. The aim of this study was to investigate if aPL antibodies could support classical pathway activation on platelets in vitro as well as in SLE patients. Furthermore, we investigated if complement deposition on platelets was associated with vascular events, either arterial or venous, when the data had been adjusted for traditional cardiovascular risk factors. Finally, we analyzed if platelet complement deposition, both C1q and C4d, was specific for SLE. We found that aPL antibodies supported C4d deposition on platelets in vitro as well as in SLE patients (p = 0.001 and p<0.05, respectively). Complement deposition on platelets was increased in SLE patients when compared with healthy individuals (p<0.0001). However, high levels of C4d deposition and a pronounced C1q deposition were also seen in patients with rheumatoid arthritis and systemic sclerosis. In SLE, C4d deposition on platelets was associated with platelet activation, complement consumption, disease activity and venous (OR = 5.3, p = 0.02), but not arterial, thrombosis, observations which were independent of traditional cardiovascular risk factors. In conclusion, several mechanisms operate in SLE to amplify platelet complement deposition, of which aPL antibodies and platelet activation were identified as important contributors in this investigation. Complement deposition on platelets was identified as a marker of venous, but not arterial thrombosis, in SLE patients independently of traditional risk factors and aPL antibodies. Further studies are needed to elucidate the role of complement deposition on platelets in development of venous thrombosis.	[Lood, Christian; Tyden, Helena; Sturfelt, Gunnar; Jonsen, Andreas; Bengtsson, Anders A.] Lund Univ, Dept Clin Sci Lund, Rheumatol Sect, Lund, Sweden; [Lood, Christian; Tyden, Helena; Sturfelt, Gunnar; Jonsen, Andreas; Bengtsson, Anders A.] Skane Univ Hosp, Lund, Sweden; [Gullstrand, Birgitta; Truedsson, Lennart] Lund Univ, Sect Microbiol Immunol & Glycobiol, Dept Lab Med Lund, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University	Lood, C (corresponding author), Lund Univ, Dept Clin Sci Lund, Rheumatol Sect, Lund, Sweden.	Christian.Lood@med.lu.se	Lood, Christian/H-5670-2019	Lood, Christian/0000-0002-6171-1952	Medical Faculty at Lund University; Crafoord Foundation; Swedish Combine Projects; Greta and Johan Kock's Foundation; King Gustaf V's 80th Birthday Foundation; Lund University Hospital; Swedish Rheumatism Association; Swedish Society of Medicine; Foundation of the National Board of Health and Welfare and Osterlund's Foundation	Medical Faculty at Lund University; Crafoord Foundation; Swedish Combine Projects; Greta and Johan Kock's Foundation; King Gustaf V's 80th Birthday Foundation; Lund University Hospital; Swedish Rheumatism Association; Swedish Society of Medicine; Foundation of the National Board of Health and Welfare and Osterlund's Foundation	This work was supported by grants from the Medical Faculty at Lund University; The Crafoord Foundation; Swedish Combine Projects; Greta and Johan Kock's Foundation; King Gustaf V's 80th Birthday Foundation; Lund University Hospital; the Swedish Rheumatism Association; Swedish Society of Medicine; and the Foundation of the National Board of Health and Welfare and Osterlund's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Homood Ibrahim A, 2012, ISRN Rheumatol, V2012, P428269, DOI 10.5402/2012/428269; ANDERSON GP, 1991, BRIT J HAEMATOL, V79, P75, DOI 10.1111/j.1365-2141.1991.tb08010.x; Betts NA, 2013, PATHOLOGY, V45, P155, DOI 10.1097/PAT.0b013e32835cc277; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Carrera-Marin AL, 2012, LUPUS, V21, P1497, DOI 10.1177/0961203312458839; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x; Holers VM, 2002, J EXP MED, V195, P211, DOI 10.1084/jem.200116116; Hughes G, 2007, CLIN REV ALLERG IMMU, V32, P3, DOI 10.1007/BF02686077; HUGHES GRV, 1994, J ROY COLL PHYS LOND, V28, P301; Jonsson G, 2007, RHEUMATOLOGY, V46, P1133, DOI 10.1093/rheumatology/kem023; JONSSON H, 1989, MEDICINE, V68, P141, DOI 10.1097/00005792-198905000-00002; Kao AH, 2013, TRANSL STROKE RES; Koskenmies S, 2004, SCAND J RHEUMATOL, V33, P246, DOI 10.1080/03009740410005386; LARSSON A, 1994, PLATELETS, V5, P149, DOI 10.3109/09537109409005528; LIN YL, 1992, BLOOD, V80, P3135; Lood C, 2012, LUPUS, V21, P1423, DOI 10.1177/0961203312457210; Lood C, 2010, BLOOD, V116, P1951, DOI 10.1182/blood-2010-03-274605; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Mehta N, 2008, STROKE, V39, P3236, DOI 10.1161/STROKEAHA.108.514687; Navratil JS, 2006, ARTHRITIS RHEUM-US, V54, P670, DOI 10.1002/art.21627; Nojima J, 2004, THROMB HAEMOSTASIS, V91, P967, DOI 10.1160/TH03-10-0608; Peerschke EIB, 2009, LUPUS, V18, P530, DOI 10.1177/0961203308099974; Pierangeli SS, 2005, ANN NY ACAD SCI, V1051, P413, DOI 10.1196/annals.1361.083; RUBIN LA, 1985, Q J MED, V55, P87; Sallai KK, 2007, SCAND J RHEUMATOL, V36, P198, DOI 10.1080/03009740601089283; Salmon JE, 2008, LUPUS, V17, P405, DOI 10.1177/0961203308090025; Shanmugavelayudam SK, 2011, PLATELETS; Shinzato M, 2005, LUPUS, V14, P953, DOI 10.1191/0961203305lu2252oa; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TESTI R, 1990, J EXP MED, V172, P701, DOI 10.1084/jem.172.3.701; TESTI R, 1992, J IMMUNOL, V148, P2867; TSUBAKIO T, 1986, BRIT J HAEMATOL, V63, P293; Vega-Ostertag M, 2004, ARTHRITIS RHEUM-US, V50, P2911, DOI 10.1002/art.20434; Vikerfors A, 2013, RHEUMATOLOGY, V52, P501, DOI 10.1093/rheumatology/kes252; Wang L, 2002, BRIT J HAEMATOL, V118, P1152, DOI 10.1046/j.1365-2141.2002.03739.x; WIENER HM, 1991, VOX SANG, V61, P111, DOI 10.1111/j.1423-0410.1991.tb00256.x; Wraith KS, 2013, BLOOD, V122, P580, DOI 10.1182/blood-2013-04-491688; Ziakas PD, 2006, CLIN EXP IMMUNOL, V145, P71, DOI 10.1111/j.1365-2249.2006.03122.x	44	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99386	10.1371/journal.pone.0099386	http://dx.doi.org/10.1371/journal.pone.0099386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922069	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300056
J	Luo, JN; Lushchak, OV; Goergen, P; Williams, MJ; Nassel, DR				Luo, Jiangnan; Lushchak, Oleh V.; Goergen, Philip; Williams, Michael J.; Nassel, Dick R.			Drosophila Insulin-Producing Cells Are Differentially Modulated by Serotonin and Octopamine Receptors and Affect Social Behavior	PLOS ONE			English	Article							SHORT NEUROPEPTIDE-F; LIFE-SPAN; GENETIC-ANALYSIS; GROWTH; METABOLISM; EXPRESSION; FOOD; PEPTIDES; NEURONS; SLEEP	A set of 14 insulin-producing cells (IPCs) in the Drosophila brain produces three insulin-like peptides (DILP2, 3 and 5). Activity in IPCs and release of DILPs is nutrient dependent and controlled by multiple factors such as fat body-derived proteins, neurotransmitters, and neuropeptides. Two monoamine receptors, the octopamine receptor OAMB and the serotonin receptor 5-HT1A, are expressed by the IPCs. These receptors may act antagonistically on adenylate cyclase. Here we investigate the action of the two receptors on activity in and output from the IPCs. Knockdown of OAMB by targeted RNAi led to elevated Dilp3 transcript levels in the brain, whereas 5-HT1A knockdown resulted in increases of Dilp2 and 5. OAMB-RNAi in IPCs leads to extended survival of starved flies and increased food intake, whereas 5-HT1A-RNAi produces the opposite phenotypes. However, knockdown of either OAMB or 5-HT1A in IPCs both lead to increased resistance to oxidative stress. In assays of carbohydrate levels we found that 5-HT1A knockdown in IPCs resulted in elevated hemolymph glucose, body glycogen and body trehalose levels, while no effects were seen after OAMB knockdown. We also found that manipulations of the two receptors in IPCs affected male aggressive behavior in different ways and 5-HT1A-RNAi reduced courtship latency. Our observations suggest that activation of 5-HT1A and OAMB signaling in IPCs generates differential effects on Dilp transcription, fly physiology, metabolism and social interactions. However the findings do not support an antagonistic action of the two monoamines and their receptors in this particular system.	[Luo, Jiangnan; Lushchak, Oleh V.; Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Goergen, Philip; Williams, Michael J.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Stockholm University; Uppsala University	Nassel, DR (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	dnassel@zoologi.su.se	Lushchak, Oleh V./ABE-4061-2020	Lushchak, Oleh V./0000-0002-4627-1987	Swedish Research Council; Carl Trygger Foundation; Stiftelsen Olle Engkvist Byggmastare and Stiftelsen Lars Hiertas Minne	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; Stiftelsen Olle Engkvist Byggmastare and Stiftelsen Lars Hiertas Minne	The study was supported by: The Swedish Research Council (D.R.N) and The Carl Trygger Foundation ( D.R.N., M.J.W.), Stiftelsen Olle Engkvist Byggmastare and Stiftelsen Lars Hiertas Minne (both to M.J.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; Bai H, 2012, AGING CELL, V11, P978, DOI 10.1111/acel.12000; Baier A, 2002, J EXP BIOL, V205, P1233; Becnel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020800; Birse RT, 2011, J EXP BIOL; Blenau W, 2011, ARTHROPOD STRUCT DEV, V40, P381, DOI 10.1016/j.asd.2011.01.004; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Certel SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013248; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; Davis SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4177; Enell LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015780; Erion R, 2012, J BIOL CHEM, V287, P32406, DOI 10.1074/jbc.M112.360875; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Geminard C, 2006, DIABETES, V55, pS5, DOI 10.2337/db06-S001; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Han KA, 1998, J NEUROSCI, V18, P3650; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040; Kapan N, 2012, CELL MOL LIFE SCI, V69, P4051, DOI 10.1007/s00018-012-1097-z; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kim YC, 2013, J NEUROSCI, V33, P1672, DOI 10.1523/JNEUROSCI.3042-12.2013; Kuo TH, 2012, PLOS GENET, V8, P640, DOI 10.1371/journal.pgen.1002684; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Lindblom J, 2006, EUR J NEUROSCI, V23, P180, DOI 10.1111/j.1460-9568.2005.04531.x; Luo JN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004052; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Mattaliano MD, 2007, MOL CELL NEUROSCI, V36, P211, DOI 10.1016/j.mcn.2007.06.008; Neckameyer WS, 2007, GENES BRAIN BEHAV, V6, P756, DOI 10.1111/j.1601-183X.2007.00307.x; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Polter AM, 2010, CELL SIGNAL, V22, P1406, DOI 10.1016/j.cellsig.2010.03.019; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sakai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088175; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Sitaraman D, 2012, J NEUROGENET, V26, P238, DOI 10.3109/01677063.2012.666298; Soderberg Jeannette A E, 2012, Front Endocrinol (Lausanne), V3, P109, DOI 10.3389/fendo.2012.00109; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Williams MJ, 2014, GENETICS, V196, P349, DOI 10.1534/genetics.113.158402; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zhang T, 2013, P NATL ACAD SCI USA, V110, P15431, DOI 10.1073/pnas.1308816110; Zhou C, 2012, J NEUROSCI, V32, P14281, DOI 10.1523/JNEUROSCI.0517-12.2012; Zumstein N, 2004, J EXP BIOL, V207, P3515, DOI 10.1242/jeb.01181	68	49	54	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99732	10.1371/journal.pone.0099732	http://dx.doi.org/10.1371/journal.pone.0099732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923784	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300089
J	Schaefer, RJ; Briskine, R; Springer, NM; Myers, CL				Schaefer, Robert J.; Briskine, Roman; Springer, Nathan M.; Myers, Chad L.			Discovering Functional Modules across Diverse Maize Transcriptomes Using COB, the Co-Expression Browser	PLOS ONE			English	Article							GENETIC-ANALYSIS; NETWORK; EXPRESSION; ASSOCIATION; INFORMATION; CYTOSCAPE; DATABASE; KNOTTED1; OMICS	Tools that provide improved ability to relate genotype to phenotype have the potential to accelerate breeding for desired traits and to improve our understanding of the molecular variants that underlie phenotypes. The availability of large-scale gene expression profiles in maize provides an opportunity to advance our understanding of complex traits in this agronomically important species. We built co-expression networks based on genome-wide expression data from a variety of maize accessions as well as an atlas of different tissues and developmental stages. We demonstrate that these networks reveal clusters of genes that are enriched for known biological function and contain extensive structure which has yet to be characterized. Furthermore, we found that co-expression networks derived from developmental or tissue atlases as compared to expression variation across diverse accessions capture unique functions. To provide convenient access to these networks, we developed a public, web-based Co-expression Browser (COB), which enables interactive queries of the genome-wide networks. We illustrate the utility of this system through two specific use cases: one in which gene-centric queries are used to provide functional context for previously characterized metabolic pathways, and a second where lists of genes produced by mapping studies are further resolved and validated using co-expression networks.	[Schaefer, Robert J.; Myers, Chad L.] Univ Minnesota Rochester, Biomed Informat & Computat Biol Grad Program, Rochester, MN 55904 USA; [Briskine, Roman; Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Springer, Nathan M.] Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN USA	University of Minnesota System; University of Minnesota Rochester; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Myers, CL (corresponding author), Univ Minnesota Rochester, Biomed Informat & Computat Biol Grad Program, Rochester, MN 55904 USA.	cmyers@cs.umn.edu		Briskine, Roman/0000-0002-6831-3914	Biomedical Informatics and Computational Biology (BICB) Fellowship; National Science Foundation [DBI-1237931, IOS 1126950, DBI 0953881]; US Department of Agriculture Hatch funds; CIFAR Genetic Networks Program; Direct For Biological Sciences [1126950] Funding Source: National Science Foundation	Biomedical Informatics and Computational Biology (BICB) Fellowship; National Science Foundation(National Science Foundation (NSF)); US Department of Agriculture Hatch funds(United States Department of Agriculture (USDA)); CIFAR Genetic Networks Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	R.S. was partially supported by a Biomedical Informatics and Computational Biology (BICB) Fellowship. This work was supported by a grant from the National Science Foundation to N.M.S. (DBI-1237931) and by US Department of Agriculture Hatch funds to N.M.S. and C.L.M.R.S., R.B. and C.L.M. were partially supported by grants from the National Science Foundation (IOS 1126950 and DBI 0953881). C.L.M. is supported by the CIFAR Genetic Networks Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; BECRAFT PW, 1994, GENETICS, V136, P295; Bolduc N, 2012, GENE DEV, V26, P1685, DOI 10.1101/gad.193433.112; DAVID FN, 1949, BIOMETRIKA, V36, P394, DOI 10.1093/biomet/36.3-4.394; de Sousa SM, 2008, PLANT MOL BIOL, V68, P203, DOI 10.1007/s11103-008-9362-0; Deshpande R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001028; Downs GS, 2013, PLANT PHYSIOL, V161, P1830, DOI 10.1104/pp.112.213231; Fan LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007612; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Foster T, 1999, PLANT CELL, V11, P1239, DOI 10.1105/tpc.11.7.1239; Fowler JE, 1996, DEV GENET, V18, P198, DOI 10.1002/(SICI)1520-6408(1996)18:3&lt;198::AID-DVG2&gt;3.0.CO;2-4; Fukushima A, 2012, PLANT PHYSIOL, V158, P1487, DOI 10.1104/pp.111.188367; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; GIROUX MJ, 1994, PLANT PHYSIOL, V106, P713, DOI 10.1104/pp.106.2.713; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huttenhower C, 2008, BIOINFORMATICS, V24, P1559, DOI 10.1093/bioinformatics/btn237; Huttenhower C, 2006, BIOINFORMATICS, V22, P2890, DOI 10.1093/bioinformatics/btl492; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kim CY, 2008, NEW PHYTOL, V180, P57, DOI 10.1111/j.1469-8137.2008.02557.x; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P785, DOI 10.1093/pcp/pcr035; Moreno-Risueno MA, 2010, CURR OPIN PLANT BIOL, V13, P126, DOI 10.1016/j.pbi.2009.11.005; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Myers CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r114; Orlando DA, 2009, METHODS MOL BIOL, V553, P57, DOI 10.1007/978-1-60327-563-7_4; Ramirez J, 2009, PLANT PHYSIOL, V151, P1878, DOI 10.1104/pp.109.145920; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Swanson-Wagner R, 2012, P NATL ACAD SCI USA, V109, P11878, DOI 10.1073/pnas.1201961109; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; VanDongen S.M., 2001, THESIS U UTRECHT; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x	43	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99193	10.1371/journal.pone.0099193	http://dx.doi.org/10.1371/journal.pone.0099193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922320	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300043
J	Xia, XY; Ge, M; Hsi, JH; He, X; Ruan, YH; Wang, ZX; Shao, YM; Pan, XM				Xia, Xia-Yu; Ge, Meng; Hsi, Jenny H.; He, Xiang; Ruan, Yu-Hua; Wang, Zhi-Xin; Shao, Yi-Ming; Pan, Xian-Ming			High-Accuracy Identification of Incident HIV-1 Infections Using a Sequence Clustering Based Diversity Measure	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SEROCONVERSION; MARKER; ASSAY	Accurate estimates of HIV-1 incidence are essential for monitoring epidemic trends and evaluating intervention efforts. However, the long asymptomatic stage of HIV-1 infection makes it difficult to effectively distinguish incident infections from chronic ones. Current incidence assays based on serology or viral sequence diversity are both still lacking in accuracy. In the present work, a sequence clustering based diversity (SCBD) assay was devised by utilizing the fact that viral sequences derived from each transmitted/founder (T/F) strain tend to cluster together at early stage, and that only the intra-cluster diversity is correlated with the time since HIV-1 infection. The dot-matrix pairwise alignment was used to eliminate the disproportional impact of insertion/deletions (indels) and recombination events, and so was the proportion of clusterable sequences (P-c) as an index to identify late chronic infections with declined viral genetic diversity. Tested on a dataset containing 398 incident and 163 chronic infection cases collected from the Los Alamos HIV database (last modified 2/8/2012), our SCBD method achieved 99.5% sensitivity and 98.8% specificity, with an overall accuracy of 99.3%. Further analysis and evaluation also suggested its performance was not affected by host factors such as the viral subtypes and transmission routes. The SCBD method demonstrated the potential of sequencing based techniques to become useful for identifying incident infections. Its use may be most advantageous for settings with low to moderate incidence relative to available resources.	[Xia, Xia-Yu; Ge, Meng; Wang, Zhi-Xin; Pan, Xian-Ming] Tsinghua Univ, Sch Life Sci, Key Lab Bioinformat, Minist Educ, Beijing 100084, Peoples R China; [Hsi, Jenny H.; He, Xiang; Ruan, Yu-Hua; Shao, Yi-Ming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Tsinghua University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao08@gmail.com; pan-xm@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022; He, Xiang/E-7082-2013	He, Xiang/0000-0003-2428-5349	Ministry of Science and Technology of China [2009CB918801]; Ministry of Health of China [2012ZX10001001-015]; International Development Research Center, Ottawa, Canada [104519-010]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Health of China; International Development Research Center, Ottawa, Canada	This work was supported in part by grant 2009CB918801 from the Ministry of Science and Technology of China, 2012ZX10001001-015 from the Ministry of Health of China, and 104519-010 from the International Development Research Center, Ottawa, Canada. The funding organizations did not have any role in the design and conduct of the study, in the collection, management, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Allam O, 2011, AIDS, V25, P2047, DOI 10.1097/QAD.0b013e32834bac66; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P40; Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Chawla A, 2007, J CLIN MICROBIOL, V45, P415, DOI 10.1128/JCM.01879-06; China MOH UNAIDS WHO, 2011, EST HIV AIDS EP CHIN; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hayashida T, 2008, AIDS RES HUM RETROV, V24, P495, DOI 10.1089/aid.2007.0150; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Justman J, 2010, SCIENCE, V329, P120, DOI 10.1126/science.1193218; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Lee HY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000240; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Murphy G, 2008, EUROSURVEILLANCE, V1, P13; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Park SY, 2011, AIDS, V25, pF13, DOI 10.1097/QAD.0b013e328349f089; Ragonnet-Cronin M, 2012, J INFECT DIS, V206, P756, DOI 10.1093/infdis/jis411; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Tey J, 1996, ANN ACAD MED SINGAP, V41, P194; Yang J, 2012, SCI CHINA LIFE SCI, V55, P328, DOI 10.1007/s11427-012-4312-0	27	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e100081	10.1371/journal.pone.0100081	http://dx.doi.org/10.1371/journal.pone.0100081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925130	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300119
J	Arends, S; Spoorenberg, A; Efde, M; Bos, R; Leijsma, MK; Bootsma, H; Veeger, NJGM; Brouwer, E; van der Veer, E				Arends, Suzanne; Spoorenberg, Anneke; Efde, Monique; Bos, Reinhard; Leijsma, Martha K.; Bootsma, Hendrika; Veeger, Nic J. G. M.; Brouwer, Elisabeth; van der Veer, Eveline			Higher Bone Turnover Is Related to Spinal Radiographic Damage and Low Bone Mineral Density in Ankylosing Spondylitis Patients with Active Disease: A Cross-Sectional Analysis	PLOS ONE			English	Article							ACTIVITY SCORE ASDAS; VERTEBRAL FRACTURES; BIOCHEMICAL MARKERS; BASE-LINE; PROGRESSION; SYNDESMOPHYTES; OSTEOPOROSIS; ASSOCIATION; CRITERIA; COHORT	Introduction: Ankylosing spondylitis (AS) is characterized by excessive bone formation and bone loss. Our aim was to investigate the association of bone turnover markers (BTM) with spinal radiographic damage and bone mineral density (BMD) in AS patients with active disease. Methods: 201 consecutive AS outpatients of the Groningen Leeuwarden AS (GLAS) cohort were included. Serum markers of bone resorption (C-telopeptides of type-I collagen, sCTX) and bone formation (procollagen type-I N-terminal peptide, PINP; bone-specific alkaline phosphatase, BALP) were measured. Z-scores were used to correct for the normal influence that age and gender have on bone turnover. Radiographs were scored by two independent readers according to modified Stoke AS Spinal Score (mSASSS). The presence of complete bridging (ankylosis of at least two vertebrae) was considered as measure of more advanced radiographic damage. Low BMD was defined as lumbar spine and/or hip BMD Z-score <= -1. Results: Of the 151 patients with complete data, 52 (34%) had >= 1 complete bridge, 49 (33%) had >= 1 syndesmophyte (nonbridging), and 50 (33%) had no syndesmophytes. 66 (44%) had low BMD. Patients with bridging had significantly higher sCTX and PINP Z-scores than patients without bridging (0.43 vs. -0.55 and 0.55 vs. 0.04, respectively). Patients with low BMD had significantly higher sCTX Z-score than patients with normal BMD (-0.08 vs. -0.61). After correcting for gender, symptom duration, and CRP, sCTX Z-score remained significantly related to the presence of low BMD alone (OR: 1.60), bridging alone (OR: 1.82), and bridging in combination with low BMD (OR: 2.26). Conclusions: This cross-sectional study in AS patients with active and relatively long-standing disease demonstrated that higher serum levels of sCTX, and to a lesser extent PINP, are associated with the presence of complete bridging. sCTX was also associated with low BMD. Longitudinal studies are needed to confirm that serum levels of sCTX can serve as objective marker for bone-related outcome in AS.	[Arends, Suzanne; Spoorenberg, Anneke; Leijsma, Martha K.; Bootsma, Hendrika; Veeger, Nic J. G. M.; Brouwer, Elisabeth; van der Veer, Eveline] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Arends, Suzanne; Efde, Monique; Bos, Reinhard] Med Ctr Leeuwarden, Leeuwarden, Netherlands	University of Groningen; Medical Center Leeuwarden	Arends, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.	s.arends@umcg.nl	Brouwer, Elisabeth/AAL-9029-2020; Bos, Reinhard/AAS-1726-2020; Arends, Suzanne/M-5436-2015; Veeger, Nic JGM/F-2966-2013; Brouwer, Elisabeth/A-3198-2015	Brouwer, Elisabeth/0000-0002-5652-4423; Arends, Suzanne/0000-0002-4422-7640; Veeger, Nic JGM/0000-0002-1492-7937; Brouwer, Elisabeth/0000-0002-5652-4423; van der Veer, Eveline/0000-0002-4825-9981	Pfizer	Pfizer(Pfizer)	The GLAS cohort was supported by an unrestricted grant from Pfizer. Pfizer had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes C, 1999, CLIN CHIM ACTA, V289, P99, DOI 10.1016/S0009-8981(99)00170-9; Appel H, 2009, ARTHRITIS RHEUM-US, V60, P3257, DOI 10.1002/art.24888; Arends S, 2011, OSTEOPOROSIS INT, V22, P1431, DOI 10.1007/s00198-010-1338-7; Arends S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3823; Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Boonen A, 2009, J RHEUMATOL, V36, P1249, DOI 10.3899/jrheum.080831; Braun J, 2006, ANN RHEUM DIS, V65, P316, DOI 10.1136/ard.2005.040758; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; CALIN A, 1994, J RHEUMATOL, V21, P2281; El Maghraoui A, 2004, JOINT BONE SPINE, V71, P291, DOI 10.1016/j.jbspin.2003.06.002; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Geusens P, 2007, CURR OPIN RHEUMATOL, V19, P335, DOI 10.1097/BOR.0b013e328133f5b3; Ghozani I, 2009, BONE, V44, P772, DOI 10.1016/j.bone.2008.12.028; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Heiland GR, 2012, ANN RHEUM DIS, V71, P572, DOI 10.1136/annrheumdis-2011-200216; Karberg K, 2005, J RHEUMATOL, V32, P1290; Lange U, 2005, OSTEOPOROSIS INT, V16, P1999, DOI 10.1007/s00198-005-1990-5; Lee W, 2007, ANN RHEUM DIS, V66, P633, DOI 10.1136/ard.2006.060293; Lukas C, 2009, ANN RHEUM DIS, V68, P18, DOI 10.1136/ard.2008.094870; Machado P, 2011, ANN RHEUM DIS, V70, P47, DOI 10.1136/ard.2010.138594; Maksymowych WP, 2007, ARTHRITIS RHEUM-US, V56, P1846, DOI 10.1002/art.22589; Maksymowych WP, 2009, J RHEUMATOL, V36, P1785, DOI 10.3899/jrheum.090346; Mitra D, 1999, J RHEUMATOL, V26, P2201; Padi MC, 2008, YONSEI MED J, V49, P288, DOI 10.3349/ymj.2008.49.2.288; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Ramiro S, 2013, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2013-204055, DOI 10.1136/ANNRHEUMDIS-2013-20405]; Spoorenberg A, 2004, J RHEUMATOL, V31, P125; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; van Tubergen A, 2012, ANN RHEUM DIS, V71, P518, DOI 10.1136/annrheumdis-2011-200411; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Vosse D, 2008, RHEUMATOLOGY, V47, P1219, DOI 10.1093/rheumatology/ken148; Vosse D, 2009, ANN RHEUM DIS, V68, P1839, DOI 10.1136/ard.2008.100503; Wanders AJB, 2004, ARTHRITIS RHEUM-US, V50, P2622, DOI 10.1002/art.20446	36	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99685	10.1371/journal.pone.0099685	http://dx.doi.org/10.1371/journal.pone.0099685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918782	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000103
J	Chen, JZ; Wang, JN; Zhu, WL				Chen, Jianzhong; Wang, Jinan; Zhu, Weiliang			Binding Modes of Three Inhibitors 8CA, F8A and I4A to A-FABP Studied Based on Molecular Dynamics Simulation	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SOLVATED INTERACTION ENERGY; BOUNDARY-ELEMENT METHOD; PARTICLE MESH EWALD; COMPUTATIONAL ANALYSIS; INSULIN-RESISTANCE; PK(A) VALUES; FORCE-FIELD; MM-PBSA; AP2	Adipocyte fatty-acid binding protein (A-FABP) is an important target of drug designs treating some diseases related to lipid-mediated biology. Molecular dynamics (MD) simulations coupled with solvated interaction energy method (SIE) were carried out to study the binding modes of three inhibitors 8CA, F8A and I4A to A-FABP. The rank of our predicted binding affinities is in accordance with experimental data. The results show that the substitution in the position 5 of N-benzyl and the seven-membered ring of N-benzyl-indole carboxylic acids strengthen the I4A binding, while the substitution in the position 2 of N-benzyl weakens the F8A binding. Computational alanine scanning and dynamics analyses were performed and the results suggest that the polar interactions of the positively charged residue R126 with the three inhibitors provide a significant contribution to inhibitor bindings. This polar interaction induces the disappearance of the correlated motion of the C terminus of A-FABP relative to the N terminus and favors the stability of the binding complex. This study is helpful for the rational design of potent inhibitors within the fields of metabolic disease, inflammation and atherosclerosis.	[Chen, Jianzhong] Shandong Jiaotong Univ, Sch Sci, Jinan, Peoples R China; [Wang, Jinan; Zhu, Weiliang] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Discovery & Design Ctr, Shanghai, Peoples R China	Shandong Jiaotong University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Chen, JZ (corresponding author), Shandong Jiaotong Univ, Sch Sci, Jinan, Peoples R China.	chenjianzhong1970@163.com; wlzhu@mail.shcnc.ac.cn	Chen, Jianzhong/L-8899-2018	Chen, Jianzhong/0000-0003-1558-4398	National Natural Science Foundation of China [11104164, 11274206, 31200545]; National 863 Program [2012AA01A305]; Dr. Start-up Foundation of Shandong Jiaotong University; Natural Science Foundation of Shandong Jiaotong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program(National High Technology Research and Development Program of China); Dr. Start-up Foundation of Shandong Jiaotong University; Natural Science Foundation of Shandong Jiaotong University	This work is supported by the National Natural Science Foundation of China (11104164, 11274206 and 31200545), the National 863 Program (Grant No. 2012AA01A305), Dr. Start-up Foundation of Shandong Jiaotong University, and Natural Science Foundation of Shandong Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay, 1995, J MED CHEM, V38, P4953, DOI 10.1021/jm00026a001; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Banaszak L, 1994, ADV PROTEIN CHEM, V45, P90; Barf T, 2009, BIOORG MED CHEM LETT, V19, P1745, DOI 10.1016/j.bmcl.2009.01.084; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Bhat S, 2006, PROTEINS, V62, P244, DOI 10.1002/prot.20682; Cabre A, 2007, Atherosclerosis, V195, pe150; Case DA, 2012, AMBER 12; Chen JZ, 2013, J COMPUT AID MOL DES, V27, P965, DOI 10.1007/s10822-013-9693-z; Chen JZ, 2012, INT J MOL SCI, V13, P2176, DOI 10.3390/ijms13022176; Chen JZ, 2011, J MOL GRAPH MODEL, V30, P46, DOI 10.1016/j.jmgm.2011.06.003; COLEMAN TG, 1977, ANN BIOMED ENG, V5, P322, DOI 10.1007/BF02367312; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hou TJ, 2007, J MED CHEM, V50, P1177, DOI 10.1021/jm0609162; Hu GD, 2010, J COMPUT AID MOL DES, V24, P687, DOI 10.1007/s10822-010-9366-0; Huang XQ, 2008, J MED CHEM, V51, P6293, DOI 10.1021/jm800607u; Huang XQ, 2012, J PHYS CHEM B, V116, P3361, DOI 10.1021/jp2111605; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Ji CG, 2011, J AM CHEM SOC, V133, P17727, DOI 10.1021/ja206212a; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Laberge M, 2008, BIOPHYS J, V94, P2737, DOI 10.1529/biophysj.107.114942; Lehmann F, 2004, BIOORG MED CHEM LETT, V14, P4445, DOI 10.1016/j.bmcl.2004.06.057; Levy R, 2004, BIOPOLYMERS, V23, P1099; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Luo Q, 2013, AMINO ACIDS, V44, P1009, DOI 10.1007/s00726-012-1435-3; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; MELKI SA, 1993, J LIPID RES, V34, P1527; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Perdih A, 2009, J MOL MODEL, V15, P983, DOI 10.1007/s00894-009-0455-8; PURISIMA EO, 1995, J COMPUT CHEM, V16, P681, DOI 10.1002/jcc.540160604; Purisima EO, 1998, J COMPUT CHEM, V19, P1494, DOI 10.1002/(SICI)1096-987X(199810)19:13<1494::AID-JCC6>3.0.CO;2-L; Ringom R, 2004, BIOORG MED CHEM LETT, V14, P4449, DOI 10.1016/j.bmcl.2004.06.058; Scheja L, 1999, DIABETES, V48, P1987, DOI 10.2337/diabetes.48.10.1987; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Verkhivker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040897; Vural B, 2008, CARDIOVASC PATHOL, V17, P392, DOI 10.1016/j.carpath.2008.02.006; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wallace EM, 2006, J MED CHEM, V49, P441, DOI 10.1021/jm050834y; Wang JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062745; Wang JN, 2010, J PHYS CHEM B, V114, P15172, DOI 10.1021/jp104508k; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang YT, 2009, J CHEM INF MODEL, V49, P2369, DOI 10.1021/ci9002238; Wu EL, 2008, CHEM-EUR J, V14, P8704, DOI 10.1002/chem.200800277; Xu Y, 2006, PROTEINS, V64, P1058, DOI 10.1002/prot.21044; Zhu T, 2013, J CHEM THEORY COMPUT, V9, P2104, DOI 10.1021/ct300999w	60	31	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99862	10.1371/journal.pone.0099862	http://dx.doi.org/10.1371/journal.pone.0099862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918907	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000122
J	Liao, Y; Lu, W; Che, Q; Yang, TT; Qiu, HF; Zhang, HJ; He, XY; Wang, JY; Qiu, MT; Zou, YF; Gu, W; Wan, XP				Liao, Yun; Lu, Wen; Che, Qi; Yang, Tingting; Qiu, Haifeng; Zhang, Huijuan; He, Xiaoying; Wang, Jingyun; Qiu, Meiting; Zou, Yingfen; Gu, Wei; Wan, Xiaoping			SHARP1 Suppresses Angiogenesis of Endometrial Cancer by Decreasing Hypoxia-Inducible Factor-1 alpha Level	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TRANSCRIPTION FACTOR DEC2; TUMOR-GROWTH; PHASE-II; EXPRESSION; CARCINOMA; METASTASIS; CELLS; MECHANISMS; RECURRENT	Recent data support a role for SHARP1, a basic helix-loop-helix transcription repressor, in the regulation of malignant cell behavior in several human cancers. However, the expression and role of SHARP1 during the development of endometrial cancer (EC) remain unclear. Here we show that upregulation of SHARP1 suppressed tumor angiogenesis by decreasing hypoxia-inducible factor-1 alpha (HIF-1 alpha), inhibited cell viability and tumor growth in EC. Immunohistochemical staining showed that the expression of SHARP1 was negatively correlated with tumor stage, histological grade, myometrial invasion, lymph node metastasis, blood vessel permeation in the myometrium and HIF-1 alpha expression. Mechanistic studies showed that SHARP1 interacted with HIF-1 alpha physically, and the protein level of HIF-1 alpha and the mRNA level of its target genes (VEGFA, ANGPTL4 and CA9) were decreased by SHARP1 under hypoxia. Upregulation of SHARP1 in EC impeded hypoxia-induced angiogenesis by reducing VEGF secretion. Immunohistochemical analysis verified a correlation between decreased SHARP1 expression and increased microvessel density in EC tissues. Additionally, SHARP1 inhibited cell viability in EC cell lines. Overexpression of SHARP1 in vivo inhibited tumor growth and angiogenesis, and decreased HIF-1 alpha expression. In this study, we established SHARP1 as a novel tumor suppressor of EC and shed light on the mechanisms by how SHARP1 inhibited EC progression. Therefore, SHARP1 may be a valuable prognostic biomarker for EC progression and shows promise as a new potential target for antiangiogenic therapeutics in human EC.	[Liao, Yun; He, Xiaoying; Wang, Jingyun; Qiu, Meiting; Zou, Yingfen; Gu, Wei] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Lu, Wen; Che, Qi; Yang, Tingting; Qiu, Haifeng; Wan, Xiaoping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Zhang, Huijuan] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Pathol, Shanghai 200030, Peoples R China; [Zhang, Huijuan] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Biobank, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gu, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	krisgu70@163.com; wanxp@sjtu.edu.cn	wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022; zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022		National Natural Science Foundation of China [81272885, 81172476, 81072139, 81072140]; Foundation Project of Shanghai Municipal Science and Technology Commission [13JC1404500]; Ph.D. Programs Foundation of the Ministry of Education of China [20120073110090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation Project of Shanghai Municipal Science and Technology Commission; Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This study was supported by the National Natural Science Foundation of China (81272885, 81172476, 81072139, 81072140), the Foundation Project of Shanghai Municipal Science and Technology Commission (No. 13JC1404500) and the Ph.D. Programs Foundation of the Ministry of Education of China (No. 20120073110090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian C, 2011, J CLIN ONCOL, V29, P2259, DOI 10.1200/JCO.2010.32.6397; Azmi S, 2003, J BIOL CHEM, V278, P20098, DOI 10.1074/jbc.M210427200; Azmi S, 2002, MECH DEVELOP, V114, P181, DOI 10.1016/S0925-4773(02)00049-7; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bhawal UK, 2011, J PATHOL, V224, P420, DOI 10.1002/path.2878; Chen MC, 2013, BIOCHEM PHARMACOL, V85, P1278, DOI 10.1016/j.bcp.2013.02.009; Creasman W, 2009, INT J GYNECOL OBSTET, V105, P109, DOI 10.1016/j.ijgo.2009.02.010; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fujimoto K, 2001, BIOCHEM BIOPH RES CO, V280, P164, DOI 10.1006/bbrc.2000.4133; Fujimoto K, 2007, INT J MOL MED, V19, P925; Gulbagci NT, 2009, EMBO REP, V10, P79, DOI 10.1038/embor.2008.207; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hamaguchi H, 2004, BIOCHEM J, V382, P43, DOI 10.1042/BJ20031760; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hill EK, 2012, DRUGS, V72, P705, DOI 10.2165/11631840-000000000-00000; Hirai M, 2001, GYNECOL ONCOL, V80, P181, DOI 10.1006/gyno.2000.6056; Jiang FZ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-425; Kafousi M, 2012, PATHOL ONCOL RES, V18, P33, DOI 10.1007/s12253-011-9413-8; Kamat AA, 2007, CLIN CANCER RES, V13, P7487, DOI 10.1158/1078-0432.CCR-07-1017; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Li YX, 2011, BREAST CANCER RES TR, V128, P667, DOI 10.1007/s10549-010-1083-9; Liu Y, 2010, GENES CELLS, V15, P315, DOI 10.1111/j.1365-2443.2010.01381.x; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Nordgren IK, 2011, CHEM SOC REV, V40, P4307, DOI 10.1039/c1cs15032d; Ostergaard L, 2013, CANCER RES, V73, P5618, DOI 10.1158/0008-5472.CAN-13-0964; Oza AM, 2011, J CLIN ONCOL, V29, P3278, DOI 10.1200/JCO.2010.34.1578; Ozbudak IH, 2008, GYNECOL ONCOL, V108, P603, DOI 10.1016/j.ygyno.2007.11.028; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Sato F, 2008, GENES CELLS, V13, P131, DOI 10.1111/j.1365-2443.2007.01153.x; Seeber LMS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-307; Shi ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032709; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Vale CL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003915.pub4; Wright JD, 2007, ANTICANCER RES, V27, P3525; Wu YY, 2012, BIOMED RES-TOKYO, V33, P75, DOI 10.2220/biomedres.33.75; Xu Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041862, 10.1371/journal.pone.0043769]; Yang TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067458; Yokoyama Y, 2000, GYNECOL ONCOL, V77, P413, DOI 10.1006/gyno.2000.5802; Yunokawa M, 2007, ONCOL REP, V17, P871	50	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99907	10.1371/journal.pone.0099907	http://dx.doi.org/10.1371/journal.pone.0099907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918449	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000125
J	Yeh, JJ; Wang, YC; Lin, CL; Chou, CYT; Yeh, TC; Wu, BT; Sung, FC; Kao, CH				Yeh, Jun-Jun; Wang, Yu-Chiao; Lin, Cheng-Li; Chou, Christine Yi-Ting; Yeh, Ting-Chun; Wu, Bing-Tsang; Sung, Fung-Chang; Kao, Chia-Hung			Nontuberculous Mycobacterial Infection Is Associated with Increased Respiratory Failure: A Nationwide Cohort Study	PLOS ONE			English	Article							THIN-SECTION CT; PULMONARY INFECTION; LUNG-DISEASE; CLINICAL CHARACTERISTICS; MEDICAL THERAPIES; AVIUM COMPLEX; EPIDEMIOLOGY	Background and Purpose: Population study on relationship between nontuberculous mycobacterial (NTM) infection and respiratory failure (RF) is limited. This study evaluated the RF risk, including acute respiratory failure (ARF), chronic respiratory failure (CRF) and ARF on CRF, in patients with NTM infection in Taiwan. Methods: We used the National Health Insurance Research Database of Taiwan to identify 3864 newly diagnosed NTM patients (NTM cohort) from 1999 to 2009, and 15456 non-NTM patients (non-NTM cohort), frequency matched by demographic status for comparison. Incidence and hazard of developing RF were measured by the end of 2010. Results: The incidence rate of RF was 4.31-fold higher in the NTM cohort than in the non-NTM cohort (44.0 vs. 10.2 per 1000 person-years), with an adjusted hazard ratio (HR) of 3.11 (95% CI: 2.73-3.54). The cumulative proportional incidence of RF was 10% higher in the NTM cohort than in the non-NTM cohort (P<0.0001). The RF risk was much greater within 6 months after the diagnosis of NTM infection with a HR of 7.45 (95% CI = 5.50-10.09). Age-specific comparison showed that the younger NTM patients had a higher HR of RF than the elderly NTM patients (HR: 4.42, 95% CI: 3.28-5.96 vs. HR: 2.52, 95% CI: 2.17-2.92). Comorbidity increased the risk of RF in both cohorts, particularly in those with chronic obstructive pulmonary disease. Conclusion: Our study suggests patients with NTM infection are at a high risk of RF. The risk appears much greater soon after patients diagnosed with NTM infection.	[Yeh, Jun-Jun; Chou, Christine Yi-Ting; Yeh, Ting-Chun; Wu, Bing-Tsang] Chia Yi Christian Hosp, Ditmanson Med Fdn, Chiayi, Taiwan; [Yeh, Jun-Jun] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Wang, Yu-Chiao; Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wang, Yu-Chiao; Lin, Cheng-Li; Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wang, Yu-Chiao; Lin, Cheng-Li; Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Chou, Christine Yi-Ting] UCSD Med Ctr Hillcres, San Diego, CA USA; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	Chia Nan University of Pharmacy & Science; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Sung, FC (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.	fcsung@mail.cmu.edu.tw; d10040@mail.cmuh.org.tw		Yeh, Jun-Jun/0000-0002-4368-7880	Taiwan Department of Health Clinical Trial and Research Center and for Excellence [DOH102-TD-B-111-004]; Taiwan Ministry of Health and Welfare Cancer Research Center for Excellence [MOHW103-TD-B-111-03];  [DMR-103-020];  [DMR-103-022]	Taiwan Department of Health Clinical Trial and Research Center and for Excellence; Taiwan Ministry of Health and Welfare Cancer Research Center for Excellence; ; 	The study was supported in part by the study projects (DMR-103-020 and DMR-103-022) in the authors' hospital and Taiwan Department of Health Clinical Trial and Research Center and for Excellence (DOH102-TD-B-111-004), and Taiwan Ministry of Health and Welfare Cancer Research Center for Excellence (MOHW103-TD-B-111-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kao CH and Sung FC have equal contribution for this study.	Andrejak C, 2013, THORAX, V68, P256, DOI 10.1136/thoraxjnl-2012-201772; Babalik A, 2012, TUBERK TORAK, V60, P20, DOI 10.5578/tt.2543; Behrendt CE, 2000, CHEST, V118, P1100, DOI 10.1378/chest.118.4.1100; Billinger ME, 2009, EMERG INFECT DIS, V15, P1562, DOI 10.3201/eid1510.090196; Booth CM, 2011, CURR ONCOL, V18, P105; Booth CM, 2008, JAMA-J AM MED ASSOC, V300, P2177, DOI 10.1001/jama.300.18.2177; Carol J, 2001, ICD 9 C M, V2, P298; Ding LW, 2006, EPIDEMIOL INFECT, V134, P1060, DOI 10.1017/S0950268805005698; Erasmus JJ, 1999, RADIOGRAPHICS, V19, P1487, DOI 10.1148/radiographics.19.6.g99no101487; Franca SA, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.10.010; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Huang JH, 1999, CHEST, V115, P1033, DOI 10.1378/chest.115.4.1033; Huang WC, 2010, J MED MICROBIOL, V59, P1203, DOI 10.1099/jmm.0.020586-0; J Carol, 2001, ICD 9 C M, V3, P298; J Carol, 2001, ICD 9 C M, V1, P298; J Carol, 2001, ICD 9 C M, V2001, P298; Jeong YJ, 2004, RADIOLOGY, V231, P880, DOI 10.1148/radiol.2313030833; Kazumi Yuko, 2013, Kansenshogaku Zasshi, V87, P424; Kim TS, 2005, AM J ROENTGENOL, V184, P1247, DOI 10.2214/ajr.184.4.01841247; Koh WJ, 2002, KOREAN J RADIOL, V3, P145, DOI 10.3348/kjr.2002.3.3.145; Kohno S, 2013, RESPIRATION, V85, P27, DOI 10.1159/000335466; Kubo K, 1998, AM J RESP CRIT CARE, V158, P979, DOI 10.1164/ajrccm.158.3.9802042; Lee AR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-558; Lee MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058214; Lewandowski K, 2003, CRIT CARE, V7, P288, DOI 10.1186/cc2352; Miravitlles M, 1999, CHEST, V116, P40, DOI 10.1378/chest.116.1.40; MOORE EH, 1993, RADIOLOGY, V187, P777, DOI 10.1148/radiology.187.3.8497629; Orsini J, 2013, INTERDISCIP PERSPECT, V2013; PRINCE DS, 1989, NEW ENGL J MED, V321, P863, DOI 10.1056/NEJM198909283211304; Ringshausen FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071109; Ringshausen FC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-231; Roussos C, 2003, EUR RESPIR J, V22, p3S, DOI 10.1183/09031936.03.00038503; Shaaban H, 2013, INT J STD AIDS; Shu CC, 2011, LUNG, V189, P467, DOI 10.1007/s00408-011-9321-4; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Sue DYLD, 2008, RESP FAILURE; Systrom DM, 2005, NEW ENGL J MED, V352, P1238, DOI 10.1056/NEJMcpc059003; WALLACE JM, 1988, WESTERN J MED, V149, P167; Wallace RJ, 1997, AM J RESP CRIT CARE, V156, pS1, DOI 10.1164/ajrccm.156.2.atsstatement; Yamazaki Y, 2000, RESPIRATION, V67, P46, DOI 10.1159/000029462; Yeh JJ, 2014, LUNG; Zheng C, 2013, QJM-INT J MED, V106, P307, DOI 10.1093/qjmed/hct022	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99260	10.1371/journal.pone.0099260	http://dx.doi.org/10.1371/journal.pone.0099260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918925	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000068
J	Levinsson, A; Olin, AC; Modig, L; Dahgam, S; Bjorck, L; Rosengren, A; Nyberg, F				Levinsson, Anna; Olin, Anna-Carin; Modig, Lars; Dahgam, Santosh; Bjorck, Lena; Rosengren, Annika; Nyberg, Fredrik			Interaction Effects of Long-Term Air Pollution Exposure and Variants in the GSTP1, GSTT1 and GSTCD Genes on Risk of Acute Myocardial Infarction and Hypertension: A Case-Control Study	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CARDIOVASCULAR-DISEASE; PARTICULATE MATTER; OXIDATIVE STRESS; MORTALITY	Introducion: Experimental and epidemiological studies have reported associations between air pollution exposure, in particular related to vehicle exhaust, and cardiovascular disease. A potential pathophysiological pathway is pollution-induced pulmonary oxidative stress, with secondary systemic inflammation. Genetic polymorphisms in genes implicated in oxidative stress, such as GSTP1, GSTT1 and GSTCD, may contribute to determining individual susceptibility to air pollution as a promoter of coronary vulnerability. Aims: We aimed to investigate effects of long-term traffic-related air pollution exposure, as well as variants in GSTP1, GSTT1 and GSTCD, on risk of acute myocardial infarction (AMI) and hypertension. In addition, we studied whether air pollution effects were modified by the investigated genetic variants. Methods: Genotype data at 7 single nucleotide polymorphisms (SNPs) in the GSTP1 gene, and one in each of the GSTT1 and GSTCD genes, as well as air pollution exposure estimates, were available for 119 AMI cases and 1310 randomly selected population controls. Population control individuals with systolic blood pressure >= 140 mmHg, diastolic blood pressure >= 90 mmHg or on daily antihypertensive medication were defined as hypertensive (n = 468). Individual air pollution exposure levels were modeled as annual means of NO2 (marker of vehicle exhaust pollutants) using central monitoring data and dispersion models, linking to participants' home addresses. Results: Air pollution was significantly associated with risk of AMI: OR 1.78 (95%CI 1.04-3.03) per 10 mu g/m(3) of long-term NO2 exposure. Three GSTP1 SNPs were significantly associated with hypertension. The effect of air pollution on risk of AMI varied by genotype strata, although the suggested interaction was not significant. We saw no obvious interaction between genetic variants in the GST genes and air pollution exposure for hypertension. Conclusion: Air pollution exposure entails an increased risk of AMI, and this risk differed over genotype strata for variants in the GSTP1, GSTT1 and GSTCD genes, albeit not statistically-significantly.	[Levinsson, Anna; Olin, Anna-Carin; Dahgam, Santosh; Nyberg, Fredrik] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Modig, Lars] Umea Univ, Dept Publ Hlth & Clin Med Occupat & Environm Med, Umea, Sweden; [Bjorck, Lena; Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Nyberg, Fredrik] AstraZeneca R&D, Molndal, Sweden	University of Gothenburg; Umea University; University of Gothenburg; AstraZeneca	Levinsson, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden.	anna.levinsson@amm.gu.se	Olin, Anna-Carin/ABH-2627-2021	Nyberg, Fredrik/0000-0003-0892-5668; Rosengren, Annika/0000-0002-5409-6605	Vastra Gotaland County Council; Swedish Council for Working Life and Social Research; Swedish Research Council; Swedish Research Council for Environment and Spatial Planning; Swedish Heart and Lung Foundation; AstraZeneca R D Sweden	Vastra Gotaland County Council; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment and Spatial Planning; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); AstraZeneca R D Sweden(AstraZeneca)	This research was supported by grants from the Vastra Gotaland County Council, the Swedish Council for Working Life and Social Research, the Swedish Research Council, the Swedish Research Council for Environment and Spatial Planning, the Swedish Heart and Lung Foundation, and AstraZeneca R & D Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, TOXICOL APPL PHARM; Bazo Ana Paula, 2011, Cardiovasc Pathol, V20, pe9, DOI 10.1016/j.carpath.2009.12.004; Berg CM, 2005, EUR J CARDIOV PREV R, V12, P115, DOI 10.1097/00149831-200504000-00005; Bessa SS, 2009, EUR J INTERN MED, V20, P625, DOI 10.1016/j.ejim.2009.06.003; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2007, J EXPO SCI ENV EPID, V17, pS61, DOI 10.1038/sj.jes.7500628; Campen MJ, 2012, CURR OPIN PULM MED, V18, P155, DOI 10.1097/MCP.0b013e32834f210a; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Huttunen K, 2012, ENVIRON RES, V116, P44, DOI 10.1016/j.envres.2012.04.004; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Johansson CSG, 2006, EXPOSE EXPOSURE COMP; Kunzli N, 2011, PROG CARDIOVASC DIS, V53, P334, DOI 10.1016/j.pcad.2010.12.006; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Mordukhovich I, 2009, ENVIRON HEALTH PERSP, V117, P1767, DOI 10.1289/ehp.0900591; Nebert Daniel W., 2004, Human Genomics, V1, P460; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Peters A, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-13; Probst-Hensch NM, 2008, ENV HLTH PERSPECT, V116; Raaschou-Nielsen O, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-60; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Rosenlund M, 2006, EPIDEMIOLOGY, V17, P383, DOI 10.1097/01.ede.0000219722.25569.0f; Ruckerl R, 2011, INHAL TOXICOL, V23, P555, DOI 10.3109/08958378.2011.593587; Schulz H, 2005, J AEROSOL MED, V18, P1, DOI 10.1089/jam.2005.18.1; Shrey K, 2011, ENVIRON TOXICOL PHAR, V31, P1, DOI 10.1016/j.etap.2010.09.002; Stephens JW, 2008, ATHEROSCLEROSIS, V200, P229, DOI 10.1016/j.atherosclerosis.2008.04.003; Wang J, 2010, MUTAGENESIS, V25, P365, DOI 10.1093/mutage/geq014; Yang IA, 2008, THORAX, V63, P555, DOI 10.1136/thx.2007.079426	28	31	31	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99043	10.1371/journal.pone.0099043	http://dx.doi.org/10.1371/journal.pone.0099043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915237	gold, Green Submitted, Green Published			2022-12-25	WOS:000340947700053
J	Schaftenaar, E; Verjans, GMGM; Getu, S; McIntyre, JA; Struthers, HE; Osterhaus, ADME; Peters, RPH				Schaftenaar, Erik; Verjans, Georges M. G. M.; Getu, Sarah; McIntyre, James A.; Struthers, Helen E.; Osterhaus, Albert D. M. E.; Peters, Remco P. H.			High Seroprevalence of Human Herpesviruses in HIV-Infected Individuals Attending Primary Healthcare Facilities in Rural South Africa	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; ZOSTER; PREVALENCE; CYTOMEGALOVIRUS; TRANSMISSION; REACTIVATION; POPULATION; PERSISTENT; ANTIBODIES; CHILDREN	Seroprevalence data of human herpesviruses (HHVs) are limited for sub-Saharan Africa. These are important to provide an indication of potential burden of HHV-related disease, in particular in human immunodeficiency virus (HIV)-infected individuals who are known to be at increased risk of these conditions in the Western world. In this cross-sectional study among 405 HIV-infected and antiretroviral therapy naive individuals in rural South Africa the seroprevalence of HHVs was: herpes simplex virus type 1 (HSV-1) (98%), herpes simplex virus type 2 (HSV-2) (87%), varicella zoster virus (VZV) (89%), and 100% for both Epstein-Barr virus (EBV) and cytomegalovirus (CMV). Independent factors associated with VZV seropositivity were low educational status and having children. Lack of in-house access to drinking water was independently associated with positive HSV-1 serostatus, whereas Shangaan ethnicity was associated with HSV-2 seropositivity. Increasing age was associated with higher IgG titres to both EBV and CMV, whereas CD4 cell count was negatively associated with EBV and CMV IgG titres. Moreover, IgG titres of HSV-1 and 2, VZV and CMV, and CMV and EBV were positively correlated. The high HHV seroprevalence emphasises the importance of awareness of these viral infections in HIV-infected individuals in South Africa.	[Schaftenaar, Erik; Verjans, Georges M. G. M.; Getu, Sarah; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Schaftenaar, Erik; McIntyre, James A.; Struthers, Helen E.; Peters, Remco P. H.] Anova Hlth Inst, Johannesburg, South Africa; [Schaftenaar, Erik; McIntyre, James A.; Struthers, Helen E.; Peters, Remco P. H.] Anova Hlth Inst, Tzaneen, South Africa; [McIntyre, James A.] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Struthers, Helen E.] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Peters, Remco P. H.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Cape Town; University of Cape Town; Maastricht University	Peters, RPH (corresponding author), Anova Hlth Inst, Johannesburg, South Africa.	rph.peters@gmail.com		Verjans, Georges/0000-0002-2465-2674; Peters, Remco Petrus Hendricus/0000-0003-2124-7275	Rotterdamse Stichting Blindenbelangen; Rotterdam global health initiative; US President's Emergency Plan for AIDS Relief (PEPFAR) program via the US Agency for International Development [674-A-00-08-00009-00]	Rotterdamse Stichting Blindenbelangen; Rotterdam global health initiative; US President's Emergency Plan for AIDS Relief (PEPFAR) program via the US Agency for International Development(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was in part funded by the Rotterdamse Stichting Blindenbelangen and the Rotterdam global health initiative. Anova Health Institute receives a grant from the US President's Emergency Plan for AIDS Relief (PEPFAR) program via the US Agency for International Development under Cooperative Agreement No. 674-A-00-08-00009-00. The views expressed in this report do not necessarily reflect those of PEPFAR or USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-111; Auvert B, 2001, AIDS, V15, P885, DOI 10.1097/00002030-200105040-00009; Camarena V, 2010, CELL HOST MICROBE, V8, P320, DOI 10.1016/j.chom.2010.09.007; Chakraborty N, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-147; Chakraborty R, 2003, CLIN INFECT DIS, V36, P922, DOI 10.1086/368207; Chatterjee K, 2010, J MED VIROL, V82, P2082, DOI 10.1002/jmv.21926; Compston LI, 2009, J MED VIROL, V81, P1860, DOI 10.1002/jmv.21614; Dollard SC, 2010, INT J CANCER, V127, P2395, DOI 10.1002/ijc.25235; Ghebrekidan H, 1999, J CLIN VIROL, V12, P53, DOI 10.1016/S0928-0197(98)00064-6; GLASER R, 1985, P SOC EXP BIOL MED, V179, P352; Haas A, 2010, EMBO MOL MED, V2, P231, DOI 10.1002/emmm.201000075; Heininger U, 2001, PEDIATR INFECT DIS J, V20, P775, DOI 10.1097/00006454-200108000-00011; Jansen K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-372; Kurth J, 2000, IMMUNITY, V13, P485, DOI 10.1016/S1074-7613(00)00048-0; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; Masuet-Aumatell C, 2013, TROP MED INT HEALTH, V18, P296, DOI 10.1111/tmi.12040; Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06; Mmbaga Elia John, 2011, East Afr J Public Health, V8, P28; Munoz TAY, 1999, ARCH MED RES, V30, P60; Nichols RA, 2011, EPIDEMICS-NETH, V3, P12, DOI 10.1016/j.epidem.2010.11.003; Nyiro JU, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-155; Ogunjimi B, 2014, J MED VIROL, V86, P812, DOI 10.1002/jmv.23749; Otiti-Sengeri J, 2008, CURR OPIN HIV AIDS, V3, P432, DOI 10.1097/COH.0b013e328302cc3d; Patel P, 2012, SEX TRANSM DIS, V39, P154, DOI 10.1097/OLQ.0b013e318239d7fd; Pearce N, 2004, ENVIRON HEALTH PERSP, V112, P1047, DOI 10.1289/ehp.6927; Rabenau HF, 2010, SEX TRANSM DIS, V37, P454, DOI 10.1097/OLQ.0b013e3181cfcc2b; Silhol R, 2010, EPIDEMIOL INFECT, V138, P482, DOI 10.1017/S0950268809990896; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Smith MZ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-100; STATISTICS SOUTH AFRICA, 2012, S AFR I KNOW HOM I U; Stowe RP, 2007, EXP GERONTOL, V42, P563, DOI 10.1016/j.exger.2007.01.005; Stowe RP, 2012, J MED VIROL, V84, P1797, DOI 10.1002/jmv.23397; Uribe-Salas F, 2009, T ROY SOC TROP MED H, V103, P151, DOI 10.1016/j.trstmh.2008.10.033; Wald Anna, 2004, Herpes, V11 Suppl 3, p130A; Weiss H, 2004, HERPES S, V11, p24A; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2005, INT WHO CLIN STAG HI; Wringe A, 2012, TROP MED INT HEALTH, V17, pe38, DOI 10.1111/j.1365-3156.2011.02925.x; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220	41	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99243	10.1371/journal.pone.0099243	http://dx.doi.org/10.1371/journal.pone.0099243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914671	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700075
J	Shin, B; Oh, H; Park, SM; Han, HE; Ye, M; Song, WK; Park, WJ				Shin, Baehyun; Oh, Hyejin; Park, Sang Min; Han, Hye-Eun; Ye, Michael; Song, Woo Keun; Park, Woo Jin			Intracellular Cleavage of Amyloid beta by a Viral Protease NIa Prevents Amyloid beta-Mediated Cytotoxicity	PLOS ONE			English	Article							NEPRILYSIN GENE-TRANSFER; A-BETA; ALZHEIMERS-DISEASE; PLAQUE-FORMATION; SYNAPTIC PLASTICITY; MOUSE MODEL; PEPTIDE; PATHOLOGY; OLIGOMERS; BRAIN	Nuclear inclusion a (NIa) of turnip mosaic virus is a cytosolic protease that cleaves amyloid beta (A beta) when heterologously overexpressed. Lentivirus-mediated expression of NIa in the brains of APP(sw)/PS1 mice significantly reduces cerebral A beta levels and plaque depositions, and improves behavioral deficits. Here, the effects of NIa and neprilysin (NEP), a well-known A beta-cleaving protease, on oligomeric A beta-induced cell death were evaluated. NIa cleaved monomeric and oligomeric A beta at a similar rate, whereas NEP only cleaved monomeric A beta. Oligomeric A beta-induced cytotoxicity and mitochondrial dysfunction were significantly ameliorated by NIa, but not by NEP. Endocytosed fluorescently-labeled A beta localized to mitochondria, and this was significantly reduced by NIa, but not by NEP. These data suggest that NIa may exerts its protective roles by degrading Ab and thus preventing mitochondrial deposition of A beta.	[Shin, Baehyun; Park, Sang Min; Han, Hye-Eun; Ye, Michael; Park, Woo Jin] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Oh, Hyejin; Song, Woo Keun] Gwangju Inst Sci & Technol, Sch Life Sci, Bio Imaging & Cell Dynam Res Ctr, Kwangju, South Korea; [Shin, Baehyun; Oh, Hyejin] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Harvard University; Massachusetts General Hospital	Park, WJ (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea.	woojinpark@me.com	Park, Sang Min/V-9194-2019		National Research Foundation of Korea [2009-0085747]; Global Research Laboratory Program - Korean Government (MEST) [M6-0605-00-0001]; Systems Biology Infrastructure Establishment Grant by GIST	National Research Foundation of Korea(National Research Foundation of Korea); Global Research Laboratory Program - Korean Government (MEST); Systems Biology Infrastructure Establishment Grant by GIST	This work was supported by a grant from the National Research Foundation of Korea (2009-0085747) and by the Global Research Laboratory Program (M6-0605-00-0001) funded by the Korean Government (MEST) and by a grant from the Systems Biology Infrastructure Establishment Grant provided by GIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Chapman KE, 2005, AM J PHYSIOL-LUNG C, V289, pL834, DOI 10.1152/ajplung.00069.2005; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105; Glabe C, 2000, NAT MED, V6, P133, DOI 10.1038/72215; Haass C, 2001, NAT NEUROSCI, V4, P859, DOI 10.1038/nn0901-859; Han HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015645; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Iijima-Ando K, 2008, J BIOL CHEM, V283, P19066, DOI 10.1074/jbc.M710509200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Jungbauer LM, 2009, J MOL RECOGNIT, V22, P403, DOI 10.1002/jmr.948; Kang H, 2001, J GEN VIROL, V82, P3115, DOI 10.1099/0022-1317-82-12-3115; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Kim TK, 2012, EXP MOL MED, V44, P740, DOI 10.3858/emm.2012.44.12.082; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li YP, 1996, BRAIN RES, V738, P196, DOI 10.1016/S0006-8993(96)00733-0; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Magrane J, 2006, EXP CELL RES, V312, P996, DOI 10.1016/j.yexcr.2005.12.009; Marr RA, 2003, J NEUROSCI, V23, P1992; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Sellamuthu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022554; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sirk D, 2007, J NEUROCHEM, V103, P1989, DOI 10.1111/j.1471-4159.2007.04907.x; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Villemagne VL, 2010, J NEUROSCI, V30, P6315, DOI 10.1523/JNEUROSCI.5180-09.2010; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yao J, 2011, J NEUROSCI, V31, P2313, DOI 10.1523/JNEUROSCI.4717-10.2011	44	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98650	10.1371/journal.pone.0098650	http://dx.doi.org/10.1371/journal.pone.0098650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915567	gold, Green Submitted, Green Published			2022-12-25	WOS:000340947700028
J	Wang, R; Munoz, EE; Zhu, SY; McGrath, BC; Cavener, DR				Wang, Rong; Munoz, Elyse E.; Zhu, Siying; McGrath, Barbara C.; Cavener, Douglas R.			Perk Gene Dosage Regulates Glucose Homeostasis by Modulating Pancreatic beta-Cell Functions	PLOS ONE			English	Article							NEONATAL DIABETES-MELLITUS; WOLCOTT-RALLISON-SYNDROME; INSULIN-SECRETION; EIF2-ALPHA KINASE; TRANSLATIONAL CONTROL; PROTEIN-SYNTHESIS; MICE; EIF2AK3; PROLIFERATION; EXPRESSION	Background: Insulin synthesis and cell proliferation are under tight regulation in pancreatic beta-cells to maintain glucose homeostasis. Dysfunction in either aspect leads to development of diabetes. PERK (EIF2AK3) loss of function mutations in humans and mice exhibit permanent neonatal diabetes that is characterized by insufficient beta-cell mass and reduced proinsulin trafficking and insulin secretion. Unexpectedly, we found that Perk heterozygous mice displayed lower blood glucose levels. Methodology: Longitudinal studies were conducted to assess serum glucose and insulin, intracellular insulin synthesis and storage, insulin secretion, and beta-cell proliferation in Perk heterozygous mice. In addition, modulation of Perk dosage specifically in beta-cells showed that the glucose homeostasis phenotype of Perk heterozygous mice is determined by reduced expression of PERK in the beta-cells. Principal Findings: We found that Perk heterozygous mice first exhibited enhanced insulin synthesis and secretion during neonatal and juvenile development followed by enhanced beta-cell proliferation and a substantial increase in beta-cell mass at the adult stage. These differences are not likely to entail the well-known function of PERK to regulate the ER stress response in cultured cells as several markers for ER stress were not differentially expressed in Perk heterozygous mice. Conclusions: In addition to the essential functions of PERK in beta-cells as revealed by severely diabetic phenotype in humans and mice completely deficient for PERK, reducing Perk gene expression by half showed that intermediate levels of PERK have a profound impact on beta-cell functions and glucose homeostasis. These results suggest that an optimal level of PERK expression is necessary to balance several parameters of beta-cell function and growth in order to achieve normoglycemia.	[Wang, Rong; Munoz, Elyse E.; Zhu, Siying; McGrath, Barbara C.; Cavener, Douglas R.] Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cavener, DR (corresponding author), Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA.	drc9@psu.edu	Wang, Rong/M-4503-2019		National Institutes of Health [DK088140]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole, by National Institutes of Health Grant DK088140 (to D.R.C.) www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bobrovnikova-Marjon E, 2008, P NATL ACAD SCI USA, V105, P16314, DOI 10.1073/pnas.0808517105; Cavener DR, 2010, TRENDS ENDOCRIN MET, V21, P714, DOI 10.1016/j.tem.2010.08.005; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Elghazi L, 2006, INT J BIOCHEM CELL B, V38, P157, DOI 10.1016/j.biocel.2005.08.017; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Feng DR, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-61; Greeley SAW, 2011, CURR DIABETES REP, V11, P519, DOI 10.1007/s11892-011-0234-7; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008008; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Iida K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-38; Iwawaki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013052; Kane C, 1996, NAT MED, V2, P1344, DOI 10.1038/nm1296-1344; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Li YL, 2003, ENDOCRINOLOGY, V144, P3505, DOI 10.1210/en.2003-0236; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Owen CR, 2005, J NEUROCHEM, V94, P1235, DOI 10.1111/j.1471-4159.2005.03276.x; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Senee V, 2004, DIABETES, V53, P1876, DOI 10.2337/diabetes.53.7.1876; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Takane KK, 2012, DIABETES, V61, P418, DOI 10.2337/db11-0580; Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010; Uchizono Y, 2007, DIABETES OBES METAB, V9, P56, DOI 10.1111/j.1463-1326.2007.00774.x; Usui M, 2012, METABOLISM, V61, P1118, DOI 10.1016/j.metabol.2012.01.004; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	43	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99684	10.1371/journal.pone.0099684	http://dx.doi.org/10.1371/journal.pone.0099684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915520	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700126
J	Peng, C; Chen, JG; Tang, W; Liu, CL; Chen, XL				Peng, Can; Chen, Jungang; Tang, Wei; Liu, Chunlan; Chen, Xulin			Kaposi's Sarcoma-Associated Herpesvirus ORF6 Gene Is Essential in Viral Lytic Replication	PLOS ONE			English	Article							DNA-BINDING PROTEIN; EPSTEIN-BARR-VIRUS; OPEN READING FRAME; FUNCTIONAL INTERACTION; B-CELLS; EXPRESSION; INFECTION; LATENCY; GENOME; ICP8	Kaposi's sarcoma associated herpesvirus (KSHV) is associated with Kaposis's sarcoma (KS), primary effusion lymphoma and multicentric Castleman's disease. KSHV encodes at least 8 open reading frames (ORFs) that play important roles in its lytic DNA replication. Among which, ORF6 of KSHV encodes an ssDNA binding protein that has been proved to participate in origin-dependent DNA replication in transient assays. To define further the function of ORF6 in the virus life cycle, we constructed a recombinant virus genome with a large deletion within the ORF6 locus by using a bacterial artificial chromosome (BAC) system. Stable 293T cells carrying the BAC36 (wild type) and BAC Delta 6 genomes were generated. When monolayers of 293T-BAC36 and 293T-BAC Delta 6 cells were induced with 12-O-tetradecanoylphorbol-13-acetate (TPA) and sodium butyrate, infectious virus was detected from the 293T-BAC36 cell supernatants only and not from the 293T-BAC Delta 6 cell supernatants. DNA synthesis was defective in 293T-BAC Delta 6 cells. Expression of ORF6 in trans in BAC Delta 6-containing cells was able to rescue both defects. Our results provide genetic evidence that ORF6 is essential for KSHV lytic replication. The stable 293T cells carrying the BAC36 and BAC Delta 6 genomes could be used as tools to investigate the detailed functions of ORF6 in the lytic replication of KSHV.	[Peng, Can; Chen, Jungang; Tang, Wei; Liu, Chunlan; Chen, Xulin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Chen, XL (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	chenxl@wh.iov.cn			National Natural Science Foundation of China [31070151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (grant 31070151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AuCoin DP, 2004, VIROLOGY, V318, P542, DOI 10.1016/j.virol.2003.10.016; Bechtel JT, 2003, J VIROL, V77, P6474, DOI 10.1128/JVI.77.11.6474-6481.2003; Brulois KF, 2012, J VIROLOGY; Budt M, 2011, J VIROL, V85, P10415, DOI 10.1128/JVI.05071-11; BUSH M, 1991, J VIROL, V65, P1082, DOI 10.1128/JVI.65.3.1082-1089.1991; Chen L, 2005, J VIROL, V79, P14383, DOI 10.1128/JVI.79.22.14383-14391.2005; Cohen JI, 2007, J VIROL, V81, P1586, DOI 10.1128/JVI.01220-06; DECAUSSIN G, 1995, J VIROL, V69, P7309, DOI 10.1128/JVI.69.11.7309-7314.1995; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Falkenberg M, 1998, J BIOL CHEM, V273, P32154, DOI 10.1074/jbc.273.48.32154; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; GAO M, 1991, J VIROL, V65, P2666, DOI 10.1128/JVI.65.5.2666-2675.1991; GAO M, 1989, J VIROL, V63, P5258, DOI 10.1128/JVI.63.12.5258-5267.1989; GODOWSKI PJ, 1986, P NATL ACAD SCI USA, V83, P256, DOI 10.1073/pnas.83.2.256; He H, 2001, ARCH VIR S, V17, P57; He XD, 2001, P NATL ACAD SCI USA, V98, P3024, DOI 10.1073/pnas.061028298; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; KINCHINGTON PR, 1988, J VIROL, V62, P802, DOI 10.1128/JVI.62.3.802-809.1988; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Lu M, 2004, J VIROL, V78, P13637, DOI 10.1128/JVI.78.24.13637-13652.2004; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Majerciak V, 2007, J VIROL, V81, P1062, DOI 10.1128/JVI.01558-06; McNamee EE, 2000, J VIROL, V74, P10122, DOI 10.1128/JVI.74.21.10122-10131.2000; Miller G, 1997, J VIROL, V71, P314, DOI 10.1128/JVI.71.1.314-324.1997; Nicholas J, 1997, J VIROL, V71, P1963, DOI 10.1128/JVI.71.3.1963-1974.1997; Parravicini C, 2000, AM J PATHOL, V156, P743, DOI 10.1016/S0002-9440(10)64940-1; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Sathish N, 2010, VIROLOGY IN PRESS; Song MJ, 2005, P NATL ACAD SCI USA, V102, P3805, DOI 10.1073/pnas.0404521102; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Tibbetts SA, 2006, VIROLOGY, V353, P210, DOI 10.1016/j.virol.2006.05.020; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Wang Y, 2004, J VIROL, V78, P8615, DOI 10.1128/JVI.78.16.8615-8629.2004; Wang Y, 2008, J VIROL, V82, P2867, DOI 10.1128/JVI.01319-07; Wang Y, 2011, J VIROL, V85, P1943, DOI 10.1128/JVI.02060-10; Wu FY, 2001, J VIROL, V75, P1487, DOI 10.1128/JVI.75.3.1487-1506.2001; Xu YY, 2006, J VIROL, V80, P9905, DOI 10.1128/JVI.01004-06; Yakushko Y, 2011, J VIROL, V85, P4612, DOI 10.1128/JVI.02068-10; Ye FC, 2004, J VIROL, V78, P11121, DOI 10.1128/JVI.78.20.11121-11129.2004; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005	47	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99542	10.1371/journal.pone.0099542	http://dx.doi.org/10.1371/journal.pone.0099542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911362	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600104
J	Zhang, YY; Guo, H; Deis, JA; Mashek, MG; Zhao, M; Ariyakumar, D; Armien, AG; Bernlohr, DA; Mashek, DG; Chen, XL				Zhang, Yuanyuan; Guo, Hong; Deis, Jessica A.; Mashek, Mara G.; Zhao, Ming; Ariyakumar, DonSanjiv; Armien, Anibal G.; Bernlohr, David A.; Mashek, Douglas G.; Chen, Xiaoli			Lipocalin 2 Regulates Brown Fat Activation via a Nonadrenergic Activation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP KINASE; ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; ENERGY-EXPENDITURE; PROTEIN-KINASE; COLD-EXPOSURE; BETA; ADIPOCYTES; INSULIN; GENE	In this study, we report that lipocalin 2 (Lcn2), a recently characterized adipokine/cytokine, is a novel regulator of brown adipose tissue (BAT) activation by modulating the adrenergic independent p38 MAPK-PGC-1 alpha-UCP1 pathway. Global Lcn2 knock-out (Lcn2(-/-)) mice have defective BAT thermogenic activation caused by cold stimulation and decreased BAT activity under high fat diet-induced obesity. Nevertheless, Lcn2(-/-) mice maintain normal sympathetic nervous system activation as evidenced by normal catecholamine release and lipolytic activity in response to cold stimulation. Further studies showed that Lcn2 deficiency impairs peroxisomal and mitochondrial oxidation of lipids and attenuates cold-induced Pgc1a and Ucp1 expression and p38 MAPK phosphorylation in BAT. Moreover, in vitro studies showed that Lcn2 deficiency reduces the thermogenic activity of brown adipocytes. Lcn2(-/-) differentiated brown adipocytes have significantly decreased expression levels of brown fat markers, decreased p38 MAPK phosphorylation, and decreased mitochondrial oxidation capacity. However, Lcn2(-/-) brown adipocytes have normal norepinephrine-stimulated p38 MAPK and hormone-sensitive lipase phosphorylation and Pgc1a and Ucp1 expression, suggesting an intact beta-adrenergic signaling activation. More intriguingly, recombinant Lcn2 was able to significantly stimulate p38 MAPK phosphorylation in brown adipocytes. Activating peroxisome proliferator-activated receptor gamma, a downstream effector of PGC-1 alpha, by thiazolidinedione administration fully reverses the BAT function of Lcn2(-/-) mice. Our findings provide evidence for the novel role Lcn2 plays in oxidative metabolism and BAT activation via an adrenergic independent mechanism.	[Zhang, Yuanyuan; Guo, Hong; Deis, Jessica A.; Mashek, Mara G.; Zhao, Ming; Mashek, Douglas G.; Chen, Xiaoli] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA; [Ariyakumar, DonSanjiv; Armien, Anibal G.] Univ Minnesota, Dept Vet Populat Med, Minnesota Vet Diagnost Lab, St Paul, MN 55108 USA; [Bernlohr, David A.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Chen, XL (corresponding author), Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN 55108 USA.	xlchen@umn.edu	Zhao, Ming/B-3341-2018; Mashek, Douglas/ABD-6844-2021	Guo, Hong/0000-0001-8024-7086; Mashek, Douglas/0000-0001-7033-3386	National Institutes of Health from the NIDDK [R01DK080743, 2P30DK050456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456, R01DK080743] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK080743 (to X. C.) and 2P30DK050456 (to Minnesota Obesity Center) from the NIDDK.	Bagattin A, 2010, P NATL ACAD SCI USA, V107, P20376, DOI 10.1073/pnas.1009176107; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Chen XL, 1997, BBA-MOL CELL RES, V1359, P136, DOI 10.1016/S0167-4889(97)00083-9; Collins S, 2010, INT J OBESITY, V34, pS28, DOI 10.1038/ijo.2010.180; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Fujishiro M, 2001, J BIOL CHEM, V276, P19800, DOI 10.1074/jbc.M101087200; Geiger PC, 2005, AM J PHYSIOL-ENDOC M, V288, pE782, DOI 10.1152/ajpendo.00477.2004; Guo H, 2013, ENDOCRINOLOGY, V154, P3525, DOI 10.1210/en.2013-1289; Guo H, 2012, ENDOCRINOLOGY, V153, P1183, DOI 10.1210/en.2011-1642; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; Jin DZ, 2011, FASEB J, V25, P754, DOI 10.1096/fj.10-165175; KRAMAR R, 1986, J CLIN CHEM CLIN BIO, V24, P109; LALONDE JM, 1994, FASEB J, V8, P1240, DOI 10.1096/fasebj.8.15.8001736; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; NEDERGAARD J, 1980, AM J PHYSIOL, V239, pC208, DOI 10.1152/ajpcell.1980.239.5.C208; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Paton CM, 2013, OBESITY, V21, pE640, DOI 10.1002/oby.20507; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Somwar R, 2000, DIABETES, V49, P1794, DOI 10.2337/diabetes.49.11.1794; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; TRAYHURN P, 1981, BIOCHIM BIOPHYS ACTA, V664, P549, DOI 10.1016/0005-2760(81)90132-6; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Warszawska JM, 2013, J CLIN INVEST, V123, P3363, DOI 10.1172/JCI67911; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096997; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	47	47	48	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22063	22077		10.1074/jbc.M114.559104	http://dx.doi.org/10.1074/jbc.M114.559104			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24917675	hybrid, Green Published			2022-12-25	WOS:000340593500023
J	Zheng, M; Chiang, YL; Lee, HL; Kong, LR; Hsu, STD; Hwang, IS; Rothfield, LI; Shih, YL				Zheng, Min; Chiang, Ya-Ling; Lee, Hsiao-Lin; Kong, Lih-Ren; Hsu, Shang-Te Danny; Hwang, Ing-Shouh; Rothfield, Lawrence I.; Shih, Yu-Ling			Self-Assembly of MinE on the Membrane Underlies Formation of the MinE Ring to Sustain Function of the Escherichia coli Min System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOLOGICAL SPECIFICITY FACTOR; DIVISION SITE SELECTION; TO-POLE OSCILLATION; CELL-DIVISION; CORRECT PLACEMENT; PROPER PLACEMENT; INHIBITOR MINC; RAPID POLE; IN-VITRO; PROTEIN	The pole-to-pole oscillation of the Min proteins in Escherichia coli results in the inhibition of aberrant polar division, thus facilitating placement of the division septum at the midcell. MinE of the Min system forms a ring-like structure that plays a critical role in triggering the oscillation cycle. However, the mechanism underlying the formation of the MinE ring remains unclear. This study demonstrates that MinE self-assembles into fibrillar structures on the supported lipid bilayer. The MinD-interacting domain of MinE shows amyloidogenic properties, providing a possible mechanism for self-assembly of MinE. Supporting the idea, mutations in residues Ile-24 and Ile-25 of the MinD-interacting domain affect fibril formation, membrane binding ability of MinE and MinD, and subcellular localization of three Min proteins. Additional mutations in residues Ile-72 and Ile-74 suggest a role of the C-terminal domain of MinE in regulating the folding propensity of the MinD-interacting domain for different molecular interactions. The study suggests a self-assembly mechanism that may underlie the ring-like structure formed by MinE-GFP observed in vivo.	[Zheng, Min; Lee, Hsiao-Lin; Kong, Lih-Ren; Hsu, Shang-Te Danny; Shih, Yu-Ling] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Chiang, Ya-Ling; Hwang, Ing-Shouh] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 013, Taiwan; [Hsu, Shang-Te Danny; Shih, Yu-Ling] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan; [Hwang, Ing-Shouh] Acad Sinica, Inst Phys, Taipei 115, Taiwan; [Rothfield, Lawrence I.] Univ Connecticut, Ctr Hlth, Dept Struct Microbial & Mol Biol, Farmington, CT 06032 USA	Academia Sinica - Taiwan; National Tsing Hua University; National Taiwan University; Academia Sinica - Taiwan; University of Connecticut	Shih, YL (corresponding author), Acad Sinica, Inst Biol Chem, 128 Sec 2 Acad Rd, Taipei 115, Taiwan.	ylshih10@gate.sinica.edu.tw	Hsu, Shang-Te Danny/L-2826-2014; Hsu, Shang-Te Danny/B-2324-2009; Hwang, Ing-Shouh/AAP-3963-2021; Shih, Yu-Ling/F-8396-2011	Hsu, Shang-Te Danny/0000-0002-7231-0185; Hwang, Ing-Shouh/0000-0002-7670-1212; Shih, Yu-Ling/0000-0002-8232-2569; LEE, Hsiao-Lin/0000-0002-4828-3383	Career Development Award from Academia Sinica [AS-98-CDA-L07]; Ministry of Science and Technology of Taiwan [NSC 102-2311-B-001-020-MY3, NSC 102-2811-B-001-076, NSC 99-2112-B-001-029-MY3]; International Human Frontier Science Program [HFSP CDA-00025/2010-C]; National Institutes of Health [R37-06032]	Career Development Award from Academia Sinica; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); International Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Career Development Award from Academia Sinica (AS-98-CDA-L07) and a general research grant from the Ministry of Science and Technology of Taiwan (NSC 102-2311-B-001-020-MY3) (to Y.-L. S.).; Supported by a postdoctoral fellowship from the Ministry of Science and Technology of Taiwan (NSC 102-2811-B-001-076).; Supported in part by a Career Development Award from the International Human Frontier Science Program (HFSP CDA-00025/2010-C).; Supported by Ministry of Science and Technology of Taiwan (NSC 99-2112-B-001-029-MY3).; Supported by Grant R37-06032 from the National Institutes of Health.	Adamcik J, 2012, MACROMOLECULES, V45, P1137, DOI 10.1021/ma202157h; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Ghasriani H, 2010, P NATL ACAD SCI USA, V107, P18416, DOI 10.1073/pnas.1007141107; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Hwang IS, 2013, ULTRAMICROSCOPY, V135, P121, DOI 10.1016/j.ultramic.2012.07.001; Kang GB, 2010, MOL MICROBIOL, V76, P1222, DOI 10.1111/j.1365-2958.2010.07160.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; King GF, 1999, MOL MICROBIOL, V31, P1161, DOI 10.1046/j.1365-2958.1999.01256.x; King GF, 2000, NAT STRUCT BIOL, V7, P1013, DOI 10.1038/80917; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Ma LY, 2003, J BACTERIOL, V185, P4948, DOI 10.1128/JB.185.16.4948-4955.2003; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rowland SL, 2000, J BACTERIOL, V182, P613, DOI 10.1128/JB.182.3.613-619.2000; Sambrook J., 2006, CONDENSED PROTOCOLS, P756; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Shih YL, 2005, MOL MICROBIOL, V58, P917, DOI 10.1111/j.1365-2958.2005.04841.x; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Shih YL, 2013, ENVIRON MICROBIOL, V15, P3229, DOI 10.1111/1462-2920.12119; Shih YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021425; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Zhou H, 2003, J BACTERIOL, V185, P4326, DOI 10.1128/JB.185.15.4326-4335.2003	41	12	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21252	21266		10.1074/jbc.M114.571976	http://dx.doi.org/10.1074/jbc.M114.571976			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24914211	hybrid, Green Published			2022-12-25	WOS:000340558300005
J	Ido, K; Nield, J; Fukao, Y; Nishimura, T; Sato, F; Ifuku, K				Ido, Kunio; Nield, Jon; Fukao, Yoichiro; Nishimura, Taishi; Sato, Fumihiko; Ifuku, Kentaro			Cross-linking Evidence for Multiple Interactions of the PsbP and PsbQ Proteins in a Higher Plant Photosystem II Supercomplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; 33 KDA PROTEIN; EXTRINSIC PROTEINS; CRYSTAL-STRUCTURE; FUNCTIONAL-PROPERTIES; BINDING; REVEALS; PSII; ARABIDOPSIS; ASSEMBLY/STABILITY	The extrinsic subunits of membrane-bound photosystem II (PSII) maintain an essential role in optimizing the water-splitting reaction of the oxygen-evolving complex (OEC), even though they have undergone drastic change during the evolution of oxyphototrophs from symbiotic cyanobacteria to chloroplasts. Two specific extrinsic proteins, PsbP and PsbQ, bind to the lumenal surface of PSII in green plants and maintain OEC conformation and stabilize overall enzymatic function; however, their precise location has not been fully resolved. In this study, PSII-enriched membranes, isolated from spinach, were subjected to chemical cross-linking combined with release-reconstitution experiments. We observed direct interactions between PsbP and PsbE, as well as with PsbR. Intriguingly, PsbP and PsbQ were further linked to the CP26 and CP43 light-harvesting proteins. In addition, two cross-linked sites, between PsbP and PsbR, and that of PsbP and CP26, were identified by tandem mass spectrometry. These data were used to estimate the binding topology and location of PsbP, and the putative positioning of PsbQ and PsbR on the lumenal surface of the PSII. Our model gives new insights into the organization of PSII extrinsic subunits in higher plants and their function in stabilizing the OEC of the PSII supercomplex.	[Ido, Kunio; Nishimura, Taishi; Sato, Fumihiko; Ifuku, Kentaro] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Nield, Jon] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Fukao, Yoichiro] Nara Inst Sci & Technol, Plant Global Educ Project, Ikoma 6300192, Japan	Kyoto University; University of London; Queen Mary University London; Nara Institute of Science & Technology	Ifuku, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan.	ifuku@kais.kyoto-u.ac.jp	Nield, Jon/C-5892-2013; Ifuku, Kentaro/H-2455-2013; Sato, Fumihiko/C-1078-2011	Nield, Jon/0000-0001-9983-0239; Sato, Fumihiko/0000-0001-9497-4452; Ifuku, Kentaro/0000-0003-0241-8008	Japan Science and Technology Agency PRESTO; JSPS [18770032]; The Royal Society; Grants-in-Aid for Scientific Research [26660087] Funding Source: KAKEN	Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); The Royal Society(Royal Society of London); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from Japan Science and Technology Agency PRESTO (to Ke. I.) and by Grant-in-aid for Young Scientists (B) from 18770032JSPS (to Ke. I.).; Supported by The Royal Society through their University Research Fellowship program.	Allahverdiyeva Y, 2013, PLANT J, V75, P671, DOI 10.1111/tpj.12230; Balsera M, 2005, J MOL BIOL, V350, P1051, DOI 10.1016/j.jmb.2005.05.044; BERNIER M, 1995, FEBS LETT, V360, P251, DOI 10.1016/0014-5793(95)00101-E; Bricker TM, 2013, PHOTOSYNTH RES, V116, P235, DOI 10.1007/s11120-013-9820-7; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Calderone V, 2003, EMBO REP, V4, P900, DOI 10.1038/sj.embor.embor923; De Las Rivas J, 2005, PHOTOCH PHOTOBIO SCI, V4, P1003, DOI 10.1039/b506874f; Ido K, 2012, J BIOL CHEM, V287, P26377, DOI 10.1074/jbc.M112.385286; Ido K, 2009, BBA-BIOENERGETICS, V1787, P873, DOI 10.1016/j.bbabio.2009.03.004; Ifuku K, 2004, EMBO REP, V5, P362, DOI 10.1038/sj.embor.7400113; Ifuku K, 2001, BBA-PROTEIN STRUCT M, V1546, P196, DOI 10.1016/S0167-4838(01)00139-X; Ifuku K, 2011, J PHOTOCH PHOTOBIO B, V104, P158, DOI 10.1016/j.jphotobiol.2011.02.006; Kakiuchi S, 2012, BBA-BIOENERGETICS, V1817, P1346, DOI 10.1016/j.bbabio.2012.01.009; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kopecky V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046694; Liu HJ, 2014, P NATL ACAD SCI USA, V111, P4638, DOI 10.1073/pnas.1323063111; Liu HJ, 2009, ARCH BIOCHEM BIOPHYS, V489, P34, DOI 10.1016/j.abb.2009.07.014; Meades GD, 2005, BIOCHEMISTRY-US, V44, P15216, DOI 10.1021/bi051704u; MIYAO M, 1988, BIOCHIM BIOPHYS ACTA, V936, P465, DOI 10.1016/0005-2728(88)90024-2; MIYAO M, 1989, BIOCHIM BIOPHYS ACTA, V977, P315, DOI 10.1016/S0005-2728(89)80086-6; Nagao R, 2010, J BIOL CHEM, V285, P29191, DOI 10.1074/jbc.M110.146092; Nagao R, 2010, PLANT CELL PHYSIOL, V51, P718, DOI 10.1093/pcp/pcq042; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; Nishimura T, 2014, BBA-BIOENERGETICS, V1837, P1447, DOI 10.1016/j.bbabio.2013.12.012; Ohta H, 2003, EUR J BIOCHEM, V270, P4156, DOI 10.1046/j.1432-1033.2003.03810.x; Pagliano C, 2014, BBA-BIOENERGETICS, V1837, P1454, DOI 10.1016/j.bbabio.2013.11.004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; SEIDLER A, 1994, BBA-BIOENERGETICS, V1187, P73, DOI 10.1016/0005-2728(94)90168-6; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Suorsa M, 2006, J BIOL CHEM, V281, P145, DOI 10.1074/jbc.M510600200; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; Tohri A, 2004, EUR J BIOCHEM, V271, P962, DOI 10.1111/j.1432-1033.2004.03998.x; Tomita M, 2009, BIOCHEMISTRY-US, V48, P6318, DOI 10.1021/bi9006308; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vinyard DJ, 2013, ANNU REV BIOCHEM, V82, P577, DOI 10.1146/annurev-biochem-070511-100425; Xu H, 2010, J PROTEOME RES, V9, P3384, DOI 10.1021/pr100369y; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; YAMAMOTO Y, 1988, J BIOL CHEM, V263, P497; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2006, J BIOL CHEM, V281, P26260, DOI 10.1074/jbc.M603582200; Yu H, 2006, BIOCHEMISTRY-US, V45, P3404, DOI 10.1021/bi051604o	44	39	42	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20150	20157		10.1074/jbc.M114.574822	http://dx.doi.org/10.1074/jbc.M114.574822			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24914208	hybrid, Green Published			2022-12-25	WOS:000339395200028
J	Brodland, GW; Veldhuis, JH; Kim, S; Perrone, M; Mashburn, D; Hutson, MS				Brodland, G. Wayne; Veldhuis, Jim H.; Kim, Steven; Perrone, Matthew; Mashburn, David; Hutson, M. Shane			CellFIT: A Cellular Force-Inference Toolkit Using Curvilinear Cell Boundaries	PLOS ONE			English	Article							LASER MICROSURGERY; FINITE-ELEMENT; DORSAL CLOSURE; MECHANICS; MORPHOGENESIS; ADHESION; INVAGINATION; INSIGHTS; REVEALS; TENSION	Mechanical forces play a key role in a wide range of biological processes, from embryogenesis to cancer metastasis, and there is considerable interest in the intuitive question, "Can cellular forces be inferred from cell shapes?'' Although several groups have posited affirmative answers to this stimulating question, nagging issues remained regarding equation structure, solution uniqueness and noise sensitivity. Here we show that the mechanical and mathematical factors behind these issues can be resolved by using curved cell edges rather than straight ones. We present a new package of force-inference equations and assessment tools and denote this new package CellFIT, the Cellular Force Inference Toolkit. In this approach, cells in an image are segmented and equilibrium equations are constructed for each triple junction based solely on edge tensions and the limiting angles at which edges approach each junction. The resulting system of tension equations is generally overdetermined. As a result, solutions can be obtained even when a modest number of edges need to be removed from the analysis due to short length, poor definition, image clarity or other factors. Solving these equations yields a set of relative edge tensions whose scaling must be determined from data external to the image. In cases where intracellular pressures are also of interest, Laplace equations are constructed to relate the edge tensions, curvatures and cellular pressure differences. That system is also generally overdetermined and its solution yields a set of pressures whose offset requires reference to the surrounding medium, an open wound, or information external to the image. We show that condition numbers, residual analyses and standard errors can provide confidence information about the inferred forces and pressures. Application of CellFIT to several live and fixed biological tissues reveals considerable force variability within a cell population, significant differences between populations and elevated tensions along heterotypic boundaries.	[Brodland, G. Wayne; Veldhuis, Jim H.; Kim, Steven; Perrone, Matthew] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada; [Mashburn, David; Hutson, M. Shane] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Hutson, M. Shane] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Hutson, M. Shane] Vanderbilt Univ, Vanderbilt Inst Integrat Biosyst Res & Educ, Nashville, TN 37235 USA	University of Waterloo; Vanderbilt University; Vanderbilt University; Vanderbilt University	Brodland, GW (corresponding author), Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada.	brodland@uwaterloo.ca		Perrone, Matthew/0000-0002-3720-212X	National Institutes of Health [1R01-GM099107]; Natural Sciences and Engineering Research Council of Canada (NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (1R01-GM099107), http://www.nih.gov/, and Natural Sciences and Engineering Research Council of Canada (NSERC), http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anon E, 2012, P NATL ACAD SCI USA, V109, P10891, DOI 10.1073/pnas.1117814109; Benko R, 2007, ANN BIOMED ENG, V35, P672, DOI 10.1007/s10439-006-9250-1; Beucher S., 1992, MATH MORPHOLOGY IMAG, V34, P433; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Brodland G. W., 2004, Applied Mechanics Review, V57, P47, DOI 10.1115/1.1583758; Brodland G. Wayne, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P89; Brodland GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044281; Brodland GW, 2010, P NATL ACAD SCI USA, V107, P22111, DOI 10.1073/pnas.1006591107; Brodland GW, 2010, HFSP J, V4, P142, DOI 10.2976/1.3338713; BRODLAND GW, 1994, J BIOMECH ENG-T ASME, V116, P146, DOI 10.1115/1.2895713; Brodland GW, 2000, J BIOMECH ENG-T ASME, V122, P402, DOI 10.1115/1.1288205; Campas O, 2014, NAT METHODS, V11, P183, DOI [10.1038/NMETH.2761, 10.1038/nmeth.2761]; Capitanio M, 2013, BIOPHYS J, V105, P1293, DOI 10.1016/j.bpj.2013.08.007; Chen HH, 2000, J BIOMECH ENG-T ASME, V122, P394, DOI 10.1115/1.1286563; Chen XG, 2009, J MECH BEHAV BIOMED, V2, P494, DOI 10.1016/j.jmbbm.2008.12.004; Chen XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015003; Cheney E, 1994, NUMERICAL MATH COMPU, V3rd; Chiou KK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002512; Coelho L. P., 2013, J OPEN RES SOFTWARE, V1; Conte V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034473, 10.1371/journal.pone.0037062]; Conte V, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016010; Cook RD, 1999, ADV MECH MAT; Cranston PG, 2010, ANN BIOMED ENG; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Davidson LA, 2008, CURR TOP DEV BIOL, V81, P113, DOI 10.1016/S0070-2153(07)81003-9; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Hayashi Fumio, 2000, ECONOMETRICS; Hibbeler R.C., 2005, MECH MAT, V6th ed.; Hibbeler R. C., 2011, STATICS MECH MAT; Hutson MS, 2009, BIOPHYS J, V97, P3075, DOI 10.1016/j.bpj.2009.09.034; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Ishihara S, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13045-8; Ishihara S, 2012, J THEOR BIOL, V313, P201, DOI 10.1016/j.jtbi.2012.08.017; Kasza KE, 2011, COLD SPRING HARB PRO, V2011; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Kwiesielewicz M, 1996, EUR J OPER RES, V93, P611, DOI 10.1016/0377-2217(95)00079-8; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Ma XY, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036004; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Martin AC, 2010, DEV BIOL, V341, P114, DOI 10.1016/j.ydbio.2009.10.031; Mashburn DN, 2012, CYTOM PART A, V81A, P409, DOI 10.1002/cyto.a.22034; Miller CJ, 2013, NAT REV GENET, V14, P733, DOI 10.1038/nrg3513; Morimatsu M, 2013, NANO LETT, V13, P3985, DOI 10.1021/nl4005145; Oda H, 2001, J CELL SCI, V114, P493; Ohnishi Y, 2014, NAT CELL BIOL, V16, P27, DOI 10.1038/ncb2881; Peralta XG, 2007, BIOPHYS J, V92, P2583, DOI 10.1529/biophysj.106.094110; Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547; RAPPAPORT R, 1977, J EXP ZOOL, V201, P375, DOI 10.1002/jez.1402010304; Schock F, 2003, GENE DEV, V17, P597, DOI 10.1101/gad.1068403; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; STEIN MB, 1982, J THEOR BIOL, V97, P625, DOI 10.1016/0022-5193(82)90363-0; Tambe DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055172; Thomas G, 2013, JOVE-J VIS EXP, DOI 10.3791/50497; Thompson D. W., 1917, GROWTH FORM; Varner VD, 2010, DEVELOPMENT, V137, P3801, DOI 10.1242/dev.054387; Wong VW, 2011, J INVEST DERMATOL, V131, P2186, DOI 10.1038/jid.2011.212; Yim EKF, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt132	60	74	74	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99116	10.1371/journal.pone.0099116	http://dx.doi.org/10.1371/journal.pone.0099116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921257	Green Submitted, Green Published, gold			2022-12-25	WOS:000338701300032
J	Drusco, A; Nuovo, GJ; Zanesi, N; Di Leva, G; Pichiorri, F; Volinia, S; Fernandez, C; Antenucci, A; Costinean, S; Bottoni, A; Rosito, IA; Liu, CG; Burch, A; Acunzo, M; Pekarsky, Y; Alder, H; Ciardi, A; Croce, CM				Drusco, Alessandra; Nuovo, Gerard J.; Zanesi, Nicola; Di Leva, Gianpiero; Pichiorri, Flavia; Volinia, Stefano; Fernandez, Cecilia; Antenucci, Anna; Costinean, Stefan; Bottoni, Arianna; Rosito, Immacolata A.; Liu, Chang-Gong; Burch, Aaron; Acunzo, Mario; Pekarsky, Yuri; Alder, Hansjuerg; Ciardi, Antonio; Croce, Carlo M.			MicroRNA Profiles Discriminate among Colon Cancer Metastasis	PLOS ONE			English	Article							EXPRESSION PROFILES; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; BREAST-CANCER; LYMPH-NODES; SURVIVAL; MIR-21; MELANOMA; INVASION; STAGE	MicroRNAs are being exploited for diagnosis, prognosis and monitoring of cancer and other diseases. Their high tissue specificity and critical role in oncogenesis provide new biomarkers for the diagnosis and classification of cancer as well as predicting patients' outcomes. MicroRNAs signatures have been identified for many human tumors, including colorectal cancer (CRC). In most cases, metastatic disease is difficult to predict and to prevent with adequate therapies. The aim of our study was to identify a microRNA signature for metastatic CRC that could predict and differentiate metastatic target organ localization. Normal and cancer tissues of three different groups of CRC patients were analyzed. RNA microarray and TaqMan Array analysis were performed on 66 Italian patients with or without lymph nodes and/or liver recurrences. Data obtained with the two assays were analyzed separately and then intersected to identify a primary CRC metastatic signature. Five differentially expressed microRNAs (hsa-miR-21, -103, -93, -31 and -566) were validated by qRT-PCR on a second group of 16 American metastatic patients. In situ hybridization was performed on the 16 American patients as well as on three distinct commercial tissues microarray (TMA) containing normal adjacent colon, the primary adenocarcinoma, normal and metastatic lymph nodes and liver. Hsa-miRNA-21, -93, and -103 upregulation together with hsa-miR-566 downregulation defined the CRC metastatic signature, while in situ hybridization data identified a lymphonodal invasion profile. We provided the first microRNAs signature that could discriminate between colorectal recurrences to lymph nodes and liver and between colorectal liver metastasis and primary hepatic tumor.	[Drusco, Alessandra; Nuovo, Gerard J.; Zanesi, Nicola; Di Leva, Gianpiero; Pichiorri, Flavia; Volinia, Stefano; Fernandez, Cecilia; Costinean, Stefan; Bottoni, Arianna; Burch, Aaron; Acunzo, Mario; Pekarsky, Yuri; Alder, Hansjuerg; Croce, Carlo M.] Ohio State Univ, MVIMG, Columbus, OH 43210 USA; [Volinia, Stefano] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Antenucci, Anna; Rosito, Immacolata A.] Regina Elena Inst Canc Res, UOSD Clin Pathol, Rome, Italy; [Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut Unit 1950, Houston, TX 77030 USA; [Ciardi, Antonio] Univ Roma La Sapienza, Dept Radiol & Oncol Sci & Pathol, I-00185 Rome, Italy	University System of Ohio; Ohio State University; University of Ferrara; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Texas System; UTMD Anderson Cancer Center; Sapienza University Rome	Croce, CM (corresponding author), Ohio State Univ, MVIMG, Columbus, OH 43210 USA.	carlo.croce@osumc.edu	Volinia, Stefano/A-3029-2010; Young, Richard A/F-6495-2012; Acunzo, Mario/ABE-1739-2020; Volinia, Stefano/AAA-9264-2019	Volinia, Stefano/0000-0003-0910-3893; Young, Richard A/0000-0001-8855-8647; Volinia, Stefano/0000-0003-0910-3893; Acunzo, Mario/0000-0002-3942-9061; Di Leva, Gianpiero/0000-0001-6759-8682; Ciardi, Antonio/0000-0001-8480-6236	NIH [U01 CA152785]; NATIONAL CANCER INSTITUTE [R21CA152785, P30CA016058] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NIH Grant U01 CA152785 microRNAs/UCRs: biomarkers for cancer risk, tumor detection, progression and treatment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Barshack I, 2010, INT J BIOCHEM CELL B, V42, P1355, DOI 10.1016/j.biocel.2009.02.021; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Chen RF, 2010, CLIN EXP ALLERGY, V40, P1482, DOI 10.1111/j.1365-2222.2010.03592.x; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Choi HK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-267; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Donnem T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029671; EDMONSON H, 1987, NEOPLASMS LIVER, P1109; Eggermont AMM, 2000, RECENT RESULTS CANC, V157, P178; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Gao W, 2012, BIOMED PHARMACOTHER, V66, P21, DOI 10.1016/j.biopha.2011.09.004; Garden OJ, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.098053; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Grunder E, 2011, EUR J CANCER, V47, P2479, DOI 10.1016/j.ejca.2011.06.041; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hayashi T, 2011, DEV BIOL, V352, P299, DOI 10.1016/j.ydbio.2011.01.030; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Leite KR, 2011, UROL ONCOL; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma XJ, 2006, ARCH PATHOL LAB MED, V130, P465; MacKie RM, 2003, NEW ENGL J MED, V348, P567, DOI 10.1056/NEJM200302063480620; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Neely LA, 2010, UROL ONCOL-SEMIN ORI, V28, P39, DOI 10.1016/j.urolonc.2008.06.006; Nuovo GJ, 2008, METHODS, V44, P39, DOI 10.1016/j.ymeth.2007.10.008; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pavlidis N, 2003, EUR J CANCER, V39, P1990, DOI 10.1016/S0959-8049(03)00547-1; Pedrioli DML, 2010, MOL CELL BIOL, V30, P3620, DOI 10.1128/MCB.00185-10; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Poritz LS, 2011, SURGERY, V150, P649, DOI 10.1016/j.surg.2011.07.049; Ramachandra RK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-41; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Riethmuller G, 2001, SEMIN CANCER BIOL, V11, P307, DOI 10.1006/scbi.2001.0386; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Salhab M, 2011, SURG ONCOL, V20, pE195, DOI 10.1016/j.suronc.2011.06.006; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; Simon R, 2007, CANCER INFORM, V3, P11; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Storli KE, 2011, INT J COLORECTAL DIS, V26, P1299, DOI 10.1007/s00384-011-1244-2; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Ulmer A, 2005, CLIN CANCER RES, V11, P5425, DOI 10.1158/1078-0432.CCR-04-1995; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van der Fits L, 2011, J INVEST DERMATOL, V131, P762, DOI 10.1038/jid.2010.349; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-616; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Weiser MR, 2008, J CLIN ONCOL, V26, P380, DOI 10.1200/JCO.2007.14.1291; Weiser MR, 2011, J CLIN ONCOL, V29, P4796, DOI 10.1200/JCO.2011.36.5080; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wszolek MF, 2011, UROL ONCOL-SEMIN ORI, V29, P794, DOI 10.1016/j.urolonc.2009.08.024; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Yang CH, 2011, J BIOL CHEM, V286, P39172, DOI 10.1074/jbc.M111.285098; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Zhang YY, 2010, MED ONCOL, V27, P685, DOI 10.1007/s12032-009-9269-x; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhu L, 2011, AM J CANCER RES, V1, P574; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	94	90	93	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e96670	10.1371/journal.pone.0096670	http://dx.doi.org/10.1371/journal.pone.0096670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921248	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300004
J	Ferreira, AJS; Siam, R; Setubal, JC; Moustafa, A; Sayed, A; Chambergo, FS; Dawe, AS; Ghazy, MA; Sharaf, H; Ouf, A; Alam, I; Abdel-Haleem, AM; Lehvaslaiho, H; Ramadan, E; Antunes, A; Stingl, U; Archer, JAC; Jankovic, BR; Sogin, M; Bajic, VB; El-Dorry, H				Ferreira, Ari J. S.; Siam, Rania; Setubal, Joao C.; Moustafa, Ahmed; Sayed, Ahmed; Chambergo, Felipe S.; Dawe, Adam S.; Ghazy, Mohamed A.; Sharaf, Hazem; Ouf, Amged; Alam, Intikhab; Abdel-Haleem, Alyaa M.; Lehvaslaiho, Heikki; Ramadan, Eman; Antunes, Andre; Stingl, Ulrich; Archer, John A. C.; Jankovic, Boris R.; Sogin, Mitchell; Bajic, Vladimir B.; El-Dorry, Hamza			Core Microbial Functional Activities in Ocean Environments Revealed by Global Metagenomic Profiling Analyses	PLOS ONE			English	Article							OXYGEN MINIMUM ZONES; HORIZONTAL GENE-TRANSFER; MARINE ECOSYSTEMS; SEA; EVOLUTION; OCEANOGRAPHY; DEEP; COMMUNITIES; PROKARYOTES; INNOVATION	Metagenomics-based functional profiling analysis is an effective means of gaining deeper insight into the composition of marine microbial populations and developing a better understanding of the interplay between the functional genome content of microbial communities and abiotic factors. Here we present a comprehensive analysis of 24 datasets covering surface and depth-related environments at 11 sites around the world's oceans. The complete datasets comprises approximately 12 million sequences, totaling 5,358 Mb. Based on profiling patterns of Clusters of Orthologous Groups (COGs) of proteins, a core set of reference photic and aphotic depth-related COGs, and a collection of COGs that are associated with extreme oxygen limitation were defined. Their inferred functions were utilized as indicators to characterize the distribution of light-and oxygen-related biological activities in marine environments. The results reveal that, while light level in the water column is a major determinant of phenotypic adaptation in marine microorganisms, oxygen concentration in the aphotic zone has a significant impact only in extremely hypoxic waters. Phylogenetic profiling of the reference photic/aphotic gene sets revealed a greater variety of source organisms in the aphotic zone, although the majority of individual photic and aphotic depth-related COGs are assigned to the same taxa across the different sites. This increase in phylogenetic and functional diversity of the core aphotic related COGs most probably reflects selection for the utilization of a broad range of alternate energy sources in the absence of light.	[Ferreira, Ari J. S.; Siam, Rania; Moustafa, Ahmed; Sayed, Ahmed; Ghazy, Mohamed A.; Sharaf, Hazem; Ouf, Amged; Abdel-Haleem, Alyaa M.; Ramadan, Eman; El-Dorry, Hamza] Amer Univ Cairo, Dept Biol, Sch Sci & Engn, Cairo, New Cairo, Egypt; [Ferreira, Ari J. S.; Siam, Rania; Moustafa, Ahmed; Sayed, Ahmed; Ghazy, Mohamed A.; Sharaf, Hazem; Ouf, Amged; Abdel-Haleem, Alyaa M.; Ramadan, Eman; El-Dorry, Hamza] Amer Univ Cairo, Sci & Technol Res Ctr, Sch Sci & Engn, Cairo, New Cairo, Egypt; [Setubal, Joao C.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Chambergo, Felipe S.] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil; [Dawe, Adam S.; Alam, Intikhab; Lehvaslaiho, Heikki; Archer, John A. C.; Jankovic, Boris R.; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia; [Antunes, Andre] Univ Minho, Inst Biotechnol & Bioengn, Ctr Biol Engn, P-4719 Braga, Portugal; [Stingl, Ulrich] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Sogin, Mitchell] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA	Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); American University Cairo; Universidade de Sao Paulo; Universidade de Sao Paulo; King Abdullah University of Science & Technology; Universidade do Minho; King Abdullah University of Science & Technology; Marine Biological Laboratory - Woods Hole	El-Dorry, H (corresponding author), Amer Univ Cairo, Dept Biol, Sch Sci & Engn, Cairo, New Cairo, Egypt.	dorry@aucegypt.edu	Ferreira, Ari J S/C-2266-2015; Chambergo, Felipe S/B-8599-2012; Sharaf, Hazem/ABG-5995-2021; Antunes, André/A-8711-2012; Moustafa, Ahmed/C-5234-2009; Ghazy, Mohamed/ABD-6832-2020; Archer, John/AAW-1990-2021; Moustafa, Ahmed/AAZ-3991-2020; Setubal, Joao Carlos/C-7305-2012; Sogin, Mitchell/AAE-7186-2019; Stingl, Uli/H-1191-2014; Bajic, Vladimir/D-2810-2009	Ferreira, Ari J S/0000-0002-7526-5543; Chambergo, Felipe S/0000-0001-7567-0656; Sharaf, Hazem/0000-0002-6728-1631; Antunes, André/0000-0001-7668-9842; Moustafa, Ahmed/0000-0002-0111-3555; Archer, John/0000-0002-3302-3933; Moustafa, Ahmed/0000-0002-0111-3555; Setubal, Joao Carlos/0000-0001-9174-2816; Alam, Intikhab/0000-0001-5306-847X; Jankovic, Boris/0000-0003-1868-6007; Abdel-haleem, Alyaa/0000-0002-3114-1100; Stingl, Uli/0000-0002-0684-2597; Bajic, Vladimir/0000-0001-5435-4750; Ramadan, Eman/0000-0002-5483-9536	King Abdullah University for Science and Technology Global Collaborative Partners (GCR) program	King Abdullah University for Science and Technology Global Collaborative Partners (GCR) program	This work was supported by King Abdullah University for Science and Technology Global Collaborative Partners (GCR) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Balaji S, 2007, J MOL BIOL, V372, P1108, DOI 10.1016/j.jmb.2007.06.084; Baumbach J, 2010, NUCLEIC ACIDS RES, V38, P7877, DOI 10.1093/nar/gkq699; BESIKTEPE ST, 1994, PROG OCEANOGR, V34, P285, DOI 10.1016/0079-6611(94)90018-3; Bryant JA, 2012, ECOLOGY, V93, P1659, DOI 10.1890/11-1204.1; Crombach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000112; Daneri G, 2000, MAR ECOL PROG SER, V197, P41, DOI 10.3354/meps197041; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Eloe EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020388; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gregoracci GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031408; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Karl DM, 2007, NAT REV MICROBIOL, V5, P759, DOI 10.1038/nrmicro1749; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kroger S, 2005, TRENDS BIOTECHNOL, V23, P250, DOI 10.1016/j.tibtech.2005.03.004; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lipson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064659; Lutz RA, 2012, SCIENCE, V336, P301, DOI 10.1126/science.1222641; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Maslov S, 2009, P NATL ACAD SCI USA, V106, P9743, DOI 10.1073/pnas.0903206106; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Osburne MS, 2010, ENVIRON MICROBIOL, V12, P1978, DOI 10.1111/j.1462-2920.2010.02203.x; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schafer H, 2010, J EXP BOT, V61, P315, DOI 10.1093/jxb/erp355; Sobecky Patricia A., 2009, V532, P435, DOI 10.1007/978-1-60327-853-9_25; Steinberg DK, 2001, DEEP-SEA RES PT II, V48, P1405, DOI 10.1016/S0967-0645(00)00148-X; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Varin T, 2012, APPL ENVIRON MICROB, V78, P549, DOI 10.1128/AEM.06354-11; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530	45	21	21	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e97338	10.1371/journal.pone.0097338	http://dx.doi.org/10.1371/journal.pone.0097338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921648	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300005
J	Lee, S; Kim, JY; Hwang, J; Kim, S; Lee, JH; Han, DH				Lee, Soohyung; Kim, Ji-Young; Hwang, Jihye; Kim, Sanguk; Lee, Jae-Hoon; Han, Dong-Hoo			Investigation of Pathogenic Genes in Peri-Implantitis from Implant Clustering Failure Patients: A Whole-Exome Sequencing Pilot Study	PLOS ONE			English	Article							CHRONIC PERIODONTITIS; EUROPEAN WORKSHOP; ASSOCIATION; SURVIVAL; DISEASES; RATES; CONSENSUS; SAMPLES; COHORT; SALIVA	Peri-implantitis is a frequently occurring gum disease linked to multi-factorial traits with various environmental and genetic causalities and no known concrete pathogenesis. The varying severity of peri-implantitis among patients with relatively similar environments suggests a genetic aspect which needs to be investigated to understand and regulate the pathogenesis of the disease. Six unrelated individuals with multiple clusterization implant failure due to severe peri-implantitis were chosen for this study. These six individuals had relatively healthy lifestyles, with minimal environmental causalities affecting peri-implantitis. Research was undertaken to investigate pathogenic genes in peri-implantitis albeit with a small number of subjects and incomplete elimination of environmental causalities. Whole-exome sequencing was performed on collected saliva samples via self DNA collection kit. Common variants with minor allele frequencies (MAF) > = 0.05 from all control datasets were eliminated and variants having high and moderate impact and loss of function were used for comparison. Gene set enrichment analysis was performed to reveal functional groups associated with the genetic variants. 2,022 genes were left after filtering against dbSNP, the 1000 Genomes East Asian population, and healthy Korean randomized subsample data (GSK project). 175 (p-value <0.05) out of 927 gene sets were obtained via GSEA (DAVID). The top 10 was chosen (p-value <0.05) from cluster enrichment showing significance of cytoskeleton, cell adhesion, and metal ion binding. Network analysis was applied to find relationships between functional clusters. Among the functional groups, ion metal binding was located in the center of all clusters, indicating dysfunction of regulation in metal ion concentration might affect cell morphology or cell adhesion, resulting in implant failure. This result may demonstrate the feasibility of and provide pilot data for a larger research project aimed at discovering biomarkers for early diagnosis of peri-implantitis.	[Lee, Soohyung; Kim, Ji-Young; Lee, Jae-Hoon; Han, Dong-Hoo] Yonsei Univ, Coll Dent, Dept Prosthodont, Oral Sci Res Ctr, Seoul 120749, South Korea; [Hwang, Jihye; Kim, Sanguk] Pohang Univ Sci & Technol, Dept IT Convergence & Engn, Pohang, South Korea	Yonsei University; Yonsei University Health System; Pohang University of Science & Technology (POSTECH)	Lee, JH (corresponding author), Yonsei Univ, Coll Dent, Dept Prosthodont, Oral Sci Res Ctr, Seoul 120749, South Korea.	jaehoon115@yuhs.ac; donghoohan@yuhs.ac		Lee, Jae Hoon/0000-0003-2281-8885; Kim, Sanguk/0000-0002-3449-3814	Oral Science Research Center and School of Dentistry Intramural Research [6-2012-0207]; Basic Science Research Program through the National research Foundation of Korea (NRF) - Ministy of Science, ICT and Future Planning [2011-0014268]; National Research Foundation of Korea (NRF) [2013018606]	Oral Science Research Center and School of Dentistry Intramural Research; Basic Science Research Program through the National research Foundation of Korea (NRF) - Ministy of Science, ICT and Future Planning; National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work is supported by research funding provided by Oral Science Research Center and School of Dentistry Intramural Research (6-2012-0207). This research was supported by Basic Science Research Program through the National research Foundation of Korea (NRF) funded by the Ministy of Science, ICT and Future Planning (2011-0014268). This research was also supported by funding provided by National Research Foundation of Korea (NRF) (2013018606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JE, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-19; ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347; Alissa R, 2012, J ORAL IMPLANTOL, V38, P51, DOI 10.1563/AAID-JOI-D-10-00086; BECKER W, 1990, International Journal of Oral and Maxillofacial Implants, V5, P31; Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x; Buser D, 2012, CLIN IMPLANT DENT R, V14, P839, DOI 10.1111/j.1708-8208.2012.00456.x; Chuang SK, 2005, J DENT RES, V84, P54, DOI 10.1177/154405910508400109; Consolaro Alberto, 2010, Dental Press J. Orthod., V15, P19; De Smet E, 2001, INT J PERIODONT REST, V21, P381; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dereka X, 2012, CLIN ORAL IMPLAN RES, V23, P775, DOI 10.1111/j.1600-0501.2011.02329.x; Esposito M, 1999, INT J ORAL MAX IMPL, V14, P473; Hall J, 2011, EUR J ORAL IMPLANTOL, V4, P371; Hansen TVO, 2007, CANCER EPIDEM BIOMAR, V16, P2072, DOI 10.1158/1055-9965.EPI-07-0611; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang K, 2014, OBESITY, V22, P984, DOI 10.1002/oby.20647; Hutton J E, 1995, Int J Oral Maxillofac Implants, V10, P33; Kadkhodazadeh Mahdi, 2013, Journal of Basic and Clinical Physiology and Pharmacology, V24, P131, DOI 10.1515/jbcpp-2012-0055; Karoussis IK, 2003, CLIN ORAL IMPLAN RES, V14, P329, DOI 10.1034/j.1600-0501.000.00934.x; Lang NP, 2011, J CLIN PERIODONTOL, V38, P178, DOI 10.1111/j.1600-051X.2010.01674.x; LeDuc CA, 2014, JIMD REP, V12, P121, DOI 10.1007/8904_2013_254; Lee CS JJ, 2004, J PERIODONTAL IMPLAN, V2, P2093; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lindhe J, 2008, J CLIN PERIODONTOL, V35, P282, DOI 10.1111/j.1600-051X.2008.01283.x; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Michalowicz BS, 2000, J PERIODONTOL, V71, P1699, DOI 10.1902/jop.2000.71.11.1699; Mombelli A, 2002, PERIODONTOL 2000, V28, P177, DOI 10.1034/j.1600-0757.2002.280107.x; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Petkovic-Curcin A, 2011, VOJNOSANIT PREGL, V68, P435, DOI 10.2298/VSP1105435P; Pjetursson BE, 2004, CLIN ORAL IMPLAN RES, V15, P625, DOI 10.1111/j.1600-0501.2004.01117.x; Polizzi G, 2013, INT J PROSTHODONT, V26, P350, DOI 10.11607/ijp.3386; Prathapachandran Jayachandran, 2012, Dent Res J (Isfahan), V9, P516; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x; Rabbani B, 2012, J HUM GENET, V57, P621, DOI 10.1038/jhg.2012.91; Raszek MM, 2001, APPL EXOME SEQUENCIN; Sanchez- Garces MA, 2004, MED ORAL PATOL ORAL, V9, P63; Sanchez-Garces Maria Angeles, 2004, Med Oral Patol Oral Cir Bucal, V9 Suppl, P69; Santos MCLG, 2002, BRAZ J ORAL SCI, V1, P103, DOI DOI 10.20396/BJOS.V1I3.8641045; Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stadlinger B, 2007, J BIOMED MATER RES B, V83B, P222, DOI 10.1002/jbm.b.30787; Teles RP HA, 2008, PERIIMPLANT INFECT C; Verrier S, 2002, BIOMATERIALS, V23, P585, DOI 10.1016/S0142-9612(01)00145-4; WEYANT RJ, 1993, J DENT RES, V72, P2, DOI 10.1177/00220345930720010201; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702; Zhou HF, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S2; Zhou HF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S20	51	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99360	10.1371/journal.pone.0099360	http://dx.doi.org/10.1371/journal.pone.0099360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921256	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300053
J	Xiu, YL; Zhao, Y; Gou, WF; Chen, S; Takano, Y; Zheng, HC				Xiu, Yin-Ling; Zhao, Yang; Gou, Wen-Feng; Chen, Shuo; Takano, Yasuo; Zheng, Hua-Chuan			Anacardic Acid Enhances the Proliferation of Human Ovarian Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HISTONE ACETYLTRANSFERASE; INHIBITION; APOPTOSIS; PHOSPHORYLATION; PROGRESSION; PRODUCTS; SURVIVAL; RECEPTOR; MARKER	Background: Anacardic acid (AA) is a mixture of 2-hydroxy-6-alkylbenzoic acid homologs. Certain antitumor activities of AA have been reported in a variety of cancers. However, the function of AA in ovarian cancer, to date, has remained unknown. Methods: Ovarian cancer cell lines were exposed to AA, after which cell proliferation, apoptosis, invasion and migration assays were performed. Phalloidin staining was used to observe lamellipodia formation. Reverse transcription polymerase chain reaction (RT-PCR) and western blotting were used to assess the mRNA and protein expression levels of Phosphatidylinositol 3-kinase (PI3K), vascular endothelial growth factor (VEGF) and caspase 3. Results: Our results showed that AA promotes ovarian cancer cell proliferation, inhibits late apoptosis, and induces cell migration and invasion, as well as lamellipodia formation. AA exposure significantly up-regulated PI3K and VEGF mRNA and protein expression, while, in contrast, it down-regulated caspase 3 mRNA and protein expression in comparison to untreated control cells. Conclusion: Taken together, our results demonstrate for the first time that AA may potentiate the proliferation, invasion, metastasis and lamellipodia formation in ovarian cancer cell lines via PI3K, VEGF and caspase 3 pathways.	[Xiu, Yin-Ling; Zhao, Yang; Chen, Shuo] China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang, Peoples R China; [Gou, Wen-Feng; Zheng, Hua-Chuan] China Med Univ, Inst Pathol & Pathophysiol, Dept Biochem & Mol Biol, Coll Basic Med, Shenyang, Peoples R China; [Takano, Yasuo] Kanagawa Canc Ctr, Clin Canc Inst, Yokohama, Kanagawa 2410815, Japan	China Medical University; China Medical University; Kanagawa Prefectural Cancer Center	Zheng, HC (corresponding author), China Med Univ, Inst Pathol & Pathophysiol, Dept Biochem & Mol Biol, Coll Basic Med, Shenyang, Peoples R China.	zheng_huachuan@hotmail.com		Gou, Wenfeng/0000-0002-4828-4298	Shenyang Outstanding Talent Foundation of China; Shenyang Science and Technology Grant [F11-264-1-10, F12-277-1-01]; Project Supported by Scientific Research Fund of Liaoning Provincial Education Department [L2010633]; Liaoning Science and Technology Grant [2009225008-11, 2013021077]; Natural Scientific Foundation of China [81172371, 81202049]	Shenyang Outstanding Talent Foundation of China; Shenyang Science and Technology Grant; Project Supported by Scientific Research Fund of Liaoning Provincial Education Department; Liaoning Science and Technology Grant; Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Shenyang Outstanding Talent Foundation of China; Shenyang Science and Technology Grant (F11-264-1-10; F12-277-1-01); the Project Supported by Scientific Research Fund of Liaoning Provincial Education Department (L2010633); Liaoning Science and Technology Grant (2009225008-11; 2013021077); and the Natural Scientific Foundation of China (81172371; 81202049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Begum P, 2002, Z NATURFORSCH C, V57, P874; Cassady JM, 1981, INT RES C MED PLANT, P93; Cejka D, 2009, BRIT J CANCER, V100, P1739, DOI 10.1038/sj.bjc.6605076; Chattopadhyaya MK, 1969, INDIAN J PHARM, V31, P104; Bizzo SMD, 2010, INT J GYNECOL OBSTET, V109, P113, DOI 10.1016/j.ijgo.2009.11.021; Dobbin ZC, 2013, INT J MOL SCI, V14, P8213, DOI 10.3390/ijms14048213; Eisenkop SM, 1998, GYNECOL ONCOL, V69, P103, DOI 10.1006/gyno.1998.4955; Gurunathan S, 2013, INT J NANOMED, V8, P4399, DOI 10.2147/IJN.S51881; Hefler LA, 2006, GYNECOL ONCOL, V103, P512, DOI 10.1016/j.ygyno.2006.03.058; Ji K, 2013, INT J MOL MED, V32, P747, DOI 10.3892/ijmm.2013.1472; Kajdaniuk D, 2011, ENDOKRYNOL POL, V62, P444; Kusio-Kobialka M, 2013, ANTI-CANCER AGENT ME, V13, P762; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lin MY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/207279; Mantia-Smaldone Gina M, 2011, Cancer Manag Res, V3, P25, DOI 10.2147/CMR.S8759; Mazzoletti M, 2010, CURR MED CHEM, V17, P4433, DOI 10.2174/092986710794182999; Rea AI, 2003, FITOTERAPIA, V74, P732, DOI 10.1016/j.fitote.2003.08.007; Schultz DJ, 2010, MOL CANCER THER, V9, P594, DOI 10.1158/1535-7163.MCT-09-0978; Seong YA, 2013, CELL BIOCH BIOPHYS; Seong YA, 2013, INT J ONCOL, V42, P1045, DOI 10.3892/ijo.2013.1763; SHOBHA SV, 1994, J NAT PRODUCTS, V57, P1755, DOI 10.1021/np50114a025; Sowmyalakshmi S, 2005, PLANTA, V220, P910, DOI 10.1007/s00425-004-1405-4; Sukumari-Ramesh S, 2011, J NEUROSURG, V114, P1681, DOI 10.3171/2010.12.JNS10588; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Tan J, 2012, CHINESE J CANCER RES, V24, P275, DOI [10.3978/j.issn.1000-9604.2012.10.07, 10.1007/s11670-012-0264-y]; Toyomizu M, 1999, LIFE SCI, V66, P229; Toyomizu Masaaki, 2003, Animal Science Journal, V74, P499, DOI 10.1046/j.1344-3941.2003.00144.x; Trevisan MTS, 2006, FOOD CHEM TOXICOL, V44, P188, DOI 10.1016/j.fct.2005.06.012; Wu YY, 2011, J PHARMACOL EXP THER, V339, P403, DOI 10.1124/jpet.111.181891; Yu B, 2014, ONCOL REP, V31, P849, DOI 10.3892/or.2013.2869; Zhao Y, 2013, GYNECOL ONCOL, V130, P570, DOI 10.1016/j.ygyno.2013.06.004	33	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99361	10.1371/journal.pone.0099361	http://dx.doi.org/10.1371/journal.pone.0099361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921663	Green Submitted, gold, Green Published			2022-12-25	WOS:000338701300054
J	Sichelstiel, A; Yadava, K; Trompette, A; Salami, O; Iwakura, Y; Nicod, LP; Marsland, BJ				Sichelstiel, Anke; Yadava, Koshika; Trompette, Aurelien; Salami, Olawale; Iwakura, Yoichiro; Nicod, Laurent P.; Marsland, Benjamin J.			Targeting IL-1 beta and IL-17A Driven Inflammation during Influenza-Induced Exacerbations of Chronic Lung Inflammation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NECROSIS-FACTOR-ALPHA; CIGARETTE-SMOKE; RESPIRATORY VIRUSES; COPD EXACERBATIONS; AIRWAY INFLAMMATION; NEUTROPHIL SURVIVAL; EMPHYSEMA; EXPRESSION; MICE	For patients with chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), exacerbations are life-threatening events causing acute respiratory distress that can even lead to hospitalization and death. Although a great deal of effort has been put into research of exacerbations and potential treatment options, the exact underlying mechanisms are yet to be deciphered and no therapy that effectively targets the excessive inflammation is available. In this study, we report that interleukin-1 beta (IL-1 beta) and interleukin-17A (IL-17A) are key mediators of neutrophilic inflammation in influenza-induced exacerbations of chronic lung inflammation. Using a mouse model of disease, our data shows a role for IL-1 beta in mediating lung dysfunction, and in driving neutrophilic inflammation during the whole phase of viral infection. We further report a role for IL-17A as a mediator of IL-1 beta induced neutrophilia at early time points during influenza-induced exacerbations. Blocking of IL-17A or IL-1 resulted in a significant abrogation of neutrophil recruitment to the airways in the initial phase of infection or at the peak of viral replication, respectively. Therefore, IL-17A and IL-1 beta are potential targets for therapeutic treatment of viral exacerbations of chronic lung inflammation	[Sichelstiel, Anke; Yadava, Koshika; Trompette, Aurelien; Salami, Olawale; Nicod, Laurent P.; Marsland, Benjamin J.] Univ Lausanne, CHUV, Serv Pneumol, Fac Biol & Med, Lausanne, Switzerland; [Sichelstiel, Anke] ETHZ, Zurich, Switzerland; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Tokyo 162, Japan	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; ETH Zurich; Tokyo University of Science	Marsland, BJ (corresponding author), Univ Lausanne, CHUV, Serv Pneumol, Fac Biol & Med, Lausanne, Switzerland.	benjamin.marsland@chuv.ch	Salami, Olawale/AAR-7462-2020; Iwakura, Yoichiro/E-5457-2011; Nicod, Laurent/ABD-3360-2020	Salami, Olawale/0000-0001-9186-8160; Iwakura, Yoichiro/0000-0002-9934-5775; Nicod, Laurent P/0000-0002-0905-916X	ETH Project [01-08-2]; Velux Stiftung	ETH Project; Velux Stiftung	This work has been funded by ETH Project Grant 01-08-2 and the Velux Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; Balbi B, 1997, EUR RESPIR J, V10, P846; Barnes PJ, 2010, SCIENCE, V330, P40, DOI 10.1126/science.1196017; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Bathoorn Erik, 2008, Int J Chron Obstruct Pulmon Dis, V3, P217; Bauer CMT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013251; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Castro P, 2004, EUR J PHARMACOL, V498, P279, DOI 10.1016/j.ejphar.2004.07.047; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Couillin I, 2009, J IMMUNOL, V183, P8195, DOI 10.4049/jimmunol.0803154; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Daffern PJ, 1999, AM J RESP CELL MOL, V21, P259, DOI 10.1165/ajrcmb.21.2.3605; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Donaldson GC, 2006, THORAX, V61, P164, DOI 10.1136/thx.2005.041806; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; Gaschler GJ, 2010, EUR RESPIR J, V36, P1131, DOI 10.1183/09031936.00113909; Gessner C, 2005, RESP MED, V99, P1229, DOI 10.1016/j.rmed.2005.02.041; Hacievliyagil SS, 2006, RESP MED, V100, P846, DOI 10.1016/j.rmed.2005.08.022; Han Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086166; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Hoogendoorn M, 2011, EUR RESPIR J, V37, P508, DOI 10.1183/09031936.00043710; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hurst JR, 2005, EUR RESPIR J, V26, P846, DOI 10.1183/09031936.05.00043405; Kersul AL, 2011, ARCH BRONCONEUMOL, V47, P176, DOI 10.1016/j.arbres.2010.12.003; Ko FWS, 2007, CHEST, V132, P900, DOI 10.1378/chest.07-0530; Kythreotis Prokopis, 2009, BMC Pulm Med, V9, P11, DOI 10.1186/1471-2466-9-11; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Larsson L, 2004, INDOOR AIR, V14, P421, DOI 10.1111/j.1600-0668.2004.00290.x; Lucey EC, 2002, LAB INVEST, V82, P79, DOI 10.1038/labinvest.3780397; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Perttunen H, 2008, COPD, V5, P163, DOI 10.1080/15412550802092969; Potena Alfredo, 2007, Int J Chron Obstruct Pulmon Dis, V2, P477; Qiu YS, 2003, AM J RESP CRIT CARE, V168, P968, DOI 10.1164/rccm.200208-794OC; Rennard SI, 2009, DRUGS, V69, P549, DOI 10.2165/00003495-200969050-00004; Rohde G, 2003, THORAX, V58, P37, DOI 10.1136/thorax.58.1.37; SAETTA M, 1985, AM REV RESPIR DIS, V131, P764; Sajjan U, 2009, AM J PHYSIOL-LUNG C, V297, pL931, DOI 10.1152/ajplung.00150.2009; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Sethi Sanjay, 2009, Proc Am Thorac Soc, V6, P532, DOI 10.1513/pats.200905-025DS; Shan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003041; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Suissa S., 2012, THORAX; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Tan WC, 2003, AM J MED, V115, P272, DOI 10.1016/S0002-9343(03)00353-X; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752; Uyttenhove C, 2006, EUR J IMMUNOL, V36, P2868, DOI 10.1002/eji.200636662; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wedzicha Jadwiga A, 2004, Proc Am Thorac Soc, V1, P115, DOI 10.1513/pats.2306030	59	31	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98440	10.1371/journal.pone.0098440	http://dx.doi.org/10.1371/journal.pone.0098440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918427	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000017
J	Smyth, TJ; Allen, I; Atkinson, A; Bruun, JT; Harmer, RA; Pingree, RD; Widdicombe, CE; Somerfield, PJ				Smyth, Tim J.; Allen, Icarus; Atkinson, Angus; Bruun, John T.; Harmer, Rachel A.; Pingree, Robin D.; Widdicombe, Claire E.; Somerfield, Paul J.			Ocean Net Heat Flux Influences Seasonal to Interannual Patterns of Plankton Abundance	PLOS ONE			English	Article							WESTERN ENGLISH-CHANNEL; SPRING PHYTOPLANKTON BLOOMS; TIME-SERIES; CONTINENTAL-SHELF; CRITICAL DEPTH; NORTH-SEA; VARIABILITY; STRATIFICATION; COMMUNITY; ZOOPLANKTON	Changes in the net heat flux (NHF) into the ocean have profound impacts on global climate. We analyse a long-term plankton time-series and show that the NHF is a critical indicator of ecosystem dynamics. We show that phytoplankton abundance and diversity patterns are tightly bounded by the switches between negative and positive NHF over an annual cycle. Zooplankton increase before the transition to positive NHF in the spring but are constrained by the negative NHF switch in autumn. By contrast bacterial diversity is decoupled from either NHF switch, but is inversely correlated (r = 20.920) with the magnitude of the NHF. We show that the NHF is a robust mechanistic tool for predicting climate change indicators such as spring phytoplankton bloom timing and length of the growing season.	[Smyth, Tim J.; Allen, Icarus; Atkinson, Angus; Bruun, John T.; Harmer, Rachel A.; Pingree, Robin D.; Widdicombe, Claire E.; Somerfield, Paul J.] Plymouth Marine Lab, Plymouth, Devon, England	Plymouth Marine Laboratory	Smyth, TJ (corresponding author), Plymouth Marine Lab, Plymouth, Devon, England.	tjsm@pml.ac.uk	Bruun, John/AAZ-1375-2021; Smyth, Tim J/D-2008-2012; Bruun, John T/C-8849-2018; Widdicombe, Claire/AAC-7358-2022; Somerfield, Paul J/J-9189-2014	Bruun, John T/0000-0003-1307-6103; Somerfield, Paul J/0000-0002-7581-5621; Smyth, Tim/0000-0003-0659-1422	Natural Environmental Research Council National Capability Western Channel Observatory; INTERREG IVA France (Channel) - England programme (FEDER); EU FP7 projects Devotes (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status) [308392]; GreenSeas (Development of global plankton data base and model system for eco-climate early warning) [265294]; NERC [pml010004, NE/L003066/1, pml010010, NE/L003279/1, pml010009, pml010006] Funding Source: UKRI; Natural Environment Research Council [pml010004, NE/L003066/1, pml010009, NE/L003279/1, pml010006, pml010010] Funding Source: researchfish	Natural Environmental Research Council National Capability Western Channel Observatory; INTERREG IVA France (Channel) - England programme (FEDER); EU FP7 projects Devotes (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status); GreenSeas (Development of global plankton data base and model system for eco-climate early warning); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is supported by the Natural Environmental Research Council funded National Capability Western Channel Observatory. It also contributes to the projects Marinexus and Charm2 funded in part by the INTERREG IVA France (Channel) - England programme (FEDER), and to the EU FP7 projects Devotes (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status, Grant Agreement number 308392) and GreenSeas (Development of global plankton data base and model system for eco-climate early warning, Grant Agreement number 265294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, EOS T AM GEOPHYS UNI, DOI DOI 10.1029/01EO00004; Behrenfeld MJ, 2010, ECOLOGY, V91, P977, DOI 10.1890/09-1207.1; Box G., 1970, TIME SERIES ANAL; Chiswell SM, 2011, MAR ECOL PROG SER, V443, P39, DOI 10.3354/meps09453; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Eloire D, 2010, J PLANKTON RES, V32, P657, DOI 10.1093/plankt/fbq009; Freund JA, 2012, MAR BIOL, V159, P2561, DOI 10.1007/s00227-012-2013-7; FUNG IY, 1984, REV GEOPHYS, V22, P177, DOI 10.1029/RG022i002p00177; Garcia-Soto C, 1998, J MAR BIOL ASSOC UK, V78, P17, DOI 10.1017/S002531540003993X; Garcia-Soto C, 2012, J MAR BIOL ASSOC UK, V92, P213, DOI 10.1017/S0025315410002134; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; GREGG MC, 1985, NATURE, V318, P140, DOI 10.1038/318140a0; Huisman J, 1999, LIMNOL OCEANOGR, V44, P1781, DOI 10.4319/lo.1999.44.7.1781; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Kiorboe T., 2008, MECH APPROACH PLANKT; Mackas DL, 2012, PROG OCEANOGR, V97, P31, DOI 10.1016/j.pocean.2011.11.005; Mahadevan A, 2012, SCIENCE, V337, P54, DOI 10.1126/science.1218740; Mann KH, 2006, DYNAMICS MARINE ECOS; Martin AP, 2005, BIOL LETT-UK, V1, P366, DOI 10.1098/rsbl.2005.0316; PINGREE RD, 1977, ESTUAR COAST MAR SCI, V5, P399, DOI 10.1016/0302-3524(77)90064-0; PINGREE RD, 1987, CONT SHELF RES, V7, P1181, DOI 10.1016/0278-4343(87)90084-7; PINGREE RD, 1989, DEEP-SEA RES, V36, P735, DOI 10.1016/0198-0149(89)90148-9; PINGREE RD, 1975, J MAR BIOL ASSOC UK, V55, P965, DOI 10.1017/S0025315400017859; PINGREE RD, 1976, J MAR BIOL ASSOC UK, V56, P845, DOI 10.1017/S0025315400020919; PINGREE RD, 1975, J MAR BIOL ASSOC UK, V55, P261, DOI 10.1017/S0025315400015939; Pingree RD, 1978, SPATIAL PATTERN PLAN; REED RK, 1977, J PHYS OCEANOGR, V7, P482, DOI 10.1175/1520-0485(1977)007<0482:OEIOTO>2.0.CO;2; REYNOLDS CS, 1993, HYDROBIOLOGIA, V249, P183, DOI 10.1007/BF00008853; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Sharples J, 2006, CONT SHELF RES, V26, P733, DOI 10.1016/j.csr.2006.01.011; Shumway R. H., 2010, TIME SERIES ANAL ITS; Smyth TJ, 2010, J PLANKTON RES, V32, P585, DOI 10.1093/plankt/fbp128; Smyth TJ, 2002, APPL OPTICS, V41, P7679, DOI 10.1364/AO.41.007679; Southward AJ, 2005, ADV MAR BIOL, V47, P1; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Taylor JR, 2011, LIMNOL OCEANOGR, V56, P2293, DOI 10.4319/lo.2011.56.6.2293; THRONDSEN J, 1978, SARSIA, V63, P273, DOI 10.1080/00364827.1978.10411349; TOWNSEND DW, 1992, NATURE, V360, P59, DOI 10.1038/360059a0; *UNESCO, 1968, ZOOPL SAMPL; Widdicombe CE, 2010, J PLANKTON RES, V32, P643, DOI 10.1093/plankt/fbp127; Yu L, 2007, ENCY OCEAN SCI, P21	41	31	31	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98709	10.1371/journal.pone.0098709	http://dx.doi.org/10.1371/journal.pone.0098709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918906	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000338631000026
J	Suarez-Pellicioni, M; Nunez-Pena, MI; Colome, A				Suarez-Pellicioni, Macarena; Isabel Nunez-Pena, Maria; Colome, Angels			Reactive Recruitment of Attentional Control in Math Anxiety: An ERP Study of Numeric Conflict Monitoring and Adaptation	PLOS ONE			English	Article							MATHEMATICS ANXIETY; ANTERIOR CINGULATE; COGNITIVE CONTROL; NEURAL ACTIVITY; PROCESSING EFFICIENCY; WORKING-MEMORY; TRAIT ANXIETY; RATING-SCALE; STROOP; PERFORMANCE	This study uses event-related brain potentials (ERPs) to investigate the electrophysiological correlates of numeric conflict monitoring in math-anxious individuals, by analyzing whether math anxiety is related to abnormal processing in early conflict detection (as shown by the N450 component) and/or in a later, response-related stage of processing (as shown by the conflict sustained potential; Conflict-SP). Conflict adaptation effects were also studied by analyzing the effect of the previous trial's congruence in current interference. To this end, 17 low math-anxious (LMA) and 17 high math-anxious (HMA) individuals were presented with a numerical Stroop task. Groups were extreme in math anxiety but did not differ in trait or state anxiety or in simple math ability. The interference effect of the current trial (incongruent-congruent) and the interference effect preceded by congruence and by incongruity were analyzed both for behavioral measures and for ERPs. A greater interference effect was found for response times in the HMA group than in the LMA one. Regarding ERPs, the LMA group showed a greater N450 component for the interference effect preceded by congruence than when preceded by incongruity, while the HMA group showed greater Conflict-SP amplitude for the interference effect preceded by congruence than when preceded by incongruity. Our study showed that the electrophysiological correlates of numeric interference in HMA individuals comprise the absence of a conflict adaptation effect in the first stage of conflict processing (N450) and an abnormal subsequent up-regulation of cognitive control in order to overcome the conflict (Conflict-SP). More concretely, our study shows that math anxiety is related to a reactive and compensatory recruitment of control resources that is implemented only when previously exposed to a stimuli presenting conflicting information.	[Suarez-Pellicioni, Macarena; Isabel Nunez-Pena, Maria; Colome, Angels] Univ Barcelona, Fac Psychol, Dept Behav Sci Methodol, Barcelona, Spain; [Suarez-Pellicioni, Macarena; Isabel Nunez-Pena, Maria] Univ Barcelona, Inst Res Brain Cognit & Behav IR3C, Barcelona, Spain; [Colome, Angels] Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona	Nunez-Pena, MI (corresponding author), Univ Barcelona, Fac Psychol, Dept Behav Sci Methodol, Barcelona, Spain.	inunez@ub.edu	colome, angels/H-2522-2015; NÚÑEZ-PEÑA, MARIA ISABEL/B-3883-2011; Suárez Pellicioni, Macarena/H-5527-2015	colome, angels/0000-0002-2976-1853; NÚÑEZ-PEÑA, MARIA ISABEL/0000-0002-3677-859X; Suárez Pellicioni, Macarena/0000-0002-9056-9561	Spanish Ministry of Economy and Competitiveness [PSI2012-35703, BES-2010-036859]; Generalitat de Catalunya [SGR2009-11]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This study was supported by grants PSI2012-35703 and BES-2010-036859 from the Spanish Ministry of Economy and Competitiveness and SGR2009-11 from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER L, 1989, MEAS EVAL COUNS DEV, V22, P143, DOI 10.1080/07481756.1989.12022923; Ansari TL, 2011, BIOL PSYCHOL, V86, P337, DOI 10.1016/j.biopsycho.2010.12.013; Appelbaum LG, 2009, CEREB CORTEX, V19, P2508, DOI 10.1093/cercor/bhp036; Ashcraft M. H., 1998, DEV MATH SKILLS STUD, P175; Ashcraft MH., 2005, HDB MATH COGNITION, P315; Baddeley A., 2007, WORKING MEMORY THOUG; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Coderre E, 2011, BRAIN RES, V1413, P51, DOI 10.1016/j.brainres.2011.07.017; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T, 2011, J COGNITIVE NEUROSCI, V23, P3903, DOI 10.1162/jocn_a_00064; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; EYSENCK MW, 1992, COGNITION EMOTION, V6, P409, DOI 10.1080/02699939208409696; Fales CL, 2008, COGN AFFECT BEHAV NE, V8, P239, DOI 10.3758/CABN.8.3.239; Faust M. W., 1996, MATH COGNITION, V2, P25, DOI DOI 10.1080/135467996387534; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hochman S. H., 1967, PSYCHON SCI, V9, P475, DOI DOI 10.3758/BF03330904; HOCHMAN SH, 1969, PERCEPT MOTOR SKILL, V28, P115, DOI 10.2466/pms.1969.28.1.115; Hopko DR, 2002, COGNITIVE THER RES, V26, P157, DOI 10.1023/A:1014578218041; Hopko DR, 1998, J ANXIETY DISORD, V12, P343, DOI 10.1016/S0887-6185(98)00019-X; Nunez-Pena MI, 2013, LEARN INDIVID DIFFER, V24, P204, DOI 10.1016/j.lindif.2012.12.009; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lansbergen MM, 2007, J PSYCHOPHYSIOL, V21, P33, DOI 10.1027/0269-8803.21.1.33; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Luck S.J., 2005, INTRO EVENT RELATED; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maloney EA, 2011, Q J EXP PSYCHOL, V64, P10, DOI 10.1080/17470218.2010.533278; Maloney EA, 2010, COGNITION, V114, P293, DOI 10.1016/j.cognition.2009.09.013; McNeely HE, 2003, J ABNORM PSYCHOL, V112, P679, DOI 10.1037/0021-843X.112.4.679; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Osinsky R, 2012, BIOL PSYCHOL, V89, P252, DOI 10.1016/j.biopsycho.2011.10.016; Osinsky R, 2010, COGN AFFECT BEHAV NE, V10, P372, DOI 10.3758/CABN.10.3.372; PALLAK MS, 1975, B PSYCHONOMIC SOC, V6, P248, DOI 10.3758/BF03336652; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; RICHARDSON FC, 1972, J COUNS PSYCHOL, V19, P551, DOI 10.1037/h0033456; Ridderinkhof KR, 2002, PSYCHOL RES-PSYCH FO, V66, P312, DOI 10.1007/s00426-002-0104-7; Rotshtein P, 2010, HUM BRAIN MAPP, V31, P1089, DOI 10.1002/hbm.20921; Soltesz F, 2011, LEARN INDIVID DIFFER, V21, P662, DOI 10.1016/j.lindif.2010.10.004; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spielberger CD., 2008, CUESTIONARIO ANSIEDA; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suarez-Pellicioni M, 2013, BIOL PSYCHOL, V94, P517, DOI 10.1016/j.biopsycho.2013.09.012; Suarez-Pellicioni M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081143; Szucs D, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-35; Szucs D, 2009, NEUROIMAGE, V47, P1960, DOI 10.1016/j.neuroimage.2009.05.048; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2005, EXP BRAIN RES, V167, P38, DOI 10.1007/s00221-005-2366-y; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; Zhu XR, 2010, NEUROSCI LETT, V478, P1, DOI 10.1016/j.neulet.2010.04.036	60	32	32	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99579	10.1371/journal.pone.0099579	http://dx.doi.org/10.1371/journal.pone.0099579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24918584	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000096
J	Babu, BK; Dinesh, P; Agrawal, PK; Sood, S; Chandrashekara, C; Bhatt, JC; Kumar, A				Babu, B. Kalyana; Dinesh, Pandey; Agrawal, Pawan K.; Sood, S.; Chandrashekara, C.; Bhatt, Jagadish C.; Kumar, Anil			Comparative Genomics and Association Mapping Approaches for Blast Resistant Genes in Finger Millet Using SSRs	PLOS ONE			English	Article							CALCIUM CONTENT; RICE BLAST; MARKERS; CORACANA; DIVERSITY; SOFTWARE; IDENTIFICATION; GENETICS	The major limiting factor for production and productivity of finger millet crop is blast disease caused by Magnaporthe grisea. Since, the genome sequence information available in finger millet crop is scarce, comparative genomics plays a very important role in identification of genes/QTLs linked to the blast resistance genes using SSR markers. In the present study, a total of 58 genic SSRs were developed for use in genetic analysis of a global collection of 190 finger millet genotypes. The 58 SSRs yielded ninety five scorable alleles and the polymorphism information content varied from 0.186 to 0.677 at an average of 0.385. The gene diversity was in the range of 0.208 to 0.726 with an average of 0.487. Association mapping for blast resistance was done using 104 SSR markers which identified four QTLs for finger blast and one QTL for neck blast resistance. The genomic marker RM262 and genic marker FMBLEST32 were linked to finger blast disease at a P value of 0.007 and explained phenotypic variance (R-2) of 10% and 8% respectively. The genomic marker UGEP81 was associated to finger blast at a P value of 0.009 and explained 7.5% of R-2. The QTLs for neck blast was associated with the genomic SSR marker UGEP18 at a P value of 0.01, which explained 11% of R-2. Three QTLs for blast resistance were found common by using both GLM and MLM approaches. The resistant alleles were found to be present mostly in the exotic genotypes. Among the genotypes of NW Himalayan region of India, VHC3997, VHC3996 and VHC3930 were found highly resistant, which may be effectively used as parents for developing blast resistant cultivars in the NW Himalayan region of India. The markers linked to the QTLs for blast resistance in the present study can be further used for cloning of the full length gene, fine mapping and their further use in the marker assisted breeding programmes for introgression of blast resistant alleles into locally adapted cultivars.	[Babu, B. Kalyana; Dinesh, Pandey; Kumar, Anil] Govind Ballabh Pant Univ Agr & Technol, Coll Basic Sci & Humanities, Dept Mol Biol & Genet Engn, Pantnagar, Uttarakhand, India; [Babu, B. Kalyana; Agrawal, Pawan K.; Sood, S.; Chandrashekara, C.; Bhatt, Jagadish C.] Vivekananda Parvateeya Krishi Anusanthan Sansthan, Biotechnol Lab, Almora, Uttarakhand, India	Govind Ballabh Pant University of Agriculture Technology; Indian Council of Agricultural Research (ICAR); ICAR - Vivekananda Parvatiya Krishi Anusandhan Sansthan	Babu, BK (corresponding author), Govind Ballabh Pant Univ Agr & Technol, Coll Basic Sci & Humanities, Dept Mol Biol & Genet Engn, Pantnagar, Uttarakhand, India.	kalyan_biotek@yahoo.co.in; anilkumar.mbge@gmail.com	Sood, Salej/AAR-3504-2020; KUMAR, ANIL/ACD-8340-2022; Boothapati, Anil Kumar/HHS-1813-2022					Arya L, 2009, J PLANT BIOCHEM BIOT, V18, P97, DOI 10.1007/BF03263303; Babu BK, 2007, GENET RESOUR CROP EV, V54, P399, DOI 10.1007/s10722-006-0002-8; Babu BK, 2014, MOL BIOL REP, V41, P3081, DOI 10.1007/s11033-014-3168-8; Babu BK, 2012, PLANT BREEDING, V131, P20, DOI 10.1111/j.1439-0523.2011.01919.x; Babu TK, 2013, EUR J PLANT PATHOL, V135, P299, DOI 10.1007/s10658-012-0086-2; Bharathi A, 2011, THESIS TAMIL NADU AG; BODMER WF, 1986, COLD SPRING HARB SYM, V51, P1; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Carine AT, 2008, PLANT PHYSIOL, V146, P21; Devos KM, 1997, PLANT MOL BIOL, V35, P3, DOI 10.1023/A:1005820229043; Dida MM, 2008, TROPICAL PLANT BIOL, P31; Dje Y, 2000, THEOR APPL GENET, V100, P918, DOI 10.1007/s001220051371; Gowda BTS, 1986, SABRO J, V18, P119; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Koide Y, 2009, JARQ-JPN AGR RES Q, V43, P255, DOI 10.6090/jarq.43.255; Kumar A, 2012, MOL BIOL REP, V39, P4949, DOI 10.1007/s11033-011-1291-3; Li SG, 2000, PROG NAT SCI, V10, P44; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Martins WS, 2009, BIOINFORMATION, V3, P282, DOI 10.6026/97320630003282; Mc Couch SR, 1988, THEOR APPL GENET, V76, P15; MILLER JC, 1990, THEOR APPL GENET, V80, P437, DOI 10.1007/BF00226743; Miyamoto M, 1996, MOL PLANT MICROBE IN, V9, P6, DOI 10.1094/MPMI-9-0-0006; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagaraja A., 2007, Journal of Mycopathological Research, V45, P237; Nagaraja A., 2010, Crop Research (Hisar), V39, P120; Nirgude M, 2014, MOL BIOL REP, V41, P1189, DOI 10.1007/s11033-013-2825-7; nja MA, 2007, FINGER MILLET BLAST; Pan QH, 1998, PLANT BREEDING, V117, P27, DOI 10.1111/j.1439-0523.1998.tb01443.x; Panwar P, 2011, MOL BIOL REP, V38, P3427, DOI 10.1007/s11033-010-0452-0; Panwar P, 2010, J GENET, V89, P121, DOI 10.1007/s12041-010-0052-8; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard J, 2003, DOCUMENTATION STRUCT; RAO A N S, 1990, Mysore Journal of Agricultural Sciences, V24, P57; Reddy INBL, 2011, MOL BREEDING, V27, P315, DOI 10.1007/s11032-010-9433-1; Rohlf FJ, 1997, NTSYS PC VERSION 2 0; rudin B, 2004, PGR NEWSL, V138, P50; Senthilvel S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-119; SOMASEKHARA YM, 1991, TROP AGR, V68, P231; Srinivasachary, 2007, THEOR APPL GENET, V115, P489, DOI 10.1007/s00122-007-0582-5; Srinivasachary MM, 2007, THEOR APPL GENET, V114, P21; Takan JP, 2012, MOL BIOTECHNOL, V50, P145, DOI 10.1007/s12033-011-9429-z; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Udupa SM, 2001, MOL GENET GENOMICS, V265, P1097, DOI 10.1007/s004380100508; Varshney RK, 2000, PLANT MOL BIOL REP, V18, P5, DOI 10.1007/BF02825288; WANG GL, 1994, GENETICS, V136, P1421; Yu JK, 2004, GENOME, V47, P805, DOI [10.1139/g04-057, 10.1139/G04-057]; YU ZH, 1991, THEOR APPL GENET, V81, P471, DOI 10.1007/BF00219436	50	45	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99182	10.1371/journal.pone.0099182	http://dx.doi.org/10.1371/journal.pone.0099182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915067	gold, Green Submitted, Green Published			2022-12-25	WOS:000340947700069
J	Leslie, T; Martin, NJ; Jack-Roosberg, C; Odongo, G; Beausoleil, E; Tuck, J; Raviprakash, K; Kochel, TJ				Leslie, Teresa; Martin, Nicholas J.; Jack-Roosberg, Carol; Odongo, George; Beausoleil, Edwin; Tuck, Jennifer; Raviprakash, Kanakatte; Kochel, Tadeusz J.			Dengue Serosurvey in Sint Eustatius	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; VIRUS; ISLANDS; HEALTH	Four distinct serotypes of dengue viruses (DENV) are the cause of re-emerging dengue fever (DF) and dengue hemorrhagic fever (DHF). Dengue circulation in the Caribbean has gone from none or single serotype to multiple serotypes co-circulating with reports of continuing cycles of progressively more severe disease in the region. Few studies have investigated dengue on Sint Eustatius. Blood samples were collected to determine the prevalence of antibodies against dengue in the Sint Eustatius population. Greater than 90% of the serum samples (184 of 204) were positive for anti-flavivirus antibodies by enzyme linked immunosorbance assay (ELISA). Plaque reduction neutralization test (PRNT), specific for dengue viruses, showed that 171 of these 184 flavivirus antibody positive sera had a neutralization titer against one or more DENV serotypes. A majority of the sera (62%) had neutralizing antibody to all four dengue serotypes. Only 26 PRNT positive sera (15%) had monotypic dengue virus neutralizing antibody, most of which (20 of 26) were against DENV2. Evidence of infection with all four serotypes was observed across all age groups except in the youngest age group (10-19 years) which contained only DENV2 positive individuals. In a multiple logistic regression model, only the length of residence on the island was a predictor of a positive dengue PRNT50 result. To our knowledge this is the first dengue serosurveillance study conducted on Sint Eustatius since the 1970s. The lack of antibodies to the DEN1, 3, and 4 in the samples collected from participants under 20 years of age suggests that only DEN2 has circulated on island since the early 1990s. The high prevalence of antibodies against dengue (83.8%) and the observation that the length of time on the island was the strongest predictor of infection suggests dengue is endemic on Sint Eustatius and a public health concern that warrants further investigation.	[Leslie, Teresa] Univ Maryland, Dept Anthropol, College Pk, MD 20742 USA; [Leslie, Teresa; Beausoleil, Edwin; Tuck, Jennifer] Eastern Caribbean Publ Hlth Fdn, Sint Eustatius, Netherlands; [Martin, Nicholas J.; Raviprakash, Kanakatte; Kochel, Tadeusz J.] Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD 20910 USA; [Jack-Roosberg, Carol] Sint Eustatius Publ Hlth Dept, Sint Eustatius, Netherlands; [Odongo, George] Queen Beatrix Med Ctr, Sint Eustatius, Netherlands	University System of Maryland; University of Maryland College Park; Naval Medical Research Center (NMRC)	Martin, NJ (corresponding author), Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD 20910 USA.	njmartin.reh@gmail.com			Military Infectious Diseases Research Program [S0353_12]	Military Infectious Diseases Research Program	This project was supported by a grant from the Military Infectious Diseases Research Program (S0353_12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CR, 1956, SCIENCE, V124, P224, DOI 10.1126/science.124.3214.224; ANSARI MZ, 1993, J CLIN LAB ANAL, V7, P230, DOI 10.1002/jcla.1860070408; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Brown T. U., 2004, Dengue Bulletin, V28, P7; GRIFFITHS BB, 1968, AM J TROP MED HYG, V17, P584, DOI 10.4269/ajtmh.1968.17.584; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Isturiz RE, 2000, INFECT DIS CLIN N AM, V14, P121, DOI 10.1016/S0891-5520(05)70221-X; Keating J, 2001, SOC SCI MED, V53, P1587, DOI 10.1016/S0277-9536(00)00443-3; Kesztyus B, 2005, DEN DUTCH CAR 15 EUR; KNUDSEN AB, 1983, MOSQ NEWS, V43, P269; Morens DM, 2008, JAMA-J AM MED ASSOC, V299, P214, DOI 10.1001/jama.2007.31-a; NEFF JM, 1967, AM J EPIDEMIOL, V86, P162, DOI 10.1093/oxfordjournals.aje.a120722; Pan American Health Organization, 1965, EPIDEMIOLOGICAL NOTE, V37, P116; Peyrefitte CN, 2005, EMERG INFECT DIS, V11, P757, DOI 10.3201/eid1105.040959; Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161; RUSSELL PK, 1967, J IMMUNOL, V99, P285; van der KUYP E., 1949, DOCUMENTA NEERLAND ET INDONESICA MORBIS TROP, V1, P69; VANDERKUYP E, 1948, AM J TROP MED, V28, P747; VANDERSAR A, 1979, TROP GEOGR MED, V31, P229; WHO, 2013, 2 WHO	21	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e95002	10.1371/journal.pone.0095002	http://dx.doi.org/10.1371/journal.pone.0095002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914538	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700002
J	Marzal, M; Guerra-Giraldez, C; Paredes, A; Cangalaya, C; Rivera, A; Gonzalez, AE; Mahanty, S; Garcia, HH; Nash, TE				Marzal, Miguel; Guerra-Giraldez, Cristina; Paredes, Adriana; Cangalaya, Carla; Rivera, Andrea; Gonzalez, Armando E.; Mahanty, Siddhartha; Garcia, Hector H.; Nash, Theodore E.		Cysticercosis Working Grp Peru	Evans Blue Staining Reveals Vascular Leakage Associated with Focal Areas of Host-Parasite Interaction in Brains of Pigs Infected with Taenia solium	PLOS ONE			English	Article							PORCINE CYSTICERCOSIS; SCHISTOSOMA-MANSONI; INFLAMMATORY REACTION; HUMAN EOSINOPHILS; BARRIER; NEUROCYSTICERCOSIS; PERMEABILITY; DISEASE; MUSCLE; LARVAE	Cysticidal drug treatment of viable Taenia solium brain parenchymal cysts leads to an acute pericystic host inflammatory response and blood brain barrier breakdown (BBB), commonly resulting in seizures. Naturally infected pigs, untreated or treated one time with praziquantel were sacrificed at 48 hr and 120 hr following the injection of Evans blue (EB) to assess the effect of treatment on larval parasites and surrounding tissue. Examination of harvested non encapsulated muscle cysts unexpectedly revealed one or more small, focal round region(s) of Evans blue dye infiltration (REBI) on the surface of otherwise non dye-stained muscle cysts. Histopathological analysis of REBI revealed focal areas of eosinophil-rich inflammatory infiltrates that migrated from the capsule into the tegument and internal structures of the parasite. In addition some encapsulated brain cysts, in which the presence of REBI could not be directly assessed, showed histopathology identical to that of the REBI. Muscle cysts with REBI were more frequent in pigs that had received praziquantel (6.6% of 3736 cysts; n = 6 pigs) than in those that were untreated (0.2% of 3172 cysts; n = 2 pigs). Similar results were found in the brain, where 20.7% of 29 cysts showed histopathology identical to muscle REBI cysts in praziquantel-treated pigs compared to the 4.3% of 47 cysts in untreated pigs. Closer examination of REBI infiltrates showed that EB was taken up only by eosinophils, a major component of the cellular infiltrates, which likely explains persistence of EB in the REBI. REBI likely represent early damaging host responses to T. solium cysts and highlight the focal nature of this initial host response and the importance of eosinophils at sites of host-parasite interaction. These findings suggest new avenues for immunomodulation to reduce inflammatory side effects of anthelmintic therapy.	[Marzal, Miguel; Guerra-Giraldez, Cristina; Paredes, Adriana; Cangalaya, Carla; Rivera, Andrea; Mahanty, Siddhartha; Garcia, Hector H.; Nash, Theodore E.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Immunopathol Neurocysticercosis, Lima, Peru; [Gonzalez, Armando E.] Univ Nacl Mayor San Marcos, Fac Med Vet, Lima 14, Peru; [Mahanty, Siddhartha; Nash, Theodore E.] NIAID, NIH, Bethesda, MD 20892 USA; [Garcia, Hector H.] Inst Nacl Ciencias Neurol, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Nacional Mayor de San Marcos; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nash, TE (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Immunopathol Neurocysticercosis, Lima, Peru.	tnash@niaid.nih.gov	Guerra-Giraldez, Cristina/AAK-8596-2020; Mayta, Holger/ABA-4755-2020	Guerra-Giraldez, Cristina/0000-0002-9287-9838; Mayta, Holger/0000-0001-5306-628X; Verastegui, Manuela/0000-0002-7500-1353; Gonzalez, Armando/0000-0003-1909-1873; Gonzales-Gustavson, Eloy/0000-0001-7328-2983; Rivera Santillan, Andrea Mercedes/0000-0003-0093-3946; Cangalaya, Carla/0000-0002-3525-8445; Mahanty, Siddhartha/0000-0003-1068-0524; Orrego Solano, Miguel Angel/0000-0003-0036-427X	National Institutes of Allergy and Infectious Diseases; Fogarty International Center/NIH [D43 TW001140]; Wellcome Trust International Senior Research Fellowship in Public Health and Tropical Medicine; National Institutes of Health; FOGARTY INTERNATIONAL CENTER [D43TW001140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000846] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust International Senior Research Fellowship in Public Health and Tropical Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by intramural program of the National Institutes of Allergy and Infectious Diseases (www.niaid.nih.gov/), National Institutes of Health, and also with partial support from the Fogarty International Center/NIH (http://www.fic.nih.gov/; Training grant D43 TW001140). HHG is supported by a Wellcome Trust International Senior Research Fellowship in Public Health and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 1999, ADV DRUG DELIVER REV, V37, P253, DOI 10.1016/S0169-409X(98)00097-0; ALLEN TH, 1950, AM J PHYSIOL, V161, P473, DOI 10.1152/ajplegacy.1950.161.3.473; Alvarez JI, 2002, J COMP PATHOL, V127, P186, DOI 10.1053/jcpa.2002.0579; BRIGHTMA.MW, 1970, J NEUROL SCI, V10, P215, DOI 10.1016/0022-510X(70)90151-6; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; CHANDRASHEKAR R, 1990, INT J PARASITOL, V20, P725, DOI 10.1016/0020-7519(90)90005-8; DEALUJA AS, 1988, VET PARASITOL, V28, P65, DOI 10.1016/0304-4017(88)90019-2; DEALUJA AS, 1989, CLIN IMAG, V13, P292, DOI 10.1016/0899-7071(89)90062-4; Deckers N, 2008, INT J PARASITOL, V38, P1191, DOI 10.1016/j.ijpara.2008.01.005; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Evans CAW, 1997, AM J TROP MED HYG, V56, P33, DOI 10.4269/ajtmh.1997.56.33; Fang WR, 2013, NEUROCHEM INT, V62, P23, DOI 10.1016/j.neuint.2012.10.012; Garcia HH, 2011, CURR OPIN INFECT DIS, V24, P423, DOI 10.1097/QCO.0b013e32834a1b20; Gonzalez AE, 2012, AM J TROP MED HYG, V87, P292, DOI 10.4269/ajtmh.2012.11-0371; Guerra-Giraldez C, 2013, EXP PARASITOL, V134, P443, DOI 10.1016/j.exppara.2013.05.005; Hafez I, 2003, J BIOL CHEM, V278, P44921, DOI 10.1074/jbc.M306013200; HANES MA, 1995, VET PATHOL, V32, P441, DOI 10.1177/030098589503200418; Ito A, 1998, PARASITE IMMUNOL, V20, P105, DOI 10.1046/j.1365-3024.1998.00108.x; ITO U, 1975, ACTA NEUROPATHOL, V34, P1; Jithendran K. P., 1998, Indian Journal of Experimental Biology, V36, P523; KASSIS AI, 1979, J IMMUNOL, V122, P398; Lampinen M, 2006, INT ARCH ALLERGY IMM, V140, P113, DOI 10.1159/000092412; Londono DP, 2002, VET PARASITOL, V109, P249, DOI 10.1016/S0304-4017(02)00290-X; Mahanty S, 2010, PROG NEUROBIOL, V91, P172, DOI 10.1016/j.pneurobio.2009.12.008; Matsumoto K, 2011, INT ARCH ALLERGY IMM, V155, P34, DOI 10.1159/000327263; MILHORAT TH, 1975, J NEUROSURG, V42, P315, DOI 10.3171/jns.1975.42.3.0315; Nash TE, 2003, ACTA TROP, V87, P61, DOI 10.1016/S0001-706X(03)00056-1; Nash T, 2012, PATHOG GLOB HEALTH, V106, P275, DOI 10.1179/2047773212Y.0000000026; Nash TE, 2011, NAT REV NEUROL, V7, P584, DOI 10.1038/nrneurol.2011.135; Nutten S, 1999, EUR J IMMUNOL, V29, P799, DOI 10.1002/(SICI)1521-4141(199903)29:03&lt;799::AID-IMMU799&gt;3.0.CO;2-1; Ooi WW, 2011, AM J TROP MED HYG, V85, P460, DOI 10.4269/ajtmh.2011.11-0221; Perez-Torres A, 2002, PARASITOL RES, V88, P150, DOI 10.1007/s00436-001-0510-6; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; Robinson P, 1997, INFECT IMMUN, V65, P2925, DOI 10.1128/IAI.65.7.2925-2931.1997; Sabin EA, 1996, J EXP MED, V184, P1871, DOI 10.1084/jem.184.5.1871; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; Sikasunge CS, 2008, VET PARASITOL, V158, P57, DOI 10.1016/j.vetpar.2008.08.014; Sikasunge CS, 2009, VET PARASITOL, V160, P242, DOI 10.1016/j.vetpar.2008.11.015; STEINWALL O, 1966, J NEUROPATH EXP NEUR, V25, P542, DOI 10.1097/00005072-196610000-00004; TAM ND, 1983, AUST J EXP BIOL MED, V61, P629, DOI 10.1038/icb.1983.59; THUMWOOD CM, 1989, BRIT J EXP PATHOL, V70, P293; TORRES A, 1992, PARASITOL RES, V78, P161, DOI 10.1007/BF00931659; WILLMS K, 1980, PARASITE IMMUNOL, V2, P261, DOI 10.1111/j.1365-3024.1980.tb00058.x; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	44	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e97321	10.1371/journal.pone.0097321	http://dx.doi.org/10.1371/journal.pone.0097321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915533	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700010
J	Perkins, AD; Tanentzapf, G				Perkins, Alexander D.; Tanentzapf, Guy			An Ongoing Role for Structural Sarcomeric Components in Maintaining Drosophila melanogaster Muscle Function and Structure	PLOS ONE			English	Article							THIN FILAMENT LENGTH; INDIRECT FLIGHT-MUSCLE; MYOSIN HEAVY; MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; STRIATED-MUSCLE; NEGATIVE GEOTAXIS; GENETIC-ANALYSIS; ACTIN-FILAMENTS; POINTED ENDS	Animal muscles must maintain their function while bearing substantial mechanical loads. How muscles withstand persistent mechanical strain is presently not well understood. The basic unit of muscle is the sarcomere, which is primarily composed of cytoskeletal proteins. We hypothesized that cytoskeletal protein turnover is required to maintain muscle function. Using the flight muscles of Drosophila melanogaster, we confirmed that the sarcomeric cytoskeleton undergoes turnover throughout adult life. To uncover which cytoskeletal components are required to maintain adult muscle function, we performed an RNAi-mediated knockdown screen targeting the entire fly cytoskeleton and associated proteins. Gene knockdown was restricted to adult flies and muscle function was analyzed with behavioural assays. Here we analyze the results of that screen and characterize the specific muscle maintenance role for several hits. The screen identified 46 genes required for muscle maintenance: 40 of which had no previously known role in this process. Bioinformatic analysis highlighted the structural sarcomeric proteins as a candidate group for further analysis. Detailed confocal and electron microscopic analysis showed that while muscle architecture was maintained after candidate gene knockdown, sarcomere length was disrupted. Specifically, we found that ongoing synthesis and turnover of the key sarcomere structural components Projectin, Myosin and Actin are required to maintain correct sarcomere length and thin filament length. Our results provide in vivo evidence of adult muscle protein turnover and uncover specific functional defects associated with reduced expression of a subset of cytoskeletal proteins in the adult animal.	[Perkins, Alexander D.; Tanentzapf, Guy] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Tanentzapf, G (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	tanentz@mail.ubc.ca	Tanentzapf, Guy/C-8864-2012	Tanentzapf, Guy/0000-0002-2443-233X; Perkins, Alexander/0000-0002-9817-2390	Natural Sciences and Engineering Research Council of Canada [356502]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	G.T. and A.D.P. gratefully acknowledge the support of the Natural Sciences and Engineering Research Council of Canada (Grant Number 356502; http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikian MJ, 2007, HUM MOL GENET, V16, P2933, DOI 10.1093/hmg/ddm254; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011; Bai JW, 2008, DEVELOPMENT, V135, P1439, DOI 10.1242/dev.012849; Barton B, 2007, J MUSCLE RES CELL M, V28, P219, DOI 10.1007/s10974-007-9120-y; Bassett DI, 2003, HUM MOL GENET, V12, pR265, DOI 10.1093/hmg/ddg279; BEALL CJ, 1991, J CELL BIOL, V114, P941, DOI 10.1083/jcb.114.5.941; Beckett K, 2006, INT REV NEUROBIOL, V75, P55, DOI 10.1016/S0074-7742(06)75003-6; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Burkart C, 2007, J MOL BIOL, V367, P953, DOI 10.1016/j.jmb.2007.01.059; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; CHUN MY, 1988, J CELL BIOL, V107, P2613, DOI 10.1083/jcb.107.6.2613; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; Contompasis JL, 2010, J MOL BIOL, V395, P340, DOI 10.1016/j.jmb.2009.11.021; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Engel Andrew G, 2008, Handb Clin Neurol, V91, P103, DOI 10.1016/S0072-9752(07)01503-5; FERNANDES J, 1991, DEVELOPMENT, V113, P67; Fraterman S, 2007, MOL CELL PROTEOMICS, V6, P728, DOI 10.1074/mcp.M600345-MCP200; FYRBERG CC, 1992, P ROY SOC B-BIOL SCI, V249, P33, DOI 10.1098/rspb.1992.0080; FYRBERG E, 1989, CELL MOTIL CYTOSKEL, V14, P118, DOI 10.1002/cm.970140121; FYRBERG EA, 1990, ANNU REV CELL BIOL, V6, P559, DOI 10.1146/annurev.cb.06.110190.003015; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Ghosh SR, 2010, EUR J CELL BIOL, V89, P437, DOI 10.1016/j.ejcb.2009.11.027; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; HU S, 1995, GENE DEV, V9, P2936, DOI 10.1101/gad.9.23.2936; KAR NC, 1979, CLIN CHIM ACTA, V94, P277, DOI 10.1016/0009-8981(79)90076-7; KARLIK CC, 1984, CELL, V38, P711, DOI 10.1016/0092-8674(84)90266-6; KRONERT WA, 1995, J MOL BIOL, V249, P111, DOI 10.1006/jmbi.1995.0283; Kucherenko MM, 2011, DEV BIOL, V352, P228, DOI 10.1016/j.ydbio.2011.01.013; Kucherenko MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002418; LAGRANGE BM, 1976, DEV BIOL, V54, P214, DOI 10.1016/0012-1606(76)90300-6; Laviolette MJ, 2005, GENETICS, V170, P779, DOI 10.1534/genetics.104.035691; LAZARO RP, 1986, AM J CLIN PATHOL, V86, P378, DOI 10.1093/ajcp/86.3.378; Leal SM, 2002, J NEUROBIOL, V50, P245, DOI 10.1002/neu.10030; Littlefield R, 1998, ANNU REV CELL DEV BI, V14, P487, DOI 10.1146/annurev.cellbio.14.1.487; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; Lopes KD, 2011, J CELL BIOL, V193, P785, DOI 10.1083/jcb.201010099; Maqbool T, 2007, J MUSCLE RES CELL M, V28, P397, DOI 10.1007/s10974-008-9133-1; Mardahl-Dumesnil M, 2001, J CELL BIOL, V155, P1043, DOI 10.1083/jcb.200108026; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miller MS, 2008, BIOPHYS J, V95, P2391, DOI [10.1529/biophysj.108.130005, 10.1529/hiophysj.108.130005]; Miller MK, 2004, TRENDS CELL BIOL, V14, P119, DOI 10.1016/j.tcb.2004.01.003; Nongthomba U, 2003, GENETICS, V164, P209; Ono S, 2010, CYTOSKELETON, V67, P677, DOI 10.1002/cm.20476; Oota S, 1999, MOL BIOL EVOL, V16, P856, DOI 10.1093/oxfordjournals.molbev.a026170; Ottenheijm CAC, 2009, HUM MOL GENET, V18, P2359, DOI 10.1093/hmg/ddp168; PAI AC, 1965, DEV BIOL, V11, P82, DOI 10.1016/0012-1606(65)90038-2; Perkins AD, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.2; Perkins AD, 2010, DEV BIOL, V338, P15, DOI 10.1016/j.ydbio.2009.10.034; Piazza N, 2011, PROG MOL BIOL TRANSL, V100, P155, DOI 10.1016/B978-0-12-384878-9.00005-4; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Rando TA, 2002, AM J PHYS MED REHAB, V81, pS175, DOI 10.1097/00002060-200211001-00018; Reedy MC, 2000, J CELL BIOL, V151, P1483, DOI 10.1083/jcb.151.7.1483; Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011; Roper K, 2005, J CELL SCI, V118, P3937, DOI 10.1242/jcs.02517; Rui YN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001208; Salmikangas P, 2003, HUM MOL GENET, V12, P189, DOI 10.1093/hmg/ddg020; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnorrer F, 2004, DEV CELL, V7, P9, DOI 10.1016/j.devcel.2004.06.010; Schnorrer F, 2007, DEV CELL, V12, P751, DOI 10.1016/j.devcel.2007.02.017; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Seto JT, 2011, EXP GERONTOL, V46, P292, DOI 10.1016/j.exger.2010.11.006; Soler C, 2004, DEVELOPMENT, V131, P6041, DOI 10.1242/dev.01527; Sparrow J, 2008, ADV EXP MED BIOL, V642, P192; Sparrow JC, 2009, NAT REV MOL CELL BIO, V10, P293, DOI 10.1038/nrm2634; Spence HJ, 2002, BIOESSAYS, V24, P542, DOI 10.1002/bies.10098; Tanner BCW, 2011, AM J PHYSIOL-CELL PH, V301, pC383, DOI 10.1152/ajpcell.00016.2011; Thornhill P, 2008, BRAIN, V131, P1551, DOI 10.1093/brain/awn078; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Vercherat C, 2009, HUM MOL GENET, V18, P4304, DOI 10.1093/hmg/ddp383; Vigoreaux JO, 2006, MOL B INT U, P143, DOI 10.1007/0-387-32963-3_12; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; ZAK R, 1977, J BIOL CHEM, V252, P3430	83	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99362	10.1371/journal.pone.0099362	http://dx.doi.org/10.1371/journal.pone.0099362			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915196	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700089
J	Powell, TY; Boonstra, TW; Martin, DM; Loo, CK; Breakspear, M				Powell, Tamara Y.; Boonstra, Tjeerd W.; Martin, Donel M.; Loo, Colleen K.; Breakspear, Michael			Modulation of Cortical Activity by Transcranial Direct Current Stimulation in Patients with Affective Disorder	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; NONINVASIVE BRAIN-STIMULATION; WORKING-MEMORY IMPROVEMENT; ANTERIOR CINGULATE; THETA-OSCILLATIONS; MAJOR DEPRESSION; EEG ALPHA; TDCS; EXCITABILITY; INHIBITION	Transcranial direct current stimulation (tDCS) has been shown to have antidepressant efficacy in patients experiencing a major depressive episode, but little is known about the underlying neurophysiology. The purpose of our study was to investigate the acute effects of tDCS on cortical activity using electroencephalography (EEG) in patients with an affective disorder. Eighteen patients diagnosed with an affective disorder and experiencing a depressive episode participated in a sham-controlled study of tDCS, each receiving a session of active (2 mA for 20 minutes) and sham tDCS to the left dorsolateral prefrontal cortex (DLPFC). The effects of tDCS on EEG activity were assessed after each session using event-related potentials (ERP) and measurement of spectral activity during a visual working memory (VWM) task. We observed task and intervention dependent effects on both ERPs and task-related alpha and theta activity, where active compared to sham stimulation resulted in a significant reduction in the N2 amplitude and reduced theta activity over frontal areas during memory retrieval. In summary a single session of anodal tDCS stimulation to the left DLPFC during a major depressive episode resulted in modulated brain activity evident in task-related EEG. Effects on the N2 and frontal theta activity likely reflect modulated activity in the medial frontal cortex and hence indicate that the after-effects of tDCS extend beyond the direct focal effects to the left DLPFC.	[Powell, Tamara Y.; Boonstra, Tjeerd W.; Martin, Donel M.; Loo, Colleen K.; Breakspear, Michael] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Powell, Tamara Y.; Boonstra, Tjeerd W.; Martin, Donel M.; Loo, Colleen K.; Breakspear, Michael] Black Dog Inst, Sydney, NSW, Australia; [Boonstra, Tjeerd W.] Vrije Univ Amsterdam, MOVE Res Inst, Amsterdam, Netherlands; [Loo, Colleen K.] St George Hosp, Kogarah, NSW, Australia; [Breakspear, Michael] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Breakspear, Michael] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia	University of New South Wales Sydney; Black Dog Institute; Vrije Universiteit Amsterdam; St George Hospital; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Powell, TY (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia.	tamara.powell@qimrberghofer.edu.au	Breakspear, Michael/ABF-6302-2020; Boonstra, Tjeerd/C-5433-2011; Breakspear, Michael/M-5859-2014	Breakspear, Michael/0000-0003-4943-3969; Boonstra, Tjeerd/0000-0002-6969-7243; Loo, Colleen/0000-0003-3267-0554; Martin, Donel/0000-0002-8452-0390; powell, tamara/0000-0003-2859-3103	ARC Thinking Systems grant [TS0669860]; National Health and Medical Research Council (NHMRC) [510142]; BrainNRG collaborative award [JSMF22002082]; Netherlands Organisation for Scientific Research (NWO) [45110-030]	ARC Thinking Systems grant(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); BrainNRG collaborative award; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by the ARC Thinking Systems grant (TS0669860); the National Health and Medical Research Council (NHMRC #510142); BrainNRG collaborative award (JSMF22002082), and the Netherlands Organisation for Scientific Research (NWO #45110-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; Arul-Anandam AP, 2009, J AFFECT DISORDERS, V117, P137, DOI 10.1016/j.jad.2009.01.016; Asada H, 1999, NEUROSCI LETT, V274, P29, DOI 10.1016/S0304-3940(99)00679-5; Awh E, 2008, NAT NEUROSCI, V11, P5, DOI 10.1038/nn0108-5; Baskaran A, 2012, NEUROPHARMACOLOGY; Boonstra TW, 2013, INT J PSYCHOPHYSIOL, V89, P409, DOI 10.1016/j.ijpsycho.2013.04.001; Brunoni AR, 2013, JAMA PSYCHIAT, V70, P383, DOI 10.1001/2013.jamapsychiatry.32; Brunoni AR, 2014, BRAIN COGNITION, V86, P1, DOI 10.1016/j.bandc.2014.01.008; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Chi RP, 2010, BRAIN RES, V1353, P168, DOI 10.1016/j.brainres.2010.07.062; da Silva MC, 2013, J PHYSIOL-PARIS, V107, P493, DOI 10.1016/j.jphysparis.2013.07.003; Dell'Osso B, 2012, EUR PSYCHIAT, V27, P513, DOI 10.1016/j.eurpsy.2011.02.008; Faria P, 2012, EPILEPSY BEHAV, V25, P417, DOI 10.1016/j.yebeh.2012.06.027; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Fukuda K, 2010, CURR OPIN NEUROBIOL, V20, P177, DOI 10.1016/j.conb.2010.03.005; Heimrath K, 2012, Front Psychiatry, V3, P56, DOI 10.3389/fpsyt.2012.00056; Hoy KE, 2013, NEUROPSYCHOLOGIA, V51, P1777, DOI 10.1016/j.neuropsychologia.2013.05.018; Jacobson L, 2012, CLIN NEUROPHYSIOL, V123, P979, DOI 10.1016/j.clinph.2011.09.016; Jensen MP, 2013, CLIN NEUROPHYSIOL, V124, P2016, DOI 10.1016/j.clinph.2013.04.009; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Kalska H, 1999, Appl Neuropsychol, V6, P96, DOI 10.1207/s15324826an0602_5; Kalu UG, 2012, PSYCHOL MED, V42, P1791, DOI 10.1017/S0033291711003059; Kasashima Y, 2012, EXP BRAIN RES, V221, P263, DOI 10.1007/s00221-012-3166-9; Keeser D, 2011, NEUROIMAGE, V55, P644, DOI 10.1016/j.neuroimage.2010.12.004; Keeser D, 2011, J NEUROSCI, V31, P15284, DOI 10.1523/JNEUROSCI.0542-11.2011; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kochan NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023960; Krause CM, 2000, CLIN NEUROPHYSIOL, V111, P2071, DOI 10.1016/S1388-2457(00)00429-6; Kuo MF, 2014, NEUROIMAGE, V85, P948, DOI 10.1016/j.neuroimage.2013.05.117; Linkenkaer-Hansen K, 2005, J NEUROSCI, V25, P10131, DOI 10.1523/JNEUROSCI.3244-05.2005; Liu ZX, 2014, NEUROIMAGE, V85, P873, DOI 10.1016/j.neuroimage.2013.08.054; Loo CK, 2012, BRIT J PSYCHIAT, V200, P52, DOI 10.1192/bjp.bp.111.097634; Maeoka H, 2012, NEUROSCI LETT, V512, P12, DOI 10.1016/j.neulet.2012.01.037; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Moran RJ, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00200; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2009, BIOL PSYCHIAT, V66, P503, DOI 10.1016/j.biopsych.2009.03.022; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Oliveira JF, 2013, NEUROSCI LETT, V537, P60, DOI 10.1016/j.neulet.2013.01.023; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Palm U, 2009, WORLD J BIOL PSYCHIA, V10, P632, DOI 10.1080/15622970802480905; Palva S, 2011, J NEUROSCI, V31, P5013, DOI 10.1523/JNEUROSCI.5592-10.2011; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rosa MA, 2012, NEUROPSYCHOPHARMACOL, V37, P102, DOI 10.1038/npp.2011.225; Rose EJ, 2006, J AFFECT DISORDERS, V90, P149, DOI 10.1016/j.jad.2005.11.003; Ruffini G, 2014, NEUROIMAGE, V89, P216, DOI 10.1016/j.neuroimage.2013.12.002; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Schestatsky P, 2013, JOVE-J VIS EXP, DOI 10.3791/50426; Segrave RA, 2010, J AFFECT DISORDERS, V127, P191, DOI 10.1016/j.jad.2010.05.022; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Terney D, 2008, J NEUROSCI, V28, P14147, DOI 10.1523/JNEUROSCI.4248-08.2008; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Tsoneva Tsvetomira, 2011, Annu Int Conf IEEE Eng Med Biol Soc, V2011, P3828, DOI 10.1109/IEMBS.2011.6090952; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Vanderhasselt MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062219; Weiland-Fiedler P, 2004, J AFFECT DISORDERS, V82, P253, DOI 10.1016/j.jad.2003.10.009; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2	65	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98503	10.1371/journal.pone.0098503	http://dx.doi.org/10.1371/journal.pone.0098503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914953	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700023
J	Willenbrock, S; Wagner, S; Reimann-Berg, N; Moulay, M; Hewicker-Trautwein, M; Nolte, I; Escobar, HM				Willenbrock, Saskia; Wagner, Siegfried; Reimann-Berg, Nicola; Moulay, Mohammed; Hewicker-Trautwein, Marion; Nolte, Ingo; Escobar, Hugo Murua			Generation and Characterisation of a Canine EGFP-HMGA2 Prostate Cancer In Vitro Model	PLOS ONE			English	Article							MOBILITY GROUP A2; CARCINOMA CELL-LINE; HMGI-C; VIVO MODEL; TUMOR-DEVELOPMENT; PERIPHERAL-BLOOD; EXPRESSION; LET-7; MICRORNA; PROTEINS	The architectural transcription factor HMGA2 is abundantly expressed during embryonic development. In several malignant neoplasias including prostate cancer, high re-expression of HMGA2 is correlated with malignancy and poor prognosis. The let-7 miRNA family is described to regulate HMGA2 negatively. The balance of let-7 and HMGA2 is discussed to play a major role in tumour aetiology. To further analyse the role of HMGA2 in prostate cancer a stable and highly reproducible in vitro model system is precondition. Herein we established a canine CT1258-EGFP-HMGA2 prostate cancer cell line stably overexpressing HMGA2 linked to EGFP and in addition the reference cell line CT1258-EGFP expressing solely EGFP to exclude EGFP-induced effects. Both recombinant cell lines were characterised by fluorescence microscopy, flow cytometry and immunocytochemistry. The proliferative effect of ectopically overexpressed HMGA2 was determined via BrdU assays. Comparative karyotyping of the derived and the initial CT1258 cell lines was performed to analyse chromosome consistency. The impact of the ectopic HMGA2 expression on its regulator let-7a was analysed by quantitative real-time PCR. Fluorescence microscopy and immunocytochemistry detected successful expression of the EGFP-HMGA2 fusion protein exclusively accumulating in the nucleus. Gene expression analyses confirmed HMGA2 overexpression in CT1258-EGFP-HMGA2 in comparison to CT1258-EGFP and native cells. Significantly higher let-7a expression levels were found in CT1258-EGFP-HMGA2 and CT1258-EGFP. The BrdU assays detected an increased proliferation of CT1258-HMGA2-EGFP cells compared to CT1258-EGFP and native CT1258. The cytogenetic analyses of CT1258-EGFP and CT1258-EGFP-HMGA2 resulted in a comparable hyperdiploid karyotype as described for native CT1258 cells. To further investigate the impact of recombinant overexpressed HMGA2 on CT1258 cells, other selected targets described to underlie HMGA2 regulation were screened in addition. The new fluorescent CT1258-EGFP-HMGA2 cell line is a stable tool enabling in vitro and in vivo analyses of the HMGA2-mediated effects on cells and the development and pathogenesis of prostate cancer.	[Willenbrock, Saskia; Wagner, Siegfried; Reimann-Berg, Nicola; Moulay, Mohammed; Nolte, Ingo; Escobar, Hugo Murua] Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany; [Wagner, Siegfried] Leibniz Univ Hannover, Inst Biophys, Hannover, Germany; [Hewicker-Trautwein, Marion] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Escobar, Hugo Murua] Univ Rostock, Div Med Haematol Oncol & Palliat Med, D-18055 Rostock, Germany	University of Veterinary Medicine Hannover, Foundation; Leibniz University Hannover; University of Veterinary Medicine Hannover, Foundation; University of Rostock	Escobar, HM (corresponding author), Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany.	Hugo.Murua.Escobar@med.uni-rostock.de	Moulay, Mohammed/AAK-5699-2021	Moulay, Mohammed/0000-0002-3082-0101	Small Animal Clinic, University of Veterinary Medicine, Hannover	Small Animal Clinic, University of Veterinary Medicine, Hannover	No third party funds supported this study. The study was financed with the internal budget of the Small Animal Clinic, University of Veterinary Medicine, Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2003, BRIT J CANCER, V89, P2104, DOI 10.1038/sj.bjc.6601391; Aggarwal S, 2006, PROSTATE, V66, P903, DOI 10.1002/pros.20413; Anidjar M, 2001, PROSTATE, V46, P2; AUMULLER G, 1990, PROSTATE, V17, P31, DOI 10.1002/pros.2990170105; Battista S, 1999, CANCER RES, V59, P4793; Belge G, 2008, GENE CHROMOSOME CANC, V47, P56, DOI 10.1002/gcc.20505; BELL FW, 1991, J AM VET MED ASSOC, V199, P1623; BELL FW, 1995, J VET INTERN MED, V9, P149, DOI 10.1111/j.1939-1676.1995.tb03288.x; BERLINGIERI MT, 1995, MOL CELL BIOL, V15, P1545; BULLERDIEK J, 1987, CANCER GENET CYTOGEN, V24, P205, DOI 10.1016/0165-4608(87)90100-2; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Cattaruzzi G, 2007, NUCLEIC ACIDS RES, V35, P1751, DOI 10.1093/nar/gkl1106; Cleynen I, 2008, INT J ONCOL, V32, P289; Cornell KK, 2000, PROSTATE, V45, P173; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Fan TM, 2007, WITHROW MACEWENS SMA; Fork MAM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-240; Gioia G, 2011, VET IMMUNOL IMMUNOP, V142, P228, DOI 10.1016/j.vetimm.2011.05.020; Henriksen J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-329; Hess JL, 1998, AM J CLIN PATHOL, V109, P251, DOI 10.1093/ajcp/109.3.251; Ikeda K, 2011, BLOOD, V117, P5860, DOI 10.1182/blood-2011-02-334425; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joetzke AE, 2010, VET COMP ONCOL, V8, P87, DOI 10.1111/j.1476-5829.2010.00207.x; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; KAIGHN ME, 1979, INVEST UROL, V17, P16; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Khanna C, 2009, CLIN CANCER RES, V15, P5671, DOI 10.1158/1078-0432.CCR-09-0719; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lai CL, 2008, PROSTATE, V68, P477, DOI 10.1002/pros.20720; Langelotz C, 2003, BRIT J CANCER, V88, P1406, DOI 10.1038/sj.bjc.6600935; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; LeRoy BE, 2009, VET J, V180, P149, DOI 10.1016/j.tvjl.2008.07.012; Li Z, DEV CELL, V23, P1176; MACEWEN EG, 1990, CANCER METAST REV, V9, P125, DOI 10.1007/BF00046339; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; MCENTEE M, 1987, PROSTATE, V11, P163, DOI 10.1002/pros.2990110207; Meyer B, 2007, LEUKEMIA LYMPHOMA, V48, P2008, DOI 10.1080/10428190701559116; Meyer B, 2007, MOL CARCINOGEN, V46, P503, DOI 10.1002/mc.20235; Miyazawa J, 2004, CANCER RES, V64, P2024, DOI 10.1158/0008-5472.CAN-03-1855; Motoyama K, 2008, CLIN CANCER RES, V14, P2334, DOI 10.1158/1078-0432.CCR-07-4667; Mueller F, 2007, ANTICANCER RES, V27, P155; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pegoraro S, 2013, ONCOTARGET, V4, P1293, DOI 10.18632/oncotarget.1136; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Qian ZR, 2009, MODERN PATHOL, V22, P431, DOI 10.1038/modpathol.2008.202; Rahman MM, 2009, BRIT J CANCER, V100, P501, DOI 10.1038/sj.bjc.6604883; Reimann N, 1996, CYTOGENET CELL GENET, V73, P140, DOI 10.1159/000134326; Reimann-Berg N, 2011, CYTOGENET GENOME RES, V132, P16, DOI 10.1159/000317077; Rogalla P, 1997, MOL CARCINOGEN, V19, P153, DOI 10.1002/(SICI)1098-2744(199707)19:3<153::AID-MC2>3.0.CO;2-F; Rommel B, 1997, LEUKEMIA LYMPHOMA, V26, P603, DOI 10.3109/10428199709050896; Roush SF, 2009, DEV BIOL, V334, P523, DOI 10.1016/j.ydbio.2009.07.012; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schubert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065064; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Smith BN, 2012, CELL ADHES MIGR, V6, P433, DOI 10.4161/cam.21687; Sorenmo K U, 2003, Vet Comp Oncol, V1, P48, DOI 10.1046/j.1476-5829.2003.00007.x; Sterenczak KA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-284; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Sutter NB, 2004, NAT REV GENET, V5, P900, DOI 10.1038/nrg1492; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tallini G, 1999, ADV ANAT PATHOL, V6, P237, DOI 10.1097/00125480-199909000-00001; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Trujillo RD, 2010, EMBO J, V29, P3272, DOI 10.1038/emboj.2010.208; VELDSCHOLTE J, 1990, BIOCHIM BIOPHYS ACTA, V1052, P187, DOI 10.1016/0167-4889(90)90075-O; Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523; Waters DJ, 1998, PROSTATE, V36, P64; Winkler S, 2005, J HERED, V96, P782, DOI 10.1093/jhered/esi085; Winkler S, 2007, CANCER GENET CYTOGEN, V177, P98, DOI 10.1016/j.cancergencyto.2007.06.008; Wisniewski JR, 2000, INT J MOL MED, V6, P409; WOLFFE AP, 1994, SCIENCE, V264, P1100, DOI 10.1126/science.8178167; Wood LJ, 2000, CANCER RES, V60, P4256; Young ARJ, 2007, GENE DEV, V21, P1005, DOI 10.1101/gad.1554707; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhu C, 2013, MOL CELL BIOCHEM, V379, P69, DOI 10.1007/s11010-013-1628-4; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134	84	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98788	10.1371/journal.pone.0098788	http://dx.doi.org/10.1371/journal.pone.0098788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914948	Green Published, gold			2022-12-25	WOS:000340947700032
J	Wong, MC; Dobi, KC; Baylies, MK				Wong, Ming-Ching; Dobi, Krista C.; Baylies, Mary K.			Discrete Levels of Twist Activity Are Required to Direct Distinct Cell Functions during Gastrulation and Somatic Myogenesis	PLOS ONE			English	Article							DROSOPHILA MESODERM DEVELOPMENT; ADHERENS JUNCTIONS; SHAPE CHANGES; FGF-RECEPTOR; TRANSCRIPTION FACTORS; DEVELOPMENTAL CONTROL; DORSOVENTRAL PATTERN; REGULATORY NETWORKS; FOUNDER CELLS; ZYGOTIC GENE	Twist (Twi), a conserved basic helix-loop-helix transcriptional regulator, directs the epithelial-to-mesenchymal transition (EMT), and regulates changes in cell fate, cell polarity, cell division and cell migration in organisms from flies to humans. Analogous to its role in EMT, Twist has been implicated in metastasis in numerous cancer types, including breast, pancreatic and prostate. In the Drosophila embryo, Twist is essential for discrete events in gastrulation and mesodermal patterning. In this study, we derive a twi allelic series by examining the various cellular events required for gastrulation in Drosophila. By genetically manipulating the levels of Twi activity during gastrulation, we find that coordination of cell division is the most sensitive cellular event, whereas changes in cell shape are the least sensitive. Strikingly, we show that by increasing levels of Snail expression in a severe twi hypomorphic allelic background, but not a twi null background, we can reconstitute gastrulation and produce viable adult flies. Our results demonstrate that the level of Twi activity determines whether the cellular events of ventral furrow formation, EMT, cell division and mesodermal migration occur.	[Wong, Ming-Ching; Dobi, Krista C.; Baylies, Mary K.] Sloan Kettering Inst, Program Dev Biol, New York, NY 10065 USA; [Wong, Ming-Ching; Baylies, Mary K.] Cornell Med Sch, Weill Grad Sch, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University	Baylies, MK (corresponding author), Sloan Kettering Inst, Program Dev Biol, New York, NY 10065 USA.	m-baylies@ski.mskcc.org		Dobi, Krista C./0000-0001-6826-2195	National Institutes of General Medicine [GM 56980]; NIH [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056989, R01GM056980] Funding Source: NIH RePORTER	National Institutes of General Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding Support: National Institutes of General Medicine GM 56980 to MKB and NIH P30 CA008748 to Memorial Sloan Kettering Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artero R, 2003, DEVELOPMENT, V130, P6257, DOI 10.1242/dev.00843; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BATE M, 1991, DEVELOPMENT, V113, P79; BAYLIES MK, 1995, DEVELOPMENT, V121, P3829; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Bernard F, 2010, DEVELOPMENT, V137, P2633, DOI 10.1242/dev.053181; BODMER R, 1993, DEVELOPMENT, V118, P719; Bonn S, 2008, CURR OPIN GENET DEV, V18, P513, DOI 10.1016/j.gde.2008.09.005; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; BRAND AH, 1993, DEVELOPMENT, V118, P401; Castanon I, 2002, GENE, V287, P11, DOI 10.1016/S0378-1119(01)00893-9; Castanon I, 2001, DEVELOPMENT, V128, P3145; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Gonzalez-Crespo S, INTERACTIONS DORSAL; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Knust E, 1996, BIOESSAYS, V18, P609, DOI 10.1002/bies.950180802; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021; LEPTIN M, 1992, DEVELOPMENT, P23; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; LILLY B, 1994, P NATL ACAD SCI USA, V91, P5662, DOI 10.1073/pnas.91.12.5662; Lin MH, 1997, DEV BIOL, V182, P240, DOI 10.1006/dbio.1996.8484; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Mathew SJ, 2011, MOL CELL BIOL, V31, P4978, DOI 10.1128/MCB.05542-11; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Nabel-Rosen H, 2005, CURR BIOL, V15, P295, DOI 10.1016/j.cub.2005.01.045; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; Park KW, 2012, BMB REP, V45, P577, DOI 10.5483/BMBRep.2012.45.10.105; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; Rembold M, CONSERVED ROLE SNAIL; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Seher TC, 2007, MECH DEVELOP, V124, P167, DOI 10.1016/j.mod.2006.12.004; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; Shishido E, 1997, DEVELOPMENT, V124, P2119; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; SIMPSON P, 1983, GENETICS, V105, P615; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652; TAYLOR MV, 1995, MECH DEVELOP, V50, P29, DOI 10.1016/0925-4773(94)00323-F; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Wilson R, 2005, DEVELOPMENT, V132, P491, DOI 10.1242/dev.01603; Wong MC, 2008, DEV BIOL, V317, P417, DOI 10.1016/j.ydbio.2008.02.020; Yagi Y, 1997, GENES CELLS, V2, P41, DOI 10.1046/j.1365-2443.1997.d01-282.x; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zheng H, 2014, ONCOGENE, V33, P1755, DOI 10.1038/onc.2013.128	60	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99553	10.1371/journal.pone.0099553	http://dx.doi.org/10.1371/journal.pone.0099553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915423	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700116
J	Bjerregaard-Andersen, K; Sommer, T; Jensen, JK; Jochimsen, B; Etzerodt, M; Morth, JP				Bjerregaard-Andersen, Kaare; Sommer, Theis; Jensen, Jan K.; Jochimsen, Bjarne; Etzerodt, Michael; Morth, J. Preben			A Proton Wire and Water Channel Revealed in the Crystal Structure of Isatin Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; STRESS	The high resolution crystal structures of isatin hydrolase from Labrenzia aggregata in the apo and the product state are described. These are the first structures of a functionally characterized metal-dependent hydrolase of this fold. Isatin hydrolase converts isatin to isatinate and belongs to a novel family of metalloenzymes that include the bacterial kynurenine formamidase. The product state, mimicked by bound thioisatinate, reveals a water molecule that bridges the thioisatinate to a proton wire in an adjacent water channel and thus allows the proton released by the reaction to escape only when the product is formed. The functional proton wire present in isatin hydrolase isoform b represents a unique catalytic feature common to all hydrolases is here trapped and visualized for the first time. The local molecular environment required to coordinate thioisatinate allows stronger and more confident identification of orthologous genes encoding isatin hydrolases within the prokaryotic kingdom. The isatin hydrolase orthologues found in human gut bacteria raise the question as to whether the indole-3-acetic acid degradation pathway is present in human gut flora.	[Bjerregaard-Andersen, Kaare; Sommer, Theis; Morth, J. Preben] Nord EMBL Partnership Univ Oslo, Norwegian Ctr Mol Med, N-0349 Oslo, Norway; [Morth, J. Preben] Oslo Univ Hosp, Expt Med Res Inst, N-0424 Oslo, Norway; [Bjerregaard-Andersen, Kaare; Jensen, Jan K.; Jochimsen, Bjarne; Etzerodt, Michael] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	University of Oslo; Aarhus University	Morth, JP (corresponding author), Univ Oslo, Ctr Mol Med Norway, POB 1137 Blindern, N-0318 Oslo, Norway.	j.p.morth@ncmm.uio.no	Morth, Jens Preben/AAP-7834-2021; Morth, Jens Preben/G-4450-2013	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Bjerregaard-Andersen, Kaare/0000-0003-3609-3408	Lundbeck Foundation [R34-2009-3616] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden)		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berry A, 2002, J IND MICROBIOL BIOT, V28, P127, DOI 10.1038/sj/jim/7000228; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; Chernyshev A, 2006, BIOPHYS J, V91, P580, DOI 10.1529/biophysj.106.083352; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; CHRISTENSEN JH, 1991, FEBS LETT, V281, P181, DOI 10.1016/0014-5793(91)80388-J; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Cukierman S, 2006, BBA-BIOENERGETICS, V1757, P876, DOI 10.1016/j.bbabio.2005.12.001; de Grotthuss C, 1806, ANN CHIM, V58, P54; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englert DL, 2009, APPL ENVIRON MICROB, V75, P4557, DOI 10.1128/AEM.02952-08; Glover V, 1998, STRESS MEDICINE, V14, P225, DOI 10.1002/(SICI)1099-1700(1998100)14:4<225::AID-SMI801>3.0.CO;2-P; Grimsley GR, 2009, PROTEIN SCI, V18, P247, DOI 10.1002/pro.19; Hamaue N, 2000, RES COMMUN MOL PATH, V108, P63; Han Q, 2012, BIOCHEM J, V446, P253, DOI 10.1042/BJ20120416; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; JENSEN JB, 1995, J BACTERIOL, V177, P5762, DOI 10.1128/jb.177.20.5762-5766.1995; Kurnasov O, 2003, FEMS MICROBIOL LETT, V227, P219, DOI 10.1016/S0378-1097(03)00684-0; Lee J, 2007, APPL ENVIRON MICROB, V73, P4100, DOI 10.1128/AEM.00360-07; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mawatari K, 2001, ANALYST, V126, P33, DOI 10.1039/b006484j; Medvedev A, 2005, STRESS, V8, P175, DOI 10.1080/10253890500342321; Medvedev AE, 2004, NEUROTOXICOLOGY, V25, P185, DOI 10.1016/S0161-813X(03)00098-6; NORMAN TR, 1992, STRESS MEDICINE, V8, P141, DOI 10.1002/smi.2460080302; Olesen MR, 1996, PLANT SOIL, V186, P143, DOI 10.1007/BF00035068; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Shinobu A, 2009, J PHYS CHEM A, V113, P7253, DOI 10.1021/jp8102047; Thomaeus A, 2008, PROTEIN SCI, V17, P1275, DOI 10.1110/ps.034173.107; WATKINS P, 1990, NEUROCHEM INT, V17, P321, DOI 10.1016/0197-0186(90)90154-L; WEYLER W, 1999, Patent No. 5866396	35	17	18	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21351	21359		10.1074/jbc.M114.568824	http://dx.doi.org/10.1074/jbc.M114.568824			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24917679	Green Published, hybrid			2022-12-25	WOS:000340558300015
J	Chen, SW; Chao, SC				Chen, Szi-Wen; Chao, Shih-Chieh			A Reweighted l(1)-Minimization Based Compressed Sensing for the Spectral Estimation of Heart Rate Variability Using the Unevenly Sampled Data	PLOS ONE			English	Article							EFFICIENT ALGORITHM; RECONSTRUCTION; SIGNALS; MODEL	In this paper, a reweighted l(1)-minimization based Compressed Sensing (CS) algorithm incorporating the Integral Pulse Frequency Modulation (IPFM) model for spectral estimation of HRV is introduced. Knowing as a novel sensing/sampling paradigm, the theory of CS asserts certain signals that are considered sparse or compressible can be possibly reconstructed from substantially fewer measurements than those required by traditional methods. Our study aims to employ a novel reweighted l(1)-minimization CS method for deriving the spectrum of the modulating signal of IPFM model from incomplete RR measurements for HRV assessments. To evaluate the performance of HRV spectral estimation, a quantitative measure, referred to as the Percent Error Power (PEP) that measures the percentage of difference between the true spectrum and the spectrum derived from the incomplete RR dataset, was used. We studied the performance of spectral reconstruction from incomplete simulated and real HRV signals by experimentally truncating a number of RR data accordingly in the top portion, in the bottom portion, and in a random order from the original RR column vector. As a result, for up to 20% data truncation/loss the proposed reweighted l(1)-minimization CS method produced, on average, 2.34%, 2.27%, and 4.55% PEP in the top, bottom, and random data-truncation cases, respectively, on Autoregressive (AR) model derived simulated HRV signals. Similarly, for up to 20% data loss the proposed method produced 5.15%, 4.33%, and 0.39% PEP in the top, bottom, and random data-truncation cases, respectively, on a real HRV database drawn from PhysioNet. Moreover, results generated by a number of intensive numerical experiments all indicated that the reweighted l(1)-minimization CS method always achieved the most accurate and high-fidelity HRV spectral estimates in every aspect, compared with the,l(1)-minimization based method and Lomb's method used for estimating the spectrum of HRV from unevenly sampled RR data.	[Chen, Szi-Wen; Chao, Shih-Chieh] Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan; [Chen, Szi-Wen] Chang Gung Univ, HARC, Taoyuan, Taiwan	Chang Gung University; Chang Gung University	Chen, SW (corresponding author), Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan.	chensw@mail.cgu.edu.tw		Chen, Szi-Wen/0000-0001-6171-0493	Taiwan National Science Council (NSC) [NSC 102-2221-E-182-023]	Taiwan National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported by the Taiwan National Science Council (NSC) under the Grant NSC 102-2221-E-182-023. The URL of Taiwan NSC is http://www.nsc.gov.tw. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Baraniuk RG, 2008, IEEE SIGNAL PROC MAG, V25, P12, DOI 10.1109/MSP.2008.915557; Baron D., 2005, P 43 ALL C COMM CONT; BERGER RD, 1986, IEEE T BIO-MED ENG, V33, P900, DOI 10.1109/TBME.1986.325789; Camm AJ, 1996, CIRCULATION, V93, P1043; Candes EJ, 2005, IEEE T INFORM THEORY, V51, P4203, DOI 10.1109/TIT.2005.858979; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Candes EJ, 2008, J FOURIER ANAL APPL, V14, P877, DOI 10.1007/s00041-008-9045-x; Chen F, 2005, P ANN INT IEEE EMBS, P936, DOI 10.1109/IEMBS.2005.1616569; Chen S-W, 2007, Journal of Medical Engineering & Technology, V31, P210, DOI 10.1080/03091900600747617; Chen SW, 2002, IEEE T BIO-MED ENG, V49, P736, DOI 10.1109/TBME.2002.1010859; Chen SW, 2006, COMPUT METH PROG BIO, V82, P187, DOI 10.1016/j.cmpb.2005.11.012; Chen SW, 2014, IEEE J BIOMED HEALTH, V18, P1081, DOI 10.1109/JBHI.2013.2282307; Chiu HW, 2001, IEEE ENG MED BIOL, V20, P69, DOI 10.1109/51.917726; Choi K, 2010, MED PHYS, V37, P5113, DOI 10.1118/1.3481510; DEBOER RW, 1985, MED BIOL ENG COMPUT, V23, P138, DOI 10.1007/BF02456750; Figueiredo MAT, 2007, IEEE J-STSP, V1, P586, DOI 10.1109/JSTSP.2007.910281; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Laguna P, 1998, IEEE T BIO-MED ENG, V45, P698, DOI 10.1109/10.678605; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mateo J, 2003, IEEE T BIO-MED ENG, V50, P334, DOI 10.1109/TBME.2003.808831; Mateo J, 2000, IEEE T BIO-MED ENG, V47, P985, DOI 10.1109/10.855925; Mitov IP, 2001, MED BIOL ENG COMPUT, V39, P348, DOI 10.1007/BF02345290; MOODY GB, 1993, COMPUT CARDIOL, P715; Orini M, 2012, BIOMED SIGNAL PROCES, V7, P141, DOI 10.1016/j.bspc.2011.05.003; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; ROMPELMAN O, 1977, MED BIOL ENG COMPUT, V15, P233, DOI 10.1007/BF02441043; Solem K, 2006, IEEE T BIO-MED ENG, V53, P13, DOI 10.1109/TBME.2005.859780; Takhar D. etal, 2006, P COMP IM 4 SPIE EL; TENVOORDE BJ, 1994, MED BIOL ENG COMPUT, V32, P63, DOI 10.1007/BF02512480	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99098	10.1371/journal.pone.0099098	http://dx.doi.org/10.1371/journal.pone.0099098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922059	Green Submitted, Green Published, gold			2022-12-25	WOS:000338701300028
J	Kaczmarek, J; Homsi, Y; van Uum, J; Metzger, C; Knolle, PA; Kolanus, W; Lang, T; Diehl, L				Kaczmarek, Julita; Homsi, Yahya; van Ueuem, Jan; Metzger, Christina; Knolle, Percy A.; Kolanus, Waldemar; Lang, Thorsten; Diehl, Linda			Liver Sinusoidal Endothelial Cell-Mediated CD8 T Cell Priming Depends on Co-Inhibitory Signal Integration over Time	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE; ACTIVATION; TOLERANCE; ANTIGEN; PHOSPHORYLATION; MICROCLUSTERS; IL-2	The initiation of adaptive immunity requires cell-to-cell contact between T cells and antigen-presenting cells. Together with immediate TCR signal transduction, the formation of an immune synapse (IS) is one of the earliest events detected during T cell activation. Here, we show that interaction of liver sinusoidal endothelial cells (LSEC) with naive CD8 T cells, which induces CD8 T cells without immediate effector function, is characterized by a multi-focal type IS. The co-inhibitory molecule B7H1, which is pivotal for the development of non-responsive LSEC-primed T cells, did not alter IS structure or TCR beta/CD11a cluster size or density, indicating that IS form does not determine the outcome of LSEC-mediated T cell activation. Instead, PD-1 signaling during CD8 T cell priming by LSEC repressed IL-2 production as well as sustained CD25 expression. When acting during the first 24 h of LSEC/CD8 T cell interaction, CD28 co-stimulation inhibited the induction of non-responsive LSEC-primed T cells. However, after more than 36 h of PD-1 signaling, CD28 co-stimulation failed to rescue effector function in LSEC-primed T cells. Together, these data show that during LSEC-mediated T cell priming, integration of co-inhibitory PD1 signaling over time turns on a program for CD8 T cell development, that cannot be overturned by co-stimulatory signals.	[Kaczmarek, Julita; Metzger, Christina; Diehl, Linda] Univ Bonn, LIMES Inst, Inst Mol Med, Bonn, Germany; [Homsi, Yahya; van Ueuem, Jan; Lang, Thorsten] Univ Bonn, LIMES Inst, Dept Membrane Biochem, Bonn, Germany; [Kolanus, Waldemar] Univ Bonn, LIMES Inst, Dept Mol Immunol, Bonn, Germany; [Knolle, Percy A.] Tech Univ Munich, Inst Mol Immunol, D-80290 Munich, Germany	University of Bonn; University of Bonn; University of Bonn; Technical University of Munich	Diehl, L (corresponding author), Univ Bonn, LIMES Inst, Inst Mol Med, Bonn, Germany.	linda.diehl@ukb.uni-bonn.de		Knolle, Percy A./0000-0003-2983-0414	grant of the german research council [CRC704]	grant of the german research council	This study was financially supported by a grant of the german research council (CRC704) to LD and TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottcher JP, 2013, CELL REPORTS, P1; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Diehl L, 2008, HEPATOLOGY, V47, P296, DOI 10.1002/hep.21965; Dustin ML, 2009, COLD SPRING HARBOR P, V1; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Fisher PJ, 2008, BLOOD, V112, P5037, DOI 10.1182/blood-2008-04-149526; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Kern M, 2010, GASTROENTEROLOGY, V138, P336, DOI 10.1053/j.gastro.2009.08.057; Knolle PA, 1999, YGAST, V116, P1428; Kruse N, 2009, HEPATOLOGY, V50, P1904, DOI 10.1002/hep.23191; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Macintyre AN, 2011, IMMUNITY, P1; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pentcheva-Hoang T, 2007, P NATL ACAD SCI USA, V104, P17765, DOI 10.1073/pnas.0708767104; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; Schurich A, 2010, J IMMUNOL, V184, P4107, DOI 10.4049/jimmunol.0902580; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Thauland TJ, 2010, IMMUNOLOGY, V131, P466, DOI 10.1111/j.1365-2567.2010.03366.x; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; von Oppen N, 2009, HEPATOLOGY, V49, P1664, DOI 10.1002/hep.22795; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	27	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99574	10.1371/journal.pone.0099574	http://dx.doi.org/10.1371/journal.pone.0099574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924593	Green Submitted, Green Published, gold			2022-12-25	WOS:000338701300076
J	Marics, I; Malapert, P; Reynders, A; Gaillard, S; Moqrich, A				Marics, Irene; Malapert, Pascale; Reynders, Ana; Gaillard, Stephane; Moqrich, Aziz			Acute Heat- Evoked Temperature Sensation Is Impaired but Not Abolished in Mice Lacking TRPV1 and TRPV3 Channels	PLOS ONE			English	Article							RECEPTOR POTENTIAL VANILLOID-1; CAPSAICIN-RECEPTOR; ION CHANNELS; THERMAL HYPERALGESIA; KERATINOCYTES; KNOCKOUT; SKIN; THERMOSENSATION; NOCICEPTION; EXPRESSION	The discovery of heat-sensitive Transient Receptor Potential Vanilloid ion channels (ThermoTRPVs) greatly advanced our molecular understanding of acute and injury-evoked heat temperature sensation. ThermoTRPV channels are activated by partially overlapping temperatures ranging from warm to supra-threshold noxious heat. TRPV1 is activated by noxious heat temperature whereas TRPV3 can be activated by warm as well as noxious heat temperatures. Loss-of-function studies in single TRPV1 and TRPV3 knock-out mice have shown that heat temperature sensation is not completely abolished suggesting functional redundancies among these two channels and highlighting the need of a detailed analysis of TRPV1::TRPV3 double knock-out mice (V1V3dKO) which is hampered by the close proximity of the loci expressing the two channels. Here we describe the generation of a novel mouse model in which trpv1 and trpv3 genes have been inactivated using bacterial artificial chromosome (BAC)-based homologous recombination in embryonic stem cells. In these mice, using classical thermosensory tests such hot plate, tail flick and the thermotaxis gradient paradigms, we confirm that TRPV1 is the master channel for sensing noxious heat temperatures and identify a cooperative role of TRPV1 and TRPV3 for sensing a well-defined window of acute moderate heat temperature. Using the dynamic hot plate assay, we unravel an intriguing and unexpected pronounced escape behavior in TRPV1 knock-out mice that was attenuated in the V1V3dKO. Together, and in agreement with the temperature activation overlap between TRPV1 and TRPV3 channels, our data provide in vivo evidence of a cooperative role between skin-derived TRPV3 and primary sensory neurons-enriched TRPV1 in modulation of moderate and noxious heat temperature sensation and suggest that other mechanisms are required for heat temperature sensation.	[Marics, Irene; Malapert, Pascale; Reynders, Ana; Gaillard, Stephane; Moqrich, Aziz] Aix Marseille Univ, CNRS, Inst Biol Dev Marseille, UMR 7288, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Moqrich, A (corresponding author), Aix Marseille Univ, CNRS, Inst Biol Dev Marseille, UMR 7288, Marseille, France.	aziz.moqrich@univ-amu.fr		moqrich, aziz/0000-0002-1937-1675; Gaillard, Stephane/0000-0001-9326-5363	CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Christoph T, 2008, MOL CELL NEUROSCI, V37, P579, DOI 10.1016/j.mcn.2007.12.006; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Garami A, 2011, J NEUROSCI, V31, P1721, DOI 10.1523/JNEUROSCI.4671-10.2011; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Huang SM, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-37; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Iida T, 2005, NEUROSCI LETT, V378, P28, DOI 10.1016/j.neulet.2004.12.007; Kunkler PE, 2011, PAIN, V152, P38, DOI 10.1016/j.pain.2010.08.021; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Miyamoto T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1371; Miyamoto T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007596; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Patapoutian A, 2005, CHEM SENSES, V30, pI193, DOI 10.1093/chemse/bjh180; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; Schicho R, 2004, EUR J NEUROSCI, V19, P1811, DOI 10.1111/j.1460-9568.2004.03290.x; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Steiner AA, 2007, J NEUROSCI, V27, P7459, DOI 10.1523/JNEUROSCI.1483-07.2007; Szallasi A, 1995, BRAIN RES, V703, P175, DOI 10.1016/0006-8993(95)01094-7; Szelenyi Z, 2004, EUR J NEUROSCI, V19, P1421, DOI 10.1111/j.1460-9568.2004.03221.x; Tamayo N, 2008, J MED CHEM, V51, P2744, DOI 10.1021/jm7014638; Todaka H, 2004, J BIOL CHEM, V279, P35133, DOI 10.1074/jbc.M406260200; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Toth DM, 2011, CELL MOL LIFE SCI, V68, P2589, DOI 10.1007/s00018-010-0569-2; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yalcin I, 2009, J PAIN, V10, P767, DOI 10.1016/j.jpain.2009.01.325	40	33	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99828	10.1371/journal.pone.0099828	http://dx.doi.org/10.1371/journal.pone.0099828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925072	gold, Green Published, Green Submitted			2022-12-25	WOS:000338701300098
J	Obirikorang, C; Osakunor, DNM; Ntaadu, B; Adarkwa, OK				Obirikorang, Christian; Osakunor, Derick Nii Mensah; Ntaadu, Benedict; Adarkwa, Opei Kwafo			Renal Function in Ghanaian HIV-Infected Patients on Highly Active Antiretroviral Therapy: A Case-Control Study	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; DISEASE; KIDNEY; PREVALENCE; MORTALITY; HEALTH; WOMEN; RISK; MEN	Background: HAART is anticipated to result in an increase in long-term survival, but may present with the development of associated complications. The aim of this study was to assess the renal function of HIV-infected patients on antiretroviral therapy. Methods: A case-control study (January to May 2013) conducted at the Suntreso Government Hospital, Kumasi, Ghana. A total of 163 HIV-infected patients (mean age 39.9 +/- 10.22) were studied, of which 111 were on HAART (HIV-HAART) and 52 were not (HIV-Controls). Serum urea, creatinine, potassium, sodium, chloride and CD4 counts were measured with the determination of eGFR (CKD-EPI and MDRD). Data was analysed using GraphPad Prism. The Chi-square, t-test, one-way ANOVA and Spearman's correlation were used. P values <0.05 were considered significant. Results: Mean CD4 count of HIV-Controls was higher than that of HIV-HAART but was not significant (p = 0.304). But for sodium levels which were higher in HIV-Controls (p = 0.0284), urea (p = 0.1209), creatinine (p = 0.7155), potassium (p = 0.454) and chloride (p = 0.6282) levels did not differ significantly between both groups. All serum biochemical parameters did not differ significantly, irrespective of duration on therapy and CD4 counts. Based on regimen, sodium, chloride, urea and creatinine did not differ significantly between TDF, EVF and NVP-based therapies. Prevalence of CKD (eGFR <60 ml/min/1.73 m(2)) in the total population was 9.9% and 3.7% with the MDRD and EPI-CKD equations respectively. Conclusions: Renal insufficiency remains prevalent in HIV patients. Changes in renal function occur in HIV infection and over the course of HAART but the difference at either stage is not significant. This suggests the role of HIV infection, HAART and the presence of traditional risk factors but not HAART in itself, in renal dysfunction. We however recommend a close monitoring of patients before and during HAART, to aid in evaluating drug combinations and implement dose modifications when necessary.	[Obirikorang, Christian; Osakunor, Derick Nii Mensah] KNUST, Coll Hlth Sci, Sch Med Sci, Dept Mol Med, Kumasi, Ghana; [Ntaadu, Benedict] KNUST, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Med Lab Technol, Kumasi, Ghana; [Adarkwa, Opei Kwafo] KATH, Dept Obstet & Gynaecol, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Osakunor, DNM (corresponding author), KNUST, Coll Hlth Sci, Sch Med Sci, Dept Mol Med, Kumasi, Ghana.	osakunor@gmail.com	Obirikorang, Christian/F-5843-2011	Obirikorang, Christian/0000-0002-6128-1358; Osakunor, Derick Nii Mensah/0000-0002-4853-5384				Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Agaba E I, 2003, Niger J Med, V12, P120; ANDIA I, 2005, 3 IAS C HIV PATH TRE; [Anonymous], 2002, HRSA Careaction, P5; [Anonymous], BMJ, V304, P809; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Berns JS, 2006, CLIN J AM SOC NEPHRO, V1, P117, DOI 10.2215/CJN.00370705; Chen M., 2001, SUPPORTING WORKERS I; Chi YC, 2007, NEPHROL DIALYSIS TRA, V10; Essien EJ, 2007, MIL MED, V172, P1177, DOI 10.7205/MILMED.172.11.1177; Estrella MM, 2010, JAIDS-J ACQ IMM DEF, V55, P217, DOI 10.1097/QAI.0b013e3181e674f4; Finney H, 2000, ANN CLIN BIOCHEM, V37, P49, DOI 10.1258/0004563001901524; Franceschini N, 2005, KIDNEY INT, V67, P1526, DOI 10.1111/j.1523-1755.2005.00232.x; Gallant JE, 2009, AIDS, V23, P1971, DOI 10.1097/QAD.0b013e32832c96e9; Gerard L, 2007, ANTIVIR THER, V12, P31; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gumodoka B, 1997, B WORLD HEALTH ORGAN, V75, P133; Gupta SK, 2004, CLIN NEPHROL, V61, P1; Haagsma JA, 2012, OCCUP ENVIRON MED, V69, P140, DOI 10.1136/oemed-2011-100068; Hunt K, 2011, J HEALTH SERV RES PO, V16, P108, DOI 10.1258/jhsrp.2010.009131; Kirunga C T, 1997, Health Transit Rev, V7 Suppl, P175; Obirikorang C, 2013, ISRN AIDS, V2013, P1; Okuonghae PO, 2011, ADV LAB MED INT, V1, P25; Onodugo Obinna D, 2013, J Int Assoc Provid AIDS Care; Owiredu WKBA, 2013, AFR HEALTH SCI, V13, P101, DOI 10.4314/ahs.v13i1.14; PADIAN NS, 1991, JAMA-J AM MED ASSOC, V266, P1664; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Peters E, 2010, PSYCHOL SCI, V21, P1369, DOI 10.1177/0956797610381506; RAO TKS, 1984, NEW ENGL J MED, V310, P669, DOI 10.1056/NEJM198403153101101; Roling J, 2006, CLIN INFECT DIS, V42, P1488, DOI 10.1086/503566; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Smith William C., 2012, INT PERSPECTIVES ED, V18, P79, DOI DOI 10.1108/IPES; Susman E, 2005, 12 C RETR OPP INF CR; Ugwuja E, 2006, INTERNET J LAB MED, V2; *UNAIDS, 2007, AIDS EP UPD; Wools-Kaloustian K, 2007, NEPHROL DIAL TRANSPL, V22, P2208, DOI 10.1093/ndt/gfm223	36	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99469	10.1371/journal.pone.0099469	http://dx.doi.org/10.1371/journal.pone.0099469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921259	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300062
J	Zhao, N; Watson, N; Xu, ZG; Chen, YJ; Waterman, J; Sankar, J; Zhu, DH				Zhao, Nan; Watson, Nevija; Xu, Zhigang; Chen, Yongjun; Waterman, Jenora; Sankar, Jagannathan; Zhu, Donghui			In Vitro Biocompatibility and Endothelialization of Novel Magnesium-Rare Earth Alloys for Improved Stent Applications	PLOS ONE			English	Article							DRUG-ELUTING STENTS; MECHANICAL-PROPERTIES; CORONARY STENTS; DEFORMATION-BEHAVIOR; CARDIOVASCULAR STENT; CORROSION BEHAVIOR; VASCULAR GRAFTS; MOLECULAR-BASIS; CELL-ADHESION; ZR ALLOYS	Magnesium (Mg) based alloys are the most advanced cardiovascular stent materials. This new generation of stent scaffold is currently under clinical evaluation with encouraging outcomes. All these Mg alloys contain a certain amount of rare earth (RE) elements though the exact composition is not yet disclosed. RE alloying can usually enhance the mechanical strength of different metal alloys but their toxicity might be an issue for medical applications. It is still unclear how RE elements will affect the magnesium (Mg) alloys intended for stent materials as a whole. In this study, we evaluated MgZnCaY-1RE, MgZnCaY-2RE, MgYZr-1RE, and MgZnYZr-1RE alloys for cardiovascular stents applications regarding their mechanical strength, corrosion resistance, hemolysis, platelet adhesion/activation, and endothelial biocompatibility. The mechanical properties of all alloys were significantly improved. Potentiodynamic polarization showed that the corrosion resistance of four alloys was at least 3-10 times higher than that of pure Mg control. Hemolysis test revealed that all the materials were non-hemolytic while little to moderate platelet adhesion was found on all materials surface. No significant cytotoxicity was observed in human aorta endothelial cells cultured with magnesium alloy extract solution for up to seven days. Direct endothelialization test showed that all the alloys possess significantly better capability to sustain endothelial cell attachment and growth. The results demonstrated the promising potential of these alloys for stent material applications in the future.					Zhao, Nan/GMX-1019-2022; Xu, Zhigang/AAC-7839-2019; Zhu, Donghui/H-9058-2017	Zhu, Donghui/0000-0002-3057-1889; Waterman, Jenora/0000-0002-6643-2768; XU, ZHIGANG/0000-0003-4477-7391	National Institute of Health [SC2NS082475]; NSF Engineering Research Center-Revolutionizing Metallic Biomaterials (ERC-RMB) at North Carolina A&T State University [NSF-0812348]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC2NS082475] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Engineering Research Center-Revolutionizing Metallic Biomaterials (ERC-RMB) at North Carolina A&T State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge funding from the National Institute of Health (SC2NS082475) and support from NSF Engineering Research Center-Revolutionizing Metallic Biomaterials (ERC-RMB) (NSF-0812348) at North Carolina A&T State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; [Anonymous], 10993122008 ISOE; Asl KM, 2010, MAT SCI ENG A-STRUCT, V527, P2027, DOI 10.1016/j.msea.2009.11.061; Ben-Hamu G, 2007, J ALLOY COMPD, V431, P269, DOI 10.1016/j.jallcom.2006.05.075; Bornapour M, 2013, ACTA BIOMATER, V9, P5319, DOI 10.1016/j.actbio.2012.07.045; Cha PR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02367; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; De Visscher G, 2012, ACTA BIOMATER, V8, P1330, DOI 10.1016/j.actbio.2011.09.016; Drynda A, 2009, J BIOMED MATER RES A, V91A, P360, DOI 10.1002/jbm.a.32235; Fan J, 2013, MAT SCI ENG C-MATER, V33, P2345, DOI 10.1016/j.msec.2013.01.063; Geis-Gerstorfer J, 2011, MATER SCI ENG B-ADV, V176, P1761, DOI 10.1016/j.mseb.2011.06.006; GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109; Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015; Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021; HANELT M, 1994, MYCOPATHOLOGIA, V128, P167, DOI 10.1007/BF01138479; Hiltunen MO, 2000, CIRCULATION, V102, P2262; Hou SS, 2013, J CHEM TECHNOL BIOT, V88, P2062, DOI 10.1002/jctb.4069; HWANG DL, 1992, AM J HYPERTENS, V5, P700, DOI 10.1093/ajh/5.10.700; Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059; Ji DW, 2013, MATER SCI TECH-LOND, V29, P480, DOI 10.1179/1743284712Y.0000000165; Kverneland A, 2011, MAT SCI ENG A-STRUCT, V528, P880, DOI 10.1016/j.msea.2010.10.001; Laser T, 2008, ACTA MATER, V56, P2791, DOI 10.1016/j.actamat.2008.02.010; Li WP, 2009, J ALLOY COMPD, V475, P227, DOI 10.1016/j.jallcom.2008.07.128; Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021; Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042; Mao L, 2012, MATER LETT, V88, P1, DOI 10.1016/j.matlet.2012.08.012; MARKS DC, 1992, LEUKEMIA RES, V16, P1165, DOI 10.1016/0145-2126(92)90114-M; MCEVER RP, 1984, J BIOL CHEM, V259, P9799; Mirza FA, 2013, MATER DESIGN, V46, P411, DOI 10.1016/j.matdes.2012.10.040; Murai T, 2003, J MATER PROCESS TECH, V141, P207, DOI 10.1016/S0924-0136(02)01106-8; Nam SW, 2013, MET MATER INT, V19, P205, DOI 10.1007/s12540-013-2010-5; Ouyang LZ, 2013, INT J HYDROGEN ENERG, V38, P2973, DOI 10.1016/j.ijhydene.2012.12.092; de Prado AP, 2013, CURR VASC PHARMACOL, V11, P74; Persaud-Sharma Dharam, 2012, J Biomim Biomater Tissue Eng, V12, P25, DOI 10.4028/www.scientific.net/JBBTE.12.25; Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029; Seitz JM, 2012, ACTA BIOMATER, V8, P3852, DOI 10.1016/j.actbio.2012.05.024; SERRUYS PW, 1991, NEW ENGL J MED, V324, P13, DOI 10.1056/NEJM199101033240103; Shahryari A, 2010, ACTA BIOMATER, V6, P695, DOI 10.1016/j.actbio.2009.07.007; Standard A.C, 2006, ANN BOOK ASTM STAND; Stanford N, 2013, MAT SCI ENG A-STRUCT, V565, P469, DOI 10.1016/j.msea.2012.10.084; Stanford N, 2013, MAT SCI ENG A-STRUCT, V565, P459, DOI 10.1016/j.msea.2012.12.023; Tian X, 2008, J ALLOY COMPD, V465, P412, DOI 10.1016/j.jallcom.2007.10.100; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Verma A, 2006, BIO-MED MATER ENG, V16, P381; Wang B, 2011, MATER SCI ENG B-ADV, V176, P1673, DOI 10.1016/j.mseb.2011.03.015; Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009; Waterhouse A, 2010, BIOMATERIALS, V31, P8332, DOI 10.1016/j.biomaterials.2010.07.062; Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012; Xiao X, 2013, J BIONIC ENG, V10, P156, DOI 10.1016/S1672-6529(13)60210-3; Xu SW, 2011, SCRIPTA MATER, V65, P269, DOI 10.1016/j.scriptamat.2011.04.026; Xu ZG, 2011, MATER SCI ENG B-ADV, V176, P1660, DOI 10.1016/j.mseb.2011.06.008; Ye CH, 2013, T NONFERR METAL SOC, V23, P996, DOI 10.1016/S1003-6326(13)62558-3; Zhang J, 2009, MATER SCI FORUM, V610-613, P810, DOI 10.4028/www.scientific.net/MSF.610-613.810; Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028; Zhang SX, 2009, MAT SCI ENG C-MATER, V29, P1907, DOI 10.1016/j.msec.2009.03.001; Zhang XB, 2013, MATER TECHNOL, V28, P155, DOI 10.1179/1753555712Y.0000000048; Zhang YJ, 2013, MED DEVICES-EVID RES, V6, P37, DOI 10.2147/MDER.S22547; Zhao MC, 2008, CORROS SCI, V50, P1939, DOI 10.1016/j.corsci.2008.04.010; Zheng WT, 2012, BIOMATERIALS, V33, P2880, DOI 10.1016/j.biomaterials.2011.12.047; Zhou M, 2012, J BIOMED MATER RES B, V100B, P111, DOI 10.1002/jbm.b.31928; Zhou WR, 2013, ACTA BIOMATER, V4	61	26	27	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98674	10.1371/journal.pone.0098674	http://dx.doi.org/10.1371/journal.pone.0098674			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921251	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300011
J	Perley, CC; Frahm, M; Click, EM; Dobos, KM; Ferrari, G; Stout, JE; Frothingham, R				Perley, Casey C.; Frahm, Marc; Click, Eva M.; Dobos, Karen M.; Ferrari, Guido; Stout, Jason E.; Frothingham, Richard			The Human Antibody Response to the Surface of Mycobacterium tuberculosis	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; PULMONARY TUBERCULOSIS; MEDIATED IMMUNITY; HUMORAL RESPONSE; INFECTION; ANTIGENS; PROFILES; CELLS; SURVIVAL; MODEL	Background: Vaccine-induced human antibodies to surface components of Haemophilus influenzae and Streptococcus pneumonia are correlated with protection. Monoclonal antibodies to surface components of Mycobacterium tuberculosis are also protective in animal models. We have characterized human antibodies that bind to the surface of live M. tuberculosis. Methods: Plasma from humans with latent tuberculosis (TB) infection (n = 23), active TB disease (n = 40), and uninfected controls (n = 9) were assayed by ELISA for reactivity to the live M. tuberculosis surface and to inactivated M. tuberculosis fractions (whole cell lysate, lipoarabinomannan, cell wall, and secreted proteins). Results: When compared to uninfected controls, patients with active TB disease had higher antibody titers to the surface of live M. tuberculosis (Delta = 0.72 log(10)), whole cell lysate (Delta = 0.82 log(10)), and secreted proteins (Delta = 0.62 log(10)), though there was substantial overlap between the two groups. Individuals with active disease had higher relative IgG avidity (Delta = 1.4 to 2.6) to all inactivated fractions. Surprisingly, the relative IgG avidity to the live M. tuberculosis surface was lower in the active disease group than in uninfected controls (Delta = -1.53, p = 0.004). Patients with active disease had higher IgG than IgM titers for all inactivated fractions (ratios, 2.8 to 10.1), but equal IgG and IgM titers to the live M. tuberculosis surface (ratio, 1.1). Higher antibody titers to the M. tuberculosis surface were observed in active disease patients who were BCG-vaccinated (Delta = 0.55 log(10), p = 0.008), foreign-born (Delta = 0.61 log10, p = 0.004), or HIV-seronegative (Delta = 0.60 log(10), p = 0.04). Higher relative IgG avidity scores to the M. tuberculosis surface were also observed in active disease patients who were BCG-vaccinated (Delta = 1.12, p<0.001) and foreign-born (Delta = 0.87, p = 0.01). Conclusions/Significance: Humans with active TB disease produce antibodies to the surface of M. tuberculosis with low avidity and with a low IgG/IgM ratio. Highly-avid IgG antibodies to the M. tuberculosis surface may be an appropriate target for future TB vaccines.	[Perley, Casey C.; Frahm, Marc; Frothingham, Richard] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Perley, Casey C.; Click, Eva M.; Ferrari, Guido; Frothingham, Richard] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC USA; [Frahm, Marc; Ferrari, Guido] Duke Univ, Med Ctr, Dept Surg, Div Surg Sci, Durham, NC 27710 USA; [Dobos, Karen M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Stout, Jason E.; Frothingham, Richard] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Colorado State University; Duke University	Frothingham, R (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	richard.frothingham@duke.edu	Ferrari, Guido/Z-2137-2019; Dobos, Karen/D-1170-2017; Ferrari, Guido/A-6088-2015	Dobos, Karen/0000-0001-7115-8524; Ferrari, Guido/0000-0001-7747-3349; Stout, Jason/0000-0002-6698-8176	NIH (Southeast Regional Center of Excellence for Emerging Infections and Biodefense) [U54 AI057157]; Duke Center for Translational Research [P30 AI051445]; Regional Biocontainment Laboratory at Duke [UC6 AI058607]; National Science Foundation Graduate Research Fellowship [2011083676]; NIH (Tuberculosis Vaccine Testing and Research Materials) [HHSN266200400091C]; Duke NIH (Center for AIDS Research) [N01 AI040082, P30 AI064518]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051445, UC6AI058607, U54AI057157, P30AI064518] Funding Source: NIH RePORTER	NIH (Southeast Regional Center of Excellence for Emerging Infections and Biodefense)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Duke Center for Translational Research; Regional Biocontainment Laboratory at Duke; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIH (Tuberculosis Vaccine Testing and Research Materials); Duke NIH (Center for AIDS Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants U54 AI057157 (Southeast Regional Center of Excellence for Emerging Infections and Biodefense), P30 AI051445 (Duke Center for Translational Research), and UC6 AI058607 (Regional Biocontainment Laboratory at Duke), and by National Science Foundation Graduate Research Fellowship 2011083676 (C.C.P.). Mycobacterial antigen fractions from Colorado State University were produced under NIH Contract HHSN266200400091C (Tuberculosis Vaccine Testing and Research Materials) and distributed by the Biodefense and Emerging Infections Research Resources Repository. Specimen collection and storage for the TB-infected subjects was supported by the Duke NIH grants N01 AI040082 and P30 AI064518 (Center for AIDS Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009; Amor YB, 2005, SCAND J IMMUNOL, V61, P139, DOI 10.1111/j.0300-9475.2005.01557.x; ANDERSEN AB, 1986, J CLIN MICROBIOL, V23, P446, DOI 10.1128/JCM.23.3.446-451.1986; Arias-Bouda LMP, 2003, CLIN DIAGN LAB IMMUN, V10, P702, DOI 10.1128/CDLI.10.4.702-709.2003; Azzurri A, 2006, INT J IMMUNOPATH PH, V19, P199; Balu S, 2011, J IMMUNOL, V186, P3113, DOI 10.4049/jimmunol.1003189; Banerjee S, 2004, P NATL ACAD SCI USA, V101, P12652, DOI 10.1073/pnas.0404347101; BARDANA EJ, 1973, CLIN EXP IMMUNOL, V13, P65; Berry JD, 2011, N BIOTECHNOL; BOTHAMLEY GH, 1989, J INFECT DIS, V159, P549, DOI 10.1093/infdis/159.3.549; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chambers MA, 2004, FEMS IMMUNOL MED MIC, V41, P93, DOI 10.1016/j.femsim.2004.01.004; Connors M, 1997, NAT MED, V3, P533, DOI 10.1038/nm0597-533; DACOSTA CTKA, 1993, CLIN EXP IMMUNOL, V91, P25; DANIEL TM, 1985, CHEST, V88, P388, DOI 10.1378/chest.88.3.388; DAVID HL, 1992, INT J LEPROSY, V60, P208; Davidow A, 2005, INFECT IMMUN, V73, P6846, DOI 10.1128/IAI.73.10.6846-6851.2005; Demkow U, 2007, J PHYSIOL PHARMACOL, V58, P117; Demkow U, 2006, J PHYSIOL PHARMACOL, V57, P63; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; Glatman-Freedman A, 1998, CLIN MICROBIOL REV, V11, P514, DOI 10.1128/CMR.11.3.514; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; Greenaway C, 2005, INT J TUBERC LUNG D, V9, P1112; Hamasur B, 2004, CLIN EXP IMMUNOL, V138, P30, DOI 10.1111/j.1365-2249.2004.02593.x; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; HOBBS MV, 1991, J CELL BIOCHEM, V46, P312, DOI 10.1002/jcb.240460406; Khan IH, 2011, CLIN VACCINE IMMUNOL, V18, P2148, DOI 10.1128/CVI.05304-11; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; LEVETON C, 1989, INFECT IMMUN, V57, P390, DOI 10.1128/IAI.57.2.390-395.1989; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; Maglione PJ, 2008, J IMMUNOL, V180, P3329, DOI 10.4049/jimmunol.180.5.3329; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; OGRA PL, 1968, NEW ENGL J MED, V279, P893, DOI 10.1056/NEJM196810242791701; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Rush JS, 2001, EUR J IMMUNOL, V31, P1150, DOI 10.1002/1521-4141(200104)31:4<1150::AID-IMMU1150>3.0.CO;2-V; Sanchez-Rodriguez C, 2002, INT J TUBERC LUNG D, V6, P706; Shen Y, 2002, INFECT IMMUN, V70, P869, DOI 10.1128/IAI.70.2.869-877.2002; Silva VMC, 2003, INT J TUBERC LUNG D, V7, P478; Stiasny K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034145; SURCEL HM, 1994, IMMUNOLOGY, V81, P171; Tjanlund A, 2006, INT IMMUNOL, V18, P807, DOI 10.1093/intimm/dxl017; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Williams A, 2004, IMMUNOLOGY, V111, P328, DOI 10.1111/j.1365-2567.2004.01809.x; World Health Organization, 2011, WHO REP 2011 GLOB CO; Yu X, 2012, CLIN VACCINE IMMUNOL, V19, P198, DOI 10.1128/CVI.05550-11	48	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98938	10.1371/journal.pone.0098938	http://dx.doi.org/10.1371/journal.pone.0098938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918450	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000035
J	Sibley, SD; Lauck, M; Bailey, AL; Hyeroba, D; Tumukunde, A; Weny, G; Chapman, CA; O'Connor, DH; Goldberg, TL; Friedrich, TC				Sibley, Samuel D.; Lauck, Michael; Bailey, Adam L.; Hyeroba, David; Tumukunde, Alex; Weny, Geoffrey; Chapman, Colin A.; O'Connor, David H.; Goldberg, Tony L.; Friedrich, Thomas C.			Discovery and Characterization of Distinct Simian Pegiviruses in Three Wild African Old World Monkey Species	PLOS ONE			English	Article							GB-VIRUS-C; HEPATITIS-G VIRUS; RNA SECONDARY STRUCTURES; C/HEPATITIS-G VIRUS; PHYLOGENETIC ANALYSIS; UNTRANSLATED REGION; SIGNAL PEPTIDES; NS5A PROTEIN; WEB SERVER; INFECTION	Within the Flaviviridae, the recently designated genus Pegivirus has expanded greatly due to new discoveries in bats, horses, and rodents. Here we report the discovery and characterization of three simian pegiviruses (SPgV) that resemble human pegivirus (HPgV) and infect red colobus monkeys (Procolobus tephrosceles), red-tailed guenons (Cercopithecus ascanius) and an olive baboon (Papio anubis). We have designated these viruses SPgV(krc), SPgV(krtg) and SPgV(kbab), reflecting their host species' common names, which include reference to their location of origin in Kibale National Park, Uganda. SPgV(krc) and SPgV(krtg) were detected in 47% (28/60) of red colobus and 42% (5/12) red-tailed guenons, respectively, while SPgV(kbab) infection was observed in 1 of 23 olive baboons tested. Infections were not associated with any apparent disease, despite the generally high viral loads observed for each variant. These viruses were monophyletic and equally divergent from HPgV and pegiviruses previously identified in chimpanzees (SPgV(cpz)). Overall, the high degree of conservation of genetic features among the novel SPgVs, HPgV and SPgV(cpz) suggests conservation of function among these closely related viruses. Our study describes the first primate pegiviruses detected in Old World monkeys, expanding the known genetic diversity and host range of pegiviruses and providing insight into the natural history of this genus.	[Sibley, Samuel D.; Goldberg, Tony L.; Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Lauck, Michael; Bailey, Adam L.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Hyeroba, David; Tumukunde, Alex; Weny, Geoffrey; Chapman, Colin A.; Goldberg, Tony L.] Makerere Univ, Kampala, Uganda; [Chapman, Colin A.] Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Sch Environm, Montreal, PQ, Canada; [O'Connor, David H.; Goldberg, Tony L.; Friedrich, Thomas C.] Wisconsin Natl Primate Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Makerere University; McGill University	Friedrich, TC (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	thomasf@primate.wisc.edu	Chapman, Colin/S-1911-2019	Chapman, Colin/0000-0002-8827-8140; o'connor, david/0000-0003-2139-470X; Sibley, Samuel/0000-0002-6754-3187; Friedrich, Thomas/0000-0001-9831-6895	National Institutes of Health (NIH), NIH-NSF Ecology of Infectious Disease program [TW009237]; UK Economic and Social Research Council [P51OD011106, P51RR000167]; University of Wisconsin School of Medicine and Public Health Wisconsin Partnership Program through the Wisconsin Center for Infectious Disease (WisCID);  [R01 AI084787]; FOGARTY INTERNATIONAL CENTER [R01TW009237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084787, R01AI098420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061, T32GM008692] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIH-NSF Ecology of Infectious Disease program; UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Wisconsin School of Medicine and Public Health Wisconsin Partnership Program through the Wisconsin Center for Infectious Disease (WisCID); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health (NIH) grants TW009237, as part of the joint NIH-NSF Ecology of Infectious Disease program, and R01 AI084787; the UK Economic and Social Research Council, through grants P51OD011106 and P51RR000167 to the Wisconsin National Primate Research Center; and by the University of Wisconsin School of Medicine and Public Health Wisconsin Partnership Program through the Wisconsin Center for Infectious Disease (WisCID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCL ACIDS RES; Adams NJ, 1998, J GEN VIROL, V79, P1871, DOI 10.1099/0022-1317-79-8-1871; Belyaev AS, 1998, J VIROL, V72, P868, DOI 10.1128/JVI.72.1.868-872.1998; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bhattarai N, 2013, J IMMUNOL, V190, P6351, DOI 10.4049/jimmunol.1300589; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Birkenmeyer LG, 1998, J MED VIROL, V56, P44, DOI 10.1002/(SICI)1096-9071(199809)56:1<44::AID-JMV8>3.0.CO;2-N; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bukh J, 1998, J INFECT DIS, V177, P855, DOI 10.1086/515255; Bukh J, 1997, VIROLOGY, V229, P429, DOI 10.1006/viro.1997.8461; Burbelo PD, 2012, J VIROL, V86, P6171, DOI 10.1128/JVI.00250-12; Chandriani S, 2013, P NATL ACAD SCI USA, V110, pE1407, DOI 10.1073/pnas.1219217110; Chang KS, 2006, VIRUS RES, V115, P1, DOI 10.1016/j.virusres.2005.06.012; Charrel RN, 1999, J GEN VIROL, V80, P2329, DOI 10.1099/0022-1317-80-9-2329; Cheng Y, 2000, J MED VIROL, V60, P28, DOI 10.1002/(SICI)1096-9071(200001)60:1<28::AID-JMV5>3.0.CO;2-S; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cuceanu NM, 2001, J GEN VIROL, V82, P713, DOI 10.1099/0022-1317-82-4-713; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Drexler JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003438; Epstein JH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000972; Erker JC, 1998, J GEN VIROL, V79, P41, DOI 10.1099/0022-1317-79-1-41; Feuerstein S, 2012, J MOL BIOL, V420, P310, DOI 10.1016/j.jmb.2012.04.023; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; George SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030653; Ghai RR, 2013, J GEN VIROL, V94, P2670, DOI 10.1099/vir.0.055509-0; Giret MTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018407; Goldberg T. L., 2012, NEW DIRECTIONS CONSE, P452; Goldberg TL, 2008, EMERG INFECT DIS, V14, P1375, DOI [10.3201/eid14.9.071196, 10.3201/eid1409.071196]; Goldberg TL, 2008, EMERG INFECT DIS, V14, P801, DOI 10.3201/eid1405.071686; Goldberg TL, 2009, J VIROL, V83, P11318, DOI 10.1128/JVI.02616-08; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039261; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Hitzler W E, 2004, Clin Lab, V50, P25; Holcik M, 1997, P NATL ACAD SCI USA, V94, P2410, DOI 10.1073/pnas.94.6.2410; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kapoor A, 2013, MBIO, V4, DOI 10.1128/mBio.00216-13; Kapoor A, 2013, J VIROL, V87, P7185, DOI 10.1128/JVI.00324-13; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lauck M, 2013, J VIROL, V87, P8971, DOI 10.1128/JVI.00888-13; Lauck M, 2012, J VIROL, V86, P3952, DOI 10.1128/JVI.06627-11; Lauck M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019056; Leary TP, 1996, J VIROL, V70, P9028, DOI 10.1128/JVI.70.12.9028-9030.1996; Leary TP, 1997, J GEN VIROL, V78, P2307, DOI 10.1099/0022-1317-78-9-2307; Lee YJ, 2001, BIOCHEM BIOPH RES CO, V286, P171, DOI 10.1006/bbrc.2001.5354; Lin C., 2006, HCV NS3 4A SERINE PR; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Longdon B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002260; Lyons S, 2012, EMERG INFECT DIS, V18, P1976, DOI 10.3201/eid1812.120498; MANDL CW, 1991, BIOTECHNIQUES, V10, P484; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mohr EL, 2011, J GEN VIROL, V92, P91, DOI 10.1099/vir.0.026088-0; Mohr EL, 2009, J VIRAL HEPATITIS, V16, P757, DOI 10.1111/j.1365-2893.2009.01194.x; Muerhoff AS, 2005, J GEN VIROL, V86, P1729, DOI 10.1099/vir.0.80854-0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Parreira R, 2012, INFECT GENET EVOL, V12, P86, DOI 10.1016/j.meegid.2011.10.011; Pavesi A, 2001, J MOL EVOL, V53, P104, DOI 10.1007/s002390010198; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plumptre AJ, 2007, BIOL CONSERV, V134, P178, DOI 10.1016/j.biocon.2006.08.021; Pybus OG, 2013, NATURE, V498, P310, DOI 10.1038/498310b; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; Ren H, 2005, WORLD J GASTROENTERO, V11, P970, DOI 10.3748/wjg.v11.i7.970; Rey D, 2000, EUR J CLIN MICROBIOL, V19, P721, DOI 10.1007/s100960000352; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Romano CM, 2008, J MOL EVOL, V66, P292, DOI 10.1007/s00239-008-9087-3; Salyer SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001597; SCHLAUDER GG, 1995, J MED VIROL, V46, P81, DOI 10.1002/jmv.1890460117; Schwarze-Zander C, 2006, J INFECT DIS, V194, P410, DOI 10.1086/505713; Simons JN, 1996, J VIROL, V70, P6126, DOI 10.1128/JVI.70.9.6126-6135.1996; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Stapleton J. T., 2012, ASSIGNMENT HUMAN SIM; Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; Supapol WB, 2011, J MED VIROL, V83, P33, DOI 10.1002/jmv.21946; Takahashi K, 1997, HEPATOL RES, V8, P139, DOI 10.1016/S1386-6346(97)00063-6; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tellinghuisen TL, 2006, J VIROL, V80, P7450, DOI 10.1128/JVI.00358-06; Thurber MI, 2013, INT J PARASITOL, V43, P613, DOI 10.1016/j.ijpara.2013.03.002; Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Wang LY, 2011, J VIROL, V85, P7954, DOI 10.1128/JVI.00339-11; Welbourn S, 2006, HCV NS2 3 PROTEASE; Xia X, 2013, MOL BIOL EVOL, V38, pW7; Yanagi M, 1999, P NATL ACAD SCI USA, V96, P2291, DOI 10.1073/pnas.96.5.2291; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	98	39	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98569	10.1371/journal.pone.0098569	http://dx.doi.org/10.1371/journal.pone.0098569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918769	Green Published, gold			2022-12-25	WOS:000338631000019
J	Skaik, Y; Vahlsing, S; Goudeva, L; Eiz-Vesper, B; Battermann, A; Blasczyk, R; Figueiredo, C				Skaik, Younis; Vahlsing, Stefanie; Goudeva, Lilia; Eiz-Vesper, Britta; Battermann, Anja; Blasczyk, Rainer; Figueiredo, Constanca			Secreted beta(3)-Integrin Enhances Natural Killer Cell Activity against Acute Myeloid Leukemia Cells	PLOS ONE			English	Article							ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION; IFN-GAMMA; NK CELLS; T-CELL; INTEGRIN; IMMUNOTHERAPY; CYTOTOXICITY; EXPRESSION; CANCER; ACTIVATION	Integrins are a large family of heterodimeric proteins that are involved in cell adhesion, migration, and proliferation. Integrin diversity and function is regulated by alternative splicing. Membrane-bound and truncated beta(3)-integrins were shown to be key players in cancer metastasis. However, the immunomodulatory functions of the soluble (s) beta(3)-integrin have not been investigated yet. In this study, we described a novel form of s beta(3)-integrin in acute myeloid leukaemia (AML) patients. Furthermore, we assessed the role of the s beta(3)-integrin in the modulation of natural killer (NK)-cell activity. Levels of s beta(3)-integrin were analysed in plasma samples of 23 AML patients and 26 healthy donors by ELISA. The capacity of s beta(3)-integrin to regulate NK cell activity was investigated using proliferation, cytokine secretion, and cytotoxicity assays. Circulating s beta(3)-integrin was detected in the plasma of 8 AML patients. NK cells showed significantly higher proliferation rates after stimulation with s beta(3)-integrin and IL-2, IL-15 (73%). Significant increases in the NK cells' secreted levels of TNF-alpha, IFN-gamma were measured in presence of s beta(3)-integrin. In addition, s beta(3)-integrin caused the upregulation of Granzyme B transcripts levels as well as FasL expression levels in NK cells. Most importantly, significantly higher K562 or AML blast target cell lysis rates were observed when NK cells were exposed to s beta(3)-integrin. This study reports the identification of a novel s beta(3)-integrin in AML patients and provides novel insights into its role in the immunomodulation of NK cell activity.	[Skaik, Younis; Vahlsing, Stefanie; Goudeva, Lilia; Eiz-Vesper, Britta; Battermann, Anja; Blasczyk, Rainer; Figueiredo, Constanca] Hannover Med Sch, Inst Transfus Med, Hannover, Germany	Hannover Medical School	Figueiredo, C (corresponding author), Hannover Med Sch, Inst Transfus Med, Hannover, Germany.	figueiredo.constanca@mh-hannover.de		Blasczyk, Rainer/0000-0003-3875-3190	Deutscher Akademischer Austauschdienst -DAAD; Excellence Cluster for Regenerative Medicine and Reconstructive Therapies - REBIRTH	Deutscher Akademischer Austauschdienst -DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Excellence Cluster for Regenerative Medicine and Reconstructive Therapies - REBIRTH	YS is supported by a scholarship of the "Deutscher Akademischer Austauschdienst -DAAD''. This study was financed in part by the Excellence Cluster for Regenerative Medicine and Reconstructive Therapies - REBIRTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2012, J IMMUNOL METHODS, V375, P166, DOI 10.1016/j.jim.2011.10.008; Barrett AJ, 2010, CLIN EXP IMMUNOL, V161, P223, DOI 10.1111/j.1365-2249.2010.04197.x; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Cho D, 2009, KOREAN J LAB MED, V29, P89, DOI 10.3343/kjlm.2009.29.2.89; DJAFFAR I, 1994, BIOCHEM J, V300, P69, DOI 10.1042/bj3000069; Eisele G, 2013, ANTICANCER RES, V33, P3563; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Geller MA, 2013, CYTOTHERAPY, V15, P1297, DOI 10.1016/j.jcyt.2013.05.022; Guilloton F, 2007, CELL SIGNAL, V19, P1132, DOI 10.1016/j.cellsig.2006.12.005; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jaimes Y, 2010, TRANSFUSION, V50, P1988, DOI 10.1111/j.1537-2995.2010.02677.x; Jin RX, 2007, CANCER BIOL THER, V6, P1559, DOI 10.4161/cbt.6.10.4710; Kim HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070194; Koehl U, 2004, BLOOD CELL MOL DIS, V33, P261, DOI 10.1016/j.bcmd.2004.08.013; Kon S, 2011, EXP CELL RES, V317, P1774, DOI 10.1016/j.yexcr.2011.04.005; Leong JW, 2011, BLOOD, V117, P2297, DOI 10.1182/blood-2011-01-327247; Lion E, 2012, LEUKEMIA, V26, P2019, DOI 10.1038/leu.2012.87; Lonsdorf AS, 2012, J BIOL CHEM, V287, P2168, DOI 10.1074/jbc.M111.269811; Orleans-Lindsay JK, 2001, CLIN EXP IMMUNOL, V126, P403, DOI 10.1046/j.1365-2249.2001.01692.x; Pardo J, 2002, EUR J IMMUNOL, V32, P2881, DOI 10.1002/1521-4141(2002010)32:10<2881::AID-IMMU2881>3.0.CO;2-K; Pieper C, 2014, BRAIN RES; Ruggeri L, 2007, CURR OPIN ONCOL, V19, P142, DOI 10.1097/CCO.0b013e3280148a1a; Ruggeri L, 2006, IMMUNOL REV, V214, P202, DOI 10.1111/j.1600-065X.2006.00455.x; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Siena L, 2014, IMMUNOLOGY, V141, P242, DOI 10.1111/imm.12190; Skaik Y, 2013, J IMMUNOL METHODS, V391, P72, DOI 10.1016/j.jim.2013.02.011; Smits ELJ, 2011, CANCER IMMUNOL IMMUN, V60, P757, DOI 10.1007/s00262-011-1022-6; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Soiffer RJ, 2008, BEST PRACT RES CL HA, V21, P455, DOI 10.1016/j.beha.2008.07.009; Szczepanski MJ, 2010, CANCER IMMUNOL IMMUN, V59, P73, DOI 10.1007/s00262-009-0724-5; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tarone G, 2000, INT J DEV BIOL, V44, P725; Verheyden S, 2008, LEUKEMIA, V22, P249, DOI 10.1038/sj.leu.2405040; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vrbanus L, 2010, COLLEGIUM ANTROPOL, V34, P705; Wang RP, 2012, J LEUKOCYTE BIOL, V91, P299, DOI 10.1189/jlb.0611308; WANG Z, 2013, TUMOUR BIOL; Whiteway A, 2003, BRIT J HAEMATOL, V120, P442, DOI 10.1046/j.1365-2141.2003.04085.x; Xu GW, 2008, BIOCHEM BIOPH RES CO, V375, P666, DOI 10.1016/j.bbrc.2008.08.077	41	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98936	10.1371/journal.pone.0098936	http://dx.doi.org/10.1371/journal.pone.0098936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919191	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000034
J	Zoubrinetzky, R; Bielle, F; Valdois, S				Zoubrinetzky, Rachel; Bielle, Frederique; Valdois, Sylviane			New Insights on Developmental Dyslexia Subtypes: Heterogeneity of Mixed Reading Profiles	PLOS ONE			English	Article							VISUAL-ATTENTION SPAN; PHONOLOGICAL DYSLEXIA; DUAL-ROUTE; WORD RECOGNITION; SPEECH SOUNDS; FMRI EVIDENCE; DEFICIT; SURFACE; CHILDREN; ACQUISITION	We examined whether classifications based on reading performance are relevant to identify cognitively homogeneous subgroups of dyslexic children. Each of the 71 dyslexic participants was selected to have a mixed reading profile, i.e. poor irregular word and pseudo-word reading performance (accuracy and speed). Despite their homogeneous reading profile, the participants were found to split into four distinct cognitive subgroups, characterized by a single phonological disorder, a single visual attention span disorder, a double deficit or none of these disorders. The two subgroups characterized by single and contrasted cognitive disorders were found to exhibit a very similar reading pattern but more contrasted spelling performance (quantitative analysis). A qualitative analysis of the error types produced in reading and spelling provided some cues about the participants' underlying cognitive deficit. The overall findings disqualify subtyping based on reading profiles as a classification method to identify cognitively homogeneous subgroups of dyslexic children. They rather show an opaque relationship between the cognitive underpinnings of developmental dyslexia and their behavioral manifestations in reading and spelling. Future neuroimaging and genetic studies should take this issue into account since synthesizing over cognitively heterogeneous children would entail potential pitfalls.	[Zoubrinetzky, Rachel; Bielle, Frederique; Valdois, Sylviane] CHU Grenoble, Ctr Referent Diagnost Troubles Langage & Apprenti, Pole Couple Enfant, F-38043 Grenoble, France; [Zoubrinetzky, Rachel; Valdois, Sylviane] Univ Grenoble Alpes, CNRS, UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Zoubrinetzky, R (corresponding author), CHU Grenoble, Ctr Referent Diagnost Troubles Langage & Apprenti, Pole Couple Enfant, F-38043 Grenoble, France.	rachel.zoubri@gmail.com			ANR Blanc ORTHOLEARN [ANR-12-BSH2-0013-01]	ANR Blanc ORTHOLEARN(French National Research Agency (ANR))	This work was supported by ANR Blanc ORTHOLEARN: ANR-12-BSH2-0013-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ans B, 1998, PSYCHOL REV, V105, P678, DOI 10.1037/0033-295X.105.4.678-723; Baciu M., 2008, NEUROPSYCHOLOGY COGN, P22; Bogliotti C, 2008, J EXP CHILD PSYCHOL, V101, P137, DOI 10.1016/j.jecp.2008.03.006; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Bosse ML, 2009, J RES READ, V32, P230, DOI 10.1111/j.1467-9817.2008.01387.x; Bosse ML, 2003, CURR PSYCHOL LETT, V1, P10; Bosse ML, 2014, J RES READ IN PRESS; Bouvier-Chaverot M., 2012, REV NEUROPSYCHOL, V4, P24, DOI [10.3917/rne.041.0024, DOI 10.3917/RNE.041.0024]; Bowey JA, 2005, J EXP CHILD PSYCHOL, V92, P203, DOI 10.1016/j.jecp.2005.06.005; BRADLEY L, 1983, NATURE, V301, P419, DOI 10.1038/301419a0; Brunsdon R, 2005, COGN NEUROPSYCHOL, V22, P213, DOI 10.1080/02643290442000077; CAMPBELL R, 1985, Q J EXP PSYCHOL-A, V37, P435, DOI 10.1080/14640748508400944; Castles A, 2004, COGNITION, V91, P77, DOI 10.1016/S0010-0277(03)00164-1; CASTLES A, 1993, COGNITION, V47, P149, DOI 10.1016/0010-0277(93)90003-E; Castles A, 1996, COGN NEUROPSYCHOL, V13, P25, DOI 10.1080/026432996382051; Castles A, 2008, J RES READ; Castles A, 2006, FROM INKMARKS TO IDEAS: CURRENT ISSUES IN LEXICAL PROCESSING, P151; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Cunningham AE, 2002, J EXP CHILD PSYCHOL, V82, P185, DOI 10.1016/S0022-0965(02)00008-5; Cunningham AE, 2006, J EXP CHILD PSYCHOL, V95, P56, DOI 10.1016/j.jecp.2006.03.008; de Jong PF, 2007, SCI STUD READ, V11, P55, DOI 10.1207/s1532799xssr1101_4; Douklias SD, 2009, COGN NEUROPSYCHOL, V26, P705, DOI 10.1080/02643291003691106; Dubois M, 2007, COGN NEUROPSYCHOL, V24, P623, DOI 10.1080/02643290701617330; Dubois M, 2010, CORTEX, V46, P717, DOI 10.1016/j.cortex.2009.11.002; Goswami U, 2003, TRENDS COGN SCI, V7, P534, DOI 10.1016/j.tics.2003.10.003; GOULANDRIS NK, 1991, COGNITIVE NEUROPSYCH, V8, P127, DOI 10.1080/02643299108253369; Griffiths YM, 2002, J EDUC PSYCHOL, V94, P34, DOI 10.1037//0022-0663.94.1.34; Hadzibeganovic T, 2010, CORTEX, V46, P1312, DOI 10.1016/j.cortex.2010.06.011; HANLEY JR, 1995, NEUROPSYCHOLOGIA, V33, P909, DOI 10.1016/0028-3932(95)00038-5; Harm MW, 1999, PSYCHOL REV, V106, P491, DOI 10.1037/0033-295X.106.3.491; Heim S, 2008, ACTA NEUROBIOL EXP, V68, P73; Howard D, 1996, COGNITIVE NEUROPSYCH, V13, P887, DOI 10.1080/026432996381854; Hulme C, 2002, J EXP CHILD PSYCHOL, V82, P2, DOI 10.1006/jecp.2002.2670; Jacquier-Roux M., 2002, ODEDYS OUTIL DEPISTA; Jimenez JE, 2009, J EXP CHILD PSYCHOL, V103, P167, DOI 10.1016/j.jecp.2009.02.004; King WM, 2007, INT J LANG COMM DIS, V42, P77, DOI 10.1080/13682820600806680; Kyte CS, 2006, J EXP CHILD PSYCHOL, V93, P166, DOI 10.1016/j.jecp.2005.09.003; Lallier M, 2013, COGNITION, V126, P121, DOI 10.1016/j.cognition.2012.09.008; Lallier M, 2010, CORTEX, V46, P231, DOI 10.1016/j.cortex.2009.03.014; Lassus-Sangosse D, 2008, VISION RES, V48, P979, DOI 10.1016/j.visres.2008.01.025; LEFAVRAIS P, 1965, TEST ALOUETTE; Lete B, 2004, BEHAV RES METH INS C, V36, P156, DOI 10.3758/BF03195560; Lobier M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058097; Lobier M, 2012, NEUROPSYCHOLOGIA, V50, P2195, DOI 10.1016/j.neuropsychologia.2012.05.023; Lobier M, 2012, CORTEX, V48, P768, DOI 10.1016/j.cortex.2011.09.003; Manis FR, 1996, COGNITION, V58, P157, DOI 10.1016/0010-0277(95)00679-6; Manis Franck, 2008, SAGE HDB DYSLEXIA, P149, DOI DOI 10.4135/9780857020987.N8; Marshall J.C., 1984, DYSLEXIA GLOBAL ISSU, P45; Martinet C, 1999, ANN PSYCHOL, V99, P577; Mousty P., 1994, EVALUER TROUBLES LEC, P127; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Peterson RL, 2013, COGNITION, V126, P20, DOI 10.1016/j.cognition.2012.08.007; Peyrin C, 2012, BRAIN LANG, V120, P381, DOI 10.1016/j.bandl.2011.12.015; Peyrin C, 2011, BRAIN LANG, V118, P128, DOI 10.1016/j.bandl.2010.06.005; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Reilhac C, 2013, NEUROPSYCHOLOGIA, V51, P601, DOI 10.1016/j.neuropsychologia.2012.12.010; ROMANI C, 1994, BRAIN LANG, V47, P482; Serniclaes W, 2001, J SPEECH LANG HEAR R, V44, P384, DOI 10.1044/1092-4388(2001/032); Share DL, 1999, J EXP CHILD PSYCHOL, V72, P95, DOI 10.1006/jecp.1998.2481; Share DL, 2004, J EXP CHILD PSYCHOL, V87, P267, DOI 10.1016/j.jecp.2004.01.001; SHARE DL, 1995, COGNITION, V55, P151, DOI 10.1016/0010-0277(94)00645-2; SNOWLING M, 1989, COGNITIVE NEUROPSYCH, V6, P379, DOI 10.1080/02643298908253289; Snowling M., 2000, DYSLEXIA; Sprenger-Charolles L, 2000, CAN J EXP PSYCHOL, V54, P87, DOI 10.1037/h0087332; Sprenger-Charolles L, 2011, SCI STUD READ, V15, P498, DOI 10.1080/10888438.2010.524463; Stanovich KE, 1997, DYSLEXIA: BIOLOGY, COGNITION AND INTERVENTION, P108; TEMPLE CM, 1983, BRIT J PSYCHOL, V74, P517, DOI 10.1111/j.2044-8295.1983.tb01883.x; Valdois S, 2004, DYSLEXIA, V10, P339, DOI 10.1002/dys.284; Valdois S, 2010, ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 1: A-G, P454; VALDOIS S, 1995, COGN NEUROPSYCHOL, V12, P31, DOI 10.1080/02643299508251991; Valdois S, 2014, CORTEX IN PRESS, DOI [10.1016/j.cortex. 2013.11.006, DOI 10.1016/J.CORTEX.2013.11.006]; Valdois S., 2003, READ WRIT, V16, P541, DOI DOI 10.1023/A:1025501406971; Valdois S, 2012, DYSLEXIA, V18, P77, DOI 10.1002/dys.1437; Valdois S, 2011, CORTEX, V47, P1197, DOI 10.1016/j.cortex.2011.05.011; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; WIMMER H, 1991, COGNITION, V40, P219, DOI 10.1016/0010-0277(91)90026-Z; Zabell Claire, 2002, Dyslexia, V8, P160, DOI 10.1002/dys.223; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; Ziegler JC, 2008, COGNITION, V107, P151, DOI 10.1016/j.cognition.2007.09.004	80	67	74	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99337	10.1371/journal.pone.0099337	http://dx.doi.org/10.1371/journal.pone.0099337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24918441	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000077
J	Hirdes, JP; Poss, JW; Mitchell, L; Korngut, L; Heckman, G				Hirdes, John P.; Poss, Jeffrey W.; Mitchell, Lori; Korngut, Lawrence; Heckman, George			Use of the interRAI CHESS Scale to Predict Mortality among Persons with Neurological Conditions in Three Care Settings	PLOS ONE			English	Article							MINIMUM DATA SET; NURSING-HOME; HEALTH; FRAILTY; INFORMATION; SURVIVAL; ASSESSMENTS; RESIDENTS; VALIDITY; DISEASE	Background: Persons with certain neurological conditions have higher mortality rates than the population without neurological conditions, but the risk factors for increased mortality within diagnostic groups are less well understood. The interRAI CHESS scale has been shown to be a strong predictor of mortality in the overall population of persons receiving health care in community and institutional settings. This study examines the performance of CHESS as a predictor of mortality among persons with 11 different neurological conditions. Methods: Survival analyses were done with interRAI assessments linked to mortality data among persons in home care (n = 359,940), complex continuing care hospitals/units (n = 88,721), and nursing homes (n = 185,309) in seven Canadian provinces/territories. Results: CHESS was a significant predictor of mortality in all 3 care settings for the 11 neurological diagnostic groups considered after adjusting for age and sex. The distribution of CHESS scores varied between diagnostic groups and within diagnostic groups in different care settings. Conclusions: CHESS is a valid predictor of mortality in neurological populations in community and institutional care. It may prove useful for several clinical, administrative, policy-development, evaluation and research purposes. Because it is routinely gathered as part of normal clinical practice in jurisdictions (like Canada) that have implemented interRAI assessment instruments, CHESS can be derived without additional need for data collection.	[Hirdes, John P.; Poss, Jeffrey W.; Heckman, George] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Mitchell, Lori] Winnipeg Reg Hlth Author, Winnipeg, MB, Canada; [Korngut, Lawrence] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada	University of Waterloo; University of Calgary	Hirdes, JP (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada.	hirdes@uwaterloo.ca		Heckman, George/0000-0003-3847-3287	Public Health Agency of Canada [6271-15-2010/3970773]; Ontario Ministry of Health and Long Term Care	Public Health Agency of Canada; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	Funding for the study was provided by the Public Health Agency of Canada, Project #6271-15-2010/3970773. Funding was also provided for the Ontario Home Care Research and Knowledge Exchange Chair (to JPH) through the Ontario Ministry of Health and Long Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JJ, 2010, AGE AGEING, V39, P755, DOI 10.1093/ageing/afq121; Bernabei R, 2009, INT GERONTOLOGY HAZZ, P69; Caesar-Chavannes CR, 2013, CHRON DIS INJ CAN, V33, P188; Carpenter GI, 2013, USING INTERRAI ASSES, P93; Czira ME, 2014, ACTA NEUROL SCAND, V130, P283, DOI 10.1111/ane.12220; Foebel AD, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-457; Forsaa EB, 2010, NEUROLOGY, V75, P1270, DOI 10.1212/WNL.0b013e3181f61311; Gambassi G, 1998, MED CARE, V36, P167, DOI 10.1097/00005650-199802000-00006; Gray LC, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-71; Hirdes JP, 2006, AGE AGEING, V35, P329, DOI 10.1093/ageing/afl036; Hirdes JP, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-27; Hirdes JP, 2012, PALLIAT SUPPORT CARE, V10, P155, DOI 10.1017/S1478951511000824; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; Hirdes JP, 2003, J AM GERIATR SOC, V51, P96, DOI 10.1034/j.1601-5215.2002.51017.x; Hjaltadottir I, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-86; Kaufmann P, 2005, NEUROLOGY, V64, P38, DOI 10.1212/01.WNL.0000148648.38313.64; Kingwell E, 2012, J NEUROL NEUROSUR PS, V83, P61, DOI 10.1136/jnnp-2011-300616; Landi F, 2000, MED CARE, V38, P1184, DOI 10.1097/00005650-200012000-00005; Lee JSW, 2009, EUR J PUBLIC HEALTH, V19, P308, DOI 10.1093/eurpub/ckp006; Lutomski JE, 2013, J AM GERIATR SOC, V61, P1625, DOI 10.1111/jgs.12430; Mitnitski AB, 2002, MECH AGEING DEV, V123, P1457, DOI 10.1016/S0047-6374(02)00082-9; Mor V, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-78; Poss J W, 2008, Healthc Manage Forum, V21, P33; Pritchard C, 2013, PUBLIC HEALTH, V127, P357, DOI 10.1016/j.puhe.2012.12.018; Rockwood K, 2011, CLIN GERIATR MED, V27, P17, DOI 10.1016/j.cger.2010.08.008; Sabia S, 2014, J GERONTOL A-BIOL, V69, P354, DOI 10.1093/gerona/glt114; Scotton WJ, 2012, AMYOTROPH LATERAL SC, V13, P502, DOI 10.3109/17482968.2012.679281; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tjam EY, 2012, INT J CARDIOL, V155, P75, DOI 10.1016/j.ijcard.2011.01.031; World Health Organization, 2007, GLOB BURD NEUR DIS E, P27	30	61	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99066	10.1371/journal.pone.0099066	http://dx.doi.org/10.1371/journal.pone.0099066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24914546	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700056
J	Sato, Y; Ando, S; Takahashi, H				Sato, Yukiyo; Ando, Sugihiro; Takahashi, Hideki			Role of Intron-Mediated Enhancement on Accumulation of an Arabidopsis NB-LRR Class R-protein that Confers Resistance to Cucumber mosaic virus	PLOS ONE			English	Article							EXON-JUNCTION COMPLEX; FLAX RUST RESISTANCE; OPEN READING FRAMES; DISEASE-RESISTANCE; GENE-EXPRESSION; HYPERSENSITIVE RESPONSE; DEFENSE RESPONSES; CELL-DEATH; MESSENGER-RNAS; SALICYLIC-ACID	The accumulation of RCY1 protein, which is encoded by RESISTANCE TO CMV(Y) (RCY1), a CC-NB-LRR class R-gene, is tightly correlated with the strength of the resistance to a yellow strain of Cucumber mosaic virus [CMV(Y)] in Arabidopsis thaliana. In order to enhance resistance to CMV by overexpression of RCY1, A. thaliana was transformed with intron-less RCY1 cDNA construct under the control of strong CaMV35S promoter. Remarkably, a relative amount of RCY1 protein accumulation in the transformants was much lower than that in plants expressing genomic RCY1 under the control of its native promoter. To identify a regulatory element of RCY1 that could cause such differential levels of RCY1 accumulation, a series of RCY1 cDNA and genomic RCY1 constructs were transiently expressed in Nicotiana benthamiana leaves by the Agrobacterium-mediated infiltration method. Comparative analysis of the level of RCY1 accumulation in the leaf tissues transiently expressing each construct indicated that the intron located in the RCY1-coding region of genomic RCY1, but not the native RCY1 genomic promoter or the 5'- and 3'-untranslated regions of RCY1, was indispensable for high level RCY1 accumulation. The increased levels of RCY1 accelerated plant disease defense reactions. Interestingly, such intron-mediated enhancement of RCY1 accumulation depended neither on the abundance of the RCY1 transcript nor on the RCY1 specific-intron sequence. Taken together, intron-mediated RCY1 expression seems to play a key role in the expression of complete resistance to CMV(Y) by maintaining RCY1 accumulation at high levels.	[Sato, Yukiyo; Ando, Sugihiro; Takahashi, Hideki] Tohoku Univ, Grad Sch Agr Sci, Dept Appl Plant Sci, Sendai, Miyagi 980, Japan	Tohoku University	Takahashi, H (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Appl Plant Sci, Sendai, Miyagi 980, Japan.	takahash@bios.tohoku.ac.jp	Ando, Sugihiro/T-5720-2019	Sato, Yukiyo/0000-0003-4514-8482	Ministry of Education, Culture, Sports, Science and Technology, Japan [22380028, 24658037]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a grant-in-aid for Scientific Research (B) (22380028) and Challenging Exploratory Research (24658037) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PA, 1997, PLANT CELL, V9, P641, DOI 10.1105/tpc.9.4.641; Ayliffe MA, 1999, PLANT J, V17, P287, DOI 10.1046/j.1365-313X.1999.00377.x; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Bechtold N, 1998, METH MOL B, V82, P259; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Borhan MH, 2004, MOL PLANT MICROBE IN, V17, P711, DOI 10.1094/MPMI.2004.17.7.711; Bourdon V, 2001, EMBO REP, V2, P394, DOI 10.1093/embo-reports/kve090; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALLIS J, 1987, GENE DEV, V1, P1183, DOI 10.1101/gad.1.10.1183; Cao YL, 2007, GENETICS, V177, P523, DOI 10.1534/genetics.107.075176; Collins N, 1999, PLANT CELL, V11, P1365, DOI 10.1105/tpc.11.7.1365; Cooley MB, 2000, PLANT CELL, V12, P663, DOI 10.1105/tpc.12.5.663; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DEAN C, 1989, PLANT CELL, V1, P201, DOI 10.1105/tpc.1.2.201; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Farrell R. E. Jr., 2007, Regulation of gene expression in plants: the role of transcript structure and processing, P1, DOI 10.1007/978-0-387-35640-2_1; Gassmann W, 2008, CURR TOP MICROBIOL, V326, P219; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Green M. R., 2012, MOL CLONING LAB MANU, V4th; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Hakata M, 2010, BREEDING SCI, V60, P575, DOI 10.1270/jsbbs.60.575; Halterman DA, 2003, PLANT PHYSIOL, V131, P558, DOI 10.1104/pp.014407; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Hondo D, 2007, MOL PLANT MICROBE IN, V20, P72, DOI 10.1094/MPMI-20-0072; Ishihara T, 2008, PLANT BIOLOGY, V10, P451, DOI 10.1111/j.1438-8677.2008.00050.x; Jeong YM, 2006, PLANT PHYSIOL, V140, P196, DOI 10.1104/pp.105.071316; Jinling Liu, 2007, Journal of Genetics and Genomics, V34, P765, DOI 10.1016/S1673-8527(07)60087-3; Kim M, 2003, J BIOL CHEM, V278, P19406, DOI 10.1074/jbc.M210539200; Koroleva OA, 2009, PLANT CELL, V21, P1592, DOI 10.1105/tpc.108.060434; LAWRENCE GJ, 1995, PLANT CELL, V7, P1195, DOI 10.1105/tpc.7.8.1195; Levy M, 2004, PLANT PHYSIOL, V135, P2392, DOI 10.1104/pp.104.044859; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mes JJ, 2000, PLANT J, V23, P183, DOI 10.1046/j.1365-313x.2000.00765.x; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Mohr TJ, 2010, MOL PLANT MICROBE IN, V23, P1303, DOI 10.1094/MPMI-01-10-0022; Mufarrege EF, 2011, J EXP BOT, V62, P5025, DOI 10.1093/jxb/err202; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Park NI, 2007, PLANTA, V225, P625, DOI 10.1007/s00425-006-0385-y; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Parra G, 2011, NUCLEIC ACIDS RES, V39, P5328, DOI 10.1093/nar/gkr043; Rethmeier N, 1997, PLANT J, V12, P895, DOI 10.1046/j.1365-313X.1997.12040895.x; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Rose AB, 1997, PLANT J, V11, P455, DOI 10.1046/j.1365-313X.1997.11030455.x; Rose AB, 2008, PLANT CELL, V20, P543, DOI 10.1105/tpc.107.057190; Schornack S, 2004, PLANT J, V37, P46, DOI 10.1046/j.1365-313X.2003.01937.x; Sekine KT, 2008, MOL PLANT MICROBE IN, V21, P1398, DOI 10.1094/MPMI-21-11-1398; Sekine KT, 2006, PLANT MOL BIOL, V62, P669, DOI 10.1007/s11103-006-9048-4; Shirano Y, 2002, PLANT CELL, V14, P3149, DOI 10.1105/tpc.005348; Takahashi H, 2004, PLANT CELL PHYSIOL, V45, P803, DOI 10.1093/pcp/pch085; Takahashi H, 2002, PLANT J, V32, P655, DOI 10.1046/j.1365-313X.2002.01453.x; TAKAHASHI H, 1994, PLANT J, V6, P369, DOI 10.1046/j.1365-313X.1994.06030369.x; TAKAHASHI H, 1993, MOL PLANT MICROBE IN, V6, P182, DOI 10.1094/MPMI-6-182; Takahashi H, 2014, PLANT CELL REP, V33, P99, DOI 10.1007/s00299-013-1515-1; Takahashi H, 2012, PHYSIOL MOL PLANT P, V79, P40, DOI 10.1016/j.pmpp.2012.03.003; Takahashi H, 2012, MOL PLANT MICROBE IN, V25, P1171, DOI 10.1094/MPMI-04-12-0076-R; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Tomaru K., 1960, B HATANO TOB EXP STN, V46, P143; XU Y, 1994, PLANT PHYSIOL, V106, P459, DOI 10.1104/pp.106.2.617; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474	67	12	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99041	10.1371/journal.pone.0099041	http://dx.doi.org/10.1371/journal.pone.0099041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915153	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700052
J	Weber, U; Rodriguez, E; Martignetti, J; Mlodzik, M				Weber, Ursula; Rodriguez, Estefania; Martignetti, John; Mlodzik, Marek			Luna, a Drosophila KLF6/KLF7, Is Maternally Required for Synchronized Nuclear and Centrosome Cycles in the Preblastoderm Embryo	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-6; CELL-CYCLE; ACTIVATION; CENTRIOLES; MITOSIS; GENOME; GENES; EYE	Kruppel like factors (KLFs) are conserved transcription factors that have been implicated in many developmental processes including differentiation, organ patterning, or regulation of stem cell pluripotency. We report the generation and analysis of loss-of-function mutants of Drosophila Klf6/7, the luna gene. We demonstrate that luna mutants are associated with very early embryonic defects prior to cellularization at the syncytial stage and cause DNA separation defects during the rapid mitotic cycles resulting in un-coupled DNA and centrosome cycles. These defects manifest themselves, both in animals that are maternally homozygous and heterozygous mutant. Surprisingly, luna is only required during the syncytial stages and not later in development, suggesting that the DNA segregation defect is linked to centrosomes, since centrosomes are dispensable for later cell divisions.	[Weber, Ursula; Mlodzik, Marek] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Weber, Ursula; Mlodzik, Marek] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Rodriguez, Estefania; Martignetti, John] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Mlodzik, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	marek.mlodzik@mssm.edu			National Institutes of Health [EY13256, CA122332]; NATIONAL CANCER INSTITUTE [R01CA122332] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant EY13256 to MM and CA122332 to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2007, PLOS GENET, V3, P2163, DOI 10.1371/journal.pgen.0030200; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; Carrera P, 1998, P NATL ACAD SCI USA, V95, P10779, DOI 10.1073/pnas.95.18.10779; CHOU TB, 1993, DEVELOPMENT, V119, P1359; D'Astolfo DS, 2008, CELL DEATH DIFFER, V15, P613, DOI 10.1038/sj.cdd.4402299; De Graeve F, 2003, GENE, V314, P55, DOI 10.1016/S0378-1119(03)00720-0; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Foe Victoria E., 1993, P149; Jenny A, 2008, BIOTECHNIQUES, V44, P335, DOI 10.2144/000112720; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Li XM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000876; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; McCleland ML, 2008, CURR BIOL, V18, P245, DOI 10.1016/j.cub.2008.01.041; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Megraw TL, 1999, DEVELOPMENT, V126, P2829; MURRAY AW, 1991, SCI AM, V264, P56, DOI 10.1038/scientificamerican0391-56; O'Dor E, 2006, DEV BIOL, V290, P312, DOI 10.1016/j.ydbio.2005.11.015; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; PREISS A, 1985, NATURE, V313, P27, DOI 10.1038/313027a0; Racca AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022438; RAFF JW, 1988, J CELL BIOL, V107, P2009, DOI 10.1083/jcb.107.6.2009; Reynolds-Kenneally J, 2005, DEV BIOL, V285, P38, DOI 10.1016/j.ydbio.2005.05.038; Rodrigues-Martins A, 2008, CELL CYCLE, V7, P11, DOI 10.4161/cc.7.1.5226; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Seetharam A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-276; SIMPSON P, 1983, GENETICS, V105, P615; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; Telley IA, 2013, NAT PROTOC, V8, P310, DOI 10.1038/nprot.2013.003; Vaizel-Ohayon D, 1999, CURR BIOL, V9, P889, DOI 10.1016/S0960-9822(99)80393-5; Van Doren M, 1998, CURR BIOL, V8, P243; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474; Zhao XA, 2010, DEV BIOL, V344, P79, DOI 10.1016/j.ydbio.2010.04.018	38	11	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e96933	10.1371/journal.pone.0096933	http://dx.doi.org/10.1371/journal.pone.0096933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915236	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700008
J	Windhager, S; Schaschl, H; Schaefer, K; Mitteroecker, P; Huber, S; Wallner, B; Fieder, M				Windhager, Sonja; Schaschl, Helmut; Schaefer, Katrin; Mitteroecker, Philipp; Huber, Susanne; Wallner, Bernard; Fieder, Martin			Variation at Genes Influencing Facial Morphology Are Not Associated with Developmental Imprecision in Human Faces	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HETEROZYGOSITY-FITNESS CORRELATIONS; FLUCTUATING ASYMMETRY; INSTABILITY; POPULATION; ROTTERDAM; GENOTYPE; SYMMETRY; DESIGN; UPDATE	Facial asymmetries are commonly used as a proxy for human developmental imprecision resulting from inbreeding, and thus reduced genetic heterozygosity. Several environmental factors influence human facial asymmetry (e. g., health care, parasites), but the generalizability of findings on genetic stressors has been limited in humans by sample characteristics (island populations, endogamy) and indirect genetic assessment (inference from pedigrees). In a sample of 3215 adult humans from the Rotterdam Study, we therefore studied the relationship of facial asymmetry, estimated from nine midfacial landmarks, with genetic variation at 102 single nucleotide polymorphism (SNP) loci recently associated with facial shape variation. We further tested whether the degree of individual heterozygosity is negatively correlated with facial asymmetry. An ANOVA tree regression did not identify any SNP relating to either fluctuating asymmetry or total asymmetry. In a general linear model, only age and sex-but neither heterozygosity nor any SNP previously reported to covary with facial shape-was significantly related to total or fluctuating asymmetry of the midface. Our study does not corroborate the common assumption in evolutionary and behavioral biology that morphological asymmetries reflect heterozygosity. Our results, however, may be affected by a relatively small degree of inbreeding, a relatively stable environment, and an advanced age in the Rotterdam sample. Further large-scale genetic studies, including gene expression studies, are necessary to validate the genetic and developmental origin of morphological asymmetries.	[Windhager, Sonja; Schaschl, Helmut; Schaefer, Katrin; Huber, Susanne; Wallner, Bernard; Fieder, Martin] Univ Vienna, Dept Anthropol, Vienna, Austria; [Windhager, Sonja] Konrad Lorenz Inst Evolut & Cognit Res, Altenberg, Austria; [Mitteroecker, Philipp] Univ Vienna, Dept Theoret Biol, Vienna, Austria; [Wallner, Bernard] Univ Vienna, Cognit Sci Platform, Vienna, Austria; [Wallner, Bernard] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna; University of Vienna	Windhager, S (corresponding author), Univ Vienna, Dept Anthropol, Vienna, Austria.	sonja.windhager@univie.ac.at	Wallner, Bernard/B-1089-2009; Schaefer, Katrin/G-8632-2011; Windhager, Sonja/K-7618-2013; Mitteroecker, Philipp/A-1591-2012	Schaefer, Katrin/0000-0002-0173-3092; Windhager, Sonja/0000-0003-1809-8678; Schaschl, Helmut/0000-0003-2826-8773; Mitteroecker, Philipp/0000-0002-5308-3837	Konrad Lorenz Institute for Evolution and Cognition Research; University of Vienna [IP 547011]	Konrad Lorenz Institute for Evolution and Cognition Research; University of Vienna	This work was supported by a fellowship of the Konrad Lorenz Institute for Evolution and Cognition Research to SW, and by the University of Vienna (Emerging Field "Comparative Human Life History: A Multilevel Approach'' to KS, Back-to-Research Grant to SH, Focus of Excellence "Biometrics of EvoDevo'' to PM, and Investitionsprojekt IP 547011 to MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Asher JH, 1996, HUM MUTAT, V7, P30, DOI 10.1002/(SICI)1098-1004(1996)7:1<30::AID-HUMU4>3.3.CO;2-H; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Beasley DE, 2013, ECOL INDIC, V30, P218, DOI 10.1016/j.ecolind.2013.02.024; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Boehringer S, 2011, EUR J HUM GENET, V19, P1192, DOI 10.1038/ejhg.2011.110; Bookstein FL, EVOL BIOL IN PRESS, P1; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Coleman Sydney R, 2006, Aesthet Surg J, V26, pS4, DOI 10.1016/j.asj.2005.09.012; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; DeWoody YD, 2005, J HERED, V96, P85, DOI 10.1093/jhered/esi017; Fatemifar G, 2013, HUM MOL GENET, V22, P3807, DOI 10.1093/hmg/ddt231; FRYDENBERG O, 1963, HEREDITAS, V50, P89; Gordon JRS, 2012, NEW ENGL J MED, V366, pE25, DOI 10.1056/NEJMicm1104059; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; HERSHKOVITZ I, 1992, AM J HUM BIOL, V4, P83, DOI 10.1002/ajhb.1310040111; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Hope D, 2013, ECON HUM BIOL, V11, P236, DOI 10.1016/j.ehb.2011.06.006; Ikram MA, 2011, EUR J EPIDEMIOL, V26, P811, DOI 10.1007/s10654-011-9624-z; Kayser M, 2008, AM J HUM GENET, V82, P411, DOI 10.1016/j.ajhg.2007.10.003; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; LIVSHITS G, 1991, HUM BIOL, V63, P441; Livshits G, 1994, DEV INSTABILITY ITS, P157; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Miller JM, 2014, MOL ECOL, V23, P1899, DOI 10.1111/mec.12707; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; MITTON JB, 1997, SELECTION NATURAL PO; Otremski I, 1993, Anthropol Anz, V51, P233; Ozener B, 2010, AM J HUM BIOL, V22, P557, DOI 10.1002/ajhb.21046; Paternoster L, 2012, AM J HUM GENET, V90, P478, DOI 10.1016/j.ajhg.2011.12.021; Penke L, 2009, EVOL HUM BEHAV, V30, P429, DOI 10.1016/j.evolhumbehav.2009.06.001; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Polak M., 2003, CAUSES CONSEQUENCES; R Core Team, 2021, R LANG ENV STAT COMP; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Schaefer K, 2006, AM J PHYS ANTHROPOL, V129, P132, DOI 10.1002/ajpa.20224; Sommer A, 2003, AM J MED GENET A, V123A, P91, DOI 10.1002/ajmg.a.20501; SUTTON PRN, 1968, ANGLE ORTHOD, V38, P82; Van Dongen S, 2011, EVOL HUM BEHAV, V32, P380, DOI 10.1016/j.evolhumbehav.2011.03.002; Vogt G, 2008, J EXP BIOL, V211, P510, DOI 10.1242/jeb.008755; Warner DR, 2007, BBA-MOL CELL RES, V1773, P814, DOI 10.1016/j.bbamcr.2007.03.016	46	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99009	10.1371/journal.pone.0099009	http://dx.doi.org/10.1371/journal.pone.0099009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914781	Green Published, gold			2022-12-25	WOS:000340947700049
J	Hayashi, K; Ogiyama, Y; Yokomi, K; Nakagawa, T; Kaino, T; Kawamukai, M				Hayashi, Kazuhiro; Ogiyama, Yuki; Yokomi, Kazumasa; Nakagawa, Tsuyoshi; Kaino, Tomohiro; Kawamukai, Makoto			Functional Conservation of Coenzyme Q Biosynthetic Genes among Yeasts, Plants, and Humans	PLOS ONE			English	Article							POLYPRENYL DIPHOSPHATE TRANSFERASE; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; UBIQUINONE BIOSYNTHESIS; ARABIDOPSIS-THALIANA; CHAIN-LENGTH; PROTEIN; SYNTHASE; ANTIOXIDANT	Coenzyme Q (CoQ) is an essential factor for aerobic growth and oxidative phosphorylation in the electron transport system. The biosynthetic pathway for CoQ has been proposed mainly from biochemical and genetic analyses of Escherichia coli and Saccharomyces cerevisiae; however, the biosynthetic pathway in higher eukaryotes has been explored in only a limited number of studies. We previously reported the roles of several genes involved in CoQ synthesis in the fission yeast Schizosaccharomyces pombe. Here, we expand these findings by identifying ten genes (dps1, dlp1, ppt1, and coq3-9) that are required for CoQ synthesis. CoQ10-deficient S. pombe coq deletion strains were generated and characterized. All mutant fission yeast strains were sensitive to oxidative stress, produced a large amount of sulfide, required an antioxidant to grow on minimal medium, and did not survive at the stationary phase. To compare the biosynthetic pathway of CoQ in fission yeast with that in higher eukaryotes, the ability of CoQ biosynthetic genes from humans and plants (Arabidopsis thaliana) to functionally complement the S. pombe coq deletion strains was determined. With the exception of COQ9, expression of all other human and plant COQ genes recovered CoQ10 production by the fission yeast coq deletion strains, although the addition of a mitochondrial targeting sequence was required for human COQ3 and COQ7, as well as A. thaliana COQ6. In summary, this study describes the functional conservation of CoQ biosynthetic genes between yeasts, humans, and plants.	[Hayashi, Kazuhiro; Ogiyama, Yuki; Yokomi, Kazumasa; Kaino, Tomohiro; Kawamukai, Makoto] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan; [Nakagawa, Tsuyoshi] Shimane Univ, Interdisciplinary Ctr Sci Res, Matsue, Shimane, Japan	Shimane University; Shimane University	Kawamukai, M (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan.	kawamuka@life.shimanen-u.ac.jp	Kawamukai, Makoto/AET-1038-2022	Kawamukai, Makoto/0000-0003-2929-8798	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24380056]; Japanese Coenzyme Q association	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Coenzyme Q association	This work was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (# 24380056) and by Japanese Coenzyme Q association (http://www.coenzymeq-jp.com/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan CM, 2013, BBA-MOL CELL BIOL L, V1831, P776, DOI 10.1016/j.bbalip.2012.12.007; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; Casarin A, 2008, BIOCHEM BIOPH RES CO, V372, P35, DOI 10.1016/j.bbrc.2008.04.172; Cui TZ, 2009, FEBS J, V276, P748, DOI 10.1111/j.1742-4658.2008.06821.x; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Ducluzeau AL, 2012, PLANT J, V69, P366, DOI 10.1111/j.1365-313X.2011.04796.x; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Forsgren M, 2004, BIOCHEM J, V382, P519, DOI 10.1042/BJ20040261; Garcia-Corzo L, 2013, HUM MOL GENET, V22, P1233, DOI 10.1093/hmg/dds530; Gin P, 2003, J BIOL CHEM, V278, P25308, DOI 10.1074/jbc.M303234200; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Jonassen T, 2000, J BIOL CHEM, V275, P12381, DOI 10.1074/jbc.275.17.12381; Jun L, 2004, PLANT CELL PHYSIOL, V45, P1882, DOI 10.1093/pcp/pch211; Kainou T, 2001, J BIOL CHEM, V276, P7876, DOI 10.1074/jbc.M007472200; Kawamukai M, 2002, J BIOSCI BIOENG, V94, P511, DOI 10.1016/S1389-1723(02)80188-8; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; Kennedy PJ, 2008, TOXICOL SCI, V106, P124, DOI 10.1093/toxsci/kfn153; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; Matsuo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059887; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Miki R, 2008, FEBS J, V275, P5309, DOI 10.1111/j.1742-4658.2008.06661.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; Nishida T, 2013, J MOL STRUCT, V1048, P375, DOI 10.1016/j.molstruc.2013.05.066; Okada K, 2004, PLANT MOL BIOL, V55, P567, DOI 10.1007/s11103-004-1298-4; Okada K, 1998, FEBS LETT, V431, P241, DOI 10.1016/S0014-5793(98)00753-4; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108; Saiki R, 2005, FEBS J, V272, P5606, DOI 10.1111/j.1742-4658.2005.04956.x; Saiki R, 2003, BIOFACTORS, V18, P229, DOI 10.1002/biof.5520180225; Saiki R, 2003, EUR J BIOCHEM, V270, P4113, DOI 10.1046/j.1432-1033.2003.03804.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Suzuki K, 1997, J BIOCHEM, V121, P496; Tay Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055041; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Uchida N, 2000, J BACTERIOL, V182, P6933, DOI 10.1128/JB.182.24.6933-6939.2000; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Zhang M, 2008, FEBS J, V275, P3653, DOI 10.1111/j.1742-4658.2008.06510.x; Zhang M, 2008, BIOFACTORS, V32, P91, DOI 10.1002/biof.5520320111	50	43	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99038	10.1371/journal.pone.0099038	http://dx.doi.org/10.1371/journal.pone.0099038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911838	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600037
J	Hutchinson, JN; Raj, T; Fagerness, J; Stahl, E; Viloria, FT; Gimelbrant, A; Seddon, J; Daly, M; Chess, A; Plenge, R				Hutchinson, John N.; Raj, Towfique; Fagerness, Jes; Stahl, Eli; Viloria, Fernando T.; Gimelbrant, Alexander; Seddon, Johanna; Daly, Mark; Chess, Andrew; Plenge, Robert			Allele-Specific Methylation Occurs at Genetic Variants Associated with Complex Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; SUSCEPTIBILITY LOCI; COMMON VARIANTS; METAANALYSIS; EXPRESSION; RISK; TWIN; AGE; POLYMORPHISM	We hypothesize that the phenomenon of allele-specific methylation (ASM) may underlie the phenotypic effects of multiple variants identified by Genome-Wide Association studies (GWAS). We evaluate ASM in a human population and document its genome-wide patterns in an initial screen at up to 380,678 sites within the genome, or up to 5% of the total genomic CpGs. We show that while substantial inter-individual variation exists, 5% of assessed sites show evidence of ASM in at least six samples; the majority of these events (81%) are under genetic influence. Many of these cis-regulated ASM variants are also eQTLs in peripheral blood mononuclear cells and monocytes and/or in high linkage-disequilibrium with variants linked to complex disease. Finally, focusing on autoimmune phenotypes, we extend this initial screen to confirm the association of cis-regulated ASM with multiple complex disease-associated variants in an independent population using next-generation bisulfite sequencing. These four variants are implicated in complex phenotypes such as ulcerative colitis and AIDS progression disease (rs10491434), Celiac disease (rs2762051), Crohn's disease, IgA nephropathy and early-onset inflammatory bowel disease (rs713875) and height (rs6569648). Our results suggest cis-regulated ASM may provide a mechanistic link between the non-coding genetic changes and phenotypic variation observed in these diseases and further suggests a route to integrating DNA methylation status with GWAS results.	[Hutchinson, John N.; Stahl, Eli; Plenge, Robert] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Hutchinson, John N.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Raj, Towfique; Viloria, Fernando T.] Broad Inst, Cambridge, MA USA; [Raj, Towfique] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Fagerness, Jes; Daly, Mark] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Gimelbrant, Alexander] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Gimelbrant, Alexander] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Seddon, Johanna] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA; [Seddon, Johanna] Tufts Med Ctr, Ophthalm Epidemiol & Genet Serv, Boston, MA USA; [Chess, Andrew] Mt Sinai Sch Med, Friedman Brain Inst, Dept Genet & Genom Sci, Fishberg Dept Neurosci,Dept Dev & Regenerat Biol, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Tufts University; Tufts Medical Center; Icahn School of Medicine at Mount Sinai	Hutchinson, JN (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA.	jhutchin@hsph.harvard.edu	Hutchinson, John/AAA-1976-2020; Daly, Mark J/B-2453-2017; Raj, Towfique/ABD-7620-2021	Hutchinson, John/0000-0002-7804-7576; Daly, Mark J/0000-0002-0949-8752; Gimelbrant, Alexander/0000-0001-6986-0285	NIH [R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648]; Burroughs Wellcome Fund; National Institutes of Health, Bethesda, MD [R01-EY11309]; Massachusetts Lions Eye Research Fund, Inc.; Research to Prevent Blindness, Inc., New York, NY; American Macular Degeneration Foundation, Northampton, MA;  [RC2-GM093080]; NATIONAL EYE INSTITUTE [R01EY011309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059648, R01AR056768, R01AR057108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093080, U01GM092691] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research Fund, Inc.; Research to Prevent Blindness, Inc., New York, NY(Research to Prevent Blindness (RPB)); American Macular Degeneration Foundation, Northampton, MA; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RMP was supported by grants from the NIH (R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648) and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. The PhenoGenetic Project of Brigham and Women's Hospital was supported by RC2-GM093080. JS was supported in part by Grants R01-EY11309 from the National Institutes of Health, Bethesda, MD; Massachusetts Lions Eye Research Fund, Inc.; Unrestricted grant from Research to Prevent Blindness, Inc., New York, NY; the American Macular Degeneration Foundation, Northampton, MA; donations to the Macular Degeneration Research Fund of the Ophthalmic Epidemiology and Genetics Service, New England Eye Center, Tufts Medical Center, Tufts University School of Medicine, Boston, MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Aranyi T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-431; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Boumber YA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000162; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Consortium TIS, 2009, NATURE, V460, P748; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Hellman A, 2007, SCIENCE, V147; Hellman A, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-11; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; JABLON S, 1967, AM J HUM GENET, V19, P133; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kang MY, 2008, CANCER-AM CANCER SOC, V112, P1699, DOI 10.1002/cncr.23335; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Limou S, 2012, CURR HIV RES, V10, P143, DOI 10.2174/157016212799937209; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Naukkarinen J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000976; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, AM J HUM GENET, V92, P517; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Stepanow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017711; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Tycko B, 2010, AM J HUM GENET, V86, P109, DOI 10.1016/j.ajhg.2010.01.021; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zeller T, PLOS ONE, V5; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438	49	30	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98464	10.1371/journal.pone.0098464	http://dx.doi.org/10.1371/journal.pone.0098464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911414	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600006
J	Pertusa, M; Gonzalez, A; Hardy, P; Madrid, R; Viana, F				Pertusa, Maria; Gonzalez, Alejandro; Hardy, Paulina; Madrid, Rodolfo; Viana, Felix			Bidirectional Modulation of Thermal and Chemical Sensitivity of TRPM8 Channels by the Initial Region of the N-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; ENDOPLASMIC-RETICULUM; CATION CHANNEL; COLD; RECEPTOR; PREDICTION; TEMPERATURE; REVEALS; ACTIVATION; PROTEINS	TRPM8, a nonselective cation channel activated by cold, voltage, and cooling compounds such as menthol, is the principal molecular detector of cold temperatures in primary sensory neurons of the somatosensory system. The N-terminal domain of TRPM8 consists of 693 amino acids, but little is known about its contribution to channel function. Here, we identified two distinct regions within the initial N terminus of TRPM8 that contribute differentially to channel activity and proper folding and assembly. Deletion or substitution of the first 40 residues yielded channels with augmented responses to cold and menthol. The thermal threshold of activation of these mutants was shifted 2 degrees C to higher temperatures, and the menthol dose-response curve was displaced to lower concentrations. Site-directed mutagenesis screening revealed that single point mutations at positions Ser-26 or Ser-27 by proline caused a comparable increase in the responses to cold and menthol. Electrophysiological analysis of the S27P mutant revealed that the enhanced sensitivity to agonists is related to a leftward shift in the voltage dependence of activation, increasing the probability of channel openings at physiological membrane potentials. In addition, we found that the region encompassing positions 40-60 is a key element in the proper folding and assembly of TRPM8. Different deletions and mutations within this region rendered channels with an impaired function that are retained within the endoplasmic reticulum. Our results suggest a critical contribution of the initial region of the N-terminal domain of TRPM8 to thermal and chemical sensitivity and the proper biogenesis of this polymodal ion channel.	[Pertusa, Maria; Gonzalez, Alejandro; Hardy, Paulina; Madrid, Rodolfo] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago 9160000, Chile; [Pertusa, Maria; Viana, Felix] Univ Miguel Hernandez, Inst Neurociencias Alicante, Consejo Super Invest Cient, Alicante 03550, Spain	Universidad de Santiago de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Pertusa, M (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago 9160000, Chile.	maria.pertusa@usach.cl	Viana, Felix/U-8533-2017; Gonzalez, Alejandro/AAG-4444-2020	Viana, Felix/0000-0003-1439-949X; Gonzalez, Alejandro/0000-0001-7513-2516; Madrid, Rodolfo/0000-0002-8623-5761; Pertusa, Maria/0000-0003-3856-9019	Chilean Fondo Nacional de Ciencia y Tecnologia [11130144, 3110128, 1131064]; Comision Nacional de Investigacion Cientifica y Tecnologica [ACT-1113]; Spanish Ministerio de Ciencia e Innovacion [SAF2010-14990, SAF2013-4608-R]; DICYT-VRIDEI of the University of Santiago de Chile	Chilean Fondo Nacional de Ciencia y Tecnologia; Comision Nacional de Investigacion Cientifica y Tecnologica; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); DICYT-VRIDEI of the University of Santiago de Chile	This work was supported by Chilean Fondo Nacional de Ciencia y Tecnologia Grants 11130144 and 3110128 (to M. P.) and 1131064 (to R. M.), Comision Nacional de Investigacion Cientifica y Tecnologica Grant Anillo ACT-1113 (to R. M. and M. P.), and Spanish Ministerio de Ciencia e Innovacion Projects SAF2010-14990 and SAF2013-4608-R (to F. V.).; Recipient of support from DICYT-VRIDEI of the University of Santiago de Chile. To whom correspondence should be addressed: Dept. de Biologia, Facultad de Quimica y Biologia, Universidad de Santiago de Chile, 9160000 Santiago, Chile. Tel.: 56-2-27181109; E-mail: maria.pertusa@usach.cl.	Almaraz L, 2014, HANDB EXP PHARMACOL, V222, P547, DOI 10.1007/978-3-642-54215-2_22; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bavencoffe A, 2010, J BIOL CHEM, V285, P9410, DOI 10.1074/jbc.M109.069377; Bidaux G, 2012, J BIOL CHEM, V287, P2948, DOI 10.1074/jbc.M111.270256; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Cao CK, 2013, CELL REP, V4, P302, DOI 10.1016/j.celrep.2013.06.022; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Choi UB, 2013, J BIOL CHEM, V288, P22506, DOI 10.1074/jbc.M113.477810; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; de Groot T, 2011, J BIOL CHEM, V286, P32132, DOI 10.1074/jbc.M111.226878; de la Pena E, 2005, J PHYSIOL-LONDON, V567, P415, DOI 10.1113/jphysiol.2005.086546; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Gallego-Sandin S, 2009, J BIOL CHEM, V284, P32591, DOI 10.1074/jbc.M109.019687; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Grieve AG, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005298; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; HENSEL H, 1951, ACTA PHYSIOL SCAND, V22, P96, DOI 10.1111/j.1748-1716.1951.tb00758.x; HEPPELMANN B, 1990, J COMP NEUROL, V292, P103, DOI 10.1002/cne.902920107; IRIUCHIJIMA J, 1960, ACTA PHYSIOL SCAND, V49, P267, DOI 10.1111/j.1748-1716.1960.tb01952.x; Janssens A, 2011, J PHYSIOL-LONDON, V589, P4827, DOI 10.1113/jphysiol.2011.216523; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kuhn FJP, 2013, PFLUG ARCH EUR J PHY, V465, P1599, DOI 10.1007/s00424-013-1302-4; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Latorre R, 2011, PHYSIOLOGY, V26, P273, DOI 10.1152/physiol.00004.2011; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lis A, 2005, N-S ARCH PHARMACOL, V371, P315, DOI 10.1007/s00210-005-1050-x; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Madrid R, 2014, CURR TOP MEMBR, V74, P293, DOI 10.1016/B978-0-12-800181-3.00011-7; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; Malkia A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-62; McCoy DD, 2011, AM J PHYSIOL-REG I, V300, pR1278, DOI 10.1152/ajpregu.00631.2010; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Montell C., 2001, SCI STKE, DOI [10.1126/stke.2001,90.re1, DOI 10.1126/STKE.2001,90.RE1]; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Pedretti A, 2009, BBA-BIOMEMBRANES, V1788, P973, DOI 10.1016/j.bbamem.2009.02.007; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Pertusa M., 2012, MUTAGENESIS, P221; Pertusa M, 2012, J BIOL CHEM, V287, P18218, DOI 10.1074/jbc.M111.312645; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Premkumar LS, 2005, J NEUROSCI, V25, P11322, DOI 10.1523/JNEUROSCI.3006-05.2005; Richter D, 2011, J BIOL CHEM, V286, P34234, DOI 10.1074/jbc.M111.278564; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sabnis AS, 2008, AM J RESP CELL MOL, V39, P466, DOI 10.1165/rcmb.2007-0440OC; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stewart AP, 2010, BIOCHEM BIOPH RES CO, V394, P383, DOI 10.1016/j.bbrc.2010.03.027; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Valero M, 2011, PFLUG ARCH EUR J PHY, V461, P99, DOI 10.1007/s00424-010-0895-0; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Vazquez E, 2006, SEMIN CELL DEV BIOL, V17, P607, DOI 10.1016/j.semcdb.2006.11.004; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146; Zhang XM, 2012, NAT CELL BIOL, V14, P850, DOI 10.1038/ncb2529	78	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21828	21843		10.1074/jbc.M114.565994	http://dx.doi.org/10.1074/jbc.M114.565994			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24917670	Green Published, hybrid			2022-12-25	WOS:000340593500003
J	Tao, WJ; Leng, XH; Chakraborty, SN; Ma, H; Arlinghaus, RB				Tao, Wenjing; Leng, Xiaohong; Chakraborty, Sandip N.; Ma, Helen; Arlinghaus, Ralph B.			c-Abl Activates Janus Kinase 2 in Normal Hematopoietic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAK2 TYROSINE KINASE; COLONY-STIMULATING FACTOR; FAMILY KINASES; ONCOGENIC ACTIVATION; POLYCYTHEMIA-VERA; CYTOKINE RECEPTOR; MUTATION; GROWTH; LEUKEMIA; BCR	Jak2 is involved in cytokine growth factor-stimulated signal transduction, but the mechanism of its activation is largely unknown. Here, we investigated Jak2 activation in a normal hematopoietic cell line, 32D mouse myeloid cells. The bimolecular fluorescence complementation studies showed that c-Abl formed a stable complex with Jak2 in live cells. Co-immunoprecipitation results showed that c-Abl bound to the beta c chain of IL-3/IL-5/GM-CSF receptors. The kinase activities of both c-Abl and Jak2 were stimulated by IL-3 in 32D cells. Decreasing c-Abl protein expression in 32D cells by inducible shRNA decreased Jak2 activity and resulted in the failure of Jak2 activation in response to IL-3. Treatment of IL-3 and serum-starved 32D cells with 1 mu M imatinib mysylate inhibited IL-3 stimulated kinase activities of both c-Abl and Jak2. In addition, the kinase-deficient Bcr-Abl mutant (p210K1172R) was defective for activation of Jak2 in 32D cells and impaired IL-3 independent growth, which was rescued by overexpression of c-Abl (+Abl). IL-3 efficiently inhibited apoptosis of 32Dp210K/R + Abl cells induced by imatinib mysylate but not Jak2 kinase inhibitor TG101209. In summary, our findings provide evidence that the kinase function of c-Abl and its C-terminal CT4 region is crucial for its interaction with Jak2 and its activation. c-Abl kinase activity induced by IL-3 is required for IL-3-stimulated Jak2 and Jak1 activation. Our findings reveal a novel regulatory role of c-Abl in Jak2 activation induced by IL-3 cytokine growth factor in 32D hematopoietic cells.	[Tao, Wenjing; Leng, Xiaohong; Chakraborty, Sandip N.; Ma, Helen; Arlinghaus, Ralph B.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Arlinghaus, RB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Unit 951, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rarlingh@mdanderson.org			National Institutes of Health from NCI [CA P01 49639]; NATIONAL CANCER INSTITUTE [P01CA049639] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA P01 49639, Project 5, from NCI.	ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; CAMPBELL GS, 1994, P NATL ACAD SCI USA, V91, P5232, DOI 10.1073/pnas.91.12.5232; Chakraborty S, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.41; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dey R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005188; Glover RT, 2000, J BIOL CHEM, V275, P12725, DOI 10.1074/jbc.275.17.12725; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Herrington J, 2001, TRENDS ENDOCRIN MET, V12, P252, DOI 10.1016/S1043-2760(01)00423-4; Huang HM, 2005, J CELL BIOCHEM, V96, P361, DOI 10.1002/jcb.20513; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kirk Rebecca, 2012, Nat Rev Clin Oncol, V9, P608, DOI 10.1038/nrclinonc.2012.174; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krempler A, 2004, GENESIS, V40, P52, DOI 10.1002/gene.20063; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Ling XY, 2003, CANCER RES, V63, P298; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Malinge S, 2007, BLOOD, V109, P2202, DOI 10.1182/blood-2006-09-045963; Mercher T, 2006, BLOOD, V108, P2770, DOI 10.1182/blood-2006-04-014712; Moresco E. M, 2006, ABL FAMILY KINASES D, V1-120; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Pradhan A, 2010, J BIOL CHEM, V285, P16651, DOI 10.1074/jbc.M109.071191; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Samanta A, 2011, LEUKEMIA, V25, P463, DOI 10.1038/leu.2010.287; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Samanta AK, 2006, CANCER RES, V66, P6468, DOI 10.1158/0008-5472.CAN-06-0025; Sandberg EM, 2004, CELL BIOCHEM BIOPHYS, V41, P207, DOI 10.1385/CBB:41:2:207; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; Silvennoinen O, 2013, BIOCHEM SOC T, V41, P1002, DOI 10.1042/BST20130005; Tao WJ, 2008, ONCOGENE, V27, P3194, DOI 10.1038/sj.onc.1210979; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao H, 2014, ONCOGENE, V33, P1429, DOI 10.1038/onc.2013.84; Zipfel PA, 2000, J IMMUNOL, V165, P6872, DOI 10.4049/jimmunol.165.12.6872	57	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21463	21472		10.1074/jbc.M114.554501	http://dx.doi.org/10.1074/jbc.M114.554501			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24923444	hybrid, Green Published			2022-12-25	WOS:000340558300024
J	Fujinaga, K; Luo, ZP; Peterlin, BM				Fujinaga, Koh; Luo, Zeping; Peterlin, B. Matija			Genetic Analysis of the Structure and Function of 7SK Small Nuclear Ribonucleoprotein (snRNP) in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR-B; LONG TERMINAL REPEAT; BROMODOMAIN PROTEIN BRD4; P-TEFB; TRANSCRIPTION ELONGATION; POSITIVE TRANSCRIPTION; HIV-1 TAT; NASCENT RNA; CYCLIN T1	The positive transcription elongation factor b (P-TEFb), comprised of cyclin-dependent kinase 9 (CDK9) and cyclins T1 (CycT1) or T2 (CycT2), activates eukaryotic transcription elongation. In growing cells, P-TEFb exists in active and inactive forms. In the latter, it is incorporated into the 7SK small nuclear ribonucleoprotein, which contains hexamethylene bisacetamide-induced proteins (HEXIM) 1 or 2, La-related protein 7 (LaRP7), methyl phosphate capping enzyme, and 7SK small nuclear RNA (7SK). HEXIM1 inhibits the kinase activity of CDK9 via interactions between 7SK, HEXIM1, and CycT1. LaRP7 and methyl phosphate capping enzyme interact with 7SK independently of HEXIM1 and P-TEFb. To analyze genetic interactions between HEXIM1 and/or LaRP7 and 7SK using a cell-based system, we established artificial heterologous RNA tethering assays in which reporter gene expression depended on interactions between selected regions of 7SK and its cognate binding partners fused to a strong activator. This system enabled us to map the HEXIM1- and LaRP7-binding regions of 7SK. Assays with various mutant 7SK plasmid targets revealed that the 5' U-U bulge and central loop of stem-loop I or RNA motif 3 of 7SK are required for transactivation, suggesting that HEXIM1 and CycT1 form a combinatorial binding surface for 7SK. Moreover, a region in HEXIM1 C-terminal to its previously mapped RNA-binding motif was also required for interactions between HEXIM1 and 7SK. Finally, a tyrosine-to-alanine mutation in HEXIM1, which is critical for its inhibitory effect on CDK9, changed HEXIM1 into an activator. These cell-based assays elucidate this important aspect of transcription elongation in vivo.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Peterlin, BM (corresponding author), Univ Calif San Francisco, Rm U432,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu			National Institute of Health CARE Center [U19 AI076113]; HARC Center [P50 GM082250, AI076113]; American Foundation of AIDS [108241-51-RGRL]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049104, U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	National Institute of Health CARE Center; HARC Center; American Foundation of AIDS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institute of Health CARE Center Grant U19 AI076113, HARC Center Grant P50 GM082250, and Grant AI076113 (to B. M. P.). This work was also supported by American Foundation of AIDS Research Grant 108241-51-RGRL (to K. F.).	Barboric M, 2005, EMBO J, V24, P4291, DOI 10.1038/sj.emboj.7600883; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Barrandon C, 2007, MOL CELL BIOL, V27, P6996, DOI 10.1128/MCB.00975-07; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Belanger F, 2009, J MOL BIOL, V386, P1094, DOI 10.1016/j.jmb.2009.01.015; Bieniasz PD, 1999, P NATL ACAD SCI USA, V96, P7791, DOI 10.1073/pnas.96.14.7791; Bigalke JM, 2011, J MOL BIOL, V414, P639, DOI 10.1016/j.jmb.2011.10.022; Blazek D, 2005, NUCLEIC ACIDS RES, V33, P7000, DOI 10.1093/nar/gki997; Byers SA, 2005, J BIOL CHEM, V280, P16360, DOI 10.1074/jbc.M500424200; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Egloff S, 2006, MOL CELL BIOL, V26, P630, DOI 10.1128/MCB.26.2.630-642.2006; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Fujinaga K, 2002, J VIROL, V76, P10873, DOI 10.1128/JVI.76.21.10873-10881.2002; Fujinaga K, 1999, P NATL ACAD SCI USA, V96, P1285, DOI 10.1073/pnas.96.4.1285; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Fujinaga K, 2012, NUCLEIC ACIDS RES, V40, P9160, DOI 10.1093/nar/gks682; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; He NH, 2011, J NEUROIMMUNE PHARM, V6, P260, DOI 10.1007/s11481-011-9267-6; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lebars I, 2010, NUCLEIC ACIDS RES, V38, P7749, DOI 10.1093/nar/gkq660; Li QT, 2007, NUCLEIC ACIDS RES, V35, P2503, DOI 10.1093/nar/gkm150; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; LU XB, 1993, J VIROL, V67, P1752, DOI 10.1128/JVI.67.4.1752-1760.1993; Marz M, 2009, MOL BIOL EVOL, V26, P2821, DOI 10.1093/molbev/msp198; McNamara RP, 2013, CELL REP, V5, P1256, DOI 10.1016/j.celrep.2013.11.003; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Muniz L, 2013, NUCLEIC ACIDS RES, V41, P4686, DOI 10.1093/nar/gkt159; Muniz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001152; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Peterlin BM, 2010, CELL CYCLE, V9, P2933, DOI 10.4161/cc.9.15.12698; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Richter S, 2002, P NATL ACAD SCI USA, V99, P7928, DOI 10.1073/pnas.122119999; Richter S, 2002, BIOCHEMISTRY-US, V41, P6391, DOI 10.1021/bi0159579; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; SELBY MJ, 1989, GENE DEV, V3, P547, DOI 10.1101/gad.3.4.547; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; SOUTHGATE C, 1990, NATURE, V345, P640, DOI 10.1038/345640a0; TILEY LS, 1992, GENE DEV, V6, P2077, DOI 10.1101/gad.6.11.2077; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5	54	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21181	21190		10.1074/jbc.M114.557751	http://dx.doi.org/10.1074/jbc.M114.557751			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24917669	hybrid, Green Published			2022-12-25	WOS:000339396600067
J	Puig-Oliveras, A; Ramayo-Caldas, Y; Corominas, J; Estelle, J; Perez-Montarelo, D; Hudson, NJ; Casellas, J; Folch, JM; Ballester, M				Puig-Oliveras, Anna; Ramayo-Caldas, Yuliaxis; Corominas, Jordi; Estelle, Jordi; Perez-Montarelo, Dafne; Hudson, Nicholas J.; Casellas, Joaquim; Folch, Josep M.; Ballester, Maria			Differences in Muscle Transcriptome among Pigs Phenotypically Extreme for Fatty Acid Composition	PLOS ONE			English	Article							EXPRESSION ANALYSIS; ADIPOSE-TISSUE; SKELETAL-MUSCLE; GENE-EXPRESSION; LONGISSIMUS-DORSI; MEAT QUALITY; METABOLISM; DEPOSITION; PHOSPHOLIPIDS; ASSOCIATIONS	Backgroud: Besides having an impact on human health, the porcine muscle fatty acid profile determines meat quality and taste. The RNA-Seq technologies allowed us to explore the pig muscle transcriptome with an unprecedented detail. The aim of this study was to identify differentially-expressed genes between two groups of 6 sows belonging to an Iberian 6 Landrace backcross with extreme phenotypes according to FA profile. Results: We sequenced the muscle transcriptome acquiring 787.5 M of 75 bp paired-end reads. About 85.1% of reads were mapped to the reference genome. Of the total reads, 79.1% were located in exons, 6.0% in introns and 14.9% in intergenic regions, indicating expressed regions not annotated in the reference genome. We identified a 34.5% of the intergenic regions as interspersed repetitive regions. We predicted a total of 2,372 putative proteins. Pathway analysis with 131 differentially-expressed genes revealed that the most statistically-significant metabolic pathways were related with lipid metabolism. Moreover, 18 of the differentially-expressed genes were located in genomic regions associated with IMF composition in an independent GWAS study in the same genetic background. Thus, our results indicate that the lipid metabolism of FAs is differently modulated when the FA composition in muscle differs. For instance, a high content of PUFA may reduce FA and glucose uptake resulting in an inhibition of the lipogenesis. These results are consistent with previous studies of our group analysing the liver and the adipose tissue transcriptomes providing a view of each of the main organs involved in lipid metabolism. Conclusions: The results obtained in the muscle transcriptome analysis increase the knowledge of the gene regulation of IMF deposition, FA profile and meat quality, in terms of taste and nutritional value. Besides, our results may be important in terms of human health.	[Puig-Oliveras, Anna; Corominas, Jordi; Folch, Josep M.; Ballester, Maria] Ctr Recerca Agrigen CRAG, Dept Genet Anim, Bellaterra, Spain; [Puig-Oliveras, Anna; Corominas, Jordi; Casellas, Joaquim; Folch, Josep M.; Ballester, Maria] UAB, Dept Ciencia Anim & Aliments, Bellaterra, Spain; [Ramayo-Caldas, Yuliaxis; Estelle, Jordi] INRA, Genet Anim & Biol Integrat GABI UMR1313, Jouy En Josas, France; [Estelle, Jordi] AgroParisTech, Genet Anim & Biol Integrat GABI UMR1313, Jouy En Josas, France; [Estelle, Jordi] Commissariat Energie Atom & Energies Alternat CEA, LREG, Jouy En Josas, France; [Perez-Montarelo, Dafne] Inst Nacl Invest Tecnol Agr & Alimentaria INIA, Dept Genet Anim, Madrid, Spain; [Hudson, Nicholas J.] Commonwealth Sci & Ind Res Org CSIRO, Food & Hlth SciencesQLD, Brisbane, Qld, Australia; [Casellas, Joaquim] IRTA, Dept Genet & Millora Anim, Lleida, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); Autonomous University of Barcelona; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Cite; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Commonwealth Scientific & Industrial Research Organisation (CSIRO); IRTA	Puig-Oliveras, A (corresponding author), Ctr Recerca Agrigen CRAG, Dept Genet Anim, Bellaterra, Spain.	anna.puig@cragenomica.es	Corominas Galbany, Jordi/B-6356-2018; Hudson, Nick/C-1201-2008; Ballester, Maria/E-7201-2016; Puig Oliveras, Anna/M-5551-2015; Estellé, Jordi/A-7976-2008; Folch, Josep M/I-4738-2015; Devis, Maria Ballester/AAV-2467-2020; Caldas, Yuliaxis Ramayo/B-6337-2014; Hudson, Nick/AAF-5644-2020; Hudson, Nicholas J/D-1606-2011	Corominas Galbany, Jordi/0000-0003-1736-1278; Ballester, Maria/0000-0002-5413-4640; Puig Oliveras, Anna/0000-0003-2551-9012; Estellé, Jordi/0000-0002-6241-1732; Folch, Josep M/0000-0003-3689-1303; Devis, Maria Ballester/0000-0002-5413-4640; Caldas, Yuliaxis Ramayo/0000-0002-8142-0159; Hudson, Nick/0000-0002-3549-9396; Hudson, Nicholas J/0000-0002-3549-9396; Casellas, Joaquim/0000-0002-4982-3556	MICINN (Ministerio de Economia y Competitividad) [AGL2011-29821-C02]; Innovation Consolider-Ingenio Program [CSD2007-00036]; Personal Investigador en Formacion (PIF) PhD grant from the Universitat Autonoma de Barcelona [458-01-1/2011]; Formacion de Personal Investigador (FPI) PhD grant from Spanish Ministerio de Educacion [BES-2009018223]; Formacion del Profesorado Universitario (FPU) PhD grant [AP2008-01450]	MICINN (Ministerio de Economia y Competitividad); Innovation Consolider-Ingenio Program; Personal Investigador en Formacion (PIF) PhD grant from the Universitat Autonoma de Barcelona; Formacion de Personal Investigador (FPI) PhD grant from Spanish Ministerio de Educacion; Formacion del Profesorado Universitario (FPU) PhD grant(German Research Foundation (DFG))	This work has been funded by MICINN project AGL2011-29821-C02 (Ministerio de Economia y Competitividad) and by the Innovation Consolider-Ingenio 2010 Program (CSD2007-00036). A. Puig-Oliveras was funded by a Personal Investigador en Formacion (PIF) PhD grant from the Universitat Autonoma de Barcelona (458-01-1/2011). J. Corominas was funded by a Formacion de Personal Investigador (FPI) PhD grant from Spanish Ministerio de Educacion (BES-2009018223), Y. Ramayo by a Formacion del Profesorado Universitario (FPU) PhD grant (AP2008-01450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Basco D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058712; Bayorh MA, 2005, CLIN EXP HYPERTENS, V27, P355, DOI 10.1081/CEH-200057423; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bosma M, 2013, BBA-MOL CELL BIOL L, V1831, P844, DOI 10.1016/j.bbalip.2013.01.007; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Chen JX, 2008, DIABETES, V57, P3335, DOI 10.2337/db08-0503; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corominas J, 2013, ANAL PORCINE ADIPOSE; Dai ZL, 2013, BIOFACTORS, V39, P383, DOI 10.1002/biof.1099; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Damon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033763; Estany J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086177; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Estevez M, 2003, MEAT SCI, V64, P499, DOI 10.1016/S0309-1740(02)00228-0; FAO, 2008, REPORT EXPERT CONSUL, VVolume 91, P180; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Hamill RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-453; He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jiang ZH, 2008, INT J BIOL SCI, V4, P345, DOI 10.7150/ijbs.4.345; Jung WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042198; Kubota T, 2013, REV ENDOCR METAB DIS, V14, P207, DOI 10.1007/s11154-013-9242-z; Lagace TA, 2013, BBA-MOL CELL RES, V1833, P2499, DOI 10.1016/j.bbamcr.2013.05.018; Leonardini A, 2009, PPAR RES, V2009, DOI 10.1155/2009/818945; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Luo J, 2006, CELL METAB, V3, P355, DOI 10.1016/j.cmet.2006.04.003; Madeira MS, 2013, BRIT J NUTR, V110, P216, DOI 10.1017/S0007114512004916; Maharani D, 2013, MOL BIOL REP, V40, P73, DOI 10.1007/s11033-012-2014-0; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Merlot E, 2012, ANIMAL, V6, P1290, DOI 10.1017/S1751731112000080; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munoz M, 2013, GENOME WIDE ANAL POR; Novgorodtseva TP, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-18; Oubaha M, 2009, BLOOD, V114, P3343, DOI 10.1182/blood-2008-12-196584; Pena RN, 2013, ANIM GENET, V44, P648, DOI 10.1111/age.12066; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Reiter SS, 2007, COMP BIOCHEM PHYS D, V2, P200, DOI 10.1016/j.cbd.2007.04.008; Renaville B, 2013, MEAT SCI, V93, P495, DOI 10.1016/j.meatsci.2012.11.019; Revilla M., 2014, Genetics, Selection, Evolution, V46; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Serra X, 1998, LIVEST PROD SCI, V56, P215, DOI 10.1016/S0301-6226(98)00151-1; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Sung HK, 2009, AM J PHYSIOL-ENDOC M, V297, pE402, DOI 10.1152/ajpendo.00122.2009; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Webb EC, 2008, MEAT SCI, V80, P28, DOI 10.1016/j.meatsci.2008.05.029; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Wilkinson S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003453; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Xi Q, 2008, CIRC RES, V102, P1118, DOI 10.1161/CIRCRESAHA.108.173948; Yendrek Craig R, 2012, BMC Res Notes, V5, P506, DOI 10.1186/1756-0500-5-506; Yu KF, 2013, INT J BIOL SCI, V9, P108, DOI 10.7150/ijbs.5306; Zhang S, 2009, J ANIM BREED GENET, V126, P259, DOI 10.1111/j.1439-0388.2008.00782.x; Zhang WA, 2010, MEAT SCI, V86, P15, DOI 10.1016/j.meatsci.2010.04.018; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]	76	46	47	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99720	10.1371/journal.pone.0099720	http://dx.doi.org/10.1371/journal.pone.0099720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926690	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100072
J	Heerah, K; Hindell, M; Guinet, C; Charrassin, JB				Heerah, Karine; Hindell, Mark; Guinet, Christophe; Charrassin, Jean-Benoit			A New Method to Quantify within Dive Foraging Behaviour in Marine Predators	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; AREA-RESTRICTED SEARCH; WEDDELL SEALS; FINE-SCALE; DIVING BEHAVIOR; PREY INTERACTIONS; MIROUNGA-LEONINA; STABLE-ISOTOPES; MOVEMENTS; DEPTH	Studies on diving behaviour classically divide a dive into three phases: the descent, bottom and ascent phases, with foraging assumed to occur during the bottom phase. The greater complexity of dive revealed through modern, high resolution data highlights the need to re-assess this approach and to consider a larger number of phases within individual dives. Two southern elephant seals (SES) were fitted with a head mounted Time Depth Recorder (TDR) and an accelerometer from which prey capture attempts were estimated. A Weddell seal was also fitted with a TDR. TDRs for both species recorded depth once per second. We quantified the within dive behaviour using an automated broken stick algorithm identifying the optimal number of segments within each dive. The vertical sinuosity of the segments was used to infer two types of behaviours, with highly sinuous segments indicating "hunting" and less sinuous segments indicating "transiting". Using the broken stick method the seals alternated between "hunting" and "transit" modes with an average of 6 +/- 2 and 7 +/- 0.02 behavioural phases within each dive for the Weddell seal and SES, respectively. In SES, 77% of prey capture attempts (identified from the acceleration data) occurred in highly sinuous phases ("hunting'') as defined by our new approach. SES spent more time in transit mode within a dive, and hunting mostly occurred during the bottom phase. Conversely the Weddell seal spent more time in hunting mode which also occurred during bottom phase but occurred mostly at shallower depths. Such differences probably reflect different foraging tactics and habitat use. For both species, hunting time differs significantly from bottom time previously used as a proxy for the time spent foraging in a dive. The hunting time defined by our method therefore provides a more accurate fine-scale description of the seals' foraging behaviour.	[Heerah, Karine; Charrassin, Jean-Benoit] MNHN, IRD, CNRS, Lab Oceanog & Climat Experimentat & Approches Num, Paris, France; [Heerah, Karine; Hindell, Mark] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Hindell, Mark] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Guinet, Christophe] Ctr Etud Biol Chize, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Tasmania; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania	Heerah, K (corresponding author), MNHN, IRD, CNRS, Lab Oceanog & Climat Experimentat & Approches Num, Paris, France.	karine.heerah@hotmail.fr	Guinet, Christophe/AAR-8457-2020	Hindell, Mark/0000-0002-7823-7185	Australian Antarctic Science grant (AAS) [2794]; Terre-Ocean-Surface Continentale-Atmosphere from Centre National d'Etudes Spatiales (TOSCA-CNES)	Australian Antarctic Science grant (AAS); Terre-Ocean-Surface Continentale-Atmosphere from Centre National d'Etudes Spatiales (TOSCA-CNES)	This study was supported by an Australian Antarctic Science grant (AAS project 2794), and program Terre-Ocean-Surface Continentale-Atmosphere from Centre National d'Etudes Spatiales (TOSCA-CNES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Goff Virginia, 2010, Endangered Species Research, V10, P83, DOI 10.3354/esr00257; Bailleul F, 2008, J ANIM ECOL, V77, P948, DOI 10.1111/j.1365-2656.2008.01407.x; Bailleul F, 2007, DEEP-SEA RES PT II, V54, P343, DOI 10.1016/j.dsr2.2006.11.005; Bailleul F, 2010, ECOGRAPHY, V33, P709, DOI 10.1111/j.1600-0587.2009.06034.x; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bost CA, 2007, DEEP-SEA RES PT II, V54, P248, DOI 10.1016/j.dsr2.2006.11.007; Burns JM, 1998, POLAR BIOL, V19, P272, DOI 10.1007/s003000050245; CASTELLINI MA, 1992, J EXP BIOL, V165, P181; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673; CORNET A, 1980, MAMMALIA, V44, P497, DOI 10.1515/mamm.1980.44.4.497; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Davis RW, 2012, DEEP SEA RES 2; Dragon A. C., 2011, MODELISATION STRATEG; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Dragon AC, 2012, MAR ECOL PROG SER, V447, P243, DOI 10.3354/meps09498; Evans K, 2012, DEEP SEA RES 2; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2002, MAR ECOL PROG SER, V231, P279, DOI 10.3354/meps231279; Fauchald P, 2000, ECOLOGY, V81, P773, DOI 10.1890/0012-9658(2000)081[0773:SDPPIT]2.0.CO;2; Fedak MA, 2001, MAR MAMMAL SCI, V17, P94, DOI 10.1111/j.1748-7692.2001.tb00982.x; Field IC, 2002, VET REC, V151, P235, DOI 10.1136/vr.151.8.235; Fuiman LA, 2002, MAR BIOL, V140, P815, DOI 10.1007/s00227-001-0752-y; Fuiman LA, 2007, DEEP-SEA RES PT II, V54, P270, DOI 10.1016/j.dsr2.2006.11.011; Gallon S, 2012, DEEP SEA RES 2; GREEN K, 1987, AUST WILDLIFE RES, V14, P475; Guinet C, 2014, MAR ECOL PROG SER, V499, P285, DOI 10.3354/meps10660; Hanuise N, 2010, J EXP BIOL, V213, P3874, DOI 10.1242/jeb.044057; Harcourt RG, 2000, POLAR BIOL, V23, P479, DOI 10.1007/s003000000109; Heerah K, 2013, DEEP SEA RES 2; Hindell MA, 2002, MAR ECOL PROG SER, V242, P275, DOI 10.3354/meps242275; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; Hindell MA, 2010, FORAGING BEHAV MARIN, P241; Hocking DP, 2013, POLAR BIOL, V36, P211, DOI 10.1007/s00300-012-1253-9; Horsburgh JM, 2008, MAR MAMMAL SCI, V24, P207, DOI 10.1111/j.1748-7692.2007.00156.x; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kooyman GL, 1968, ANTARCT RES SER, V3, P227; Lake S, 2003, MAR ECOL PROG SER, V254, P293, DOI 10.3354/meps254293; LEBOEUF BJ, 1988, CAN J ZOOL, V66, P446, DOI 10.1139/z88-064; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Marshall CD, 2008, J EXP BIOL, V211, P699, DOI 10.1242/jeb.009852; Mcintyre T, 2012, ANTARCT SCI, V24, P561, DOI 10.1017/S0954102012000570; Millot G.., 2011, COMPRENDRE R ALISER, V2; Mitani Y, 2004, MAR ECOL PROG SER, V281, P275, DOI 10.3354/meps281275; Mitani Y, 2003, POLAR BIOL, V26, P311, DOI 10.1007/s00300-003-0487-y; Moline MA, 2008, ANN NY ACAD SCI, V1134, P267, DOI 10.1196/annals.1439.010; Naito Y, 2010, POLAR SCI, V4, P309, DOI 10.1016/j.polar.2010.05.009; Naito Y, 2013, FUNCT ECOL, V27, P710, DOI 10.1111/1365-2435.12083; Plotz J, 2001, POLAR BIOL, V24, P901, DOI 10.1007/s003000100297; R Core Team, 2022, R LANG ENV STAT COMP; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Sato K, 2008, J EXP BIOL, V211, P58, DOI 10.1242/jeb.009811; Scheffer A, 2012, MAR ECOL PROG SER, V465, P281, DOI 10.3354/meps09884; Schreer JF, 1996, MAR MAMMAL SCI, V12, P227, DOI 10.1111/j.1748-7692.1996.tb00573.x; Schreer JF, 2001, ECOL MONOGR, V71, P137, DOI 10.1890/0012-9615(2001)071[0137:CDPOPA]2.0.CO;2; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Simpkins MA, 2001, MAR MAMMAL SCI, V17, P909, DOI 10.1111/j.1748-7692.2001.tb01305.x; Suzuki I, 2009, POLAR BIOL, V32, P667, DOI 10.1007/s00300-009-0596-3; TESTA JW, 1994, CAN J ZOOL, V72, P1700, DOI 10.1139/z94-229; Thums M, 2013, J ANIM ECOL, V82, P72, DOI 10.1111/j.1365-2656.2012.02021.x; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Watanabe Y, 2003, MAR ECOL PROG SER, V252, P283, DOI 10.3354/meps252283; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Wheatley Kathryn E, 2006, BMC Vet Res, V2, P8, DOI 10.1186/1746-6148-2-8; Zimmer I, 2010, AQUAT BIOL, V8, P269, DOI 10.3354/ab00213	68	30	30	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99329	10.1371/journal.pone.0099329	http://dx.doi.org/10.1371/journal.pone.0099329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922323	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300050
J	Jensen, HA; Bunaciu, RP; Ibabao, CN; Myers, R; Varner, JD; Yen, A				Jensen, Holly A.; Bunaciu, Rodica P.; Ibabao, Christopher N.; Myers, Rebecca; Varner, Jeffrey D.; Yen, Andrew			Retinoic Acid Therapy Resistance Progresses from Unilineage to Bilineage in HL-60 Leukemic Blasts	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; LIGAND-BINDING DOMAIN; CELL-DIFFERENTIATION; MONOCYTIC DIFFERENTIATION; RAR-ALPHA; MYELOID DIFFERENTIATION; INCREASED SENSITIVITY; VITAMIN-D-3 ANALOGS; EXPRESSION; ACTIVATION	Emergent resistance can be progressive and driven by global signaling aberrations. All-trans retinoic acid (RA) is the standard therapeutic agent for acute promyelocytic leukemia, but 10-20% of patients are not responsive, and initially responsive patients relapse and develop retinoic acid resistance. The patient-derived, lineage-bipotent acute myeloblastic leukemia (FAB M2) HL-60 cell line is a potent tool for characterizing differentiation-induction therapy responsiveness and resistance in t(15; 17)-negative cells. Wild-type (WT) HL-60 cells undergo RA-induced granulocytic differentiation, or monocytic differentiation in response to 1,25-dihydroxyvitamin D3 (D3). Two sequentially emergent RA-resistant HL-60 cell lines, R38+ and R38-, distinguishable by RA-inducible CD38 expression, do not arrest in G1/G0 and fail to upregulate CD11b and the myeloid-associated signaling factors Vav1, c-Cbl, Lyn, Fgr, and c-Raf after RA treatment. Here, we show that the R38+ and R38- HL-60 cell lines display a progressive reduced response to D3-induced differentiation therapy. Exploiting the biphasic dynamic of induced HL-60 differentiation, we examined if resistance-related defects occurred during the first 24 h (the early or "precommitment'' phase) or subsequently (the late or "lineage-commitment'' phase). HL-60 were treated with RA or D3 for 24 h, washed and retreated with either the same, different, or no differentiation agent. Using flow cytometry, D3 was able to induce CD38, CD11b and CD14 expression, and G1/G0 arrest when present during the lineage-commitment stage in R38+ cells, and to a lesser degree in R38- cells. Clustering analysis of cytometry and quantified Western blot data indicated that WT, R38+ and R38- HL-60 cells exhibited decreasing correlation between phenotypic markers and signaling factor expression. Thus differentiation induction therapy resistance can develop in stages, with initial partial RA resistance and moderate vitamin D3 responsiveness (unilineage maturation block), followed by bilineage maturation block and progressive signaling defects, notably the reduced expression of Vav1, Fgr, and c-Raf.	[Jensen, Holly A.; Varner, Jeffrey D.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY USA; [Bunaciu, Rodica P.; Yen, Andrew] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA; [Ibabao, Christopher N.] Cornell Univ, Dept Biol, Ithaca, NY USA; [Myers, Rebecca] Rutgers State Univ, Dept Biol, New Brunswick, NJ 08903 USA	Cornell University; Cornell University; Cornell University; Rutgers State University New Brunswick	Yen, A (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA.	ay13@cornell.edu		Bunaciu, Rodica/0000-0002-3101-0928	NIH [R01 CA033505, R01 CA152870]; NIH/PS-OC; NYSTEM NY Dept. Health; Cornell Vertebrate Genomics (VERGE); NSF [CBET-0846876]; Directorate For Engineering [0846876] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA033505, R01CA152870] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/PS-OC; NYSTEM NY Dept. Health; Cornell Vertebrate Genomics (VERGE); NSF(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01 CA033505 and R01 CA152870 from NIH (A.Y.) and NIH/PS-OC (Shuler/A.Y./R.P.B.), NYSTEM NY Dept. Health (A.Y.), Cornell Vertebrate Genomics (VERGE) (R. P. B.), and CBET-0846876 from NSF (J.D.V./H.A.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINS KB, 1995, BLOOD, V86, P2475; Battle TE, 2000, EXP CELL RES, V254, P287, DOI 10.1006/excr.1999.4766; Battle TE, 2001, EUR J CELL BIOL, V80, P59, DOI 10.1078/0171-9335-00141; Bertagnolo V, 2012, CELL SIGNAL, V24, P612, DOI 10.1016/j.cellsig.2011.11.017; Bertagnolo V, 2011, CELL TISSUE RES, V345, P163, DOI 10.1007/s00441-011-1195-5; Brooks SC, 1996, BLOOD, V87, P227; Bunaciu RP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-39; Bunaciu RP, 2011, CANCER RES, V71, P2371, DOI 10.1158/0008-5472.CAN-10-2299; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Cheung FSG, 2012, EXPERT REV ANTICANC, V12, P811, DOI [10.1586/era.12.53, 10.1586/ERA.12.53]; Congleton J, 2012, LEUKEMIA, V26, P1180, DOI 10.1038/leu.2011.390; Dore BT, 1996, LEUKEMIA RES, V20, P761, DOI 10.1016/0145-2126(96)00043-4; DORE BT, 1994, LEUKEMIA, V8, P2179; DORE BT, 1993, LEUKEMIA RES, V17, P749, DOI 10.1016/0145-2126(93)90108-W; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Gallagher RE, 2002, LEUKEMIA, V16, P1940, DOI 10.1038/sj.leu.2402719; Harrison J.S., 2012, LEUK RES TREAT, V2012, DOI DOI 10.1155/2012/125814; HAZIOT A, 1988, J IMMUNOL, V141, P547; Hong HY, 2001, DIFFERENTIATION, V68, P55, DOI 10.1046/j.1432-0436.2001.068001055.x; Hu LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013305; Jensen HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058621; KATAGIRI K, 1991, J IMMUNOL, V146, P701; Koshizuka K, 1999, BREAST CANCER RES TR, V53, P113, DOI 10.1023/A:1006123819675; Kropf PL, 2010, LEUKEMIA, V24, P663, DOI 10.1038/leu.2009.267; Lamkin TJ, 2006, J CELL BIOCHEM, V97, P1328, DOI 10.1002/jcb.20745; MAZZONE A, 1995, HAEMATOLOGICA, V80, P161; Mori J, 1999, JPN J CANCER RES, V90, P660, DOI 10.1111/j.1349-7006.1999.tb00798.x; Muto A, 1999, BLOOD, V93, P2225, DOI 10.1182/blood.V93.7.2225.407a05_2225_2233; NILSSON B, 1984, BRIT J HAEMATOL, V57, P365, DOI 10.1111/j.1365-2141.1984.tb02910.x; NORMAN AW, 1990, CANCER RES, V50, P6857; Oeth P, 1998, BLOOD, V91, P2857, DOI 10.1182/blood.V91.8.2857.2857_2857_2865; PRATT MAC, 1990, MOL CELL BIOL, V10, P6445, DOI 10.1128/MCB.10.12.6445; REBEL VI, 1992, LEUKEMIA RES, V16, P443, DOI 10.1016/0145-2126(92)90169-8; Rego EM, 2001, SEMIN HEMATOL, V38, P54, DOI 10.1053/shem.2001.20865; Reiterer G, 2007, CANCER RES, V67, P7765, DOI 10.1158/0008-5472.CAN-07-0014; Reiterer G, 2006, CANCER RES, V66, P9083, DOI 10.1158/0008-5472.CAN-06-0972; ROBERTSON KA, 1992, BLOOD, V80, P1885; Shao WL, 1997, BLOOD, V89, P4282, DOI 10.1182/blood.V89.12.4282; Shen M, 2011, LEUK LYMPHOMA; Shen MQ, 2009, J BIOL CHEM, V284, P25664, DOI 10.1074/jbc.M109.014241; SKOWRONSKI RJ, 1995, ENDOCRINOLOGY, V136, P20, DOI 10.1210/en.136.1.20; Smith J, 2009, EXP CELL RES, V315, P2241, DOI 10.1016/j.yexcr.2009.03.004; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Wang XN, 2001, J CELL BIOCHEM, V80, P471, DOI 10.1002/1097-4644(20010315)80:4<471::AID-JCB1001>3.0.CO;2-J; WARRELL RP, 1993, BLOOD, V82, P1949, DOI 10.1182/blood.V82.7.1949.bloodjournal8271949; Welch H, 1997, ONCOGENE, V15, P2021, DOI 10.1038/sj.onc.1201356; YEN A, 1984, J CELL PHYSIOL, V118, P277, DOI 10.1002/jcp.1041180310; Yen A, 2000, IN VITRO CELL DEV-AN, V36, P249; YEN A, 1987, CANCER RES, V47, P129; YEN A, 1994, EUR J CELL BIOL, V65, P103; YEN A, 1990, CANCER RES, V50, P1411; YEN A, 1987, EXP CELL RES, V173, P80, DOI 10.1016/0014-4827(87)90333-8; YEN A, 1995, J CELL PHYSIOL, V163, P502, DOI 10.1002/jcp.1041630310; Yen A, 1999, IN VITRO CELL DEV-AN, V35, P527; Yen A, 1998, CANCER RES, V58, P3163; ZHOU JY, 1991, BLOOD, V78, P75; ZINZAR S, 1989, LEUKEMIA RES, V13, P23, DOI 10.1016/0145-2126(89)90027-1	60	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98929	10.1371/journal.pone.0098929	http://dx.doi.org/10.1371/journal.pone.0098929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922062	Green Submitted, gold, Green Published			2022-12-25	WOS:000338701300021
J	Garmendia-Torres, C; Skupin, A; Michael, SA; Ruusuvuori, P; Kuwada, NJ; Falconnet, D; Cary, GA; Hansen, C; Wiggins, PA; Dudley, AM				Garmendia-Torres, Cecilia; Skupin, Alexander; Michael, Sean A.; Ruusuvuori, Pekka; Kuwada, Nathan J.; Falconnet, Didier; Cary, Gregory A.; Hansen, Carl; Wiggins, Paul A.; Dudley, Aimee M.			Unidirectional P-Body Transport during the Yeast Cell Cycle	PLOS ONE			English	Article							CYTOPLASMIC PROCESSING BODIES; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNAS; BUDDING YEAST; PROTEIN LOCALIZATION; SYSTEMS BIOLOGY; GENE DELETION; GRANULES; BUD; IDENTIFICATION	P-bodies belong to a large family of RNA granules that are associated with post-transcriptional gene regulation, conserved from yeast to mammals, and influence biological processes ranging from germ cell development to neuronal plasticity. RNA granules can also transport RNAs to specific locations. Germ granules transport maternal RNAs to the embryo, and neuronal granules transport RNAs long distances to the synaptic dendrites. Here we combine microfluidic-based fluorescent microscopy of single cells and automated image analysis to follow p-body dynamics during cell division in yeast. Our results demonstrate that these highly dynamic granules undergo a unidirectional transport from the mother to the daughter cell during mitosis as well as a constrained "hovering'' near the bud site half an hour before the bud is observable. Both behaviors are dependent on the Myo4p/She2p RNA transport machinery. Furthermore, single cell analysis of cell size suggests that PBs play an important role in daughter cell growth under nutrient limiting conditions.	[Garmendia-Torres, Cecilia] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Skupin, Alexander] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg; [Skupin, Alexander] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Michael, Sean A.; Cary, Gregory A.] Inst Syst Biol, Seattle, WA USA; [Ruusuvuori, Pekka] Tampere Univ Technol, Pori, Finland; [Ruusuvuori, Pekka] Univ Tampere, BioMediTech, Tampere, Finland; [Kuwada, Nathan J.; Wiggins, Paul A.] Univ Washington, Seattle, WA 98195 USA; [Falconnet, Didier; Hansen, Carl] Univ British Columbia, Dept Phys & Astron, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Cary, Gregory A.; Dudley, Aimee M.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Dudley, Aimee M.] Pacific Northwest Diabet Res Inst, Washington, DC USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Luxembourg; University of California System; University of California San Diego; Institute for Systems Biology (ISB); Tampere University; Tampere University; University of Washington; University of Washington Seattle; University of British Columbia; University of Washington; University of Washington Seattle	Dudley, AM (corresponding author), Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA.	aimee.dudley@gmail.com	Ruusuvuori, Pekka/C-9229-2016	Wiggins, Paul/0000-0002-8316-4339; Cary, Gregory/0000-0003-3573-5229; Dudley, Aimee/0000-0003-3644-0625; SKUPIN, Alexander/0000-0002-8955-8304	University of Luxembourg - Institute for Systems Biology Strategic Partnership; U.S. National Institutes of Health (Center for Systems Biology) [P50 GM076547]; Academy of Finland [140052]; Div Of Molecular and Cellular Bioscience [1151043] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	University of Luxembourg - Institute for Systems Biology Strategic Partnership; U.S. National Institutes of Health (Center for Systems Biology)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by the University of Luxembourg - Institute for Systems Biology Strategic Partnership, the U.S. National Institutes of Health (Center for Systems Biology, P50 GM076547) and the Academy of Finland (project #140052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Aizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049783; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; Beucher S., 1993, MATH MORPHOLOGY IMAG, P433, DOI DOI 10.1201/9781482277234-12; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dehlinger D, 2013, BIOTECHNOL BIOENG, V110, P838, DOI 10.1002/bit.24757; Delneri D, 2008, NAT GENET, V40, P113, DOI 10.1038/ng.2007.49; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Falconnet D, 2011, LAB CHIP, V11, P466, DOI [10.1039/c0lc00228c, 10.1039/c01c00228c]; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Fukunaga K, 1990, INTRO STAT PATTERN R; Gaillard H, 2008, MOL BIOL CELL, V19, P4980, DOI 10.1091/mbc.E08-02-0193; Hansen CL, 2004, P NATL ACAD SCI USA, V101, P14431, DOI 10.1073/pnas.0405847101; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iwaki A, 2012, BIOCHEM J, V446, P225, DOI 10.1042/BJ20120583; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Lavut A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002527; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/nmeth.2069, 10.1038/NMETH.2069]; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Ramachandran V, 2011, MOL CELL, V43, P973, DOI 10.1016/j.molcel.2011.06.032; Rose MD., 1990, METHODS YEAST GENETI; Ruusuvuori P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-248; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Voronina E., 2011, COLD SPRING HARB PER, V3; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477	49	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99428	10.1371/journal.pone.0099428	http://dx.doi.org/10.1371/journal.pone.0099428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918601	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000084
J	Karlen, W; Gan, H; Chiu, M; Dunsmuir, D; Zhou, GH; Dumont, GA; Ansermino, JM				Karlen, Walter; Gan, Heng; Chiu, Michelle; Dunsmuir, Dustin; Zhou, Guohai; Dumont, Guy A.; Ansermino, J. Mark			Improving the Accuracy and Efficiency of Respiratory Rate Measurements in Children Using Mobile Devices	PLOS ONE			English	Article								The recommended method for measuring respiratory rate (RR) is counting breaths for 60 s using a timer. This method is not efficient in a busy clinical setting. There is an urgent need for a robust, low-cost method that can help front-line health care workers to measure RR quickly and accurately. Our aim was to develop a more efficient RR assessment method. RR was estimated by measuring the median time interval between breaths obtained from tapping on the touch screen of a mobile device. The estimation was continuously validated by measuring consistency (% deviation from the median) of each interval. Data from 30 subjects estimating RR from 10 standard videos with a mobile phone application were collected. A sensitivity analysis and an optimization experiment were performed to verify that a RR could be obtained in less than 60 s; that the accuracy improves when more taps are included into the calculation; and that accuracy improves when inconsistent taps are excluded. The sensitivity analysis showed that excluding inconsistent tapping and increasing the number of tap intervals improved the RR estimation. Efficiency (time to complete measurement) was significantly improved compared to traditional methods that require counting for 60 s. There was a trade-off between accuracy and efficiency. The most balanced optimization result provided a mean efficiency of 9.9 s and a normalized root mean square error of 5.6%, corresponding to 2.2 breaths/min at a respiratory rate of 40 breaths/min. The obtained 6-fold increase in mean efficiency combined with a clinically acceptable error makes this approach a viable solution for further clinical testing. The sensitivity analysis illustrating the trade-off between accuracy and efficiency will be a useful tool to define a target product profile for any novel RR estimation device.	[Karlen, Walter; Dumont, Guy A.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V5Z 1M9, Canada; [Gan, Heng; Dunsmuir, Dustin; Ansermino, J. Mark] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Chiu, Michelle] Univ British Columbia, Fac Med, Vancouver, BC V5Z 1M9, Canada; [Zhou, Guohai] Univ British Columbia, Dept Stat, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Karlen, W (corresponding author), Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V5Z 1M9, Canada.	walter.karlen@ieee.org	Karlen, Walter/C-6290-2008; Karlen, Walter/AAN-9397-2020	Karlen, Walter/0000-0001-8643-3074; Karlen, Walter/0000-0001-8643-3074; Dumont, Guy/0000-0003-2048-4391; Ansermino, J Mark/0000-0001-8427-2035; Zhou, Guohai/0000-0002-8826-403X; Dunsmuir, Dustin/0000-0001-9717-3685; Gan, Heng/0000-0003-2894-9114	Swiss National Science Foundation; Grand Challenges Canada Rising Stars in Global Health grant	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Grand Challenges Canada Rising Stars in Global Health grant	WK is supported by the Swiss National Science Foundation (www.snf.ch) and a Grand Challenges Canada Rising Stars in Global Health grant (www.grandchallenges.ca). The research was conducted using internal University funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, RRate on Google Play website, Patent No. [US 4625292, 4625292]; Centre for Clinical Practice, 2007, AC ILL PAT HOSP REC; Edmonds ZV, 2002, ANN EMERG MED, V39, P233, DOI 10.1067/mem.2002.122017; FENNER A, 1973, PEDIATR RES, V7, P174, DOI 10.1203/00006450-197304000-00020; Folke M, 2003, MED BIOL ENG COMPUT, V41, P377, DOI 10.1007/BF02348078; International Data Corporation (IDC), 2003, TECHNICAL REPORT; Karlen W, 2013, IEEE T BIO-MED ENG, V60, P1946, DOI 10.1109/TBME.2013.2246160; Lovett PB, 2005, ANN EMERG MED, V45, P68, DOI 10.1016/j.annemergmed.2004.06.016; Petersen CL, 2013, ACM SIGPLAN NOTICES, V48, P357, DOI [10.1145/2500365.2500615, 10.1145/2544174.2500615]; Philip J, 1982, P 17 ANN AAMI M SAN; Philip J, 1981, P 16 ANN AAMI M WASH; Strange B, 2013, TECHNICAL REPORT; Synovate Uganda, 2011, ARI TIMER RES REPORT; Vital Wave Consulting, 2009, MHEALTH DEV OPP MOB; Wardlaw TM, 2006, PNEUMONIA FORGOTTEN; World Health Organization, 1990, TECHNICAL REPORT; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	17	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99266	10.1371/journal.pone.0099266	http://dx.doi.org/10.1371/journal.pone.0099266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919062	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000069
J	Li, JJ; Zhang, HM; Shen, ZY; Zhou, YJ; Fang, NY; Wang, L; Wang, B; Wang, JW; Tang, ZZ				Li, Jianjun; Zhang, Hongman; Shen, Zhiyong; Zhou, Yuejiao; Fang, Ningye; Wang, Lu; Wang, Bin; Wang, Jiangwei; Tang, Zhenzhu			Screening for Acute HIV Infections and Estimating HIV Incidence among Female Sex Workers from Low-Grade Venues in Guangxi, China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ENZYME-IMMUNOASSAY; SUBTYPE CRF01-AE; YUNNAN PROVINCE; RISK BEHAVIORS; KAIYUAN CITY; SEROCONVERSION; TRANSMISSION; SYPHILIS; PREVALENCE	Background: Guangxi has become one of the provinces with the most severe HIV-1 epidemic in China, where heterosexual contact is the dominant transmission route. However, data of acute HIV infections and HIV incidence among female sex workers (FSWs) from low-grade venues are scant. Methods: A cross-sectional survey was performed among FSWs from low-grade venues in Guangxi. HIV antibody screening was performed by rapid testing (RT). HIV antibody-negative specimens were screened by pooled nucleic acid amplification testing (NAAT) for acute HIV infections. HIV antibody-positive specimens were further analyzed by Western blot (WB), followed by an HIV-1 BED capture enzyme immunoassay (BED-CEIA) to identify the recent infections. HIV-1 incidence was estimated by the data of pooled NAAT and BED-CEIA, respectively. Results: A total of 7936 FSWs were recruited and answered the questionnaires. We successfully collected the blood samples from 6469 (81.5%) participants, of which 139 (2.1%) were HIV antibody-positive and 6330 (97.9%) were HIV antibodynegative by RT. With pooled NAAT, 7 cases were found to be HIV RNA positive, representing an additional 5.0% of HIVinfected persons and an estimated HIV incidence of 1.45 (95% CI: 1.17-1.76) per 100 person years. There were 137 positive and 2 indeterminate by WB, of which 124 (90.5%) positive specimens were subjected to BED-CEIA testing identifying 28 recent infections. The HIV incidence determined by BED-CEIA testing was 1.04 (95% CI: 0.65-1.43) per 100 person years. The overall prevalence of HIV among FSWs from low-grade venues in Guangxi was 2.2% (95% CI: 1.9-2.6). Conclusions: We found that the addition of HIV RNA screening to routine HIV antibody testing significantly improved the detection of HIV infection among FSWs from low-grade venues in Guangxi. Our findings also provided the useful baseline data of HIV incidence among this population for targeting local HIV prevention, intervention, monitoring and treatment.	[Li, Jianjun; Zhang, Hongman; Fang, Ningye; Wang, Lu; Wang, Bin; Wang, Jiangwei] Guangxi Ctr Dis Control & Prevent, Inst HIV AIDS Prevent & Control, Guangxi Cent Lab HIV AIDS Confirmat, Nanning, Peoples R China; [Shen, Zhiyong; Zhou, Yuejiao] Guangxi Ctr Dis Control & Prevent, Inst HIV AIDS Prevent & Control, Nanning, Peoples R China; [Tang, Zhenzhu] Guangxi Ctr Dis Control & Prevent, Nanning, Peoples R China		Tang, ZZ (corresponding author), Guangxi Ctr Dis Control & Prevent, Nanning, Peoples R China.	tangzhzh@163.com			Fund of National Natural Science [81360442]; project of Guangxi science and technology development plan [12980031-4]	Fund of National Natural Science(National Natural Science Foundation of China (NSFC)); project of Guangxi science and technology development plan	This work was supported by Fund of National Natural Science (81360442) and project of Guangxi science and technology development plan (12980031-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CHIN J AIDS STD; Brookmeyer R, 1999, BIOMETRICS, V55, P608, DOI 10.1111/j.0006-341X.1999.00608.x; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P234, DOI 10.1097/QAI.0b013e31815e4011; BUSCH MP, 1995, TRANSFUSION, V35, P91, DOI 10.1046/j.1537-2995.1995.35295125745.x; Calypte Biomedical Corporation, 2005, CAL HIV 1 BED INC EI; Center for Disease Control and Prevention Office of the Global AIDS Coordinator, 2006, INT REC US BED CAPT; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P731; Chinese Center for Disease Control and Prevention, 2009, NAT GUID DET HIV AID; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Li L, 2013, J MED VIROL, V85, P388, DOI 10.1002/jmv.23360; Lu F, 2009, SE ASIAN J TROP MED, V40, P263; Morandi PA, 1998, J CLIN MICROBIOL, V36, P1534, DOI 10.1128/JCM.36.6.1534-1538.1998; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Patel P, 2006, JAIDS-J ACQ IMM DEF, V42, P75, DOI 10.1097/01.qai.0000218363.21088.ad; Pilcher CD, 2001, JAMA-J AM MED ASSOC, V286, P1713, DOI 10.1001/jama.286.14.1713; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2002, JAMA-J AM MED ASSOC, V288, P216, DOI 10.1001/jama.288.2.216; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; Quinn TC, 2000, AIDS, V14, P2751, DOI 10.1097/00002030-200012010-00015; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Wang BX, 2012, J INFECT DIS, V206, P907, DOI 10.1093/infdis/jis466; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wang L, 2009, JAIDS-J ACQ IMM DEF, V50, P414, DOI 10.1097/QAI.0b013e3181958530; Wang N, 2010, INT J EPIDEMIOL, V39, pII21, DOI 10.1093/ije/dyq209; Wang Y, 2013, S CHINA J PREV MED, V39, P6; Wu ZY, 2010, JAIDS-J ACQ IMM DEF, V53, pS1, DOI 10.1097/QAI.0b013e3181c7d379; Xu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055413, 10.1371/journal.pone.0059050]; Xu JJ, 2008, SEX TRANSM DIS, V35, P558, DOI 10.1097/OLQ.0b013e318165926b; Xu JJ, 2010, INT J INFECT DIS, V14, pE608, DOI 10.1016/j.ijid.2009.09.004; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhou YJ, 2013, AIDS CARE, V25, P1433, DOI 10.1080/09540121.2013.772282; Zhu BY, 2012, JPN J INFECT DIS, V65, P75	36	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99522	10.1371/journal.pone.0099522	http://dx.doi.org/10.1371/journal.pone.0099522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918933	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000092
J	Muller, B; Anders, M; Reinstein, J				Mueller, Barbara; Anders, Maria; Reinstein, Jochen			In Vitro Analysis of Human Immunodeficiency Virus Particle Dissociation: Gag Proteolytic Processing Influences Dissociation Kinetics	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; TYPE-1 GAG; HIV-1 PARTICLES; ENERGY-TRANSFER; CAPSID PROTEIN; MATURATION; INFECTIVITY; MICROSCOPY; MUTATIONS; MEMBRANE	Human immunodeficiency virus particles undergo a step of proteolytic maturation, in which the main structural polyprotein Gag is cleaved into its mature subunits matrix (MA), capsid (CA), nucleocapsid (NC) and p6. Gag proteolytic processing is accompanied by a dramatic structural rearrangement within the virion, which is necessary for virus infectivity and has been proposed to proceed through a sequence of dissociation and reformation of the capsid lattice. Morphological maturation appears to be tightly regulated, with sequential cleavage events and two small spacer peptides within Gag playing important roles by regulating the disassembly of the immature capsid layer and formation of the mature capsid lattice. In order to measure the influence of individual Gag domains on lattice stability, we established Forster's resonance energy transfer (FRET) reporter virions and employed rapid kinetic FRET and light scatter measurements. This approach allowed us to measure dissociation properties of HIV-1 particles assembled in eukaryotic cells containing Gag proteins in different states of proteolytic processing. While the complex dissociation behavior of the particles prevented an assignment of kinetic rate constants to individual dissociation steps, our analyses revealed characteristic differences in the dissociation properties of the MA layer dependent on the presence of additional domains. The most striking effect observed here was a pronounced stabilization of the MA-CA layer mediated by the presence of the 14 amino acid long spacer peptide SP1 at the CA C-terminus, underlining the crucial role of this peptide for the resolution of the immature particle architecture.	[Mueller, Barbara; Anders, Maria] Univ Heidelberg Hosp, Dept Infect Dis, Heidelberg, Germany; [Reinstein, Jochen] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg 1, Germany	Ruprecht Karls University Heidelberg; Max Planck Society	Muller, B (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis, Heidelberg, Germany.	Barbara_Mueller@med.uni-heidelberg.de	Muller, Barbara/AAC-4483-2020		University Hospital Heidelberg; Max-Planck-Society; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitaet Heidelberg	University Hospital Heidelberg; Max-Planck-Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitaet Heidelberg	This work was supported by core funding from the University Hospital Heidelberg (BM, MA) and the Max-Planck-Society (JR). BM and JR are investigators of the CellNetworks Cluster of Excellence (EXC81). The authors acknowledge support by the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitaet Heidelberg within the funding programme 'Open Access Publishing'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurahman S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-69; Accola MA, 1998, J VIROL, V72, P2072, DOI 10.1128/JVI.72.3.2072-2078.1998; Adamson C.S., 2012, MOL BIOL INT, V2012; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Carlson LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001173; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; Gluschankof P, 1997, VIROLOGY, V230, P125, DOI 10.1006/viro.1997.8453; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Hogue IB, 2009, J VIROL, V83, P7322, DOI 10.1128/JVI.02545-08; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Keller PW, 2013, J VIROL, V87, P13655, DOI 10.1128/JVI.01408-13; Koch P, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-84; KONVALINKA J, 1995, EUR J BIOCHEM, V228, P191, DOI 10.1111/j.1432-1033.1995.tb20249.x; KRAUSSLICH HG, 1995, J VIROL, V69, P3407; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2002, J VIROL, V76, P6900, DOI 10.1128/JVI.76.14.6900-6908.2002; Larson DR, 2003, J CELL BIOL, V162, P1233, DOI 10.1083/jcb.200303200; Li F, 2003, P NATL ACAD SCI USA, V100, P13555, DOI 10.1073/pnas.2234683100; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; PARK J, 1993, VIROLOGY, V194, P843, DOI 10.1006/viro.1993.1328; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Perrin-Tricaud C, 1999, VIROLOGY, V255, P20, DOI 10.1006/viro.1998.9573; Poole E, 2005, TRAFFIC, V6, P741, DOI 10.1111/j.1600-0854.2005.00312.x; REICIN AS, 1995, J VIROL, V69, P642, DOI 10.1128/JVI.69.2.642-650.1995; ROSE JR, 1995, J VIROL, V69, P2751; Salzwedel K, 2007, AIDS REV, V9, P162; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Sundquist W.I., 2012, COLD SPRING HARB PER, V2; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Zhou J, 2005, J BIOL CHEM, V280, P42149, DOI 10.1074/jbc.M508951200	40	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99504	10.1371/journal.pone.0099504	http://dx.doi.org/10.1371/journal.pone.0099504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915417	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700107
J	Feng, Q; Zhu, ML; Wei, KC; Bian, LM				Feng, Qian; Zhu, Meiling; Wei, Kongchang; Bian, Liming			Cell-Mediated Degradation Regulates Human Mesenchymal Stem Cell Chondrogenesis and Hypertrophy in MMP-Sensitive Hyaluronic Acid Hydrogels	PLOS ONE			English	Article							IN-VITRO; EXTRACELLULAR-MATRIX; II COLLAGEN; FATE; MINERALIZATION; CONDENSATION; DISRUPTION; INDUCTION; INVASION; CULTURES	Photocrosslinked methacrylated hyaluronic acid (MeHA) hydrogels support chondrogenesis of encapsulated human mesenchymal stem cells (hMSCs). However, the covalent crosslinks formed via chain polymerization in these hydrogels are hydrolytically non-degradable and restrict cartilage matrix spatial distribution and cell spreading. Meanwhile, cells are known to remodel their surrounding extracellular matrix (ECM) by secreting catabolic enzymes, such as MMPs. Hydrogels that are created with bifunctional crosslinkers containing MMP degradable peptide sequences have been shown to influence hMSC differentiations. However, crosslinks formed in the MMP-degradable hydrogels of these previous studies are also prone to hydrolysis, thereby confounding the effect of MMP-mediated degradation. The objective of this study is to develop a MMP-sensitive but hydrolytically stable hydrogel scaffold and investigate the effect of MMP-mediated hydrogel degradation on the chondrogenesis of the encapsulated hMSCs. Hyaluronic acid macromers were modified with maleimide groups and crosslinked with MMP-cleavable peptides or control crosslinkers containing dual thiol groups. The chondrogenesis of the hMSCs encapsulated in the hydrolytically stable MMP-sensitive HA hydrogels were compared with that of the MMP-insensitive HA hydrogels. It was found that hMSCs encapsulated in the MMP-sensitive hydrogels switched to a more spreaded morphology while cells in the MMP-insensitive hydrogels remained in round shape. Furthermore, hMSCs in the MMP-sensitive hydrogels expressed higher level of chondrogenic marker genes but lower level of hypertrophic genes compared to cells in the MMP-insensitive hydrogels. As a result, more cartilage specific matrix molecules but less calcification was observed in the MMP-degradable hydrogels than in the MMP-insensitive hydrogels. Findings from this study demonstrate that cell-mediated scaffold degradation regulates the chondrogenesis and hypertrophy of hMSCs encapsulated in HA hydrogels.	[Feng, Qian; Zhu, Meiling; Wei, Kongchang; Bian, Liming] Chinese Univ Hong Kong, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Feng, Qian; Zhu, Meiling; Wei, Kongchang; Bian, Liming] Chinese Univ Hong Kong, Dept Mech & Automat Engn, Hong Kong, Hong Kong, Peoples R China; [Feng, Qian; Zhu, Meiling; Wei, Kongchang; Bian, Liming] Chinese Univ Hong Kong, Shun Hing Inst Adv Engn, Hong Kong, Hong Kong, Peoples R China; [Bian, Liming] Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Bian, LM (corresponding author), Chinese Univ Hong Kong, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China.	lbian@mae.cuhk.edu.hk	Bian, Liming/A-7183-2011; Bian, Liming/AAQ-5504-2020; Wei, Phenihus/M-5422-2013; Bian, Liming/AAV-3801-2021; Wei, Kongchang/K-2096-2013	Bian, Liming/0000-0003-4739-0918; Wei, Phenihus/0000-0002-6555-2768; Wei, Kongchang/0000-0002-6555-2768; Feng, Qian/0000-0003-3196-0840	Research Grants Council of Hong Kong [439913]; Faculty of Engineering in the Chinese University of Hong Kong; Shun Hing Institute of Advanced Engineering, the Chinese University of Hong Kong [BME-8115043]; Lui Che Woo Foundation; National Natural Science Foundation of China [31300796]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Faculty of Engineering in the Chinese University of Hong Kong; Shun Hing Institute of Advanced Engineering, the Chinese University of Hong Kong(Chinese University of Hong Kong); Lui Che Woo Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work described in this paper was supported by an Early Career Scheme grant from the Research Grants Council of Hong Kong (Project No. 439913). This work is supported by a direct grant from the Faculty of Engineering in the Chinese University of Hong Kong. This research is also supported by project BME-8115043 of the Shun Hing Institute of Advanced Engineering, the Chinese University of Hong Kong. This research project was made possible by equipment/resources donated by Lui Che Woo Foundation. Project 31300796 is supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266; Bahney CS, 2011, FASEB J, V25, P1486, DOI 10.1096/fj.10-165514; Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]; Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110; Bian LM, 2013, BIOMATERIALS, V34, P413, DOI 10.1016/j.biomaterials.2012.09.052; Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033; BOSKEY AL, 1991, CRIT REV ORAL BIOL M, V2, P369, DOI 10.1177/10454411910020030501; CHEN CC, 1984, CALCIFIED TISSUE INT, V36, P285, DOI 10.1007/BF02405332; DeLise AM, 2002, J CELL BIOCHEM, V87, P342, DOI 10.1002/jcb.10308; Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156; Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jubeck B, 2008, ARTHRITIS RHEUM-US, V58, P2809, DOI 10.1002/art.23762; Jubeck B, 2009, ARTHRITIS RHEUM-US, V60, P2741, DOI 10.1002/art.24773; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035; Kim J, 2010, J BIOMED MATER RES A, V95A, P673, DOI 10.1002/jbm.a.32884; Lim YB, 2003, J CELL BIOCHEM, V88, P713, DOI 10.1002/jcb.10389; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Maleski MP, 1996, EXP CELL RES, V225, P55, DOI 10.1006/excr.1996.0156; McGowan KB, 2002, OSTEOARTHR CARTILAGE, V10, P580, DOI 10.1053/joca.2002.0794; Mello MA, 2006, J ORTHOP RES, V24, P2095, DOI 10.1002/jor.20233; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Nakamura M, 2005, BIOCHEM BIOPH RES CO, V333, P1011, DOI 10.1016/j.bbrc.2005.06.010; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Park Y, 2004, TISSUE ENG, V10, P515, DOI 10.1089/107632704323061870; Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574; Schwartz Z, 2011, AM J VET RES, V72, P42, DOI 10.2460/ajvr.72.1.42; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x; Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200; Wu SC, 2010, BIOMATERIALS, V31, P631, DOI 10.1016/j.biomaterials.2009.09.089; ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115	39	40	41	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99587	10.1371/journal.pone.0099587	http://dx.doi.org/10.1371/journal.pone.0099587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911871	Green Submitted, gold, Green Published			2022-12-25	WOS:000337165600107
J	Wang, YL; Jeong, Y; Jhiang, SM; Yu, LB; Menq, CH				Wang, Yuliang; Jeong, Younkoo; Jhiang, Sissy M.; Yu, Lianbo; Menq, Chia-Hsiang			Quantitative Characterization of Cell Behaviors through Cell Cycle Progression via Automated Cell Tracking	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; MICROSCOPY; MIGRATION; MOTILITY; SEGMENTATION; DIFFUSION	Cell behaviors are reflections of intracellular tension dynamics and play important roles in many cellular processes. In this study, temporal variations in cell geometry and cell motion through cell cycle progression were quantitatively characterized via automated cell tracking for MCF-10A non-transformed breast cells, MCF-7 non-invasive breast cancer cells, and MDA-MB-231 highly metastatic breast cancer cells. A new cell segmentation method, which combines the threshold method and our modified edge based active contour method, was applied to optimize cell boundary detection for all cells in the field-of-view. An automated cell-tracking program was implemented to conduct live cell tracking over 40 hours for the three cell lines. The cell boundary and location information was measured and aligned with cell cycle progression with constructed cell lineage trees. Cell behaviors were studied in terms of cell geometry and cell motion. For cell geometry, cell area and cell axis ratio were investigated. For cell motion, instantaneous migration speed, cell motion type, as well as cell motion range were analyzed. We applied a cell-based approach that allows us to examine and compare temporal variations of cell behavior along with cell cycle progression at a single cell level. Cell body geometry along with distribution of peripheral protrusion structures appears to be associated with cell motion features. Migration speed together with motion type and motion ranges are required to distinguish the three cell-lines examined. We found that cells dividing or overlapping vertically are unique features of cell malignancy for both MCF-7 and MDA-MB-231 cells, whereas abrupt changes in cell body geometry and cell motion during mitosis are unique to highly metastatic MDA-MB-231 cells. Taken together, our live cell tracking system serves as an invaluable tool to identify cell behaviors that are unique to malignant and/or highly metastatic breast cancer cells.	[Wang, Yuliang; Jeong, Younkoo; Menq, Chia-Hsiang] Ohio State Univ, Dept Mech & Aerosp Engn, Precis Measurement & Control Lab, Columbus, OH 43210 USA; [Wang, Yuliang; Jhiang, Sissy M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Jhiang, Sissy M.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Yu, Lianbo] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Menq, CH (corresponding author), Ohio State Univ, Dept Mech & Aerosp Engn, Precis Measurement & Control Lab, Columbus, OH 43210 USA.	menq.1@osu.edu	Menq, Chia-Hsiang/AAT-9302-2021; yu, lianbo/B-3472-2010		National Science Foundation [CMMI-1067962]; National Institutes of Health/National Cancer Institute developmental research program [P50CA168505]; Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P50CA168505, P01CA124570, P30CA016058] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Cancer Institute developmental research program; Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by National Science Foundation CMMI-1067962 (to CMH) and National Institutes of Health/National Cancer Institute P50CA168505 developmental research program (to CMH). YW is a recipient of Pelotonia postdoctoral fellowship from the Ohio State University Comprehensive Cancer Center. The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ARMSTRONG PB, 1985, CANCER METAST REV, V4, P59, DOI 10.1007/BF00047737; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Bunyak F, 2006, I S BIOMED IMAGING, P1040; Chakravorty R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083251; Cheng JR, 2009, IEEE T BIO-MED ENG, V56, P741, DOI 10.1109/TBME.2008.2008635; Czirok A, 1998, PHYS REV LETT, V81, P3038, DOI 10.1103/PhysRevLett.81.3038; Dufour A, 2005, IEEE T IMAGE PROCESS, V14, P1396, DOI 10.1109/TIP.2005.852790; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Goodman JAN, 1995, INTRO FOURIER OPTICS, P220; Guo LL, 2009, OPHTHALMIC RES, V42, P213, DOI 10.1159/000232971; Henrickson SE, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.112pt2; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Malpica N, 1997, CYTOMETRY, V28, P289, DOI 10.1002/(SICI)1097-0320(19970801)28:4<289::AID-CYTO3>3.0.CO;2-7; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Meijering E, 2009, SEMIN CELL DEV BIOL, V20, P894, DOI 10.1016/j.semcdb.2009.07.004; Mendoz E, 2011, CELL MOL BIOENG, V4, P411, DOI 10.1007/s12195-011-0193-8; Palaniappan K., 2004, IEEE CVPR WORKSH ART, V1, P25; Pathak A, 2013, INTEGR BIOL, V5, P1067; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rajah TT, 1998, IN VITRO CELL DEV-AN, V34, P626, DOI 10.1007/s11626-996-0009-7; Rapoport DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027315; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Scherf N, 2012, EXP HEMATOL, V40, P119, DOI 10.1016/j.exphem.2011.10.009; Selinummi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007497; Silletti S, 1997, Pathol Oncol Res, V3, P230, DOI 10.1007/BF02899927; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Weiger MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058859; Zimmer C, 2002, IEEE T MED IMAGING, V21, P1212, DOI 10.1109/TMI.2002.806292	35	11	11	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98762	10.1371/journal.pone.0098762	http://dx.doi.org/10.1371/journal.pone.0098762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911281	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600013
J	Alqarni, SSM; Murthy, A; Zhang, W; Przewloka, MR; Silva, APG; Watson, AA; Lejon, S; Pei, XY; Smits, AH; Kloet, SL; Wang, HX; Shepherd, NE; Stokes, PH; Blobel, GA; Vermeulen, M; Glover, DM; Mackay, JP; Laue, ED				Alqarni, Saad S. M.; Murthy, Andal; Zhang, Wei; Przewloka, Marcin R.; Silva, Ana P. G.; Watson, Aleksandra A.; Lejon, Sara; Pei, Xue Y.; Smits, Arne H.; Kloet, Susan L.; Wang, Hongxin; Shepherd, Nicholas E.; Stokes, Philippa H.; Blobel, Gerd A.; Vermeulen, Michiel; Glover, David M.; Mackay, Joel P.; Laue, Ernest D.			Insight into the Architecture of the NuRD Complex STRUCTURE OF THE RbAp48-MTA1 SUBCOMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; TRANSCRIPTIONAL REPRESSION; MI-2/NURD COMPLEX; STRUCTURAL BASIS; DNA METHYLATION; SOMATIC-CELLS; ZINC-FINGER; PROTEIN; BINDING; DOMAINS	The nucleosome remodeling and deacetylase (NuRD) complex is a widely conserved transcriptional co-regulator that harbors both nucleosome remodeling and histone deacetylase activities. It plays a critical role in the early stages of ES cell differentiation and the reprogramming of somatic to induced pluripotent stem cells. Abnormalities in several NuRD proteins are associated with cancer and aging. We have investigated the architecture of NuRDby determining the structure of a subcomplex comprising RbAp48 and MTA1. Surprisingly, RbAp48 recognizes MTA1 using the same site that it uses to bind histone H4, showing that assembly into NuRD modulates RbAp46/48 interactions with histones. Taken together with other results, our data show that the MTA proteins act as scaffolds for NuRD complex assembly. We further show that the RbAp48-MTA1 interaction is essential for the in vivo integration of RbAp46/48 into the NuRD complex.	[Alqarni, Saad S. M.; Silva, Ana P. G.; Shepherd, Nicholas E.; Stokes, Philippa H.; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Murthy, Andal; Zhang, Wei; Watson, Aleksandra A.; Lejon, Sara; Pei, Xue Y.; Laue, Ernest D.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Przewloka, Marcin R.; Glover, David M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Smits, Arne H.; Kloet, Susan L.; Vermeulen, Michiel] UMC Utrecht, Dept Mol Canc Res, NL-3584 CG Utrecht, Netherlands; [Wang, Hongxin; Blobel, Gerd A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Sydney; University of Cambridge; University of Cambridge; Utrecht University; Utrecht University Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mackay, JP (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	joel.mackay@sydney.edu.au; e.d.laue@bioc.cam.ac.uk	Alqarni, Saad/AAH-2502-2020; Przewloka, Marcin R./AAA-5137-2020; Shepherd, Nicholas/H-6781-2016; Kloet, Susan L./Y-5513-2018; Vermeulen, Michiel/C-8883-2013; Mackay, Joel/D-6834-2011	Przewloka, Marcin R./0000-0002-0329-9162; Shepherd, Nicholas/0000-0001-6234-4456; Kloet, Susan L./0000-0001-9189-0640; Vermeulen, Michiel/0000-0003-0836-6894; Mackay, Joel/0000-0001-7508-8033; Glover, David/0000-0003-0956-0103; Smits, Arne H/0000-0001-5011-0898; Laue, Ernest/0000-0002-7476-4148	National Institutes of Health [OD010949-10]; European Commission through 4DCell-Fate project (EC FP7) [CP 277899]; Cancer Research UK [11431] Funding Source: researchfish; Medical Research Council [G1001696] Funding Source: researchfish; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER; MRC [G1001696] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission through 4DCell-Fate project (EC FP7); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Janusz Debski and Michal Dadlez (Institute of Biochemistry and Biophysics, Polish Academy of Sciences) for the mass spectrometry analysis of protein samples purified from D. melanogaster cells. We also thank the Drosophila Genomics Resource Center, which is supported by the National Institutes of Health Grant OD010949-10, for Drosophila cDNA clones. We are grateful to Prof. Ben F. Luisi for help with X-ray data collection. We also thank the European Commission for support through the 4DCell-Fate project (EC FP7 CP 277899).	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Brackertz M, 2002, J BIOL CHEM, V277, P40958, DOI 10.1074/jbc.M207467200; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; D'Avino PP, 2009, METHODS MOL BIOL, V545, P99, DOI 10.1007/978-1-60327-993-2_6; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng Q, 2002, MOL CELL BIOL, V22, P536, DOI 10.1128/MCB.22.2.536-546.2002; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Gnanapragasam MN, 2011, P NATL ACAD SCI USA, V108, P7487, DOI 10.1073/pnas.1015341108; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee BM, 2007, J MOL BIOL, V371, P1274, DOI 10.1016/j.jmb.2007.06.021; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Li DQ, 2012, CANCER RES, V72, P387, DOI 10.1158/0008-5472.CAN-11-2345; Li W, 2009, TISSUE CELL, V41, P390, DOI 10.1016/j.tice.2009.04.002; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Mackay JP, 2007, TRENDS BIOCHEM SCI, V32, P530, DOI 10.1016/j.tibs.2007.09.006; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Morra R, 2012, FEBS LETT, V586, P2513, DOI 10.1016/j.febslet.2012.06.017; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Musselman CA, 2012, P NATL ACAD SCI USA, V109, P787, DOI 10.1073/pnas.1113655109; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Nair SS, 2013, MOL CELL, V49, P704, DOI 10.1016/j.molcel.2012.12.016; Nowak AJ, 2011, J BIOL CHEM, V286, P23388, DOI 10.1074/jbc.M110.207407; Pavlopoulos E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006373; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Przewloka MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000478; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Ramirez J, 2012, MOL CELL BIOL, V32, P5078, DOI 10.1128/MCB.00819-12; Roche AE, 2008, J MOL CELL CARDIOL, V44, P352, DOI 10.1016/j.yjmcc.2007.10.023; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Spruijt CG, 2010, MOL BIOSYST, V6, P1700, DOI 10.1039/c004108d; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Watson AA, 2012, J MOL BIOL, V422, P3, DOI 10.1016/j.jmb.2012.04.031; Wu M, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-1; Zhang W, 2013, NAT STRUCT MOL BIOL, V20, P29, DOI 10.1038/nsmb.2446; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	64	59	59	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21844	21855		10.1074/jbc.M114.558940	http://dx.doi.org/10.1074/jbc.M114.558940			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24920672	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000340593500004
J	Moreno-Dominguez, A; El-Yazbi, AF; Zhu, HL; Colinas, O; Zhong, XZ; Walsh, EJ; Cole, DM; Kargacin, GJ; Walsh, MP; Cole, WC				Moreno-Dominguez, Alejandro; El-Yazbi, Ahmed F.; Zhu, Hai-Lei; Colinas, Olaia; Zhong, X. Zoe; Walsh, Emma J.; Cole, Dylan M.; Kargacin, Gary J.; Walsh, Michael P.; Cole, William C.			Cytoskeletal Reorganization Evoked by Rho-associated kinase- and Protein Kinase C-catalyzed Phosphorylation of Cofilin and Heat Shock Protein 27, Respectively, Contributes to Myogenic Constriction of Rat Cerebral Arteries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; STIMULATED ACTIN POLYMERIZATION; LIGHT-CHAIN PHOSPHORYLATION; SIGNAL-TRANSDUCTION; CA2+ SENSITIZATION; MAP KINASE; MYOSIN PHOSPHORYLATION; DEPOLYMERIZING FACTOR; RESISTANCE ARTERIES; FORCE AUGMENTATION	Our understanding of the molecular events contributing to myogenic control of diameter in cerebral resistance arteries in response to changes in intravascular pressure, a fundamental mechanism regulating blood flow to the brain, is incomplete. Myosin light chain kinase and phosphatase activities are known to be increased and decreased, respectively, to augment phosphorylation of the 20-kDa regulatory light chain subunits (LC20) of myosin II, which permits cross-bridge cycling and force development. Here, we assessed the contribution of dynamic reorganization of the actin cytoskeleton and thin filament regulation to the myogenic response and serotonin-evoked constriction of pressurized rat middle cerebral arteries. Arterial diameter and the levels of phosphorylated LC20, calponin, caldesmon, cofilin, and HSP27, as well as G-actin content, were determined. A decline in G-actin content was observed following pressurization from 10 mm Hg to between 40 and 120 mm Hg and in three conditions in which myogenic or agonist-evoked constriction occurred in the absence of a detectable change in LC20 phosphorylation. No changes in thin filament protein phosphorylation were evident. Pressurization reduced G-actin content and elevated the levels of cofilin and HSP27 phosphorylation. Inhibitors of Rho-associated kinase and PKC prevented the decline in G-actin; reduced cofilin and HSP27 phosphoprotein content, respectively; and blocked the myogenic response. Furthermore, phosphorylation modulators of HSP27 and cofilin induced significant changes in arterial diameter and G-actin content of myogenically active arteries. Taken together, our findings suggest that dynamic reorganization of the cytoskeleton involving increased actin polymerization in response to Rho-associated kinase and PKC signaling contributes significantly to force generation in myogenic constriction of cerebral resistance arteries.	[Moreno-Dominguez, Alejandro; El-Yazbi, Ahmed F.; Zhu, Hai-Lei; Colinas, Olaia; Zhong, X. Zoe; Walsh, Emma J.; Cole, Dylan M.; Kargacin, Gary J.; Cole, William C.] Univ Calgary, Dept Physiol & Pharmacol, Smooth Muscle Res Grp, Libin Cardiovasc Inst, Calgary, AB T2N 4N1, Canada; [Walsh, Michael P.] Univ Calgary, Dept Biochem & Mol Biol, Smooth Muscle Res Grp, Libin Cardiovasc Inst, Calgary, AB T2N 4N1, Canada; Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary	Cole, WC (corresponding author), Univ Calgary, Fac Med, Smooth Muscle Res Grp, Dept Physiol & Pharmacol,Libin Cardiovasc Inst, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	wcole@ucalgary.ca	Zhu, Hai-Lei/AFY-5595-2022; El-Yazbi, Ahmed/AAT-6837-2021; Moreno, Alejandro/AAB-5021-2019	El-Yazbi, Ahmed/0000-0003-3432-3038; Moreno, Alejandro/0000-0003-2341-2297; Colinas, Olalla/0000-0002-1190-0157	Canadian Institutes of Health Research [MOP-97988, MOP-13505]; Kertland Family Fellowship Fund & Andrew Family Professorship; Alberta Heritage Foundation for Medical Research/Canadian Institutes of Health Research; Spanish Ministry of Education; Alberta Innovates-Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kertland Family Fellowship Fund & Andrew Family Professorship; Alberta Heritage Foundation for Medical Research/Canadian Institutes of Health Research; Spanish Ministry of Education(Spanish Government); Alberta Innovates-Health Solutions	This work was supported by Canadian Institutes of Health Research Grants MOP-97988 and MOP-13505; fellowship awards from the Kertland Family Fellowship Fund & Andrew Family Professorship (to A. M.-D.), Alberta Heritage Foundation for Medical Research/Canadian Institutes of Health Research (to A. F. E.), the Spanish Ministry of Education (to O. C.), and Alberta Innovates-Health Solutions (to H.-L. Z.); and a Studentship award from Alberta Innovates-Health Solutions (to X. Z. Z.).	Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Bakker ENTP, 1999, CARDIOVASC RES, V41, P229, DOI 10.1016/S0008-6363(98)00161-8; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Bitar KN, 2002, AM J PHYSIOL-GASTR L, V282, pG894, DOI 10.1152/ajpgi.00141.2001; CAIRNS J, 1994, J BIOL CHEM, V269, P9176; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen XS, 2008, AM J PHYSIOL-HEART C, V295, pH2172, DOI 10.1152/ajpheart.91437.2007; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; Cipolla MJ, 1998, STROKE, V29, P1223, DOI 10.1161/01.STR.29.6.1223; Cole WC, 2011, ARCH BIOCHEM BIOPHYS, V510, P160, DOI 10.1016/j.abb.2011.02.024; Coulson RJ, 2002, AM J PHYSIOL-HEART C, V283, pH2268, DOI 10.1152/ajpheart.00542.2002; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Dessy C, 2000, AM J PHYSIOL-HEART C, V279, pH916, DOI 10.1152/ajpheart.2000.279.3.H916; Dessy C, 1998, AM J PHYSIOL-CELL PH, V275, pC1081, DOI 10.1152/ajpcell.1998.275.4.C1081; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Dowell ML, 2005, J APPL PHYSIOL, V98, P489, DOI 10.1152/japplphysiol.01378.2003; Dubroca C, 2005, HYPERTENSION, V45, P974, DOI 10.1161/01.HYP.0000164582.63421.2d; Eddinger TJ, 2007, J PHARMACOL EXP THER, V320, P865, DOI 10.1124/jpet.106.109363; El-Yazbi AF, 2010, J PHYSIOL-LONDON, V588, P1747, DOI 10.1113/jphysiol.2010.187146; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Flavahan NA, 2005, AM J PHYSIOL-HEART C, V288, pH660, DOI 10.1152/ajpheart.00608.2004; Gallant C, 2011, AM J PHYSIOL-CELL PH, V300, pC1356, DOI 10.1152/ajpcell.00450.2010; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Gerthoffer WT, 2005, CAN J PHYSIOL PHARM, V83, P851, DOI 10.1139/Y05-088; Gokina NI, 2002, AM J PHYSIOL-HEART C, V282, pH1410, DOI 10.1152/ajpheart.00441.2001; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; HILL MA, 1990, AM J PHYSIOL, V259, pH1586, DOI 10.1152/ajpheart.1990.259.5.H1586; Hirano K, 2007, J PHARMACOL SCI, V104, P109, DOI 10.1254/jphs.CP0070027; Horowitz A, 1996, AM J PHYSIOL-HEART C, V270, pH1858, DOI 10.1152/ajpheart.1996.270.5.H1858; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P1516, DOI 10.1002/cncr.25599; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Jaggar JH, 2001, AM J PHYSIOL-CELL PH, V281, pC439, DOI 10.1152/ajpcell.2001.281.2.C439; JAWOROWSKI A, 1995, FEBS LETT, V365, P167, DOI 10.1016/0014-5793(95)00451-E; Jin JP, 2000, BIOCHEM J, V350, P579, DOI 10.1042/0264-6021:3500579; Johnson RP, 2009, J PHYSIOL-LONDON, V587, P2537, DOI 10.1113/jphysiol.2008.168252; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kaneko T, 2000, BIOCHEM BIOPH RES CO, V273, P110, DOI 10.1006/bbrc.2000.2901; Karibe A, 1997, AM J PHYSIOL-HEART C, V272, pH1165, DOI 10.1152/ajpheart.1997.272.3.H1165; Kato K, 2001, CELL STRESS CHAPERON, V6, P16, DOI 10.1379/1466-1268(2001)006<0016:PKICSS>2.0.CO;2; KAYE D, 1993, CIRCULATION, V88, P1101, DOI 10.1161/01.CIR.88.3.1101; Khromov AS, 2004, BIOPHYS J, V86, P2318, DOI 10.1016/S0006-3495(04)74289-7; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Kim HR, 2010, AM J PHYSIOL-CELL PH, V298, pC559, DOI 10.1152/ajpcell.00431.2009; Kim YS, 2008, CLIN SCI, V115, P255, DOI 10.1042/CS20070458; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Koltsova SV, 2008, CELL PHYSIOL BIOCHEM, V21, P29, DOI 10.1159/000113744; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; Larsen JK, 1997, AM J PHYSIOL-LUNG C, V273, pL930, DOI 10.1152/ajplung.1997.273.5.L930; Maizels ET, 1998, BIOCHEM J, V332, P703, DOI 10.1042/bj3320703; Malmqvist U, 1997, P NATL ACAD SCI USA, V94, P7655, DOI 10.1073/pnas.94.14.7655; MARSTON SB, 1992, J BIOL CHEM, V267, P16796; Massett MP, 2002, AM J PHYSIOL-HEART C, V283, pH2282, DOI 10.1152/ajpheart.00544.2002; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; McVicker CG, 2007, AM J RESP CELL MOL, V36, P721, DOI 10.1165/rcmb.2006-0409OC; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; Moreno-Dominguez A, 2013, J PHYSIOL-LONDON, V591, P1235, DOI 10.1113/jphysiol.2012.243576; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Mufti RE, 2010, J PHYSIOL-LONDON, V588, P3983, DOI 10.1113/jphysiol.2010.193300; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Murphy RA, 2005, CAN J PHYSIOL PHARM, V83, P857, DOI 10.1139/Y05-090; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Ohanian V, 2005, HYPERTENSION, V46, P93, DOI 10.1161/01.HYP.0000167990.82235.3c; Osol G, 2002, AM J PHYSIOL-HEART C, V283, pH2260, DOI 10.1152/ajpheart.00634.2002; OSOL G, 1991, CIRC RES, V68, P359, DOI 10.1161/01.RES.68.2.359; OSOL G, 1993, AM J PHYSIOL, V265, pH415, DOI 10.1152/ajpheart.1993.265.1.H415; PAVALKO FM, 1995, AM J PHYSIOL-CELL PH, V268, pC563, DOI 10.1152/ajpcell.1995.268.3.C563; Pohl J, 1997, AM J PHYSIOL-LUNG C, V272, pL115, DOI 10.1152/ajplung.1997.272.1.L115; RATZ PH, 1989, AM J PHYSIOL, V256, pC96, DOI 10.1152/ajpcell.1989.256.1.C96; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Saito Shin-Ya, 1996, Journal of Smooth Muscle Research, V32, P51; Shaw L, 2003, J VASC RES, V40, P1, DOI 10.1159/000068940; Shin KD, 2005, J BIOL CHEM, V280, P41439, DOI 10.1074/jbc.M507209200; Somlyo AP, 2004, J MUSCLE RES CELL M, V25, P613; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Srinivasan R, 2008, AM J PHYSIOL-HEART C, V294, pH961, DOI 10.1152/ajpheart.00939.2007; Staiculescu MC, 2013, CARDIOVASC RES, V98, P428, DOI 10.1093/cvr/cvt034; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Straub SV, 2007, TRENDS CARDIOVAS MED, V17, P183, DOI 10.1016/j.tcm.2007.05.001; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; Tejani AD, 2011, AM J PHYSIOL-CELL PH, V301, pC1470, DOI 10.1152/ajpcell.00149.2011; Tejani AD, 2010, AM J PHYSIOL-CELL PH, V298, pC182, DOI 10.1152/ajpcell.00326.2009; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Walsh MP, 2013, J CEREBR BLOOD F MET, V33, P1, DOI 10.1038/jcbfm.2012.144; Walsh MP, 2011, AM J PHYSIOL-RENAL, V300, pF73, DOI 10.1152/ajprenal.00011.2010; Walsh MP, 1996, BIOCHEM CELL BIOL, V74, P485, DOI 10.1139/o96-053; Wang H, 2010, CYTOSKELETON, V67, P456, DOI 10.1002/cm.20458; Wier WG, 2008, J PHYSIOL-LONDON, V586, P2437, DOI 10.1113/jphysiol.2008.151522; Wieske M, 2001, EUR J BIOCHEM, V268, P2083, DOI 10.1046/j.1432-1327.2001.02082.x; WINDER SJ, 1990, J BIOL CHEM, V265, P10148; Xiao DL, 2004, AM J PHYSIOL-HEART C, V286, pH1615, DOI 10.1152/ajpheart.00981.2003; Yamin R, 2012, J PHYSIOL-LONDON, V590, P4145, DOI 10.1113/jphysiol.2012.232306; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Zhao R, 2008, J BIOL CHEM, V283, P36522, DOI 10.1074/jbc.M805294200; ZOU H, 1995, AM J PHYSIOL-HEART C, V269, pH1590, DOI 10.1152/ajpheart.1995.269.5.H1590	102	34	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20939	20952		10.1074/jbc.M114.553743	http://dx.doi.org/10.1074/jbc.M114.553743			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24914207	Green Published, hybrid			2022-12-25	WOS:000339396600047
J	Ibarbalz, FM; Perez, MV; Figuerola, ELM; Erijman, L				Ibarbalz, Federico M.; Victoria Perez, Maria; Figuerola, Eva L. M.; Erijman, Leonardo			The Bias Associated with Amplicon Sequencing Does Not Affect the Quantitative Assessment of Bacterial Community Dynamics	PLOS ONE			English	Article							SPECIES RICHNESS; WASTE-WATER; DIVERSITY; PRIMERS; UNIQUE; LENGTH; TOOLS; TAXA	The performance of two sets of primers targeting variable regions of the 16S rRNA gene V1-V3 and V4 was compared in their ability to describe changes of bacterial diversity and temporal turnover in full-scale activated sludge. Duplicate sets of high-throughput amplicon sequencing data of the two 16S rRNA regions shared a collection of core taxa that were observed across a series of twelve monthly samples, although the relative abundance of each taxon was substantially different between regions. A case in point was the changes in the relative abundance of filamentous bacteria Thiothrix, which caused a large effect on diversity indices, but only in the V1-V3 data set. Yet the relative abundance of Thiothrix in the amplicon sequencing data from both regions correlated with the estimation of its abundance determined using fluorescence in situ hybridization. In nonmetric multidimensional analysis samples were distributed along the first ordination axis according to the sequenced region rather than according to sample identities. The dynamics of microbial communities indicated that V1-V3 and the V4 regions of the 16S rRNA gene yielded comparable patterns of: 1) the changes occurring within the communities along fixed time intervals, 2) the slow turnover of activated sludge communities and 3) the rate of species replacement calculated from the taxa-time relationships. The temperature was the only operational variable that showed significant correlation with the composition of bacterial communities over time for the sets of data obtained with both pairs of primers. In conclusion, we show that despite the bias introduced by amplicon sequencing, the variable regions V1-V3 and V4 can be confidently used for the quantitative assessment of bacterial community dynamics, and provide a proper qualitative account of general taxa in the community, especially when the data are obtained over a convenient time window rather than at a single time point.	[Ibarbalz, Federico M.; Victoria Perez, Maria; Figuerola, Eva L. M.; Erijman, Leonardo] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol INGEBI, RA-1033 Buenos Aires, DF, Argentina; [Victoria Perez, Maria] Agua & Saneamientos Argentinos SA AySA, Buenos Aires, DF, Argentina; [Erijman, Leonardo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Erijman, L (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol INGEBI, RA-1033 Buenos Aires, DF, Argentina.	erijman@dna.uba.ar	Erijman, Leonardo/AAI-1359-2020; Core, UNC Microbiome/AAB-3304-2022	Erijman, Leonardo/0000-0001-7525-2112; Figuerola, Eva Lucia Margarita/0000-0002-7784-1452	FONCyT [1877]; UBACYT; AYSA-CONICET [3816/11]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	FONCyT(FONCyT); UBACYT; AYSA-CONICET; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partly funded by FONCyT (PICT 2012 No. 1877), UBACYT, and by a cooperative agreement AYSA-CONICET (Res. 3816/11). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2005, ECOLOGY, V86, P2032, DOI 10.1890/05-0067; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Ayarza JM, 2011, MICROB ECOL, V61, P486, DOI 10.1007/s00248-010-9762-y; Ayarza JM, 2010, MICROB ECOL, V59, P436, DOI 10.1007/s00248-009-9581-1; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Daims H, 2009, COLD SPRING HARB PRO, V2009; Eichner CA, 1999, APPL ENVIRON MICROB, V65, P102; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Falk MW, 2009, WATER RES, V43, P842, DOI 10.1016/j.watres.2008.11.021; Fernandez A, 1999, APPL ENVIRON MICROB, V65, P3697; Forney LJ, 2004, CURR OPIN MICROBIOL, V7, P210, DOI 10.1016/j.mib.2004.04.015; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gonzalez A, 2012, CURR OPIN BIOTECH, V23, P431, DOI 10.1016/j.copbio.2011.11.017; Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4; Heinrich F, 2013, AQUAT MICROB ECOL, V70, P33, DOI 10.3354/ame01637; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Ibarbalz FM, 2013, WATER RES, V47, P3854, DOI 10.1016/j.watres.2013.04.010; Jenkins D, 2004, MANUAL CAUSES ACTIVA; Ju F, 2014, ENVIRON MICROBIOL, V16, P2421, DOI 10.1111/1462-2920.12355; Kaewpipat K, 2002, WATER SCI TECHNOL, V46, P19, DOI 10.2166/wst.2002.0450; Kanagawa T, 2000, APPL ENVIRON MICROB, V66, P5043, DOI 10.1128/AEM.66.11.5043-5052.2000; Kim TS, 2013, APPL MICROBIOL BIOT, V97, P1755, DOI 10.1007/s00253-012-4002-7; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; LaPara TM, 2002, WATER RES, V36, P638, DOI 10.1016/S0043-1354(01)00277-9; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magurran AE, 2010, PHILOS T R SOC B, V365, P3611, DOI 10.1098/rstb.2010.0285; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; Oliver A, 2012, MICROBIAL ECOLOGICAL THEORY: CURRENT PERSPECTIVES, P71; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; REYSENBACH AL, 1992, APPL ENVIRON MICROB, V58, P3417, DOI 10.1128/AEM.58.10.3417-3418.1992; Scheiner SM, 2011, ECOL MONOGR, V81, P195, DOI 10.1890/10-1426.1; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A., 2010, MICROB ECOL, V59, P546, DOI [10.1007/s00248-009-9589-6, DOI 10.1007/s00248-009-9589-6]; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Smith S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf110; Suchankova P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076431, 10.1371/journal.pone.0071284]; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Wang X, 2010, J APPL MICROBIOL, V109, P1218, DOI 10.1111/j.1365-2672.2010.04742.x; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Werker AG, 2006, WATER SCI TECHNOL, V54, P11, DOI 10.2166/wst.2006.366; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zhang W, 2014, BIORESOURCE TECHNOL, V151, P397, DOI 10.1016/j.biortech.2013.10.004	60	38	38	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99722	10.1371/journal.pone.0099722	http://dx.doi.org/10.1371/journal.pone.0099722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923665	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300088
J	Maranon, E; Cermeno, P; Huete-Ortega, M; Lopez-Sandoval, DC; Mourino-Carballido, B; Rodriguez-Ramos, T				Maranon, Emilio; Cermeno, Pedro; Huete-Ortega, Maria; Lopez-Sandoval, Daffne C.; Mourino-Carballido, Beatriz; Rodriguez-Ramos, Tamara			Resource Supply Overrides Temperature as a Controlling Factor of Marine Phytoplankton Growth	PLOS ONE			English	Article							NUTRIENT LIMITATION; COMMUNITY STRUCTURE; METABOLIC BALANCE; ECOSYSTEM RIA; OCEAN; RATES; RESPIRATION; DEPENDENCE; CARBON; PHOTOSYNTHESIS	The universal temperature dependence of metabolic rates has been used to predict how ocean biology will respond to ocean warming. Determining the temperature sensitivity of phytoplankton metabolism and growth is of special importance because this group of organisms is responsible for nearly half of global primary production, sustains most marine food webs, and contributes to regulate the exchange of CO2 between the ocean and the atmosphere. Phytoplankton growth rates increase with temperature under optimal growth conditions in the laboratory, but it is unclear whether the same degree of temperature dependence exists in nature, where resources are often limiting. Here we use concurrent measurements of phytoplankton biomass and carbon fixation rates in polar, temperate and tropical regions to determine the role of temperature and resource supply in controlling the large-scale variability of in situ metabolic rates. We identify a biogeographic pattern in phytoplankton metabolic rates, which increase from the oligotrophic subtropical gyres to temperate regions and then coastal waters. Variability in phytoplankton growth is driven by changes in resource supply and appears to be independent of seawater temperature. The lack of temperature sensitivity of realized phytoplankton growth is consistent with the limited applicability of Arrhenius enzymatic kinetics when substrate concentrations are low. Our results suggest that, due to widespread resource limitation in the ocean, the direct effect of sea surface warming upon phytoplankton growth and productivity may be smaller than anticipated.	[Maranon, Emilio; Mourino-Carballido, Beatriz; Rodriguez-Ramos, Tamara] Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain; [Cermeno, Pedro; Lopez-Sandoval, Daffne C.] CSIC, Inst Ciencias Mar, Barcelona, Spain; [Huete-Ortega, Maria] Univ Sheffield, Dept Chem & Biol Engn, Sheffield, S Yorkshire, England	Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Sheffield	Maranon, E (corresponding author), Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain.	em@uvigo.es	C, López-Sandoval D./O-8516-2018; Mourino, Beatriz/E-8635-2016; Marañón, Emilio/Q-5817-2019; Marañón, Emilio/F-3013-2013; Huete-Ortega, Maria/K-4530-2014; Ramos, Tamara Rodríguez/P-6883-2017	C, López-Sandoval D./0000-0002-4605-0113; Marañón, Emilio/0000-0003-1572-2121; Marañón, Emilio/0000-0003-1572-2121; Huete-Ortega, Maria/0000-0002-8746-5518; Ramos, Tamara Rodríguez/0000-0002-8766-9991; Mourino-Carballido, Beatriz/0000-0001-7961-1477; Cermeno, Pedro/0000-0002-3902-3475	Spanish Ministry of Science and Innovation through research projects 'Macroecological patterns in marine phytoplankton' [CTM2008-03699]; MALASPINA [CSD2008-00077]; Role of turbulence and nutrient supply dynamics on the structure of marine phytoplankton communities [CTM2012-30680]; Ramon y Cajal-MEC	Spanish Ministry of Science and Innovation through research projects 'Macroecological patterns in marine phytoplankton'(Ministry of Science and Innovation, Spain (MICINN)); MALASPINA; Role of turbulence and nutrient supply dynamics on the structure of marine phytoplankton communities; Ramon y Cajal-MEC(Spanish Government)	This research was funded by the Spanish Ministry of Science and Innovation through research projects 'Macroecological patterns in marine phytoplankton' (CTM2008-03699), 'MALASPINA 2010' (CSD2008-00077) and 'Role of turbulence and nutrient supply dynamics on the structure of marine phytoplankton communities (CTM2012-30680). PC and BMC were supported by a Ramon y Cajal-MEC contract. This is contribution 250 of the AMT programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; BANSE K, 1991, LIMNOL OCEANOGR, V36, P1886, DOI 10.4319/lo.1991.36.8.1886; BANSE K, 1995, ICES J MAR SCI, V52, P265, DOI 10.1016/1054-3139(95)80043-3; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Berry J. A., 1981, PHYSL PLANT ECOLOGY, P277, DOI [10.1007/978-3-642-68090-8-11, DOI 10.1007/978-3-642-68090-8_11, DOI 10.1007/978-3-642-68090-8]; Bissinger JE, 2008, LIMNOL OCEANOGR, V53, P487, DOI 10.4319/lo.2008.53.2.0487; Boyd PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063091; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cermeno P, 2006, ESTUAR COAST SHELF S, V67, P251, DOI 10.1016/j.ecss.2005.11.027; CULLEN JJ, 1992, ENVIR SCI R, V43, P69; Davey M, 2008, LIMNOL OCEANOGR, V53, P1722, DOI 10.4319/lo.2008.53.5.1722; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Degerman R, 2013, AQUAT MICROB ECOL, V68, P131, DOI 10.3354/ame01609; Doney SC, 1996, DEEP-SEA RES PT II, V43, P591, DOI 10.1016/0967-0645(95)00104-2; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Falkowski P, 2012, NATURE, V483, pS17, DOI 10.1038/483S17a; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FENCHEL T, 1974, OECOLOGIA, V14, P317, DOI 10.1007/BF00384576; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Frew R, 2001, DEEP-SEA RES PT II, V48, P2467, DOI 10.1016/S0967-0645(01)00004-2; FURNAS MJ, 1990, J PLANKTON RES, V12, P1117, DOI 10.1093/plankt/12.6.1117; Gall MP, 2001, DEEP-SEA RES PT II, V48, P2571, DOI 10.1016/S0967-0645(01)00009-1; Gall MP, 2001, DEEP-SEA RES PT II, V48, P2551, DOI 10.1016/S0967-0645(01)00008-X; GEIDER RJ, 1987, NEW PHYTOL, V106, P1, DOI 10.1111/j.1469-8137.1987.tb04788.x; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GOLDMAN JC, 1974, LIMNOL OCEANOGR, V19, P756, DOI 10.4319/lo.1974.19.5.0756; GOLDMAN JC, 1979, NATURE, V279, P210, DOI 10.1038/279210a0; Griffith SM, 2001, ANN BOT-LONDON, V87, P599, DOI 10.1006/anbo.2001.1380; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Kirchman DL, 2002, MAR ECOL PROG SER, V233, P303, DOI 10.3354/meps233303; Laws EA, 2013, ANNU REV MAR SCI, V5, P247, DOI 10.1146/annurev-marine-121211-172258; LI WKW, 1985, DEEP-SEA RES, V32, P1381, DOI 10.1016/0198-0149(85)90054-8; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Litchman E, 2012, MAR ECOL PROG SER, V470, P235, DOI 10.3354/meps09912; Lopez-Urrutia A, 2006, P NATL ACAD SCI USA, V103, P8739, DOI 10.1073/pnas.0601137103; Maranon E, 2005, LIMNOL OCEANOGR, V50, P299, DOI 10.4319/lo.2005.50.1.0299; Maranon E, 2000, DEEP-SEA RES PT I, V47, P825, DOI 10.1016/S0967-0637(99)00087-4; Maranon E, 2013, ECOL LETT, V16, P371, DOI 10.1111/ele.12052; Marinov I, 2010, BIOGEOSCIENCES, V7, P3941, DOI 10.5194/bg-7-3941-2010; Moisan JR, 2002, ECOL MODEL, V153, P197, DOI 10.1016/S0304-3800(02)00008-X; Montagnes DJS, 2001, LIMNOL OCEANOGR, V46, P2008, DOI 10.4319/lo.2001.46.8.2008; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Nogueira E, 1997, ESTUAR COAST SHELF S, V44, P285, DOI 10.1006/ecss.1996.0119; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; Reay DS, 2001, MAR ECOL PROG SER, V219, P51, DOI 10.3354/meps219051; Regaudie-De-Gioux A, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003907; RHEE GY, 1981, LIMNOL OCEANOGR, V26, P635, DOI 10.4319/lo.1981.26.4.0635; Schmittner A, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002283; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Staehr PA, 2006, FRESHWATER BIOL, V51, P249, DOI 10.1111/j.1365-2427.2005.01490.x; Staehr PA, 2006, PHYCOLOGIA, V45, P648, DOI 10.2216/06-04.1; Tadonleke RD, 2010, LIMNOL OCEANOGR, V55, P973, DOI 10.4319/lo.2010.55.3.0973; Taucher J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045934; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; Toseland A, 2013, NAT CLIM CHANGE, V3, P979, DOI 10.1038/NCLIMATE1989; Veldhuis MJW, 2004, DEEP-SEA RES PT I, V51, P507, DOI 10.1016/j.dsr.2003.12.002; Wohlers-Zollner J, 2011, LIMNOL OCEANOGR, V56, P599, DOI 10.4319/lo.2011.56.2.0599; Yvon-Durocher G, 2010, PHILOS T R SOC B, V365, P2117, DOI 10.1098/rstb.2010.0038	65	70	70	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99312	10.1371/journal.pone.0099312	http://dx.doi.org/10.1371/journal.pone.0099312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921945	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000338701300048
J	Stanoev, A; Trpevski, D; Kocarev, L				Stanoev, Angel; Trpevski, Daniel; Kocarev, Ljupco			Modeling the Spread of Multiple Concurrent Contagions on Networks	PLOS ONE			English	Article							POPULATION-DYNAMICS; COEXISTENCE; DISEASES; PATTERNS	Many contagions spread over various types of communication networks and their spreading dynamics have been extensively studied in the literature. Here we propose a general model for the concurrent spread of an arbitrary number of contagions in complex networks. The model is stochastic and runs in discrete time, and includes two widely used mechanisms by which a node can change its state. The first, termed the spontaneous state change mechanism, describes spontaneous transition to another state, while the second, termed the contact-induced state change mechanism, describes acquiring other contagions due to contact with the neighbors. We consider reactive discrete-time spreading processes of multiple concurrent contagions where time steps are of finite size without neglecting the possibility of multiple infecting events in a single time step. An essential element for making the model numerically tractable is the use of an approximation for the probability that a node transits to a specific state given any set of neighboring states. Different transmission probabilities may be present between each pair of states. We also derive corresponding continuous-time equations that are simple and intuitive. The model includes many well-known epidemic and rumor spreading models as a special case and it naturally captures spreading processes in multiplex networks.	[Stanoev, Angel; Trpevski, Daniel; Kocarev, Ljupco] Macedonian Acad Sci & Arts, Skopje, North Macedonia		Kocarev, L (corresponding author), Macedonian Acad Sci & Arts, Skopje, North Macedonia.	lkocarev@manu.edu.mk	Kocarev, Ljupco/AAS-3002-2020	Stanoev, Angel/0000-0001-6478-7496; Trpevski, Daniel/0000-0001-9068-6744	Macedonian Academy of Sciences and Arts	Macedonian Academy of Sciences and Arts	This work was partially supported by the Macedonian Academy of Sciences and Arts. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ANDERSON R M, 1991; Andersson H., 2000, STOCHASTIC EPIDEMIC, V4; Bornholdt S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.058701; Brauer F., 2012, MATH MODELS POPULATI; Chakrabarti D, 2008, ACM T INFORM SYST SE, V10, DOI 10.1145/1284680.1284681; Cozzo E, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050801; Daley D. J., 2001, EPIDEMIC MODELLING I, V15; Daley D.J, 1964, J I MATH APPL, V1, P42, DOI DOI 10.1093/IMAMAT/1.1.42; DALEY DJ, 1964, NATURE, V204, P1118, DOI 10.1038/2041118a0; Faloutsos C., 2012, P 18 ACM SIGKDD INT, P426; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Gomez S, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/38009; Gomez S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036105; Gomez-Gardenes J, 2008, P NATL ACAD SCI USA, V105, P1399, DOI 10.1073/pnas.0707332105; Granell C, 2013, ARXIV13064136; Guerra B, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.035101; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Karrer B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036106; Kermack WO, 1932, P R SOC LOND A-CONTA, V138, P55, DOI 10.1098/rspa.1932.0171; Kosmidis K, 2005, PHYSICA A, V353, P595, DOI 10.1016/j.physa.2005.02.038; Lipsitch M, 2009, EPIDEMICS-NETH, V1, P2, DOI 10.1016/j.epidem.2008.07.001; Maki D.P., 1973, MATH MODELS APPL EMP; Nekovee M, 2007, PHYSICA A, V374, P457, DOI 10.1016/j.physa.2006.07.017; Newman MEJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108701; Oli MK, 2006, ECOL MODEL, V198, P183, DOI 10.1016/j.ecolmodel.2006.04.007; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Prakash BA, 2012, KNOWL INF SYST, V33, P549, DOI 10.1007/s10115-012-0520-y; Prakash BA, 2012, P 21 INT C WORLD WID, P1037, DOI [10.1145/2187836.2187975, DOI 10.1145/2187836.2187975]; Roche B, 2010, EPIDEMICS-NETH, V2, P92, DOI 10.1016/j.epidem.2010.03.002; Smilkov D, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016114; Sneppen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013326; Stauffer D, 2005, PHYS LIFE REV, V2, P89, DOI 10.1016/j.plrev.2005.03.001; Trpevski D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056102; Uekermann F, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036108; Wang Y, 2003, SYM REL DIST SYST, P25; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei XT, 2012, ACM SIGCOMM COMP COM, V42, P5, DOI 10.1145/2378956.2378958; Wolfowitz J., 1963, P AM MATH SOC, V14, P733, DOI [DOI 10.1090/S0002-9939-1963-0154756-3, 10.1090/S0002-9939-1963-0154756-3]	38	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e95669	10.1371/journal.pone.0095669	http://dx.doi.org/10.1371/journal.pone.0095669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922541	Green Submitted, Green Published, gold			2022-12-25	WOS:000338701300003
J	Tebruegge, M; Ritz, N; Koetz, K; Noguera-Julian, A; Seddon, JA; Welch, SB; Tsolia, M; Kampmann, B				Tebruegge, Marc; Ritz, Nicole; Koetz, Karsten; Noguera-Julian, Antoni; Seddon, James A.; Welch, Steven B.; Tsolia, Maria; Kampmann, Beate		Paediat TB Network European	Availability and Use of Molecular Microbiological and Immunological Tests for the Diagnosis of Tuberculosis in Europe	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; LINE-PROBE ASSAY; XPERT MTB/RIF; PULMONARY TUBERCULOSIS; RESPIRATORY SPECIMENS; RAPID DIAGNOSIS; COMPLEX; RESISTANCE; RIFAMPIN; FEASIBILITY	Introduction: Currently only limited data exist regarding the availability and clinical use of molecular and immunological tests for tuberculosis (TB) in the European setting. Methods: Web-based survey of Paediatric-Tuberculosis-Network-European-Trialsgroup (ptbnet) and Tuberculosis-Network-European-Trialsgroup (TBnet) members conducted June to December 2013. Both networks comprise clinicians, microbiologists, epidemiologists and researchers predominately based in Europe. Results: 191 healthcare professionals from 31 European countries participated. Overall, 26.8% of respondents did not have access to the Xpert MTB/RIF assay; only 44.6% had access to the assay in-house. However, a substantial proportion had access to other commercial and/or non-commercial PCR-based assays for TB (68.8% and 31.8%, respectively). Only 6.4% did not have access to any PCR-based assays for TB. A large proportion of participants with access to the Xpert MTB/RIF assay had used it for the analysis of non-respiratory samples [pleural fluid: 36.5%, gastric aspirates: 34.7%, cerebrospinal fluid: 34.7%, stool samples: 4.3%, blood/serum: 2.6%, 'other samples' (which included biopsy/tissue samples, lymph node aspirates, joint aspirates and urine samples): 16.5%]. Regarding interferon-gamma release assays, a greater proportion of respondents had access to the QuantiFERON-TB Gold assay (84.7%) than to the T-SPOT.TB assay (52.2%). Conclusions: Both immunological and molecular TB tests are widely available across Europe. The QuantiFERON-TB Gold assay is more widely used than the T-SPOT.TB assay, which may reflect the difficulties of integrating an ELISPOT assay into the routine laboratory setting. Although Xpert MTB/RIF assays are optimised and solely licensed for the analysis of sputum samples, in clinical practice they are commonly used for non-respiratory samples. Further research is needed to establish how current molecular TB tests impact on patient care and outcome in the routine clinical setting.	[Tebruegge, Marc] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Tebruegge, Marc] Univ Hosp Southampton NHS Fdn Trust, Dept Paediat Infect Dis & Immunol, Southampton, Hants, England; [Tebruegge, Marc] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Tebruegge, Marc; Ritz, Nicole] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Ritz, Nicole] Univ Childrens Hosp Basel, Infect Dis Unit, Basel, Switzerland; [Koetz, Karsten] Sahlgrens Univ Hosp, Dept Paediat, Gothenburg, Sweden; [Noguera-Julian, Antoni] Univ Barcelona, Hosp St Joan de Deu, Dept Paediat, Barcelona, Spain; [Seddon, James A.; Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Fac Med, Acad Dept Paediat, London, England; [Welch, Steven B.] Heart England NHS Fdn Trust, Birmingham Chest Clin, Southampton, Hants, England; [Tsolia, Maria] Univ Athens, Sch Med, P&A Kyriakou Childrens Hosp, Univ Dept Pediat 2, Athens 11528, Greece; [Kampmann, Beate] Med Res Council MRC Unit Gambia, Banjul, Gambia	University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Melbourne; University of Basel; Sahlgrenska University Hospital; University of Barcelona; Imperial College London; Heart of England NHS Foundation Trust; Athens Medical School; National & Kapodistrian University of Athens; University of London; London School of Hygiene & Tropical Medicine	Tebruegge, M (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England.	m.tebruegge@soton.ac.uk	Ritz, Nicole/G-2924-2015; Ritz, Nicole/L-1452-2019; Seddon, James/HHC-2093-2022	Ritz, Nicole/0000-0002-1498-1685; Ritz, Nicole/0000-0002-1498-1685; Seddon, James/0000-0002-2296-2302	UK National Institute for Health Research (NIHR); NIHR Southampton Respiratory Biomedical Research Unit; UK Technology Strategy Board (TSB); University of Basel; NIHR Senior Research Fellowship; MRC Program grant; Rozalia Foundation; Academy of Medical Sciences (AMS) [AMS-SGCL11-Seddon] Funding Source: researchfish; Medical Research Council [MC_UP_A900_1115, MC_UP_A900_1122] Funding Source: researchfish; National Institute for Health Research [CL-2011-26-004, CL-2012-21-006, SRF-2009-02-07] Funding Source: researchfish; MRC [MC_UP_A900_1122, MC_UP_A900_1115] Funding Source: UKRI	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Southampton Respiratory Biomedical Research Unit; UK Technology Strategy Board (TSB); University of Basel; NIHR Senior Research Fellowship; MRC Program grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rozalia Foundation; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	No funding specifically related to this study was received. MT is supported by a Clinical Lectureship provided by the UK National Institute for Health Research (NIHR), the NIHR Southampton Respiratory Biomedical Research Unit, and a research grant provided by the UK Technology Strategy Board (TSB). NR is supported by a career advancement grant from the University of Basel and a grant from the Rozalia Foundation. BK is supported by an NIHR Senior Research Fellowship and an MRC Program grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablanedo-Terrazas Y, 2014, LARYNGOSCOPE, V124, P1382, DOI 10.1002/lary.24478; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Barnard M, 2012, AM J RESP CRIT CARE, V186, P1298, DOI 10.1164/rccm.201205-0960OC; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; DAMATO RF, 1995, J CLIN MICROBIOL, V33, P1832, DOI 10.1128/JCM.33.7.1832-1834.1995; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Eisenhut M, 2012, NEW ENGL J MED, V367, P1568, DOI 10.1056/NEJMc1210173; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2013, TUB SURV MON EUR 201; Heifets L, 2000, J CLIN MICROBIOL, V38, P1227, DOI 10.1128/JCM.38.3.1227-1230.2000; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Lacoma A, 2008, J CLIN MICROBIOL, V46, P3660, DOI 10.1128/JCM.00618-08; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Ligthelm LJ, 2011, J CLIN MICROBIOL, V49, P3967, DOI 10.1128/JCM.01310-11; Moure R, 2012, J CLIN MICROBIOL, V50, P513, DOI 10.1128/JCM.06467-11; Nhu NTQ, 2014, J CLIN MICROBIOL, V52, P226, DOI 10.1128/JCM.01834-13; Nicol MP, 2013, CLIN INFECT DIS, V57, pE18, DOI 10.1093/cid/cit230; Nulty DD, 2008, ASSESS EVAL HIGH EDU, V33, P301, DOI 10.1080/02602930701293231; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536; Pfyffer GE, 1999, J CLIN MICROBIOL, V37, P137, DOI 10.1128/JCM.37.1.137-140.1999; Porcel JM, 2013, INT J TUBERC LUNG D, V17, P1217, DOI 10.5588/ijtld.13.0178; Tebruegge M, 2010, EUR RESPIR J, V36, P214, DOI 10.1183/09031936.00025510; Tebruegge M, 2013, THORAX, V68, P588, DOI 10.1136/thoraxjnl-2012-202824; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; U.S. Food and Drug Administration, 2013, XPERT MTB RIF ASS DE; US Food and Drug Administration, 2001, DEV APPR CLEAR QUANT; Viveiros M, 2005, J CLIN MICROBIOL, V43, P4880, DOI 10.1128/JCM.43.9.4880-4884.2005; VUORINEN P, 1995, J CLIN MICROBIOL, V33, P1856, DOI 10.1128/JCM.33.7.1856-1859.1995; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2014, WHO MON XPERT MTB RI; World Health Organization, 2013, XPERT MTBRIF ASSAY D	36	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99129	10.1371/journal.pone.0099129	http://dx.doi.org/10.1371/journal.pone.0099129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922084	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300035
J	Ranji, P; Rauthan, M; Pitot, C; Pilon, M				Ranji, Parmida; Rauthan, Manish; Pitot, Christophe; Pilon, Marc			Loss of HMG-CoA Reductase in C-elegans Causes Defects in Protein Prenylation and Muscle Mitochondria	PLOS ONE			English	Article							GERM-CELL MIGRATION; CAENORHABDITIS-ELEGANS; MEVALONATE PATHWAY; UPR; ACTIVATION	HMG-CoA reductase is the rate-limiting enzyme in the mevalonate pathway and the target of cholesterol-lowering statins. We characterized the C elegans hmgr-1(tm4368) mutant, which lacks HMG-CoA reductase, and show that its phenotypes recapitulate that of statin treatment, though in a more severe form. Specifically, the hmgr-1(tm4368) mutant has defects in growth, reproduction and protein prenylation, is rescued by exogenous mevalonate, exhibits constitutive activation of the UPRer and requires less mevalonate to be healthy when the UPRmt is activated by a constitutively active form of ATFS-1. We also show that different amounts of mevalonate are required for different physiological processes, with reproduction requiring the highest levels. Finally, we provide evidence that the mevalonate pathway is required for the activation of he UPRmt.	[Ranji, Parmida; Rauthan, Manish; Pitot, Christophe; Pilon, Marc] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg	Pilon, M (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	marc.pilon@cmb.gu.se	Pilon, Marc/B-9955-2008; Pilon, Marc/AAY-4082-2020	Pilon, Marc/0000-0003-3919-2882; Pilon, Marc/0000-0003-3919-2882; Ranji, Parmida/0000-0003-4502-1000	National Institute of Health Office of Research Infrasctructure Program [P400D010440]; Swedish Research Council; Cancerfonden; Carl Trygger Stiftelse; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institute of Health Office of Research Infrasctructure Program; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); Carl Trygger Stiftelse; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institute of Health Office of Research Infrasctructure Program (P400D010440). This work was funded by the Swedish Research Council, Cancerfonden and Carl Trygger Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd TT, 2011, EXPERT OPIN DRUG SAF, V10, P373, DOI 10.1517/14740338.2011.540568; Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Groenewoud MJ, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130185; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Patel TN, 2007, EUR HEART J, V28, P664, DOI 10.1093/eurheartj/ehl445; Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110; Rauthan M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-243; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Santos AC, 2004, DEV CELL, V6, P283, DOI 10.1016/S1534-5807(04)00023-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Thorpe JL, 2004, DEV CELL, V6, P295, DOI 10.1016/S1534-5807(04)00032-2; Westwood FR, 2008, TOXICOL PATHOL, V36, P345, DOI 10.1177/0192623307311412; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612	27	12	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e100033	10.1371/journal.pone.0100033	http://dx.doi.org/10.1371/journal.pone.0100033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918786	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000127
J	Tucker, AC; Escalante-Semerena, JC				Tucker, Alex C.; Escalante-Semerena, Jorge C.			Determinants within the C-Terminal Domain of Streptomyces lividans Acetyl-CoA Synthetase that Block Acetylation of Its Active Site Lysine In Vitro by the Protein Acetyltransferase (Pat) Enzyme	PLOS ONE			English	Article							COENZYME-A; RHODOPSEUDOMONAS-PALUSTRIS; SALMONELLA-ENTERICA; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; IDENTIFICATION; VECTORS; DEACETYLASE; ACTIVATION; EXPRESSION	Reversible lysine acetylation (RLA) is a widespread regulatory mechanism that modulates the function of proteins involved in diverse cellular processes. A strong case has been made for RLA control exerted by homologues of the Salmonella enterica protein acetyltransferase (SePat) enzyme on the broadly distributed AMP-forming CoA ligase (a.k.a. acyl-CoA synthetases) family of metabolic enzymes, with acetyl-CoA synthetase (Acs) being the paradigm in the field. Here we investigate why the Acs homologue in Streptomyces lividans (S/Acs) is poorly acetylated in vitro by the S. lividans protein acetyltransferase (S/Pat) enzyme. Chimeras of S. enterica Acs (SeAcs) and S. lividans Acs (S/Acs) constructed during the course of this work were acetylated by S/PatA in vitro, retained most of their activity, and were under RLA control in a heterologous host. We identified SeAcs residues N- and C-terminal to the target lysine that when introduced into SlAcs, rendered the latter under RLA control. These results lend further support to the idea that Pat enzymes interact with extensive surfaces of their substrates. Finally, we suggest that acetylation of SlAcs depends on factors or conditions other than those present in our in vitro system. We also discuss possible explanations why SlAcs is not controlled by RLA as defined in other bacterial species.	[Tucker, Alex C.; Escalante-Semerena, Jorge C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Escalante-Semerena, JC (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	jcescala@uga.edu			United States Public Health Service; National Institutes of Health [R01 GM062203]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062203, T32GM007215] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by United States Public Health Service, National Institutes of Health grant R01 GM062203. The funders had no role in the design, data collection and analysis, decision to publish or preparation of the manuscript. A	BERKOWIT.D, 1968, J BACTERIOL, V96, P215, DOI 10.1128/JB.96.1.215-220.1968; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Crosby HA, 2012, J BIOL CHEM, V287, P41392, DOI 10.1074/jbc.M112.417360; Crosby HA, 2012, J BIOL CHEM, V287, P15590, DOI 10.1074/jbc.M112.352104; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; Elion E. A., 2007, CURRENT PROTOCOLS MO; Gardner JG, 2006, J BACTERIOL, V188, P5460, DOI 10.1128/JB.00215-06; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Kuo YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054896; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Mikulik K, 2012, BIOCHEM CELL BIOL, V90, P179, DOI [10.1139/O11-086, 10.1139/o11-086]; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; SASSE J, 1991, CURRENT PROTOCOLS MO; Shirai A, 2008, J BIOL CHEM, V283, P10745, DOI 10.1074/jbc.M709211200; Soppa J, 2010, ARCHAEA, V2010, DOI 10.1155/2010/820681; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2003, GENETICS, V163, P545; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Thao S, 2011, CURR OPIN MICROBIOL, V14, P200, DOI 10.1016/j.mib.2010.12.013; Tucker AC, 2013, MOL MICROBIOL, V87, P152, DOI 10.1111/mmi.12088; Tucker AC, 2010, J BACTERIOL, V192, P6200, DOI 10.1128/JB.00874-10; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t	39	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99817	10.1371/journal.pone.0099817	http://dx.doi.org/10.1371/journal.pone.0099817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918787	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000115
J	Andersen, CL; Lindegaard, H; Vestergaard, H; Siersma, VD; Hasselbalch, HC; Olivarius, ND; Bjerrum, OW; Junker, P				Andersen, Christen Lykkegaard; Lindegaard, Hanne; Vestergaard, Hanne; Siersma, Volkert Dirk; Hasselbalch, Hans Carl; Olivarius, Niels de Fine; Bjerrum, Ole Weis; Junker, Peter			Risk of Lymphoma and Solid Cancer among Patients with Rheumatoid Arthritis in a Primary Care Setting	PLOS ONE			English	Article							MALIGNANT-LYMPHOMAS; THERAPY; EOSINOPHILIA; INFLAMMATION; AUTOIMMUNE; DISORDERS; LEUKEMIA; UPDATE; HEALTH; COHORT	Background: Several studies have demonstrated an association between rheumatoid arthritis (RA) and lymphoproliferative malignancies, but pathogenic mechanisms remain unclear. We investigated 1) the risk of lymphoproliferative malignancies and solid tumors in adults with RA identified in primary care and 2) the possible mediating role of blood eosinophilia in the clonal evolution of cancer in these patients. Methods: From the Copenhagen Primary Care Differential Count (CopDiff) Database, we identified 356,196 individuals with at least one differential cell count (DIFF) encompassing the eosinophil count between 2000-2007. From these, one DIFF was randomly chosen (the index DIFF). By linking to the Danish National Patient Register, we categorized the selected individuals according to known longstanding (>= 3 years) or recent onset (<3 years) RA prior to the index DIFF. In addition, the cohort was stratified according to management in primary or secondary care. From the Danish Cancer Registry we ascertained malignancies within four years following the index DIFF. Using multivariable logistic regression, odds ratios (OR) were calculated and adjusted for sex, age, year, month, eosinophilia, comorbid conditions and C-reactive protein (CRP). Results: 921 patients had recent onset RA and 2,578 had longer disease duration. Seventy three percent of RA patients were managed in primary care. After adjustment for sex, age, year, and month, neither recent onset nor long-standing RA was associated with incident lymphoproliferative malignancies or solid cancers. These risk estimates did not change when eosinophilia, CRP, and comorbidities were included in the models. Conclusions: In this large cohort of patients with RA of short or long duration recruited from a primary care resource, RA was not associated with an increased risk of lymphoproliferative or solid cancers during 4 years of follow-up, when the models were adjusted for confounders. Blood eosinophilia could not be identified as a mediator of cancer development in the present setting.	[Andersen, Christen Lykkegaard; Hasselbalch, Hans Carl] Roskilde Univ Hosp, Dept Hematol, Roskilde, Denmark; [Andersen, Christen Lykkegaard; Siersma, Volkert Dirk; Olivarius, Niels de Fine] Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Copenhagen, Denmark; [Andersen, Christen Lykkegaard; Siersma, Volkert Dirk; Olivarius, Niels de Fine] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark; [Lindegaard, Hanne; Junker, Peter] Odense Univ Hosp, Dept Rheumatol, DK-5000 Odense, Denmark; [Vestergaard, Hanne] Odense Univ Hosp, Dept Hematol, DK-5000 Odense, Denmark; [Bjerrum, Ole Weis] Copenhagen Univ Hosp, Dept Hematol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Copenhagen	Andersen, CL (corresponding author), Roskilde Univ Hosp, Dept Hematol, Roskilde, Denmark.	christenla@gmail.com	de Fine Olivarius, Niels/K-6832-2015; Bjerrum, Ole Weis/AAF-9999-2019; Lindegaard, Hanne Merete/AAV-5437-2020; Siersma, Volkert D/G-6867-2016; Hasselbalch, Hans/H-2217-2017	de Fine Olivarius, Niels/0000-0001-6465-3615; Lindegaard, Hanne Merete/0000-0002-5675-3859; Siersma, Volkert D/0000-0003-1941-2681; Hasselbalch, Hans/0000-0003-3936-8032; Lykkegaard Andersen, Christen Bertel/0000-0001-7753-6768	Danish Cancer Society; Eva & Henry Frankels' memorial foundation; Axel Muusfeldts memorial foundation	Danish Cancer Society(Danish Cancer Society); Eva & Henry Frankels' memorial foundation; Axel Muusfeldts memorial foundation	Christen Lykkegaard Andersen wishes to thank The Danish Cancer Society, which has granted a three-year scholarship (2010-2013). The authors would also like to express their gratitude to Eva & Henry Frankels' memorial foundation and Axel Muusfeldts memorial foundation for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo L, 2008, SEMIN ARTHRITIS RHEU, V37, P388, DOI 10.1016/j.semarthrit.2007.08.006; Andersen CL, 2013, AM J HEMATOL, V88, P843, DOI 10.1002/ajh.23515; Askling Johan, 2007, Curr Rheumatol Rep, V9, P421, DOI 10.1007/s11926-007-0067-1; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Baecklund E, 2014, SEMIN CANCER BIOL, V24, P61, DOI 10.1016/j.semcancer.2013.12.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Chakravarty EF, 2005, J RHEUMATOL, V32, P2130; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YJ, 2011, ARTHRITIS RHEUM-US, V63, P352, DOI 10.1002/art.30134; Cools J, 2005, HAEMATOLOGICA, V90, P582; Cush JJ, 2012, RHEUM DIS CLIN N AM, V38, P761, DOI 10.1016/j.rdc.2012.09.006; Ekstrom K, 2003, ARTHRITIS RHEUM-US, V48, P963, DOI 10.1002/art.10939; Smedby KE, 2006, CANCER EPIDEM BIOMAR, V15, P2069, DOI 10.1158/1055-9965.EPI-06-0300; Franklin J, 2006, ANN RHEUM DIS, V65, P617, DOI 10.1136/ard.2005.044784; Geborek P, 2005, ANN RHEUM DIS, V64, P699, DOI 10.1136/ard.2004.030528; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Gotlib J, 2014, AM J HEMATOL, V89, P325, DOI 10.1002/ajh.23664; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Hemminki K, 2013, BRIT J HAEMATOL, V161, P677, DOI 10.1111/bjh.12330; Jacobsen EA, 2012, BLOOD, V120, P3882, DOI 10.1182/blood-2012-06-330845; Kargili AE, 2004, RHEUMATOL INT, V24, P321, DOI 10.1007/s00296-004-0469-6; Khurana R, 2008, J RHEUMATOL, V35, P1704; Lichtman MA, 2010, ONCOLOGIST, V15, P1083, DOI 10.1634/theoncologist.2010-0206; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mellemkjaer L, 1996, EUR J CANCER, V32A, P1753, DOI 10.1016/0959-8049(96)00210-9; Mercer LK, 2013, RHEUMATOLOGY, V52, P91, DOI 10.1093/rheumatology/kes350; Morton LM, 2005, CANCER EPIDEM BIOMAR, V14, P925, DOI 10.1158/1055-9965.EPI-04-0693; PANUSH RS, 1971, ANN INTERN MED, V75, P199, DOI 10.7326/0003-4819-75-2-199; Pedersen M, 2004, EUR J EPIDEMIOL, V19, P1097, DOI 10.1007/s10654-004-1025-0; Ramiro S, 2014, ANN RHEUM DIS, V73, P529, DOI 10.1136/annrheumdis-2013-204575; Simonsson M, 1999, SCAND J RHEUMATOL, V28, P340; Tefferi A, 2006, BRIT J HAEMATOL, V133, P468, DOI 10.1111/j.1365-2141.2006.06038.x; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P1433, DOI 10.1002/art.22579; Woodward M., 2005, EPIDEMIOLOGY STUDY D, P278	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99388	10.1371/journal.pone.0099388	http://dx.doi.org/10.1371/journal.pone.0099388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914777	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700094
J	Bang, C; Weidenbach, K; Gutsmann, T; Heine, H; Schmitz, RA				Bang, Corinna; Weidenbach, Katrin; Gutsmann, Thomas; Heine, Holger; Schmitz, Ruth A.			The Intestinal Archaea Methanosphaera stadtmanae and Methanobrevibacter smithii Activate Human Dendritic Cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; METHANOGENIC BACTERIA; BREATH-METHANE; DIVERSITY; PEPTIDES; INNATE; HEALTH; MEMBER; DNA	The methanoarchaea Methanosphaera stadtmanae and Methanobrevibacter smithii are known to be part of the indigenous human gut microbiota. Although the immunomodulatory effects of bacterial gut commensals have been studied extensively in the last decade, the impact of methanoarchaea in human's health and disease was rarely examined. Consequently, we studied and report here on the effects of M. stadtmanae and M. smithii on human immune cells. Whereas exposure to M. stadtmanae leads to substantial release of proinflammatory cytokines in monocyte-derived dendritic cells (moDCs), only weak activation was detected after incubation with M. smithii. Phagocytosis of M. stadtmanae by moDCs was demonstrated by confocal microscopy as well as transmission electronic microscopy (TEM) and shown to be crucial for cellular activation by using specific inhibitors. Both strains, albeit to different extents, initiate a maturation program in moDCs as revealed by up-regulation of the cell-surface receptors CD86 and CD197 suggesting additional activation of adaptive immune responses. Furthermore, M. stadtmanae and M. smithii were capable to alter the gene expression of antimicrobial peptides in moDCs to different extents. Taken together, our findings strongly argue that the archaeal gut inhabitants M. stadtmanae and M . smithii are specifically recognized by the human innate immune system. Moreover, both strains are capable of inducing an inflammatory cytokine response to different extents arguing that they might have diverse immunomodulatory functions. that the impact of intestinal methanoarchaea on pathological conditions involving the gut microbiota has been underestimated until now.	[Bang, Corinna; Weidenbach, Katrin; Schmitz, Ruth A.] Univ Kiel, Inst Gen Microbiol, Kiel, Germany; [Gutsmann, Thomas] Res Ctr Borstel, Div Biophys, Borstel, Germany; [Heine, Holger] Airway Res Ctr North, Res Ctr Borstel, Div Innate Immun, Borstel, Germany	University of Kiel; Forschungszentrum Borstel; Forschungszentrum Borstel	Schmitz, RA (corresponding author), Univ Kiel, Inst Gen Microbiol, Kiel, Germany.	rschmitz@ifam.uni-kiel.de	Heine, Holger/H-4552-2012; Gutsmann, Thomas/E-6100-2011	Heine, Holger/0000-0001-8128-5068; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829; Bang, Corinna/0000-0001-6814-6151	German research foundation (DFG) [SCHM1051/11-1]	German research foundation (DFG)(German Research Foundation (DFG))	This work was support by German research foundation (DFG) (SCHM1051/11-1) (www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 2007, J BIOL CHEM, V282, P14719, DOI 10.1074/jbc.M608920200; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bang C, 2012, ANTIMICROB AGENTS CH, V56, P4123, DOI 10.1128/AAC.00661-12; Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; BELAY N, 1988, APPL ENVIRON MICROB, V54, P600, DOI 10.1128/AEM.54.2.600-603.1988; BELAY N, 1990, J CLIN MICROBIOL, V28, P1666, DOI 10.1128/JCM.28.7.1666-1668.1990; Blais-Lecours P, 2011, PLOS ONE, V6; Blais-Lecours P, 2014, PLOS ONE, V9; BOYUM A, 1964, NATURE, V204, P793, DOI 10.1038/204793a0; Cavicchioli R, 2003, BIOESSAYS, V25, P1119, DOI 10.1002/bies.10354; Chaban B, 2006, CAN J MICROBIOL, V52, P73, DOI [10.1139/WDS-147, 10.1139/w05-147]; CHEN CY, 1994, J IMMUNOL, V152, P4929; de Macario EC, 2009, INT J MED MICROBIOL, V299, P99, DOI 10.1016/j.ijmm.2008.06.011; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; DEMACARIO EC, 1982, J IMMUNOL, V129, P1670; DEMACARIO EC, 1983, P NATL ACAD SCI-BIOL, V80, P6346; DEMACARIO EC, 1984, J IMMUNOL, V132, P883; Dridi B, 2011, ANAEROBE, P1; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Eckburg PB, 2003, INFECT IMMUN, V71, P591, DOI 10.1128/IAI.71.2.591-596.2003; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gutsmann T, 2005, J ENDOTOXIN RES, V11, P167, DOI 10.1179/096805105X37330; HAINES A, 1977, LANCET, V2, P481; HART D N J, 1990, International Reviews of Immunology, V6, P127, DOI 10.3109/08830189009056624; Heine H, 2007, J ENDOTOXIN RES, V13, P126, DOI 10.1177/0968051907079122; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Kandler O, 1998, CELL MOL LIFE SCI, V54, P305, DOI 10.1007/s000180050156; Konig H, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P1; KONIG H, 1988, CAN J MICROBIOL, V34, P395, DOI 10.1139/m88-071; KONIG H, 1982, ZBL BAKT MIK HYG I C, V3, P179; Levitt MD, 2006, CLIN GASTROENTEROL H, V4, P123, DOI 10.1016/j.cgh.2005.11.006; Lipscomb MF, 2002, PHYSIOL REV, V82, P97, DOI 10.1152/physrev.00023.2001; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; MILLER TL, 1985, ARCH MICROBIOL, V141, P116, DOI 10.1007/BF00423270; MILLER TL, 1984, APPL ENVIRON MICROB, V48, P449, DOI 10.1128/AEM.48.2.449-450.1984; MILLER TL, 1982, APPL ENVIRON MICROB, V43, P227, DOI 10.1128/AEM.43.1.227-232.1982; PIQUE JM, 1984, GASTROENTEROLOGY, V87, P601; Probst AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065388; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Scanlan PD, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-79; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Turpin J, 1986, J Clin Apher, V3, P111, DOI 10.1002/jca.2920030207; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200	53	81	84	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99411	10.1371/journal.pone.0099411	http://dx.doi.org/10.1371/journal.pone.0099411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915454	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700099
J	Finkelstein, EA; Chay, J; Bajpai, S				Finkelstein, Eric A.; Chay, Junxing; Bajpai, Shailendra			The Economic Burden of Self-Reported and Undiagnosed Cardiovascular Diseases and Diabetes on Indonesian Households	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; CORONARY-HEART-DISEASE; WEIGHT-LOSS; HEALTH; PRODUCTIVITY; PREVENTION; OBESITY; RISK; HYPERTENSION; INDIVIDUALS	Objectives: The goal of this study is: (1) to estimate the current direct out-of-pocket (OOP) and indirect non-communicable diseases (NCD) burden on Indonesian households and (2) to project NCD prevalence and burden in 2020 focusing specifically on hypertension, diabetes, heart problems and stroke. Methods: This study relies on econometric analyses based on four waves of the Indonesian Family Life Survey (IFLS). Results: In aggregate, of the NCDs studied, heart problems exert the greatest economic burden on households, costing Int$1.56 billion in OOP and indirect burden in 2010. This was followed by hypertension (Int$1.36 billion), diabetes (Int$0.81 billion) and stroke (Int$0.29 billion). The OOP and indirect burden of these conditions is estimated to be Int$4.02 billion. Diabetes and stroke are expected to have the largest proportional increases in burden by 2020; 56.0% for diabetes and 56.9% for stroke to total Int$1.27 billion and Int$0.45 billion respectively. The burden of heart problems in 2020 is expected to increase by 34.4% to total Int$2.09 billion and hypertension burden will increase by 46.1% to Int$1.99 billion. In 2020, these conditions are expected to impose an economic burden of Int$5.80 billion. Conclusion: In conclusion, this study demonstrates the significant burden of 4 primary NCDs on Indonesian households. In addition to the indirect burden, hypertension, diabetes, heart problems and stroke account for 8% of the nation's OOP healthcare expenditure, and due to rising disease prevalence and an aging population, this figure is expected to increase to 12% by 2020 without a significant health intervention.	[Finkelstein, Eric A.; Chay, Junxing] Duke NUS Grad Med Sch, Hlth Serv & Syst Res Program, Singapore, Singapore; [Finkelstein, Eric A.] Duke Univ, Global Hlth Inst, Durham, NC USA; [Bajpai, Shailendra] Sanofi Aventis, Med Affairs, Singapore, Singapore	National University of Singapore; Duke University; Sanofi-Aventis	Finkelstein, EA (corresponding author), Duke NUS Grad Med Sch, Hlth Serv & Syst Res Program, Singapore, Singapore.	eric.finkelstein@duke-nus.edu.sg		Chay, Junxing/0000-0002-3291-4523	Sanofi-Aventis Singapore Pte. Ltd	Sanofi-Aventis Singapore Pte. Ltd	These findings are the result of work supported by Sanofi-Aventis Singapore Pte. Ltd. The views expressed in this paper are those of the authors, and no official endorsement by Sanofi-Aventis is intended or should be inferred. Publication of the study results was not contingent upon sponsor's approval. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Bilger M, 2013, MED CARE, V51, P471, DOI 10.1097/MLR.0b013e318286e437; Chang Hoo-Sun, 2012, J Prev Med Public Health, V45, P291, DOI 10.3961/jpmph.2012.45.5.291; Chapman RH, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-11; Clegg A, 2003, INT J OBESITY, V27, P1167, DOI 10.1038/sj.ijo.0802394; Cobiac LJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000110; Finkelstein EA, 2010, J OCCUP ENVIRON MED, V52, P971, DOI 10.1097/JOM.0b013e3181f274d2; Fox KM, 2008, CURR MED RES OPIN, V24, P3323, DOI [10.1185/03007990802520045, 10.1185/03007990802520045 ]; Friedman RH, 1996, AM J HYPERTENS, V9, P285, DOI 10.1016/0895-7061(95)00353-3; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Gulliford M, 2013, EUR J HEALTH ECON, P1; HATZIANDREU EI, 1988, AM J PUBLIC HEALTH, V78, P1417, DOI 10.2105/AJPH.78.11.1417; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hoerger TJ, 2004, ANN INTERN MED, V140, P689, DOI 10.7326/0003-4819-140-9-200405040-00008; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; International Diabetes Federation, 2009, IDF DIAB ATL; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Leartsakulpanitch Jittrakul, 2007, Journal of the Medical Association of Thailand, V90, P1925; Lightwood J, 2009, AM J PUBLIC HEALTH, V99, P2230, DOI 10.2105/AJPH.2008.152595; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Liu JLY, 2002, HEART, V88, P597, DOI 10.1136/heart.88.6.597; Luengo-Fernandez R, 2006, HEART, V92, P1384, DOI 10.1136/hrt.2005.072173; Ma Y, 2010, EUR J NEUROL, V17, P1270, DOI 10.1111/j.1468-1331.2010.03007.x; McManus RJ, 2005, BMJ-BRIT MED J, V331, P493, DOI 10.1136/bmj.38558.393669.E0; Ministry of Health and National Institute of Health Research and Development, 2008, NAT REP BAS HLTH RES; Muller-Nordhorn J, 2008, CLIN RES CARDIOL, V97, P152, DOI 10.1007/s00392-007-0602-0; National Heart Lung and Blood Institute, 2003, 7 JNC NAT HEART LUNG; National Institute for Health and Clinical Excellence, 2007, GUID MAN; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Rice D P, 1981, Vital Health Stat 3, P1; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P424, DOI 10.2105/AJPH.57.3.424; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P1954, DOI 10.2105/AJPH.57.11.1954; Shaw LJ, 2006, CIRCULATION, V114, P894, DOI 10.1161/CIRCULATIONAHA.105.609990; Sullivan PW, 2007, VALUE HEALTH, V10, P443, DOI 10.1111/j.1524-4733.2007.00199.x; Sutrisna B, 2009, MEDIA MEDIKA INDONES, V43, P247; Thabrany H., 2012, INDONESIA HEAVEN CIG; WHO, 2006, BMI CLASS; WHO, 2011, GLOB STAT REP NONC D; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2003, MAK CHOC HLTH WHO GU; World Health Organization, WHO HLTH EXP SER; Zheng H, 2010, APPL HEALTH ECON HEA, V8, P179, DOI 10.2165/11530520-000000000-00000	44	20	20	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99572	10.1371/journal.pone.0099572	http://dx.doi.org/10.1371/journal.pone.0099572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24915510	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700117
J	Zdzalik, D; Vagbo, CB; Kirpekar, F; Davydova, E; Puscian, A; Maciejewska, AM; Krokan, HE; Klungland, A; Tudek, B; van den Born, E; Falnes, PO				Zdzalik, Daria; Vagbo, Cathrine B.; Kirpekar, Finn; Davydova, Erna; Puscian, Alicja; Maciejewska, Agnieszka M.; Krokan, Hans E.; Klungland, Arne; Tudek, Barbara; van den Born, Erwin; Falnes, Pal O.			Protozoan ALKBH8 Oxygenases Display both DNA Repair and tRNA Modification Activities	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; OBESITY-ASSOCIATED FTO; ESCHERICHIA-COLI; OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; WOBBLE POSITION; ENZYME ALKB; PROTEINS; BACTERIAL; LESIONS	The ALKBH family of Fe(II) and 2-oxoglutarate dependent oxygenases comprises enzymes that display sequence homology to AlkB from E. coli, a DNA repair enzyme that uses an oxidative mechanism to dealkylate methyl and etheno adducts on the nucleobases. Humans have nine different ALKBH proteins, ALKBH1-8 and FTO. Mammalian and plant ALKBH8 are tRNA hydroxylases targeting 5-methoxycarbonylmethyl-modified uridine (mcm(5)U) at the wobble position of tRNA(Gly(UCC)). In contrast, the genomes of some bacteria encode a protein with strong sequence homology to ALKBH8, and robust DNA repair activity was previously demonstrated for one such protein. To further explore this apparent functional duality of the ALKBH8 proteins, we have here enzymatically characterized a panel of such proteins, originating from bacteria, protozoa and mimivirus. All the enzymes showed DNA repair activity in vitro, but, interestingly, two protozoan ALKBH8s also catalyzed wobble uridine modification of tRNA, thus displaying a dual in vitro activity. Also, we found the modification status of tRNA(Gly(UCC)) to be unaltered in an ALKBH8 deficient mutant of Agrobacterium tumefaciens, indicating that bacterial ALKBH8s have a function different from that of their eukaryotic counterparts. The present study provides new insights on the function and evolution of the ALKBH8 family of proteins.	[Zdzalik, Daria; Davydova, Erna; van den Born, Erwin; Falnes, Pal O.] Univ Oslo, Dept Biosci, Oslo, Norway; [Zdzalik, Daria; Puscian, Alicja; Tudek, Barbara] Univ Warsaw, Inst Genet & Biotechnol, Warsaw, Poland; [Vagbo, Cathrine B.; Krokan, Hans E.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Kirpekar, Finn] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Puscian, Alicja] Polish Acad Sci, M Nencki Inst Expt Biol, Dept Neurophysiol, Warsaw, Poland; [Maciejewska, Agnieszka M.; Tudek, Barbara] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Klungland, Arne] Oslo Univ Hosp, Clin Diagnost & Intervent, Rikshosp, Oslo, Norway; [Klungland, Arne] Oslo Univ Hosp, Inst Med Microbiol, Rikshosp, Oslo, Norway; [Klungland, Arne] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; University of Warsaw; Norwegian University of Science & Technology (NTNU); University of Southern Denmark; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo	Falnes, PO (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	pal.falnes@ibv.uio.no	Zdżalik-Bielecka, Daria P/N-6785-2015; Maciejewska, Agnieszka M/B-2287-2012; Vågbø, Cathrine Broberg/N-3226-2017; Puscian, Alicja/AAQ-7575-2021; Falnes, Pål Ø./AAA-4581-2020; Klungland, Arne/X-1233-2019	Vågbø, Cathrine Broberg/0000-0003-3959-7409; Puscian, Alicja/0000-0002-7029-1275; Zdzalik-Bielecka, Daria/0000-0003-3096-8293; Davydova, Erna/0000-0001-7072-4539; Kirpekar, Finn/0000-0003-1901-2266; Maciejewska, Agnieszka M./0000-0002-1268-2606; Falnes, Pal/0000-0001-8114-6025; Klungland, Arne/0000-0001-7274-3661	Research Council of Norway; Norwegian Cancer Society; Polish-Norwegian Research Programme [PNRF-143-A1-1/07]; Iceland, Liechtenstein and Norway - European Economic Area Financial Mechanism; Norwegian Financial Mechanism	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Polish-Norwegian Research Programme; Iceland, Liechtenstein and Norway - European Economic Area Financial Mechanism; Norwegian Financial Mechanism	This work was supported by the Research Council of Norway; the Norwegian Cancer Society; the Polish-Norwegian Research Programme (PNRF-143-A1-1/07) and by Iceland, Liechtenstein and Norway by means of co-financing from the European Economic Area Financial Mechanism and the Norwegian Financial Mechanism as part of the Scholarship and Training Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; ARAVIND L, 2001, GENOME BIOL, V2; Blatny JM, 1997, APPL ENVIRON MICROB, V63, P370, DOI 10.1128/AEM.63.2.370-379.1997; Calvo JA, 2012, J CLIN INVEST, V122, P2680, DOI 10.1172/JCI63338; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Dinglay S, 2000, GENE DEV, V14, P2097; DOSANJH MK, 1994, P NATL ACAD SCI USA, V91, P1024, DOI 10.1073/pnas.91.3.1024; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; Falnes PO, 2003, RES MICROBIOL, V154, P531, DOI 10.1016/S0923-2508(03)00150-5; Frick LE, 2007, P NATL ACAD SCI USA, V104, P755, DOI 10.1073/pnas.0607377104; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gros L, 2003, MUTAT RES-FUND MOL M, V531, P219, DOI 10.1016/j.mrfmmm.2003.07.008; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim MY, 2007, CHEM RES TOXICOL, V20, P1075, DOI 10.1021/tx700167v; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Koivisto P, 2003, J BIOL CHEM, V278, P44348, DOI 10.1074/jbc.M307361200; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Leihne V, 2011, NUCLEIC ACIDS RES, V39, P7688, DOI 10.1093/nar/gkr406; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Maciejewska AM, 2013, J BIOL CHEM, V288, P432, DOI 10.1074/jbc.M112.353342; Maciejewska AM, 2010, MUTAT RES-FUND MOL M, V684, P24, DOI 10.1016/j.mrfmmm.2009.11.005; Mantri M, 2012, FEBS J, V279, P1563, DOI 10.1111/j.1742-4658.2012.08496.x; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Ougland R, 2012, STEM CELLS, V30, P2672, DOI 10.1002/stem.1228; Pastore C, 2012, J BIOL CHEM, V287, P2130, DOI 10.1074/jbc.M111.286187; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Ringvoll J, 2008, CANCER RES, V68, P4142, DOI 10.1158/0008-5472.CAN-08-0796; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; van den Born E, 2008, NUCLEIC ACIDS RES, V36, P5451, DOI 10.1093/nar/gkn519; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; van den Born E, 2009, NUCLEIC ACIDS RES, V37, P7124, DOI 10.1093/nar/gkp774; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	57	25	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98729	10.1371/journal.pone.0098729	http://dx.doi.org/10.1371/journal.pone.0098729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914785	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700031
J	Katz, A; Tal, DM; Heller, D; Haviv, H; Rabah, B; Barkana, Y; Marcovich, AL; Karlish, SJD				Katz, Adriana; Tal, Daniel M.; Heller, Dan; Haviv, Haim; Rabah, Bilal; Barkana, Yaniv; Marcovich, Arie L.; Karlish, Steven J. D.			Digoxin Derivatives with Enhanced Selectivity for the alpha 2 Isoform of Na, K-ATPase EFFECTS ON INTRAOCULAR PRESSURE IN RABBITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY EPITHELIAL-CELLS; OUABAIN-BINDING-SITE; DEPENDENT ADENOSINE-TRIPHOSPHATASE; DISSOCIATION RATE CONSTANTS; CARDIOTONIC STEROIDS; CARDIAC-GLYCOSIDES; CRYSTAL-STRUCTURE; OUTFLOW FACILITY; NA,K-ATPASE; INHIBITION	In the ciliary epithelium of the eye, the pigmented cells express the alpha 1 beta 1 isoform of Na, K-ATPase, whereas the nonpigmented cells express mainly the alpha 2 beta 3 isoform of Na, K-ATPase. In principle, a Na, K-ATPase inhibitor with selectivity for alpha 2 could effectively reduce intraocular pressure with only minimal local and systemic toxicity. Such an inhibitor could be applied topically provided it was sufficiently permeable via the cornea. Previous experiments with recombinant human alpha 1 beta 1, alpha 2 beta 1, and alpha 3 beta 1 isoforms showed that the classical cardiac glycoside, digoxin, is partially alpha 2-selective and also that the tris-digitoxose moiety is responsible for isoform selectivity. This led to a prediction that modification of the third digitoxose might increase alpha 2 selectivity. A series of perhydro-1,4-oxazepine derivatives of digoxin have been synthesized by periodate oxidation and reductive amination using a variety of R-NH2 substituents. Several derivatives show enhanced selectivity for alpha 2 over alpha 1, close to 8-fold in the best case. Effects of topically applied cardiac glycosides on intraocular pressure in rabbits have been assessed by their ability to either prevent or reverse acute intraocular pressure increases induced by 4-aminopyridine or a selective agonist of the A3 adenosine receptor. Two relatively alpha 2-selective digoxin derivatives efficiently normalize the ocular hypertension, by comparison with digoxin, digoxigenin, or ouabain. This observation is consistent with a major role of alpha 2 in aqueous humor production and suggests that, potentially, alpha 2-selective digoxin derivatives could be of interest as novel drugs for control of intraocular pressure.	[Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Heller, Dan; Barkana, Yaniv] Asaf Harofeh Hosp, Dept Ophthalmol, IL-608183 Zerifin, Israel; [Rabah, Bilal; Marcovich, Arie L.] Kaplan Hosp, Dept Ophthalmol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Kaplan Medical Center	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il		Heller, Dan/0000-0001-5441-9278	Israel Science Foundation [789/12]; Israel Ministry of Trade and Industry Kamin-Yeda Program [47146]	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Trade and Industry Kamin-Yeda Program	This work was supported by Israel Science Foundation Grant 789/12 and Israel Ministry of Trade and Industry Kamin-Yeda Program Project 47146.	ADAMCZYK M, 1995, STEROIDS, V60, P753, DOI 10.1016/0039-128X(95)00115-7; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Carre DA, 2000, AM J PHYSIOL-CELL PH, V279, pC440, DOI 10.1152/ajpcell.2000.279.2.C440; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Cornelius F, 2013, J BIOL CHEM, V288, P6602, DOI 10.1074/jbc.M112.442137; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Dismuke WM, 2009, BRIT J OPHTHALMOL, V93, P104, DOI 10.1136/bjo.2008.142133; Do CW, 2004, J MEMBRANE BIOL, V200, P1, DOI 10.1007/s00232-004-0688-5; EDELMAN JL, 1994, AM J PHYSIOL, V266, pC1210, DOI 10.1152/ajpcell.1994.266.5.C1210; FERRAIOLO BL, 1979, EUR J PHARMACOL, V55, P19, DOI 10.1016/0014-2999(79)90143-2; FROM AHL, 1990, MOL CELL BIOCHEM, V94, P157, DOI 10.1007/BF00214122; HALL C, 1980, P NATL ACAD SCI-BIOL, V77, P4529, DOI 10.1073/pnas.77.8.4529; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Huang B, 2003, ARCH OPHTHALMOL-CHIC, V121, P840, DOI 10.1001/archopht.121.6.840; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Li A, 2012, EXP EYE RES, V96, P4, DOI 10.1016/j.exer.2012.01.009; Li A, 2010, AM J PHYSIOL-CELL PH, V299, pC1308, DOI 10.1152/ajpcell.00333.2010; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; Ruoho A E, 1980, Ann N Y Acad Sci, V346, P90, DOI 10.1111/j.1749-6632.1980.tb22093.x; Sandtner W, 2011, J BIOL CHEM, V286, P38177, DOI 10.1074/jbc.M111.267682; SATOH D, 1970, Chemical and Pharmaceutical Bulletin (Tokyo), V18, P94; SIMON KA, 1962, ARCH OPHTHALMOL-CHIC, V68, P227; Socci RR, 2003, PHARMACOLOGY, V69, P108, DOI 10.1159/000072364; Tamiya S, 2003, INVEST OPHTH VIS SCI, V44, P4395, DOI 10.1167/iovs.03-0287; TICHO U, 1979, BRIT J OPHTHALMOL, V63, P646, DOI 10.1136/bjo.63.9.646; Tsai J., 2004, MED MANAGEMENT GLAUC MED MANAGEMENT GLAUC, V2nd; Wasserstrom JA, 2005, AM J PHYSIOL-HEART C, V289, pH1781, DOI 10.1152/ajpheart.00707.2004; Wetzel RK, 2001, INVEST OPHTH VIS SCI, V42, P763; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; YODA A, 1973, MOL PHARMACOL, V9, P51; YODA A, 1974, MOL PHARMACOL, V10, P494	37	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21153	21162		10.1074/jbc.M114.557629	http://dx.doi.org/10.1074/jbc.M114.557629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24917667	hybrid, Green Published			2022-12-25	WOS:000339396600065
J	Dorweiler, JE; Ni, T; Zhu, J; Munroe, SH; Anderson, JT				Dorweiler, Jane E.; Ni, Ting; Zhu, Jun; Munroe, Stephen H.; Anderson, James T.			Certain Adenylated Non-Coding RNAs, Including 5' Leader Sequences of Primary MicroRNA Transcripts, Accumulate in Mouse Cells following Depletion of the RNA Helicase MTR4	PLOS ONE			English	Article							RIBOSOMAL-RNA; QUALITY-CONTROL; NUCLEAR-RNA; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; POLY(A) POLYMERASE; U3B RNA; EXOSOME; YEAST; POLYADENYLATION	RNA surveillance plays an important role in posttranscriptional regulation. Seminal work in this field has largely focused on yeast as a model system, whereas exploration of RNA surveillance in mammals is only recently begun. The increased transcriptional complexity of mammalian systems provides a wider array of targets for RNA surveillance, and, while many questions remain unanswered, emerging data suggest the nuclear RNA surveillance machinery exhibits increased complexity as well. We have used a small interfering RNA in mouse N2A cells to target the homolog of a yeast protein that functions in RNA surveillance (Mtr4p). We used high-throughput sequencing of polyadenylated RNAs (PA-seq) to quantify the effects of the mMtr4 knockdown (KD) on RNA surveillance. We demonstrate that overall abundance of polyadenylated protein coding mRNAs is not affected, but several targets of RNA surveillance predicted from work in yeast accumulate as adenylated RNAs in the mMtr4KD. microRNAs are an added layer of transcriptional complexity not found in yeast. After Drosha cleavage separates the pre-miRNA from the microRNA's primary transcript, the byproducts of that transcript are generally thought to be degraded. We have identified the 59 leading segments of pri-miRNAs as novel targets of mMtr4 dependent RNA surveillance.	[Dorweiler, Jane E.; Munroe, Stephen H.; Anderson, James T.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Ni, Ting; Zhu, Jun] NHLBI, DNA Sequencing & Genom Core, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA	Marquette University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Munroe, SH (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	Stephen.munroe@marquette.edu; james.anderson@marquette.edu	Dorweiler, Jane/K-3116-2019		Marquette University Way Klingler College of Arts and Sciences; Marquette University Department of Biological Sciences; National Heart Lung Blood Institute, National Institutes of Health; National Institutes of Health [1R15GM100445-01A1]; open access charge: Marquette University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM100445] Funding Source: NIH RePORTER	Marquette University Way Klingler College of Arts and Sciences; Marquette University Department of Biological Sciences; National Heart Lung Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); open access charge: Marquette University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Marquette University Way Klingler College of Arts and Sciences to J.T.A.; by Marquette University Department of Biological Sciences to J.T.A. and S.H.M.; and by intramural research program at National Heart Lung Blood Institute, National Institutes of Health to J.Z.; and by National Institutes of Health grant number 1R15GM100445-01A1 to J.T.A. Funding for open access charge: Marquette University and National Institutes of Health grant number 1R15GM100445-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; Assenholt J, 2008, RNA, V14, P2305, DOI 10.1261/rna.1108008; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Bassuk AG, 2007, NEUROGENETICS, V8, P45, DOI 10.1007/s10048-006-0067-8; Beaulieu YB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003078; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Bremer J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012450; Bresson SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003893; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; Bruserud O, 2007, CURR PHARM BIOTECHNO, V8, P318, DOI 10.2174/138920107783018408; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; CRAIG N, 1987, P NATL ACAD SCI USA, V84, P629, DOI 10.1073/pnas.84.3.629; CRAIG N, 1991, MOL CELL BIOL, V11, P458, DOI 10.1128/MCB.11.1.458; Cristodero M, 2007, NUCLEIC ACIDS RES, V35, P7023, DOI 10.1093/nar/gkm736; DARNELL JE, 1968, BACTERIOL REV, V32, P262, DOI 10.1128/MMBR.32.3.262-290.1968; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Dieci G, 2013, BBA-GENE REGUL MECH, V1829, P296, DOI 10.1016/j.bbagrm.2012.09.010; Dogini DB, 2008, J MOL NEUROSCI, V35, P331, DOI 10.1007/s12031-008-9068-4; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Eda A, 2011, GENE, V485, P46, DOI 10.1016/j.gene.2011.05.034; Eda A, 2009, BIOCHEM BIOPH RES CO, V388, P648, DOI 10.1016/j.bbrc.2009.08.040; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Etheridge RD, 2009, MOL BIOCHEM PARASIT, V164, P66, DOI 10.1016/j.molbiopara.2008.11.004; Fasken MB, 2011, J BIOL CHEM, V286, P37429, DOI 10.1074/jbc.M111.271494; Fogel BL, 2006, NEUROLOGY, V67, P2083, DOI 10.1212/01.wnl.0000247661.19601.28; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; GILHAM PT, 1970, ANNU REV BIOCHEM, V39, P227, DOI 10.1146/annurev.bi.39.070170.001303; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haracska L, 2005, MOL CELL BIOL, V25, P10183, DOI 10.1128/MCB.25.22.10183-10189.2005; Hessle V, 2009, MOL BIOL CELL, V20, P3459, DOI 10.1091/mbc.E09-01-0079; Holub P, 2012, NUCLEIC ACIDS RES, V40, P5679, DOI 10.1093/nar/gks223; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Inoue K, 2000, J BIOL CHEM, V275, P32793, DOI 10.1074/jbc.M004560200; Jia HJ, 2011, CELL, V145, P890, DOI 10.1016/j.cell.2011.05.010; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kawahara H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00030; Kent T, 2009, RNA, V15, P14, DOI 10.1261/rna.1384709; Kim MY, 2009, BMB REP, V42, P125, DOI 10.5483/BMBRep.2009.42.3.125; Kim T, 2013, INT J MOL SCI, V14, P4934, DOI 10.3390/ijms14034934; KLEBE RJ, 1969, J CELL BIOL, V43, pA69; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang S, 1996, MOL CELL BIOL, V16, P5139; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; MATTAJ IW, 1993, FASEB J, V7, P47, DOI 10.1096/fasebj.7.1.8422974; MAZAN S, 1990, GENE, V94, P263, DOI 10.1016/0378-1119(90)90397-A; MAZAN S, 1991, CYTOGENET CELL GENET, V56, P18, DOI 10.1159/000133037; MAZAN S, 1988, J BIOL CHEM, V263, P19461; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; MURAMATSU M, 1966, BIOCHIM BIOPHYS ACTA, V123, P116, DOI 10.1016/0005-2787(66)90164-X; Nabavi S, 2008, CURR GENET, V54, P175, DOI 10.1007/s00294-008-0210-1; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P461, DOI 10.1097/01.jnen.0000240474.27791.f3; Ni T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-615; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Pendrak ML, 2011, RNA, V17, P2235, DOI 10.1261/rna.028050.111; Perumal K, 2002, GENE EXPRESSION, V10, P59; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; PRESTAYKO A W, 1970, Journal of Molecular Biology, V47, P505, DOI 10.1016/0022-2836(70)90318-9; Rammelt C, 2011, RNA, V17, P1737, DOI 10.1261/rna.2787011; Saba Reuben, 2008, P73, DOI 10.1007/978-1-4020-8533-8_5; Scherrer K, 2003, TRENDS BIOCHEM SCI, V28, P566, DOI 10.1016/j.tibs.2003.08.004; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Schonrock N, 2012, CELL MOL LIFE SCI, V69, P3543, DOI 10.1007/s00018-012-1125-z; Schonrock N, 2012, EXP NEUROL, V235, P447, DOI 10.1016/j.expneurol.2011.11.013; Shcherbik N, 2010, EMBO REP, V11, P106, DOI 10.1038/embor.2009.271; Sloan KE, 2012, BIOCHEM SOC T, V40, P850, DOI 10.1042/BST20120061; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2; Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5; Thompson DM, 2007, MOL CELL BIOL, V27, P92, DOI 10.1128/MCB.01023-06; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2; West S, 2006, MOL CELL, V21, P437, DOI 10.1016/j.molcel.2005.12.008; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Will S, 2013, GENOME RES; Wolin SL, 2012, TRENDS GENET, V28, P306, DOI 10.1016/j.tig.2012.03.005; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	103	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99430	10.1371/journal.pone.0099430	http://dx.doi.org/10.1371/journal.pone.0099430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926684	Green Published, Green Submitted, gold			2022-12-25	WOS:000338278100040
J	Bonardi, D; Papini, N; Pasini, M; Dileo, L; Orizio, F; Monti, E; Caimi, L; Venerando, B; Bresciani, R				Bonardi, Dario; Papini, Nadia; Pasini, Mario; Dileo, Loredana; Orizio, Flavia; Monti, Eugenio; Caimi, Luigi; Venerando, Bruno; Bresciani, Roberto			Sialidase NEU3 Dynamically Associates to Different Membrane Domains Specifically Modifying Their Ganglioside Pattern and Triggering Akt Phosphorylation	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LIPID RAFTS; GM3 BINDING; EXPRESSION; CELLS; MICRODOMAINS; ROLES; IDENTIFICATION; CAVEOLIN; PROTEIN	Lipid rafts are known to regulate several membrane functions such as signaling, trafficking and cellular adhesion. The local enrichment in sphingolipids and cholesterol together with the low protein content allows their separation by density gradient flotation after extraction with non-ionic detergent at low temperature. These structures are also referred to as detergent resistant membranes (DRM). Among sphingolipids, gangliosides play important roles in different biological events, including signal transduction and tumorigenesis. Sialidase NEU3 shows high enzymatic specificity toward gangliosides. Moreover, the enzyme is present both at the cell surface and in endosomal structures and cofractionates with caveolin. Although changes in the expression level of NEU3 have been correlated to different tumors, little is known about the precise distribution of the protein and its ability in modifying the ganglioside composition of DRM and non-DRM, thus regulating intracellular events. By means of inducible expression cell system we found that i) newly synthesized NEU3 is initially associated to non-DRM; ii) at steady state the protein is equally distributed between the two membrane subcompartments, i. e., DRM and non-DRM; iii) NEU3 is degraded via the proteasomal pathway; iv) the enzyme specifically modifies the ganglioside composition of the membrane areas where it resides; and v) NEU3 triggers phosphorylation of Akt, even in absence of exogenously administered EGF. Taken together our data demonstrate that NEU3 regulates the DRM ganglioside content and it can be considered as a modulator of Akt phosphorylation, further supporting the role of this enzyme in cancer and tumorigenesis.	[Bonardi, Dario; Pasini, Mario; Orizio, Flavia; Monti, Eugenio; Caimi, Luigi; Bresciani, Roberto] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Papini, Nadia; Dileo, Loredana; Venerando, Bruno] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy	University of Brescia; University of Milan	Bresciani, R (corresponding author), Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.	brescian@med.unibs.it	papini, nadia/M-2425-2017; Bresciani, Roberto/AAA-9728-2020	papini, nadia/0000-0003-4066-4955; Bresciani, Roberto/0000-0002-7881-7550; MONTI, Eugenio/0000-0002-4742-7445; Caimi, Luigi/0000-0002-7163-9405	"Ministero dell'Istruzione, dell'Universita e della Ricerca" (MIUR); Regione Lombardia; Network Enable Drug Discovery (NEDD) grant; Fondazione Cariplo [2010-0700]; AIRC [IG-13131]	"Ministero dell'Istruzione, dell'Universita e della Ricerca" (MIUR)(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia(Regione Lombardia); Network Enable Drug Discovery (NEDD) grant; Fondazione Cariplo(Fondazione Cariplo); AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by "Ministero dell'Istruzione, dell'Universita e della Ricerca" (MIUR) to EM, BV, LC and RB; Regione Lombardia (http://www.regione.lombardia.it) and Network Enable Drug Discovery (NEDD) grant to EM; Fondazione Cariplo (2010-0700) and AIRC (IG-13131) to BV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chakrabarti O, 2011, MOL BIOL CELL, V22, P1625, DOI 10.1091/mbc.E10-07-0638; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Hasegawa T, 2000, J BIOL CHEM, V275, P14778; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Miyagi T, 2008, PROTEOMICS, V8, P3303, DOI 10.1002/pmic.200800248; Miyagi T, 2008, BBA-GEN SUBJECTS, V1780, P532, DOI 10.1016/j.bbagen.2007.09.016; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 2000, BIOCHEM J, V349, P343, DOI 10.1042/0264-6021:3490343; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Pilecka I, 2011, EXP CELL RES, V317, P1093, DOI 10.1016/j.yexcr.2011.02.002; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Sonnino S, 2013, CURR MED CHEM, V20, P4; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; Wang XQ, 2001, GLYCOBIOLOGY, V11, P515, DOI 10.1093/glycob/11.7.515; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Wang Y, 2001, EUR J BIOCHEM, V268, P2201, DOI 10.1046/j.1432-1327.2001.02069.x; Wickstrom SA, 2003, J BIOL CHEM, V278, P37895, DOI 10.1074/jbc.M303569200; Zanchetti G, 2007, BIOCHEM J, V408, P211, DOI 10.1042/BJ20070503	35	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99405	10.1371/journal.pone.0099405	http://dx.doi.org/10.1371/journal.pone.0099405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925219	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300059
J	Putko, BN; Wang, ZC; Lo, J; Anderson, T; Becher, H; Dyck, JRB; Kassiri, Z; Oudit, GY				Putko, Brendan N.; Wang, Zuocheng; Lo, Jennifer; Anderson, Todd; Becher, Harald; Dyck, Jason R. B.; Kassiri, Zamaneh; Oudit, Gavin Y.		Alberta HEART Investigators	Circulating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fraction: Evidence for a Divergence in Pathophysiology	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; DIASTOLIC FUNCTION; MORTALITY; ANGIOTENSIN-CONVERTING-ENZYME-2; COMORBIDITIES; DYSFUNCTION; POPULATION; PREVALENCE; BIOMARKERS; PROGNOSIS	Background: Various pathways have been implicated in the pathogenesis of heart failure (HF) with preserved ejection fraction (HFPEF). Inflammation in response to comorbid conditions, such as hypertension and diabetes, may play a proportionally larger role in HFPEF as compared to HF with reduced ejection fraction (HFREF). Methods and Results: This study investigated inflammation mediated by the tumor necrosis factor-alpha (TNF alpha) axis in community-based cohorts of HFPEF patients (n = 100), HFREF patients (n = 100) and healthy controls (n = 50). Enzyme-linked immunosorbent assays were used to investigate levels of TNF alpha, its two receptors (TNFR1 and TNFR2), and a non-TNF alpha cytokine, interleukin-6 (IL-6), in plasma derived from peripheral blood samples. Plasma levels of TNF alpha and TNFR1 were significantly elevated in HFPEF relative to controls, while levels of TNFR2 were significantly higher in HFPEF than both controls and HFREF. TNF alpha, TNFR1 and TNFR2 were each significantly associated with at least two of the following: age, estimated glomerular filtration rate, hypertension, diabetes, smoking, peripheral vascular disease or history of atrial fibrillation. TNFR2 levels were also significantly associated with increasing grade of diastolic dysfunction and severity of symptoms in HFPEF. Conclusions: Inflammation mediated through TNF alpha and its receptors, TNFR1 and TNFR2, may represent an important component of a comorbidity-induced inflammatory response that partially drives the pathophysiology of HFPEF.	[Putko, Brendan N.; Wang, Zuocheng; Lo, Jennifer; Becher, Harald; Oudit, Gavin Y.] Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB, Canada; [Putko, Brendan N.; Wang, Zuocheng; Lo, Jennifer; Becher, Harald; Dyck, Jason R. B.; Kassiri, Zamaneh; Oudit, Gavin Y.] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Anderson, Todd] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [Dyck, Jason R. B.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Kassiri, Zamaneh] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	University of Alberta; University of Alberta; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Alberta; University of Alberta	Oudit, GY (corresponding author), Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB, Canada.	gavin.oudit@ualberta.ca	Thompson, Richard B/E-9821-2011	Dyck, Jason/0000-0002-7045-2884	Canadian Institutes of Health Research [MOP-86602]; Alberta Innovates [201200819] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work was funded by the Canadian Institutes of Health Research, MOP-86602, http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	'Alessio AD, 2012, J CELL MOL MED, V16, P627, DOI 10.1111/j.1582-4934.2011.01353.x; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bionda C, 2006, ANN CLIN LAB SCI, V36, P299; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Cheng JM, 2013, EUR J HEART FAIL, V15, P1350, DOI 10.1093/eurjhf/hft106; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Defer N, 2007, J BIOL CHEM, V282, P35564, DOI 10.1074/jbc.M704003200; Dunlay SM, 2008, CIRCULATION, V118, P625, DOI 10.1161/CIRCULATIONAHA.107.759191; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Epelman S, 2009, J CARD FAIL, V15, P565, DOI 10.1016/j.cardfail.2009.01.014; Feldman AM, 2013, CIRC-HEART FAIL, V6, P461, DOI 10.1161/CIRCHEARTFAILURE.112.000185; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Haykowsky MJ, 2012, J AM COLL CARDIOL, V60, P120, DOI 10.1016/j.jacc.2012.02.055; Ho JE, 2012, J AM COLL CARDIOL, V60, P1249, DOI 10.1016/j.jacc.2012.04.053; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lovren F, 2008, AM J PHYSIOL-HEART C, V295, pH1377, DOI 10.1152/ajpheart.00331.2008; Luo Y, 2010, ARTERIOSCL THROM VAS, V30, P1307, DOI 10.1161/ATVBAHA.110.204222; Marti CN, 2014, CIRC-HEART FAIL, V7, P5, DOI 10.1161/CIRCHEARTFAILURE.113.000344; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Niethammer M, 2008, INT J CARDIOL, V129, P111, DOI 10.1016/j.ijcard.2007.05.061; Oh JK, 2011, CIRC-CARDIOVASC IMAG, V4, P444, DOI 10.1161/CIRCIMAGING.110.961623; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Patel VB, 2014, J MOL CELL CARDIOL, V66, P167, DOI 10.1016/j.yjmcc.2013.11.017; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Putko BN, 2014, CAN J CARDIOL, V30, P264, DOI 10.1016/j.cjca.2013.12.021; RICKHAM PP, 1964, BRIT MED J, V2, P173; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Santhanakrishnan R, 2012, EUR J HEART FAIL, V14, P1338, DOI 10.1093/eurjhf/hfs130; Valgimigli M, 2005, CIRCULATION, V111, P863, DOI 10.1161/01.CIR.0000155614.35441.69; van Veldhuisen DJ, 2013, J AM COLL CARDIOL, V61, P1498, DOI 10.1016/j.jacc.2012.12.044; Wu CK, 2011, CRIT CARE MED, V39, P984, DOI 10.1097/CCM.0b013e31820a91b9; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369; Zile MR, 2011, CIRCULATION, V124, P2491, DOI 10.1161/CIRCULATIONAHA.110.011031; Zile MR, 2011, CIRC-HEART FAIL, V4, P246, DOI 10.1161/CIRCHEARTFAILURE.110.958199	42	80	83	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99495	10.1371/journal.pone.0099495	http://dx.doi.org/10.1371/journal.pone.0099495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923671	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300069
J	Samuni-Blank, M; Izhaki, I; Laviad, S; Bar-Massada, A; Gerchman, Y; Halpern, M				Samuni-Blank, Michal; Izhaki, Ido; Laviad, Sivan; Bar-Massada, Avi; Gerchman, Yoram; Halpern, Malka			The Role of Abiotic Environmental Conditions and Herbivory in Shaping Bacterial Community Composition in Floral Nectar	PLOS ONE			English	Article							MICROBIAL BIOGEOGRAPHY; REPRODUCTIVE-BIOLOGY; BETA DIVERSITY; POLLINATION; NICHES; MAINTENANCE; RICHNESS; PATTERNS; ECOLOGY	Identifying the processes that drive community assembly has long been a central theme in ecology. For microorganisms, a traditional prevailing hypothesis states that "everything is everywhere, but the environment selects". Although the bacterial community in floral nectar may be affected by both atmosphere (air-borne bacteria) and animals as dispersal vectors, the environmental and geographic factors that shape microbial communities in floral nectar are unknown. We studied culturable bacterial communities in Asphodelus aestivus floral nectar and in its typical herbivorous bug Capsodes infuscatus, along an aridity gradient. Bacteria were sampled from floral nectar and bugs at four sites, spanning a geographical range of 200 km from Mediterranean to semi-arid conditions, under open and bagged flower treatments. In agreement with the niche assembly hypothesis, the differences in bacterial community compositions were explained by differences in abiotic environmental conditions. These results suggest that microbial model systems are useful for addressing macro-ecological questions. In addition, similar bacterial communities were found in the nectar and on the surface of the bugs that were documented visiting the flowers. These similarities imply that floral nectar bacteria dispersal is shaped not only by air borne bacteria and nectar consumers as previously reported, but also by visiting vectors like the mirid bugs.	[Samuni-Blank, Michal; Izhaki, Ido; Laviad, Sivan; Halpern, Malka] Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Bar-Massada, Avi; Gerchman, Yoram; Halpern, Malka] Univ Haifa, Dept Biol & Environm, Oranim, Tivon, Israel	University of Haifa; University of Haifa	Halpern, M (corresponding author), Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	mhalpern@research.haifa.ac.il	Izhaki, Ido/I-9712-2019; Gerchman, Yoram/H-4698-2019; Gerchman, Yoram/F-5226-2015; Halpern, Malka/AAH-1498-2019	Izhaki, Ido/0000-0002-4525-4683; Gerchman, Yoram/0000-0002-8637-9589; Halpern, Malka/0000-0002-3407-2198; Laviad-Shitrit, Sivan/0000-0002-0911-3453	Israel Science Foundation (ISF) [189/08, 1094/12]	Israel Science Foundation (ISF)(Israel Science Foundation)	This study was supported by grants from the Israel Science Foundation (ISF, grants no. 189/08 and 1094/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Aizenberg-Gershtein Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067556; Alvarez-Perez S, 2013, FEMS MICROBIOL ECOL, V83, P685, DOI 10.1111/1574-6941.12027; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; AYAL Y, 1993, OECOLOGIA, V93, P518, DOI 10.1007/BF00328960; AYAL Y, 1994, ECOL ENTOMOL, V19, P207, DOI 10.1111/j.1365-2311.1994.tb00411.x; Becking L.G.M.B, 1934, GEOBIOLOGIE INLEIDIN; BERNARDELLO L, 1994, BOT J LINN SOC, V114, P293, DOI 10.1006/bojl.1994.1019; Chanbusarakum L, 2008, J INVERTEBR PATHOL, V99, P318, DOI 10.1016/j.jip.2008.09.001; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clements F.E., 1916, PLANT SUCCESSION ANA; Colwell RK, 2004, ESTIMATES STAT ESTIM; de Vega C, 2009, S AFR J BOT, V75, P798, DOI 10.1016/j.sajb.2009.07.016; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Forcone A, 1997, BIOCHEM SYST ECOL, V25, P395, DOI 10.1016/S0305-1978(97)00030-6; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Gomes NCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014065; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Gotelli, 2013, ENCY BIODIVERSITY, V5; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Halpern M, 2013, INT J SYST EVOL MICR, V63, P4259, DOI 10.1099/ijs.0.052217-0; Hantsis-Zacharov E, 2007, APPL ENVIRON MICROB, V73, P7162, DOI 10.1128/AEM.00866-07; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Herrera CM, 2010, P ROY SOC B-BIOL SCI, V277, P747, DOI 10.1098/rspb.2009.1485; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1991, B MATH BIOL, V53, P193, DOI 10.1007/BF02464429; Jacquemyn H, 2013, MICROBIOLOGYOPEN, V2, P644, DOI 10.1002/mbo3.103; Jacquemyn H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056917; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Lifante ZD, 1996, PLANT SYST EVOL, V200, P177, DOI 10.1007/BF00984934; Logue Jurg Brendan, 2008, Freshwater Reviews, V1, P99, DOI 10.1608/FRJ-1.1.9; MAC ARTHUR ROBERT H., 1967; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Miambi E, 2003, INT J FOOD MICROBIOL, V82, P111, DOI 10.1016/S0168-1605(02)00256-8; Mitchell RJ, 2004, ECOLOGY, V85, P1527, DOI 10.1890/03-0388; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Ollerton J., 2012, Journal of Pollination Ecology, V9, P85; Pozo MI, 2011, MICROB ECOL, V61, P82, DOI 10.1007/s00248-010-9682-x; Samocha Y, 2010, ARTHROPOD-PLANT INTE, V4, P153, DOI 10.1007/s11829-010-9091-6; SANDHU DK, 1985, MICROB ECOL, V11, P51, DOI 10.1007/BF02015108; SCHUSTER A, 1993, NEW PHYTOL, V123, P165; Senderovich Y, 2008, ISME J, V2, P276, DOI 10.1038/ismej.2007.114; Senderovich Y, 2013, ISME J, V7, P2147, DOI 10.1038/ismej.2013.100; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Team R, 2012, R LANG ENV STAT COMP; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Vannette RL, 2013, P ROYAL SOC B, V280; Waser NM., 2006, PLANT POLLINATOR INT; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	59	32	33	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99107	10.1371/journal.pone.0099107	http://dx.doi.org/10.1371/journal.pone.0099107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922317	Green Submitted, Green Published, gold			2022-12-25	WOS:000338701300029
J	Biswas, S; Haselier, C; Mataruga, A; Thumann, G; Walter, P; Muller, F				Biswas, Sonia; Haselier, Christine; Mataruga, Anja; Thumann, Gabriele; Walter, Peter; Mueller, Frank			Pharmacological Analysis of Intrinsic Neuronal Oscillations in rd10 Retina	PLOS ONE			English	Article							CONE BIPOLAR CELLS; DEGENERATING MOUSE RETINA; INNER PLEXIFORM LAYER; GLUTAMATE-RECEPTOR; LIGHT RESPONSES; GANGLION-CELLS; AII AMACRINE; MAMMALIAN RETINA; ROD PATHWAYS; ION CHANNELS	In the widely used mouse model of retinal degeneration, rd1, the loss of photoreceptors leads to rhythmic electrical activity of around 10-16 Hz in the remaining retinal network. Recent studies suggest that this oscillation is formed within the electrically coupled network of AII amacrine cells and ON-bipolar cells. A second mouse model, rd10, displays a delayed onset and slower progression of degeneration, making this mouse strain a better model for human retinitis pigmentosa. In rd10, oscillations occur at a frequency of 3-7 Hz, raising the question whether oscillations have the same origin in the two mouse models. As rd10 is increasingly being used as a model to develop experimental therapies, it is important to understand the mechanisms underlying the spontaneous rhythmic activity. To study the properties of oscillations in rd10 retina we combined multi electrode recordings with pharmacological manipulation of the retinal network. Oscillations were abolished by blockers for ionotropic glutamate receptors and gap junctions. Frequency and amplitude of oscillations were modulated strongly by blockers of inhibitory receptors and to a lesser extent by blockers of HCN channels. In summary, although we found certain differences in the pharmacological modulation of rhythmic activity in rd10 compared to rd1, the overall pattern looked similar. This suggests that the generation of rhythmic activity may underlie similar mechanisms in rd1 and rd10 retina.	[Biswas, Sonia; Mataruga, Anja; Mueller, Frank] Forschungszentrum Julich, Inst Complex Syst, Cellular Biophys, ICS 4, D-52425 Julich, Germany; [Haselier, Christine; Thumann, Gabriele; Walter, Peter] Rhein Westfal TH Aachen, Dept Ophthalmol, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University	Muller, F (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Cellular Biophys, ICS 4, D-52425 Julich, Germany.	f.mueller@fz-juelich.de	Walter, Peter/L-5982-2018; Mueller, Frank/I-7196-2013	Walter, Peter/0000-0001-8745-6593; Mueller, Frank/0000-0001-7264-1227	Deutsche Forschungsgemeinschaft [TH 603/15-1, WA 1472/6-1, MU 3036/3-1, MU 3036/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) (grants TH 603/15-1 to GT, WA 1472/6-1 to PW, MU 3036/3-1 and MU 3036/2-1 to FM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLANKS JC, 1974, J COMP NEUROL, V156, P95, DOI 10.1002/cne.901560108; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chua J, 2009, J COMP NEUROL, V514, P473, DOI 10.1002/cne.22029; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Dhingra A, 2011, J NEUROSCI, V31, P3962, DOI 10.1523/JNEUROSCI.6007-10.2011; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P377, DOI 10.1113/jphysiol.1981.sp013714; ENZ R, 1995, VISUAL NEUROSCI, V12, P501, DOI 10.1017/S0952523800008403; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; Farajian R, 2011, J PHYSIOL-LONDON, V589, P4473, DOI 10.1113/jphysiol.2011.213371; Feigenspan A, 1998, J NEUROSCI, V18, P6776; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Fyk-Kolodziej B, 2007, J COMP NEUROL, V501, P891, DOI 10.1002/cne.21287; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Goo YS, 2011, KOREAN J PHYSIOL PHA, V15, P415, DOI 10.4196/kjpp.2011.15.6.415; Goo YS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/035003; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Ivanova E, 2006, VISUAL NEUROSCI, V23, P143, DOI 10.1017/S0952523806232048; Jae SA, 2013, KOREAN J PHYSIOL PHA, V17, P229, DOI 10.4196/kjpp.2013.17.3.229; Jones BW, 2012, JPN J OPHTHALMOL, V56, P289, DOI 10.1007/s10384-012-0147-2; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kaur T, 2012, J PHYSIOL-LONDON, V590, P179, DOI 10.1113/jphysiol.2011.218974; Knop GC, 2008, EUR J NEUROSCI, V28, P2221, DOI 10.1111/j.1460-9568.2008.06512.x; Koike C, 2010, CELL CALCIUM, V48, P95, DOI 10.1016/j.ceca.2010.08.004; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; KOLB H, 1983, VISION RES, V23, P301, DOI 10.1016/0042-6989(83)90078-0; Krizaj D, 2010, VISION RES, V50, P2460, DOI 10.1016/j.visres.2010.08.034; Lin YH, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-7; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Mataruga A, 2007, J COMP NEUROL, V502, P1123, DOI 10.1002/cne.21367; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Morgans CW, 2010, BIOESSAYS, V32, P609, DOI 10.1002/bies.200900198; MULLER F, 1992, VISUAL NEUROSCI, V9, P415, DOI 10.1017/S0952523800010828; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; Nakamura M, 2010, MOL VIS, V16, P425; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Pan F, 2007, VISUAL NEUROSCI, V24, P609, DOI 10.1017/S0952523807070472; PEICHL L, 1994, VISUAL NEUROSCI, V11, P501, DOI 10.1017/S095252380000242X; Petit-Jacquea J, 2005, J NEUROPHYSIOL, V94, P1770, DOI 10.1152/jn.00279.2005; Phillips MJ, 2010, J COMP NEUROL, V518, P2071, DOI 10.1002/cne.22322; Puthussery T, 2009, EUR J NEUROSCI, V29, P1533, DOI 10.1111/j.1460-9568.2009.06728.x; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Strettoi E, 2002, J NEUROSCI, V22, P5492; Strettoi E, 2003, VISION RES, V43, P867, DOI 10.1016/S0042-6989(02)00594-1; Toychiev AH, 2013, J NEUROSCI, V33, P13972, DOI 10.1523/JNEUROSCI.2399-13.2013; Trenholm S, 2012, J PHYSIOL-LONDON, V590, P2501, DOI 10.1113/jphysiol.2011.225060; Trexler EB, 2005, J NEUROPHYSIOL, V93, P1476, DOI 10.1152/jn.00597.2004; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Varela C, 2003, VISION RES, V43, P879, DOI 10.1016/S0042-6989(02)00493-5; Veruki ML, 2009, J NEUROPHYSIOL, V101, P2339, DOI 10.1152/jn.00112.2009; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Ye JH, 2007, PHYSIOL MEAS, V28, P1079, DOI 10.1088/0967-3334/28/9/009; Ye JH, 2008, IEEE ENG MED BIO, P2465, DOI 10.1109/IEMBS.2008.4649699	61	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99075	10.1371/journal.pone.0099075	http://dx.doi.org/10.1371/journal.pone.0099075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918437	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000047
J	Boning, D; Littschwager, A; Hutler, M; Beneke, R; Staab, D				Boening, Dieter; Littschwager, Angela; Huetler, Matthias; Beneke, Ralph; Staab, Doris			Hemoglobin Oxygen Affinity in Patients with Cystic Fibrosis	PLOS ONE			English	Article							HIGH-ALTITUDE HYPOXIA; RED-BLOOD-CELLS; DISSOCIATION CURVE; NITRIC-OXIDE; IN-VIVO; UNTRAINED SUBJECTS; LUNG-DISEASE; TRANSPORT; BOHR; GLUTATHIONE	In patients with cystic fibrosis lung damages cause arterial hypoxia. As a typical compensatory reaction one might expect changes in oxygen affinity of hemoglobin. Therefore position (standard half saturation pressure P(50)st) and slope (Hill's n) of the O-2 dissociation curve as well as the Bohr coefficients (BC) for CO2 and lactic acid were determined in blood of 14 adult patients (8 males, 6 females) and 14 healthy controls (6 males, 8 females). While Hill's n amounted to approximately 2.6 in all subjects, P50st was slightly increased by 1mmHg in both patient groups (controls male 26.7 +/- 0.2, controls female 27.0 +/- 0.1, patients male 27.7 +/- 0.5, patients female 28.0 +/- 0.3 mmHg; mean and standard error, overall p<0.01). Main cause was a rise of 1-2 mu mol/g hemoglobin in erythrocytic 2,3-biphosphoglycerate concentration. One patient only, clearly identified as an outlier and with the mutation G551D, showed a reduction of both P(50)st (24.5 mmHg) and [2,3-biphosphoglycerate] (9.8 mu mol/g hemoglobin). There were no differences in BCCO2, but small sex differences in the BC for lactic acid in the controls which were not detectable in the patients. Causes for the right shift of the O-2 dissociation curve might be hypoxic stimulation of erythrocytic glycolysis and an increased red cell turnover both causing increased [2,3-biphosphoglycerate]. However, for situations with additional hypercapnia as observed in exercising patients a left shift seems to be a more favourable adaptation in cystic fibrosis. Additionally when in vivo PO2 values were corrected to the standard conditions they mostly lay left of the in vitro O-2 dissociation curve in both patients and controls. This hints to unknown fugitive factors influencing oxygen affinity.	[Boening, Dieter; Littschwager, Angela; Huetler, Matthias; Beneke, Ralph] Charite, Inst Sportmed, D-13353 Berlin, Germany; [Staab, Doris] Charite, Klin Padiat Pneumol & Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Boning, D (corresponding author), Charite, Inst Sportmed, D-13353 Berlin, Germany.	dieter.boening@charite.de	Böning, Dieter/AAM-7720-2020	Boning, Dieter/0000-0001-7090-592X	Christiane Herzog Stiftung fur Mukoviszidose-Kranke	Christiane Herzog Stiftung fur Mukoviszidose-Kranke	Funding provided by the following Foundation: Christiane Herzog Stiftung fur Mukoviszidose-Kranke, http://www.christianeherzogstiftung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTURSON G, 1971, ACTA ANAESTH SCAND, P39; Balaban DY, 2013, RESP PHYSIOL NEUROBI, V186, P45, DOI 10.1016/j.resp.2012.12.011; Barrett PM, 2012, HUM MOL GENET, V21, pR66, DOI 10.1093/hmg/dds345; Baumann R, 1987, COMPR PHYSIOL, P147; Beall CM, 2002, P NATL ACAD SCI USA, V99, P17215, DOI 10.1073/pnas.252649199; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Ben Rayana MC, 2008, CLIN CHEM LAB MED, V46, P21, DOI 10.1515/CCLM.2008.001; BERGHOUT AGRV, 1984, PEDIATR RES, V18, P1017; Boning D, 2008, EUR J APPL PHYSIOL, V103, P127, DOI 10.1007/s00421-008-0675-0; Boning D, 2007, EUR J APPL PHYSIOL, V99, P163, DOI 10.1007/s00421-006-0328-0; Boning D, 2013, RESP PHYSIOL NEUROBI, V188, P79, DOI 10.1016/j.resp.2013.05.008; BONING D, 1978, RESP PHYSIOL, V34, P195, DOI 10.1016/0034-5687(78)90028-2; BONING D, 1975, EUR J APPL PHYSIOL O, V34, P1, DOI 10.1007/BF00999910; BONING D, 1987, BLUT, V54, P361, DOI 10.1007/BF00626019; BONING D, 1976, EUR J APPL PHYSIOL O, V35, P243, DOI 10.1007/BF00423283; Boning D, 2001, INT J SPORTS MED, V22, P572, DOI 10.1055/s-2001-18530; BONING D, 1993, J APPL PHYSIOL, V74, P710, DOI 10.1152/jappl.1993.74.2.710; BRAUMANN KM, 1979, EUR J APPL PHYSIOL, V42, P51, DOI 10.1007/BF00421104; BRAUMANN KM, 1982, J APPL PHYSIOL, V52, P1524, DOI 10.1152/jappl.1982.52.6.1524; Campbell KL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-214; CHRISTIANSEN TF, 1981, P IFCC EXP PAN PH BL, P77; Christoforou Elena, 2005, J Cyst Fibros, V4, P151, DOI 10.1016/j.jcf.2005.05.013; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; CRAESCU CT, 1986, J BIOL CHEM, V261, P4710; Cristancho E, 2007, HIGH ALT MED BIOL, V8, P296, DOI 10.1089/ham.2007.8406; Derichs N, 2013, EUR RESPIR REV, V22, P58, DOI 10.1183/09059180.00008412; Diem K, 1969, WISSENSCHAFTLICHE TA; Duranton C, 2012, AM J PATHOL, V181, P1367, DOI 10.1016/j.ajpath.2012.06.017; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; Fischer R, 2007, PEDIATR PULM, V42, P1193, DOI 10.1002/ppul.20717; GARBY L, 1972, ACTA PHYSIOL SCAND, V84, P482, DOI 10.1111/j.1748-1716.1972.tb05198.x; Gladwin MT, 1999, J CLIN INVEST, V104, P937, DOI 10.1172/JCI7637; Head CA, 1997, J CLIN INVEST, V100, P1193, DOI 10.1172/JCI119631; Hrinczenko BW, 2000, BRIT J HAEMATOL, V110, P412, DOI 10.1046/j.1365-2141.2000.02203.x; HUCKAUF H, 1976, B EUR PHYSIOPATH RES, V12, P129; Hudson VM, 2001, FREE RADICAL BIO MED, V30, P1440, DOI 10.1016/S0891-5849(01)00530-5; Hughes JMB, 1996, EUR RESPIR J, V9, P184, DOI 10.1183/09031936.96.09020184; HUMPELER E, 1977, PFLUG ARCH EUR J PHY, V372, P287, DOI 10.1007/BF01063866; HUMPELER E, 1973, PFLUG ARCH EUR J PHY, V343, P151, DOI 10.1007/BF00585710; Hutler M, 2000, CLIN CHIM ACTA, V301, P213, DOI 10.1016/S0009-8981(00)00349-1; JURGENS KD, 1988, J COMP PHYSIOL B, V158, P469, DOI 10.1007/BF00691144; Mairbaurl H, 2012, COMPR PHYSIOL, V2, P1463, DOI 10.1002/cphy.c080113; Makhro A, 2013, AM J PHYSIOL-CELL PH, V305, pC1123, DOI 10.1152/ajpcell.00031.2013; MEIER U, 1974, PFLUG ARCH EUR J PHY, V349, P203, DOI 10.1007/BF00592448; Morgan T J, 1999, Crit Care Resusc, V1, P93; MORPURGO G, 1976, P NATL ACAD SCI USA, V73, P747, DOI 10.1073/pnas.73.3.747; MORPURGO G, 1970, NATURE, V227, P387, DOI 10.1038/227387a0; MORSE M, 1950, J CLIN INVEST, V29, P1091, DOI 10.1172/JCI102341; O'connor T M, 2002, J Cyst Fibros, V1, P31, DOI 10.1016/S1569-1993(01)00004-2; ORZALESI MM, 1973, AM REV RESPIR DIS, V107, P928; QUANJER PH, 1993, EUR RESPIR J, V6, P85, DOI 10.1183/09041950.085s1693; RASMUSSEN B, 1975, J APPL PHYSIOL, V38, P250, DOI 10.1152/jappl.1975.38.2.250; ROLLEMA HS, 1975, J BIOL CHEM, V250, P1333; ROSENTHAL A, 1977, PEDIATRICS, V59, P588; ROSENTHAL A, 1977, PEDIATRICS, V59, P919; Samaja M, 2003, EUR J APPL PHYSIOL, V90, P351, DOI 10.1007/s00421-003-0954-8; Schillers H, 2008, PFLUG ARCH EUR J PHY, V456, P163, DOI 10.1007/s00424-007-0399-8; SCHMIDT W, 1990, INT J SPORTS MED, V11, P15, DOI 10.1055/s-2007-1024755; SCHMIDT W, 1987, RESP PHYSIOL, V68, P215, DOI 10.1016/S0034-5687(87)80007-5; SMITH JE, 1976, AM J VET RES, V37, P1135; SPROULE BJ, 1960, J CLIN INVEST, V39, P378, DOI 10.1172/JCI104048; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Uhle MJ, 2004, THESIS UNIVERSITATSM; VICHINSKY EP, 1984, J PEDIATR-US, V105, P15, DOI 10.1016/S0022-3476(84)80349-2; von Pickardt B, 2003, THESIS FREIE U BERLI; WAGENER JS, 1983, AM J PEDIAT HEMATOL, V5, P153; Watts KD, 2011, PEDIATR PULM, V46, P683, DOI 10.1002/ppul.21428; Weber RE, 2007, RESP PHYSIOL NEUROBI, V158, P132, DOI 10.1016/j.resp.2007.05.001; West JB., 2007, HIGH ALTITUDE MED PH; Winslow RM, 2007, RESP PHYSIOL NEUROBI, V158, P121, DOI 10.1016/j.resp.2007.03.011; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	71	10	10	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e97932	10.1371/journal.pone.0097932	http://dx.doi.org/10.1371/journal.pone.0097932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919182	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000010
J	Chen, P; Hu, H; Chen, Z; Cai, XX; Zhang, Z; Yang, Y; Yu, N; Zhang, J; Xia, L; Ge, J; Yu, KM; Zhuang, J				Chen, Pei; Hu, Huan; Chen, Zhao; Cai, Xiaoxiao; Zhang, Zhang; Yang, Ying; Yu, Na; Zhang, Jing; Xia, Lei; Ge, Jian; Yu, Keming; Zhuang, Jing			BRCA1 Silencing Is Associated with Failure of DNA Repairing in Retinal Neurocytes	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; END-JOINING ACTIVITY; NEURAL STEM-CELLS; DAMAGE RESPONSE; GENOMIC STABILITY; RGC-5 CELLS; RAT-BRAIN; MAINTENANCE; DEFICIENCY	Retinal post-mitotic neurocytes display genomic instability after damage induced by physiological or pathological factors. The involvement of BRCA1, an important factor in development and DNA repair in mature retinal neurocytes remains unclear. Thus, we investigated the developmental expression profile of BRCA1 in the retina and defined the role of BRCA1 in DNA repair in retinal neurocytes. Our data show the expression of BRCA1 is developmentally down-regulated in the retinas of mice after birth. Similarly, BRCA1 is down-regulated after differentiation induced by TSA in retinal precursor cells. An end-joining activity assay and DNA fragmentation analysis indicated that the DNA repair capacity is significantly reduced. Moreover, DNA damage in differentiated cells or cells in which BRCA1 is silenced by siRNA interference is more extensive than that in precursor cells subjected to ionizing radiation. To further investigate non-homologous end joining (NHEJ), the major repair pathway in non-divided neurons, we utilized an NHEJ substrate (pEPI-NHEJ) in which double strand breaks are generated by I-SceI. Our data showed that differentiation and the down-regulation of BRCA1 respectively result in a 2.39-fold and 1.68-fold reduction in the total NHEJ frequency compared with that in cells with normal BRCA1. Furthermore, the analysis of NHEJ repair junctions of the plasmid substrate indicated that BRCA1 is involved in the fidelity of NHEJ. In addition, as expected, the down-regulation of BRCA1 significantly inhibits the viability of retina precursor cells. Therefore, our data suggest that BRCA1 plays a critical role in retinal development and repairs DNA damage of mature retina neurocytes.	[Chen, Pei; Hu, Huan; Chen, Zhao; Cai, Xiaoxiao; Zhang, Zhang; Yang, Ying; Yu, Na; Zhang, Jing; Xia, Lei; Ge, Jian; Yu, Keming; Zhuang, Jing] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhuang, J (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhuangj@mail.sysu.edu.cn			National Natural Science Foundation [30970923, 81170850]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	All the studies were funded by the grants from the National Natural Science Foundation (Project: 30970923, 81170850). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; dit Huart LM, 2004, MOL CELL NEUROSCI, V26, P441, DOI 10.1016/j.mcn.2004.04.002; Evans Teresa A, 2007, Int J Med Sci, V4, P140; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Jenke ACW, 2004, P NATL ACAD SCI USA, V101, P11322, DOI 10.1073/pnas.0401355101; Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013; Jiang GC, 2013, J BIOL CHEM, V288, P8966, DOI 10.1074/jbc.M112.412650; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Korhonen L, 2003, J NEUROSCI RES, V71, P769, DOI 10.1002/jnr.10546; Li J, 2011, BIOCHEM BIOPH RES CO, V410, P40, DOI 10.1016/j.bbrc.2011.05.101; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Meulle A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003345; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Oka A, 2000, NEUROSCI LETT, V292, P167, DOI 10.1016/S0304-3940(00)01462-2; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Ren KQ, 2002, J NEUROCHEM, V80, P949, DOI 10.1046/j.0022-3042.2002.00776.x; Saha T, 2010, J BIOL CHEM, V285, P19092, DOI 10.1074/jbc.M110.104430; Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129; Schulte-Uentrop L, 2008, NUCLEIC ACIDS RES, V36, P2561, DOI 10.1093/nar/gkn094; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Sharma S, 2007, BRAIN RES BULL, V73, P48, DOI 10.1016/j.brainresbull.2007.02.001; Swain U, 2011, MECH AGEING DEV, V132, P374, DOI 10.1016/j.mad.2011.04.012; Szaflik JP, 2009, MUTAT RES-FUND MOL M, V669, P169, DOI 10.1016/j.mrfmmm.2009.06.008; Tilgner K, 2013, CELL DEATH DIFFER, V20, P1089, DOI 10.1038/cdd.2013.44; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang Y, 2000, GENE DEV, V14, P927; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003; Willers H, 2006, RADIAT RES, V166, P567, DOI 10.1667/RR0524.1; Wood JPM, 2010, INVEST OPHTH VIS SCI, V51, P3774, DOI 10.1167/iovs.09-4305; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu G, 2008, MECH AGEING DEV, V129, P366, DOI 10.1016/j.mad.2008.03.001; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; Zhong Q, 2002, CANCER RES, V62, P3966; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zhuang J, 2006, CANCER RES, V66, P1401, DOI 10.1158/0008-5472.CAN-05-3278; Zhuang J, 2010, NEUROREPORT, V21, P282, DOI 10.1097/WNR.0b013e328336ee7e; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444; Zhuang J, 2009, BIOCHEM BIOPH RES CO, V380, P650, DOI 10.1016/j.bbrc.2009.01.162	47	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99371	10.1371/journal.pone.0099371	http://dx.doi.org/10.1371/journal.pone.0099371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919198	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000082
J	Delatorre, E; Mir, D; Bello, G				Delatorre, Edson; Mir, Daiana; Bello, Gonzalo			Spatiotemporal Dynamics of the HIV-1 Subtype G Epidemic in West and Central Africa	PLOS ONE			English	Article							ANTIRETROVIRAL DRUG-RESISTANCE; HUMAN-IMMUNODEFICIENCY-VIRUS; NORTH-CENTRAL NIGERIA; NAIVE PREGNANT-WOMEN; SUB-SAHARAN AFRICA; NON-B SUBTYPES; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; HIGH PREVALENCE; BURKINA-FASO	The human immunodeficiency virus type 1 (HIV-1) subtype G is the second most prevalent HIV-1 clade in West Africa, accounting for nearly 30% of infections in the region. There is no information about the spatiotemporal dynamics of dissemination of this HIV-1 clade in Africa. To this end, we analyzed a total of 305 HIV-1 subtype G pol sequences isolated from 11 different countries from West and Central Africa over a period of 20 years (1992 to 2011). Evolutionary, phylogeographic and demographic parameters were jointly estimated from sequence data using a Bayesian coalescent-based method. Our analyses indicate that subtype G most probably emerged in Central Africa in 1968 (1956-1976). From Central Africa, the virus was disseminated to West and West Central Africa at multiple times from the middle 1970s onwards. Two subtype G strains probably introduced into Nigeria and Togo between the middle and the late 1970s were disseminated locally and to neighboring countries, leading to the origin of two major western African clades (G(WA-I) and G(WA-II)). Subtype G clades circulating in western and central African regions displayed an initial phase of exponential growth followed by a decline in growth rate since the early/middle 1990s; but the mean epidemic growth rate of G(WA-I) (0.75 year(-1)) and G(WA-II) (0.95 year(-1)) clades was about two times higher than that estimated for central African lineages (0.47 year(-1)). Notably, the overall evolutionary and demographic history of G(WA-I) and G(WA-II) clades was very similar to that estimated for the CRF06_cpx clade circulating in the same region. These results support the notion that the spatiotemporal dissemination dynamics of major HIV-1 clades circulating in western Africa have probably been shaped by the same ecological factors.	[Delatorre, Edson; Mir, Daiana; Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil.	gbellobr@gmail.com	Delatorre, Edson/J-8330-2015; , daiana/J-5515-2019; Bentancor, Gonzalo Jose Bello/N-7377-2019; Bello, Gonzalo/E-6842-2013	Delatorre, Edson/0000-0002-5746-0820; , daiana/0000-0002-3172-4867; Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; 	FAPERJ [E-26/111.758/2012]; CNPq [472896/2012-1]	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Public Health Service grants E-26/111.758/2012 from the FAPERJ and 472896/2012-1 from the CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Agwale SM, 2002, VACCINE, V20, P2131, DOI 10.1016/S0264-410X(02)00059-2; Ajoge HO, 2012, AIDS RES HUM RETROV, V28, P115, DOI [10.1089/aid.2011.0115, 10.1089/AID.2011.0115]; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Archer J, 2007, AIDS, V21, P1693, DOI 10.1097/QAD.0b013e32825eabd0; Ayouba A, 2009, AIDS RES HUM RETROV, V25, P1193, DOI 10.1089/aid.2009.0142; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bobkova M, 2013, AIDS REV, V15, P204; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Caron M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-64; Chamberland A, 2012, SEX TRANSM INFECT, V88, P179, DOI 10.1136/sextrans-2011-050209; Chaplin B, 2011, AIDS RES HUM RETROV, V27, P71, DOI 10.1089/aid.2010.0050; Charpentier C, 2011, ANTIVIR THER, V16, P429, DOI 10.3851/IMP1754; Cuevas MT, 2002, AIDS, V16, P1643, DOI 10.1097/00002030-200208160-00010; Dagnra AY, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-30; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072448; Delatorre E, 2013, AIDS, V27, P1313, DOI 10.1097/QAD.0b013e32835f1df4; Delgado E, 2008, JAIDS-J ACQ IMM DEF, V48, P599, DOI 10.1097/QAI.0b013e3181806c0e; Derache A, 2008, J ANTIMICROB CHEMOTH, V62, P456, DOI 10.1093/jac/dkn234; Diop-Ndiaye H, 2010, AIDS RES HUM RETROV, V26, P1133, DOI 10.1089/aid.2009.0295; Djoko CF, 2010, AIDS RES HUM RETROV, V26, P1027, DOI 10.1089/aid.2010.0046; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568; Esteves A, 2002, AIDS RES HUM RETROV, V18, P313, DOI 10.1089/088922202753519089; FAghokeng A, 2009, ANTIVIR THER, V14, P401; Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0; Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Fischetti L, 2004, J MED VIROL, V73, P158, DOI 10.1002/jmv.20070; Gisselquist David, 2004, SAHARA J, V1, P114; Gnisci D, 2009, W AFRICAN STUDIES RE, P67; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamel DJ, 2007, AIDS RES HUM RETROV, V23, P1189, DOI 10.1089/aid.2007.0037; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Imade GE, 2014, AIDS RES HUM RETROV, V30, P127, DOI [10.1089/aid.2013.0074, 10.1089/AID.2013.0074]; Kalish ML, 2004, EMERG INFECT DIS, V10, P1227; Kouri V, 2012, J CLIN VIROL, V55, P348, DOI 10.1016/j.jcv.2012.08.019; Koyalta D, 2009, CLIN INFECT DIS, V49, P155, DOI 10.1086/599611; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Machado LY, 2012, AIDS RES HUM RETROV, V28, P956, DOI [10.1089/aid.2011.0295, 10.1089/AID.2011.0295]; Maiga AI, 2012, AIDS RES HUM RETROVI; Mamadou S, 2002, AIDS RES HUM RETROV, V18, P723, DOI 10.1089/088922202760072357; Marechal V, 2006, AIDS RES HUM RETROV, V22, P1036, DOI 10.1089/aid.2006.22.1036; Mehta SR, 2011, INFECT GENET EVOL, V11, P975, DOI 10.1016/j.meegid.2011.03.009; Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8; Nii-Trebi NI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071972; Ojesina AI, 2006, AIDS RES HUM RETROV, V22, P770, DOI 10.1089/aid.2006.22.770; Ouedraogo-Traore R, 2003, AIDS, V17, P441, DOI 10.1097/00002030-200302140-00019; Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009; Pandrea I, 2002, AIDS RES HUM RETROV, V18, P1103, DOI 10.1089/088922202320567842; Peeters M, 2000, AIDS RES HUM RETROV, V16, P315, DOI 10.1089/088922200309197; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179; Rambaut A., 2014, FIGTREE V14 TREE FIG; Salama P, 2001, AIDS, V15, pS4, DOI 10.1097/00002030-200104003-00002; Sankale JL, 2007, AIDS RES HUM RETROV, V23, P1020, DOI 10.1089/aid.2006.0304; Suchard M., 2007, TRACER V1 6; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166; Tatem AJ, 2012, AIDS, V26, P2351, DOI 10.1097/QAD.0b013e328359a904; Tebit DM, 2009, J MED VIROL, V81, P1691, DOI 10.1002/jmv.21600; Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217; Toni TD, 2007, AIDS RES HUM RETROV, V23, P1155, DOI 10.1089/aid.2007.0072; Vergne L, 2006, ANTIVIR THER, V11, P575; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Yaotse DA, 2009, INFECT GENET EVOL, V9, P646, DOI 10.1016/j.meegid.2009.04.002; Yusim K, 2001, PHILOS T R SOC B, V356, P855, DOI 10.1098/rstb.2001.0859; Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25	80	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98908	10.1371/journal.pone.0098908	http://dx.doi.org/10.1371/journal.pone.0098908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918930	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000032
J	Laszlo, Z; Solyom, K; Prazsmari, H; Barta, Z; Tothmeresz, B				Laszlo, Zoltan; Solyom, Katalin; Prazsmari, Hunor; Barta, Zoltan; Tothmeresz, Bela			Predation on Rose Galls: Parasitoids and Predators Determine Gall Size through Directional Selection	PLOS ONE			English	Article							OPTIMAL CLUTCH SIZE; VARIABLE SELECTION; BIRD PREDATION; TROPHIC LEVELS; HYMENOPTERA; WASP; INSECTS; OAK	Both predators and parasitoids can have significant effects on species' life history traits, such as longevity or clutch size. In the case of gall inducers, sporadically there is evidence to suggest that both vertebrate predation and insect parasitoid attack may shape the optimal gall size. While the effects of parasitoids have been studied in detail, the influence of vertebrate predation is less well-investigated. To better understand this aspect of gall size evolution, we studied vertebrate predation on galls of Diplolepis rosae on rose (Rosa canina) shrubs. We measured predation frequency, predation incidence, and predation rate in a large-scale observational field study, as well as an experimental field study. Our combined results suggest that, similarly to parasitoids, vertebrate predation makes a considerable contribution to mortality of gall inducer larvae. On the other hand, its influence on gall size is in direct contrast to the effect of parasitoids, as frequency of vertebrate predation increases with gall size. This suggests that the balance between predation and parasitoid attack shapes the optimal size of D. rosae galls.	[Laszlo, Zoltan; Prazsmari, Hunor] Univ Babes Bolyai, Hungarian Dept Biol & Ecol, R-3400 Cluj Napoca, Romania; [Solyom, Katalin] Univ Debrecen, Dept Ecol, Debrecen, Hungary; [Barta, Zoltan] Univ Debrecen, Dept Evolutionary Zool, MTA DE Lendulet Behav Ecol Res Grp, Debrecen, Hungary; [Tothmeresz, Bela] Univ Debrecen, MTA DE Biodivers & Ecosyst Serv Res Grp, Debrecen, Hungary	Babes Bolyai University from Cluj; University of Debrecen; MTA-DE Biodiversity & Ecosystem Services Research Group; University of Debrecen	Laszlo, Z (corresponding author), Univ Babes Bolyai, Hungarian Dept Biol & Ecol, R-3400 Cluj Napoca, Romania.	laszlozoltan@gmail.com	Laszlo, Zoltan/F-8651-2011	Laszlo, Zoltan/0000-0001-5064-4785; Barta, Zoltan/0000-0002-7121-9865; Tothmeresz, Bela/0000-0002-4766-7668	Romanian Ministry of Education; CNCS - UEFISCDI [PN-II-RU-PD-2012-3-0065 (45/30.04.2013)]; Hungarian Research Fund [OTKA K75696];  [TA MOP 4.2.1./B-09/1/KONV-2010-0007];  [TAMOP-4.2.2/B-10/1-2010-0024]	Romanian Ministry of Education(Ministry of Education and Research - Romania); CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ; 	The work of ZL was supported by a grant of the Romanian Ministry of Education, CNCS - UEFISCDI, project number PN-II-RU-PD-2012-3-0065 (45/30.04.2013). The work of BT was supported by the TA MOP 4.2.1./B-09/1/KONV-2010-0007, and TAMOP-4.2.2/B-10/1-2010-0024 projects. ZB was supported by a Hungarian Research Fund grant (OTKA K75696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson, 1997, EVOL ECOL, V29; Abrahamson WG, 1997, MONOGR POPUL BIOL, P26; [Anonymous], FORAGING THEORY; Askew R. R., 1961, Transactions of the Society for British Entomology, V14, P237; Bailey JK, 2003, OIKOS, V101, P127, DOI 10.1034/j.1600-0706.2003.12185.x; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; CONFER JL, 1985, J FIELD ORNITHOL, V56, P56; Crawley MJ, 2013, R BOOK, P557; Floyd T, 1996, ECOLOGY, V77, P1544, DOI 10.2307/2265550; Freese G, 1996, OECOLOGIA, V108, P293, DOI 10.1007/BF00334654; HAILS RS, 1992, J ANIM ECOL, V61, P567, DOI 10.2307/5612; Ito M, 2004, J FOREST RES-JPN, V9, P355, DOI 10.1007/s10310-004-0091-1; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; KATO K, 1993, RES POPUL ECOL, V35, P1, DOI 10.1007/BF02515640; Kohnen A, 2011, BIOL J LINN SOC, V102, P369, DOI 10.1111/j.1095-8312.2010.01582.x; Laszlo Z, 2006, ACTA ZOOL ACAD SCI H, V52, P373; Laszlo Z, 2013, B ENTOMOL RES, V103, P326, DOI 10.1017/S0007485312000764; Laszlo Z, 2008, ENTOMOL FENNICA, V19, P168, DOI 10.33338/ef.84432; MARQUIS RJ, 1994, ECOLOGY, V75, P2007, DOI 10.2307/1941605; MCGINLEY MA, 1989, EVOL ECOL, V3, P150, DOI 10.1007/BF02270917; Nordlander G., 1973, Entomologisk Tidskrift, V94, P148; Orrock JL, 2010, ETHOLOGY, V116, P338, DOI 10.1111/j.1439-0310.2010.01740.x; Pearson D.E., 1999, Northwestern Naturalist, V80, P26, DOI 10.2307/3536631; PRICE PW, 1986, ECOLOGY, V67, P1593, DOI 10.2307/1939090; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; SCHLICHTER L, 1978, CAN FIELD NAT, V92, P71; Schonrogge K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053959; SCHRODER D., 1967, Technical Bulletin. Commonwealth Institute of Biological Control, P93; Shealer DA, 1999, AM MIDL NAT, V142, P102, DOI 10.1674/0003-0031(1999)142[0102:FPOEGS]2.0.CO;2; STILLE B, 1984, OECOLOGIA, V63, P364, DOI 10.1007/BF00390666; STILLE B, 1985, GENETICA, V67, P145, DOI 10.1007/BF02424421; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; Stone GN, 2002, ANNU REV ENTOMOL, V47, P633, DOI 10.1146/annurev.ento.47.091201.145247; Strong AM, 2000, OECOLOGIA, V125, P370, DOI 10.1007/s004420000467; TSCHARNTKE T, 1992, ECOLOGY, V73, P1689, DOI 10.2307/1940020; Van Hezewijk BH, 2003, ECOL ENTOMOL, V28, P593, DOI 10.1046/j.1365-2311.2003.00553.x; WEIS AE, 1992, EVOLUTION, V46, P1674, DOI [10.1111/j.1558-5646.1992.tb01161.x, 10.2307/2410023]; WEIS AE, 1994, EVOLUTION, V48, P734, DOI 10.1111/j.1558-5646.1994.tb01357.x; WEIS AE, 1983, ECOLOGY, V64, P688, DOI 10.2307/1937190	39	7	9	5	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99806	10.1371/journal.pone.0099806	http://dx.doi.org/10.1371/journal.pone.0099806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918448	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000113
J	Mary, N; Barasc, H; Ferchaud, S; Billon, Y; Meslier, F; Robelin, D; Calgaro, A; Loustau-Dudez, AM; Bonnet, N; Yerle, M; Acloque, H; Ducos, A; Pinton, A				Mary, Nicolas; Barasc, Harmonie; Ferchaud, Stephane; Billon, Yvon; Meslier, Frederic; Robelin, David; Calgaro, Anne; Loustau-Dudez, Anne-Marie; Bonnet, Nathalie; Yerle, Martine; Acloque, Herve; Ducos, Alain; Pinton, Alain			Meiotic Recombination Analyses of Individual Chromosomes in Male Domestic Pigs (Sus scrofa domestica)	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX LENGTH; CROSSOVER INTERFERENCE; HUMAN GENOME; LINKAGE MAP; CROSSING-OVER; HOT-SPOTS; MOUSE; MLH1; ANEUPLOIDY; FREQUENCY	For the first time in the domestic pig, meiotic recombination along the 18 porcine autosomes was directly studied by immunolocalization of MLH1 protein. In total, 7,848 synaptonemal complexes from 436 spermatocytes were analyzed, and 13,969 recombination sites were mapped. Individual chromosomes for 113 of the 436 cells (representing 2,034 synaptonemal complexes) were identified by immunostaining and fluorescence in situ hybridization (FISH). The average total length of autosomal synaptonemal complexes per cell was 190.3 mu m, with 32.0 recombination sites (crossovers), on average, per cell. The number of crossovers and the lengths of the autosomal synaptonemal complexes showed significant intra- (i.e. between cells) and inter-individual variations. The distributions of recombination sites within each chromosomal category were similar: crossovers in metacentric and submetacentric chromosomes were concentrated in the telomeric regions of the p- and q-arms, whereas two hotspots were located near the centromere and in the telomeric region of acrocentrics. Lack of MLH1 foci was mainly observed in the smaller chromosomes, particularly chromosome 18 (SSC18) and the sex chromosomes. All autosomes displayed positive interference, with a large variability between the chromosomes.	[Mary, Nicolas; Barasc, Harmonie; Robelin, David; Calgaro, Anne; Loustau-Dudez, Anne-Marie; Bonnet, Nathalie; Yerle, Martine; Acloque, Herve; Ducos, Alain; Pinton, Alain] INRA, Genet Physiol & Syst Elevage UMR1388, F-31326 Castanet Tolosan, France; [Mary, Nicolas; Barasc, Harmonie; Robelin, David; Calgaro, Anne; Loustau-Dudez, Anne-Marie; Bonnet, Nathalie; Yerle, Martine; Acloque, Herve; Ducos, Alain; Pinton, Alain] Univ Toulouse INPT ENSAT, Genet Physiol & Syst Elevage UMR1388, Castanet Tolosan, France; [Mary, Nicolas; Barasc, Harmonie; Robelin, David; Calgaro, Anne; Loustau-Dudez, Anne-Marie; Bonnet, Nathalie; Yerle, Martine; Acloque, Herve; Ducos, Alain; Pinton, Alain] Univ Toulouse INPT ENVT, Genet Physiol & Syst Elevage UMR1388, Toulouse, France; [Ferchaud, Stephane; Billon, Yvon; Meslier, Frederic] UE1372 GenESI Genet Expt & Syst Innovants, Surgeres, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Mary, N (corresponding author), INRA, Genet Physiol & Syst Elevage UMR1388, F-31326 Castanet Tolosan, France.	n.mary@envt.fr	Barasc, Harmonie/AAS-9519-2020; MARY, Nicolas/AAT-9071-2020; Ducos, Alain/AAQ-3673-2020; Pinton, Alain/AAQ-1648-2020	Barasc, Harmonie/0000-0002-1644-4701; MARY, Nicolas/0000-0002-7304-5555; Ducos, Alain/0000-0002-2741-9579; Pinton, Alain/0000-0002-0809-7180; Acloque, Herve/0000-0003-4761-1055				Anderson LK, 1999, GENETICS, V151, P1569; Baier B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004125; Barasc H, 2014, THERIOGENOLOGY, V81, P368, DOI 10.1016/j.theriogenology.2013.10.006; Basheva EA, 2008, CHROMOSOME RES, V16, P709, DOI 10.1007/s10577-008-1221-y; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Berchowitz LE, 2010, CURR GENOMICS, V11, P91, DOI 10.2174/138920210790886835; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Bidau CJ, 2001, HEREDITY, V87, P305, DOI 10.1046/j.1365-2540.2001.00877.x; Borodin P M, 2008, Tsitologiia, V50, P62; Borodin PM, 2009, ANIM GENET, V40, P235, DOI 10.1111/j.1365-2052.2008.01808.x; Borodin PM, 2008, GENETICS, V178, P621, DOI 10.1534/genetics.107.079665; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Broman KW, 2002, GENETICS, V160, P1123; Brown PW, 2005, AM J HUM GENET, V77, P556, DOI 10.1086/468188; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Codina-Pascual M, 2006, MOL HUM REPROD, V12, P123, DOI 10.1093/molehr/gal007; Codina-Pascual M, 2005, HUM REPROD, V20, P2133, DOI 10.1093/humrep/dei023; Colombo PC, 1997, HEREDITY, V79, P214, DOI 10.1038/sj.hdy.6881930; de Boer E, 2007, J CELL SCI, V120, P731, DOI 10.1242/jcs.003186; de Boer E, 2006, P NATL ACAD SCI USA, V103, P9607, DOI 10.1073/pnas.0600418103; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; Drouaud J, 2007, PLOS GENET, V3, P1096, DOI 10.1371/journal.pgen.0030106; Ducos A, 2008, CYTOGENET GENOME RES, V120, P26, DOI 10.1159/000118738; Ducos A, 1998, J HERED, V89, P136, DOI 10.1093/jhered/89.2.136; EGOZCUE J, 1983, HUM GENET, V65, P185, DOI 10.1007/BF00286660; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Ford CE, 1980, P 1 INT C STAND BAND; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Garcia-Cruz R, 2011, CHROMOSOMA; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Hall H, 2006, CURR OPIN GENET DEV, V16, P323, DOI 10.1016/j.gde.2006.04.011; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; HULTEN M, 1974, HEREDITAS, V76, P55; Hulten MA, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-10; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Lian J, 2008, HUM MOL GENET, V17, P2583, DOI 10.1093/hmg/ddn158; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Massip K, 2010, CHROMOSOME RES, V18, P925, DOI 10.1007/s10577-010-9162-7; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mikawa S, 1999, ANIM GENET, V30, P407, DOI 10.1046/j.1365-2052.1999.00493.x; Mompart F, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-30; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Pan ZZ, 2012, AM J MED GENET A, V158A, P581, DOI 10.1002/ajmg.a.35222; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; Pinton A, 2011, CYTOGENET GENOME RES, V133, P202, DOI 10.1159/000321794; Pita M, 2008, J ZOOL SYST EVOL RES, V46, P186, DOI 10.1111/j.1439-0469.2008.00466.x; Reeves A, 2001, GENOME, V44, P439, DOI 10.1139/gen-44-3-439; Rogel-Gaillard C, 1999, CYTOGENET CELL GENET, V85, P205, DOI 10.1159/000015294; Rogel-Gaillard C, 1997, CYTOGENET CELL GENET, V79, P79, DOI 10.1159/000134687; SCHWARZACHER T, 1984, CHROMOSOMA, V91, P12, DOI 10.1007/BF00286480; Shi QH, 2002, AM J HUM GENET, V71, P254, DOI 10.1086/341559; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; Sun F, 2006, HUM REPROD, V21, P2335, DOI 10.1093/humrep/del190; Sun F, 2006, HUM MOL GENET, V15, P2376, DOI 10.1093/hmg/ddl162; Tempest HG, 2011, SYST BIOL REPROD MED, V57, P93, DOI 10.3109/19396368.2010.504879; Templado C, 2013, MOL HUM REPROD, V19, P634, DOI 10.1093/molehr/gat039; Tortereau F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-586; Villagomez DAF, 2009, CYTOGENET GENOME RES, V126, P110, DOI 10.1159/000245911; VILLAGOMEZ DAF, 1993, HEREDITAS, V118, P87, DOI 10.1111/j.1601-5223.1993.t01-3-00087.x; Vingborg RKK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-134; Vozdova M, 2013, CYTOGENET GENOME RES, V140, P36, DOI 10.1159/000350444; Vranis NM, 2010, GENES-BASEL, V1, P505, DOI 10.3390/genes1030505; Wessa P., 2013, FREE STAT SOFTWARE; Wong AK, 2010, GENETICS, V184, P595, DOI 10.1534/genetics.109.106831; Yang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019255	73	23	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99123	10.1371/journal.pone.0099123	http://dx.doi.org/10.1371/journal.pone.0099123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919066	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000051
J	Chen, XL; Yang, K; Zhang, WH; Chen, XZ; Zhang, B; Chen, ZX; Chen, JP; Zhou, ZG; Hu, JK				Chen, Xiao-Long; Yang, Kun; Zhang, Wei-Han; Chen, Xin-Zu; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang; Hu, Jian-Kun			Metastasis, Risk Factors and Prognostic Significance of Splenic Hilar Lymph Nodes in Gastric Adenocarcinoma	PLOS ONE			English	Article							SPLEEN PRESERVATION; TOTAL GASTRECTOMY; CANCER; SPLENECTOMY; CARCINOMA; CHEMOTHERAPY; DISSECTION; SURVIVAL; IMPACT	Background: The metastatic rate and risk factors of splenic hilar (No. 10) lymph nodes (LNs) in gastric adenocarcinoma were still variable and uncertain, and the prognostic significance of No. 10 LNs was also controversial. The aim of this retrospective study was to analyze the metastatic rate, risk factors and prognostic significance of No. 10 LNs in gastric adenocarcinoma. Methods: From August 2007 to December 2011, 205 patients who were diagnosed with primary gastric adenocarcinoma and underwent total or proximal gastrectomy plus No. 10 LNs dissection in West China Hospital were enrolled. Clinicopathological features and survival outcomes were retrospectively analyzed. Results: Mean numbers of harvested LNs and metastatic LNs were 34.8 +/- 12.6 (15-73) and 8.7 +/- 10.8 (0-67), respectively. The proportion of cases with positive No. 10 LNs was 8.8% (18/205). In all 204 dissected No. 10 LNs, 47 LNs (23.0%) were metastatic. In 52.2% (107/205) patients, the dissected splenic hilar tissues were histologically determined as only fat tissues but without LNs structure. Histological evidence of LNs structure was found in 98 (47.8%) patients with 18.4% (18/98) metastatic No. 10 LNs. In multivariate logistic regression analysis, metastasis of No. 10 LNs was significantly correlated with No. 4sa LNs (p = 0.010) and pN stage (p = 0.012). Regarding survival analysis, 199 (97.1%) patients were followed up (0.6-74.8 months). In all patients with R0 resection, metastatic No. 10 LNs caused significantly worse prognosis both in Kaplan-Meier (p = 0.006) and Cox regression analysis (p = 0.031). Conclusions: Although the metastatic rate of No. 10 LNs was 8.8%, dissection of No. 10 LNs might be meaningful due to the poor prognosis of positive cases. And attentions should be also paid to its correlated factors including pN stage and No. 4sa LNs.	[Chen, Xiao-Long; Yang, Kun; Zhang, Wei-Han; Chen, Xin-Zu; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang; Hu, Jian-Kun] Sichuan Univ, West China Hosp, Dept Gastrointestinal, Chengdu, Sicuhan, Peoples R China	Sichuan University	Hu, JK (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal, Chengdu, Sicuhan, Peoples R China.	hujkwch@126.com	Chen, Xin-Zu/K-2988-2019; Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Zhang, Wei-Han/AAS-3536-2021	, Zongguang/0000-0002-7616-1199				Ajani JA, 1998, ONCOLOGY-NY, V12, P44; Ajani JA, 2010, J NATL COMPR CANC NE, V8, P378, DOI 10.6004/jnccn.2010.0030; Aoyagi K, 2010, WORLD J HEPATOL, V2, P81, DOI 10.4254/wjh.v2.i2.81; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Chen XZ, 2008, WORLD J GASTROENTERO, V14, P2715, DOI 10.3748/wjg.14.2715; Chen XZ, 2010, J AM COLL SURGEONS, V210, P100, DOI 10.1016/j.jamcollsurg.2009.09.033; Chikara K, 2001, HEPATO-GASTROENTEROL, V48, P908; Csendes A, 2002, SURGERY, V131, P401, DOI 10.1067/msy.2002.121891; Degiuli M, 1997, EUR J SURG ONCOL, V23, P310, DOI 10.1016/S0748-7983(97)90696-X; Fatouros M, 2005, ANTICANCER RES, V25, P3023; Hu JK, 2009, SURG TODAY, V39, P207, DOI 10.1007/s00595-008-3856-x; Ikeguchi M, 2004, AM SURGEON, V70, P645; Ishikawa S, 2009, WORLD J SURG, V33, P1687, DOI 10.1007/s00268-009-0083-6; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kunisaki C, 2007, J GASTROINTEST SURG, V11, P1039, DOI 10.1007/s11605-007-0186-z; MAEHARA Y, 1991, CANCER, V67, P3006, DOI 10.1002/1097-0142(19910615)67:12<3006::AID-CNCR2820671213>3.0.CO;2-V; Monig SP, 2001, J SURG ONCOL, V76, P89; Nashimoto A, 2012, INT J SURG ONCOL, V2012, DOI 10.1155/2012/301530; OKAJIMA K, 1995, WORLD J SURG, V19, P537, DOI 10.1007/BF00294715; Okinaga K, 2006, J EXP CLIN CANC RES, V25, P339; SASAKO M, 1995, BRIT J SURG, V82, P346, DOI 10.1002/bjs.1800820321; Shin SH, 2009, ANN SURG ONCOL, V16, P1304, DOI 10.1245/s10434-009-0389-5; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Wen L, 2012, HEPATO-GASTROENTEROL, V59, P633, DOI 10.5754/hge11834; Yang K, 2009, WORLD J GASTROENTERO, V15, P5352, DOI 10.3748/wjg.15.5352; Yu W, 2006, BRIT J SURG, V93, P559, DOI 10.1002/bjs.5353; Zhang Cheng-hai, 2011, Zhonghua Wei Chang Wai Ke Za Zhi, V14, P589; Zhu GL, 2012, J SURG ONCOL, V105, P786, DOI 10.1002/jso.22149	30	12	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99650	10.1371/journal.pone.0099650	http://dx.doi.org/10.1371/journal.pone.0099650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915065	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700123
J	Wang, J; Zhou, M; Wang, XB; Yang, XL; Wang, MH; Zhang, CX; Zhou, SZ; Tang, N				Wang, Ji; Zhou, Min; Wang, Xiaobin; Yang, Xiaoling; Wang, Maohua; Zhang, Chunxiang; Zhou, Shuzhi; Tang, Ni			Impact of Ketamine on Learning and Memory Function, Neuronal Apoptosis and Its Potential Association with miR-214 and PTEN in Adolescent Rats	PLOS ONE			English	Article							ANESTHESIA; NEURODEGENERATION; NEUROTOXICITY; ANTAGONIST; PROPOFOL; CANCER; MODEL; PAIN; AGE	Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is used as a general pediatric anesthetic and antidepressive drug. Recent studies suggest that ketamine enhances neuronal apoptosis in developing rats. The goal of this study is to explore whether ketamine could result in learning and memory impairment and neurodegeneration in adolescent rats, and if so, whether the effects of ketamine are associated with miR-214 and PTEN expression. Fifty-day-old SD rats were randomly divided into three groups receiving ketamine at 30, or 80 mg/kg, i.p. or saline for seven consecutive days. Twenty-four hours after the last treatment, learning and memory function were tested by the Morris water maze. The rats were then decapitated, and the brains were isolated for detection of neuronal apoptosis and protein PTEN expression by TUNEL and immunohistochemistry respectively. Expression levels of the miR-214 and PTEN in the hippocampus were measured by qRT-PCR and western blot analysis respectively. Ketamine administered to the adolescent rats at a dose of 80 mg/kg rather than the lower dose of 30 mg/kg caused learning and memory impairment, increased the number of apoptotic cells in the hippocampal CA(1) region, cerebral cortex and subcortical region, decreased the miR-214 levels and increased PTEN protein expression in hippocampus. The results suggest that ketamine at a dose of 80 mg/kg in the adolescent rats is able to induce the learning and memory impairment and neurodegeneration, in which the down-regulation of miR-214 and high expression of PTEN protein may be involved.	[Wang, Ji; Zhou, Min; Wang, Xiaobin; Yang, Xiaoling; Wang, Maohua; Zhou, Shuzhi; Tang, Ni] Luzhou Med Coll, Affiliated Hosp, Dept Anesthesiol, Luzhou, Sichuan, Peoples R China; [Zhang, Chunxiang] Rush Univ, Rush Med Coll, Dept Pharmacol, Chicago, IL 60612 USA	Southwest Medical University; Rush University	Wang, XB (corresponding author), Luzhou Med Coll, Affiliated Hosp, Dept Anesthesiol, Luzhou, Sichuan, Peoples R China.	wangxiaobin67@163.com	Wang, Maohua/GNW-6319-2022	Wang, Maohua/0000-0003-2252-2291	National Natural Science Foundation of China [8127147]; International Cooperation, Department of Science & Technology of Sichuan Province [2011HH0031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation, Department of Science & Technology of Sichuan Province	This project was supported by the Projects of the National Natural Science Foundation of China (Grant No. 8127147) and International Cooperation, Department of Science & Technology of Sichuan Province (Grant No. 2011HH0031) to X. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Becker A, 2004, PROG NEURO-PSYCHOPH, V28, P1267, DOI 10.1016/j.pnpbp.2004.06.019; Campbell LL, 2011, TOXICOLOGY, V283, P1, DOI 10.1016/j.tox.2011.01.014; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; EVANS AM, 1986, BIOL REPROD, V34, P322, DOI 10.1095/biolreprod34.2.322; Gama CS, 2012, SCHIZOPHR RES, V141, P162, DOI 10.1016/j.schres.2012.08.002; Garcia LSB, 2008, PROG NEURO-PSYCHOPH, V32, P140, DOI 10.1016/j.pnpbp.2007.07.027; Gomes LMRS, 2011, PAIN PHYSICIAN, V14, P83; Hayashi H, 2002, PAEDIATR ANAESTH, V12, P770, DOI 10.1046/j.1460-9592.2002.00883.x; Huang LN, 2012, BRAIN RES, V1476, P164, DOI 10.1016/j.brainres.2012.07.059; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Kitagishi Y, 2013, INT J MOL MED, V31, P511, DOI 10.3892/ijmm.2013.1235; Kohrs R, 1998, ANESTH ANALG, V87, P1186, DOI 10.1097/00000539-199811000-00039; Kos T, 2006, EUR NEUROPSYCHOPHARM, V16, P297, DOI 10.1016/j.euroneuro.2005.10.001; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2013, INT J MOL MED, V32, P439, DOI 10.3892/ijmm.2013.1411; Lin C, 2005, PEDIATR ANESTH, V15, P91, DOI 10.1111/j.1460-9592.2005.01475.x; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Schmid RL, 1999, PAIN, V82, P111, DOI 10.1016/S0304-3959(99)00044-5; Schwarzenbach H, 2012, BREAST CANCER RES TR, V134, P933, DOI 10.1007/s10549-012-1988-6; Shi YJ, 2012, J CELL SCI, V125, P4687, DOI 10.1242/jcs.093765; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Straiko MMW, 2009, ANESTHESIOLOGY, V110, P862, DOI 10.1097/ALN.0b013e31819b5eab; Veilleux-Lemieux D, 2013, J AM ASSOC LAB ANIM, V52, P567; Vutskits Laszlo, 2007, Ideggyogy Sz, V60, P109; Wang J, 2011, ANESTHESIOLOGY, V115, P812, DOI 10.1097/ALN.0b013e31822f16ae; Wang XB, 2012, J ECT, V28, P128, DOI 10.1097/YCT.0b013e31824d1d02; Wang XB, 2011, PSYCHIAT RES, V185, P248, DOI 10.1016/j.psychres.2010.04.046; WATERMAN AE, 1978, BRIT J ANAESTH, V50, P885, DOI 10.1093/bja/50.9.885; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhang CX, 2008, PHYSIOL GENOMICS, V33, P139, DOI 10.1152/physiolgenomics.00034.2008; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055; Zhang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086149; Zou XJ, 2009, INT J DEV NEUROSCI, V27, P727, DOI 10.1016/j.ijdevneu.2009.06.010; Zou XJ, 2009, TOXICOL SCI, V108, P149, DOI 10.1093/toxsci/kfn270	39	24	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99855	10.1371/journal.pone.0099855	http://dx.doi.org/10.1371/journal.pone.0099855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914689	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700138
J	Wang, XJ; Jin, X; Dun, BQ; Kong, N; Jia, SR; Tang, QL; Wang, ZX				Wang, Xu-Jing; Jin, Xi; Dun, Bao-Qing; Kong, Ning; Jia, Shi-Rong; Tang, Qiao-Ling; Wang, Zhi-Xing			Gene-Splitting Technology: A Novel Approach for the Containment of Transgene Flow in Nicotiana tabacum	PLOS ONE			English	Article							INTEIN; CHLOROPLAST; STRATEGIES; RESISTANCE; PLASTIDS; SUBUNIT	The potential impact of transgene escape on the environment and food safety is a major concern to the scientists and public. This work aimed to assess the effect of intein-mediated gene splitting on containment of transgene flow. Two fusion genes, EPSPSn-In and Ic-EPSPSc, were constructed and integrated into N. tabacum, using Agrobacterium tumefaciens-mediated transformation. EPSPSn-In encodes the first 295 aa of the herbicide resistance gene 5-enolpyruvyl shikimate-3-phosphate synthase (EPSPS) fused with the first 123 aa of the Ssp DnaE intein (In), whereas Ic-EPSPSc encodes the 36 C-terminal aa of the Ssp DnaE intein (Ic) fused to the rest of EPSPS C terminus peptide sequences. Both EPSPSn-In and Ic-EPSPSc constructs were introduced into the same N. tabacum genome by genetic crossing. Hybrids displayed resistance to the herbicide N-(phosphonomethyl)-glycine (glyphosate). Western blot analysis of protein extracts from hybrid plants identified full-length EPSPS. Furthermore, all hybrid seeds germinated and grew normally on glyphosate selective medium. The 6-8 leaf hybrid plants showed tolerance of 2000 ppm glyphosate in field spraying. These results indicated that functional EPSPS protein was reassembled in vivo by intein-mediated trans-splicing in 100% of plants. In order to evaluate the effect of the gene splitting technique for containment of transgene flow, backcrossing experiments were carried out between hybrids, in which the foreign genes EPSPSn-In and Ic-EPSPSc were inserted into different chromosomes, and non-transgenic plants NC89. Among the 2812 backcrossing progeny, about 25% (664 plantlets) displayed glyphosate resistance. These data indicated that transgene flow could be reduced by 75%. Overall, our findings provide a new and highly effective approach for biological containment of transgene flow.	[Wang, Xu-Jing; Jin, Xi; Kong, Ning; Jia, Shi-Rong; Tang, Qiao-Ling; Wang, Zhi-Xing] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Dun, Bao-Qing] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wang, ZX (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	wangcotton@126.com	Jia, Shirong/L-8788-2019		Major Project of China on New Varieties of GMO Cultivation [2013ZX08010-003]; National Natural Science Foundation of China [31100408]	Major Project of China on New Varieties of GMO Cultivation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Project of China on New Varieties of GMO Cultivation (2013ZX08010-003) and the National Natural Science Foundation of China (31100408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmad H, 2005, PLANTA, V222, P372, DOI 10.1007/s00425-005-1540-6; Benitez EP, 2010, CROP SCI, V50, P185, DOI 10.2135/cropsci2009.02.0108; Bock R, 2004, TRENDS BIOTECHNOL, V22, P311, DOI 10.1016/j.tibtech.2004.03.005; Chin HG, 2003, P NATL ACAD SCI USA, V100, P4510, DOI 10.1073/pnas.0736538100; Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1272, DOI 10.1104/pp.107.106062; Dun BQ, 2007, APPL ENVIRON MICROB, V73, P7997, DOI 10.1128/AEM.00956-07; Dyer GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005734; Elleuche S, 2010, APPL MICROBIOL BIOT, V87, P479, DOI 10.1007/s00253-010-2628-x; Gidoni D, 2008, IN VITRO CELL DEV-PL, V44, P457, DOI 10.1007/s11627-008-9140-3; Gils M, 2012, METHODS MOL BIOL, V847, P123, DOI 10.1007/978-1-61779-558-9_11; Heuberger S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014128; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Huesken Alexandra, 2010, Environmental Biosafety Research, V9, P67, DOI 10.1051/ebr/2010009; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; James C, 2013, CHINA BIOTECH, V33, P1; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Kempken F, 2010, BIOTECH AGR FOREST, V64, P253, DOI 10.1007/978-3-642-02391-0_14; Khan MS, 2005, TRENDS BIOTECHNOL, V23, P217, DOI 10.1016/j.tibtech.2005.03.006; Leflon M, 2010, PLANT BREEDING, V129, P13, DOI 10.1111/j.1439-0523.2009.01645.x; Moon HS, 2010, TRENDS BIOTECHNOL, V28, P3, DOI 10.1016/j.tibtech.2009.09.008; Munsch M, 2008, MAYDICA, V53, P261; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Rieben S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029730; Ruf S, 2007, P NATL ACAD SCI USA, V104, P6998, DOI 10.1073/pnas.0700008104; Svab Z, 2007, P NATL ACAD SCI USA, V104, P7003, DOI 10.1073/pnas.0700063104; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Yang JJ, 2003, P NATL ACAD SCI USA, V100, P3513, DOI 10.1073/pnas.0635899100; Yoshida H, 2007, PLANT BIOTECHNOL J, V5, P835, DOI 10.1111/j.1467-7652.2007.00291.x; [朱玉 Zhu Yu], 2003, [分子植物育种, Molecular Plant Breeding], V1, P435	29	7	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99651	10.1371/journal.pone.0099651	http://dx.doi.org/10.1371/journal.pone.0099651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915192	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700124
J	Panngom, K; Lee, SH; Park, DH; Sim, GB; Kim, YH; Uhm, HS; Park, G; Choi, EH				Panngom, Kamonporn; Lee, Sang Hark; Park, Dae Hoon; Sim, Geon Bo; Kim, Yong Hee; Uhm, Han Sup; Park, Gyungsoon; Choi, Eun Ha			Non-Thermal Plasma Treatment Diminishes Fungal Viability and Up-Regulates Resistance Genes in a Plant Host	PLOS ONE			English	Article							PATHOGENESIS-RELATED GENE; PROGRAMMED CELL-DEATH; NITRIC-OXIDE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; NADPH OXIDASES; APOPTOSIS; TOMATO; GROWTH; WILT	Reactive oxygen and nitrogen species can have either harmful or beneficial effects on biological systems depending on the dose administered and the species of organism exposed, suggesting that application of reactive species can possibly produce contradictory effects in disease control, pathogen inactivation and activation of host resistance. A novel technology known as atmospheric-pressure non-thermal plasma represents a means of generating various reactive species that adversely affect pathogens (inactivation) while simultaneously up-regulating host defense genes. The anti-microbial efficacy of this technology was tested on the plant fungal pathogen Fusarium oxysporum f.sp. lycopersici and its susceptible host plant species Solanum lycopercicum. Germination of fungal spores suspended in saline was decreased over time after exposed to argon (Ar) plasma for 10 min. Although the majority of treated spores exhibited necrotic death, apoptosis was also observed along with the up-regulation of apoptosis related genes. Increases in the levels of peroxynitrite and nitrite in saline following plasma treatment may have been responsible for the observed spore death. In addition, increased transcription of pathogenesis related (PR) genes was observed in the roots of the susceptible tomato cultivar (S. lycopercicum) after exposure to the same Ar plasma dose used in fungal inactivation. These data suggest that atmospheric-pressure non-thermal plasma can be efficiently used to control plant fungal diseases by inactivating fungal pathogens and up-regulating mechanisms of host resistance.	[Panngom, Kamonporn; Sim, Geon Bo; Kim, Yong Hee; Uhm, Han Sup; Park, Gyungsoon; Choi, Eun Ha] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea; [Lee, Sang Hark] Kwangwoon Univ, Plasma Display Panel Res Ctr, Seoul, South Korea; [Panngom, Kamonporn; Sim, Geon Bo; Uhm, Han Sup; Park, Gyungsoon; Choi, Eun Ha] Kwangwoon Univ, Dept Plasma Biosci & Display, Seoul, South Korea; [Park, Dae Hoon; Uhm, Han Sup; Park, Gyungsoon; Choi, Eun Ha] Kwangwoon Univ, Dept Elect & Biol Phys, Seoul, South Korea	Kwangwoon University; Kwangwoon University; Kwangwoon University; Kwangwoon University	Park, G (corresponding author), Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea.	gyungp@kw.ac.kr; ehchoi@kw.ac.kr	Choi, Eun Ha/AFN-9488-2022; Panngom, Kamonporn/HHN-3668-2022	Choi, Eun Ha/0000-0001-5385-1878; Park, Gyungsoon/0000-0003-1592-3847	National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2010-0027963, NRF-2013R1A1A3011245]; Rural Development Administration, Republic of Korea [PJ009891]	National Research Foundation of Korea (NRF) - Korean government (MSIP)(National Research Foundation of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (NRF-2010-0027963, NRF-2013R1A1A3011245) and also by the Rural Development Administration, Republic of Korea (PJ009891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arjunan KP, 2012, J R SOC INTERFACE, V9, P147, DOI 10.1098/rsif.2011.0220; Baidya S, 2011, APPL ENVIRON MICROB, V77, P5524, DOI 10.1128/AEM.00638-11; Basaran P, 2008, FOOD MICROBIOL, V25, P626, DOI 10.1016/j.fm.2007.12.005; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Buelna-Chontal M, 2013, CELL SIGNAL, V25, P2548, DOI 10.1016/j.cellsig.2013.08.007; Di Pietro A, 2003, MOL PLANT PATHOL, V4, P315, DOI [10.1046/j.1364-3703.2003.00180.x, 10.1046/J.1364-3703.2003.00180.X]; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Filaire E, 2012, JOINT BONE SPINE, V79, P341, DOI 10.1016/j.jbspin.2012.03.007; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Ianoul A, 2002, ANAL CHEM, V74, P1458, DOI 10.1021/ac010863q; Ito S, 2007, FEBS LETT, V581, P3217, DOI 10.1016/j.febslet.2007.06.010; Jiang JF, 2014, PLASMA SCI TECHNOL, V16, DOI 10.1088/1009-0630/16/1/12; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kanazawa S, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034010; Kavroulakis N, 2006, ANN BOT-LONDON, V98, P555, DOI 10.1093/aob/mcl149; Kayano Y, 2013, FUNGAL GENET BIOL, V56, P87, DOI 10.1016/j.fgb.2013.05.001; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Larkin RP, 1998, PLANT DIS, V82, P1022, DOI 10.1094/PDIS.1998.82.9.1022; Li D, 2012, AM J MED SCI, V344, P486, DOI 10.1097/MAJ.0b013e3182579dc6; Liu P, 2010, MYCOLOGIA, V102, P311, DOI 10.3852/09-176; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nejad P, 2000, BIOL CONTROL, V18, P208, DOI 10.1006/bcon.2000.0837; Ninnemann H, 1996, PHOTOCHEM PHOTOBIOL, V64, P393, DOI 10.1111/j.1751-1097.1996.tb02477.x; Oehmigen K, 2011, PLASMA PROCESS POLYM, V8, P904, DOI 10.1002/ppap.201000099; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Papapostolou I, 2010, FUNGAL BIOL-UK, V114, P387, DOI 10.1016/j.funbio.2010.01.010; Park G, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3684632; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Rieger L, 2004, WATER SCI TECHNOL, V50, P143, DOI 10.2166/wst.2004.0682; Ryu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066231; Schlicht M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00351; Selcuk M, 2008, BIORESOURCE TECHNOL, V99, P5104, DOI 10.1016/j.biortech.2007.09.076; Semighini CP, 2006, MOL MICROBIOL, V59, P753, DOI 10.1111/j.1365-2958.2005.04976.x; Shi M, 2012, MICROBIOL-SGM, V158, P166, DOI 10.1099/mic.0.052670-0; Taheri P., 2012, J BOT, DOI [10.1155/2012/137037, DOI 10.1155/2012/137037]; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Tornero P, 1997, MOL PLANT MICROBE IN, V10, P624, DOI 10.1094/MPMI.1997.10.5.624; Tudzynski P, 2012, CURR OPIN MICROBIOL, V15, P653, DOI 10.1016/j.mib.2012.10.002; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Wang YX, 2011, AM J PHYSIOL-CELL PH, V301, pC695, DOI 10.1152/ajpcell.00322.2010; Weller R, 2001, J APPL MICROBIOL, V90, P648, DOI 10.1046/j.1365-2672.2001.01291.x; Won DongChan, 2013, Korean Journal of Breeding Science, V45, P153, DOI 10.9787/KJBS.2013.45.2.153	53	76	78	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99300	10.1371/journal.pone.0099300	http://dx.doi.org/10.1371/journal.pone.0099300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911947	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600068
J	Quan, JH; Yusufzai, T				Quan, Jinhua; Yusufzai, Timur			The Tumor Suppressor Chromodomain Helicase DNA-binding Protein 5 (CHD5) Remodels Nucleosomes by Unwrapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; XENOPUS-LAEVIS; IN-VITRO; CHROMATIN; COMPLEX; GENE; SWI/SNF; ACF; TRANSLOCATION; SUBFAMILIES	Although mutations or deletions of chromodomain helicase DNA-binding protein 5 (CHD5) have been linked to cancer and implicate CHD5 in tumor suppression, the ATP-dependent activity of CHD5 is currently unknown. In this study, we discovered that CHD5 is a chromatin remodeling factor with a unique enzymatic activity. CHD5 can expose nucleosomal DNA at one or two discrete positions in the nucleosome. The exposure of the nucleosomal DNA by CHD5 is dependent on ATP hydrolysis, but continued ATP hydrolysis is not required to maintain the nucleosomes in their remodeled state. The activity of CHD5 is distinct from other related chromatin remodeling ATPases, such as ACF and BRG1, and does not lead to complete disruption or destabilization of the nucleosome. Rather, CHD5 likely initiates remodeling in a manner similar to that of other remodeling factors but does not significantly reposition the nucleosome. While the related factor CHD4 shows strong ATPase activity, it does not unwrap nucleosomes as efficiently as CHD5. Our findings add to the growing evidence that chromatin remodeling ATPases have diverse roles in modulating chromatin structure.	Harvard Univ, Sch Med, Dept Biol Chem, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Yusufzai, T (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,JF520, Boston, MA 02115 USA.	timur_yusufzai@dfci.harvard.edu			Dana-Farber Cancer Institute; William F. Milton Fund; Claudia Adams Barr Program	Dana-Farber Cancer Institute; William F. Milton Fund; Claudia Adams Barr Program	This work was supported by the Dana-Farber Cancer Institute, the William F. Milton Fund, and the Claudia Adams Barr Program.	Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Cho I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003407; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dechassa ML, 2010, MOL CELL, V38, P590, DOI 10.1016/j.molcel.2010.02.040; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Garcia I, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-277; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gorringe KL, 2008, NEOPLASIA, V10, P1253, DOI 10.1593/neo.08718; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Mulero-Navarro S, 2008, EPIGENETICS-US, V3, P210, DOI 10.4161/epi.3.4.6610; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; Oliver SS, 2012, BIOCHEMISTRY-US, V51, P6534, DOI 10.1021/bi3006972; Paul S, 2013, CELL REP, V3, P92, DOI 10.1016/j.celrep.2012.12.009; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Potts RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024515; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rattner BP, 2009, MOL CELL, V34, P620, DOI 10.1016/j.molcel.2009.04.014; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang L, 2013, J CLIN NEUROSCI, V20, P958, DOI 10.1016/j.jocn.2012.07.021; WOLFFE AP, 1986, CELL, V44, P381, DOI 10.1016/0092-8674(86)90459-9; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; YOUNG D, 1983, MOL CELL BIOL, V3, P720, DOI 10.1128/MCB.3.4.720; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	42	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20717	20726		10.1074/jbc.M114.568568	http://dx.doi.org/10.1074/jbc.M114.568568			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24923445	Green Published, hybrid			2022-12-25	WOS:000339396600029
J	Reyes-Hernandez, OD; Vega, L; Jimenez-Rios, MA; Martinez-Cervera, PF; Lugo-Garcia, JA; Hernandez-Cadena, L; Ostrosky-Wegman, P; Orozco, L; Elizondo, G				Reyes-Hernandez, Octavio D.; Vega, Libia; Jimenez-Rios, Miguel A.; Martinez-Cervera, Pedro F.; Lugo-Garcia, Juan A.; Hernandez-Cadena, Leticia; Ostrosky-Wegman, Patricia; Orozco, Lorena; Elizondo, Guillermo			The PXR rs7643645 Polymorphism Is Associated with the Risk of Higher Prostate-Specific Antigen Levels in Prostate Cancer Patients	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; GENETIC VARIANT; CLINICAL PRESENTATION; XENOBIOTIC RECEPTOR; ACID-PHOSPHATASE; PROMOTER VARIANT; AFRICAN-AMERICAN; CYP3A4; EXPRESSION; CYTOCHROME-P-450	Levels of enzymes that determine testosterone catabolism such as CYP3A4 have been associated with prostate cancer (PCa) risk. Although some studies have related CYP3A4*1B allele, a gene polymorphism that modifies CYP3A4 expression level, with PCa risk, others have failed, suggesting that additional genetic variants may be involved. Expression of CYP3A4 is largely due to the activation of Pregnane X Receptor (PXR). Particularly, rs2472677 and rs7643645 PXR polymorphisms modify CYP3A4 expression levels. To evaluate whether PXR-HNF3 beta/T (rs2472677), PXR-HNF4/G (rs7643645), and CYP3A4*1B (rs2740574) polymorphisms are associated with PCa a case control-study was performed. The multiple testing analysis showed that the PXR-HNF4/G polymorphism was associated with higher levels of prostate-specific antigen (PSA) in patients with PCa (OR = 3.99, p = 0.03). This association was stronger in patients diagnosed at the age of 65 years or older (OR = 10.8, p = 0.006). Although the CYP3A4*1B/*1B genotype was overrepresented in PCa patients, no differences were observed in the frequency of this and PXR-HNF3 beta/T alleles between controls and cases. Moreover, no significant association was found between these polymorphisms and PSA, Gleason grade, or tumor lymph node metastasis.	[Reyes-Hernandez, Octavio D.; Lugo-Garcia, Juan A.] Hosp Juarez Mexico, Lab Genet & Diagnost Mol, Mexico City, DF, Mexico; [Vega, Libia] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Toxicol, Mexico City, DF, Mexico; [Jimenez-Rios, Miguel A.; Martinez-Cervera, Pedro F.] Inst Nacl Cancerol, Dept Urol, Mexico City, DF, Mexico; [Hernandez-Cadena, Leticia] Inst Nacl Salud Publ, Dept Salud Ambiental, Mexico City, DF, Mexico; [Ostrosky-Wegman, Patricia] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Orozco, Lorena] Inst Nacl Med Genom, Lab Inmunogenom & Enfermedades Metab, Mexico City, DF, Mexico; [Elizondo, Guillermo] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Elizondo, G (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Mexico City, DF, Mexico.	gazuela@cinvestav.mx		Vega, Libia/0000-0002-4993-5267; Orozco, Lorena/0000-0002-5801-9180; ostrosky-wegman, patricia/0000-0002-8564-3472; Hernandez Cadena, Leticia/0000-0003-3807-2758	CONACyT [13756]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACyT (www.conacyt.gob.mx) grant number 13756. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirimani B, 2003, ENVIRON MOL MUTAGEN, V42, P299, DOI 10.1002/em.10199; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Ball SE, 1999, CLIN PHARMACOL THER, V66, P288, DOI 10.1016/S0009-9236(99)70037-8; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; BRIAN WR, 1990, BIOCHEMISTRY-US, V29, P11280, DOI 10.1021/bi00503a018; Fujimura T, 2012, CANCER SCI, V103, P176, DOI 10.1111/j.1349-7006.2011.02143.x; Fujimura T, 2009, UROLOGY, V74, P391, DOI 10.1016/j.urology.2009.02.033; Gray MA, 2013, J STEROID BIOCHEM, V133, P110, DOI 10.1016/j.jsbmb.2012.09.025; Hsing AW, 2008, CANCER EPIDEM BIOMAR, V17, P2525, DOI 10.1158/1055-9965.EPI-08-0448; Hsing AW, 2006, FRONT BIOSCI-LANDMRK, V11, P1388, DOI 10.2741/1891; Hsing AW, 1996, J NATL CANCER I, V88, P1093, DOI 10.1093/jnci/88.16.1093; Hustert E, 2001, DRUG METAB DISPOS, V29, P1454; Johnson JL, 2005, BIOCHEM J, V391, P699, DOI 10.1042/BJ20050380; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Konno Y, 2009, MOL PHARMACOL, V75, P265, DOI 10.1124/mol.108.051904; Kraft P, 2009, NAT REV GENET, V10, P264, DOI 10.1038/nrg2516; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lamba J, 2008, DRUG METAB DISPOS, V36, P169, DOI 10.1124/dmd.107.016600; Lamba JK, 2002, PHARMACOGENETICS, V12, P121, DOI 10.1097/00008571-200203000-00006; LIN MF, 1993, ARCH BIOCHEM BIOPHYS, V300, P384, DOI 10.1006/abbi.1993.1052; Ozdemir V, 2000, PHARMACOGENETICS, V10, P373, DOI 10.1097/00008571-200007000-00001; Paris PL, 1999, CANCER EPIDEM BIOMAR, V8, P901; Rebbeck TR, 1998, J NATL CANCER I, V90, P1225, DOI 10.1093/jnci/90.16.1225; SCHRODER FH, 1992, PROSTATE, P129; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Spurdle AB, 2002, PHARMACOGENETICS, V12, P355, DOI 10.1097/00008571-200207000-00003; SUNDIN M, 1987, J BIOL CHEM, V262, P12293; Taioli E, 2013, PROSTATE, V73, P668, DOI 10.1002/pros.22612; Tayeb MT, 2002, ONCOL REP, V9, P653; THUMMEL KE, 1994, J PHARMACOL EXP THER, V271, P557; Wandel C, 2000, CLIN PHARMACOL THER, V68, P82, DOI 10.1067/mcp.2000.108506; WAXMAN DJ, 1988, ARCH BIOCHEM BIOPHYS, V263, P424, DOI 10.1016/0003-9861(88)90655-8; Webber MM, 1995, CLIN CANCER RES, V1, P1089; YOUNG CYF, 1991, CANCER RES, V51, P3748; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zeigler-Johnson CM, 2002, HUM HERED, V54, P13, DOI 10.1159/000066695	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99974	10.1371/journal.pone.0099974	http://dx.doi.org/10.1371/journal.pone.0099974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924803	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300115
J	Walters, P; Barley, EA; Mann, A; Phillips, R; Tylee, A				Walters, Paul; Barley, Elizabeth A.; Mann, Anthony; Phillips, Rachel; Tylee, Andre			Depression in Primary Care Patients with Coronary Heart Disease: Baseline Findings from the UPBEAT UK Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSION; GENERAL-PRACTITIONERS; MANAGING DEPRESSION; RISK-FACTOR; PREVALENCE; MORTALITY; ANXIETY	Background: An association between depression and coronary heart disease is now accepted but there has been little primary care research on this topic. The UPBEAT-UK studies are centred on a cohort of primary patients with coronary heart disease assessed every six months for up to four years. The aim of this research was to determine the prevalence and associations of depression in this cohort at baseline. Method: Participants with coronary heart disease were recruited from general practice registers and assessed for cardiac symptoms, depression, quality of life and social problems. Results: 803 people participated. 42% had a documented history of myocardial infarction, 54% a diagnosis of ischaemic heart disease or angina. 44% still experienced chest pain. 7% had an ICD-10 defined depressive disorder. Factors independently associated with this diagnosis were problems living alone (OR 5.49, 95% CI 2.11-13.30), problems carrying out usual activities (OR 3.71, 95% CI 1.93-7.14), experiencing chest pain (OR 3.27, 95% CI 1.58-6.76), other pains or discomfort (OR 3.39, 95% CI 1.42-8.10), younger age (OR 0.95 per year 95% CI 0.92-0.98). Conclusion: Problems living alone, chest pain and disability are important predictors of depression in this population.	[Walters, Paul] Univ NHS Fdn Trust, Univ Dept Mental Hlth, Dorset HealthCare, Bournemouth, Dorset, England; [Walters, Paul] Bournemouth Univ, Bournemouth, Dorset, England; [Barley, Elizabeth A.] Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London WC2R 2LS, England; [Mann, Anthony; Phillips, Rachel; Tylee, Andre] Kings Coll London, Sect Primary Care Mental Hlth, Hlth Serv, London WC2R 2LS, England; [Mann, Anthony; Phillips, Rachel; Tylee, Andre] Kings Coll London, Sect Primary Care Mental Hlth, Populat Res Dept, London WC2R 2LS, England	Bournemouth University; University of London; King's College London; University of London; King's College London; University of London; King's College London	Walters, P (corresponding author), Univ NHS Fdn Trust, Univ Dept Mental Hlth, Dorset HealthCare, Bournemouth, Dorset, England.	Paul.Walters@dhuft.nhs.uk	Barley, Elizabeth/M-6663-2019	Phillips, Rachel/0000-0002-3634-7845; Barley, Elizabeth/0000-0001-9955-0384	NIHR Mental Health BRC at the Institute of Psychiatry; Kings College London; South London and Maudsley Foundation Trust; National Institute for Health Research [MET-08-08-101, RP-PG-0606-1048] Funding Source: researchfish	NIHR Mental Health BRC at the Institute of Psychiatry; Kings College London(General Electric); South London and Maudsley Foundation Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	AT is partly funded by the NIHR Mental Health BRC at the Institute of Psychiatry, Kings College London and South London and Maudsley Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barley EA, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-1; Barley EA, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-47; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Brown G., 1978, SOCIAL ORIGINS DEPRE; Carroll K, 2003, J PUBLIC HEALTH MED, V25, P29, DOI 10.1093/pubmed/fdg007; CORNEY RH, 1985, PSYCHOL MED, V15, P637, DOI 10.1017/S0033291700031494; Davidson KW, 2006, PSYCHOSOM MED, V68, P645, DOI 10.1097/01.psy.0000233233.48738.22; Dickens C, 2008, PSYCHOSOM MED, V70, P450, DOI 10.1097/PSY.0b013e31816a74de; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Goldberg DP., 1992, COMMON MENTAL DISORD; Gulliksson Mats, 2007, BMC Cardiovasc Disord, V7, P36, DOI 10.1186/1471-2261-7-36; Herbst S, 2007, PSYCHOSOM MED, V69, P729, DOI 10.1097/PSY.0b013e3181574977; Kendrick T, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13220; Lett HS, 2004, PSYCHOSOM MED, V66, P305, DOI 10.1097/01.psy.0000126207.43307.c0; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; MARKS JN, 1979, PSYCHOL MED, V9, P337, DOI 10.1017/S0033291700030853; Pajak P, 2012, EUROPEAN J PREVANTIV, V20, P331; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rimington LD, 2001, THORAX, V56, P266, DOI 10.1136/thorax.56.4.266; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Salokangas RKR, 1998, J AFFECT DISORDERS, V48, P171, DOI 10.1016/S0165-0327(97)00171-7; Singleton N., 2001, PSYCHIAT MORBIDITY A; The Information Centre for Health and Social Care, QUAL OUTC FRAM 2010; Tylee A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-58; Tylee A, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-38; USTUN TB, 1995, MENTAL ILLNESS GEN H; Wilhelm K, 2003, J AFFECT DISORDERS, V75, P155, DOI 10.1016/S0165-0327(02)00040-X; World Health Organisation, 1993, ICD 10 CLASS MENT BE; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98342	10.1371/journal.pone.0098342	http://dx.doi.org/10.1371/journal.pone.0098342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24922312	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000338701300008
J	Bai, XS; Zhang, EK; Ye, H; Nandakumar, V; Wang, Z; Chen, LH; Tang, CN; Li, JH; Li, HJ; Zhang, W; Han, W; Lou, F; Zhang, DD; Sun, H; Dong, HC; Zhang, GC; Liu, ZY; Dong, ZS; Guo, BS; Yan, H; Yan, CW; Wang, L; Su, ZY; Li, YY; Jones, L; Huang, XF; Chen, SY; Gao, JL				Bai, Xusheng; Zhang, Enke; Ye, Hua; Nandakumar, Vijayalakshmi; Wang, Zhuo; Chen, Lihong; Tang, Chuanning; Li, Jianhui; Li, Huijin; Zhang, Wei; Han, Wei; Lou, Feng; Zhang, Dandan; Sun, Hong; Dong, Haichao; Zhang, Guangchun; Liu, Zhiyuan; Dong, Zhishou; Guo, Baishuai; Yan, He; Yan, Chaowei; Wang, Lu; Su, Ziyi; Li, Yangyang; Jones, Lindsey; Huang, Xue F.; Chen, Si-Yi; Gao, Jinglong			PIK3CA and TP53 Gene Mutations in Human Breast Cancer Tumors Frequently Detected by Ion Torrent DNA Sequencing	PLOS ONE			English	Article							KINASE INHIBITORS; OVARIAN-CANCER; PREVENTION; EXPRESSION; LAPATINIB; HER2; P53; REDUCTION; EFFICACY; RECEPTOR	Breast cancer is the most common malignancy and the leading cause of cancer deaths in women worldwide. While specific genetic mutations have been linked to 5-10% of breast cancer cases, other environmental and epigenetic factors influence the development and progression of the cancer. Since unique mutations patterns have been observed in individual cancer samples, identification and characterization of the distinctive breast cancer molecular profile is needed to develop more effective target therapies. Until recently, identifying genetic cancer mutations via personalized DNA sequencing was impractical and expensive. The recent technological advancements in next-generation DNA sequencing, such as the semiconductor-based Ion Torrent sequencing platform, has made DNA sequencing cost and time effective with more reliable results. Using the Ion Torrent Ampliseq Cancer Panel, we sequenced 737 loci from 45 cancer-related genes to identify genetic mutations in 105 human breast cancer samples. The sequencing analysis revealed missense mutations in PIK3CA, and TP53 genes in the breast cancer samples of various histologic types. Thus, this study demonstrates the necessity of sequencing individual human cancers in order to develop personalized drugs or combination therapies to effectively target individual, breast cancer-specific mutations.	[Bai, Xusheng; Zhang, Enke; Wang, Zhuo; Chen, Lihong; Li, Jianhui; Li, Huijin; Zhang, Wei; Han, Wei; Gao, Jinglong] Peoples Hosp Shan Xi Prov, Cent Lab, Xian, Peoples R China; [Ye, Hua; Tang, Chuanning; Lou, Feng; Zhang, Dandan; Sun, Hong; Dong, Haichao; Zhang, Guangchun; Liu, Zhiyuan; Dong, Zhishou; Guo, Baishuai; Yan, He; Yan, Chaowei; Wang, Lu; Su, Ziyi; Li, Yangyang] San Valley Biotechnol Inc, Beijing, Peoples R China; [Jones, Lindsey; Huang, Xue F.; Chen, Si-Yi] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California	Chen, SY (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	siyichen@usc.edu; gaojinglong126@126.com			National Natural Science Foundation of China; Wu Jieping Foundation; National Institute of Health [R01 CA90427, R01 AI084811]; NATIONAL CANCER INSTITUTE [R01CA090427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084811] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wu Jieping Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the grants from National Natural Science Foundation of China, the Wu Jieping Foundation, and the National Institute of Health (R01 CA90427 & R01 AI084811 to SY Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsner J, 2000, CLIN CANCER RES, V6, P3923; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bertucci Francois, 2008, J Biol, V7, P6, DOI 10.1186/jbiol67; Blackburn GL, 2007, AM J CLIN NUTR, V86, p878S, DOI 10.1093/ajcn/86.3.878S; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2627, DOI 10.1002/cncr.22656; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Chen WY, 2007, NAT CLIN PRACT ONCOL, V4, P415, DOI 10.1038/ncponc0851; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; EASTON DF, 1995, AM J HUM GENET, V56, P265; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Fabian CJ, 2007, INT J CLIN PRACT, V61, P2051, DOI 10.1111/j.1742-1241.2007.01587.x; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Ferlay J, 2013, IARC CANCERBASE; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kang S, 2005, CELL CYCLE, V4, P578, DOI 10.4161/cc.4.4.1593; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Lazzeroni M, 2013, HEMATOL ONCOL CLIN N, V27, P657, DOI 10.1016/j.hoc.2013.05.009; Levin B, 2012, MOL MED, V18, P1327, DOI 10.2119/molmed.2012.00280; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Montemurro F, 2007, EXPERT OPIN BIOL TH, V7, P257, DOI 10.1517/14712598.7.2.257; Nakopoulou LL, 1996, J PATHOL, V179, P31, DOI 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O; Nielsen DL, 2013, BREAST, V22, P1, DOI 10.1016/j.breast.2012.09.008; Obiorah I, 2011, MATURITAS, V70, P315, DOI 10.1016/j.maturitas.2011.09.006; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Roukos DH, 2012, ANN SURG ONCOL, V19, P3646, DOI 10.1245/s10434-012-2542-9; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Toi M, 2009, BRIT J CANCER, V101, P1676, DOI 10.1038/sj.bjc.6605343; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; Xia WL, 2007, CANCER RES, V67, P1170, DOI 10.1158/0008-5472.CAN-06-2101; Xu Bing-He, 2011, Chin J Cancer, V30, P327; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	39	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99306	10.1371/journal.pone.0099306	http://dx.doi.org/10.1371/journal.pone.0099306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918944	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000074
J	He, JS; Yang, L; Han, XY; Zheng, GF; Zheng, WY; Wei, GQ; Wu, WJ; Ye, XJ; Shi, JM; Xie, WZ; Li, L; Zhang, J; Huang, WJ; Zhao, Y; Huang, H; Zhang, XJ; Fu, JP; Cai, Z				He, Jingsong; Yang, Li; Han, Xiaoyan; Zheng, Gaofeng; Zheng, Weiyan; Wei, Guoqing; Wu, Wenjun; Ye, Xiujin; Shi, Jimin; Xie, Wanzhuo; Li, Li; Zhang, Jie; Huang, Weijia; Zhao, Yi; Huang, He; Zhang, Xuejin; Fu, Jiaping; Cai, Zhen			The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; INDUCTION TREATMENT PRIOR; HERPES-ZOSTER EVENTS; COMPLETE RESPONSE; AUTOLOGOUS TRANSPLANTATION; PERIPHERAL NEUROPATHY; PLUS DEXAMETHASONE; TREATED PATIENTS; SINGLE-CENTER; APEX TRIAL	Introduction: Bortezomib has significantly improved multiple myeloma (MM) response rates, but strategies for choosing bortezomib-based regimens for initial MM therapy are not standardized. Here, we describe four bortezomib-based therapies in Chinese MM patients to determine the optimal chemotherapeutic approach. Methods: Newly diagnosed symptomatic MM patients at three hematological centers between February 1, 2006 and May 31, 2013 were treated with therapies including bortezomib plus dexamethasone (PD) or combinations of PD with either adriamycin (PAD), cyclophosphamide (PCD) or thalidomide (PTD) for every 28 days. Results: The overall response rate of all the 215 eligible patients was 90.2%. The ORR for PCD, PAD, PTD and PD were 97.4%, 93.2%, 85.3% and 77.8% while the effects with VGPR or better were 63.7%, 62.7%, 44.2% and 37.8%, respectively. The effect of ORR, VGPR and CR/nCR for the PCD regimen was better than the PD protocol. Median PFS for all patients was 29.0 months with significant differences observed among treatment groups. Median OS of all the patients was not reached, but three-drug combinations were superior to PD alone. Frequently observed toxicities were neutropenia, thrombocytopenia, fatigue, infection, herpes zoster, and peripheral neuropathy. The incidence of peripheral neuropathy (PN) in PTD group was significantly higher than other three groups, especially grade 2-3 PN. Treatment with anti-viral agent acyclovir significantly reduced the incidence of herpes zoster. Conclusions: Our experience indicated that bortezomib-based regimens were effective and well-tolerated in the Chinese population studied; three-drug combinations PCD, PAD were superior to PD, especially with respect to PCD.	[He, Jingsong; Yang, Li; Han, Xiaoyan; Zheng, Gaofeng; Zheng, Weiyan; Wei, Guoqing; Wu, Wenjun; Ye, Xiujin; Shi, Jimin; Xie, Wanzhuo; Li, Li; Zhang, Jie; Huang, Weijia; Zhao, Yi; Huang, He; Cai, Zhen] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [He, Jingsong; Yang, Li; Han, Xiaoyan; Zheng, Gaofeng; Zheng, Weiyan; Wei, Guoqing; Wu, Wenjun; Ye, Xiujin; Shi, Jimin; Xie, Wanzhuo; Li, Li; Zhang, Jie; Huang, Weijia; Zhao, Yi; Huang, He; Cai, Zhen] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Multiple Myeloma Treatment Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xuejin] Red Cross Hosp Hangzhou, Dept Hematol, Hangzhou, Zhejiang, Peoples R China; [Fu, Jiaping] Shaoxing Peoples Hosp, Dept Hematol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Cai, Z (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	caiz@zju.edu.cn	han, xiao/HDN-9782-2022		Major International (region) Co-elaboration Research Project of Chinese National Natural Science Foundation [81120108018]; National Natural Science Foundation of China [91029740, 81071936, 30900533]; Key project of the Ministry of Health of China; Scientific Research Program for Public Interests from the Health Ministry of China [201002024]	Major International (region) Co-elaboration Research Project of Chinese National Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key project of the Ministry of Health of China; Scientific Research Program for Public Interests from the Health Ministry of China	This work was supported by Major International (region) Co-elaboration Research Project of Chinese National Natural Science Foundation (Project No. 81120108018); National Natural Science Foundation of China (Project No. 91029740, 81071936, 30900533); Key project of the Ministry of Health of China (Project 2010-2012); Scientific Research Program for Public Interests from the Health Ministry of China (Project No. 201002024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2011, JPN J CLIN ONCOL, V41, P876, DOI 10.1093/jjco/hyr063; Badros A, 2007, CANCER-AM CANCER SOC, V110, P1042, DOI 10.1002/cncr.22921; Barlogie B, 2008, CANCER-AM CANCER SOC, V113, P355, DOI 10.1002/cncr.23546; Blade J, 2008, ANN ONCOL, V19, P117, DOI 10.1093/annonc/mdn437; Cavo M, 2005, BLOOD, V106, P35, DOI 10.1182/blood-2005-02-0522; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Chanan-Khan A, 2008, J CLIN ONCOL, V26, P4784, DOI 10.1200/JCO.2007.14.9641; Chaudhry V, 2008, J PERIPHER NERV SYST, V13, P275, DOI 10.1111/j.1529-8027.2008.00193.x; de la Rubia J, 2011, EXPERT REV HEMATOL, V4, P381, DOI [10.1586/ehm.11.38, 10.1586/EHM.11.38]; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Harousseau JL, 2006, HAEMATOLOGICA, V91, P1498; Harousseau JL, 2010, BLOOD, V116, P3743, DOI 10.1182/blood-2010-03-275800; Harousseau JL, 2010, J CLIN ONCOL, V28, P4621, DOI 10.1200/JCO.2009.27.9158; Harousseau JL, 2009, BLOOD, V114, P3139, DOI 10.1182/blood-2009-03-201053; Jagannath S, 2009, BRIT J HAEMATOL, V146, P619, DOI 10.1111/j.1365-2141.2009.07803.x; Lahuerta JJ, 2008, J CLIN ONCOL, V26, P5775, DOI 10.1200/JCO.2008.17.9721; Kim SJ, 2008, CLIN LYMPHOMA MYELOM, V8, P237, DOI 10.3816/CLM.2008.n.031; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Mateos MV, 2010, LANCET ONCOL, V11, P934, DOI 10.1016/S1470-2045(10)70187-X; Mohty B, 2010, HAEMATOL-HEMATOL J, V95, P311, DOI 10.3324/haematol.2009.012674; Niesvizky R, 2008, BRIT J HAEMATOL, V143, P46, DOI 10.1111/j.1365-2141.2008.07303.x; Ohguchi H, 2009, INT J HEMATOL, V89, P342, DOI 10.1007/s12185-009-0279-4; Palumbo A, 2008, ANN ONCOL, V19, P1160, DOI 10.1093/annonc/mdn018; Palumbo A, 2010, J CLIN ONCOL, V28, P800, DOI 10.1200/JCO.2009.22.7561; Rajkumar SV, 2012, HEMATOL-AM SOC HEMAT, P354, DOI 10.1182/asheducation-2012.1.354; Reeder CB, 2009, LEUKEMIA, V23, P1337, DOI 10.1038/leu.2009.26; Reeder CB, 2010, BLOOD, V115, P3416, DOI 10.1182/blood-2010-02-271676; Richardson PG, 2009, BRIT J HAEMATOL, V144, P895, DOI 10.1111/j.1365-2141.2008.07573.x; Rosinol L, 2007, J CLIN ONCOL, V25, P4452, DOI 10.1200/JCO.2007.12.3323; Sonneveld P, 2012, J CLIN ONCOL, V30, P2946, DOI 10.1200/JCO.2011.39.6820; Tao ZF, 2007, CHINESE MED J-PEKING, V120, P1655, DOI 10.1097/00029330-200710010-00002; Tong Y, 2007, AM J HEMATOL, V82, P403, DOI 10.1002/ajh.20838; van de Velde HJK, 2007, HAEMATOLOGICA, V92, P1399, DOI 10.3324/haematol.11534; Vickrey E, 2009, CANCER-AM CANCER SOC, V115, P229, DOI 10.1002/cncr.24006; Wang LD, 2012, HEMATOL ONCOL, V30, P57, DOI 10.1002/hon.1007; Zheng WY, 2009, LEUKEMIA RES, V33, P1615, DOI 10.1016/j.leukres.2009.04.006	37	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99174	10.1371/journal.pone.0099174	http://dx.doi.org/10.1371/journal.pone.0099174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918626	Green Submitted, gold, Green Published			2022-12-25	WOS:000338631000054
J	Dies, H; Toppozini, L; Rheinstadter, MC				Dies, Hannah; Toppozini, Laura; Rheinstaedter, Maikel C.			The Interaction between Amyloid-beta Peptides and Anionic Lipid Membranes Containing Cholesterol and Melatonin	PLOS ONE			English	Article							X-RAY-DIFFRACTION; LIQUID-ORDERED STATE; ALZHEIMERS-DISEASE; PHOSPHOLIPID-MEMBRANES; PROTEIN INTERACTIONS; PHASE DMPC; BILAYERS; FLUID; DOMAINS; MODEL	One of the hallmarks of Alzheimer's disease is the formation of senile plaques, primarily consisting of amyloid-beta (A beta) peptides. Peptide-membrane and peptide-lipid interactions are thought to be crucial in this process. We studied the interaction of A beta(1-42) and A beta(25-35) peptides with anionic lipid membranes made of dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphoserine (DMPS) using X-ray diffraction. We compare the experimentally determined electron densities in the gel state of the membranes with density calculations from peptide structures reported in the Protein Data Bank in order to determine the position of the peptide in the bilayers. The full length peptide A beta(1-42) was found to embed in the hydrocarbon core of the anionic lipid bilayers. Two populations were found for the A beta(25-35) peptide: (1) membrane-bound states in the hydrophilic head group region of the bilayers, where the peptides align parallel to the membranes, and (2) an embedded state in the bilayer center. Aging plays an important role in the development of Alzheimer's, in particular with respect to changes in cholesterol and melatonin levels in the brain tissue. Immiscible cholesterol plaques were created by addition of 30 mol% cholesterol to the anionic membranes. The A beta(25-35) peptides were found to strongly interact with the lipid bilayers, displacing further cholesterol molecules into the plaques, effectively lowering the cholesterol concentration in the membranes and increasing the total fraction of cholesterol plaques. Addition of 30 mol% melatonin molecules to the anionic membranes drastically reduced the population of the membrane-embedded A beta state. These results present experimental evidence for an interaction between A beta peptides, melatonin and cholesterol in lipid membranes.	[Dies, Hannah; Toppozini, Laura; Rheinstaedter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	McMaster University	Rheinstadter, MC (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	rheinstadter@mcmaster.ca	Rheinstadter, Maikel C/D-5322-2009; Bacon, Hannah/AAQ-9604-2021	Rheinstadter, Maikel C/0000-0002-0558-7475; Bacon, Hannah/0000-0002-2772-141X	Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI); Ontario Ministry of Economic Development and Innovation; NSERC Undergraduate Research Awards (USRA); NSERC Graduate Scholarship (CGS); Early Researcher Award of the Province of Ontario	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Economic Development and Innovation; NSERC Undergraduate Research Awards (USRA); NSERC Graduate Scholarship (CGS); Early Researcher Award of the Province of Ontario	This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council Canada (NRC), the Canada Foundation for Innovation (CFI) and the Ontario Ministry of Economic Development and Innovation. H. D. is the recipient of an NSERC Undergraduate Research Awards (USRA), L. T. is the recipient of an NSERC Graduate Scholarship (CGS), M. C. R. is the recipient of an Early Researcher Award of the Province of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2000, CHEM PHYS LIPIDS, V107, P93, DOI 10.1016/S0009-3084(00)00154-7; Ahyayauch H, 2012, BIOPHYS J, V103, P453, DOI 10.1016/j.bpj.2012.06.043; Apajalahti T, 2009, FARADAY DISCUSS, V2010; Armstrong CL, 2014, SOFT MATTER, V10, P2600, DOI 10.1039/c3sm51757h; Armstrong CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066162; Armstrong CL, 2012, EUR BIOPHYS J BIOPHY, V41, P901, DOI 10.1007/s00249-012-0826-4; Armstrong CL, 2011, PROTEIN PEPTIDE LETT, V18, P344; Barrett MA, 2013, SOFT MATTER, V9, P9342, DOI 10.1039/c3sm50700a; Barrett MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034357; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Buchsteiner A, 2012, SOFT MATTER, V8, P424, DOI 10.1039/c1sm06823g; Buchsteiner A, 2010, BBA-BIOMEMBRANES, V1798, P1969, DOI 10.1016/j.bbamem.2010.06.024; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Casuso I, 2010, BIOPHYS J, V99, pL47, DOI 10.1016/j.bpj.2010.07.028; Chaudhuri A, 2011, BBA-BIOMEMBRANES, V1808, P19, DOI 10.1016/j.bbamem.2010.10.013; Choucair A, 2007, BBA-BIOMEMBRANES, V1768, P146, DOI 10.1016/j.bbamem.2006.09.005; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; D'Ursi AM, 2004, J MED CHEM, V47, P4231, DOI 10.1021/jm040773o; Dai J, 2010, J PHYS CHEM B, V114, P840, DOI 10.1021/jp909061h; Dante S, 2002, BIOPHYS J, V83, P2610, DOI 10.1016/S0006-3495(02)75271-5; Dante S, 2011, BBA-BIOMEMBRANES, V1808, P2646, DOI 10.1016/j.bbamem.2011.07.024; Dante S, 2006, EUR BIOPHYS J BIOPHY, V35, P523, DOI 10.1007/s00249-006-0062-x; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; de Lima VR, 2010, J PINEAL RES, V49, P169, DOI 10.1111/j.1600-079X.2010.00782.x; de Meyer F, 2009, P NATL ACAD SCI USA, V106, P3654, DOI 10.1073/pnas.0809959106; de Meyer FJM, 2010, J PHYS CHEM B, V114, P10451, DOI 10.1021/jp103903s; Ding H, 2012, BIOPHYS J, V103, P1500, DOI 10.1016/j.bpj.2012.08.051; Drolle E., 2013, BIOCHIM BIOPHYS ACTA, V1828; Drolle E, 2012, BIOPHYS J, V103, pL27, DOI 10.1016/j.bpj.2012.06.053; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; Fonseca ACRG, 2010, EXP NEUROL, V223, P282, DOI 10.1016/j.expneurol.2009.09.013; Fragneto G, 2007, CR PHYS, V8, P865, DOI 10.1016/j.crhy.2007.09.003; Gilbert BJ, 2013, J CLIN PATHOL, V66, P362, DOI 10.1136/jclinpath-2013-201515; Hall A, 2010, J PHYS CHEM B, V114, P7797, DOI 10.1021/jp912175d; Hane F, 2011, J ALZHEIMERS DIS, V26, P485, DOI 10.3233/JAD-2011-102112; Hristova K, 1998, BIOPHYS J, V74, P2419, DOI 10.1016/S0006-3495(98)77950-0; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Jao SC, 1997, AMYLOID, V4, P240, DOI 10.3109/13506129709003835; KING GI, 1971, PHYS LETT A, VA 35, P259, DOI 10.1016/0375-9601(71)90371-9; Kucerka N, 2005, BIOPHYS J, V88, P2626, DOI 10.1529/biophysj.104.056606; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; Lenne PF, 2009, SOFT MATTER, V5, P2841, DOI 10.1039/b822956b; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Maltseva E, 2004, CHEMPHYSCHEM, V5, P1185, DOI 10.1002/cphc.200400045; Martinez-Senac MD, 1999, EUR J BIOCHEM, V265, P744, DOI 10.1046/j.1432-1327.1999.00775.x; Mason RP, 2003, BBA-BIOMEMBRANES, V1610, P198, DOI 10.1016/S0005-2736(03)00018-X; Mason RP, 1996, BIOCHEM BIOPH RES CO, V222, P78, DOI 10.1006/bbrc.1996.0699; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Meinhardt S, 2013, P NATL ACAD SCI USA, V110, P4476, DOI 10.1073/pnas.1221075110; Mills TT, 2008, BIOPHYS J, V95, P669, DOI 10.1529/biophysj.107.127845; Mouritsen OG, 2010, BBA-BIOMEMBRANES, V1798, P1286, DOI 10.1016/j.bbamem.2010.02.017; NAGLE JF, 1989, BIOPHYS J, V55, P309, DOI 10.1016/S0006-3495(89)82806-1; Nagle JF, 1996, BIOPHYS J, V70, P1419, DOI 10.1016/S0006-3495(96)79701-1; Nagle JF, 2013, FARADAY DISCUSS, V161, P11, DOI 10.1039/c2fd20121f; Niemela PS, 2007, PLOS COMPUT BIOL, V3, P304, DOI 10.1371/journal.pcbi.0030034; Novakova E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051911; Pabst G, 2010, CHEM PHYS LIPIDS, V163, P460, DOI 10.1016/j.chemphyslip.2010.03.010; Pan JJ, 2012, BBA-BIOMEMBRANES, V1818, P2135, DOI 10.1016/j.bbamem.2012.05.007; Papanikolaou A, 2005, J BIOL CHEM, V280, P26406, DOI 10.1074/jbc.M413927200; Pappolla MA, 1997, J NEUROSCI, V17, P1683; Pappolla MA, 2000, J NEURAL TRANSM, V107, P203, DOI 10.1007/s007020050018; Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Poojari C, 2012, BIOCH BIOPHYSICA ACT; Poojari C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078399; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Raguz M, 2011, BBA-BIOMEMBRANES, V1808, P1072, DOI 10.1016/j.bbamem.2010.12.019; Rapaport H, 2001, BIOPHYS J, V81, P2729, DOI 10.1016/S0006-3495(01)75915-2; Reiter RJ, 2002, ANN NY ACAD SCI, V959, P238, DOI 10.1111/j.1749-6632.2002.tb02096.x; Rheinstadter MC, 2013, CURR OPIN COLLOID IN, V18, P440, DOI 10.1016/j.cocis.2013.07.001; Rheinstadter MC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.128104; Saija A, 2002, EUR J PHARM BIOPHARM, V53, P209, DOI 10.1016/S0939-6411(01)00239-9; Sani MA, 2011, FEBS LETT, V585, P749, DOI 10.1016/j.febslet.2011.02.011; Sasahara K, 2013, PHYS CHEM CHEM PHYS, V15, P8929, DOI 10.1039/c3cp44517h; Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Simons M, 2001, NEUROLOGY, V57, P1089, DOI 10.1212/WNL.57.6.1089; Sodt AJ, 2014, J AM CHEM SOC, V136, P725, DOI 10.1021/ja4105667; Solomonov I, 2005, BIOPHYS J, V88, P1809, DOI 10.1529/biophysj.104.044834; Solomonov I, 2009, EUR PHYS J E, V30, P215, DOI 10.1140/epje/i2009-10498-2; Strodel B, 2010, J AM CHEM SOC, V132, P13300, DOI 10.1021/ja103725c; Thakur G, 2009, COLLOID SURFACE B, V74, P436, DOI 10.1016/j.colsurfb.2009.07.043; Toppozini L, 2012, SOFT MATTER, V8, P11839, DOI 10.1039/c2sm26546j; Tristram-Nagle S, 2002, BIOPHYS J, V83, P3324, DOI 10.1016/S0006-3495(02)75333-2; Tsai HHG, 2010, PROTEINS, V78, P1909, DOI 10.1002/prot.22705; Tulenko TN, 1998, J LIPID RES, V39, P947; Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Vance DE, 2000, BBA-MOL CELL BIOL L, V1529, P1, DOI 10.1016/S1388-1981(00)00133-5; Wang JZ, 2006, ACTA PHARMACOL SIN, V27, P41, DOI 10.1111/j.1745-7254.2006.00260.x; Watkins EB, 2011, P NATL ACAD SCI USA, V108, P6975, DOI 10.1073/pnas.1014579108; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Wood WG, 2003, BBA-BIOMEMBRANES, V1610, P281, DOI 10.1016/S0005-2736(03)00025-7; WORCESTER DL, 1976, J MOL BIOL, V100, P359, DOI 10.1016/S0022-2836(76)80068-X; Wu YH, 2005, J PINEAL RES, V38, P145, DOI 10.1111/j.1600-079X.2004.00196.x; Ziblat R, 2011, ANGEW CHEM INT EDIT, V50, P3620, DOI 10.1002/anie.201004470; Ziblat R, 2012, BIOPHYS J, V103, P255, DOI 10.1016/j.bpj.2012.05.025; Ziblat R, 2010, J AM CHEM SOC, V132, P9920, DOI 10.1021/ja103975g	106	57	58	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99124	10.1371/journal.pone.0099124	http://dx.doi.org/10.1371/journal.pone.0099124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915524	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700064
J	Matallana-Surget, S; Derock, J; Leroy, B; Badri, H; Deschoenmaeker, F; Wattiez, R				Matallana-Surget, Sabine; Derock, Jeremy; Leroy, Baptiste; Badri, Hanene; Deschoenmaeker, Frederic; Wattiez, Ruddy			Proteome-Wide Analysis and Diel Proteomic Profiling of the Cyanobacterium Arthrospira platensis PCC 8005	PLOS ONE			English	Article							CIRCADIAN CLOCK; SHOTGUN PROTEOMICS; EXPRESSION; PROTEINS; BINDING; GENOME; GENES; CYCLE; IDENTIFICATION; ADAPTATION	The filamentous cyanobacterium Arthrospira platensis has a long history of use as a food supply and it has been used by the European Space Agency in the MELiSSA project, an artificial microecosystem which supports life during long-term manned space missions. This study assesses progress in the field of cyanobacterial shotgun proteomics and light/dark diurnal cycles by focusing on Arthrospira platensis. Several fractionation workflows including gel-free and gel-based protein/peptide fractionation procedures were used and combined with LC-MS/MS analysis, enabling the overall identification of 1306 proteins, which represents 21% coverage of the theoretical proteome. A total of 30 proteins were found to be significantly differentially regulated under light/dark growth transition. Interestingly, most of the proteins showing differential abundance were related to photosynthesis, the Calvin cycle and translation processes. A novel aspect and major achievement of this work is the successful improvement of the cyanobacterial proteome coverage using a 3D LC-MS/MS approach, based on an immobilized metal affinity chromatography, a suitable tool that enabled us to eliminate the most abundant protein, the allophycocyanin. We also demonstrated that cell growth follows a light/dark cycle in A. platensis. This preliminary proteomic study has highlighted new characteristics of the Arthrospira platensis proteome in terms of diurnal regulation.	[Matallana-Surget, Sabine; Derock, Jeremy; Leroy, Baptiste; Badri, Hanene; Deschoenmaeker, Frederic; Wattiez, Ruddy] Univ Mons, Interdisciplinary Mass Spectrometry Ctr CISMa, Dept Prote & Microbiol, B-7000 Mons, Belgium; [Badri, Hanene] Belgian Nucl Res Ctr SCK CEN, Inst Environm Hlth & Safety, Expert Grp Mol & Cellular Biol, Microbiol Unit, Mol, Belgium	University of Mons; Belgian Nuclear Research Centre (SCK-CEN)	Wattiez, R (corresponding author), Univ Mons, Interdisciplinary Mass Spectrometry Ctr CISMa, Dept Prote & Microbiol, B-7000 Mons, Belgium.	ruddy.wattiez@umh.ac.be	Surget, Sabine Matallana/AAM-1004-2020	Surget, Sabine Matallana/0000-0002-6023-3215; wattiez, ruddy/0000-0003-2071-4310; Leroy, Baptiste/0000-0001-7166-4478	European Space Agency (ESA-PRODEX); Belgian Federal Office; FNRS [2877824]	European Space Agency (ESA-PRODEX)(European Space Agency); Belgian Federal Office; FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the European Space Agency (ESA-PRODEX) and the Belgian Federal Office. This work was also partially financed by the FNRS under grant "grand equipement'' no. 2877824. Frederic Deschoenmaeker is an F.R.I.A. PhD student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Asato Y, 2003, CELL MOL LIFE SCI, V60, P663, DOI 10.1007/s00018-003-2079-y; Axmann IM, 2009, J BACTERIOL, V191, P5342, DOI 10.1128/JB.00419-09; Barber J, 2003, PHOTOCH PHOTOBIO SCI, V2, P536, DOI 10.1039/b300063j; Barrios-Llerena Martin E., 2006, Briefings in Functional Genomics & Proteomics, V5, P121, DOI 10.1093/bfgp/ell021; Belay A., 2020, J AM NUTRACEUTICAL A, V5, P27; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; BINDER BJ, 1995, APPL ENVIRON MICROB, V61, P708, DOI 10.1128/AEM.61.2.708-717.1995; CARPENTER CD, 1994, PLANT PHYSIOL, V104, P1015, DOI 10.1104/pp.104.3.1015; Cogne G, 2003, BIOTECHNOL BIOENG, V81, P588, DOI 10.1002/bit.10504; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; Dong GG, 2008, CURR OPIN MICROBIOL, V11, P541, DOI 10.1016/j.mib.2008.10.003; Doolittle W F, 1979, Adv Microb Physiol, V20, P1; Ekman M, 2006, MOL PLANT MICROBE IN, V19, P1251, DOI 10.1094/MPMI-19-1251; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; Gan CS, 2005, PROTEOMICS, V5, P2468, DOI 10.1002/pmic.200401266; Hendrickx L, 2006, RES MICROBIOL, V157, P77, DOI 10.1016/j.resmic.2005.06.014; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Holtzendorff J, 2001, J BACTERIOL, V183, P915, DOI 10.1128/JB.183.3.915-920.2001; Hongsthong A, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-33; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Janssen PJ, 2010, J BACTERIOL, V192, P2465, DOI 10.1128/JB.00116-10; Johnson CH, 1996, MOL MICROBIOL, V21, P5, DOI 10.1046/j.1365-2958.1996.00613.x; Kim YO, 2006, PLANT CELL PHYSIOL, V47, P793, DOI 10.1093/pcp/pcj047; Koksharova OA, 2007, MICROBIOL-SGM, V153, P2505, DOI 10.1099/mic.0.2007/007039-0; Kondo T, 2000, BIOESSAYS, V22, P10, DOI 10.1002/(SICI)1521-1878(200001)22:1<10::AID-BIES4>3.0.CO;2-A; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Leroy B, 2010, PROTEOMICS, V10, P2281, DOI 10.1002/pmic.200900286; Mastroleo F, 2009, J PROTEOME RES, V8, P2530, DOI 10.1021/pr900007d; Matallana-Surget S, 2010, EXPERT REV PROTEOMIC, V7, P5, DOI [10.1586/epr.09.101, 10.1586/EPR.09.101]; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; MERGENHAGEN D, 1987, EUR J CELL BIOL, V43, P203; Mullineaux CW, 2009, J BACTERIOL, V191, P5333, DOI 10.1128/JB.00719-09; Nikaido SS, 2000, PHOTOCHEM PHOTOBIOL, V71, P758, DOI 10.1562/0031-8655(2000)071<0758:DACVIS>2.0.CO;2; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Sergeyenko TV, 2000, FEMS MICROBIOL LETT, V193, P213, DOI 10.1016/S0378-1097(00)00482-1; Srivastava R, 2005, PROTEOMICS, V5, P4905, DOI 10.1002/pmic.200500111; Tan XM, 2011, J BACTERIOL, V193, P2675, DOI 10.1128/JB.01454-10; Toepel J, 2008, J BACTERIOL, V190, P3904, DOI 10.1128/JB.00206-08; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Vonshak A., 1997, SPIRULINA PLATENSIS, P43; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang DN, 2013, INT J MOL SCI, V14, P9018, DOI 10.3390/ijms14059018; Xu Y, 2000, EMBO J, V19, P3349, DOI 10.1093/emboj/19.13.3349; Zhang LF, 2009, J PROTEOME RES, V8, P2892, DOI 10.1021/pr900024w	49	25	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99076	10.1371/journal.pone.0099076	http://dx.doi.org/10.1371/journal.pone.0099076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914774	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700058
J	Su, ML; Chang, TM; Chiang, CH; Chang, HC; Hou, MF; Li, WS; Hung, WC				Su, Mei-Lin; Chang, Tsung-Ming; Chiang, Chi-Hsiang; Chang, Han-Chen; Hou, Ming-Feng; Li, Wen-Shan; Hung, Wen-Chun			Inhibition of Chemokine (C-C Motif) Receptor 7 Sialylation Suppresses CCL19-Stimulated Proliferation, Invasion and Anti-Anoikis	PLOS ONE			English	Article							CYCLIN D1 DEGRADATION; HUMAN BREAST-CANCER; UP-REGULATES CCR7; PROTEIN GLYCOSYLATION; DENDRITIC CELLS; SIALIC ACIDS; PHOSPHORYLATION; EXPRESSION; SURFACE; METASTASIS	Chemokine (C-C motif) receptor 7 (CCR7) is involved in lymph-node homing of naive and regulatory T cells and lymphatic metastasis of cancer cells. Sialic acids comprise a group of monosaccharide units that are added to the terminal position of the oligosaccharide chain of glycoproteins by sialyation. Recent studies suggest that aberrant sialylation of receptor proteins contributes to proliferation, motility, and drug resistance of cancer cells. In this study, we addressed whether CCR7 is a sialylated receptor protein and tried to elucidate the effect of sialylation in the regulation of signal transduction and biological function of CCR7. Our results demonstrated that alpha-2, 3-sialyltransferase which catalyze sialylation reaction in vivo was overexpressed in breast tumor tissues and cell lines. Lectin blot analysis clearly demonstrated that CCR7 receptor was sialyated in breast cancer cells. Chemokine (C-C motif) ligand 19 (CCL19), the cognate ligand for CCR7, induced the activation of extracellular signal-regulated kinase (ERK) and AKT signaling and increased the expression of cell cycle regulatory proteins and proliferation of breast cancer cells. When cells were pre-treated with a sialyltransferase inhibitor AL10 or sialidase, CCL19-induced cell growth was significantly suppressed. CCL19 also increased invasion and prevented anoikis by up-regulating pro-survival proteins Bcl-2 and Bcl-xL. Inhibition of sialylation by AL10 totally abolished these effects. Finally, we showed that AL10 inhibited tumorigenicity of breast cancer in experimental animals. Taken together, we demonstrate for the first time that CCR7 receptor is a sialylated protein and sialylation is important for the paracrine stimulation by its endogenous ligand CCL19. In addition, inhibition of aberrant sialylation of CCR7 suppresses proliferation and invasion and triggers anoikis in breast cancer cells. Targeting of sialylation enzymes may be a novel strategy for breast cancer treatment.	[Su, Mei-Lin; Hung, Wen-Chun] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Chang, Tsung-Ming; Chiang, Chi-Hsiang; Hung, Wen-Chun] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Dept Surg, Coll Med, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Municipal Tatung Hosp, Dept Surg, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chang, Han-Chen; Li, Wen-Shan] Acad Sinica, Inst Chem, Taipei, Taiwan	National Sun Yat Sen University; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Academia Sinica - Taiwan	Li, WS (corresponding author), Acad Sinica, Inst Chem, Taipei, Taiwan.	wenshan@chem.sinica.edu.tw; hung1228@nhri.org.tw	Hung, Wen-Chun/F-4846-2011; Chiang, Chih-Po/AAZ-5092-2020; Li, Wen-Shan/F-1972-2015	Chiang, Chih-Po/0000-0002-5399-3902; Li, Wen-Shan/0000-0002-8359-4582; Hou, Ming-Feng/0000-0001-6030-9702	Excellence for Cancer Research Center Grant, the Ministry of Health and Welfare [MOHW103-TD-B-111-05]; National Science Council, Taiwan, Republic of China [NSC-102-2321-B-400-003]	Excellence for Cancer Research Center Grant, the Ministry of Health and Welfare; National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by the grants: (1) MOHW103-TD-B-111-05 from Excellence for Cancer Research Center Grant, the Ministry of Health and Welfare and (2) NSC-102-2321-B-400-003 from National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Chiang CH, 2010, J CELL PHYSIOL, V223, P492, DOI 10.1002/jcp.22068; Chuang CW, 2013, J CELL PHYSIOL, V228, P341, DOI 10.1002/jcp.24136; Crespo HJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00491; Cui HX, 2011, ONCOL REP, V25, P1365, DOI 10.3892/or.2011.1192; De Laurentiis A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007898; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Feng Q, 2007, ONCOGENE, V26, P5098, DOI 10.1038/sj.onc.1210309; Fodero LR, 2001, J NEUROCHEM, V79, P1022, DOI 10.1046/j.1471-4159.2001.00640.x; Frommhold D, 2008, J EXP MED, V205, P1435, DOI 10.1084/jem.20070846; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hsu MC, 2008, MODERN PATHOL, V21, P609, DOI [10.1038/modpathol.2008.23, 10.1038/mpath.2008.23]; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kilker RL, 2004, J STEROID BIOCHEM, V92, P63, DOI 10.1016/j.jsbmb.2004.05.005; Kilker RL, 2006, CANCER RES, V66, P11478, DOI 10.1158/0008-5472.CAN-06-1755; Ma H, 2015, ONCOGENE, V34, P726, DOI 10.1038/onc.2014.7; MAGUIRE TM, 1994, NEUROBIOL AGING, V15, P99, DOI 10.1016/0197-4580(94)90149-X; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Pan MR, 2008, J BIOL CHEM, V283, P11155, DOI 10.1074/jbc.M710038200; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Pshezhetsky AV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P736, DOI 10.1134/S0006297913070067; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Schneider F, 2001, CANCER RES, V61, P4605; Shannon LA, 2010, J BIOL CHEM, V285, P38781, DOI 10.1074/jbc.M110.152173; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Vaites LP, 2011, MOL CELL BIOL, V31, P4513, DOI 10.1128/MCB.05733-11; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Zhou FB, 2010, J BIOCHEM, V148, P273, DOI 10.1093/jb/mvq062; Zou YL, 2004, J BIOL CHEM, V279, P27790, DOI 10.1074/jbc.M403042200	43	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98823	10.1371/journal.pone.0098823	http://dx.doi.org/10.1371/journal.pone.0098823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915301	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700035
J	Wang, HQ; Yang, J; Zhang, XW; Yan, LN; Yang, JY				Wang, Haiqing; Yang, Jian; Zhang, Xiaowu; Yan, Lunan; Yang, Jiayin			Liver Resection in Hepatitis B-Related Hepatocellular Carcinoma: Clinical Outcomes and Safety in Overweight and Obese Patients	PLOS ONE			English	Article							BODY-MASS-INDEX; PERIOPERATIVE OUTCOMES; RESOURCE UTILIZATION; CHINESE ADULTS; COMPLICATIONS; SURGERY; HEPATECTOMY; CIRRHOSIS; IMPACT; CANCER	Objective and Background: Although many studies on evaluating the safety of liver resection in obese patients have been conducted, the results remain contradictory. The aim of our study was to investigate the safety of overweight and obese patients undergoing liver resection for hepatitis B-related hepatocellular carcinoma in a large sample. Methods: In a retrospective cohort with 1543 hepatitis B-related hepatocellular carcinoma patients, the subjects were stratified into four groups according to their body mass index(BMI): obesity(BMI >= 28), overweight(BMI: 24.0-27.9), normal weight(BMI: 18.5-23.9) and underweight(BMI<18.5). The Dindo-Clavien classification system was used for grading complications. Clinical characteristics and operative outcomes were compared among the four groups. Risk factors for postoperative complications were evaluated by multivariate analysis. Results: According to the category criteria of the Working Group on Obesity in China (WGOC) criteria, 73(4.7%) obese, 412(26.7%) overweight, 982(63.6%) normal weight and 76(4.9%) underweight patients were included in our cohort. Overweight and obese patients had more preoperative comorbidities such as hypertension(P<0.001). Mortality, total complications and complications classified by Clavien system were similar among the four groups except that the underweight patients had fewer total complications. However, postoperative wound complication was more common in overweight and obese patients(6.3% vs 2.5%, P<0.001,11.0% vs 2.5%, P = 0.001). Multivariate analysis revealed that BMI was not an independently significant factor for postoperative complications. Conclusions: Liver resection for obese and overweight patients is safe and BMI itself is not a risk factor for mortality and morbidity.	[Wang, Haiqing; Yang, Jian; Zhang, Xiaowu; Yan, Lunan; Yang, Jiayin] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu 610064, Peoples R China	Sichuan University	Yang, JY (corresponding author), Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu 610064, Peoples R China.	yangjygyz@163.com			National Science and Technology Major Project of China [2012ZX10002-016, 2012ZX10002-017]	National Science and Technology Major Project of China	This work was supported by National Science and Technology Major Project of China, No. 2012ZX10002-016 and No. 2012ZX10002-017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzan S, 2010, WORLD J SURG, V34, P2960, DOI 10.1007/s00268-010-0756-1; Bower M, 2013, AM J SURG, V205, P685, DOI 10.1016/j.amjsurg.2012.07.034; Breitenstein S, 2010, ANN SURG, V252, P726, DOI 10.1097/SLA.0b013e3181fb8c1a; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 1996, GASTROENTEROLOGY, V111, P1018, DOI 10.1016/S0016-5085(96)70070-7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Cucchetti A, 2011, BRIT J SURG, V98, P1147, DOI 10.1002/bjs.7516; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Dindo D, 2003, LANCET, V361, P2032, DOI 10.1016/S0140-6736(03)13640-9; Gedaly R, 2009, ANN SURG, V249, P414, DOI 10.1097/SLA.0b013e31819a032d; Hawn MT, 2005, ANN SURG, V241, P821, DOI 10.1097/01.sla.0000161044.20857.24; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Itoh S, 2012, J SURG RES, V178, P640, DOI 10.1016/j.jss.2012.05.063; Mathur AK, 2010, J GASTROINTEST SURG, V14, P1285, DOI 10.1007/s11605-010-1232-9; Mathur AK, 2010, J GASTROINTEST SURG, V14, P849, DOI 10.1007/s11605-010-1163-5; Mullen JT, 2008, ANN SURG ONCOL, V15, P2164, DOI 10.1245/s10434-008-9990-2; Mullen JT, 2009, ANN SURG, V250, P166, DOI 10.1097/SLA.0b013e3181ad8935; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Okamura Y, 2012, J HEPATO-BIL-PAN SCI, V19, P449, DOI 10.1007/s00534-011-0461-y; Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Saunders JK, 2012, ARCH SURG-CHICAGO, V147, P331, DOI 10.1001/archsurg.2011.1404; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Vigano L, 2011, HPB, V13, P103, DOI 10.1111/j.1477-2574.2010.00252.x; Wen TF, 2007, HEPATOL RES, V37, P346, DOI 10.1111/j.1872-034X.2007.00061.x; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	30	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99281	10.1371/journal.pone.0099281	http://dx.doi.org/10.1371/journal.pone.0099281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914932	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700077
J	Zhang, YC; Zhang, J; Song, TT; Li, JY; Tian, J; Jin, KN; Yao, YC				Zhang, Yanchen; Zhang, Jie; Song, Tingting; Li, Jinyan; Tian, Ji; Jin, Kaina; Yao, Yuncong			Low Medium pH Value Enhances Anthocyanin Accumulation in Malus Crabapple Leaves	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; FLAVONOID BIOSYNTHESIS; RED COLORATION; COLORFUL MODEL; FLOWER COLOR; APPLE FRUIT; EXPRESSION; PETUNIA; GENE; PROTEIN	Anthocyanin is a critical factor involved in coloration of plant tissues, but the mechanism how medium pH values affect anthocyanin accumulation in woody plants is unknown. We analyzed anthocyanin composition and the expression of elements encoding anthocyanin and flavonols biosynthesis underlying different medium pH values by using three different leave color type cultivars. HPLC analysis demonstrated that high medium pH values treatment induced a dramatic decrease in the concentration of cyaniding in crabapple leaves. Conversely, the high medium pH values induced up-regulation of the content of flavones and flavonols, suggesting that low pH treatment-induced anthocyanin accumulation. Quantitative real time PCR experiment showed the expression level of anthocyanidin synthase (McANS) and uridine diphosphate glucose flavonoid 3-O-glucosyltransferase (McUFGT) was up-regulated by low pH values treatment, and high medium pH value treatment up-regulate the transcription level of flavonol synthase (McFLS). Meanwhile, several MYB TFs have been suggested in the regulation of pH responses. These results strongly indicate that the low pH treatment-induced anthocyanin accumulation is mediated by the variation of mRNA transcription of the anthocyanin biosynthetic genes.	[Zhang, Yanchen; Zhang, Jie; Song, Tingting; Li, Jinyan; Tian, Ji; Jin, Kaina; Yao, Yuncong] Beijing Agr Univ, Plant Sci & Technol Coll, Beijing 100094, Peoples R China; [Zhang, Jie; Song, Tingting; Tian, Ji; Yao, Yuncong] Beijing Agr Univ, Key Lab New Technol Agr Applicat Beijing, Beijing 100094, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture	Yao, YC (corresponding author), Beijing Agr Univ, Plant Sci & Technol Coll, Beijing 100094, Peoples R China.	yaoyc_20@126.com			Beijing Municipal Education Commission [PXM2012_014207_000036]; Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality [PHR20110515]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality [IDHT20140509]; National Natural Science Foundation of China [31301762]	Beijing Municipal Education Commission(Beijing Municipal Commission of Education); Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the science and technology project of Beijing Municipal Education Commission (PXM2012_014207_000036) and the Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (PHR20110515), the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality (IDHT20140509) and the National Natural Science Foundation of China (31301762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakowska A, 2003, FOOD CHEM, V81, P349, DOI 10.1016/S0308-8146(02)00429-6; Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; CARRENO J, 1995, FOOD RES INT, V28, P373, DOI 10.1016/0963-9969(95)00008-A; DEVLAMING P, 1983, THEOR APPL GENET, V66, P271, DOI 10.1007/BF00251158; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Espley RV, 2013, PLANT BIOTECHNOL J, V11, P408, DOI 10.1111/pbi.12017; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Fraser LG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-28; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Gutha LR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-187; Henry-Kirk RA, 2012, J EXP BOT, V63, P5437, DOI 10.1093/jxb/ers193; Honda T, 2002, HETEROCYCLES, V56, P633, DOI 10.3987/REV-01-SR(K)2; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Ohno S, 2011, J EXP BOT, V62, P5105, DOI 10.1093/jxb/err216; Palapol Y, 2009, PLANTA, V229, P1323, DOI 10.1007/s00425-009-0917-3; Quattrocchio F, 2006, PLANT CELL, V18, P1274, DOI 10.1105/tpc.105.034041; Ravaglia D, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-68; Shen HX, 2012, ACTA PHYSIOL PLANT, V34, P1353, DOI 10.1007/s11738-012-0932-z; Spelt C, 2002, PLANT CELL, V14, P2121, DOI 10.1105/tpc.003772; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Telias A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-93; Tian J, 2011, SCI HORTIC-AMSTERDAM, V129, P449, DOI 10.1016/j.scienta.2011.04.015; Wadl PA, 2010, EUPHYTICA, V176, P99, DOI 10.1007/s10681-010-0219-7; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu XL, 2005, J AGR FOOD CHEM, V53, P3101, DOI 10.1021/jf0478861; YOSHIDA K, 1995, NATURE, V373, P291, DOI 10.1038/373291a0; Zhou XR, 2008, NEW PHYTOL, V178, P532, DOI 10.1111/j.1469-8137.2008.02384.x	27	26	30	11	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e97904	10.1371/journal.pone.0097904	http://dx.doi.org/10.1371/journal.pone.0097904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914811	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700013
J	Dourado, M; Wong, E; Hackos, DH				Dourado, Michelle; Wong, Evera; Hackos, David H.			Pannexin-1 Is Blocked by Its C-Terminus through a Delocalized Non-Specific Interaction Surface	PLOS ONE			English	Article							GAP-JUNCTION PROTEINS; FIND-ME SIGNAL; ATP RELEASE; INFLAMMASOME ACTIVATION; P2X(7) RECEPTOR; 1 CHANNELS; FAMILY; HEMICHANNELS; MEMBRANE; INACTIVATION	The Pannexin-1 (Panx1) channel is known to become activated under a variety of physiological conditions resulting in the release of medium-sized molecules such as ATP and amino acids from the cell. The detailed molecular mechanism of activation of the channel resulting in the opening of the Pannexin pore is poorly understood. The best-studied gating mechanism is caspase-3/7-mediated cleavage and truncation of the c-terminus. In the absence of caspase-cleavage, the cterminal peptide maintains the channel in the closed state, possibly by directly plugging the pore from the intracellular side. We sought to understand in detail the part of the c-terminus necessary for this interaction by alanine-scanning and truncation mutagenesis of the c-terminal gating peptide. These experiments demonstrate that no single amino acid sidechain is necessary for this interaction. In fact, replacing blocks of 10-12 amino acids in different parts of the c-terminal peptide with alanines fails to disrupt the ability of the c-terminus to keep the channel closed. Surprisingly, even replacing the entire c-terminal gating peptide with a scrambled peptide of the same length maintains the interaction in some cases. Further analysis revealed that the interaction surface, while delocalized, is located within the amino-terminal two-thirds of the c-terminal peptide. Such a delocalized and potentially low-affinity interaction surface is allowed due to the high effective concentration of the c-terminal peptide near the inner vestibule of the pore and likely explains why this region is poorly conserved between species. This type of weak interaction with a tethered gating peptide may be required to maintain high-sensitivity to caspase-dependent activation.	[Dourado, Michelle; Wong, Evera; Hackos, David H.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA	Roche Holding; Genentech	Hackos, DH (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	davidhh@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This research has been supported by Genentech, Inc., a for-profit pharmaceutical company. The funder provided support in the form of salaries for authors (DHH, EW, MD), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Billaud M, 2011, CIRC RES, V109, P80, DOI 10.1161/CIRCRESAHA.110.237594; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; Dahl G, 2012, BRAIN RES, V1487, P150, DOI 10.1016/j.brainres.2012.04.058; Dvoriantchikova G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031991; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Hanley PJ, 2012, J BIOL CHEM, V287, P10650, DOI 10.1074/jbc.M111.332676; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Ma WH, 2012, PFLUG ARCH EUR J PHY, V463, P585, DOI 10.1007/s00424-012-1077-z; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Qiu F, 2011, FEBS LETT, V585, P3430, DOI 10.1016/j.febslet.2011.09.033; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romanov RA, 2012, J CELL SCI, V125, P5514, DOI 10.1242/jcs.111062; Sandilos JK, 2012, J PHYSIOL-LONDON, V590, P6257, DOI 10.1113/jphysiol.2012.240911; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Wang HB, 2013, PROTEIN CELL, V4, P259, DOI 10.1007/s13238-013-2114-1; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weilinger NL, 2012, J NEUROSCI, V32, P12579, DOI 10.1523/JNEUROSCI.1267-12.2012; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	34	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99596	10.1371/journal.pone.0099596	http://dx.doi.org/10.1371/journal.pone.0099596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911976	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600108
J	Shukla, S; Patric, IRP; Patil, V; Shwetha, SD; Hegde, AS; Chandramouli, BA; Arivazhagan, A; Santosh, V; Somasundaram, K				Shukla, Sudhanshu; Patric, Irene Rosita Pia; Patil, Vikas; Shwetha, Shivayogi D.; Hegde, Alangar S.; Chandramouli, Bangalore A.; Arivazhagan, Arimappamagan; Santosh, Vani; Somasundaram, Kumaravel			Methylation Silencing of ULK2, an Autophagy Gene, Is Essential for Astrocyte Transformation and Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; CELL-DEATH; MICROSATELLITE INSTABILITY; MAMMARY TUMORIGENESIS; COLORECTAL-CANCER; MALIGNANT GLIOMA; POOR-PROGNOSIS; GLIOBLASTOMA; PHENOTYPE; SURVIVAL	Glioblastoma (GBM) is the most aggressive type of brain tumor and shows very poor prognosis. Here, using genome-wide methylation analysis, we show that G-CIMP+ and G-CIMP-subtypes enrich distinct classes of biological processes. One of the hypermethylated genes in GBM, ULK2, an upstream autophagy inducer, was found to be down-regulated in GBM. Promoter hypermethylation of ULK2 was confirmed by bisulfite sequencing. GBM and glioma cell lines had low levels of ULK2 transcripts, which could be reversed upon methylation inhibitor treatment. ULK2 promoter methylation and transcript levels showed significant negative correlation. Ectopic overexpression of ULK2-induced autophagy, which further enhanced upon nutrient starvation or temozolomide chemotherapy. ULK2 also inhibited the growth of glioma cells, which required autophagy induction as kinase mutant of ULK2 failed to induce autophagy and inhibit growth. Furthermore, ULK2 induced autophagy and inhibited growth in Ras-transformed immortalized Baby Mouse Kidney (iBMK) ATG5(+/+) but not in autophagy-deficient ATG5(-/-) cells. Growth inhibition due to ULK2 induced high levels of autophagy under starvation or chemotherapy utilized apoptotic cell death but not at low levels of autophagy. Growth inhibition by ULK2 also appears to involve catalase degradation and reactive oxygen species generation. ULK2 overexpression inhibited anchorage independent growth, inhibited astrocyte transformation in vitro and tumor growth in vivo. Of all autophagy genes, we found ULK2 and its homologue ULK1 were only down-regulated in all grades of glioma. Thus these results altogether suggest that inhibition of autophagy by ULK1/2 down-regulation is essential for glioma development.	[Shukla, Sudhanshu; Patric, Irene Rosita Pia; Patil, Vikas; Somasundaram, Kumaravel] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Hegde, Alangar S.] Sri Satya Sai Inst Higher Med Sci, Bangalore 560066, Karnataka, India; [Chandramouli, Bangalore A.; Arivazhagan, Arimappamagan] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India; [Shwetha, Shivayogi D.; Santosh, Vani] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India	Somasundaram, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in	Shukla, Sudhanshu/L-3530-2016; Shukla, Sudhanshu/K-7830-2017; Shukla, Sudhanshu/AAC-8650-2020	Shukla, Sudhanshu/0000-0002-5069-9708; Shukla, Sudhanshu/0000-0002-5069-9708; Shukla, Sudhanshu/0000-0002-5069-9708	Indian Council of Medical Research; Department of Biotechnology; Department of Science; University Grants Commission	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology; Department of Science; University Grants Commission(University Grants Commission, India)	The results published here are in whole or part based upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI. The use of datasets from Institute NC, 2005 and Phillips et al., 2006 is acknowledged. Infrastructural support by funding from Indian Council of Medical Research, Department of Biotechnology, Department of Science, and University Grants Commission to the Department of Microbiology and Cell Biology is acknowledged. The Central Animal Facility of the Indian Institute of Science is acknowledged for animal experiments. We thank Professors M. R. S. Rao and P. Kondaiah for valuable suggestions. We thank Dr. H. Noushmehr for help in acquiring TCGA data. We also thank B. Thota, Shruti Bhargava, K. Chandrashekar, K. Prem, and B. C. Shailaja for the help rendered.	Arcella A, 2013, BRAIN RES, V1495, P37, DOI 10.1016/j.brainres.2012.11.044; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Cheong H, 2014, AUTOPHAGY, V10, P45, DOI 10.4161/auto.26505; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho DH, 2012, ANTICANCER RES, V32, P4091; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Devaney JM, 2013, PROSTATE CANCER P D, V16, P292, DOI 10.1038/pcan.2013.21; Ehrlich M, 2002, J NUTR, V132, p2424S, DOI 10.1093/jn/132.8.2424S; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Fu T, 2012, CLIN CANCER RES, V18, P4743, DOI 10.1158/1078-0432.CCR-12-0707; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Garcia-Manero G, 2008, CURR OPIN ONCOL, V20, P705, DOI 10.1097/CCO.0b013e328313699c; Goi T, 2003, SURG TODAY, V33, P702, DOI 10.1007/s00595-002-2567-y; Gonzalez-Gomez P, 2003, INT J ONCOL, V22, P601; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jung CH, 2011, AUTOPHAGY, V7, P1212, DOI 10.4161/auto.7.10.16660; Kang MR, 2009, J PATHOL, V217, P702, DOI 10.1002/path.2509; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kaza N, 2012, BRAIN PATHOL, V22, P89, DOI 10.1111/j.1750-3639.2011.00544.x; Kim MS, 2008, HUM PATHOL, V39, P1059, DOI 10.1016/j.humpath.2007.11.013; Kim SJ, 2006, BBA-GENE STRUCT EXPR, V1759, P451, DOI 10.1016/j.bbaexp.2006.09.003; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang CY, 2010, CURR OPIN CELL BIOL, V22, P226, DOI 10.1016/j.ceb.2009.11.003; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; McAfee Q, 2012, P NATL ACAD SCI USA, V109, P8253, DOI 10.1073/pnas.1118193109; Nagarajan RP, 2009, SEMIN CANCER BIOL, V19, P188, DOI 10.1016/j.semcancer.2009.02.005; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shukla S, 2013, CANCER RES, V73, P6563, DOI 10.1158/0008-5472.CAN-13-0298; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang CR, 2013, NAT NEUROSCI, V16, P532, DOI 10.1038/nn.3365; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Wu ZZ, 2010, BIOCHEM PHARMACOL, V80, P262, DOI 10.1016/j.bcp.2010.03.029; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103	53	62	64	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22306	22318		10.1074/jbc.M114.567032	http://dx.doi.org/10.1074/jbc.M114.567032			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24923441	Green Published, hybrid			2022-12-25	WOS:000340593500042
J	Duttke, SHC				Duttke, Sascha H. C.			RNA Polymerase III Accurately Initiates Transcription from RNA Polymerase II Promoters in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; CORE PROMOTER; EUKARYOTIC TRANSCRIPTION; DROSOPHILA; BOX; CHROMATIN; ELEMENT; GENE; TBP; IDENTIFICATION	In eukaryotes, there are three major RNA polymerases (Pol) in the nucleus, which are commonly described as transcribing non-overlapping subsets of genes. Structural studies have highlighted a conserved core shared among all three transcription systems. Initiation of human Pol III from TATA box-containing Pol II promoters under conditions with impaired Pol II transcription activity have been described previously. RNA polymerase III and Pol II were found to co-localize at the promoters of the c-myc gene and the RPPH1 sRNA in vivo. Here, I report that Pol III can, like Pol II, initiate transcription from most tested Pol II core promoters when assayed with crude human nuclear extracts (HSK, SNF, or Dignam). Both polymerases often initiate from the same transcription start site, and depend on a TATA box or AT-rich region but not the downstream promoter element (DPE) or the motif ten element (MTE). Moderate (similar to 2-fold) changes in the ratio of DNA template to nuclear extract were sufficient to change Pol II-mediated transcription to a mixture of Pol II- and Pol III-, or to a solely Pol III-dependent initiation of transcription from Pol II promoters. Polymerase specificity is thus not fixed but a variable that depends on the properties of the promoter and the transcription conditions. These findings provide functional evidence for a close similarity between the Pol II and Pol III transcription complexes, and additionally explain previous controversies in the literature.	[Duttke, Sascha H. C.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Duttke, SHC (corresponding author), Univ Calif San Diego, Sect Mol Biol 0347, Div Biol Sci, Pacific Hall,Rm 2216,9500 Gilman Dr, La Jolla, CA 92093 USA.	sduttke@ucsd.edu		Duttke, Sascha H/0000-0003-4717-000X	National Institutes of Health [R01 GM041249]; University of California San Diego Molecular Biology/Cancer Center Fellowship; Ruth Newmark Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego Molecular Biology/Cancer Center Fellowship; Ruth Newmark Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM041249 (to J. T. Kadonaga) and the University of California San Diego Molecular Biology/Cancer Center Fellowship and Ruth Newmark Fellowship (to S. D.).	Alberts B, 2002, MOL BIOL CELL; BENTLEY DL, 1989, GENE DEV, V3, P1179, DOI 10.1101/gad.3.8.1179; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dumay-Odelot H., 2014, TRANSCRIPTI IN PRESS; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; Faresse NJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003028; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; George Catherine P., 1996, P133; Goodfellow Sarah J, 2013, Subcell Biochem, V61, P211, DOI 10.1007/978-94-007-4525-4_10; GUNNERY S, 1995, MOL CELL BIOL, V15, P3597; Hausner W, 2001, J BACTERIOL, V183, P3025, DOI 10.1128/JB.183.10.3025-3031.2001; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; KAMAKAKA RT, 1991, P NATL ACAD SCI USA, V88, P1024, DOI 10.1073/pnas.88.3.1024; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; KASSAVETIS GA, 1992, CELL, V71, P1055, DOI 10.1016/0092-8674(92)90399-W; Knutson BA, 2013, BBA-GENE REGUL MECH, V1829, P265, DOI 10.1016/j.bbagrm.2012.08.003; Kober I, 1998, J MOL BIOL, V284, P7, DOI 10.1006/jmbi.1998.2165; Kuryan BG, 2012, P NATL ACAD SCI USA, V109, P1931, DOI 10.1073/pnas.1109994109; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lenzmeier BA, 1997, J VIROL, V71, P2577, DOI 10.1128/JVI.71.3.2577-2580.1997; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Listerman I, 2007, PLOS GENET, V3, P2268, DOI 10.1371/journal.pgen.0030212; LOBO SM, 1989, CELL, V58, P55, DOI 10.1016/0092-8674(89)90402-9; MITCHELL MT, 1992, J BIOL CHEM, V267, P1995; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Orioli A, 2012, GENE, V493, P185, DOI 10.1016/j.gene.2011.06.015; Orioli A, 2011, NUCLEIC ACIDS RES, V39, P5499, DOI 10.1093/nar/gkr074; PIRAS G, 1994, J VIROL, V68, P6170, DOI 10.1128/JVI.68.10.6170-6179.1994; PRUZAN R, 1992, NUCLEIC ACIDS RES, V20, P5705, DOI 10.1093/nar/20.21.5705; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Roeder RG, 2003, NAT MED, V9, P1239, DOI 10.1038/nm938; ROEDER RG, 1974, J BIOL CHEM, V249, P241; ROWLANDS T, 1994, SCIENCE, V264, P1326, DOI 10.1126/science.8191287; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; SCHULTZ LD, 1976, P NATL ACAD SCI USA, V73, P1029, DOI 10.1073/pnas.73.4.1029; SENTENAC A, 1985, CRC CR REV BIOCH MOL, V18, P31, DOI 10.3109/10409238509082539; SHARP PA, 1992, CELL, V68, P819, DOI 10.1016/0092-8674(92)90023-6; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; STEINBERG TH, 1990, J BIOL CHEM, V265, P499; STEINBERG TH, 1992, J BIOL CHEM, V267, P20204; SUSSMAN DJ, 1991, NUCLEIC ACIDS RES, V19, P5045, DOI 10.1093/nar/19.18.5045; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; Theisen JWM, 2013, J BIOL CHEM, V288, P7096, DOI 10.1074/jbc.M112.438697; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Verma N, 2013, J BIOL CHEM, V288, P27564, DOI 10.1074/jbc.C113.503094; WAMPLER SL, 1992, GENE DEV, V6, P1542, DOI 10.1101/gad.6.8.1542; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8606, DOI 10.1073/pnas.92.19.8606; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P3426, DOI 10.1073/pnas.71.9.3426; White R. J., 1998, RNA POLYMERASE 3 TRA	62	15	16	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20396	20404		10.1074/jbc.M114.563254	http://dx.doi.org/10.1074/jbc.M114.563254			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24917680	Green Published, hybrid			2022-12-25	WOS:000339395200050
J	Escott-Price, V; Bellenguez, C; Wang, LS; Choi, SH; Harold, D; Jones, L; Holmans, P; Gerrish, A; Vedernikov, A; Richards, A; DeStefano, AL; Lambert, JC; Ibrahim-Verbaas, CA; Naj, AC; Sims, R; Jun, G; Bis, JC; Beecham, GW; Grenier-Boley, B; Russo, G; Thornton-Wells, TA; Denning, N; Smith, AV; Chouraki, V; Thomas, C; Ikram, MA; Zelenika, D; Vardarajan, BN; Kamatani, Y; Lin, CF; Schmidt, H; Kunkle, B; Dunstan, ML; Vronskaya, M; Johnson, AD; Ruiz, A; Bihoreau, MT; Reitz, C; Pasquier, F; Hollingworth, P; Hanon, O; Fitzpatrick, AL; Buxbaum, JD; Campion, D; Crane, PK; Baldwin, C; Becker, T; Gudnason, V; Cruchaga, C; Craig, D; Amin, N; Berr, C; Lopez, OL; De Jager, PL; Deramecourt, V; Johnston, JA; Evans, D; Lovestone, S; Letenneur, L; Hernandez, I; Rubinsztein, DC; Eiriksdottir, G; Sleegers, K; Goate, AM; Fievet, N; Huentelman, MJ; Gill, M; Brown, K; Kamboh, MI; Keller, L; Barberger-Gateau, P; McGuinness, B; Larson, EB; Myers, AJ; Dufouil, C; Todd, S; Wallon, D; Love, S; Rogaeva, E; Gallacher, J; St George-Hyslop, P; Clarimon, J; Lleo, A; Bayer, A; Tsuang, DW; Yu, L; Tsolaki, M; Bossu, P; Spalletta, G; Proitsi, P; Collinge, J; Sorbi, S; Garcia, FS; Fox, NC; Hardy, J; Naranjo, MCD; Bosco, P; Clarke, R; Brayne, C; Galimberti, D; Scarpini, E; Bonuccelli, U; Mancuso, M; Siciliano, G; Moebus, S; Mecocci, P; Del Zompo, M; Maier, W; Hampel, H; Pilotto, A; Frank-Garcia, A; Panza, F; Solfrizzi, V; Caffarra, P; Nacmias, B; Perry, W; Mayhaus, M; Lannfelt, L; Hakonarson, H; Pichler, S; Carrasquillo, MM; Ingelsson, M; Beekly, D; Alvarez, V; Zou, FG; Valladares, O; Younkin, SG; Coto, E; Hamilton-Nelson, KL; Gu, W; Razquin, C; Pastor, P; Mateo, I; Owen, MJ; Faber, KM; Jonsson, PV; Combarros, O; O'Donovan, MC; Cantwell, LB; Soininen, H; Blacker, D; Mead, S; Mosley, TH; Bennett, DA; Harris, TB; Fratiglioni, L; Holmes, C; de Bruijn, RFAG; Passmore, P; Montine, TJ; Bettens, K; Rotter, JI; Brice, A; Morgan, K; Foroud, TM; Kukull, WA; Hannequin, D; Powell, JF; Nalls, MA; Ritchie, K; Lunetta, KL; Kauwe, JSK; Boerwinkle, E; Riemenschneider, M; Boada, M; Hiltunen, M; Martin, ER; Schmidt, R; Rujescu, D; Dartigues, JF; Mayeux, R; Tzourio, C; Hofman, A; Nothen, MM; Graff, C; Psaty, BM; Haines, JL; Lathrop, M; Pericak-Vance, MA; Launer, LJ; Van Broeckhoven, C; Farrer, LA; van Duijn, CM; Ramirez, A; Seshadri, S; Schellenberg, GD; Amouyel, P; Williams, J				Escott-Price, Valentina; Bellenguez, Celine; Wang, Li-San; Choi, Seung-Hoan; Harold, Denise; Jones, Lesley; Holmans, Peter; Gerrish, Amy; Vedernikov, Alexey; Richards, Alexander; DeStefano, Anita L.; Lambert, Jean-Charles; Ibrahim-Verbaas, Carla A.; Naj, Adam C.; Sims, Rebecca; Jun, Gyungah; Bis, Joshua C.; Beecham, Gary W.; Grenier-Boley, Benjamin; Russo, Giancarlo; Thornton-Wells, Tricia A.; Denning, Nicola; Smith, Albert V.; Chouraki, Vincent; Thomas, Charlene; Ikram, M. Arfan; Zelenika, Diana; Vardarajan, Badri N.; Kamatani, Yoichiro; Lin, Chiao-Feng; Schmidt, Helena; Kunkle, Brian; Dunstan, Melanie L.; Vronskaya, Maria; Johnson, Andrew D.; Ruiz, Agustin; Bihoreau, Marie-Therese; Reitz, Christiane; Pasquier, Florence; Hollingworth, Paul; Hanon, Olivier; Fitzpatrick, Annette L.; Buxbaum, Joseph D.; Campion, Dominique; Crane, Paul K.; Baldwin, Clinton; Becker, Tim; Gudnason, Vilmundur; Cruchaga, Carlos; Craig, David; Amin, Najaf; Berr, Claudine; Lopez, Oscar L.; De Jager, Philip L.; Deramecourt, Vincent; Johnston, Janet A.; Evans, Denis; Lovestone, Simon; Letenneur, Luc; Hernandez, Isabel; Rubinsztein, David C.; Eiriksdottir, Gudny; Sleegers, Kristel; Goate, Alison M.; Fievet, Nathalie; Huentelman, Matthew J.; Gill, Michael; Brown, Kristelle; Kamboh, M. Ilyas; Keller, Lina; Barberger-Gateau, Pascale; McGuinness, Bernadette; Larson, Eric B.; Myers, Amanda J.; Dufouil, Carole; Todd, Stephen; Wallon, David; Love, Seth; Rogaeva, Ekaterina; Gallacher, John; St George-Hyslop, Peter; Clarimon, Jordi; Lleo, Alberto; Bayer, Anthony; Tsuang, Debby W.; Yu, Lei; Tsolaki, Magda; Bossu, Paola; Spalletta, Gianfranco; Proitsi, Petra; Collinge, John; Sorbi, Sandro; Garcia, Florentino Sanchez; Fox, Nick C.; Hardy, John; Deniz Naranjo, Maria Candida; Bosco, Paolo; Clarke, Robert; Brayne, Carol; Galimberti, Daniela; Scarpini, Elio; Bonuccelli, Ubaldo; Mancuso, Michelangelo; Siciliano, Gabriele; Moebus, Susanne; Mecocci, Patrizia; Del Zompo, Maria; Maier, Wolfgang; Hampel, Harald; Pilotto, Alberto; Frank-Garcia, Ana; Panza, Francesco; Solfrizzi, Vincenzo; Caffarra, Paolo; Nacmias, Benedetta; Perry, William; Mayhaus, Manuel; Lannfelt, Lars; Hakonarson, Hakon; Pichler, Sabrina; Carrasquillo, Minerva M.; Ingelsson, Martin; Beekly, Duane; Alvarez, Victoria; Zou, Fanggeng; Valladares, Otto; Younkin, Steven G.; Coto, Eliecer; Hamilton-Nelson, Kara L.; Gu, Wei; Razquin, Cristina; Pastor, Pau; Mateo, Ignacio; Owen, Michael J.; Faber, Kelley M.; Jonsson, Palmi V.; Combarros, Onofre; O'Donovan, Michael C.; Cantwell, Laura B.; Soininen, Hilkka; Blacker, Deborah; Mead, Simon; Mosley, Thomas H., Jr.; Bennett, David A.; Harris, Tamara B.; Fratiglioni, Laura; Holmes, Clive; de Bruijn, Renee F. A. G.; Passmore, Peter; Montine, Thomas J.; Bettens, Karolien; Rotter, Jerome I.; Brice, Alexis; Morgan, Kevin; Foroud, Tatiana M.; Kukull, Walter A.; Hannequin, Didier; Powell, John F.; Nalls, Michael A.; Ritchie, Karen; Lunetta, Kathryn L.; Kauwe, John S. K.; Boerwinkle, Eric; Riemenschneider, Matthias; Boada, Merce; Hiltunen, Mikko; Martin, Eden R.; Schmidt, Reinhold; Rujescu, Dan; Dartigues, Jean-Francois; Mayeux, Richard; Tzourio, Christophe; Hofman, Albert; Noethen, Markus M.; Graff, Caroline; Psaty, Bruce M.; Haines, Jonathan L.; Lathrop, Mark; Pericak-Vance, Margaret A.; Launer, Lenore J.; Van Broeckhoven, Christine; Farrer, Lindsay A.; van Duijn, Cornelia M.; Ramirez, Alfredo; Seshadri, Sudha; Schellenberg, Gerard D.; Amouyel, Philippe; Williams, Julie		United Kingdom Brain Expression	Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease	PLOS ONE			English	Article							GENOME SCAN METAANALYSIS; IDENTIFIES VARIANTS; BIPOLAR DISORDER; COMMON VARIANTS; ASSOCIATION; TP53INP1; LOCI; CLU; SCHIZOPHRENIA; TARGET	Background: Alzheimer's disease is a common debilitating dementia with known heritability, for which 20 late onset susceptibility loci have been identified, but more remain to be discovered. This study sought to identify new susceptibility genes, using an alternative gene-wide analytical approach which tests for patterns of association within genes, in the powerful genome-wide association dataset of the International Genomics of Alzheimer's Project Consortium, comprising over 7 m genotypes from 25,580 Alzheimer's cases and 48,466 controls. Principal Findings: In addition to earlier reported genes, we detected genome-wide significant loci on chromosomes 8 (TP53INP1, p = 1.4x10(-6)) and 14 (IGHV1-67 p = 7.9x10(-8)) which indexed novel susceptibility loci. Significance: The additional genes identified in this study, have an array of functions previously implicated in Alzheimer's disease, including aspects of energy metabolism, protein degradation and the immune system and add further weight to these pathways as potential therapeutic targets in Alzheimer's disease.	[Escott-Price, Valentina; Harold, Denise; Jones, Lesley; Holmans, Peter; Gerrish, Amy; Vedernikov, Alexey; Richards, Alexander; Sims, Rebecca; Denning, Nicola; Thomas, Charlene; Dunstan, Melanie L.; Vronskaya, Maria; Hollingworth, Paul; Owen, Michael J.; O'Donovan, Michael C.; Williams, Julie] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales; [Bellenguez, Celine; Lambert, Jean-Charles; Grenier-Boley, Benjamin; Chouraki, Vincent; Fievet, Nathalie; Amouyel, Philippe] INSERM, U744, F-59045 Lille, France; [Bellenguez, Celine; Lambert, Jean-Charles; Grenier-Boley, Benjamin; Chouraki, Vincent; Pasquier, Florence; Deramecourt, Vincent; Amouyel, Philippe] Univ Lille 2, Lille, France; [Bellenguez, Celine; Lambert, Jean-Charles; Grenier-Boley, Benjamin; Chouraki, Vincent; Fievet, Nathalie; Amouyel, Philippe] Inst Pasteur, F-59019 Lille, France; [Wang, Li-San; Lin, Chiao-Feng; Valladares, Otto; Cantwell, Laura B.; Schellenberg, Gerard D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Choi, Seung-Hoan; DeStefano, Anita L.; Jun, Gyungah; Lunetta, Kathryn L.; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Ibrahim-Verbaas, Carla A.] Erasmus MC Univ Med Ctr, Dept Epidemiol & Neurol, Rotterdam, Netherlands; [Naj, Adam C.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Naj, Adam C.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Jun, Gyungah; Vardarajan, Badri N.; Baldwin, Clinton; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA; [Jun, Gyungah; Lathrop, Mark; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Bis, Joshua C.; Fitzpatrick, Annette L.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Beecham, Gary W.; Kunkle, Brian; Perry, William; Hamilton-Nelson, Kara L.; Pericak-Vance, Margaret A.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA; [Beecham, Gary W.; Perry, William; Pericak-Vance, Margaret A.] Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL USA; [Russo, Giancarlo] ETH Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Thornton-Wells, Tricia A.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Smith, Albert V.; Gudnason, Vilmundur; Jonsson, Palmi V.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Smith, Albert V.; Gudnason, Vilmundur; Eiriksdottir, Gudny] Iceland Heart Assoc, Kopavogur, Iceland; [Chouraki, Vincent; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Ikram, M. Arfan; Hofman, Albert] Erasmus MC Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan; Hofman, Albert] Erasmus MC Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Ikram, M. Arfan; Hofman, Albert] Erasmus MC Univ Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Ikram, M. Arfan; Hofman, Albert; van Duijn, Cornelia M.] Netherlands Consortium Hlth Aging, Leiden, Netherlands; [Zelenika, Diana; Bihoreau, Marie-Therese] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Kamatani, Yoichiro; Lathrop, Mark] Fdn Jean Dausset CEPH, Paris, France; [Schmidt, Helena] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Zelenika, Diana; United Kingdom Brain Expression] UCL Inst Neurol, Dept Mol Neurosci, Reta Lila Weston Res Labs, London, England; [Johnson, Andrew D.] NHLBI, Cardiovasc Epidemiol & Human Genom Branch, Framingham Heart Study, Framingham, MA USA; [Ruiz, Agustin; Hernandez, Isabel; Boada, Merce] Fundacio ACE, Memory Clin, Inst Catala Neurociencies Aplicades, Barcelona, Spain; [Vardarajan, Badri N.; Reitz, Christiane; Mayeux, Richard] Columbia Univ, Dept Neurol, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA; [Vardarajan, Badri N.; Reitz, Christiane; Mayeux, Richard] Columbia Univ, Dept Neurol, Gertrude H Sergievsky Ctr, New York, NY USA; [Pasquier, Florence; Deramecourt, Vincent; Amouyel, Philippe] CHRU Lille, CNR MAJ, F-59037 Lille, France; [Hanon, Olivier] Univ Paris 05, Sorbonne Paris 5, Broca Hosp, Dept Geriatr, Paris, France; [Fitzpatrick, Annette L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Fitzpatrick, Annette L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genom Sci, New York, NY USA; [Campion, Dominique; Wallon, David; Hannequin, Didier] Rouen Univ Hosp, CNR MAJ, INSERM, U1079, F-76031 Rouen, France; [Crane, Paul K.; Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA USA; [Becker, Tim] Univ Bonn, German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Becker, Tim] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Cruchaga, Carlos; Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Cruchaga, Carlos; Goate, Alison M.] Washington Univ, Sch Med, Hope Ctr Program Prot Aggregat & Neurodegenerat, St Louis, MO USA; [Craig, David; Johnston, Janet A.; McGuinness, Bernadette; Todd, Stephen; Passmore, Peter] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Ageing Grp, Belfast, Antrim, North Ireland; [Amin, Najaf; van Duijn, Cornelia M.] Erasmus MC Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Berr, Claudine; Ritchie, Karen] Hop Colombiere, Fac Med, INSERM, U1061, Montpellier, France; [Lopez, Oscar L.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol & Psychiat, Inst Neurosci, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Boston, MA USA; [Evans, Denis] Rush Univ, Med Ctr, Dept Internal Med, Rush Inst Hlth Aging, Chicago, IL 60612 USA; [Lovestone, Simon; Barberger-Gateau, Pascale; Proitsi, Petra; Powell, John F.] Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England; [Letenneur, Luc; Dufouil, Carole; Dartigues, Jean-Francois] Victor Segalen Univ, INSERM, U897, F-33076 Bordeaux, France; [Rubinsztein, David C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Sleegers, Kristel; Bettens, Karolien; Van Broeckhoven, Christine] Univ Antwerp VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, B-2610 Antwerp, Belgium; [Sleegers, Kristel; Bettens, Karolien; Van Broeckhoven, Christine] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2020 Antwerp, Belgium; [Huentelman, Matthew J.] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [Gill, Michael] Univ Dublin Trinity Coll, Discipline Psychiat, Dublin 2, Ireland; [Brown, Kristelle; Morgan, Kevin] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2RD, England; [Kamboh, M. Ilyas] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Kamboh, M. Ilyas] Univ Pittsburgh, Alzheimers Dis Res Ctr, Pittsburgh, PA USA; [Keller, Lina] Karolinska Inst, Dept Neurobiol, Care Sci & Soc, Aging Reasearch Ctr, Stockholm, Sweden; [Keller, Lina; Fratiglioni, Laura] Stockholm Univ, S-10691 Stockholm, Sweden; [Larson, Eric B.] Grp Hlth Res Inst, Grp Hlth, Seattle, WA USA; [Myers, Amanda J.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Love, Seth] Univ Bristol, Inst Clin Neurosci, Sch Clin Sci, Frenchay Hosp, Bristol, Avon, England; [Rogaeva, Ekaterina; St George-Hyslop, Peter] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Gallacher, John; Bayer, Anthony] Cardiff Univ, Neuadd Meirionnydd, Univ Wales Hosp, Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [St George-Hyslop, Peter] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Clarimon, Jordi; Lleo, Alberto] Univ Autonoma Barcelona, St Pau Hosp, IIB St Pau, Dept Neurol, E-08193 Barcelona, Spain; [Clarimon, Jordi; Lleo, Alberto] Ctr Networker Biomed Res Neurodegenerat Dis CIBER, Barcelona, Spain; [Tsuang, Debby W.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Yu, Lei; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Tsolaki, Magda] Aristotle Univ Thessaloniki, Dept Neurol 3, GR-54006 Thessaloniki, Greece; [Bossu, Paola; Spalletta, Gianfranco] Fdn Santa Lucia, Rome, Italy; [Collinge, John; Mead, Simon] UCL Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, London, England; [Sorbi, Sandro; Nacmias, Benedetta] Univ Florence, NEUROFARBA Dept Neurosci Psychol Drug Res & Child, Florence, Italy; [Sorbi, Sandro; Nacmias, Benedetta] Univ Florence, Ctr Ric Trasferimento & Alta Formaz DENOTHE, Florence, Italy; [Garcia, Florentino Sanchez; Deniz Naranjo, Maria Candida] Hosp Univ Dr Negrin, Dept Immunol, Las Palmas Gran Canaria, Spain; [Fox, Nick C.] UCL Inst Neurol, Dept Neurodegenerat Dis, Dementia Res Ctr, London, England; [Hardy, John] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Hardy, John] Inst Neurol, Reta Lilla Weston Labs, London WC1N 3BG, England; [Bosco, Paolo] IRCCS Assoc Oasi Maria SS, Troina, Italy; [Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, OHAP, Oxford, England; [Brayne, Carol] Univ Cambridge, Inst Publ Hlth, CFAS, Cambridge, England; [Galimberti, Daniela; Scarpini, Elio] Univ Milan, Fdn Ca Granda, IRCCS Osped Policlin, Milan, Italy; [Bonuccelli, Ubaldo; Mancuso, Michelangelo; Siciliano, Gabriele] Univ Pisa, Neurol Clin, Pisa, Italy; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Mecocci, Patrizia] Univ Perugia, Dept Clin & Expt Med, Sect Gerontol & Geriatr, I-06100 Perugia, Italy; [Del Zompo, Maria] Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, Cagliari, Italy; [Maier, Wolfgang] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Maier, Wolfgang; Noethen, Markus M.] German Ctr Neurodegenerat Dis DZNE Bonn, Bonn, Germany; [Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat, D-60054 Frankfurt, Germany; [Hampel, Harald; Rujescu, Dan] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Pilotto, Alberto] IRCCS Casa Sollievo Sofferenza, Gerontol & Geriatr Res Lab, San Giovanni Rotondo, Italy; [Frank-Garcia, Ana] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Frank-Garcia, Ana] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Frank-Garcia, Ana] Hosp la Paz IdIPaz, Inst Invest Sanitaria, Madrid, Spain; [Panza, Francesco; Solfrizzi, Vincenzo] Univ Bari, Ctr Aging Brain, Dept Geriatr, Bari, Italy; [Caffarra, Paolo] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Caffarra, Paolo] Ctr Cognit Disorders AUSL, Parma, Italy; [Mayhaus, Manuel; Pichler, Sabrina] Univ Hosp, Dept Psychiat, Saarland, Germany; [Lannfelt, Lars; Ingelsson, Martin] Uppsala Univ, Dept Publ Health Geriatr, Uppsala, Sweden; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Carrasquillo, Minerva M.; Zou, Fanggeng; Younkin, Steven G.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Beekly, Duane] Univ Washington, Natl Alzheimers Coordinating Ctr, Seattle, WA 98195 USA; [Alvarez, Victoria; Coto, Eliecer] Genet Mol Huca Oviedo, Oviedo, Spain; [Gu, Wei; Riemenschneider, Matthias] Univ Hosp, Dept Psychiat, Saarland, Germany; [Razquin, Cristina; Pastor, Pau] Univ Navarra, Sch Med, Ctr Appl Med Res, Neurogenet Lab,Div Neurosci, E-31080 Pamplona, Spain; [Pastor, Pau] Inst Salud Carlos III, Ctr Invest Biome Red Enfermedades Neurodegenerat, CIBERNED, Madrid, Spain; [Mateo, Ignacio; Combarros, Onofre] Univ Cantabria, Marques de Valdecilla Univ Hosp, Neurol Serv, E-39005 Santander, Spain; [Mateo, Ignacio; Combarros, Onofre] Univ Cantabria, Marques de Valdecilla Univ Hosp, CIBERNED, E-39005 Santander, Spain; [Mateo, Ignacio; Combarros, Onofre] IFIMAV, Santander, Spain; [Faber, Kelley M.; Foroud, Tatiana M.] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; [Jonsson, Palmi V.] Landspitali Univ Hosp, Reykjavik, Iceland; [Soininen, Hilkka; Hiltunen, Mikko] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Soininen, Hilkka; Hiltunen, Mikko] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Blacker, Deborah] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Blacker, Deborah] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Mosley, Thomas H., Jr.] Univ Mississippi, Med Ctr, Dept Geriatr Med, Jackson, MS 39216 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Harris, Tamara B.; Launer, Lenore J.] NIH, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Fratiglioni, Laura] Karolinska Inst, Care Sci & Soc, Dept Neurobiol, Aging Res Ctr, Stockholm, Sweden; [Fratiglioni, Laura; Graff, Caroline] Karolinska Univ Hosp Huddinge, Genet Unit, Dept Geriatr Med, Stockholm, Sweden; [Holmes, Clive] Univ Southampton, Sch Med, Div Clin Neurosci, Southampton, Hants, England; [de Bruijn, Renee F. A. G.] Erasmus MC Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands; [de Bruijn, Renee F. A. G.] Erasmus MC Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Montine, Thomas J.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Brice, Alexis] Univ Paris 06, INSERM UMR S975 CNRS UMR 7225, Ctr Rech, Inst Cerveau & Moelle Epiniere CRICM,Hop Salpetri, Paris, France; [Brice, Alexis] Hop La Pitie Salpetriere, AP HP, Paris, France; [Kukull, Walter A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Nalls, Michael A.] NIA, Neurogenet Lab, Intramural Res Program, Bethesda, MD 20892 USA; [Ritchie, Karen] Univ London Imperial Coll Sci Technol & Med, London, England; [Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol, Houston, TX 77030 USA; [Boada, Merce] Univ Autonoma Barcelona VHIR UAB, Inst Recerca, Hosp Univ Vall d Hebron, Barcelona, Spain; [Schmidt, Reinhold] Med Univ Graz, Dept Neurol, Graz, Austria; [Dartigues, Jean-Francois] CHU Bordeaux, Ctr Memoire Ressources & Rech Bordeaux, Bordeaux, France; [Tzourio, Christophe] Victor Segalen Univ, INSERM, U708, Bordeaux, France; [Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Inst Human Genet, Bonn, Germany; [Graff, Caroline] Karolinska Inst, Dept Neurobiol, Care Sci & Soc, KIADRC, Stockholm, Sweden; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Haines, Jonathan L.] Vanderbilt Univ, Vanderbilt Ctr Human Genet Res, Nashville, TN 37235 USA; [Haines, Jonathan L.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Lathrop, Mark] McGill Univ, Montreal, PQ, Canada; [Lathrop, Mark] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [van Duijn, Cornelia M.] Ctr Med Syst Biol, Leiden, Netherlands; [Ramirez, Alfredo] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Ramirez, Alfredo] Univ Bonn, Inst Human Genet, Bonn, Germany; [Seshadri, Sudha] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Amouyel, Philippe] CHRU Lille, F-59037 Lille, France	Cardiff University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Pennsylvania; Pennsylvania Medicine; Boston University; Erasmus University Rotterdam; Erasmus MC; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Boston University; Boston University; University of Washington; University of Washington Seattle; University of Miami; University of Miami; Swiss Federal Institutes of Technology Domain; ETH Zurich; Vanderbilt University; University of Iceland; Icelandic Heart Association; Boston University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH; Medical University of Graz; University of London; University College London; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Columbia University; Columbia University; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Broca - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Washington; University of Washington Seattle; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn; Washington University (WUSTL); Washington University (WUSTL); Queens University Belfast; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rush University; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Cambridge; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Translational Genomics Research Institute; Trinity College Dublin; University of Nottingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Karolinska Institutet; Stockholm University; University of Miami; University of Bristol; University of Toronto; Cardiff University; University of Cambridge; University of Cambridge; Autonomous University of Barcelona; University of Washington; University of Washington Seattle; Rush University; Aristotle University of Thessaloniki; IRCCS Santa Lucia; University of London; University College London; University of Florence; University of Florence; University of London; University College London; University of London; University College London; University of London; University College London; IRCCS Oasi Maria SS; University of Oxford; University of Cambridge; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Pisa; University of Duisburg Essen; University of Perugia; University of Cagliari; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Goethe University Frankfurt; University of Munich; IRCCS Casa Sollievo Della Sofferenza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED; Universita degli Studi di Bari Aldo Moro; University of Parma; Uppsala University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Mayo Clinic; University of Washington; University of Washington Seattle; Central University Hospital Asturias; University of Navarra; CIBERNED; Instituto de Salud Carlos III; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; CIBERNED; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Indiana University System; Indiana University-Purdue University Indianapolis; Landspitali National University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Mississippi; University of Mississippi Medical Center; Rush University; National Institutes of Health (NIH) - USA; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Southampton; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Imperial College London; Brigham Young University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Medical University of Graz; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Bonn; Karolinska Institutet; Group Health Cooperative; Vanderbilt University; Case Western Reserve University; McGill University; Boston University; Boston University; University of Bonn; University of Bonn; Framingham Heart Study; Universite de Lille - ISITE; CHU Lille	Schellenberg, GD (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	gerardsc@mail.med.upenn.edu; philippe.amouyel@pasteur-lille.fr; WilliamsJ@cf.ac.uk	Ruiz, Agustin/G-5677-2012; Russo, Giancarlo/GQY-5601-2022; Deramecourt, Vincent/G-5504-2018; Mancuso, Michelangelo/K-4170-2016; Belllenguez, Céline/Y-3183-2018; Brayne, Carol/AAA-4285-2020; Yu, Lei/AAT-3685-2020; Pasquier, Florence/F-1527-2017; graff, caroline/A-2545-2009; Ritchie, Karen/G-3571-2013; Buxbaum, Joseph D/G-6001-2010; Tsuang, Debby/L-7234-2016; Melief, Erica/M-6436-2019; Hanon, Olivier/GWR-0220-2022; lambert, jean-charles/F-8787-2013; Schmidt, Reinhold/E-1137-2014; Nacmias, Benedetta/J-5084-2018; Bayer, Antony/H-4376-2019; Reitz, Christiane/GNP-0257-2022; Van Broeckhoven, Christine/G-8362-2017; Ikram, M. Arfan/AAM-5225-2021; O'Donovan, Michael C/P-7005-2018; Rubinsztein, David C/C-3472-2011; Fox, Nick C/AAE-1849-2021; Caffarra, Paolo/K-6567-2016; Bonuccelli, Ubaldo/K-8681-2016; Spalletta, Gianfranco/K-3828-2018; Van Broeckhoven, Christine/M-7853-2019; Gudnason, Vilmundur/AAE-7126-2019; DARTIGUES, Jean François/T-4513-2019; Bossù, Paola/E-4832-2014; Haines, Jonathan/C-3374-2012; Gu, Wei/G-4003-2010; Bayer, Antony/H-4434-2019; Lleó, Alberto/K-5783-2019; Tzourio, christophe/B-4015-2009; brice, alexis/AAE-8275-2019; Cruchaga, Carlos/ABF-4065-2020; Dufouil, Carole/J-4968-2012; Kauwe, John/AAC-6646-2021; berr, Claudine/D-5238-2014; Kamatani, Yoichiro/N-5513-2015; Panza, Francesco/Y-2539-2019; Ramirez, Alfredo/S-5126-2019; Bellenguez, Céline/X-4004-2019; Fox, Nick C/B-1319-2009; LETENNEUR, Luc/T-4424-2019; McGuinness, Bernadette/AAH-2755-2021; Galimberti, Daniela/N-7209-2019; Razquin, Cristina/H-2366-2017; alvarez, victoria/ABC-7891-2021; , beccie/AAM-3770-2021; Alvarez, Maria/GZH-1345-2022; Tzourio, christophe/L-6344-2019; Johnson, Andrew D/G-6520-2013; Rotter, Jerome/AAY-6598-2021; Smith, Albert Vernon/K-5150-2015; solfrizzi, vincenzo/AAL-3222-2020; Wallon, David/AAI-1352-2020; Mecocci, Patrizia/W-2116-2019; Farrer, Lindsay/AAS-1035-2020; Hardy, John/C-2451-2009; Powell, John F/G-4412-2011; Brice, Alexis/A-2170-2009; Todd, Stephen/AAF-6729-2020; García, Ana Frank/I-5159-2015; Panza, Francesco/M-6804-2017; Gudnason, Vilmundur/K-6885-2015; Rujescu, Dan/GRS-3875-2022; Dufouil, Carole/F-5751-2014; alvarez, victoria/GXV-1088-2022; Holmans, Peter/F-4518-2015; Pastor, Pau/C-9834-2009; Lambert, jean-charles/A-9553-2014; Scarpini, Elio/K-6547-2016	Deramecourt, Vincent/0000-0001-9742-7833; Mancuso, Michelangelo/0000-0003-2738-8562; Belllenguez, Céline/0000-0002-1240-7874; Brayne, Carol/0000-0001-5307-663X; Pasquier, Florence/0000-0001-9880-9788; Ritchie, Karen/0000-0002-0688-8982; Tsuang, Debby/0000-0002-4716-1894; lambert, jean-charles/0000-0003-0829-7817; Nacmias, Benedetta/0000-0001-9338-9040; Van Broeckhoven, Christine/0000-0003-0183-7665; O'Donovan, Michael C/0000-0001-7073-2379; Fox, Nick C/0000-0002-6660-657X; Caffarra, Paolo/0000-0003-2246-5223; Bonuccelli, Ubaldo/0000-0001-6218-6312; Spalletta, Gianfranco/0000-0002-7432-4249; Van Broeckhoven, Christine/0000-0003-0183-7665; Gudnason, Vilmundur/0000-0001-5696-0084; Bossù, Paola/0000-0002-1432-0078; Haines, Jonathan/0000-0002-4351-4728; Gu, Wei/0000-0003-3951-6680; Bayer, Antony/0000-0002-7514-248X; Tzourio, christophe/0000-0002-6517-2984; brice, alexis/0000-0002-0941-3990; Cruchaga, Carlos/0000-0002-0276-2899; Kauwe, John/0000-0001-8641-2468; berr, Claudine/0000-0001-5254-7655; Panza, Francesco/0000-0002-7220-0656; Ramirez, Alfredo/0000-0003-4991-763X; Bellenguez, Céline/0000-0002-1240-7874; Fox, Nick C/0000-0002-6660-657X; LETENNEUR, Luc/0000-0002-3274-937X; McGuinness, Bernadette/0000-0002-7028-5633; Galimberti, Daniela/0000-0002-9284-5953; Razquin, Cristina/0000-0003-3480-2645; alvarez, victoria/0000-0002-1916-2523; , beccie/0000-0002-3885-1199; Tzourio, christophe/0000-0002-6517-2984; Johnson, Andrew D/0000-0001-6369-5178; Smith, Albert Vernon/0000-0003-1942-5845; solfrizzi, vincenzo/0000-0002-8524-0315; Mecocci, Patrizia/0000-0003-0729-5246; Hardy, John/0000-0002-3122-0423; Powell, John F/0000-0001-6124-439X; García, Ana Frank/0000-0003-3858-9116; Panza, Francesco/0000-0002-7220-0656; Gudnason, Vilmundur/0000-0001-5696-0084; Dufouil, Carole/0000-0003-2442-4476; alvarez, victoria/0000-0002-1916-2523; Holmans, Peter/0000-0003-0870-9412; Pastor, Pau/0000-0002-7493-8777; Lambert, jean-charles/0000-0003-0829-7817; Buxbaum, Joseph/0000-0001-8898-8313; Mead, Simon/0000-0002-4326-1468; Hanon, Olivier/0000-0002-4697-122X; Jun, Gyungah/0000-0002-3230-8697; Proitsi, Petroula/0000-0002-2553-6974; Morgan, Kevin/0000-0002-8217-2396; Escott-Price, Valentina/0000-0003-1784-5483; Nothen, Markus/0000-0002-8770-2464; Scarpini, Elio/0000-0002-6395-2119; Van Duijn, Cornelia/0000-0002-2374-9204; Love, Seth/0000-0001-8683-3625; Graff, Caroline/0000-0002-9949-2951; sorbi, sandro/0000-0002-0380-6670; Wallon, David/0000-0002-2634-7198; Seshadri, Sudha/0000-0001-6135-2622; Ruiz Laza, Agustin/0000-0003-2633-2495; Goate, Alison/0000-0002-0576-2472; Kamboh, M. Ilyas/0000-0002-3453-1438; Chouraki, Vincent/0000-0002-4698-1794; Williams, Julie/0000-0002-4069-0259; Holmes, Clive/0000-0003-1999-6912; Todd, Stephen/0000-0002-2312-9195; Tsolaki, Magda/0000-0002-2072-8010; Farrer, Lindsay/0000-0001-5533-4225; Lunetta, Kathryn/0000-0002-9268-810X; Crane, Paul/0000-0003-4278-7465; Kukull, Walter/0000-0001-8761-9014; Amin, Najaf/0000-0002-8944-1771; Harold, Denise/0000-0001-5195-0143; Gill, Michael/0000-0003-0206-5337; Clarimon, Jordi/0000-0002-6824-6942; Lin, Chiao-Feng/0000-0002-6177-8807; Gerrish, Amy/0000-0002-5982-1685; Hampel, Harald/0000-0003-0894-8982; St George-Hyslop, Peter/0000-0003-0796-7209; Denning, Nicola/0000-0001-8467-7382; Moebus, Susanne/0000-0002-0072-5410; Lovestone, Simon/0000-0003-0473-4565; Amouyel, Philippe/0000-0001-9088-234X	French National Foundation; Institut Pasteur de Lille, Inserm, FRC (fondation pour la recherche sur le cerveau) and Rotary; LABEX (laboratory of excellence program investment for the future) DISTALZ grant (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease); LABEX GENMED grant (Medical Genomics); IGAP; National Foundation for Alzheimer's disease and related disorders, the Institut Pasteur de Lille and the Centre National de Genotypage; The Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Agence Francaise, de Securite Sanitaire des Produits de Sante; ANR; Eisai; Belgian Science Policy Office Interuniversity Attraction Poles program; Foundation Alzheimer Research (SAO-FRA); Flemish Government initiated Methusalem Excellence Program; Research Foundation Flanders (FWO); University of Antwerp Research Fund, Belgium; Health Research Council of the Academy of Finland; Kuopio University Hospital [5772708]; Nordic Centre of Excellence in Neurodegeneration; Cassa di Risparmio di Pistoia e Pescia [2012]; Cassa di Risparmio di Firenze [2012]; Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek; Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona; ADNI; Abbott; AstraZeneca AB; Bayer Schering Pharma AG; Bristol-Myers Squibb; Eisai Global Clinical Development; Elan Corporation; Genentech; GE Healthcare; Glaxo-SmithKline; Innogenetics; Johnson and Johnson; Eli Lilly and Co; Medpace, Inc; Merck and Co., Inc.; Novartis AG; Pfizer Inc; F. Hoffman-La Roche; Schering-Plough; Synarc, Inc.; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Dana Foundation; National Institute of Biomedical Imaging and Bioengineering; NIA [U01 AG024904, RC2 AG036535, K01 AG030514]; ADNI (National Institutes of Health) [U01 AG024904]; National Institute on Aging; The Canadian Institutes of Health Research; NIH [K01 AG030514, P30 AG010129]; Alzheimer Association (LAF) [IIRG-08-89720]; Alzheimer Association (MP-V) [IIRG-05-14147]; United States Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program; Wellcome Trust; Howard Hughes Medical Institute; Canadian Institute of Health; LABEX; CNG; EADI; Aquitaine and Bourgogne Regional Councils, Agence Nationale de la Recherche;  [RF-2010-2319722]; MRC [MC_PC_14095, MC_U123192748, MC_U137686857, G0902227, MC_U123160651, MR/K013041/1] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756, R01HL080295, R01HL093029, ZIAHL006170, R01HL087652, R01HL038444, RC2HL102419, U01HL080295] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034504, U01AG024904, R01AG041797, R01AG037212, U24AG021886, P01AG003991, P30AG010129, R01AG019085, R01AG020098, P50AG008671, R01AG021547, R01AG030653, P30AG010161, U01AG049505, P50AG025688, P30AG013846, P50AG005681, P01AG010491, R01AG023629, R01AG041232, R56AG023629, U01AG016976, P50AG005136, R01AG041718, RC2AG036535, R01AG027058, R01AG008122, P30AG010124, P50AG005142, R01AG019757, N01AG012100, R01AG017917, U01AG006781, P50AG005133, R56AG020098, K01AG030514, R01AG015928, R01AG027944, R01AG033193, ZIAAG007270, RF1AG015819] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-BIG2009-1, ARUK-PG2014-1, ARUK-PG2014-2, ARUK-NCG2014A-1] Funding Source: researchfish; Medical Research Council [MC_U123192748, MC_U123160651, MC_PC_14095, MR/K013041/1, G0902227, MC_U137686857, MR/L010305/1, MR/L501517/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084, NF-SI-0508-10123, NF-SI-0512-10053, NF-SI-0513-10134] Funding Source: researchfish; Alzheimer&quot;s Society [167, 164] Funding Source: researchfish	French National Foundation; Institut Pasteur de Lille, Inserm, FRC (fondation pour la recherche sur le cerveau) and Rotary; LABEX (laboratory of excellence program investment for the future) DISTALZ grant (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease); LABEX GENMED grant (Medical Genomics); IGAP; National Foundation for Alzheimer's disease and related disorders, the Institut Pasteur de Lille and the Centre National de Genotypage; The Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Agence Francaise, de Securite Sanitaire des Produits de Sante(General Electric); ANR(French National Research Agency (ANR)); Eisai(Eisai Co Ltd); Belgian Science Policy Office Interuniversity Attraction Poles program; Foundation Alzheimer Research (SAO-FRA); Flemish Government initiated Methusalem Excellence Program; Research Foundation Flanders (FWO)(FWO); University of Antwerp Research Fund, Belgium; Health Research Council of the Academy of Finland(Academy of Finland); Kuopio University Hospital; Nordic Centre of Excellence in Neurodegeneration; Cassa di Risparmio di Pistoia e Pescia; Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek; Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona; ADNI; Abbott(Abbott Laboratories); AstraZeneca AB(AstraZeneca); Bayer Schering Pharma AG(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai Global Clinical Development(Eisai Co Ltd); Elan Corporation; Genentech(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); Glaxo-SmithKline(GlaxoSmithKline); Innogenetics; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Eli Lilly and Co(Eli Lilly); Medpace, Inc; Merck and Co., Inc.(Merck & Company); Novartis AG; Pfizer Inc(Pfizer); F. Hoffman-La Roche; Schering-Plough(Merck & CompanySchering Plough Corporation); Synarc, Inc.; Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Dana Foundation; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ADNI (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); The Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association (LAF); Alzheimer Association (MP-V); United States Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program; Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institute of Health(Canadian Institutes of Health Research (CIHR)); LABEX; CNG; EADI; Aquitaine and Bourgogne Regional Councils, Agence Nationale de la Recherche(French National Research Agency (ANR)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Alzheimer&quot;s Society	The i-Select chips was funded by the French National Foundation on Alzheimer's disease and related disorders. The French National Fondation on Alzheimer's disease and related disorders supported several I-GAP meetings and communications. Data management involved the Centre National de Genotypage, and was supported by the Institut Pasteur de Lille, Inserm, FRC (fondation pour la recherche sur le cerveau) and Rotary. This work has been developed and supported by the LABEX (laboratory of excellence program investment for the future) DISTALZ grant (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease) and by the LABEX GENMED grant (Medical Genomics). The French National Foundation on Alzheimer's disease and related disorders and the Alzheimer's Association (Chicago, Illinois) grant supported IGAP in-person meetings, communication and the Alzheimer's Association (Chicago, Illinois) grant provided some funds to each consortium for analyses. EADI The authors thank Dr. Anne Boland (CNG) for her technical help in preparing the DNA samples for analyses. This work was supported by the National Foundation for Alzheimer's disease and related disorders, the Institut Pasteur de Lille and the Centre National de Genotypage. The Three-City Study was performed as part of a collaboration between the Institut National de la Sante et de la Recherche Medicale (Inserm), the Victor Segalen Bordeaux II University and Sanofi-Synthelabo. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Agence Francaise, de Securite Sanitaire des Produits de Sante, the Aquitaine and Bourgogne Regional Councils, Agence Nationale de la Recherche, ANR supported the COGINUT and COVADIS projects. Fondation de France and the joint French Ministry of Research/INSERM << Cohortes et collections de donnees biologiques >> programme. Lille Genopole received an unconditional grant from Eisai. The Three-city biological bank was developed and maintained by the laboratory for genomic analysis LAG-BRC - Institut Pasteur de Lille. Belgium sample collection: The patients were clinically and pathological characterized by the neurologists Sebastiaan Engelborghs, Rik Vandenberghe and Peter P. De Deyn, and in part genetically by Caroline Van Cauwenberghe, Karolien Bettens and Kristel Sleegers. Research at the Antwerp site is funded in part by the Belgian Science Policy Office Interuniversity Attraction Poles program, the Foundation Alzheimer Research (SAO-FRA), the Flemish Government initiated Methusalem Excellence Program, the Research Foundation Flanders (FWO) and the University of Antwerp Research Fund, Belgium. Karolien Bettens is a postdoctoral fellow of the FWO. The Antwerp site authors thank the personnel of the VIB Genetic Service Facility, the Biobank of the Institute Born-Bunge and the Departments of Neurology and Memory Clinics at the Hospital Network Antwerp and the University Hospitals Leuven. Finish sample collection: Financial support for this project was provided by the Health Research Council of the Academy of Finland, EVO grant 5772708 of Kuopio University Hospital, and the Nordic Centre of Excellence in Neurodegeneration. Italian sample collections: the Bologna site (FL) obtained funds from the Italian Ministry of research and University as well as Carimonte Foundation.; The Florence site was supported by grant RF-2010-2319722, grant from the the Cassa di Risparmio di Pistoia e Pescia (Grant 2012) and the Cassa di Risparmio di Firenze (Grant 2012). The Milan site was supported by a grant from the (funding via numerous sources including Stichting MS Research, Brain Net Europe, Hersenstichting Nederland Breinbrekend Werk, International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek), Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona. Marcelle Morrison-Bogorad, PhD., Tony Phelps, PhD and Walter Kukull PhD are thanked for helping to co-ordinate this collection. ADNI Funding for ADNI is through the Northern California Institute for Research and Education by grants from Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, Glaxo-SmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., Alzheimer's Association, Alzheimer's Drug Discovery Foundation, the Dana Foundation, and by the National Institute of Biomedical Imaging and Bioengineering and NIA grants U01 AG024904, RC2 AG036535, K01 AG030514. Data collection and sharing for this project was funded by the ADNI (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. The authors thank Drs. D. Stephen Snyder and Marilyn Miller from NIA who are ex-o_cio ADGC members. Support was also from the Alzheimer's Association (LAF, IIRG-08-89720; MP-V, IIRG-05-14147) and the United States Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program. Peter St George-Hyslop is supported by Wellcome Trust, Howard Hughes Medical Institute, and the Canadian Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316; Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Bettens K, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-3; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Chen Y, 2013, MOL CELL PROTEOMICS, V12, P2804, DOI 10.1074/mcp.M112.025882; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169; Driver JA, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1442; Fall T, 2012, DIABETIC MED, V29, pE62, DOI 10.1111/j.1464-5491.2012.03665.x; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Giusiano S, 2012, PROSTATE, V72, P1286, DOI 10.1002/pros.22477; Guerreiro RJ, 2011, BIOCHEM SOC T, V39, P910, DOI 10.1042/BST0390910; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Haupt A, 2010, OBESITY, V18, P1212, DOI 10.1038/oby.2009.413; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Katz C, 2012, J BIOL CHEM, V287, P15016, DOI 10.1074/jbc.M111.328377; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Lambert JCea, 2013, EXTENDED METAANALYSI; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Moskvina V, 2007, HUM HERED, V64, P63, DOI 10.1159/000101424; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Moskvina V, 2011, GENET EPIDEMIOL, V35, P861, DOI 10.1002/gepi.20636; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; RISCH N, 1990, AM J HUM GENET, V46, P222; Roe CM, 2010, NEUROLOGY, V74, P106, DOI 10.1212/WNL.0b013e3181c91873; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Seillier M, 2012, CELL DEATH DIFFER, V19, P1525, DOI 10.1038/cdd.2012.30; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Seux M, 2011, ONCOGENE, V30, P3049, DOI 10.1038/onc.2011.25; Terwilliger JD, 2006, EUR J HUM GENET, V14, P426, DOI 10.1038/sj.ejhg.5201583; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Watson CT, 2012, GENES IMMUN, V13, P363, DOI 10.1038/gene.2012.12; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011	43	81	83	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e94661	10.1371/journal.pone.0094661	http://dx.doi.org/10.1371/journal.pone.0094661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922517	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000338701300002
J	Hutchens, MP; Kosaka, Y; Zhang, W; Fujiyoshi, T; Murphy, S; Alkayed, N; Anderson, S				Hutchens, Michael P.; Kosaka, Yasuharu; Zhang, Wenri; Fujiyoshi, Tetsuhiro; Murphy, Stephanie; Alkayed, Nabil; Anderson, Sharon			Estrogen-Mediated Renoprotection following Cardiac Arrest and Cardiopulmonary Resuscitation Is Robust to GPR30 Gene Deletion	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; PERFORMANCE LIQUID-CHROMATOGRAPHY; G-PROTEIN; IN-VIVO; EXPERIMENTAL STROKE; RECEPTOR; 17-BETA-ESTRADIOL; MICE; ISCHEMIA	Introduction: Acute kidney injury is a serious, sexually dimorphic perioperative complication, primarily attributed to hypoperfusion. We previously found that estradiol is renoprotective after cardiac arrest and cardiopulmonary resuscitation in ovariectomized female mice. Additionally, we found that neither estrogen receptor alpha nor beta mediated this effect. We hypothesized that the G protein estrogen receptor (GPR30) mediates the renoprotective effect of estrogen. Methods: Ovariectomized female and gonadally intact male wild-type and GPR30 gene-deleted mice were treated with either vehicle or 17 beta-estradiol for 7 days, then subjected to cardiac arrest and cardiopulmonary resuscitation. Twenty four hours later, serum creatinine and urea nitrogen were measured, and histologic renal injury was evaluated by unbiased stereology. Results: In both males and females, GPR30 gene deletion was associated with reduced serum creatinine regardless of treatment. Estrogen treatment of GPR30 gene-deleted males and females was associated with increased preprocedural weight. In ovariectomized female mice, estrogen treatment did not alter resuscitation, but was renoprotective regardless of GPR30 gene deletion. In males, estrogen reduced the time-to-resuscitate and epinephrine required. In wild-type male mice, serum creatinine was reduced, but neither serum urea nitrogen nor histologic outcomes were affected by estrogen treatment. In GPR30 gene-deleted males, estrogen did not alter renal outcomes. Similarly, renal injury was not affected by G1 therapy of ovariectomized female wild-type mice. Conclusion: Treatment with 17 beta-estradiol is renoprotective after whole-body ischemia-reperfusion in ovariectomized female mice irrespective of GPR30 gene deletion. Treatment with the GPR30 agonist G1 did not alter renal outcome in females. We conclude GPR30 does not mediate the renoprotective effect of estrogen in ovariectomized female mice. In males, estrogen therapy was not renoprotective. Estrogen treatment of GPR30 gene-deleted mice was associated with increased preprocedural weight in both sexes. Of significance to further investigation, GPR30 gene deletion was associated with reduced serum creatinine, regardless of treatment.	[Hutchens, Michael P.; Kosaka, Yasuharu; Zhang, Wenri; Fujiyoshi, Tetsuhiro; Murphy, Stephanie; Alkayed, Nabil] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA; [Anderson, Sharon] Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Hutchens, MP (corresponding author), Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA.	hutchenm@ohsu.edu		Hutchens, Michael/0000-0001-8583-1812	National Institute of Diabetes and Digestive and Kidney Disease [DK90754]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090754] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by a grant from the National Institute of Diabetes and Digestive and Kidney Disease (http://www2.niddk.nih.gov), #DK90754 to MPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigouy B, 2013, NAT METHODS, V10, P1048, DOI 10.1038/nmeth.2692; Ardelt AA, 2005, STROKE, V36, P337, DOI 10.1161/01.STR.0000153795.38388.72; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bove T, 2004, J CARDIOTHOR VASC AN, V18, P442, DOI 10.1053/j.jvca.2004.05.021; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; Dietrich W, 2008, ANESTHESIOLOGY, V108, P189, DOI 10.1097/01.anes.0000299428.55062.67; Doddakula Kishore, 2007, Interact Cardiovasc Thorac Surg, V6, P314, DOI 10.1510/icvts.2006.148874; Duff GL, 1941, AM J MED SCI, V201, P429; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Ford J, 2011, J BONE MINER RES, V26, P298, DOI 10.1002/jbmr.209; Foryst-Ludwig A, 2010, J STEROID BIOCHEM, V122, P74, DOI 10.1016/j.jsbmb.2010.06.012; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Hofmeister MV, 2012, AM J PHYSIOL-RENAL, V302, pF358, DOI 10.1152/ajprenal.00343.2011; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Hutchens MP, 2008, ANESTH ANALG, V107, P239, DOI 10.1213/ane.0b013e318178ca42; Hutchens MP, 2008, RESUSCITATION, V76, P89, DOI 10.1016/j.resuscitation.2007.06.031; Hutchens MP, 2012, AM J PHYSIOL-RENAL, V303, pF377, DOI 10.1152/ajprenal.00354.2011; Hutchens MP, 2010, ANESTHESIOLOGY, V112, P395, DOI 10.1097/ALN.0b013e3181c98da9; Keppler A, 2007, KIDNEY INT, V71, P74, DOI 10.1038/sj.ki.5001988; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kim J, 2006, J BIOL CHEM, V281, P20349, DOI 10.1074/jbc.M512740200; Kosaka Y, 2012, TRANSL STROKE RES, V3, P500, DOI 10.1007/s12975-012-0211-8; Kowdley Gopal C, 2005, Curr Surg, V62, P64, DOI 10.1016/j.cursur.2004.06.007; Li X, 2012, AM J PHYSIOL-RENAL, V302, pF519, DOI 10.1152/ajprenal.00011.2011; Liang Y, 2001, BRAIN RES BULL, V54, P661, DOI 10.1016/S0361-9230(01)00483-X; Lindsey SH, 2011, HYPERTENSION, V58, P665, DOI 10.1161/HYPERTENSIONAHA.111.175174; Lindsey SH, 2011, J CARDIOVASC PHARM; Liu SB, 2013, BRAIN RES BULL, V93, P27, DOI 10.1016/j.brainresbull.2012.10.004; Meyer MR, 2010, PHARMACOLOGY, V86, P58, DOI 10.1159/000315497; MEYER MH, 1985, ANAL BIOCHEM, V144, P285, DOI 10.1016/0003-2697(85)90118-6; Micevych PE, 2012, NEUROENDOCRINOLOGY, V96, P103, DOI 10.1159/000338400; Muller V, 2002, KIDNEY INT, V62, P1364, DOI 10.1111/j.1523-1755.2002.kid590.x; Noppens RR, 2005, CRIT CARE MED, V33, P1595, DOI 10.1097/01.CCM.0000169884.81769.F7; Park KM, 2004, J BIOL CHEM, V279, P52282, DOI 10.1074/jbc.M407629200; Park KM, 2005, BIOCHEM BIOPH RES CO, V328, P312, DOI 10.1016/j.bbrc.2004.12.177; Perez E, 2005, BRAIN RES, V1038, P216, DOI 10.1016/j.brainres.2005.01.026; Qiu J, 2003, J NEUROSCI, V23, P9529; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Satake A, 2008, KIDNEY INT, V73, P308, DOI 10.1038/sj.ki.5002690; Sharma G., 2013, ENDOCRINOLOGY; Shibata Y, 2004, J CARDIOVASC PHARM, V44, pS459, DOI 10.1097/01.fjc.0000166315.38258.e1; Simpkins JW, 2012, NEUROENDOCRINOLOGY, V96, P119, DOI 10.1159/000338409; Song HK, 2008, ANN THORAC SURG, V85, P2040, DOI 10.1016/j.athoracsur.2008.02.082; Tanaka R, 2013, EUR J PHARMACOL, V714, P397, DOI 10.1016/j.ejphar.2013.07.008; Thakar CV, 2003, AM J KIDNEY DIS, V41, P742, DOI 10.1016/S0272-6386(03)00021-0; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Toran-Allerand CD, 2005, ANN NY ACAD SCI, V1052, P136, DOI 10.1196/annals.1347.009; Wang C, 2008, MOL ENDOCRINOL, V22, P636, DOI 10.1210/me.2007-0359; Wang C, 2009, J IMMUNOL, V182, P3294, DOI 10.4049/jimmunol.0803205; Weil BR, 2010, SURGERY, V148, P436, DOI 10.1016/j.surg.2010.03.011; Yue W, 2010, INT J CANCER, V127, P1748, DOI 10.1002/ijc.25207; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339	55	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99910	10.1371/journal.pone.0099910	http://dx.doi.org/10.1371/journal.pone.0099910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923556	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300106
J	Toro, AR; Maymo, JL; Ibarbalz, FM; Perez, AP; Maskin, B; Faletti, AG; Margalet, VS; Varone, CL				Rayen Toro, Ayelen; Lorena Maymo, Julieta; Matias Ibarbalz, Federico; Perez Perez, Antonio; Maskin, Bernardo; Graciela Faletti, Alicia; Sanchez Margalet, Victor; Laura Varone, Cecilia			Leptin Is an Anti-Apoptotic Effector in Placental Cells Involving p53 Downregulation	PLOS ONE			English	Article							TROPHOBLAST APOPTOSIS; EXPRESSION; PROTEIN; BAX; DEATH; BCL-2; PROLIFERATION; ACTIVATION; PREGNANCY; EMBRYO	Leptin, a peripheral signal synthetized by the adipocyte to regulate energy metabolism, can also be produced by placenta, where it may work as an autocrine hormone. We have previously demonstrated that leptin promotes proliferation and survival of trophoblastic cells. In the present work, we aimed to study the molecular mechanisms that mediate the survival effect of leptin in placenta. We used the human placenta choriocarcinoma BeWo and first trimester Swan-71 cell lines, as well as human placental explants. We tested the late phase of apoptosis, triggered by serum deprivation, by studying the activation of Caspase-3 and DNA fragmentation. Recombinant human leptin added to BeWo cell line and human placental explants, showed a decrease on Caspase-3 activation. These effects were dose dependent. Maximal effect was achieved at 250 ng leptin/ml. Moreover, inhibition of endogenous leptin expression with 2 mu M of an antisense oligonucleotide, reversed Caspase-3 diminution. We also found that the cleavage of Poly [ADP-ribose] polymerase-1 (PARP-1) was diminished in the presence of leptin. We analyzed the presence of low DNA fragments, products from apoptotic DNA cleavage. Placental explants cultivated in the absence of serum in the culture media increased the apoptotic cleavage of DNA and this effect was prevented by the addition of 100 ng leptin/ml. Taken together these results reinforce the survival effect exerted by leptin on placental cells. To improve the understanding of leptin mechanism in regulating the process of apoptosis we determined the expression of different intermediaries in the apoptosis cascade. We found that under serum deprivation conditions, leptin increased the anti-apoptotic BCL-2 protein expression, while downregulated the pro-apoptotic BAX and BID proteins expression in Swan-71 cells and placental explants. In both models leptin augmented BCL-2/BAX ratio. Moreover we have demonstrated that p53, one of the key cell cycle-signaling proteins, is downregulated in the presence of leptin under serum deprivation. On the other hand, we determined that leptin reduced the phosphorylation of Ser-46 p53 that plays a pivotal role for apoptotic signaling by p53. Our data suggest that the observed anti-apoptotic effect of leptin in placenta is in part mediated by the p53 pathway. In conclusion, we provide evidence that demonstrates that leptin is a trophic factor for trophoblastic cells.	[Rayen Toro, Ayelen; Lorena Maymo, Julieta; Matias Ibarbalz, Federico; Laura Varone, Cecilia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Inst Quim Biol, Buenos Aires, DF, Argentina; [Perez Perez, Antonio; Sanchez Margalet, Victor] Univ Seville, Fac Med, Hosp Univ Virgen Macarena, Dept Bioquim Med & Biol Mol, Seville, Spain; [Maskin, Bernardo] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Graciela Faletti, Alicia] Univ Buenos Aires, Fac Med, Ctr Estudios Farmacol & Bot, Buenos Aires, DF, Argentina	University of Buenos Aires; Hospital Universitario Virgen Macarena; University of Sevilla; University of Buenos Aires	Varone, CL (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Inst Quim Biol, Buenos Aires, DF, Argentina.	cvarone@qb.fcen.uba.ar	Sánchez-Margalet, Victor/AAB-9986-2021; Maymo, Julieta/AAU-3777-2020	Sánchez-Margalet, Victor/0000-0001-8638-8680; Maymo, Julieta/0000-0003-1308-9887	CONICET fellowship; Instituto de Salud Carlos III [CM07/00025]; Universidad de Buenos Aires (UBACYT); ANPCyT [PICT 2008-0425]; CONICET [PIP 2010-247]; Fundacion Florencio Fiorini, Buenos Aires, Argentina; Instituto de Salud Carlos III, Spain [PS09/00119]	CONICET fellowship(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Universidad de Buenos Aires (UBACYT)(University of Buenos Aires); ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Florencio Fiorini, Buenos Aires, Argentina; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	Grant Support: ART and JLM are supported by a CONICET fellowship. APP is a research fellow supported by the Instituto de Salud Carlos III (CM07/00025). This project was supported by the Universidad de Buenos Aires (UBACYT), the ANPCyT (PICT 2008-0425), the CONICET (PIP 2010-247), the Fundacion Florencio Fiorini, Buenos Aires, Argentina and the Instituto de Salud Carlos III (PS09/00119), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire AD, 2000, OBSTET GYNECOL, V96, P271, DOI 10.1016/S0029-7844(00)00895-4; Bajoria R, 2002, PLACENTA, V23, P103, DOI 10.1053/plac.2001.0769; Basanez G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001399; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruno A, 2005, J IMMUNOL, V174, P8090, DOI 10.4049/jimmunol.174.12.8090; Butte NF, 1997, J CLIN ENDOCR METAB, V82, P585, DOI 10.1210/jc.82.2.585; Caprio M, 2001, TRENDS ENDOCRIN MET, V12, P65, DOI 10.1016/S1043-2760(00)00352-0; Cervero A, 2005, REPROD BIOMED ONLINE, V10, P217, DOI 10.1016/S1472-6483(10)60943-1; Cockell AP, 1997, BRIT J OBSTET GYNAEC, V104, P235, DOI 10.1111/j.1471-0528.1997.tb11052.x; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Fujita Y, 2002, CLIN EXP IMMUNOL, V128, P21, DOI 10.1046/j.1365-2249.2002.01797.x; Gambino YP, 2012, PLACENTA; Gambino YP, 2010, BIOL REPROD; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Heazell AEP, 2008, PLACENTA, V29, P772, DOI 10.1016/j.placenta.2008.07.003; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3; Henson MC, 2005, BIOL REPROD; Houseknecht KL, 1998, DOMEST ANIM ENDOCRIN, V15, P457, DOI 10.1016/S0739-7240(98)00035-6; Hromadnikova I, 2012, DNA CELL BIOL, V31, P1221, DOI 10.1089/dna.2011.1530; Huppertz B, 2005, PLACENTA, V26, pS46, DOI 10.1016/j.placenta.2005.02.002; Huppertz Berthold, 2005, Birth Defects Research, V75, P249, DOI 10.1002/bdrc.20056; Iwagaki S, 2004, GYNECOL ENDOCRINOL, V18, P263, DOI 10.1080/0951359042000196277; Kadyrov M, 2006, AM J OBSTET GYNECOL, V194, P557, DOI 10.1016/j.ajog.2005.07.035; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Lam QLK, 2010, P NATL ACAD SCI USA, V107, P13812, DOI 10.1073/pnas.1004185107; Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906; Levy R, 2000, PLACENTA, V21, P1, DOI 10.1053/plac.1999.0450; Li XX, 2005, J BIOL CHEM, V280, P24245, DOI 10.1074/jbc.M414637200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magarinos MP, 2007, BIOL REPROD, V76, P203, DOI 10.1095/biolreprod.106.051391; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Maymo JL, 2011, PLACENTA, V32, pS146, DOI 10.1016/j.placenta.2011.01.004; Maymo JL, 2010, ENDOCRINOLOGY, V151, P3738, DOI 10.1210/en.2010-0064; Maymo JL, 2009, ENDOCRINOLOGY, V150, P304, DOI 10.1210/en.2008-0522; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; MIYASHITA T, 1995, CELL, V80, P293; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Perez-Perez A, 2008, ARCH BIOCHEM BIOPHYS, V477, P390, DOI 10.1016/j.abb.2008.06.015; Perez-Perez A, 2010, BIOCHEM BIOPH RES CO, V396, P956, DOI 10.1016/j.bbrc.2010.05.031; Perez-Perez A, 2009, BIOL REPROD, V81, P826, DOI 10.1095/biolreprod.109.076513; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Prives C, 1999, J PATHOL, V187, P112; Ramhorst R, 2012, AM J REPROD IMMUNOL, V67, P17, DOI 10.1111/j.1600-0897.2011.01056.x; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Reitman ML, 2001, BIOCHEM SOC T, V29, P68, DOI 10.1042/BST0290068; Renault TT, 2013, INT J BIOCHEM CELL B, V45, P64, DOI 10.1016/j.biocel.2012.09.022; Sagawa N, 2002, PLACENTA, V23, pS80, DOI 10.1053/plac.2002.0814; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Senaris R, 1997, ENDOCRINOLOGY, V138, P4501, DOI 10.1210/en.138.10.4501; Sharp AN, 2010, AM J REPROD IMMUNOL, V64, P159, DOI 10.1111/j.1600-0897.2010.00837.x; Standley PR, 2002, AM J HYPERTENS, V15, P565, DOI 10.1016/S0895-7061(02)02272-0; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Tran VH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.191; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zinkel SS, 2013, ONCOGENE, V32, P3213, DOI 10.1038/onc.2012.454	62	30	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99187	10.1371/journal.pone.0099187	http://dx.doi.org/10.1371/journal.pone.0099187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922063	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300042
J	Shieh, JM; Shen, CJ; Chang, WC; Cheng, HC; Chan, YY; Huang, WC; Chang, WC; Chen, BK				Shieh, Jiunn-Min; Shen, Chih-Jie; Chang, Wei-Chiao; Cheng, Hung-Chi; Chan, Ya-Yi; Huang, Wan-Chen; Chang, Wen-Chang; Chen, Ben-Kuen			An Increase in Reactive Oxygen Species by Deregulation of ARNT Enhances Chemotherapeutic Drug-Induced Cancer Cell Death	PLOS ONE			English	Article							RECEPTOR NUCLEAR TRANSLOCATOR; GENE-EXPRESSION; APOPTOSIS; STRESS; DOXORUBICIN; ACTIVATION; MDR1; AHR	Background: Unique characteristics of tumor microenvironments can be used as targets of cancer therapy. The aryl hydrocarbon receptor nuclear translocator (ARNT) is an important mediator of tumor progression. However, the functional role of ARNT in chemotherapeutic drug-treated cancer remains unclear. Methodology/Principal Findings: Here, we found that knockdown of ARNT in cancer cells reduced the proliferation rate and the transformation ability of those cells. Moreover, cisplatin-induced cell apoptosis was enhanced in ARNT-deficient cells. Expression of ARNT also decreased in the presence of cisplatin through proteasomal degradation pathway. However, ARNT level was maintained in cisplatin-treated drug-resistant cells, which prevented cell from apoptosis. Interestingly, reactive oxygen species (ROS) dramatically increased when ARNT was knocked down in cancer cells, enhancing cisplatin-induced apoptosis. ROS promoted cell death was inhibited in cells treated with the ROS scavenger, N-acetyl-cysteine (NAC). Conclusions/Significance: These results suggested that the anticancer activity of cisplatin is attributable to its induction of the production of ROS by ARNT degradation. Targeting ARNT could be a potential strategy to eliminate drug resistance in cancer cells.	[Shieh, Jiunn-Min] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Shieh, Jiunn-Min] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan; [Shen, Chih-Jie; Huang, Wan-Chen; Chen, Ben-Kuen] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharmacol, Dept Clin Pharmacol, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharmacol, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Wanfang Hosp, Dept Pharm, Taipei, Taiwan; [Cheng, Hung-Chi] Natl Cheng Kung Univ, Inst Biochem, Tainan 70101, Taiwan; [Chan, Ya-Yi; Chen, Ben-Kuen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Chang, Wen-Chang; Chen, Ben-Kuen] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; National Cheng Kung University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Chen, BK (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan.	bkchen58@mail.ncku.edu.tw	Huang, Wan-Chen/N-2472-2019	Huang, Wan-Chen/0000-0002-7341-4373; Chang, Wei-Chiao/0000-0002-8573-5924; SHEN, CHIH-JIE/0000-0001-7392-056X	National Science Council of the Republic of China [NSC 102-2628-B-006-011-MY3]; Headquarters of University Advancement at the National Cheng Kung University	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Headquarters of University Advancement at the National Cheng Kung University	This work was supported by grant NSC 102-2628-B-006-011-MY3 from the National Science Council of the Republic of China. This research was supported in part by the Headquarters of University Advancement at the National Cheng Kung University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Chan YY, 2013, MOL PHARMACOL, V84, P591, DOI 10.1124/mol.113.087197; Chang KY, 2011, CLIN CANCER RES, V17, P7116, DOI 10.1158/1078-0432.CCR-11-0796; Chang KY, 2009, J BIOL CHEM, V284, P9908, DOI 10.1074/jbc.M806210200; Choi H, 2006, MOL PHARMACOL, V70, P1664, DOI 10.1124/mol.106.025817; Dalton TP, 2002, CHEM-BIOL INTERACT, V141, P77, DOI 10.1016/S0009-2797(02)00067-4; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; GROS P, 1991, P NATL ACAD SCI USA, V88, P7289, DOI 10.1073/pnas.88.16.7289; Gu CH, 2013, LEUKEMIA RES, V37, P1750, DOI 10.1016/j.leukres.2013.10.010; Huang WC, 2010, CELL MOL LIFE SCI, V67, P3523, DOI 10.1007/s00018-010-0392-9; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Joo MS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.427; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kang HJ, 2006, J BIOL CHEM, V281, P14654, DOI 10.1074/jbc.M601613200; Ko SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055795; Kobayashi A, 1996, J BIOL CHEM, V271, P12310, DOI 10.1074/jbc.271.21.12310; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Oda Y, 2012, TOXICOL APPL PHARM, V260, P222, DOI 10.1016/j.taap.2012.02.012; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Suzuki H, 2001, ONCOGENE, V20, P5779, DOI 10.1038/sj.onc.1204742; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Wang QO, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-159; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200	34	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99242	10.1371/journal.pone.0099242	http://dx.doi.org/10.1371/journal.pone.0099242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921657	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300047
J	Xie, JS; Wang, RM; Chang, S				Xie, Jiushu; Wang, Ruiming; Chang, Song			The Mechanism of Valence-Space Metaphors: ERP Evidence for Affective Word Processing	PLOS ONE			English	Article							SPATIAL ATTENTION; SELECTIVE ATTENTION; TIME; PERFORMANCE; EMBODIMENT; POTENTIALS; SHIFTS; N100; P50; BAD	Embodied cognition contends that the representation and processing of concepts involve perceptual, somatosensory, motoric, and other physical re-experiencing information. In this view, affective concepts are also grounded in physical information. For instance, people often say "feeling down'' or "cheer up'' in daily life. These phrases use spatial information to understand affective concepts. This process is referred to as valence-space metaphor. Valence-space metaphors refer to the employment of spatial information (lower/higher space) to elaborate affective concepts (negative/positive concepts). Previous studies have demonstrated that processing affective words affects performance on a spatial detection task. However, the mechanism(s) behind this effect remain unclear. In the current study, we hypothesized that processing affective words might produce spatial information. Consequently, spatial information would affect the following spatial cue detection/discrimination task. In Experiment 1, participants were asked to remember an affective word. Then, they completed a spatial cue detection task while event-related potentials were recorded. The results indicated that the top cues induced enhanced amplitude of P200 component while participants kept positive words relative to negative words in mind. On the contrary, the bottom cues induced enhanced P200 amplitudes while participants kept negative words relative to positive words in mind. In Experiment 2, we conducted a behavioral experiment that employed a similar paradigm to Experiment 1, but used arrows instead of dots to test the attentional nature of the valence-space metaphor. We found a similar facilitation effect as found in Experiment 1. Positive words facilitated the discrimination of upper arrows, whereas negative words facilitated the discrimination of lower arrows. In summary, affective words might activate spatial information and cause participants to allocate their attention to corresponding locations. Valence-space metaphors might be grounded in attention allocation.	[Xie, Jiushu; Wang, Ruiming; Chang, Song] S China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China	South China Normal University	Wang, RM (corresponding author), S China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	wangrm@scnu.edu.cn			National Natural Science Foundation of China [31200785]; National Excellent Doctoral Dissertation Foundation of China [201204]; Humanities and Social Science Research Base Project from the Ministry of Education of China [13JJD190006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Excellent Doctoral Dissertation Foundation of China; Humanities and Social Science Research Base Project from the Ministry of Education of China	This research was funded by National Natural Science Foundation of China (31200785), National Excellent Doctoral Dissertation Foundation of China (201204) and Humanities and Social Science Research Base Project from the Ministry of Education of China (13JJD190006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge U, 2010, COGNITION, V116, P303, DOI 10.1016/j.cognition.2010.05.010; Barsalou LW, 2008, CURR DIR PSYCHOL SCI, V17, P91, DOI 10.1111/j.1467-8721.2008.00555.x; Barsalou LW, 2009, PHILOS T R SOC B, V364, P1281, DOI 10.1098/rstb.2008.0319; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Barsalou LW, 2005, TRENDS COGN SCI, V9, P309, DOI 10.1016/j.tics.2005.05.003; Beteleva T. G., 2006, Human Physiology, V32, P509, DOI 10.1134/S0362119706050021; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; de la Vega I, 2012, J EXP PSYCHOL HUMAN, V38, P375, DOI 10.1037/a0024979; Doallo S, 2007, NEUROSCI LETT, V418, P111, DOI 10.1016/j.neulet.2007.03.009; Eimer M, 2000, BIOL PSYCHOL, V52, P205, DOI 10.1016/S0301-0511(00)00028-4; Eimer M, 2003, COGNITIVE BRAIN RES, V15, P308, DOI 10.1016/S0926-6410(02)00203-3; Ferreira-Santos F, 2012, CLIN NEUROPHYSIOL, V123, P1300, DOI 10.1016/j.clinph.2011.11.036; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Gole M, 2012, NEUROSCI LETT, V507, P112, DOI 10.1016/j.neulet.2011.11.054; Gozli DG, 2013, VIS COGN, V21, P628, DOI 10.1080/13506285.2013.815680; Gozli DG, 2013, J EXP PSYCHOL GEN, V142, P1028, DOI 10.1037/a0030362; Hess U, 2013, SOC COGNITION, V31, P72, DOI 10.1521/soco.2013.31.1.72; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Joormann J, 2007, J ABNORM PSYCHOL, V116, P80, DOI 10.1037/0021-843X.116.1.80; JUNHONG H, 2013, PLOS ONE, V0008; Kranjec A, 2010, COGNITION, V114, P111, DOI 10.1016/j.cognition.2009.09.008; Lakens D, 2012, J EXP PSYCHOL GEN, V141, P584, DOI 10.1037/a0026468; Lakens D, 2012, J EXP PSYCHOL LEARN, V38, P726, DOI 10.1037/a0024955; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Leppanen JM, 2007, BRAIN RES, V1166, P103, DOI 10.1016/j.brainres.2007.06.060; Lijffijt M, 2012, J PSYCHIATR RES, V46, P743, DOI 10.1016/j.jpsychires.2012.03.001; Lijffijt M, 2009, PSYCHOPHYSIOLOGY, V46, P1059, DOI 10.1111/j.1469-8986.2009.00845.x; Louwerse MM, 2010, COGNITION, V114, P96, DOI 10.1016/j.cognition.2009.09.002; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; LUCK SJ, 1995, INT J NEUROSCI, V80, P281, DOI 10.3109/00207459508986105; Ma QG, 2010, NEUROSCI LETT, V483, P206, DOI 10.1016/j.neulet.2010.08.009; Macaluso E, 2010, CORTEX, V46, P282, DOI 10.1016/j.cortex.2009.05.010; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Merritt DJ, 2010, COGNITION, V117, P191, DOI 10.1016/j.cognition.2010.08.011; Murphy G. L., 2002, BIG BOOK CONCEPTS; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2009, J PERS SOC PSYCHOL, V96, P1120, DOI 10.1037/a0015574; Oliveri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007933; Ouellet M, 2010, J EXP PSYCHOL HUMAN, V36, P17, DOI 10.1037/a0017176; Potts GF, 2001, COGNITIVE BRAIN RES, V11, P147, DOI 10.1016/S0926-6410(00)00075-6; Rosch E., 1978, COGNITION CATEGORIZA, P27, DOI DOI 10.1037/0012-1649.16.5.391; Smith LB, 2005, COGNITIVE SCI, V29, P665, DOI 10.1207/s15516709cog0000_13; Torralbo A, 2006, COGNITIVE SCI, V30, P745, DOI 10.1207/s15516709cog0000_67; van Dantzig S, 2009, J EXP SOC PSYCHOL, V45, P345, DOI 10.1016/j.jesp.2008.11.001; Vermeulen N, 2007, COGNITIVE SCI, V31, P183, DOI 10.1080/03640210709336990; [王一牛 WANG Yi-Niu], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P608; Weger UW, 2008, PSYCHON B REV, V15, P426, DOI 10.3758/PBR.15.2.426; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Wiswede D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005754; Yun XY, 2011, NEUROSCI LETT, V498, P10, DOI 10.1016/j.neulet.2011.04.040; Zwaan RA, 2003, PSYCHON B REV, V10, P954, DOI 10.3758/BF03196557; Zwaan RA, 2003, COGNITION, V87, pB79, DOI 10.1016/S0010-0277(02)00235-4	56	14	14	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99479	10.1371/journal.pone.0099479	http://dx.doi.org/10.1371/journal.pone.0099479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24923271	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300063
J	Boudreau, JE; Le Luduec, JB; Hsu, KC				Boudreau, Jeanette E.; Le Luduec, Jean-Benoit; Hsu, Katharine C.			Development of a Novel Multiplex PCR Assay to Detect Functional Subtypes of KIR3DL1 Alleles	PLOS ONE			English	Article							NK CELL RECEPTORS; HLA-B; INHIBITORY RECEPTORS; CLASS-I; EXPRESSION; POLYMORPHISM; DIVERSITY; COMBINATION; REPERTOIRE; HAPLOTYPES	Among NK cell receptor-ligand partnerships, KIR3DL1 and HLA-Bw4 demonstrate the greatest diversity; permutations of their allelic combinations titrate NK reactivity. Balancing selection has maintained distinct subtypes of KIR3DL1 alleles in global populations, implying that each may provide unique fitness advantages and variably influence disease processes. Though approaches exist for determining HLA-B allotypes, practical methods for identifying KIR3DL1 alleles are lacking. We have developed a PCR-based approach that identifies functional subtypes of KIR3DL1 alleles; it is suitable for research and may have clinical application. Six allele subsets were identified based on expression characteristics of the eleven most common KIR3DL1 alleles represented in reported populations. The remaining 62 low-frequency alleles were distributed into these groups based on sequence homology to coding regions. Subtype-specific SNPs were found in exons 3, 4, and 7, and used as priming sites for five multiplex PCR reactions. Genomic DNA derived from 175 unrelated donors and 52 related individuals from 6 families demonstrated >99.5% concordance between sequence-based typing and our novel approach. Finally, PCR-based typing accurately predicted NK phenotypes obtained by flow cytometry after staining with DX9 and Z27 monoclonal antibodies. This novel approach facilitates high-throughput analysis of KIR3DL1 allotypes to enable a broader understanding of KIR3DL1 and HLA-Bw4 interaction in health and disease.	[Boudreau, Jeanette E.; Le Luduec, Jean-Benoit; Hsu, Katharine C.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Program Immunol, New York, NY 10021 USA; [Hsu, Katharine C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Hsu, Katharine C.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Hsu, KC (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	hsuk@mskcc.org		Boudreau, Jeanette/0000-0003-0203-2180; LE LUDUEC, Jean-Benoit/0000-0002-1046-2941	National Institutes of Health U01 [AI069197]; National Institutes of Health R01 [HL088134]; Office of Naval Research [N00014-08-1207]; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA023766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069197] Funding Source: NIH RePORTER	National Institutes of Health U01; National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health U01 (#AI069197) to KCH, National Institutes of Health R01 (#HL088134) to KCH (http://grants.nih.gov/grants/funding/ funding_program.htm). The NMDP reference KIR typing and samples were supported by funding from the Office of Naval Research grant N00014-08-1207. The funders had no role in study design, data collection and and analysis, decision to publish, or preparation of the manuscript.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bonaparte MI, 2004, BLOOD, V104, P2087, DOI 10.1182/blood-2004-02-0696; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Gagne K, 2013, EUR J IMMUNOL, V43, P1085, DOI 10.1002/eji.201243007; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; Halfpenny IA, 2004, HUM IMMUNOL, V65, P602, DOI 10.1016/j.humimm.2004.03.003; Hollenbach JA, 2009, IMMUNOGENETICS, V61, P663, DOI 10.1007/s00251-009-0396-5; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Jiang W, 2012, GENOME RES, V22, P1845, DOI 10.1101/gr.137976.112; KEATING PJ, 1995, BRIT J CANCER, V72, P405, DOI 10.1038/bjc.1995.346; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lebedeva TV, 2007, HUM IMMUNOL, V68, P789, DOI 10.1016/j.humimm.2007.07.002; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2003, J IMMUNOL, V171, P2192, DOI 10.4049/jimmunol.171.5.2192; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; O'Connor GM, 2007, J IMMUNOL, V178, P235, DOI 10.4049/jimmunol.178.1.235; O'Connor GM, 2014, J IMMUNOL, V192, P2875, DOI 10.4049/jimmunol.1303142; O'Connor GM, 2013, CRIT REV IMMUNOL, V33, P203, DOI 10.1615/CritRevImmunol.2013007409; Pando MJ, 2003, J IMMUNOL, V171, P6640, DOI 10.4049/jimmunol.171.12.6640; Parham P, 2011, J IMMUNOL, V187, P11, DOI 10.4049/jimmunol.0902332; Pascal V, 2007, J IMMUNOL, V179, P1625, DOI 10.4049/jimmunol.179.3.1625; Ruggeri L, 2007, BLOOD, V110, P433, DOI 10.1182/blood-2006-07-038687; Sharma D, 2009, J IMMUNOL, V183, P4569, DOI 10.4049/jimmunol.0901734; Sun JY, 2008, TISSUE ANTIGENS, V72, P578, DOI 10.1111/j.1399-0039.2008.01141.x; Tarek N, 2012, J CLIN INVEST, V122, P3260, DOI 10.1172/JCI62749; Thomas R, 2008, J IMMUNOL, V180, P6743, DOI 10.4049/jimmunol.180.10.6743; Trundley A, 2007, EUR J IMMUNOL, V37, P780, DOI 10.1002/eji.200636773; Venstrom JM, 2012, NEW ENGL J MED, V367, P805, DOI 10.1056/NEJMoa1200503; Vierra-Green C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047491; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Yu J, 2007, J IMMUNOL, V179, P5977, DOI 10.4049/jimmunol.179.9.5977	34	29	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99543	10.1371/journal.pone.0099543	http://dx.doi.org/10.1371/journal.pone.0099543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919192	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000094
J	Chen, CH; Cheng, CY; Chen, YC; Sue, YM; Liu, CT; Cheng, TH; Hsu, YH; Chen, TH				Chen, Cheng-Hsien; Cheng, Chung-Yi; Chen, Yen-Cheng; Sue, Yuh-Mou; Liu, Chung-Te; Cheng, Tzu-Hurng; Hsu, Yung-Ho; Chen, Tso-Hsiao			MicroRNA-328 Inhibits Renal Tubular Cell Epithelial-to-Mesenchymal Transition by Targeting the CD44 in Pressure-Induced Renal Fibrosis	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; DIABETIC-NEPHROPATHY; CARDIAC FIBROSIS; IN-VIVO; EXPRESSION; OSTEOPONTIN; CANCER; FIBROGENESIS; HYALURONAN; GROWTH	Epithelial-mesenchymal transition (EMT) occurs in stressed tubular epithelial cells, contributing to renal fibrosis. Initial mechanisms promoting EMT are unknown. Pressure force is an important mechanism contributing to the induction and progression of renal fibrogenesis in ureteric obstruction. In our study of cultured rat renal tubular cells (NRK-52E) under 60 mmHg of pressure, we found that the epithelial marker E-cadherin decreased and mesenchymal markers, e.g., alpha-smooth muscle actin, fibronectin and Snail, increased. Pressure also induced the expression of connective tissue growth factor and transforming growth factor-beta. MicroRNA array assays showed that pressure reduced miR-328 at the initial stage of pressurization. We identified a potential target sequence of miR-328 in rat CD44 3'-untranslated regions. In contrast with the miR-328 expression, CD44 expression was up-regulated at the initial pressurization stage. We also found that miR-328 expression decreased and CD44 increased in ureteric obstruction kidneys in the animal study. CD44 siRNA transfection significantly increased E-cadherin expression and inhibited pressure-induced EMT. Both hyaluronan binding peptide pep-1 and osteopontin neutralizing antibody inhibited pressure-induced EMT. Our results suggest that miR-328-mediated CD44 transient upregulation is an important trigger of the pressure-induced EMT in renal fibrosis.	[Chen, Cheng-Hsien; Cheng, Chung-Yi; Chen, Yen-Cheng; Sue, Yuh-Mou; Liu, Chung-Te; Chen, Tso-Hsiao] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Chen, Cheng-Hsien; Hsu, Yung-Ho] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Nephrol, New Taipei City, Taiwan; [Cheng, Tzu-Hurng] China Med Univ, Dept Biol Sci & Technol, Coll Life Sci, Taichung, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; China Medical University Taiwan	Chen, TH (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.	tsohsiao@yahoo.com.tw			Taiwan National Science Council [NSC 101-2314-B-038-018]; Wan Fang Hospital [102swf06]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Wan Fang Hospital	This work was supported by grants from the Taiwan National Science Council (grant number: NSC 101-2314-B-038-018), and Wan Fang Hospital (grant number: 102swf06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Broadbelt NV, 2007, AM J PHYSIOL-RENAL, V293, pF1877, DOI 10.1152/ajprenal.00238.2007; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Chen CF, 2001, NEUROUROL URODYNAM, V20, P125, DOI 10.1002/1520-6777(2001)20:1<125::AID-NAU14>3.0.CO;2-Y; Chen CH, 2013, EUR J PHARMACOL, V700, P65, DOI 10.1016/j.ejphar.2012.12.017; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Eddy AA, 2005, PEDIATR NEPHROL, V20, P1369, DOI 10.1007/s00467-005-1995-5; Felsen D, 2003, J UROLOGY, V169, P373, DOI 10.1016/S0022-5347(05)64130-4; Garg Minal, 2013, World J Stem Cells, V5, P188, DOI 10.4252/wjsc.v5.i4.188; Graf K, 2004, HYPERTENSION, V44, P809, DOI 10.1161/01.HYP.0000148459.25908.49; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaneto H, 1999, KIDNEY INT, V56, P2137, DOI 10.1046/j.1523-1755.1999.00790.x; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim MK, 2013, INT J CLIN EXP PATHO, V6, P1747; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066356; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Lin CH, 2013, INT J MOL SCI, V14, P13266, DOI 10.3390/ijms140713266; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Marhaba R, 2004, J MOL HISTOL, V35, P211; Misseri Rosalia, 2005, Curr Urol Rep, V6, P140, DOI 10.1007/s11934-005-0083-5; Mummert ME, 2005, IMMUNOL RES, V31, P189, DOI 10.1385/IR:31:3:189; Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Naor D, 2007, ANN NY ACAD SCI, V1110, P233, DOI 10.1196/annals.1423.025; Nicholas SB, 2010, KIDNEY INT, V77, P588, DOI 10.1038/ki.2009.518; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Phillips Aled, 2007, Chang Gung Med J, V30, P2; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vaughan E Darracott Jr, 2004, J Urol, V172, P2563, DOI 10.1097/01.ju.0000144286.53562.95; Vongwiwatana A, 2005, AM J TRANSPLANT, V5, P1367, DOI 10.1111/j.1600-6143.2005.00843.x; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang S, 2008, NEPHROL DIAL TRANSPL, V23, P2167, DOI 10.1093/ndt/gfn115; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu B, 2012, J UROLOGY, V188, P1033, DOI 10.1016/j.juro.2012.05.004; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047270; Xu CG, 2013, EXP THER MED, V6, P731, DOI 10.3892/etm.2013.1197; Xu D, 2013, TRANSPL P, V45, P659, DOI 10.1016/j.transproceed.2012.02.048; Xu XT, 2012, BRIT J CANCER, V106, P1320, DOI 10.1038/bjc.2012.88; Zahradka P, 2008, CIRC RES, V102, P270, DOI 10.1161/CIRCRESAHA.107.170555; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	49	29	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99802	10.1371/journal.pone.0099802	http://dx.doi.org/10.1371/journal.pone.0099802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919189	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000112
J	Gregory, AJ; Beck, JL				Gregory, Andrew J.; Beck, Jeffrey L.			Spatial Heterogeneity in Response of Male Greater Sage-Grouse Lek Attendance to Energy Development	PLOS ONE			English	Article							WINTER HABITAT SELECTION; REGRESSION	Landscape modification due to rapidly expanding energy development, in particular oil and gas, in the westernUSA, have prompted concerns over how such developments may impact wildlife. One species of conservation concern across much of the Intermountain West is the greater sage-grouse (Centrocercusurophasianus). Sage-grouse have been petitioned for listing under provisions of the Endangered Species Act 7 times and the state of Wyoming alone represents 64% of the extant sage-grouse population in the eastern portion of their range. Consequently, the relationship between sage-grouse populations and oil and gas development in Wyoming is an important component to managing the long-term viability of this species. We used 814 leks from the Wyoming Game and Fish Department's lek survey database and well pad data from the Wyoming Oil and Gas Conservation Commission to evaluate changes in sage-grouse lek counts as a function of oil and gas development since 1991. From 1991-2011 we found that oil and gas well-pad density increased 3.6-fold across the state and was associated with a 24% decline in the number of male sage-grouse. Using a spatial and temporally structured analysis via Geographically Weighted Regression, we found a 1-to-4 year time lag between development density and lek decline. Sage-grouse also responded to development densities at multiple spatial neighborhoods surrounding leks, including broad scales of 10 km. However, sage-grouse lek counts do not always decline as a result of oil and gas development. We found similar development densities resulting in different sage-grouse lek count responses, suggesting that development density alone is insufficient to predict the impacts that oil and gas development have on sage-grouse. Finally, our analysis suggests a maximum development density of 1 well-pad within 2 km of leks to avoid measurable impacts within 1 year, and <6 well-pads within 10 km of leks to avoid delayed impacts.	[Gregory, Andrew J.] Bowling Green State Univ, Sch Earth Environm & Soc, Bowling Green, OH 43403 USA; [Beck, Jeffrey L.] Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA	University System of Ohio; Bowling Green State University; University of Wyoming	Gregory, AJ (corresponding author), Bowling Green State Univ, Sch Earth Environm & Soc, Bowling Green, OH 43403 USA.	agregor@bgsu.edu		Gregory, Andrew/0000-0003-1905-3236	Northern Arizona University; Gordon and Betty Moore Foundation; University of Wyoming	Northern Arizona University; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); University of Wyoming	The Wyoming Game and Fish Department provided funding for our study. Support for A. Gregory was provided by Northern Arizona University and a grant from the Gordon and Betty Moore Foundation. Support for J. Beck was provided by the University of Wyoming. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; American Gas Association, 2013, STAT PROF NAT GAS; American Wind Energy Association, 2013, STAT FACT SHEETS; Charlton M., 2003, GWR 3 SOFTWARE GEOGR; Charlton M., 2009, GEOGRAPHICALLY WEIGH; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cleveland WS, 1996, TECHNICAL REPORT; Connelly JW, 2011, STUD AVIAN BIOL, P53; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Doherty K. E., 2008, THESIS U MONTANA MIS; Doherty KE, 2011, STUD AVIAN BIOL, P505; Doherty KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010339; Ellis EC, 2008, ANTHROPOGENICBIOMES; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fedy BC, 2011, J WILDLIFE MANAGE, V75, P1022, DOI 10.1002/jwmg.155; Fedy BC, 2011, OECOLOGIA, V165, P915, DOI 10.1007/s00442-010-1768-0; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gamo R.S., 2013, WILDL PROF, V7, P56; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gilbert MM, 2011, J WILDLIFE MANAGE, V75, P816, DOI 10.1002/jwmg.123; Hagen C.A., 2010, T 75 N AM WILDL NAT, V75, P96; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Hess JE, 2012, J WILDLIFE MANAGE, V76, P1625, DOI 10.1002/jwmg.417; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Hornaday W.T., 1916, NEW YORK ZOOLOGICAL, V5, P179; Hurvich CM, 1998, J ROY STAT SOC B, V60, P271, DOI 10.1111/1467-9868.00125; International Energy Agency, 2008, WORLD EN OUTL 2008; JENNI DA, 1978, J WILDLIFE MANAGE, V42, P46, DOI 10.2307/3800688; Johnson DH, 2011, STUD AVIAN BIOL, P407; Long J.S., 2006, REGRESSION MODELS CA; Noss R. F., 1994, SAVING NATURES LEGAC; R Core Team, 2012, R LANG ENV STAT COMP; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Schroeder MA, 2004, CONDOR, V106, P363, DOI 10.1650/7425; Schwarz CJ, 2001, J AGR BIOL ENVIR ST, V6, P195, DOI 10.1198/108571101750524706; Taylor RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071256; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; U.S. Fish and Wildlife Service, 2010, FED REGISTER, V75, P13909; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Zimmerman D, 1999, MATH GEOL, V31, P375, DOI 10.1023/A:1007586507433	41	29	29	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e97132	10.1371/journal.pone.0097132	http://dx.doi.org/10.1371/journal.pone.0097132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918922	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000008
J	Chew, M; Rahim, AA; Ross, OB				Chew, Melvin; Rahim, Azman Abdul; Ross, Othman bin Haji			Tinggianthura alba: A New Genus and Species of Anthuridae (Isopoda, Cymothoida, Anthuroidea) from Pulau Tinggi, Johor, Malaysia with an Updated Key to the Genera of Anthuridae	PLOS ONE			English	Article							TIOMAN ARCHIPELAGO; CRUSTACEA	A new anthurid isopod from dead coral rubble and stones in the intertidal area of Pulau Tinggi, Johor, Malaysia, is described. It is placed in a new genus and species, Tinggianthura alba. Tinggianthura is characterized by: (1) subtriangular carpus shape of pereopods 4-7, (2) pereopod 1 propodus palm without prominent tooth or steps and (3) maxillipedal palp 2-articled.	[Chew, Melvin; Rahim, Azman Abdul; Ross, Othman bin Haji] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Dept Marine Sci, Bangi 43600, Selangor, Malaysia; [Rahim, Azman Abdul; Ross, Othman bin Haji] Univ Kebangsaan Malaysia, Fac Sci & Technol, Marine Ecosyst Res Ctr EKOMAR, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Rahim, AA (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Dept Marine Sci, Bangi 43600, Selangor, Malaysia.	abarahim@gmail.com	Rahim, Azman Abdul/AAJ-8832-2020	Rahim, Azman Abdul/0000-0002-8964-6638	Universiti Kebangsaan Malaysia [DIP-2012-020, GUP-2012-057]	Universiti Kebangsaan Malaysia	This work was supported by Universiti Kebangsaan Malaysia, grant numbers: DIP-2012-020 and GUP-2012-057 (www.ukm.my). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt A, 2003, INVERTEBR SYST, V17, P893, DOI 10.1071/IS02032; Muller Hans-Georg, 1993, Mitteilungen aus dem Zoologischen Museum in Berlin, V69, P19; MULLER HG, 1992, REV SUISSE ZOOL, V99, P369, DOI 10.5962/bhl.part.79835; MULLER HG, 1992, CAH BIOL MAR, V33, P179; MULLER HG, 1992, ZOOL ANZ, V228, P156; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Negoescu Ileana, 1997, Travaux du Museum National d'Histoire Naturelle "Grigore Antipa", V38, P177; Poore GCB, 2009, ZOOKEYS, P171, DOI 10.3897/zookeys.18.198; Poore GCB, 2001, CRUSTACEAN ISS, V13, P63	9	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99072	10.1371/journal.pone.0099072	http://dx.doi.org/10.1371/journal.pone.0099072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914642	gold, Green Published			2022-12-25	WOS:000340947700057
J	Hsieh, TY; Nillegoda, NB; Tyedmers, J; Bukau, B; Mogk, A; Kramer, G				Hsieh, Tzung-yang; Nillegoda, Nadinath B.; Tyedmers, Jens; Bukau, Bernd; Mogk, Axel; Kramer, Guenter			Monitoring Protein Misfolding by Site-Specific Labeling of Proteins In Vivo	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; FLUORESCENT-PROBE	Incorporating fluorescent amino acids by suppression of the TAG amber codon is a useful tool for site-specific labeling of proteins and visualizing their localization in living cells. Here we use a plasmid encoded orthogonal tRNA/aminoacyl-tRNA synthetase pair to site-specifically label firefly luciferase with the environmentally sensitive fluorescent amino acid, 3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid (ANAP) and explore the detectability of conformational changes in labeled luciferase in the yeast cytoplasm. We find that ANAP labeling efficiency is greatly increased in [PSI+] cells and show that analysis of the ANAP fluorescence emission by confocal imaging allows for tracking the thermal unfolding and aggregation of luciferase in vivo. Furthermore we demonstrate that flow cytometry can be used to study conformational changes in luciferase and chaperone-mediated refolding in quantitative terms and at the level of single cells. This experimental setup for the first time allows for the direct analysis of the folding state of a protein in living cells and may serve as valuable new tool for examining mechanisms of protein folding, misfolding and aggregation.	[Hsieh, Tzung-yang; Nillegoda, Nadinath B.; Tyedmers, Jens; Bukau, Bernd; Mogk, Axel; Kramer, Guenter] Univ Heidelberg ZMBH, Deutsch Krebsforschungszentrum DKFZ, DKFZ ZMBH Alliance, Zentrum Mol Biol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Kramer, G (corresponding author), Univ Heidelberg ZMBH, Deutsch Krebsforschungszentrum DKFZ, DKFZ ZMBH Alliance, Zentrum Mol Biol, Heidelberg, Germany.	g.kramer@zmbh.uni-heidelberg.de		Nillegoda, Nadinath/0000-0002-9980-3991; Kramer, Gunter/0000-0001-7552-8393; Bukau, Bernd/0000-0003-0521-7199	Deutsche Forschungsgemeinschaft (DFG) [SFB638]; Alexander von Humboldt Stiftung; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS)	This work was supported by the SFB638 of the Deutsche Forschungsgemeinschaft (DFG) to G.K. and B.B., a postdoc fellowship of the Alexander von Humboldt Stiftung to N.B.N. and a PhD scholarship of the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS) to T.Y.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Chatterjee A, 2013, J AM CHEM SOC, V135, P12540, DOI 10.1021/ja4059553; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Dobson Christopher M., 1998, EMBO (European Molecular Biology Organization) Journal, V17, P5251, DOI 10.1093/emboj/17.18.5251; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Lee HS, 2009, J AM CHEM SOC, V131, P12921, DOI 10.1021/ja904896s; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Sadlish H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001763; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025	18	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99395	10.1371/journal.pone.0099395	http://dx.doi.org/10.1371/journal.pone.0099395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915041	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700096
J	Woo, J; Park, H; Sung, SH; Moon, BI; Suh, H; Lim, W				Woo, Joohyun; Park, Heejung; Sung, Sun Hee; Moon, Byung-In; Suh, Hyunsuk; Lim, Woosung			Prognostic Value of Human Apurinic/Apyrimidinic Endonuclease 1 (APE1) Expression in Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; DNA-DAMAGING AGENTS; REPAIR; LOCALIZATION; HAP1; TRANSCRIPTION; APE1/REF-1; HAP1/REF-1; RESISTANCE; APE/REF-1	Human apurinic/apyrimidinic endonuclease 1 (APE1) is an essential protein for DNA base excision repair (BER) and redox regulation. The ability of cancer cells to recognize DNA damage and initiate DNA repair is an important mechanism for therapeutic resistance. Several recent studies have suggested that APE1 expression levels and/or subcellular dysregulation may be used to indicate the sensitivity of tumors to radiotherapy or chemotherapy. In this study, we assessed the prognostic significance of APE1 and differences in APE1 expression levels according to breast cancer molecular subtypes. We analyzed formalin-fixed, paraffin-embedded tumor tissue sections from 243 cases diagnosed as invasive breast cancer at Ewha Womans University Medical Center between January 2003 and December 2008. Immunohistochemistry was performed and the nuclear level of APE1 was scored by taking into account the percentage of positive cells. Medical records were reviewed to investigate clinicopathologic characteristics. We found that nuclear APE1 high-level expression (proportion >= 50%) in breast cancer showed a tendency towards unfavorable prognosis regarding disease-free survival (p = 0.093). However, there was no significant difference in overall survival between low and high-level expression groups (p = 0.294). Interestingly, within the Ki-67 low-level expression group, APE1 low-level expression was significantly associated with poor overall survival (p = 0.007). A significant positive correlation was observed between APE1 nuclear expression and estrogen receptor status (75.7% vs. 59.7%, p = 0.022). Also, the luminal A subtype was the most commonly observed breast cancer subtype in the APE1 high-level expression group (61.6% vs. 45.2%, p = 0.000). This study suggests that APE1 expression may be associated with breast cancer prognosis. In particular, its role as a prognostic factor would be significant for breast cancers with a low Ki-67 proliferation index. It is proposed that nuclear APE1 may be a novel target in breast cancer with a low proliferation rate to obtain better outcome.	[Woo, Joohyun; Moon, Byung-In; Lim, Woosung] Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Surg, Seoul, South Korea; [Park, Heejung; Sung, Sun Hee] Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Pathol, Seoul, South Korea; [Suh, Hyunsuk] Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Plast Surg, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Lim, W (corresponding author), Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Surg, Seoul, South Korea.	limw@ewha.ac.kr			Ewha Womans University Research Grant	Ewha Womans University Research Grant	This work was supported by a 2010 Ewha Womans University Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar A, 2010, BRIT J CANCER, V102, P704, DOI 10.1038/sj.bjc.6605541; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Curtis CD, 2009, MOL ENDOCRINOL, V23, P1346, DOI 10.1210/me.2009-0093; Di Maso V, 2007, MOL MED, V13, P89, DOI 10.2119/2006-00084.DiMaso; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hayashi S, 1997, NUCLEIC ACIDS RES, V25, P4035, DOI 10.1093/nar/25.20.4035; Kakolyris S, 1998, BRIT J CANCER, V77, P1169, DOI 10.1038/bjc.1998.194; Kakolyris S, 1999, J PATHOL, V189, P351, DOI 10.1002/(SICI)1096-9896(199911)189:3<351::AID-PATH435>3.0.CO;2-1; Koukourakis MI, 2001, INT J RADIAT ONCOL, V50, P27, DOI 10.1016/S0360-3016(00)01561-3; Li M, 2013, HUMAN APURINIC APYRI, V1; Likhite VS, 2004, J BIOL CHEM, V279, P16875, DOI 10.1074/jbc.M313155200; Moore DH, 2000, CLIN CANCER RES, V6, P602; Poletto M, 2012, BIOCHEM BIOPH RES CO, V424, P34, DOI 10.1016/j.bbrc.2012.06.039; Puglisi F, 2002, ONCOL REP, V9, P11; REMMELE W, 1987, PATHOLOGE, V8, P138; Robertson KA, 2001, CANCER RES, V61, P2220; ROBSON CN, 1992, NUCLEIC ACIDS RES, V20, P4417, DOI 10.1093/nar/20.17.4417; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Schultz-Norton JR, 2006, MOL ENDOCRINOL, V20, P1982, DOI 10.1210/me.2006-0006; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; WALKER LJ, 1994, NUCLEIC ACIDS RES, V22, P4884, DOI 10.1093/nar/22.23.4884; Wang D, 2004, MOL CANCER THER, V3, P679; Wang D, 2009, LUNG CANCER, V66, P298, DOI 10.1016/j.lungcan.2009.02.019; Webster KA, 2001, ANTIOXID REDOX SIGN, V3, P535, DOI 10.1089/15230860152542916; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23	25	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99528	10.1371/journal.pone.0099528	http://dx.doi.org/10.1371/journal.pone.0099528			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914806	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700112
J	Wu, JS; Kao, EF; Lee, CN				Wu, Jain-Shing; Kao, E-Fong; Lee, Chung-Nan			Discovering Hidden Connections among Diseases, Genes and Drugs Based on Microarray Expression Profiles with Negative-Term Filtering	PLOS ONE			English	Article							THYMIDINE PHOSPHORYLASE; GEFITINIB; INHIBITOR; APOPTOSIS; CANCER; DIFFERENTIATION; COMBINATION; PREDICTION; LYMPHOMA; TOOL	Microarrays based on gene expression profiles (GEPs) can be tailored specifically for a variety of topics to provide a precise and efficient means with which to discover hidden information. This study proposes a novel means of employing existing GEPs to reveal hidden relationships among diseases, genes, and drugs within a rich biomedical database, PubMed. Unlike the co-occurrence method, which considers only the appearance of keywords, the proposed method also takes into account negative relationships and non-relationships among keywords, the importance of which has been demonstrated in previous studies. Three scenarios were conducted to verify the efficacy of the proposed method. In Scenario 1, disease and drug GEPs (disease: lymphoma cancer, lymph node cancer, and drug: cyclophosphamide) were used to obtain lists of disease-and drug-related genes. Fifteen hidden connections were identified between the diseases and the drug. In Scenario 2, we adopted different diseases and drug GEPs (disease: AML-ALL dataset and drug: Gefitinib) to obtain lists of important diseases and drug-related genes. In this case, ten hidden connections were identified. In Scenario 3, we obtained a list of disease-related genes from the disease-related GEP (liver cancer) and the drug (Capecitabine) on the PharmGKB website, resulting in twenty-two hidden connections. Experimental results demonstrate the efficacy of the proposed method in uncovering hidden connections among diseases, genes, and drugs. Following implementation of the weight function in the proposed method, a large number of the documents obtained in each of the scenarios were judged to be related: 834 of 4028 documents, 789 of 1216 documents, and 1928 of 3791 documents in Scenarios 1, 2, and 3, respectively. The negative-term filtering scheme also uncovered a large number of negative relationships as well as non-relationships among these connections: 97 of 834, 38 of 789, and 202 of 1928 in Scenarios 1, 2, and 3, respectively.	[Wu, Jain-Shing; Lee, Chung-Nan] Natl Sun Yat Sen Univ, Dept Comp Sci & Engn, Kaohsiung 80424, Taiwan; [Kao, E-Fong; Lee, Chung-Nan] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan	National Sun Yat Sen University; Kaohsiung Medical University	Lee, CN (corresponding author), Natl Sun Yat Sen Univ, Dept Comp Sci & Engn, Kaohsiung 80424, Taiwan.	cnlee@mail.cse.nsysu.edu.tw	Wu, JainShing/AAG-1828-2019	Wu, JainShing/0000-0002-4856-7423; Kao, E-Fong/0000-0003-4051-9651				Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Buyko Ekaterina, 2009, BIONLP 09 SHARED TAS; BYRNE JA, 1993, HUM GENET, V91, P275; Chang GC, 2008, EUR J PHARMACOL, V600, P37, DOI 10.1016/j.ejphar.2008.10.024; Chen X, 2004, MODERN PATHOL, V17, P1198, DOI 10.1038/modpathol.3800167; Eickelberg O, 2001, FASEB J, V15, P797, DOI 10.1096/fj.00-0233com; Ezaki Takahiro, 2005, Int J Clin Oncol, V10, P171, DOI 10.1007/s10147-005-0488-7; Foster FM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2328; Frijters R, 2008, NUCLEIC ACIDS RES, V36, pW406, DOI 10.1093/nar/gkn215; Frijters R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000943; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hewett M, 2002, NUCLEIC ACIDS RES, V30, P163, DOI 10.1093/nar/30.1.163; Homayouni R, 2005, BIOINFORMATICS, V21, P104, DOI 10.1093/bioinformatics/bth464; Jari Bjorne<spacing Tapio, 2011, P BIONLP SHAR TASK 2, P183; JS Wu, 2010, CIIS LAB TECH REP 20; Kancherla RR, 2001, CANCER, V91, P463, DOI 10.1002/1097-0142(20010201)91:3<463::AID-CNCR1023>3.0.CO;2-R; Ko JC, 2011, BIOCHEM PHARMACOL, V81, P680, DOI 10.1016/j.bcp.2010.12.008; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Li J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000450; Markaverich BM, 2010, J STEROID BIOCHEM, V122, P219, DOI 10.1016/j.jsbmb.2010.06.006; McDonald R., 2005, P HUM LANG TECHN C C, P523, DOI [10.3115/1220575.1220641, DOI 10.3115/1220575.1220641]; Minagawa Y, 2001, Hum Cell, V14, P237; Nasukawa T, 2003, P 2 INT C KNOWL CAPT, P23; Noh EK, 2010, LEUKEMIA RES, V34, P1501, DOI 10.1016/j.leukres.2010.02.016; Sanchez-Graillet O, 2007, BIOINFORMATICS, V23, pI424, DOI 10.1093/bioinformatics/btm184; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Shrader M, 2007, CANCER RES, V67, P1430, DOI 10.1158/0008-5472.CAN-06-1224; Smalheiser NR, 1998, COMPUT METH PROG BIO, V57, P149, DOI 10.1016/S0169-2607(98)00033-9; Spasser MA, 1997, J AM SOC INFORM SCI, V48, P707, DOI 10.1002/(SICI)1097-4571(199708)48:8<707::AID-ASI4>3.3.CO;2-B; Stegmaier K, 2005, BLOOD, V106, P2841, DOI 10.1182/blood-2005-02-0488; Swanson D. R., 2001, B AM SOC INFORM SCI, V27, P12; SWANSON DR, 1986, LIBR QUART, V56, P103, DOI 10.1086/601720; Tomiuk S, 2001, Brief Bioinform, V2, P329, DOI 10.1093/bib/2.4.329; Xiao YS, 2004, J CANCER RES CLIN, V130, P546, DOI 10.1007/s00432-004-0565-8; Yu X, 2011, DNA CELL BIOL, V30, P777, DOI 10.1089/dna.2011.1223; Zhang X, 2010, CANCER SCI, V101, P2163, DOI 10.1111/j.1349-7006.2010.01664.x	36	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98826	10.1371/journal.pone.0098826	http://dx.doi.org/10.1371/journal.pone.0098826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915461	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700036
J	Yamada-Fowler, N; Fredrikson, M; Soderkvist, P				Yamada-Fowler, Naomi; Fredrikson, Mats; Soderkvist, Peter			Caffeine Interaction with Glutamate Receptor Gene GRIN2A: Parkinson's Disease in Swedish Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ADENOSINE RECEPTORS; RISK-FACTORS; CANCER-RISK; COFFEE; LOCI; MAPT; POLYMORPHISM; REPLICATION; CONSUMPTION	A complex interplay between genetic and environmental factors is thought to be involved in the etiology of Parkinson's disease (PD). A recent genome-wide association and interaction study (GWAIS) identified GRIN2A, which encodes an NMDA-glutamate-receptor subunit involved in brain's excitatory neurotransmission, as a PD genetic modifier in inverse association with caffeine intake. Here in, we attempted to replicate the reported association of a single nucleotide polymorphism, GRIN2A_rs4998386, and its interaction with caffeine intake with PD in patient-control study in an ethnically homogenous population in southeastern Sweden, as consistent and independent genetic association studies are the gold standard for the validation of genome-wide association studies. All the subjects (193 sporadic PD patients and 377 controls) were genotyped, and the caffeine intake data was obtained by questionnaire. We observed an association between rs4998386 and PD with odds ratio (OR) of 0.61, 95% confidence intervals (CI) of 0.39-0.96, p = 0.03, under a model excluding rare TT allele. There was also a strong significance in joint effects of gene and caffeine on PD risk (TC heavy caffeine vs. CC light caffeine: OR = 0.38, 95% CI = [0.20-0.70], p = 0.002) and gene-caffeine interaction (OR = 0.998, 95% CI = [0.991-0.999], p<0.001). Overall, our results are in support of the findings of the GWAIS and provided additional evidence indicating PD protective effects of coffee drinking/caffeine intake as well as the interaction with glutamate receptor genotypes.	[Yamada-Fowler, Naomi; Soderkvist, Peter] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden; [Fredrikson, Mats] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Occupat & Environm Med, Linkoping, Sweden	Linkoping University; Linkoping University	Yamada-Fowler, N (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden.	naomi.yamada@liu.se			Foundation for Parkinson's Research at Linkoping University, Sweden (Stiftelsen for Parkinsonforskning) [20110525]	Foundation for Parkinson's Research at Linkoping University, Sweden (Stiftelsen for Parkinsonforskning)	This study was funded by the Foundation for Parkinson's Research at Linkoping University, Sweden (Stiftelsen for Parkinsonforskning, 20110525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeck CR, 2005, NEUROPHARMACOLOGY, V49, P17, DOI 10.1016/j.neuropharm.2005.01.024; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gelber RP, 2011, J ALZHEIMERS DIS, V23, P607, DOI 10.3233/JAD-2010-101428; Hallstrom H, 2006, OSTEOPOROSIS INT, V17, P1055, DOI 10.1007/s00198-006-0109-y; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Itokawa M, 2003, NEUROSCI LETT, V345, P53, DOI 10.1016/S0304-3940(03)00501-9; Iwayama-Shigeno Y, 2005, NEUROSCI LETT, V378, P102, DOI 10.1016/j.neulet.2004.12.013; Larsson SC, 2006, INT J CANCER, V119, P2186, DOI 10.1002/ijc.22105; Mata IF, 2011, MOVEMENT DISORD, V26, P819, DOI 10.1002/mds.23642; Saft Carsten, 2011, PLoS Curr, V3, pRRN1247, DOI 10.1371/currents.RRN1247; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sharma M, 2012, NEUROLOGY, V79, P659, DOI 10.1212/WNL.0b013e318264e353; Turic D, 2004, MOL PSYCHIATR, V9, P169, DOI 10.1038/sj.mp.4001387; Winkler S, 2007, EUR J HUM GENET, V15, P1163, DOI 10.1038/sj.ejhg.5201901; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6	21	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99294	10.1371/journal.pone.0099294	http://dx.doi.org/10.1371/journal.pone.0099294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915238	Green Submitted, gold, Green Published			2022-12-25	WOS:000340947700080
J	Kitazoe, Y; Tanaka, M				Kitazoe, Yasuhiro; Tanaka, Masashi			Evolution of Mitochondrial Power in Vertebrate Metazoans	PLOS ONE			English	Article							RESPIRATORY COMPLEX I; CYTOCHROME-C-OXIDASE; MULTIDIMENSIONAL VECTOR-SPACE; MEMBRANE-PROTEINS; PHYLOGENY; LONGEVITY; CYSTEINE; GENOME; ENERGETICS; THREONINE	Background: Basal metabolic rate (BMR) has a very strong body-mass (M) dependence in an individual animal group, and BMR per unit mass (msBMR) converges on a markedly narrow range even across major taxonomic groups. However, it is here a basic question in metazoan biology how much BMR per unit mitochondrion (mtBMR) changes, and then whether mtBMR can be related to the original molecular mechanism of action of mt-encoded membrane proteins (MMPs) playing a central role in cellular energy production. Methodology/Principal Findings: Analyzing variations of amino-acid compositions of MMPs across 13 metazoan animal groups, incorporating 2022 sequences, we found a strong inverse correlation between Ser/Thr composition (STC) and hydrophobicity (HYD). A majority of animal groups showed an evolutionary pathway of a gradual increase in HYD and decrease in STC, whereas only the deuterostome lineage revealed a rapid decrease in HYD and increase in STC. The strongest correlations appeared in 5 large subunits (ND4, ND5, ND2, CO1, and CO3) undergoing dynamic conformational changes for the proton-pumping function. The pathway of the majority groups is well understood as reflecting natural selection to reduce mtBMR, since simply raising HYD in MMPs (surrounded by the lipid bilayer) weakens their mobility and strengthens their stability. On the other hand, the marked decrease in HYD of the deuterostome elevates mtBMR, but is accompanied with their instability heightening a turnover rate of mitochondria and then cells. Interestingly, cooperative networks of interhelical hydrogen-bonds between motifs involving Ser and Thr residues can enhance MMP stability. Conclusion/Significance: This stability enhancement lowers turnover rates of mitochondria/cells and may prolong even longevity, and was indeed founded by strong positive correlations of STC with both mtBMR and longevity. The lowest HYD and highest STC in Aves and Mammals are congruent with their very high mtBMR and long longevity.	[Kitazoe, Yasuhiro] Kochi Med Sch, Ctr Med Informat Sci, Nankoku, Kochi, Japan; [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Tokyo, Japan	Kochi University; Tokyo Metropolitan Institute of Gerontology	Kitazoe, Y (corresponding author), Kochi Med Sch, Ctr Med Informat Sci, Nankoku, Kochi, Japan.	kitazoeyasuhiro@yahoo.co.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [A-22240072, B-21390459, C-21590411]; Ministry of Health, Labor, and Welfare of Japan [23-016, 23-116, 24-005]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (A-22240072 B-21390459 and C-21590411 to M.T.) by Grants-in-Aid for Research on Intractable Diseases (Mitochondrial Disorders) from the Ministry of Health, Labor, and Welfare of Japan (23-016, 23-116 and 24-005 to M.T.) and by grants for scientific research from the Takeda Science Foundation (to M.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; COWAN R, 1990, Peptide Research, V3, P75; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012; Hildebrand PW, 2008, BIOPHYS J, V94, P1945, DOI 10.1529/biophysj.107.110395; Jobson RW, 2010, MITOCHONDRION, V10, P540, DOI 10.1016/j.mito.2010.05.013; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kitazoe Y, 2005, MOL BIOL EVOL, V22, P704, DOI 10.1093/molbev/msi051; Kitazoe Y, 2001, MOL BIOL EVOL, V18, P812, DOI 10.1093/oxfordjournals.molbev.a003863; Kitazoe Y, 2011, GENOME BIOL EVOL, V3, P1233, DOI 10.1093/gbe/evr079; Kitazoe Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003343; Lane N., 2005, POWER SEX SUICIDE MI; Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051; Lane N, 2011, SCIENCE, V334, P184, DOI 10.1126/science.1214012; Lane N, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-35; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Lunzer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001162; Maina JN, 2000, J EXP BIOL, V203, P3045; Makarieva AM, 2008, P NATL ACAD SCI USA, V105, P16994, DOI 10.1073/pnas.0802148105; Marechal A, 2012, BBA-BIOENERGETICS, V1817, P620, DOI 10.1016/j.bbabio.2011.08.011; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Moosmann B, 2008, AGING CELL, V7, P32, DOI 10.1111/j.1474-9726.2007.00349.x; Moosmann B, 2011, EXP GERONTOL, V46, P164, DOI 10.1016/j.exger.2010.08.034; Mourier A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001129; Owen RJ, 2014, NATURE, V505, P169; Porter RK, 2001, CELL MOL LIFE SCI, V58, P815, DOI 10.1007/PL00000902; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schindeldecker M, 2011, MECH AGEING DEV, V132, P171, DOI 10.1016/j.mad.2011.03.002; Schmitz J, 2002, MOL BIOL EVOL, V19, P544, DOI 10.1093/oxfordjournals.molbev.a004110; Suarez RK, 1999, J EXP ZOOL, V284, P1, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;1::AID-JEZ1&gt;3.0.CO;2-P; Suarez RK, 1998, J EXP BIOL, V201, P1065; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Yamashita T, 2012, J AM CHEM SOC, V134, P1147, DOI 10.1021/ja209176e	42	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98188	10.1371/journal.pone.0098188	http://dx.doi.org/10.1371/journal.pone.0098188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911874	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600128
J	Wang, JM; Du, J; Jin, Q				Wang, Jianmin; Du, Jiang; Jin, Qi			Class I ADP-Ribosylation Factors Are Involved in Enterovirus 71 Replication	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; NUCLEOTIDE EXCHANGE FACTORS; CELLULAR-PROTEIN SECRETION; BREFELDIN-A; ENDOPLASMIC-RETICULUM; POLIOVIRUS INFECTION; MEMBRANE ASSOCIATION; 3A PROTEINS; ARF FAMILY; RNA	Enterovirus 71 is one of the major causative agents of hand, foot, and mouth disease in infants and children. Replication of enterovirus 71 depends on host cellular factors. The viral replication complex is formed in novel, cytoplasmic, vesicular compartments. It has not been elucidated which cellular pathways are hijacked by the virus to create these vesicles. Here, we investigated whether proteins associated with the cellular secretory pathway were involved in enterovirus 71 replication. We used a loss-of-function assay, based on small interfering RNA. We showed that enterovirus 71 RNA replication was dependent on the activity of Class I ADP-ribosylation factors. Simultaneous depletion of ADP-ribosylation factors 1 and 3, but not three others, inhibited viral replication in cells. We also demonstrated with various techniques that the brefeldin-A-sensitive guanidine nucleotide exchange factor, GBF1, was critically important for enterovirus 71 replication. Our results suggested that enterovirus 71 replication depended on GBF1-mediated activation of Class I ADP-ribosylation factors. These results revealed a connection between enterovirus 71 replication and the cellular secretory pathway; this pathway may represent a novel target for antiviral therapies.	[Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jin, Q (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	zdsys@vip.sina.com	wang, jian/GVS-0711-2022		National Natural Science Foundation of China [31300154]; National Science and Technology Major Project of China [2011ZX10004-001, 2013ZX10004-101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China	This work was supported by the National Natural Science Foundation of China (No. 31300154) and National Science and Technology Major Project of China (Project No. 2011ZX10004-001 and No. 2013ZX10004-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2011, J VIROL, V85, P2364, DOI 10.1128/JVI.02249-10; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Belov GA, 2005, J VIROL, V79, P7207, DOI 10.1128/JVI.79.11.7207-7216.2005; Belov GA, 2007, J VIROL, V81, P9259, DOI 10.1128/JVI.00840-07; Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06; Belov GA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000216; BIENZ K, 1992, J VIROL, V66, P2740, DOI 10.1128/JVI.66.5.2740-2747.1992; BIENZ K, 1994, ARCH VIROL, P147; Buck KW, 1996, ADV VIRUS RES, V47, P159, DOI 10.1016/S0065-3527(08)60736-8; Choe SS, 2005, VIROLOGY, V337, P18, DOI 10.1016/j.virol.2005.03.036; Cuconati A, 1998, J VIROL, V72, P6456, DOI 10.1128/JVI.72.8.6456-6464.1998; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DOEDENS J, 1994, ARCH VIROL, P159; DOEDENS JR, 1995, EMBO J, V14, P894, DOI 10.1002/j.1460-2075.1995.tb07071.x; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Egger D, 2005, J GEN VIROL, V86, P707, DOI 10.1099/vir.0.80442-0; Gazina EV, 2002, J VIROL, V76, P11113, DOI 10.1128/JVI.76.21.11113-11122.2002; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Hyodo K, 2013, J VIROL, V87, P163, DOI 10.1128/JVI.02383-12; IRURZUN A, 1992, VIROLOGY, V191, P166, DOI 10.1016/0042-6822(92)90178-R; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Kudelko M, 2012, J BIOL CHEM, V287, P767, DOI 10.1074/jbc.M111.270579; Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Liao Hung-Tsai, 2001, Acta Paediatrica Taiwanica, V42, P27; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Manolea F, 2010, MOL BIOL CELL, V21, P1836, DOI 10.1091/mbc.E10-01-0016; MAYNELL LA, 1992, J VIROL, V66, P1985, DOI 10.1128/JVI.66.4.1985-1994.1992; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popoff V, 2011, J BIOL CHEM, V286, P35634, DOI 10.1074/jbc.M111.261800; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Rust RC, 2001, J VIROL, V75, P9808, DOI 10.1128/JVI.75.20.9808-9818.2001; Santiago-Tirado FH, 2011, TRENDS CELL BIOL, V21, P515, DOI 10.1016/j.tcb.2011.05.005; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038035; Wessels E, 2005, J VIROL, V79, P5163, DOI 10.1128/JVI.79.8.5163-5173.2005; Wessels E, 2006, J VIROL, V80, P11852, DOI 10.1128/JVI.01225-06; Wessels E, 2006, DEV CELL, V11, P191, DOI 10.1016/j.devcel.2006.06.005; Zhang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032135	45	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99768	10.1371/journal.pone.0099768	http://dx.doi.org/10.1371/journal.pone.0099768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911624	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600116
J	Stojanovski, BM; Hunter, GA; Jahn, M; Jahn, D; Ferreira, GC				Stojanovski, Bosko M.; Hunter, Gregory A.; Jahn, Martina; Jahn, Dieter; Ferreira, Gloria C.			Unstable Reaction Intermediates and Hysteresis during the Catalytic Cycle of 5-Aminolevulinate Synthase IMPLICATIONS FROM USING PSEUDO AND ALTERNATE SUBSTRATES AND A PROMISCUOUS ENZYME VARIANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOLEVULINIC-ACID SYNTHASE; PHOSPHATE COFACTOR-BINDING; REACTION-MECHANISM; HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; 8-AMINO-7-OXONONANOATE SYNTHASE; RHODOPSEUDOMONAS-SPHEROIDES; SERINE PALMITOYLTRANSFERASE; BIOTIN BIOSYNTHESIS; CRYSTAL-STRUCTURE	5-Aminolevulinate (ALA), an essential metabolite in all heme-synthesizing organisms, results from the pyridoxal 5'-phosphate (PLP)-dependent enzymatic condensation of glycine with succinyl-CoA in non-plant eukaryotes and alpha-proteobacteria. The predicted chemical mechanism of this ALA synthase (ALAS)-catalyzed reaction includes a short-lived glycine quinonoid intermediate and an unstable 2-amino-3-ketoadipate intermediate. Using liquid chromatography coupled with tandem mass spectrometry to analyze the products from the reaction of murine erythroid ALAS (mALAS2) with O-methylglycine and succinyl-CoA, we directly identified the chemical nature of the inherently unstable 2-amino-3-ketoadipate intermediate, which predicates the glycine quinonoid species as its precursor. With stopped-flow absorption spectroscopy, we detected and confirmed the formation of the quinonoid intermediate upon reacting glycine with ALAS. Significantly, in the absence of the succinyl-CoA substrate, the external aldimine predominates over the glycine quinonoid intermediate. When instead of glycine, L-serine was reacted with ALAS, a lag phase was observed in the progress curve for the L-serine external aldimine formation, indicating a hysteretic behavior in ALAS. Hysteresis was not detected in the T148A-catalyzed L-serine external aldimine formation. These results with T148A, a mALAS2 variant, which, in contrast to wild-type mALAS2, is active with L-serine, suggest that active site Thr-148 modulates ALAS strict amino acid substrate specificity. The rate of ALA release is also controlled by a hysteretic kinetic mechanism (observed as a lag in the ALA external aldimine formation progress curve), consistent with conformational changes governing the dissociation of ALA from ALAS.	[Stojanovski, Bosko M.; Hunter, Gregory A.; Ferreira, Gloria C.] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33612 USA; [Jahn, Martina; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany	State University System of Florida; University of South Florida; Braunschweig University of Technology	Ferreira, GC (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, MDC 7, Tampa, FL 33612 USA.	gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217; Jahn, Dieter/0000-0002-4064-9205	National Institutes of Health [GM080270]; American Heart Association [10GRNT4300073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Grant GM080270 and the American Heart Association Greater SE Affiliate Grant 10GRNT4300073, (to G.C.F.).	ABBOUD MM, 1974, J CHEM SOC CHEM COMM, P643, DOI 10.1039/c39740000643; AKHTAR M, 1968, CHEM COMMUN, P1691, DOI 10.1039/c19680001691; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Bottomley SS, 2004, WINTROBES CLIN HEMAT, P1011; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; FERREIRA GC, 1993, PROTEIN SCI, V2, P1959, DOI 10.1002/pro.5560021117; FERREIRA GC, 1993, J BIOL CHEM, V268, P584; Fratz E. J., 2013, HDB PORPHYRIN SCI, P1; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; GIBSON KD, 1958, BIOCHEM J, V70, P71, DOI 10.1042/bj0700071; GONG J, 1995, BIOCHEMISTRY-US, V34, P1678, DOI 10.1021/bi00005a024; Gong J, 1996, BIOCHEMISTRY-US, V35, P14109, DOI 10.1021/bi961296h; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; HUNTER GA, 1995, ANAL BIOCHEM, V226, P221, DOI 10.1006/abio.1995.1217; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; Hunter GA, 2011, BBA-PROTEINS PROTEOM, V1814, P1467, DOI 10.1016/j.bbapap.2010.12.015; Ikushiro H, 2011, BBA-PROTEINS PROTEOM, V1814, P1474, DOI 10.1016/j.bbapap.2011.02.005; Jahan N, 2009, J MOL BIOL, V392, P763, DOI 10.1016/j.jmb.2009.07.042; Kaufholz AL, 2013, BIOCHEM J, V451, P205, DOI 10.1042/BJ20121041; Kerbarh O, 2006, CHEM COMMUN, P60, DOI 10.1039/b511837a; KIKUCHI G, 1958, J BIOL CHEM, V233, P1214; LAGHAI A, 1977, BIOCHEM SOC T, V5, P299, DOI 10.1042/bst0050299; Lendrihas T, 2010, J BIOL CHEM, V285, P13704, DOI 10.1074/jbc.M109.074237; Lendrihas T, 2009, PROTEIN SCI, V18, P1847, DOI 10.1002/pro.195; Li JB, 2008, MOLECULES, V13, P1111, DOI 10.3390/molecules13051111; Mann S, 2011, BBA-PROTEINS PROTEOM, V1814, P1459, DOI 10.1016/j.bbapap.2010.12.004; MARCUS JP, 1993, BIOCHEM BIOPH RES CO, V190, P1066, DOI 10.1006/bbrc.1993.1157; NANDI DL, 1978, J BIOL CHEM, V253, P8872; Ploux O, 1996, EUR J BIOCHEM, V236, P301, DOI 10.1111/j.1432-1033.1996.00301.x; Raman MCC, 2009, J BIOL CHEM, V284, P17328, DOI 10.1074/jbc.M109.008680; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Shoolingin-Jordan PM, 2003, BBA-PROTEINS PROTEOM, V1647, P361, DOI 10.1016/S1570-9639(03)00095-5; Spirig T, 2008, J BIOL CHEM, V283, P18113, DOI 10.1074/jbc.M801929200; Tan DW, 1996, BIOCHEMISTRY-US, V35, P8934, DOI 10.1021/bi952918m; Tan DW, 1998, BIOCHEMISTRY-US, V37, P1478, DOI 10.1021/bi971928f; UMANOFF H, 1988, J BACTERIOL, V170, P4969, DOI 10.1128/jb.170.10.4969-4971.1988; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; ZAMAN Z, 1973, BIOCHEM J, V135, P257, DOI 10.1042/bj1350257; Zhang JS, 2002, J BIOL CHEM, V277, P44660, DOI 10.1074/jbc.M203584200	42	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22915	22925		10.1074/jbc.M114.574731	http://dx.doi.org/10.1074/jbc.M114.574731			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24920668	hybrid, Green Published			2022-12-25	WOS:000341017200032
J	Liang, YJ; Gao, ZQ; Wang, F; Zhang, YL; Dong, YH; Liu, QS				Liang, Yajing; Gao, Zengqiang; Wang, Fei; Zhang, Yangli; Dong, Yuhui; Liu, Quansheng			Structural and Functional Characterization of Escherichia coli Toxin-Antitoxin Complex DinJ-YafQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CRYSTAL-STRUCTURE; STRESS-RESPONSE; CELL-DEATH; YOEB TOXIN; SYSTEM; MECHANISM; RIBOSOME; MAZF; STABILIZER	Toxin YafQ functions as a ribonuclease in the dinJ-yafQ toxin-antitoxin system of Escherichia coli. Antitoxin DinJ neutralizes YafQ-mediated toxicity by forming a stable protein complex. Here, crystal structures of the (DinJ)(2)-(YafQ)(2) complex and the isolated YafQ toxin have been determined. The structure of the heterotetrameric complex (DinJ)(2)-(YafQ)(2) revealed that the N-terminal region of DinJ folds into a ribbonhelix-helix motif and dimerizes for DNA recognition, and the C-terminal portion of each DinJ exclusively wraps around a YafQ molecule. Upon incorporation into the heterotetrameric complex, a conformational change of YafQ in close proximity to the catalytic site of the typical microbial ribonuclease fold was observed and validated. Mutagenesis experiments revealed that a DinJ mutant restored YafQ RNase activity in a tetramer complex in vitro but not in vivo. An electrophoretic mobility shift assay showed that one of the palindromic sequences present in the upstream intergenic region of DinJ served as a binding sequences for both the DinJ-YafQ complex and the antitoxin DinJ alone. Based on structure-guided and site-directed mutagenesis of DinJ-YafQ, we showed that two pairs of amino acids in DinJ were important for DNA binding; the R8A and K16A substitutions and the S31A and R35A substitutions in DinJ abolished the DNA binding ability of the DinJ-YafQ complex.	[Liang, Yajing] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Liang, Yajing; Gao, Zengqiang; Wang, Fei; Dong, Yuhui; Liu, Quansheng] Chinese Acad Sci, Inst High Energy Phys, Multidiscipline Res Ctr, Beijing 100049, Peoples R China; [Zhang, Yangli] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Chongqing 400016, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chongqing Medical University	Dong, YH (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Multidiscipline Res Ctr, Beijing 100049, Peoples R China.	dongyh@ihep.ac.cn; liuqsh@ihep.ac.cn		Liu, Quansheng/0000-0001-6439-1205; Dong, Yuhui/0000-0002-4422-4685; Gao, Zengqiang/0000-0002-9100-9929	National Basic Research Program of China [2012CB917201]; National Natural Science Foundation of China [31170689, 11179022]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2012CB917201 and National Natural Science Foundation of China Grants 31170689 and 11179022.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Armalyte J, 2012, J BACTERIOL, V194, P1523, DOI 10.1128/JB.06104-11; Blower TR, 2012, NUCLEIC ACIDS RES, V40, P6158, DOI 10.1093/nar/gks231; Boggild A, 2012, STRUCTURE, V20, P1641, DOI 10.1016/j.str.2012.08.017; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Chan WT, 2011, J BACTERIOL, V193, P4612, DOI 10.1128/JB.05187-11; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evdokimov A, 2009, ACTA CRYSTALLOGR D, V65, P875, DOI 10.1107/S0907444909018800; Feng S, 2013, NUCLEIC ACIDS RES, V41, P9549, DOI 10.1093/nar/gkt742; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; GOHDA K, 1994, J BIOL CHEM, V269, P17531; Han KD, 2011, J BIOL CHEM, V286, P4842, DOI 10.1074/jbc.M109.097840; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039185; Harrison JJ, 2009, ANTIMICROB AGENTS CH, V53, P2253, DOI 10.1128/AAC.00043-09; Hu Ming-Xi, 2010, Int J Microbiol, V2010, P781430, DOI 10.1155/2010/781430; Hu Y, 2012, ENVIRON MICROBIOL, V14, P669, DOI 10.1111/j.1462-2920.2011.02618.x; Hurley JM, 2011, J BIOL CHEM, V286, P14770, DOI 10.1074/jbc.M110.108969; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Motiejunaite R, 2007, FEMS MICROBIOL LETT, V268, P112, DOI 10.1111/j.1574-6968.2006.00563.x; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Schureck MA, 2014, J BIOL CHEM, V289, P1060, DOI 10.1074/jbc.M113.512095; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Takahashi Y, 2000, J BIOCHEM-TOKYO, V128, P723, DOI 10.1093/oxfordjournals.jbchem.a022807; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Unterholzner Simon J, 2013, Mob Genet Elements, V3, pe26219; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zhang F, 2012, ACTA CRYSTALLOGR F, V68, P894, DOI 10.1107/S1744309112024037; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhang YL, 2009, J BIOL CHEM, V284, P25522, DOI 10.1074/jbc.M109.036624	51	24	27	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21191	21202		10.1074/jbc.M114.559773	http://dx.doi.org/10.1074/jbc.M114.559773			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24923448	Green Published, hybrid			2022-12-25	WOS:000339396600068
J	Hu, N; Mora-Jensen, H; Theilgaard-Monch, K; Doornbos-van der Meer, B; Huitema, MG; Stegeman, CA; Heeringa, P; Kallenberg, CGM; Westra, J				Hu, Nan; Mora-Jensen, Helena; Theilgaard-Monch, Kim; Doornbos-van der Meer, Berber; Huitema, Minke G.; Stegeman, Coen A.; Heeringa, Peter; Kallenberg, Cees G. M.; Westra, Johanna			Differential Expression of Granulopoiesis Related Genes in Neutrophil Subsets Distinguished by Membrane Expression of CD177	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; WEGENERS-GRANULOMATOSIS; SURFACE EXPRESSION; PROTEINASE-3 PR3; UP-REGULATION; NB1 GP; VASCULITIS; ANTIGEN; MYELOPEROXIDASE; SPECIFICITY	Objective: Differential gene expression in CD177(+) and CD177(-) neutrophils was investigated, in order to detect possible differences in neutrophil function which could be related to the pathogenesis of ANCA-associated Vasculitides (AAV). Methods: Neutrophils were isolated from healthy controls (HC) with high, negative or bimodal CD177 expression, and sorted into CD177(+) and CD177(-) subpopulations. Total RNA was screened for expression of 24,000 probes with Illumina Ref8 Beadchips. Genes showing differential expression between CD177(+) and CD177(-) subsets in microarray analysis were reassessed using quantitative-PCR. CD177 expression on neutrophil precursors in bone marrow was analyzed using quantitative PCR and flowcytometry. Results: The proportion of CD177(+) cells increased during neutrophil maturation in bone marrow. Fold change analysis of gene expression profile of sorted CD177(+) and CD177(-) neutrophils resulted in 14 genes with fold change (fc) >3 difference in expression. Interestingly, 10 of these genes have been reported to change significantly in expression during neutrophil maturation, and most of these genes were granule protein (GP) coding genes. mRNA expression levels measured by RT-PCR of a number of these GP, and of PR3 and MPO were higher in the CD177(-) neutrophil subset in HC, however, particular granule protein amounts were comparable between CD177(+) and CD177(-) neutrophil subsets. AAV patients had higher amounts of CD177(+) neutrophils, but contrary to neutrophils from HC expression of GP-genes was increased, possibly due to activation. Conclusion: The neutrophil population can be distinguished by membrane expression of CD177 into subsets that are different in expression of GP mRNA but not in GP protein production. GP gene expression is also elevated in AAV patients, which is not explained by skewed distribution of CD177(+) and CD177(-) subsets but may be associated with neutrophil activation during on-going inflammation.	[Hu, Nan] Peking Univ, Hosp 1, Dept Med, Beijing 100871, Peoples R China; [Mora-Jensen, Helena] Univ Copenhagen, Rigshosp, Dept Hematol, Granulocyte Res Lab, DK-2100 Copenhagen, Denmark; [Theilgaard-Monch, Kim] Univ Copenhagen, Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Theilgaard-Monch, Kim] Univ Copenhagen, Biotech & Res Innovat Ctr, Copenhagen, Denmark; [Theilgaard-Monch, Kim] Lund Univ, Dept Hematol, Skane Univ Hosp, Lund, Sweden; [Doornbos-van der Meer, Berber; Huitema, Minke G.; Kallenberg, Cees G. M.; Westra, Johanna] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Stegeman, Coen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	Peking University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Lund University; Skane University Hospital; University of Groningen; University of Groningen; University of Groningen	Westra, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	johanna.westra@umcg.nl	Heeringa, Peter/A-6008-2009	Heeringa, Peter/0000-0001-8684-763X; Theilgaard-Monch, Kim/0000-0002-4239-4939; Stegeman, Coen/0000-0002-0224-0927	Novo Nordisk Fonden [NNF12OC1015986] Funding Source: researchfish; The Danish Cancer Society [R72-A4572] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)		Abdgawad M, 2010, CLIN EXP IMMUNOL, V161, P89, DOI 10.1111/j.1365-2249.2010.04154.x; Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Abdulahad WH, 2008, ARTHRITIS RHEUM-US, V58, P2196, DOI 10.1002/art.23557; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Boomsma MM, 2000, ARTHRITIS RHEUM-US, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O; Chen M, 2010, NAT REV RHEUMATOL, V6, P653, DOI 10.1038/nrrheum.2010.158; Ciavatta DJ, 2010, J CLIN INVEST, V120, P3209, DOI 10.1172/JCI40034; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; Gohring K, 2004, BRIT J HAEMATOL, V126, P252, DOI 10.1111/j.1365-2141.2004.05027.x; GOLDSCHMEDING R, 1989, J CLIN INVEST, V84, P1577, DOI 10.1172/JCI114335; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Hu N, 2009, ARTHRITIS RHEUM-US, V60, P1548, DOI 10.1002/art.24442; Jelinek J, 2007, EXP HEMATOL, V35, P1677, DOI 10.1016/j.exphem.2007.09.008; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; JENNETTE JC, 1990, BLOOD, V75, P2263; KALLENBERG CGM, 1994, KIDNEY INT, V46, P1, DOI 10.1038/ki.1994.239; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kissel K, 2002, BLOOD, V99, P4231, DOI 10.1182/blood.V99.11.4231; Matsuo K, 2000, TRANSFUSION, V40, P654, DOI 10.1046/j.1537-2995.2000.40060654.x; Meyerson HJ, 2013, AM J CLIN PATHOL, V140, P658, DOI 10.1309/AJCPDFBEBQZW1OI7; Mora-Jensen H, 2011, J LEUKOCYTE BIOL, V90, P629, DOI 10.1189/jlb.0311123; Moritz E, 2010, VOX SANG, V98, P160, DOI 10.1111/j.1423-0410.2009.01233.x; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Ohlsson S, 2004, MEDIAT INFLAMM, V13, P275, DOI 10.1080/09629350400003100; Pliyev BK, 2012, EUR J HAEMATOL, V89, P236, DOI 10.1111/j.1600-0609.2012.01817.x; Rarok AA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000028642.26222.00; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Schreiber A, 2003, J AM SOC NEPHROL, V14, P68, DOI 10.1097/01.ASN.0000040751.83734.D1; Stroncek DF, 1998, TRANSFUSION MED, V8, P119; STRONCEK DF, 1990, BLOOD, V75, P744; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; van Rossum AP, 2007, ANN RHEUM DIS, V66, P1350, DOI 10.1136/ard.2006.063230; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Witko-Sarsat V, 1999, J AM SOC NEPHROL, V10, P1224; Wolff J, 2003, BLOOD, V102, P731, DOI 10.1182/blood-2002-09-2831; Wolff JC, 2006, TRANSFUSION, V46, P132, DOI 10.1111/j.1537-2995.2005.00676.x; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Yang JJ, 2004, J AM SOC NEPHROL, V15, P2103, DOI 10.1097/01.ASN.0000135058.46193.72	38	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99671	10.1371/journal.pone.0099671	http://dx.doi.org/10.1371/journal.pone.0099671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926686	Green Published, gold, Green Submitted			2022-12-25	WOS:000338278100064
J	Habig, C; Geffers, R; Distl, O				Habig, Christin; Geffers, Robert; Distl, Ottmar			A Replication Study for Genome-Wide Gene Expression Levels in Two Layer Lines Elucidates Differentially Expressed Genes of Pathways Involved in Bone Remodeling and Immune Responsiveness	PLOS ONE			English	Article							FEATHER PECKING BEHAVIOR; MANUAL RESTRAINT; STRESS; CHICKEN; MICROARRAY; POLYMORPHISM; RESPONSES; REDUCTASE; COMT	The current replication study confirmed significant differences in gene expression profiles of the cerebrum among the two commercial layer lines Lohmann Selected Leghorn (LSL) and Lohmann Brown (LB). Microarray analyses were performed for 30 LSL and another 30 LB laying hens kept in the small group housing system Eurovent German. A total of 14,103 microarray probe sets using customized Affymetrix ChiGene-1_0-st Arrays with 20,399 probe sets were differentially expressed among the two layer lines LSL and LB (FDR adjusted P-value <0.05). An at least 2-fold change in expression levels could be observed for 388 of these probe sets. In LSL, 214 of the 388 probe sets were down- and 174 were up-regulated and vice versa for the LB layer line. Among the 174 up-regulated probe sets in LSL, we identified 51 significantly enriched Gene ontology (GO) terms of the biological process category. A total of 63 enriched GO-terms could be identified for the 214 down-regulated probe sets of the layer line LSL. We identified nine genes significantly differentially expressed between the two layer lines in both microarray experiments. These genes play a crucial role in protection of neuronal cells from oxidative stress, bone mineral density and immune response among the two layer lines LSL and LB. Thus, the different regulation of these genes may significantly contribute to phenotypic trait differences among these layer lines. In conclusion, these novel findings provide a basis for further research to improve animal welfare in laying hens and these layer lines may be of general interest as an animal model.	[Habig, Christin; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany	University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de			Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Federal Office for Agriculture and Food (BLE), Bonn, Germany [PGI 06.01 28 1-36.004-07]	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Federal Office for Agriculture and Food (BLE), Bonn, Germany	This project and CH have been supported by funds of the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) via the Federal Office for Agriculture and Food (BLE), Bonn, Germany, under the innovation support program (PGI 06.01 28 1-36.004-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berczi I, 1998, ANN NY ACAD SCI, V851, P3, DOI 10.1111/j.1749-6632.1998.tb08969.x; Bottje WG, 2012, POULTRY SCI, V91, P2576, DOI 10.3382/ps.2012-02204; Burt DW, 2007, POULTRY SCI, V86, P1460, DOI 10.1093/ps/86.7.1460; Chang MT, 2013, REPROD DOMEST ANIM, V48, P98, DOI 10.1111/j.1439-0531.2012.02038.x; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cogburn LA, 2007, POULTRY SCI, V86, P2059, DOI 10.1093/ps/86.10.2059; Dantzer R, 1997, ACTA PHYSIOL SCAND, V161, P43; DOHMS JE, 1991, VET IMMUNOL IMMUNOP, V30, P89, DOI 10.1016/0165-2427(91)90011-Z; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Glaser R, 1998, ANN NY ACAD SCI, V840, P649, DOI 10.1111/j.1749-6632.1998.tb09603.x; Gross W. B., 1993, Livestock handling and transport., P21; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Habig C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046787; Hocking PM, 2011, ANIMAL WELFARE 2011, P270; Kaminski Stanislaw, 2002, Journal of Applied Genetics, V43, P123; Kjaer JB, 1997, BRIT POULTRY SCI, V38, P333, DOI 10.1080/00071669708417999; Kjaer JB, 2000, APPL ANIM BEHAV SCI, V65, P331, DOI 10.1016/S0168-1591(99)00064-7; Korte SM, 1997, PHYSIOL BEHAV, V62, P437, DOI 10.1016/S0031-9384(97)00149-2; Korte SM, 1999, PHYSIOL BEHAV, V65, P649; Labouriau R, 2009, POULTRY SCI, V88, P2052, DOI 10.3382/ps.2009-00113; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Li CL, 2012, POULTRY SCI, V91, P3184, DOI 10.3382/ps.2012-02392; Li D, 2012, CHEM-BIOL INTERACT, V195, P25, DOI 10.1016/j.cbi.2011.09.007; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lorentzon M, 2004, J BONE MINER RES, V19, P2005, DOI 10.1359/JBMR.040909; Magnusson U, 1998, AM J VET RES, V59, P421; MAXWELL MH, 1993, WORLD POULTRY SCI J, V49, P34, DOI 10.1079/WPS19930004; McCall MN, 2012, BRIEF BIOINFORM, V13, P536, DOI 10.1093/bib/bbr072; Nie HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011990; NILES MJ, 1995, P NATL ACAD SCI USA, V92, P2884, DOI 10.1073/pnas.92.7.2884; Picklo MJ, 2001, BRAIN RES, V916, P229, DOI 10.1016/S0006-8993(01)02897-9; Rubin JB, 2002, DEVELOPMENT, V129, P2223; SCANLON PD, 1979, SCIENCE, V203, P63, DOI 10.1126/science.758679; Sheridan JF, 1998, ANN NY ACAD SCI, V840, P803, DOI 10.1111/j.1749-6632.1998.tb09618.x; Shum L, 2002, ARTHRITIS RES, V4, P94, DOI 10.1186/ar396; Stolk L, 2007, J CLIN ENDOCR METAB, V92, P3206, DOI 10.1210/jc.2006-2136; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Yao JB, 2004, PHYSIOL GENOMICS, V19, P84, DOI 10.1152/physiolgenomics.00123.2004; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	39	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98350	10.1371/journal.pone.0098350	http://dx.doi.org/10.1371/journal.pone.0098350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922511	Green Submitted, Green Published, gold			2022-12-25	WOS:000338701300009
J	Liang, Y; Zhou, YY; Zhang, JW; Rao, T; Zhou, LJ; Xing, R; Wang, Q; Fu, HX; Hao, K; Xie, L; Wang, GJ				Liang, Yan; Zhou, Yuanyuan; Zhang, Jingwei; Rao, Tai; Zhou, Lijun; Xing, Rong; Wang, Qian; Fu, Hanxu; Hao, Kun; Xie, Lin; Wang, Guangji			Pharmacokinetic Compatibility of Ginsenosides and Schisandra Lignans in Shengmai-san: From the Perspective of P-Glycoprotein	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; INTESTINAL CACO-2 CELLS; IN-VITRO; CYCLOSPORINE-A; RATS; ABSORPTION; TRANSPORT; EXTRACT; EFFLUX; INJURY	Background: Phytochemical-mediated alterations in P-glycoprotein (P-gp) activity may result in herb-drug interactions by altering drug pharmacokinetics. Shengmai-san, a traditional Chinese herbal medicine composed by Panax Ginseng, Ophiopogon Japonicus, and Schisandra Chinensis, is routinely being used for treating various coronary heart diseases. In our previous studies, Schisandra Lignans Extract (SLE) was proved as a strong P-gp inhibitor, and herein, the compatibility of Shengmai-san was studied by investigating the influence of SLE on the pharmacokinetics of the ginsenosides from the perspective of P-gp. Methodology: Pharmacokinetic experiments were firstly performed based on in vitro uptake, efflux and transport experiments in Caco-2, LLC-PK1 wild-type and MDR1-overexpressing L-MDR1 cells. During the whole experiment, digoxin, a classical P-gp substrate, was used as a positive control drug to verify the cells used are the valid models. Meanwhile, the effects of SLE on the pharmacokinetics of ginsenosides were further investigated in rats after single-dose and multi-dose of SLE. Results and Conclusions: The efflux ratios of ginsenoside Rb2, Rc, Rg2, Rg3, Rd and Rb1 were found more than 3.5 in L-MDR1 cells and can be decreased significantly by verapamil (a classical P-gp inhibitor). Contrarily, the efflux ratios of other ginsenosides (Rh1, F1, Re, and Rg1) were lower than 2.0 and not affected by verapamil. Then, the effects of SLE on the uptake and transport of ginsenosides were investigated, and SLE was found can significantly enhance the uptake and inhibit the efflux ratio of ginsenoside Rb2, Rc, Rg2, Rg3, Rd and Rb1 in Caco-2 and L-MDR1 cells. Besides, In vivo experiments showed that single-dose and multi-dose of SLE at 500 mg/kg could increase the area under the plasma concentration time curve of Rb2, Rc and Rd significantly without affecting terminal elimination half-time. In conclusion, SLE could enhance the exposure of ginsenosides Rb2, Rc, Rg2, Rg3, Rd and Rb1 significantly.	[Liang, Yan; Zhou, Yuanyuan; Zhang, Jingwei; Rao, Tai; Zhou, Lijun; Xing, Rong; Wang, Qian; Fu, Hanxu; Hao, Kun; Xie, Lin; Wang, Guangji] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Xie, L (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	jsxielin@sina.com.cn; guangjiwang@hotmail.com	Zhou, Li/GSE-4531-2022		National Nature Science Foundation [81102881, 81273589, 81374054]; Natural Science Foundation of Jiangsu Province [BK20131311]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Nature Science Foundation (81102881, 81273589, 81374054), Natural Science Foundation of Jiangsu Province (Grants BK20131311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angela PA, 2000, J NUTR, V130, P1329; Bao Hong, 2010, Chin J Cancer, V29, P937; Cao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081650; Chen CY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/703815; Fan L, 2009, XENOBIOTICA, V39, P249, DOI 10.1080/00498250802687657; Feng Y, 2006, ARTIF INTELL MED, V38, P219, DOI 10.1016/j.artmed.2006.07.005; Gnoth MJ, 2011, J PHARMACOL EXP THER, V338, P372, DOI 10.1124/jpet.111.180240; Han M, 2006, PLANTA MED, V72, P398, DOI 10.1055/s-2005-916211; Hashiguchi Y, 2013, BIOCHEM BIOPH RES CO, V439, P221, DOI 10.1016/j.bbrc.2013.08.054; Hoenders H J R, 2006, Tijdschr Psychiatr, V48, P733; Kim SW, 2003, BIOCHEM PHARMACOL, V65, P75, DOI 10.1016/S0006-2952(02)01446-6; Li LH, 2013, CHIN J NAT MEDICINES, V11, P222, DOI [10.1016/S1875-5364(13)60020-5, 10.3724/SP.J.1009.2013.00222]; Lin TX, 2009, DTSCH Z AKUPUNKT, V52, P27, DOI 10.1016/J.DZA.2009.05.008; Liu HF, 2009, DRUG METAB DISPOS, V37, P2290, DOI 10.1124/dmd.109.029819; Meng Z, 2007, BIOMED CHROMATOGR, V21, P635, DOI 10.1002/bmc.799; Mills E, 2005, THER DRUG MONIT, V27, P549, DOI 10.1097/01.ftd.0000170880.95267.90; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Seo TB, 2009, J PHARMACOL SCI, V110, P483, DOI 10.1254/jphs.09044FP; Wang J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/896467; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang SP, 2012, J ETHNOPHARMACOL, V143, P412, DOI 10.1016/j.jep.2012.07.033; Wang XJ, 2013, MOL CELL PROTEOMICS, V12, P1226, DOI 10.1074/mcp.M112.021683; Yang Z, 2012, DRUG METAB DISPOS, V40, P1538, DOI 10.1124/dmd.111.044008; Yao HT, 2008, J ETHNOPHARMACOL, V116, P49, DOI 10.1016/j.jep.2007.10.043; Yoo HH, 2007, PLANTA MED, V73, P444, DOI 10.1055/s-2007-967178; Yu CP, 2013, PHYTOMEDICINE, V20, P648, DOI 10.1016/j.phymed.2013.01.008; Zhang JM, 2013, J ETHNOPHARMACOL, V147, P128, DOI 10.1016/j.jep.2013.02.019; Zhang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035768; Zhang JZ, 2012, J ETHNOPHARMACOL, V144, P277, DOI 10.1016/j.jep.2012.09.009; Zhou SF, 2005, EUR J PHARM SCI, V24, P513, DOI 10.1016/j.ejps.2005.01.006	32	23	29	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98717	10.1371/journal.pone.0098717	http://dx.doi.org/10.1371/journal.pone.0098717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922060	gold, Green Submitted, Green Published			2022-12-25	WOS:000338701300014
J	Miller, JA; Teel, DJ; Peterson, WT; Baptista, AM				Miller, Jessica A.; Teel, David J.; Peterson, William T.; Baptista, Antonio M.			Assessing the Relative Importance of Local and Regional Processes on the Survival of a Threatened Salmon Population	PLOS ONE			English	Article							SIZE-SELECTIVE MORTALITY; JUVENILE CHINOOK SALMON; COLUMBIA RIVER; ONCORHYNCHUS-TSHAWYTSCHA; LIFE-HISTORY; FRESH-WATER; OCEAN; FISH; RECRUITMENT; CLIMATE	Research on regulatory mechanisms in biological populations often focuses on environmental covariates. An integrated approach that combines environmental indices with organismal-level information can provide additional insight on regulatory mechanisms. Survival of spring/summer Snake River Chinook salmon (Oncorhynchus tshawytscha) is consistently low whereas some adjacent populations with similar life histories experience greater survival. It is not known if populations with differential survival respond similarly during early marine residence, a critical period in the life history. Ocean collections, genetic stock identification, and otolith analyses were combined to evaluate the growth-mortality and match-mismatch hypotheses during early marine residence of spring/summer Snake River Chinook salmon. Interannual variation in juvenile attributes, including size at marine entry and marine growth rate, was compared with estimates of survival and physical and biological metrics. Multiple linear regression and multi-model inference were used to evaluate the relative importance of biological and physical metrics in explaining interannual variation in survival. There was relatively weak support for the match-mismatch hypothesis and stronger evidence for the growth-mortality hypothesis. Marine growth and size at capture were strongly, positively related to survival, a finding similar to spring Chinook salmon from the Mid-Upper Columbia River. In hindcast models, basin-scale indices (Pacific Decadal Oscillation (PDO) and the North Pacific Gyre Oscillation (NPGO)) and biological indices (juvenile salmon catch-per-unit-effort (CPUE) and a copepod community index (CCI)) accounted for substantial and similar portions of variation in survival for juvenile emigration years 1998-2008 (R-2 > 0.70). However, in forecast models for emigration years 2009-2011, there was an increasing discrepancy between predictions based on the PDO (50-448% of observed value) compared with those based on the NPGO (68-212%) or biological indices (CPUE and CCI: 83-172%). Overall, the PDO index was remarkably informative in earlier years but other basin-scale and biological indices provided more accurate indications of survival in recent years.	[Miller, Jessica A.] Oregon State Univ, Coastal Oregon Marine Expt Stn, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Teel, David J.] NOAA Fisheries, NW Fisheries Sci Ctr, Manchester, WA USA; [Peterson, William T.] NOAA Fisheries, NW Fisheries Sci Ctr, Newport, OR USA; [Baptista, Antonio M.] Oregon Hlth & Sci Univ, NSF Sci & Technol Ctr Coastal Margin Observat & P, Beaverton, OR USA	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Science Foundation (NSF); Oregon Health & Science University	Miller, JA (corresponding author), Oregon State Univ, Coastal Oregon Marine Expt Stn, Dept Fisheries & Wildlife, Newport, OR 97365 USA.	jessica.miller@oregonstate.edu		Baptista, Antonio/0000-0002-7641-5937; Miller, Jessica/0000-0002-6491-4085	Bonneville Power Administration (BPA) [00053808, 00052946/00059479]; National Science Foundation (NSF) [OCE-0424602]; National Oceanic and Atmospheric Administration's Integrated Ocean Observing System program	Bonneville Power Administration (BPA); National Science Foundation (NSF)(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration's Integrated Ocean Observing System program	This work was supported by the Bonneville Power Administration (BPA Contract No. 00053808 to Oregon State University and No. 00052946/00059479 to Oregon Health and Science University). The Virtual Columbia River is also partially supported by the National Science Foundation (NSF) (OCE-0424602) and the National Oceanic and Atmospheric Administration's Integrated Ocean Observing System program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achord S, 2011, MONITORING MIGRATION, P123; Achord Stephen, 1996, North American Journal of Fisheries Management, V16, P302, DOI 10.1577/1548-8675(1996)016<0302:UOPITP>2.3.CO;2; Anderson D.R., 2008, MODEL BASED INFERENC; ANDERSON J T, 1988, Journal of Northwest Atlantic Fishery Science, V8, P55; Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; Bailey KM, 2000, MAR ECOL PROG SER, V198, P215, DOI 10.3354/meps198215; Barnett-Johnson R, 2010, ENVIRON BIOL FISH, V89, P533, DOI 10.1007/s10641-010-9662-5; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Botsford LW, 2001, ICES J MAR SCI, V58, P1081, DOI 10.1006/jmsc.2001.1085; Budy P, 2002, N AM J FISH MANAGE, V22, P35, DOI 10.1577/1548-8675(2002)022&lt;0035:ELDMOS&gt;2.0.CO;2; Burke BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054134; Burla M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC004964; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Checkley DMJ, 1988, SCIENCE, V335, P356; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Cushing DH, 1975, MARINE ECOLOGY FISHE; DiLorenzo E, 2008, GEOPHYS RES LETT, V35, P6; Elsdon TS, 2003, MAR ECOL PROG SER, V260, P263, DOI 10.3354/meps260263; FOGARTY MJ, 1991, TRENDS ECOL EVOL, V6, P241, DOI 10.1016/0169-5347(91)90069-A; Haeseker SL, 2012, T AM FISH SOC, V141, P121, DOI 10.1080/00028487.2011.652009; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Healey M.C., 1991, PACIFIC SALMON LIFE, P313; Hickey B, 2005, CONT SHELF RES, V25, P1631, DOI 10.1016/j.csr.2005.04.010; Hooff RC, 2006, LIMNOL OCEANOGR, V51, P2607, DOI 10.4319/lo.2006.51.6.2607; Houde ED, 2008, J NW ATL FISH SCI, V41; Kalinowski S.T., 2007, ONCOR COMPUTER PROGR; Keister JE, 2011, GLOBAL CHANGE BIOL, V17, P2498, DOI 10.1111/j.1365-2486.2010.02383.x; Kent AJR, 2006, AM MINERAL, V91, P1401, DOI 10.2138/am.2006.2030; LASKER R, 1975, FISH B-NOAA, V73, P453; Lawson PW, 2004, CAN J FISH AQUAT SCI, V61, P360, DOI 10.1139/F04-003; Lehodey P, 2006, J CLIMATE, V19, P5009, DOI 10.1175/JCLI3898.1; Logerwell EA, 2003, FISH OCEANOGR, V12, P554, DOI 10.1046/j.1365-2419.2003.00238.x; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Meekan MG, 2006, MAR ECOL PROG SER, V317, P237, DOI 10.3354/meps317237; Miller JA, 2011, J EXP MAR BIOL ECOL, V405, P42, DOI 10.1016/j.jembe.2011.05.017; Miller JA, 2009, J FISH BIOL, V75, P39, DOI 10.1111/j.1095-8649.2009.02262.x; Miller JA, 2013, CAN J FISH AQUAT SCI, V70, P617, DOI 10.1139/cjfas-2012-0354; Miller JA, 2011, CAN J FISH AQUAT SCI, V68, P603, DOI [10.1139/F11-002, 10.1139/f2011-002]; Miller JA, 2010, MAR ECOL PROG SER, V408, P227, DOI 10.3354/meps08613; Morgan CA, 2003, MAR ECOL PROG SER, V249, P223, DOI 10.3354/meps249223; Myers J, 1998, NOAA TECH MEMO, P443; NEILSON JD, 1982, CAN J FISH AQUAT SCI, V39, P1340, DOI 10.1139/f82-180; Pearcy W. G., 1992, OCEAN ECOLOGY PACIFI; PETERMAN RM, 1987, SCIENCE, V235, P354, DOI 10.1126/science.235.4786.354; PETERMAN RM, 1988, CAN J FISH AQUAT SCI, V45, P8, DOI 10.1139/f88-002; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Prentice E.F., 1990, American Fisheries Society Symposium, P317; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rechisky EL, 2013, P NATL ACAD SCI USA, V110, P6883, DOI 10.1073/pnas.1219910110; Rupp DE, 2012, FISH OCEANOGR, V21, P1, DOI 10.1111/j.1365-2419.2011.00605.x; Scheuerell MD, 2009, J APPL ECOL, V46, P983, DOI 10.1111/j.1365-2664.2009.01693.x; Seeb LW, 2007, FISHERIES, V32, P540, DOI 10.1577/1548-8446(2007)32[540:DOASDD]2.0.CO;2; Shanks A, 2010, CAL COOP OCEAN FISH, V51, P106; Sogard SM, 1997, B MAR SCI, V60, P1129; Teel DJ, 2009, T AM FISH SOC, V138, P211, DOI 10.1577/T08-084.1; Tomaro LM, 2012, MAR ECOL PROG SER, V452, P237, DOI 10.3354/meps09620; Tuomikoski J, 2013, COMP SURVIVAL STUDY; Woodson LE, 2013, MAR ECOL PROG SER, V487, P163, DOI 10.3354/meps10353; Zabel RW, 2004, ECOLOGY, V85, P795, DOI 10.1890/02-0719; Zhang YL, 2008, OCEAN MODEL, V21, P71, DOI 10.1016/j.ocemod.2007.11.005; Zhang YL, 2004, CONT SHELF RES, V24, P2187, DOI 10.1016/j.csr.2004.07.021	64	21	22	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99814	10.1371/journal.pone.0099814	http://dx.doi.org/10.1371/journal.pone.0099814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924741	Green Published, gold			2022-12-25	WOS:000338701300096
J	Sanchez-Fresneda, R; Martinez-Esparza, M; Maicas, S; Arguelles, JC; Valentin, E				Sanchez-Fresneda, Ruth; Martinez-Esparza, Maria; Maicas, Sergi; Argueelles, Juan-Carlos; Valentin, Eulogio			In Candida parapsilosis the ATC1 Gene Encodes for an Acid Trehalase Involved in Trehalose Hydrolysis, Stress Resistance and Virulence	PLOS ONE			English	Article							GALLERIA-MELLONELLA; ATH1 GENE; PROTEIN; DISRUPTION; ALBICANS; EPIDEMIOLOGY; GROWTH; PHOSPHORYLASE; EVOLUTIONARY; PREDICTION	An ORF named CPAR2-208980 on contig 005809 was identified by screening a Candida parapsilosis genome data base. Its 67% identity with the acid trehalase sequence from C. albicans (ATC1) led us to designate it CpATC1. Homozygous mutants that lack acid trehalase activity were constructed by gene disruption at the two CpATC1 chromosomal alleles. Phenotypic characterization showed that atc1 Delta null cells were unable to grow on exogenous trehalose as carbon source, and also displayed higher resistance to environmental challenges, such as saline exposure (1.2 M NaCl), heat shock (42 degrees C) and both mild and severe oxidative stress (5 and 50 mM H2O2). Significant amounts of intracellular trehalose were specifically stored in response to the thermal upshift in both wild type and mutant strains. Analysis of their antioxidant activities revealed that catalase was only triggered in response to heat shock in atc1 Delta cells, whereas glutathione reductase was activated upon mild oxidative stress in wild type and reintegrant strains, and in response to the whole set of stress treatments in the homozygous mutant. Furthermore, yeast cells with double CpATC1 deletion were significantly attenuated in non-mammalian infection models, suggesting that CpATC1 is required for the pathobiology of the fungus. Our results demonstrate the involvement of CpAtc1 protein in the physiological hydrolysis of external trehalose in C. parapsilosis, where it also plays a major role in stress resistance and virulence.	[Sanchez-Fresneda, Ruth; Argueelles, Juan-Carlos] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Murcia, Spain; [Sanchez-Fresneda, Ruth; Martinez-Esparza, Maria] Univ Murcia, Fac Med, Dept Bioquim Biol Mol & Inmunol B, Murcia, Spain; [Sanchez-Fresneda, Ruth; Martinez-Esparza, Maria] Univ Murcia, Murcia, Spain; [Sanchez-Fresneda, Ruth; Valentin, Eulogio] Univ Valencia, Fac Farm, Dept Microbiol & Ecol, E-46010 Valencia, Spain; [Maicas, Sergi] Univ Valencia, Fac Biol, Dept Microbiol & Ecol, Valencia, Spain	University of Murcia; University of Murcia; University of Murcia; University of Valencia; University of Valencia	Arguelles, JC (corresponding author), Univ Murcia, Fac Biol, Dept Genet & Microbiol, Campus Espinardo, Murcia, Spain.	arguelle@um.es	Sanchez-Fresneda, Ruth/ABF-7327-2020; Maicas, Sergi/L-7462-2014; Valentin, Eulogio/K-1436-2017; Martínez-Esparza, María/R-9646-2019; Maicas, Sergi/J-6563-2019	Maicas, Sergi/0000-0003-4360-611X; Valentin, Eulogio/0000-0002-7895-9460; Martínez-Esparza, María/0000-0001-5765-8231; 	Ministerio de Economia y Competitividad, ISCIII, Spain [PI12/01797]; Cespa Servicios Urbanos de Murcia, S.A	Ministerio de Economia y Competitividad, ISCIII, Spain; Cespa Servicios Urbanos de Murcia, S.A	The experimental work has been supported by grant PI12/01797 (Ministerio de Economia y Competitividad, ISCIII, Spain). The authors are also indebted to the financial contract provided by Cespa Servicios Urbanos de Murcia, S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; Al-Bader N, 2010, INFECT IMMUN, V78, P3007, DOI 10.1128/IAI.00813-09; ALESHIN AE, 1994, J MOL BIOL, V238, P575, DOI 10.1006/jmbi.1994.1316; Alizadeh P, 1996, FEBS LETT, V391, P273, DOI 10.1016/0014-5793(96)00751-X; Almirante B, 2006, J CLIN MICROBIOL, V44, P1681, DOI 10.1128/JCM.44.5.1681-1685.2006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1996, BIOCH MOL BIOL BERLI; ARGUELLES JC, 1988, A VAN LEEUW J MICROB, V54, P555, DOI 10.1007/BF00588391; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Bates PA, 2001, PROTEINS, P39; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Burke D., 2000, METHODS YEAST GENETI; Castillo L, 2006, FUNGAL GENET BIOL, V43, P124, DOI 10.1016/j.fgb.2005.12.002; Mesa-Arango AC, 2013, MED MYCOL, V51, P461, DOI 10.3109/13693786.2012.737031; Cheema MS, 2011, MED MYCOL, V49, P202, DOI 10.3109/13693786.2010.512301; de Groot PWJ, 2012, FUNGAL GENET BIOL, V49, P173, DOI 10.1016/j.fgb.2011.12.009; dEnfert C, 1997, MOL MICROBIOL, V24, P203, DOI 10.1046/j.1365-2958.1997.3131693.x; Ding C, 2007, EUKARYOT CELL, V6, P1310, DOI 10.1128/EC.00136-07; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Fallon AM, 2001, INSECT BIOCHEM MOLEC, V31, P263, DOI 10.1016/S0965-1748(00)00146-6; Fallon John, 2012, Methods Mol Biol, V845, P469, DOI 10.1007/978-1-61779-539-8_33; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; FUJIMURA HA, 1993, BIOTECHNIQUES, V14, P538; Garcia-Rodas R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024485; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Gonzalez-Parraga P, 2003, YEAST, V20, P1161, DOI 10.1002/yea.1029; Gonzalez-Parraga P, 2011, BBA-GEN SUBJECTS, V1810, P777, DOI 10.1016/j.bbagen.2011.04.012; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hernandez J, 1999, NEW PHYTOL, V141, P241, DOI 10.1046/j.1469-8137.1999.00341.x; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ishihara R, 1997, GENE, V202, P69, DOI 10.1016/S0378-1119(97)00455-1; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim J, 1996, APPL ENVIRON MICROB, V62, P1563, DOI 10.1128/AEM.62.5.1563-1569.1996; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lobaina Rodriguez Tamara, 2010, Rev Cubana Med Trop, V62, P48; Lupetti A, 2002, J CLIN MICROBIOL, V40, P2363, DOI 10.1128/JCM.40.7.2363-2369.2002; Martinez-Esparza M, 2007, CLIN MICROBIOL INFEC, V13, P384, DOI 10.1111/j.1469-0691.2007.01663.x; Martinez-Esparza M, 2009, INT J MED MICROBIOL, V299, P453, DOI 10.1016/j.ijmm.2008.12.001; Nwaka S, 1996, FEBS LETT, V386, P235, DOI 10.1016/0014-5793(96)00450-4; Parrou JL, 2005, FEMS YEAST RES, V5, P503, DOI 10.1016/j.femsyr.2005.01.002; Pedreno Y, 2004, J BIOL CHEM, V279, P40852, DOI 10.1074/jbc.M400216200; Pedreno Y, 2007, MICROBIOL-SGM, V153, P1372, DOI 10.1099/mic.0.2006/003921-0; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Romani L, 1999, CURR OPIN MICROBIOL, V2, P363, DOI 10.1016/S1369-5274(99)80064-2; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Stam MR, 2005, CARBOHYD RES, V340, P2728, DOI 10.1016/j.carres.2005.09.018; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; van Asbeck EC, 2009, CRIT REV MICROBIOL, V35, P283, DOI 10.3109/10408410903213393; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; WEEMS JJ, 1992, CLIN INFECT DIS, V14, P756, DOI 10.1093/clinids/14.3.756; Zaragoza O, 1998, J BACTERIOL, V180, P3809, DOI 10.1128/JB.180.15.3809-3815.1998; Zaragoza O, 2002, MICROBIOL-SGM, V148, P1281, DOI 10.1099/00221287-148-5-1281	61	27	28	0	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99113	10.1371/journal.pone.0099113	http://dx.doi.org/10.1371/journal.pone.0099113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922533	gold, Green Published, Green Submitted			2022-12-25	WOS:000338701300031
J	Wang, RH; Xu, S; Liu, XY; Zhang, YY; Wang, JZ; Zhang, ZX				Wang, Ruohan; Xu, Sai; Liu, Xiangyu; Zhang, Yiyuan; Wang, Jianzhong; Zhang, Zhixiang			Thermogenesis, Flowering and the Association with Variation in Floral Odour Attractants in Magnolia sprengeri (Magnoliaceae)	PLOS ONE			English	Article							TEMPERATURE REGULATION; POLLINATION ECOLOGY; BEETLE POLLINATION; AFRICAN CYCAD; HEAT; BIOLOGY; CONES; RESPIRATION; PRECISION; RESPONSES	Magnolia sprengeri Pamp. is an ornamentally and ecologically important tree that blooms at cold temperatures in early spring. In this study, thermogenesis and variation in the chemical compounds of floral odours and insect visitation in relation to flowering cycles were studied to increase our understanding of the role of floral thermogenesis in the pollination biology of M. sprengeri. There were five distinct floral stages across the floral cycle of this species: pre-pistillate, pistillate, pre-staminate, staminate and post-staminate. Floral thermogenesis during anthesis and consisted of two distinct peaks: one at the pistillate stage and the other at the staminate stage. Insects of five families visited M. sprengeri during the floral cycle, and sap beetles (Epuraea sp., Nitidulidae) were determined to be the most effective pollinators, whereas bees (Apis cerana, Apidae) were considered to be occasional pollinators. A strong fragrance was released during thermogenesis, consisting of 18 chemical compounds. Although the relative proportions of these compounds varied at different floral stages across anthesis, linalool, 1-iodo-2-methylundecane and 2,2,6-trimethyl-6-vinyltetrahydro-2H-pyran-3-ol were dominant. Importantly, we found that the floral blends released during the pistillate and staminate stages were very similar, and coincided with flower visitation by sap beetles and the two thermogenic episodes. Based on these results, we propose that odour acts as a signal for a reward (pollen) and that an odour mimicry of staminate-stage flowers occurs during the pistillate stage.	[Wang, Ruohan; Xu, Sai; Zhang, Yiyuan; Wang, Jianzhong] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Tree Breeding,Minist Educ, Beijing, Peoples R China; [Liu, Xiangyu; Zhang, Zhixiang] Beijing Forestry Univ, Coll Nat Conservat, Lab Systemat Evolut & Biogeog Woody Plants, Beijing, Peoples R China; [Xu, Sai] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China	Beijing Forestry University; Beijing Forestry University; Tsinghua University	Zhang, ZX (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Lab Systemat Evolut & Biogeog Woody Plants, Beijing, Peoples R China.	zxzhang@bjfu.edu.cn	Xu, Sai/L-9259-2016	Xu, Sai/0000-0002-5395-4903	Fundamental Research Funds for Central Universities [YX 2014-14]; National Science Fund of China [31100450, J1103516]	Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); National Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for Central Universities (No. YX 2014-14) and the National Science Fund of China (No. 31100450 & No. J1103516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albre J, 2003, BOT J LINN SOC, V141, P205, DOI 10.1046/j.1095-8339.2003.00139.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Azuma Hiroshi, 1997, Plant Species Biology, V12, P69, DOI 10.1111/j.1442-1984.1997.tb00159.x; Azuma Hiroshi, 1999, Plant Species Biology, V14, P121, DOI 10.1046/j.1442-1984.1999.00015.x; Dieringer G, 1999, INT J PLANT SCI, V160, P64, DOI 10.1086/314099; Endress P. K., 1994, DIVERSITY EVOLUTIONA; Endress PK, 2010, PHILOS T R SOC B, V365, P411, DOI 10.1098/rstb.2009.0228; Ervik Finn, 1999, Acta Botanica Venezuelica, V22, P195; Gottsberger G, 2012, FLORA, V207, P107, DOI 10.1016/j.flora.2011.11.003; Ishida Kiyoshi, 1996, Plant Species Biology, V11, P199, DOI 10.1111/j.1442-1984.1996.tb00146.x; Kang YX, 2011, PLANT BIOSYST, V145, P906, DOI 10.1080/11263504.2011.633352; KIKUZAWA K, 1990, Plant Species Biology, V5, P255, DOI 10.1111/j.1442-1984.1990.tb00185.x; KNUTSON RM, 1974, SCIENCE, V186, P746, DOI 10.1126/science.186.4165.746; Kuchmeister Heike, 1998, Acta Amazonica, V28, P217; Kumano-Nomura Y, 2009, J PLANT RES, V122, P183, DOI 10.1007/s10265-008-0204-6; Lamprecht I, 2002, THERMOCHIM ACTA, V391, P107, DOI 10.1016/S0040-6031(02)00168-5; Li JK, 2009, ANN BOT-LONDON, V103, P1159, DOI 10.1093/aob/mcp051; Meeuse B. J. D., 1988, Sexual Plant Reproduction, V1, P3, DOI 10.1007/BF00227016; NADEL H, 1994, ENVIRON ENTOMOL, V23, P878, DOI 10.1093/ee/23.4.878; Proches S, 2009, AM J BOT, V96, P1722, DOI 10.3732/ajb.0800377; R Development Core Team, 2012, R LANG ENV STAT COMP; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Sapir Y, 2006, OECOLOGIA, V147, P53, DOI 10.1007/s00442-005-0246-6; Seymour RS, 2008, J EXP BOT, V59, P1353, DOI 10.1093/jxb/ern042; Seymour RS, 2010, FUNCT PLANT BIOL, V37, P870, DOI 10.1071/FP10039; Seymour RS, 2010, PLANTA, V231, P1291, DOI 10.1007/s00425-010-1128-7; Seymour RS, 2009, ANN BOT-LONDON, V104, P823, DOI 10.1093/aob/mcp168; Seymour RS, 2009, BIOL LETTERS, V5, P568, DOI 10.1098/rsbl.2009.0064; Seymour RS, 2000, AQUAT BOT, V67, P155, DOI 10.1016/S0304-3770(00)00087-5; Seymour RS, 2004, PLANT CELL ENVIRON, V27, P1014, DOI 10.1111/j.1365-3040.2004.01206.x; Seymour RS, 2003, NATURE, V426, P243, DOI 10.1038/426243a; Suinyuy TN, 2013, ANN BOT-LONDON, V112, P891, DOI 10.1093/aob/mct159; Takacs S, 2009, P ROY SOC B-BIOL SCI, V276, P649, DOI 10.1098/rspb.2008.0742; Terry I, 2007, SCIENCE, V318, P70, DOI 10.1126/science.1145147; THIEN LB, 1974, AM J BOT, V61, P1037, DOI 10.2307/2441921; Thien LB, 2000, INT J PLANT SCI, V161, pS225, DOI 10.1086/317575; Tomimatsu Hiroshi, 2003, Plant Species Biology, V18, P123, DOI 10.1111/j.1442-1984.2003.00090.doc.x; Wagner AM, 2008, BBA-BIOENERGETICS, V1777, P993, DOI 10.1016/j.bbabio.2008.04.001; Wang RH, 2013, TREES-STRUCT FUNCT, V27, P1755, DOI 10.1007/s00468-013-0921-x; Wang RH, 2010, FLORA, V205, P259, DOI 10.1016/j.flora.2009.04.003; Xia NH, 2008, FLORA CHINA, P48; Yasukawa S, 1992, PLANT SPEC BIOL, V7, P121	42	17	21	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99356	10.1371/journal.pone.0099356	http://dx.doi.org/10.1371/journal.pone.0099356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922537	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300052
J	Ben Haddou, T; Beni, S; Hosztafi, S; Malfacini, D; Calo, G; Schmidhammer, H; Spetea, M				Ben Haddou, Tanila; Beni, Szabolcs; Hosztafi, Sandor; Malfacini, Davide; Calo, Girolamo; Schmidhammer, Helmut; Spetea, Mariana			Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity	PLOS ONE			English	Article							IN-VITRO; DERIVATIVES; 6-AMINO	Morphine and structurally related derivatives are highly effective analgesics, and the mainstay in the medical management of moderate to severe pain. Pharmacological actions of opioid analgesics are primarily mediated through agonism at the m opioid peptide (MOP) receptor, a G protein-coupled receptor. Position 17 in morphine has been one of the most manipulated sites on the scaffold and intensive research has focused on replacements of the 17-methyl group with other substituents. Structural variations at the N-17 of the morphinan skeleton led to a diversity of molecules appraised as valuable and potential therapeutics and important research probes. Discovery of therapeutically useful morphine-like drugs has also targeted the C-6 hydroxyl group, with oxymorphone as one of the clinically relevant opioid analgesics, where a carbonyl instead of a hydroxyl group is present at position 6. Herein, we describe the effect of N-substituent variation in morphine and oxymorphone on in vitro and in vivo biological properties and the emerging structure-activity relationships. We show that the presence of a N-phenethyl group in position 17 is highly favorable in terms of improved affinity and selectivity at the MOP receptor, potent agonism and antinociceptive efficacy. The N-phenethyl derivatives of morphine and oxymorphone were very potent in stimulating G protein coupling and intracellular calcium release through the MOP receptor. In vivo, they were highly effective against acute thermal nociception in mice with marked increased antinociceptive potency compared to the lead molecules. It was also demonstrated that a carbonyl group at position 6 is preferable to a hydroxyl function in these N-phenethyl derivatives, enhancing MOP receptor affinity and agonist potency in vitro and in vivo. These results expand the understanding of the impact of different moieties at the morphinan nitrogen on ligand-receptor interaction, molecular mode of action and signaling, and may be instrumental to the development of new opioid therapeutics.	[Ben Haddou, Tanila; Schmidhammer, Helmut; Spetea, Mariana] Univ Innsbruck, Inst Pharm, Dept Pharmaceut Chem, A-6020 Innsbruck, Austria; [Ben Haddou, Tanila; Schmidhammer, Helmut; Spetea, Mariana] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Beni, Szabolcs; Hosztafi, Sandor] Semmelweis Univ, Dept Pharmaceut Chem, H-1085 Budapest, Hungary; [Malfacini, Davide; Calo, Girolamo] Univ Ferrara, Dept Med Sci, Pharmacol Sect, I-44100 Ferrara, Italy; [Malfacini, Davide; Calo, Girolamo] Univ Ferrara, Italian Inst Neurosci, I-44100 Ferrara, Italy	University of Innsbruck; University of Innsbruck; Semmelweis University; University of Ferrara; University of Ferrara	Spetea, M (corresponding author), Univ Innsbruck, Inst Pharm, Dept Pharmaceut Chem, A-6020 Innsbruck, Austria.	Mariana.Spetea@uibk.ac.at		Spetea, Mariana/0000-0002-2379-5358; Schmidhammer, Helmut/0000-0001-8752-5050; Malfacini, Davide/0000-0003-4562-9550	Austrian Science Fund (FWF) [TRP 19-B18]; University of Ferrara (FAR grant); Janos Bolyai Research Scholarship; Austrian Exchange Service (Osterreichischer Austauschdienst GmbH, OeAD) fellowship;  [OTKA PD109373]; Austrian Science Fund (FWF) [TRP 19] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Ferrara (FAR grant); Janos Bolyai Research Scholarship(Hungarian Academy of Sciences); Austrian Exchange Service (Osterreichischer Austauschdienst GmbH, OeAD) fellowship; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF): TRP 19-B18 (MS), Hungarian Research Grant: OTKA PD109373 (SB), and the University of Ferrara (FAR grant to GC). S. Beni thanks the Hungarian Academy of Sciences for the financial support under the Janos Bolyai Research Scholarship and for the Austrian Exchange Service (Osterreichischer Austauschdienst GmbH, OeAD) fellowship (2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton RF, 2003, OPIOID RECEPTORS ANT, P371; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; BENYHE S, 1994, LIFE SCI, V55, P969, DOI 10.1016/0024-3205(94)00631-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camarda Valeria, 2013, Methods Mol Biol, V937, P293; CLARK RL, 1953, J AM CHEM SOC, V75, P4963, DOI 10.1021/ja01116a024; Furst S, 2008, ACTA PHYSIOL HUNG, V95, P3, DOI 10.1556/APhysiol.95.2008.1.1; Goodman AJ, 2007, CHEMMEDCHEM, V2, P1552, DOI 10.1002/cmdc.200700143; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hart ER, 1944, J PHARMACOL EXP THER, V82, P339; HOSZTAFI S, 1992, SYNTHETIC COMMUN, V22, P2527, DOI 10.1080/00397919208021649; Houde R.W., 1956, FED PROC, V15, P440; Jacobson AE, 1998, BIOL EVALUATION COMP, VXXII; KNOLL J, 1975, NEUROPHARMACOLOGY, V14, P921, DOI 10.1016/0028-3908(75)90046-5; KUTTER E, 1970, J MED CHEM, V13, P801, DOI 10.1021/jm00299a003; LASAGNA L, 1954, J PHARMACOL EXP THER, V112, P356; Lewis JW, 2011, TOP CURR CHEM, V299, P93, DOI 10.1007/128_2010_89; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; LOEW GH, 1978, J MED CHEM, V21, P101, DOI 10.1021/jm00199a018; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marcus DA, 2009, CURR CLIN PRACT, P1, DOI 10.1007/978-1-60327-465-4; May EL, 1998, MED CHEM RES, V8, P311; Mayyas F, 2010, J PAIN SYMPTOM MANAG, V39, P296, DOI 10.1016/j.jpainsymman.2009.07.010; Pasternak GW, 2013, PHARMACOL REV, V65, P1257, DOI 10.1124/pr.112.007138; Schmidhammer H, 2013, CURR PHARM DESIGN, V19, P7391; Schmidhammer H, 2011, TOP CURR CHEM, V299, P63, DOI 10.1007/128_2010_77; SEKI I, 1964, Yakugaku Zasshi, V84, P280; Sevarino Kevin A., 2009, P227, DOI 10.1007/978-1-59745-197-0_12; SMALL LF, 1958, J ORG CHEM, V23, P1387, DOI 10.1021/jo01103a615; Spetea M, 2004, EUR J PHARMACOL, V483, P301, DOI 10.1016/j.ejphar.2003.10.049; Spetea M, 2012, CURR MED CHEM, V19, P2442, DOI 10.2174/092986712800269308; Spetea M, 2013, CURR PHARM DESIGN, V19, P7415; Spetea M, 2011, J MED CHEM, V54, P980, DOI 10.1021/jm101211p; Spetea M, 2010, EUR J PHARM SCI, V41, P125, DOI 10.1016/j.ejps.2010.05.018; Toll L, 1998, NIDA Res Monogr, V178, P440; Unna K, 1943, J PHARMACOL EXP THER, V79, P27; WEISS U, 1965, J MED CHEM, V8, P123, DOI 10.1021/jm00325a028; WINTER CA, 1957, ARCH INT PHARMACOD T, V110, P186; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	39	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99231	10.1371/journal.pone.0099231	http://dx.doi.org/10.1371/journal.pone.0099231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919067	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000338631000063
J	Marrachelli, VG; Monleon, D; Rentero, P; Mansego, ML; Morales, JM; Galan, I; Segura, R; Martinez, F; Martin-Escudero, JC; Briongos, L; Marin, P; Lliso, G; Chaves, FJ; Redon, J				Marrachelli, Vannina G.; Monleon, Daniel; Rentero, Pilar; Mansego, Maria L.; Manuel Morales, Jose; Galan, Inma; Segura, Remedios; Martinez, Fernando; Carlos Martin-Escudero, Juan; Briongos, Laisa; Marin, Pablo; Lliso, Gloria; Javier Chaves, Felipe; Redon, Josep			Genomic and Metabolomic Profile Associated to Microalbuminuria	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; HYPERTENSION; INSULIN; DISEASE; POLYMORPHISM; HEALTH; SERUM	To identify factors related with the risk to develop microalbuminuria using combined genomic and metabolomic values from a general population study. One thousand five hundred and two subjects, Caucasian, more than 18 years, representative of the general population, were included. Blood pressure measurement and albumin/creatinine ratio were measured in a urine sample. Using SNPlex, 1251 SNPs potentially associated to urinary albumin excretion (UAE) were analyzed. Serum metabolomic profile was assessed by H-1 NMR spectra using a Brucker Advance DRX 600 spectrometer. From the total population, 1217 (mean age 54 +/- 19, 50.6% men, ACR>30 mg/g in 81 subjects) with high genotyping call rate were analysed. A characteristic metabolomic profile, which included products from mitochondrial and extra mitochondrial metabolism as well as branched amino acids and their derivative signals, were observed in microalbuminuric as compare to normoalbuminuric subjects. The comparison of the metabolomic profile between subjects with different UAE status for each of the genotypes associated to microalbuminuria revealed two SNPs, the rs10492025_TT of RPH3A gene and the rs4359_CC of ACE gene, with minimal or no statistically significant differences. Subjects with and without microalbuminuria, who shared the same genotype and metabolomic profile, differed in age. Microalbuminurics with the CC genotype of the rs4359 polymorphism and with the TT genotype of the rs10492025 polymorphism were seven years older and seventeen years younger, respectively as compared to the whole microalbuminuric subjects. With the same metabolomic environment, characteristic of subjects with microalbuminuria, the TT genotype of the rs10492025 polymorphism seems to increase and the CC genotype of the rs4359 polymorphism seems to reduce risk to develop microalbuminuria.	[Marrachelli, Vannina G.; Monleon, Daniel; Manuel Morales, Jose; Segura, Remedios] INCLIVA, Hlth Res Inst, Metabol & Mol Image Lab, Valencia, Spain; [Rentero, Pilar; Galan, Inma; Marin, Pablo; Javier Chaves, Felipe] INCLIVA, Hlth Res Inst, Genotyping & Genet Diag Unit, Valencia, Spain; [Mansego, Maria L.] Univ Navarra, Dept Nutr Food Sci & Physiol, E-31080 Pamplona, Spain; [Mansego, Maria L.; Martinez, Fernando; Lliso, Gloria; Redon, Josep] Hlth Inst Carlos III, CIBERObn, Madrid, Spain; [Martinez, Fernando; Briongos, Laisa; Redon, Josep] Univ Valencia, Hosp Clin, Hypertens Unit, Valencia, Spain; [Carlos Martin-Escudero, Juan] Hosp Rio Hortega, Valladolid, Spain; [Javier Chaves, Felipe] Hlth Inst Carlos III, CIBERDem, Madrid, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Valencia; Hospital del Rio Hortega; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Monleon, D (corresponding author), INCLIVA, Hlth Res Inst, Metabol & Mol Image Lab, Valencia, Spain.	daniel.monleon@uv.es	REDON, JOSEP/E-1719-2019; Monleon, Daniel/GNP-4083-2022; Monleon, Daniel/A-5078-2010; Chaves-Martinez, Felipe Javier/ABC-3294-2021; marrachelli, vannina G/L-6041-2014; MartÃnez, Fernando/AAO-5879-2021; tatay, jose manuel morales/L-7972-2014; Redon, Josep/L-5997-2019; Rentero-Garrido, Pilar/AAC-1788-2019; MANSEGO, MARIA/A-5687-2011	Monleon, Daniel/0000-0002-4803-1573; Monleon, Daniel/0000-0002-4803-1573; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; marrachelli, vannina G/0000-0002-4097-3312; MartÃnez, Fernando/0000-0001-8562-4477; tatay, jose manuel morales/0000-0002-4404-6735; Redon, Josep/0000-0001-8777-6773; Marin-Garcia, Pablo/0000-0003-3988-2365; MANSEGO, MARIA/0000-0001-8914-7890; Segura, Remedios/0000-0001-7923-4448; Lliso-Ribera, Gloria/0000-0002-8569-5133; Rentero-Garrido, Pilar/0000-0002-6158-0104; Martin-Escudero, Juan Carlos/0000-0002-6209-6509	Ingenious Hypercare Network of Excellence, Life sciences, genomics and biotechnology for health, 6th Framework Programme; EU-MASCARA HEALTH, European Commission, 7th Framework Programme [2011.2.4.2-2];  [PS09/02014];  [SAF2011-23029];  [PI 12/02615]	Ingenious Hypercare Network of Excellence, Life sciences, genomics and biotechnology for health, 6th Framework Programme; EU-MASCARA HEALTH, European Commission, 7th Framework Programme; ; ; 	The study has been funded by the Ingenious Hypercare Network of Excellence, Life sciences, genomics and biotechnology for health, 6th Framework Programme; EU-MASCARA HEALTH, 2011.2.4.2-2 European Commission, 7th Framework Programme; and the grants PS09/02014, SAF2011-23029 and PI 12/02615. The funders had no role in the study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Atkins RC, 2004, KIDNEY INT, V66, pS22, DOI 10.1111/j.1523-1755.2004.09206.x; Batch BC, 2013, METABOLISM, V62, P961, DOI 10.1016/j.metabol.2013.01.007; Bodi V, 2012, J AM COLL CARDIOL, V59, P1629, DOI 10.1016/j.jacc.2011.09.083; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Feldt-Rasmussen B, 2000, DIABETES METAB, V26, P64; Gavin JR, 1999, DIABETES CARE, V22, pS5; Giner V, 2004, J INTERN MED, V255, P588, DOI 10.1046/j.1365-2796.2003.01280.x; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Huang Y, 2011, CARDIOVASC RES, V90, P220, DOI 10.1093/cvr/cvr070; IWASAKI Y, 1980, GASTROENTEROLOGY, V78, P677; Lee JD, 2008, MICROSC MICROANAL, V14, P507, DOI 10.1017/S1431927608080628; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liang MY, 2011, KIDNEY INT, V80, P15, DOI 10.1038/ki.2011.84; Lorente-Galdos B, 2012, INT J DATA MIN BIOIN, V6, P324, DOI 10.1504/IJDMB.2012.049249; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Martinez F, 2010, J HYPERTENS, V28, P213, DOI 10.1097/HJH.0b013e328333afb3; Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/00004872-200307000-00015; Monleon D, 2010, CANCER RES, V70, P8426, DOI 10.1158/0008-5472.CAN-10-1498; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; NICHOLSON JK, 1984, LANCET, V2, P751; Pedrinelli R, 2002, J HUM HYPERTENS, V16, P79, DOI 10.1038/sj.jhh.1001316; Pontremoli R, 2000, KIDNEY INT, V57, P561, DOI 10.1046/j.1523-1755.2000.t01-1-00876.x; Rastaldi MP, 2003, AM J PATHOL, V163, P889, DOI 10.1016/S0002-9440(10)63449-9; Redon J, 2000, HYPERTENSION, V35, P490, DOI 10.1161/01.HYP.35.1.490; Redon J, 2006, CURR HYPERTENS REP, V8, P171, DOI 10.1007/s11906-006-0015-x; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Stuveling EM, 2004, HYPERTENSION, V43, P791, DOI 10.1161/01.HYP.0000120125.08867.42; Toto Robert D, 2004, J Clin Hypertens (Greenwich), V6, P2, DOI 10.1111/j.1524-6175.2004.4064.x; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xie BG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/805683	33	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98227	10.1371/journal.pone.0098227	http://dx.doi.org/10.1371/journal.pone.0098227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918908	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000014
J	Sato, T; Manabe, K; Hamada, N				Sato, Tatsuhiko; Manabe, Kentaro; Hamada, Nobuyuki			Microdosimetric Analysis Confirms Similar Biological Effectiveness of External Exposure to Gamma-Rays and Internal Exposure to Cs-137, Cs-134, and I-131	PLOS ONE			English	Article							FUKUSHIMA NUCLEAR ACCIDENT; CYTOPLASMIC IRRADIATION; SAFETY REGULATIONS; RADIATION; MODEL; RADIONUCLIDES; PARTICLE; INDUCTION; ELECTRON; PHITS	The risk of internal exposure to Cs-137, Cs-134, and I-131 is of great public concern after the accident at the Fukushima-Daiichi nuclear power plant. The relative biological effectiveness (RBE, defined herein as effectiveness of internal exposure relative to the external exposure to gamma-rays) is occasionally believed to be much greater than unity due to insufficient discussions on the difference of their microdosimetric profiles. We therefore performed a Monte Carlo particle transport simulation in ideally aligned cell systems to calculate the probability densities of absorbed doses in subcellular and intranuclear scales for internal exposures to electrons emitted from Cs-137, Cs-134, and I-131, as well as the external exposure to 662 keV photons. The RBE due to the inhomogeneous radioactive isotope (RI) distribution in subcellular structures and the high ionization density around the particle trajectories was then derived from the calculated microdosimetric probability density. The RBE for the bystander effect was also estimated from the probability density, considering its non-linear dose response. The RBE due to the high ionization density and that for the bystander effect were very close to 1, because the microdosimetric probability densities were nearly identical between the internal exposures and the external exposure from the 662 keV photons. On the other hand, the RBE due to the RI inhomogeneity largely depended on the intranuclear RI concentration and cell size, but their maximum possible RBE was only 1.04 even under conservative assumptions. Thus, it can be concluded from the microdosimetric viewpoint that the risk from internal exposures to Cs-137, Cs-134, and I-131 should be nearly equivalent to that of external exposure to gamma-rays at the same absorbed dose level, as suggested in the current recommendations of the International Commission on Radiological Protection.	[Sato, Tatsuhiko; Manabe, Kentaro] Japan Atom Energy Agcy, Res Grp Radiat Protect, Tokai, Ibaraki, Japan; [Hamada, Nobuyuki] Cent Res Inst Elect Power Ind, Radiat Safety Res Ctr, Nucl Technol Res Lab, Komae, Tokyo 201, Japan	Japan Atomic Energy Agency; Central Research Institute of Electric Power Industry - Japan	Sato, T (corresponding author), Japan Atom Energy Agcy, Res Grp Radiat Protect, Shirakata Shirane 2-4, Tokai, Ibaraki, Japan.	sato.tatsuhiko@jaea.go.jp	Sato, Tatsuhiko/G-5964-2012	Sato, Tatsuhiko/0000-0001-9902-7083; Hamada, Nobuyuki/0000-0003-2518-6131	Japan Atomic Energy Agency	Japan Atomic Energy Agency(Japan Atomic Energy Agency)	This work was supported by Japan Atomic Energy Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, 36 ICRU M; [Anonymous], 1986, 40 ICRU, DOI DOI 10.1093/JICRU_OS21.1.30; Blyth BJ, 2011, RADIAT RES, V176, P139, DOI 10.1667/RR2548.1; *CERRIE, 2004, REP COMM EX RAD RISK; EAPEN J, 1971, Journal of Radiation Research, V12, P51, DOI 10.1269/jrr.12.51; Fakir H, 2009, RADIAT RES, V171, P320, DOI 10.1667/RR1293.1; GODDU SM, 1994, J NUCL MED, V35, P303; Goddu SM, 1996, ACTA ONCOL, V35, P909, DOI 10.3109/02841869609104045; Hamada N, 2008, BIOL SCI SPACE, V22, P46, DOI DOI 10.2187/BSS.22.46; Hamada N, 2012, J RADIAT RES, V53, P641, DOI 10.1093/jrr/rrs032; Hamada N, 2012, J ENVIRON RADIOACTIV, V111, P83, DOI 10.1016/j.jenvrad.2011.08.008; Hamada Nobuyuki, 2011, Curr Mol Pharmacol, V4, P79; Harrison JD, 2003, INT J RADIAT BIOL, V79, P1, DOI 10.1080/0955300021000038671; Harrison JD, 2002, RADIAT PROT DOSIM, V98, P299, DOI 10.1093/oxfordjournals.rpd.a006722; International Commission on Radiological Protection, 2008, ICRP PUBL; International Commission on Radiological Protection, 2013, ICRP PUBL, V123; International Commission on Radiological Protection, 2009, ICRP PUBL, V110; International Commission on Radiological Protection, 2007, ICRP PUBL; International Commission on Radiological Protection, 2003, ICRP PUBL, V92; International Committee on Radiological Protection, 1991, ICRP PUBL; Leggett RW, 2010, RADIAT RES, V174, P496, DOI 10.1667/RR2243.1; Leggett RW, 2003, SCI TOTAL ENVIRON, V317, P235, DOI 10.1016/S0048-9697(03)00333-4; McMahon SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054526; Morgan WF, 2015, CANCER LETT, V356, P17, DOI 10.1016/j.canlet.2013.09.009; Mothersill C, 2001, RADIAT RES, V155, P759, DOI 10.1667/0033-7587(2001)155[0759:RIBEPH]2.0.CO;2; Nikjoo H, 2003, INT J RADIAT BIOL, V79, P43, DOI 10.1080/0955300021000034701; Roomans G, 1971, J CELL SCI, V21, P119; Sato T, 2006, RADIAT PROT DOSIM, V122, P41, DOI 10.1093/rpd/ncl407; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Sato T, 2012, RADIAT RES, V178, P341, DOI 10.1667/RR2842.1; Sato T, 2009, RADIAT RES, V171, P107, DOI 10.1667/RR1510.1; Shuryak I, 2007, RADIAT RES, V168, P741, DOI 10.1667/RR1117.1; Stewart RD, 2006, RADIAT RES, V165, P460, DOI 10.1667/RR3520.1; Tomita M, 2010, RADIAT RES, V173, P380, DOI 10.1667/RR1995.1; Wu LJ, 1999, P NATL ACAD SCI USA, V96, P4959, DOI 10.1073/pnas.96.9.4959; Zhou HN, 2009, J RADIAT RES, V50, pA59, DOI 10.1269/jrr.08120S	36	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99831	10.1371/journal.pone.0099831	http://dx.doi.org/10.1371/journal.pone.0099831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919099	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000117
J	Ye, K; Felimban, R; Traianedes, K; Moulton, SE; Wallace, GG; Chung, J; Quigley, A; Choong, PFM; Myers, DE				Ye, Ken; Felimban, Raed; Traianedes, Kathy; Moulton, Simon E.; Wallace, Gordon G.; Chung, Johnson; Quigley, Anita; Choong, Peter F. M.; Myers, Damian E.			Chondrogenesis of Infrapatellar Fat Pad Derived Adipose Stem Cells in 3D Printed Chitosan Scaffold	PLOS ONE			English	Article							AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE DEFECTS; MICROFRACTURE TECHNIQUE; OSTEOCHONDRAL DEFECTS; KNEE-JOINT; TISSUE; DIFFERENTIATION; COLLAGEN; MATRIX; REGENERATION	Infrapatellar fat pad adipose stem cells (IPFP-ASCs) have been shown to harbor chondrogenic potential. When combined with 3D polymeric structures, the stem cells provide a source of stem cells to engineer 3D tissues for cartilage repair. In this study, we have shown human IPFP-ASCs seeded onto 3D printed chitosan scaffolds can undergo chondrogenesis using TGF beta 3 and BMP6. By week 4, a pearlescent, cartilage-like matrix had formed that penetrated the top layers of the chitosan scaffold forming a 'cap' on the scaffold. Chondrocytic morphology showed typical cells encased in extracellular matrix which stained positively with toluidine blue. Immunohistochemistry demonstrated positive staining for collagen type II and cartilage proteoglycans, as well as collagen type I. Real time PCR analysis showed up-regulation of collagen type II, aggrecan and SOX9 genes when IPFP-ASCs were stimulated by TGF beta 3 and BMP6. Thus, IPFP-ASCs can successfully undergo chondrogenesis using TGF beta 3 and BMP6 and the cartilage-like tissue that forms on the surface of 3D-printed chitosan scaffold may prove useful as an osteochondral graft.	[Ye, Ken; Felimban, Raed; Choong, Peter F. M.; Myers, Damian E.] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia; [Ye, Ken; Felimban, Raed; Choong, Peter F. M.; Myers, Damian E.] St Vincents Hosp, Dept Orthopaed, Fitzroy, Vic 3065, Australia; [Traianedes, Kathy; Quigley, Anita] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Traianedes, Kathy; Quigley, Anita] Univ Melbourne, St Vincents Hosp, Dept Clin Neurosci, Fitzroy, Vic 3065, Australia; [Moulton, Simon E.; Wallace, Gordon G.; Chung, Johnson] Univ Wollongong, ARC Ctr Excellence Elect Sci ACES, Intelligent Polymer Res Inst, North Wollongong, NSW, Australia	St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; University of Wollongong	Myers, DE (corresponding author), Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia.	damianem@unimelb.edu.au	FELIMBAN, RAED/AAX-4537-2020; Wallace, Gordon G/H-1123-2011; Choong, Peter/F-1109-2014; Chung, Johnson/F-9854-2011; Myers, Damian E/L-5302-2013; Moulton, Simon/AAS-1452-2021	Wallace, Gordon G/0000-0002-0381-7273; Choong, Peter/0000-0002-3522-7374; Chung, Johnson/0000-0003-2449-3607; Moulton, Simon/0000-0002-8320-3852; Quigley, Anita/0000-0002-4060-2079; Myers, Damian/0000-0002-7569-9907; FELIMBAN, RAED/0000-0002-0853-2162; Choong, Peter/0000-0001-7333-7665	Australian Orthopaedics Association Research Foundation (AOA Research Foundation); Australian Research Council (ARC); National Health and Medical Research Council (NHMRC) Postgraduate Scholarship [APP1017633]	Australian Orthopaedics Association Research Foundation (AOA Research Foundation); Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC) Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded through the Australian Orthopaedics Association Research Foundation (AOA Research Foundation), Australian Research Council (ARC) and National Health and Medical Research Council (NHMRC) Postgraduate Scholarship for author K Ye (APP1017633). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategi A, 2010, J BIOMED MATER RES A, V95A, P1132, DOI 10.1002/jbm.a.32912; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045; Bae DK, 2006, ARTHROSCOPY, V22, P367, DOI 10.1016/j.arthro.2006.01.015; Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905; Bedi A, 2010, J BONE JOINT SURG AM, V92A, P994, DOI 10.2106/JBJS.I.00895; Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012; Breinan HA, 2000, J ORTHOPAED RES, V18, P781, DOI 10.1002/jor.1100180516; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Buckley CT, 2010, J BIOMECH, V43, P920, DOI 10.1016/j.jbiomech.2009.11.005; Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; Dragoo JL, 2003, J BONE JOINT SURG BR, V85B, P740, DOI 10.1302/0301-620X.85B5.13587; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Felimban R, 2014, TISSUE ENG A; French MM, 2004, ANN BIOMED ENG, V32, P50, DOI 10.1023/B:ABME.0000007790.65773.e0; Gobbi A, 2009, AM J SPORT MED, V37, P1083, DOI 10.1177/0363546509331419; Goessler UR, 2006, OTOLARYNG HEAD NECK, V134, P510, DOI 10.1016/j.otohns.2005.10.026; Goessler UR, 2004, INT J MOL MED, V14, P1015; Gooding CR, 2006, KNEE, V13, P203, DOI 10.1016/j.knee.2006.02.011; Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004; Jurgens WJFM, 2009, CYTOTHERAPY, V11, P1052, DOI 10.3109/14653240903219122; Khan WS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2448; Lee KH, 2001, HUM GENE THER, V12, P1805, DOI 10.1089/104303401750476294; Lee SY, 2008, BIOCHEM BIOPH RES CO, V376, P148, DOI 10.1016/j.bbrc.2008.08.138; Lefebvre V, 1998, MATRIX BIOL, V16, P529; Mandl EW, 2002, TISSUE ENG, V8, P573, DOI 10.1089/107632702760240490; Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b; MeridaVelasco JA, 1997, ANAT REC, V248, P269, DOI 10.1002/(SICI)1097-0185(199706)248:2<269::AID-AR14>3.0.CO;2-N; Mithoefer K, 2005, J BONE JOINT SURG AM, V87A, P1911, DOI 10.2106/JBJS.D.02846; Mithoefer K, 2006, AM J SPORT MED, V34, P1413, DOI 10.1177/0363546506288240; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402; Ogawa R, 2010, CURR STEM CELL RES T, V5, P129, DOI 10.2174/157488810791268627; Steadman J Richard, 2003, J Knee Surg, V16, P83; Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033; Suh JKF, 2000, BIOMATERIALS, V21, P2589; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056; Zaslav K, 2009, AM J SPORT MED, V37, P42, DOI 10.1177/0363546508322897; Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	44	81	85	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99410	10.1371/journal.pone.0099410	http://dx.doi.org/10.1371/journal.pone.0099410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918443	Green Published, Green Accepted, gold			2022-12-25	WOS:000338631000083
J	Zabala, J; Diaz, B; Salona-Bordas, MI				Zabala, Jabi; Diaz, Beatriz; Salona-Bordas, Marta I.			Seasonal Blowfly Distribution and Abundance in Fragmented Landscapes. Is It Useful in Forensic Inference about Where a Corpse Has Been Decaying?	PLOS ONE			English	Article							DIPTERA CALLIPHORIDAE; ARTHROPOD SUCCESSION; INSECT SUCCESSION; CARRION; FLIES; URBAN; DECOMPOSITION; ENTOMOLOGY; OCCUPANCY; GRADIENT	Blowflies are insects of forensic interest as they may indicate characteristics of the environment where a body has been laying prior to the discovery. In order to estimate changes in community related to landscape and to assess if blowfly species can be used as indicators of the landscape where a corpse has been decaying, we studied the blowfly community and how it is affected by landscape in a 7,000 km(2) region during a whole year. Using baited traps deployed monthly we collected 28,507 individuals of 10 calliphorid species, 7 of them well represented and distributed in the study area. Multiple Analysis of Variance found changes in abundance between seasons in the 7 analyzed species, and changes related to land use in 4 of them (Calliphora vomitoria, Lucilia ampullacea, L. caesar and L. illustris). Generalised Linear Model analyses of abundance of these species compared with landscape descriptors at different scales found only a clear significant relationship between summer abundance of C. vomitoria and distance to urban areas and degree of urbanisation. This relationship explained more deviance when considering the landscape composition at larger geographical scales (up to 2,500 m around sampling site). For the other species, no clear relationship between land uses and abundance was found, and therefore observed changes in their abundance patterns could be the result of other variables, probably small changes in temperature. Our results suggest that blowfly community composition cannot be used to infer in what kind of landscape a corpse has decayed, at least in highly fragmented habitats, the only exception being the summer abundance of C. vomitoria.	[Zabala, Jabi; Diaz, Beatriz; Salona-Bordas, Marta I.] Univ Basque Country, Fac Sci & Technol, Dept Zool & Anim Cell Biol, Bilbao, Spain; [Zabala, Jabi] Sebero Otxoa, Arrigorriaga 48480, Biscay, Spain; [Diaz, Beatriz] Aranzadi Sci Soc, Dept Entomol, San Sebastian, Guipuzcoa, Spain	University of Basque Country	Salona-Bordas, MI (corresponding author), Univ Basque Country, Fac Sci & Technol, Dept Zool & Anim Cell Biol, Bilbao, Spain.	m.salona@ehu.es	Zabala, Jabi/B-8157-2009	Zabala, Jabi/0000-0002-1425-1594; SalonaBordas, Marta/0000-0002-6873-7784	Basque Government; University of the Basque Country	Basque Government(Basque Government); University of the Basque Country	Field work and technicians assistance was supported by a research project funded by the Basque Government and the University of the Basque Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GS, 1996, J FORENSIC SCI, V41, P617; Arnaldos MI, 2004, INT J LEGAL MED, V118, P197, DOI 10.1007/s00414-004-0446-3; Arnaldos MI, 2006, CIENCIA FORENSE, V8, P63; Baz A, 2007, ANN SOC ENTOMOL FR, V43, P289, DOI 10.1080/00379271.2007.10697524; Bordas Marta Ines Salona, 2009, Boletin de la Asociacion Espanola de Entomologia, V33, P63; BRAACK LEO, 1986, ONDERSTEPOORT J VET, V53, P13; Brundage A, 2011, FORENSIC SCI INT, V212, P115, DOI 10.1016/j.forsciint.2011.05.023; Castillo Miralbes M, 2002, MONOGRAFIAS SOC ENTO, V6, P96; CATTS EP, 1992, ANNU REV ENTOMOL, V37, P253, DOI 10.1146/annurev.en.37.010192.001345; Crawley MJ., 2007, R BOOK; Garcia-Rojo Ana Marie, 2004, Boletin de la SEA, V34, P263; Goff M L, 1993, Forensic Sci Rev, V5, P81; Gonzalez Mora D., 1990, Eos-Revista Espanola de Entomologia, V65, P39; Gonzalez Mora D, 1988, EOS, V64, P91; Grassberger M, 2004, J MED ENTOMOL, V41, P511, DOI 10.1603/0022-2585-41.3.511; Hwang C, 2005, MED VET ENTOMOL, V19, P379, DOI 10.1111/j.1365-2915.2005.00583.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kavazos CRJ, 2012, LANDSCAPE URBAN PLAN, V106, P183, DOI 10.1016/j.landurbplan.2012.03.002; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Martinez-Sanchez A, 2000, MED VET ENTOMOL, V14, P56, DOI 10.1046/j.1365-2915.2000.00205.x; Moneo Pellitero J, 2007, B SOC ENTOMOLOGICA A, V40, P479; NUORTEVA PEKKA, 1963, ANN ENTOMOL FENNICA, V29, P1; PERIS S V, 1991, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Biologica, V87, P187; Castro CPE, 2011, ANN SOC ENTOMOL FR, V47, P128; R Core Team, 2021, R LANG ENV STAT COMP; Rognes K., 1991, BLOWFLIES DIPTERA CA; Schoenly KG, 2006, AM BIOL TEACH, V68, P402, DOI 10.1662/0002-7685(2006)68[402:RDAITS]2.0.CO;2; Sharanowski BJ, 2008, FORENSIC SCI INT, V179, P219, DOI 10.1016/j.forsciint.2008.05.019; Smith K. G. V., 1986, A manual of forensic entomology.; Turner B, 1999, FORENSIC SCI INT, V101, P113, DOI 10.1016/S0379-0738(99)00018-3; Zabala J, 2005, EUR J WILDLIFE RES, V51, P157, DOI 10.1007/s10344-005-0094-z; Zabala J, 2006, ORNIS FENNICA, V83, P97; Zumpt F., 1956, pUnpaginated; Zuur Alain F., 2009, P1	34	31	32	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99668	10.1371/journal.pone.0099668	http://dx.doi.org/10.1371/journal.pone.0099668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918607	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000102
J	Zotta, T; Ricciardi, A; Ianniello, RG; Parente, E; Reale, A; Rossi, F; Iacumin, L; Comi, G; Coppola, R				Zotta, Teresa; Ricciardi, Annamaria; Ianniello, Rocco G.; Parente, Eugenio; Reale, Anna; Rossi, Franca; Iacumin, Lucilla; Comi, Giuseppe; Coppola, Raffaele			Assessment of Aerobic and Respiratory Growth in the Lactobacillus casei Group	PLOS ONE			English	Article							OXIDATIVE STRESS RESISTANCE; SUPEROXIDE-DISMUTASE; MANGANESE CATALASE; PYRUVATE OXIDASE; PLANTARUM WCFS1; CLONING; METABOLISM; EXPRESSION; BACTERIA; HEME	One hundred eighty four strains belonging to the species Lactobacillus casei, L. paracasei and L. rhamnosus were screened for their ability to grow under aerobic conditions, in media containing heme and menaquinone and/or compounds generating reactive oxygen species (ROS), in order to identify respiratory and oxygen-tolerant phenotypes. Most strains were able to cope with aerobic conditions and for many strains aerobic growth and heme or heme/menaquinone supplementation increased biomass production compared to anaerobic cultivation. Only four L. casei strains showed a catalase-like activity under anaerobic, aerobic and respiratory conditions and were able to survive in presence of H2O2 (1 mM). Almost all L. casei and L. paracasei strains tolerated menadione (0.2 mM) and most tolerated pyrogallol (50 mM), while L. rhamnosus was usually resistant only to the latter compound. This is the first study in which an extensive screening of oxygen and oxidative stress tolerance of members of the L. casei group has been carried out. Results allowed the selection of strains showing the typical traits of aerobic and respiratory metabolism (increased pH and biomass under aerobic or respiratory conditions) and unique oxidative stress response properties. Aerobic growth and respiration may confer technological and physiological advantages in the L. casei group and oxygen-tolerant phenotypes could be exploited in several food industry applications.	[Zotta, Teresa; Ricciardi, Annamaria; Parente, Eugenio; Reale, Anna; Coppola, Raffaele] CNR, Ist Sci Alimentaz, Avellino, Italy; [Ricciardi, Annamaria; Ianniello, Rocco G.; Parente, Eugenio] Univ Basilicata, Scuola Sci Agr Forestali Alimentari & Ambientali, I-85100 Potenza, Italy; [Rossi, Franca; Coppola, Raffaele] Univ Molise, Dipartimento Agr Ambiente & Alimenti, Campobasso, Italy; [Iacumin, Lucilla; Comi, Giuseppe] Univ Udine, Dipartimento Sci Alimenti, I-33100 Udine, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Basilicata; University of Molise; University of Udine	Zotta, T (corresponding author), CNR, Ist Sci Alimentaz, Avellino, Italy.	teresa.zotta@isa.cnr.it	Reale, Anna/AAX-7486-2020; Iacumin, Lucilla/ABD-7559-2021; Comi, Giuseppe/GYE-0141-2022; Rossi, Franca/X-8036-2018; Coppola, Raffaele/A-3291-2012; Parente, Eugenio/B-3809-2014	Iacumin, Lucilla/0000-0003-2967-8109; Rossi, Franca/0000-0002-7443-1538; Parente, Eugenio/0000-0002-5716-2348; COPPOLA, RAFFAELE/0000-0003-1849-6801; Reale, Anna/0000-0001-5576-257X; Ricciardi, Annamaria/0000-0002-6146-8331; Zotta, Teresa/0000-0001-8228-6804	Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome, Italy; Project FIRB 2010 "Futuro in Ricerca'' [RBFR107VML]	Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome, Italy(Ministry of Education, Universities and Research (MIUR)); Project FIRB 2010 "Futuro in Ricerca''	This work was funded by Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome, Italy, Project FIRB 2010 "Futuro in Ricerca'', n. RBFR107VML. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2004, APPL ENVIRON MICROB, V70, P603, DOI 10.1128/AEM.70.1.603-606.2004; An HR, 2011, J AGR FOOD CHEM, V59, P3851, DOI 10.1021/jf200251k; An HR, 2010, MOL BIOTECHNOL, V45, P155, DOI 10.1007/s12033-010-9254-9; Andrus JM, 2003, ARCH BIOCHEM BIOPHYS, V420, P103, DOI 10.1016/j.abb.2003.09.007; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; BARANYI J., 1996, DMFIT MANUAL VERSION; Baureder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036725; Beulens JWJ, 2013, BRIT J NUTR, V110, P1357, DOI 10.1017/S0007114513001013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Brooijmans RJW, 2009, APPL ENVIRON MICROB, V75, P3580, DOI 10.1128/AEM.00147-09; Brooijmans R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-28; Cai H, 2009, GENOME BIOL EVOL, V1, P239, DOI 10.1093/gbe/evp019; De Vendittis A, 2010, MOL BIOSYST, V6, P1973, DOI 10.1039/c003557b; Douillard FP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003683; Frolkova P, 2012, FOLIA MICROBIOL, V57, P439, DOI 10.1007/s12223-012-0115-8; Goffin P, 2006, APPL ENVIRON MICROB, V72, P7933, DOI 10.1128/AEM.00659-06; Guidone A, 2013, WORLD J MICROB BIOT, V29, P1713, DOI 10.1007/s11274-013-1334-0; Hertzberger RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057235; Igarashi T, 1996, J BIOL CHEM, V271, P29521, DOI 10.1074/jbc.271.47.29521; Kang TS, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-10; KNAUF HJ, 1992, APPL ENVIRON MICROB, V58, P832, DOI 10.1128/AEM.58.3.832-839.1992; KONO Y, 1983, J BACTERIOL, V155, P742, DOI 10.1128/JB.155.2.742-746.1983; Lechardeur D, 2012, J BIOL CHEM, V287, P4752, DOI 10.1074/jbc.M111.297531; Lechardeur D, 2011, CURR OPIN BIOTECH, V22, P143, DOI 10.1016/j.copbio.2010.12.001; Nagpal R, 2012, FEMS MICROBIOL LETT, V334, P1, DOI 10.1111/j.1574-6968.2012.02593.x; Pedersen MB, 2012, ANNU REV FOOD SCI T, V3, P37, DOI 10.1146/annurev-food-022811-101255; Quatravaux S, 2006, J APPL MICROBIOL, V101, P903, DOI 10.1111/j.1365-2672.2006.02955.x; Ricciardi A, 2014, ANN MICROBIOL, V64, P1861, DOI 10.1007/s13213-014-0819-x; RISSE B, 1992, PROTEIN SCI, V1, P1699, DOI 10.1002/pro.5560011218; Rochat T, 2006, APPL ENVIRON MICROB, V72, P5143, DOI 10.1128/AEM.00482-06; Salvetti E, 2012, PROBIOTICS ANTIMICRO, V4, P217, DOI 10.1007/s12602-012-9117-8; SANDERS JW, 1995, J BACTERIOL, V177, P5254, DOI 10.1128/jb.177.18.5254-5260.1995; Sawai H, 2012, J BIOL CHEM, V287, P30755, DOI 10.1074/jbc.M112.370916; Serata M, 2012, MICROBIOL-SGM, V158, P953, DOI 10.1099/mic.0.053942-0; Settanni L, 2010, FOOD MICROBIOL, V27, P691, DOI 10.1016/j.fm.2010.05.023; Singh S, 2009, LWT-FOOD SCI TECHNOL, V42, P448, DOI 10.1016/j.lwt.2008.05.019; Smokvina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068731; Strus M, 2009, J PHYSIOL PHARMACOL, V60, P49; Tindall BJ, 2008, INT J SYST EVOL MICR, V58, P1764, DOI 10.1099/ijs.0.2008/005330-0; Toh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075073; Wang GH, 2011, J IND MICROBIOL BIOT, V38, P985, DOI 10.1007/s10295-010-0871-x; Watanabe M, 2012, APPL ENVIRON MICROB, V78, P4062, DOI 10.1128/AEM.00287-12; Watanabe M, 2012, MICROBIOL-SGM, V158, P293, DOI 10.1099/mic.0.051250-0; Zotta T, 2014, J APPL MICROBIOL, V116, P632, DOI 10.1111/jam.12398; Zotta T, 2013, J APPL MICROBIOL, V115, P848, DOI 10.1111/jam.12285; Zotta T, 2012, INT J FOOD MICROBIOL, V155, P51, DOI 10.1016/j.ijfoodmicro.2012.01.017	47	55	56	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99189	10.1371/journal.pone.0099189	http://dx.doi.org/10.1371/journal.pone.0099189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918811	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000055
J	Goodson, JM; Kantarci, A; Hartman, ML; Denis, GV; Stephens, D; Hasturk, H; Yaskell, T; Vargas, J; Wang, XS; Cugini, M; Barake, R; Alsmadi, O; Al-Mutawa, S; Ariga, J; Soparkar, P; Behbehani, J; Behbehani, K; Welty, F				Goodson, J. Max; Kantarci, Alpdogan; Hartman, Mor-Li; Denis, Gerald V.; Stephens, Danielle; Hasturk, Hatice; Yaskell, Tina; Vargas, Jorel; Wang, Xiaoshan; Cugini, Maryann; Barake, Roula; Alsmadi, Osama; Al-Mutawa, Sabiha; Ariga, Jitendra; Soparkar, Pramod; Behbehani, Jawad; Behbehani, Kazem; Welty, Francine			Metabolic Disease Risk in Children by Salivary Biomarker Analysis	PLOS ONE			English	Article							REACTIVE PROTEIN-LEVELS; PLASMA-INSULIN; CHRONIC PERIODONTITIS; NONDIABETIC SUBJECTS; DIABETIC-PATIENTS; WHOLE SALIVA; INFLAMMATION; OBESITY; GLUCOSE; ADOLESCENTS	Objective: The study of obesity-related metabolic syndrome or Type 2 diabetes (T2D) in children is particularly difficult because of fear of needles. We tested a non-invasive approach to study inflammatory parameters in an at-risk population of children to provide proof-of-principle for future investigations of vulnerable subjects. Design and Methods: We evaluated metabolic differences in 744, 11-year old children selected from underweight, normal healthy weight, overweight and obese categories by analyzing fasting saliva samples for 20 biomarkers. Saliva supernatants were obtained following centrifugation and used for analyses. Results: Salivary C-reactive protein (CRP) was 6 times higher, salivary insulin and leptin were 3 times higher, and adiponectin was 30% lower in obese children compared to healthy normal weight children (all P<0.0001). Categorical analysis suggested that there might be three types of obesity in children. Distinctly inflammatory characteristics appeared in 76% of obese children while in 13%, salivary insulin was high but not associated with inflammatory mediators. The remaining 11% of obese children had high insulin and reduced adiponectin. Forty percent of the non-obese children were found in groups which, based on biomarker characteristics, may be at risk for becoming obese. Conclusions: Significantly altered levels of salivary biomarkers in obese children from a high-risk population, suggest the potential for developing non-invasive screening procedures to identify T2D-vulnerable individuals and a means to test preventative strategies.	[Goodson, J. Max; Kantarci, Alpdogan; Hartman, Mor-Li; Stephens, Danielle; Hasturk, Hatice; Yaskell, Tina; Vargas, Jorel; Wang, Xiaoshan; Cugini, Maryann; Soparkar, Pramod] Forsyth Res Inst, Dept Appl Oral Sci, Cambridge, MA 02142 USA; [Denis, Gerald V.] Boston Univ, Sch Med, Canc Res Ctr, Boston, MA 02118 USA; [Barake, Roula; Alsmadi, Osama; Behbehani, Kazem] Dasman Diabet Inst, Kuwait, Kuwait; [Al-Mutawa, Sabiha; Ariga, Jitendra] Minist Hlth, Kuwait, Kuwait; [Behbehani, Jawad] Kuwait Univ, Fac Dent, Kuwait, Kuwait; [Welty, Francine] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA	Harvard University; Forsyth Institute; Boston University; Kuwait University; Harvard University; Beth Israel Deaconess Medical Center	Goodson, JM (corresponding author), Forsyth Res Inst, Dept Appl Oral Sci, Cambridge, MA 02142 USA.	mgoodson@forsyth.org		Denis, Gerald/0000-0001-9886-0401; Barake, Roula/0000-0002-9461-2897	Dasman Diabetes Institute in Kuwait; NATIONAL CANCER INSTITUTE [U01CA182898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK090455] Funding Source: NIH RePORTER	Dasman Diabetes Institute in Kuwait; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by a grant from the Dasman Diabetes Institute in Kuwait. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rashdan I, 2010, ANGIOLOGY, V61, P42, DOI 10.1177/0003319709333226; Arellano-Garcia MT, 2008, ORAL DIS, V14, P705, DOI 10.1111/j.1601-0825.2008.01488.x; Aydin S, 2007, J BIOCHEM MOL BIOL, V40, P29; BAGDADE JD, 1967, J CLIN INVEST, V46, P1549, DOI 10.1172/JCI105646; Browne RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059498; CDC, 2012, CHILD TEEN BMI CALC; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Farb MG, 2011, J AM COLL CARDIOL, V58, P232, DOI 10.1016/j.jacc.2011.01.051; Floriano PN, 2009, CLIN CHEM, V55, P1530, DOI 10.1373/clinchem.2008.117713; Gornowicz A, 2012, ANN AGR ENV MED, V19, P711; Groschl M, 2009, BIOESSAYS, V31, P843, DOI 10.1002/bies.200900013; Groschl M, 2001, J CLIN ENDOCR METAB, V86, P5234, DOI 10.1210/jc.86.11.5234; Gupta MA, 2013, CLIN DERMATOL, V31, P1, DOI 10.1016/j.clindermatol.2011.11.018; Hettmansperger TP, 2012, ROBUST NONPARAMETRIC; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; Janket SJ, 2008, ORAL SURG ORAL MED O, V105, P173, DOI 10.1016/j.tripleo.2007.06.027; Kahn SE, 2006, DIABETES, V55, P2357, DOI 10.2337/db06-0116; Kamaryt J, 1989, Cesk Pediatr, V44, P517; Kang EH, 2011, CLIN EXP RHEUMATOL, V29, P970; Kinney JS, 2007, ANN NY ACAD SCI, V1098, P230, DOI 10.1196/annals.1384.028; KNIP M, 1993, AM J CLIN NUTR, V57, P490, DOI 10.1093/ajcn/57.4.490; Lee JY, 2007, ORAL DIS, V13, P550, DOI 10.1111/j.1601-0825.2006.01332.x; Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004; MARCHETTI P, 1990, DIABETES METAB, V16, P16; MARCHETTI P, 1986, DIABETOLOGIA, V29, P695, DOI 10.1007/BF00870278; Naidoo T, 2012, CARDIOVASC J AFR, V23, P501, DOI 10.5830/CVJA-2012-058; Nielsen AA, 2005, SCAND J GASTROENTERO, V40, P1444, DOI 10.1080/00365520510023774; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Ozcaka O, 2011, J PERIODONTAL RES, V46, P592, DOI 10.1111/j.1600-0765.2011.01377.x; PASIC J, 1988, DIABETES CARE, V11, P489, DOI 10.2337/diacare.11.6.489; Rai Balwant, 2008, J Oral Sci, V50, P53, DOI 10.2334/josnusd.50.53; Rathnayake N, 2013, J CLIN PERIODONTOL, V40, P140, DOI 10.1111/jcpe.12038; Renaldi Olly, 2009, Acta Med Indones, V41, P20; Rosa JS, 2011, J CLIN RES PEDIATR E, V3, P115, DOI 10.4274/jcrpe.v3i3.23; Scheicher ME, 2007, EUR RESPIR J, V29, P489, DOI 10.1183/09031936.00060205; Sexton WM, 2011, J CLIN PERIODONTOL, V38, P434, DOI 10.1111/j.1600-051X.2011.01706.x; Shea S, 2003, OBES RES, V11, P95, DOI 10.1038/oby.2003.15; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shpitzer T, 2009, BRIT J CANCER, V101, P1194, DOI 10.1038/sj.bjc.6605290; Surdacka A, 2011, ARCH ORAL BIOL, V56, P428, DOI 10.1016/j.archoralbio.2010.11.005; Suriano K, 2010, J PEDIAT; Teles RP, 2009, J PERIODONTAL RES, V44, P411, DOI 10.1111/j.1600-0765.2008.01119.x; TENOVUO J, 1986, J DENT RES, V65, P62, DOI 10.1177/00220345860650011101; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	44	78	80	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98799	10.1371/journal.pone.0098799	http://dx.doi.org/10.1371/journal.pone.0098799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915044	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700033
J	Gorvel, L; Textoris, J; Banchereau, R; Ben Amara, A; Tantibhedhyangkul, W; von Bargen, K; Ka, MB; Capo, C; Ghigo, E; Gorvel, JP; Mege, JL				Gorvel, Laurent; Textoris, Julien; Banchereau, Romain; Ben Amara, Amira; Tantibhedhyangkul, Wiwit; von Bargen, Kristin; Ka, Mignane B.; Capo, Christian; Ghigo, Eric; Gorvel, Jean-Pierre; Mege, Jean-Louis			Intracellular Bacteria Interfere with Dendritic Cell Functions: Role of the Type I Interferon Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; ORIENTIA-TSUTSUGAMUSHI; GENE-EXPRESSION; SCRUB TYPHUS; ENDOPLASMIC-RETICULUM; TROPHERYMA-WHIPPLEI; COXIELLA-BURNETII; HUMAN MACROPHAGES; DC-SIGN; BRUCELLA	Dendritic cells (DCs) orchestrate host defenses against microorganisms. In infectious diseases due to intracellular bacteria, the inefficiency of the immune system to eradicate microorganisms has been attributed to the hijacking of DC functions. In this study, we selected intracellular bacterial pathogens with distinct lifestyles and explored the responses of monocyte-derived DCs (moDCs). Using lipopolysaccharide as a control, we found that Orientia tsutsugamushi, the causative agent of scrub typhus that survives in the cytosol of target cells, induced moDC maturation, as assessed by decreased endocytosis activity, the ability to induce lymphocyte proliferation and the membrane expression of phenotypic markers. In contrast, Coxiella burnetii, the agent of Q fever, and Brucella abortus, the agent of brucellosis, both of which reside in vacuolar compartments, only partly induced the maturation of moDCs, as demonstrated by a phenotypic analysis. To analyze the mechanisms used by C. burnetii and B. abortus to alter moDC activation, we performed microarray and found that C. burnetii and B. abortus induced a specific signature consisting of TLR4, TLR3, STAT1 and interferon response genes. These genes were down-modulated in response to C. burnetii and B. abortus but up-modulated in moDCs activated by lipopolysaccharide and O. tsutsugamushi. This transcriptional alteration was associated with the defective interferon-beta production. This study demonstrates that intracellular bacteria specifically affect moDC responses and emphasizes how C. burnetii and B. abortus interfere with moDC activation and the antimicrobial immune response. We believe that comparing infection by several bacterial species may be useful for defining new pathways and biomarkers and for developing new treatment strategies.	[Gorvel, Laurent; Textoris, Julien; Ben Amara, Amira; Tantibhedhyangkul, Wiwit; Ka, Mignane B.; Capo, Christian; Ghigo, Eric; Mege, Jean-Louis] Aix Marseille Univ, INSERM U1095, IRD198, CNRS,UMR 7278, Marseille, France; [Banchereau, Romain] Baylor Inst Immunol Res, Dallas, TX USA; [von Bargen, Kristin; Gorvel, Jean-Pierre] Aix Marseille Univ, CNRS, INSERM, UM2,U1104,UMR7280,CIML, Marseille, France; [Tantibhedhyangkul, Wiwit] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Baylor Scott & White Health; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Mahidol University	Mege, JL (corresponding author), Aix Marseille Univ, INSERM U1095, IRD198, CNRS,UMR 7278, Marseille, France.	jean-louis.mege@univ-amu.fr	GORVEL, Laurent/AAB-1749-2020; Eric, Ghigo/N-9427-2016; Textoris, Julien/H-3317-2019; MEGE, JEAN-LOUIS/O-6063-2016; Gorvel, Jean-Pierre/O-1332-2018	GORVEL, Laurent/0000-0001-7526-261X; Textoris, Julien/0000-0002-3821-9337; Gorvel, Jean-Pierre/0000-0002-2829-9804; tantibhedhyangkul, wiwit/0000-0003-0943-9012				Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Andres S, 2011, FEMS IMMUNOL MED MIC, V61, P168, DOI 10.1111/j.1574-695X.2010.00761.x; Balboa L, 2010, IMMUNOL CELL BIOL, V88, P716, DOI 10.1038/icb.2010.22; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; Barry AO, 2012, CELL HOST MICROBE, V12, P751, DOI 10.1016/j.chom.2012.10.015; Ben Amara A, 2013, J IMMUNOL, V191, P5501, DOI 10.4049/jimmunol.1300988; Ben Amara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015315; Benoit M, 2008, EUR J IMMUNOL, V38, P1065, DOI 10.1002/eji.200738067; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Celli J, 2006, RES MICROBIOL, V157, P93, DOI 10.1016/j.resmic.2005.10.002; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Choi JH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001981; Miraglia MC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-47; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; de Almeida LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023135; de Bagues MPJ, 2005, INFECT IMMUN, V73, P3178, DOI 10.1128/IAI.73.5.3178-3183.2005; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Desnues B, 2005, J INFECT DIS, V192, P1642, DOI 10.1086/491745; Desnues B, 2005, J IMMUNOL, V175, P4575, DOI 10.4049/jimmunol.175.7.4575; Dimitrakopoulos O, 2013, MICROBES INFECT, V15, P450, DOI 10.1016/j.micinf.2013.04.007; Edelson BT, 2012, ADV IMMUNOL, V113, P33, DOI 10.1016/B978-0-12-394590-7.00006-3; Feau S, 2005, BLOOD, V105, P697, DOI 10.1182/blood-2004-03-1059; Ge Y, 2011, MICROBES INFECT, V13, P638, DOI 10.1016/j.micinf.2011.03.003; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gorvel L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.11; Granucci F, 2002, TRENDS IMMUNOL, V23, P169, DOI 10.1016/S1471-4906(02)02187-7; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Martirosyan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055117; Ojcius DM, 1998, J IMMUNOL, V160, P1297; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Paris DH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001466; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Tam MA, 2004, TRENDS IMMUNOL, V25, P335, DOI 10.1016/j.it.2004.05.004; Tantibhedhyangkul W, 2013, MICROB PATHOGENESIS, V55, P55, DOI 10.1016/j.micpath.2012.10.001; Tantibhedhyangkul W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001028; Textoris J, 2012, RECENT RES DEV IMMUN, V8, P49; Wang YH, 2009, AUTOPHAGY, V5, P540, DOI 10.4161/auto.5.4.8167; Wei L, 2012, CURR MICROBIOL, V65, P133, DOI 10.1007/s00284-012-0136-1; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Zenk SF, 2009, J IMMUNOL, V183, P2697, DOI 10.4049/jimmunol.0900937	48	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99420	10.1371/journal.pone.0099420	http://dx.doi.org/10.1371/journal.pone.0099420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915541	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700100
J	Dittrich-Domergue, F; Joubes, J; Moreau, P; Lessire, R; Stymne, S; Domergue, F				Dittrich-Domergue, Franziska; Joubes, Jerome; Moreau, Patrick; Lessire, Rene; Stymne, Sten; Domergue, Frederic			The Bifunctional Protein TtFARAT from Tetrahymena thermophila Catalyzes the Formation of both Precursors Required to Initiate Ether Lipid Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY ACYL-COENZYME; DIHYDROXYACETONE PHOSPHATE ACYLTRANSFERASE; COA REDUCTASE 1; ARABIDOPSIS-THALIANA; SUBSTRATE SPECIFICITIES; WAX BIOSYNTHESIS; IDENTIFICATION; GENE; SYNTHASE; GLYCEROL-3-PHOSPHATE	The biosynthesis of ether lipids and wax esters requires as precursors fatty alcohols, which are synthesized by fatty acyl reductases (FARs). The presence of ether glycerolipids as well as branched wax esters has been reported in several free-living ciliate protozoa. In the genome of Tetrahymena thermophila, the only ORF sharing similarities with FARs is fused to an acyltransferase-like domain, whereas, in most other organisms, FARs are monofunctional proteins of similar size and domain structure. Here, we used heterologous expression in plant and yeast to functionally characterize the activities catalyzed by this protozoan protein. Transient expression in tobacco epidermis of a truncated form fused to the green fluorescence protein followed by confocal microscopy analysis suggested peroxisomal localization. In vivo approaches conducted in yeast indicated that the N-terminal FAR-like domain produced both 16:0 and 18:0 fatty alcohols, whereas the C-terminal acyltransferase-like domain was able to rescue the lethal phenotype of the yeast double mutant gat1 Delta gat2 Delta. Using in vitro approaches, we further demonstrated that this domain is a dihydroxyacetone phosphate acyltransferase that uses preferentially 16:0-coenzyme A as an acyl donor. Finally, coexpression in yeast with the alkyl-dihydroxyacetone phosphate synthase from T. thermophila resulted the detection of various glycerolipids with an ether bond, indicating reconstitution of the ether lipid biosynthetic pathway. Together, these results demonstrate that this FAR-like protein is peroxisomal and bifunctional, providing both substrates required by alkyl-dihydroxyacetone phosphate synthase to initiate ether lipid biosynthesis.	[Dittrich-Domergue, Franziska; Joubes, Jerome; Moreau, Patrick; Lessire, Rene; Domergue, Frederic] Univ Bordeaux, UMR 5200, Lab Biogenese Membranaire, F-33000 Bordeaux, France; [Dittrich-Domergue, Franziska; Joubes, Jerome; Moreau, Patrick; Lessire, Rene; Domergue, Frederic] Ctr Natl Rech Sci, UMR 5200, Lab Biogenese Membranaire, F-33000 Bordeaux, France; [Stymne, Sten] Swedish Univ Agr Sci, Dept Plant Breeding, S-23053 Alnarp, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Swedish University of Agricultural Sciences	Domergue, F (corresponding author), Univ Bordeaux, CNRS UMR 5200, Lab Biogenese Membranaire, Batiment A3 INRA Bordeaux Aquitaine, F-33140 Villenave Dornon, France.	frederic.domergue@u-bordeaux.fr		Domergue, Frederic/0000-0002-0183-7000; Moreau, Patrick/0000-0001-9318-3464; Joubes, Jerome/0000-0001-5385-450X	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was part of a project entitled "Industrial Crops Producing Added Value Oils for Novel Chemicals," which was supported by a grant from the European Commission Framework 7.	Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Biermann J, 1998, BBA-LIPID LIPID MET, V1393, P137, DOI 10.1016/S0005-2760(98)00071-X; Biermann J, 1999, EUR J BIOCHEM, V261, P492, DOI 10.1046/j.1432-1327.1999.00295.x; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; BURDETT K, 1991, J BIOL CHEM, V266, P12201; Chacon MG, 2013, J BIOL CHEM, V288, P30345, DOI 10.1074/jbc.M113.499715; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; CLARKE MR, 1970, NATURE, V228, P873, DOI 10.1038/228873a0; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; DeVet ECJM, 1997, EUR J BIOCHEM, V247, P511; Domergue F, 2010, PLANT PHYSIOL, V153, P1539, DOI 10.1104/pp.110.158238; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; GHISLAIN M, 1994, PLANT MOL BIOL, V24, P835, DOI 10.1007/BF00014439; Honsho M, 2013, J BIOL CHEM, V288, P34588, DOI 10.1074/jbc.M113.498345; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; INUI H, 1982, FEBS LETT, V150, P89, DOI 10.1016/0014-5793(82)81310-0; JONES CL, 1980, J BIOL CHEM, V255, P8289; Joubes J, 2008, PLANT MOL BIOL, V67, P547, DOI 10.1007/s11103-008-9339-z; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Magnusson CD, 2011, CHEM PHYS LIPIDS, V164, P315, DOI 10.1016/j.chemphyslip.2011.04.010; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; POLLARD MR, 1979, LIPIDS, V14, P651, DOI 10.1007/BF02533451; Razeto A, 2007, STRUCTURE, V15, P683, DOI 10.1016/j.str.2007.04.009; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Rowland O, 2012, PLANT SCI, V193, P28, DOI 10.1016/j.plantsci.2012.05.002; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Salibian A, 2009, BRAZ J BIOL, V69, P437, DOI 10.1590/S1519-69842009000200029; Salim HMW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-279; Tcherkez G, 2013, PLANT CELL ENVIRON, V36, P1586, DOI 10.1111/pce.12066; Thai TP, 1997, FEBS LETT, V420, P205, DOI 10.1016/S0014-5793(97)01495-6; THOMPSON GA, 1977, BIOCHIM BIOPHYS ACTA, V472, P55, DOI 10.1016/0304-4157(77)90014-4; THOMPSON GA, 1967, BIOCHEMISTRY-US, V6, P2015, DOI 10.1021/bi00859a020; Turkish AR, 2005, J BIOL CHEM, V280, P14755, DOI 10.1074/jbc.M500025200; van Grunsven EG, 1998, P NATL ACAD SCI USA, V95, P2128, DOI 10.1073/pnas.95.5.2128; Wheeler M. A., 1795, LIPIDS, V10, P260; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zufferey R, 2006, J BIOL CHEM, V281, P7952, DOI 10.1074/jbc.M512911200	43	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21984	21994		10.1074/jbc.M114.579318	http://dx.doi.org/10.1074/jbc.M114.579318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24917677	Green Published, hybrid			2022-12-25	WOS:000340593500015
J	Carbonetto, B; Rascovan, N; Alvarez, R; Mentaberry, A; Vazquez, MP				Carbonetto, Belen; Rascovan, Nicolas; Alvarez, Roberto; Mentaberry, Alejandro; Vazquez, Martin P.			Structure, Composition and Metagenomic Profile of Soil Microbiomes Associated to Agricultural Land Use and Tillage Systems in Argentine Pampas	PLOS ONE			English	Article							ORGANIC-MATTER; RIBOSOMAL-RNA; NO-TILLAGE; NITROGEN-FERTILIZATION; BACTERIAL COMMUNITIES; REVEALS DIFFERENCES; CARBON; PATTERNS; SUSTAINABILITY; AGGREGATION	Agriculture is facing a major challenge nowadays: to increase crop production for food and energy while preserving ecosystem functioning and soil quality. Argentine Pampas is one of the main world producers of crops and one of the main adopters of conservation agriculture. Changes in soil chemical and physical properties of Pampas soils due to different tillage systems have been deeply studied. Still, not much evidence has been reported on the effects of agricultural practices on Pampas soil microbiomes. The aim of our study was to investigate the effects of agricultural land use on community structure, composition and metabolic profiles on soil microbiomes of Argentine Pampas. We also compared the effects associated to conventional practices with the effects of no-tillage systems. Our results confirmed the impact on microbiome structure and composition due to agricultural practices. The phyla Verrucomicrobia, Plactomycetes, Actinobacteria, and Chloroflexi were more abundant in non cultivated soils while Gemmatimonadetes, Nitrospirae and WS3 were more abundant in cultivated soils. Effects on metabolic metagenomic profiles were also observed. The relative abundance of genes assigned to transcription, protein modification, nucleotide transport and metabolism, wall and membrane biogenesis and intracellular trafficking and secretion were higher in cultivated fertilized soils than in non cultivated soils. We also observed significant differences in microbiome structure and taxonomic composition between soils under conventional and no-tillage systems. Overall, our results suggest that agronomical land use and the type of tillage system have induced microbiomes to shift their life-history strategies. Microbiomes of cultivated fertilized soils (i.e. higher nutrient amendment) presented tendencies to copiotrophy while microbiomes of non cultivated homogenous soils appeared to have a more oligotrophic life-style. Additionally, we propose that conventional tillage systems may promote copiotrophy more than no-tillage systems by decreasing soil organic matter stability and therefore increasing nutrient availability.	[Carbonetto, Belen; Rascovan, Nicolas; Vazquez, Martin P.] Predio CCT Rosario, Inst Agrobiotecnol Rosario INDEAR, Santa Fe, Argentina; [Alvarez, Roberto] Univ Buenos Aires, Fac Agron, Buenos Aires, DF, Argentina; [Mentaberry, Alejandro] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Carbonetto, B (corresponding author), Predio CCT Rosario, Inst Agrobiotecnol Rosario INDEAR, Santa Fe, Argentina.	belen.carbonetto@indear.com; martin.vazquez@indear.com	Rascovan, Nicolás/Q-4531-2018	Rascovan, Nicolás/0000-0002-2129-5878; Carbonetto, Maria Belen/0000-0002-2784-5324	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PAE 37164]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	Funding for this work was provided by Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina-PAE 37164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaras B, 2012, APPL SOIL ECOL, V61, P305, DOI 10.1016/j.apsoil.2011.11.016; ALVAREZ R, 1995, SOIL TILL RES, V33, P17, DOI 10.1016/0167-1987(94)00432-E; Alvarez R, 2009, SOIL TILL RES, V104, P1, DOI 10.1016/j.still.2009.02.005; Alvarez R, 2001, SOIL USE MANAGE, V17, P62, DOI 10.1111/j.1475-2743.2001.tb00010.x; Aon MA, 2001, APPL SOIL ECOL, V18, P239, DOI 10.1016/S0929-1393(01)00153-6; Apple JK, 2007, ISME J, V1, P729, DOI 10.1038/ismej.2007.86; Attard E, 2010, ENVIRON MICROBIOL, V12, P315, DOI 10.1111/j.1462-2920.2009.02070.x; Balmford A, 2005, GLOBAL CHANGE BIOL, V11, P1594, DOI 10.1111/j.1365-2486.2005.001035.x; Barabote RD, 2009, GENOME RES, V19, P1033, DOI 10.1101/gr.084848.108; Bayer C, 2000, SOIL TILL RES, V54, P101, DOI 10.1016/S0167-1987(00)00090-8; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Berhongaray G, 2013, GEODERMA, V192, P97, DOI 10.1016/j.geoderma.2012.07.016; Bernardos JN, 2001, AGR SYST, V69, P215, DOI 10.1016/S0308-521X(01)00027-0; Bongiovanni MD, 2006, GEODERMA, V136, P660, DOI 10.1016/j.geoderma.2006.05.002; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Cai L, 2011, COLD SH Q B, V76, P195, DOI 10.1101/sqb.2011.76.010769; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Deng WD, 2008, MOL BIOL REP, V35, P265, DOI 10.1007/s11033-007-9079-1; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dion P., 2008, MICROBIOLOGY EXTREME; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Dong L, 2009, SOIL BIOL BIOCHEM, V41, P1612, DOI 10.1016/j.soilbio.2009.04.023; Doucette CD, 2011, NAT CHEM BIOL, V7, P894, DOI [10.1038/NCHEMBIO.685, 10.1038/nchembio.685]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards AL, 2010, RNA, V16, P2144, DOI 10.1261/rna.2341610; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Figuerola ELM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051075; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fortunato CS, 2012, ISME J, V6, P554, DOI 10.1038/ismej.2011.135; Galantini J, 2006, SOIL TILL RES, V87, P72, DOI 10.1016/j.still.2005.02.032; Gee G.W., 1986, METHODS SOIL ANAL PA, P383, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; Gomez E, 2000, APPL SOIL ECOL, V15, P273, DOI 10.1016/S0929-1393(00)00078-0; Hall A.J., 1992, P413; Hevia GG, 2003, GEODERMA, V116, P265, DOI 10.1016/S0016-7061(03)00104-6; Jiao Y, 2006, GEODERMA, V134, P24, DOI 10.1016/j.geoderma.2005.08.012; Kassam A, 2009, INT J AGR SUSTAIN, V7, P292, DOI 10.3763/ijas.2009.0477; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kindt R, 2005, TREE DIVERSITY ANAL; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; LANGDALE GW, 1992, SOIL TECHNOL, V5, P81, DOI 10.1016/0933-3630(92)90009-P; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Lavado RS, 2008, MATERIA ORGANICA VAL, P1; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; LOPEZ MF, 1984, CAN J MICROBIOL, V30, P746, DOI 10.1139/m84-114; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Maixner F, 2006, ENVIRON MICROBIOL, V8, P1487, DOI 10.1111/j.1462-2920.2006.01033.x; McInerney MJ, 2009, CURR OPIN BIOTECH, V20, P623, DOI 10.1016/j.copbio.2009.10.001; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Nievas F, 2012, APPL SOIL ECOL, V53, P74, DOI 10.1016/j.apsoil.2011.11.010; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Plaza-Bonilla D, 2013, GEODERMA, V193, P76, DOI 10.1016/j.geoderma.2012.10.022; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quiroga AR, 1996, SOIL SCI, V161, P104, DOI 10.1097/00010694-199602000-00004; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Rascovan N, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-21; Rhoades J. D., 1996, Methods of soil analysis. Part 3 - chemical methods., P417; Pontes DS, 2007, J IND MICROBIOL BIOT, V34, P463, DOI 10.1007/s10295-007-0219-3; Sanudo-Wilhelmy SA, 2012, P NATL ACAD SCI; Satorre E. H., 1999, Wheat: ecology and physiology of yield determination., P333; Scholes MC, 2013, SCIENCE, V342, P565, DOI 10.1126/science.1244579; Sieber JR, 2012, ANNU REV MICROBIOL, V66, P429, DOI 10.1146/annurev-micro-090110-102844; Slepetiene A, 2005, GEODERMA, V127, P207, DOI 10.1016/j.geoderma.2004.12.001; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Souza RC, 2013, APPL SOIL ECOL, V72, P49, DOI 10.1016/j.apsoil.2013.05.021; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tivet F, 2013, GEODERMA, V209, P214, DOI 10.1016/j.geoderma.2013.06.008; Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Yan DL, 2007, P NATL ACAD SCI USA, V104, P9475, DOI 10.1073/pnas.0703360104; Zabaloy MC, 2008, APPL SOIL ECOL, V40, P1, DOI 10.1016/j.apsoil.2008.02.004; Zabaloy MC, 2012, APPL SOIL ECOL, V61, P333, DOI 10.1016/j.apsoil.2011.12.004; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0	90	118	124	5	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99949	10.1371/journal.pone.0099949	http://dx.doi.org/10.1371/journal.pone.0099949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923965	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300109
J	Liu, B; Meng, D; Wei, TT; Zhang, SY; Hu, YX; Wang, M				Liu, Bo; Meng, Di; Wei, Tangting; Zhang, Siyi; Hu, Yanxin; Wang, Ming			Apoptosis and Pro-inflammatory Cytokine Response of Mast Cells Induced by Influenza A Viruses	PLOS ONE			English	Article							HUMAN MACROPHAGES; BCL-2 FAMILY; HOST IMMUNE; INFECTION; PROTEIN; ACTIVATION; CASPASE-1; INDUCTION; SURVIVAL; NECROSIS	The pathogenesis of the influenza A virus has been investigated heavily, and both the inflammatory response and apoptosis have been found to have a definitive role in this process. The results of studies performed by the present and other groups have indicated that mast cells may play a role in the severity of the disease. To further investigate cellular responses to influenza A virus infection, apoptosis and inflammatory response were studied in mouse mastocytoma cell line P815. This is the first study to demonstrate that H1N1 (A/WSN/33), H5N1 (A/Chicken/Henan/1/04), and H7N2 (A/Chicken/Hebei/2/02) influenza viruses can induce mast cell apoptosis. They were found to do this mainly through the mitochondria/cytochrome c-mediated intrinsic pathway, and the activation of caspase 8-mediated extrinsic pathway was here found to be weak. Two pro-apoptotic Bcl-2 homology domain 3 (BH3) -only molecules Bim and Puma appeared to be involved in the apoptotic pathways. When virus-induced apoptosis was inhibited in P815 cells using pan-caspase (Z-VAD-fmk) and caspase-9 (Z-LEHD-fmk) inhibitors, the replication of these three subtypes of viruses was suppressed and the secretions of pro-inflammatory cytokines and chemokines, including IL-6, IL-18, TNF-alpha, and MCP-1, decreased. The results of this study may further understanding of the role of mast cells in host defense and pathogenesis of influenza virus. They may also facilitate the development of novel therapeutic aids against influenza virus infection.	[Liu, Bo; Meng, Di; Wei, Tangting; Zhang, Siyi; Hu, Yanxin; Wang, Ming] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Zoonosis, Beijing 100094, Peoples R China; [Wang, Ming] China Anim Husb Grp, Zhongmu Inst, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Hu, YX (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Zoonosis, Beijing 100094, Peoples R China.	huyx@cau.edu.cn; vetdean@cau.edu.cn			National Natural Science Foundation of China [31272531]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31272531). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Alfredsson J, 2005, CELL DEATH DIFFER, V12, P136, DOI 10.1038/sj.cdd.4401537; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Brincks EL, 2008, HUM IMMUNOL, V69, P634, DOI 10.1016/j.humimm.2008.07.012; Brown MG, 2009, J LEUKOCYTE BIOL, V85, P71, DOI 10.1189/jlb.0308167; Brydon EWA, 2005, FEMS MICROBIOL REV, V29, P837, DOI 10.1016/j.femsre.2004.12.003; Brydon EWA, 2003, J GEN VIROL, V84, P2389, DOI 10.1099/vir.0.18913-0; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Choi YK, 2006, EXP MOL MED, V38, P11, DOI 10.1038/emm.2006.2; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Ekoff M, 2007, BLOOD, V110, P3209, DOI 10.1182/blood-2007-02-073957; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fujimoto I, 1998, CELL DEATH DIFFER, V5, P426, DOI 10.1038/sj.cdd.4400362; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Graham AC, 2013, J IMMUNOL, V190, P4676, DOI 10.4049/jimmunol.1202096; Halder UC, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.75; Herold S, 2012, J LEUKOCYTE BIOL, V92, P75, DOI 10.1189/jlb.1011530; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hu YX, 2012, J VIROL, V86, P3347, DOI 10.1128/JVI.06053-11; Ito T, 2002, VIRUS RES, V84, P27, DOI 10.1016/S0168-1702(01)00414-2; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kurokawa M, 1999, INT J MOL MED, V3, P527; Lam WY, 2008, J VIROL, V82, P2741, DOI 10.1128/JVI.01712-07; Marcet CW, 2013, IMMUNOL RES, V56, P32, DOI 10.1007/s12026-012-8377-4; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Pirhonen J, 2001, EUR J IMMUNOL, V31, P726, DOI 10.1002/1521-4141(200103)31:3<726::AID-IMMU726>3.0.CO;2-5; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Shelburne CP, 2011, ADV EXP MED BIOL, V716, P162, DOI 10.1007/978-1-4419-9533-9_10; SINKOVICS JG, 1991, ACTA MICROBIOL HUNG, V38, P321; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Stray SJ, 2001, VIRUS RES, V77, P3, DOI 10.1016/S0168-1702(01)00260-X; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; TAKIZAWA T, 1995, VIROLOGY, V209, P288, DOI 10.1006/viro.1995.1260; Technau-Ihling K, 2001, ARCH VIROL, V146, P1655, DOI 10.1007/s007050170054; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Us D, 2008, MIKROBIYOL BUL, V42, P365; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Xing Z, 2011, AM J RESP CELL MOL, V44, P24, DOI 10.1165/rcmb.2009-0120OC; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Yang W, 2009, MOL CELL BIOCHEM, V332, P233, DOI 10.1007/s11010-009-0196-0; Yeung TK, 1999, BIOCHEM BIOPH RES CO, V263, P398, DOI 10.1006/bbrc.1999.1375	48	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e100109	10.1371/journal.pone.0100109	http://dx.doi.org/10.1371/journal.pone.0100109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923273	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300122
J	Luchetti, M; Montebarocci, O; Rossi, N; Cutti, AG; Sutin, AR				Luchetti, Martina; Montebarocci, Ornella; Rossi, Nicolino; Cutti, Andrea G.; Sutin, Angelina R.			Autobiographical Memory and Psychological Distress in a Sample of Upper-Limb Amputees	PLOS ONE			English	Article							PSYCHOSOCIAL ADJUSTMENT; POSTTRAUMATIC-STRESS; BREAST-CANCER; TRAUMATIC UPPER; AMPUTATION; DISORDER; PHENOMENOLOGY; PEOPLE; SCALE	Amputation is a traumatic and life-changing event that can take years to adjust to. The present study (a) examines psychological adjustment in a specific trauma-exposed sample, (b) compares the phenomenology (e. g., vividness) of amputation-related memories to more recent memories, and (c) tests whether memory phenomenology is associated with psychological distress. A total of 24 upper-limb amputees recalled two autobiographical memories-an amputation-related memory and a recent memory-and rated the phenomenological qualities of each memory, including Vividness, Coherence, Emotional Intensity, Visual Perspective, and Distancing. Participants also completed self-rated measures of psychological distress and personality. The sample was generally well adjusted; participants showed no relevant symptoms of anxiety and depression, and personality scores were similar to the general population. There were no significant differences in phenomenology between the two types of memories recalled. Even though amputation-related memories were, on average, almost 20 years older than the recent memories, they retained their intense phenomenology. Despite the intensity of the memory, none of the phenomenological dimensions were associated with psychological distress. It is worth to further define which dimensions of phenomenology characterize memories of traumatic events, and their association with individuals' psychological reactions.	[Luchetti, Martina; Montebarocci, Ornella; Rossi, Nicolino] Univ Bologna, Dept Psychol, I-40126 Bologna, Italy; [Cutti, Andrea G.] INAIL, Prosthesis Ctr, Bologna, Italy; [Sutin, Angelina R.] Florida State Univ, Coll Med, Dept Behav Sci & Social Med, Tallahassee, FL 32306 USA	University of Bologna; State University System of Florida; Florida State University	Luchetti, M (corresponding author), Univ Bologna, Dept Psychol, I-40126 Bologna, Italy.	martina.luchetti3@unibo.it	Luchetti, Martina/A-4530-2017; Cutti, Andrea Giovanni/GZM-7387-2022	Luchetti, Martina/0000-0002-7370-8443; MONTEBAROCCI, ORNELLA/0000-0001-5429-1307; ROSSI, NICOLINO CESARE FRANCO/0000-0003-2060-6926				38Singer J. A., 2010, PRAGMATIC CASE STUDI, V6, P134, DOI DOI 10.14713/PCSP.V6I3.1041; Baumgartner RF, 2001, J REHABIL RES DEV, V38, pVII; Brewin CR, 2007, MEMORY, V15, P227, DOI 10.1080/09658210701256423; Cheung E, 2003, REHABIL PSYCHOL, V48, P109, DOI 10.1037/0090-5550.48.2.109; Coffey L, 2009, DIABETIC MED, V26, P1063, DOI 10.1111/j.1464-5491.2009.02802.x; Craft MA, 2013, J ADV NURS, V69, P305, DOI 10.1111/j.1365-2648.2012.06008.x; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Datta D, 2004, CLIN REHABIL, V18, P172, DOI 10.1191/0269215504cr716oa; Dekel S, 2013, PSYCHOL TRAUMA-US, V5, P26, DOI 10.1037/a0022750; Desmond DM, 2007, J PSYCHOSOM RES, V62, P15, DOI 10.1016/j.jpsychores.2006.07.027; Desmond DM, 2006, J PAIN SYMPTOM MANAG, V31, P362, DOI 10.1016/j.jpainsymman.2005.08.014; Fossati A, 2011, EUR J PSYCHOL ASSESS, V27, P50, DOI 10.1027/1015-5759/a000043; Hesse E., 2008, HDB ATTACHMENT THEOR, V2, P552; Horgan O, 2004, DISABIL REHABIL, V26, P837, DOI 10.1080/09638280410001708869; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; John O, 1991, BIG 5 INVENTORY VERS; Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P293, DOI 10.1037/0022-006X.73.2.293; Murray C, 2010, AMPUTATION, PROSTHESIS USE, AND PHANTOM LIMB PAIN, P175, DOI 10.1007/978-0-387-87462-3_12; National Limb Loss Information Center, 2008, FACT SHEET STAT CAUS; Nilsson-Ihrfelt E, 2004, J PSYCHOSOM RES, V57, P363, DOI 10.1016/j.jpsychores.2004.01.009; Ostlie K, 2011, DISABIL REHABIL, V33, P1594, DOI 10.3109/09638288.2010.540293; Richards JM, 2000, J ABNORM PSYCHOL, V109, P156, DOI 10.1037/0021-843X.109.1.156; Rubin DC, 2008, J EXP PSYCHOL GEN, V137, P591, DOI 10.1037/a0013165; Rybarczyk B, 2004, DISABIL REHABIL, V26, P944, DOI 10.1080/09638280410001708986; Singer J. A, 1993, REMEMBERED SELF; Singer JA, 2011, INT J PSYCHOANAL, V92, P1183, DOI 10.1111/j.1745-8315.2011.00415.x; Sumner JA, 2012, CLIN PSYCHOL REV, V32, P34, DOI 10.1016/j.cpr.2011.10.003; Sutin AR, 2007, MEMORY, V15, P390, DOI 10.1080/09658210701256654; Sutin AR, 2009, J COUNS PSYCHOL, V56, P351, DOI 10.1037/a0014917; Thomsen DK, 2007, NARRAT INQ, V17, P349; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99803	10.1371/journal.pone.0099803	http://dx.doi.org/10.1371/journal.pone.0099803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24924483	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300094
J	Mirabella, F; Murison, A; Aronson, LI; Wardell, CP; Thompson, AJ; Hanrahan, SJ; Fok, JHL; Pawlyn, C; Kaiser, MF; Walker, BA; Davies, FE; Morgan, GJ				Mirabella, Fabio; Murison, Alexander; Aronson, Lauren I.; Wardell, Christopher P.; Thompson, Andrew J.; Hanrahan, Sarah J.; Fok, Jacqueline H. L.; Pawlyn, Charlotte; Kaiser, Martin F.; Walker, Brian A.; Davies, Faith E.; Morgan, Gareth J.			A Novel Functional Role for MMSET in RNA Processing Based on the Link Between the REIIBP Isoform and Its Interaction with the SMN Complex	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; MULTIPLE-MYELOMA; RIBONUCLEOPROTEIN BIOGENESIS; HISTONE METHYLTRANSFERASE; GENE-EXPRESSION; LYSINE 36; PROTEIN; T(4/14); PATHWAY; METHYLATION	The chromosomal translocation t(4; 14) deregulates MMSET (WHSC1/NSD2) expression and is a poor prognostic factor in multiple myeloma (MM). MMSET encodes two major protein isoforms. We have characterized the role of the shorter isoform (REIIBP) in myeloma cells and identified a clear and novel interaction of REIIBP with members of the SMN (survival of motor neuron) complex that directly affects the assembly of the spliceosomal ribonucleic particles. Using RNA-seq we show that REIIBP influences the RNA splicing pattern of the cell. This new discovery provides novel insights into the understanding of MM pathology, and potential new leads for therapeutic targeting.	[Mirabella, Fabio; Murison, Alexander; Aronson, Lauren I.; Wardell, Christopher P.; Fok, Jacqueline H. L.; Pawlyn, Charlotte; Kaiser, Martin F.; Walker, Brian A.; Davies, Faith E.; Morgan, Gareth J.] Inst Canc Res, Ctr Myeloma Res, Div Mol Pathol, Sutton, Surrey, England; [Thompson, Andrew J.; Hanrahan, Sarah J.] Inst Canc Res, Prote Core Facil, London SW3 6JB, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Morgan, GJ (corresponding author), Inst Canc Res, Ctr Myeloma Res, Div Mol Pathol, Sutton, Surrey, England.	gareth.morgan@icr.ac.uk	Thompson, Andrew/B-1463-2014; Wardell, Christopher/B-5053-2018; Mirabella, Fabio/GVU-1467-2022	Thompson, Andrew/0000-0003-2413-3281; Wardell, Christopher/0000-0002-9416-7818; Mirabella, Fabio/0000-0003-3785-6868; morgan, gareth/0000-0002-4271-6360; Aronson, Lauren/0000-0002-8479-5685; Fok, Jacqueline Hoi Lam/0000-0002-6563-3023; Kaiser, Martin/0000-0002-3677-4804; Pawlyn, Charlotte/0000-0002-7190-0028; Davies, Faith/0000-0002-3971-2393; Walker, Brian/0000-0002-8615-6254	programme grant from Myeloma UK [MUK005X]; NIHR Biomedical Research Centre at the Royal Marsden Hospital	programme grant from Myeloma UK; NIHR Biomedical Research Centre at the Royal Marsden Hospital	This work was supported by a programme grant from Myeloma UK [MUK005X] (http://www.myeloma.org.uk/) and funding from The NIHR Biomedical Research Centre at the Royal Marsden Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson LI, 2013, LEUKEMIA, V27, P2397, DOI 10.1038/leu.2013.150; Battle DJ, 2007, J BIOL CHEM, V282, P27953, DOI 10.1074/jbc.M702317200; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Boyd KD, 2012, LEUKEMIA, V26, P349, DOI 10.1038/leu.2011.204; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brito JLR, 2009, HAEMATOL-HEMATOL J, V94, P78, DOI 10.3324/haematol.13426; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Chu L, 2012, J CLIN INVEST, V122, P2793, DOI 10.1172/JCI63051; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fu Y, 2011, NUCLEIC ACIDS RES, V39, P4396, DOI 10.1093/nar/gkr026; Fuller HR, 2010, J PROTEOME RES, V9, P556, DOI 10.1021/pr900884g; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Hao LT, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-28; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Z, 2013, CANCER RES, V73, P6277, DOI 10.1158/0008-5472.CAN-13-1000; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Keats JJ, 2003, BLOOD, V101, P1520, DOI 10.1182/blood-2002-06-1675; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Lucio-Eterovic AK, 2011, TRANSCR-AUSTIN, V2, P158, DOI 10.4161/trns.2.4.16217; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Mirabella F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.9; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; PADGETT RA, 1983, CELL, V35, P101, DOI 10.1016/0092-8674(83)90212-X; Patel SB, 2008, NUCLEIC ACIDS RES, V36, P6482, DOI 10.1093/nar/gkn658; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Ronchetti D, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.41; Todoerti K, 2005, BRIT J HAEMATOL, V131, P214, DOI 10.1111/j.1365-2141.2005.05741.x; Walker BA, 2010, BLOOD, V116, pE56, DOI 10.1182/blood-2010-04-279596; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052; Workman E, 2012, BRAIN RES, V1462, P93, DOI 10.1016/j.brainres.2012.02.051; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhang L, 2013, CANCER LETT, V339, P49, DOI 10.1016/j.canlet.2013.07.023; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	58	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99493	10.1371/journal.pone.0099493	http://dx.doi.org/10.1371/journal.pone.0099493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923560	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300068
J	Monnier, J; Zabel, BA				Monnier, Justin; Zabel, Brian A.			Anti-Asialo GM1 NK Cell Depleting Antibody Does Not Alter the Development of Bleomycin Induced Pulmonary Fibrosis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; LUNG INFLAMMATION; INTERFERON-GAMMA; INFECTION; MICE; SUSCEPTIBILITY; INHIBITION; INJURY; CD8(+)	Despite circumstantial evidence postulating a protective role for NK cells in many fibrotic conditions, their contribution to the development of pulmonary fibrosis has yet to be tested. Lung-migrating NK cells are thought to attenuate the development of bleomycin induced pulmonary fibrosis (BIPF) by providing anti-fibrotic mediators and cytokines, such as IFN-gamma. If true, we reasoned that depletion of NK cells during experimentally-induced fibrotic disease would lead to exacerbated fibrosis. To test this, we treated mice with NK cell-depleting antisera (anti-asialo GM1) and evaluated lung inflammation and fibrosis in the BIPF model. While NK cell infiltration into the airways was maximal at day 10 after bleomycin injection, NK cells represented a minor portion (1-3%) of the total leukocytes in BAL fluid. Anti-asialo GM1 significantly abrogated NK cell numbers over the course of the disease. Depletion of NK cells with anti-asialo GM1 before and throughout the BIPF model, or during just the fibrotic phase did not alter fibrosis development or affect the levels of any of the pro-inflammatory/pro-fibrotic cytokines measured (IL-1 beta, IL-17, IFN-gamma, TGF-beta and TNF-alpha). In addition, adoptively transferred NK cells, which were detectable systemically and in the airways throughout BIPF, failed to impact lung fibrosis. These findings indicate that NK cells likely do not play an essential protective role in controlling pulmonary fibrosis development.	[Monnier, Justin] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Monnier, Justin; Zabel, Brian A.] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto Inst Res & Educ, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Zabel, BA (corresponding author), Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto Inst Res & Educ, Palo Alto, CA 94304 USA.	bazabel@alum.mit.edu			Department of Defense [W81XWH-11-1-0512]; NIH [AI-079320]; NIH T-32 training [T32-AI07290-25, T32-AI07290-24]; American Cancer Society; FACS Core Facility of the Stanford Digestive Disease Center [P30 DK056339]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079320, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T-32 training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); FACS Core Facility of the Stanford Digestive Disease Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Department of Defense grant W81XWH-11-1-0512 and NIH grant AI-079320 to BAZ; by fellowships to JM under NIH T-32 training grant T32-AI07290-25, T32-AI07290-24 and the American Cancer Society; and by the FACS Core Facility of the Stanford Digestive Disease Center under P30 DK056339. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Aono Y, 2012, AM J RESP CRIT CARE, V185, P525, DOI 10.1164/rccm.201103-0561OC; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; BITTERMAN PB, 1986, NEW ENGL J MED, V314, P1343, DOI 10.1056/NEJM198605223142103; Burdick MD, 2005, AM J RESP CRIT CARE, V171, P261, DOI 10.1164/rccm.200409-1164OC; Chen ES, 2001, AM J RESP CELL MOL, V24, P545, DOI 10.1165/ajrcmb.24.5.4064; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Gao K, 2013, CANCER LETT, V335, P463, DOI 10.1016/j.canlet.2013.03.002; Horikawa M, 2006, AM J PATHOL, V169, P740, DOI 10.2353/ajpath.2006.060086; Hummel S, 2002, J LEUKOCYTE BIOL, V72, P898; Jessen B, 2011, BLOOD, V118, P4620, DOI 10.1182/blood-2011-05-356113; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Jiang DH, 2010, J CLIN INVEST, V120, P2049, DOI 10.1172/JCI38644; KASAI M, 1980, EUR J IMMUNOL, V10, P175, DOI 10.1002/eji.1830100304; Kataoka S, 2004, DNA CELL BIOL, V23, P549, DOI 10.1089/dna.2004.23.549; Kim JH, 2005, AM J PATHOL, V167, P1231, DOI 10.1016/S0002-9440(10)61211-4; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Koyama K, 2002, PARASITE IMMUNOL, V24, P527, DOI 10.1046/j.1365-3024.2002.00497.x; Kumar P, 2013, MUCOSAL IMMUNOL, V6, P69, DOI 10.1038/mi.2012.49; Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Nishikado H, 2011, J IMMUNOL, V186, P5766, DOI 10.4049/jimmunol.1100370; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Segel MJ, 2003, AM J PHYSIOL-LUNG C, V285, pL1255, DOI 10.1152/ajplung.00303.2002; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Slifka MK, 2000, J IMMUNOL, V164, P2009, DOI 10.4049/jimmunol.164.4.2009; Small CL, 2010, J IMMUNOL, V184, P2048, DOI 10.4049/jimmunol.0902772; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Tian ZG, 2013, HEPATOLOGY, V57, P1654, DOI 10.1002/hep.26115; Tighe RM, 2011, AM J RESP CELL MOL, V45, P781, DOI 10.1165/rcmb.2010-0471OC; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; Waggoner SN, 2013, J VIROLOGY; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; WILTROUT RH, 1985, J LEUKOCYTE BIOL, V37, P597, DOI 10.1002/jlb.37.5.597; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zaldivar MM, 2012, LAB INVEST, V92, P724, DOI 10.1038/labinvest.2012.48; Zhou G, 2013, EUR J IMMUNOL, V43, P929, DOI 10.1002/eji.201242620	40	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99350	10.1371/journal.pone.0099350	http://dx.doi.org/10.1371/journal.pone.0099350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922516	gold, Green Published, Green Submitted			2022-12-25	WOS:000338701300051
J	Park, HJ; Kim, DH; Choi, JY; Kim, WJ; Kim, JY; Senejani, AG; Hwang, SS; Kim, LK; Tobiasova, Z; Lee, GR; Craft, J; Bothwell, ALM; Choi, JM				Park, Hong-Jai; Kim, Do-Hyun; Choi, Jin-Young; Kim, Won-Ju; Kim, Ji Yun; Senejani, Alireza G.; Hwang, Soo Seok; Kim, Lark Kyun; Tobiasova, Zuzana; Lee, Gap Ryol; Craft, Joseph; Bothwell, Alfred L. M.; Choi, Je-Min			PPAR gamma Negatively Regulates T Cell Activation to Prevent Follicular Helper T Cells and Germinal Center Formation	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; NUCLEAR RECEPTORS; AGONISTS; EXPRESSION; IMMUNOREGULATION; INFLAMMATION; MATURATION; PHENOTYPE; ICOS; MICE	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a transcription factor that regulates lipid and glucose metabolism. Although studies of PPAR gamma ligands have demonstrated its regulatory functions in inflammation and adaptive immunity, its intrinsic role in T cells and autoimmunity has yet to be fully elucidated. Here we used CD4-PPAR gamma(KO) mice to investigate PPAR gamma-deficient T cells, which were hyper-reactive to produce higher levels of cytokines and exhibited greater proliferation than wild type T cells with increased ERK and AKT phosphorylation. Diminished expression of I kappa B alpha, Sirt1, and Foxo1, which are inhibitors of NF-kappa B, was observed in PPAR gamma-deficient T cells that were prone to produce all the signature cytokines under Th1, Th2, Th17, and Th9 skewing condition. Interestingly, 1-year-old CD4-PPAR gamma(KO) mice spontaneously developed moderate autoimmune phenotype by increased activated T cells, follicular helper T cells (T-FH cells) and germinal center B cells with glomerular inflammation and enhanced autoantibody production. Sheep red blood cell immunization more induced T-FH cells and germinal centers in CD4-PPAR gamma(KO) mice and the T cells showed increased of Bcl-6 and IL-21 expression suggesting its regulatory role in germinal center reaction. Collectively, these results suggest that PPAR gamma has a regulatory role for T-FH cells and germinal center reaction to prevent autoimmunity.	[Park, Hong-Jai; Kim, Do-Hyun; Kim, Won-Ju; Kim, Ji Yun; Choi, Je-Min] Hanyang Univ, Res Inst Nat Sci, Dept Life Sci, Seoul 133791, South Korea; [Park, Hong-Jai; Kim, Do-Hyun; Kim, Won-Ju; Kim, Ji Yun; Choi, Je-Min] Hanyang Biomed Res Inst, Seoul, South Korea; [Choi, Jin-Young; Craft, Joseph] Yale Univ, Sch Med, Dept Internal Med Rheumatol, New Haven, CT USA; [Senejani, Alireza G.] Yale Univ, Sch Med, Dept Therapeut Radiol & Genet, New Haven, CT USA; [Hwang, Soo Seok; Lee, Gap Ryol] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Kim, Lark Kyun; Tobiasova, Zuzana; Craft, Joseph; Bothwell, Alfred L. M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Hanyang University; Yale University; Yale University; Sogang University; Yale University	Bothwell, ALM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	alfred.bothwell@yale.edu; jeminchoi@hanyang.ac.kr	Hwang, Soo Seok/AAL-3292-2020	Hwang, Soo Seok/0000-0002-1635-4191; Kim, Wonju/0000-0002-1800-0485; Choi, Je-Min/0000-0002-9482-710X	Basic Science Research Program through National Research Foundation of Korea [NRF-2011-0012859, NRF-2013R1A1A2A10060048]; NIH [HL088258, AR40072]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR040072, R01AR040072] Funding Source: NIH RePORTER	Basic Science Research Program through National Research Foundation of Korea(National Research Foundation of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Basic Science Research Program through National Research Foundation of Korea grants (NRF-2011-0012859 and NRF-2013R1A1A2A10060048) to J.M. Choi. It also was supported by NIH grant HL088258 to A.L.M. Bothwell and AR40072 to J. Craft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Choi JM, 2012, MOL CELLS, V33, P217, DOI 10.1007/s10059-012-2297-y; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Hsueh WA, 2001, ARTERIOSCL THROM VAS, V21, P1891, DOI 10.1161/hq1201.100261; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; LANE P, 1994, J EXP MED, V179, P819, DOI 10.1084/jem.179.3.819; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Park Hong-Jai, 2014, Immune Netw, V14, P21, DOI 10.4110/in.2014.14.1.21; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Su DM, 2009, DIABETES, V58, P2624, DOI 10.2337/db09-0232; Sweet RA, 2012, CURR OPIN IMMUNOL, V24, P658, DOI 10.1016/j.coi.2012.10.003; Tobiasova Z, 2011, CIRCULATION, V124, P196, DOI 10.1161/CIRCULATIONAHA.110.015396; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Wohlfert EA, 2007, J IMMUNOL, V178, P4129, DOI 10.4049/jimmunol.178.7.4129; Xiong SQ, 2011, J BIOL CHEM, V286, P5289, DOI 10.1074/jbc.M110.163667; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yang XY, 2000, J BIOL CHEM, V275, P4541, DOI 10.1074/jbc.275.7.4541; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902	45	25	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99127	10.1371/journal.pone.0099127	http://dx.doi.org/10.1371/journal.pone.0099127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921943	gold, Green Published, Green Submitted			2022-12-25	WOS:000338701300034
J	Seino, S; Shinkai, S; Fujiwara, Y; Obuchi, S; Yoshida, H; Hirano, H; Kim, HK; Ishizaki, T; Takahashi, R				Seino, Satoshi; Shinkai, Shoji; Fujiwara, Yoshinori; Obuchi, Shuichi; Yoshida, Hideyo; Hirano, Hirohiko; Kim, Hun Kyung; Ishizaki, Tatsuro; Takahashi, Ryutaro		TMIG-LISA Res Grp	Reference Values and Age and Sex Differences in Physical Performance Measures for Community-Dwelling Older Japanese: A Pooled Analysis of Six Cohort Studies	PLOS ONE			English	Article							WALKING SPEED; GAIT SPEED; HANDGRIP STRENGTH; MUSCLE STRENGTH; RURAL-COMMUNITY; TOTAL MORTALITY; GO TEST; ADULTS; DECLINE; PEOPLE	Objectives: To determine age- and sex-specific reference values for six physical performance measures, i.e. hand-grip strength, one-legged stance, and gait speed and step length at both usual and maximum paces, and to investigate age and sex differences in these measures among community-dwelling older Japanese adults. Methods: We conducted a pooled analysis of data from six cohort studies collected between 2002 and 2011 as part of the Tokyo Metropolitan Institute of Gerontology-Longitudinal Interdisciplinary Study on Aging. The pooled analysis included cross-sectional data from 4683 nondisabled, community-dwelling adults aged 65 years or older (2168 men, 2515 women; mean age: 74.0 years in men and 73.9 years in women). Results: Unweighted simple mean (standard deviation) hand-grip strength, one-legged stance, usual gait speed, usual gait step length, maximum gait speed, and maximum gait step length were 31.7 (6.7) kg, 39.3 (23.0) s, 1.29 (0.25) m/s, 67.7 (10.0) cm, 1.94 (0.38) m/s, and 82.3 (11.6) cm, respectively, in men and 20.4 (5.0) kg, 36.8 (23.4) s, 1.25 (0.27) m/s, 60.8 (10.0) cm, 1.73 (0.36) m/s, and 69.7 (10.8) cm, respectively, in women. All physical performance measures showed significant decreasing trends with advancing age in both sexes (all P<0.001 for trend). We also constructed age-and sex-specific appraisal standards according to quintiles. With increasing age, the sex difference in hand-grip strength decreased significantly (P<0.001 for age and sex interaction). In contrast, sex differences significantly increased in all other measures (all P<0.05 for interactions) except step length at maximum pace. Conclusion: Our pooled analysis yielded inclusive age-and sex-specific reference values and appraisal standards for major physical performance measures in nondisabled, community-dwelling, older Japanese adults. The characteristics of age-related decline in physical performance measures differed between sexes.	[Seino, Satoshi; Shinkai, Shoji; Fujiwara, Yoshinori; Obuchi, Shuichi; Yoshida, Hideyo; Hirano, Hirohiko; Kim, Hun Kyung; Ishizaki, Tatsuro; Takahashi, Ryutaro] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo, Japan; [Seino, Satoshi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; Japan Society for the Promotion of Science	Shinkai, S (corresponding author), Tokyo Metropolitan Inst Gerontol, Itabashi Ku, 35-2 Sakae, Tokyo, Japan.	sshinkai@tmig.or.jp		Seino, Satoshi/0000-0002-3620-8730	Tokyo Metropolitan Government; Japan Arteriosclerosis Prevention Fund; Research Institute of Science and Technology for Society; Japan Science and Technology Agency; International Life Sciences Institute of Japan; Japan Society for the Promotion of Science [17659192]; Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan [H14-Chouju-006, H15-Ganyobo-065, H15-Seisaku-017, H16-Chouju-031, H23-Chouju-Ippan-001, H23-Chouju-Ippan-002];  [14370150];  [17390194];  [21390212]; Grants-in-Aid for Scientific Research [24792611, 24390173, 26282201, 26310111] Funding Source: KAKEN	Tokyo Metropolitan Government(Tokyo Metropolitan Government); Japan Arteriosclerosis Prevention Fund; Research Institute of Science and Technology for Society; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); International Life Sciences Institute of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Tokyo Metropolitan Government, the Japan Arteriosclerosis Prevention Fund (jals.gr.jp/en/index.html), the Research Institute of Science and Technology for Society, the Japan Science and Technology Agency (www.ristex.jp/EN/index.html), International Life Sciences Institute of Japan (www.ilsijapan.org/English/ILSIJapan/ILJ/IL.php), Grants-in-Aid for Scientific Research (B) (2) 14370150, (B) 17390194, (B) 21390212, and a Grant-in-Aid for Exploratory Research 17659192 from the Japan Society for the Promotion of Science, and Health Labour Sciences Research Grants H14-Chouju-006, H15-Ganyobo-065, H15-Seisaku-017, H16-Chouju-031, H23-Chouju-Ippan-001, and H23-Chouju-Ippan-002 from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1991, MULTIPLE REGRESSION; Aoyagi K, 2001, BMC Geriatr, V1, P3, DOI 10.1186/1471-2318-1-3; Beauchet O, 2013, J NUTR HEALTH AGING, V17, P235, DOI 10.1007/s12603-012-0394-4; Bohannon Richard W, 2006, J Geriatr Phys Ther, V29, P64; Bohannon RW, 2006, PERCEPT MOTOR SKILL, V103, P215, DOI 10.2466/PMS.103.1.215-222; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Bohannon RW, 1997, ARCH PHYS MED REHAB, V78, P26, DOI 10.1016/S0003-9993(97)90005-8; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari M, 2011, JAMA-J AM MED ASSOC, V305, P93, DOI 10.1001/jama.2010.1970; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Coldham F, 2006, J HAND THER, V19, P318, DOI 10.1197/j.jht.2006.04.002; COOPER R, 2011, PLOS ONE, V0006; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Fess EE., 1992, CLIN ASSESSMENT RECO, P41; Fitzpatrick AL, 2007, J GERONTOL A-BIOL, V62, P1244, DOI 10.1093/gerona/62.11.1244; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fujiwara Y, 2013, J GERIATR PSYCH NEUR, V26, P209, DOI 10.1177/0891988713497096; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Graham JE, 2008, ARCH PHYS MED REHAB, V89, P865, DOI 10.1016/j.apmr.2007.11.029; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; Hamilton A, 1994, J Hand Ther, V7, P163; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Ishizaki T, 2000, J AM GERIATR SOC, V48, P1424, DOI 10.1111/j.1532-5415.2000.tb02632.x; Ishizaki T, 2011, J EPIDEMIOL, V21, P176, DOI 10.2188/jea.JE20100138; Ishizaki T, 2009, GERONTOLOGY, V55, P344, DOI 10.1159/000183749; Kamide N, 2011, GERIATR GERONTOL INT, V11, P445, DOI 10.1111/j.1447-0594.2011.00704.x; Kan Mari, 2006, Nihon Koshu Eisei Zasshi, V53, P688; Kenny RA, 2013, J AM GERIATR SOC, V61, pS279, DOI [10.1111/jgs.12195, 10.1111/jgs.12200]; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Lindemann U, 2008, GAIT POSTURE, V27, P91, DOI 10.1016/j.gaitpost.2007.02.005; Lindernann U, 2008, AGING CLIN EXP RES, V20, P394; Murayama H, 2012, J EPIDEMIOL, V22, P551, DOI 10.2188/jea.JE20120015; Neyeloff Jeruza L, 2012, BMC Res Notes, V5, P52, DOI 10.1186/1756-0500-5-52; Oh-Park M, 2010, J AM GERIATR SOC, V58, P1512, DOI 10.1111/j.1532-5415.2010.02962.x; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Sallinen J, 2010, J AM GERIATR SOC, V58, P1721, DOI 10.1111/j.1532-5415.2010.03035.x; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Schoene D, 2013, J AM GERIATR SOC, V61, P202, DOI 10.1111/jgs.12106; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; Shinkai S, 2008, ARCH INTERN MED, V168, P200, DOI 10.1001/archinternmed.2007.64; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Suzuki Takao, 2003, Nihon Koshu Eisei Zasshi, V50, P39; Taniguchi Y, 2012, J GERONTOL A-BIOL, V67, P796, DOI 10.1093/gerona/glr243; Tseng L.A., 2013, J GERONTOL A-BIOL, V69, P93; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Verghese J, 2013, J GERONTOL A-BIOL, V68, P412, DOI 10.1093/gerona/gls191; Vianna LC, 2007, J STRENGTH COND RES, V21, P1310; Volpato S, 2011, J GERONTOL A-BIOL, V66, P89, DOI 10.1093/gerona/glq167; Wang CY, 2012, PERCEPT MOTOR SKILL, V114, P469, DOI 10.2466/10.25.26.PMS.114.2.469-478; Woo J, 1999, J AM GERIATR SOC, V47, P1257, DOI 10.1111/j.1532-5415.1999.tb05209.x; Yoshida Yuko, 2008, Nihon Koshu Eisei Zasshi, V55, P221; Yukawa M, 2000, J AM GERIATR SOC, V48, P1527, DOI 10.1111/jgs.2000.48.11.1527	58	84	85	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99487	10.1371/journal.pone.0099487	http://dx.doi.org/10.1371/journal.pone.0099487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24923425	gold, Green Published, Green Submitted			2022-12-25	WOS:000338701300067
J	Chianese, C; Gunning, AC; Giachini, C; Daguin, F; Balercia, G; Ars, E; Lo Giacco, D; Ruiz-Castane, E; Forti, G; Krausz, C				Chianese, Chiara; Gunning, Adam C.; Giachini, Claudia; Daguin, Fabrice; Balercia, Giancarlo; Ars, Elisabet; Lo Giacco, Deborah; Ruiz-Castane, Eduard; Forti, Gianni; Krausz, Csilla			X Chromosome-Linked CNVs in Male Infertility: Discovery of Overall Duplication Load and Recurrent, Patient-Specific Gains with Potential Clinical Relevance	PLOS ONE			English	Article							PSEUDOAUTOSOMAL REGION; DNA-REPLICATION; Y-CHROMOSOME; DIAGNOSIS; GENES; CELLS	Introduction: Spermatogenesis is a highly complex process involving several thousand genes, only a minority of which have been studied in infertile men. In a previous study, we identified a number of Copy Number Variants (CNVs) by high-resolution array-Comparative Genomic Hybridization (a-CGH) analysis of the X chromosome, including 16 patient-specific X chromosome-linked gains. Of these, five gains (DUP1A, DUP5, DUP20, DUP26 and DUP40) were selected for further analysis to evaluate their clinical significance. Materials and Methods: The copy number state of the five selected loci was analyzed by quantitative-PCR on a total of 276 idiopathic infertile patients and 327 controls in a conventional case-control setting (199 subjects belonged to the previous a-CGH study). For one interesting locus (intersecting DUP1A) additional 338 subjects were analyzed. Results and Discussion: All gains were confirmed as patient-specific and the difference in duplication load between patients and controls is significant (p = 1.65 x 10(-4)). Two of the CNVs are private variants, whereas 3 are found recurrently in patients and none of the controls. These CNVs include, or are in close proximity to, genes with testis-specific expression. DUP1A, mapping to the PAR1, is found at the highest frequency (1.4%) that was significantly different from controls (0%) (p = 0.047 after Bonferroni correction). Two mechanisms are proposed by which DUP1A may cause spermatogenic failure: i) by affecting the correct regulation of a gene with potential role in spermatogenesis; ii) by disturbing recombination between PAR1 regions during meiosis. This study allowed the identification of novel spermatogenesis candidate genes linked to the 5 CNVs and the discovery of the first recurrent, X-linked gain with potential clinical relevance.	[Chianese, Chiara; Gunning, Adam C.; Giachini, Claudia; Daguin, Fabrice; Forti, Gianni; Krausz, Csilla] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Chianese, Chiara; Gunning, Adam C.; Giachini, Claudia; Daguin, Fabrice; Forti, Gianni; Krausz, Csilla] Ctr Excellence DeNothe, Florence, Italy; [Balercia, Giancarlo] Polytech Univ Marche, Umberto I Hosp, Dept Clin & Mol Sci, Div Endocrinol, Ancona, Italy; [Chianese, Chiara; Ars, Elisabet; Lo Giacco, Deborah] Univ Autonoma Barcelona, Fundacio Puigvert, Mol Biol Lab, E-08193 Barcelona, Spain; [Lo Giacco, Deborah; Ruiz-Castane, Eduard; Krausz, Csilla] Univ Autonoma Barcelona, Fundacio Puigvert, Androl Serv, E-08193 Barcelona, Spain	University of Florence; Marche Polytechnic University; Autonomous University of Barcelona; Fundacio Puigvert; Autonomous University of Barcelona; Fundacio Puigvert	Krausz, C (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy.	c.krausz@dfc.unifi.it	Ars, Elisabet/AAM-8454-2021	Ars, Elisabet/0000-0002-4118-4358; Krausz, Csilla Gabriella/0000-0001-6748-8918	Tuscan Regional Health Research Program; Spanish Ministry of Health [FIS-11/02254]; PRIN; European Commission - Reproductive Biology Early Research Training (REPROTRAIN) [289880]	Tuscan Regional Health Research Program; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); European Commission - Reproductive Biology Early Research Training (REPROTRAIN)	This work was supported by the Tuscan Regional Health Research Program; Spanish Ministry of Health (grant FIS-11/02254); PRIN 2009; European Commission - Reproductive Biology Early Research Training (REPROTRAIN, Project Number: 289880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chalmel F, 2012, HUM REPROD, V27, P3233, DOI 10.1093/humrep/des301; CHANDLEY AC, 1971, CYTOGENETICS, V10, P295, DOI 10.1159/000130149; Eward KL, 2004, J CELL SCI, V117, P5875, DOI 10.1242/jcs.01503; Filatov DA, 2004, MOL BIOL EVOL, V21, P410, DOI 10.1093/molbev/msh032; Jorgez CJ, 2011, J CLIN ENDOCR METAB, V96, pE674, DOI 10.1210/jc.2010-2018; Krausz C, 2014, ANDROLOGY-US, V2, P5, DOI 10.1111/j.2047-2927.2013.00173.x; Krausz C, 2011, J ENDOCRINOL INVEST, V34, P376, DOI [10.1007/BF03347463, 10.3275/7612]; Krausz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044887; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; Lopes AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003349; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; MOHANDAS TK, 1992, AM J HUM GENET, V51, P526; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Mueller JL, 2013, NAT GENET, V45, P1083, DOI 10.1038/ng.2705; Prakash SK, 1999, GENOMICS, V59, P77, DOI 10.1006/geno.1999.5844; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Tuttelmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019426; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yan Z, 2000, MOL CELL BIOL, V20, P1021, DOI 10.1128/MCB.20.3.1021-1029.2000; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	22	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e97746	10.1371/journal.pone.0097746	http://dx.doi.org/10.1371/journal.pone.0097746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914684	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700012
J	Di-Poi, C; Lacasse, J; Rogers, SM; Aubin-Horth, N				Di-Poi, Carole; Lacasse, Jennyfer; Rogers, Sean M.; Aubin-Horth, Nadia			Extensive Behavioural Divergence following Colonisation of the Freshwater Environment in Threespine Sticklebacks	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; GASTEROSTEUS-ACULEATUS; 3-SPINED STICKLEBACK; ANTIPREDATOR BEHAVIOR; POPULATIONS; EVOLUTION; BOLDNESS; TEMPERAMENT; INFORMATION; AGGRESSION	Colonisation of novel environments means facing new ecological challenges often resulting in the evolution of striking divergence in phenotypes. However, little is known about behavioural divergence following colonisation, despite the predicted importance of the role of behavioural phenotype-environment associations in adaptive divergence. We studied the threespine stickleback (Gasterosteus aculeatus), a model system for postglacial colonisation of freshwater habitats largely differing in ecological conditions from the ones faced by the descendants of the marine ancestor. We found that common-environment reared freshwater juveniles were less social, more active and more aggressive than their marine counterparts. This behavioural divergence could represent the result of natural selection that acted on individuals following freshwater colonisation, with predation as a key selection agent. Alternatively, the behavioural profile of freshwater juveniles could represent the characteristics of individuals that preferentially invaded freshwater after the glacial retreat, drawn from the standing variation present in the marine population.	[Di-Poi, Carole; Lacasse, Jennyfer; Aubin-Horth, Nadia] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Di-Poi, Carole; Lacasse, Jennyfer; Aubin-Horth, Nadia] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ G1K 7P4, Canada; [Rogers, Sean M.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Laval University; Laval University; University of Calgary	Aubin-Horth, N (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	Nadia.Aubin-Horth@bio.ulaval.ca	Di Poi, Carole/H-6493-2017	Di Poi, Carole/0000-0001-7846-5287	Government of Canada Post-Doctoral Research Fellowship; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Technology Futures New Faculty Award	Government of Canada Post-Doctoral Research Fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures New Faculty Award	Funding was provided to C. Di-Poi by the Government of Canada Post-Doctoral Research Fellowship, to N. Aubin-Horth and S. Rogers through Natural Sciences and Engineering Research Council of Canada Discovery grants and an Alberta Innovates Technology Futures New Faculty Award to S. Rogers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin-Horth N, 2012, HORM BEHAV, V61, P140, DOI 10.1016/j.yhbeh.2011.11.008; BAKKER TCM, 1988, ANIM BEHAV, V36, P1556, DOI 10.1016/S0003-3472(88)80233-1; Barrett RDH, 2011, P ROY SOC B-BIOL SCI, V278, P233, DOI 10.1098/rspb.2010.0923; Barrett RDH, 2009, BIOL LETTERS, V5, P788, DOI 10.1098/rsbl.2009.0416; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bell MA, 1994, EVOLUTIONARY BIOL TH, P571; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braithwaite VA, 2003, J FISH BIOL, V63, P74, DOI 10.1111/j.1095-8649.2003.00218.x; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Brydges NM, 2008, J ANIM ECOL, V77, P229, DOI 10.1111/j.1365-2656.2007.01343.x; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; Chamberlain NL, 2009, SCIENCE, V326, P847, DOI 10.1126/science.1179141; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cooper WJ, 2010, PLOS ONE, V5, pA38, DOI 10.1371/journal.pone.0009551; Cresko WA, 2007, GENETICA, V129, P105, DOI 10.1007/s10709-006-0036-z; Dalziel AC, 2012, EVOLUTION, V66, P1226, DOI 10.1111/j.1558-5646.2011.01498.x; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dzieweczynski TL, 2011, J FISH BIOL, V79, P776, DOI 10.1111/j.1095-8649.2011.03064.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; GILES N, 1984, ANIM BEHAV, V32, P264, DOI 10.1016/S0003-3472(84)80346-2; GODIN JGJ, 1988, NATURE, V333, P69, DOI 10.1038/333069a0; Grant PR, 2011, HOW AND WHY SPECIES, P218; Greenwood AK, 2011, HEREDITY, V107, P155, DOI 10.1038/hdy.2011.1; Greenwood AK, 2013, CURR BIOL, V23, P1884, DOI 10.1016/j.cub.2013.07.058; Herczeg G, 2011, J EVOLUTION BIOL, V24, P2434, DOI 10.1111/j.1420-9101.2011.02371.x; Herczeg G, 2012, EVOL ECOL, V26, P109, DOI 10.1007/s10682-011-9491-9; Huizinga M, 2009, J EVOLUTION BIOL, V22, P1860, DOI 10.1111/j.1420-9101.2009.01799.x; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; Kitano J, 2010, CURR BIOL, V20, P2124, DOI 10.1016/j.cub.2010.10.050; Knowles LL, 2005, MOL ECOL, V14, P4023, DOI 10.1111/j.1365-294X.2005.02711.x; Lacasse J, 2012, CURR ZOOL, V58, P53, DOI 10.1093/czoolo/58.1.53; Laskowski KL, 2013, ECOL LETT, V16, P746, DOI 10.1111/ele.12105; Losos JB., 2009, LIZARDS EVOLUTIONARY, P528; MAGURRAN AE, 1991, BEHAVIOUR, V118, P214, DOI 10.1163/156853991X00292; MAGURRAN AE, 1992, P ROY SOC B-BIOL SCI, V248, P117, DOI 10.1098/rspb.1992.0050; Marchinko KB, 2009, EVOLUTION, V63, P127, DOI 10.1111/j.1558-5646.2008.00529.x; Nomakuchi S, 2009, BEHAV ECOL, V20, P340, DOI 10.1093/beheco/arp001; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Pitcher T. J, 1993, BEHAV TELEOST FISHES; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rogers SM, 2012, EVOLUTION, V66, P2439, DOI 10.1111/j.1558-5646.2012.01622.x; Rogers SM, 2002, EVOLUTION, V56, P2322; Saimoto RK, 1993, THESIS U BRIT COLUMB, P97; Schluter D, 2000, OXFORD SERIES ECOLOG, V296; Schluter D, 2010, PHILOS T R SOC B, V365, P2479, DOI 10.1098/rstb.2010.0036; SNYDER RJ, 1989, CAN J ZOOL, V67, P2448, DOI 10.1139/z89-345; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Wark AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018316	49	14	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98980	10.1371/journal.pone.0098980	http://dx.doi.org/10.1371/journal.pone.0098980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914554	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700047
J	Souza, TAJ; Noll, FB; Bicudo, HEMD; Madi-Ravazzi, L				Jorge Souza, Tiago Alves; Noll, Fernando Barbosa; Melara de Campos Bicudo, Hermione Elly; Madi-Ravazzi, Lilian			Scanning Electron Microscopy of Male Terminalia and Its Application to Species Recognition and Phylogenetic Reconstruction in the Drosophila saltans Group	PLOS ONE			English	Article							ESTERASE PATTERNS; MOLECULAR EVOLUTION; DIPTERA; NUCLEAR	The Drosophila saltans group consists of five subgroups and 21 species, most of which have been identified only by morphological aspects of the male terminalia revealed by drawings using a camera lucida and a bright-field microscope. However, several species in the group, mainly those included in the saltans subgroup, are difficult to differentiate using only these characteristics. In this study, we used scanning electron microscopy (SEM) to analyze 19 structures of the male terminalia in 10 species from the five saltans subgroups. Among these structures, nine could be identified only through SEM analysis. We aimed to find other characteristics useful for morphological recognition of these species and to use these characteristics for phylogenetic reconstruction. These morphological differences enabled us to effectively distinguish among sibling species. These findings confirmed the monophyly of this group as previously determined in evolutionary studies based on other markers. The single most parsimonious tree (CI = 87 and RI = 90) indicated that the cordata subgroup is the most basal lineage and the saltans subgroup is the most apical lineage, as shown in earlier studies based on morphological data. However, our findings differed somewhat from these studies with respect to the phylogenetic relationships of species in the saltans group indicating that this group is still a puzzle that remains to be deciphered.	[Jorge Souza, Tiago Alves] Univ Sao Paulo, Dept Genet, BR-14049 Ribeirao Preto, Brazil; [Noll, Fernando Barbosa] Sao Paulo State Univ, UNESP IBILCE, Dept Bot & Zool, Sao Jose Do Rio Preto, SP, Brazil; [Melara de Campos Bicudo, Hermione Elly; Madi-Ravazzi, Lilian] Sao Paulo State Univ, UNESP IBILCE, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista	Madi-Ravazzi, L (corresponding author), Sao Paulo State Univ, UNESP IBILCE, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil.	lilian@ibilce.unesp.br	de Souza, Tiago Alves Jorge/I-8236-2019; Madi-Ravazzi, Lilian/H-2587-2013; FERNANDO, NOLL B/A-3606-2008; NOLL, FERNANDO BARBOSA/N-1206-2019	de Souza, Tiago Alves Jorge/0000-0001-9308-4773; Madi-Ravazzi, Lilian/0000-0002-6250-0794; FERNANDO, NOLL B/0000-0003-0207-1067; NOLL, FERNANDO BARBOSA/0000-0003-0207-1067	FAPESP (Foundation for supporting research of the Sao Paulo State) [07/07180-3]	FAPESP (Foundation for supporting research of the Sao Paulo State)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Foundation for supporting research of the Sao Paulo State, Process number: 07/07180-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachli G., 2004, FAUNA ENTOMOL SCAD, V39; Bernardo AA, 2009, GENETICA, V137, P111, DOI 10.1007/s10709-009-9357-z; BICUDO H E M C, 1978, Revista Brasileira de Genetica, V1, P11; Bicudo HEMC., 1979, REV BRAS GENET, V2, P247; BICUDO HEMD, 1973, GENETICA, V44, P313; BICUDO HEMD, 1973, GENETICA, V44, P520; Clark JB, 1997, P NATL ACAD SCI USA, V94, P11428, DOI 10.1073/pnas.94.21.11428; CLARK JB, 1995, MOL BIOL EVOL, V12, P902; de Castro JP, 2004, J MOL EVOL, V59, P31, DOI 10.1007/s00239-004-2601-3; de Castro JP, 2004, MOL PHYLOGENET EVOL, V32, P383, DOI 10.1016/j.ympev.2004.01.005; Evans JP, 2011, P ROY SOC B-BIOL SCI, V278, P2611, DOI 10.1098/rspb.2010.2453; Goloboff P.A., 2003, TREE ANAL USING NEW; GRIMALDI DA, 1990, B AM MUS NAT HIST, P1; Jamjoom Manal B., 2006, World Journal of Zoology, V1, P64; LEITE ACR, 1995, MEM I OSWALDO CRUZ, V90, P475, DOI 10.1590/S0074-02761995000400008; MAGALHAES LE, 1962, U TEX PUBL, V6205, P135; Magalhaes LE, 1957, BRAZ J BIOL, V16, P273; MOURAO CELSO ABBADE, 1967, PAP AVULS PEP ZOOL SAP PAULO, V20, P123; Nascimento AP, 2006, GENETICA, V126, P265, DOI 10.1007/s10709-005-8459-5; Nascimento AP, 2002, GENETICA, V114, P41, DOI 10.1023/A:1014672502359; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; O'Grady PM, 1998, MOL BIOL EVOL, V15, P656, DOI 10.1093/oxfordjournals.molbev.a025969; O'Grady PM, 2002, MOL PHYLOGENET EVOL, V22, P442, DOI 10.1006/mpev.2001.1053; Rodriguez-Trelles F, 1999, MOL PHYLOGENET EVOL, V13, P110, DOI 10.1006/mpev.1999.0631; Silva JC, 2000, MOL BIOL EVOL, V17, P1542, DOI 10.1093/oxfordjournals.molbev.a026253; THROCKMORTON LH, 1962, U TEX PUBL, V6205, P489; Torres FR, 2006, BIOTA NEOTROP, V8, P47; VILELA C R, 1983, Revista Brasileira de Entomologia, V27, P1; Wieczorek K, 2012, ZOOMORPHOLOGY, V131, P303, DOI 10.1007/s00435-012-0163-2; Yassin A, 2008, MOL ECOL RESOUR, V8, P491, DOI 10.1111/j.1471-8286.2007.02020.x; Yassin Amir, 2009, Zoological Research, V30, P225, DOI 10.3724/SP.J.1141.2009.03225	31	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e97156	10.1371/journal.pone.0097156	http://dx.doi.org/10.1371/journal.pone.0097156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915442	Green Submitted, gold, Green Published			2022-12-25	WOS:000340947700009
J	Mandel, JR; McAssey, EV; Nambeesan, S; Garcia-Navarro, E; Burke, JM				Mandel, Jennifer R.; McAssey, Edward V.; Nambeesan, Savithri; Garcia-Navarro, Elena; Burke, John M.			Molecular Evolution of Candidate Genes for Crop-Related Traits in Sunflower (Helianthus annuus L.)	PLOS ONE			English	Article							CULTIVATED SUNFLOWER; SEED-GERMINATION; ARTIFICIAL SELECTION; GIBBERELLIC-ACID; PHYTOCHROME B; DOMESTICATION; ARABIDOPSIS; TOMATO; WILD; POLYMORPHISMS	Evolutionary analyses aimed at detecting the molecular signature of selection during crop domestication and/or improvement can be used to identify genes or genomic regions of likely agronomic importance. Here, we describe the DNA sequence-based characterization of a pool of candidate genes for crop-related traits in sunflower. These genes, which were identified based on homology to genes of known effect in other study systems, were initially sequenced from a panel of improved lines. All genes that exhibited a paucity of sequence diversity, consistent with the possible effects of selection during the evolution of cultivated sunflower, were then sequenced from a panel of wild sunflower accessions an outgroup. These data enabled formal tests for the effects of selection in shaping sequence diversity at these loci. When selection was detected, we further sequenced these genes from a panel of primitive landraces, thereby allowing us to investigate the likely timing of selection (i.e., domestication vs. improvement). We ultimately identified seven genes that exhibited the signature of positive selection during either domestication or improvement. Genetic mapping of a subset of these genes revealed co-localization between candidates for genes involved in the determination of flowering time, seed germination, plant growth/development, and branching and QTL that were previously identified for these traits in cultivated x wild sunflower mapping populations.	[Mandel, Jennifer R.; McAssey, Edward V.; Nambeesan, Savithri; Burke, John M.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Garcia-Navarro, Elena] CSIC, Inst Agr Sostenible, Cordoba, Spain	University System of Georgia; University of Georgia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Burke, JM (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	jmburke@uga.edu	Burke, John M/A-3502-2013	Burke, John M/0000-0002-1412-5539; Mandel, Jennifer/0000-0003-3539-2991	USDA National Institute of Food and Agriculture [2008-35300-19263]; NSF Plant Genome Research Program [DBI-0820451]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); NSF Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by funding from the USDA National Institute of Food and Agriculture (2008-35300-19263) and the NSF Plant Genome Research Program (DBI-0820451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baack EJ, 2008, MOL ECOL, V17, P666, DOI 10.1111/j.1365-294X.2007.03596.x; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bachlava E, 2010, THEOR APPL GENET, V120, P829, DOI 10.1007/s00122-009-1212-1; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Blackman BK, 2013, J EXP BOT, V64, P421, DOI 10.1093/jxb/ers359; Blackman BK, 2011, MOL ECOL, V20, P3503, DOI 10.1111/j.1365-294X.2011.05166.x; Blackman BK, 2011, GENETICS, V187, P271, DOI 10.1534/genetics.110.121327; Bowers JE, 2012, G3-GENES GENOM GENET, V2, P721, DOI 10.1534/g3.112.002659; Brunick R, 2007, THESIS; Burke JM, 2002, GENETICS, V161, P1257; Burke JM, 2007, CURR OPIN GENET DEV, V17, P525, DOI 10.1016/j.gde.2007.09.003; Casal JJ, 1998, SEED SCI RES, V8, P317, DOI 10.1017/S0960258500004256; Chakrabarti M, 2013, P NATL ACAD SCI USA, V110, P17125, DOI 10.1073/pnas.1307313110; Chapman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071941; Chapman MA, 2012, THEOR APPL GENET, V125, P897, DOI 10.1007/s00122-012-1881-z; Chapman MA, 2008, PLANT CELL, V20, P2931, DOI 10.1105/tpc.108.059808; Dechaine JM, 2009, NEW PHYTOL, V184, P828, DOI 10.1111/j.1469-8137.2009.02964.x; DOEBLEY J, 1995, GENETICS, V141, P333; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Fick GN., 1997, SUNFLOWER TECHNOLOGY, P395, DOI DOI 10.2134/AGR0NM0N-0GR35.C8; Filiault DL, 2008, P NATL ACAD SCI USA, V105, P3157, DOI 10.1073/pnas.0712174105; GOYNE PJ, 1989, AGRON J, V81, P826, DOI 10.2134/agronj1989.00021962008100050025x; GOYNE PJ, 1987, AGRON J, V79, P704, DOI 10.2134/agronj1987.00021962007900040025x; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; HAMMER K, 1984, Kulturpflanze, V32, P11; HEISER C. B. JUN., 1951, Proceedings of the American Philosophical Society, V95, P432; HEISER CB, 1954, AM MIDL NAT, V51, P287, DOI 10.2307/2422222; HEISER CB, 1945, MISS BOT GARDEN B, V3, P163; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; HUDSON RR, 1987, GENETICS, V116, P153; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kolkman JM, 2007, GENETICS, V177, P457, DOI 10.1534/genetics.107.074054; LEWONTIN RC, 1973, GENETICS, V74, P175; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Mandel J, 2011, THEOR APPL GENET, V123, P693, DOI 10.1007/s00122-011-1619-3; Mandel JR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003378; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Neff MM, 2012, DEV CELL, V22, P687, DOI 10.1016/j.devcel.2012.04.003; Nesbitt TC, 2001, PLANT PHYSIOL, V127, P575, DOI [10.1104/pp.010087, 10.1104/pp.127.2.575]; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Putt E.D., 1997, SUNFLOWER TECHNOLOGY, V2nd ed., P1, DOI [10.2134/agronmonogr35, DOI 10.2134/AGRONMONOGR35.C1]; Renaut S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2833; Rogers C., 1982, SUNFLOWER SPECIES US; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Soleri Daniela, 1993, Journal of Ethnobiology, V13, P203; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wills DM, 2007, GENETICS, V176, P2589, DOI 10.1534/genetics.107.075333; Wills DM, 2010, J HERED, V101, P727, DOI 10.1093/jhered/esq089; Wright SI, 2005, MOL BIOL EVOL, V22, P506, DOI 10.1093/molbev/msi035; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Zhang N, 2012, THEOR APPL GENET, V125, P273, DOI 10.1007/s00122-012-1832-8	62	7	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99620	10.1371/journal.pone.0099620	http://dx.doi.org/10.1371/journal.pone.0099620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914686	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700120
J	Wang, Y; Shen, J; Xiong, XX; Xu, YH; Zhang, H; Huang, CJ; Tian, Y; Jiao, CY; Wang, XH; Li, XC				Wang, Yun; Shen, Jian; Xiong, Xuanxuan; Xu, Yonghua; Zhang, Hai; Huang, Changjun; Tian, Yuan; Jiao, Chengyu; Wang, Xuehao; Li, Xiangcheng			Remote Ischemic Preconditioning Protects against Liver Ischemia-Reperfusion Injury via Heme Oxygenase-1-Induced Autophagy	PLOS ONE			English	Article							HEPATIC ISCHEMIA; ISCHEMIA/REPERFUSION INJURY; INDUCED CYTOTOXICITY; OXIDATIVE STRESS; RAT HEPATOCYTES; MICE; CELLS; MODEL; GENE; ACTIVATION	Background: Growing evidence has linked autophagy to a protective role of preconditioning in liver ischemia/reperfusion (IR). Heme oxygenase-1 (HO-1) is essential in limiting inflammation and preventing the apoptotic response to IR. We previously demonstrated that HO-1 is up-regulated in liver graft after remote ischemic preconditioning (RIPC). The aim of this study was to confirm that RIPC protects against IR via HO-1-mediated autophagy. Methods: RIPC was performed with regional ischemia of limbs before liver ischemia, and HO-1 activity was inhibited preoperation. Autophagy was assessed by the expression of light chain 3-II (LC3-II). The HO-1/extracellular signal-related kinase (ERK)/p38/mitogen-activated protein kinase (MAPK) pathway was detected in an autophagy model and mineral oil-induced IR in vitro. Results: In liver IR, the expression of LC3-II peaked 12-24 h after IR, and the ultrastructure revealed abundant autophagosomes in hepatocytes after IR. Autophagy was inhibited when HO-1 was inactivated, which we believe resulted in the aggravation of liver IR injury (IRI) in vivo. Hemin-induced autophagy also protected rat hepatocytes from IRI in vitro, which was abrogated by HO-1 siRNA. Phosphorylation of p38-MAPK and ERK1/2 was up-regulated in hemin-pretreated liver cells and down-regulated after treatment with HO-1 siRNA. Conclusions: RIPC may protect the liver from IRI by induction of HO-1/p38-MAPK-dependent autophagy.	[Huang, Changjun; Tian, Yuan; Jiao, Chengyu; Wang, Xuehao; Li, Xiangcheng] Nanjing Med Univ, Affiliated Hosp 1, Dept Liver Transplantat Ctr, Minist Publ Hlth,Key Lab Living Donor Liver Trans, Nanjing, Jiangsu, Peoples R China; [Wang, Yun] Southeast Univ Xuzhou, Tumor Res Inst, Southeast Univ Med Sch Xuzhou, Affiliated Hosp,Xuzhou City Cent Hosp, Xuzhou, Jiangsu, Peoples R China; [Shen, Jian] Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Xiong, Xuanxuan] Southeast Univ Med Sch Xuzhou, Affiliated Hosp, Xuzhou City Cent Hosp, Dept Gastroenterol 2, Xuzhou, Jiangsu, Peoples R China; [Xu, Yonghua] Yancheng First Peoples Hosp, Dept Gen Surg, Yancheng, Jiangsu, Peoples R China; [Zhang, Hai] Jiangsu Univ, Affiliated Hosp 1, Dept Gen Surg, Zhenjiang, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China; Nanjing Medical University; Southeast University - China; Jiangsu University	Li, XC (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Liver Transplantat Ctr, Minist Publ Hlth,Key Lab Living Donor Liver Trans, Nanjing, Jiangsu, Peoples R China.	drxcli@njmu.edu.cn	huang, changjun/F-9012-2019; li, xiang/GWM-6319-2022	huang, changjun/0000-0002-5211-9367; 	National Natural Science Foundation of China [81170415, 81302108]; Nanjing Medical University [2012NJMU087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University	The study was supported by grants from the National Natural Science Foundation of China (81170415) from Dr. Xiangcheng Li, and from the National Natural Science Foundation of China (81302108) from Dr. Jian Shen, and from Nanjing Medical University (2012NJMU087). Dr. Xiangcheng Li had a role in study design, data collection and analysis, decision to publish, and Dr. Jian Shen also had role in study design, data collection and analysis, decision to publish.	Abu-Amara M, 2011, LIVER TRANSPLANT, V17, P70, DOI 10.1002/lt.22204; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Cardinal J, 2009, HEPATOLOGY, V50, P565, DOI 10.1002/hep.23021; Choi BM, 2003, HEPATOLOGY, V37, P810, DOI 10.1053/jhep.2003.50114; David A, 2010, NEPHRON EXP NEPHROL, V115, pe33; Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237; Devey L, 2009, TRANSPLANTATION, V88, P308, DOI 10.1097/TP.0b013e3181ae3067; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Esposti DD, 2010, AUTOPHAGY, V6, P172, DOI 10.4161/auto.6.1.10699; Kim HS, 2008, NITRIC OXIDE-BIOL CH, V18, P256, DOI 10.1016/j.niox.2008.02.002; Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768; Kim JS, 2008, HEPATOLOGY, V47, P1725, DOI 10.1002/hep.22187; Lai IR, 2006, TRANSPLANTATION, V81, P1311, DOI 10.1097/01.tp.0000203555.14546.63; Meldrum KK, 2003, CIRC RES, V92, P293, DOI 10.1161/01.RES.0000057754.35180.99; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shan Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P219, DOI 10.1006/abbi.2000.1921; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Tapuria N, 2009, HPB, V11, P108, DOI 10.1111/j.1477-2574.2009.00006.x; Teoh NC, 2003, J GASTROEN HEPATOL, V18, P891, DOI 10.1046/j.1440-1746.2003.03056.x; Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian; Wang HQ, 2012, NEUROTOX RES, V21, P368, DOI 10.1007/s12640-011-9292-5; Wang HQ, 2010, BRAIN RES, V1360, P159, DOI 10.1016/j.brainres.2010.08.100; Wang JH, 2012, AUTOPHAGY, V8, P140, DOI 10.4161/auto.8.1.18391; Wang JH, 2011, GASTROENTEROLOGY, V141, P2188, DOI 10.1053/j.gastro.2011.08.005; Yang YC, 2011, FREE RADICAL BIO MED, V51, P2073, DOI 10.1016/j.freeradbiomed.2011.09.007; Yao P, 2007, J HEPATOL, V47, P253, DOI 10.1016/j.jhep.2007.02.008; Yun N, 2012, J PHYSIOL SCI, V62, P199, DOI 10.1007/s12576-012-0199-6; Yun N, 2010, ANTIOXID REDOX SIGN, V13, P1503, DOI 10.1089/ars.2009.2873; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Zhang WJ, 2013, BIOCHEM BIOPH RES CO, V434, P492, DOI 10.1016/j.bbrc.2013.03.101	34	57	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98834	10.1371/journal.pone.0098834	http://dx.doi.org/10.1371/journal.pone.0098834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914543	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700038
J	Williams, DL; Mann, BK				Williams, David L.; Mann, Brenda K.			Efficacy of a Crosslinked Hyaluronic Acid-Based Hydrogel as a Tear Film Supplement: A Masked Controlled Study	PLOS ONE			English	Article							CANINE KERATOCONJUNCTIVITIS SICCA; OPHTHALMIC APPLICATIONS; EYE DROPS; GEL; MODEL	Keratoconjunctivitis sicca (KCS), or dry eye, is a significant medical problem in both humans and dogs. Treating KCS often requires the daily application of more than one type of eye drop in order to both stimulate tear prodcution and provide a tear supplement to increase hydration and lubrication. A previous study demonstrated the potential for a crosslinked hyaluronic acid-based hydrogel (xCMHA-S) to reduce the clinical signs associated with KCS in dogs while using a reduced dosing regimen of only twice-daily administration. The present study extended those results by comparing the use of the xCMHA-S to a standard HA-containing tear supplement in a masked, randomized clinical study in dogs with a clinical diagnosis of KCS. The xCMHA-S was found to significantly improve ocular surface health (conjunctival hyperaemia, ocular irritation, and ocular discharge) to a greater degree than the alternative tear supplement (P = 0.0003). Further, owners reported the xCMHA-S treatment as being more highly effective than the alternative tear supplement (P = 0.0024). These results further demonstrate the efficacy of the xCMHA-S in reducing the clinical signs associated with KCS, thereby improving patient health and owner happiness.	[Williams, David L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Mann, Brenda K.] SentrX Anim Care Inc, Salt Lake City, UT USA; [Mann, Brenda K.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	University of Cambridge; Utah System of Higher Education; University of Utah	Williams, DL (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	dlw33@cam.ac.uk						Barbucci R, 2002, BIOMATERIALS, V23, P4503, DOI 10.1016/S0142-9612(02)00194-1; Bron AJ, 1998, EUR J OPHTHALMOL, V8, P81, DOI 10.1177/112067219800800206; Festing Michael F W, 2002, ILAR J, V43, P244; GIBBS DA, 1968, BIOPOLYMERS, V6, P777, DOI 10.1002/bip.1968.360060603; Guillaumie F, 2010, J BIOMED MATER RES A, V92A, P1421, DOI 10.1002/jbm.a.32481; Hamano T, 1996, JPN J OPHTHALMOL, V40, P62; Higashide T, 2008, CLIN OPHTHALMOL, V2, P21; KASWAN RL, 1989, ARCH OPHTHALMOL-CHIC, V107, P1210, DOI 10.1001/archopht.1989.01070020276038; KOBAYASHI Y, 1994, BIORHEOLOGY, V31, P235; Nakamura S, 2004, CORNEA, V23, P390, DOI 10.1097/00003226-200405000-00015; NEWCOMBE RG, 1987, BRIT J OPHTHALMOL, V71, P645, DOI 10.1136/bjo.71.9.645; Rah MJ, 2011, OPTOMETRY, V82, P38, DOI 10.1016/j.optm.2010.08.003; Smith JA, 2007, OCUL SURF, V5, P93; Stonecipher K, 2005, CURR MED RES OPIN, V21, P1057, DOI 10.1185/030079905X50615; Williams David, 2012, Vet Res Forum, V3, P229; Williams DL, 2008, VET CLIN N AM-SMALL, V38, P251, DOI 10.1016/j.cvsm.2007.12.002; Williams DL, 2013, INT J BIOMATER, V2013, DOI 10.1155/2013/460437; Yang GH, 2010, VET OPHTHALMOL, V13, P144, DOI 10.1111/j.1463-5224.2010.00771.x; Yang GF, 2011, INT J GYNECOL CANCER, V21, P486, DOI 10.1097/IGC.0b013e31820fa168	19	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99766	10.1371/journal.pone.0099766	http://dx.doi.org/10.1371/journal.pone.0099766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914681	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700129
J	Nielsen, JR; Kristensen, K; Lewy, P; Bastardie, F				Nielsen, J. Rasmus; Kristensen, Kasper; Lewy, Peter; Bastardie, Francois			A Statistical Model for Estimation of Fish Density Including Correlation in Size, Space, Time and between Species from Research Survey Data	PLOS ONE			English	Article							GADUS-MORHUA L.; BALTIC COD; RECRUITMENT; ABUNDANCE; DYNAMICS; PATTERNS; STOCK	Trawl survey data with high spatial and seasonal coverage were analysed using a variant of the Log Gaussian Cox Process (LGCP) statistical model to estimate unbiased relative fish densities. The model estimates correlations between observations according to time, space, and fish size and includes zero observations and over-dispersion. The model utilises the fact the correlation between numbers of fish caught increases when the distance in space and time between the fish decreases, and the correlation between size groups in a haul increases when the difference in size decreases. Here the model is extended in two ways. Instead of assuming a natural scale size correlation, the model is further developed to allow for a transformed length scale. Furthermore, in the present application, the spatial-and size-dependent correlation between species was included. For cod (Gadus morhua) and whiting (Merlangius merlangus), a common structured size correlation was fitted, and a separable structure between the time and space-size correlation was found for each species, whereas more complex structures were required to describe the correlation between species (and space-size). The within-species time correlation is strong, whereas the correlations between the species are weaker over time but strong within the year.	[Nielsen, J. Rasmus; Kristensen, Kasper; Lewy, Peter; Bastardie, Francois] Tech Univ Denmark, Natl Inst Aquat Resources DTU AQUA, Charlottenlund, Denmark	Technical University of Denmark	Nielsen, JR (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources DTU AQUA, Charlottenlund, Denmark.	rn@aqua.dtu.dk	Nielsen, J. Rasmus/AAG-2647-2021	Nielsen, J. Rasmus/0000-0002-2833-3873; Kristensen, Kasper/0000-0003-3425-3762; Bastardie, Francois/0000-0002-2669-6179	International Femern Belt Science Provision Project (Femern Baelt A/S, DK); Danish Strategic Research Council Project IMAGE (MAFIA); EU	International Femern Belt Science Provision Project (Femern Baelt A/S, DK); Danish Strategic Research Council Project IMAGE (MAFIA); EU(European Commission)	This study was funded by the International Femern Belt Science Provision Project (Femern Baelt A/S, DK). Smaller parts of the study have been supported by the Danish Strategic Research Council Project IMAGE (MAFIA) and the EU FP7 SOCIOEC Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastardie F, 2014, CAN J FISH AQUAT SCI, V71, P366, DOI 10.1139/cjfas-2013-0126; Bastardie F, 2010, FISH RES, V101, P188, DOI 10.1016/j.fishres.2009.10.009; Bastardie F, 2010, ICES J MAR SCI, V67, P71, DOI 10.1093/icesjms/fsp228; Bromley PJ, 1997, ICES J MAR SCI, V54, P846, DOI 10.1006/jmsc.1996.0211; Cressie N. A. C., 1993, STAT SPATIAL DATA WI; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Eero M, 2012, CONSERV LETT, P1; ENGAS A, 1989, J CONSEIL, V45, P269; Hrafnkelsson B, 2004, CAN J FISH AQUAT SCI, V61, P1135, DOI 10.1139/F04-049; ICES, 2012, 2012ACOM10 ICES WGBF; ICES, 2012, 2012SSGESST02 ICES W; Jansen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038758; Koster FW, 2001, CAN J FISH AQUAT SCI, V58, P1516, DOI 10.1139/cjfas-58-8-1516; Kristensen K, 2009, THESIS U COPENHAGEN; Kristensen K, 2006, CAN J FISH AQUAT SCI, V63, P2531, DOI 10.1139/F06-135; Kristensen K, 2014, CAN J FISH AQUAT SCI, V71, P326, DOI 10.1139/cjfas-2013-0151; Lewy P, 2004, CAN J FISH AQUAT SCI, V61, P636, DOI 10.1139/F04-034; Lewy P, 2009, CAN J FISH AQUAT SCI, V66, P1809, DOI 10.1139/F09-114; Lundgren B, 2008, ICES J MAR SCI, V65, P581, DOI 10.1093/icesjms/fsn031; Marchal P, 2001, ICES J MAR SCI, V58, P298, DOI 10.1006/jmsc.2000.1011; Neuenfeldt S, 2000, ICES J MAR SCI, V57, P300, DOI 10.1006/jmsc.2000.0647; Nielsen J.R., 2009, WORLD FISH, V58, P8; Nielsen JR, 1999, ICES J MAR SCI, V56, P627, DOI 10.1006/jmsc.1999.0515; Nielsen JR, 2001, A4JF2001 DG FISH EUR; Nilsson LAF, 2003, AQUAT LIV RES, V16; O'Neill MF, 2003, FISH RES, V60, P471, DOI 10.1016/S0165-7836(02)00101-7; Rivoirard J., 2008, GEOSTATISTICS ESTIMA; Rue H., 2005, GAUSSIAN MARKOV RAND; Sparholt Henrik, 1994, Dana, V10, P131; Stefansson G, 1996, ICES J MAR SCI, V53, P577, DOI 10.1006/jmsc.1996.0079; Stelzenmuller V, 2005, MAR BIOL RES, V1, P375, DOI 10.1080/17451000500361009; Uzars D, 2000, ICES J MAR SCI, V57, P324, DOI 10.1006/jmsc.1999.0527	32	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99151	10.1371/journal.pone.0099151	http://dx.doi.org/10.1371/journal.pone.0099151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911631	Green Published, gold			2022-12-25	WOS:000337165600046
J	Chao, J; Huo, TI; Cheng, HY; Tsai, JC; Liao, JW; Lee, MS; Qin, XM; Hsieh, MT; Pao, LH; Peng, WH				Chao, Jung; Huo, Teh-Ia; Cheng, Hao-Yuan; Tsai, Jen-Chieh; Liao, Jiunn-Wang; Lee, Meng-Shiou; Qin, Xue-Mei; Hsieh, Ming-Tsuen; Pao, Li-Heng; Peng, Wen-Huang			Gallic Acid Ameliorated Impaired Glucose and Lipid Homeostasis in High Fat Diet-Induced NAFLD Mice	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; TYPE-2 DIABETES-MELLITUS; LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; METABOLIC-RESPONSES; INSULIN-RESISTANCE; HEPATIC STEATOSIS; NMR-SPECTROSCOPY; OXIDATIVE STRESS; BLOOD-PLASMA	Gallic acid (GA), a naturally abundant plant phenolic compound in vegetables and fruits, has been shown to have potent anti-oxidative and anti-obesity activity. However, the effects of GA on nonalcoholic fatty liver disease (NAFLD) are poorly understood. In this study, we investigated the beneficial effects of GA administration on nutritional hepatosteatosis model by a more "holistic view" approach, namely H-1 NMR-based metabolomics, in order to prove efficacy and to obtain information that might lead to a better understanding of the mode of action of GA. Male C57BL/6 mice were placed for 16 weeks on either a normal chow diet, a high fat diet (HFD, 60%), or a high fat diet supplemented with GA (50 and 100 mg/kg/day, orally). Liver histopathology and serum biochemical examinations indicated that the daily administration of GA protects against hepatic steatosis, obesity, hypercholesterolemia, and insulin resistance among the HFD-induced NAFLD mice. In addition, partial least squares discriminant analysis scores plots demonstrated that the cluster of HFD fed mice is clearly separated from the normal group mice plots, indicating that the metabolic characteristics of these two groups are distinctively different. Specifically, the GA-treated mice are located closer to the normal group of mice, indicating that the HFD-induced disturbances to the metabolic profile were partially reversed by GA treatment. Our results show that the hepatoprotective effect of GA occurs in part through a reversing of the HFD caused disturbances to a range of metabolic pathways, including lipid metabolism, glucose metabolism (glycolysis and gluconeogenesis), amino acids metabolism, choline metabolism and gut-microbiota-associated metabolism. Taken together, this study suggested that a H-1 NMR-based metabolomics approach is a useful platform for natural product functional evaluation. The selected metabolites are potentially useful as preventive action biomarkers and could also be used to help our further understanding of the effect of GA in hepatosteatosis mice.	[Chao, Jung; Huo, Teh-Ia] Natl Yang Ming Univ, Coll Med, Inst Pharmacol, Taipei 112, Taiwan; [Huo, Teh-Ia] Natl Taiwan Univ Hosp, Dept Oncol & Internal Med, Taipei, Taiwan; [Cheng, Hao-Yuan] Chung Jen Coll Nursing Hlth Sci & Management, Dept Nursing, Chiayi, Taiwan; [Tsai, Jen-Chieh] Asia Univ, Coll Hlth Sci, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Tsai, Jen-Chieh] Jen Teh Jr Coll Med Nursing & Management, Miaoli, Taiwan; [Liao, Jiunn-Wang] Natl Chung Hsing Univ, Grad Inst Vet Pathol, Taichung 40227, Taiwan; [Lee, Meng-Shiou; Hsieh, Ming-Tsuen; Peng, Wen-Huang] China Med Univ, Coll Pharm, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Qin, Xue-Mei] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan, Peoples R China; [Pao, Li-Heng] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Pao, Li-Heng] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; Asia University Taiwan; National Chung Hsing University; China Medical University Taiwan; Shanxi University; Chang Gung University of Science & Technology; National Defense Medical Center	Pao, LH (corresponding author), Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan.	paolh@ndmctsgh.edu.tw; whpeng@mail.cmu.edu.tw		Liao, Jiunn-Wang/0000-0001-7374-1203; Lee, Meng-Shiou/0000-0003-3470-4121	National Science Council, Taiwan [NSC100-2320-B-039-013, NSC101-2320-B-039-032-MY2]; Committee on Chinese Medicine and Pharmacy, Department of Health, Executive Yuan [CCMP102-RD-014]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Committee on Chinese Medicine and Pharmacy, Department of Health, Executive Yuan	This study is supported in part by the National Science Council, Taiwan (NSC100-2320-B-039-013, NSC101-2320-B-039-032-MY2) and Committee on Chinese Medicine and Pharmacy, Department of Health, Executive Yuan (CCMP102-RD-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2001, AM J GASTROENTEROL, V96, P2711; Bao YQ, 2009, J PROTEOME RES, V8, P1623, DOI 10.1021/pr800643w; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bialonska D, 2010, INT J FOOD MICROBIOL, V140, P175, DOI 10.1016/j.ijfoodmicro.2010.03.038; Bjerrum JT, 2010, J PROTEOME RES, V9, P954, DOI 10.1021/pr9008223; Brand HS, 1998, AMINO ACIDS, V15, P373, DOI 10.1007/BF01320901; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Carrola J, 2011, J PROTEOME RES, V10, P221, DOI 10.1021/pr100899x; Center for Drug Evaluation and Research, 2005, GUID IND EST MAX SAF; Choi CS, 2002, AM J PHYSIOL-ENDOC M, V283, pE233, DOI 10.1152/ajpendo.00557.2001; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Commission E, 2002, OP SCI COMM FOOD UPP; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Eriksson L JE, 2006, MULTI MEGAVARIATE 1, P307; GROOTVELD M, 1993, FEBS LETT, V322, P266, DOI 10.1016/0014-5793(93)81584-M; Gupte AA, 2009, DIABETES, V58, P567, DOI 10.2337/db08-1070; He QH, 2011, J PROTEOME RES, V10, P5214, DOI 10.1021/pr200688u; He QH, 2009, AMINO ACIDS, V37, P199, DOI 10.1007/s00726-008-0192-9; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Hsiang CY, 2013, FOOD CHEM, V136, P426, DOI 10.1016/j.foodchem.2012.08.009; Hsu CL, 2007, BRIT J NUTR, V98, P727, DOI 10.1017/S000711450774686X; INOUE M, 1995, BIOL PHARM BULL, V18, P1526; Jang A, 2008, CHEM-BIOL INTERACT, V174, P109, DOI 10.1016/j.cbi.2008.05.018; Kim HK, 2011, TRENDS BIOTECHNOL, V29, P267, DOI 10.1016/j.tibtech.2011.02.001; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Klein MS, 2011, METABOLOMICS, V7, P237, DOI 10.1007/s11306-010-0243-6; Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536; KROES BH, 1992, PLANTA MED, V58, P499, DOI 10.1055/s-2006-961535; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lee JE, 2011, J AGR FOOD CHEM, V59, P10579, DOI 10.1021/jf202304z; LEE WM, 1987, HEPATOLOGY, V7, P906, DOI 10.1002/hep.1840070519; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Li HK, 2009, PHYTOTHER RES, V23, P1332, DOI 10.1002/ptr.2590; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Llorach R, 2012, J AGR FOOD CHEM, V60, P8797, DOI 10.1021/jf301142b; Ma J, 2003, J NAT PROD, V66, P983, DOI 10.1021/np020576x; Maheshwari DT, 2011, FOOD CHEM TOXICOL, V49, P2422, DOI 10.1016/j.fct.2011.06.061; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; McLoughlin GA, 2009, J PROTEOME RES, V8, P1943, DOI 10.1021/pr800892u; Mehta K, 2002, NUTR REV, V60, P289, DOI 10.1301/002966402320387224; Melis GC, 2004, CURR OPIN CLIN NUTR, V7, P59, DOI 10.1097/00075197-200401000-00011; Miyazaki T, 2012, AMINO ACIDS; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Niho N, 2001, FOOD CHEM TOXICOL, V39, P1063, DOI 10.1016/S0278-6915(01)00054-0; Oi Y, 2012, PHYTOTHER RES, V26, P475, DOI 10.1002/ptr.3602; Peng CH, 2011, J AGR FOOD CHEM, V59, P2663, DOI 10.1021/jf1043508; Poeze M, 2008, CLIN NUTR, V27, P523, DOI 10.1016/j.clnu.2008.04.006; Punithavathi VR, 2011, J BIOCHEM MOL TOXIC, V25, P68, DOI 10.1002/jbt.20360; Rajalakshmi K, 2001, FOOD CHEM TOXICOL, V39, P919, DOI 10.1016/S0278-6915(01)00022-9; Rezzi S, 2007, J PROTEOME RES, V6, P513, DOI 10.1021/pr060522z; Ringeissen S, 2003, BIOMARKERS, V8, P240, DOI 10.1080/1354750031000149124; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sheng XY, 2011, AM J PHYSIOL-ENDOC M, V300, pE886, DOI 10.1152/ajpendo.00332.2010; Song Z, 2007, AM J PHYSIOL-GASTR L, V293, pG894, DOI 10.1152/ajpgi.00133.2007; Tian Y, 2012, J PROTEOME RES, V11, P1397, DOI 10.1021/pr2011507; Timbrell JA, 1996, ADV EXP MED BIOL, V403, P125; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Vinaixa M, 2010, J PROTEOME RES, V9, P2527, DOI 10.1021/pr901203w; Wang SH, 2011, J AGR FOOD CHEM, V59, P3686, DOI 10.1021/jf1048386; Wang X, 2012, MOL CELL PROTEOMICS; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Wang YL, 2008, P NATL ACAD SCI USA, V105, P6127, DOI 10.1073/pnas.0801777105; Wang YL, 2006, J PROTEOME RES, V5, P1535, DOI 10.1021/pr0504182; WATERFIELD CJ, 1991, ARCH TOXICOL, V65, P548, DOI 10.1007/BF01973715; Xu W, 2012, J PROTEOME RES; Xuan JK, 2011, J PROTEOME RES, V10, P5433, DOI 10.1021/pr2006796; Yang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016641; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zhang LM, 2011, J PROTEOME RES, V10, P614, DOI 10.1021/pr100792q; Zhao XJ, 2012, J PROTEOME RES, V11, P4712, DOI 10.1021/pr300533a	77	129	138	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e96969	10.1371/journal.pone.0096969	http://dx.doi.org/10.1371/journal.pone.0096969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918580	Green Submitted, gold, Green Published			2022-12-25	WOS:000338631000006
J	Kidgell, JT; de Nys, R; Hu, Y; Paul, NA; Roberts, DA				Kidgell, Joel T.; de Nys, Rocky; Hu, Yi; Paul, Nicholas A.; Roberts, David A.			Bioremediation of a Complex Industrial Effluent by Biosorbents Derived from Freshwater Macroalgae	PLOS ONE			English	Article							METAL-IONS; WASTE-WATER; BIOSORPTION; ALGAE; ADSORPTION; CAPACITY; SORPTION; BIOMASS; PH; EXCHANGE	Biosorption with macroalgae is a promising technology for the bioremediation of industrial effluents. However, the vast majority of research has been conducted on simple mock effluents with little data available on the performance of biosorbents in complex effluents. Here we evaluate the efficacy of dried biomass, biochar, and Fe-treated biomass and biochar to remediate 21 elements from a real-world industrial effluent from a coal-fired power station. The biosorbents were produced from the freshwater macroalga Oedogonium sp. (Chlorophyta) that is native to the industrial site from which the effluent was sourced, and which has been intensively cultivated to provide a feed stock for biosorbents. The effect of pH and exposure time on sorption was also assessed. These biosorbents showed specificity for different suites of elements, primarily differentiated by ionic charge. Overall, biochar and Fe-biochar were more successful biosorbents than their biomass counterparts. Fe-biochar adsorbed metalloids (As, Mo, and Se) at rates independent of effluent pH, while untreated biochar removed metals (Al, Cd, Ni and Zn) at rates dependent on pH. This study demonstrates that the biomass of Oedogonium is an effective substrate for the production of biosorbents to remediate both metals and metalloids from a complex industrial effluent.	[Kidgell, Joel T.; de Nys, Rocky; Paul, Nicholas A.; Roberts, David A.] James Cook Univ, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia; [Kidgell, Joel T.; de Nys, Rocky; Paul, Nicholas A.; Roberts, David A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Hu, Yi] James Cook Univ, Adv Analyt Ctr, Townsville, Qld 4811, Australia	James Cook University; James Cook University; James Cook University	Roberts, DA (corresponding author), James Cook Univ, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia.	david.roberts1@jcu.edu.au	Roberts, David A/D-9322-2012; Paul, Nicholas/B-6496-2009; de Nys, Rocky/D-6741-2012	Roberts, David A/0000-0003-0261-691X; de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535; Kidgell, Joel/0000-0002-1551-6769	Advanced Manufacturing Cooperative Research Centre (AMCRC); Australian Government's Cooperative Research Centre Scheme; Australian Renewable Energy Agency (ARENA)	Advanced Manufacturing Cooperative Research Centre (AMCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Renewable Energy Agency (ARENA)(Australian Renewable Energy Agency (ARENA))	This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage with the co-operation of Stanwell Energy Corporation. This project is supported by the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme, and the Australian Renewable Energy Agency (ARENA). Stanwell Energy Corporation provided effluents for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANZECC (Australian and New Zealand Environment and Conservation Council), 2000, GUID FRESH MAR WAT Q; Bird MI, 2011, BIORESOURCE TECHNOL, V102, P1886, DOI 10.1016/j.biortech.2010.07.106; BRADY JM, 1995, ENZYME MICROB TECH, V17, P791, DOI 10.1016/0141-0229(95)00142-R; Chen C, 2007, CHEMOSPHERE, V69, P1610, DOI 10.1016/j.chemosphere.2007.05.043; CRIST RH, 1994, ENVIRON SCI TECHNOL, V28, P1859, DOI 10.1021/es00060a016; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; Domozych DS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00082; Entwistle TJ, 2007, ALGAE AUSTR BATRACHO; Esmaeili A, 2010, NAT PROD RES, V24, P341, DOI 10.1080/14786410903064915; Esposito A, 2002, CHEM ENG SCI, V57, P307, DOI 10.1016/S0009-2509(01)00399-2; Farrell M, 2013, J HAZARD MATER, V250, P29, DOI 10.1016/j.jhazmat.2013.01.073; Figueira MM, 1997, BIOTECHNOL BIOENG, V54, P344; Figueira MM, 2000, ENVIRON SCI TECHNOL, V34, P4320, DOI 10.1021/es001027l; Frankenberger W. T. Jr., 2004, Irrigation and Drainage Systems, V18, P19, DOI 10.1023/B:IRRI.0000019422.68706.59; Gadd GM, 2009, J CHEM TECHNOL BIOT, V84, P13, DOI 10.1002/jctb.1999; GARNHAM GW, 1994, CHANGES IN FLUXES IN ESTUARIES: IMPLICATIONS FROM SCIENCE TO MANAGEMENT, P289; Jankowski J, 2006, FUEL, V85, P243, DOI 10.1016/j.fuel.2005.05.028; Jolliffe, 2002, PRINCIPAL COMPONENT; Karthikeyan S, 2007, BIORESOURCE TECHNOL, V98, P452, DOI 10.1016/j.biortech.2006.01.010; Kogej A, 2001, WORLD J MICROB BIOT, V17, P677, DOI 10.1023/A:1012901224684; Lalvani SB, 2004, SELEMIUM REMOVAL AGR; Latva S, 2003, ANAL CHIM ACTA, V478, P229, DOI 10.1016/S0003-2670(02)01524-6; Lawton RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090223; Lee HS, 2004, MINER ENG, V17, P487, DOI 10.1016/j.mineng.2004.01.002; MANCEAU A, 1994, J COLLOID INTERF SCI, V168, P87, DOI 10.1006/jcis.1994.1396; Mehta SK, 2005, CRIT REV BIOTECHNOL, V25, P113, DOI 10.1080/07388550500248571; Mehta SK, 2000, EUR J PROTISTOL, V36, P443, DOI 10.1016/S0932-4739(00)80050-4; Oman J, 2002, WASTE MANAGE, V22, P617, DOI 10.1016/S0956-053X(01)00038-1; Pavasant P, 2006, BIORESOURCE TECHNOL, V97, P2321, DOI 10.1016/j.biortech.2005.10.032; PETERSON HG, 1984, CAN J FISH AQUAT SCI, V41, P974, DOI 10.1139/f84-111; PIRSZEL J, 1995, J IND MICROBIOL, V14, P319, DOI 10.1007/BF01569945; Quinn GP, 2003, EXPT DESIGN DATA ANA; Roberts DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081631; Saunders RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036470; Schijf J, 2010, ENVIRON SCI TECHNOL, V44, P1644, DOI 10.1021/es9029667; Schneegurt MA, 2001, ENVIRON SCI TECHNOL, V35, P3786, DOI 10.1021/es010766e; Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036; SIGG L, 1994, EURO CH ENV, V5, P153; Stumm W., 1996, AQUATIC CHEM CHEM EQ; TOBIN JM, 1984, APPL ENVIRON MICROB, V47, P821, DOI 10.1128/AEM.47.4.821-824.1984; Vieira DM, 2007, ELECTRON J BIOTECHN, V10, P368, DOI 10.2225/vol10-issue3-fulltext-3; VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001; Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2; Volesky B, 2007, WATER RES, V41, P4017, DOI 10.1016/j.watres.2007.05.062; Yang T, 2012, ENVIRON SCI TECHNOL, V46, P2251, DOI 10.1021/es204034z; Zamil SS, 2009, BIORESOURCE TECHNOL, V100, P1895, DOI 10.1016/j.biortech.2008.10.014; Zhang N, 2008, WATER RES, V42, P3809, DOI 10.1016/j.watres.2008.07.025	47	23	23	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e94706	10.1371/journal.pone.0094706	http://dx.doi.org/10.1371/journal.pone.0094706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919058	gold, Green Published, Green Accepted			2022-12-25	WOS:000338631000003
J	Kolokoltsova, OA; Grant, AM; Huang, C; Smith, JK; Poussard, AL; Tian, B; Brasier, AR; Peters, CJ; Tseng, CTK; de la Torre, JC; Paessler, S				Kolokoltsova, Olga A.; Grant, Ashley M.; Huang, Cheng; Smith, Jennifer K.; Poussard, Allison L.; Tian, Bing; Brasier, Allan R.; Peters, Clarence J.; Tseng, Chien-Te Kent; de la Torre, Juan C.; Paessler, Slobodan			RIG-I Enhanced Interferon Independent Apoptosis upon Junin Virus Infection	PLOS ONE			English	Article							ARGENTINE HEMORRHAGIC-FEVER; LYMPHATIC TISSUE; RHESUS MACAQUES; GUINEA-PIGS; CELLS; REPLICATION; VACCINE; STRAIN; ARENAVIRUS; PHOSPHATIDYLSERINE	Junin virus (JUNV) is the etiological agent of Argentine hemorrhagic fever (AHF), a human disease with a high case-fatality rate. It is widely accepted that arenaviral infections, including JUNV infections, are generally non-cytopathic. In contrast, here we demonstrated apoptosis induction in human lung epithelial carcinoma (A549), human hepatocarcinoma and Vero cells upon infection with the attenuated Candid#1 strain of, JUNV as determined by phosphatidylserine (PS) translocation, Caspase 3 (CASP3) activation, Poly (ADP-ribose) polymerase (PARP) cleavage and/or chromosomal DNA fragmentation. Moreover, as determined by DNA fragmentation, we found that the pathogenic Romero strain of JUNV was less cytopathic than Candid#1 in human hepatocarcinoma and Vero, but more apoptotic in A549 and Vero E6 cells. Additionally, we found that JUNV-induced apoptosis was enhanced by RIG-I signaling. Consistent with the previously reported role of RIG-I like helicase (RLH) signaling in initiating programmed cell death, we showed that cell death or DNA fragmentation of Candid#1-infected A549 cells was decreased upon siRNA or shRNA silencing of components of RIG-I pathway in spite of increased virus production. Similarly, we observed decreased DNA fragmentation in JUNV-infected human hepatocarcinoma cells deficient for RIG-I when compared with that of RIG-I-competent cells. In addition, DNA fragmentation detected upon Candid#1 infection of type I interferon (IFN)-deficient Vero cells suggested a type I IFN-independent mechanism of apoptosis induction in response to JUNV. Our work demonstrated for the first time apoptosis induction in various cells of mammalian origin in response to JUNV infection and partial mechanism of this cell death.	[Kolokoltsova, Olga A.; Grant, Ashley M.; Huang, Cheng; Smith, Jennifer K.; Poussard, Allison L.; Peters, Clarence J.; Paessler, Slobodan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Tian, Bing; Brasier, Allan R.] UTMB, Galveston, TX USA; [Peters, Clarence J.; Tseng, Chien-Te Kent] UTMB, Dept Microbiol & Immunol, Galveston, TX USA; [de la Torre, Juan C.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Scripps Research Institute	Paessler, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	slpaessl@utmb.edu	Huang, Cheng/R-6619-2017	Huang, Cheng/0000-0001-5402-353X; Brasier, Allan/0000-0002-5012-4090	Public Health Service [R01AI093445]; Sealy Center for Vaccine Development and McLaughlin Predoctoral Fellowships; Vale Asche/McLaughlin Foundation; W.M. Keck Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093445] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Sealy Center for Vaccine Development and McLaughlin Predoctoral Fellowships; Vale Asche/McLaughlin Foundation; W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant R01AI093445 to S.P. and J.C.D.L.T. Olga Kolokoltsova was supported by the Sealy Center for Vaccine Development and McLaughlin Predoctoral Fellowships. Ashley Grant was supported by a training fellowship from the Vale Asche/McLaughlin Foundation and from the W.M. Keck Foundation to the Gulf Coast Consortia through the Keck Center for Virus Imaging, University of Texas Medical Branch, Galveston, TX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarino CG, 1997, J GEN VIROL, V78, P1605, DOI 10.1099/0022-1317-78-7-1605; Albarino CG, J VIROL; AMBROSIO M, 1990, ACTA VIROL, V34, P58; Animal and Plant Health Inspection Service CDC, SEL AG TOX LIST; Olsen S J, 2000, MMWR CDC Surveill Summ, V49, P1; ARENDS MJ, 1990, AM J PATHOL, V136, P593; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bossi Philippe, 2004, Euro Surveill, V9, pE11, DOI 10.2807/esm.09.12.00504-en; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; CARBALLAL G, 1981, J INFECT DIS, V143, P7, DOI 10.1093/infdis/143.1.7; Charrel RN, 2010, VET MICROBIOL, V140, P213, DOI 10.1016/j.vetmic.2009.08.027; Charrel RN, 2008, CURR OPIN MICROBIOL, V11, P362, DOI 10.1016/j.mib.2008.06.001; Chattopadhyay S, 2011, J VIROL, V85, P3708, DOI 10.1128/JVI.02133-10; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; CONTIGIANI M, 1993, ACTA VIROL, V37, P41; de Wilde AH, 2013, J GEN VIROL, V94, P1749, DOI 10.1099/vir.0.052910-0; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; Goni SE, 2010, VIRUS GENES, V40, P320, DOI 10.1007/s11262-010-0450-2; ENRIA DA, 1994, ANTIVIR RES, V23, P23, DOI 10.1016/0166-3542(94)90030-2; ENRIA DA, 1987, ANTIVIR RES, V7, P353, DOI 10.1016/0166-3542(87)90017-9; Enria DA, 2008, ANTIVIR RES, V78, P132, DOI 10.1016/j.antiviral.2007.10.010; FADOK VA, 1992, J IMMUNOL, V148, P2207; Ferrer PE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002083; Fields BN, 2013, FIELDS VIROLOGY; Gallardo F, 1970, MED S1, V1, P77; Garcia JB, 2000, VIROLOGY, V272, P127, DOI 10.1006/viro.2000.0345; Ghiringhelli PD, 1997, AM J TROP MED HYG, V56, P216, DOI 10.4269/ajtmh.1997.56.216; Goni SE, 2006, VIRUS GENES, V32, P37, DOI 10.1007/s11262-005-5843-2; GONZALEZ PH, 1980, ARCH PATHOL LAB MED, V104, P250; GREENMAN DL, 1987, J TOXICOL ENV HEALTH, V22, P113, DOI 10.1002/jmv.1890220203; Groseth A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001137; Harrison LH, 1999, CLIN INFECT DIS, V28, P1091, DOI 10.1086/514749; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Huang C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001659; KENYON RH, 1992, INTERVIROLOGY, V33, P23; Kepp O, 2009, APOPTOSIS, V14, P364, DOI 10.1007/s10495-008-0303-9; Kepp O, 2009, CURR OPIN ONCOL, V21, P71, DOI 10.1097/CCO.0b013e32831bc375; Kolokoltsova OA, 2010, J VIROL, V84, P13063, DOI 10.1128/JVI.01389-10; LAGUENS M, 1983, INFECT IMMUN, V41, P1279, DOI 10.1128/IAI.41.3.1279-1283.1983; LAGUENS RM, 1986, MED MICROBIOL IMMUN, V175, P187, DOI 10.1007/BF02122447; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Licata JM, 2003, INT REV IMMUNOL, V22, P451, DOI 10.1080/08830180305217; Maher SG, 2007, CURR MED CHEM, V14, P1279, DOI 10.2174/092986707780597907; MAIZTEGUI J, 1986, MED MICROBIOL IMMUN, V175, P149, DOI 10.1007/BF02122437; Maiztegui JI, 1998, J INFECT DIS, V177, P277, DOI 10.1086/514211; MAIZTEGUI JI, 1975, B WORLD HEALTH ORGAN, V52, P567; Martins SD, 2012, VIRUSES-BASEL, V4, P2736, DOI 10.3390/v4112736; MCKEE KT, 1985, J INFECT DIS, V152, P218, DOI 10.1093/infdis/152.1.218; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Muller S, 2007, J GEN VIROL, V88, P1568, DOI 10.1099/vir.0.82529-0; NIAID, 2013, BIOD EM INF DIS; Park SH, 2006, MOL CELLS, V21, P21; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Rahman ZSM, 2011, IMMUNOL RES, V51, P125, DOI 10.1007/s12026-011-8248-4; RUGGIERO HA, 1986, PRESSE MED, V15, P2239; Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; US Department of Health and Human Services, 2009, BIOSAFETY MICROBIOLO, V5th; Vince JE, 2010, EMBO J, V29, P1627, DOI 10.1038/emboj.2010.79; Wolff S, 2013, J VIROL, V87, P224, DOI 10.1128/JVI.01929-12; Yun NE, 2008, AM J TROP MED HYG, V79, P275, DOI 10.4269/ajtmh.2008.79.275	64	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99610	10.1371/journal.pone.0099610	http://dx.doi.org/10.1371/journal.pone.0099610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918927	Green Submitted, Green Published, gold			2022-12-25	WOS:000338631000098
J	Barleon, L; Wahl, J; Morfeld, P; Deters, C; Lichtmess, A; Haas-Braahler, S; Muller, U; Breitstadt, R; Pfeiffer, N				Barleon, Lorenz; Wahl, Jochen; Morfeld, Peter; Deters, Claudia; Lichtmess, Andrea; Haas-Braehler, Sibylle; Mueller, Uta; Breitstadt, Rolf; Pfeiffer, Norbert			The Evonik-Mainz-Eye-Care-Study (EMECS): Design and Execution of the Screening Investigation	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; COST-EFFECTIVENESS; DIABETIC-RETINOPATHY; VISUAL IMPAIRMENT; POPULATION; PREVALENCE; WORLDWIDE; WORK	Purpose: To determine if screening for major ophthalmological diseases is feasible within the frame of routine occupational medicine examinations in a large working population. Methods: 13037 employees of Evonik Industries aged 40 to 65 years were invited to be screened for major ophthalmological diseases (glaucoma, age related macular degeneration and diabetic retinopathy between June 2007 and March 2008 within an extended setting of occupational medicine. Ophthalmological examinations consisted of visual acuity, objective refraction, pachymetry, tonometry, perimetry (frequency doubling technology), confocal scanning laser ophthalmoscopy and digital fundus photography. Participants responded to a questionnaire addressing history of ocular and general diseases and social history. Results: 4183 participants (961 female and 3222 male) were examined at 13 different sites. Response rates for eligible persons at those sites ranged from 17.9 to 60.5% but were in part limited by availability of examination slots. Average age of participants was 48.4 +/- 5.4 years (mean +/- SD). 4147 out of 4183 subjects (99.1%) had a visual acuity >= 0.5 in the better eye and 3665 out of 4183 (87.6%) subjects had a visual acuity >= 0.8 in the better eye. 1629 participants (38.9%) had previously not been seen by an ophthalmologist at all or not within the last three years. Conclusion: This article describes the study design and basic characteristics of study participants within a large occupational medicine based screening study for ophthalmological diseases. Response rates exceeded expectations and were limiting examination capacity. Meaningful data could be obtained for almost all participants. We reached participants who previously had not received ophthalmic care. Thus, ophthalmological screening appears to be feasible within the frame of routine occupational medicine examinations.	[Barleon, Lorenz; Wahl, Jochen; Deters, Claudia; Lichtmess, Andrea; Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany; [Morfeld, Peter] Univ Cologne, Inst Occupat Med Environm Med & Prevent Res, D-50931 Cologne, Germany; [Morfeld, Peter] Inst Occupat Epidemiol & Risk Assessment Evonik I, Essen, Germany; [Haas-Braehler, Sibylle] Evonik Ind, Occupat Hlth, Hanau, Germany; [Mueller, Uta; Breitstadt, Rolf] Evonik Ind, Occupat Hlth, Essen, Germany	Johannes Gutenberg University of Mainz; University of Cologne; Evonik Industries; Evonik Industries; Evonik Industries	Barleon, L (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany.	L.Barleon@diak-ka.de	Pfeiffer, Norbert/AAO-7586-2020		Evonik Industries	Evonik Industries	This investigation was sponsored by a grant from Evonik Industries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler W, 2010, KLIN MONATSBL AUGENH, V227, P905, DOI 10.1055/s-0029-1245425; [Anonymous], 1991, Ophthalmology, V98, P786; Antony K, 2007, GMS HLTH TECHNOL ASS, V3, P1; Antony K, 2007, GMS HLTH TECHNOL ASS, V3, P57; BAVC, 2002, INF FUHR BUND CHEM E; Boivin J F, 1996, J Med Screen, V3, P154; Buch H, 2001, OPHTHALMOLOGY, V108, P2347, DOI 10.1016/S0161-6420(01)00823-5; Burr J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11410; Costa G, 2007, ERGONOMICS, V50, P1914, DOI 10.1080/00140130701676054; de Voogd S, 2005, OPHTHALMOLOGY, V112, P1487, DOI 10.1016/j.ophtha.2005.04.018; DGUV, 2010, DTSCH GES UNF BER GR; DGUV, 2007, DTSCH GES UNF GUID O; FAA, 2006, FED AV ADM GUID AV M; GFK-Marktforschung, 2010, HITL VORS AP UMSCH 1; GOTTLIEB LK, 1983, SURV OPHTHALMOL, V28, P206, DOI 10.1016/0039-6257(83)90098-X; Hernandez R, 2008, J GLAUCOMA, V17, P159, DOI 10.1097/IJG.0b013e31814b9693; Hernandez RA, 2008, INT J TECHNOL ASSESS, V24, P203, DOI 10.1017/S0266462308080288; HSE, 2000, HLTH SAF GUID 6 HSG6; HSE, 2003, WORK DISPL SCREEN EQ; Le Blanc R, 1989, Surv Ophthalmol, V33 Suppl, P445, DOI 10.1016/0039-6257(89)90082-9; Le Blanc R, 1989, SURV OPHTHALMOL S, P449; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Meyer C, 2006, IST GLAUKOMSCREENING; Mowatt G, 2008, INVEST OPHTH VIS SCI, V49, P5373, DOI 10.1167/iovs.07-1501; Peto T, 2012, CURR DIABETES REP, V12, P338, DOI 10.1007/s11892-012-0285-4; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; ROTHMAN KJ, 2008, MODERN EPIDEMIOLOGY; Schmier JK, 2007, PHARMACOECONOMICS, V25, P287, DOI 10.2165/00019053-200725040-00003; SHARIT J, 1994, ERGONOMICS, V37, P559, DOI 10.1080/00140139408963674; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; StataCorp, 2009, STAT REL 11 STAT SOF; Sundling V, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-17; Tuomi K, 2001, OCCUP MED-OXFORD, V51, P318, DOI 10.1093/occmed/51.5.318; Vaahtoranta-Lehtonen H, 2007, ACTA OPHTHALMOL SCAN, V85, P508, DOI 10.1111/j.1600-0420.2007.00947.x; Wagner G, 1974, SEHVERMOGEN FARBTUCH; Yamauchi Y, 2012, JPN J OPHTHALMOL, V56, P577, DOI 10.1007/s10384-012-0184-x	37	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98538	10.1371/journal.pone.0098538	http://dx.doi.org/10.1371/journal.pone.0098538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915063	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700024
J	Bruckner, S; Kammer, T				Brueckner, Sabrina; Kammer, Thomas			Is Theta Burst Stimulation Applied to Visual Cortex Able to Modulate Peripheral Visual Acuity?	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; LOW-FREQUENCY; MOTOR; EXCITABILITY; PSYCHOPHYSICS; SUPPRESSION; DEPRESSION; PLASTICITY; PHOSPHENES; ANISOTROPY	Repetitive transcranial magnetic stimulation is usually applied to visual cortex to explore the effects on cortical excitability. Most researchers therefore concentrate on changes of phosphene threshold, rarely on consequences for visual performance. Thus, we investigated peripheral visual acuity in the four quadrants of the visual field using Landolt C optotypes before and after repetitive stimulation of the visual cortex. We applied continuous and intermittend theta burst stimulation with various stimulation intensities (60%, 80%, 100%, 120% of individual phosphene threshold) as well as monophasic and biphasic 1 Hz stimulation, respectively. As an important result, no serious adverse effects were observed. In particular, no seizure was induced, even with theta burst stimulation applied with 120% of individual phosphene threshold. In only one case stimulation was ceased because the subject reported intolerable pain. Baseline visual acuity decreased over sessions, indicating a continuous training effect. Unexpectedly, none of the applied transcranial magnetic stimulation protocols had an effect on performance: no change in visual acuity was found in any of the four quadrants of the visual field. Binocular viewing as well as the use of peripheral instead of foveal presentation of the stimuli might have contributed to this result. Furthermore, intraindividual variability could have masked the TMS-induced effects on visual acuity.	[Brueckner, Sabrina; Kammer, Thomas] Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany	Ulm University	Bruckner, S (corresponding author), Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany.	sabrina.brueckner@uni-ulm.de	Kammer, Thomas/K-2168-2012	Kammer, Thomas/0000-0002-2769-5645; Lorenz, Sabrina/0000-0001-5798-4838				Agostino R, 2008, EUR J NEUROSCI, V28, P822, DOI 10.1111/j.1460-9568.2008.06373.x; Antal A, 2002, NEUROREPORT, V13, P2229, DOI 10.1097/00001756-200212030-00013; Boroojerdi B, 2000, NEUROLOGY, V54, P1529, DOI 10.1212/WNL.54.7.1529; Boroojerdi B, 2002, CLIN NEUROPHYSIOL, V113, P1501, DOI 10.1016/S1388-2457(02)00198-0; Bower JD, 2012, ATTEN PERCEPT PSYCHO, V74, P942, DOI 10.3758/s13414-012-0283-2; Brighina F, 2002, EXP BRAIN RES, V145, P177, DOI 10.1007/s00221-002-1096-7; Bruckner S, 2013, NEUROSCIENCE, V233, P64, DOI 10.1016/j.neuroscience.2012.12.033; Cazzoli D, 2009, EUR J NEUROSCI, V29, P1271, DOI 10.1111/j.1460-9568.2009.06665.x; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Darrien JH, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-13; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; Epstein CM, 1996, J CLIN NEUROPHYSIOL, V13, P242, DOI 10.1097/00004691-199605000-00008; Fierro B, 2005, J PHYSIOL-LONDON, V565, P659, DOI 10.1113/jphysiol.2004.080184; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; Gamboa OL, 2010, EXP BRAIN RES, V204, P181, DOI 10.1007/s00221-010-2293-4; Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8; Gentner R, 2008, CEREB CORTEX, V18, P2046, DOI 10.1093/cercor/bhm239; Harpaz Y, 2009, CORTEX, V45, P1097, DOI 10.1016/j.cortex.2009.01.002; Huang YZ, 2010, J PHYSIOL-LONDON, V588, P3683, DOI 10.1113/jphysiol.2010.191361; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Kamke MR, 2012, J NEUROSCI, V32, P7001, DOI 10.1523/JNEUROSCI.1028-12.2012; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P2015, DOI 10.1016/S1388-2457(01)00673-3; Kammer T, 2005, EXP BRAIN RES, V160, P118, DOI 10.1007/s00221-004-1991-1; Kammer T, 2005, EXP BRAIN RES, V160, P129, DOI 10.1007/s00221-004-1992-0; Kammer T, 2002, EXP BRAIN RES, V145, P407, DOI 10.1007/s00221-002-1160-3; Kammer T, 2007, NEUROIMAGE, V36, P313, DOI 10.1016/j.neuroimage.2007.03.001; Kastner S, 1998, EXP BRAIN RES, V118, P19, DOI 10.1007/s002210050251; Knoch D, 2005, CEREB CORTEX, V15, P885, DOI 10.1093/cercor/bhh196; Kondo M, 2008, JPN PSYCHOL RES, V50, P93, DOI 10.1111/j.1468-5884.2008.00365.x; Kraft A, 2010, EXP BRAIN RES, V207, P283, DOI 10.1007/s00221-010-2453-6; Low FN, 1943, AM J PHYSIOL, V140, P0083, DOI 10.1152/ajplegacy.1943.140.1.83; Meese TS, 2006, J VISION, V6, P1224, DOI 10.1167/6.11.7; MEYER BU, 1991, ELECTROEN CLIN NEURO, P121; Nyffeler T, 2008, EUR J NEUROSCI, V27, P1809, DOI 10.1111/j.1460-9568.2008.06154.x; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; Nyffeler T, 2009, STROKE, V40, P2791, DOI 10.1161/STROKEAHA.109.552323; Oberman L, 2011, J CLIN NEUROPHYSIOL, V28, P67, DOI 10.1097/WNP.0b013e318205135f; Oberman LM, 2009, BRAIN STIMUL, V2, P246, DOI 10.1016/j.brs.2009.03.003; Palomares M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020779; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Sack AT, 2005, SCIENCE, V308, P702, DOI 10.1126/science.1107784; Saint-Amour D, 2005, EUR J NEUROSCI, V21, P1107, DOI 10.1111/j.1460-9568.2005.03914.x; Salminen-Vaparanta N, 2012, HUM BRAIN MAPP, V33, P652, DOI 10.1002/hbm.21237; Suppa A, 2008, J PHYSIOL-LONDON, V586, P4489, DOI 10.1113/jphysiol.2008.156596; Tashiro K, 2007, NEUROREPORT, V18, P229, DOI 10.1097/WNR.0b013e3280113977; Thielscher A, 2010, CEREB CORTEX, V20, P328, DOI 10.1093/cercor/bhp102; To MPS, 2011, VISION RES, V51, P1686, DOI 10.1016/j.visres.2011.05.010; Waterston ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010354; Westheimer G, 2001, VISION RES, V41, P47, DOI 10.1016/S0042-6989(00)00245-5; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zafar N, 2008, CLIN NEUROPHYSIOL, V119, P1393, DOI 10.1016/j.clinph.2008.02.006	52	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99429	10.1371/journal.pone.0099429	http://dx.doi.org/10.1371/journal.pone.0099429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914682	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700102
J	Markowicz, S; Matalinska, J; Kurzepa, K; Bochynska, M; Biernacka, M; Samluk, A; Dudek, D; Skurzak, H; Yoshikawa, M; Lipkowski, AW				Markowicz, Sergiusz; Matalinska, Joanna; Kurzepa, Katarzyna; Bochynska, Marta; Biernacka, Marzena; Samluk, Anna; Dudek, Dorota; Skurzak, Henryk; Yoshikawa, Masaaki; Lipkowski, Andrzej W.			Anticancer Properties of Peptide Fragments of Hair Proteins	PLOS ONE			English	Article							KERATIN; CELLS; GENE; SKIN; SUPERINFECTION; CYTOTOXICITY; SENSITIVITY; EXPRESSION; DEFENSINS; TISSUE	The primary function of hair and fur covering mammalian skin is to provide mechanical and thermal protection for the body. The proteins that constitute hair are extremely resistant to degradation by environmental factors. However, even durable materials can be slowly broken down by mechanical stresses, biodegradation mediated by endogenous enzymes in the skin or host microbes. We hypothesised that the biodegradation products of hair may possess bioprotective properties, which supplement their physical protective properties. Although evolutionary processes have led to a reduction in the amount of hair on the human body, it is possible that the bioprotective properties of hair biodegradation products have persisted. The human skin is exposed to various environmental carcinogenic factors. Therefore, we hypothesised that the potential bioprotective mechanisms of hair degradation products affect melanoma growth. We used pepsin to partially digest hair enzymatically, and this process produced a water-soluble lysate containing a mixture of peptides, including fragments of keratin and keratin-associated proteins. We found out that the mixtures of soluble peptides obtained from human hair inhibited the proliferation of human melanoma cells in vitro. Moreover, the hair-derived peptide mixtures also inhibited the proliferation of B lymphoma cells and urinary bladder cancer cells. Normal human cells varied in their susceptibility to the effects of the lysate; the hair-derived peptide mixtures modulated the proliferation of normal human fibroblasts but did not inhibit the proliferation of human mesenchymal cells derived from umbilical cord stromal cells. These results suggest that hair-derived peptides may represent a new class of anti-proliferative factors derived from basically structural proteins. Identification of active regulatory compounds and recognition of the mechanism of their action might pave the way to elaboration of new anticancer drugs.	[Matalinska, Joanna; Bochynska, Marta; Lipkowski, Andrzej W.] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland; [Markowicz, Sergiusz; Biernacka, Marzena; Samluk, Anna; Dudek, Dorota; Skurzak, Henryk] Maria Sklodowska Curie Mem Inst & Oncol Ctr, Warsaw, Poland; [Kurzepa, Katarzyna] Ind Chem Res Inst, PL-01793 Warsaw, Poland; [Yoshikawa, Masaaki] Res Inst Prod Dev, Sakyo Ku, Kyoto, Japan; [Lipkowski, Andrzej W.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Maria Sklodowska-Curie National Research Institute of Oncology; Industrial Chemistry Research Institute; Tufts University	Lipkowski, AW (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland.	andrzej@lipkowski.org	; Kurzepa, Katarzyna/W-5796-2018	Markowicz, Sergiusz/0000-0003-1280-6514; Kurzepa, Katarzyna/0000-0001-9822-0922; Matalinska, Joanna/0000-0003-0837-7171	Polish Research Grant [2011/01/B/ST5/07818]; Regional Cluster Grant for Peptide Sciences in Mazovia, Poland	Polish Research Grant; Regional Cluster Grant for Peptide Sciences in Mazovia, Poland	This work was partially supported by the Polish Research Grant 2011/01/B/ST5/07818 and Regional Cluster Grant for Peptide Sciences in Mazovia, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER W, 1994, INT J CANCER, V59, P717, DOI 10.1002/ijc.2910590522; Bhutia SK, 2008, TRENDS BIOTECHNOL, V26, P210, DOI 10.1016/j.tibtech.2008.01.002; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; Chen YQ, 2010, PEPTIDES, V31, P1504, DOI 10.1016/j.peptides.2010.05.010; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Gewartowski K, 2006, ACTA BIOCHIM POL, V53, P179; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Harris F, 2013, MED RES REV, V33, P190, DOI 10.1002/med.20252; Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076; Iwasaki T, 2009, PEPTIDES, V30, P660, DOI 10.1016/j.peptides.2008.12.019; Jorritsma A, 2009, IMMUNOTHERAPY-UK, V1, P679, DOI [10.2217/imt.09.20, 10.2217/IMT.09.20]; Jurga M, 2009, TISSUE ENG PART C-ME, V15, P365, DOI 10.1089/ten.tec.2008.0485; KLEIN G, 1972, INT J CANCER, V10, P44, DOI 10.1002/ijc.2910100108; Krishnan B, 2013, PROSTATE, V73, P60, DOI 10.1002/pros.22540; Kulik J, 2001, MELANOMA RES, V11, P65, DOI 10.1097/00008390-200102000-00008; LICHTENSTEIN A, 1986, BLOOD, V68, P1407; Lipkowski AW, 2009, POLIMERY-W, V54, P386, DOI 10.14314/polimery.2009.386; Markowicz S, 2012, MED ONCOL, V29, P2966, DOI 10.1007/s12032-012-0168-1; Matalinska J, 2013, FOLIA NEUROPATHOL, V51, P132, DOI 10.5114/fn.2013.35956; NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221; NYORMOI O, 1973, INT J CANCER, V12, P396, DOI 10.1002/ijc.2910120211; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Pojda Z, 2008, BLOOD, V112, P1189, DOI 10.1182/blood.V112.11.3465.3465; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Rogers MA, 1998, J BIOL CHEM, V273, P26683, DOI 10.1074/jbc.273.41.26683; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; Rogers MA, 2000, J INVEST DERMATOL, V114, P464, DOI 10.1046/j.1523-1747.2000.00910.x; Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999; Sage J, 2014, MATRIX BIOL, V33, P41, DOI 10.1016/j.matbio.2013.07.002; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2009, PIGM CELL MELANOMA R, V22, P154, DOI 10.1111/j.1755-148X.2008.00540.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; STEINERT PM, 1985, CELL, V42, P411, DOI 10.1016/0092-8674(85)90098-4; Szenajch J, 2003, CLIN CHEM, V49, P1450, DOI 10.1373/49.9.1450	38	3	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98073	10.1371/journal.pone.0098073	http://dx.doi.org/10.1371/journal.pone.0098073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915193	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700016
J	Pan, LN; Zhu, W; Li, Y; Xu, XL; Guo, LJ; Lu, Q; Wang, J				Pan, Lin-na; Zhu, Wei; Li, Yang; Xu, Xu-lin; Guo, Lian-jun; Lu, Qing; Wang, Jian			Astrocytic Toll-Like Receptor 3 Is Associated with Ischemic Preconditioning-Induced Protection against Brain Ischemia in Rodents	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NF-KAPPA-B; HEMORRHAGIC BRAIN; IN-VITRO; NEUROPROTECTION; INFLAMMATION; INJURY; MECHANISMS; STROKE; TLR3	Background: Cerebral ischemic preconditioning (IPC) protects brain against ischemic injury. Activation of Toll-like receptor 3 (TLR3) signaling can induce neuroprotective mediators, but whether astrocytic TLR3 signaling is involved in IPC-induced ischemic tolerance is not known. Methods: IPC was modeled in mice with three brief episodes of bilateral carotid occlusion. In vitro, IPC was modeled in astrocytes by 1-h oxygen-glucose deprivation (OGD). Injury and components of the TLR3 signaling pathway were measured after a subsequent protracted ischemic event. A neutralizing antibody against TLR3 was used to evaluate the role of TLR3 signaling in ischemic tolerance. Results: IPC in vivo reduced brain damage from permanent middle cerebral artery occlusion in mice and increased expression of TLR3 in cortical astrocytes. IPC also reduced damage in isolated astrocytes after 12-h OGD. In astrocytes, IPC or 12-h OGD alone increased TLR3 expression, and 12-h OGD alone increased expression of phosphorylated NF kappa B (pNF kappa B). However, IPC or 12-h OGD alone did not alter the expression of Toll/interleukin receptor domain-containing adaptorinducing IFN beta (TRIF) or phosphorylated interferon regulatory factor 3 (pIRF3). Exposure to IPC before OGD increased TRIF and pIRF3 expression but decreased pNF kappa B expression. Analysis of cytokines showed that 12-h OGD alone increased IFNb and IL-6 secretion; 12-h OGD preceded by IPC further increased IFNb secretion but decreased IL-6 secretion. Preconditioning with TLR3 ligand Poly I:C increased pIRF3 expression and protected astrocytes against ischemic injury; however, cells treated with a neutralizing antibody against TLR3 lacked the IPC- and Poly I:C-induced ischemic protection and augmentation of IFN beta. Conclusions: The results suggest that IPC-induced ischemic tolerance is mediated by astrocytic TLR3 signaling. This reprogramming of TLR3 signaling by IPC in astrocytes may play an important role in suppression of the post-ischemic inflammatory response and thereby protect against ischemic damage. The mechanism may be via activation of the TLR3/ TRIF/IRF3 signaling pathway.	[Pan, Lin-na; Li, Yang; Xu, Xu-lin; Guo, Lian-jun; Lu, Qing] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Hubei, Peoples R China; [Pan, Lin-na] Second Hosp Nanchang, Dept Med Neurol, Nanchang, Jiangxi, Peoples R China; [Zhu, Wei] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Emergency Internal Med, Wuhan 430074, Hubei, Peoples R China; [Zhu, Wei; Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Xu, Xu-lin; Guo, Lian-jun; Lu, Qing] Key Lab Drug Target Res & Pharmacodynam Evaluat, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Nanchang University; Huazhong University of Science & Technology; Johns Hopkins University	Lu, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Hubei, Peoples R China.	qinglu@mail.hust.edu.cn	Wang, Jian/I-4874-2019	Wang, Jian/0000-0003-2291-640X	National Natural Science Foundation of China [81001432, 81173038, 81001425]; National Institutes of Health [K01AG031926, R01AT007317, R01NS078026]; National Center for Complementary & Integrative Health [R01AT007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG031926] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Natural Science Foundation of China http://www.nsfc.gov.cn/ (No. 81001432 reveived by QL, No. 81173038 reveive by LJG, No. 81001425 received by XLX), and the National Institutes of Health http://www.nih.gov/ (K01AG031926, R01AT007317, R01NS078026 reveived by JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Borysiewicz E, 2013, J NEUROIMMUNOL, V255, P54, DOI 10.1016/j.jneuroim.2012.11.002; Bowen KK, 2006, NEUROCHEM INT, V49, P127, DOI 10.1016/j.neuint.2006.02.011; Bsibsi M, 2006, GLIA, V53, P688, DOI 10.1002/glia.20328; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chang CF, 2014, ANN CLIN TRANSL NEUR, V1, P258, DOI 10.1002/acn3.54; Cho S, 2005, J CEREBR BLOOD F MET, V25, P493, DOI 10.1038/sj.jcbfm.9600058; Gabryel B, 2001, NEUROTOX RES, V3, P205, DOI 10.1007/BF03033192; Gesuete R, 2012, J NEUROCHEM, V123, P75, DOI 10.1111/j.1471-4159.2012.07946.x; Grilli M, 2000, EUR J NEUROSCI, V12, P2265, DOI 10.1046/j.1460-9568.2000.00090.x; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Hecker M, 2013, MOL NEUROBIOL; Hyakkoku K, 2010, NEUROSCIENCE, V171, P258, DOI 10.1016/j.neuroscience.2010.08.054; Kilic U, 2008, NEUROBIOL DIS, V31, P33, DOI 10.1016/j.nbd.2008.03.002; Koyama Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-51; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Liu HP, 2002, NEUROSCI LETT, V327, P146, DOI 10.1016/S0304-3940(02)00371-3; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lu Q, 2011, NITRIC OXIDE-BIOL CH, V24, P132, DOI 10.1016/j.niox.2011.01.007; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Marsh B, 2009, J NEUROSCI, V29, P9839, DOI 10.1523/JNEUROSCI.2496-09.2009; Marsh BJ, 2008, CURR OPIN PHARMACOL, V8, P8, DOI 10.1016/j.coph.2007.09.009; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; McCusker RH, 2013, J EXP BIOL, V216, P84, DOI 10.1242/jeb.073411; Packard AEB, 2012, J CEREBR BLOOD F MET, V32, P242, DOI 10.1038/jcbfm.2011.160; Pan LN, 2012, ACTA PHARMACOL SIN, V33, P1246, DOI 10.1038/aps.2012.122; Pradillo JM, 2009, J NEUROCHEM, V109, P287, DOI 10.1111/j.1471-4159.2009.05972.x; Vannet BMRAV, 2007, ANGLE ORTHOD, V77, P716, DOI 10.2319/052706-212.1; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Shpargel Karl B, 2008, Cleve Clin J Med, V75 Suppl 2, pS77; Sparapani M, 1997, GLIA, V20, P203, DOI 10.1002/(SICI)1098-1136(199707)20:3<203::AID-GLIA4>3.0.CO;2-8; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Vartanian KB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-140; Veldhuis TB, 2003, J CEREBR BLOOD F MET, V23, P1060, DOI 10.1097/01.WCB.0000080701.47016.24; Veldhuis TB, 2003, J CEREBR BLOOD F MET, V23, P1029, DOI 10.1097/01.WCB.0000080703.47016.B6; Wang J, 2008, NEUROSCIENCE, V155, P1133, DOI 10.1016/j.neuroscience.2008.07.004; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang J, 2006, NEUROBIOL DIS, V22, P473, DOI 10.1016/j.nbd.2005.12.009; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wu H, 2012, NEUROBIOL DIS, V45, P388, DOI 10.1016/j.nbd.2011.08.028; Wu T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-22; Zan L, 2014, NEUROSCIENCE, V262, P118, DOI 10.1016/j.neuroscience.2013.12.060; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003	50	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99526	10.1371/journal.pone.0099526	http://dx.doi.org/10.1371/journal.pone.0099526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914679	Green Submitted, gold, Green Published			2022-12-25	WOS:000340947700111
J	Rios, RS; Salgado-Luarte, C; Gianoli, E				Rios, Rodrigo S.; Salgado-Luarte, Cristian; Gianoli, Ernesto			Species Divergence and Phylogenetic Variation of Ecophysiological Traits in Lianas and Trees	PLOS ONE			English	Article							PLANT FUNCTIONAL TRAITS; NATURAL-SELECTION; EMERGING PATTERNS; TROPICAL FORESTS; GLOBAL ANALYSIS; LIFE-HISTORY; LEAF TRAITS; EVOLUTION; RATES; GROWTH	The climbing habit is an evolutionary key innovation in plants because it is associated with enhanced clade diversification. We tested whether patterns of species divergence and variation of three ecophysiological traits that are fundamental for plant adaptation to light environments (maximum photosynthetic rate [A(max)], dark respiration rate [R-d], and specific leaf area [SLA]) are consistent with this key innovation. Using data reported from four tropical forests and three temperate forests, we compared phylogenetic distance among species as well as the evolutionary rate, phylogenetic distance and phylogenetic signal of those traits in lianas and trees. Estimates of evolutionary rates showed that R-d evolved faster in lianas, while SLA evolved faster in trees. The mean phylogenetic distance was 1.2 times greater among liana species than among tree species. Likewise, estimates of phylogenetic distance indicated that lianas were less related than by chance alone (phylogenetic evenness across 63 species), and trees were more related than expected by chance (phylogenetic clustering across 71 species). Lianas showed evenness for R-d, while trees showed phylogenetic clustering for this trait. In contrast, for SLA, lianas exhibited phylogenetic clustering and trees showed phylogenetic evenness. Lianas and trees showed patterns of ecophysiological trait variation among species that were independent of phylogenetic relatedness. We found support for the expected pattern of greater species divergence in lianas, but did not find consistent patterns regarding ecophysiological trait evolution and divergence. R-d followed the species-level pattern, i.e., greater divergence/evolution in lianas compared to trees, while the opposite occurred for SLA and no pattern was detected for A(max). R-d may have driven lianas' divergence across forest environments, and might contribute to diversification in climber clades.	[Rios, Rodrigo S.; Salgado-Luarte, Cristian; Gianoli, Ernesto] Univ La Serena, Dept Biol, La Serena, Chile; [Gianoli, Ernesto] Univ Concepcion, Dept Bot, Concepcion, Chile	Universidad de La Serena; Universidad de Concepcion	Gianoli, E (corresponding author), Univ La Serena, Dept Biol, La Serena, Chile.	egianoli@userena.cl	Rios, Rodrigo S./C-5098-2015; Gianoli, Ernesto/A-7984-2015	Rios, Rodrigo S./0000-0003-3068-0118; Gianoli, Ernesto/0000-0003-4246-8640	FONDECYT [1100585]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was funded by the FONDECYT grant 1100585 (http://www.conicyt.cl/fondecyt/). FONDECYT is the Chilean Agency of Research Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2009, P NATL ACAD SCI USA, V106, P19699, DOI 10.1073/pnas.0901635106; Ackerly DD, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P391; Ackerly DD, 2000, BIOSCIENCE, V50, P979, DOI 10.1641/0006-3568(2000)050[0979:TEOPET]2.0.CO;2; Adams DC, 2009, P ROY SOC B-BIOL SCI, V276, P2729, DOI 10.1098/rspb.2009.0543; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Cai ZQ, 2009, OECOLOGIA, V161, P25, DOI 10.1007/s00442-009-1355-4; Cornelissen JHC, 1997, OECOLOGIA, V111, P460, DOI 10.1007/s004420050259; Dodd ME, 1999, EVOLUTION, V53, P732, DOI [10.2307/2640713, 10.1111/j.1558-5646.1999.tb05367.x]; Duran SM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0301; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; EWERS FW, 1991, OECOLOGIA, V88, P233, DOI 10.1007/BF00320816; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gallagher RV, 2012, J BIOGEOGR, V39, P1757, DOI 10.1111/j.1365-2699.2012.02773.x; GARTNER BL, 1990, AM J BOT, V77, P742, DOI 10.2307/2444366; Gastauer M, 2013, ECOL INFORM, V15, P85, DOI 10.1016/j.ecoinf.2013.03.005; Geber MA, 2003, INT J PLANT SCI, V164, pS21, DOI 10.1086/368233; Gentry A.H., 1991, BIOL VINES, P3; Gentry AH, 1991, BIOL VINES, P393, DOI DOI 10.1017/CBO9780511897658.017; Gianoli E, 2004, P ROY SOC B-BIOL SCI, V271, P2011, DOI 10.1098/rspb.2004.2827; Gianoli E, 2014, ECOLOGY LIA IN PRESS; Gianoli E, 2013, OECOLOGIA, V173, P13, DOI 10.1007/s00442-013-2590-2; Gianoli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038831; Gianoli E, 2010, J VEG SCI, V21, P66, DOI 10.1111/j.1654-1103.2009.01124.x; Gilbert B, 2006, ECOLOGY, V87, P1281, DOI 10.1890/0012-9658(2006)87[1281:LHTITT]2.0.CO;2; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Heard Stephen B., 1995, Historical Biology, V10, P151; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Hunter JP, 1998, TRENDS ECOL EVOL, V13, P31, DOI 10.1016/S0169-5347(97)01273-1; Jacobsen AL, 2012, AM J BOT, V99, P1583, DOI 10.3732/ajb.1200140; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kooyman RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080685; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Lambers H., 1998, PLANT PHYSL ECOLOGY, P299, DOI 10.1007/978-1-4757-2855-2; Lanfear R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2836; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Magnuson-Ford K, 2012, AM NAT, V180, P225, DOI 10.1086/666649; Mooers AO, 1999, AM NAT, V154, P249, DOI 10.1086/303226; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; O'Meara BC, 2006, EVOLUTION, V60, P922; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pearcy RW, 2007, FUNCTIONAL PLANT ECO, P213, DOI DOI 10.1201/9781420007626.CH7; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; R Core Team, 2021, R LANG ENV STAT COMP; Revell LJ, 2013, SYST BIOL, V62, P339, DOI 10.1093/sysbio/sys084; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Riveros M., 1995, ECOLOGIA BOSQUES NAT, P235; Saldana A, 2007, EVOL ECOL, V21, P651, DOI 10.1007/s10682-006-9143-7; Salgado-Luarte C, 2012, AM NAT, V180, pE42, DOI 10.1086/666612; Santiago LS, 2007, FUNCT ECOL, V21, P19, DOI 10.1111/j.1365-2435.2006.01218.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; van der Heijden GM, 2013, BIOTROPICA, V45, P682, DOI 10.1111/btp.12060; van der Sande MT, 2013, OECOLOGIA, V172, P961, DOI 10.1007/s00442-012-2563-x; Verdu M, 2007, J ECOL, V95, P1316, DOI 10.1111/j.1365-2745.2007.01300.x; Walls RL, 2011, AM J BOT, V98, P244, DOI 10.3732/ajb.1000154; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Wyka TP, 2013, ANN BOT-LONDON, V112, P1667, DOI 10.1093/aob/mct236; Zheng L, 2009, FUNCT ECOL, V23, P1059, DOI 10.1111/j.1365-2435.2009.01596.x; Zhu SD, 2009, PLANT ECOL, V204, P295, DOI 10.1007/s11258-009-9592-5	75	8	8	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99871	10.1371/journal.pone.0099871	http://dx.doi.org/10.1371/journal.pone.0099871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914958	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700140
J	Hoffmann, B; Proust, H; Belcram, K; Labrune, C; Boyer, FD; Rameau, C; Bonhomme, S				Hoffmann, Beate; Proust, Helene; Belcram, Katia; Labrune, Cecile; Boyer, Francois-Didier; Rameau, Catherine; Bonhomme, Sandrine			Strigolactones Inhibit Caulonema Elongation and Cell Division in the Moss Physcomitrella patens	PLOS ONE			English	Article							PLANT HORMONES; ARABIDOPSIS-THALIANA; RESISTANT MUTANTS; SEED-GERMINATION; ROOT-SYSTEM; TIP GROWTH; RICE; PERCEPTION; MOLECULES; RESPONSES	In vascular plants, strigolactones (SLs) are known for their hormonal role and for their role as signal molecules in the rhizosphere. SLs are also produced by the moss Physcomitrella patens, in which they act as signaling factors for controlling filament extension and possibly interaction with neighboring individuals. To gain a better understanding of SL action at the cellular level, we investigated the effect of exogenously added molecules (SLs or analogs) in moss growth media. We used the previously characterized Ppccd8 mutant that is deficient in SL synthesis and showed that SLs affect moss protonema extension by reducing caulonema cell elongation and mainly cell division rate, both in light and dark conditions. Based on this effect, we set up bioassays to examine chemical structure requirements for SL activity in moss. The results suggest that compounds GR24, GR5, and 5-deoxystrigol are active in moss (as in pea), while other analogs that are highly active in the control of pea branching show little activity in moss. Interestingly, the karrikinolide KAR1, which shares molecular features with SLs, did not have any effect on filament growth, even though the moss genome contains several genes homologous to KAI2 (encoding the KAR1 receptor) and no canonical homologue to D14 (encoding the SL receptor). Further studies should investigate whether SL signaling pathways have been conserved during land plant evolution.	[Hoffmann, Beate; Proust, Helene; Belcram, Katia; Labrune, Cecile; Boyer, Francois-Didier; Rameau, Catherine; Bonhomme, Sandrine] Inst Natl Rech Agron AgroParisTech, UMR1318, Inst Jean Pierre Bourgin, Versailles, France; [Boyer, Francois-Didier] CNRS, Ctr Rech Gif, Inst Chim Subst Nat, UPR2301, Gif Sur Yvette, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Bonhomme, S (corresponding author), Inst Natl Rech Agron AgroParisTech, UMR1318, Inst Jean Pierre Bourgin, Versailles, France.	Sandrine.Bonhomme@versailles.inra.fr	Bonhomme, Sandrine/AAF-5961-2021		Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT); Agence Nationale de la Recherche [ANR-12-BSV6-004-01]	Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT); Agence Nationale de la Recherche(French National Research Agency (ANR))	H.P. was supported by a PhD fellowship from the Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT). The authors are grateful to the Agence Nationale de la Recherche (contract ANR-12-BSV6-004-01) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2011, P NATL ACAD SCI USA, V108, P20242, DOI 10.1073/pnas.1111902108; Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Akiyama K, 2010, PLANT CELL PHYSIOL, V51, P1104, DOI 10.1093/pcp/pcq058; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Arite T, 2012, J PLANT GROWTH REGUL, V31, P165, DOI 10.1007/s00344-011-9228-6; ASHTON NW, 1979, PLANTA, V144, P427, DOI 10.1007/BF00380118; ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Bonhomme Sandrine, 2013, Methods Mol Biol, V959, P21, DOI 10.1007/978-1-62703-221-6_2; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Boyer FD, 2014, MOL PLANT, V7, P675, DOI 10.1093/mp/sst163; Boyer FD, 2012, PLANT PHYSIOL, V159, P1524, DOI 10.1104/pp.112.195826; Brewer PB, 2013, MOL PLANT, V6, P18, DOI 10.1093/mp/sss130; Carol RJ, 2002, PHILOS T ROY SOC B, V357, P815, DOI 10.1098/rstb.2002.1092; Chen VX, 2010, CHEM-EUR J, V16, P13941, DOI 10.1002/chem.201002817; Cohen M, 2013, MOL PLANT, V6, P141, DOI 10.1093/mp/sss134; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Cove D, 2006, ANNU REV PLANT BIOL, V57, P497, DOI 10.1146/annurev.arplant.57.032905.105338; de Saint Germain A, 2013, CURR OPIN PLANT BIOL, V16, P583, DOI 10.1016/j.pbi.2013.06.007; de Saint Germain A, 2013, PLANT PHYSIOL, V163, P1012, DOI 10.1104/pp.113.220541; Delaux PM, 2012, NEW PHYTOL, V195, P857, DOI 10.1111/j.1469-8137.2012.04209.x; Dun EA, 2009, TRENDS PLANT SCI, V14, P364, DOI 10.1016/j.tplants.2009.04.003; Flematti GR, 2004, SCIENCE, V305, P977, DOI 10.1126/science.1099944; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Fukui K, 2011, BIOORG MED CHEM LETT, V21, P4905, DOI 10.1016/j.bmcl.2011.06.019; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Guo YX, 2013, P NATL ACAD SCI USA, V110, P8284, DOI 10.1073/pnas.1306265110; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Hu ZY, 2010, PLANT CELL PHYSIOL, V51, P1136, DOI 10.1093/pcp/pcq075; JENKINS GI, 1986, PLANT CELL ENVIRON, V9, P637, DOI 10.1111/j.1365-3040.1986.tb01621.x; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Koltai H, 2011, NEW PHYTOL, V190, P545, DOI 10.1111/j.1469-8137.2011.03678.x; Ligrone R, 2012, ANN BOT-LONDON, V109, P851, DOI 10.1093/aob/mcs017; Menand B, 2007, J EXP BOT, V58, P1843, DOI 10.1093/jxb/erm047; Nadal M, 2013, CURR OPIN PLANT BIOL, V16, P473, DOI 10.1016/j.pbi.2013.06.005; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Nelson DC, 2009, PLANT PHYSIOL, V149, P863, DOI 10.1104/pp.108.131516; Prandi C, 2013, MOL PLANT, V6, P113, DOI 10.1093/mp/sss133; Proust H, 2011, DEVELOPMENT, V138, P1531, DOI 10.1242/dev.058495; Rasmussen A, 2013, PLANTA, V238, P615, DOI 10.1007/s00425-013-1911-3; Rasmussen A, 2013, MOL PLANT, V6, P100, DOI 10.1093/mp/sss110; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Schaefer DG, 2001, PLANT PHYSIOL, V127, P1430, DOI 10.1104/pp.010786; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Wang Y, 2013, DEV CELL, V27, P681, DOI 10.1016/j.devcel.2013.11.010; Waters MT, 2013, MOL PLANT, V6, P63, DOI 10.1093/mp/sss127; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Waters MT, 2011, PLANT SIGNAL BEHAV, V6, P1418, DOI 10.4161/psb.6.9.17303; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878; Zwanenburg B, 2013, BIOORG MED CHEM LETT, V23, P5182, DOI 10.1016/j.bmcl.2013.07.004; Zwanenburg B, 2013, MOL PLANT, V6, P38, DOI 10.1093/mp/sss141; Zwanenburg B, 2009, PEST MANAG SCI, V65, P478, DOI 10.1002/ps.1706	56	30	31	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99206	10.1371/journal.pone.0099206	http://dx.doi.org/10.1371/journal.pone.0099206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911649	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600056
J	Moghim, N; Corne, DW				Moghim, Negin; Corne, David W.			Predicting Epileptic Seizures in Advance	PLOS ONE			English	Article							ACCUMULATED ENERGY; REAL-TIME; OSCILLATIONS; ALGORITHMS; DYNAMICS; LONG	Epilepsy is the second most common neurological disorder, affecting 0.6-0.8% of the world's population. In this neurological disorder, abnormal activity of the brain causes seizures, the nature of which tend to be sudden. Antiepileptic Drugs (AEDs) are used as long-term therapeutic solutions that control the condition. Of those treated with AEDs, 35% become resistant to medication. The unpredictable nature of seizures poses risks for the individual with epilepsy. It is clearly desirable to find more effective ways of preventing seizures for such patients. The automatic detection of oncoming seizures, before their actual onset, can facilitate timely intervention and hence minimize these risks. In addition, advance prediction of seizures can enrich our understanding of the epileptic brain. In this study, drawing on the body of work behind automatic seizure detection and prediction from digitised Invasive Electroencephalography (EEG) data, a prediction algorithm, ASPPR (Advance Seizure Prediction via Pre-ictal Relabeling), is described. ASPPR facilitates the learning of predictive models targeted at recognizing patterns in EEG activity that are in a specific time window in advance of a seizure. It then exploits advanced machine learning coupled with the design and selection of appropriate features from EEG signals. Results, from evaluating ASPPR independently on 21 different patients, suggest that seizures for many patients can be predicted up to 20 minutes in advance of their onset. Compared to benchmark performance represented by a mean S1-Score (harmonic mean of Sensitivity and Specificity) of 90.6% for predicting seizure onset between 0 and 5 minutes in advance, ASPPR achieves mean S1-Scores of: 96.30% for prediction between 1 and 6 minutes in advance, 96.13% for prediction between 8 and 13 minutes in advance, 94.5% for prediction between 14 and 19 minutes in advance, and 94.2% for prediction between 20 and 25 minutes in advance.	[Moghim, Negin; Corne, David W.] Heriot Watt Univ, Edinburgh, Midlothian, Scotland	Heriot Watt University	Moghim, N (corresponding author), Heriot Watt Univ, Edinburgh, Midlothian, Scotland.	neg.moghim@gmail.com			SICSA prize studentship [09/200903/2013]; Department of Computer Science, Heriot-Watt University [09/2009-03/2013]	SICSA prize studentship; Department of Computer Science, Heriot-Watt University	This project was supported by a SICSA prize studentship (http://www.sicsa.ac.uk/) for the timespan of 09/200903/2013. This study was also part-supported by the Department of Computer Science, Heriot-Watt University (http://www.macs.hw.ac.uk/departments/computerscience.htm) for the timespan of 09/2009-03/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1999, EPILEPSIA, V40, P1484, DOI 10.1111/j.1528-1157.1999.tb02030.x; Baumgartner C, 1998, PREICTAL SPECT TEMPO; Ben-Hur A, 2010, METHODS MOL BIOL, V609, P223, DOI 10.1007/978-1-60327-241-4_13; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chaovalitwongse W, 2005, EPILEPSY RES, V64, P93, DOI 10.1016/j.eplepsyres.2005.03.009; Chapelle O, 2007, NEURAL COMPUT, V19, P1155, DOI 10.1162/neco.2007.19.5.1155; Chavez M, 2003, IEEE T BIO-MED ENG, V50, P571, DOI 10.1109/TBME.2003.810696; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costa RP, 2008, LECT NOTES ARTIF INT, V5178, P281, DOI 10.1007/978-3-540-85565-1_35; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; Daubechies I, 1998, J FOURIER ANAL APPL; De Clercq W, 2003, LANCET, V361, P971, DOI 10.1016/S0140-6736(03)12780-8; EEGLAB, 2011, EEGLAP OP SOURC MATL; Elger CE, 2008, EPILEPSY BEHAV, V12, P501, DOI 10.1016/j.yebeh.2008.01.003; Federico P, 2005, BRAIN, V128, P1811, DOI 10.1093/brain/awh533; Gigola S, 2004, J NEUROSCI METH, V138, P107, DOI 10.1016/j.jneumeth.2004.03.016; Grassberger P, 1983, PHYS REV LETT; Grassberger P, 1991, INT J BIFURCAT CHAOS, V1, P521, DOI 10.1142/S0218127491000403; Hand D., 2001, ADAP COMP MACH LEARN; Harrison MAF, 2005, CLIN NEUROPHYSIOL, V116, P527, DOI 10.1016/j.clinph.2004.08.022; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; IASEMIDIS L D, 1990, Brain Topography, V2, P187, DOI 10.1007/BF01140588; Iasemidis LD, 2005, CLIN NEUROPHYSIOL, V116, P532, DOI 10.1016/j.clinph.2004.10.013; Kaiser D, 2013, SEMIN PEDIATR NEUROL, V20, P242, DOI 10.1016/j.spen.2013.10.005; KANTZ H, 1994, PHYS LETT A, V185, P77, DOI 10.1016/0375-9601(94)90991-1; Kantz H., 2004, NONLINEAR TIME SERIE; Kerem DH, 2005, MED BIOL ENG COMPUT, V43, P230, DOI 10.1007/BF02345960; Knerr S, 1990, SINGLE LAYER LEARNIN, P41, DOI [10.1007/978-3-642-76153-9_5, DOI 10.1007/978-3-642-76153-9_5]; Kononenko I, 1997, APPL INTELL, V7, P39, DOI 10.1023/A:1008280620621; Kononenko I., 1994, Machine Learning: ECML-94. European Conference on Machine Learning. Proceedings, P171; Kressel UHG, 1999, PAIRWISE CLASSIFICAT; Le Van Quyen M, 2001, J CLIN NEUROPHYSIOL, V18, P191, DOI 10.1097/00004691-200105000-00001; Le Van Quyen M, 1999, NEUROREPORT, V10, P2149; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667; Mormann F, 2006, CURR OPIN NEUROL, V19, P187, DOI 10.1097/01.wco.0000218237.52593.bc; Mormann F, 2005, CLIN NEUROPHYSIOL, V116, P569, DOI 10.1016/j.clinph.2004.08.025; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Noachtar S, 2009, EPILEPSY BEHAV, V15, P22, DOI 10.1016/j.yebeh.2009.02.035; Ott E., 2002, CHAOS DYNAMICAL SYST, V2nd, DOI DOI 10.1017/CBO9780511803260; Parri HR, 2001, NEUROREPORT, V12, P3897, DOI 10.1097/00001756-200112210-00008; PRANDONI P., 2008, SIGNAL PROCESSING CO, DOI [10.1201/9781439808009, DOI 10.1201/9781439808009]; Ren LK, 2011, ANN NEUROL, V69, P201, DOI 10.1002/ana.22158; REYNOLDS EH, 1983, LANCET, V2, P952; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; ROGOWSKI Z, 1981, BIOL CYBERN, V42, P9, DOI 10.1007/BF00335153; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Salant Y, 1998, MED BIOL ENG COMPUT, V36, P549, DOI 10.1007/BF02524422; Schuster H.G., 2006, DETERMINISTIC CHAOS, V4th ed; SIEGEL A, 1982, EPILEPSIA, V23, P47, DOI 10.1111/j.1528-1157.1982.tb05052.x; Stein AG, 2000, EPILEPSY RES, V39, P103, DOI 10.1016/S0920-1211(99)00107-2; Teixeira CA, 2011, J NEUROSCI METH, V200, P257, DOI 10.1016/j.jneumeth.2011.07.002; Theodore WH, 2004, LANCET NEUROL, V3, P111, DOI 10.1016/S1474-4422(03)00664-1; Uniklinik-freiburg.de, 2013, SECT EP; Van Quyen ML, 2003, EPILEPSIA, V44, P30; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; VIGLIONE S S, 1975, Electroencephalography and Clinical Neurophysiology, V39, P435; Winterhalder M, 2006, EPILEPSY RES, V72, P80, DOI 10.1016/j.eplepsyres.2006.06.012	59	63	63	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99334	10.1371/journal.pone.0099334	http://dx.doi.org/10.1371/journal.pone.0099334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911316	gold, Green Published			2022-12-25	WOS:000337165600074
J	Sun, YF; Yu, H; Zhou, JJ; Pickett, JA; Wu, KM				Sun, Yufeng; Yu, Hao; Zhou, Jing-Jiang; Pickett, John A.; Wu, Kongming			Plant Volatile Analogues Strengthen Attractiveness to Insect	PLOS ONE			English	Article							BT COTTON; ATTRACTANT	Green leaf bug Apolygus lucorum (Meyer-Dur) is one of the major pests in agriculture. Management of A. lucorum was largely achieved by using pesticides. However, the increasing population of A. lucorum since growing Bt cotton widely and the increased awareness of ecoenvironment and agricultural product safety makes their population-control very challenging. Therefore this study was conducted to explore a novel ecological approach, synthetic plant volatile analogues, to manage the pest. Here, plant volatile analogues were first designed and synthesized by combining the bioactive components of bionone and benzaldehyde. The stabilities of beta-ionone, benzaldehyde and analogue 3 g were tested. The electroantennogram (EAG) responses of A. lucorum adult antennae to the analogues were recorded. And the behavior assay and filed experiment were also conducted. In this study, thirteen analogues were acquired. The analogue 3 g was demonstrated to be more stable than beta-ionone and benzaldehyde in the environment. Many of the analogues elicited EAG responses, and the EAG response values to 3 g remained unchanged during seven-day period. 3 g was also demonstrated to be attractive to A. lucorum adults in the laboratory behavior experiment and in the field. Its attractiveness persisted longer than beta-ionone and benzaldehyde. This indicated that 3 g can strengthen attractiveness to insect and has potential as an attractant. Our results suggest that synthetic plant volatile analogues can strengthen attractiveness to insect. This is the first published study about synthetic plant volatile analogues that have the potential to be used in pest control. Our results will support a new ecological approach to pest control and it will be helpful to ecoenvironment and agricultural product safety.	[Sun, Yufeng; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Yu, Hao] Henan Inst Sci & Technol, Dept Entomol, Xinxiang, Peoples R China; [Zhou, Jing-Jiang; Pickett, John A.] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Henan Institute of Science & Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn			National Natural Science Foundation of China [31321004]; Chinese Ministry of Agriculture [201103012]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194, BB/J020281/1] Funding Source: researchfish; BBSRC [BB/J020281/1, BBS/E/C/00005194] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the National Natural Science Funds (No. 31321004) from National Natural Science Foundation of China and the Special Fund for Agro-scientific Research in the Public Interest (201103012) from the Chinese Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin EA, 2000, HORTSCIENCE, V35, P1013, DOI 10.21273/HORTSCI.35.6.1013; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; BLUM MS, 1969, COMP BIOCHEM PHYSIOL, V29, P461, DOI 10.1016/0010-406X(69)91766-6; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Chen W, 2012, THESIS HUAZHONG AGR; Cruz-Lopez L, 2006, J CHEM ECOL, V32, P351, DOI 10.1007/s10886-005-9006-7; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; HEDIN PA, 1971, PHYTOCHEMISTRY, V10, P3316, DOI 10.1016/S0031-9422(00)97414-4; James DG, 2005, J CHEM ECOL, V31, P481, DOI 10.1007/s10886-005-2020-y; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kolosova N, 2001, PLANT CELL, V13, P2333, DOI 10.1105/tpc.13.10.2333; Lee BH, 2001, CROP PROT, V20, P317, DOI 10.1016/S0261-2194(00)00158-7; Liu F, 2011, THESIS BEIJING U TEC; LOUGHRIN JH, 1990, PHYTOCHEMISTRY, V29, P2473, DOI 10.1016/0031-9422(90)85169-G; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2009, B ENTOMOL RES, V99, P543, DOI 10.1017/S000748530800655X; Lu YH, 2007, ENVIRON ENTOMOL, V36, P1007, DOI 10.1603/0046-225X(2007)36[1007:FPOLLM]2.0.CO;2; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Martel JW, 2005, AGR FOREST ENTOMOL, V7, P71, DOI 10.1111/j.1461-9555.2005.00247.x; Murai T, 2000, J CHEM ECOL, V26, P2557, DOI 10.1023/A:1005536713025; OBATA T, 1981, JPN J APPL ENTOMOL Z, V25, P47, DOI 10.1303/jjaez.25.47; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pickett JA, 1998, BIOCHEMIST, V20, P8, DOI DOI 10.1016/J.PHYT0CHEM.2011.04.011; Price P.W., 2011, INSECT ECOLOGY BEHAV; Roelofs W.L., 1984, Springer Series in Experimental Entomology, V1984, P131; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Simpson M, 2011, J APPL ECOL, V48, P580, DOI 10.1111/j.1365-2664.2010.01946.x; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Tian WH, 2012, THESIS SHANXI NORMAL; TING Yen-chin, 1963, Acta Phytophylacica Sinica, Peking, V2, P285; Ting YQ, 1964, ACTA ENTOMOL SINICA, V13, P298; Underwood BA, 2005, PLANT PHYSIOL, V138, P255, DOI 10.1104/pp.104.051144; Wang SF, 2005, J AGR FOOD CHEM, V53, P6240, DOI 10.1021/jf0502202; Xiao C, 2000, ACTA AGR JIANGXI, V12, P27	36	8	8	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99142	10.1371/journal.pone.0099142	http://dx.doi.org/10.1371/journal.pone.0099142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911460	Green Accepted, gold, Green Published			2022-12-25	WOS:000337165600045
J	Tarumi, W; Itoh, MT; Suzuki, N				Tarumi, Wataru; Itoh, Masanori T.; Suzuki, Nao			Effects of 5 alpha- Dihydrotestosterone and 17 beta- Estradiol on the Mouse Ovarian Follicle Development and Oocyte Maturation	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; GRANULOSA-CELLS; IN-VITRO; ER-BETA; MEIOTIC RESUMPTION; GROWTH; RAT; PROGESTERONE; EXPRESSION; DIFFERENTIATION	We have previously reported that androstenedione induces abnormalities of follicle development and oocyte maturation in the mouse ovary. In granulosa cells of the ovarian follicle, androstenedione is aromatized to 17 beta-estradiol (E-2). To determine whether the androgen or estrogen acts directly on the follicle to induce the above-mentioned abnormalities, we compared the effects of a non-aromatizable androgen, 5 alpha-dihydrotestosterone (DHT), with those of E-2 on murine follicular development and oocyte maturation in a single follicle culture system. The high dose (10(-6) M) of DHT prompted normal follicular development, and there was no effect on oocyte meiotic maturation after stimulation with human chorionic gonadotropin (hCG) and epidermal growth factor (EGF). In contrast, culture with the high dose (10(-6) M) of E-2 delayed follicular growth and also suppressed proliferation of granulosa cells and antrum formation. Furthermore, culture with E-2 delayed or inhibited oocyte meiotic maturation, such as chromosome alignment on the metaphase plate and extrusion of the first polar body, after addition of hCG and EGF. In conclusion, these findings demonstrate that E-2, but not DHT, induces abnormalities of follicular development, which leads to delay or inhibition of oocyte meiotic maturation.	[Tarumi, Wataru; Suzuki, Nao] St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan; [Itoh, Masanori T.] Tokyo Med & Dent Univ, Coll Liberal Arts & Sci, Dept Biol, Chiba, Japan	Saint Marianna University; Tokyo Medical & Dental University (TMDU)	Tarumi, W (corresponding author), St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan.	wt02022569@marianna-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22591839]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ( no. 22591839 to M.T.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; AZZOLIN GC, 1983, P SOC EXP BIOL MED, V172, P70; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Beker-van Woudenberg AR, 2004, BIOL REPROD, V70, P1465, DOI 10.1095/biolreprod.103.025684; BENDELL JJ, 1991, ENDOCRINOLOGY, V128, P2663, DOI 10.1210/endo-128-5-2663; Borman SM, 2004, BIOL REPROD, V71, P366, DOI 10.1095/biolreprod.103.023390; Britt KL, 2002, J ENDOCRINOL, V175, P269, DOI 10.1677/joe.0.1750269; Can A, 2005, MOL HUM REPROD, V11, P389, DOI 10.1093/molehr/gah179; Conti M, 2002, MOL CELL ENDOCRINOL, V187, P153, DOI 10.1016/S0303-7207(01)00686-4; Couse JF, 2005, ENDOCRINOLOGY, V146, P3247, DOI 10.1210/en.2005-0213; Crisosto N, 2009, ENDOCRINE, V36, P339, DOI 10.1007/s12020-009-9227-6; Cui XS, 2006, THERIOGENOLOGY, V66, P267, DOI 10.1016/j.theriogenology.2005.11.011; DORRINGTON JH, 1975, ENDOCRINOLOGY, V97, P1328, DOI 10.1210/endo-97-5-1328; Drummond AE, 2002, MOL CELL ENDOCRINOL, V191, P27, DOI 10.1016/S0303-7207(02)00052-7; Dupont S, 2000, DEVELOPMENT, V127, P4277; Emmen JMA, 2005, ENDOCRINOLOGY, V146, P2817, DOI 10.1210/en.2004-1108; Eppig JJ, 2005, BIOL REPROD, V73, P351, DOI 10.1095/biolreprod.105.041798; FORTUNE JE, 1977, ENDOCRINOLOGY, V100, P1341, DOI 10.1210/endo-100-5-1341; Gava N, 2004, ENDOCRINOLOGY, V145, P3487, DOI 10.1210/en.2004-0212; Gill A, 2004, MOL ENDOCRINOL, V18, P97, DOI 10.1210/me.2003-0326; Hewitt Sylvia Curtis, 2002, Rev Endocr Metab Disord, V3, P193, DOI 10.1023/A:1020068224909; Hofbauer LC, 1999, EUR J ENDOCRINOL, V141, P195, DOI 10.1530/eje.0.1410195; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Li Q, 2013, MOL ENDOCRINOL, V27, P1468, DOI 10.1210/me.2013-1082; Lund TD, 2006, J NEUROSCI, V26, P1448, DOI 10.1523/JNEUROSCI.3777-05.2006; Mehlmann LM, 2005, DEV BIOL, V288, P397, DOI 10.1016/j.ydbio.2005.09.030; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Okutsu Y, 2010, FERTIL STERIL, V93, P927, DOI 10.1016/j.fertnstert.2008.10.064; Orisaka M, 2009, ENDOCRINOLOGY, V150, P2740, DOI 10.1210/en.2008-1536; Otala M, 2004, FERTIL STERIL, V82, P1077, DOI 10.1016/j.fertnstert.2004.06.032; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Rosenfeld CS, 2001, MOL REPROD DEV, V59, P336, DOI 10.1002/mrd.1039; Shimada M, 2004, J MOL ENDOCRINOL, V33, P209, DOI 10.1677/jme.0.0330209; Siqueira LC, 2012, THERIOGENOLOGY, V77, P1779, DOI 10.1016/j.theriogenology.2011.12.022; Sotomayor-Zarate R, 2008, BIOL REPROD, V78, P673, DOI 10.1095/biolreprod.107.063974; Tarumi W, 2012, FERTIL STERIL, V97, P469, DOI 10.1016/j.fertnstert.2011.11.040; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Vendola KA, 1998, J CLIN INVEST, V101, P2622, DOI 10.1172/JCI2081; Yang MY, 2006, BIOL REPROD, V75, P924, DOI 10.1095/biolreprod.106.051813; ZAVA DT, 1978, ENDOCRINOLOGY, V103, P624, DOI 10.1210/endo-103-2-624	42	32	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99423	10.1371/journal.pone.0099423	http://dx.doi.org/10.1371/journal.pone.0099423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911314	gold, Green Submitted, Green Published			2022-12-25	WOS:000337165600084
J	Yu, CS; Cheng, CW; Su, WC; Chang, KC; Huang, SW; Hwang, JK; Lu, CH				Yu, Chin-Sheng; Cheng, Chih-Wen; Su, Wen-Chi; Chang, Kuei-Chung; Huang, Shao-Wei; Hwang, Jenn-Kang; Lu, Chih-Hao			CELLO2GO: A Web Server for Protein subCELlular LOcalization Prediction with Functional Gene Ontology Annotation	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; GENOMICS; NETWORKS; TERMS; TOOL; GO	CELLO2GO (http://cello.life.nctu.edu.tw/cello2go/) is a publicly available, web-based system for screening various properties of a targeted protein and its subcellular localization. Herein, we describe how this platform is used to obtain a brief or detailed gene ontology (GO)-type categories, including subcellular localization(s), for the queried proteins by combining the CELLO localization-predicting and BLAST homology-searching approaches. Given a query protein sequence, CELLO2GO uses BLAST to search for homologous sequences that are GO annotated in an in-house database derived from the UniProt KnowledgeBase database. At the same time, CELLO attempts predict at least one subcellular localization on the basis of the species in which the protein is found. When homologs for the query sequence have been identified, the number of terms found for each of their GO categories, i.e., cellular compartment, molecular function, and biological process, are summed and presented as pie charts representing possible functional annotations for the queried protein. Although the experimental subcellular localization of a protein may not be known, and thus not annotated, CELLO can confidentially suggest a subcellular localization. CELLO2GO should be a useful tool for research involving complex subcellular systems because it combines CELLO and BLAST into one platform and its output is easily manipulated such that the user-specific questions may be readily addressed.	[Yu, Chin-Sheng; Cheng, Chih-Wen; Su, Wen-Chi; Chang, Kuei-Chung] Feng Chia Univ, Dept Informat Engn & Comp Sci, Taichung 40724, Taiwan; [Yu, Chin-Sheng] Feng Chia Univ, Masters Program Biomed Informat & Biomed Engn, Taichung 40724, Taiwan; [Huang, Shao-Wei] Tzu Chi Univ, Dept Med Informat, Hualien, Taiwan; [Hwang, Jenn-Kang] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Hwang, Jenn-Kang] Natl Chiao Tung Univ, Ctr Bioinformat Res, Hsinchu, Taiwan; [Lu, Chih-Hao] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	Feng Chia University; Feng Chia University; Tzu Chi University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; China Medical University Taiwan	Lu, CH (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	chlu@mail.cmu.edu.tw		Chang, Shu-chuan/0000-0002-7087-0744	National Science Council of Taiwan [NSC-101-2113-M-035-002]; Academic Summit Program of National Science Council of Taiwan [NSC-103-2745-B-009-001]; "Center for Bioinformatics Research of Aiming for the Top University Program" of National Chiao Tung University and Ministry of Education of Taiwan; China Medical University of Taiwan [CMU99-N2-02-2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academic Summit Program of National Science Council of Taiwan; "Center for Bioinformatics Research of Aiming for the Top University Program" of National Chiao Tung University and Ministry of Education of Taiwan; China Medical University of Taiwan(China Medical University)	This work was supported by grant in part from the National Science Council of Taiwan [NSC-101-2113-M-035-002 to CSY], the Academic Summit Program of National Science Council of Taiwan [NSC-103-2745-B-009-001 to JKH], the "Center for Bioinformatics Research of Aiming for the Top University Program" of National Chiao Tung University and Ministry of Education of Taiwan, and China Medical University of Taiwan [CMU99-N2-02-2 to CHL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; Blum T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-274; Chawley P, 2014, GENOMICS, V103, P83, DOI 10.1016/j.ygeno.2013.12.002; Chi SM, 2012, BIOINFORMATICS, V28, P1028, DOI 10.1093/bioinformatics/bts062; Chou KC, 2004, BIOCHEM BIOPH RES CO, V320, P1236, DOI 10.1016/j.bbrc.2004.06.073; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-503; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI DOI 10.1093/nar/gkh066; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Laurila K, 2011, AMINO ACIDS, V40, P975, DOI 10.1007/s00726-010-0724-y; Lee K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn619; Luo HW, 2012, APPL ENVIRON MICROB, V78, P6550, DOI 10.1128/AEM.01406-12; Luo HW, 2009, P NATL ACAD SCI USA, V106, P21219, DOI 10.1073/pnas.0907586106; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mooney C, 2011, BIOINFORMATICS, V27, P2812, DOI 10.1093/bioinformatics/btr494; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Nair R, 2003, NUCLEIC ACIDS RES, V31, P3337, DOI 10.1093/nar/gkg514; Nair R, 2002, PROTEIN SCI, V11, P2836, DOI 10.1110/ps.0207402; Paramasivam N, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00218; Park S, 2009, J PROTEOME RES, V8, P3367, DOI 10.1021/pr900018z; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Wan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089545; Wan SB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-290; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	33	330	338	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99368	10.1371/journal.pone.0099368	http://dx.doi.org/10.1371/journal.pone.0099368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911789	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600077
J	Zhao, X; Cui, HX; Chen, WJ; Wang, Y; Cui, B; Sun, CJ; Meng, ZG; Liu, GQ				Zhao, Xiang; Cui, Haixin; Chen, Wenjie; Wang, Yan; Cui, Bo; Sun, Changjiao; Meng, Zhigang; Liu, Guoqiang			Morphology, Structure and Function Characterization of PEI Modified Magnetic Nanoparticles Gene Delivery System	PLOS ONE			English	Article							DNA NANOPARTICLES; MAGNETOFECTION; THERAPEUTICS	Modified magnetic nanoparticles are used as non-viral gene carriers in biological applications. To achieve successful gene delivery, it is critical that nanoparticles effectually assemble with nucleic acids. However, relatively little work has been conducted on the assemble mechanisms between nanoparticles and DNA, and its effects on transfection efficiency. Using biophysical and biochemical characterization, along with Atomic force microscopy (AFM) and Transmission electron microscopy (TEM), we investigate the morphologies, assembling structures and gene delivering abilities of the PEI modified magnetic nanoparticles (MNPs) gene delivery system. In this gene delivery system, MNP/DNA complexes are formed via binding of DNA onto the surface of MNPs. MNPs are favorable to not only increase DNA concentration but also prevent DNA degradation. Magnetofection experiments showed that MNPs has low cytotoxicity and introduces highly stable transfection in mammalian somatic cells. In addition, different binding ratios between MNPs and DNA result in various morphologies of MNP/DNA complexes and have an influence on transfection efficiency. Dose-response profile indicated that transfection efficiency positively correlate with MNP/DNA ratio. Furthermore, intracellular tracking demonstrate that MNPs move though the cell membranes, deliver and release exogenous DNA into the nucleus.	[Zhao, Xiang; Cui, Haixin; Chen, Wenjie; Wang, Yan; Cui, Bo; Sun, Changjiao; Liu, Guoqiang] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Zhao, Xiang; Cui, Haixin] Chinese Acad Agr Sci, Nano Biol Res Ctr, Beijing 100193, Peoples R China; [Meng, Zhigang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Cui, HX (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	cuihaixin@caas.cn		CHEN, WenJie/0000-0001-9512-9664; Meng, ZhiGang/0000-0001-8959-5685	Genetically Modified Organisms Breeding Major Projects [2009ZX08010-006B]	Genetically Modified Organisms Breeding Major Projects	The authors thank the Genetically Modified Organisms Breeding Major Projects (No. 2009ZX08010-006B) for the financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Arvizo RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024374; Barreto JA, 2011, ADV MATER, V23, pH18, DOI 10.1002/adma.201100140; Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Fallini C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-17; Gu JL, 2011, SCI CHINA LIFE SCI, V54, P793, DOI 10.1007/s11427-011-4215-5; Gu W, 2010, EUR CELLS MAT S, V20, P294; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Harush-Frenkel O, 2007, BIOCHEM BIOPH RES CO, V353, P26, DOI 10.1016/j.bbrc.2006.11.135; Honig D, 2010, BIOMACROMOLECULES, V11, P1802, DOI 10.1021/bm1002569; Krotz F, 2003, MOL THER, V7, P700, DOI 10.1016/S1525-0016(03)00065-0; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Lee H, 2012, NAT NANOTECHNOL, V7, P389, DOI [10.1038/nnano.2012.73, 10.1038/NNANO.2012.73]; MacDonald C, 2010, NANOMEDICINE-UK, V5, P65, DOI 10.2217/NNM.09.97; Mykhaylyk O, 2007, NAT PROTOC, V2, P2391, DOI 10.1038/nprot.2007.352; Namgung R, 2010, BIOMATERIALS, V31, P4204, DOI 10.1016/j.biomaterials.2010.01.123; Park IK, 2008, BIOMATERIALS, V29, P724, DOI 10.1016/j.biomaterials.2007.10.018; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Plank C, 2011, ADV DRUG DELIVER REV, V63, P1300, DOI 10.1016/j.addr.2011.08.002; Prijic S, 2010, J MEMBRANE BIOL, V236, P167, DOI 10.1007/s00232-010-9271-4; Qi LF, 2012, BIOMACROMOLECULES, V13, P2723, DOI 10.1021/bm3006903; Rackstraw BJ, 2001, LANGMUIR, V17, P3185, DOI 10.1021/la001456x; Roy I, 2005, P NATL ACAD SCI USA, V102, P279, DOI 10.1073/pnas.0408039101; Schillinger U, 2005, J MAGN MAGN MATER, V293, P501, DOI 10.1016/j.jmmm.2005.01.032; Singh R, 2009, TRENDS BIOTECHNOL, V27, P220, DOI 10.1016/j.tibtech.2009.01.003; Thanh NTK, 2010, NANO TODAY, V5, P213, DOI 10.1016/j.nantod.2010.05.003; Thurn KT, 2011, NANOMED-NANOTECHNOL, V7, P123, DOI 10.1016/j.nano.2010.09.004; Vijayanathan V, 2004, NUCLEIC ACIDS RES, V32, P127, DOI 10.1093/nar/gkg936; Vijayanathan V, 2002, BIOCHEMISTRY-US, V41, P14085, DOI 10.1021/bi0203987; Volcke C, 2006, J BIOTECHNOL, V125, P11, DOI 10.1016/j.jbiotec.2006.02.010; Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159	33	16	17	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98919	10.1371/journal.pone.0098919	http://dx.doi.org/10.1371/journal.pone.0098919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911360	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600024
J	Nakatsukasa, K; Kanada, A; Matsuzaki, M; Byrne, SD; Okumura, F; Kamura, T				Nakatsukasa, Kunio; Kanada, Akira; Matsuzaki, Mariko; Byrne, Stuart D.; Okumura, Fumihiko; Kamura, Takumi			The Nutrient Stress-induced Small GTPase Rab5 Contributes to the Activation of Vesicle Trafficking and Vacuolar Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL-DNA; YEAST; AUTOPHAGY; PROTEINS; REVEALS; PATHWAY; FUSION; VPS21; LOCALIZATION	Rab family small GTPases regulate membrane trafficking by spatiotemporal recruitment of various effectors. However, it remains largely unclear how the expression and functions of Rab proteins are regulated in response to extracellular or intracellular stimuli. Here we show that Ypt53, one isoform of Rab5 in Saccharomyces cerevisiae, is up-regulated significantly under nutrient stress. Under non-stress conditions, Vps21, a constitutively expressed Rab5 isoform, is crucial to Golgi-vacuole trafficking and to vacuolar hydrolase activity. However, when cells are exposed to nutrient stress for an extended period of time, the up-regulated Ypt53 and the constitutive Vps21 function redundantly to maintain these activities, which, in turn, prevent the accumulation of reactive oxygen species and maintain mitochondrial respiration. Together, our results clarify the relative roles of these constitutive and nutrient stress-inducible Rab5 proteins that ensure adaptable vesicle trafficking and vacuolar hydrolase activity, thereby allowing cells to adapt to environmental changes.	[Nakatsukasa, Kunio; Kanada, Akira; Matsuzaki, Mariko; Byrne, Stuart D.; Okumura, Fumihiko; Kamura, Takumi] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University	Nakatsukasa, K (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	z47875a@cc.nagoya-u.ac.jp; z47617a@nucc.cc.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25870312, 25291023]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [24112006]; Grants-in-Aid for Scientific Research [24112006] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 25870312 (to K. N.) and 25291023 (to T. K.) and by Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant 24112006 (to T. K.).	Amberg DC., 2005, METHODS YEAST GENETI; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Balderhaar HJK, 2013, P NATL ACAD SCI USA, V110, P3823, DOI 10.1073/pnas.1221785110; Barbieri MA, 1998, J BIOL CHEM, V273, P25850, DOI 10.1074/jbc.273.40.25850; Bridges D, 2012, J BIOL CHEM, V287, P20913, DOI 10.1074/jbc.M111.334060; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Dou ZX, 2013, MOL CELL, V50, P29, DOI 10.1016/j.molcel.2013.01.022; Frei SB, 2006, MOL CELL BIOL, V26, P7299, DOI 10.1128/MCB.02405-05; Gerrard SR, 2000, MOL BIOL CELL, V11, P613, DOI 10.1091/mbc.11.2.613; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jie LZ, 1999, EMBO J, V18, P58, DOI 10.1093/emboj/18.1.58; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Liu Y, 2011, MOL BIOL CELL, V22, P1575, DOI 10.1091/mbc.E10-08-0716; Lo SY, 2012, NAT STRUCT MOL BIOL, V19, P40, DOI 10.1038/nsmb.2162; Markgraf DF, 2009, MOL BIOL CELL, V20, P5276, DOI 10.1091/mbc.E09-06-0521; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakamura A, 1996, J BIOCHEM, V119, P768; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nakatsukasa K, 2013, MOL BIOL CELL, V24, P1765, DOI 10.1091/mbc.E12-12-0907; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Pei G, 2012, J LEUKOCYTE BIOL, V92, P41, DOI 10.1189/jlb.0212076; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; PITTMAN D, 1960, GENETICS, V45, P1023; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; STEVENS TH, 1986, J CELL BIOL, V102, P1551, DOI 10.1083/jcb.102.5.1551; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	47	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20970	20978		10.1074/jbc.M114.548297	http://dx.doi.org/10.1074/jbc.M114.548297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24923442	Green Published, hybrid			2022-12-25	WOS:000339396600050
J	Costoya, X; deCastro, M; Gomez-Gesteira, M; Santos, F				Costoya, Xurxo; deCastro, Maite; Gomez-Gesteira, Moncho; Santos, Fran			Mixed Layer Depth Trends in the Bay of Biscay over the Period 1975-2010	PLOS ONE			English	Article							DATA ASSIMILATION ANALYSIS; SEA-SURFACE TEMPERATURE; UPPER OCEAN 1950-95; INTERANNUAL VARIABILITY; SOUTHERN BAY; CLIMATE	Wintertime trends in mixed layer depth (MLD) were calculated in the Bay of Biscay over the period 1975-2010 using the Simple Ocean Data Assimilation (SODA) package. The reliability of the SODA database was confirmed correlating its results with those obtained from the experimental Argo database over the period 2003-2010. An iso-thermal layer depth (TLD) and an iso-pycnal layer depth (PLD) were defined using the threshold difference method with Delta T = 0.5 degrees C and Delta sigma(theta) = 0.125 kg/m(3). Wintertime trends of the MLD were calculated using winter extended (December-March) anomalies and annual maxima. Trends calculated for the whole Bay of Biscay using both parameters (TLD and PLD) showed to be dependent on the area. Thus, MLD became deeper in the southeastern corner and shallower in the rest of the area. Air temperature was shown to play a key role in regulating the different spatial behavior of the MLD. Negative air temperature trends localized in the southeastern corner coincide with MLD deepening in this area, while, positive air temperature trends are associated to MLD shoaling in the rest of the bay. Additionally, the temperature trend calculated along the first 700 m of the water column is in good agreement with the different spatial behavior revealed for the MLD trend.	[Costoya, Xurxo; deCastro, Maite; Gomez-Gesteira, Moncho; Santos, Fran] Univ Vigo, Fac Ciencias, EPHYSLAB, Orense, Spain	Universidade de Vigo	Costoya, X (corresponding author), Univ Vigo, Fac Ciencias, EPHYSLAB, Orense, Spain.	xurxocostoya@uvigo.es	Gesteira, Moncho Gomez/R-9431-2019; deCastro, Maite/R-6739-2019	Gesteira, Moncho Gomez/0000-0002-0661-9731; deCastro, Maite/0000-0001-6443-3620; Santos, Fran/0000-0002-4576-3744; Costoya, Xurxo/0000-0001-8050-760X	Xunta de Galicia through the Plan Galego de Investigacion, Innovacion e Crecemento; Innovacion e Crecemento (Plan I2C) in collaboration with the International Campus do Mar	Xunta de Galicia through the Plan Galego de Investigacion, Innovacion e Crecemento; Innovacion e Crecemento (Plan I2C) in collaboration with the International Campus do Mar	X. Costoya is supported by the Xunta de Galicia through the Plan Galego de Investigacion, Innovacion e Crecemento 2011-2015 (Plan I2C) in collaboration with the International Campus do Mar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates NR, 2001, DEEP-SEA RES PT II, V48, P1507, DOI 10.1016/S0967-0645(00)00151-X; BRAINERD KE, 1995, DEEP-SEA RES PT I, V42, P1521, DOI 10.1016/0967-0637(95)00068-H; Carton JA, 2000, J PHYS OCEANOGR, V30, P311, DOI [10.1175/1520-0485(2000)030<0311:ASODAA>2.0.CO;2, 10.1175/1520-0485(2000)030<0294:ASODAA>2.0.CO;2]; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Carton JA, 2008, J CLIMATE, V21, P1029, DOI 10.1175/2007JCLI1798.1; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; deCastro M, 2009, CONT SHELF RES, V29, P1053, DOI 10.1016/j.csr.2008.11.016; Dumousseaud C, 2010, BIOGEOSCIENCES, V7, P1481, DOI 10.5194/bg-7-1481-2010; Garcia-Soto C, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001012; Garcia-Soto C, 2009, CONT SHELF RES, V29, P1111, DOI 10.1016/j.csr.2008.12.012; Giese BS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006695; Goikoetxea N, 2009, CONT SHELF RES, V29, P1060, DOI 10.1016/j.csr.2008.11.014; Gomez-Gesteira M, 2013, CONT SHELF RES, V65, P73, DOI 10.1016/j.csr.2013.06.014; Gomez-Gesteira M, 2011, CLIM RES, V48, P109, DOI 10.3354/cr00967; Gomez-Gesteira M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004315; Gonzalez-Pola C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002367; Gruber N, 2002, SCIENCE, V298, P2374, DOI 10.1126/science.1077077; Holte J, 2009, J ATMOS OCEAN TECH, V26, P1920, DOI 10.1175/2009JTECHO543.1; Hosoda S, 2010, J OCEANOGR, V66, P773, DOI 10.1007/s10872-010-0063-3; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Kara AB, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000736; Koutsikopoulos C, 1998, OCEANOL ACTA, V21, P335, DOI 10.1016/S0399-1784(98)80020-0; Koutsikopoulos C, 1996, SCI MAR, V60, P9; Levitus S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037155; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Levitus S, 1994, NESDIS ATLAS SERIES, V4; Liu HL, 2009, J CLIMATE, V22, P6104, DOI 10.1175/2009JCLI2974.1; Llope M, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002963; Lorbacher K, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2003JC002157; Michaels AF, 1996, DEEP-SEA RES PT II, V43, P157, DOI 10.1016/0967-0645(96)00004-5; Michel S, 2009, AQUAT LIVING RESOUR, V22, P447, DOI 10.1051/alr/2009054; Montegut CD, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003953; Monterey G., 1997, NOAA ATLAS NESDIS; Nilsen JEO, 2006, PROG OCEANOGR, V70, P58, DOI 10.1016/j.pocean.2006.03.014; Pascual A, 2004, ELSEV OCEANOGR SERIE, V70, P53; Patti B, 2010, ESTUAR COAST SHELF S, V88, P45, DOI 10.1016/j.ecss.2010.03.004; Planque B., 2003, ICES J MAR SCI, V219, P61; PRICE JF, 1986, J GEOPHYS RES-OCEANS, V91, P8411, DOI 10.1029/JC091iC07p08411; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Roemmich D., 2001, OBSERVING OCEANS 21, P248; Santos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050666; Saunders PM, 1982, J MAR RES, V40, P641; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Cabrillo RS, 2011, OCEAN DYNAM, V61, P1215, DOI 10.1007/s10236-011-0407-6; Somavilla R, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004974; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; UNESCO, 1983, 44 UNESCO, V44; Wilks D. S, 1995, STAT METHODS ATMOSPH; Wong A., 2013, AGRO QUALITY CONTROL; Zheng YX, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005190	50	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99321	10.1371/journal.pone.0099321	http://dx.doi.org/10.1371/journal.pone.0099321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922066	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300049
J	McLeod, BA; Frasier, TR; Lucas, Z				McLeod, Brenna A.; Frasier, Timothy R.; Lucas, Zoe			Assessment of the Extirpated Maritimes Walrus Using Morphological and Ancient DNA Analysis	PLOS ONE			English	Article							ODOBENUS-ROSMARUS-ROSMARUS; ATLANTIC WALRUS; BOWHEAD WHALES; DIRECTIONAL ASYMMETRY; MITOCHONDRIAL-DNA; PORPOISE; CANADA; BONES; WEST	Species biogeography is a result of complex events and factors associated with climate change, ecological interactions, anthropogenic impacts, physical geography, and evolution. To understand the contemporary biogeography of a species, it is necessary to understand its history. Specimens from areas of localized extinction are important, as extirpation of species from these areas may represent the loss of unique adaptations and a distinctive evolutionary trajectory. The walrus (Odobenus rosmarus) has a discontinuous circumpolar distribution in the arctic and subarctic that once included the southeastern Canadian Maritimes region. However, exploitation of the Maritimes population during the 16th-18th centuries led to extirpation, and the species has not inhabited areas south of 55 degrees N for similar to 250 years. We examined genetic and morphological characteristics of specimens from the Maritimes, Atlantic (O. r. rosmarus) and Pacific (O. r. divergens) populations to test the hypothesis that the first group was distinctive. Analysis of Atlantic and Maritimes specimens indicated that most skull and mandibular measurements were significantly different between the Maritimes and Atlantic groups and discriminant analysis of principal components confirmed them as distinctive groups, with complete isolation of skull features. The Maritimes walrus appear to have been larger animals, with larger and more robust tusks, skulls and mandibles. The mtDNA control region haplotypes identified in Maritimes specimens were unique to the region and a greater average number of nucleotide differences were found between the regions (Atlantic and Maritimes) than within either group. Levels of diversity (h and p) were lower in the Maritimes, consistent with other studies of species at range margins. Our data suggest that the Maritimes walrus was a morphologically and genetically distinctive group that was on a different evolutionary path from other walrus found in the north Atlantic.	[McLeod, Brenna A.; Frasier, Timothy R.] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada; [McLeod, Brenna A.; Lucas, Zoe] Nova Scotia Museum Nat Hist, Halifax, NS, Canada; [Lucas, Zoe] Friends Green Horse Soc, Halifax, NS, Canada	Saint Marys University - Canada	McLeod, BA (corresponding author), St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada.	bmysticetus@gmail.com		Frasier, Brenna/0000-0002-8535-1410	ExxonMobil; The Friends of the Green Horse Society; Nova Scotia Museum of Natural History	ExxonMobil(Exxon Mobil Corporation); The Friends of the Green Horse Society; Nova Scotia Museum of Natural History	The research was funded by ExxonMobil (www.exxonmobil.com), The Friends of the Green Horse Society (http://www.greenhorsesociety.com), and the Nova Scotia Museum of Natural History (http://naturalhistory.novascotia.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GLOVER M., 1930, JOUR MAMMALOGY, V11, P139, DOI 10.2307/1374062; Allen J. A., 1876, American Naturalist, Vx, P708; Allen Joel Asaph, 1880, HIST N AM PINNIPEDS; AMANO M, 1992, MAR MAMMAL SCI, V8, P240, DOI 10.1111/j.1748-7692.1992.tb00407.x; Andersen LW, 1998, MOL ECOL, V7, P1323, DOI 10.1046/j.1365-294x.1998.00455.x; Andersen LW, 2000, CAN J ZOOL, V78, P1999, DOI 10.1139/cjz-78-11-1999; Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Born EW, 2001, POLAR BIOL, V24, P713; BOUCHARD MA, 1993, CAN J EARTH SCI, V30, P1715, DOI 10.1139/e93-150; Chessel D., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; CLAPHAM PJ, 1995, ANIM BEHAV, V50, P73, DOI 10.1006/anbe.1995.0222; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Department of Fisheries and Oceans, 2008, SPEC RISK ACT REC ST; Drummond A.J., MOL EVOLUTION PHYLOG; Dyke AS, 1999, ARCTIC, V52, P160; FAY F H, 1985, Mammalian Species, P1, DOI 10.2307/3503810; Fay FH, 1982, N AM FAUNA, DOI DOI 10.3996/NAFA.74.0001; Fay FH, 1981, HDB MARINE MAMMALS, V1, P1; Fisher KI, 1997, CAN J ZOOL, V75, P1166, DOI 10.1139/z97-139; Galatius A, 2005, MAR MAMMAL SCI, V21, P401, DOI 10.1111/j.1748-7692.2005.tb01240.x; Gjertz I, 1995, POPULATION ASSESSMEN; Harington C.R., 2003, ANNOTATED BIBLIO QUA; Harington C. Richard, 2004, Geographie Physique et Quaternaire, V57, P85; HARINGTON CR, 1993, GEOGR PHYS QUATERN, V47, P111, DOI 10.7202/032935ar; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irwin DL, 2003, BIOTECHNIQUES, V34, P932, DOI 10.2144/03345bm06; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Kasuya T, 1970, Scient. Rep. Whales Res. Inst., Tokyo, VNo. 22, P39; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levermann Nette, 2003, BMC Ecology, V3, P1; Lindqvist C, 2009, ZOOL SCR, V38, P113, DOI 10.1111/j.1463-6409.2008.00364.x; Lowry L, 2009, IUCN RED LIST THREAT; Mansfield AW, 1958, FISH RES BOARD CAN M, V653; MANVILLE RICHARD H., 1960, JOUR MAMMAL, V41, P499, DOI 10.2307/1377539; Martijn CA, 2003, NLS, V19, P44; Mays SA, 2002, J ARCHAEOL SCI, V29, P435, DOI 10.1006/jasc.2002.0729; McLeod BA, 2008, ARCTIC, V61, P61; McLeod BA, 2012, MAR MAMMAL SCI, V28, pE426, DOI 10.1111/j.1748-7692.2011.00551.x; Miller R.F., 1990, Atlantic Geology, V26, P97; Miller RF, 1997, GEOGR PHYS QUATERN, V51, P107, DOI 10.7202/004852ar; MOWAT F, 1984, SEA SLAUGHTER; Naughton D., 2012, NATURAL HIST CANADIA, DOI 10.3138/9781442669574; O'Corry-Crowe G, 2008, ECOL APPL, V18, pS56, DOI 10.1890/06-0795.1; Outridge PM, 2003, ARCTIC, V56, P82, DOI 10.14430/arctic605; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Rastogi T, 2004, CAN J ZOOL, V82, P1647, DOI 10.1139/Z04-146; Repenning C.A., 1979, PROCEEDINGS OF THE ANNUAL BIOLOGY COLLOQUIUM (OREGON STATE UNIVERSITY), P357; Richer S, 2003, GLOBE MAIL; Ross G.J.B., 1990, P101; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sariyar-Akbulut B, 2010, CHEM BIOCHEM ENG Q, V24, P119; SCHEFFER VB, 1967, J MAMMAL, V48, P459; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Shaw J, 2002, QUATERNARY SCI REV, V21, P1861, DOI 10.1016/S0277-3791(02)00004-5; Sheffield G, 2009, MAR MAMMAL SCI, V25, P761, DOI 10.1111/j.1748-7692.2009.00316.x; Sobey DG, 2007, CAN FIELD NAT, V121, P384, DOI 10.22621/cfn.v121i4.510; STEELE J, 1995, INT J OSTEOARCHAEOL, V5, P39, DOI 10.1002/oa.1390050105; Stewart REA, 2008, ARCTIC, V61, P292; TERSHY BR, 1992, MAR MAMMAL SCI, V8, P315, DOI 10.1111/j.1748-7692.1992.tb00416.x; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Wiig O, 1996, J ZOOL, V240, P495; Wiig O, 2007, POLAR BIOL, V31, P69, DOI 10.1007/s00300-007-0334-7; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; WRIGHT BRUCE S., 1951, CANADIAN FIELD NAT, V65, P61	71	13	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99569	10.1371/journal.pone.0099569	http://dx.doi.org/10.1371/journal.pone.0099569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924490	Green Published, gold			2022-12-25	WOS:000338701300075
J	Curtis, TH; McCandless, CT; Carlson, JK; Skomal, GB; Kohler, NE; Natanson, LJ; Burgess, GH; Hoey, JJ; Pratt, HL				Curtis, Tobey H.; McCandless, Camilla T.; Carlson, John K.; Skomal, Gregory B.; Kohler, Nancy E.; Natanson, Lisa J.; Burgess, George H.; Hoey, John J.; Pratt, Harold L., Jr.			Seasonal Distribution and Historic Trends in Abundance of White Sharks, Carcharodon carcharias, in the Western North Atlantic Ocean	PLOS ONE			English	Article							NEW-SOUTH-WALES; MIGRATION PATTERNS; HARBOR PORPOISE; POPULATIONS; MOVEMENTS; PREDATION; BEHAVIOR; HABITAT; CATCH; BEACHES	Despite recent advances in field research on white sharks (Carcharodon carcharias) in several regions around the world, opportunistic capture and sighting records remain the primary source of information on this species in the northwest Atlantic Ocean (NWA). Previous studies using limited datasets have suggested a precipitous decline in the abundance of white sharks from this region, but considerable uncertainty in these studies warrants additional investigation. This study builds upon previously published data combined with recent unpublished records and presents a synthesis of 649 confirmed white shark records from the NWA compiled over a 210-year period (1800-2010), resulting in the largest white shark dataset yet compiled from this region. These comprehensive records were used to update our understanding of their seasonal distribution, relative abundance trends, habitat use, and fisheries interactions. All life stages were present in continental shelf waters year-round, but median latitude of white shark occurrence varied seasonally. White sharks primarily occurred between Massachusetts and New Jersey during summer and off Florida during winter, with broad distribution along the coast during spring and fall. The majority of fishing gear interactions occurred with rod and reel, longline,and gillnet gears. Historic abundance trends from multiple sources support a significant decline in white shark abundance in the 1970s and 1980s, but there have been apparent increases in abundance since the 1990s when a variety of conservation measures were implemented. Though the white shark's inherent vulnerability to exploitation warrants continued protections, our results suggest a more optimistic outlook for the recovery of this iconic predator in the Atlantic.	[Curtis, Tobey H.] NOAA, Natl Marine Fisheries Serv, Greater Atlantic Reg Fisheries Off, Gloucester, MA 01930 USA; [McCandless, Camilla T.; Kohler, Nancy E.; Natanson, Lisa J.; Hoey, John J.; Pratt, Harold L., Jr.] NOAA, Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, Narragansett, RI USA; [Carlson, John K.] NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Panama City, FL USA; [Skomal, Gregory B.] Massachusetts Div Marine Fisheries, New Bedford, MA USA; [Burgess, George H.] Univ Florida, Florida Museum Nat Hist, Florida Program Shark Res, Gainesville, FL 32611 USA; [Pratt, Harold L., Jr.] Mote Marine Lab, Summerland Key, FL USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Massachusetts Division of Marine Fisheries; State University System of Florida; University of Florida; Mote Marine Laboratory & Aquarium	Curtis, TH (corresponding author), NOAA, Natl Marine Fisheries Serv, Greater Atlantic Reg Fisheries Off, Gloucester, MA 01930 USA.	Tobey.Curtis@noaa.gov	Pratt, Harold/AAK-9544-2020	Curtis, Tobey/0000-0003-0164-7335				Adam Peter J., 2004, Mammalian Species, P1, DOI 10.1644/747; Adams DH, 1994, MAR FISH REV, V56, P24; [Anonymous], 1996, GREAT WHITE SHARKS B; ARNOLD PW, 1972, J FISH RES BOARD CAN, V29, P1213, DOI 10.1139/f72-179; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Beerkircher L.R., 2002, MAR FISH REV, V64, P40, DOI DOI 10.1037/0003-066x.59.1.29; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; BRODIE P, 1983, CAN J FISH AQUAT SCI, V40, P267, DOI 10.1139/f83-040; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce Barry D., 2012, P225; Burgess GH, 2005, FISHERIES, V30, P30; CAREY FG, 1982, COPEIA, P254; Carlson JK, 2012, J FISH BIOL, V80, P1749, DOI 10.1111/j.1095-8649.2011.03193.x; Casey J.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P2; Chapple TK, 2011, BIOL LETTERS, V7, P581, DOI 10.1098/rsbl.2011.0124; CLARK EUGENIE, 1965, BULL MAR SCI, V15, P13; CLIFF G, 1989, S AFR J MARINE SCI, V8, P131, DOI 10.2989/02577618909504556; Clua Eric, 2012, P343; Compagno L. J. V., 2001, FAO SPECIES CATALOGU, V2; Conn P. B., 2010, SE DAT ASS REV 21 AS; Conn PB, 2010, CAN J FISH AQUAT SCI, V67, P108, DOI 10.1139/F09-175; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; COSEWIC, 2006, COSEWIC ASS STAT REP; Curtis TH, 2006, CALIF FISH GAME, V92, P113; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Dudley SFJ, 2006, MAR FRESHWATER RES, V57, P225, DOI 10.1071/MF05156; Duffy Clinton A.J., 2012, P301; Ellis R, 1991, GREAT WHITE SHARK; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Ezcurra JM., 2012, OXYGEN CONSUMPTION R, P17; Fergusson IK, 1996, GREAT WHITE SHARKS, P321, DOI 10.1016/B978-012415031-7/50031-8; Francis Malcolm P., 2012, P319; Francis MP, 1996, GREAT WHITE SHARKS, P157, DOI 10.1016/B978-012415031-7/50016-1; Garrison LP, 2007, NOAANMFSSEFSC553; Goldman KJ, 1997, J COMP PHYSIOL B, V167, P423, DOI 10.1007/s003600050092; Gubili Chrysoula, 2012, P357; Hale L. F., 2011, NMFSSEFSC611 NOAA; Hamady LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084006; Hoey JJ, 2005, SE DAT ASS REV DAT W; IUCN, 2022, IUCN RED LIST THREAT; KLIMLEY AP, 1992, COPEIA, P680; Klimley AP, 1985, S CAL ACAD SCI MEM, V9, P15; Kock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055048; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Kohler N. E., 1996, NMFSNE110 NOAA; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Long DJ, 1996, GREAT WHITE SHARKS, P293, DOI 10.1016/B978-012415031-7/50028-8; Lowe Christopher G., 2012, P169; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Maunder MN, 2001, CAN J FISH AQUAT SCI, V58, P795, DOI 10.1139/cjfas-58-4-795; McCandless CT, 2010, SE DAT ASS REV 21 DA; McKinney JA, 2012, MAR ECOL PROG SER, V458, P199, DOI 10.3354/meps09777; McPherson JM, 2009, DIVERS DISTRIB, V15, P880, DOI 10.1111/j.1472-4642.2009.00596.x; Mollet HF, 1996, GREAT WHITE SHARKS, P91, DOI 10.1016/B978-012415031-7/50011-2; Mollomo Paul, 1998, Northeastern Naturalist, V5, P207, DOI 10.2307/3858620; Morgan A, 2009, MAR FISH REV, V71, P23; National Marine Fisheries Service, 1993, FISH MAN PLAN SHARKS; National Marine Fisheries Service, 1997, FRAM SEAS ADJ MAN ME; Pratt HL, 1996, GREAT WHITE SHARKS, P131, DOI 10.1016/B978-012415031-7/50014-8; PRATT HL, 1982, FISH B-NOAA, V80, P153; R Development Core Team, 2012, R LANG ENV STAT COMP; Reid DD, 2011, MAR FRESHWATER RES, V62, P676, DOI 10.1071/MF10162; REID DD, 1992, AUST J MAR FRESH RES, V43, P283; RIVAS L R, 1982, Florida Scientist, V45, P40; Santana-Morales Omar, 2012, P187; Shepherd GR, 2006, FISH B-NOAA, V104, P559; Skomal Gregory B., 2012, P405; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Smith-Vaniz WF, 1999, AM SOC ICHTHVOLOGIST, V4; Springer S., 1960, Fishery Bulletin United States, V61, P1; SPRINGER STEWART, 1939, COPEIA, V1939, P114, DOI 10.2307/1435964; STRONG WR, 1992, AUST J MAR FRESH RES, V43, P13; Taylor JKD, 2013, MAR MAMMAL SCI, V29, P204, DOI 10.1111/j.1748-7692.2011.00542.x; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; Turnbull SD, 2012, NORTHEAST NAT, V19, P705, DOI 10.1656/045.019.0416; Welsh AH, 1996, ECOL MODEL, V88, P297, DOI 10.1016/0304-3800(95)00113-1; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; Wintner SP, 1999, FISH B-NOAA, V97, P153; Wood-Lafond SA, 2009, THESIS U MASSACHUSET	81	64	64	2	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99240	10.1371/journal.pone.0099240	http://dx.doi.org/10.1371/journal.pone.0099240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918579	gold, Green Published			2022-12-25	WOS:000338631000066
J	Dirks-Hofmeister, ME; Singh, R; Leufken, CM; Inlow, JK; Moerschbacher, BM				Dirks-Hofmeister, Mareike E.; Singh, Ratna; Leufken, Christine M.; Inlow, Jennifer K.; Moerschbacher, Bruno M.			Structural Diversity in the Dandelion (Taraxacum officinale) Polyphenol Oxidase Family Results in Different Responses to Model Substrates	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; PLANT CATECHOL OXIDASE; CRYSTAL-STRUCTURE; AUREUSIDIN SYNTHASE; MULTIGENE FAMILY; TYROSINASE; PROTEIN; EXPRESSION; PURIFICATION; CLONING	Polyphenol oxidases (PPOs) are ubiquitous type-3 copper enzymes that catalyze the oxygen-dependent conversion of o-diphenols to the corresponding quinones. In most plants, PPOs are present as multiple isoenzymes that probably serve distinct functions, although the precise relationship between sequence, structure and function has not been addressed in detail. We therefore compared the characteristics and activities of recombinant dandelion PPOs to gain insight into the structure-function relationships within the plant PPO family. Phylogenetic analysis resolved the 11 isoenzymes of dandelion into two evolutionary groups. More detailed in silico and in vitro analyses of four representative PPOs covering both phylogenetic groups were performed. Molecular modeling and docking predicted differences in enzyme-substrate interactions, providing a structure-based explanation for grouping. One amino acid side chain positioned at the entrance to the active site (position H-B2+1) potentially acts as a "selector'' for substrate binding. In vitro activity measurements with the recombinant, purified enzymes also revealed group-specific differences in kinetic parameters when the selected PPOs were presented with five model substrates. The combination of our enzyme kinetic measurements and the in silico docking studies therefore indicate that the physiological functions of individual PPOs might be defined by their specific interactions with different natural substrates.	[Dirks-Hofmeister, Mareike E.; Singh, Ratna; Leufken, Christine M.; Moerschbacher, Bruno M.] Univ Munster, Dept Plant Biol & Biotechnol, D-48149 Munster, Germany; [Inlow, Jennifer K.] Indiana State Univ, Dept Chem & Phys, Terre Haute, IN 47809 USA	University of Munster; Indiana State University	Dirks-Hofmeister, ME (corresponding author), Univ Munster, Dept Plant Biol & Biotechnol, D-48149 Munster, Germany.	mareike.dirks-hofmeister@uni-muenster.de	Singh, Ratna/AAM-7340-2021; Moerschbacher, Bruno M/C-2012-2017	Singh, Ratna/0000-0003-0487-2861; Dirks-Hofmeister, Mareike E./0000-0002-9634-6932	doctorate scholarship program of the Deutsche Bundesstiftung Umwelt (DBU); internal funds of the University	doctorate scholarship program of the Deutsche Bundesstiftung Umwelt (DBU); internal funds of the University	The work was funded in part by the doctorate scholarship program of the Deutsche Bundesstiftung Umwelt (DBU) and partly by internal funds of the University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chazarra S, 2001, J AGR FOOD CHEM, V49, P4870, DOI 10.1021/jf0100301; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chopra G, 2010, PROTEINS, V78, P2668, DOI 10.1002/prot.22781; Constabel CP, 1998, PHYTOCHEMISTRY, V47, P507, DOI 10.1016/S0031-9422(97)00539-6; Dirks-Hofmeister ME, 2012, PLANT MOL BIOL, V80, P203, DOI 10.1007/s11103-012-9943-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1972; Eicken C, 1999, CURR OPIN STRUC BIOL, V9, P677, DOI 10.1016/S0959-440X(99)00029-9; Elumalai P, 2011, INT J BIOL MACROMOL, V49, P134, DOI 10.1016/j.ijbiomac.2011.03.017; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Espin JC, 1999, J AGR FOOD CHEM, V47, P3518, DOI 10.1021/jf981275p; Flurkey WH, 2008, J INORG BIOCHEM, V102, P2160, DOI 10.1016/j.jinorgbio.2008.08.007; Gerdemann C, 2002, J INORG BIOCHEM, V89, P155, DOI 10.1016/S0162-0134(01)00399-3; GOLBECK JH, 1981, PLANT PHYSIOL, V67, P977, DOI 10.1104/pp.67.5.977; Kanade SR, 2007, FEBS J, V274, P4177, DOI 10.1111/j.1742-4658.2007.05944.x; Kanade SR, 2006, BIOCHEM J, V395, P551, DOI 10.1042/BJ20051509; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marri C, 2003, PHYTOCHEMISTRY, V63, P745, DOI 10.1016/S0031-9422(03)00353-4; Marusek CM, 2006, J INORG BIOCHEM, V100, P108, DOI 10.1016/j.jinorgbio.2005.10.008; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; MAYER AM, 1979, PHYTOCHEMISTRY, V18, P193, DOI 10.1016/0031-9422(79)80057-6; MOORE BM, 1990, J BIOL CHEM, V265, P4982; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Munoz JL, 2006, ANAL BIOCHEM, V351, P128, DOI 10.1016/j.ab.2006.01.011; Nakayama T, 2000, SCIENCE, V290, P1163, DOI 10.1126/science.290.5494.1163; NEWMAN SM, 1993, PLANT MOL BIOL, V21, P1035, DOI 10.1007/BF00023601; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pourcel L, 2007, TRENDS PLANT SCI, V12, P29, DOI 10.1016/j.tplants.2006.11.006; Raj SN, 2006, FUNCT PLANT BIOL, V33, P563, DOI 10.1071/FP06003; Richter C, 2012, MOL PLANT MICROBE IN, V25, P200, DOI 10.1094/MPMI-04-11-0082; Rodrigues JPGLM, 2012, NUCLEIC ACIDS RES, V40, pW323, DOI 10.1093/nar/gks376; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Shetty SM, 2011, PHYTOCHEMISTRY, V72, P2275, DOI 10.1016/j.phytochem.2011.08.028; Steiner U, 1999, PLANTA, V208, P114, DOI 10.1007/s004250050541; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sullivan ML, 2004, PLANT PHYSIOL, V136, P3234, DOI 10.1104/pp.104.047449; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tepper AWJW, 2005, J AM CHEM SOC, V127, P567, DOI 10.1021/ja0454687; Thipyapong P, 2004, PLANTA, V220, P105, DOI 10.1007/s00425-004-1330-6; Thipyapong P, 2004, PLANT SCI, V167, P693, DOI 10.1016/j.plantsci.2004.04.008; Thipyapong P, 1997, PLANT PHYSIOL, V115, P409, DOI 10.1104/pp.115.2.409; Thipyapong P, 2007, MOLECULES, V12, P1569, DOI 10.3390/12081569; THYGESEN PW, 1995, PLANT PHYSIOL, V109, P525, DOI 10.1104/pp.109.2.525; Tran LT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-395; Virador VM, 2010, J AGR FOOD CHEM, V58, P1189, DOI 10.1021/jf902939q; Wahler D, 2009, PLANT PHYSIOL, V151, P334, DOI 10.1104/pp.109.138743; Walker JRL, 1998, BIOTECHNOL GENET ENG, V15, P457, DOI 10.1080/02648725.1998.10647966; Wang JH, 2004, PLANTA, V220, P87, DOI 10.1007/s00425-004-1327-1	58	23	24	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99759	10.1371/journal.pone.0099759	http://dx.doi.org/10.1371/journal.pone.0099759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918587	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000108
J	Walsh, MG; Haseeb, MA				Walsh, Michael G.; Haseeb, M. A.			Small-Area Estimation of the Probability of Toxocariasis in New York City Based on Sociodemographic Neighborhood Composition	PLOS ONE			English	Article							CANIS INFECTION; UNITED-STATES; RISK-FACTORS; CHILDREN; POVERTY; AMERICA	Toxocariasis is increasingly recognized as an important neglected infection of poverty (NIP) in developed countries, and may constitute the most important NIP in the United States (US) given its association with chronic sequelae such as asthma and poor cognitive development. Its potential public health burden notwithstanding, toxocariasis surveillance is minimal throughout the US and so the true burden of disease remains uncertain in many areas. The Third National Health and Nutrition Examination Survey conducted a representative serologic survey of toxocariasis to estimate the prevalence of infection in diverse US subpopulations across different regions of the country. Using the NHANES III surveillance data, the current study applied the predicted probabilities of toxocariasis to the sociodemographic composition of New York census tracts to estimate the local probability of infection across the city. The predicted probability of toxocariasis ranged from 6% among US-born Latino women with a university education to 57% among immigrant men with less than a high school education. The predicted probability of toxocariasis exhibited marked spatial variation across the city, with particularly high infection probabilities in large sections of Queens, and smaller, more concentrated areas of Brooklyn and northern Manhattan. This investigation is the first attempt at small-area estimation of the probability surface of toxocariasis in a major US city. While this study does not define toxocariasis risk directly, it does provide a much needed tool to aid the development of toxocariasis surveillance in New York City.	[Walsh, Michael G.; Haseeb, M. A.] Suny Downstate Med Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Brooklyn, NY 11203 USA; [Haseeb, M. A.] Suny Downstate Med Ctr, Coll Med, Dept Cell Biol, Brooklyn, NY 11203 USA; [Haseeb, M. A.] Suny Downstate Med Ctr, Coll Med, Dept Pathol & Med, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Walsh, MG (corresponding author), Suny Downstate Med Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Brooklyn, NY 11203 USA.	thegowda@gmail.com		Walsh, Michael/0000-0002-6441-3635				Bureau USC, AM FACFINDER SEARCH; Congdon P, 2011, INT J PUBLIC HEALTH, V56, P15, DOI 10.1007/s00038-010-0143-6; Geography UCB, TIGER PROD; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000400; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000256; MARMOR M, 1987, AM J PUBLIC HEALTH, V77, P554, DOI 10.2105/AJPH.77.5.554; Nelson S, 1996, NEUROTOXICOL TERATOL, V18, P167, DOI 10.1016/0892-0362(95)02018-7; Walsh MG, 2012, INT J PARASITOL, V42, P1159, DOI 10.1016/j.ijpara.2012.10.002; Walsh MG, 2011, INT J PARASITOL, V41, P243, DOI 10.1016/j.ijpara.2010.09.006; Won KY, 2008, AM J TROP MED HYG, V79, P552, DOI 10.4269/ajtmh.2008.79.552	10	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99303	10.1371/journal.pone.0099303	http://dx.doi.org/10.1371/journal.pone.0099303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918785	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000073
J	Matic, MG; Coric, VM; Savic-Radojevic, AR; Bulat, PV; Pljesa-Ercegovac, MS; Dragicevic, DP; Djukic, TI; Simic, TP; Pekmezovic, TD				Matic, Marija G.; Coric, Vesna M.; Savic-Radojevic, Ana R.; Bulat, Petar V.; Pljesa-Ercegovac, Marija S.; Dragicevic, Dejan P.; Djukic, Tatjana I.; Simic, Tatjana P.; Pekmezovic, Tatjana D.			Does Occupational Exposure to Solvents and Pesticides in Association with Glutathione S-Transferase A1, M1, P1, and T1 Polymorphisms Increase the Risk of Bladder Cancer? The Belgrade Case-Control Study	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; GENETIC SUSCEPTIBILITY; GSTM1; GSTT1; IDENTIFICATION; METABOLISM; NAT2	Objective: We investigated the role of the glutathione S-transferase A1, M1, P1 and T1 gene polymorphisms and potential effect modification by occupational exposure to different chemicals in Serbian bladder cancer male patients. Patients and Methods: A hospital-based case-control study of bladder cancer in men comprised 143 histologically confirmed cases and 114 age-matched male controls. Deletion polymorphism of glutathione S-transferase M1 and T1 was identified by polymerase chain reaction method. Single nucleotide polymorphism of glutathione S-transferase A1 and P1 was identified by restriction fragment length polymorphism method. As a measure of effect size, odds ratio (OR) with corresponding 95% confidence interval (95% CI) was calculated. Results: The glutathione S-transferase A1, T1 and P1 genotypes did not contribute independently toward the risk of bladder cancer, while the glutathione S-transferase M1-null genotype was overrepresented among cases (OR = 2.1, 95% CI = 1.1-4.2, p = 0.032). The most pronounced effect regarding occupational exposure to solvents and glutathione S-transferase genotype on bladder cancer risk was observed for the low activity glutathione S-transferase A1 genotype (OR = 9.2, 95% CI = 2.4-34.7, p = 0.001). The glutathione S-transferase M1-null genotype also enhanced the risk of bladder cancer among subjects exposed to solvents (OR = 6,5, 95% CI = 2.1-19.7, p = 0.001). The risk of bladder cancer development was 5.3-fold elevated among glutathione S-transferase T1-active patients exposed to solvents in comparison with glutathione Stransferase T1-active unexposed patients (95% CI = 1.9-15.1, p = 0.002). Moreover, men with glutathione S-transferase T1-active genotype exposed to pesticides exhibited 4.5 times higher risk in comparison with unexposed glutathione Stransferase T1-active subjects (95% CI = 0.9-22.5, p = 0.067). Conclusion: Null or low-activity genotypes of the glutathione S-transferase A1, T1, and P1 did not contribute independently towards the risk of bladder cancer in males. However, in association with occupational exposure, low activity glutathione Stransferase A1 and glutathione S-transferase M1-null as well as glutathione S-transferase T1-active genotypes increase individual susceptibility to bladder cancer.	[Matic, Marija G.; Coric, Vesna M.; Savic-Radojevic, Ana R.; Pljesa-Ercegovac, Marija S.; Djukic, Tatjana I.; Simic, Tatjana P.] Univ Belgrade, Fac Med, Inst Med & Clin Biochem, Belgrade, Serbia; [Bulat, Petar V.] Inst Occupat Hlth, Belgrade, Serbia; [Dragicevic, Dejan P.] Clin Ctr Serbia, Urol Clin, Belgrade, Serbia; [Pekmezovic, Tatjana D.] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia; [Matic, Marija G.; Coric, Vesna M.; Savic-Radojevic, Ana R.; Bulat, Petar V.; Pljesa-Ercegovac, Marija S.; Dragicevic, Dejan P.; Djukic, Tatjana I.; Simic, Tatjana P.; Pekmezovic, Tatjana D.] Univ Belgrade, Fac Med, Belgrade, Serbia	University of Belgrade; Clinical Centre of Serbia; University of Belgrade; University of Belgrade	Pekmezovic, TD (corresponding author), Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia.	pekmezovic@sezampro.rs	Pljesa-Ercegovac, Marija/AFS-8309-2022	Bulat, Petar/0000-0002-4311-8960; Simic, Tatjana/0000-0001-8683-5129; Coric, Vesna/0000-0003-0227-821X; Djukic, Tatjana/0000-0003-1959-5115	Ministry of Education and Science of the Republic of Serbia [175052, 175087]	Ministry of Education and Science of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education and Science of the Republic of Serbia (Grants number: 175052 and 175087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman SZ, 1996, CANCER LETT, V107, P229, DOI 10.1016/0304-3835(96)04832-X; American Cancer Society, 2012, BLADD CANC 2012; Band PR, 2005, J OCCUP ENVIRON MED, V47, P854, DOI 10.1097/01.jom.0000169094.77036.1d; BONASSI S, 1989, INT J CANCER, V44, P648, DOI 10.1002/ijc.2910440415; Buzio L, 2003, OCCUP ENVIRON MED, V60, P789, DOI 10.1136/oem.60.10.789; Clapp R, 2005, ENV OCCUPATIONAL CAU; Coles BF, 2005, METHOD ENZYMOL, V401, P9, DOI 10.1016/S0076-6879(05)01002-5; CORDIER S, 1993, INT J EPIDEMIOL, V22, P403, DOI 10.1093/ije/22.3.403; Di Pietro G, 2010, EXPERT OPIN DRUG MET, V6, P153, DOI 10.1517/17425250903427980; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Falck GCM, 1999, MUTAT RES-GEN TOX EN, V441, P225, DOI 10.1016/S1383-5718(99)00051-0; Guengerich P, 2005, GLUTATHIONE TRANSFER, P9; Harries LW, 1997, CARCINOGENESIS, V18, P641, DOI 10.1093/carcin/18.4.641; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Heuser VD, 2007, TOXICOLOGY, V232, P235, DOI 10.1016/j.tox.2007.01.011; Hirvonen Ari, 2005, Toxicol Appl Pharmacol, V207, P329, DOI 10.1016/j.taap.2004.11.030; Honaker MT, 2013, J BIOL CHEM, V288, P18599, DOI 10.1074/jbc.M112.445767; IARC Monographs Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V99, P1; International Agency for Research on Cancer, 2010, IARC MONOGRAPHS EVAL, P43; Karami S, 2008, CARCINOGENESIS, V29, P1567, DOI 10.1093/carcin/bgn153; Kim JJ, 2012, CURR UROL REP, V13, P147, DOI 10.1007/s11934-012-0238-0; Landi S, 2000, MUTAT RES-REV MUTAT, V463, P247, DOI 10.1016/S1383-5742(00)00050-8; LAVECCHIA C, 1990, INT J EPIDEMIOL, V19, P264, DOI 10.1093/ije/19.2.264; Lohi J, 2008, AM J IND MED, V51, P668, DOI 10.1002/ajim.20606; Lynge E, 1997, CANCER CAUSE CONTROL, V8, P406, DOI 10.1023/A:1018461406120; Miller DR, 2006, CANCER-AM CANCER SOC, V107, P1570, DOI 10.1002/cncr.22124; Moore LE, 2010, CANCER RES, V70, P6527, DOI 10.1158/0008-5472.CAN-09-4167; Olfert SM, 2006, SOUTH MED J, V99, P1256, DOI 10.1097/01.smj.0000247266.10393.72; Pukkala E, 2009, ACTA ONCOL, V48, P646, DOI 10.1080/02841860902913546; RISCH HA, 1988, BRIT J IND MED, V45, P361; Rossi AM, 1999, PHARMACOGENETICS, V9, P445; Ruder AM, 2013, OCCUP ENVIRON MED, V70, P73, DOI 10.1136/oemed-2011-100588; Savic-Radojevic A, 2007, EUR UROL, V52, P470, DOI 10.1016/j.eururo.2007.01.046; Scarpato R, 1996, ENVIRON MOL MUTAGEN, V27, P263, DOI 10.1002/(SICI)1098-2280(1996)27:4<263::AID-EM3>3.0.CO;2-E; SCHULTE PA, 1987, OCCUP MED, V2, P85; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simic T, 2005, UROLOGY, V65, P1035, DOI 10.1016/j.urology.2005.01.005; Simic T, 2009, NAT REV UROL, V6, P281, DOI 10.1038/nrurol.2009.49; Thier R, 2002, TOXICOL LETT, V127, P321, DOI 10.1016/S0378-4274(01)00515-X; VIEL JF, 1995, OCCUP ENVIRON MED, V52, P587, DOI 10.1136/oem.52.9.587; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Zahm SH, 1997, J OCCUP ENVIRON MED, V39, P1055, DOI 10.1097/00043764-199711000-00006	43	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99448	10.1371/journal.pone.0099448	http://dx.doi.org/10.1371/journal.pone.0099448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914957	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700104
J	Ramirez, AG; Munoz, E; Holden, AEC; Adeigbe, RT; Suarez, L				Ramirez, Amelie G.; Munoz, Edgar; Holden, Alan E. C.; Adeigbe, Rebecca T.; Suarez, Lucina			Incidence of Hepatocellular Carcinoma in Texas Latinos, 1995-2010: An Update	PLOS ONE			English	Article							UNITED-STATES; SURVIVAL; TRENDS	Background: A previous study showed Hepatocellular Carcinoma (HCC) rates to be higher among Latinos in Texas and highest among South Texas Latinos compared to other non-Hispanic whites (NHW) and other Latinos in the United States (U.S.). We used more recent data to assess trends in HCC among Texas Latinos and to reassess the elevated HCC incidence rate in Texas Latinos. Methods: We used data from the U.S. SEER Program and the Texas Cancer Registry to calculate annual and 3-year moving average age-specific and age-adjusted HCC incidence rates, annual percent changes (APCs), and their corresponding 95% confidence intervals for Latinos and NHW in the U.S., Texas and South Texas. Results: Texas Latino male and female incidence rates were 3.1 and 4.0 times higher than their NHW counterparts in SEER regions. Latino males and females in South Texas had the highest rates of HCC incidence overall; rate ratios were 3.6 and 4.2 among South Texas Latino males and females compared to SEER NHW counterparts. There are statistically significant increases in HCC incidence rates in all groups (Texas and South Texas Latinos and NHW groups) and across all age groups. The elevated HCC rates in Texas Latinos are consistent over the 1995-2010 period. Conclusions: The incidence of HCC among Latinos in South Texas remains higher than elsewhere in the U.S. and warrants closer investigation of potential risk factors related to prevailing conditions unique to the population including higher obesity and diabetes rates, environmental, cultural and socioeconomic factors and possibly genetic predisposition.	[Ramirez, Amelie G.; Munoz, Edgar; Holden, Alan E. C.; Adeigbe, Rebecca T.; Suarez, Lucina] Univ Texas Hlth Sci Ctr San Antonio, Inst Hlth Promot Res, San Antonio, TX 78229 USA; [Ramirez, Amelie G.; Holden, Alan E. C.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Ramirez, AG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Hlth Promot Res, San Antonio, TX 78229 USA.	ramirezag@uthscsa.edu	Munoz, Edgar/L-1857-2019	Munoz, Edgar/0000-0002-1555-8408	Cancer Center Support Group of the Cancer Therapy and Research Center at the University of Texas Health Science at Center San Antonio, an NCI-designated Cancer Center [P30CA054174]; Redes En AcciA3n: The National Latino Cancer Research Network [U01 CA114657-05]; NATIONAL CANCER INSTITUTE [P30CA054174, U01CA114657] Funding Source: NIH RePORTER	Cancer Center Support Group of the Cancer Therapy and Research Center at the University of Texas Health Science at Center San Antonio, an NCI-designated Cancer Center; Redes En AcciA3n: The National Latino Cancer Research Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge the Cancer Center Support Group of the Cancer Therapy and Research Center at the University of Texas Health Science at Center San Antonio, an NCI-designated Cancer Center (grant # P30CA054174) and Redes En AcciA3n: The National Latino Cancer Research Network (U01 CA114657-05) for support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Artinyan A, 2010, CANCER-AM CANCER SOC, V116, P1367, DOI 10.1002/cncr.24817; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Fritz A, 2000, INT CLASSIFICATION D; Hu DJ, 2013, HEPATOLOGY, V58, P856, DOI 10.1002/hep.26286; Institute for Health Promotion Research, 2007, S TEX HLTH STAT REV; Mendez-Sanchez N, 2007, ANN HEPATOL, V6, P279; NAACCR: North American Association of Central Cancer Registries, 2008, GUID ENH LAT LAT ID; National Cancer Institute DCCPS Surveillance Research Program Surveillance Systems Branch, 2012, SURV EP END RES SEER; Ramirez AG, 2013, S TEXAS HLTH STATUS, P7, DOI [10.1007/978-3-319-00233-0_2, DOI 10.1007/978-3-319-00233-0_2]; Ramirez AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035573; REED TE, 1974, SCIENCE, V185, P283, DOI 10.1126/science.185.4147.283; Saunders D, 2010, ALIMENT PHARM THER, V31, P1051, DOI 10.1111/j.1365-2036.2010.04271.x; Texas Department of State Health Services Texas Cancer Registry, SEER STAT DAT 1995 2; U. S. Census Bureau, 2008, US CENS BUR 2008 201; Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160	16	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99365	10.1371/journal.pone.0099365	http://dx.doi.org/10.1371/journal.pone.0099365			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915432	gold, Green Published, Green Submitted			2022-12-25	WOS:000340947700090
J	Saunders, NR; Noor, NM; Dziegielewska, KM; Wheaton, BJ; Liddelow, SA; Steer, DL; Ek, CJ; Habgood, MD; Wakefield, MJ; Lindsay, H; Truettner, J; Miller, RD; Smith, AI; Dietrich, WD				Saunders, Norman R.; Noor, Natassya M.; Dziegielewska, Katarzyna M.; Wheaton, Benjamin J.; Liddelow, Shane A.; Steer, David L.; Ek, C. Joakim; Habgood, Mark D.; Wakefield, Matthew J.; Lindsay, Helen; Truettner, Jessie; Miller, Robert D.; Smith, A. Ian; Dietrich, W. Dalton			Age-Dependent Transcriptome and Proteome Following Transection of Neonatal Spinal Cord of Monodelphis domestica (South American Grey Short-Tailed Opossum)	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; AXONAL REGENERATION; UBIQUITIN LIGASE; DIFFERENTIAL EXPRESSION; INFLAMMATORY RESPONSE; THERAPEUTIC HYPOTHERMIA; GALECTIN-1 EXPRESSION	This study describes a combined transcriptome and proteome analysis of Monodelphis domestica response to spinal cord injury at two different postnatal ages. Previously we showed that complete transection at postnatal day 7 (P7) is followed by profuse axon growth across the lesion with near-normal locomotion and swimming when adult. In contrast, at P28 there is no axon growth across the lesion, the animals exhibit weight-bearing locomotion, but cannot use hind limbs when swimming. Here we examined changes in gene and protein expression in the segment of spinal cord rostral to the lesion at 24 h after transection at P7 and at P28. Following injury at P7 only forty genes changed (all increased expression); most were immune/inflammatory genes. Following injury at P28 many more genes changed their expression and the magnitude of change for some genes was strikingly greater. Again many were associated with the immune/inflammation response. In functional groups known to be inhibitory to regeneration in adult cords the expression changes were generally muted, in some cases opposite to that required to account for neurite inhibition. For example myelin basic protein expression was reduced following injury at P28 both at the gene and protein levels. Only four genes from families with extracellular matrix functions thought to influence neurite outgrowth in adult injured cords showed substantial changes in expression following injury at P28: Olfactomedin 4 (Olfm4, 480 fold compared to controls), matrix metallopeptidase (Mmp1, 104 fold), papilin (Papln, 152 fold) and integrin alpha 4 (Itga4, 57 fold). These data provide a resource for investigation of a priori hypotheses in future studies of mechanisms of spinal cord regeneration in immature animals compared to lack of regeneration at more mature stages.	[Saunders, Norman R.; Noor, Natassya M.; Dziegielewska, Katarzyna M.; Wheaton, Benjamin J.; Liddelow, Shane A.; Habgood, Mark D.] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia; [Liddelow, Shane A.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Steer, David L.; Smith, A. Ian] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Ek, C. Joakim] Univ Gothenburg, Dept Neurosci & Physiol, Gothenburg, Sweden; [Wakefield, Matthew J.; Lindsay, Helen] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Wakefield, Matthew J.] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Lindsay, Helen] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Truettner, Jessie; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Miller, Robert D.] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA	University of Melbourne; Stanford University; Monash University; University of Gothenburg; Walter & Eliza Hall Institute; University of Melbourne; University of Zurich; University of Miami; University of New Mexico	Saunders, NR (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia.	n.saunders@unimelb.edu.au	Wakefield, Matthew J/A-7795-2008; Wheaton, Ben/AAC-7037-2021; Wakefield, Matthew/X-7593-2019; Liddelow, Shane/ABE-6456-2020	Wakefield, Matthew J/0000-0001-6624-4698; Wakefield, Matthew/0000-0001-6624-4698; Liddelow, Shane/0000-0002-0840-1437; Miller, Robert/0000-0002-8479-8819; Lindsay, Helen/0000-0001-8614-1661; Saunders, Norman/0000-0001-6660-7639; Wheaton, Benjamin/0000-0003-0619-4777	Victoria Neurotrauma Initiative	Victoria Neurotrauma Initiative	This project was supported by the Victoria Neurotrauma Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afjehi-Sadat L, 2010, J PROTEOME RES, V9, P1591, DOI 10.1021/pr901049a; AGUAYO AJ, 1981, J EXP BIOL, V95, P231; Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Akbik F, 2011, EXPT NEUROLOGY; Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Anders A, 2011, HTSEQ ANAL HIGH THRO; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Biancheri R, 2013, EUR J HUM GENET, V21, P34, DOI 10.1038/ejhg.2012.93; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Cajal S, 1928, DEGENERATION REGENER; Catania A, 2008, TRENDS NEUROSCI, V31, P353, DOI 10.1016/j.tins.2008.04.002; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Chen AS, 2010, J NEUROTRAUM, V27, P263, DOI 10.1089/neu.2009.1051; Chen KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072567; Choi DW, 2008, J BIOL CHEM, V283, P4682, DOI 10.1074/jbc.M708873200; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Cruz-Orengo L, 2007, NEUROSCI LETT, V418, P49, DOI 10.1016/j.neulet.2007.03.015; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Dulhunty A, 2009, J PHYSIOL-LONDON, V587, P3135, DOI 10.1113/jphysiol.2009.171959; Dziegielewska KM, 2000, J COMP NEUROL, V423, P373, DOI 10.1002/1096-9861(20000731)423:3<373::AID-CNE2>3.0.CO;2-D; Ek CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043484; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Eva R, 2012, INT REV NEUROBIOL, V106, P75, DOI 10.1016/B978-0-12-407178-0.00004-1; Farlow DN, 2000, J CELL BIOCHEM, V80, P171; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fleming JC, 2008, EXP NEUROL, V214, P147, DOI 10.1016/j.expneurol.2008.04.024; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fry EJ, 2003, J COMP NEUROL, V466, P422, DOI 10.1002/cne.10904; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gardiner NJ, 2011, DEV NEUROBIOL, V71, P1054, DOI 10.1002/dneu.20950; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Gris P, 2003, MOL CELL NEUROSCI, V24, P555, DOI 10.1016/S1044-7431(03)00211-2; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hamada Y, 1996, J NEUROCHEM, V66, P1525; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hollis ER, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00005; Hu WH, 2002, J NEUROCHEM, V81, P36, DOI 10.1046/j.1471-4159.2002.00788.x; Hurtado A, 2012, EXP NEUROL, V233, P606, DOI 10.1016/j.expneurol.2010.11.015; Iketani M, 2013, DEV NEUROBIOL, V73, P230, DOI 10.1002/dneu.22058; Isaksson J, 1999, J NEUROTRAUM, V16, P165, DOI 10.1089/neu.1999.16.165; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jungbluth S, 1999, DEVELOPMENT, V126, P2751; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; KRAUS DB, 1987, LAB ANIM SCI, V37, P478; Kubota F, 2008, INT J DEV BIOL, V52, P397, DOI 10.1387/ijdb.072424fk; Kulkarni NH, 2000, GENET RES, V76, P41, DOI 10.1017/S0016672300004584; Kumamaru H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2132; Kurihara D, 2010, NEUROSCI RES, V66, P265, DOI 10.1016/j.neures.2009.11.008; Lane MA, 2007, EUR J NEUROSCI, V25, P1725, DOI 10.1111/j.1460-9568.2007.05439.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li C, 2011, NEUROSCIENCE, V197, P121, DOI 10.1016/j.neuroscience.2011.08.031; Lin AW, 2003, J NEUROBIOL, V56, P328, DOI 10.1002/neu.10239; Lin JT, 2012, J COMP NEUROL, V520, P1509, DOI 10.1002/cne.22808; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu WL, 2006, EXP CELL RES, V312, P1785, DOI 10.1016/j.yexcr.2006.02.011; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McGraw J, 2005, EXP NEUROL, V195, P103, DOI 10.1016/j.expneurol.2005.04.004; McGraw J, 2004, NEUROSCIENCE, V128, P713, DOI 10.1016/j.neuroscience.2004.06.075; McKerracher L, 2012, INT REV NEUROBIOL, V105, P117, DOI 10.1016/B978-0-12-398309-1.00007-X; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Miller RD, 2010, SEMIN IMMUNOL, V22, P3, DOI 10.1016/j.smim.2009.11.005; Mladinic M, 2005, CELL MOL NEUROBIOL, V25, P407, DOI 10.1007/s10571-005-3150-z; Mladinic M, 2010, BRAIN RES, V1363, P20, DOI 10.1016/j.brainres.2010.09.024; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; Noor NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062120; Noor NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027465; Parra ZE, 2009, J IMMUNOL, V182, P154, DOI 10.4049/jimmunol.182.1.154; Pei XH, 2011, CANCER RES, V71, P2969, DOI 10.1158/0008-5472.CAN-10-4300; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Pinzon A, 2008, EXP NEUROL, V213, P129, DOI 10.1016/j.expneurol.2008.05.018; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Ponyeam W, 2012, CELL SIGNAL, V24, P290, DOI 10.1016/j.cellsig.2011.08.020; Reddy SJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E4; Redies C, 2008, DEV DYNAM, V237, P2496, DOI 10.1002/dvdy.21650; Saunders NR, 1998, J NEUROSCI, V18, P339; SAUNDERS NR, 1989, ANAT EMBRYOL, V180, P227, DOI 10.1007/BF00315881; SAUNDERS NR, 1992, P ROY SOC B-BIOL SCI, V250, P171, DOI 10.1098/rspb.1992.0146; Seale SM, 2012, PHARMACOL BIOCHEM BE, V101, P77, DOI 10.1016/j.pbb.2011.12.006; Seo JH, 2011, HUM MOL GENET, V20, P4324, DOI 10.1093/hmg/ddr359; Sharp KG, 2012, EXP NEUROL, V233, P625, DOI 10.1016/j.expneurol.2010.12.020; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Swisher JFA, 2007, J LEUKOCYTE BIOL, V82, P1174, DOI 10.1189/jlb.0307154; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; Tello J.F, 1911, TRAB LAB INVEST BIOL, V9, P123; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; van den Berg R, 2012, ADV EXP MED BIOL, V970, P173, DOI 10.1007/978-3-7091-0932-8_8; Veeravalli KK, 2012, J NEUROTRAUM, V29, P2251, DOI 10.1089/neu.2012.2460; Veeravalli KK, 2009, NEUROBIOL DIS, V36, P200, DOI 10.1016/j.nbd.2009.07.012; Verhaagen Joost, 2012, Handb Clin Neurol, V109, P595, DOI 10.1016/B978-0-444-52137-8.00037-1; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; Wang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045931; Wang XM, 1998, J COMP NEUROL, V398, P83; Wheaton BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071181; Wheaton BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026826; Xiao Lin, 2005, Shengli Xuebao, V57, P705; Xu J, 2001, J NEUROSCI, V21, P92, DOI 10.1523/JNEUROSCI.21-01-00092.2001; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007; Yau TO, 2002, DEV BIOL, V252, P287, DOI 10.1006/dbio.2002.0849; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6; Zhu H, 2012, EXP BIOL MED, V237, P143, DOI 10.1258/ebm.2011.011152	121	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99080	10.1371/journal.pone.0099080	http://dx.doi.org/10.1371/journal.pone.0099080			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914927	Green Published, gold			2022-12-25	WOS:000340947700059
J	Shahzad, K; Bionaz, M; Trevisi, E; Bertoni, G; Rodriguez-Zas, SL; Loor, JJ				Shahzad, Khuram; Bionaz, Massimo; Trevisi, Erminio; Bertoni, Giuseppe; Rodriguez-Zas, Sandra L.; Loor, Juan J.			Integrative Analyses of Hepatic Differentially Expressed Genes and Blood Biomarkers during the Peripartal Period between Dairy Cows Overfed or Restricted-Fed Energy Prepartum	PLOS ONE			English	Article							FEED RESTRICTION; LIPID-METABOLISM; INFLAMMATORY CONDITIONS; ENDOPLASMIC-RETICULUM; FAT MOBILIZATION; EARLY LACTATION; LIVER-FUNCTION; PERFORMANCE; ADAPTATIONS; STEATOSIS	Using published dairy cattle liver transcriptomics dataset along with novel blood biomarkers of liver function, metabolism, and inflammation we have attempted an integrative systems biology approach applying the classical functional enrichment analysis using DAVID, a newly-developed Dynamic Impact Approach (DIA), and an upstream gene network analysis using Ingenuity Pathway Analysis (IPA). Transcriptome data was generated from experiments evaluating the impact of prepartal plane of energy intake [overfed (OF) or restricted (RE)] on liver of dairy cows during the peripartal period. Blood biomarkers uncovered that RE vs. OF led to greater prepartal liver distress accompanied by a low-grade inflammation and larger proteolysis (i.e., higher haptoglobin, bilirubin, and creatinine). Post-partum the greater bilirubinaemia and lipid accumulation in OF vs. RE indicated a large degree of liver distress. The re-analysis of microarray data revealed that expression of.4,000 genes was affected by diet x time. The bioinformatics analysis indicated that RE vs. OF cows had a liver with a greater lipid and amino acid catabolic capacity both pre-and post-partum while OF vs. RE cows had a greater activation of pathways/functions related to triglyceride synthesis. Furthermore, RE vs. OF cows had a larger (or higher capacity to cope with) ER stress likely associated with greater protein synthesis/processing, and a higher activation of inflammatory-related functions. Liver in OF vs. RE cows had a larger cell proliferation and cell-to-cell communication likely as a response to the greater lipid accumulation. Analysis of upstream regulators indicated a pivotal role of several lipid-related transcription factors (e.g., PPARs, SREBPs, and NFE2L2) in priming the liver of RE cows to better face the early postpartal metabolic and inflammatory challenges. An all-encompassing dynamic model was proposed based on the findings.	[Shahzad, Khuram; Rodriguez-Zas, Sandra L.; Loor, Juan J.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Shahzad, Khuram; Rodriguez-Zas, Sandra L.; Loor, Juan J.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [Shahzad, Khuram; Rodriguez-Zas, Sandra L.; Loor, Juan J.] Univ Illinois, Illinois Informat Inst, Urbana, IL USA; [Bionaz, Massimo] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Trevisi, Erminio; Bertoni, Giuseppe] Univ Cattolica Sacro Cuore, Ist Zootecn, I-20123 Milan, Italy; [Trevisi, Erminio; Bertoni, Giuseppe] Univ Cattolica Sacro Cuore, Ctr Ric Nutrigenom, I-20123 Milan, Italy; [Rodriguez-Zas, Sandra L.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Oregon State University; Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; University of Illinois System; University of Illinois Urbana-Champaign	Bionaz, M (corresponding author), Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA.	massimo.bionaz@oregonstate.edu; jloor@illinois.edu	Shahzad, Khuram/AAC-8884-2019; Bionaz, Massimo/I-4222-2018; Loor, Juan J./H-3760-2012	Bionaz, Massimo/0000-0002-0674-1892; Loor, Juan J./0000-0003-1586-4365; TREVISI, Erminio/0000-0003-1644-1911; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Shahzad, Dr Khuram/0000-0002-2333-1684				Akbar H, 2013, J DAIRY SCI, V96, P2201, DOI 10.3168/jds.2012-6036; Anderson DEJ, 2012, BIOCHEM BIOPH RES CO, V427, P159, DOI 10.1016/j.bbrc.2012.09.034; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Apte UM, 2004, TOXICOL PATHOL, V32, P567, DOI 10.1080/01926230490508812; BAIRD GD, 1981, FED PROC, V40, P2530; Bell AW, 2000, P NUTR SOC, V59, P119, DOI 10.1017/S0029665100000148; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bertoni G, 2008, J DAIRY SCI, V91, P3300, DOI 10.3168/jds.2008-0995; Bionaz M, 2007, J DAIRY SCI, V90, P1740, DOI 10.3168/jds.2006-445; BIONAZ M, 2013, PPAR RES, DOI DOI 10.1155/2013/684159; Bionaz M, 2012, GENE REGUL SYST BIO, V6, P109, DOI 10.4137/GRSB.S9852; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032455; Braun JP, 2003, VET CLIN PATH, V32, P162, DOI 10.1111/j.1939-165X.2003.tb00332.x; DALE H, 1979, NORD VET MED, V31, P97; Daley CA, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-10; Dann HM, 2006, J DAIRY SCI, V89, P3563, DOI 10.3168/jds.S0022-0302(06)72396-7; DELGIUDICE GD, 1992, CAN J ZOOL, V70, P974, DOI 10.1139/z92-139; Donkin SS, 2012, ROLE LIVER METABOLIS, P97; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Etzler ME, 2009, ESSENTIALS GLYCOBIOL; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; Farney JK, 2013, AM J PHYSIOL-REG I, V305, pR110, DOI 10.1152/ajpregu.00152.2013; Federico A, 2010, WORLD J GASTROENTERO, V16, P4762, DOI 10.3748/wjg.v16.i38.4762; Flach RJR, 2011, J BIOL CHEM, V286, P22195, DOI 10.1074/jbc.M110.210237; Grala TM, 2013, PHYSL GENOMICS; Grum DE, 1996, J DAIRY SCI, V79, P1836, DOI 10.3168/jds.S0022-0302(96)76552-9; Hebbring SJ, 2007, HUM MOL GENET, V16, P463, DOI 10.1093/hmg/ddl468; Hornick JL, 1998, J ANIM SCI, V76, P260; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hu YD, 2009, DRUG METAB DISPOS, V37, P841, DOI 10.1124/dmd.108.024059; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huls M, 2009, J PHARMACOL EXP THER, V328, P3, DOI 10.1124/jpet.107.132225; JONES SJ, 1990, J ANIM SCI, V68, P2707; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708, DOI 10.1152/physrev.1989.69.3.708; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kurzawski M, 2012, ENVIRON TOXICOL PHAR, V34, P87, DOI 10.1016/j.etap.2012.03.001; Kusunoki M, 2003, DIABETES, V52, pA341; Ling PR, 2004, AM J PHYSIOL-REG I, V287, pR801, DOI 10.1152/ajpregu.00715.2003; LOBLEY GE, 1992, J ANIM SCI, V70, P3264; Loor JJ, 2010, ANIMAL, V4, P1110, DOI 10.1017/S1751731110000960; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Loor JJ, 2006, PHYSIOL GENOMICS, V27, P29, DOI 10.1152/physiolgenomics.00036.2006; Loor JJ, 2011, J MAMMARY GLAND BIOL, V16, P305, DOI 10.1007/s10911-011-9232-2; Lu Y, 2006, BIOCHEM BIOPH RES CO, V344, P221, DOI 10.1016/j.bbrc.2006.03.111; Madero M, 2011, CURR OPIN NEPHROL HY, V20, P622, DOI 10.1097/MNH.0b013e32834ba210; Mandard S, 2013, PPAR RES, V2013, DOI 10.1155/2013/613864; McCarthy SD, 2010, PHYSIOL GENOMICS, V42A, P188, DOI 10.1152/physiolgenomics.00118.2010; METZ S, 1983, J CLIN INVEST, V71, P1191, DOI 10.1172/JCI110868; MULLER MJ, 1981, J NUTR, V111, P1370; Noguchi R, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.19; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Overton TR, 1998, J ANIM SCI, V76, P2938; Petit HV, 2007, J DAIRY SCI, V90, P4780, DOI 10.3168/jds.2007-0066; Prinsen BHCMT, 2003, J LIPID RES, V44, P1341, DOI 10.1194/jlr.M300023-JLR200; Rajman M, 2006, COMP BIOCHEM PHYS A, V145, P363, DOI 10.1016/j.cbpa.2006.07.004; Remppis S, 2011, ASIAN AUSTRAL J ANIM, V24, P540, DOI 10.5713/ajas.2011.10134; Sahoo A, 2009, J ANIM SCI, V87, P2664, DOI 10.2527/jas.2008-0906; Spears JW, 2011, J ANIM SCI, V89, P2502, DOI 10.2527/jas.2010-3265; Sullivan TM, 2009, THERIOGENOLOGY, V72, P1202, DOI 10.1016/j.theriogenology.2009.07.016; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Trevisi E, 2012, RES VET SCI, V93, P695, DOI 10.1016/j.rvsc.2011.11.008; Trevisi E, 2009, J ANIM SCI, V87, P3020, DOI 10.2527/jas.2008-1178; TUCKER WB, 1991, J ANIM SCI, V69, P1205; Valenti L, 2013, DIABETES; Varady KA, 2009, NUTRITION, V25, P486, DOI 10.1016/j.nut.2008.10.017; Viana LD, 2013, ONCOLOGY-BASEL, V84, P81, DOI 10.1159/000343436; Weber C, 2013, J DAIRY SCI, V96, P5670, DOI 10.3168/jds.2012-6277	67	30	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99757	10.1371/journal.pone.0099757	http://dx.doi.org/10.1371/journal.pone.0099757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914544	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700128
J	Sun, JC; Xu, T; Zuo, Q; Wang, RB; Qi, AQ; Cao, WL; Sun, AJ; Sun, XJ; Xu, JJ				Sun, Jing-chuan; Xu, Tao; Zuo, Qiao; Wang, Ruo-bing; Qi, Ai-qing; Cao, Wen-luo; Sun, Ai-jun; Sun, Xue-jun; Xu, Jiajun			Hydrogen-Rich Saline Promotes Survival of Retinal Ganglion Cells in a Rat Model of Optic Nerve Crush	PLOS ONE			English	Article							REDUCING OXIDATIVE STRESS; PUPILLARY LIGHT REFLEX; ISCHEMIA/REPERFUSION INJURY; PARKINSONS-DISEASE; FREE-RADICALS; PROTECTS; GLUTAMATE; MICE; MICROGLIA; APOPTOSIS	Objective: To investigate the effect of molecular hydrogen (H-2) in a rat model subjected to optic nerve crush (ONC). Methods: We tested the hypothesis that after optic nerve crush (ONC), retinal ganglion cell (RGC) could be protected by H-2. Rats in different groups received saline or hydrogen-rich saline every day for 14 days after ONC. Retinas from animals in each group underwent measurements of hematoxylin and eosin (H&E) staining, cholera toxin beta (CTB) tracing, gamma synuclein staining, and terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) staining 2 weeks post operation. Flash visual evoked potentials (FVEP) and pupillary light reflex (PLR) were then tested to evaluate the function of optic nerve. The malondialdehyde (MDA) level in retina was evaluated. Results: H&E, gamma synuclein staining and CTB tracing showed that the survival rate of RGCs in hydrogen saline-treated group was significantly higher than that in saline-treated group. Apoptosis of RGCs assessed by TUNEL staining were less observed in hydrogen saline-treated group. The MDA level in retina of H-2 group was much lower than that in placebo group. Furthermore, animals treated with hydrogen saline showed better function of optic nerve in assessments of FVEP and PLR. Conclusion: These results demonstrated that H-2 protects RGCs and helps preserve the visual function after ONC and had a neuroprotective effect in a rat model subjected to ONC.	[Sun, Jing-chuan; Xu, Tao; Zuo, Qiao; Qi, Ai-qing; Cao, Wen-luo; Sun, Ai-jun; Xu, Jiajun] Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China; [Sun, Jing-chuan; Xu, Tao; Zuo, Qiao] Second Mil Med Univ, Grad Management Unit, Shanghai, Peoples R China; [Wang, Ruo-bing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Sun, Xue-jun] Second Mil Med Univ, Fac Naval Med, Dept Diving Med, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Naval Medical University	Xu, JJ (corresponding author), Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China.	xujiajun1963@126.com	Piccione, Giuseppe/P-3394-2015; sun, xuejun/A-5561-2010	Piccione, Giuseppe/0000-0002-4736-1087; sun, xuejun/0000-0003-2387-5531	National Basic Research Program of China (973 Program) [2005CB724302]; Creativity and Innovation Training Program of Second Military Medical University [MS2010035]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Creativity and Innovation Training Program of Second Military Medical University	This work was supported by The National Basic Research Program of China (973 Program 2005CB724302) and the Creativity and Innovation Training Program of Second Military Medical University (MS2010035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; Cai JM, 2008, NEUROSCI LETT, V441, P167, DOI 10.1016/j.neulet.2008.05.077; Cai JM, 2009, BRAIN RES, V1256, P129, DOI 10.1016/j.brainres.2008.11.048; CHAN KMC, 1995, EUR J NEUROSCI, V7, P2053, DOI 10.1111/j.1460-9568.1995.tb00628.x; Chen H, 2010, BIOCHEM BIOPH RES CO, V393, P308, DOI 10.1016/j.bbrc.2010.02.005; Chen J, 2004, PHARMAZIE, V59, P155; Clutton S, 1997, BRIT MED BULL, V53, P662; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DEMEDIUK P, 1989, J NEUROSCI RES, V23, P95, DOI 10.1002/jnr.490230113; FLAMM ES, 1978, STROKE, V9, P445, DOI 10.1161/01.STR.9.5.445; Fu Y, 2009, NEUROSCI LETT, V453, P81, DOI 10.1016/j.neulet.2009.02.016; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Fukuda KI, 2007, BIOCHEM BIOPH RES CO, V361, P670, DOI 10.1016/j.bbrc.2007.07.088; Galindo-Romero C, 2013, INVEST OPHTH VIS SCI, V54, P974, DOI 10.1167/iovs.12-11207; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Grozdanic S, 2003, CURR EYE RES, V26, P371, DOI 10.1076/ceyr.26.5.371.15439; Huang Y, 2011, BRAIN RES, V1378, P125, DOI 10.1016/j.brainres.2010.12.071; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P11, DOI 10.1016/j.bbrc.2009.05.117; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P316, DOI 10.1016/j.bbrc.2009.06.024; Kajiyama S, 2008, NUTR RES, V28, P137, DOI 10.1016/j.nutres.2008.01.008; Kanski JJ, 2003, CLIN OPHTHALMOLOGY; Kikkawa YS, 2009, NEUROREPORT, V20, P689, DOI 10.1097/WNR.0b013e32832a5c68; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kreutz MR, 1999, RESTOR NEUROL NEUROS, V14, P127; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Li J, 2010, BRAIN RES, V1328, P152, DOI 10.1016/j.brainres.2010.02.046; Li YP, 2011, CYTOTECHNOLOGY, V63, P119, DOI 10.1007/s10616-010-9317-6; Lin Y, 2011, NEUROSCI LETT, V487, P12, DOI 10.1016/j.neulet.2010.09.064; Matteucci A, 2005, EXP BRAIN RES, V167, P641, DOI 10.1007/s00221-005-0068-0; Oharazawa H, 2009, INVEST OPHTH VIS SCI; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Qian LR, 2010, FREE RADICAL RES, V44, P275, DOI 10.3109/10715760903468758; Schori H, 2001, J NEUROIMMUNOL, V119, P199, DOI 10.1016/S0165-5728(01)00358-7; Shingu C, 2010, J ANESTH, V24, P569, DOI 10.1007/s00540-010-0942-1; Surgucheva I, 2008, MOL VIS, V14, P1540; Terasaki Y, 2011, AM J PHYSIOL-LUNG C, V301, pL415, DOI 10.1152/ajplung.00008.2011; Vorwerk CK, 2004, BRAIN RES BULL, V62, P485, DOI 10.1016/S0361-9230(03)00075-3; Wang C, 2011, NEUROSCI LETT, V491, P127, DOI 10.1016/j.neulet.2011.01.022; Wang F, 2011, J SURG RES, V167, pE339, DOI 10.1016/j.jss.2010.11.005; Wang RB, 2010, J NEUROTRAUM, V27, P763, DOI 10.1089/neu.2009.1005; Wei LH, 2012, EXP EYE RES, V94, P117, DOI 10.1016/j.exer.2011.11.016; Whiteley SJO, 1998, EXP NEUROL, V154, P560, DOI 10.1006/exnr.1998.6959; Wilhelm H, 2003, J NEURO-OPHTHALMOL, V23, P42, DOI 10.1097/00041327-200303000-00010; Zhao LQ, 2011, INT J BIOL SCI, V7, P297, DOI 10.7150/ijbs.7.297; Zheng XF, 2009, FREE RADICAL RES, V43, P478, DOI 10.1080/10715760902870603	46	143	151	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99299	10.1371/journal.pone.0099299	http://dx.doi.org/10.1371/journal.pone.0099299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915536	Green Published, gold			2022-12-25	WOS:000340947700082
J	Sakurai, Y; Anzai, I; Furukawa, Y				Sakurai, Yasuyuki; Anzai, Itsuki; Furukawa, Yoshiaki			A Primary Role for Disulfide Formation in the Productive Folding of Prokaryotic Cu,Zn-superoxide Dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU,ZN SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; COPPER CHAPERONE; POSTTRANSLATIONAL MODIFICATIONS; STRUCTURAL DYNAMICS; ZINC; SALMONELLA; OXYGEN; BOND; MUTATIONS	Enzymatic activation of Cu,Zn-superoxide dismutase (SOD1) requires not only binding of a catalytic copper ion but also formation of an intramolecular disulfide bond. Indeed, the disulfide bond is completely conserved among all species possessing SOD1; however, it remains obscure how disulfide formation controls the enzymatic activity of SOD1. Here, we show that disulfide formation is a primary event in the folding process of prokaryotic SOD1 (SodC) localized to the periplasmic space. Escherichia coli SodC was found to attain beta-sheet structure upon formation of the disulfide bond, whereas disulfide-reduced SodC assumed little secondary structure even in the presence of copper and zinc ions. Moreover, reduction of the disulfide bond made SodC highly susceptible to proteolytic degradation. We thus propose that the thiol-disulfide status in SodC controls the intracellular stability of this antioxidant enzyme and that the oxidizing environment of the periplasm is required for the enzymatic activation of SodC.	[Sakurai, Yasuyuki; Anzai, Itsuki; Furukawa, Yoshiaki] Keio Univ, Dept Chem, Lab Mech Chem Biomol, Yokohama, Kanagawa 2238522, Japan	Keio University	Furukawa, Y (corresponding author), Keio Univ, Dept Chem, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp	Furukawa, Yoshiaki/F-2871-2014	Furukawa, Yoshiaki/0000-0002-1918-372X; Anzai, Itsuki/0000-0001-9307-943X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25291028, 24657093]; Cooperative Research in Joint Studies at Institute for Molecular Science, Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cooperative Research in Joint Studies at Institute for Molecular Science, Japan	This work was supported by Grants-in-aid 25291028 for Scientific Research (B) and 24657093 for Challenging Exploratory Research (to Y. F.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Cooperative Research in Joint Studies at Institute for Molecular Science, Japan.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Banci L, 2005, P NATL ACAD SCI USA, V102, P7541, DOI 10.1073/pnas.0502450102; Battistoni A, 1996, BIOCHEM J, V320, P713, DOI 10.1042/bj3200713; Battistoni A, 1998, J BIOL CHEM, V273, P5655, DOI 10.1074/jbc.273.10.5655; Battistoni A, 1999, FEBS LETT, V443, P313, DOI 10.1016/S0014-5793(98)01725-6; BENOV LT, 1994, J BIOL CHEM, V269, P25310; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Cupane A, 1995, BIOCHEMISTRY-US, V34, P16313, DOI 10.1021/bi00050a011; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; DONG AC, 1995, ARCH BIOCHEM BIOPHYS, V320, P59, DOI 10.1006/abbi.1995.1342; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Imlay KRC, 1996, J BACTERIOL, V178, P2564, DOI 10.1128/jb.178.9.2564-2571.1996; Ishikawa H, 2007, P NATL ACAD SCI USA, V104, P19309, DOI 10.1073/pnas.0709760104; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Krishnakumar R, 2007, J BACTERIOL, V189, P4343, DOI 10.1128/JB.00010-07; Leitch JM, 2009, J BIOL CHEM, V284, P21863, DOI 10.1074/jbc.M109.000489; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Lyons TJ, 2000, J BIOL INORG CHEM, V5, P189, DOI 10.1007/s007750050363; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mealman TD, 2011, BIOCHEMISTRY-US, V50, P2559, DOI 10.1021/bi102012j; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Pesce A, 1997, J MOL BIOL, V274, P408, DOI 10.1006/jmbi.1997.1400; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SALVATO B, 1989, BIOCHIM BIOPHYS ACTA, V998, P14, DOI 10.1016/0167-4838(89)90112-X; Spagnolo L, 2004, J BIOL CHEM, V279, P33447, DOI 10.1074/jbc.M404699200; Sroga GE, 2002, BIOTECHNOL BIOENG, V78, P761, DOI 10.1002/bit.10269; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; WEBER MJ, 1966, P NATL ACAD SCI USA, V55, P1224, DOI 10.1073/pnas.55.5.1224	43	15	15	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20139	20149		10.1074/jbc.M114.567677	http://dx.doi.org/10.1074/jbc.M114.567677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24917671	hybrid, Green Published			2022-12-25	WOS:000339395200027
J	Mamo, H				Mamo, Hassen			Intestinal Parasitic Infections among Prison Inmates and Tobacco Farm Workers in Shewa Robit, North-Central Ethiopia	PLOS ONE			English	Article							TRANSMITTED HELMINTH INFECTIONS; SCHOOL-CHILDREN; PREVALENCE; GROWTH; HOOKWORM	Background: Intestinal parasitic infections (IPIs) particularly soil-transmitted helminthiasis (STH) and schistosomiasis are among neglected tropical diseases (NTDs) globally. Apart from being associated with anemia, malabsorption and retarded cognitive development these diseases are complicating the clinical picture of more serious infections like HIV, TB and malaria. Renewed and up-to-date information on the epidemiology of IPIs in more vulnerable groups such as irrigated-farm workers and prisoners would significantly contribute towards improving the health condition of such at-risk groups. Methods: A cross-sectional survey was conducted to determine the prevalence of IPIs among prison inmates and tobacco farm workers in Shewa-Robit, north-central Ethiopia in November 2008. A total of 236 fecal samples were examined microscopically to detect helminths and/or protozoa using direct-smear and formol-ether concentration methods. Results: Overall, 8 intestinal parasite species have been recovered singly or in combinations from 146 (61.8 %) samples. The prevalence in prison population (88/121 = 72.7%) was significantly higher than that in tobacco farm (58/115 = 50.4%). There were no significant differences in the prevalence of IPI by most socio-demographics. Except for hookworm there was no significant difference in parasite prevalence between different age-groups though the frequency of individual parasites slightly varied between the age-groups. Multivariate logistic regression analysis showed that inmates were more likely to acquire IPIs than tobacco-farm workers (Odds Ratio (OR) = 2.62, 95% confidence interval (CI) = 1.52-4.5). In addition, participants who did not report past treatment for IPIs were more likely to acquire IPIs than participants who self-reported treatment for IPIs in the past twelve months (OR = 3.25, 95% CI = 1.75-6.06). All other socio-demographics were not significantly associated with IPIs in univariate analysis. Entamoeba histolytica/dispar/moshkovskii was the most frequently encountered species in both study sites accounting for 48.8 and 51.7 percent of the positives in prison and tobacco farm population respectively. Other intestinal parasites detected, with slight variation in prevalence in the two study areas, were hookworm, Ascaris lumbricoides, Trichuris trichiura, Schistosoma mansoni, Strongyloides stercolaris, Hymenolepis nana and Taenia sp. 35.5 and 33.0 percent of the total positive cases were mixed infections in Shewa Robit prison and tobacco farm, respectively. Conclusion: The results show that IPIs are common health problems in the studied populations.	Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia	Addis Ababa University	Mamo, H (corresponding author), Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.	binmamo@yahoo.com	Mamo, Hassen/AAX-3481-2020	Mamo, Hassen/0000-0001-9541-8976	Addis Ababa University	Addis Ababa University	This study was funded by Addis Ababa University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2011, ASIAN PAC J TROP MED, V4, P661, DOI 10.1016/S1995-7645(11)60168-5; Alonso-Sanz M, 1995, ENFERM INFEC MICR CL, V13, P228; Amuga G, 2006, INT J NAT APPL SCI, V2, P7; [Anonymous], 1987, WHO TECH REP SER, P7; [Anonymous], 2012, ADDIS FORTUNE N 1106, V12; Birrie H., 1998, SCHISTOSOMIASIS ETHI, V2, P29; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Colman S, 2013, AJMR, V1, P11, DOI DOI 10.15413/ajmr.2012.0103; Degarege Abraham, 2010, BMC Res Notes, V3, P143, DOI 10.1186/1756-0500-3-143; Dejenie T, 2009, ETHIOP J HEALTH DEV, V23, P48; Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Fraser A, 2007, HLTH PRISONS WHO GUI, P21; Hotez P, 2008, ANN NY ACAD SCI, V1136, P38, DOI 10.1196/annals.1425.000; Jemaneh L, 2000, ETHIOPIAN MED J, V38, P105; Jemaneh L, 1998, ETHIOPIAN MED J, V36, P1; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; King JD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002223; Kloos H, 1993, ECOLOGY HLTH DIS ETH, P223; Knopp S, 2009, AM J TROP MED HYG, V81, P1071, DOI 10.4269/ajtmh.2009.09-0377; Koroma MM, 1996, J TROP PEDIATRICS, V42, P371, DOI 10.1093/tropej/42.6.371; KYRONSEPPA H, 1976, SCAND J INFECT DIS, V8, P199, DOI 10.3109/inf.1976.8.issue-3.15; Mahfouz AAR, 1997, J TROP PEDIATRICS, V43, P341, DOI 10.1093/tropej/43.6.341; Mamo H, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-51; McConnell E., 1976, Ethiopian Medical Journal, V14, P159; Mecroritch E, 1965, AM J TROP MED HYG, V4, P719; Munyekenye OG, 2005, EMERG INFECT DIS, V11, P1571, DOI 10.3201/eid1110.050106; Nasr NA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-27; Okolie N, 2008, INT J PARASITIC DIS, V4; Ostan I, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-342; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Pullan RL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-81; Rayan P, 2010, INDIAN J PATHOL MICR, V53, P498, DOI 10.4103/0377-4929.68292; Schmidt G.D., 2009, FDN PARASITOLOGY EDS, V8th; STEPHENSON LS, 1993, J NUTR, V123, P1036; Sugunan A. P., 1996, Journal of Communicable Diseases, V28, P253; Tedla S., 1989, Sinet, an Ethiopian Journal of Science, V12, P25; Wegayehu T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-151; Weisbuch JC, 1992, PUBLIC HLTH PREVENTI, P1159; *WHO, 2006, NEGL TROP DIS HIDD S; Wokem GN, 2008, NIG J PARASIT, V29, P115; World Health Organization, 1991, BAS LAB METH MED PAR	41	25	25	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99559	10.1371/journal.pone.0099559	http://dx.doi.org/10.1371/journal.pone.0099559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926687	Green Submitted, Green Published, gold			2022-12-25	WOS:000338278100048
J	Campos-Martorell, M; Montero, MA; Hernandez-Guillamon, M; Rosell, A; Gomis, J; Salat, D; Garcia-Bonilla, L; Montaner, J				Campos-Martorell, Mireia; Angeles Montero, Ma; Hernandez-Guillamon, Mar; Rosell, Anna; Gomis, Javier; Salat, David; Garcia-Bonilla, Lidia; Montaner, Joan			Rat Middle Cerebral Artery Occlusion Is Not a Suitable Model for the Study of Stroke-Induced Spontaneous Infections	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MEDICAL COMPLICATIONS; ISCHEMIC-STROKE; IMMUNODEPRESSION; ACTIVATION; INJURY; IMMUNODEFICIENCY; PNEUMONIA	Background: Infections related to stroke-induced immunodepression are an important complication causing a high rate of death in patients. Several experimental studies in mouse stroke models have described this process but it has never been tested in other species such as rats. Methods: Our study focused on the appearance of secondary systemic and pulmonary infections in ischemic rats, comparing with sham and naive animals. For that purpose, male Wistar rats were subjected to embolic middle cerebral artery occlusion (eMCAO) or to transient MCAO (tMCAO) inserting a nylon filament. Forty-eight hours after ischemia, blood and lung samples were evaluated. Results: In eMCAO set, ischemic rats showed a significant decrease in blood-peripheral lymphocytes (naive = 58.8 +/- 18.1%, ischemic = 22.9 +/- 16.4%) together with an increase in polymorphonuclears (PMNs) (naive = 29.2 +/- 14.7%, ischemic = 71.7 +/- 19.5%), while no change in monocytes was observed. The increase in PMNs counts was positively correlated with worse neurological outcome 48 hours after eMCAO (r = 0.55, p = 0.043). However, sham animals showed similar changes in peripheral leukocytes as those seen in ischemic rats (lymphocytes: 40.1 +/- 19.7%; PMNs: 51.7 +/- 19.2%). Analysis of bacteriological lung growth showed clear differences between naive (0 +/- 0 CFU/mL; log10) and both sham (3.9 +/- 2.5 CFU/mL; log10) and ischemic (4.3 +/- 2.9 CFU/mL; log10) groups. Additionally, naive animals presented non-pathological lung histology, while both sham and ischemic showed congestion, edema or hemorrhage. Concordant results were found in the second set of animals submitted to a tMCAO. Conclusions: Inflammatory and infection changes in Wistar rats subjected to MCAO models may be attributed not only to the brain ischemic injury but to the surgical aggression and/or anaesthetic stress. Consequently, we suggest that stroke-induced immunodepression in ischemic experimental models should be interpreted with caution in further experimental and translational studies, at least in rat stroke models that entail cervicotomy and cranial trepanation.	[Campos-Martorell, Mireia; Hernandez-Guillamon, Mar; Rosell, Anna; Garcia-Bonilla, Lidia; Montaner, Joan] Univ Autonoma Barcelona, Inst Recerca Vall dHebron, Neurovasc Res Lab, E-08193 Barcelona, Spain; [Angeles Montero, Ma] Hosp Valle De Hebron, Dept Anat Pathol, Barcelona, Spain; [Gomis, Javier] Univ Autonoma Barcelona, Inst Recerca Vall dHebron, Infect Dis Res Lab, E-08193 Barcelona, Spain; [Salat, David; Montaner, Joan] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Neurol, Neurovasc Unit, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Montaner, J (corresponding author), Univ Autonoma Barcelona, Inst Recerca Vall dHebron, Neurovasc Res Lab, E-08193 Barcelona, Spain.	31862jmv@comb.cat	Montero, Angeles/AAQ-1696-2021; Montaner, Joan/D-3063-2015	Montero, Angeles/0000-0002-2381-6833; Montaner, Joan/0000-0003-4845-2279; Rosell Novel, Anna/0000-0003-1082-3599; Hernandez Guillamon, Maria Mar/0000-0001-8844-0091	FIS [FI 10/00508]; Spanish Ministry of Health; European Union's Seventh Framework Programme (European Stroke Network) [n degrees201024, n degrees202213]; Eurosalud Programme [EUS2008-03610]; Spanish stroke research network INVICTUS [RD12/0014/0005]	FIS(Instituto de Salud Carlos III); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European Union's Seventh Framework Programme (European Stroke Network); Eurosalud Programme; Spanish stroke research network INVICTUS	MC is supported by a FIS grant (FI 10/00508) from the Spanish Ministry of Health, and MHG and AR are senior researchers of the Miguel Servet Programme (CP12/03259 and CP09/00265), all those from the Instituto de Salud Carlos III from the Spanish Ministry of Economy. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreements n degrees 201024 and n degrees 202213 (European Stroke Network), Eurosalud Programme (EUS2008-03610) and the Spanish stroke research network INVICTUS (RD12/0014/0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASADULLAH K, 1995, CRIT CARE MED, V23, P1976, DOI 10.1097/00003246-199512000-00006; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Buck BH, 2008, STROKE, V39, P355, DOI 10.1161/STROKEAHA.107.490128; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Carmichael S Thomas, 2005, NeuroRx, V2, P396; CZLONKOWSKA A, 1979, J NEUROL SCI, V43, P455, DOI 10.1016/0022-510X(79)90024-8; Denes A, 2011, J CEREBR BLOOD F MET, V31, P1036, DOI 10.1038/jcbfm.2010.198; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Elneihoum AM, 1996, STROKE, V27, P1734, DOI 10.1161/01.STR.27.10.1734; Engel O, 2010, EXP TRANSL STROKE ME, V15; Garcia-Bonilla L, 2011, BRAIN RES, V1373, P211, DOI 10.1016/j.brainres.2010.12.005; Gu LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059602; HENON H, 1995, STROKE, V26, P392, DOI 10.1161/01.STR.26.3.392; Hernandez-Guillamon M, 2010, STROKE, V41, P1528, DOI 10.1161/STROKEAHA.110.584623; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Jin R, 2013, STROKE, V44, P1135, DOI 10.1161/STROKEAHA.111.000633; Johnston KC, 1998, STROKE, V29, P447, DOI 10.1161/01.STR.29.2.447; KALRA L, 1995, STROKE, V26, P990, DOI 10.1161/01.STR.26.6.990; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; KOSTIC V, 1988, EUR NEUROL, V28, P331, DOI 10.1159/000116296; Kurabayashi H, 1996, J MED, V27, P171; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Liesz A, 2009, STROKE, V40, P2849, DOI 10.1161/STROKEAHA.109.549618; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meisel C, 2004, STROKE, V35, P2, DOI 10.1161/01.STR.0000109041.89959.4C; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Pfeilschifter Waltraud, 2011, Exp Transl Stroke Med, V3, P2, DOI 10.1186/2040-7378-3-2; Popovich P, 2009, NAT MED, V15, P736, DOI 10.1038/nm0709-736; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Prass K, 2006, STROKE, V37, P2607, DOI 10.1161/01.STR.0000240409.68739.2b; Schulte-Herbruggen O, 2006, NEUROIMMUNOMODULAT, V13, P13, DOI 10.1159/000092109; Urra X, 2009, NEUROSCIENCE, V158, P1174, DOI 10.1016/j.neuroscience.2008.06.014; Vermeij FH, 2009, CEREBROVASC DIS, V27, P465, DOI 10.1159/000210093; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Yan J, 2009, J NEUROIMMUNOL, V206, P112, DOI 10.1016/j.jneuroim.2008.11.001	38	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99169	10.1371/journal.pone.0099169	http://dx.doi.org/10.1371/journal.pone.0099169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922549	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300038
J	Kadoya, T; Takenaka, A; Ishihama, F; Fujita, T; Ogawa, M; Katsuyama, T; Kadono, Y; Kawakubo, N; Serizawa, S; Takahashi, H; Takamiya, M; Fujii, S; Matsuda, H; Muneda, K; Yokota, M; Yonekura, K; Yahara, T				Kadoya, Taku; Takenaka, Akio; Ishihama, Fumiko; Fujita, Taku; Ogawa, Makoto; Katsuyama, Teruo; Kadono, Yasuro; Kawakubo, Nobumitsu; Serizawa, Shunsuke; Takahashi, Hideki; Takamiya, Masayuki; Fujii, Shinji; Matsuda, Hiroyuki; Muneda, Kazuo; Yokota, Masatsugu; Yonekura, Koji; Yahara, Tetsukazu			Crisis of Japanese Vascular Flora Shown By Quantifying Extinction Risks for 1618 Taxa	PLOS ONE			English	Article							BIODIVERSITY	Although many people have expressed alarm that we are witnessing a mass extinction, few projections have been quantified, owing to limited availability of time-series data on threatened organisms, especially plants. To quantify the risk of extinction, we need to monitor changes in population size over time for as many species as possible. Here, we present the world's first quantitative projection of plant species loss at a national level, with stochastic simulations based on the results of population censuses of 1618 threatened plant taxa in 3574 map cells of ca. 100 km(2). More than 500 lay botanists helped monitor those taxa in 1994-1995 and in 2003-2004. We projected that between 370 and 561 vascular plant taxa will go extinct in Japan during the next century if past trends of population decline continue. This extinction rate is approximately two to three times the global rate. Using time-series data, we show that existing national protected areas (PAs) covering ca. 7% of Japan will not adequately prevent population declines: even core PAs can protect at best <60% of local populations from decline. Thus, the Aichi Biodiversity Target to expand PAs to 17% of land (and inland water) areas, as committed to by many national governments, is not enough: only 29.2% of currently threatened species will become non-threatened under the assumption that probability of protection success by PAs is 0.5, which our assessment shows is realistic. In countries where volunteers can be organized to monitor threatened taxa, censuses using our method should be able to quantify how fast we are losing species and to assess how effective current conservation measures such as PAs are in preventing species extinction.	[Kadoya, Taku; Takenaka, Akio; Ishihama, Fumiko] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Fujita, Taku] Nat Conservat Soc Japan, Chuo Ku, Tokyo, Japan; [Ogawa, Makoto] Tokushima Prefectural Museum, Tokushima, Japan; [Katsuyama, Teruo] Kanagawa Prefectural Museum Nat Hist, Odawara, Kanagawa, Japan; [Kadono, Yasuro] Kobe Univ, Fac Sci, Kobe, Hyogo 657, Japan; [Kawakubo, Nobumitsu] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan; [Serizawa, Shunsuke] Aichi Kyoiku Univ, Dept Biol, Kariya, Aichi, Japan; [Takahashi, Hideki] Hokkaido Univ Museum, Sapporo, Hokkaido, Japan; [Takamiya, Masayuki] Kumamoto Univ, Dept Environm Sci, Kumamoto, Japan; [Fujii, Shinji] Univ Human Environm, Div Human Environm, Okazaki, Aichi, Japan; [Matsuda, Hiroyuki; Muneda, Kazuo] Yokohama Natl Univ, Fac Nat Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 240, Japan; [Yokota, Masatsugu] Univ Ryukyus, Fac Sci, Nakagami, Okinawa, Japan; [Yonekura, Koji] Tohoku Univ, Ctr Acad Resources & Arch, Bot Gardens, Aoba Ku, Sendai, Miyagi 980, Japan; [Yahara, Tetsukazu] Kyushu Univ, Dept Biol, Higashi Ku, Fukuoka 812, Japan	National Institute for Environmental Studies - Japan; Kobe University; Gifu University; Aichi University Education; Hokkaido University; Kumamoto University; Yokohama National University; University of the Ryukyus; Tohoku University; Kyushu University	Kadoya, T (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan.	kadoya@nies.go.jp	Ishihama, Fumiko/AAC-1461-2022; Ogawa, Makoto/AAE-6161-2021	Yahara, Tetsukazu/0000-0001-5105-7152	Ministry of the Environment of Japan and the Japanese Society of Plant Taxonomists; Environment Research and Technology Development fund of the Ministry of the Environment, Japan [S9-1]; Grants-in-Aid for Scientific Research [25550102] Funding Source: KAKEN	Ministry of the Environment of Japan and the Japanese Society of Plant Taxonomists; Environment Research and Technology Development fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the Ministry of the Environment of Japan and the Japanese Society of Plant Taxonomists, and in part by the Environment Research and Technology Development fund (S9-1) of the Ministry of the Environment, Japan.	Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; IUCN, 2022, IUCN RED LIST THREAT; IUCN U.-W., 2012, WORLD DAT PROT AR WD; Kadoya T, 2009, BIOL CONSERV, V142, P1899, DOI 10.1016/j.biocon.2009.02.033; Kadoya T, 2009, BIOL CONSERV, V142, P1011, DOI 10.1016/j.biocon.2009.01.012; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Moilanen A., 2009, SPATIAL CONSERVATION; Moore JL, 2003, ECOGRAPHY, V26, P595, DOI 10.1034/j.1600-0587.2003.03467.x; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; SMITH FDM, 1993, NATURE, V364, P494, DOI 10.1038/364494b0; Yahara T, 1998, P JPN SOC PLANT TAXO, V13, P89	14	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98954	10.1371/journal.pone.0098954	http://dx.doi.org/10.1371/journal.pone.0098954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922311	gold, Green Submitted, Green Published			2022-12-25	WOS:000338701300022
J	Nourian, Z; Li, M; Leo, MD; Jaggar, JH; Braun, AP; Hill, MA				Nourian, Zahra; Li, Min; Leo, M. Dennis; Jaggar, Jonathan H.; Braun, Andrew P.; Hill, Michael A.			Large Conductance Ca2+-Activated K+ Channel (BKCa) alpha-Subunit Splice Variants in Resistance Arteries from Rat Cerebral and Skeletal Muscle Vasculature	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; SURFACE EXPRESSION; SMOOTH-MUSCLE; MEMBRANE TRAFFICKING; CALCIUM; VOLTAGE; SENSITIVITY; MODULATION; CLONING; BRAIN	Previous studies report functional differences in large conductance Ca2+ activated-K+ channels (BKCa) of smooth muscle cells (VSMC) from rat cerebral and cremaster muscle resistance arteries. The present studies aimed to determine if this complexity in BKCa activity may, in part, be due to splice variants in the pore-forming alpha-subunit. BKCa variants in the intracellular C terminus of the alpha-subunit, and their relative expression to total alpha-subunit, were examined by qPCR. Sequencing of RT-PCR products showed two alpha-subunit variants, ZERO and STREX, to be identical in cremaster and cerebral arteries. Levels of STREX mRNA expression were, however, significantly higher in cremaster VSMCs (28.9 +/- 4.2% of total alpha-BKCa) compared with cerebral vessels (16.5 +/- 0.9%). Further, a low level of BKCa SS4 alpha-subunit variant was seen in cerebral arteries, while undetectable in cremaster arteries. Protein biotinylation assays, in expression systems and arterial preparations, were used to determine whether differences in splice variant mRNA expression affect surface membrane/cytosolic location of the channel. In AD-293 and CHO-K1 cells, rat STREX was more likely to be located at the plasma membrane compared to ZERO, although the great majority of channel protein was in the membrane in both cases. Co-expression of beta 1-BKCa subunit with STREX or ZERO did not influence the dominant membrane expression of alpha-BKCa subunits, whereas in the absence of alpha-BKCa, a significant proportion of beta 1-subunit remained cytosolic. Biotinylation assays of cremaster and cerebral arteries showed that differences in STREX/ZERO expression do not alter membrane/cytosolic distribution of the channel under basal conditions. These data, however, revealed that the amount of alpha-BKCa in cerebral arteries is approximately 20X higher than in cremaster vessels. Thus, the data support the major functional differences in BKCa activity in cremaster, as compared to cerebral VSMCs, being related to total alpha-BKCa expression, regardless of differences in splice variant expression.	[Nourian, Zahra; Li, Min; Hill, Michael A.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Hill, Michael A.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Leo, M. Dennis; Jaggar, Jonathan H.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Braun, Andrew P.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Tennessee System; University of Tennessee Health Science Center; University of Calgary	Hill, MA (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	hillmi@missouri.edu	Hill, Michael/AAV-5350-2020	Hill, Michael/0000-0002-4455-2072	National Institutes of Health [RO1 HL092241, P01 HL095486]; Natural Sciences and Engineering Research Council of Canada [RGPIN/312240]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092241, P01HL095486, R01HL110347, R01HL067061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Institutes of Health (RO1 HL092241: Michael A. Hill and P01 HL095486: Gerald Meininger, P.I.) and the Natural Sciences and Engineering Research Council of Canada (RGPIN/312240: Andrew P. Braun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister JP, 2009, CIRC RES, V105, P948, DOI 10.1161/CIRCRESAHA.109.203620; Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Chen L, 2010, J BIOL CHEM, V285, P23263, DOI 10.1074/jbc.M110.139758; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Chiu YH, 2010, MOL PHARMACOL, V77, P497, DOI 10.1124/mol.109.061929; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Clifford PS, 2011, ARTERIOSCL THROM VAS, V31, P2889, DOI 10.1161/ATVBAHA.111.236570; Crnich R, 2010, AM J PHYSIOL-CELL PH, V299, pC682, DOI 10.1152/ajpcell.00101.2010; Ha TS, 2000, EUR J BIOCHEM, V267, P910, DOI 10.1046/j.1432-1327.2000.01076.x; Hill MA, 2010, FEBS LETT, V584, P2033, DOI 10.1016/j.febslet.2010.02.045; Jackson WF, 1998, AM J PHYSIOL-HEART C, V274, pH27, DOI 10.1152/ajpheart.1998.274.1.H27; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Kim EY, 2007, NEUROSCIENCE, V146, P1652, DOI 10.1016/j.neuroscience.2007.03.038; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald SHF, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-37; Mahmoud SF, 2002, J NEUROSCI METH, V115, P189, DOI 10.1016/S0165-0270(02)00015-8; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MEININGER GA, 1991, AM J PHYSIOL, V261, pH950, DOI 10.1152/ajpheart.1991.261.3.H950; Poulsen AN, 2011, PFLUG ARCH EUR J PHY, V461, P65, DOI 10.1007/s00424-010-0887-0; Poulsen AN, 2009, BBA-BIOMEMBRANES, V1788, P380, DOI 10.1016/j.bbamem.2008.10.001; REINHART PH, 1991, J NEUROSCI, V11, P1627; Rosati B, 2004, CIRC RES, V94, P874, DOI 10.1161/01.RES.0000124921.81025.1F; Sandow SL, 2009, AM J PHYSIOL-HEART C, V297, pH1, DOI 10.1152/ajpheart.00042.2009; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Shipston MJ, 2013, BIOCHEM SOC T, V41, P67, DOI 10.1042/BST20120226; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Shipston MJ, 1999, MOL ENDOCRINOL, V13, P1728, DOI 10.1210/me.13.10.1728; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian LJ, 2001, J PHYSIOL-LONDON, V537, P57, DOI 10.1111/j.1469-7793.2001.0057k.x; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Wu RS, 2010, KIDNEY INT, V78, P963, DOI 10.1038/ki.2010.325; Wulf H, 2008, CELL TISSUE RES, V334, P359, DOI 10.1007/s00441-008-0701-x; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162; Yang Y, 2013, J PHYSIOL-LONDON, V591, P1277, DOI 10.1113/jphysiol.2012.241562; Yang Y, 2009, J PHYSIOL-LONDON, V587, P3025, DOI 10.1113/jphysiol.2009.169920; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zarei MM, 2001, J BIOL CHEM, V276, P16232, DOI 10.1074/jbc.M008852200	47	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98863	10.1371/journal.pone.0098863	http://dx.doi.org/10.1371/journal.pone.0098863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921651	Green Published, Green Submitted, gold			2022-12-25	WOS:000338701300019
J	Skobo, T; Benato, F; Grumati, P; Meneghetti, G; Cianfanelli, V; Castagnaro, S; Chrisam, M; Di Bartolomeo, S; Bonaldo, P; Cecconi, F; Dalla Valle, L				Skobo, Tatjana; Benato, Francesca; Grumati, Paolo; Meneghetti, Giacomo; Cianfanelli, Valentina; Castagnaro, Silvia; Chrisam, Martina; Di Bartolomeo, Sabrina; Bonaldo, Paolo; Cecconi, Francesco; Dalla Valle, Luisa			Zebrafish ambra1a and ambra1b Knockdown Impairs Skeletal Muscle Development	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; AUTOPHAGY; CELLS; MYOPATHIES; SLOW; MYOD	The essential role of autophagy in muscle homeostasis has been clearly demonstrated by phenotype analysis of mice with muscle-specific inactivation of genes encoding autophagy-related proteins. Ambra1 is a key component of the Beclin 1 complex and, in zebrafish, it is encoded by two paralogous genes, ambra1a and ambra1b, both required for normal embryogenesis and larval development. In this study we focused on the function of Ambra1, a positive regulator of the autophagic process, during skeletal muscle development by means of morpholino (MO)-mediated knockdown and compared the phenotype of zebrafish Ambra1-depleted embryos with that of Ambra1(gt/gt) mouse embryos. Morphological analysis of zebrafish morphant embryos revealed that silencing of ambra1 impairs locomotor activity and muscle development, as well as myoD1 expression. Skeletal muscles in ATG-morphant embryos displayed severe histopathological changes and contained only small areas of organized myofibrils that were widely dispersed throughout the cell. Double knockdown of ambra1a and ambra1b resulted in a more severe phenotype whereas defects were much less evident in splice-morphants. The morphants phenotypes were effectively rescued by co-injection with human AMBRA1 mRNA. Together, these results indicate that ambra1a and ambra1b are required for the correct development and morphogenesis of skeletal muscle.	[Skobo, Tatjana; Benato, Francesca; Meneghetti, Giacomo; Dalla Valle, Luisa] Univ Padua, Dept Biol, Padua, Italy; [Grumati, Paolo; Castagnaro, Silvia; Chrisam, Martina; Bonaldo, Paolo] Univ Padua, Dept Mol Med, Padua, Italy; [Cianfanelli, Valentina; Di Bartolomeo, Sabrina; Cecconi, Francesco] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Cecconi, Francesco] Santa Lucia Fdn, IRCCS, Dept Neurosci, Rome, Italy; [Cecconi, Francesco] Danish Canc Soc, Res Ctr, Unit Cell Stress & Survival, Copenhagen, Denmark	University of Padua; University of Padua; University of Rome Tor Vergata; IRCCS Santa Lucia; Danish Cancer Society	Cecconi, F (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	francesco.cecconi@uniroma2.it; luisa.dallavalle@unipd.it	Grumati, Paolo/AAA-5787-2019; Di+Bartolomeo, Sabrina/AAB-9791-2019; Cecconi, Francesco/K-3969-2016; Cianfanelli, Valentina/AAA-2682-2020; Dalla Valle, Luisa/G-6721-2011	Cecconi, Francesco/0000-0002-5614-4359; Cianfanelli, Valentina/0000-0002-3857-9463; Dalla Valle, Luisa/0000-0001-8097-6369; DI BARTOLOMEO, Sabrina/0000-0002-5748-1541; Castagnaro, Silvia/0000-0003-4753-0597; Chrisam, Martina/0000-0002-5328-1737; Bonaldo, Paolo/0000-0002-9571-8140; Skobo, Tatjana/0000-0002-4868-5606	Telethon-Italy [GGP10225]; University of Padova; AIRC; FISM; Italian Ministry of University and Research; Italian Ministry of Health (Ricerca Finalizzata and Ricerca Corrente); Lundbeck Foundation [R165-2013-15982] Funding Source: researchfish	Telethon-Italy(Fondazione Telethon); University of Padova; AIRC(Fondazione AIRC per la ricerca sul cancro); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health (Ricerca Finalizzata and Ricerca Corrente); Lundbeck Foundation(Lundbeckfonden)	This work was financially supported by Telethon-Italy (Grant GGP10225) and by University of Padova (RFO-ex 60%). FC is also supported by AIRC (IG2010), FISM (2009), the Italian Ministry of University and Research (PRIN 2009 and FIRB Accordi di Programma 2011), the Italian Ministry of Health (Ricerca Finalizzata and Ricerca Corrente). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benato F, 2013, AUTOPHAGY, V9, P476, DOI 10.4161/auto.23278; Berger J, 2010, NEUROMUSCULAR DISORD, V20, P826, DOI 10.1016/j.nmd.2010.08.004; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Carmignac V, 2011, HUM MOL GENET, V20, P4891, DOI 10.1093/hmg/ddr427; Choi JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003875; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Dolez M, 2011, DEVELOPMENT, V138, P97, DOI 10.1242/dev.053975; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Ellis K, 2013, J CELL BIOL, V200, P667, DOI 10.1083/jcb.201212095; Fimia GM, 2013, ONCOGENE, V32, P3311, DOI 10.1038/onc.2012.455; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Gibbs EM, 2013, FEBS J, V280, P4187, DOI 10.1111/febs.12412; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Jackson HE, 2013, MECH DEVELOP, V130, P447, DOI 10.1016/j.mod.2013.06.001; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nord H, 2013, J CELL SCI, V126, P1868, DOI 10.1242/jcs.119917; Ochi H, 2007, DEV GROWTH DIFFER, V49, P1, DOI 10.1111/j.1440-169x.2007.00905.x; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041; Seger C, 2011, DEV DYNAM, V240, P2440, DOI 10.1002/dvdy.22745; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vainshtein A, 2014, J MOL MED, V92, P127, DOI 10.1007/s00109-013-1096-z; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5	35	30	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99210	10.1371/journal.pone.0099210	http://dx.doi.org/10.1371/journal.pone.0099210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922546	Green Published, gold, Green Submitted			2022-12-25	WOS:000338701300045
J	Chen, R; Shi, YH; Amiduo, R; Tuokan, T; Suzuk, L				Chen, Rui; Shi, Yonghua; Amiduo, Reshalaity; Tuokan, Talaf; Suzuk, Lalai			Expression and Prognostic Value of Aquaporin 1, 3 in Cervical Carcinoma in Women of Uygur Ethnicity from Xinjiang, China	PLOS ONE			English	Article							CELL-MIGRATION; ANGIOGENESIS	Background: Overexpression of several aquaporins has been reported in different types of human cancer but the role of aquaporins in carcinogenesis has not yet been clearly defined. There is few report concerning role of aquaporins in human cervical carcinogenesis so far. Here, we determined the expression and prognostic value of aquaporin 1, 3 in cervical carcinoma in Chinese women of Uygur ethnicity. Methods and Results: Real-time PCR analyses demonstrated aquaporin 1, 3 mRNA were differentially expressed in cervical carcinoma, CIN 2-3 and mild cervicitis. Immunofluorescent and immunohistochemical analyses demonstrated aquaporin 1 was predominantly localized to stromal endothelial cells in cervical lesions. Aquaporin 3 was localized to the membrane of normal squamous epithelium, CIN and carcinoma cells. Aquaporin 1 and 3 were upregulated in cervical cancer compared to mild cervicitis and CIN2-3 (P<0.05); Tumor expression of aquaporin 1, 3 significantly increased in advanced stage disease, and patients with deeper tumor infiltration, lymph node metastases or larger tumor volume (P<0.05). Multivariate analysis demonstrated that aquaporin 1, 3 were not independent prognostic factors in cervical carcinoma. Conclusion: Aquaporins may participate in the initiation and progression of cervical carcinoma by promoting tumor growth, invasion or lymph node metastasis. Further study is required to determine whether aquaporins have potential as prognostic factors in cervical cancer.	[Chen, Rui] Xinjiang Med Univ, Affiliated Hosp 3, Dept Gynecol, Urumqi, Xinjiang, Peoples R China; [Shi, Yonghua; Amiduo, Reshalaity; Tuokan, Talaf; Suzuk, Lalai] Xinjiang Med Univ, Basic Med Coll, Dept Pathol, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Shi, YH (corresponding author), Xinjiang Med Univ, Basic Med Coll, Dept Pathol, Urumqi, Xinjiang, Peoples R China.	z5826711@126.com			National Natural Science Foundation of China [81060216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (Grant Number: 81060216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056735; Freeman SJ, 2012, RADIOGRAPHICS, V32, P1805, DOI 10.1148/rg.326125519; Hayashi Y, 2007, NEOPLASIA, V9, P777, DOI 10.1593/neo.07454; Hwang Insang, 2012, Chonnam Med J, V48, P174, DOI 10.4068/cmj.2012.48.3.174; Ishimoto S, 2012, INT J ONCOL, V41, P67, DOI [10.3892/ijo.2012.1445, 10.3892/ijo.2011.1445]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ji C, 2008, CANCER CHEMOTH PHARM, V62, P857, DOI 10.1007/s00280-007-0674-6; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kao SCH, 2012, CANCER-AM CANCER SOC, V118, P2952, DOI 10.1002/cncr.26497; Kusayama M, 2011, CANCER SCI, V102, P1128, DOI 10.1111/j.1349-7006.2011.01927.x; Loreto C, 2010, CURR NEUROPHARMACOL, V8, P105, DOI 10.2174/157015910791233196; Otterbach F, 2010, BREAST CANCER RES TR, V120, P67, DOI 10.1007/s10549-009-0370-9; Pan H, 2008, INT J GYNECOL OBSTET, V101, P239, DOI 10.1016/j.ijgo.2007.12.006; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Peng YH, 2003, ZHONGHUA FU CHAN KE, V38, P764; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Shen LZ, 2010, BIOMED PHARMACOTHER, V64, P313, DOI 10.1016/j.biopha.2009.12.003; Shi YH, 2012, J PRACTICAL ONCOLOGY, V27, P18; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yang JH, 2011, HISTOL HISTOPATHOL, V26, P1197, DOI 10.14670/HH-26.1197	22	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98576	10.1371/journal.pone.0098576	http://dx.doi.org/10.1371/journal.pone.0098576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918928	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000020
J	Chou, JP; Ramirez, CM; Ryba, DM; Koduri, MP; Effros, RB				Chou, Jennifer P.; Ramirez, Christina M.; Ryba, Danielle M.; Koduri, Megha P.; Effros, Rita B.			Prostaglandin E-2 Promotes Features of Replicative Senescence in Chronically Activated Human CD8+T Cells	PLOS ONE			English	Article							IN-VITRO SENESCENCE; T-CELL; HIV-1 INFECTION; EXPRESSION; PROLIFERATION; LYMPHOCYTES; RECEPTOR; DIFFERENTIATION; NONPROGRESSORS; COSTIMULATION	Prostaglandin E-2 (PGE(2)), a pleiotropic immunomodulatory molecule, and its free radical catalyzed isoform, iso-PGE(2), are frequently elevated in the context of cancer and chronic infection. Previous studies have documented the effects of PGE(2) on the various CD4+ T cell functions, but little is known about its impact on cytotoxic CD8+ T lymphocytes, the immune cells responsible for eliminating virally infected and tumor cells. Here we provide the first demonstration of the dramatic effects of PGE(2) on the progression of human CD8+ T cells toward replicative senescence, a terminal dysfunctional state associated multiple pathologies during aging and chronic HIV-1 infection. Our data show that exposure of chronically activated CD8+ T cells to physiological levels of PGE2 and iso-PGE(2) promotes accelerated acquisition of markers of senescence, including loss of CD28 expression, increased expression of p16 cell cycle inhibitor, reduced telomerase activity, telomere shortening and diminished production of key cytotoxic and survival cytokines. Moreover, the CD8+ T cells also produced higher levels of reactive oxygen species, suggesting that the resultant oxidative stress may have further enhanced telomere loss. Interestingly, we observed that even chronic activation per se resulted in increased CD8+ T cell production of PGE(2), mediated by higher COX-2 activity, thus inducing a negative feedback loop that further inhibits effector function. Collectively, our data suggest that the elevated levels of PGE(2) and iso-PGE(2), seen in various cancers and HIV-1 infection, may accelerate progression of CD8+ T cells towards replicative senescence in vivo. Inhibition of COX-2 activity may, therefore, provide a strategy to counteract this effect.	[Chou, Jennifer P.; Ryba, Danielle M.; Koduri, Megha P.; Effros, Rita B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Effros, Rita B.] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; [Ramirez, Christina M.] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Effros, RB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	reffros@mednet.ucla.edu	Ramirez, Christina/AAT-5088-2021	Ramirez, Christina/0000-0002-8435-0416	 [R01AG032422 (Effros)];  [U01 AI35040 (Detels)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI035043] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	R01AG032422 (Effros), U01 AI35040 (Detels). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMAN GP, 1994, CELL IMMUNOL, V158, P182, DOI 10.1006/cimm.1994.1266; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bluestone JA, 1997, J IMMUNOL, V158, P1989; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Brose SA, 2011, J LIPID RES, V52, P850, DOI 10.1194/jlr.D013441; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chou JP, 2013, CURR PHARM DESIGN, V19, P1680; DOSREIS GA, 1986, CELL IMMUNOL, V101, P213, DOI 10.1016/0008-8749(86)90199-1; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Effros RB, 2003, EXP GERONTOL, V38, P1243, DOI 10.1016/j.exger.2003.09.004; Fabricius D, 2010, J IMMUNOL, V184, P677, DOI 10.4049/jimmunol.0902028; Fitzgerald DW, 2012, CANCER PREV RES, V5, P34, DOI 10.1158/1940-6207.CAPR-11-0496; HAMMARSTROM S, 1983, ANNU REV BIOCHEM, V52, P355, DOI 10.1146/annurev.bi.52.070183.002035; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Jin X, 1998, EUR J IMMUNOL, V28, P3564, DOI 10.1002/(SICI)1521-4141(199811)28:11<3564::AID-IMMU3564>3.3.CO;2-A; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Kong Y, 2011, J AGING RES, V2011, DOI [10.4061/2011/963172, DOI 10.4061/2011/963172]; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lv GC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-207; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Parish ST, 2010, J CLIN IMMUNOL, V30, P798, DOI 10.1007/s10875-010-9449-7; PERILLO NL, 1993, MECH AGEING DEV, V67, P173, DOI 10.1016/0047-6374(93)90121-7; Pettersen FO, 2011, J VIROL, V85, P6557, DOI 10.1128/JVI.00073-11; Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x; Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027; Rodriguez G, 2013, J BIOL CHEM, V288, P7137, DOI 10.1074/jbc.M112.408765; Saldanha SN, 2003, ANAL BIOCHEM, V315, P1, DOI 10.1016/S0003-2697(02)00663-2; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; Sarr D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-45; Sreeramkumar V, 2012, IMMUNOL CELL BIOL, V90, P579, DOI 10.1038/icb.2011.75; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Tosato M, 2007, CLIN INTERV AGING, V2, P401; Valenzuela HF, 2002, CLIN IMMUNOL, V105, P117, DOI 10.1006/clim.2002.5271; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	36	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99432	10.1371/journal.pone.0099432	http://dx.doi.org/10.1371/journal.pone.0099432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918932	gold, Green Submitted, Green Published			2022-12-25	WOS:000338631000086
J	Dattilo, W; Fagundes, R; Gurka, CAQ; Silva, MSA; Vieira, MCL; Izzo, TJ; Diaz-Castelazo, C; Del-Claro, K; Rico-Gray, V				Dattilo, Wesley; Fagundes, Roberth; Gurka, Carlos A. Q.; Silva, Mara S. A.; Vieira, Marisa C. L.; Izzo, Thiago J.; Diaz-Castelazo, Cecilia; Del-Claro, Kleber; Rico-Gray, Victor			Individual-Based Ant-Plant Networks: Diurnal-Nocturnal Structure and Species-Area Relationship	PLOS ONE			English	Article							EXTRAFLORAL NECTAR SECRETION; ANIMAL MUTUALISTIC NETWORKS; ITACOLOMI STATE-PARK; TROPICAL RAIN-FOREST; ECOLOGICAL NETWORKS; TEMPORAL VARIATION; FORBIDDEN LINKS; PROTECTION; HERBIVORY; NESTEDNESS	Despite the importance and increasing knowledge of ecological networks, sampling effort and intrapopulation variation has been widely overlooked. Using continuous daily sampling of ants visiting three plant species in the Brazilian Neotropical savanna, we evaluated for the first time the topological structure over 24 h and species-area relationships (based on the number of extrafloral nectaries available) in individual-based ant-plant networks. We observed that diurnal and nocturnal ant-plant networks exhibited the same pattern of interactions: a nested and non-modular pattern and an average level of network specialization. Despite the high similarity in the ants' composition between the two collection periods, ant species found in the central core of highly interacting species totally changed between diurnal and nocturnal sampling for all plant species. In other words, this "night-turnover'' suggests that the ecological dynamics of these ant-plant interactions can be temporally partitioned (day and night) at a small spatial scale. Thus, it is possible that in some cases processes shaping mutualistic networks formed by protective ants and plants may be underestimated by diurnal sampling alone. Moreover, we did not observe any effect of the number of extrafloral nectaries on ant richness and their foraging on such plants in any of the studied ant-plant networks. We hypothesize that competitively superior ants could monopolize individual plants and allow the coexistence of only a few other ant species, however, other alternative hypotheses are also discussed. Thus, sampling period and species-area relationship produces basic information that increases our confidence in how individual-based ant-plant networks are structured, and the need to consider nocturnal records in ant-plant network sampling design so as to decrease inappropriate inferences.	[Dattilo, Wesley; Rico-Gray, Victor] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico; [Fagundes, Roberth; Del-Claro, Kleber] Univ Fed Uberlandia, Inst Biol, Lab Ecol Comportamental & Interacoes, BR-38400 Uberlandia, MG, Brazil; [Fagundes, Roberth] Univ Fed Ouro Preto, Ouro Preto, Brazil; [Gurka, Carlos A. Q.; Silva, Mara S. A.; Vieira, Marisa C. L.; Izzo, Thiago J.] Univ Fed Mato Grosso, Cuiaba, Brazil; [Diaz-Castelazo, Cecilia] Inst Ecol AC, Red Interacc Multitrof, Xalapa, Veracruz, Mexico	Universidad Veracruzana; Universidade Federal de Uberlandia; Universidade Federal de Ouro Preto; Universidade Federal de Mato Grosso; Instituto de Ecologia - Mexico	Dattilo, W (corresponding author), Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico.	wdattilo@hotmail.com	Del-Claro, K/C-5570-2013; Del-Claro, Kleber/N-3700-2019; , WD/A-6371-2012; Díaz Castelazo, Cecilia/Q-8973-2018; Izzo, Thiago/K-7405-2012	Del-Claro, K/0000-0001-8886-9568; , WD/0000-0002-4758-4379; Díaz Castelazo, Cecilia/0000-0002-0185-6607; Izzo, Thiago/0000-0002-4613-3787	CNPq [237339/2012-9]; CONACYT [489746]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Servio P. Ribeiro has provided useful information on species-area relationships. The authors also wish to thank Lucas Kaminski and DeniseLange for support in the identification of Qualea grandiflora and to Gustavo Araujo for his help in the fieldwork. WD was supported by the CNPq (no. 237339/2012-9) and CONACYT (no. 489746). MCLV was supported by CNPq. RF, CAQG and MSAS were supported by CAPES. KDC has a researcher fellowship from CNPq.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Alves-Silva E, 2013, NATURWISSENSCHAFTEN, V100, P525, DOI 10.1007/s00114-013-1048-z; [Anonymous], [No title captured]; Araujo MS, 2010, OIKOS, V119, P81, DOI 10.1111/j.1600-0706.2009.17624.x; Baker-Meio B, 2012, J ECOL, V100, P242, DOI 10.1111/j.1365-2745.2011.01892.x; Baldock KCR, 2011, ECOLOGY, V92, P687, DOI 10.1890/10-1110.1; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; Bluthgen N, 2004, J ANIM ECOL, V73, P155, DOI 10.1111/j.1365-2656.2004.00789.x; Bluthgen N, 2000, OECOLOGIA, V125, P229, DOI 10.1007/s004420000449; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Byk J, 2010, ACTA ETHOL, V13, P33, DOI 10.1007/s10211-010-0071-8; Campos RI, 2006, ECOGRAPHY, V29, P442, DOI 10.1111/j.2006.0906-7590.04520.x; Cantor M, 2013, OIKOS, V122, P1085, DOI 10.1111/j.1600-0706.2012.00070.x; Chamberlain SA, 2009, FUNCT ECOL, V23, P196, DOI 10.1111/j.1365-2435.2008.01472.x; Chamberlain SA, 2010, OECOLOGIA, V164, P741, DOI 10.1007/s00442-010-1673-6; COSTA FMCB, 1992, ECOL ENTOMOL, V17, P363, DOI 10.1111/j.1365-2311.1992.tb01071.x; Marquitti FMD, 2014, ECOGRAPHY, V37, P221, DOI 10.1111/j.1600-0587.2013.00506.x; Dattilo W, 2014, AM J PRIMATOL, V76, P670, DOI 10.1002/ajp.22261; Dattilo W, 2014, ECOLOGY, V95, P475, DOI 10.1890/12-1647.1; Dattilo W, 2014, J TROP ECOL, V30, P165, DOI 10.1017/S0266467413000813; Dattilo W, 2013, OIKOS, V122, P1643, DOI 10.1111/j.1600-0706.2013.00562.x; Dattilo Wesley, 2012, Network Biology, V2, P127; Dattilo W, 2013, ECOL ENTOMOL, V38, P374, DOI 10.1111/een.12029; Dattilo W, 2013, ARTHROPOD-PLANT INTE, V7, P455, DOI 10.1007/s11829-013-9256-1; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; de la Fuente MAS, 1999, OECOLOGIA, V118, P192, DOI 10.1007/s004420050718; Del-Claro K, 1999, BIOTROPICA, V31, P135, DOI 10.2307/2663967; Devoto M, 2011, ECOL ENTOMOL, V36, P25, DOI 10.1111/j.1365-2311.2010.01247.x; Diaz-Castelazo C, 2004, ECOSCIENCE, V11, P472, DOI 10.1080/11956860.2004.11682857; Diaz-Castelazo C, 2013, ANN BOT-LONDON, V111, P1285, DOI 10.1093/aob/mct071; Djieto-Lordon C, 2004, ACTA OECOL, V26, P109, DOI 10.1016/j.actao.2004.03.007; Dutra VF, 2008, ACTA BOT BRAS, V22, P547, DOI 10.1590/S0102-33062008000200021; Falcao JCF, 2014, J PLANT INTERACT, V9, P137, DOI 10.1080/17429145.2013.782513; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; Gomez JM, 2012, P ROY SOC B-BIOL SCI, V279, P1754, DOI 10.1098/rspb.2011.2244; Fujaco MAG, 2010, REM-REV ESC MINAS, V63, P695, DOI 10.1590/S0370-44672010000400016; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hagen M, 2012, ADV ECOL RES, V46, P89, DOI 10.1016/B978-0-12-396992-7.00002-2; Heil M, 2000, FUNCT ECOL, V14, P749, DOI 10.1046/j.1365-2435.2000.00480.x; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Holldobler B., 1990, pi; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Koptur S, 1998, AM J BOT, V85, P736, DOI 10.2307/2446544; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; Livingston GF, 2010, ECOL RES, V25, P1129, DOI 10.1007/s11284-010-0738-7; MAC ARTHUR ROBERT H., 1967; Milliken W, 1998, BIOTROPICA, V30, P530, DOI 10.1111/j.1744-7429.1998.tb00093.x; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Oliveira PS, 1999, FUNCT ECOL, V13, P623, DOI 10.1046/j.1365-2435.1999.00360.x; OLIVEIRA PS, 1991, ANT - PLANT INTERACTIONS, P198; Powell S, 2011, J ANIM ECOL, V80, P352, DOI 10.1111/j.1365-2656.2010.01779.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; Rico-Gray Victor, 2006, Acta Zool. Mex, V22, P23; Rios RS, 2008, OECOLOGIA, V156, P577, DOI 10.1007/s00442-008-1024-z; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Santos GMM, 2014, ECOL ENTOMO IN PRESS; Schoereder Jose H., 2010, Terrestrial Arthropod Reviews, V3, P3, DOI 10.1163/187498310X487785; SCHUPP EW, 1991, ANT - PLANT INTERACTIONS, P175; SILVESTRE R., 2001, REV BRAS ENTOMOL, V44, P71; Strauss SY, 2009, ECOLOGY, V90, P419, DOI 10.1890/07-1533.1; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, OIKOS, V108, P421, DOI 10.1111/j.0030-1299.2005.13619.x; Villamil N, 2013, ANN BOT-LONDON, V112, P701, DOI 10.1093/aob/mct005; Zardo DC, 2010, REV UNIARA, V13, P105, DOI DOI 10.25061/2527-2675/REBRAM/2010.V13I2.143.	78	50	53	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99838	10.1371/journal.pone.0099838	http://dx.doi.org/10.1371/journal.pone.0099838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918750	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000121
J	Maurer, F; Arcos, MAN; Bauer, P				Maurer, Felix; Arcos, Maria Augusta Naranjo; Bauer, Petra			Responses of a Triple Mutant Defective in Three Iron Deficiency-Induced BASIC HELIX-LOOP-HELIX Genes of the Subgroup Ib(2) to Iron Deficiency and Salicylic Acid	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; FERRIC-CHELATE REDUCTASE; ARABIDOPSIS-THALIANA; METAL HOMEOSTASIS; CIRCADIAN CLOCK; GENOME-WIDE; FACTOR FIT; PROTEIN; EXPRESSION; NICOTIANAMINE	Plants are sessile organisms that adapt to external stress by inducing molecular and physiological responses that serve to better cope with the adverse growth condition. Upon low supply of the micronutrient iron, plants actively increase the acquisition of soil iron into the root and its mobilization from internal stores. The subgroup Ib(2) BHLH genes function as regulators in this response, however their concrete functions are not fully understood. Here, we analyzed a triple loss of function mutant of BHLH39, BHLH100 and BHLH101 (3xbhlh mutant). We found that this mutant did not have any iron uptake phenotype if iron was provided. However, under iron deficiency the mutant displayed a more severe leaf chlorosis than the wild type. Microarray-based transcriptome analysis revealed that this mutant phenotype resulted in the mis-regulation of 198 genes, out of which only 15% were associated with iron deficiency regulation itself. A detailed analysis revealed potential targets of the bHLH transcription factors as well as genes reflecting an exaggerated iron deficiency response phenotype. Since the BHLH genes of this subgroup have been brought into the context of the plant hormone salicylic acid, we investigated whether the 3xbhlh mutant might have been affected by this plant signaling molecule. Although a very high number of genes responded to SA, also in a differential manner between mutant and wild type, we did not find any indication for an association of the BHLH gene functions in SA responses upon iron deficiency. In summary, our study indicates that the bHLH subgroup Ib(2) transcription factors do not only act in iron acquisition into roots but in other aspects of the adaptation to iron deficiency in roots and leaves.	[Maurer, Felix; Arcos, Maria Augusta Naranjo; Bauer, Petra] Univ Saarland, Dept Biosci Plant Biol, D-66123 Saarbrucken, Germany; [Arcos, Maria Augusta Naranjo; Bauer, Petra] Univ Dusseldorf, Inst Bot, Dusseldorf, Germany; [Arcos, Maria Augusta Naranjo; Bauer, Petra] Univ Dusseldorf, Cluster Excellence Plant Sci CEPLAS, Dusseldorf, Germany	Saarland University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Cologne	Bauer, P (corresponding author), Univ Saarland, Dept Biosci Plant Biol, D-66123 Saarbrucken, Germany.	petra.bauer@hhu.de			University of Saarland; Heinrich Heine University Dusseldorf; Deutsche Forschungsgemeinschaft [DFG-Ba1610/5-1]	University of Saarland; Heinrich Heine University Dusseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been partly funded by the University of Saarland and the Heinrich Heine University Dusseldorf. Funding by the Deutsche Forschungsgemeinschaft grant No. DFG-Ba1610/5-1to PB is was provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer P, 2007, PLANT PHYSIOL BIOCH, V45, P260, DOI 10.1016/j.plaphy.2007.03.006; Bauer P, 2011, PLANT SIGNAL BEHAV, V6, P1669, DOI 10.4161/psb.6.11.17847; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Buckhout TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-147; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Chen YY, 2013, PLANT PHYSIOL, V161, P1409, DOI 10.1104/pp.112.212068; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; de Benoist B, 2008, WHO GLOBAL DATABASE; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-1110-1148, DOI 10.1186/1471-2105-1110-1148]; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Garcia M, 2010, CINEASTE, V35, P61; Garcia MJ, 2011, PLANT PHYSIOL BIOCH, V49, P537, DOI 10.1016/j.plaphy.2011.01.019; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Hong S, 2013, PLANT PHYSIOL, V161, P893, DOI 10.1104/pp.112.208603; Ivanov R, 2012, MOL PLANT, V5, P27, DOI 10.1093/mp/ssr065; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; Kang HG, 2003, PLANT J, V35, P362, DOI 10.1046/j.1365-313X.2003.01812.x; Klatte M, 2009, PLANT PHYSIOL, V150, P257, DOI 10.1104/pp.109.136374; Klatte Marco, 2009, V479, P61, DOI 10.1007/978-1-59745-289-2_4; Koen E, 2013, PLANT SCI, V209, P1, DOI 10.1016/j.plantsci.2013.04.006; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Lingam S, 2011, PLANT CELL, V23, P1815, DOI 10.1105/tpc.111.084715; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Maurer F, 2011, PLANT PHYSIOL BIOCH, V49, P530, DOI 10.1016/j.plaphy.2011.01.025; Meiser J, 2011, PLANT PHYSIOL, V157, P2154, DOI 10.1104/pp.111.183285; Mukherjee I, 2006, PLANTA, V223, P1178, DOI 10.1007/s00425-005-0165-0; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Palmer CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003953; Peiffer GA, 2012, PLANT PHYSIOL, V158, P1745, DOI 10.1104/pp.111.189860; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Salome PA, 2013, EMBO J, V32, P511, DOI 10.1038/emboj.2012.330; Schuler M, 2012, PLANT CELL, V24, P2380, DOI 10.1105/tpc.112.099077; Schuler M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-87; Sivitz A, 2011, PLANT J, V66, P1044, DOI 10.1111/j.1365-313X.2011.04565.x; Sivitz AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044843; Stacey MG, 2008, PLANT PHYSIOL, V146, P589, DOI 10.1104/pp.107.108183; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Wang HY, 2007, PLANTA, V226, P773, DOI 10.1007/s00425-007-0524-0; Wang N, 2013, MOL PLANT, V6, P503, DOI 10.1093/mp/sss089; Yang TJW, 2010, PLANT PHYSIOL, V152, P2130, DOI 10.1104/pp.109.152728; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26; Yuan YX, 2005, CELL RES, V15, P613, DOI 10.1038/sj.cr.7290331; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	51	31	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99234	10.1371/journal.pone.0099234	http://dx.doi.org/10.1371/journal.pone.0099234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919188	gold, Green Published, Green Submitted			2022-12-25	WOS:000338631000064
J	Nedergaard, MK; Kristoffersen, K; Michaelsen, SR; Madsen, J; Poulsen, HS; Stockhausen, MT; Lassen, U; Kjaer, A				Nedergaard, Mette K.; Kristoffersen, Karina; Michaelsen, Signe R.; Madsen, Jacob; Poulsen, Hans S.; Stockhausen, Marie-Therese; Lassen, Ulrik; Kjaer, Andreas			The Use of Longitudinal F-18-FET MicroPET Imaging to Evaluate Response to Irinotecan in Orthotopic Human Glioblastoma Multiforme Xenografts	PLOS ONE			English	Article							AMINO-ACID TRANSPORTERS; O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET; UPTAKE KINETICS; BRAIN-TUMORS; IN-VITRO; GLIOMA; GRADE; BEVACIZUMAB; MANAGEMENT; MODEL	Objectives: Brain tumor imaging is challenging. Although F-18-FET PET is widely used in the clinic, the value of 18F-FET MicroPET to evaluate brain tumors in xenograft has not been assessed to date. The aim of this study therefore was to evaluate the performance of in vivo F-18-FET MicroPET in detecting a treatment response in xenografts. In addition, the correlations between the F-18-FET tumor accumulation and the gene expression of Ki67 and the amino acid transporters LAT1 and LAT2 were investigated. Furthermore, Ki67, LAT1 and LAT2 gene expression in xenograft and archival patient tumors was compared. Methods: Human GBM cells were injected orthotopically in nude mice and F-18-FET uptake was followed by weekly MicroPET/CT. When tumor take was observed, mice were treated with CPT-11 or saline weekly. After two weeks of treatment the brain tumors were isolated and quantitative polymerase chain reaction were performed on the xenograft tumors and in parallel on archival patient tumor specimens. Results:The relative tumor-to-brain (T/B) ratio of SUV, was significantly lower after one week (123 +/- 6%, n = 7 vs. 147 +/- 6%, n = 7; p = 0.018) and after two weeks (142 +/- 8%, n = 5 vs. 204 +/- 27%, n = 4; p = 0.047) in the CPT-11 group compared with the control group. Strong negative correlations between SUVmax T/B ratio and LAT1 (r = 0.62, p = 0.04) and LAT2 (r = 0.67, p = 0.02) were observed. In addition, a strong positive correlation between LAT1 and Ki67 was detected in xenografts. Furthermore, a 1.6 fold higher expression of LAT1 and a 23 fold higher expression of LAT2 were observed in patient specimens compared to xenografts. Conclusions: F-18-FET MicroPET can be used to detect a treatment response to CPT-11 in GBM xenografts. The strong negative correlation between SUVmax T/B ratio and LAT1/LAT2 indicates an export transport function. We suggest that (FFET)-F-18 PET may be used for detection of early treatment response in patients.	[Nedergaard, Mette K.; Madsen, Jacob; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Nedergaard, Mette K.; Madsen, Jacob; Kjaer, Andreas] Rigshosp, Cluster Mol Imaging, DK-2100 Copenhagen, Denmark; [Nedergaard, Mette K.; Madsen, Jacob; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Kristoffersen, Karina; Michaelsen, Signe R.; Poulsen, Hans S.; Stockhausen, Marie-Therese] Rigshosp, Finsen Ctr, Dept Radiat Biol, DK-2100 Copenhagen, Denmark; [Lassen, Ulrik] Rigshosp, Finsen Ctr, Dept Oncol, Phase Unit 1, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nedergaard, MK (corresponding author), Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark.	Mette.kjoelhede.nedergaard@regionh.dk	Michaelsen, Signe/ABB-1451-2020; Lassen, Ulrik/AAH-2799-2021; Kjaer, Andreas/E-8932-2015	Michaelsen, Signe/0000-0001-9047-6384; Lassen, Ulrik/0000-0002-3865-4574; Kjaer, Andreas/0000-0002-2706-5547	Danish Cancer Society; Danish National Advanced Technology Foundation; AP Moller Foundation; Lundbeck Foundation; Novo Nordisk Foundation; Svend Andersen Foundation; John and Birthe Meyer Foundation; Novo Nordisk Fonden [NNF13OC0007149] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Danish National Advanced Technology Foundation; AP Moller Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Svend Andersen Foundation; John and Birthe Meyer Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding from The Danish Cancer Society; Danish National Advanced Technology Foundation, AP Moller Foundation, The Lundbeck Foundation, Novo Nordisk Foundation, Svend Andersen Foundation, The John and Birthe Meyer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; El Ali HH, 2012, DIAGNOSTICS, V2, P42, DOI 10.3390/diagnostics2040042; Fletcher JW, 2008, J NUCL MED, V49, P480, DOI 10.2967/jnumed.107.047787; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Galldiks N, 2012, CASE REP ONCOL, V5, P490, DOI 10.1159/000342480; Galldiks N, 2013, EUR J NUCL MED MOL I, V40, P22, DOI 10.1007/s00259-012-2251-4; Galldiks N, 2012, J NUCL MED, V53, P1048, DOI 10.2967/jnumed.111.098590; Gulyas B, 2012, Q J NUCL MED MOL IM, V56, P173; Haining Z, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-4; Heinzel A, 2013, J NUCL MED, V54, P1217, DOI 10.2967/jnumed.113.120089; Heiss P, 1999, J NUCL MED, V40, P1367; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hutterer M, 2011, J NUCL MED, V52, P856, DOI 10.2967/jnumed.110.086645; Jeong SY, 2012, NUCL MED BIOL, V39, P977, DOI 10.1016/j.nucmedbio.2012.02.009; Kim DK, 2004, NEUROSCI RES, V50, P437, DOI 10.1016/j.neures.2004.08.003; Kristoffersen K, 2013, CANCER BIOL THER, V14, P625, DOI 10.4161/cbt.24595; Kuroda J, 2010, CLIN CANCER RES, V16, P521, DOI 10.1158/1078-0432.CCR-09-2393; Lahoutte T, 2004, J NUCL MED, V45, P1591; Langen KJ, 2006, NUCL MED BIOL, V33, P287, DOI 10.1016/j.nucmedbio.2006.01.002; Langen KJ, 2003, NUCL MED BIOL, V30, P501, DOI 10.1016/S0969-8051(03)00023-4; Menichetti L, 2011, APPL RADIAT ISOTOPES, V69, P1717, DOI 10.1016/j.apradiso.2011.02.037; Nihashi T, 2013, AM J ROENTGENOL, V200, pW654, DOI 10.2214/AJR.12.9168; OLIVERO WC, 1995, J NEUROL NEUROSUR PS, V58, P250, DOI 10.1136/jnnp.58.2.250; Popperl G, 2007, EUR J NUCL MED MOL I, V34, P1933, DOI 10.1007/s00259-007-0534-y; Pope WB, 2011, CURR NEUROL NEUROSCI, V11, P336, DOI 10.1007/s11910-011-0179-x; Popperl G, 2004, EUR J NUCL MED MOL I, V31, P1464, DOI 10.1007/s00259-004-1590-1; Sai KKS, 2013, J NUCL MED, V54, P1120, DOI 10.2967/jnumed.112.113217; Stockhausen MT, 2011, EXP CELL RES, V317, P1513, DOI 10.1016/j.yexcr.2011.04.001; Verreault M, 2012, J CONTROL RELEASE, V158, P34, DOI 10.1016/j.jconrel.2011.09.095; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang HE, 2005, NUCL MED BIOL, V32, P367, DOI 10.1016/j.nucmedbio.2005.01.005; Wang LM, 2011, NUCL MED BIOL, V38, P53, DOI 10.1016/j.nucmedbio.2010.07.005; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wester HJ, 1999, J NUCL MED, V40, P205; Wiriyasermkul P, 2012, J NUCL MED, V53, P1253, DOI 10.2967/jnumed.112.103069	35	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e100009	10.1371/journal.pone.0100009	http://dx.doi.org/10.1371/journal.pone.0100009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918622	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000126
J	Nwosu, BU; Maranda, L				Nwosu, Benjamin Udoka; Maranda, Louise			The Effects of Vitamin D Supplementation on Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Children and Adolescents with Vitamin D Deficiency and Either Type 1 or Type 2 Diabetes Mellitus	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NUTRITION EXAMINATION SURVEY; PLACEBO-CONTROLLED TRIAL; INSULIN-RESISTANCE; ALANINE AMINOTRANSFERASE; SERUM 25-HYDROXYVITAMIN-D; CARDIOVASCULAR-DISEASE; GLUCOSE-HOMEOSTASIS; NATIONAL-HEALTH; BIRTH-COHORT	Background: The effects of vitamin D supplementation on mild hepatic dysfunction and glycemic control are unclear in children and adolescents with either type 1 (T1D) or type 2 diabetes (T2D). Hypothesis: Vitamin D supplementation will improve hepatic dysfunction and glycemic control. Aim: To determine the effect of vitamin D supplementation on alanine transaminase (ALT), hemoglobin A1c (HbA1c), and serum 25-hydroxyvitamin D [25(OH)D] concentration. Subjects and Methods: A retrospective study of 131 subjects with either T1D (n = 88:46 females, 42 males), or T2D (n = 43:26 females, 17 males) of ages 3-18 years between 2007-2013. All subjects had (1) a diagnosis of diabetes for >12 mo, (2) received vitamin D supplementation for the management of vitamin D deficiency (3) had baseline and subsequent simultaneous measurements of HbA1c, ALT, and 25(OH)D. Vitamin D deficiency was defined as 25(OH)D concentration of <50 nmol/L (20 ng/mL). Results: At baseline, vitamin D deficiency occurred in 72.1% of patients with T2D and in 37.5% of T1D patients (p<0.001). Patients with T2D had significantly higher values for BMI SDS (p<0.001), alanine transaminase (ALT) (p = 0.001), but lower 25(OH)D (p<0.001), and no difference in HbA1c (p = 0.94), and total daily dose (TDD) of insulin per kg body weight (p = 0.48) as compared to T1D patients. After 3 months of vitamin D supplementation, there was a significant increase in 25(OH)D in both T2D (p = 0.015), and T1D patients (p<0.001); significant reduction in BMI SDS (p = 0.015) and ALT (p = 0.012) in T2D, but not in T1D. There was a clinically-significant decrease in HbA1c in T2D from 8.5 +/- 2.9% at baseline to 7.7 +/- 2.5 at 3 mo, but not in T1D, 8.5 +/- 1.2 to 8.53 +/- 1.1%. Conclusions: Vitamin D supplementation in subjects with T2D was associated with statistically significant decreases in BMI SDS, ALT, and a clinically-significant decrease in HbA1c.	[Nwosu, Benjamin Udoka] Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01605 USA; [Maranda, Louise] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Nwosu, BU (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01605 USA.	Benjamin.Nwosu@umassmemorial.org			Department of Pediatrics; Faculty Diversity Scholars Program, University of Massachusetts Medical School, Worcester, MA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	Department of Pediatrics; Faculty Diversity Scholars Program, University of Massachusetts Medical School, Worcester, MA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in part by a grant to Benjamin U. Nwosu from the Department of Pediatrics, and the Faculty Diversity Scholars Program, University of Massachusetts Medical School, Worcester, MA. He is also a member of the UMass Diabetes and Endocrine Research Center (DK32520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2009, ANN MED, V41, P265, DOI 10.1080/07853890802552437; Aljabri KS, 2010, ANN SAUDI MED, V30, P454, DOI 10.4103/0256-4947.72265; Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Barchetta I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-85; Baynes KCR, 1997, DIABETOLOGIA, V40, P344, DOI 10.1007/s001250050685; Burgert TS, 2006, J CLIN ENDOCR METAB, V91, P4287, DOI 10.1210/jc.2006-1010; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Christakos S, 1979, BIOCHEM BIOPH RES CO, V89, P56; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; Dahlquist G, 1999, DIABETOLOGIA, V42, P51, DOI 10.1007/s001250051112; de Boer IH, 2007, J AM SOC NEPHROL, V18, P235, DOI 10.1681/ASN.2006040394; Di Cesar DJ, 2006, DIABETES CARE, V29, P174, DOI 10.2337/diacare.29.1.174; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; Drincic A, 2013, J CLIN ENDOCR METAB, V98, P4845, DOI 10.1210/jc.2012-4103; Drincic AT, 2012, OBESITY, V20, P1444, DOI 10.1038/oby.2011.404; Ford ES, 2008, DIABETES CARE, V31, P1138, DOI [10.2337/dc07-2159, 10.2337/dc08-1138]; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Greer RM, 2013, PEDIATR DIABETES, V14, P31, DOI 10.1111/j.1399-5448.2012.00890.x; Grineva EN, 2013, AGING-US, V5, P575; Hahn S, 2006, EXP CLIN ENDOCR DIAB, V114, P577, DOI 10.1055/s-2006-948308; Heinemann L, 2010, Int J Clin Pract Suppl, P29, DOI 10.1111/j.1742-1241.2009.02276.x; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Hypponen E, 2006, DIABETES CARE, V29, P2244, DOI 10.2337/dc06-0946; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Jorde R, 2009, EUR J NUTR, V48, P349, DOI 10.1007/s00394-009-0020-3; Kelly A, 2011, ARCH DIS CHILD, V96, P447, DOI 10.1136/adc.2010.187591; Kositsawat J, 2010, DIABETES CARE, V33, P1236, DOI 10.2337/dc09-2150; Kostoglou-Athanassiou I, 2013, THER ADV ENDOCRINOL, V4, P122, DOI 10.1177/2042018813501189; Kuczmarski R J, 2000, Adv Data, P1; Liangpunsakul S, 2011, DIGEST DIS SCI, V56, P2124, DOI 10.1007/s10620-011-1707-x; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Manco M, 2010, HEPATOLOGY, V51, P2229, DOI 10.1002/hep.23724; Monami M, 2008, METABOLISM, V57, P387, DOI 10.1016/j.metabol.2007.10.015; Nadeau KJ, 2005, J PEDIATR GASTR NUTR, V41, P94, DOI 10.1097/01.MPG.0000164698.03164.E5; Nagpal J, 2009, DIABETIC MED, V26, P19, DOI 10.1111/j.1464-5491.2008.02636.x; Nikooyeh B, 2011, AM J CLIN NUTR, V93, P764, DOI 10.3945/ajcn.110.007336; NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216; Nwosu BU, 2012, J PEDIATR ENDOCR MET, V25, P181, DOI 10.1515/jpem-2011-0403; Ortega RM, 2009, INT J VITAM NUTR RES, V79, P71, DOI 10.1024/0300-9831.79.2.71; Ostergard M, 2011, EUR J CLIN NUTR, V65, P657, DOI 10.1038/ejcn.2010.285; Perez-Ferre N, 2012, ENDOCR PRACT, V18, P676, DOI 10.4158/EP12025.OR; Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025; Ryu OH, 2013, ENDOCR J; Schwimmer JB, 2003, J PEDIATR-US, V143, P500, DOI 10.1067/S0022-3476(03)00325-1; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Shab-Bidar S, 2012, DIABETES-METAB RES, V28, P424, DOI 10.1002/dmrr.2290; Strobel F, 2013, HORM METAB RES; Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x; Sun X, 2008, INT J OBESITY, V32, P1305, DOI 10.1038/ijo.2008.59; Sung KC, 2013, J CLIN ENDOCR METAB, V98, P3637, DOI 10.1210/jc.2013-1519; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Tamborlane WV, 2005, PEDIATR DIABETES, V6, P13; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Witham MD, 2010, DIABETOLOGIA, V53, P2112, DOI 10.1007/s00125-010-1838-1; Zelber-Sagi S, 2013, LIVER INT, V33, P1406, DOI 10.1111/liv.12200; Zemel MB, 2008, NUTR REV, V66, pS139, DOI 10.1111/j.1753-4887.2008.00099.x; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	63	32	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99646	10.1371/journal.pone.0099646	http://dx.doi.org/10.1371/journal.pone.0099646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918447	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000101
J	Omland, T; Lie, KA; Akre, H; Sandlie, LE; Jebsen, P; Sandvik, L; Nymoen, DA; Bzhalava, D; Dillner, J; Brondbo, K				Omland, Turid; Lie, Kathrine A.; Akre, Harriet; Sandlie, Lars Erik; Jebsen, Peter; Sandvik, Leiv; Nymoen, Dag Andre; Bzhalava, Davit; Dillner, Joakim; Brondbo, Kjell			Recurrent Respiratory Papillomatosis: HPV Genotypes and Risk of High-Grade Laryngeal Neoplasia	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; SQUAMOUS-CELL CARCINOMAS; JUVENILE-ONSET; MALIGNANT-TRANSFORMATION; DNA; CONDYLOMATA; INFECTION; TYPE-11; CANCER; IDENTIFICATION	Patients with recurrent respiratory papillomatosis (RRP) in Norway treated between 1987 and 2009 were recruited to this cohort study. They were followed from disease onset and data recorded until January 2012. Here, we describe the distribution of human papillomavirus (HPV) genotypes, the prevalence of multiple HPV infections, and the risk of high-grade laryngeal neoplasia and respiratory tract invasive carcinoma in a large cohort of patients with RRP. We also examined whether HPV genotype, gender, age or clinical course are risk factors for this development. Clinical records and histological specimens were reviewed. Using formalin-fixed paraffin-embedded biopsies, HPV genotyping were performed by quantitative polymerase chain reaction assays identifying 15 HPV types. HPV-negative specimens were analyzed by metagenomic sequencing. Paraffin blocks were available in 224/238 patients. The DNA quality was approved in 221/224 cases. HPV DNA was detected in 207/221 patients and all were HPV 6 or HPV 11 positive, comprising HPV 6 in 133/207, HPV 11 in 40/207 cases and HPV 6/11 in 15/207 cases. Co-infection with one or two high-risk HPV types together with HPV 6 or HPV 11 was present in 19/207 patients. Metagenomic sequencing of 14 HPV-negative specimens revealed HPV 8 in one case. In total, 39/221 patients developed high-grade laryngeal neoplasia. 8/221 patients developed carcinoma of the respiratory tract (six patients with laryngeal carcinoma and two patients with lung carcinoma). High-grade laryngeal neoplasias were found more frequently in HPV-negative versus HPV-positive patients, (RR = 2.35, 95% CI 1.1, 4.99), as well as respiratory tract carcinomas (RR = 48, 95% CI 10.72, 214.91). In summary, the majority of RRP were associated with HPV 6 and/or 11. HPV-negative RRP biopsies occurred more frequently in adult-onset patients, and were associated with an increased risk of laryngeal neoplasia and carcinoma in the respiratory tract.	[Omland, Turid; Akre, Harriet; Brondbo, Kjell] Oslo Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Oslo, Norway; [Omland, Turid; Akre, Harriet; Brondbo, Kjell] Univ Oslo, Inst Clin Med, Oslo, Norway; [Lie, Kathrine A.; Sandlie, Lars Erik; Jebsen, Peter; Nymoen, Dag Andre] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Sandvik, Leiv] Oslo Univ Hosp, Dept Biostat, Oslo, Norway; [Sandvik, Leiv] Univ Oslo, Fac Dent, Oslo, Norway; [Bzhalava, Davit; Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Bzhalava, Davit; Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden; [Bzhalava, Davit; Dillner, Joakim] Karolinska Inst, Dept Biostat, Stockholm, Sweden; [Bzhalava, Davit; Dillner, Joakim] Karolinska Hosp, Dept Clin Microbiol & Pathol, S-10401 Stockholm, Sweden	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Omland, T (corresponding author), Oslo Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Oslo, Norway.	tuomland@ous-hf.no		Bzhalava, Davit/0000-0002-7646-7892	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by grants from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aubin F, 2008, CLIN INFECT DIS, V47, P610, DOI 10.1086/590560; Blumin JH, 2009, ANN OTO RHINOL LARYN, V118, P481, DOI 10.1177/000348940911800704; Brown DR, 1999, J CLIN MICROBIOL, V37, P3316, DOI 10.1128/JCM.37.10.3316-3322.1999; Buchinsky FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002263; Bzhalava D DJ, 2013, J DATA MINING GENOMI, V4; Bzhalava D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065953; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; DERKAY CS, 1995, ARCH OTOLARYNGOL, V121, P1386; Donne AJ, 2010, INT J PEDIATR OTORHI, V74, P7, DOI 10.1016/j.ijporl.2009.09.004; DOYLE DJ, 1994, ARCH OTOLARYNGOL, V120, P1273; Draganov P, 2006, INT J PEDIATR OTORHI, V70, P469, DOI 10.1016/j.ijporl.2005.07.018; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Friis S, 1997, J INFECT DIS, V175, P743, DOI 10.1086/513966; GAYLIS B, 1991, AM J OTOLARYNG, V12, P104, DOI 10.1016/0196-0709(91)90045-H; Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Go C, 2003, ANN OTO RHINOL LARYN, V112, P298, DOI 10.1177/000348940311200402; Grce M, 2000, ANTICANCER RES, V20, P2097; Hall JE, 2011, OTOLARYNG HEAD NECK, V144, P252, DOI 10.1177/0194599810391626; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Hobbs Christopher G L, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P88, DOI 10.1097/00020840-200404000-00006; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Johansson H, 2013, VIROLOGY, V440, P1, DOI 10.1016/j.virol.2013.01.023; KASHIMA H, 1993, ANN OTO RHINOL LARYN, V102, P580, DOI 10.1177/000348949310200802; KASHIMA H, 1988, LARYNGOSCOPE, V98, P619; KASHIMA HK, 1992, LARYNGOSCOPE, V102, P9; Kjaer S K, 1989, IARC Sci Publ, P113; Kjaer SK, 2007, J INFECT DIS, V196, P1447, DOI 10.1086/522863; Kocjan BJ, 2013, J INFECT DIS, V207, P583, DOI 10.1093/infdis/jis733; Koskinen WJ, 2007, J CANCER RES CLIN, V133, P673, DOI 10.1007/s00432-007-0219-8; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lacey CJ, 2006, VACCINE S3, V24, pS3; LACK EE, 1980, LANCET, V2, P592; Lee LA, 2008, LARYNGOSCOPE, V118, P50, DOI 10.1097/MLG.0b013e318155a288; LIE ES, 1994, ACTA OTO-LARYNGOL, V114, P209, DOI 10.3109/00016489409126044; Lin HW, 2010, AM J OTOLARYNG, V31, P291, DOI 10.1016/j.amjoto.2009.02.019; LINDEBERG H, 1989, ACTA OTO-LARYNGOL, V107, P141, DOI 10.3109/00016488909127491; Lindh M, 2007, J CLIN VIROL, V40, P321, DOI 10.1016/j.jcv.2007.09.009; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Omland T, 2012, LARYNGOSCOPE, V122, P1595, DOI 10.1002/lary.23327; Penaloza-Plascencia M, 2000, ARCH OTOLARYNGOL, V126, P1119, DOI 10.1001/archotol.126.9.1119; Rabah R, 2001, PEDIATR DEVEL PATHOL, V4, P68, DOI 10.1007/s100240010105; Reidy PM, 2004, LARYNGOSCOPE, V114, P1906, DOI 10.1097/01.mlg.0000147918.81733.49; Sanchez GI, 2012, HEAD NECK; Silverberg MJ, 2003, OBSTET GYNECOL, V101, P645, DOI 10.1016/S0029-7844(02)03081-8; Skerlev M, 2002, CLIN DERMATOL, V20, P173, DOI 10.1016/S0738-081X(02)00210-9; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; SOLOMON D, 1985, LARYNGOSCOPE, V95, P900; Sturegard E, 2013, SEX TRANSM DIS, V40, P123, DOI 10.1097/OLQ.0b013e31827aa9b3; Vandepapeliere P, 2005, J INFECT DIS, V192, P2099, DOI 10.1086/498164; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Walboomers JMM, 1997, J PATHOL, V181, P253, DOI 10.1002/(SICI)1096-9896(199703)181:3<253::AID-PATH755>3.0.CO;2-0; Wiatrak BJ, 2004, LARYNGOSCOPE, V114, P1, DOI 10.1097/01.mlg.000148224.83491.0f; World Health Organization Classification of Tumours, 2005, WHO CLASS TUM PATH G	59	59	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99114	10.1371/journal.pone.0099114	http://dx.doi.org/10.1371/journal.pone.0099114			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918765	Green Submitted, gold, Green Published			2022-12-25	WOS:000338631000049
J	Schyns, JF; Hoekstra, AY				Schyns, Joep F.; Hoekstra, Arjen Y.			The Added Value of Water Footprint Assessment for National Water Policy: A Case Study for Morocco	PLOS ONE			English	Article							CONSUMPTION	A Water Footprint Assessment is carried out for Morocco, mapping the water footprint of different activities at river basin and monthly scale, distinguishing between surface- and groundwater. The paper aims to demonstrate the added value of detailed analysis of the human water footprint within a country and thorough assessment of the virtual water flows leaving and entering a country for formulating national water policy. Green, blue and grey water footprint estimates and virtual water flows are mainly derived from a previous grid-based (5x5 arc minute) global study for the period 1996-2005. These estimates are placed in the context of monthly natural runoff and waste assimilation capacity per river basin derived from Moroccan data sources. The study finds that: (i) evaporation from storage reservoirs is the second largest form of blue water consumption in Morocco, after irrigated crop production; (ii) Morocco's water and land resources are mainly used to produce relatively low-value (in US$/m(3) and US$/ha) crops such as cereals, olives and almonds; (iii) most of the virtual water export from Morocco relates to the export of products with a relatively low economic water productivity (in US$/m(3)); (iv) blue water scarcity on a monthly scale is severe in all river basins and pressure on groundwater resources by abstractions and nitrate pollution is considerable in most basins; (v) the estimated potential water savings by partial relocation of crops to basins where they consume less water and by reducing water footprints of crops down to benchmark levels are significant compared to demand reducing and supply increasing measures considered in Morocco's national water strategy.	[Schyns, Joep F.; Hoekstra, Arjen Y.] Univ Twente, Twente Water Ctr, NL-7500 AE Enschede, Netherlands	University of Twente	Schyns, JF (corresponding author), Univ Twente, Twente Water Ctr, POB 217, NL-7500 AE Enschede, Netherlands.	j.f.schyns@utwente.nl	Schyns, Joep/N-3675-2019; Schyns, Joep F/H-8559-2014; Hoekstra, Arjen Y./B-4980-2008	Schyns, Joep/0000-0001-5058-353X; Schyns, Joep F/0000-0001-5058-353X; Hoekstra, Arjen Y./0000-0002-4769-5239	Deltares; Institute for Innovation and Governance Studies (IGS) of the University of Twente	Deltares; Institute for Innovation and Governance Studies (IGS) of the University of Twente	The research was funded by Deltares (http://www.deltares.nl/en). Karen Meijer (Deltares) had a role in study design. Wil van der Krogt (Deltares) had a role in data collection. The writing stage of the manuscript was funded by the Institute for Innovation and Governance Studies (IGS) of the University of Twente (http://www.utwente.nl/Igs/). The funders had no role in data analysis, decision to publish, or preparation of the manuscript.	Al-Taiee TM, 2012, IHP 7 SERIES GROUNDW, V4, P35; Aldaya M. M., 2010, WATER POLICY SPAIN, p[49, 59]; Aldaya MM, 2010, WATER RESOUR MANAG, V24, P941, DOI 10.1007/s11269-009-9480-8; [Anonymous], 2010, GREEN BLUE GREY WATE; Chahed J, 2011, VALUE WATER RES REPO, V54, P99; Chapagain A.K, 2008, GLOBALIZATION WATER; FAO, 2013, GLOB MAP MONTHL REF; FAO, 2013, AQUASTAT ONL DAT COU; FAO, 2013, FAOSTAT ONL DAT; FAO, 2013, AQUASTAT ONL DAT GEO; Finigue A., 2017, G OGRAPHIE; Hoekstra A., 2003, VALUE WATER RES REPO, V12; Hoekstra AY, 2007, WATER RESOUR MANAG, V21, P35, DOI 10.1007/s11269-006-9039-x; Hoekstra A.Y., 2011, WATER FOOTPRINT ASSE, DOI DOI 10.1080/0969160X.2011.593864; Hoekstra AY, 2007, ECOL ECON, V64, P143, DOI 10.1016/j.ecolecon.2007.02.023; Hoekstra AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032688; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Hoekstra AY., 2013, WATER FOOTPRINT MODE; Hoff H, 2010, J HYDROL, V384, P177, DOI 10.1016/j.jhydrol.2009.06.026; ITC, 2007, SITA VERS 1996 2005; Laouina A, 2001, INTERDEPENDENCY AGR, V2001, P17; Mekonnen MM, 2010, HYDROL EARTH SYST SC, V14, P1259, DOI 10.5194/hess-14-1259-2010; Mekonnen M. M., 2011, VALUE WATER RES REPO, V50; Ministry EMWE, 2012, EAUX SOUT; Ministry EMWE, 2011, STRAT NAT EAU; Riad S., 2003, THESIS; Rockstrom J, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006767; Schuol J, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006609; Tekken V, 2012, WATER-SUI, V4, P959, DOI 10.3390/w4040959; Weiland FCS, 2010, HYDROL EARTH SYST SC, V14, P1595, DOI 10.5194/hess-14-1595-2010	30	98	102	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99705	10.1371/journal.pone.0099705	http://dx.doi.org/10.1371/journal.pone.0099705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919194	Green Published, Green Submitted, gold			2022-12-25	WOS:000338631000106
J	Zhou, LM; Zheng, W; Luo, MJ; Feng, J; Jin, ZC; Wang, Y; Zhang, DL; Tang, QX; He, Y				Zhou, Limin; Zheng, Wei; Luo, Majing; Feng, Jing; Jin, Zhichun; Wang, Yan; Zhang, Dunlan; Tang, Qiongxiu; He, Yan			dbCerEx: A Web-Based Database for the Analysis of Cervical Cancer Transcriptomes	PLOS ONE			English	Article							CELL-CYCLE; EXPRESSION; GENES	Background: Cervical cancers are ranked the second-most hazardous ailments among women worldwide. In the past two decades, microarray technologies have been applied to study genes involved in malignancy progress. However, in most of the published microarray studies, only a few genes were reported leaving rather a large amount of data unused. Also, RNA-Seq data has become more standard for transcriptome analysis and is widely applied in cancer studies. There is a growing demand for a tool to help the experimental researchers who are keen to explore cervical cancer gene therapy, but lack computer expertise to access and analyze the high throughput gene expression data. Description: The dbCerEx database is designed to retrieve and process gene expression data from cervical cancer samples. It includes the genome wide expression profiles of cervical cancer samples, as well as a web utility to cluster genes with similar expression patterns. This feature will help researchers conduct further research to uncover novel gene functions. Conclusion: The dbCerEx database is freely available for non-commercial use at http://128.135.207.10/dbCerEx/, and will be updated and integrated with more features as needed.	[Zhou, Limin; Jin, Zhichun; Wang, Yan; Zhang, Dunlan; Tang, Qiongxiu] Hubei Maternal & Child Hlth Hosp, Wuhan, Hubei, Peoples R China; [Zheng, Wei] Yichang Humanwell Pharmaceut Co, Yichang, Hubei, Peoples R China; [He, Yan] Huazhong Agr Univ, Coll Fisheries, Wuhan, Peoples R China; [Luo, Majing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Feng, Jing] Wuhan Univ, Int Sch Software, Wuhan 430072, Peoples R China	Huazhong Agricultural University; Wuhan University; Wuhan University	He, Y (corresponding author), Huazhong Agr Univ, Coll Fisheries, Wuhan, Peoples R China.	heyan@mail.hzau.edu.cn	Zhou, Li/GSE-4531-2022		National Natural Science Founds of China [31202013]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120146120007]; Fundamental Research Funds for the Central Universities [2011QC075]	National Natural Science Founds of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is supported by the National Natural Science Founds of China (Program No. 31202013), Specialized Research Fund for the Doctoral Program of Higher Education of China (Program No 20120146120007), Fundamental Research Funds for the Central Universities (Program No. 2011QC075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachtiary B, 2006, CLIN CANCER RES, V12, P5632, DOI 10.1158/1078-0432.CCR-06-0357; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Imadome K, 2010, CANCER BIOL THER, V10, P1019, DOI 10.4161/cbt.10.10.13249; Iwakawa M, 2007, CANCER BIOL THER, V6, P905, DOI 10.4161/cbt.6.6.4098; Kloth JN, 2008, J PATHOL, V215, P222, DOI 10.1002/path.2347; Mine KL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2693; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rajkumar T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-365; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Team R, 2008, R LANG ENV STAT COMP; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056	20	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99834	10.1371/journal.pone.0099834	http://dx.doi.org/10.1371/journal.pone.0099834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918550	Green Published, gold, Green Submitted			2022-12-25	WOS:000338631000120
J	Chen, J; Rashid, T; Feng, GL				Chen, Jian; Rashid, Tahir; Feng, Guolei			A Comparative Study between Solenopsis invicta and Solenopsis richteri on Tolerance to Heat and Desiccation Stresses	PLOS ONE			English	Article							FIRE ANT HYMENOPTERA; FORMICIDAE POPULATIONS; WATER RELATIONS; PHYSIOLOGY; FORAGERS	Solenopsis invicta and Solenopsis richteri are two very closely related invasive ant species; however, S. invicta is a much more successful invader. Physiological tolerance to abiotic stress has been hypothesized to be important to the success of an invasive species. In this study, we tested the hypothesis that S. invicta is more tolerant to heat and desiccation stress than S. richteri. The data strongly support our hypothesis. S. invicta was found to be significantly less vulnerable than S. richteri to both heat and desiccation stress. Despite S. richteri having significantly higher body water content, S. invicta was less sensitive to desiccation stress due to its significantly lower water loss rate (higher desiccation resistance). After the cuticular lipid was removed, S. invicta still had a significantly lower water loss rate than S. richteri, indicating that cuticular lipids were not the only factors accounting for difference in the desiccation resistance between these two species. Since multiple biological and/or ecological traits can contribute to the invasion success of a particular species, whether the observed difference in tolerance to heat and desiccation stresses is indeed associated with the variation in invasion success between these two species can only be confirmed by further extensive comparative study.	[Chen, Jian] ARS, Biol Control Pests Res Unit, USDA, Stoneville, MS 38776 USA; [Rashid, Tahir; Feng, Guolei] Alcorn State Univ, Extens Res Demonstrat Farm & Technol Transfer Ctr, Mound Bayou, MS USA	United States Department of Agriculture (USDA); Alcorn State University	Chen, J (corresponding author), ARS, Biol Control Pests Res Unit, USDA, Stoneville, MS 38776 USA.	jian.chen@ars.usda.gov						Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Bennett VA, 2005, J EXP BIOL, V208, P4467, DOI 10.1242/jeb.01892; Boyles JG, 2009, J THERM BIOL, V34, P81, DOI 10.1016/j.jtherbio.2008.10.005; BUREN W F, 1972, Journal of the Georgia Entomological Society, V7, P1; Callcott A.M., 2002, P 2002 IMP FIR ANT C, P91; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; DUNCAN FD, 1994, J EXP ZOOL, V270, P350, DOI 10.1002/jez.1402700404; Edney E.B., 1977, WATER BALANCE LAND A, P17; Finke M.D., 2008, ENCY ENTOMOLOGY, V2nd, P2687; FRANCKE OF, 1985, SOUTHWEST NAT, V30, P59, DOI 10.2307/3670657; Hadley N. F, 1994, WATER RELATIONS TERR; Holldobler B., 1990, pi; Holmstrup Martin, 2010, P166, DOI 10.1017/CBO9780511675997.008; HOOD WG, 1990, PHYSIOL ENTOMOL, V15, P23, DOI 10.1111/j.1365-3032.1990.tb00489.x; James SS, 2002, ENVIRON ENTOMOL, V31, P127, DOI 10.1603/0046-225X-31.1.127; Johnson RA, 2000, PHYSIOL ENTOMOL, V25, P48, DOI 10.1046/j.1365-3032.2000.00170.x; JOUVENAZ DP, 1990, WESTV STUD, P620; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; LIGHTON JRB, 1989, PHYSIOL ZOOL, V62, P1232, DOI 10.1086/physzool.62.6.30156211; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Morrison LW, 2004, BIOL INVASIONS, V6, P183, DOI 10.1023/B:BINV.0000022135.96042.90; Oliver JB, 2009, J ENTOMOL SCI, V44, P149, DOI 10.18474/0749-8004-44.2.149; Pitts JP, 2005, ZOOL SCR, V34, P493, DOI 10.1111/j.1463-6409.2005.00203.x; Porter SD, 1997, ENVIRON ENTOMOL, V26, P373, DOI 10.1093/ee/26.2.373; PORTER SD, 1992, J ECON ENTOMOL, V85, P1155; Quinlan MC, 1999, PHYSIOL ENTOMOL, V24, P293, DOI 10.1046/j.1365-3032.1999.00140.x; Ross KG, 2005, MOL ECOL, V14, P3419, DOI 10.1111/j.1365-294X.2005.02661.x; Schilman PE, 2007, PHYSIOL ENTOMOL, V32, P1, DOI 10.1111/j.1365-3032.2006.00533.x; Streett DA, 2006, FLA ENTOMOL, V89, P91, DOI 10.1653/0015-4040(2006)89[91:SOIFAH]2.0.CO;2; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; Tschinkel W.R., 2006, FIRE ANTS, P747; Valles SM, 2003, INSECT SOC, V50, P199, DOI 10.1007/s00040-003-0662-8; VANDERMEER RK, 1989, J CHEM ECOL, V15, P1757, DOI 10.1007/BF01012263; Yang CC, 2010, BIOL INVASIONS, V12, P3307, DOI 10.1007/s10530-010-9724-9; Yoder JA, 2006, J INSECT PHYSIOL, V52, P202, DOI 10.1016/j.jinsphys.2005.10.005	36	8	9	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e96842	10.1371/journal.pone.0096842	http://dx.doi.org/10.1371/journal.pone.0096842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915009	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700006
J	Cho, S; Shi, K; Seffernick, JL; Dodge, AG; Wackett, LP; Aihara, H				Cho, Seunghee; Shi, Ke; Seffernick, Jennifer L.; Dodge, Anthony G.; Wackett, Lawrence P.; Aihara, Hideki			Cyanuric Acid Hydrolase from Azorhizobium caulinodans ORS 571: Crystal Structure and Insights into a New Class of Ser-Lys Dyad Proteins	PLOS ONE			English	Article							SEQUENCE; MODEL; DIFFRACTION; ENZYME; SYSTEM; FAMILY; SUITE	Cyanuric acid hydrolase (CAH) catalyzes the hydrolytic ring-opening of cyanuric acid (2,4,6-trihydroxy-1,3,5-triazine), an intermediate in s-triazine bacterial degradation and a by-product from disinfection with trichloroisocyanuric acid. In the present study, an X-ray crystal structure of the CAH-barbituric acid inhibitor complex from Azorhizobium caulinodans ORS 571 has been determined at 2.7 angstrom resolution. The CAH protein fold consists of three structurally homologous domains forming a beta-barrel-like structure with external alpha-helices that result in a three-fold symmetry, a dominant feature of the structure and active site that mirrors the three-fold symmetrical shape of the substrate cyanuric acid. The active site structure of CAH is similar to that of the recently determined AtzD with three pairs of active site Ser-Lys dyads. In order to determine the role of each Ser-Lys dyad in catalysis, a mutational study using a highly sensitive, enzyme-coupled assay was conducted. The 10(9)-fold loss of activity by the S226A mutant was at least ten times lower than that of the S79A and S333A mutants. In addition, bioinformatics analysis revealed the Ser226/Lys156 dyad as the only absolutely conserved dyad in the CAH/barbiturase family. These data suggest that Lys156 activates the Ser226 nucleophile which can then attack the substrate carbonyl. Our combination of structural, mutational, and bioinformatics analyses differentiates this study and provides experimental data for mechanistic insights into this unique protein family.	[Cho, Seunghee; Shi, Ke; Seffernick, Jennifer L.; Wackett, Lawrence P.; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; [Seffernick, Jennifer L.; Dodge, Anthony G.; Wackett, Lawrence P.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Wackett, Lawrence P.] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wackett, LP (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA.	wacke003@umn.edu; aihar001@umn.edu		, Ke/0000-0003-4175-3714	BioTechnology Institute; National Center for Food Safety and Defense; Lonza; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095558] Funding Source: NIH RePORTER	BioTechnology Institute(Ankara University); National Center for Food Safety and Defense; Lonza; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the BioTechnology Institute, a grant from the National Center for Food Safety and Defense, and a grant from Lonza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; Burman JD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-30; Cho S, 2013, ACTA CRYSTALLOGR F, V69, P880, DOI 10.1107/S1744309113017077; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dobson RLM, 2008, TOXICOL SCI, V106, P251, DOI 10.1093/toxsci/kfn160; Dodge AG, 2013, J BACTERIOL, V195, P5233, DOI 10.1128/JB.00965-13; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fruchey I, 2003, APPL ENVIRON MICROB, V69, P3653, DOI 10.1128/AEM.69.6.3653-3657.2003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huthmacher K., 2000, ULLMANNS ENCY IND CH, DOI [10.1002/14356007.a08_191, DOI 10.1002/14356007.A08_191]; JUTZI K, 1982, BIOCHEM J, V208, P679, DOI 10.1042/bj2080679; Karns JS, 1999, APPL ENVIRON MICROB, V65, P3512; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Knapik AA, 2012, ACTA CRYSTALLOGR F, V68, P1294, DOI 10.1107/S1744309112041796; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; Oelschlaeger P, 2005, PROTEIN SCI, V14, P765, DOI 10.1110/ps.041093405; Peat TS, 2013, MOL MICROBIOL, V88, P1149, DOI 10.1111/mmi.12249; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saen-Oon S, 2008, BIOPHYS J, V94, P4078, DOI 10.1529/biophysj.107.121913; Seffernick JL, 2012, J BACTERIOL, V194, P4579, DOI 10.1128/JB.00791-12; Soong CL, 2001, BIOCHEM BIOPH RES CO, V286, P222, DOI 10.1006/bbrc.2001.5356; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	32	9	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99349	10.1371/journal.pone.0099349	http://dx.doi.org/10.1371/journal.pone.0099349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915109	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700088
J	Shivarov, V; Ivanova, M; Naumova, E				Shivarov, Velizar; Ivanova, Milena; Naumova, Elissaveta			Rapid Detection of DNMT3A R882 Mutations in Hematologic Malignancies Using a Novel Bead-Based Suspension Assay with BNA(NC) Probes	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; LOCKED NUCLEIC-ACID; POOR-PROGNOSIS; RISK STRATIFICATION; SOMATIC MUTATIONS; MULTIPLEX ASSAY; IDENTIFICATION; METHYLATION; TECHNOLOGY; IMPACT	Mutations in the human DNA methyl transferase 3A (DNMT3A) gene are recurrently identified in several hematologic malignancies such as Philadelphia chromosome-negative myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS), MPN/MDS overlap syndromes and acute myeloid leukemia (AML). They have been shown to confer worse prognosis in some of these entities. Notably, about 2/3 of these mutations are missense mutations in codon R882 of the gene. We aimed at the development and validation of a novel easily applicable in routine practice method for quantitative detection of the DNMT3A p. R882C/H/R/S mutations bead-based suspension assay. Initial testing on plasmid constructs showed excellent performance of BNA(NC)-modified probes with an optimal hybridization temperature of 66 degrees C. The method appeared to be quantitative and showed sensitivity of 2.5% for different mutant alleles, making it significantly superior to direct sequencing. The assay was further validated on plasmid standards at different ratios between wild type and mutant alleles and on clinical samples from 120 patients with known or suspected myeloid malignancies. This is the first report on the quantitative detection of DNMT3A R882 mutations using bead-based suspension assay with BNA(NC)-modified probes. Our data showed that it could be successfully implemented in the diagnostic work-up for patients with myeloid malignancies, as it is rapid, easy and reliable in terms of specificity and sensitivity.	[Shivarov, Velizar] Natl Hematol Hosp, Lab Hematopathol & Immunol, Sofia, Bulgaria; [Ivanova, Milena; Naumova, Elissaveta] Med Univ, Alexandrovska Univ Hosp, Dept Clin Immunol, Sofia, Bulgaria	Medical University Sofia	Shivarov, V (corresponding author), Natl Hematol Hosp, Lab Hematopathol & Immunol, Sofia, Bulgaria.	vshivarov@abv.bg	Shivarov, Velizar/B-4553-2008; Ivanova, MIlena/AAY-9725-2021; Naumova, Elissaveta/AFT-1332-2022	Shivarov, Velizar/0000-0001-5362-7999; 	National Science Fund, Bulgaria [5/16.12.2009, ID_09_157]	National Science Fund, Bulgaria(National Science Fund of Bulgaria)	This work was supported financially by Project ID_09_157 (Contract 5/16.12.2009) from the National Science Fund, Bulgaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-405; Bisling KE, 2014, LEUKEMIA LYMPHOMA, V55, P711, DOI 10.3109/10428194.2013.811580; Brewin JN, 2013, LEUKEMIA LYMPHOMA, V54, P1336, DOI 10.3109/10428194.2012.736986; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gaidzik VI, 2013, BLOOD, V121, P4769, DOI 10.1182/blood-2012-10-461624; Grossmann V, 2013, J MOL DIAGN, V15, P473, DOI 10.1016/j.jmoldx.2013.03.003; Grossmann V, 2013, GENE CHROMOSOME CANC, V52, P410, DOI 10.1002/gcc.22039; Hafez M, 2010, J MOL DIAGN, V12, P629, DOI 10.2353/jmoldx.2010.090219; Holz-Schietinger C, 2012, J BIOL CHEM, V287, P30941, DOI 10.1074/jbc.M112.366625; Hou HA, 2014, LEUKEMIA, V28, P50, DOI 10.1038/leu.2013.236; Itzykson R, 2013, BEST PRACT RES CL HA, V26, P355, DOI 10.1016/j.beha.2014.01.001; Ivanova M, 2008, HUM IMMUNOL, V69, P877, DOI 10.1016/j.humimm.2008.09.007; Ivanova MI, 2011, LEUKEMIA RES, V35, P1120, DOI 10.1016/j.leukres.2011.04.012; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Kihara R, 2014, LEUKEMIA IN PRESS; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Koshkin AA, 1998, J AM CHEM SOC, V120, P13252, DOI 10.1021/ja9822862; Laosinchai-Wolf W, 2011, J CLIN PATHOL, V64, P30, DOI 10.1136/jcp.2010.081539; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026906; Luthra R, 2013, HAEMATOLOGI IN PRESS; Marcucci G, 2012, J CLIN ONCOL, V30, P742, DOI 10.1200/JCO.2011.39.2092; Murati A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-304; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Paradis FW, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-54; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Rahman SMA, 2008, J AM CHEM SOC, V130, P4886, DOI 10.1021/ja710342q; Ribeiro AFT, 2012, BLOOD, V119, P5824, DOI 10.1182/blood-2011-07-367961; Shackelford Rodney E, 2013, Methods Mol Biol, V999, P93, DOI 10.1007/978-1-62703-357-2_6; Shivarov V, 2013, LEUKEMIA RES, V37, P1445, DOI 10.1016/j.leukres.2013.07.032; Shivarov V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076944; Shivarov V, 2013, LEUKEMIA LYMPHOMA, V54, P1343, DOI 10.3109/10428194.2012.745526; Shivarov V, 2011, LEUKEMIA LYMPHOMA, V52, P2023, DOI 10.3109/10428194.2011.584995; Singh RR, 2012, J MOL DIAGN, V14, P336, DOI 10.1016/j.jmoldx.2012.02.009; Traina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043090; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Wallace J, 2003, LEUKEMIA, V17, P1411, DOI 10.1038/sj.leu.2402986; Wertheim GBW, 2014, J MOL DIAGN, V16, P207, DOI 10.1016/j.jmoldx.2013.10.010; Wu SY, 2010, CLIN CHEM LAB MED, V48, P1103, DOI 10.1515/CCLM.2010.227; Xu J, 2014, P NATL ACAD IN PRESS; Yamamoto T, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/707323	43	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99769	10.1371/journal.pone.0099769	http://dx.doi.org/10.1371/journal.pone.0099769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914952	Green Published, gold, Green Submitted			2022-12-25	WOS:000340947700131
J	Skinner, C; Patfield, S; Stanker, LH; Fratamico, P; He, XH				Skinner, Craig; Patfield, Stephanie; Stanker, Larry H.; Fratamico, Pina; He, Xiaohua			New High-Affinity Monoclonal Antibodies against Shiga Toxin 1 Facilitate the Detection of Hybrid Stx1/Stx2 In Vivo	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; ESCHERICHIA-COLI; ENCODING BACTERIOPHAGES; B-SUBUNIT; VARIANTS; MICE; ASSOCIATION; STRAINS; DISEASE; STEC	Background: Shiga toxin-producing E. coli (STEC) are a group of common and potentially deadly intestinal pathogens expressing Shiga toxin (Stx) as a primary virulence factor. Of the two types of Stx, Stx2 is responsible for more severe symptoms during infection, while Stx1 is almost identical to the Shiga toxin from Shigella dysenteriae, a ubiquitous pathogen in developing countries. Although antibodies against Stx1 have been reported, few have reached the affinity needed for assembling highly sensitive immunoassays. Sensitive and affordable immunoassays for Stx1 and Stx2 could help improve detection of STEC in livestock, food, the environment, and in clinical samples resulting in improved food safety and human health. Method and Findings: Three new monoclonal antibodies (mAbs) against the B subunit of Stx1 were generated using recombinant toxoid Stx1E167Q and hybridoma technology. These new mAbs recognize all subtypes of Stx1, but do not cross-react with any subtype of Stx2. In addition, they exhibited the ability to neutralize Stx1 toxicity in Vero cell assays. An optimized sandwich ELISA using of a pair of these mAbs had a limit of detection of 8.7 pg/mL, which is superior to any existing assay of this kind. Using one of these Stx1 mAbs in concert with Stx2 mAbs, the presence of hybrid Stx1/Stx2 toxin in the culture media of STEC strains that express both Stx1 and Stx2 was demonstrated. Conclusions: These new mAbs provide a mix of availability, utility, versatility, and most importantly, increased sensitivity for detection of Stx1. There are numerous potential applications for these mAbs, including low-cost detection assays and therapeutic use. Analysis of hybrid Stx1/2 could provide new insights on the structure, activity, and cellular targets of Shiga toxins.	[Skinner, Craig; Patfield, Stephanie; Stanker, Larry H.; He, Xiaohua] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Fratamico, Pina] USDA ARS, Eastern Reg Res Ctr, Wyndmoor, PA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	He, XH (corresponding author), USDA ARS, Western Reg Res Ctr, 800 Buchanan St, Albany, CA 94710 USA.	xiaohua.he@ars.usda.gov			USDA-ARS National Program [NP108]; CRIS project [5325-42000-048-00D]	USDA-ARS National Program; CRIS project	This research was supported by USDA-ARS National Program NP108, CRIS project 5325-42000-048-00D. The U.S. Department of Agriculture is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison HE, 2007, FUTURE MICROBIOL, V2, P165, DOI 10.2217/17460913.2.2.165; Beutin L, 2007, J APPL MICROBIOL, V102, P630, DOI 10.1111/j.1365-2672.2006.03139.x; Burk C, 2003, J CLIN MICROBIOL, V41, P2106, DOI 10.1128/JCM.41.5.2106-2112.2003; CANTEY JR, 1985, J INFECT DIS, V151, P766, DOI 10.1093/infdis/151.5.766; Cheng LW, 2013, TOXINS, V5, P1845, DOI 10.3390/toxins5101845; Feng PCH, 2011, APPL ENVIRON MICROB, V77, P6699, DOI 10.1128/AEM.00370-11; Friedrich AW, 2003, J CLIN MICROBIOL, V41, P2448, DOI 10.1128/JCM.41.6.2448-2453.2003; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Gaston MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069823; He X, 2012, J IMMUNOL METHODS; He XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076368; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; He XH, 2011, APPL ENVIRON MICROB, V77, P3558, DOI 10.1128/AEM.02205-10; HEAD SC, 1991, J BIOL CHEM, V266, P3617; Herold S, 2004, INT J MED MICROBIOL, V294, P115, DOI 10.1016/j.ijmm.2004.06.023; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Moxley RA, 2000, VET CLIN N AM-FOOD A, V16, P175, DOI 10.1016/S0749-0720(15)30142-0; Muthing J, 2012, GLYCOBIOLOGY, V22, P849, DOI 10.1093/glycob/cws009; Nassar FJ, 2013, FOODBORNE PATHOG DIS, V10, P805, DOI 10.1089/fpd.2013.1510; Ojha SC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/412370; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schmidt H, 2001, RES MICROBIOL, V152, P687, DOI 10.1016/S0923-2508(01)01249-9; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076563; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059760; Smith MJ, 2006, VACCINE, V24, P4122, DOI 10.1016/j.vaccine.2006.02.035; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Tzipori S, 2004, CLIN MICROBIOL REV, V17, P926, DOI 10.1128/CMR.17.4.926-941.2004; WEINSTEIN DL, 1989, INFECT IMMUN, V57, P3743, DOI 10.1128/IAI.57.12.3743-3750.1989; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Yamagami S, 2001, J INFECT DIS, V184, P738, DOI 10.1086/323082; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	34	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99854	10.1371/journal.pone.0099854	http://dx.doi.org/10.1371/journal.pone.0099854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914553	Green Submitted, Green Published, gold			2022-12-25	WOS:000340947700137
J	Acosta, JR; Goldsbury, C; Winnick, C; Badrock, AP; Fraser, ST; Laird, AS; Hall, TE; Don, EK; Fifita, JA; Blair, IP; Nicholson, GA; Cole, NJ				Acosta, Jamie Rae; Goldsbury, Claire; Winnick, Claire; Badrock, Andrew P.; Fraser, Stuart T.; Laird, Angela S.; Hall, Thomas E.; Don, Emily K.; Fifita, Jennifer A.; Blair, Ian P.; Nicholson, Garth A.; Cole, Nicholas J.			Mutant Human FUS Is Ubiquitously Mislocalized and Generates Persistent Stress Granules in Primary Cultured Transgenic Zebrafish Cells	PLOS ONE			English	Article							SARCOMA FUS; MUTATIONS; PROTEINS; FUS/TLS; GENE	FUS mutations can occur in familial amyotrophic lateral sclerosis (fALS), a neurodegenerative disease with cytoplasmic FUS inclusion bodies in motor neurons. To investigate FUS pathology, we generated transgenic zebrafish expressing GFP-tagged wild-type or fALS (R521C) human FUS. Cell cultures were made from these zebrafish and the subcellular localization of human FUS and the generation of stress granule (SG) inclusions examined in different cell types, including differentiated motor neurons. We demonstrate that mutant FUS is mislocalized from the nucleus to the cytosol to a similar extent in motor neurons and all other cell types. Both wild-type and R521C FUS localized to SGs in zebrafish cells, demonstrating an intrinsic ability of human FUS to accumulate in SGs irrespective of the presence of disease-associated mutations or specific cell type. However, elevation in relative cytosolic to nuclear FUS by the R521C mutation led to a significant increase in SG assembly and persistence within a sub population of vulnerable cells, although these cells were not selectively motor neurons.	[Acosta, Jamie Rae; Goldsbury, Claire; Laird, Angela S.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Acosta, Jamie Rae; Goldsbury, Claire; Winnick, Claire; Badrock, Andrew P.; Fraser, Stuart T.; Don, Emily K.; Cole, Nicholas J.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Acosta, Jamie Rae; Goldsbury, Claire; Winnick, Claire; Badrock, Andrew P.; Cole, Nicholas J.] Univ Sydney, Discipline Anat & Histol, Sydney, NSW 2006, Australia; [Fraser, Stuart T.] Univ Sydney, Discipline Physiol, Sydney, NSW 2006, Australia; [Laird, Angela S.; Fifita, Jennifer A.; Blair, Ian P.; Nicholson, Garth A.] Univ Sydney, ANZAC Res Inst, Sydney, NSW 2006, Australia; [Winnick, Claire; Badrock, Andrew P.; Don, Emily K.; Fifita, Jennifer A.; Blair, Ian P.; Nicholson, Garth A.; Cole, Nicholas J.] Macquarie Univ, Australian Sch Adv Med, Motorneurone Dis Res Ctr, Sydney, NSW 2109, Australia; [Hall, Thomas E.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; ANZAC Research Institute; Macquarie University; University of Queensland	Goldsbury, C (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.	claire.goldsbury@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016; cole, nicholas/M-7010-2016; Hall, Thomas/J-2125-2014	Hall, Thomas/0000-0002-7718-7614; Fifita, Jennifer/0000-0002-0814-0118; Goldsbury, Claire/0000-0003-0647-1789; Laird, Angela/0000-0002-6860-9192; Nicholson, Garth/0000-0001-9694-066X; Cole, Nicholas/0000-0003-1006-2662; Don, Emily/0000-0001-5371-0135; Fraser, Stuart/0000-0003-3795-9461; Blair, Ian/0000-0003-3083-0075	National Health and Medical Research Council (NHMRC), Australia; Rebecca Cooper Medical Research Foundation; MND Research Institute of Australia The Snow Foundation	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca Cooper Medical Research Foundation; MND Research Institute of Australia The Snow Foundation	Funding provided by The National Health and Medical Research Council (NHMRC), Australia, The Rebecca Cooper Medical Research Foundation and The MND Research Institute of Australia The Snow Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Armstrong GAB, 2013, HUM MOL GENET, V22, P4282, DOI 10.1093/hmg/ddt278; Belzil VV, 2009, NEUROLOGY, V73, P1176, DOI 10.1212/WNL.0b013e3181bbfeef; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Corrado L, 2010, J MED GENET, V47, P190, DOI 10.1136/jmg.2009.071027; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Drepper C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.11.017; Fujita K, 2008, ACTA NEUROPATHOL, V116, P439, DOI 10.1007/s00401-008-0415-x; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Huang C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002011; Hyman AH, 2011, NATURE, V480, P34, DOI 10.1038/480034a; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Kawamata H, 2011, METHODS MOL BIOL, V793, P3, DOI 10.1007/978-1-61779-328-8_1; Kino Y, 2011, NUCLEIC ACIDS RES, V39, P2781, DOI 10.1093/nar/gkq1162; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lemmens R, 2007, HUM MOL GENET, V16, P2359, DOI 10.1093/hmg/ddm193; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Ticozzi N, 2009, NEUROLOGY, V73, P1180, DOI 10.1212/WNL.0b013e3181bbff05; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vanderweyde T, 2012, J NEUROSCI, V32, P8270, DOI 10.1523/JNEUROSCI.1592-12.2012	32	15	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e90572	10.1371/journal.pone.0090572	http://dx.doi.org/10.1371/journal.pone.0090572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24912067	Green Published, gold			2022-12-25	WOS:000337165600119
J	Gur, I; Fujiwara, K; Hasegawa, K; Yoshikawa, K				Gur, Ibrahim; Fujiwara, Kazushiro; Hasegawa, Koichi; Yoshikawa, Kazuaki			Necdin Promotes Ubiquitin-Dependent Degradation of PIAS1 SUMO E3 Ligase	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; NEURONAL GROWTH SUPPRESSOR; MAGE GENE FAMILY; NUCLEAR-MATRIX; POSTEMBRYONIC NEUROGENESIS; TRANSCRIPTION FACTOR; PROTEIN INHIBITOR; ACTIVATED STAT1; SMC5-6 COMPLEX; MOUSE-BRAIN	Necdin, a pleiotropic protein that promotes differentiation and survival of mammalian neurons, is a member of MAGE (melanoma antigen) family proteins that share a highly conserved MAGE homology domain. Several MAGE proteins interact with ubiquitin E3 ligases and modulate their activities. However, it remains unknown whether MAGE family proteins interact with SUMO (small ubiquitin-like modifier) E3 ligases such as PIAS (protein inhibitor of activated STAT) family, Nsmce2/Mms21 and Cbx4/Pc2. In the present study, we examined whether necdin interacts with these SUMO E3 ligases. Coimmunoprecipitation analysis revealed that necdin, MAGED1, MAGEF1 and MAGEL2 bound to PIAS1 but not to Nsmce2 or Cbx4. These SUMO E3 ligases bound to MAGEA1 but failed to interact with necdin-like 2/MAGEG1. Necdin bound to PIAS1 central domains that are highly conserved among PIAS family proteins and suppressed PIAS1-dependent sumoylation of the substrates STAT1 and PML (promyelocytic leukemia protein). Remarkably, necdin promoted degradation of PIAS1 via the ubiquitin-proteasome pathway. In transfected HEK293A cells, amino-and carboxyl-terminally truncated mutants of PIAS1 bound to necdin but failed to undergo necdin-dependent ubiquitination. Both PIAS1 and necdin were associated with the nuclear matrix, where the PIAS1 terminal deletion mutants failed to localize, implying that the nuclear matrix is indispensable for necdin-dependent ubiquitination of PIAS1. Our data suggest that necdin suppresses PIAS1 both by inhibiting SUMO E3 ligase activity and by promoting ubiquitin- dependent degradation.	[Gur, Ibrahim; Fujiwara, Kazushiro; Hasegawa, Koichi; Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 565, Japan	Osaka University	Yoshikawa, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 565, Japan.	yoshikaw@protein.osaka-u.ac.jp			Japan Society for the Promotion of Science [24300134]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research B2 (24300134) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023764; AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Bischof JM, 2003, DEV DYNAM, V228, P475, DOI 10.1002/dvdy.10398; Chibuk TK, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-22; Chomez P, 2001, CANCER RES, V61, P5544; Denuc A, 2010, BIOCHEM SOC T, V38, P34, DOI 10.1042/BST0380034; Depaux A, 2007, ONCOGENE, V26, P6665, DOI 10.1038/sj.onc.1210486; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duval D, 2003, FEBS LETT, V554, P111, DOI 10.1016/S0014-5793(03)01116-5; Francois S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043335; Fujiwara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030948; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; Hasegawa K, 2012, J NEUROSCI, V32, P5562, DOI 10.1523/JNEUROSCI.0142-12.2012; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Huang ZY, 2013, J NEUROSCI, V33, P10362, DOI 10.1523/JNEUROSCI.5682-12.2013; Hudson JJR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017270; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Katsura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020365; Kegel A, 2010, COLD SH Q B, V75, P179, DOI 10.1101/sqb.2010.75.047; Kobayashi M, 2002, J BIOL CHEM, V277, P42128, DOI 10.1074/jbc.M205024200; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Kurita M, 2006, J NEUROSCI, V26, P12003, DOI 10.1523/JNEUROSCI.3002-06.2006; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Kuwako K, 2005, J NEUROSCI, V25, P7090, DOI 10.1523/JNEUROSCI.2083-05.2005; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2001, J BIOL CHEM, V276, P36624, DOI 10.1074/jbc.M101085200; Lopez-Sanchez N, 2007, PHYSIOL GENOMICS, V30, P156, DOI 10.1152/physiolgenomics.00249.2006; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Minamide R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084460; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Nakada Y, 1998, GENE, V213, P65, DOI 10.1016/S0378-1119(98)00206-6; Niinobe M, 2000, DEV NEUROSCI-BASEL, V22, P310, DOI 10.1159/000017455; Nishimura I, 2008, NEUROSCIENCE, V154, P572, DOI 10.1016/j.neuroscience.2008.03.075; Nishimura I, 2007, GENE EXPR PATTERNS, V7, P244, DOI 10.1016/j.modgep.2006.09.008; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pold M, 1999, GENOMICS, V59, P161, DOI 10.1006/geno.1999.5870; Rabellino A, 2012, CANCER RES, V72, P2275, DOI 10.1158/0008-5472.CAN-11-3159; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Sudharsan R, 2012, J CELL SCI, V125, P5819, DOI 10.1242/jcs.110825; Takazaki R, 2002, EXP CELL RES, V277, P220, DOI 10.1006/excr.2002.5558; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 2005, J CELL BIOCHEM, V94, P804, DOI 10.1002/jcb.20345; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Taniura H, 2002, J CELL BIOCHEM, V84, P545, DOI 10.1002/jcb.10047.abs; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Taylor EM, 2008, MOL CELL BIOL, V28, P1197, DOI 10.1128/MCB.00767-07; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.333; Zhao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048240; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	71	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99503	10.1371/journal.pone.0099503	http://dx.doi.org/10.1371/journal.pone.0099503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911587	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600096
J	Sikkema, WKA; Strikwerda, A; Sharma, M; Assi, K; Salh, B; Cox, ME; Mills, J				Sikkema, William K. A.; Strikwerda, Arend; Sharma, Manju; Assi, Kiran; Salh, Baljinder; Cox, Michael E.; Mills, Julia			Regulation of Mitotic Cytoskeleton Dynamics and Cytokinesis by Integrin-Linked Kinase in Retinoblastoma Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; SPINDLE ORGANIZATION; GENOMIC INSTABILITY; CYCLE PROGRESSION; PROLIFERATION; CENTROSOME; ILK; OSTEOSARCOMA; GLIOBLASTOMA	During cell division integrin-linked kinase (ILK) has been shown to regulate microtubule dynamics and centrosome clustering, processes involved in cell cycle progression, and malignant transformation. In this study, we examine the effects of downregulating ILK on mitotic function in human retinoblastoma cell lines. These retinal cancer cells, caused by the loss of function of two gene alleles (Rb1) that encode the retinoblastoma tumour suppressor, have elevated expression of ILK. Here we show that inhibition of ILK activity results in a concentration-dependent increase in nuclear area and multinucleated cells. Moreover, inhibition of ILK activity and expression increased the accumulation of multinucleated cells over time. In these cells, aberrant cytokinesis and karyokinesis correlate with altered mitotic spindle organization, decreased levels of cortical F-actin and centrosome de-clustering. Centrosome de-clustering, induced by ILK siRNA, was rescued in FLAG-ILK expressing Y79 cells as compared to those expressing FLAG-tag alone. Inhibition of ILK increased the proportion of cells exhibiting mitotic spindles and caused a significant G2/M arrest as early as 24 hours after exposure to QLT-0267. Live cell analysis indicate ILK downregulation causes an increase in multipolar anaphases and failed cytokinesis (bipolar and multipolar) of viable cells. These studies extend those indicating a critical function for ILK in mitotic cytoskeletal organization and describe a novel role for ILK in cytokinesis of Rb deficient cells.	[Sikkema, William K. A.; Strikwerda, Arend; Mills, Julia] Trinity Western Univ, Dept Biol, Langley, BC, Canada; [Sharma, Manju; Cox, Michael E.] Vancouver Coastal Hlth Res Inst, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Assi, Kiran; Salh, Baljinder] Univ British Columbia, Div Gastroenterol, Vancouver, BC V5Z 1M9, Canada; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Trinity Western University; Vancouver Coastal Health Research Institute; University of British Columbia; Simon Fraser University	Mills, J (corresponding author), Trinity Western Univ, Dept Biol, Langley, BC, Canada.	julia.mills@twu.ca			Murdock College Research Program for Life Sciences; Murdock General Science Grant; Murdock Trust	Murdock College Research Program for Life Sciences; Murdock General Science Grant; Murdock Trust	The authors gratefully acknowledge the award from the Murdock College Research Program for Life Sciences that made this research possible. A Murdock General Science Grant as a match to the CFI Leaders Opportunity Fund Grant enabled the purchase of the Olympus DSU spinning disk confocal used in this study. The Molecular and Cell Biology laboratory and Cell Culture laboratory in which these studies took place were made possible by a grant from Murdock Trust as a match to the Industry Canada Knowledge Infrastructure Program Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2012, NAT CELL BIOL; Assi K, 2008, GUT, V57, P931, DOI 10.1136/gut.2007.142778; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Chen Z, 2011, GRAEF ARCH CLIN EXP, V249, P1399, DOI 10.1007/s00417-010-1607-3; Dobreva I, 2008, J PROTEOME RES, V7, P1740, DOI 10.1021/pr700852r; Edwards LA, 2008, MOL CANCER THER, V7, P59, DOI 10.1158/1535-7163.MCT-07-0329; Fielding AB, 2011, ONCOGENE, V30, P521, DOI 10.1038/onc.2010.431; Fielding AB, 2008, CELL CYCLE, V7, P1899, DOI 10.4161/cc.7.13.6204; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Fielding A, 2009, CANCER METAST REV, V28, P99, DOI 10.1007/s10555-008-9177-0; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gagne D, 2010, J CELL PHYSIOL, V222, P387, DOI 10.1002/jcp.21963; Galimberti F, 2011, CLIN CANCER RES, V17, P1218, DOI 10.1158/1078-0432.CCR-10-1178; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gkretsi V, 2007, HEPATOLOGY, V45, P1025, DOI 10.1002/hep.21540; Hannigan GE, 2011, ONCOGENE, V30, P4375, DOI 10.1038/onc.2011.177; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; HOWARD MA, 1989, ARCH OPHTHALMOL-CHIC, V107, P1025, DOI 10.1001/archopht.1989.01070020087037; Huang CY, 2011, BIOCHEM PHARMACOL, V81, P577, DOI 10.1016/j.bcp.2010.12.005; Kalra J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2252; Koul D, 2005, MOL CANCER THER, V4, P1681, DOI 10.1158/1535-7163.MCT-05-0258; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053702; MacPherson D, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-9; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Manning AL, 2011, TRENDS CELL BIOL, V21, P433, DOI 10.1016/j.tcb.2011.05.003; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Mills J, 2006, J NEUROSCI, V26, P830, DOI 10.1523/JNEUROSCI.1852-05.2006; Mills J, 2003, J NEUROSCI, V23, P1638; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Seigel GM, 2005, MOL VIS, V11, P729; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Zhu J, 2005, ANTICANCER RES, V25, P1919	37	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98838	10.1371/journal.pone.0098838	http://dx.doi.org/10.1371/journal.pone.0098838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911651	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600016
J	Xing, K; Hoffmann, AA; Ma, CS				Xing, Kun; Hoffmann, Ary A.; Ma, Chun-Sen			Does Thermal Variability Experienced at the Egg Stage Influence Life History Traits across Life Cycle Stages in a Small Invertebrate?	PLOS ONE			English	Article							PLUTELLA-XYLOSTELLA LEPIDOPTERA; MYZUS-PERSICAE HEMIPTERA; DIAMONDBACK MOTH; INCUBATION-TEMPERATURE; HATCHLING PHENOTYPES; CONSTANT; SURVIVAL; INSECT; GROWTH; PERFORMANCE	Although effects of thermal stability on eggs have often been considered in vertebrates, there is little data thermal stability in insect eggs even though these eggs are often exposed in nature to widely fluctuating ambient conditions. The modularity of development in invertebrates might lead to compensation across life cycle stages but this remains to be tested particularly within the context of realistic temperature fluctuations encountered in nature. We simulated natural temperate fluctuations on eggs of the worldwide cruciferous insect pest, the diamondback moth (DBM), Plutella xylostella (L.), while maintaining the same mean temperature (25 degrees C +/- 0 degrees C, 25 +/- 4 degrees C, 25 +/- 6 degrees C, 25 +/- 8 degrees C, 25 +/- 10 degrees C, 25 +/- 12 degrees C) and assessed egg development, survival and life history traits across developmental stages. Moderate fluctuations (25 +/- 4 degrees C, 25 +/- 6 degrees C) did not influence performance compared to the constant temperature treatment, and none of the treatments influenced egg survival. However the wide fluctuating temperatures (25 +/- 10 degrees C, 25 +/- 2 degrees C) slowed development time and led to an increase in pre-pupal mass, although these changes did not translate into any effects on longevity or fecundity at the adult stage. These findings indicate that environmental effects can extend across developmental stages despite the modularity of moth development but also highlight that there are few fitness consequences of the most variable thermal conditions likely to be experienced by Plutella xylostella.	[Xing, Kun; Ma, Chun-Sen] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Climate Change Biol Res Grp, Beijing 100193, Peoples R China; [Hoffmann, Ary A.] Univ Melbourne, Dept Zool, Inst Bio21, Parkville, Vic 3052, Australia; [Hoffmann, Ary A.] Univ Melbourne, Dept Genet, Inst Bio21, Parkville, Vic 3052, Australia	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Melbourne; University of Melbourne	Ma, CS (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Climate Change Biol Res Grp, Beijing 100193, Peoples R China.	machunsen@caas.cn	Hoffmann, Ary/C-2961-2011; Ma, Chun-Sen/K-5414-2019; Hoffmann, Ary/R-2972-2019	Ma, Chun-Sen/0000-0002-3253-6921; Hoffmann, Ary/0000-0001-9497-7645	Ministry of Agriculture (MOA), PR China [201103021]	Ministry of Agriculture (MOA), PR China	This research was financially supported by a research grant (201103021) from the Ministry of Agriculture (MOA), PR China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrewartha SJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P597, DOI 10.1086/652245; Andrews RM, 2012, BIOL J LINN SOC, V106, P851, DOI 10.1111/j.1095-8312.2012.01901.x; Angilletta MJ, 2009, BIO HABIT, P35; Berger D, 2008, FUNCT ECOL, V22, P523, DOI 10.1111/j.1365-2435.2008.01392.x; Boardman L, 2013, J INSECT PHYSIOL, V59, P781, DOI 10.1016/j.jinsphys.2013.05.005; Booth DT, 2006, PHYSIOL BIOCHEM ZOOL, V79, P274, DOI 10.1086/499988; Braganza K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019998; Chen Fei-Zhou, 2003, Acta Ecologica Sinica, V23, P688; Chen TX, 2007, PLATEAU METEOR, V1, P17; Chen Yi-xin, 2011, Fujian Nongye Xuebao, V26, P611; Davis JA, 2006, ENVIRON ENTOMOL, V35, P1461, DOI 10.1603/0046-225X(2006)35[1461:EOHAFT]2.0.CO;2; Dmitriew C, 2005, OECOLOGIA, V142, P150, DOI 10.1007/s00442-004-1712-2; Du WG, 2009, J THERM BIOL, V34, P250, DOI 10.1016/j.jtherbio.2009.03.002; Escobar A, 2012, INSECT SCI, V19, P657, DOI 10.1111/j.1744-7917.2011.01470.x; Estay SA, 2011, POPUL ECOL, V53, P53, DOI 10.1007/s10144-010-0216-7; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; GHARIB B, 1983, FEBS LETT, V160, P119, DOI 10.1016/0014-5793(83)80949-1; Golizadeh A, 2007, INSECT SCI, V14, P309, DOI 10.1111/j.1744-7917.2007.00157.x; Golizadeh Ali, 2009, Journal of Asia-Pacific Entomology, V12, P207, DOI 10.1016/j.aspen.2009.05.002; Hassan MW, 2011, J ECON ENTOMOL, V104, P1436, DOI 10.1603/EC11046; Huey R.B., 1990, Cold Spring Harbor Monograph Series, V19, P37; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Liu SS, 1999, B ENTOMOL RES, V89, P53, DOI 10.1017/S0007485399000073; Ma CS, 2004, ENTOMOL EXP APPL, V110, P65, DOI 10.1111/j.0013-8703.2004.00123.x; Macqueen DJ, 2008, BIOL LETTERS, V4, P294, DOI 10.1098/rsbl.2007.0620; Makowski K, 2008, ATMOS CHEM PHYS, V8, P6483, DOI 10.5194/acp-8-6483-2008; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Micheli-Campbell MA, 2012, J ZOOL, V288, P143, DOI 10.1111/j.1469-7998.2012.00934.x; Ozanne SE, 2002, TRENDS ENDOCRIN MET, V13, P368, DOI 10.1016/S1043-2760(02)00666-5; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Petavy G, 2004, EVOL ECOL RES, V6, P873; PITTS GC, 1986, GROWTH, V50, P419; Potter KA, 2011, FUNCT ECOL, V25, P548, DOI 10.1111/j.1365-2435.2010.01807.x; QAYYUM A, 1987, J AUST ENTOMOL SOC, V26, P295; Rohmer C, 2004, J EXP BIOL, V207, P2735, DOI 10.1242/jeb.01087; Roux O, 2010, B ENTOMOL RES, V100, P543, DOI 10.1017/S0007485309990575; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Salvucci ME, 2000, J THERM BIOL, V25, P353, DOI 10.1016/S0306-4565(99)00107-2; Sarfraz RM, 2011, ENTOMOL SCI, V14, P20, DOI 10.1111/j.1479-8298.2010.00413.x; Shirai Y, 2000, B ENTOMOL RES, V90, P357, DOI 10.1017/S0007485300000481; Stevens MM, 1998, AQUAT INSECT, V20, P181, DOI 10.1076/aqin.20.3.181.4470; Stoks R, 2012, ANNU REV ENTOMOL, V57, P249, DOI 10.1146/annurev-ento-120710-100557; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Umeya K, 1973, JPN J APPL ENTOMOL Z, P112; WORNER SP, 1992, ENVIRON ENTOMOL, V21, P689, DOI 10.1093/ee/21.4.689; Xing Kun, 2013, Yingyong Shengtai Xuebao, V24, P1769; YANG YL, 1995, OECOLOGIA, V104, P225, DOI 10.1007/BF00328587; Yengkokpam S, 2013, AQUAC NUTR, V19, P297; Zerebecki RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014806; Zhao F, 2014, J ANIM ECOL, V83, P769, DOI 10.1111/1365-2656.12196	51	24	29	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99500	10.1371/journal.pone.0099500	http://dx.doi.org/10.1371/journal.pone.0099500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911213	Green Published, gold			2022-12-25	WOS:000337165600093
J	Hinamoto, N; Maeshima, Y; Saito, D; Yamasaki, H; Tanabe, K; Nasu, T; Watatani, H; Ujike, H; Kinomura, M; Sugiyama, H; Sonoda, H; Sato, Y; Makino, H				Hinamoto, Norikazu; Maeshima, Yohei; Saito, Daisuke; Yamasaki, Hiroko; Tanabe, Katsuyuki; Nasu, Tatsuyo; Watatani, Hiroyuki; Ujike, Haruyo; Kinomura, Masaru; Sugiyama, Hitoshi; Sonoda, Hikaru; Sato, Yasufumi; Makino, Hirofumi			Urinary and Plasma Levels of Vasohibin-1 Can Predict Renal Functional Deterioration in Patients with Renal Disorders	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NEGATIVE FEEDBACK REGULATOR; BASEMENT-MEMBRANE GLOMERULONEPHRITIS; GLOMERULAR CAPILLARY REPAIR; TYPE-2 DIABETIC MICE; REMNANT KIDNEY MODEL; IMPAIRED ANGIOGENESIS; HEMODIALYSIS-PATIENTS; EXPRESSION; VEGF	Vasohibin-1 (VASH-1) is a negative feedback regulator of angiogenesis, and a small vasohibin-binding protein (SVBP) serves as its secretory chaperone and contributes to its antiangiogenic effects. In the present study, we aimed to define the clinical significance of VASH-1 and SVBP in patients with chronic kidney disease (CKD). We recruited 67 Japanese hospitalized patients with renal disorders with (n = 45) or without (n = 22) renal biopsy samples and 10 Japanese healthy controls. We evaluated the correlations between the plasma and urinary levels of VASH-1/VASH-1-SVBP complex/SVBP and the clinicopathological parameters. The plasma levels of VASH-1 were inversely correlated with age and systolic and diastolic blood pressure and positively correlated with crescent formation. Increased plasma and urinary levels of VASH-1 and VASH-1-SVBP complex were significantly correlated with worse renal outcomes. These results demonstrate an association between elevated urinary and plasma levels of VASH-1 and progressive decline of the renal function, thus suggesting a potential role for VASH-1 in predicting a worse renal prognosis in patients with renal disease, including CKD.	[Hinamoto, Norikazu; Maeshima, Yohei; Saito, Daisuke; Yamasaki, Hiroko; Tanabe, Katsuyuki; Nasu, Tatsuyo; Watatani, Hiroyuki; Ujike, Haruyo; Kinomura, Masaru; Sugiyama, Hitoshi; Makino, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008530, Japan; [Maeshima, Yohei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Cardiovasc Dis, Okayama 7008530, Japan; [Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Ctr Chron Kidney Dis & Peritoneal Dialysis, Okayama 7008530, Japan; [Sonoda, Hikaru] Shionogi, Discovery Res Labs, Osaka, Japan; [Sato, Yasufumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Vasc Biol, Sendai, Miyagi 980, Japan	Okayama University; Okayama University; Okayama University; Shionogi & Company Limited; Tohoku University	Maeshima, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008530, Japan.	ymaeshim@md.okayama-u.ac.jp	Sato, Yasufumi/AAF-3367-2019; Tanabe, Katsuyuki/J-1341-2019; Sugiyama, Hitoshi/B-2252-2011	Tanabe, Katsuyuki/0000-0003-4767-5892; Sugiyama, Hitoshi/0000-0002-4127-6471	JSPS KAKENHI [20590958, 23591193]; Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	A portion of this study was supported by JSPS KAKENHI Grant Number (20590958, 23591193, YM) and the Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University (2010-2013, YM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Flyvbjerg A, 2002, DIABETES, V51, P3090, DOI 10.2337/diabetes.51.10.3090; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Futrakul N, 2008, CLIN HEMORHEOL MICRO, V38, P201; Guo QY, 2009, NEPHROL DIAL TRANSPL, V24, P3468, DOI 10.1093/ndt/gfp315; Hara A, 2006, KIDNEY INT, V69, P1986, DOI 10.1038/sj.ki.5000439; Heishi T, 2010, AM J PATHOL, V176, P1950, DOI 10.2353/ajpath.2010.090829; Hirokoshi K, 2007, NEPHRON CLIN PRACT, V106, pC43, DOI 10.1159/000101483; Hohenstein B, 2010, NEPHROL DIAL TRANSPL, V25, P3170, DOI 10.1093/ndt/gfq200; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Hosaka T, 2009, AM J PATHOL, V175, P430, DOI 10.2353/ajpath.2009.080788; Kang DH, 2001, AM J KIDNEY DIS, V37, P601, DOI 10.1053/ajkd.2001.22087; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Kang DH, 2001, J AM SOC NEPHROL, V12, P1448, DOI 10.1681/ASN.V1271448; Kim W, 2006, NY TIMES BK REV, P1; Kim YG, 2000, KIDNEY INT, V58, P2390, DOI 10.1046/j.1523-1755.2000.00422.x; Kitamoto Y, 1997, J CLIN INVEST, V99, P2351, DOI 10.1172/JCI119416; Lemley KV, 2002, KIDNEY INT, V61, P1475, DOI 10.1046/j.1523-1755.2002.00269.x; Li DJ, 2010, CANCER SCI, V101, P448, DOI 10.1111/j.1349-7006.2009.01388.x; Long DA, 2001, J AM SOC NEPHROL, V12, P2721, DOI 10.1681/ASN.V12122721; Macconi D, 2006, AM J PATHOL, V168, P42, DOI 10.2353/ajpath.2006.050398; Mallamaci F, 2008, J HYPERTENS, V26, P1875, DOI 10.1097/HJH.0b013e328307c3d2; Masuda Y, 2001, AM J PATHOL, V159, P599, DOI 10.1016/S0002-9440(10)61731-2; Miyashita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046459; Miyazaki Y, 2012, CLIN CANCER RES, V18, P4145, DOI 10.1158/1078-0432.CCR-12-0073; Nasu T, 2012, AM J PHYSIOL-RENAL, V302, pF1616, DOI 10.1152/ajprenal.00538.2011; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; Ostendorf T, 1999, J CLIN INVEST, V104, P913, DOI 10.1172/JCI6740; Rizkalla B, 2005, J HYPERTENS, V23, P153, DOI 10.1097/00004872-200501000-00026; Saito D, 2011, AM J PHYSIOL-RENAL, V300, pF873, DOI 10.1152/ajprenal.00503.2010; Shen JK, 2006, FASEB J, V20, P723, DOI 10.1096/fj.05-5046fje; Shimizu A, 2004, J AM SOC NEPHROL, V15, P2655, DOI 10.1097/01.ASN.0000141038.28733.F2; Shulman K, 1996, J AM SOC NEPHROL, V7, P661; Sung SH, 2006, J AM SOC NEPHROL, V17, P3093, DOI 10.1681/ASN.2006010064; Suzuki Y, 2010, J CELL SCI, V123, P3094, DOI 10.1242/jcs.067538; Tamaki K, 2010, CANCER SCI, V101, P1051, DOI 10.1111/j.1349-7006.2009.01483.x; Tamaki K, 2009, CANCER SCI, V100, P88, DOI 10.1111/j.1349-7006.2008.01015.x; Thorner PS, 2008, J AM SOC NEPHROL, V19, P495, DOI 10.1681/ASN.2006101115; Tufro A, 1999, J AM SOC NEPHROL, V10, P2125; Wang G, 2009, AM J HYPERTENS, V22, P300, DOI 10.1038/ajh.2008.360; Wang QZ, 2012, MED ONCOL, V29, P2727, DOI 10.1007/s12032-011-0106-7; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Watanabe T, 2012, TRANSPL P, V44, P1155, DOI 10.1016/j.transproceed.2012.02.022; Woolf AS, 2001, PEDIATR NEPHROL, V16, P177, DOI 10.1007/s004670000509; Yamashita H, 2006, BIOCHEM BIOPH RES CO, V345, P919, DOI 10.1016/j.bbrc.2006.04.176; Yoshinaga K, 2008, CANCER SCI, V99, P914, DOI 10.1111/j.1349-7006.2008.00777.x; Yoshinaga K, 2011, CANCER SCI, V102, P446, DOI 10.1111/j.1349-7006.2010.01812.x; Yuan HT, 2002, KIDNEY INT, V61, P2078, DOI 10.1046/j.1523-1755.2002.00381.x	50	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e96932	10.1371/journal.pone.0096932	http://dx.doi.org/10.1371/journal.pone.0096932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	25255225	gold, Green Submitted, Green Published			2022-12-25	WOS:000340947700007
J	Zhou, YX; Yu, F; Duong, T				Zhou, Yongxia; Yu, Fang; Duong, Timothy			Multiparametric MRI Characterization and Prediction in Autism Spectrum Disorder Using Graph Theory and Machine Learning	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; FUNCTIONAL CONNECTIVITY; CORTICAL THICKNESS; FEATURE-SELECTION; BRAIN; CHILDREN; CORTEX; PERFORMANCE; NETWORKS; MIND	This study employed graph theory and machine learning analysis of multiparametric MRI data to improve characterization and prediction in autism spectrum disorders (ASD). Data from 127 children with ASD (13.5 +/- 6.0 years) and 153 age- and gender-matched typically developing children (14.5 +/- 5.7 years) were selected from the multi-center Functional Connectome Project. Regional gray matter volume and cortical thickness increased, whereas white matter volume decreased in ASD compared to controls. Small-world network analysis of quantitative MRI data demonstrated decreased global efficiency based on gray matter cortical thickness but not with functional connectivity MRI (fcMRI) or volumetry. An integrative model of 22 quantitative imaging features was used for classification and prediction of phenotypic features that included the autism diagnostic observation schedule, the revised autism diagnostic interview, and intelligence quotient scores. Among the 22 imaging features, four (caudate volume, caudate-cortical functional connectivity and inferior frontal gyrus functional connectivity) were found to be highly informative, markedly improving classification and prediction accuracy when compared with the single imaging features. This approach could potentially serve as a biomarker in prognosis, diagnosis, and monitoring disease progression.	[Zhou, Yongxia] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Yu, Fang; Duong, Timothy] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, South Texas Vet Hlth Care Syst, Dept Vet Affairs,Dept Ophthalmol, San Antonio, TX 78229 USA	University of Pennsylvania; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Duong, T (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, South Texas Vet Hlth Care Syst, Dept Vet Affairs,Dept Ophthalmol, San Antonio, TX 78229 USA.	duongt@uthscsa.edu	Yu, Fang/AAO-9407-2020; Duong, Tim/AAL-8357-2021	Duong, Tim/0000-0001-6403-2827; Zhou, Yongxia (Sharon)/0000-0002-4931-2318; O'Neill, Christopher/0000-0003-4003-8727	NINDS NIH HHS [R01 NS039135] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039135] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Bastiaansen JA, 2011, BIOL PSYCHIAT, V69, P832, DOI 10.1016/j.biopsych.2010.11.007; Buitelaar JK, 1999, J CHILD PSYCHOL PSYC, V40, P869, DOI 10.1111/1469-7610.00505; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Di Martino A, 2014, Mol Psychiatry, V19, P659, DOI 10.1038/mp.2013.78; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Duchesnay E, 2011, NEUROIMAGE, V57, P1003, DOI 10.1016/j.neuroimage.2011.05.011; Ebisch SJH, 2011, HUM BRAIN MAPP, V32, P1013, DOI 10.1002/hbm.21085; Ecker C, 2013, JAMA PSYCHIAT, V70, P59, DOI 10.1001/jamapsychiatry.2013.265; Ecker C, 2009, NEUROREPORT, V20, P1155, DOI 10.1097/WNR.0b013e32832ec181; Elliott MA, 1999, MAGN RESON MED, V41, P450, DOI 10.1002/(SICI)1522-2594(199903)41:3<450::AID-MRM4>3.0.CO;2-9; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fletcher PT, 2010, NEUROIMAGE, V51, P1117, DOI 10.1016/j.neuroimage.2010.01.083; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Gagliardi F, 2011, ARTIF INTELL MED, V52, P123, DOI 10.1016/j.artmed.2011.04.002; Gallese V, 2013, DEV MED CHILD NEUROL, V55, P15, DOI 10.1111/j.1469-8749.2012.04398.x; Geva S, 2011, BRAIN, V134, P3071, DOI 10.1093/brain/awr232; Hamilton AFD, 2013, DEV COGN NEUROS-NETH, V3, P91, DOI 10.1016/j.dcn.2012.09.008; Hardan AY, 2006, AM J PSYCHIAT, V163, P1290, DOI 10.1176/appi.ajp.163.7.1290; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hsieh L, 2001, BRAIN LANG, V76, P227, DOI 10.1006/brln.2000.2382; Huang Y Y, 1983, Sheng Li Ke Xue Jin Zhan, V14, P356; Hui W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045502; Jakab A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060982; Kang S, 2013, RES DEV DISABIL, V34, P739, DOI 10.1016/j.ridd.2012.10.007; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Khan S, 2013, P NATL ACAD SCI USA, V110, P3107, DOI 10.1073/pnas.1214533110; Lange N, 2010, AUTISM RES, V3, P350, DOI 10.1002/aur.162; Langen M, 2007, BIOL PSYCHIAT, V62, P262, DOI 10.1016/j.biopsych.2006.09.040; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Lee PS, 2009, CEREB CORTEX, V19, P1787, DOI 10.1093/cercor/bhn209; Nixon P, 2004, J COGNITIVE NEUROSCI, V16, P289, DOI 10.1162/089892904322984571; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peters JM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-54; Rapin I, 2008, PEDIATR CLIN N AM, V55, P1129, DOI 10.1016/j.pcl.2008.07.005; Rizzolatti G, 2010, EXP BRAIN RES, V200, P223, DOI 10.1007/s00221-009-2002-3; Rudie JD, 2012, CEREB CORTEX, V22, P1025, DOI 10.1093/cercor/bhr171; Sahyoun CP, 2010, NEUROPSYCHOLOGIA, V48, P86, DOI 10.1016/j.neuropsychologia.2009.08.013; Sivaswamy L, 2010, J CHILD NEUROL, V25, P1223, DOI 10.1177/0883073809358765; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Turner Katherine C, 2006, Behav Brain Funct, V2, P34, DOI 10.1186/1744-9081-2-34; Uddin Lucina Q, 2013, Front Hum Neurosci, V7, P458, DOI 10.3389/fnhum.2013.00458; van der Zande FHR, 2005, NEURORADIOLOGY, V47, P114, DOI 10.1007/s00234-004-1274-3; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Vissers ME, 2012, NEUROSCI BIOBEHAV R, V36, P604, DOI 10.1016/j.neubiorev.2011.09.003; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Zhou Y, 2013, AM J NEURORADIOL, V34, P1180, DOI 10.3174/ajnr.A3386; Zhou Yongxia, 2013, ISRN Geriatr, V2013; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310	56	78	78	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e90405	10.1371/journal.pone.0090405	http://dx.doi.org/10.1371/journal.pone.0090405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	25051234	gold, Green Published, Green Submitted			2022-12-25	WOS:000338701300001
J	Lee, HK; Song, HE; Lee, HB; Kim, CS; Koketsu, M; Ngan, LTM; Ahn, YJ				Lee, Hyun-Kyung; Song, Ha Eun; Lee, Haeng-Byung; Kim, Cheol-Soo; Koketsu, Mamoru; Luong Thi My Ngan; Ahn, Young-Joon			Growth Inhibitory, Bactericidal, and Morphostructural Effects of Dehydrocostus Lactone from Magnolia sieboldii Leaves on Antibiotic-Susceptible and -Resistant Strains of Helicobacter pylori	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; IN-VITRO; MEDICINAL-PLANTS; UREASE; OMEPRAZOLE; PHYTOCHEMICALS; CLARITHROMYCIN; METRONIDAZOLE; THERAPY; PH	Helicobacter pylori is associated with various diseases of the upper gastrointestinal tract, such as gastric inflammation and duodenal and gastric ulcers. The aim of the study was to assess anti-H. pylori effects of the sesquiterpene lactone dehydrocostus lactone (DCL) from Magnolia sieboldii leaves, compared to commercial pure DCL, two previously known sesquiterpene lactones (costunolide and parthenolide), (-)-epigallocatechin gallate, and four antibiotics. The antibacterial activity of natural DCL toward antibiotic-susceptible H. pylori ATCC 700392 and H. pylori ATCC 700824 strains (MIC, 4.9 and 4.4 mg/L) was similar to that of commercial DCL and was more effective than costunolide, parthenolide, and EGCG. The activity of DCL was slightly lower than that of metronidazole (MIC, 1.10 and 1.07 mg/L). The antibacterial activity of DCL was virtually identical toward susceptible and resistant strains, even though resistance to amoxicillin (MIC, 11.1 mg/L for PED 503G strain), clarithromycin (49.8 mg/L for PED 3582GA strain), metronidazole (21.6 mg/L for H. pylori ATCC 43504 strain; 71.1 mg/L for 221 strain), or tetracycline (14.2 mg/L for B strain) was observed. This finding indicates that DCL and the antibiotics do not share a common mode of action. The bactericidal activity of DCL toward H. pylori ATCC 43504 was not affected by pH values examined (4.0-7.0). DCL caused considerable conversion to coccoid form (94 versus 49% at 8 and 4 mg/L of DCL for 48 h). The Western blot analysis revealed that urease subunits (UreA and UreB) of H. pylori ATCC 43504 were not affected by 10 mM of DCL, whereas UreA monomer band completely disappeared at 0.1 mM of (-)-epigallocatechin gallate. Global efforts to reduce the level of antibiotics justify further studies on M. sieboldii leaf-derived materials containing DCL as potential antibacterial products or a lead molecule for the prevention or eradication of drug-resistant H. pylori.	[Lee, Hyun-Kyung; Lee, Haeng-Byung] Seoul Natl Univ, Coll Agr & Life Sci, Interdisciplinary Program Agr Biotechnol, Seoul, South Korea; [Song, Ha Eun; Ahn, Young-Joon] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Cheol-Soo] Halla Bot Garden, Jeju City, Jeju, South Korea; [Koketsu, Mamoru] Gifu Univ, Dept Chem & Biomol Sci, Gifu, Japan; [Luong Thi My Ngan] Vietnam Natl Univ, Ho Chi Minh City Univ Sci, Fac Biol, Dept Plant Biotechnol & Biotransformat, Ho Chi Minh City, Vietnam	Seoul National University (SNU); Seoul National University (SNU); Gifu University; Vietnam National University Hanoi; Vietnam National University Hochiminh City	Ngan, LTM (corresponding author), Vietnam Natl Univ, Ho Chi Minh City Univ Sci, Fac Biol, Dept Plant Biotechnol & Biotransformat, Ho Chi Minh City, Vietnam.	ltmngan@hcmus.edu.vn; yjahn@snu.ac.kr	Cho, Eunyoung/AAV-4469-2020; Kim, Cho-il/B-5961-2011	Cho, Eunyoung/0000-0001-6594-2582; Luong, Ngan/0000-0003-0500-007X	Brain Korea 21 PLUS through the National Research Foundation of Korea - Ministry of Education of the Korean Government	Brain Korea 21 PLUS through the National Research Foundation of Korea - Ministry of Education of the Korean Government	This work was carried out with the support by the Brain Korea 21 PLUS through the National Research Foundation of Korea funded by the Ministry of Education of the Korean Government to Y.-J. Ahn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsson I, 1999, J ANTIMICROB CHEMOTH, V44, P629, DOI 10.1093/jac/44.5.629; Buhling A, 2001, ALIMENT PHARM THER, V15, P1445, DOI 10.1046/j.1365-2036.2001.01033.x; Chaturvedi D., 2011, SESQUITERPENE LACTON, P313; Cho SH, 2003, J APPL MICROBIOL, V95, P7, DOI 10.1046/j.1365-2672.2003.01998.x; Cole SP, 1999, J INFECT DIS, V180, P1713, DOI 10.1086/315079; Cole SP, 1997, INFECT IMMUN, V65, P843, DOI 10.1128/IAI.65.2.843-846.1997; De Leo M, 2006, PHYTOCHEMISTRY, V67, P2623, DOI 10.1016/j.phytochem.2006.07.017; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Fabry W, 1996, CHEMOTHERAPY, V42, P315, DOI 10.1159/000239460; Francesco Vincenzo De, 2011, World J Gastrointest Pathophysiol, V2, P35, DOI 10.4291/wjgp.v2.i3.35; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Funatogawa K, 2004, MICROBIOL IMMUNOL, V48, P251, DOI 10.1111/j.1348-0421.2004.tb03521.x; Gerrits MM, 2006, LANCET INFECT DIS, V6, P699, DOI 10.1016/S1473-3099(06)70627-2; Graham DY, 2014, CLIN GASTROENTEROL H, V12, P177, DOI 10.1016/j.cgh.2013.05.028; Haristoy X, 2005, PLANTA MED, V71, P326, DOI 10.1055/s-2005-864098; Hifumi E, 2005, FEBS J, V272, P4497, DOI 10.1111/j.1742-4658.2005.04869.x; Icatlo FC, 1998, J BIOL CHEM, V273, P18130, DOI 10.1074/jbc.273.29.18130; ITOH T, 1987, MICROBIOL IMMUNOL, V31, P603, DOI 10.1111/j.1348-0421.1987.tb03121.x; Kim KW, 2007, MICRON, V38, P626, DOI 10.1016/j.micron.2006.09.006; Kusters JG, 1997, INFECT IMMUN, V65, P3672, DOI 10.1128/IAI.65.9.3672-3679.1997; Lee Hyun-Kyung, 2004, Journal of Applied Biological Chemistry, V47, P91; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; Lin YT, 2005, APPL ENVIRON MICROB, V71, P8558, DOI 10.1128/AEM.71.12.8558-8564.2005; Luong TMN, 2012, J AGR FOOD CHEM, V60, P9062, DOI 10.1021/jf3035034; Mabe K, 1999, ANTIMICROB AGENTS CH, V43, P1788, DOI 10.1128/AAC.43.7.1788; MALANOSKI GJ, 1993, EUR J CLIN MICROBIOL, V12, P131, DOI 10.1007/BF01967591; Marshall BJ, 2005, MED CLIN N AM, V89, P313, DOI 10.1016/j.mcna.2004.09.001; Matsubara S, 2003, BIOCHEM BIOPH RES CO, V310, P715, DOI 10.1016/j.bbrc.2003.09.066; Megraud F, 2007, CLIN MICROBIOL REV, V20, P280, DOI 10.1128/CMR.00033-06; Nakao M, 1998, HELICOBACTER, V3, P21, DOI 10.1046/j.1523-5378.1998.08024.x; Nascimento GGF, 2000, BRAZ J MICROBIOL, V31, P247; Ohno T, 2003, HELICOBACTER, V8, P207, DOI 10.1046/j.1523-5378.2003.00146.x; Park BS, 2006, J ETHNOPHARMACOL, V105, P255, DOI 10.1016/j.jep.2005.11.005; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Rimbara E, 2011, NAT REV GASTRO HEPAT, V8, P79, DOI 10.1038/nrgastro.2010.210; Saito N, 2003, J INFECTION, V46, P49, DOI 10.1053/jinf.2002.1047; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Sekiguchi H, 2008, J CLIN BIOCHEM NUTR, V43, P109, DOI 10.3164/jcbn.2008054; SHIBATA K, 1995, ANTIMICROB AGENTS CH, V39, P1295, DOI 10.1128/AAC.39.6.1295; Sjostrom JE, 1996, J MED MICROBIOL, V44, P425; TANIGUCHI M, 1995, BIOSCI BIOTECH BIOCH, V59, P2064, DOI 10.1271/bbb.59.2064; Taylor David N., 1995, P551; Wang YC, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep147; Watt IM, 1997, PRICIPLES PRACTICE E; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Wink M, 2006, ADV PHYTOMED, V3, P251; Yoshikawa M, 2000, BIOORGAN MED CHEM, V8, P2071, DOI 10.1016/S0968-0896(00)00127-9; Zeyrek FY, 2005, ANN MICROBIOL, V55, P125	48	99	102	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95530	10.1371/journal.pone.0095530	http://dx.doi.org/10.1371/journal.pone.0095530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747984	Green Submitted, gold, Green Published			2022-12-25	WOS:000335226500121
J	Wu, CC; Tsai, TH; Chang, C; Lee, TT; Lin, C; Cheng, IHJ; Sun, MC; Chuang, YJ; Chen, BS				Wu, Chia-Chou; Tsai, Tsung-Han; Chang, Chieh; Lee, Tian-Thai; Lin, Che; Cheng, Irene Han-Juo; Sun, Mu-Chien; Chuang, Yung-Jen; Chen, Bor-Sen			On the Crucial Cerebellar Wound Healing-Related Pathways and Their Cross-Talks after Traumatic Brain Injury in Danio rerio	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ZEBRAFISH MODEL; CELL-MIGRATION; IMMUNE-SYSTEM; REGENERATION; NEUROTRANSMITTERS; NEUROGENESIS; CANNABINOIDS; PATHOGENESIS; MECHANISMS	Upon injury, the direct damage and the subsequent secondary injury in the brain often result in chronic neurological disorders. Due to multifactorial nature of secondary injury and subsequent complex cellular responses, much of the underlying mechanisms are unclear. This study used an adult zebrafish cerebellum injury model to investigate the phenotypes and the secondary injury responses for recovery mechanisms of injured brain. Using the time course microarray analysis, a candidate protein-protein interaction (PPI) network was refined as cerebellar wound healing PPI network by dynamic modeling and big data mining. Pathway enrichment and ontological analysis were incorporated into the refined network to highlight the main molecular scheme of cerebellar wound healing. Several significant pathways, including chemokine, Phosphatidylinositide 3-kinases, and axon guidance signaling pathway and their cross-talks through PI3K, PAK2, and PLXNA3 were identified to coordinate for neurogenesis and angiogenesis, which are essential for the restoration of the injured brain. Our finding provides an insight into the molecular restoration mechanisms after traumatic brain injury, and open up new opportunity to devise the treatment for traumatic brain injury in human.	[Wu, Chia-Chou; Tsai, Tsung-Han; Lin, Che; Chen, Bor-Sen] Natl Tsing Hua Univ, Deptartment Elect Engn, Hsinchu, Taiwan; [Chang, Chieh; Lee, Tian-Thai; Chuang, Yung-Jen] Natl Tsing Hua Univ, Deptartment Med Sci, Hsinchu, Taiwan; [Chang, Chieh; Lee, Tian-Thai; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Cheng, Irene Han-Juo] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Stroke Ctr, Changhua, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Deptartment Neurol, Changhua, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital	Chen, BS (corresponding author), Natl Tsing Hua Univ, Deptartment Elect Engn, Hsinchu, Taiwan.	bschen@ee.nthu.edu.tw	Wu, Chia-Chou/L-1058-2013; Chen, Bor-Sen/D-9114-2017; Hsu, Yuan-Man/K-7074-2015	Wu, Chia-Chou/0000-0002-4009-6858; Chang, Jia-Hao/0000-0001-7843-2688; Chang, Chiung-Hung/0000-0001-6917-4875; Hsu, Yuan-Man/0000-0002-4575-7475	National Science Council of Taiwan, R.O.C. [NSC 102-2745-E-007-001-ASP]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	The work was supported by the National Science Council of Taiwan, R.O.C. [NSC 102-2745-E-007-001-ASP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2010, ADV EXP MED BIOL, V695, P184, DOI 10.1007/978-1-4419-7037-4_13; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; BLALOCK JE, 1992, CHEM IMMUNOL, V52, P1; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Cameron DA, 2005, MOL VIS, V11, P775; Chen BS, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-46; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hui SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084212; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Levin ED, 2009, FRONT NEUROSCI, P293; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lukacs NW, 2001, NAT REV IMMUNOL, V1, P108, DOI 10.1038/35100503; Martins RAP, 2008, BRAIN RES, V1192, P37, DOI 10.1016/j.brainres.2007.04.076; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Postlethwait J, 1999, METHOD CELL BIOL, V60, P149; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Qiu YH, 1996, ADV NEUROIMMUNOL, V6, P223, DOI 10.1016/S0960-5428(96)00018-6; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Ridley AJ, 2001, J CELL SCI, V114, P2713; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233; Wang YC, 2010, BMC SYST BIOL, V4, DOI [10.1186/1752-0509-4-S2-S1, 10.1186/1752-0509-4-20]; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Yang SK, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-19	49	16	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e97902	10.1371/journal.pone.0097902	http://dx.doi.org/10.1371/journal.pone.0097902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926785	gold, Green Submitted, Green Published			2022-12-25	WOS:000338278100009
J	Liu, J; Huang, JS; Su, TX; Bertoldi, K; Clarke, DR				Liu, Jia; Huang, Jiangshui; Su, Tianxiang; Bertoldi, Katia; Clarke, David R.			Structural Transition from Helices to Hemihelices	PLOS ONE			English	Article							NONLINEAR DYNAMICS; TENDRIL PERVERSION; FILAMENTS; LEAVES; INSTABILITIES; KIRCHHOFF; MECHANICS; STRIPS; EDGES; RODS	Helices are amongst the most common structures in nature and in some cases, such as tethered plant tendrils, a more complex but related shape, the hemihelix forms. In its simplest form it consists of two helices of opposite chirality joined by a perversion. A recent, simple experiment using elastomer strips reveals that hemihelices with multiple reversals of chirality can also occur, a richness not anticipated by existing analyses. Here, we show through analysis and experiments that the transition from a helical to a hemihelical shape, as well as the number of perversions, depends on the height to width ratio of the strip's cross-section. Our findings provides the basis for the deterministic manufacture of a variety of complex three-dimensional shapes from flat strips.	[Liu, Jia; Huang, Jiangshui; Su, Tianxiang; Bertoldi, Katia; Clarke, David R.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Bertoldi, Katia; Clarke, David R.] Harvard Univ, Kavli Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University	Bertoldi, K (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	bertoldi@seas.harvard.edu; clarke@seas.harvard.edu	Huang, Jiangshui/G-5833-2010	Huang, Jiangshui/0000-0002-3523-2165; Liu, Jia/0000-0002-5628-8889; Liu, Jianfeng/0000-0003-1172-7080; Clarke, David/0000-0002-5902-7369	Materials Research Science and Engineering Center under NSF [DMR-0820484]; National Science Foundation [CMMI-1149456-CAREER, CMMI-1333835]; Wyss institute through the Seed Grant Program	Materials Research Science and Engineering Center under NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Wyss institute through the Seed Grant Program	This work was supported by the Materials Research Science and Engineering Center under NSF Award No. DMR-0820484. K.B. also acknowledges support from the National Science Foundation (CMMI-1149456-CAREER) and the Wyss institute through the Seed Grant Program. D.R. acknowledges funding from the National Science Foundation (CMMI-1333835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon S, 2011, SCIENCE, V333, P1726, DOI 10.1126/science.1203874; Audoly B, 2002, CR MECANIQUE, V330, P831, DOI 10.1016/S1631-0721(02)01545-0; Audoly B, 2010, ELASTICITY GEOMETRY; Ball P, 1999, SELF MADE TAPESTRY P; Balluffi RW, 2005, KINETICS OF MATERIALS, P1; Bower A.F., 2009, APPL MECH SOLIDS; Budynas R.G., 2002, ROARKS FORMULAS STRE; Chapman RE, 1965, BIOL SKIN HAIR GROWT; Chen Z, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3530441; COLEMAN BD, 1993, ARCH RATION MECH AN, V121, P339, DOI 10.1007/BF00375625; Darwin C, 1888, MOVEMENTS HABITS CLI, P55; Forterre Y, 2011, SCIENCE, V333, P1715, DOI 10.1126/science.1210734; Gent AN, 1996, RUBBER CHEM TECHNOL, V69, P59, DOI 10.5254/1.3538357; Gerbode SJ, 2012, SCIENCE, V337, P1087, DOI 10.1126/science.1223304; Goriely A, 1997, PHYSICA D, V105, P20, DOI 10.1016/S0167-2789(96)00290-4; Goriely A, 1997, PHYSICA D, V105, P45, DOI 10.1016/S0167-2789(97)83389-1; Goriely A, 2000, PHYS REV E, V61, P4508, DOI 10.1103/PhysRevE.61.4508; Goriely A, 2000, NONLINEAR DYNAM, V21, P101, DOI 10.1023/A:1008366526875; Goriely A, 1998, PHYS REV LETT, V80, P1564, DOI 10.1103/PhysRevLett.80.1564; Gray A, 1868, GRAYS LESSONS BOT VE, P38; Huang JS, 2012, SOFT MATTER, V8, P6291, DOI 10.1039/c2sm25278c; Kirchhoff G, 1859, J REINE ANGEW MATH, V56, P285, DOI DOI 10.1515/CRLL.1859.56.285; Kirchhoff G., 1876, MECHANIK, V28; Listing JB, 1847, VORSTUDIEN TOPOLOGIE, VI, P811; Marder M, 2003, EUROPHYS LETT, V62, P498, DOI 10.1209/epl/i2003-00334-5; Maxwell MC, 1873, TREATISE ELECT MAGNE, VII, P456; McMillen T, 2002, J NONLINEAR SCI, V12, P241, DOI 10.1007/s00332-002-0493-1; Patricio P, 1998, PHYSICA D, V124, P285, DOI 10.1016/S0167-2789(98)00203-6; Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; Sharon E, 2004, AM SCI, V92, P254, DOI 10.1511/2004.47.932; Sharon E, 2002, NATURE, V419, P579, DOI 10.1038/419579a; Sharon E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046211; Silverberg JL, 2012, P NATL ACAD SCI USA, V109, P16794, DOI 10.1073/pnas.1209287109; Thompson D. W., 1917, GROWTH FORM; Valverde J, 2010, J NONLINEAR SCI, V20, P309, DOI 10.1007/s00332-010-9059-9; Zhou HJ, 1999, J CHEM PHYS, V110, P1247, DOI 10.1063/1.478167	36	76	75	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e93183	10.1371/journal.pone.0093183	http://dx.doi.org/10.1371/journal.pone.0093183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24915574	Green Submitted, Green Published, gold			2022-12-25	WOS:000335298200007
J	Kim, H; Choi, K; Kang, H; Lee, SY; Chi, SW; Lee, MS; Song, J; Im, D; Choi, Y; Cho, SC				Kim, Hyeongki; Choi, Kwangman; Kang, Hyunju; Lee, So-Young; Chi, Seung-Wook; Lee, Min-Sung; Song, Jaehyoung; Im, Donghwa; Choi, Yura; Cho, Sungchan			Identification of a Novel Function of CX-4945 as a Splicing Regulator	PLOS ONE			English	Article							PROTEIN-KINASE CK2; PRE-MESSENGER-RNA; SERINE-RICH; SR PROTEINS; IN-VIVO; DISEASE; PHOSPHORYLATION; INHIBITOR; FAMILY; PURIFICATION	Alternative splicing is a nearly ubiquitous versatile process that controls gene expression and creates numerous protein isoforms with different functions from a single gene. The significance of alternative splicing has been confirmed by the increasing number of human diseases that are caused by misregulation of splicing events. Very few compounds, however, have been reported to act as inhibitors of alternative splicing, and their potential clinical use needs to be evaluated. Here, we report that CX-4945, a previously well-characterized inhibitor of casein kinase 2 (CK2) and a molecule currently in clinical trials (Phase II) for cancer treatment, regulates splicing in mammalian cells in a CK2-independent manner. Transcriptome-wide analysis using exon array also showed a widespread alteration in alternative splicing of numerous genes. We found that CX-4945 potently inhibits the Cdc2-like kinases (Clks) in vitro and in turn, leads to suppression of the phosphorylation of serine/arginine-rich (SR) proteins in mammalian cells. Surprisingly, the overall efficacy of CX-4945 on Clks (IC50 = 3-90 nM) was stronger than that of TG-003, the strongest inhibitor reported to date. Of the Clks, Clk2 was most strongly inhibited by CX-4945 in an ATP-competitive manner. Our research revealed an unexpected activity of the drug candidate CX-4945 as a potent splicing modulator and also suggested a potential application for therapy of diseases caused by abnormal splicing.	[Kim, Hyeongki; Choi, Kwangman; Kang, Hyunju; Song, Jaehyoung; Im, Donghwa; Choi, Yura; Cho, Sungchan] Korea Res Inst Biosci & Biotechnol, Targeted Med Res Ctr, Cheongwon, Chungbuk, South Korea; [Kim, Hyeongki; Cho, Sungchan] Univ Sci & Technol, Dept Biomol Sci, Taejon, South Korea; [Lee, So-Young] Minist Food & Drug Safety, Int Cooperat Off, Cheongwon, Chungbuk, South Korea; [Chi, Seung-Wook; Lee, Min-Sung] Korea Res Inst Biosci & Biotechnol, BioMed Prote Res Ctr, Cheongwon, Chungbuk, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ministry of Food & Drug Safety (MFDS), Republic of Korea; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Cho, SC (corresponding author), Korea Res Inst Biosci & Biotechnol, Targeted Med Res Ctr, Cheongwon, Chungbuk, South Korea.	sungchan@kribb.re.kr		Shin, Ju-Young/0000-0003-1010-7525	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2003182]; KRIBB Research Initiative Program	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; KRIBB Research Initiative Program	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2003182) and KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Bardella C, 2004, CANCER RES, V64, P5154, DOI 10.1158/0008-5472.CAN-04-0600; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Cabrejos ME, 2004, J CELL BIOCHEM, V93, P2, DOI 10.1002/jcb.20209; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Chabot B, 1996, TRENDS GENET, V12, P472, DOI 10.1016/0168-9525(96)10037-8; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Coombs TC, 2013, BIOORG MED CHEM LETT, V23, P3654, DOI 10.1016/j.bmcl.2013.02.096; DAHMUS ME, 1981, J BIOL CHEM, V256, P3319; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Ferguson AD, 2011, FEBS LETT, V585, P104, DOI 10.1016/j.febslet.2010.11.019; FU XD, 1995, RNA, V1, P663; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Hertel KJ, 2005, TRENDS BIOCHEM SCI, V30, P115, DOI 10.1016/j.tibs.2005.01.002; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kim E, 2008, RNA BIOL, V5, P17, DOI 10.4161/rna.5.1.5944; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Kuroyanagi N, 1998, BIOCHEM BIOPH RES CO, V242, P357, DOI 10.1006/bbrc.1997.7913; Levinson N, 2006, RNA, V12, P925, DOI 10.1261/rna.8306; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Nayler O, 1997, BIOCHEM J, V326, P693, DOI 10.1042/bj3260693; Ng B, 2004, J ALLERGY CLIN IMMUN, V114, P1463, DOI 10.1016/j.jaci.2004.09.006; Pagano MA, 2007, CHEMBIOCHEM, V8, P129, DOI 10.1002/cbic.200600293; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pilch B, 2001, CANCER RES, V61, P6876; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Sanford J R, 2003, Prog Mol Subcell Biol, V31, P33; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Valcarcel J, 1996, TRENDS BIOCHEM SCI, V21, P296, DOI 10.1016/0968-0004(96)10039-6; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Younis I, 2010, MOL CELL BIOL, V30, P1718, DOI 10.1128/MCB.01301-09; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	53	78	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94978	10.1371/journal.pone.0094978	http://dx.doi.org/10.1371/journal.pone.0094978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743259	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100056
J	Lee, HJ; Cho, JI; Lee, HSH; Kim, CI; Cho, E				Lee, Hae-Jeung; Cho, Jang-ik; Lee, Hye-Seung H.; Kim, Cho-il; Cho, Eunyoung			Intakes of Dairy Products and Calcium and Obesity in Korean Adults: Korean National Health and Nutrition Examination Surveys (KNHANES) 2007-2009	PLOS ONE			English	Article							BODY-MASS INDEX; DIETARY CALCIUM; FAT OXIDATION; YOUNG-ADULTS; WEIGHT; CONSUMPTION; OVERWEIGHT; ADIPOSITY; WOMEN; FOODS	Background: The possible effects of dairy product intake against obesity have been suggested in animal studies; however, the association is still not well established in epidemiological studies. Few studies in Asian countries with relatively low intake of dairy products exist. Objective: We investigated the association between dairy products and calcium intake and obesity in Korean population with relatively low intake of dairy products. Subjects and Methods: Our study population consisted of adults (n = 7173) aged 19-64 among participants of the 2007, 2008 and 2009 Korean National Health and Nutrition Examination Survey who had not made any attempt of intentional weight loss. Dietary intake data from food frequency questionnaire (FFQ) and 24-hour recall were used. Dairy products included milk and yogurt in the FFQ. Obesity was defined as BMI >= 25 kg/m(2). Results: Higher frequency of dairy product intake was associated with a reduced prevalence of obesity (OR = 0.63; 95% CI = 0.45-0.89 for >= 2 times/day vs. <= 1 time/month; p for trend = 0.003) using the intake data from FFQ. Similarly, high frequency of milk or yogurt intake had an inverse association with obesity. The association between milk and yogurt intake and obesity was similar when the intake from 24-hour recall was examined. Higher calcium intake from dairy products as well as total dietary calcium intake was associated with a decreased prevalence of obesity (OR = 0.83; 95% CI = 0.71-0.98 for highest vs. lowest quintile of dairy calcium intake; p for trend = 0.02, OR = 0.78; 95% CI = 0.64-0.94 for highest vs. lowest quintile of total calcium intake; p for trend = 0.04). The associations appeared to be stronger in women than in men. Conclusion: These results suggest that high consumption of dairy products is associated with a lower prevalence of obesity and that calcium in dairy products may be one of the components contributing to the association. Further longitudinal studies are warranted to replicate our findings.	[Lee, Hae-Jeung] Eulji Univ, Dept Food & Nutr, Songnam, Gyeonggi Do, South Korea; [Cho, Jang-ik] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Lee, Hye-Seung H.; Cho, Eunyoung] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Lee, Hye-Seung H.; Cho, Eunyoung] Harvard Univ, Sch Med, Boston, MA USA; [Kim, Cho-il] Korea Hlth Ind Dev Inst, Dept Hlth Ind & Policy, Cheongwon Gun, Chungcheongbuk, South Korea; [Cho, Eunyoung] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, Providence, RI 02912 USA	Eulji University; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University	Cho, E (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	eunyoung.cho@channing.harvard.edu	Cho, Eunyoung/AAV-4469-2020; Kim, Cho-il/B-5961-2011	Cho, Eunyoung/0000-0001-6594-2582; Luong, Ngan/0000-0003-0500-007X				Alonso A, 2009, J HUM NUTR DIET, V22, P336, DOI 10.1111/j.1365-277X.2009.00967.x; [Anonymous], 2009, KOR NAT HLTH NUTR EX; Bortolotti M, 2008, AM J CLIN NUTR, V88, P877, DOI 10.1093/ajcn/88.4.877; Brooks BM, 2006, J AM COLL NUTR, V25, P523, DOI 10.1080/07315724.2006.10719568; DENKE MA, 1993, J NUTR, V123, P1047; Dougkas A, 2011, NUTR RES REV, V24, P72, DOI 10.1017/S095442241000034X; Faghih S, 2011, NUTR METAB CARDIOVAS, V21, P499, DOI 10.1016/j.numecd.2009.11.013; Heaney RP, 2002, J AM COLL NUTR, V21, p152S, DOI 10.1080/07315724.2002.10719213; Jacobsen R, 2005, INT J OBESITY, V29, P292, DOI 10.1038/sj.ijo.0802785; Jacqmain M, 2003, AM J CLIN NUTR, V77, P1448, DOI 10.1093/ajcn/77.6.1448; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Loos RJF, 2004, J NUTR, V134, P1772, DOI 10.1093/jn/134.7.1772; Louie JCY, 2011, OBES REV, V12, pE582, DOI 10.1111/j.1467-789X.2011.00881.x; Major GC, 2008, OBES REV, V9, P428, DOI 10.1111/j.1467-789X.2007.00465.x; Marques-Vidal P, 2006, INT J OBESITY, V30, P88, DOI 10.1038/sj.ijo.0803045; Ministry of Health and Welfare, 2005, KOR NAT HLTH NUTR EX; Ministry of Health and Welfare, 2008, KOR NAT HLTH NUTR EX; Mirmiran P, 2005, INT J OBESITY, V29, P115, DOI 10.1038/sj.ijo.0802838; Murakami K, 2006, NUTRITION, V22, P490, DOI 10.1016/j.nut.2005.12.003; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Rajpathak SN, 2006, AM J CLIN NUTR, V83, P559, DOI 10.1093/ajcn.83.3.559; Schrager S, 2005, J AM BOARD FAM PRACT, V18, P205, DOI 10.3122/jabfm.18.3.205; Shah NP, 2000, BRIT J NUTR, V84, pS3; St-Onge MP, 2003, INT J OBESITY, V27, P1565, DOI 10.1038/sj.ijo.0802467; Van Loan M, 2009, J AM COLL NUTR, V28, p120S, DOI 10.1080/07315724.2009.10719805; Vergnaud AC, 2008, AM J CLIN NUTR, V88, P1248, DOI 10.3945/ajcn.2007.25151; Wang YW, 2004, INT J OBESITY, V28, P941, DOI 10.1038/sj.ijo.0802641; WELBERG JWM, 1994, ANN NUTR METAB, V38, P185, DOI 10.1159/000177810; *WHO W PAC REG OFF, 2000, AS PAC PERSP RED OB; 이계오, 2007, 조사연구, V8, P67; Zemel MB, 2005, J AM COLL NUTR, V24, p537S, DOI 10.1080/07315724.2005.10719502; Zemel MB, 2004, AM J CLIN NUTR, V79, P907; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67; Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212	35	99	102	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99085	10.1371/journal.pone.0099085	http://dx.doi.org/10.1371/journal.pone.0099085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24747984	Green Published, Green Submitted, gold			2022-12-25	WOS:000340947700062
J	Zhang, ZX; Zhao, H; Tang, J; Li, Z; Li, Z; Chen, DM; Lin, WX				Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Li, Zhou; Chen, Dongmei; Lin, Wenxiong			A Proteomic Study on Molecular Mechanism of Poor Grain-Filling of Rice (Oryza sativa L.) Inferior Spikelets	PLOS ONE			English	Article							STARCH BIOSYNTHETIC-ENZYMES; JAPONICA/INDICA HYBRID RICE; 14-3-3 PROTEINS; POSTANTHESIS DEVELOPMENT; SUPERIOR SPIKELETS; PLANT-METABOLISM; DIFFERENTIAL EXPRESSION; SIGNAL-TRANSDUCTION; DIFFERENT POSITIONS; BARLEY GRAINS	Cultivars of rice (Oryza sativa L.), especially of the type with large spikelets, often fail to reach the yield potential as expected due to the poor grain-filling on the later flowering inferior spikelets (in contrast to the earlier-flowering superior spikelets). The present study showed that the size and grain weight of superior spikelets (SS) was greater than those of inferior spikelets (IS), and the carbohydrate supply should not be the major problem for the poor grain-filling because there was adequate amount of sucrose in IS at the initial grain-filling stage. High resolution two-dimensional gel electrophoresis (2-DE) in combination with Coomassie-brilliant blue (CBB) and Pro-Q Diamond phosphoprotein fluorescence stain revealed that 123 proteins in abundance and 43 phosphoproteins generated from phosphorylation were significantly different between SS and IS. These proteins and phosphoproteins were involved in different cellular and metabolic processes with a prominently functional skew toward metabolism and protein synthesis/destination. Expression analyses of the proteins and phosphoproteins associated with different functional categories/subcategories indicated that the starch synthesis, central carbon metabolism, N metabolism and cell growth/division were closely related to the poor grain-filling of IS. Functional and expression pattern studies also suggested that 14-3-3 proteins played important roles in IS poor grain-filling by regulating the activity of starch synthesis enzymes. The proteome and phosphoproteome obtained from this study provided a better understanding of the molecular mechanism of the IS poor grain-filling. They were also expected to be highly useful for improving the grain filling of rice.	[Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Lin, Wenxiong] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Li, Zhou; Chen, Dongmei; Lin, Wenxiong] Fujian Agr & Forestry Univ, Fujian Prov Key Lab Agroecol Proc & Safety Monito, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China.	wenxiong181@163.com		liu, chun ming/0000-0002-7271-362X; Hoi, Maggie Pui Man/0000-0003-2630-3707; Zhang, Zhao/0000-0002-7323-5500; Song, Yin/0000-0002-6037-777X	National Natural Science Foundation of China [31271670]; Provincial Natural Science Foundation of Fujian, China [2012J01075, 2013J01092]; Department of Education Science and Technology Project of Fujian, China [JK2011014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Fujian, China(Natural Science Foundation of Fujian Province); Department of Education Science and Technology Project of Fujian, China	This work was sponsored by the National Natural Science Foundation of China (No. 31271670), Provincial Natural Science Foundation of Fujian, China (No. 2012J01075, 2013J01092), and Department of Education Science and Technology Project of Fujian, China (No. JK2011014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Chitteti BR, 2007, PROTEOMICS, V7, P1473, DOI 10.1002/pmic.200600871; Chung HJ, 1999, TRENDS PLANT SCI, V4, P367, DOI 10.1016/S1360-1385(99)01462-4; COHEN P, 1985, EUR J BIOCHEM, V151, P439, DOI 10.1111/j.1432-1033.1985.tb09121.x; Colleoni C., 2003, Journal of Applied Glycoscience, V50, P207; Comparot S, 2003, J EXP BOT, V54, P595, DOI 10.1093/jxb/erg057; COOPER JA, 1984, J BIOL CHEM, V259, P7835; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; El-Sharkawy I, 2010, J EXP BOT, V61, P1761, DOI 10.1093/jxb/erq043; Fageria NK, 2007, J PLANT NUTR, V30, P843, DOI 10.1080/15226510701374831; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Ferl RJ, 1996, ANNU REV PLANT PHYS, V47, P49, DOI 10.1146/annurev.arplant.47.1.49; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; GARRELS JI, 1983, METHOD ENZYMOL, V100, P411; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Gururaj A, 2004, ONCOGENE, V23, P8118, DOI 10.1038/sj.onc.1207969; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Ishimaru T, 2003, FUNCT PLANT BIOL, V30, P1139, DOI 10.1071/FP03122; Kato T, 2007, PLANT PROD SCI, V10, P442, DOI 10.1626/pps.10.442; Kikuchi H, 1999, PLANT MOL BIOL, V39, P149, DOI 10.1023/A:1006156214716; Kim YM, 2012, MOL CELLS, V33, P617, DOI 10.1007/s10059-012-0080-8; Lin XM, 2008, J PROTEOME RES, V7, P1235, DOI 10.1021/pr7005928; LUR HS, 1993, PLANT PHYSIOL, V103, P273, DOI 10.1104/pp.103.1.273; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mayer U, 2002, CURR OPIN PLANT BIOL, V5, P494, DOI 10.1016/S1369-5266(02)00302-3; Mechin V, 2007, PLANT PHYSIOL, V143, P1203, DOI 10.1104/pp.106.092148; Membre N, 1997, PLANT MOL BIOL, V35, P459, DOI 10.1023/A:1005833028582; Meyer LJ, 2012, PLANT PHYSIOL, V159, P517, DOI 10.1104/pp.111.191700; Mohapatra PK, 2009, PLANT SCI, V176, P256, DOI 10.1016/j.plantsci.2008.11.001; MOHAPATRA PK, 1993, AUST J PLANT PHYSIOL, V20, P231, DOI 10.1071/PP9930231; MURTY PSS, 1982, INDIAN J PLANT PHYSI, V25, P40; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Ramasamy S, 1997, FIELD CROP RES, V51, P65, DOI 10.1016/S0378-4290(96)01039-8; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rolletschek H, 2004, J EXP BOT, V55, P1351, DOI 10.1093/jxb/erh130; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Sehnke PC, 1996, CURR BIOL, V6, P1403, DOI 10.1016/S0960-9822(96)00742-7; Sehnke PC, 2001, P NATL ACAD SCI USA, V98, P765, DOI 10.1073/pnas.021304198; Song JianMin, 2009, Acta Agronomica Sinica, V35, P1445, DOI 10.3724/SP.J.1006.2009.01445; Tadege M, 1999, TRENDS PLANT SCI, V4, P320, DOI 10.1016/S1360-1385(99)01450-8; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Tao LongXing, 2003, Chinese Journal of Rice Science, V17, P149; Teng B, 2012, MOL BREEDING, V30, P583, DOI 10.1007/s11032-011-9647-x; Teo CJ, 2011, ACTA PHYSIOL PLANT, V33, P2259, DOI 10.1007/s11738-011-0765-1; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Thitisaksakul M, 2012, J CEREAL SCI, V56, P67, DOI 10.1016/j.jcs.2012.04.002; van Dongen JT, 2004, PLANT PHYSIOL, V135, P1809, DOI 10.1104/pp.104.040980; Vassileva V. N., 2005, PLANT BIOTECHNOL, V22, P171; Wojtaszek P, 1997, J EXP BOT, V48, P2015, DOI 10.1093/jexbot/48.317.2015; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2003, PLANT GROWTH REGUL, V41, P185, DOI 10.1023/B:GROW.0000007503.95391.38; Yang JC, 2002, CROP SCI, V42, P766, DOI 10.2135/cropsci2002.0766; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; YOSHIDA S, 1972, ANN REV PLANT PHYSIO, V23, P437, DOI 10.1146/annurev.pp.23.060172.002253; Yoshida S, 1976, ANNU REV PLANT PHYS, P46; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang ZhiXing, 2012, Australian Journal of Crop Science, V6, P316; Zhang ZX, 2012, PLANT SCI, V185, P259, DOI 10.1016/j.plantsci.2011.11.012; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Zhu QS, 1988, ACTA AGRON SIN, V3, P182; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x	70	98	104	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89140	10.1371/journal.pone.0089140	http://dx.doi.org/10.1371/journal.pone.0089140			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586550	Green Submitted, Green Published, gold			2022-12-25	WOS:000331717900056
